Citrus Sinensis ID: 001434
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1078 | 2.2.26 [Sep-21-2011] | |||||||
| O49318 | 1124 | Probable leucine-rich rep | yes | no | 0.956 | 0.917 | 0.656 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.943 | 0.922 | 0.628 | 0.0 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.936 | 0.917 | 0.521 | 0.0 | |
| P93194 | 1109 | Receptor-like protein kin | N/A | no | 0.932 | 0.906 | 0.371 | 0.0 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.900 | 0.855 | 0.386 | 1e-180 | |
| C0LGR3 | 1091 | Probable LRR receptor-lik | no | no | 0.887 | 0.877 | 0.374 | 1e-178 | |
| C0LGQ5 | 1249 | LRR receptor-like serine/ | no | no | 0.862 | 0.744 | 0.386 | 1e-177 | |
| Q9FZ59 | 1088 | Leucine-rich repeat recep | no | no | 0.928 | 0.920 | 0.371 | 1e-175 | |
| Q9M2Z1 | 1002 | Leucine-rich repeat recep | no | no | 0.811 | 0.873 | 0.401 | 1e-175 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.822 | 0.777 | 0.385 | 1e-174 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 1384 bits (3582), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 726/1106 (65%), Positives = 843/1106 (76%), Gaps = 75/1106 (6%)
Query: 40 IVGFWLVVMLLVCTTEGLNSEGHYLLELKNS-LHDEFNFLKSWKSTDQTPCSWIGVNCTS 98
VG ++ LLV T+E LNS+G +LLELKN D N L +W D+TPC+WIGVNC+S
Sbjct: 16 FVGVLFLLTLLVWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSS 75
Query: 99 DFEP------VVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRL 152
VV SLDL++MN +G +SPSIGGLV+L YL+LAYN LTG IPREIGNCS+L
Sbjct: 76 QGSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKL 135
Query: 153 EHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTG 212
E ++LNNNQF G IP E+ KLS L S NICNN +SG LPE +G+L +L + VAYTNNLTG
Sbjct: 136 EVMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTG 195
Query: 213 PLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESL 272
PLP+S+GNL L FRAGQN SG+IP EI C +L++LGLAQN I G LPKEIGML L
Sbjct: 196 PLPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKL 255
Query: 273 TEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNG 332
E++LW N+ +GFIP ++GN T L+TLALY N+LVG IP E+GN+K L KLYLY+N+LNG
Sbjct: 256 QEVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNG 315
Query: 333 TIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNL 392
TIP+E+G LS V EID SEN L+GEIP E SKI+ LRLL+LFQN+LTG+IPNELS LRNL
Sbjct: 316 TIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNL 375
Query: 393 TKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTG 452
KLDLSIN LTGPIP GFQ+LT MRQLQLF NSL+G IP GLGLYS LWVVDFS N L+G
Sbjct: 376 AKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSG 435
Query: 453 RIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENL 512
+IPP +CQ SNLI+LNLG N++FGNIP VL C++LLQLR+VGN LTG FP ELCKL NL
Sbjct: 436 KIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNL 495
Query: 513 YAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTG 572
AIELDQN+FSGP+PPEI CQKLQRLH+A N F+S LP E+ LS LVTFN+SSN LTG
Sbjct: 496 SAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTG 555
Query: 573 LIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHL 632
IP EI NC LQRLD+S NSF+GSLP ELG+L QLEIL+LSEN+FSGNIP T+GNL+HL
Sbjct: 556 PIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHL 615
Query: 633 TELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLS 692
TELQMGGNLFSG IPP+LG LSSLQIA+NLSYN+ SG IPPE+G L LL +L LNNNHLS
Sbjct: 616 TELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLS 675
Query: 693 GEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPS 752
GEIP+ FENLSSLLG NFSYNNLTG LP FQNM ++SFLGN+GLCG + +C PS
Sbjct: 676 GEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSC--DPS 733
Query: 753 SGSVPPLNNV------------------------------------------YFPPKEGF 770
S P ++++ Y KE F
Sbjct: 734 HSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHFLRNPVEPTAPYVHDKEPF 793
Query: 771 --------------SFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKL---- 812
+ +D++EAT FHDS+IVG GA GTVYKAVM SGK +AVKKL
Sbjct: 794 FQESDIYFVPKERFTVKDILEATKGFHDSYIVGRGACGTVYKAVMPSGKTIAVKKLESNR 853
Query: 813 -ASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG--SNLLIYEYMERGSLGELL 869
+N NN ++SFRAEILTLGKIRHRNIV+LY FCYHQG SNLL+YEYM RGSLGELL
Sbjct: 854 EGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSFCYHQGSNSNLLLYEYMSRGSLGELL 913
Query: 870 H-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928
H G S +++WPTRF IALGAAEGLAYLHHDCKPRI HRDIKSNNIL+D+ FEAHVGDFGL
Sbjct: 914 HGGKSHSMDWPTRFAIALGAAEGLAYLHHDCKPRIIHRDIKSNNILIDENFEAHVGDFGL 973
Query: 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD 988
AKVIDMP SKS+SAVAGSYGYIAPEYAYTMKVTEKCDIYS+GVVLLELLTG+ PVQPL+
Sbjct: 974 AKVIDMPLSKSVSAVAGSYGYIAPEYAYTMKVTEKCDIYSFGVVLLELLTGKAPVQPLEQ 1033
Query: 989 GGDLATWVRNYIRDHSLTPGIFDTRL-NVEDESIVDHMILVLKVALMCTSISPFDRPSMR 1047
GGDLATW RN+IRDHSLT I D L VED+ I++HMI V K+A++CT SP DRP+MR
Sbjct: 1034 GGDLATWTRNHIRDHSLTSEILDPYLTKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMR 1093
Query: 1048 EVVSMLIESNEREGRFNSSPT-YDLP 1072
EVV MLIES ER G+ S T DLP
Sbjct: 1094 EVVLMLIESGERAGKVIVSTTCSDLP 1119
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 1303 bits (3371), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 678/1078 (62%), Positives = 804/1078 (74%), Gaps = 61/1078 (5%)
Query: 54 TEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTS-DFEPVVWSLDLNAM 112
T GLN EG YLLE+K+ D L++W S D PC W GV C++ +P V SL+L++M
Sbjct: 24 TTGLNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWTGVMCSNYSSDPEVLSLNLSSM 83
Query: 113 NFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGK 172
+G LSPSIGGLVHL LDL+YN L+G IP+EIGNCS LE L LNNNQF G+IP E+GK
Sbjct: 84 VLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSSLEILKLNNNQFDGEIPVEIGK 143
Query: 173 LSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQN 232
L SL +L I NN ISG+LP +GNL SL V Y+NN++G LP+SIGNL+ L FRAGQN
Sbjct: 144 LVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNISGQLPRSIGNLKRLTSFRAGQN 203
Query: 233 AISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGN 292
ISGS+P+EI GC+SL +LGLAQN + G LPKEIGML+ L++++LW+N+ +GFIP E+ N
Sbjct: 204 MISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKKLSQVILWENEFSGFIPREISN 263
Query: 293 CTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSEN 352
CT L+TLALY N LVG IPKE+G+L+ L LYLYRN LNGTIPREIGNLS EID SEN
Sbjct: 264 CTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSEN 323
Query: 353 SLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQH 412
+L GEIP E I GL LL+LF+NQLTG IP ELS+L+NL+KLDLSIN LTGPIP+GFQ+
Sbjct: 324 ALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQY 383
Query: 413 LTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYN 472
L + LQLF+NSL+G IPP LG YS LWV+D S N+L+GRIP +LC +SN+I+LNLG N
Sbjct: 384 LRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTN 443
Query: 473 KLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIEN 532
L GNIPT + C+TL+QLRL N+L G FP LCK N+ AIEL QN+F G IP E+ N
Sbjct: 444 NLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGN 503
Query: 533 CQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHN 592
C LQRL +A+N FT ELP+E+G LSQL T NISSN LTG +P EI NC LQRLD+ N
Sbjct: 504 CSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCN 563
Query: 593 SFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD 652
+F G+LP+E+G+L QLE+LKLS N SG IP LGNLS LTELQMGGNLF+G IP ELG
Sbjct: 564 NFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGS 623
Query: 653 LSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSY 712
L+ LQIALNLSYN L+G IPPEL L +LEFLLLNNN+LSGEIPS+F NLSSLLG NFSY
Sbjct: 624 LTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSY 683
Query: 713 NNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNC------GASPSSGS----------- 755
N+LTGP IP +N+ +SSF+GNEGLCG P+ C S S+G
Sbjct: 684 NSLTGP---IPLLRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKIIA 740
Query: 756 ---------------------VPPLNNVYFPPKEG----------------FSFQDVVEA 778
P+ V ++G F+FQD+V A
Sbjct: 741 ITAAVIGGVSLMLIALIVYLMRRPVRTVASSAQDGQPSEMSLDIYFPPKEGFTFQDLVAA 800
Query: 779 TYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREG---NNIESSFRAEILTLGKI 835
T NF +SF+VG GA GTVYKAV+ +G +AVKKLASN EG NN+++SFRAEILTLG I
Sbjct: 801 TDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEILTLGNI 860
Query: 836 RHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYL 895
RHRNIVKL+GFC HQGSNLL+YEYM +GSLGE+LH SCNL+W RF IALGAA+GLAYL
Sbjct: 861 RHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHDPSCNLDWSKRFKIALGAAQGLAYL 920
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP SKSMSA+AGSYGYIAPEYA
Sbjct: 921 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPHSKSMSAIAGSYGYIAPEYA 980
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015
YTMKVTEK DIYSYGVVLLELLTG+ PVQP+D GGD+ WVR+YIR +L+ G+ D RL
Sbjct: 981 YTMKVTEKSDIYSYGVVLLELLTGKAPVQPIDQGGDVVNWVRSYIRRDALSSGVLDARLT 1040
Query: 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSSPTYDLPQ 1073
+EDE IV HM+ VLK+AL+CTS+SP RPSMR+VV MLIES EG T +L Q
Sbjct: 1041 LEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERSEGEQEHLDTEELTQ 1098
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 1040 bits (2689), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 558/1071 (52%), Positives = 713/1071 (66%), Gaps = 61/1071 (5%)
Query: 45 LVVMLLVCT-----TEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSD 99
+ ++++C+ LN EG LLE K L+D +L SW D PC+W G+ CT
Sbjct: 7 FLAIVILCSFSFILVRSLNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTH- 65
Query: 100 FEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNN 159
V S+DLN MN +G+LSP I L L L+++ N ++G IP+++ C LE L L
Sbjct: 66 -LRTVTSVDLNGMNLSGTLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCT 124
Query: 160 NQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIG 219
N+F G IP +L + +L L +C N + G++P +GNLSSL + V Y+NNLTG +P S+
Sbjct: 125 NRFHGVIPIQLTMIITLKKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMA 184
Query: 220 NLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWD 279
LR LR+ RAG+N SG IP+EISGC+SL++LGLA+N + GSLPK++ L++LT+++LW
Sbjct: 185 KLRQLRIIRAGRNGFSGVIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQ 244
Query: 280 NQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIG 339
N+L+G IP +GN ++L+ LAL+ N G IP+E+G L + +LYLY N+L G IPREIG
Sbjct: 245 NRLSGEIPPSVGNISRLEVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIG 304
Query: 340 NLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSI 399
NL EID SEN L G IP EF I L+LL LF+N L G IP EL L L KLDLSI
Sbjct: 305 NLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSI 364
Query: 400 NYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLC 459
N L G IP Q L + LQLF+N L G IPP +G YS V+D S N L+G IP H C
Sbjct: 365 NRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFC 424
Query: 460 QNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ 519
+ LI+L+LG NKL GNIP D+ C++L +L L N LTGS P+EL L+NL A+EL Q
Sbjct: 425 RFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQ 484
Query: 520 NKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIV 579
N SG I ++ + L+RL +ANN FT E+P E+GNL+++V FNISSN LTG IP E+
Sbjct: 485 NWLSGNISADLGKLKNLERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELG 544
Query: 580 NCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGG 639
+C+T+QRLD+S N F G + ELG L LEIL+LS+N+ +G IP + G+L+ L ELQ+GG
Sbjct: 545 SCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGG 604
Query: 640 NLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAF 699
NL S IP ELG L+SLQI+LN+S+NNLSG+IP LG L +LE L LN+N LSGEIP++
Sbjct: 605 NLLSENIPVELGKLTSLQISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASI 664
Query: 700 ENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGA-SPSSGS--- 755
NL SLL N S NNL G +P FQ MD S+F GN GLC +C P S S
Sbjct: 665 GNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNFAGNHGLCNSQRSHCQPLVPHSDSKLN 724
Query: 756 ---------------VPPLNNVY-----------------FPPKEGFSFQDVVEATY--- 780
+ +V+ F E + DV+++ Y
Sbjct: 725 WLINGSQRQKILTITCIVIGSVFLITFLGLCWTIKRREPAFVALEDQTKPDVMDSYYFPK 784
Query: 781 -------------NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRA 827
NF + ++G GA GTVYKA M G+++AVKKL S EG + ++SFRA
Sbjct: 785 KGFTYQGLVDATRNFSEDVVLGRGACGTVYKAEMSGGEVIAVKKLNSRGEGASSDNSFRA 844
Query: 828 EILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG--SSCNLEWPTRFMIA 885
EI TLGKIRHRNIVKLYGFCYHQ SNLL+YEYM +GSLGE L +C L+W R+ IA
Sbjct: 845 EISTLGKIRHRNIVKLYGFCYHQNSNLLLYEYMSKGSLGEQLQRGEKNCLLDWNARYRIA 904
Query: 886 LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG 945
LGAAEGL YLHHDC+P+I HRDIKSNNILLD++F+AHVGDFGLAK+ID+ SKSMSAVAG
Sbjct: 905 LGAAEGLCYLHHDCRPQIVHRDIKSNNILLDERFQAHVGDFGLAKLIDLSYSKSMSAVAG 964
Query: 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL 1005
SYGYIAPEYAYTMKVTEKCDIYS+GVVLLEL+TG+ PVQPL+ GGDL WVR IR+
Sbjct: 965 SYGYIAPEYAYTMKVTEKCDIYSFGVVLLELITGKPPVQPLEQGGDLVNWVRRSIRNMIP 1024
Query: 1006 TPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056
T +FD RL+ D+ V M LVLK+AL CTS SP RP+MREVV+M+ E+
Sbjct: 1025 TIEMFDARLDTNDKRTVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEA 1075
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P93194|RPK1_IPONI Receptor-like protein kinase OS=Ipomoea nil GN=INRPK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 636 bits (1640), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 407/1097 (37%), Positives = 595/1097 (54%), Gaps = 92/1097 (8%)
Query: 48 MLLVCTTE------GLNSEGHYLLEL-KNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDF 100
+L +C+T LNS+G LL L ++ + +SW ++D TPCSW+GV C D
Sbjct: 9 LLFLCSTSSIYAAFALNSDGAALLSLTRHWTSIPSDITQSWNASDSTPCSWLGVEC--DR 66
Query: 101 EPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNN 160
V +L+L++ +G P I L HL + L+ N G IP ++GNCS LEH+ L++N
Sbjct: 67 RQFVDTLNLSSYGISGEFGPEISHLKHLKKVVLSGNGFFGSIPSQLGNCSLLEHIDLSSN 126
Query: 161 QFSGKIPAELGKLSSLVSLNI------------------------CNNMISGALPEGLGN 196
F+G IP LG L +L +L++ N ++G++P +GN
Sbjct: 127 SFTGNIPDTLGALQNLRNLSLFFNSLIGPFPESLLSIPHLETVYFTGNGLNGSIPSNIGN 186
Query: 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQN 256
+S L N +GP+P S+GN+ L+ N + G++P ++ ++L L + N
Sbjct: 187 MSELTTLWLDDNQFSGPVPSSLGNITTLQELYLNDNNLVGTLPVTLNNLENLVYLDVRNN 246
Query: 257 DIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGN 316
+ G++P + + + I L +NQ TG +P LGNCT L+ +S L G IP G
Sbjct: 247 SLVGAIPLDFVSCKQIDTISLSNNQFTGGLPPGLGNCTSLREFGAFSCALSGPIPSCFGQ 306
Query: 317 LKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQN 376
L L LYL N +G IP E+G + ++ L +N L GEIP E ++ L+ L L+ N
Sbjct: 307 LTKLDTLYLAGNHFSGRIPPELGKCKSMIDLQLQQNQLEGEIPGELGMLSQLQYLHLYTN 366
Query: 377 QLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGL 436
L+G +P + +++L L L N L+G +PV L Q+ L L+EN TG IP LG
Sbjct: 367 NLSGEVPLSIWKIQSLQSLQLYQNNLSGELPVDMTELKQLVSLALYENHFTGVIPQDLGA 426
Query: 437 YSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGN 496
S L V+D + N TG IPP+LC L L LGYN L G++P+D+ C TL +L L N
Sbjct: 427 NSSLEVLDLTRNMFTGHIPPNLCSQKKLKRLLLGYNYLEGSVPSDLGGCSTLERLILEEN 486
Query: 497 SLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGN 556
+L G P + + +NL +L N F+GPIPP + N + + +++++N + +P E+G+
Sbjct: 487 NLRGGLP-DFVEKQNLLFFDLSGNNFTGPIPPSLGNLKNVTAIYLSSNQLSGSIPPELGS 545
Query: 557 LSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSEN 616
L +L N+S N+L G++P E+ NC L LD SHN GS+P+ LG+L +L L L EN
Sbjct: 546 LVKLEHLNLSHNILKGILPSELSNCHKLSELDASHNLLNGSIPSTLGSLTELTKLSLGEN 605
Query: 617 KFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELG 676
FSG IP++L + L LQ+GGNL +G+IPP +G L +L+ +LNLS N L+G +P +LG
Sbjct: 606 SFSGGIPTSLFQSNKLLNLQLGGNLLAGDIPP-VGALQALR-SLNLSSNKLNGQLPIDLG 663
Query: 677 KLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPL-PSIPQFQNMDISSFLG 735
KL +LE L +++N+LSG + + SL N S+N +GP+ PS+ +F N +SF G
Sbjct: 664 KLKMLEELDVSHNNLSGTL-RVLSTIQSLTFINISHNLFSGPVPPSLTKFLNSSPTSFSG 722
Query: 736 NEGLCGRPVGNCGASPSSGSVPPLNNVYFPPKEGFS------------------------ 771
N LC + A P S + P N K G S
Sbjct: 723 NSDLCINCPADGLACPESSILRPCNMQSNTGKGGLSTLGIAMIVLGALLFIICLFLFSAF 782
Query: 772 -----------------------FQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVA 808
V+EAT N +D +++G GA+GT+YKA + K+ A
Sbjct: 783 LFLHCKKSVQEIAISAQEGDGSLLNKVLEATENLNDKYVIGKGAHGTIYKATLSPDKVYA 842
Query: 809 VKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGEL 868
VKKL N S R EI T+GK+RHRN++KL F + L++Y YME GSL ++
Sbjct: 843 VKKLVFTGIKNGSVSMVR-EIETIGKVRHRNLIKLEEFWLRKEYGLILYTYMENGSLHDI 901
Query: 869 LHGSS--CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 926
LH ++ L+W TR IA+G A GLAYLH DC P I HRDIK NILLD E H+ DF
Sbjct: 902 LHETNPPKPLDWSTRHNIAVGTAHGLAYLHFDCDPAIVHRDIKPMNILLDSDLEPHISDF 961
Query: 927 GLAKVIDMPQSKSMS-AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQP 985
G+AK++D + S V G+ GY+APE A+T + + D+YSYGVVLLEL+T + + P
Sbjct: 962 GIAKLLDQSATSIPSNTVQGTIGYMAPENAFTTVKSRESDVYSYGVVLLELITRKKALDP 1021
Query: 986 LDDG-GDLATWVRNYIRDHSLTPGIFDTRLNVE--DESIVDHMILVLKVALMCTSISPFD 1042
+G D+ WVR+ I D L E D S+++ + L +AL C
Sbjct: 1022 SFNGETDIVGWVRSVWTQTGEIQKIVDPSLLDELIDSSVMEQVTEALSLALRCAEKEVDK 1081
Query: 1043 RPSMREVVSMLIESNER 1059
RP+MR+VV L + R
Sbjct: 1082 RPTMRDVVKQLTRWSIR 1098
|
Possible role in short-day photoperiod floral induction. Ipomoea nil (taxid: 35883) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 633 bits (1632), Expect = e-180, Method: Compositional matrix adjust.
Identities = 394/1020 (38%), Positives = 572/1020 (56%), Gaps = 49/1020 (4%)
Query: 81 WKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTG 140
W +D PC W + C+S +V +++ ++ P+I L L ++ LTG
Sbjct: 61 WNPSDSDPCQWPYITCSSSDNKLVTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTG 120
Query: 141 YIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSL 200
I EIG+CS L + L++N G+IP+ LGKL +L L + +N ++G +P LG+ SL
Sbjct: 121 AISSEIGDCSELIVIDLSSNSLVGEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSL 180
Query: 201 VDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNA-ISGSIPAEISGCQSLQILGLAQNDIG 259
+ + N L+ LP +G + L RAG N+ +SG IP EI C++L++LGLA I
Sbjct: 181 KNLEIFDNYLSENLPLELGKISTLESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKIS 240
Query: 260 GSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKF 319
GSLP +G L L + ++ L+G IP ELGNC++L L LY N+L G +PKE+G L+
Sbjct: 241 GSLPVSLGQLSKLQSLSVYSTMLSGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQN 300
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
L K+ L++N L+G IP EIG + + IDLS N +G IP F ++ L+ L L N +T
Sbjct: 301 LEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNIT 360
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL 439
G IP+ LS+ L + + N ++G IP L ++ ++N L G IP L
Sbjct: 361 GSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQN 420
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
L +D S NYLTG +P L Q NL L L N + G IP ++ NC +L++LRLV N +T
Sbjct: 421 LQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRIT 480
Query: 500 GSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQ 559
G P + L+NL ++L +N SGP+P EI NC++LQ L+++NN LP + +L++
Sbjct: 481 GEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTK 540
Query: 560 LVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
L ++SSN LTG IP + + ++L RL +S NSF G +P+ LG L++L LS N S
Sbjct: 541 LQVLDVSSNDLTGKIPDSLGHLISLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNIS 600
Query: 620 GNIPSTLGNLSHL-TELQMGGNLFSGEIPPEL-----------------GDLSSLQ---- 657
G IP L ++ L L + N G IP + GDLS+L
Sbjct: 601 GTIPEELFDIQDLDIALNLSWNSLDGFIPERISALNRLSVLDISHNMLSGDLSALSGLEN 660
Query: 658 -IALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHL-SGEIPSAFENLSSLLGSNFSYNNL 715
++LN+S+N SG +P L+ + NN L S S F + SS L + ++
Sbjct: 661 LVSLNISHNRFSGYLPDSKVFRQLIGAEMEGNNGLCSKGFRSCFVSNSSQLTTQRGVHSH 720
Query: 716 TGPLPSIPQFQNMDISSFLGNEGLCG--RPVGNCGASPSSGSVPPLNNVYFPPKEGFSFQ 773
I + +++ L G+ R S + L F P + +F
Sbjct: 721 R---LRIAIGLLISVTAVLAVLGVLAVIRAKQMIRDDNDSETGENLWTWQFTPFQKLNFT 777
Query: 774 DVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKL--------ASNREGNNIESSF 825
V + ++G G G VYKA M + +++AVKKL + + + SF
Sbjct: 778 -VEHVLKCLVEGNVIGKGCSGIVYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSF 836
Query: 826 RAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSS--CNLEWPTRFM 883
AE+ TLG IRH+NIV+ G C+++ + LL+Y+YM GSLG LLH S C+L W R+
Sbjct: 837 SAEVKTLGSIRHKNIVRFLGCCWNKNTRLLMYDYMSNGSLGSLLHERSGVCSLGWEVRYK 896
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-SKSMSA 942
I LGAA+GLAYLHHDC P I HRDIK+NNIL+ FE ++GDFGLAK++D ++S +
Sbjct: 897 IILGAAQGLAYLHHDCVPPIVHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNT 956
Query: 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQP-LDDGGDLATWVRNYIR 1001
+AGSYGYIAPEY Y+MK+TEK D+YSYGVV+LE+LTG+ P+ P + DG + WV+ IR
Sbjct: 957 IAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWVKK-IR 1015
Query: 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE-SNERE 1060
D + D L ES V+ M+ L VAL+C + P DRP+M++V +ML E ERE
Sbjct: 1016 DIQ----VIDQGLQARPESEVEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEICQERE 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGR3|Y4265_ARATH Probable LRR receptor-like serine/threonine-protein kinase At4g26540 OS=Arabidopsis thaliana GN=At4g26540 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 627 bits (1616), Expect = e-178, Method: Compositional matrix adjust.
Identities = 396/1058 (37%), Positives = 574/1058 (54%), Gaps = 101/1058 (9%)
Query: 57 LNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTG 116
L+ +G LL K+ L+ + SW D +PC+W+GV C E V + L M+ G
Sbjct: 25 LDQQGQALLSWKSQLNISGDAFSSWHVADTSPCNWVGVKCNRRGE--VSEIQLKGMDLQG 82
Query: 117 SLS-PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSS 175
SL S+ L LT L L+ LTG IP+EIG+ + LE L L++N SG IP E+ +L
Sbjct: 83 SLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLKK 142
Query: 176 LVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNA-I 234
L +L++ N + G +P +GNLS LV+ + + N L+G +P+SIG L+NL+V RAG N +
Sbjct: 143 LKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKNL 202
Query: 235 SGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCT 294
G +P EI C++L +LGLA+ + G LP IG L+ + I ++ + L+G IP E+G CT
Sbjct: 203 RGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYCT 262
Query: 295 KLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSL 354
+LQ L LY N++ G IP +G LK L L L++N L G IP E+GN + ID SEN L
Sbjct: 263 ELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLL 322
Query: 355 NGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLT 414
G IP F K+ L+ L L NQ++G IP EL++ LT L++ N +TG IP +L
Sbjct: 323 TGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLR 382
Query: 415 QMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
+ ++N LTG IP L L +D S+N L+G IP + NL L L N L
Sbjct: 383 SLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSNDL 442
Query: 475 FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQ 534
G IP D+ NC L +LRL GN L GS P E+ L+NL +++ +N+ G IPP I C+
Sbjct: 443 SGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGCE 502
Query: 535 KLQRLHIANNYFT-----SELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDI 589
L+ L + N + + LPK L + S N L+ +PP I L +L++
Sbjct: 503 SLEFLDLHTNSLSGSLLGTTLPK------SLKFIDFSDNALSSTLPPGIGLLTELTKLNL 556
Query: 590 SHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT-ELQMGGNLFSGEIPP 648
+ N G +P E+ T + L++L L EN FSG IP LG + L L + N F GEIP
Sbjct: 557 AKNRLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPS 616
Query: 649 ELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGS 708
DL +L + L++S+N L+G++ + +L +L+
Sbjct: 617 RFSDLKNLGV-LDVSHNQLTGNL-------------------------NVLTDLQNLVSL 650
Query: 709 NFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPSS--GSVPPLN------ 760
N SYN+ +G LP+ P F+ + +S N GL + P++ SV L
Sbjct: 651 NISYNDFSGDLPNTPFFRRLPLSDLASNRGLYISNAISTRPDPTTRNSSVVRLTILILVV 710
Query: 761 -------------------------------NVYFPPKEGFSFQDVVEATYNFHDSFIVG 789
V K FS D+V+ N + ++G
Sbjct: 711 VTAVLVLMAVYTLVRARAAGKQLLGEEIDSWEVTLYQKLDFSIDDIVK---NLTSANVIG 767
Query: 790 SGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH 849
+G+ G VY+ + SG+ +AVKK+ S E +F +EI TLG IRHRNIV+L G+C +
Sbjct: 768 TGSSGVVYRITIPSGESLAVKKMWSKEE----SGAFNSEIKTLGSIRHRNIVRLLGWCSN 823
Query: 850 QGSNLLIYEYMERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ LL Y+Y+ GSL LHG+ C ++W R+ + LG A LAYLHHDC P I H
Sbjct: 824 RNLKLLFYDYLPNGSLSSRLHGAGKGGC-VDWEARYDVVLGVAHALAYLHHDCLPTIIHG 882
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKV--------IDMPQSKSMSAVAGSYGYIAPEYAYTM 958
D+K+ N+LL FE ++ DFGLA+ ID+ + + +AGSYGY+APE+A
Sbjct: 883 DVKAMNVLLGPHFEPYLADFGLARTISGYPNTGIDLAKPTNRPPMAGSYGYMAPEHASMQ 942
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQP-LDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017
++TEK D+YSYGVVLLE+LTG+ P+ P L G L WVR+++ + + D RL+
Sbjct: 943 RITEKSDVYSYGVVLLEVLTGKHPLDPDLPGGAHLVKWVRDHLAEKKDPSRLLDPRLDGR 1002
Query: 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055
+SI+ M+ L VA +C S +RP M++VV+ML E
Sbjct: 1003 TDSIMHEMLQTLAVAFLCVSNKANERPLMKDVVAMLTE 1040
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGQ5|GSO1_ARATH LRR receptor-like serine/threonine-protein kinase GSO1 OS=Arabidopsis thaliana GN=GSO1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 622 bits (1605), Expect = e-177, Method: Compositional matrix adjust.
Identities = 395/1021 (38%), Positives = 555/1021 (54%), Gaps = 91/1021 (8%)
Query: 114 FTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKL 173
G++ +G L +L L+LA N LTG IP ++G S+L++L L NQ G IP L L
Sbjct: 227 LNGTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQYLSLMANQLQGLIPKSLADL 286
Query: 174 SSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSI-GNLRNLRVFRAGQN 232
+L +L++ N ++G +PE N+S L+D V N+L+G LP+SI N NL
Sbjct: 287 GNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSLPKSICSNNTNLEQLVLSGT 346
Query: 233 AISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGN 292
+SG IP E+S CQSL+ L L+ N + GS+P+ + L LT++ L +N L G + + N
Sbjct: 347 QLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELTDLYLHNNTLEGTLSPSISN 406
Query: 293 CTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSEN 352
T LQ L LY NNL G++PKE+ L+ L L+LY N +G IP+EIGN + + ID+ N
Sbjct: 407 LTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGEIPQEIGNCTSLKMIDMFGN 466
Query: 353 SLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQH 412
GEIP ++ L LL L QN+L G +P L + L LDL+ N L+G IP F
Sbjct: 467 HFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLNILDLADNQLSGSIPSSFGF 526
Query: 413 LTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYN 472
L + QL L+ NSL G +P L L ++ SHN L G I P LC +S+ + ++ N
Sbjct: 527 LKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGTIHP-LCGSSSYLSFDVTNN 585
Query: 473 KLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIEN 532
IP ++ N + L +LRL N LTG P L K+ L +++ N +G IP ++
Sbjct: 586 GFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELSLLDMSSNALTGTIPLQLVL 645
Query: 533 CQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHN 592
C+KL + + NN+ + +P +G LSQL +SSN +P E+ NC L L + N
Sbjct: 646 CKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVESLPTELFNCTKLLVLSLDGN 705
Query: 593 SFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD 652
S GS+P E+G L L +L L +N+FSG++P +G LS L EL++ N +GEIP E+G
Sbjct: 706 SLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLYELRLSRNSLTGEIPVEIGQ 765
Query: 653 LSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSY 712
L LQ AL+LSYNN +G IP +G L LE L L++N L+GE+P + ++ SL N S+
Sbjct: 766 LQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTGEVPGSVGDMKSLGYLNVSF 825
Query: 713 NNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNC----------GASPSS----GSVPP 758
NNL G L QF SFLGN GLCG P+ C G S S ++
Sbjct: 826 NNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRCNRVRSNNKQQGLSARSVVIISAISA 883
Query: 759 LNNV---------YFPPKEGFSFQDVVEATYNFHDS-----------FIVGSGAYGTVYK 798
L + +F + F F+ V + + S F G+ ++
Sbjct: 884 LTAIGLMILVIALFFKQRHDF-FKKVGHGSTAYTSSSSSSQATHKPLFRNGASKSDIRWE 942
Query: 799 AVMD---------------SGKI----------VAVKK------LASNREGNNIESSFRA 827
+M+ SGK+ VAVKK L SN+ SF
Sbjct: 943 DIMEATHNLSEEFMIGSGGSGKVYKAELENGETVAVKKILWKDDLMSNK-------SFSR 995
Query: 828 EILTLGKIRHRNIVKLYGFC--YHQGSNLLIYEYMERGSLGELLHGSSCNLE-------W 878
E+ TLG+IRHR++VKL G+C +G NLLIYEYM+ GS+ + LH LE W
Sbjct: 996 EVKTLGRIRHRHLVKLMGYCSSKSEGLNLLIYEYMKNGSIWDWLHEDKPVLEKKKKLLDW 1055
Query: 879 PTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM---P 935
R IA+G A+G+ YLHHDC P I HRDIKS+N+LLD EAH+GDFGLAKV+
Sbjct: 1056 EARLRIAVGLAQGVEYLHHDCVPPIVHRDIKSSNVLLDSNMEAHLGDFGLAKVLTENCDT 1115
Query: 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG-DLAT 994
+ S + A SYGYIAPEYAY++K TEK D+YS G+VL+E++TG+ P + D+
Sbjct: 1116 NTDSNTWFACSYGYIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTDSVFGAEMDMVR 1175
Query: 995 WVRNYIR-DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
WV ++ S + D +L D VL++AL CT SP +RPS R+ L
Sbjct: 1176 WVETHLEVAGSARDKLIDPKLKPLLPFEEDAACQVLEIALQCTKTSPQERPSSRQACDSL 1235
Query: 1054 I 1054
+
Sbjct: 1236 L 1236
|
Together with GSO2, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FZ59|PEPR2_ARATH Leucine-rich repeat receptor-like protein kinase PEPR2 OS=Arabidopsis thaliana GN=PEPR2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1587), Expect = e-175, Method: Compositional matrix adjust.
Identities = 398/1071 (37%), Positives = 576/1071 (53%), Gaps = 70/1071 (6%)
Query: 45 LVVMLLVCTTEGLNSEGHYLLEL-KNSLHDEFNFLKSWK--STDQTPCS--WIGVNCTSD 99
L V + + LNS+G LL L K+ +WK +++ TPC+ W GV C
Sbjct: 15 LFVYFRIDSVSSLNSDGLALLSLLKHFDKVPLEVASTWKENTSETTPCNNNWFGVICDLS 74
Query: 100 FEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNN 159
VV +L+L+A +G L IG L L LDL+ N +G +P +GNC+ LE+L L+N
Sbjct: 75 GN-VVETLNLSASGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPSTLGNCTSLEYLDLSN 133
Query: 160 NQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIG 219
N FSG++P G L +L L + N +SG +P +G L LVD NNL+G +P+ +G
Sbjct: 134 NDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVDLRMSYNNLSGTIPELLG 193
Query: 220 NLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWD 279
N L N ++GS+PA + ++L L ++ N +GG L + L + L
Sbjct: 194 NCSKLEYLALNNNKLNGSLPASLYLLENLGELFVSNNSLGGRLHFGSSNCKKLVSLDLSF 253
Query: 280 NQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIG 339
N G +P E+GNC+ L +L + NL G IP +G L+ ++ + L N L+G IP+E+G
Sbjct: 254 NDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVIDLSDNRLSGNIPQELG 313
Query: 340 NLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSI 399
N S + + L++N L GEIP SK+ L+ L LF N+L+G IP + +++LT++ +
Sbjct: 314 NCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPIGIWKIQSLTQMLVYN 373
Query: 400 NYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLC 459
N LTG +PV L +++L LF N G IP LGL L VD N TG IPPHLC
Sbjct: 374 NTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVDLLGNRFTGEIPPHLC 433
Query: 460 QNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ 519
L + LG N+L G IP + C+TL ++RL N L+G P E + +L + L
Sbjct: 434 HGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGVLP-EFPESLSLSYVNLGS 492
Query: 520 NKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIV 579
N F G IP + +C+ L + ++ N T +P E+GNL L N+S N L G +P ++
Sbjct: 493 NSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLGLLNLSHNYLEGPLPSQLS 552
Query: 580 NCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGG 639
C L D+ NS GS+P+ + + L L LS+N F G IP L L L++L++
Sbjct: 553 GCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQFLAELDRLSDLRIAR 612
Query: 640 NLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAF 699
N F G+IP +G L SL+ L+LS N +G IP LG L LE L ++NN L+G + S
Sbjct: 613 NAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGALINLERLNISNNKLTGPL-SVL 671
Query: 700 ENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLC-----------GRPVGNC- 747
++L SL + SYN TGP+P + N S F GN LC + +C
Sbjct: 672 QSLKSLNQVDVSYNQFTGPIP-VNLLSNS--SKFSGNPDLCIQASYSVSAIIRKEFKSCK 728
Query: 748 ---------------GASPS----------------SGSVPPLNNVYFPPKEGFSFQDVV 776
G+S S G+ N+ V+
Sbjct: 729 GQVKLSTWKIALIAAGSSLSVLALLFALFLVLCRCKRGTKTEDANILAEEGLSLLLNKVL 788
Query: 777 EATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKL--ASNREGNNIESSFRAEILTLGK 834
AT N D +I+G GA+G VY+A + SG+ AVKKL A + N + + EI T+G
Sbjct: 789 AATDNLDDKYIIGRGAHGVVYRASLGSGEEYAVKKLIFAEHIRANQ---NMKREIETIGL 845
Query: 835 IRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSS---CNLEWPTRFMIALGAAEG 891
+RHRN+++L F + L++Y+YM GSL ++LH + L+W RF IALG + G
Sbjct: 846 VRHRNLIRLERFWMRKEDGLMLYQYMPNGSLHDVLHRGNQGEAVLDWSARFNIALGISHG 905
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
LAYLHHDC P I HRDIK NIL+D E H+GDFGLA+++D + S + V G+ GYIA
Sbjct: 906 LAYLHHDCHPPIIHRDIKPENILMDSDMEPHIGDFGLARILD-DSTVSTATVTGTTGYIA 964
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTPV-QPLDDGGDLATWVRNYI---RDHSLTP 1007
PE AY +++ D+YSYGVVLLEL+TG+ + + + ++ +WVR+ + D T
Sbjct: 965 PENAYKTVRSKESDVYSYGVVLLELVTGKRALDRSFPEDINIVSWVRSVLSSYEDEDDTA 1024
Query: 1008 G-IFDTRLNVE--DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055
G I D +L E D + + I V +AL CT P +RPSMR+VV L +
Sbjct: 1025 GPIVDPKLVDELLDTKLREQAIQVTDLALRCTDKRPENRPSMRDVVKDLTD 1075
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9M2Z1|BAME2_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase BAM2 OS=Arabidopsis thaliana GN=BAM2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 615 bits (1586), Expect = e-175, Method: Compositional matrix adjust.
Identities = 382/952 (40%), Positives = 515/952 (54%), Gaps = 77/952 (8%)
Query: 173 LSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQN 232
L + SL++ +SG L + +L L + N ++GP+P I NL LR N
Sbjct: 68 LRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYELRHLNLSNN 127
Query: 233 AISGSIPAEIS-GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELG 291
+GS P E+S G +L++L L N++ G LP + L L + L N +G IP+ G
Sbjct: 128 VFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFSGKIPATYG 187
Query: 292 NCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL-YRNELNGTIPREIGNLSMVTEIDLS 350
L+ LA+ N L G+IP E+GNL L +LY+ Y N +P EIGNLS + D +
Sbjct: 188 TWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLSELVRFDAA 247
Query: 351 ENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGF 410
L GEIP E K+ L LFL N TG I EL + +L +DLS N TG IP F
Sbjct: 248 NCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMFTGEIPTSF 307
Query: 411 QHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLG 470
L + L LF N L G IP +G L V+ N TG IP L +N L++L+L
Sbjct: 308 SQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENGRLVILDLS 367
Query: 471 YNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI 530
NKL G +P ++ + L+ L +GN L GS P L K E+L I + +N +G IP E+
Sbjct: 368 SNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFLNGSIPKEL 427
Query: 531 ENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDIS 590
KL ++ + +NY T ELP G +S L ++ +S
Sbjct: 428 FGLPKLSQVELQDNYLTGELPISGGGVSG-----------------------DLGQISLS 464
Query: 591 HNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPEL 650
+N GSLP +G L ++ L L NKFSG+IP +G L L++L NLFSG I PE+
Sbjct: 465 NNQLSGSLPAAIGNLSGVQKLLLDGNKFSGSIPPEIGRLQQLSKLDFSHNLFSGRIAPEI 524
Query: 651 GDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNF 710
L ++LS N LSG IP EL + +L +L L+ NHL G IP ++ SL +F
Sbjct: 525 SRCKLLTF-VDLSRNELSGDIPNELTGMKILNYLNLSRNHLVGSIPVTIASMQSLTSVDF 583
Query: 711 SYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPSSGSVPPLN---------- 760
SYNNL+G +PS QF + +SF+GN LCG +G CG V PL+
Sbjct: 584 SYNNLSGLVPSTGQFSYFNYTSFVGNSHLCGPYLGPCGKGTHQSHVKPLSATTKLLLVLG 643
Query: 761 ----NVYFP------------------------PKEGFSFQDVVEATYNFHDSFIVGSGA 792
++ F + F+ DV+++ + I+G G
Sbjct: 644 LLFCSMVFAIVAIIKARSLRNASEAKAWRLTAFQRLDFTCDDVLDS---LKEDNIIGKGG 700
Query: 793 YGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS 852
G VYK M G +VAVK+LA+ G++ + F AEI TLG+IRHR+IV+L GFC + +
Sbjct: 701 AGIVYKGTMPKGDLVAVKRLATMSHGSSHDHGFNAEIQTLGRIRHRHIVRLLGFCSNHET 760
Query: 853 NLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSN 911
NLL+YEYM GSLGE+LHG +L W TR+ IAL AA+GL YLHHDC P I HRD+KSN
Sbjct: 761 NLLVYEYMPNGSLGEVLHGKKGGHLHWNTRYKIALEAAKGLCYLHHDCSPLIVHRDVKSN 820
Query: 912 NILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYG 970
NILLD FEAHV DFGLAK + D S+ MSA+AGSYGYIAPEYAYT+KV EK D+YS+G
Sbjct: 821 NILLDSNFEAHVADFGLAKFLQDSGTSECMSAIAGSYGYIAPEYAYTLKVDEKSDVYSFG 880
Query: 971 VVLLELLTGRTPVQPLDDGGDLATWVRNYI-RDHSLTPGIFDTRLNVEDESIVDHMILVL 1029
VVLLEL+TG+ PV DG D+ WVR+ + + D RL+ V H V
Sbjct: 881 VVLLELITGKKPVGEFGDGVDIVQWVRSMTDSNKDCVLKVIDLRLSSVPVHEVTH---VF 937
Query: 1030 KVALMCTSISPFDRPSMREVVSMLIESNE----REGRFNSSPTYDLPQIHET 1077
VAL+C +RP+MREVV +L E + ++ S T P I+E+
Sbjct: 938 YVALLCVEEQAVERPTMREVVQILTEIPKIPLSKQQAAESDVTEKAPAINES 989
|
Necessary for male gametophyte development, as well as ovule specification and function. Involved in cell-cell communication process required during early anther development, and regulating cell division and differentiation to organize cell layers. Required for the development of high-ordered vascular strands within the leaf and a correlated control of leaf shape, size and symmetry. May regulate the CLV1-dependent CLV3-mediated signaling in meristems maintenance. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 614 bits (1583), Expect = e-174, Method: Compositional matrix adjust.
Identities = 379/983 (38%), Positives = 543/983 (55%), Gaps = 96/983 (9%)
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+P L SL L I ++G LPE LG+ L +N L G +P S+ LRNL
Sbjct: 97 LPKNLPAFRSLQKLTISGANLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLE 156
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDN-QLTG 284
N ++G IP +IS C L+ L L N + GS+P E+G L L I + N +++G
Sbjct: 157 TLILNSNQLTGKIPPDISKCSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISG 216
Query: 285 FIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMV 344
IPSE+G+C+ L L L ++ G +P +G LK L L +Y ++G IP ++GN S +
Sbjct: 217 QIPSEIGDCSNLTVLGLAETSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSEL 276
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
++ L ENSL+G IP E ++T L LFL+QN L G IP E+ + NL +DLS+N L+G
Sbjct: 277 VDLFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSG 336
Query: 405 PIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNL 464
IP L+ + + + +N +G IP + S L + N ++G IP L + L
Sbjct: 337 SIPSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKL 396
Query: 465 IMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSG 524
+ N+L G+IP + +C L L L NSLTG+ P L L NL + L N SG
Sbjct: 397 TLFFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSG 456
Query: 525 PIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTL 584
IP EI NC L RL + N T E+P +G+L ++ + SSN L G +P EI +C L
Sbjct: 457 FIPQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSEL 516
Query: 585 QRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG 644
Q +D+S+NS GSLPN + +L L++L +S N+FSG IP++LG L L +L + NLFSG
Sbjct: 517 QMIDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSG 576
Query: 645 ------------------------EIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDL 680
EIP ELGD+ +L+IALNLS N L+G IP ++ L+
Sbjct: 577 SIPTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNK 636
Query: 681 LEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLC 740
L L L++N L G++ + N+ +L+ N SYN+ +G LP F+ + GN+ LC
Sbjct: 637 LSILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLC 695
Query: 741 -------------GRPVGNCGASPSS--------------------GSVP---------- 757
G +G+ G + + G+V
Sbjct: 696 SSTQDSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVIRARRNIDN 755
Query: 758 ----PLNNVY---FPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVK 810
L Y F P + +F V + + ++G G G VY+A +D+G+++AVK
Sbjct: 756 ERDSELGETYKWQFTPFQKLNFS-VDQIIRCLVEPNVIGKGCSGVVYRADVDNGEVIAVK 814
Query: 811 KL-------ASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863
KL + + N+ SF AE+ TLG IRH+NIV+ G C+++ + LL+Y+YM G
Sbjct: 815 KLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLLMYDYMPNG 874
Query: 864 SLGELLH---GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE 920
SLG LLH GSS L+W R+ I LGAA+GLAYLHHDC P I HRDIK+NNIL+ FE
Sbjct: 875 SLGSLLHERRGSS--LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKANNILIGLDFE 932
Query: 921 AHVGDFGLAKVIDMPQ-SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG 979
++ DFGLAK++D + + VAGSYGYIAPEY Y+MK+TEK D+YSYGVV+LE+LTG
Sbjct: 933 PYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYGVVVLEVLTG 992
Query: 980 RTPVQP-LDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSI 1038
+ P+ P + +G L WVR + + + D+ L E+ D M+ VL AL+C +
Sbjct: 993 KQPIDPTVPEGIHLVDWVRQ----NRGSLEVLDSTLRSRTEAEADEMMQVLGTALLCVNS 1048
Query: 1039 SPFDRPSMREVVSMLIE-SNERE 1060
SP +RP+M++V +ML E ERE
Sbjct: 1049 SPDERPTMKDVAAMLKEIKQERE 1071
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1078 | ||||||
| 255554244 | 1112 | BRASSINOSTEROID INSENSITIVE 1 precursor, | 0.979 | 0.949 | 0.735 | 0.0 | |
| 224057652 | 1106 | predicted protein [Populus trichocarpa] | 0.971 | 0.946 | 0.744 | 0.0 | |
| 224072618 | 1106 | predicted protein [Populus trichocarpa] | 0.971 | 0.946 | 0.734 | 0.0 | |
| 147843348 | 1066 | hypothetical protein VITISV_039668 [Viti | 0.972 | 0.983 | 0.762 | 0.0 | |
| 359477838 | 1105 | PREDICTED: probable leucine-rich repeat | 0.970 | 0.946 | 0.735 | 0.0 | |
| 449432462 | 1106 | PREDICTED: probable leucine-rich repeat | 0.973 | 0.948 | 0.677 | 0.0 | |
| 356577570 | 1162 | PREDICTED: probable leucine-rich repeat | 0.970 | 0.900 | 0.661 | 0.0 | |
| 449465256 | 1103 | PREDICTED: probable leucine-rich repeat | 0.970 | 0.948 | 0.673 | 0.0 | |
| 224144663 | 1071 | predicted protein [Populus trichocarpa] | 0.943 | 0.949 | 0.664 | 0.0 | |
| 297741905 | 1032 | unnamed protein product [Vitis vinifera] | 0.934 | 0.975 | 0.712 | 0.0 |
| >gi|255554244|ref|XP_002518162.1| BRASSINOSTEROID INSENSITIVE 1 precursor, putative [Ricinus communis] gi|223542758|gb|EEF44295.1| BRASSINOSTEROID INSENSITIVE 1 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 1588 bits (4113), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 816/1109 (73%), Positives = 922/1109 (83%), Gaps = 53/1109 (4%)
Query: 22 RDIKMLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSW 81
R +M + SRR EV GFWLV+ +LV T+EGLNSEG YLL+LKN HDEFN L++W
Sbjct: 5 RGDEMSACINSRRAFEV-FAGFWLVITVLVSTSEGLNSEGQYLLDLKNGFHDEFNRLENW 63
Query: 82 KSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGY 141
KS DQTPC WIGVNCT+D+EPVV SL+L+ MN +G LSPSIGGLV+L YLDL+YN L
Sbjct: 64 KSIDQTPCGWIGVNCTTDYEPVVQSLNLSLMNLSGILSPSIGGLVNLRYLDLSYNMLAEN 123
Query: 142 IPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLV 201
IP IGNCS L LYLNNN+FSG++PAELG LS L SLNICNN ISG+ PE GN++SL+
Sbjct: 124 IPNTIGNCSMLLSLYLNNNEFSGELPAELGNLSLLQSLNICNNRISGSFPEEFGNMTSLI 183
Query: 202 DFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGS 261
+ VAYTNNLTGPLP SIGNL+NL+ FRAG+N ISGSIPAEISGCQSL++LGLAQN IGG
Sbjct: 184 EVVAYTNNLTGPLPHSIGNLKNLKTFRAGENKISGSIPAEISGCQSLELLGLAQNAIGGE 243
Query: 262 LPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLT 321
LPKEIGML SLT+++LW+NQLTGFIP E+GNCTKL+TLALY+NNLVG IP ++GNLKFLT
Sbjct: 244 LPKEIGMLGSLTDLILWENQLTGFIPKEIGNCTKLETLALYANNLVGPIPADIGNLKFLT 303
Query: 322 KLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGV 381
KLYLYRN LNGTIPREIGNLSMV EID SEN L GEIP E SKI GL LL+LF+NQLTGV
Sbjct: 304 KLYLYRNALNGTIPREIGNLSMVMEIDFSENYLTGEIPIEISKIKGLHLLYLFENQLTGV 363
Query: 382 IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLW 441
IPNELSSLRNLTKLDLS N L+GPIP GFQ+LT+M QLQLF+N LTGG+P GLGLYS LW
Sbjct: 364 IPNELSSLRNLTKLDLSSNNLSGPIPFGFQYLTEMVQLQLFDNFLTGGVPQGLGLYSKLW 423
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGS 501
VVDFS N LTGRIPPHLC++SNL++LN+ NK +GNIPT +LNC++L+QLRLVGN LTG
Sbjct: 424 VVDFSDNALTGRIPPHLCRHSNLMLLNMESNKFYGNIPTGILNCKSLVQLRLVGNRLTGG 483
Query: 502 FPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLV 561
FP ELC+L NL AIELDQNKFSGPIP I +CQKLQRLHIANNYFT+ELPKE+GNLSQLV
Sbjct: 484 FPSELCRLVNLSAIELDQNKFSGPIPQAIGSCQKLQRLHIANNYFTNELPKEIGNLSQLV 543
Query: 562 TFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN 621
TFN+SSN+L G IPPEIVNC LQRLD+SHNSFV +LP+ELGTL QLE+LKLSENKFSGN
Sbjct: 544 TFNVSSNLLKGRIPPEIVNCKMLQRLDLSHNSFVDALPDELGTLLQLELLKLSENKFSGN 603
Query: 622 IPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLL 681
IP LGNLSHLTELQMGGN FSGEIP +LG LSSLQIA+NLS NNL+G+IPPELG L+LL
Sbjct: 604 IPPALGNLSHLTELQMGGNFFSGEIPRQLGSLSSLQIAMNLSNNNLTGAIPPELGNLNLL 663
Query: 682 EFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCG 741
EFLLLNNNHL+GEIP FENLSSLLG NFS+NNLTGPLP +P FQNM +SSFLGN+GLCG
Sbjct: 664 EFLLLNNNHLTGEIPDTFENLSSLLGCNFSFNNLTGPLPPVPLFQNMAVSSFLGNDGLCG 723
Query: 742 RPVGNCGASPSSGS-------------------------------------------VP- 757
+G C SGS VP
Sbjct: 724 GHLGYCNGDSFSGSNASFKSMDAPRGRIITTVAAAVGGVSLILIAVLLYFMRRPAETVPS 783
Query: 758 --------PLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAV 809
P +++YF PKEGFS QD+VEAT NFHDS++VG GA GTVYKAVM +G+ +AV
Sbjct: 784 VRDTESSSPDSDIYFRPKEGFSLQDLVEATNNFHDSYVVGRGACGTVYKAVMHTGQTIAV 843
Query: 810 KKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL 869
KKLASNREG+NIE+SF+AEILTLG IRHRNIVKL+GFCYHQGSNLL+YEYM RGSLGE L
Sbjct: 844 KKLASNREGSNIENSFQAEILTLGNIRHRNIVKLFGFCYHQGSNLLLYEYMARGSLGEQL 903
Query: 870 HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929
HG SC+LEWPTRFMIALGAAEGLAYLHHDCKPRI HRDIKSNNILLDD FEAHVGDFGLA
Sbjct: 904 HGPSCSLEWPTRFMIALGAAEGLAYLHHDCKPRIIHRDIKSNNILLDDNFEAHVGDFGLA 963
Query: 930 KVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG 989
K+IDMPQSKSMSA+AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG TPVQPLD G
Sbjct: 964 KIIDMPQSKSMSAIAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGLTPVQPLDQG 1023
Query: 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
GDL TWV+NY+R+HSLT GI D+RL+++D+SIVDHM+ VLK+ALMCT++SPFDRPSMREV
Sbjct: 1024 GDLVTWVKNYVRNHSLTSGILDSRLDLKDQSIVDHMLTVLKIALMCTTMSPFDRPSMREV 1083
Query: 1050 VSMLIESNEREGRFNSSPTYDLPQIHETR 1078
V MLIESNERE F SSPTYDLP + +
Sbjct: 1084 VLMLIESNEREESFISSPTYDLPLKEDAK 1112
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224057652|ref|XP_002299290.1| predicted protein [Populus trichocarpa] gi|222846548|gb|EEE84095.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1575 bits (4078), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 817/1098 (74%), Positives = 912/1098 (83%), Gaps = 51/1098 (4%)
Query: 26 MLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTD 85
M +S+RV E+ + G LV +LL+CTTE LNSEG LLELKNSLHDEFN L++WKSTD
Sbjct: 1 MSAHFRSKRVFELRLAGILLVSILLICTTEALNSEGQRLLELKNSLHDEFNHLQNWKSTD 60
Query: 86 QTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPRE 145
QTPCSW GVNCTS +EPVVWSL++++MN +G+LSPSIGGLV+L Y DL+YN +TG IP+
Sbjct: 61 QTPCSWTGVNCTSGYEPVVWSLNMSSMNLSGTLSPSIGGLVNLQYFDLSYNLITGDIPKA 120
Query: 146 IGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVA 205
IGNCS L+ LYLNNNQ SG+IPAELG+LS L LNICNN ISG+LPE G LSSLV+FVA
Sbjct: 121 IGNCSLLQLLYLNNNQLSGEIPAELGELSFLERLNICNNRISGSLPEEFGRLSSLVEFVA 180
Query: 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKE 265
YTN LTGPLP SIGNL+NL+ RAGQN ISGSIP+EISGCQSL++LGLAQN IGG LPKE
Sbjct: 181 YTNKLTGPLPHSIGNLKNLKTIRAGQNEISGSIPSEISGCQSLKLLGLAQNKIGGELPKE 240
Query: 266 IGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
+GML +LTE++LW+NQ++GFIP ELGNCT L+TLALYSN L G IPKE+GNL+FL KLYL
Sbjct: 241 LGMLGNLTEVILWENQISGFIPKELGNCTNLETLALYSNTLTGPIPKEIGNLRFLKKLYL 300
Query: 326 YRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE 385
YRN LNGTIPREIGNLSM EID SEN L GEIPTEFSKI GLRLL+LFQNQLT VIP E
Sbjct: 301 YRNGLNGTIPREIGNLSMAAEIDFSENFLTGEIPTEFSKIKGLRLLYLFQNQLTSVIPKE 360
Query: 386 LSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDF 445
LSSLRNLTKLDLSIN+LTGPIP GFQ+LT+M QLQLF+NSL+GGIP G GL+S LWVVDF
Sbjct: 361 LSSLRNLTKLDLSINHLTGPIPSGFQYLTEMLQLQLFDNSLSGGIPQGFGLHSRLWVVDF 420
Query: 446 SHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLE 505
S N LTGRIPPHLCQ SNLI+LNL N+L+GNIPT VLNC+TL+QLRLVGN+ TG FP E
Sbjct: 421 SDNDLTGRIPPHLCQLSNLILLNLDSNRLYGNIPTGVLNCQTLVQLRLVGNNFTGGFPSE 480
Query: 506 LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNI 565
LCKL NL AIELDQN F+GP+PPEI NCQ+LQRLHIANNYFTSELPKE+GNL QLVTFN
Sbjct: 481 LCKLVNLSAIELDQNSFTGPVPPEIGNCQRLQRLHIANNYFTSELPKEIGNLFQLVTFNA 540
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
SSN+LTG IPPE+VNC LQRLD+SHNSF +LP+ LGTL QLE+L+LSENKFSGNIP
Sbjct: 541 SSNLLTGRIPPEVVNCKMLQRLDLSHNSFSDALPDGLGTLLQLELLRLSENKFSGNIPPA 600
Query: 626 LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLL 685
LGNLSHLTELQMGGN FSG+IPP LG LSSLQIA+NLSYNNL+GSIPPELG L+LLEFLL
Sbjct: 601 LGNLSHLTELQMGGNSFSGQIPPALGSLSSLQIAMNLSYNNLTGSIPPELGNLNLLEFLL 660
Query: 686 LNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVG 745
LNNNHL+GEIP FENLSSLLG NFSYN LTGPLPSIP FQNM SSFLGN+GLCG P+G
Sbjct: 661 LNNNHLNGEIPITFENLSSLLGCNFSYNELTGPLPSIPLFQNMATSSFLGNKGLCGGPLG 720
Query: 746 NCGASPSSGSVPPLN--------------------------------------------- 760
C PSSGSV N
Sbjct: 721 YCSGDPSSGSVVQKNLDAPRGRIITIVAAIVGGVSLVLIIVILYFMRRPTETAPSIHDQE 780
Query: 761 ------NVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLAS 814
++YFP K+G +FQD+VEAT NFHDS+++G GA GTVYKAVM SGKI+AVKKLAS
Sbjct: 781 NPSTESDIYFPLKDGLTFQDLVEATNNFHDSYVLGRGACGTVYKAVMRSGKIIAVKKLAS 840
Query: 815 NREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSC 874
NREG++IE+SFRAEILTLGKIRHRNIVKLYGFCYH+GSNLL+YEYM RGSLGELLH SC
Sbjct: 841 NREGSDIENSFRAEILTLGKIRHRNIVKLYGFCYHEGSNLLLYEYMARGSLGELLHEPSC 900
Query: 875 NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934
LEW TRF++ALGAAEGLAYLHHDCKPRI HRDIKSNNILLDD FEAHVGDFGLAKVIDM
Sbjct: 901 GLEWSTRFLVALGAAEGLAYLHHDCKPRIIHRDIKSNNILLDDNFEAHVGDFGLAKVIDM 960
Query: 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLAT 994
PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG+TPVQPLD GGDL T
Sbjct: 961 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGKTPVQPLDQGGDLVT 1020
Query: 995 WVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054
W R Y+R+HSLT GI D RL++ED+S V HMI VLK+AL+CTS+SP DRPSMREVV MLI
Sbjct: 1021 WARQYVREHSLTSGILDERLDLEDQSTVAHMIYVLKIALLCTSMSPSDRPSMREVVLMLI 1080
Query: 1055 ESNEREGRFNSSPTYDLP 1072
ESNEREG S TY P
Sbjct: 1081 ESNEREGNLTLSSTYVFP 1098
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224072618|ref|XP_002303809.1| predicted protein [Populus trichocarpa] gi|222841241|gb|EEE78788.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1573 bits (4072), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 806/1098 (73%), Positives = 910/1098 (82%), Gaps = 51/1098 (4%)
Query: 26 MLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTD 85
M +S V E+ + G LV LL+ TTEGLNS+GH+LLELKN+LHDEFN L++WKSTD
Sbjct: 1 MSAYFRSSGVFELGLAGILLVTFLLIFTTEGLNSDGHHLLELKNALHDEFNHLQNWKSTD 60
Query: 86 QTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPRE 145
QTPCSW GV+CT D+EP+VWSLDLN+MN +G+LSP IGGLV+L Y DL++NE+TG IP+
Sbjct: 61 QTPCSWTGVSCTLDYEPLVWSLDLNSMNLSGTLSPGIGGLVNLRYFDLSHNEITGDIPKA 120
Query: 146 IGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVA 205
IGNCS L++ YLNNNQ SG+IPAELG+LS L LNICNN ISG+LPE G LSSLV+FVA
Sbjct: 121 IGNCSLLQYFYLNNNQLSGEIPAELGRLSFLERLNICNNQISGSLPEEFGRLSSLVEFVA 180
Query: 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKE 265
YTN LTGPLP+SI NL+NL+ RAGQN ISGSIPAEISGCQSL++LGLAQN IGG LPKE
Sbjct: 181 YTNKLTGPLPRSIRNLKNLKTIRAGQNQISGSIPAEISGCQSLKLLGLAQNKIGGELPKE 240
Query: 266 IGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
+ ML +LTE++LW+NQ++G IP ELGNCT L+TLALY+N L G IP E+GNLKFL KLYL
Sbjct: 241 LAMLGNLTELILWENQISGLIPKELGNCTNLETLALYANALAGPIPMEIGNLKFLKKLYL 300
Query: 326 YRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE 385
YRN LNGTIPREIGNLSM TEID SEN L G+IPTEFSKI GLRLL+LFQNQLTGVIPNE
Sbjct: 301 YRNGLNGTIPREIGNLSMATEIDFSENFLTGKIPTEFSKIKGLRLLYLFQNQLTGVIPNE 360
Query: 386 LSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDF 445
LS LRNLTKLDLSIN+LTGPIP GFQ+LT+M QLQLF NSL+GGIP LGLYS LWVVDF
Sbjct: 361 LSILRNLTKLDLSINHLTGPIPFGFQYLTEMLQLQLFNNSLSGGIPQRLGLYSQLWVVDF 420
Query: 446 SHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLE 505
S N LTGRIPPHLC++SNLI+LNL N+L+GNIPT VLNC+TL+QLRLVGN TG FP E
Sbjct: 421 SDNDLTGRIPPHLCRHSNLILLNLDSNRLYGNIPTGVLNCQTLVQLRLVGNKFTGGFPSE 480
Query: 506 LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNI 565
LCKL NL AIEL+QN F+GP+PPE+ NC++LQRLHIANNYFTSELPKE+GNLSQLVTFN
Sbjct: 481 LCKLVNLSAIELNQNMFTGPLPPEMGNCRRLQRLHIANNYFTSELPKELGNLSQLVTFNA 540
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
SSN+LTG IPPE+VNC LQRLD+SHNSF +LP+ELGTL QLE+L+LSENKFSGNIP
Sbjct: 541 SSNLLTGKIPPEVVNCKMLQRLDLSHNSFSDALPDELGTLLQLELLRLSENKFSGNIPLA 600
Query: 626 LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLL 685
LGNLSHLTELQMGGN FSG IPP LG LSSLQI +NLSYN+L+GSIPPELG L+LLEFLL
Sbjct: 601 LGNLSHLTELQMGGNSFSGRIPPSLGLLSSLQIGMNLSYNSLTGSIPPELGNLNLLEFLL 660
Query: 686 LNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVG 745
LNNNHL+GEIP FENLSSLLG NFSYN LTG LPS FQNM ISSF+GN+GLCG P+G
Sbjct: 661 LNNNHLTGEIPKTFENLSSLLGCNFSYNELTGSLPSGSLFQNMAISSFIGNKGLCGGPLG 720
Query: 746 NCGASPSSGSVP------------------------------------------------ 757
C SSGSVP
Sbjct: 721 YCSGDTSSGSVPQKNMDAPRGRIITIVAAVVGGVSLILIIVILYFMRHPTATASSVHDKE 780
Query: 758 ---PLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLAS 814
P +N+YFP K+G +FQD+V+AT NFHDS++VG GA GTVYKAVM SGK +AVKKLAS
Sbjct: 781 NPSPESNIYFPLKDGITFQDLVQATNNFHDSYVVGRGACGTVYKAVMRSGKTIAVKKLAS 840
Query: 815 NREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSC 874
+REG++IE+SF+AEILTLGKIRHRNIVKLYGFCYH+GSNLL+YEY+ RGSLGELLHG SC
Sbjct: 841 DREGSSIENSFQAEILTLGKIRHRNIVKLYGFCYHEGSNLLLYEYLARGSLGELLHGPSC 900
Query: 875 NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934
+LEW TRFM+ALGAAEGLAYLHHDCKP I HRDIKSNNILLDD FEAHVGDFGLAKVIDM
Sbjct: 901 SLEWSTRFMVALGAAEGLAYLHHDCKPIIIHRDIKSNNILLDDNFEAHVGDFGLAKVIDM 960
Query: 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLAT 994
PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG+TPVQPLD GGDL T
Sbjct: 961 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGKTPVQPLDQGGDLVT 1020
Query: 995 WVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054
W R+Y+RDHSLT GI D RL++ED+S V HMI LK+AL+CTS+SPFDRPSMREVV MLI
Sbjct: 1021 WARHYVRDHSLTSGILDDRLDLEDQSTVAHMISALKIALLCTSMSPFDRPSMREVVLMLI 1080
Query: 1055 ESNEREGRFNSSPTYDLP 1072
ESNEREG S TYD P
Sbjct: 1081 ESNEREGNLTLSSTYDFP 1098
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147843348|emb|CAN79986.1| hypothetical protein VITISV_039668 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1553 bits (4022), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 808/1059 (76%), Positives = 909/1059 (85%), Gaps = 11/1059 (1%)
Query: 24 IKMLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKS 83
I+M K +SRR+ V GF +V LLVC +EGLNSEG LLELK+ L+D+FN L +W
Sbjct: 3 IRMSKNCRSRRLFGVGFTGFLIVAALLVCGSEGLNSEGLLLLELKHGLYDQFNHLYNWNP 62
Query: 84 TDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIP 143
+DQTPC WIGVNCT ++PVV SLDLN+MN +G+LSPSIGGL +LTYLD+++N LTG IP
Sbjct: 63 SDQTPCGWIGVNCTG-YDPVVISLDLNSMNLSGTLSPSIGGLSYLTYLDVSHNGLTGNIP 121
Query: 144 REIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDF 203
+EIGNCS+LE L LN+NQF G IPAE LS L LN+CNN +SG PE +GNL +LV+
Sbjct: 122 KEIGNCSKLETLCLNDNQFDGSIPAEFCSLSCLTDLNVCNNKLSGPFPEEIGNLYALVEL 181
Query: 204 VAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLP 263
VAYTNNLTGPLP+S GNL++L+ FRAGQNAISGS+PAEI GC+SL+ LGLAQND+ G +P
Sbjct: 182 VAYTNNLTGPLPRSFGNLKSLKTFRAGQNAISGSLPAEIGGCRSLRYLGLAQNDLAGEIP 241
Query: 264 KEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKL 323
KEIGML +LT+++LW NQL+GF+P ELGNCT L+TLALY NNLVG+IP+E+G+LKFL KL
Sbjct: 242 KEIGMLRNLTDLILWGNQLSGFVPKELGNCTHLETLALYQNNLVGEIPREIGSLKFLKKL 301
Query: 324 YLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIP 383
Y+YRNELNGTIPREIGNLS TEID SEN L G IPTEFSKI GL+LL+LFQN+L+GVIP
Sbjct: 302 YIYRNELNGTIPREIGNLSQATEIDFSENYLTGGIPTEFSKIKGLKLLYLFQNELSGVIP 361
Query: 384 NELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVV 443
NELSSLRNL KLDLSIN LTGPIPVGFQ+LTQM QLQLF+N LTG IP LGLYS LWVV
Sbjct: 362 NELSSLRNLAKLDLSINNLTGPIPVGFQYLTQMFQLQLFDNRLTGRIPQALGLYSPLWVV 421
Query: 444 DFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFP 503
DFS N+LTG IP H+C+ SNLI+LNL NKL+GNIP VL C++L+QLRLVGNSLTGSFP
Sbjct: 422 DFSQNHLTGSIPSHICRRSNLILLNLESNKLYGNIPMGVLKCKSLVQLRLVGNSLTGSFP 481
Query: 504 LELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTF 563
LELC+L NL AIELDQNKFSG IPPEI NC++LQRLH+ANNYFTSELPKE+GNLS+LVTF
Sbjct: 482 LELCRLVNLSAIELDQNKFSGLIPPEIANCRRLQRLHLANNYFTSELPKEIGNLSELVTF 541
Query: 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP 623
NISSN LTG IPP IVNC LQRLD+S NSFV +LP ELGTL QLE+LKLSENKFSGNIP
Sbjct: 542 NISSNFLTGQIPPTIVNCKMLQRLDLSRNSFVDALPKELGTLLQLELLKLSENKFSGNIP 601
Query: 624 STLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEF 683
+ LGNLSHLTELQMGGNLFSGEIPPELG LSSLQIA+NLSYNNL G IPPELG L LLEF
Sbjct: 602 AALGNLSHLTELQMGGNLFSGEIPPELGALSSLQIAMNLSYNNLLGRIPPELGNLILLEF 661
Query: 684 LLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRP 743
LLLNNNHLSGEIPS F NLSSL+G NFSYN+LTGPLPSIP FQNM SSF+GNEGLCG
Sbjct: 662 LLLNNNHLSGEIPSTFGNLSSLMGCNFSYNDLTGPLPSIPLFQNMVSSSFIGNEGLCGGR 721
Query: 744 VGNCGASPSSGSVPP-LNNVYFP---------PKEGFSFQDVVEATYNFHDSFIVGSGAY 793
+ NC +PS SVPP L +V P EGF+FQD+VEAT NFHDS++VG GA
Sbjct: 722 LSNCNGTPSFSSVPPSLESVDAPRGKIITVVAAVEGFTFQDLVEATNNFHDSYVVGRGAC 781
Query: 794 GTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853
GTVYKAVM SG+ +AVKKLASNREGN+I++SFRAEILTLGKIRHRNIVKLYGFCYHQGSN
Sbjct: 782 GTVYKAVMHSGQTIAVKKLASNREGNSIDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 841
Query: 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNI 913
LL+YEYM RGSLGELLHG+SC+LEW TRF IALGAAEGLAYLHHDCKPRI HRDIKSNNI
Sbjct: 842 LLLYEYMARGSLGELLHGASCSLEWQTRFTIALGAAEGLAYLHHDCKPRIIHRDIKSNNI 901
Query: 914 LLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVL 973
LLD FEAHVGDFGLAKV+DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVL
Sbjct: 902 LLDSNFEAHVGDFGLAKVVDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVL 961
Query: 974 LELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVAL 1033
LELLTGRTPVQPLD GGDL +WVRNYIRDHSLT IFDTRLN+EDE+ VDHMI VLK+A+
Sbjct: 962 LELLTGRTPVQPLDQGGDLVSWVRNYIRDHSLTSEIFDTRLNLEDENTVDHMIAVLKIAI 1021
Query: 1034 MCTSISPFDRPSMREVVSMLIESNEREGRFNSSPTYDLP 1072
+CT++SP DRPSMREVV MLIESNE EG + SSP DLP
Sbjct: 1022 LCTNMSPPDRPSMREVVLMLIESNEHEGYYISSPINDLP 1060
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359477838|ref|XP_002283031.2| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At2g33170-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1551 bits (4016), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 809/1100 (73%), Positives = 912/1100 (82%), Gaps = 54/1100 (4%)
Query: 26 MLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTD 85
M K +SRR+ V GF +V LLVC +EGLNSEG LLELK+ L+D+FN L +W +D
Sbjct: 1 MSKNCRSRRLFGVGFTGFLIVAALLVCGSEGLNSEGLLLLELKHGLYDQFNHLYNWNPSD 60
Query: 86 QTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPRE 145
QTPC WIGVNCT ++PVV SLDLN+MN +G+LSPSIGGL +LTYLD+++N LTG IP+E
Sbjct: 61 QTPCGWIGVNCTG-YDPVVISLDLNSMNLSGTLSPSIGGLSYLTYLDVSHNGLTGNIPKE 119
Query: 146 IGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVA 205
IGNCS+LE L LN+NQF G IPAE LS L LN+CNN +SG PE +GNL +LV+ VA
Sbjct: 120 IGNCSKLETLCLNDNQFDGSIPAEFCSLSCLTDLNVCNNKLSGPFPEEIGNLYALVELVA 179
Query: 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKE 265
YTNNLTGPLP+S GNL++L+ FRAGQNAISGS+PAEI GC+SL+ LGLAQND+ G +PKE
Sbjct: 180 YTNNLTGPLPRSFGNLKSLKTFRAGQNAISGSLPAEIGGCRSLRYLGLAQNDLAGEIPKE 239
Query: 266 IGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
IGML +LT+++LW NQL+GF+P ELGNCT L+TLALY NNLVG+IP+E+G+LKFL KLY+
Sbjct: 240 IGMLRNLTDLILWGNQLSGFVPKELGNCTHLETLALYQNNLVGEIPREIGSLKFLKKLYI 299
Query: 326 YRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE 385
YRNELNGTIPREIGNLS TEID SEN L G IPTEFSKI GL+LL+LFQN+L+GVIPNE
Sbjct: 300 YRNELNGTIPREIGNLSQATEIDFSENYLTGGIPTEFSKIKGLKLLYLFQNELSGVIPNE 359
Query: 386 LSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDF 445
LSSLRNL KLDLSIN LTGPIPVGFQ+LTQM QLQLF+N LTG IP LGLYS LWVVDF
Sbjct: 360 LSSLRNLAKLDLSINNLTGPIPVGFQYLTQMFQLQLFDNRLTGRIPQALGLYSPLWVVDF 419
Query: 446 SHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLE 505
S N+LTG IP H+C+ SNLI+LNL NKL+GNIP VL C++L+QLRLVGNSLTGSFPLE
Sbjct: 420 SQNHLTGSIPSHICRRSNLILLNLESNKLYGNIPMGVLKCKSLVQLRLVGNSLTGSFPLE 479
Query: 506 LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNI 565
LC+L NL AIELDQNKFSG IPPEI NC++LQRLH+ANNYFTSELPKE+GNLS+LVTFNI
Sbjct: 480 LCRLVNLSAIELDQNKFSGLIPPEIANCRRLQRLHLANNYFTSELPKEIGNLSELVTFNI 539
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
SSN LTG IPP IVNC LQRLD+S NSFV +LP ELGTL QLE+LKLSENKFSGNIP+
Sbjct: 540 SSNFLTGQIPPTIVNCKMLQRLDLSRNSFVDALPKELGTLLQLELLKLSENKFSGNIPAA 599
Query: 626 LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLL 685
LGNLSHLTELQMGGNLFSGEIPPELG LSSLQIA+NLSYNNL G IPPELG L LLEFLL
Sbjct: 600 LGNLSHLTELQMGGNLFSGEIPPELGALSSLQIAMNLSYNNLLGRIPPELGNLILLEFLL 659
Query: 686 LNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVG 745
LNNNHLSGEIPS F NLSSL+G NFSYN+LTGPLPSIP FQNM SSF+GNEGLCG +
Sbjct: 660 LNNNHLSGEIPSTFGNLSSLMGCNFSYNDLTGPLPSIPLFQNMVSSSFIGNEGLCGGRLS 719
Query: 746 NCGASPSSGSVPP----------------------------------------------- 758
NC +PS SVPP
Sbjct: 720 NCNGTPSFSSVPPSLESVDAPRGKIITVVAAVVGGISLILIVIILYFMRRPVEVVASLQD 779
Query: 759 ------LNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKL 812
++++YFPPKEGF+FQD+VEAT NFHDS++VG GA GTVYKAVM SG+ +AVKKL
Sbjct: 780 KEIPSSVSDIYFPPKEGFTFQDLVEATNNFHDSYVVGRGACGTVYKAVMHSGQTIAVKKL 839
Query: 813 ASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGS 872
ASNREGN+I++SFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL+YEYM RGSLGELLHG+
Sbjct: 840 ASNREGNSIDNSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLLYEYMARGSLGELLHGA 899
Query: 873 SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932
SC+LEW TRF IALGAAEGLAYLHHDCKPRI HRDIKSNNILLD FEAHVGDFGLAKV+
Sbjct: 900 SCSLEWQTRFTIALGAAEGLAYLHHDCKPRIIHRDIKSNNILLDSNFEAHVGDFGLAKVV 959
Query: 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992
DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLD GGDL
Sbjct: 960 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDQGGDL 1019
Query: 993 ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052
+WVRNYIRDHSLT IFDTRLN+EDE+ VDHMI VLK+A++CT++SP DRPSMREVV M
Sbjct: 1020 VSWVRNYIRDHSLTSEIFDTRLNLEDENTVDHMIAVLKIAILCTNMSPPDRPSMREVVLM 1079
Query: 1053 LIESNEREGRFNSSPTYDLP 1072
LIESNE EG + SSP DLP
Sbjct: 1080 LIESNEHEGYYISSPINDLP 1099
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449432462|ref|XP_004134018.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At2g33170-like [Cucumis sativus] gi|449526431|ref|XP_004170217.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At2g33170-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1461 bits (3781), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 744/1098 (67%), Positives = 872/1098 (79%), Gaps = 49/1098 (4%)
Query: 24 IKMLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKS 83
+ M +KS V VGFW ++LL CT++GLN EG LLELK +L D+F+ LK+W
Sbjct: 3 LNMFGDVKSWEGFLVRFVGFWFTIILLFCTSQGLNLEGLSLLELKRTLKDDFDSLKNWNP 62
Query: 84 TDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIP 143
DQTPCSWIGV CTS PVV SL+L + +GS++P IG L+HLT LDL+YN TG IP
Sbjct: 63 ADQTPCSWIGVKCTSGEAPVVSSLNLKSKKLSGSVNPIIGNLIHLTSLDLSYNNFTGNIP 122
Query: 144 REIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDF 203
+EIGNCS LE+L LNNN F GKIP ++G L+SL SLNICNN ISG++PE G LSSLV+F
Sbjct: 123 KEIGNCSGLEYLSLNNNMFEGKIPPQMGNLTSLRSLNICNNRISGSIPEEFGKLSSLVEF 182
Query: 204 VAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLP 263
VAYTN LTGPLP+SIGNL+NL+ FRAGQNAISGS+P+EISGCQSL +LGLAQN IGG LP
Sbjct: 183 VAYTNQLTGPLPRSIGNLKNLKRFRAGQNAISGSLPSEISGCQSLNVLGLAQNQIGGELP 242
Query: 264 KEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKL 323
KE+GML +LTE++LW NQ +G IP ELGNC L+ LALY+NNLVG IPK +GNL L KL
Sbjct: 243 KELGMLRNLTEMILWGNQFSGNIPEELGNCKSLEVLALYANNLVGLIPKTLGNLSSLKKL 302
Query: 324 YLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIP 383
YLYRN LNGTIP+EIGNLS+V EID SEN L GEIP+E SKI GL LLFLF+N L GVIP
Sbjct: 303 YLYRNALNGTIPKEIGNLSLVEEIDFSENYLTGEIPSELSKIKGLHLLFLFKNLLNGVIP 362
Query: 384 NELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVV 443
+E S+L NLT+LDLS+N L GPIP GFQ+ T+M QLQLF+NSL+G IP GLGLYS LWVV
Sbjct: 363 DEFSTLSNLTRLDLSMNDLRGPIPFGFQYFTKMVQLQLFDNSLSGSIPSGLGLYSWLWVV 422
Query: 444 DFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFP 503
DFS N LTG IP HLC +SNL +LNL NK +GNIP+ +LNC++L+QLRL GN LTG+FP
Sbjct: 423 DFSLNNLTGTIPSHLCHHSNLSILNLESNKFYGNIPSGILNCKSLVQLRLGGNMLTGAFP 482
Query: 504 LELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTF 563
ELC LENL AIEL QNKFSGP+P +I C KLQRL IANN+FTS LPKE+GNL+QLVTF
Sbjct: 483 SELCSLENLSAIELGQNKFSGPVPTDIGRCHKLQRLQIANNFFTSSLPKEIGNLTQLVTF 542
Query: 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP 623
N+SSN + G +P E NC LQRLD+SHN+F GSLPNE+G+L QLE+L LSENKFSGNIP
Sbjct: 543 NVSSNRIIGQLPLEFFNCKMLQRLDLSHNAFTGSLPNEIGSLSQLELLILSENKFSGNIP 602
Query: 624 STLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEF 683
+ LGN+ +TELQ+G N FSGEIP ELG L SLQIA++LSYNNL+G IPPELG+L LLE
Sbjct: 603 AGLGNMPRMTELQIGSNSFSGEIPKELGSLLSLQIAMDLSYNNLTGRIPPELGRLYLLEI 662
Query: 684 LLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRP 743
LLLNNNHL+G+IP+ F+NLSSL NFSYN+L+GP+PSIP FQNM SF+GN+GLCG P
Sbjct: 663 LLLNNNHLTGQIPTEFDNLSSLSVCNFSYNDLSGPIPSIPLFQNMGTDSFIGNDGLCGGP 722
Query: 744 VGNCGASPSSGSVPPLN------------------------------------------- 760
+G+C + S S P N
Sbjct: 723 LGDCSGNSYSHSTPLENANTSRGKIITGIASAIGGISLILIVIILHHMRRPHESSMPNKE 782
Query: 761 ------NVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLAS 814
+ Y PPKEGF+F D+VE T NFHDS+I+G GA GTVYKAV+ +G+I+AVKKLAS
Sbjct: 783 IPSSDSDFYLPPKEGFTFHDLVEVTNNFHDSYIIGKGACGTVYKAVVHTGQIIAVKKLAS 842
Query: 815 NREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSC 874
NREGN++E+SF+AEILTLG+IRHRNIVKLYG+CYHQG NLL+YEYM RGSLGEL+HGSSC
Sbjct: 843 NREGNSVENSFQAEILTLGQIRHRNIVKLYGYCYHQGCNLLLYEYMARGSLGELIHGSSC 902
Query: 875 NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934
L+WPTRF IA+GAA+GLAYLHHDCKP+I HRDIKSNNILLDD FEAHVGDFGLAKVIDM
Sbjct: 903 CLDWPTRFTIAVGAADGLAYLHHDCKPKIVHRDIKSNNILLDDHFEAHVGDFGLAKVIDM 962
Query: 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLAT 994
P SKSMSAVAGSYGYIAPEYAY+MKVTEKCDIYS+GVVLLELLTG+TPVQPLD GGDL T
Sbjct: 963 PHSKSMSAVAGSYGYIAPEYAYSMKVTEKCDIYSFGVVLLELLTGKTPVQPLDQGGDLVT 1022
Query: 995 WVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054
WV+N+IR+HS T IFD+RLN++D SIV+HM+ VLK+ALMCTS+SPFDRPSMREVVSML
Sbjct: 1023 WVKNFIRNHSYTSRIFDSRLNLQDRSIVEHMMSVLKIALMCTSMSPFDRPSMREVVSMLT 1082
Query: 1055 ESNEREGRFNSSPTYDLP 1072
ESNE+E F SP DLP
Sbjct: 1083 ESNEQEVNFIPSPDSDLP 1100
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356577570|ref|XP_003556897.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At2g33170-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1432 bits (3706), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 734/1109 (66%), Positives = 865/1109 (77%), Gaps = 63/1109 (5%)
Query: 23 DIKMLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWK 82
DIKM +K R I +L++ LL+C+TEGLN+EG LL+LK LHD+ N L++W+
Sbjct: 53 DIKMAGDIKEGRAGCSVI---FLLLTLLLCSTEGLNTEGQILLDLKKGLHDKSNVLENWR 109
Query: 83 STDQTPCSWIGVNCTSDFEP---VVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELT 139
TD+TPC W+GVNCT D VV + + IGGL +LTYL+LAYN+LT
Sbjct: 110 FTDETPCGWVGVNCTHDDNNNFLVVSLNLSSLNLSGSLNAAGIGGLTNLTYLNLAYNKLT 169
Query: 140 GYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSS 199
G IP+EIG C LE+LYLNNNQF G IPAELGKLS L SLNI NN +SG LP+ GNLSS
Sbjct: 170 GNIPKEIGECLNLEYLYLNNNQFEGPIPAELGKLSVLKSLNIFNNKLSGVLPDEFGNLSS 229
Query: 200 LVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIG 259
LV+ VA++N L GPLP+SIGNL+NL FRAG N I+G++P EI GC SL +LGLAQN IG
Sbjct: 230 LVELVAFSNFLVGPLPKSIGNLKNLVNFRAGANNITGNLPKEIGGCTSLILLGLAQNQIG 289
Query: 260 GSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKF 319
G +P+EIGML +L E+VLW NQL+G IP E+GNCT L+ +A+Y NNLVG IPKE+GNLK
Sbjct: 290 GEIPREIGMLANLNELVLWGNQLSGPIPKEIGNCTNLENIAIYGNNLVGPIPKEIGNLKS 349
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
L LYLYRN+LNGTIPREIGNLS ID SENSL G IP+EF KI+GL LLFLF+N LT
Sbjct: 350 LRWLYLYRNKLNGTIPREIGNLSKCLSIDFSENSLVGHIPSEFGKISGLSLLFLFENHLT 409
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL 439
G IPNE SSL+NL++LDLSIN LTG IP GFQ+L +M QLQLF+NSL+G IP GLGL S
Sbjct: 410 GGIPNEFSSLKNLSQLDLSINNLTGSIPFGFQYLPKMYQLQLFDNSLSGVIPQGLGLRSP 469
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
LWVVDFS N LTGRIPPHLC+NS+L++LNL N+L+GNIPT +LNC++L QL L+ N LT
Sbjct: 470 LWVVDFSDNKLTGRIPPHLCRNSSLMLLNLAANQLYGNIPTGILNCKSLAQLLLLENRLT 529
Query: 500 GSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQ 559
GSFP ELCKLENL AI+L++N+FSG +P +I NC KLQR HIA+NYFT ELPKE+GNLSQ
Sbjct: 530 GSFPSELCKLENLTAIDLNENRFSGTLPSDIGNCNKLQRFHIADNYFTLELPKEIGNLSQ 589
Query: 560 LVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
LVTFN+SSN+ TG IP EI +C LQRLD+S N+F GS P+E+GTLQ LEILKLS+NK S
Sbjct: 590 LVTFNVSSNLFTGRIPREIFSCQRLQRLDLSQNNFSGSFPDEVGTLQHLEILKLSDNKLS 649
Query: 620 GNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLD 679
G IP+ LGNLSHL L M GN F GEIPP LG L++LQIA++LSYNNLSG IP +LG L+
Sbjct: 650 GYIPAALGNLSHLNWLLMDGNYFFGEIPPHLGSLATLQIAMDLSYNNLSGRIPVQLGNLN 709
Query: 680 LLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFL-GNEG 738
+LEFL LNNNHL GEIPS FE LSSLLG NFS+NNL+GP+PS FQ+M ISSF+ GN G
Sbjct: 710 MLEFLYLNNNHLDGEIPSTFEELSSLLGCNFSFNNLSGPIPSTKIFQSMAISSFIGGNNG 769
Query: 739 LCGRPVGNCGASPSS--------------------------------------------- 753
LCG P+G+C + P+S
Sbjct: 770 LCGAPLGDC-SDPASHSDTRGKSFDSSRAKIVMIIAASVGGVSLVFILVILHFMRRPRES 828
Query: 754 -----GSVPPL--NNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKI 806
G+ PP +++YFPPKEGF+F D+VEAT FH+S+++G GA GTVYKAVM SGK
Sbjct: 829 TDSFVGTEPPSPDSDIYFPPKEGFTFHDLVEATKRFHESYVIGKGACGTVYKAVMKSGKT 888
Query: 807 VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866
+AVKKLASNREGNNIE+SFRAEI TLG+IRHRNIVKLYGFCY QGSNLL+YEYMERGSLG
Sbjct: 889 IAVKKLASNREGNNIENSFRAEITTLGRIRHRNIVKLYGFCYQQGSNLLLYEYMERGSLG 948
Query: 867 ELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 926
ELLHG++ NLEWP RFMIALGAAEGLAYLHHDCKP+I HRDIKSNNILLD+ FEAHVGDF
Sbjct: 949 ELLHGNASNLEWPIRFMIALGAAEGLAYLHHDCKPKIIHRDIKSNNILLDENFEAHVGDF 1008
Query: 927 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPL 986
GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD YS+GVVLLELLTGRTPVQPL
Sbjct: 1009 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDTYSFGVVLLELLTGRTPVQPL 1068
Query: 987 DDGGDLATWVRNYIRDH--SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRP 1044
+ GGDL TWVRN+IRDH +LTP + D+R+++ED++ V+HM+ VLK+AL+CTS+SP RP
Sbjct: 1069 EQGGDLVTWVRNHIRDHNNTLTPEMLDSRVDLEDQTTVNHMLTVLKLALLCTSVSPTKRP 1128
Query: 1045 SMREVVSMLIESNEREGRFNSSPTY-DLP 1072
SMREVV MLIESNEREG + TY DLP
Sbjct: 1129 SMREVVLMLIESNEREGNLTLTQTYHDLP 1157
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449465256|ref|XP_004150344.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g63930-like [Cucumis sativus] gi|449515008|ref|XP_004164542.1| PREDICTED: probable leucine-rich repeat receptor-like protein kinase At5g63930-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1422 bits (3682), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 737/1095 (67%), Positives = 882/1095 (80%), Gaps = 49/1095 (4%)
Query: 26 MLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTD 85
ML +S V ++V L++ L + GLN EGH+LLELKN++ D F L++W S+D
Sbjct: 1 MLYYFESGSVSSAKLVVVLLLLACLFNISHGLNQEGHFLLELKNNISDPFGSLRNWDSSD 60
Query: 86 QTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPRE 145
+TPC W GVNCTS EPVV+SL L++ N +GSLS SIG L+HLTYL++++NELTG IP+E
Sbjct: 61 ETPCGWTGVNCTSSEEPVVYSLYLSSKNLSGSLSSSIGKLIHLTYLNVSFNELTGIIPKE 120
Query: 146 IGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVA 205
IG+C RLE+L LNNN+F+G++P+ELG+L+SLV LNICNN I G+ PE +GNL SLV+ VA
Sbjct: 121 IGDCIRLEYLILNNNKFNGQLPSELGRLTSLVKLNICNNGIHGSFPEEIGNLKSLVELVA 180
Query: 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKE 265
YTNN+TGPLP+S G L++L +FRAGQNAISGS+PAEI C++L+ LGLAQN + G LPKE
Sbjct: 181 YTNNITGPLPRSFGKLKSLTIFRAGQNAISGSLPAEIGQCENLETLGLAQNQLEGDLPKE 240
Query: 266 IGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
+GML++LTE++LW+NQ++G +P ELGNCT L LALY NNL G IPKE GNL L KLY+
Sbjct: 241 LGMLKNLTELILWENQISGILPKELGNCTSLTVLALYQNNLGGPIPKEFGNLISLMKLYI 300
Query: 326 YRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE 385
YRN LNGTIP E+GNLS+ E+D SEN L GEIP E SKI GL+LL+LFQNQLTG+IPNE
Sbjct: 301 YRNALNGTIPAELGNLSLAIEVDFSENYLTGEIPKELSKIEGLQLLYLFQNQLTGIIPNE 360
Query: 386 LSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDF 445
LSSL +LTKLDLSIN LTGP+P GFQ++ + QLQLF+NSL+G IP GLG S LWVVDF
Sbjct: 361 LSSLSSLTKLDLSINNLTGPVPFGFQYMPSLSQLQLFDNSLSGSIPQGLGRNSPLWVVDF 420
Query: 446 SHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLE 505
S N LTGRIPPHLC++SNLI+LNL NKL+GNIPT +LNC++LLQ+RLVGN TG FP
Sbjct: 421 SDNLLTGRIPPHLCRHSNLIILNLESNKLYGNIPTGILNCKSLLQVRLVGNRFTGGFPSA 480
Query: 506 LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNI 565
CKL NL AI+LDQN+FSGP+PPEI NCQKLQRLHIANNYFTS LPKE+GNL QL TFN+
Sbjct: 481 FCKLVNLTAIDLDQNRFSGPLPPEIRNCQKLQRLHIANNYFTSHLPKEIGNLVQLATFNV 540
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
SSN+ TG IPPEIVNC LQRLD+S+N F +LP E+G+L QLEIL++S+NKFSG+IP
Sbjct: 541 SSNLFTGPIPPEIVNCKILQRLDLSNNFFENTLPKEIGSLLQLEILRVSDNKFSGSIPRE 600
Query: 626 LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLL 685
L NLSHLTELQMGGN FSG IP ELG L SLQI+LNLS+N L+G+IP ELG L+LLE+LL
Sbjct: 601 LKNLSHLTELQMGGNSFSGSIPSELGSLKSLQISLNLSFNMLTGTIPLELGNLNLLEYLL 660
Query: 686 LNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVG 745
LNNN L+GEIPS+F NLSSL+G NFSYN+L GP+PSIP FQNM +SSF+GN+GLCG P+G
Sbjct: 661 LNNNSLTGEIPSSFANLSSLMGCNFSYNDLRGPIPSIPLFQNMPLSSFVGNKGLCGGPLG 720
Query: 746 NCGASPSSGSVPPLN--------------------------------------------- 760
+C S S+P N
Sbjct: 721 DCNGDSLSPSIPSFNSMNGPRGRIITGIAAAIGGVSIVLIGIILYCMKRPSKMMQNKETQ 780
Query: 761 ----NVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNR 816
+VYFPPKEGF+FQD++EAT +FH+S +VG GA GTVYKAVM SG+++AVKKLASNR
Sbjct: 781 SLDSDVYFPPKEGFTFQDLIEATNSFHESCVVGKGACGTVYKAVMRSGQVIAVKKLASNR 840
Query: 817 EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNL 876
EG+NI++SFRAEI TLGKIRHRNIVKLYGFCYHQGSNLL+YEYMERGSLGELLHG+ CNL
Sbjct: 841 EGSNIDNSFRAEISTLGKIRHRNIVKLYGFCYHQGSNLLLYEYMERGSLGELLHGTECNL 900
Query: 877 EWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936
EWPTRF IA+GAAEGL YLHH CKPRI HRDIKSNNILLD KFEAHVGDFGLAKV+DMPQ
Sbjct: 901 EWPTRFTIAIGAAEGLDYLHHGCKPRIIHRDIKSNNILLDYKFEAHVGDFGLAKVMDMPQ 960
Query: 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV 996
SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG+TPVQP+D GGDL TWV
Sbjct: 961 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGKTPVQPIDQGGDLVTWV 1020
Query: 997 RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056
+NY+RDHS++ G+ D RLN++D++ V+HM+ VLK+ALMCTS+SPF RPSMREVVS+L+ES
Sbjct: 1021 KNYMRDHSMSSGMLDQRLNLQDQATVNHMLTVLKIALMCTSLSPFHRPSMREVVSLLLES 1080
Query: 1057 NEREGRFNSSPTYDL 1071
E + + TY+L
Sbjct: 1081 TEPDEDHIPALTYNL 1095
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224144663|ref|XP_002325367.1| predicted protein [Populus trichocarpa] gi|222862242|gb|EEE99748.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1415 bits (3664), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 711/1070 (66%), Positives = 838/1070 (78%), Gaps = 53/1070 (4%)
Query: 45 LVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVV 104
LVV LL + GLN+EG YLL++K+ + D +N L +W D PC W GVNCTSD+ PVV
Sbjct: 2 LVVSLLFHQSMGLNAEGQYLLDIKSRIGDTYNHLSNWNPNDSIPCGWKGVNCTSDYNPVV 61
Query: 105 WSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG 164
W LDL++MN +GSLSPSIGGLVHLT LDL++N L+ IP EIGNCS LE LYLNNN F
Sbjct: 62 WRLDLSSMNLSGSLSPSIGGLVHLTLLDLSFNALSQNIPSEIGNCSSLESLYLNNNLFES 121
Query: 165 KIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNL 224
++P EL KLS L +LN+ NN ISG P+ +GNLSSL +AY+NN+TG LP S+GNL++L
Sbjct: 122 QLPVELAKLSCLTALNVANNRISGPFPDQIGNLSSLSLLIAYSNNITGSLPASLGNLKHL 181
Query: 225 RVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTG 284
R FRAGQN ISGS+P+EI GC+SL+ LGLAQN + G +PKEIGML++LT ++L NQL+G
Sbjct: 182 RTFRAGQNLISGSLPSEIGGCESLEYLGLAQNQLSGEIPKEIGMLQNLTALILRSNQLSG 241
Query: 285 FIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMV 344
IP EL NCT L+TLALY N LVG IPKE+GNL +L + YLYRN LNGTIPREIGNLS
Sbjct: 242 PIPMELSNCTYLETLALYDNKLVGPIPKELGNLVYLKRFYLYRNNLNGTIPREIGNLSSA 301
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
EID SEN L GEIP E I GL LL++F+N LTGVIP+EL++L NLTKLD+SIN LTG
Sbjct: 302 LEIDFSENELTGEIPIELKNIAGLSLLYIFENMLTGVIPDELTTLENLTKLDISINNLTG 361
Query: 405 PIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNL 464
IPVGFQH+ Q+ LQLF+NSL+G IP GLG+Y LWVVD S+N+LTGRIP HLC+N NL
Sbjct: 362 TIPVGFQHMKQLIMLQLFDNSLSGVIPRGLGVYGKLWVVDISNNHLTGRIPRHLCRNENL 421
Query: 465 IMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSG 524
I+LN+G N L G IPT V NC L+QL L N L GSFP +LCKL NL ++ELDQN F+G
Sbjct: 422 ILLNMGSNNLTGYIPTGVTNCRPLVQLHLAENGLVGSFPSDLCKLANLSSLELDQNMFTG 481
Query: 525 PIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTL 584
PIPPEI C LQRLH++ N+FT ELPKE+G LSQLV FN+S+N LTG+IP EI NC L
Sbjct: 482 PIPPEIGQCHVLQRLHLSGNHFTGELPKEIGKLSQLVFFNVSTNFLTGVIPAEIFNCKML 541
Query: 585 QRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG 644
QRLD++ N+FVG+LP+E+G L QLEILKLSEN+ S +IP +GNLS LT+LQMGGN FSG
Sbjct: 542 QRLDLTRNNFVGALPSEIGALSQLEILKLSENQLSEHIPVEVGNLSRLTDLQMGGNSFSG 601
Query: 645 EIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSS 704
EIP ELG +SSLQIALNLSYNNL+G+IP ELG L LLEFLLLN+NHLSGEIP AF+ LSS
Sbjct: 602 EIPAELGGISSLQIALNLSYNNLTGAIPAELGNLVLLEFLLLNDNHLSGEIPDAFDKLSS 661
Query: 705 LLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPSSGSVPP------ 758
LLG NFS N+LTGPLPS+P FQ ISSFLGN+GLCG +GNC P S PP
Sbjct: 662 LLGCNFSNNDLTGPLPSLPLFQKTGISSFLGNKGLCGGTLGNCNEFPHLSSHPPDTEGTS 721
Query: 759 -----------------------------------------------LNNVYFPPKEGFS 771
++++YF PK+GF+
Sbjct: 722 VRIGKIIAIISAVIGGSSLILIIVIIYFMRRPVAIIASLPDKPSSSPVSDIYFSPKDGFT 781
Query: 772 FQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILT 831
FQD+V AT NF DSF++G GA GTVYKAV+ G+I+AVK+LASNREGNNI++SFRAEILT
Sbjct: 782 FQDLVVATDNFDDSFVLGRGACGTVYKAVLRCGRIIAVKRLASNREGNNIDNSFRAEILT 841
Query: 832 LGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEG 891
LG IRHRNIVKLYGFC HQGSNLL+YEY+ RGSLGELLHGSSC L+W TRF IALGAA+G
Sbjct: 842 LGNIRHRNIVKLYGFCNHQGSNLLLYEYLARGSLGELLHGSSCGLDWRTRFKIALGAAQG 901
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
LAYLHHDCKPRIFHRDIKSNNILLD+KFEAHVGDFGLAKVIDMPQ KSMSAVAGSYGYIA
Sbjct: 902 LAYLHHDCKPRIFHRDIKSNNILLDEKFEAHVGDFGLAKVIDMPQWKSMSAVAGSYGYIA 961
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011
PEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ LD GGDL +WVRNYI+ HSL+PG+ D
Sbjct: 962 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQSLDQGGDLVSWVRNYIQVHSLSPGMLD 1021
Query: 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061
R+N++D++ + HMI V+K+AL+CTS+SP DRP+MREVVSML+ESN+ EG
Sbjct: 1022 DRINLQDQNTIPHMITVMKIALVCTSMSPLDRPTMREVVSMLMESNKLEG 1071
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297741905|emb|CBI33340.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1413 bits (3658), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 760/1066 (71%), Positives = 849/1066 (79%), Gaps = 59/1066 (5%)
Query: 26 MLKKLKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTD 85
M K +SRR+ V GF +V LLVC +EGLNSEG LLELK+ L+D+FN L +W +D
Sbjct: 1 MSKNCRSRRLFGVGFTGFLIVAALLVCGSEGLNSEGLLLLELKHGLYDQFNHLYNWNPSD 60
Query: 86 QTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPRE 145
QTPC WIGVNCT ++PVV SLDLN+MN +G+LSPSIGGL +LTYLD+++N LTG IP+E
Sbjct: 61 QTPCGWIGVNCTG-YDPVVISLDLNSMNLSGTLSPSIGGLSYLTYLDVSHNGLTGNIPKE 119
Query: 146 IGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVA 205
IGNCS+LE L LN+NQF G IPAE C+ LS L D
Sbjct: 120 IGNCSKLETLCLNDNQFDGSIPAEF-----------CS-------------LSCLTDLNV 155
Query: 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKE 265
N L+GP P+ IGNL L A N ++G +P +SL+ QN I GSLP E
Sbjct: 156 CNNKLSGPFPEEIGNLYALVELVAYTNNLTGPLPRSFGNLKSLKTFRAGQNAISGSLPAE 215
Query: 266 IGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
IG F+P ELGNCT L+TLALY NNLVG+IP+E+G+LKFL KLY+
Sbjct: 216 IGGC---------------FVPKELGNCTHLETLALYQNNLVGEIPREIGSLKFLKKLYI 260
Query: 326 YRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE 385
YRNELNGTIPREIGNLS TEID SEN L G IPTEFSKI GL+LL+LFQN+L+GVIPNE
Sbjct: 261 YRNELNGTIPREIGNLSQATEIDFSENYLTGGIPTEFSKIKGLKLLYLFQNELSGVIPNE 320
Query: 386 LSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDF 445
LSSLRNL KLDLSIN LTGPIPVGFQ+LTQM QLQLF+N LTG IP LGLYS LWVVDF
Sbjct: 321 LSSLRNLAKLDLSINNLTGPIPVGFQYLTQMFQLQLFDNRLTGRIPQALGLYSPLWVVDF 380
Query: 446 SHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLE 505
S N+LTG IP H+C+ SNLI+LNL NKL+GNIP VL C++L+QLRLVGNSLTGSFPLE
Sbjct: 381 SQNHLTGSIPSHICRRSNLILLNLESNKLYGNIPMGVLKCKSLVQLRLVGNSLTGSFPLE 440
Query: 506 LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNI 565
LC+L NL AIELDQNKFSG IPPEI NC++LQRLH+ANNYFTSELPKE+GNLS+LVTFNI
Sbjct: 441 LCRLVNLSAIELDQNKFSGLIPPEIANCRRLQRLHLANNYFTSELPKEIGNLSELVTFNI 500
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
SSN LTG IPP IVNC LQRLD+S NSFV +LP ELGTL QLE+LKLSENKFSGNIP+
Sbjct: 501 SSNFLTGQIPPTIVNCKMLQRLDLSRNSFVDALPKELGTLLQLELLKLSENKFSGNIPAA 560
Query: 626 LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLL 685
LGNLSHLTELQMGGNLFSGEIPPELG LSSLQIA+NLSYNNL G IPPELG L LLEFLL
Sbjct: 561 LGNLSHLTELQMGGNLFSGEIPPELGALSSLQIAMNLSYNNLLGRIPPELGNLILLEFLL 620
Query: 686 LNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVG 745
LNNNHLSGEIPS F NLSSL+G NFSYN+LTGPLPSIP FQNM SSF+GNEGLCG +
Sbjct: 621 LNNNHLSGEIPSTFGNLSSLMGCNFSYNDLTGPLPSIPLFQNMVSSSFIGNEGLCGGRLS 680
Query: 746 NCGASPSSGSVPPLNNVYFPPK-------------------EGFSFQDVVEATYNFHDSF 786
NC +PS SVPP P+ EGF+FQD+VEAT NFHDS+
Sbjct: 681 NCNGTPSFSSVPPSLESVDAPRGKIITVVAAVVGGISLILIEGFTFQDLVEATNNFHDSY 740
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+VG GA GTVYKAVM SG+ +AVKKLASNREGN+I++SFRAEILTLGKIRHRNIVKLYGF
Sbjct: 741 VVGRGACGTVYKAVMHSGQTIAVKKLASNREGNSIDNSFRAEILTLGKIRHRNIVKLYGF 800
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
CYHQGSNLL+YEYM RGSLGELLHG+SC+LEW TRF IALGAAEGLAYLHHDCKPRI HR
Sbjct: 801 CYHQGSNLLLYEYMARGSLGELLHGASCSLEWQTRFTIALGAAEGLAYLHHDCKPRIIHR 860
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
DIKSNNILLD FEAHVGDFGLAKV+DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI
Sbjct: 861 DIKSNNILLDSNFEAHVGDFGLAKVVDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 920
Query: 967 YSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMI 1026
YSYGVVLLELLTGRTPVQPLD GGDL +WVRNYIRDHSLT IFDTRLN+EDE+ VDHMI
Sbjct: 921 YSYGVVLLELLTGRTPVQPLDQGGDLVSWVRNYIRDHSLTSEIFDTRLNLEDENTVDHMI 980
Query: 1027 LVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSSPTYDLP 1072
VLK+A++CT++SP DRPSMREVV MLIESNE EG + SSP DLP
Sbjct: 981 AVLKIAILCTNMSPPDRPSMREVVLMLIESNEHEGYYISSPINDLP 1026
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 1078 | ||||||
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.667 | 0.640 | 0.659 | 0.0 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.660 | 0.646 | 0.607 | 0.0 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.639 | 0.625 | 0.503 | 3.2e-285 | |
| TAIR|locus:2120362 | 1249 | GSO1 "GASSHO1" [Arabidopsis th | 0.598 | 0.516 | 0.394 | 3.4e-182 | |
| TAIR|locus:2154344 | 1135 | AT5G48940 [Arabidopsis thalian | 0.618 | 0.587 | 0.358 | 8.1e-179 | |
| TAIR|locus:2161825 | 1090 | AT5G56040 [Arabidopsis thalian | 0.599 | 0.592 | 0.383 | 6.5e-177 | |
| TAIR|locus:2131518 | 1091 | AT4G26540 [Arabidopsis thalian | 0.564 | 0.558 | 0.398 | 7.4e-176 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.550 | 0.519 | 0.370 | 1.4e-174 | |
| TAIR|locus:2011339 | 1120 | AT1G35710 [Arabidopsis thalian | 0.585 | 0.563 | 0.391 | 4.7e-172 | |
| TAIR|locus:2007918 | 1088 | PEPR2 "PEP1 receptor 2" [Arabi | 0.653 | 0.647 | 0.358 | 1.3e-171 |
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2468 (873.8 bits), Expect = 0., Sum P(2) = 0.
Identities = 481/729 (65%), Positives = 567/729 (77%)
Query: 41 VGFWLVVMLLVCTTEGLNSEGHYLLELKN-SLHDEFNFLKSWKSTDQTPCSWIGVNCTSD 99
VG ++ LLV T+E LNS+G +LLELKN D N L +W D+TPC+WIGVNC+S
Sbjct: 17 VGVLFLLTLLVWTSESLNSDGQFLLELKNRGFQDSLNRLHNWNGIDETPCNWIGVNCSSQ 76
Query: 100 FEP------VVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLE 153
VV SLDL++MN +G +SPSIGGLV+L YL+LAYN LTG IPREIGNCS+LE
Sbjct: 77 GSSSSSNSLVVTSLDLSSMNLSGIVSPSIGGLVNLVYLNLAYNALTGDIPREIGNCSKLE 136
Query: 154 HLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGP 213
++LNNNQF G IP E+ KLS L S NICNN +SG LPE +G+L +L + VAYTNNLTGP
Sbjct: 137 VMFLNNNQFGGSIPVEINKLSQLRSFNICNNKLSGPLPEEIGDLYNLEELVAYTNNLTGP 196
Query: 214 LPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLT 273
LP+S+GNL L FRAGQN SG+IP EI C +L++LGLAQN I G LPKEIGML L
Sbjct: 197 LPRSLGNLNKLTTFRAGQNDFSGNIPTEIGKCLNLKLLGLAQNFISGELPKEIGMLVKLQ 256
Query: 274 EIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGT 333
E++LW N+ +GFIP ++GN T L+TLALY N+LVG IP E+GN+K L KLYLY+N+LNGT
Sbjct: 257 EVILWQNKFSGFIPKDIGNLTSLETLALYGNSLVGPIPSEIGNMKSLKKLYLYQNQLNGT 316
Query: 334 IPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT 393
IP+E+G LS V EID SEN L+GEIP E SKI+ LRLL+LFQN+LTG+IPNELS LRNL
Sbjct: 317 IPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYLFQNKLTGIIPNELSKLRNLA 376
Query: 394 KLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGR 453
KLDLSIN LTGPIP GFQ+LT MRQLQLF NSL+G IP GLGLYS LWVVDFS N L+G+
Sbjct: 377 KLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQGLGLYSPLWVVDFSENQLSGK 436
Query: 454 IPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLY 513
IPP +CQ SNLI+LNLG N++FGNIP VL C++LLQLR+VGN LTG FP ELCKL NL
Sbjct: 437 IPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRVVGNRLTGQFPTELCKLVNLS 496
Query: 514 AIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGL 573
AIELDQN+FSGP+PPEI CQKLQRLH+A N F+S LP E+ LS LVTFN+SSN LTG
Sbjct: 497 AIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNEISKLSNLVTFNVSSNSLTGP 556
Query: 574 IPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT 633
IP EI NC LQRLD+S NSF+GSLP ELG+L QLEIL+LSEN+FSGNIP T+GNL+HLT
Sbjct: 557 IPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRLSENRFSGNIPFTIGNLTHLT 616
Query: 634 ELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEXXXXXXXXXXXXXXXXXSG 693
ELQMGGNLFSG IPP+LG LSSLQIA+NLSYN+ SG IPPE SG
Sbjct: 617 ELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPPEIGNLHLLMYLSLNNNHLSG 676
Query: 694 EIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPSS 753
EIP+ FENLSSLLG NFSYNNLTG LP FQNM ++SFLGN+GLCG + +C PS
Sbjct: 677 EIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSFLGNKGLCGGHLRSC--DPSH 734
Query: 754 GSVPPLNNV 762
S P ++++
Sbjct: 735 SSWPHISSL 743
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2221 (786.9 bits), Expect = 0., Sum P(2) = 0.
Identities = 435/716 (60%), Positives = 536/716 (74%)
Query: 33 RRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWI 92
+ ++++ + L+++LL+ T GLN EG YLLE+K+ D L++W S D PC W
Sbjct: 3 KEMMKLAVFFISLLLILLISETTGLNLEGQYLLEIKSKFVDAKQNLRNWNSNDSVPCGWT 62
Query: 93 GVNCTS-DFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSR 151
GV C++ +P V SL+L++M +G LSPSIGGLVHL LDL+YN L+G IP+EIGNCS
Sbjct: 63 GVMCSNYSSDPEVLSLNLSSMVLSGKLSPSIGGLVHLKQLDLSYNGLSGKIPKEIGNCSS 122
Query: 152 LEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLT 211
LE L LNNNQF G+IP E+GKL SL +L I NN ISG+LP +GNL SL V Y+NN++
Sbjct: 123 LEILKLNNNQFDGEIPVEIGKLVSLENLIIYNNRISGSLPVEIGNLLSLSQLVTYSNNIS 182
Query: 212 GPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLES 271
G LP+SIGNL+ L FRAGQN ISGS+P+EI GC+SL +LGLAQN + G LPKEIGML+
Sbjct: 183 GQLPRSIGNLKRLTSFRAGQNMISGSLPSEIGGCESLVMLGLAQNQLSGELPKEIGMLKK 242
Query: 272 LTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELN 331
L++++LW+N+ +GFIP E+ NCT L+TLALY N LVG IPKE+G+L+ L LYLYRN LN
Sbjct: 243 LSQVILWENEFSGFIPREISNCTSLETLALYKNQLVGPIPKELGDLQSLEFLYLYRNGLN 302
Query: 332 GTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRN 391
GTIPREIGNLS EID SEN+L GEIP E I GL LL+LF+NQLTG IP ELS+L+N
Sbjct: 303 GTIPREIGNLSYAIEIDFSENALTGEIPLELGNIEGLELLYLFENQLTGTIPVELSTLKN 362
Query: 392 LTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLT 451
L+KLDLSIN LTGPIP+GFQ+L + LQLF+NSL+G IPP LG YS LWV+D S N+L+
Sbjct: 363 LSKLDLSINALTGPIPLGFQYLRGLFMLQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLS 422
Query: 452 GRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLEN 511
GRIP +LC +SN+I+LNLG N L GNIPT + C+TL+QLRL N+L G FP LCK N
Sbjct: 423 GRIPSYLCLHSNMIILNLGTNNLSGNIPTGITTCKTLVQLRLARNNLVGRFPSNLCKQVN 482
Query: 512 LYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLT 571
+ AIEL QN+F G IP E+ NC LQRL +A+N FT ELP+E+G LSQL T NISSN LT
Sbjct: 483 VTAIELGQNRFRGSIPREVGNCSALQRLQLADNGFTGELPREIGMLSQLGTLNISSNKLT 542
Query: 572 GLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSH 631
G +P EI NC LQRLD+ N+F G+LP+E+G+L QLE+LKLS N SG IP LGNLS
Sbjct: 543 GEVPSEIFNCKMLQRLDMCCNNFSGTLPSEVGSLYQLELLKLSNNNLSGTIPVALGNLSR 602
Query: 632 LTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEXXXXXXXXXXXXXXXXX 691
LTELQMGGNLF+G IP ELG L+ LQIALNLSYN L+G IPPE
Sbjct: 603 LTELQMGGNLFNGSIPRELGSLTGLQIALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNL 662
Query: 692 SGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNC 747
SGEIPS+F NLSSLLG NFSYN+LTGP+P + +N+ +SSF+GNEGLCG P+ C
Sbjct: 663 SGEIPSSFANLSSLLGYNFSYNSLTGPIPLL---RNISMSSFIGNEGLCGPPLNQC 715
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1704 (604.9 bits), Expect = 3.2e-285, Sum P(2) = 3.2e-285
Identities = 348/691 (50%), Positives = 454/691 (65%)
Query: 57 LNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTG 116
LN EG LLE K L+D +L SW D PC+W G+ CT V S+DLN MN +G
Sbjct: 24 LNEEGRVLLEFKAFLNDSNGYLASWNQLDSNPCNWTGIACTH--LRTVTSVDLNGMNLSG 81
Query: 117 SLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSL 176
+LSP I L L L+++ N ++G IP+++ C LE L L N+F G IP +L + +L
Sbjct: 82 TLSPLICKLHGLRKLNVSTNFISGPIPQDLSLCRSLEVLDLCTNRFHGVIPIQLTMIITL 141
Query: 177 VSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG 236
L +C N + G++P +GNLSSL + V Y+NNLTG +P S+ LR LR+ RAG+N SG
Sbjct: 142 KKLYLCENYLFGSIPRQIGNLSSLQELVIYSNNLTGVIPPSMAKLRQLRIIRAGRNGFSG 201
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
IP+EISGC+SL++LGLA+N + GSLPK++ L++LT+++LW N+L+G IP +GN ++L
Sbjct: 202 VIPSEISGCESLKVLGLAENLLEGSLPKQLEKLQNLTDLILWQNRLSGEIPPSVGNISRL 261
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
+ LAL+ N G IP+E+G L + +LYLY N+L G IPREIGNL EID SEN L G
Sbjct: 262 EVLALHENYFTGSIPREIGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTG 321
Query: 357 EIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQM 416
IP EF I L+LL LF+N L G IP EL L L KLDLSIN L G IP Q L +
Sbjct: 322 FIPKEFGHILNLKLLHLFENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYL 381
Query: 417 RQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFG 476
LQLF+N L G IPP +G YS V+D S N L+G IP H C+ LI+L+LG NKL G
Sbjct: 382 VDLQLFDNQLEGKIPPLIGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSG 441
Query: 477 NIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKL 536
NIP D+ C++L +L L N LTGS P+EL L+NL A+EL QN SG I ++ + L
Sbjct: 442 NIPRDLKTCKSLTKLMLGDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNL 501
Query: 537 QRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVG 596
+RL +ANN FT E+P E+GNL+++V FNISSN LTG IP E+ +C+T+QRLD+S N F G
Sbjct: 502 ERLRLANNNFTGEIPPEIGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSG 561
Query: 597 SLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSL 656
+ ELG L LEIL+LS+N+ +G IP + G+L+ L ELQ+GGNL S IP ELG L+SL
Sbjct: 562 YIAQELGQLVYLEILRLSDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSL 621
Query: 657 QIALNLSYNNLSGSIPPEXXXXXXXXXXXXXXXXXSGEIPSAFENLSSLLGSNFSYNNLT 716
QI+LN+S+NNLSG+IP SGEIP++ NL SLL N S NNL
Sbjct: 622 QISLNISHNNLSGTIPDSLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLV 681
Query: 717 GPLPSIPQFQNMDISSFLGNEGLCGRPVGNC 747
G +P FQ MD S+F GN GLC +C
Sbjct: 682 GTVPDTAVFQRMDSSNFAGNHGLCNSQRSHC 712
|
|
| TAIR|locus:2120362 GSO1 "GASSHO1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1164 (414.8 bits), Expect = 3.4e-182, Sum P(2) = 3.4e-182
Identities = 258/654 (39%), Positives = 366/654 (55%)
Query: 95 NCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEH 154
NC SD V++ N +N G++ +G L +L L+LA N LTG IP ++G S+L++
Sbjct: 213 NC-SDL--TVFTAAENMLN--GTIPAELGRLENLEILNLANNSLTGEIPSQLGEMSQLQY 267
Query: 155 LYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPL 214
L L NQ G IP L L +L +L++ N ++G +PE N+S L+D V N+L+G L
Sbjct: 268 LSLMANQLQGLIPKSLADLGNLQTLDLSANNLTGEIPEEFWNMSQLLDLVLANNHLSGSL 327
Query: 215 PQSI-GNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLT 273
P+SI N NL +SG IP E+S CQSL+ L L+ N + GS+P+ + L LT
Sbjct: 328 PKSICSNNTNLEQLVLSGTQLSGEIPVELSKCQSLKQLDLSNNSLAGSIPEALFELVELT 387
Query: 274 EIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGT 333
++ L +N L G + + N T LQ L LY NNL G++PKE+ L+ L L+LY N +G
Sbjct: 388 DLYLHNNTLEGTLSPSISNLTNLQWLVLYHNNLEGKLPKEISALRKLEVLFLYENRFSGE 447
Query: 334 IPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT 393
IP+EIGN + + ID+ N GEIP ++ L LL L QN+L G +P L + L
Sbjct: 448 IPQEIGNCTSLKMIDMFGNHFEGEIPPSIGRLKELNLLHLRQNELVGGLPASLGNCHQLN 507
Query: 394 KLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGR 453
LDL+ N L+G IP F L + QL L+ NSL G +P L L ++ SHN L G
Sbjct: 508 ILDLADNQLSGSIPSSFGFLKGLEQLMLYNNSLQGNLPDSLISLRNLTRINLSHNRLNGT 567
Query: 454 IPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLY 513
I P LC +S+ + ++ N IP ++ N + L +LRL N LTG P L K+ L
Sbjct: 568 IHP-LCGSSSYLSFDVTNNGFEDEIPLELGNSQNLDRLRLGKNQLTGKIPWTLGKIRELS 626
Query: 514 AIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGL 573
+++ N +G IP ++ C+KL + + NN+ + +P +G LSQL +SSN
Sbjct: 627 LLDMSSNALTGTIPLQLVLCKKLTHIDLNNNFLSGPIPPWLGKLSQLGELKLSSNQFVES 686
Query: 574 IPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT 633
+P E+ NC L L + NS GS+P E+G L L +L L +N+FSG++P +G LS L
Sbjct: 687 LPTELFNCTKLLVLSLDGNSLNGSIPQEIGNLGALNVLNLDKNQFSGSLPQAMGKLSKLY 746
Query: 634 ELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEXXXXXXXXXXXXXXXXXSG 693
EL++ N +GEIP E+G L LQ AL+LSYNN +G IP +G
Sbjct: 747 ELRLSRNSLTGEIPVEIGQLQDLQSALDLSYNNFTGDIPSTIGTLSKLETLDLSHNQLTG 806
Query: 694 EIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNC 747
E+P + ++ SL N S+NNL G L QF SFLGN GLCG P+ C
Sbjct: 807 EVPGSVGDMKSLGYLNVSFNNLGGKLKK--QFSRWPADSFLGNTGLCGSPLSRC 858
|
|
| TAIR|locus:2154344 AT5G48940 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1061 (378.5 bits), Expect = 8.1e-179, Sum P(2) = 8.1e-179
Identities = 241/673 (35%), Positives = 366/673 (54%)
Query: 45 LVVMLLVCTTEGLNSEGHYLLE-LKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPV 103
L + + +T +E L+ L +S + W +D PC W + C+S +
Sbjct: 24 LFLAFFISSTSASTNEVSALISWLHSSNSPPPSVFSGWNPSDSDPCQWPYITCSSSDNKL 83
Query: 104 VWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFS 163
V +++ ++ P+I L L ++ LTG I EIG+CS L + L++N
Sbjct: 84 VTEINVVSVQLALPFPPNISSFTSLQKLVISNTNLTGAISSEIGDCSELIVIDLSSNSLV 143
Query: 164 GKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRN 223
G+IP+ LGKL +L L + +N ++G +P LG+ SL + + N L+ LP +G +
Sbjct: 144 GEIPSSLGKLKNLQELCLNSNGLTGKIPPELGDCVSLKNLEIFDNYLSENLPLELGKIST 203
Query: 224 LRVFRAGQNA-ISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQL 282
L RAG N+ +SG IP EI C++L++LGLA I GSLP +G L L + ++ L
Sbjct: 204 LESIRAGGNSELSGKIPEEIGNCRNLKVLGLAATKISGSLPVSLGQLSKLQSLSVYSTML 263
Query: 283 TGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLS 342
+G IP ELGNC++L L LY N+L G +PKE+G L+ L K+ L++N L+G IP EIG +
Sbjct: 264 SGEIPKELGNCSELINLFLYDNDLSGTLPKELGKLQNLEKMLLWQNNLHGPIPEEIGFMK 323
Query: 343 MVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402
+ IDLS N +G IP F ++ L+ L L N +TG IP+ LS+ L + + N +
Sbjct: 324 SLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSSNNITGSIPSILSNCTKLVQFQIDANQI 383
Query: 403 TGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNS 462
+G IP L ++ ++N L G IP L L +D S NYLTG +P L Q
Sbjct: 384 SGLIPPEIGLLKELNIFLGWQNKLEGNIPDELAGCQNLQALDLSQNYLTGSLPAGLFQLR 443
Query: 463 NLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKF 522
NL L L N + G IP ++ NC +L++LRLV N +TG P + L+NL ++L +N
Sbjct: 444 NLTKLLLISNAISGVIPLEIGNCTSLVRLRLVNNRITGEIPKGIGFLQNLSFLDLSENNL 503
Query: 523 SGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCM 582
SGP+P EI NC++LQ L+++NN LP + +L++L ++SSN LTG IP + + +
Sbjct: 504 SGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLSSLTKLQVLDVSSNDLTGKIPDSLGHLI 563
Query: 583 TLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT-ELQMGGNL 641
+L RL +S NSF G +P+ LG L++L LS N SG IP L ++ L L + N
Sbjct: 564 SLNRLILSKNSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNS 623
Query: 642 FSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEXXXXXXXXXXXXXXXXXSGEIPSAFEN 701
G IP + L+ L + L++S+N LSG + SG +P + +
Sbjct: 624 LDGFIPERISALNRLSV-LDISHNMLSGDLSA-LSGLENLVSLNISHNRFSGYLPDS-KV 680
Query: 702 LSSLLGSNFSYNN 714
L+G+ NN
Sbjct: 681 FRQLIGAEMEGNN 693
|
|
| TAIR|locus:2161825 AT5G56040 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1121 (399.7 bits), Expect = 6.5e-177, Sum P(2) = 6.5e-177
Identities = 253/660 (38%), Positives = 374/660 (56%)
Query: 57 LNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTG 116
++ +G LL K+ L+ + L SWK+++ PC W+G+ C + V + L M+F G
Sbjct: 28 IDEQGLALLSWKSQLNISGDALSSWKASESNPCQWVGIKCNERGQ--VSEIQLQVMDFQG 85
Query: 117 SL-SPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSS 175
L + ++ + LT L L LTG IP+E+G+ S LE L L +N SG+IP ++ KL
Sbjct: 86 PLPATNLRQIKSLTLLSLTSVNLTGSIPKELGDLSELEVLDLADNSLSGEIPVDIFKLKK 145
Query: 176 LVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNA-I 234
L L++ N + G +P LGNL +L++ + N L G +P++IG L+NL +FRAG N +
Sbjct: 146 LKILSLNTNNLEGVIPSELGNLVNLIELTLFDNKLAGEIPRTIGELKNLEIFRAGGNKNL 205
Query: 235 SGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCT 294
G +P EI C+SL LGLA+ + G LP IG L+ + I L+ + L+G IP E+GNCT
Sbjct: 206 RGELPWEIGNCESLVTLGLAETSLSGRLPASIGNLKKVQTIALYTSLLSGPIPDEIGNCT 265
Query: 295 KLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSL 354
+LQ L LY N++ G IP +G LK L L L++N L G IP E+G + +DLSEN L
Sbjct: 266 ELQNLYLYQNSISGSIPVSMGRLKKLQSLLLWQNNLVGKIPTELGTCPELFLVDLSENLL 325
Query: 355 NGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLT 414
G IP F + L+ L L NQL+G IP EL++ LT L++ N ++G IP LT
Sbjct: 326 TGNIPRSFGNLPNLQELQLSVNQLSGTIPEELANCTKLTHLEIDNNQISGEIPPLIGKLT 385
Query: 415 QMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
+ ++N LTG IP L L +D S+N L+G IP + + NL L L N L
Sbjct: 386 SLTMFFAWQNQLTGIIPESLSQCQELQAIDLSYNNLSGSIPNGIFEIRNLTKLLLLSNYL 445
Query: 475 FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQ 534
G IP D+ NC L +LRL GN L G+ P E+ L+NL I++ +N+ G IPPEI C
Sbjct: 446 SGFIPPDIGNCTNLYRLRLNGNRLAGNIPAEIGNLKNLNFIDISENRLIGNIPPEISGCT 505
Query: 535 KLQRLHIANNYFTSELPKEVGNLSQLVTF-NISSNMLTGLIPPEIVNCMTLQRLDISHNS 593
L+ + + +N T LP G L + + F ++S N LTG +P I + L +L+++ N
Sbjct: 506 SLEFVDLHSNGLTGGLP---GTLPKSLQFIDLSDNSLTGSLPTGIGSLTELTKLNLAKNR 562
Query: 594 FVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT-ELQMGGNLFSGEIPPELGD 652
F G +P E+ + + L++L L +N F+G IP+ LG + L L + N F+GEIP
Sbjct: 563 FSGEIPREISSCRSLQLLNLGDNGFTGEIPNELGRIPSLAISLNLSCNHFTGEIPSRFSS 622
Query: 653 LSSLQIALNLSYNNLSGSIPPEXXXXXXXXXXXXXXXXXSGEIPSA--FENLS-SLLGSN 709
L++L L++S+N L+G++ SGE+P+ F L S+L SN
Sbjct: 623 LTNLG-TLDVSHNKLAGNLNV-LADLQNLVSLNISFNEFSGELPNTLFFRKLPLSVLESN 680
|
|
| TAIR|locus:2131518 AT4G26540 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1112 (396.5 bits), Expect = 7.4e-176, Sum P(2) = 7.4e-176
Identities = 247/620 (39%), Positives = 357/620 (57%)
Query: 57 LNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTG 116
L+ +G LL K+ L+ + SW D +PC+W+GV C E V + L M+ G
Sbjct: 25 LDQQGQALLSWKSQLNISGDAFSSWHVADTSPCNWVGVKCNRRGE--VSEIQLKGMDLQG 82
Query: 117 SLS-PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSS 175
SL S+ L LT L L+ LTG IP+EIG+ + LE L L++N SG IP E+ +L
Sbjct: 83 SLPVTSLRSLKSLTSLTLSSLNLTGVIPKEIGDFTELELLDLSDNSLSGDIPVEIFRLKK 142
Query: 176 LVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNA-I 234
L +L++ N + G +P +GNLS LV+ + + N L+G +P+SIG L+NL+V RAG N +
Sbjct: 143 LKTLSLNTNNLEGHIPMEIGNLSGLVELMLFDNKLSGEIPRSIGELKNLQVLRAGGNKNL 202
Query: 235 SGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCT 294
G +P EI C++L +LGLA+ + G LP IG L+ + I ++ + L+G IP E+G CT
Sbjct: 203 RGELPWEIGNCENLVMLGLAETSLSGKLPASIGNLKRVQTIAIYTSLLSGPIPDEIGYCT 262
Query: 295 KLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSL 354
+LQ L LY N++ G IP +G LK L L L++N L G IP E+GN + ID SEN L
Sbjct: 263 ELQNLYLYQNSISGSIPTTIGGLKKLQSLLLWQNNLVGKIPTELGNCPELWLIDFSENLL 322
Query: 355 NGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLT 414
G IP F K+ L+ L L NQ++G IP EL++ LT L++ N +TG IP +L
Sbjct: 323 TGTIPRSFGKLENLQELQLSVNQISGTIPEELTNCTKLTHLEIDNNLITGEIPSLMSNLR 382
Query: 415 QMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
+ ++N LTG IP L L +D S+N L+G IP + NL L L N L
Sbjct: 383 SLTMFFAWQNKLTGNIPQSLSQCRELQAIDLSYNSLSGSIPKEIFGLRNLTKLLLLSNDL 442
Query: 475 FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQ 534
G IP D+ NC L +LRL GN L GS P E+ L+NL +++ +N+ G IPP I C+
Sbjct: 443 SGFIPPDIGNCTNLYRLRLNGNRLAGSIPSEIGNLKNLNFVDISENRLVGSIPPAISGCE 502
Query: 535 KLQRLHIANNYFTSELPKEVGN-LSQLVTF-NISSNMLTGLIPPEIVNCMTLQRLDISHN 592
L+ L + N + L +G L + + F + S N L+ +PP I L +L+++ N
Sbjct: 503 SLEFLDLHTNSLSGSL---LGTTLPKSLKFIDFSDNALSSTLPPGIGLLTELTKLNLAKN 559
Query: 593 SFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT-ELQMGGNLFSGEIPPELG 651
G +P E+ T + L++L L EN FSG IP LG + L L + N F GEIP
Sbjct: 560 RLSGEIPREISTCRSLQLLNLGENDFSGEIPDELGQIPSLAISLNLSCNRFVGEIPSRFS 619
Query: 652 DLSSLQIALNLSYNNLSGSI 671
DL +L + L++S+N L+G++
Sbjct: 620 DLKNLGV-LDVSHNQLTGNL 638
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1031 (368.0 bits), Expect = 1.4e-174, Sum P(2) = 1.4e-174
Identities = 222/599 (37%), Positives = 341/599 (56%)
Query: 78 LKSWKSTDQTPCS-WIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYN 136
L +W S D TPC+ W + C+S + + +D+ ++ SL ++ L L ++
Sbjct: 58 LFNWNSIDNTPCNNWTFITCSS--QGFITDIDIESVPLQLSLPKNLPAFRSLQKLTISGA 115
Query: 137 ELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGN 196
LTG +P +G+C L+ L L++N G IP L KL +L +L + +N ++G +P +
Sbjct: 116 NLTGTLPESLGDCLGLKVLDLSSNGLVGDIPWSLSKLRNLETLILNSNQLTGKIPPDISK 175
Query: 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNA-ISGSIPAEISGCQSLQILGLAQ 255
S L + + N LTG +P +G L L V R G N ISG IP+EI C +L +LGLA+
Sbjct: 176 CSKLKSLILFDNLLTGSIPTELGKLSGLEVIRIGGNKEISGQIPSEIGDCSNLTVLGLAE 235
Query: 256 NDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVG 315
+ G+LP +G L+ L + ++ ++G IPS+LGNC++L L LY N+L G IP+E+G
Sbjct: 236 TSVSGNLPSSLGKLKKLETLSIYTTMISGEIPSDLGNCSELVDLFLYENSLSGSIPREIG 295
Query: 316 NLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQ 375
L L +L+L++N L G IP EIGN S + IDLS N L+G IP+ +++ L +
Sbjct: 296 QLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPSSIGRLSFLEEFMISD 355
Query: 376 NQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
N+ +G IP +S+ +L +L L N ++G IP LT++ + N L G IPPGL
Sbjct: 356 NKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFFAWSNQLEGSIPPGLA 415
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
+ L +D S N LTG IP L NL L L N L G IP ++ NC +L++LRL
Sbjct: 416 DCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQEIGNCSSLVRLRLGF 475
Query: 496 NSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVG 555
N +TG P + L+ + ++ N+ G +P EI +C +LQ + ++NN LP V
Sbjct: 476 NRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMIDLSNNSLEGSLPNPVS 535
Query: 556 NLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSE 615
+LS L ++S+N +G IP + ++L +L +S N F GS+P LG L++L L
Sbjct: 536 SLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPTSLGMCSGLQLLDLGS 595
Query: 616 NKFSGNIPSTLGNLSHLT-ELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPP 673
N+ SG IPS LG++ +L L + N +G+IP ++ L+ L I L+LS+N L G + P
Sbjct: 596 NELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSI-LDLSHNMLEGDLAP 653
|
|
| TAIR|locus:2011339 AT1G35710 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 4.7e-172, Sum P(2) = 4.7e-172
Identities = 248/633 (39%), Positives = 349/633 (55%)
Query: 108 DLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIP 167
DL+ + TG +SPS+G L +LT L L N LT IP E+GN + L L+ N+ +G IP
Sbjct: 132 DLSTNHLTGEISPSLGNLKNLTVLYLHQNYLTSVIPSELGNMESMTDLALSQNKLTGSIP 191
Query: 168 AELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVF 227
+ LG L +L+ L + N ++G +P LGN+ S+ D N LTG +P ++GNL+NL V
Sbjct: 192 SSLGNLKNLMVLYLYENYLTGVIPPELGNMESMTDLALSQNKLTGSIPSTLGNLKNLMVL 251
Query: 228 RAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIP 287
+N ++G IP EI +S+ L L+QN + GS+P +G L++LT + L+ N LTG IP
Sbjct: 252 YLYENYLTGVIPPEIGNMESMTNLALSQNKLTGSIPSSLGNLKNLTLLSLFQNYLTGGIP 311
Query: 288 SELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEI 347
+LGN + L L +N L G IP +GNLK LT LYLY N L G IP E+GN+ + ++
Sbjct: 312 PKLGNIESMIDLELSNNKLTGSIPSSLGNLKNLTILYLYENYLTGVIPPELGNMESMIDL 371
Query: 348 DLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIP 407
L+ N L G IP+ F + L L+L+ N LTGVIP EL ++ ++ LDLS N LTG +P
Sbjct: 372 QLNNNKLTGSIPSSFGNLKNLTYLYLYLNYLTGVIPQELGNMESMINLDLSQNKLTGSVP 431
Query: 408 VGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIML 467
F + T++ L L N L+G IPPG+ S L + N TG P +C+ L +
Sbjct: 432 DSFGNFTKLESLYLRVNHLSGAIPPGVANSSHLTTLILDTNNFTGFFPETVCKGRKLQNI 491
Query: 468 NLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIP 527
+L YN L G IP + +C++L++ R +GN TG +L I+ NKF G I
Sbjct: 492 SLDYNHLEGPIPKSLRDCKSLIRARFLGNKFTGDIFEAFGIYPDLNFIDFSHNKFHGEIS 551
Query: 528 PEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRL 587
E KL L ++NN T +P E+ N++QLV ++S+N L G +P I N L RL
Sbjct: 552 SNWEKSPKLGALIMSNNNITGAIPTEIWNMTQLVELDLSTNNLFGELPEAIGNLTNLSRL 611
Query: 588 DISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIP 647
++ N G +P L L LE L LS N FS IP T + L ++ + N F G IP
Sbjct: 612 RLNGNQLSGRVPAGLSFLTNLESLDLSSNNFSSEIPQTFDSFLKLHDMNLSRNKFDGSIP 671
Query: 648 PELGDLSSLQIALNLSYNNLSGSIPPEXXXXXXXXXXXXXXXXXSGEIPSAFENLSSLLG 707
L L+ L L+LS+N L G IP + SG IP+ FE + +L
Sbjct: 672 -RLSKLTQLT-QLDLSHNQLDGEIPSQLSSLQSLDKLDLSHNNLSGLIPTTFEGMIALTN 729
Query: 708 SNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLC 740
+ S N L GPLP P F+ + N GLC
Sbjct: 730 VDISNNKLEGPLPDTPTFRKATADALEENIGLC 762
|
|
| TAIR|locus:2007918 PEPR2 "PEP1 receptor 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1107 (394.7 bits), Expect = 1.3e-171, Sum P(2) = 1.3e-171
Identities = 257/716 (35%), Positives = 382/716 (53%)
Query: 30 LKSRRVLEVEIVGFWLVVMLLVCTTEGLNSEGHYLLEL-KNSLHDEFNFLKSWK--STDQ 86
+++ +LE+ ++ L V + + LNS+G LL L K+ +WK +++
Sbjct: 1 MRNLGLLEITLLCS-LFVYFRIDSVSSLNSDGLALLSLLKHFDKVPLEVASTWKENTSET 59
Query: 87 TPCS--WIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPR 144
TPC+ W GV C VV +L+L+A +G L IG L L LDL+ N +G +P
Sbjct: 60 TPCNNNWFGVICDLSGN-VVETLNLSASGLSGQLGSEIGELKSLVTLDLSLNSFSGLLPS 118
Query: 145 EIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFV 204
+GNC+ LE+L L+NN FSG++P G L +L L + N +SG +P +G L LVD
Sbjct: 119 TLGNCTSLEYLDLSNNDFSGEVPDIFGSLQNLTFLYLDRNNLSGLIPASVGGLIELVDLR 178
Query: 205 AYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPK 264
NNL+G +P+ +GN L N ++GS+PA + ++L L ++ N +GG L
Sbjct: 179 MSYNNLSGTIPELLGNCSKLEYLALNNNKLNGSLPASLYLLENLGELFVSNNSLGGRLHF 238
Query: 265 EIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLY 324
+ L + L N G +P E+GNC+ L +L + NL G IP +G L+ ++ +
Sbjct: 239 GSSNCKKLVSLDLSFNDFQGGVPPEIGNCSSLHSLVMVKCNLTGTIPSSMGMLRKVSVID 298
Query: 325 LYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPN 384
L N L+G IP+E+GN S + + L++N L GEIP SK+ L+ L LF N+L+G IP
Sbjct: 299 LSDNRLSGNIPQELGNCSSLETLKLNDNQLQGEIPPALSKLKKLQSLELFFNKLSGEIPI 358
Query: 385 ELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVD 444
+ +++LT++ + N LTG +PV L +++L LF N G IP LGL L VD
Sbjct: 359 GIWKIQSLTQMLVYNNTLTGELPVEVTQLKHLKKLTLFNNGFYGDIPMSLGLNRSLEEVD 418
Query: 445 FSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPL 504
N TG IPPHLC L + LG N+L G IP + C+TL ++RL N L+G P
Sbjct: 419 LLGNRFTGEIPPHLCHGQKLRLFILGSNQLHGKIPASIRQCKTLERVRLEDNKLSGVLP- 477
Query: 505 ELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFN 564
E + +L + L N F G IP + +C+ L + ++ N T +P E+GNL L N
Sbjct: 478 EFPESLSLSYVNLGSNSFEGSIPRSLGSCKNLLTIDLSQNKLTGLIPPELGNLQSLGLLN 537
Query: 565 ISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS 624
+S N L G +P ++ C L D+ NS GS+P+ + + L L LS+N F G IP
Sbjct: 538 LSHNYLEGPLPSQLSGCARLLYFDVGSNSLNGSIPSSFRSWKSLSTLVLSDNNFLGAIPQ 597
Query: 625 TLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEXXXXXXXXXX 684
L L L++L++ N F G+IP +G L SL+ L+LS N +G IP
Sbjct: 598 FLAELDRLSDLRIARNAFGGKIPSSVGLLKSLRYGLDLSANVFTGEIPTTLGALINLERL 657
Query: 685 XXXXXXXSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLC 740
+G + S ++L SL + SYN TGP+P + N S F GN LC
Sbjct: 658 NISNNKLTGPL-SVLQSLKSLNQVDVSYNQFTGPIP-VNLLSNS--SKFSGNPDLC 709
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
ID ![]() | Name ![]() | Annotated EC number ![]() | Identity ![]() | Query coverage ![]() | Hit coverage ![]() | RBH(Q2H) ![]() | RBH(H2Q) ![]() |
| O49318 | Y2317_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6564 | 0.9564 | 0.9172 | yes | no |
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| estExt_fgenesh4_pg.C_LG_I0469 | hypothetical protein (1107 aa) | ||||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1078 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-158 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 5e-51 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-47 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-46 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-45 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-44 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-43 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 7e-39 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-36 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-32 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-32 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-32 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 5e-30 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-30 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-29 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-29 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-28 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-28 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-28 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-28 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-28 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-27 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-27 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-27 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 9e-25 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-24 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-24 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 5e-24 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 9e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-23 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-23 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 5e-23 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 6e-23 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-22 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-22 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-22 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-22 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 7e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 2e-21 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-21 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 3e-21 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-21 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-21 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-20 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-20 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-20 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 3e-20 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-20 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-20 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-20 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-20 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 1e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-19 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 2e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 2e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 5e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-18 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 7e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-18 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-17 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-17 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-17 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 3e-17 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 3e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 5e-17 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 6e-17 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-16 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-16 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-16 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-16 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 2e-16 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-16 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-16 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-16 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-16 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-16 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 4e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-16 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-16 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-16 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 4e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 6e-16 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-16 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 6e-16 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 8e-16 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 8e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-16 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-15 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-15 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-15 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-15 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-15 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-15 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-15 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 4e-15 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 5e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 6e-15 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-15 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 8e-15 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-14 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-14 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-14 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-14 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 2e-14 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-14 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-14 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-14 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 8e-14 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-14 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-13 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-13 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-13 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-13 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-13 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-13 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-13 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-13 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 9e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-12 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-12 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 1e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 2e-12 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-12 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-12 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-12 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 5e-12 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-12 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 6e-12 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 9e-12 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 9e-12 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-11 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-11 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-11 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-11 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 4e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-11 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 5e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 7e-11 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 7e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 7e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 8e-11 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 9e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-10 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 1e-10 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 1e-10 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-10 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-10 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-10 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-10 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 3e-10 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 4e-10 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 4e-10 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-10 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-10 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-10 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 6e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-09 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 2e-09 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-09 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-09 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 2e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| pfam08263 | 42 | pfam08263, LRRNT_2, Leucine rich repeat N-terminal | 2e-09 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-09 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 3e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-09 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-09 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 6e-09 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 8e-09 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-09 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-08 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-08 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-08 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 3e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 3e-08 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-08 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-08 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 7e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 9e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-07 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-07 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 2e-07 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-07 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-07 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 2e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-07 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 5e-07 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 6e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-07 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 8e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 2e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-06 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-06 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 9e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-05 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-05 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-05 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-05 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 8e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-05 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 4e-04 | |
| PLN03210 | 1153 | PLN03210, PLN03210, Resistant to P | 4e-04 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 9e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.001 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| cd00116 | 319 | cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribo | 0.001 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.002 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.002 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.002 | |
| PRK15370 | 754 | PRK15370, PRK15370, E3 ubiquitin-protein ligase Sl | 0.003 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 493 bits (1271), Expect = e-158
Identities = 341/1038 (32%), Positives = 502/1038 (48%), Gaps = 171/1038 (16%)
Query: 64 LLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIG 123
LL K+S++D +L +W S+ C W G+ C + V S+DL+ N +G +S +I
Sbjct: 34 LLSFKSSINDPLKYLSNWNSSA-DVCLWQGITCNNSSR--VVSIDLSGKNISGKISSAIF 90
Query: 124 GLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNIC 182
L ++ ++L+ N+L+G IP +I S L +L L+NN F+G IP G + +L +L++
Sbjct: 91 RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLS 148
Query: 183 NNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI 242
NNM L+G +P IG+ +L+V G N + G IP +
Sbjct: 149 NNM------------------------LSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184
Query: 243 SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALY 302
+ SL+ L LA N + G +P+E+G ++SL I L N L+G IP E+G T L L L
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEF 362
NNL G IP +GNLK L L+LY+N+L+G IP I +L + +DLS+NSL+GEIP
Sbjct: 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELV 304
Query: 363 SKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLF 422
++ L +L LF N TG IP L+SL L + LQL+
Sbjct: 305 IQLQNLEILHLFSNNFTGKIPVALTSLPRL------------------------QVLQLW 340
Query: 423 ENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDV 482
N +G IP LG ++ L V+D S N LTG IP LC + N
Sbjct: 341 SNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGN------------------- 381
Query: 483 LNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIA 542
L +L L NSL G IP + C+ L+R+ +
Sbjct: 382 -----LFKLILFSNSLEGE------------------------IPKSLGACRSLRRVRLQ 412
Query: 543 NNYFTSELPKEVGNLSQLVTF-NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNE 601
+N F+ ELP E L LV F +IS+N L G I + +LQ L ++ N F G LP+
Sbjct: 413 DNSFSGELPSEFTKL-PLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471
Query: 602 LGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALN 661
G+ ++LE L LS N+FSG +P LG+LS L +L++ N SGEIP EL L ++L+
Sbjct: 472 FGS-KRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKL-VSLD 529
Query: 662 LSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPS 721
LS+N LSG IP ++ +L L L+ N LSGEIP N+ SL+ N S+N+L G LPS
Sbjct: 530 LSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPS 589
Query: 722 IPQFQNMDISSFLGNEGLCGRPVGNCGASPSSGSVPPLNNVYFPPK-------------- 767
F ++ S+ GN LCG ++ +PP V P
Sbjct: 590 TGAFLAINASAVAGNIDLCG--------GDTTSGLPPCKRVRKTPSWWFYITCTLGAFLV 641
Query: 768 ---EGFSF-----QDVVEAT----------YNFHDSFIVGSGAYGTVYKAVMDSGKIVAV 809
F F ++ +E F DS + S + ++ + I
Sbjct: 642 LALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITINDILSSLKEENVISRG 701
Query: 810 KKLASN-------------REGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856
KK AS +E N++ S +EI +GK++H NIVKL G C + LI
Sbjct: 702 KKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761
Query: 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD 916
+EY+E +L E+L NL W R IA+G A+ L +LH C P + ++ I++D
Sbjct: 762 HEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817
Query: 917 DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 976
K E H+ L ++ +S+ Y+APE T +TEK DIY +G++L+EL
Sbjct: 818 GKDEPHL-RLSLPGLLCTDTKCFISS-----AYVAPETRETKDITEKSDIYGFGLILIEL 871
Query: 977 LTGRTPVQPLDDG-GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMC 1035
LTG++P G + W R D L I D + + + ++ V+ +AL C
Sbjct: 872 LTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWI-DPSIRGDVSVNQNEIVEVMNLALHC 930
Query: 1036 TSISPFDRPSMREVVSML 1053
T+ P RP +V+ L
Sbjct: 931 TATDPTARPCANDVLKTL 948
|
Length = 968 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 180 bits (459), Expect = 5e-51
Identities = 86/266 (32%), Positives = 121/266 (45%), Gaps = 18/266 (6%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+GSG++GTVYKA +GKIVAVK L E + + + R EI L ++ H NIV+L
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ L+ EY E G L + L L IAL GL YLH + I H
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLS-RGGPLSEDEAKKIALQILRGLEYLHSN---GIIH 121
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-YAYTMKVTEKC 964
RD+K NILLD+ + DFGLAK + S S++ G+ Y+APE K
Sbjct: 122 RDLKPENILLDENGVVKIADFGLAKKLLKSSS-SLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 965 DIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024
D++S GV+L ELLTG+ P + + L I L ++
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENI-----------LDQLQLIRRILGPPLEFDEPKWSSG 229
Query: 1025 MILVLKVALMCTSISPFDRPSMREVV 1050
+ C + P RP+ E++
Sbjct: 230 SEEAKDLIKKCLNKDPSKRPTAEEIL 255
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 8e-47
Identities = 75/192 (39%), Positives = 102/192 (53%), Gaps = 8/192 (4%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +GTVY A +GK VA+K + + +++ EI L K+ H NIVKLYG
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKII-KKEDSSSLLEELLREIEILKKLNHPNIVKLYGV 59
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ L+ EY E GSL +LL + L I L EGL YLH I HR
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHS-NG--IIHR 116
Query: 907 DIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-YAYTMKVTEKC 964
D+K NILLD D + + DFGL+K++ +S + V G+ Y+APE +EK
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSEKS 175
Query: 965 DIYSYGVVLLEL 976
DI+S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 2e-46
Identities = 77/264 (29%), Positives = 115/264 (43%), Gaps = 22/264 (8%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G++G VY A +GK+VA+K + ++ EI L K++H NIV+LY
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVI-KKKKIKKDRERILREIKILKKLKHPNIVRLYD 64
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ L+ EY E G L +LL E RF L YLH I H
Sbjct: 65 VFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARF-YLRQILSALEYLH---SKGIVH 120
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RD+K NILLD+ + DFGLA+ +D + ++ G+ Y+APE + D
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGE--KLTTFVGTPEYMAPEVLLGKGYGKAVD 178
Query: 966 IYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHM 1025
I+S GV+L ELLTG+ P L + I + ++ E + ++ +
Sbjct: 179 IWSLGVILYELLTGKP---PFPGDDQLLELFKK-IGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 1026 ILVLKVALMCTSISPFDRPSMREV 1049
LV P R + E
Sbjct: 235 -LVKD---------PEKRLTAEEA 248
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 2e-45
Identities = 78/277 (28%), Positives = 119/277 (42%), Gaps = 39/277 (14%)
Query: 789 GSGAYGTVYKAVMDSGKI-----VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
G GA+G VYK + VAVK L + IE F E + K+ H N+VKL
Sbjct: 8 GEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNVVKL 66
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
G C + ++ EYME G L L + L AL A G+ YL K I
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES--KNFI 124
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS---YGYIAPEYAYTMKV 960
HRD+ + N L+ + + DFGL++ + G ++APE K
Sbjct: 125 -HRDLAARNCLVGENLVVKISDFGLSRDLY---DDDYYRKRGGKLPIRWMAPESLKEGKF 180
Query: 961 TEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIR---DHSLTPGIFDTRLNV 1016
T K D++S+GV+L E+ T G P + + ++ +++N R + P ++D
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSN-EEVLEYLKNGYRLPQPPNCPPELYD----- 234
Query: 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ L C + P DRP+ E+V +L
Sbjct: 235 --------------LMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 161 bits (411), Expect = 1e-44
Identities = 79/280 (28%), Positives = 111/280 (39%), Gaps = 44/280 (15%)
Query: 789 GSGAYGTVYKAVMDSGK-----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
G GA+G VYK + VAVK L E F E + K+ H NIV+L
Sbjct: 8 GEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIVRL 66
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
G C ++ EYM G L + L L +AL A+G+ YL
Sbjct: 67 LGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE---SKNF 123
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTM 958
HRD+ + N L+ + + DFGL++ I G G + APE
Sbjct: 124 VHRDLAARNCLVTENLVVKISDFGLSRDI---YEDDYYRKRGG-GKLPIKWMAPESLKDG 179
Query: 959 KVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL--- 1014
K T K D++S+GV+L E+ T G P + V + D RL
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-----NEEVLELLED--------GYRLPRP 226
Query: 1015 -NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
N DE + ++ L C + P DRP+ E+V L
Sbjct: 227 ENCPDE--------LYELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 2e-43
Identities = 76/275 (27%), Positives = 119/275 (43%), Gaps = 34/275 (12%)
Query: 789 GSGAYGTVYKAVMDSGKI-----VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
G GA+G VYK + VAVK L + IE F E + K+ H NIVKL
Sbjct: 8 GEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIVKL 66
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPR 902
G C + +++ EYM G L + L + L AL A G+ YL K
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES--KNF 124
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
I HRD+ + N L+ + + DFGL++ + + ++APE K T
Sbjct: 125 I-HRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKFTS 183
Query: 963 KCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRD---HSLTPGIFDTRLNVED 1018
K D++S+GV+L E+ T G P + + ++ +++ R + P ++
Sbjct: 184 KSDVWSFGVLLWEIFTLGEEPYPGMSN-AEVLEYLKKGYRLPKPPNCPPELY-------- 234
Query: 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
K+ L C + P DRP+ E+V +L
Sbjct: 235 -----------KLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 6e-43
Identities = 81/292 (27%), Positives = 118/292 (40%), Gaps = 57/292 (19%)
Query: 787 IVGSGAYGTVYKAVMDSGK----IVAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
+G GA+G VYK + VAVK L AS E F E + K+ H N
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEE----RKDFLKEARVMKKLGHPN 57
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTR--------FMIALGAAEG 891
+V+L G C + L+ EYME G L + L S P + A+ A+G
Sbjct: 58 VVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI- 950
+ YL + HRD+ + N L+ + + DFGL++ + + G +
Sbjct: 118 MEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVY----DDDYYRKKTGGKLP 170
Query: 951 ----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSL 1005
APE T K D++S+GV+L E+ T G TP L V Y+R
Sbjct: 171 IRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-----NEEVLEYLRK--- 222
Query: 1006 TPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
RL DE + ++ L C + P DRP+ E+V L
Sbjct: 223 -----GYRLPKPEYCPDE--------LYELMLSCWQLDPEDRPTFSELVERL 261
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 7e-39
Identities = 69/203 (33%), Positives = 98/203 (48%), Gaps = 22/203 (10%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFR-----AEILTLGKIRHRNIV 841
+G G +G VYKA +GK VA+K + +ES + EI L K +H NIV
Sbjct: 8 IGKGGFGEVYKARHKRTGKEVAIKVI-------KLESKEKKEKIINEIQILKKCKHPNIV 60
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
K YG Y + L ++ E+ GSL +LL ++ L + +GL YLH
Sbjct: 61 KYYG-SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLH---S 116
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
I HRDIK+ NILL E + DFGL+ + D +M G+ ++APE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVINGKP 173
Query: 960 VTEKCDIYSYGVVLLELLTGRTP 982
K DI+S G+ +EL G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 3e-37
Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 12/202 (5%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
++G G++G+VY A+ D+G+++AVK + + + + EI L ++H NIV+ YG
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 846 FCYH-QGSNLLIY-EYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKP 901
+ + L I+ EY+ GSL LL L P ++ + EGLAYLH
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGK-LPEPVIRKYTRQI--LEGLAYLH---SN 120
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPEYAYTMKV 960
I HRDIK NIL+D + DFG AK + D+ + +V G+ ++APE +
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY 180
Query: 961 TEKCDIYSYGVVLLELLTGRTP 982
DI+S G ++E+ TG+ P
Sbjct: 181 GRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-36
Identities = 70/211 (33%), Positives = 103/211 (48%), Gaps = 22/211 (10%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G G+ G VYK +GKI A+KK+ + + E+ TL +VK YG
Sbjct: 10 GQGSSGVVYKVRHKPTGKIYALKKIHVDGD-EEFRKQLLRELKTLRSCESPYVVKCYGAF 68
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCKPRIFH 905
Y +G ++ EYM+ GSL +LL P + IA +GL YLH K I H
Sbjct: 69 YKEGEISIVLEYMDGGSLADLL--KKVGK-IPEPVLAYIARQILKGLDYLHT--KRHIIH 123
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE------YAYTMK 959
RDIK +N+L++ K E + DFG++KV++ + + V G+ Y++PE Y+Y
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGESYSY--- 179
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQPLDDGG 990
DI+S G+ LLE G+ P P
Sbjct: 180 ---AADIWSLGLTLLECALGKFPFLPPGQPS 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-32
Identities = 68/207 (32%), Positives = 106/207 (51%), Gaps = 12/207 (5%)
Query: 779 TYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH 837
Y D ++G GA+G VYK + +++G VA+K+++ + S EI L ++H
Sbjct: 1 NYQLGD--LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKH 58
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLH 896
NIVK G S +I EY E GSL +++ ++ + +GLAYLH
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV--LQGLAYLH 116
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAVAGSYGYIAPEYA 955
+ + HRDIK+ NIL + DFG+A K+ D+ SK ++V G+ ++APE
Sbjct: 117 ---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV--SKDDASVVGTPYWMAPEVI 171
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ DI+S G ++ELLTG P
Sbjct: 172 EMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 72/214 (33%), Positives = 101/214 (47%), Gaps = 23/214 (10%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G VY AV +D+G+++AVK++ E+ L ++H N+VK YG
Sbjct: 8 IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGV 67
Query: 847 CYHQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
H+ + EY G+L ELL HG + + + L EGLAYLH I H
Sbjct: 68 EVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLH---SHGIVH 122
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG--------YIAPEYAYT 957
RDIK NI LD +GDFG A + K+ + G Y+APE
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKL-----KNNTTTMGEEVQSLAGTPAYMAPEVITG 177
Query: 958 MKVTEK---CDIYSYGVVLLELLTGRTPVQPLDD 988
K DI+S G V+LE+ TG+ P LD+
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 3e-32
Identities = 87/301 (28%), Positives = 123/301 (40%), Gaps = 25/301 (8%)
Query: 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRH-R 838
++ +G G++G VY A K+VA+K LA E + F EI L + H
Sbjct: 1 SYRILRKLGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLH--GSSCNLEWPTRFMIALGAAEGLAYLH 896
NIVKLY F +GS L+ EY++ GSL +LL G L I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 897 HDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKS-----MSAVAGSYGYI 950
I HRDIK NILLD D + DFGLAK++ P S S S G+ GY+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 951 APEYAYTM---KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLA-TWVRNYIRDHSLT 1006
APE + + DI+S G+ L ELLTG P + + + T
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSS 1066
++ + P +R S +S + ++ + + S
Sbjct: 236 ASPLSPSNPELISKAASDLL------KKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLS 289
Query: 1067 P 1067
Sbjct: 290 D 290
|
Length = 384 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-30
Identities = 69/221 (31%), Positives = 95/221 (42%), Gaps = 38/221 (17%)
Query: 782 FHDSFI-----VGSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESS-FRAEIL 830
F + +G G +G V D +G+ VAVK L N G S F EI
Sbjct: 1 FEKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIE 58
Query: 831 TLGKIRHRNIVKLYGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGA 888
L + H NIVK G C G LI EY+ GSL + L + + +
Sbjct: 59 ILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQI 118
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG 948
+G+ YL R HRD+ + NIL++ + + DFGLAKV+ P+ K Y
Sbjct: 119 CKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVL--PEDK-------DYY 166
Query: 949 YI-----------APEYAYTMKVTEKCDIYSYGVVLLELLT 978
Y+ APE T K + D++S+GV L EL T
Sbjct: 167 YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 9e-30
Identities = 62/198 (31%), Positives = 105/198 (53%), Gaps = 11/198 (5%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G+YG+VYKA+ ++G++VA+K + + I EI L + IVK YG
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK----EISILKQCDSPYIVKYYG 65
Query: 846 FCYHQGSNLLI-YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
Y + ++L I EY GS+ +++ ++ L I +GL YLH +
Sbjct: 66 -SYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKI 121
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRDIK+ NILL+++ +A + DFG++ + +K + V G+ ++APE + K
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAK-RNTVIGTPFWMAPEVIQEIGYNNKA 180
Query: 965 DIYSYGVVLLELLTGRTP 982
DI+S G+ +E+ G+ P
Sbjct: 181 DIWSLGITAIEMAEGKPP 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 7e-29
Identities = 72/210 (34%), Positives = 108/210 (51%), Gaps = 19/210 (9%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR----NIVKL 843
G+G G V K + +GKI+AVK + I + + +IL I H+ IV
Sbjct: 10 GAGNSGVVSKVLHRPTGKIMAVKTIRLE-----INEAIQKQILRELDILHKCNSPYIVGF 64
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCKP 901
YG Y+ G + EYM+ GSL ++L P R + IA+ +GL YLH K
Sbjct: 65 YGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEKHK- 121
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVT 961
I HRD+K +NIL++ + + + DFG++ + S + + V G+ Y+APE +
Sbjct: 122 -IIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LVNSLAKTFV-GTSSYMAPERIQGNDYS 177
Query: 962 EKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
K DI+S G+ L+EL TGR P P +D D
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPD 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 8e-29
Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVK--KLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+GSG YG VYKA +G++VA+K KL G++ E + EI L + RH NIV +
Sbjct: 11 IGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFEI-IQQEISMLKECRHPNIVAYF 66
Query: 845 GFCYHQGSNLLI-YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
G Y + L I EY GSL ++ + L + +GLAYLH K
Sbjct: 67 G-SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK--- 122
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA---YTMKV 960
HRDIK NILL + + + DFG++ + +K S + Y ++APE A
Sbjct: 123 IHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPY-WMAPEVAAVERKGGY 181
Query: 961 TEKCDIYSYGVVLLELLTGRTP 982
KCDI++ G+ +EL + P
Sbjct: 182 DGKCDIWALGITAIELAELQPP 203
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G YG VYKA +G+IVA+KK+ + E I S+ EI L +++H NIVKL
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLD 65
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPRI 903
+ + L++EY + L + L L M L GLAY H RI
Sbjct: 66 VIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQL--LRGLAYCHSH---RI 119
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYTM 958
HRD+K NIL++ + DFGLA+ +P V + Y APE Y+
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW-YRAPEILLGSKHYST 178
Query: 959 KVTEKCDIYSYGVVLLELLTGR 980
V DI+S G + E++TG+
Sbjct: 179 AV----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 65/206 (31%), Positives = 96/206 (46%), Gaps = 14/206 (6%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA+G V+KA ++G+ VA+KK+A R I + EI L +H +VKL
Sbjct: 8 IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDV 67
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPRIF 904
H +L+ EYM L E+L L +M L +G+AY+H I
Sbjct: 68 FPHGSGFVLVMEYMPS-DLSEVLRDEERPLPEAQVKSYMRML--LKGVAYMH---ANGIM 121
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TMKVTEK 963
HRD+K N+L+ + DFGLA++ + + S + Y APE Y K
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPG 181
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDG 989
D+++ G + ELL G PL G
Sbjct: 182 VDLWAVGCIFAELLNG----SPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 71/200 (35%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA G VYKA +GK VA+KK+ N E EIL + +H NIV Y
Sbjct: 27 IGEGASGEVYKATDRATGKEVAIKKM--RLRKQNKELIIN-EILIMKDCKHPNIVDYYD- 82
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPR 902
Y G L ++ EYM+ GSL +++ + + IA E GL YLH
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRM---NEPQIAYVCREVLQGLEYLH---SQN 136
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
+ HRDIKS+NILL + DFG A + +SK S V Y ++APE
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPY-WMAPEVIKRKDYGP 195
Query: 963 KCDIYSYGVVLLELLTGRTP 982
K DI+S G++ +E+ G P
Sbjct: 196 KVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-28
Identities = 73/205 (35%), Positives = 99/205 (48%), Gaps = 11/205 (5%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIE-SSFRAEILTLGKIRHR 838
F +G G YG VY+A SG+IVA+KK+ + E + I SS R EI L +RH
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLR-EITLLLNLRHP 66
Query: 839 NIVKLYGFCY--HQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH 896
NIV+L H S L+ EY E+ L LL + L GL YLH
Sbjct: 67 NIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
+ I HRD+K +N+LL DK + DFGLA+ +P K M+ + Y APE
Sbjct: 126 ENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA-KPMTPKVVTLWYRAPELLL 181
Query: 957 TMKV-TEKCDIYSYGVVLLELLTGR 980
T D+++ G +L ELL +
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 73/279 (26%), Positives = 118/279 (42%), Gaps = 45/279 (16%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G++G VY GK+ +K++ SN E + E+ L K+ H NI+K Y
Sbjct: 8 IGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYE 66
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCN---------LEWPTRFMIALGAAEGLAYLH 896
+G ++ EY + G L + + L+W + L L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW----FVQL--CLALKYLH 120
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA--VAGSYGYIAPEY 954
+I HRDIK NI L +GDFG++KV+ S A V G+ Y++PE
Sbjct: 121 ---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVL---SSTVDLAKTVVGTPYYLSPEL 174
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR-DHSLTPGIFDTR 1013
K DI+S G VL EL T + P + G +L ++ + P + +
Sbjct: 175 CQNKPYNYKSDIWSLGCVLYELCTLKHPFE----GENLLELALKILKGQYPPIPSQYSSE 230
Query: 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052
L ++V ++ P +RPS+ +++
Sbjct: 231 LR----NLVSSLL----------QKDPEERPSIAQILQS 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 12/222 (5%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G YG VYKA +G+IVA+KK+ E I + EI L ++ H NI+KL
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDV 66
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
H+G L++E+M+ L +L+ L +GLA+ H I HR
Sbjct: 67 FRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHR 122
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV-TEKCD 965
D+K N+L++ + + DFGLA+ P V + Y APE K + D
Sbjct: 123 DLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW-YRAPELLLGDKGYSTPVD 181
Query: 966 IYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007
I+S G + ELL+ R P+ P ++ I TP
Sbjct: 182 IWSVGCIFAELLSRR-PLFPGKS--EIDQL--FKIFRTLGTP 218
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 69/208 (33%), Positives = 100/208 (48%), Gaps = 20/208 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
+G G YG VYKA +G++VA+KK+ + +EG I ++ R EI L K+RH NIV+L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPI-TAIR-EIKLLQKLRHPNIVRL 63
Query: 844 YGFC--YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
+GS +++EYM+ L LL EGL YLH +
Sbjct: 64 KEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN--- 119
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----AY 956
I HRDIK +NIL+++ + DFGLA+ S + + Y PE Y
Sbjct: 120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRY 179
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
+V D++S G +L EL G+ Q
Sbjct: 180 GPEV----DMWSVGCILAELFLGKPIFQ 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-27
Identities = 69/206 (33%), Positives = 96/206 (46%), Gaps = 25/206 (12%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G++G V D+GK+ A+K L + +E + E L +I H IVKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTL-TERNILSRINHPFIVKLH 59
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCK 900
+ + L L+ EY G L L E RF AAE L YLH
Sbjct: 60 -YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFY----AAEIVLALEYLH---S 111
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY----AY 956
I +RD+K NILLD + DFGLAK + S++ + G+ Y+APE Y
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY 170
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTP 982
V D +S GV+L E+LTG+ P
Sbjct: 171 GKAV----DWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 66/199 (33%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY 848
G+G +G V+ + VAVK L + G +F E + K+RH +V+LY C
Sbjct: 15 GAGQFGEVWMGTWNGTTKVAVKTL---KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 849 HQGSNLLIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+ ++ EYM +GSL + L G L P +A AEG+AYL HRD
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRD 128
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI---APEYAYTMKVTEKC 964
+ + NIL+ + + DFGLA++I + +A G+ I APE A + T K
Sbjct: 129 LAARNILVGENLVCKIADFGLARLI---EDDEYTAREGAKFPIKWTAPEAANYGRFTIKS 185
Query: 965 DIYSYGVVLLELLT-GRTP 982
D++S+G++L E++T GR P
Sbjct: 186 DVWSFGILLTEIVTYGRVP 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 76/271 (28%), Positives = 115/271 (42%), Gaps = 36/271 (13%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G G +G V G+ VAVK L + ++ F AE + +RH N+V+L G
Sbjct: 14 IGKGEFGDVMLGDY-RGQKVAVKCL--KDDSTAAQA-FLAEASVMTTLRHPNLVQLLGVV 69
Query: 848 YHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
++ EYM +GSL + L G + + + AL EG+ YL H
Sbjct: 70 LQGNPLYIVTEYMAKGSLVDYLRSRGRAV-ITLAQQLGFALDVCEGMEYLEEK---NFVH 125
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RD+ + N+L+ + A V DFGLAK Q V + APE K + K D
Sbjct: 126 RDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK----WTAPEALREKKFSTKSD 181
Query: 966 IYSYGVVLLELLT-GRTPV--QPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022
++S+G++L E+ + GR P PL D+ V R + P E
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVEKGYRMEA--P-----------EGCP 225
Query: 1023 DHMILVLKVALMCTSISPFDRPSMREVVSML 1053
V KV C + P RP+ +++ L
Sbjct: 226 PE---VYKVMKDCWELDPAKRPTFKQLREQL 253
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 9e-25
Identities = 58/196 (29%), Positives = 95/196 (48%), Gaps = 7/196 (3%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+GSG +G V+ + VA+K + REG E F E + K+ H +V+LYG C
Sbjct: 12 IGSGQFGLVWLGYWLEKRKVAIKTI---REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC 68
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+ L++E+ME G L + L T + L EG+AYL + HRD
Sbjct: 69 TERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRD 125
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 967
+ + N L+ + V DFG+ + + Q S + + +PE K + K D++
Sbjct: 126 LAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 968 SYGVVLLELLT-GRTP 982
S+GV++ E+ + G+TP
Sbjct: 186 SFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 66/213 (30%), Positives = 96/213 (45%), Gaps = 23/213 (10%)
Query: 787 IVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G++GTV K S GKI+ K++ + +E+ L +++H NIV+ Y
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66
Query: 846 FCYHQGSNLLIYEYME---RGSLGELLHGSSCNLE---------WPTRFMIALGAAEGLA 893
SN +Y ME G L +L+ C E W R + L A L
Sbjct: 67 R-IIDRSNQTLYIVMEYCEGGDLAQLI--QKCKKERKYIEEEFIW--RILTQLLLA--LY 119
Query: 894 YLHH--DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
H+ D + HRD+K NI LD +GDFGLAK++ S + + V Y Y++
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPY-YMS 178
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
PE M EK DI+S G ++ EL P
Sbjct: 179 PEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 62/197 (31%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+GSG +G V++ + + VA+K L S+ + F+ E+ L ++RH++++ L+ C
Sbjct: 14 LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQD--FQKEVQALKRLRHKHLISLFAVC 71
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSC-NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+I E ME+GSL L L + +A AEG+AYL HR
Sbjct: 72 SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHR 128
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+ + NIL+ + V DFGLA++I S S Y + APE A + K D+
Sbjct: 129 DLAARNILVGEDLVCKVADFGLARLIKEDVYLS-SDKKIPYKWTAPEAASHGTFSTKSDV 187
Query: 967 YSYGVVLLELLT-GRTP 982
+S+G++L E+ T G+ P
Sbjct: 188 WSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 91/299 (30%), Positives = 130/299 (43%), Gaps = 59/299 (19%)
Query: 783 HDSFI--VGSGAYGTV----YKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKI 835
H FI +G G +G+V Y + D+ G++VAVKKL + + F EI L +
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEH--LRDFEREIEILKSL 62
Query: 836 RHRNIVKLYGFCYHQGS-NL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
+H NIVK G CY G NL L+ EY+ GSL + L L+ + A +G+
Sbjct: 63 QHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGME 122
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV----AGSYGY 949
YL R HRD+ + NIL++ + +GDFGL KV+ PQ K V +
Sbjct: 123 YLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVL--PQDKEYYKVREPGESPIFW 177
Query: 950 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009
APE K + D++S+GVVL EL T Y P
Sbjct: 178 YAPESLTESKFSVASDVWSFGVVLYELFT--------------------YSDKSCSPPAE 217
Query: 1010 FDTRL--NVEDESIVDHMILVLK---------------VALM--CTSISPFDRPSMREV 1049
F + + + + IV H+I +LK A+M C + P RPS E+
Sbjct: 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSEL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V++ + ++ VAVK L + G F AE + K+RH +++LY C
Sbjct: 14 LGAGQFGEVWEGLWNNTTPVAVKTL---KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSC-NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ ++ E M+ GSL E L G + L+ P +A A G+AYL HR
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLE---AQNYIHR 127
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+ + N+L+ + V DFGLA+VI ++ + APE A + + K D+
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187
Query: 967 YSYGVVLLELLT-GRTP 982
+S+G++L E++T GR P
Sbjct: 188 WSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 25/207 (12%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFR---AEILTLGKIRHRNIVKL 843
+GSG++G+VY+ + +D G AVK+++ +G + + + EI L K++H NIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 844 YGFCYHQGSNLLIY-EYMERGSLGELL--HGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
G + NL I+ E + GSL +LL +GS P + GL YLH
Sbjct: 68 LG-TEREEDNLYIFLELVPGGSLAKLLKKYGS---FPEPVIRLYTRQILLGLEYLHDR-- 121
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----A 955
HRDIK NIL+D + DFG+AK + + S + GS ++APE
Sbjct: 122 -NTVHRDIKGANILVDTNGVVKLADFGMAKQV-VEFS-FAKSFKGSPYWMAPEVIAQQGG 178
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y + DI+S G +LE+ TG+ P
Sbjct: 179 YGLAA----DIWSLGCTVLEMATGKPP 201
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 30/212 (14%)
Query: 787 IVGSGAYGTVYKAVM----DSGKI-VAVKKL--ASNREGNNIESSFRAEILTLGKIRHRN 839
++GSGA+GTVYK V + KI VA+K L ++ + N E + + H +
Sbjct: 14 VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK---EILDEAYVMASVDHPH 70
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLH------GSSCNLEWPTRFMIALGAAEGLA 893
+V+L G C LI + M G L + + GS L W + A+G++
Sbjct: 71 VVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMS 123
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--GYIA 951
YL + R+ HRD+ + N+L+ + DFGLAK++D K A G ++A
Sbjct: 124 YLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD-VDEKEYHAEGGKVPIKWMA 179
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
E T K D++SYGV + EL+T G P
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-23
Identities = 63/227 (27%), Positives = 97/227 (42%), Gaps = 32/227 (14%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVK---KLASNREGNNIESSFRAEILTLGKI- 835
+F I+G G++ TV A ++ K A+K K +E ++ E L ++
Sbjct: 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-KKVKYVKI-EKEVLTRLN 59
Query: 836 RHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAY 894
H I+KLY + + NL + EY G L + + E TRF A L Y
Sbjct: 60 GHPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAE-ILLALEY 117
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS---------------KS 939
LH I HRD+K NILLD + DFG AKV+D S +
Sbjct: 118 LH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEK 174
Query: 940 MSAVAGSY-G---YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
S+ G Y++PE + D+++ G ++ ++LTG+ P
Sbjct: 175 NRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 66/208 (31%), Positives = 102/208 (49%), Gaps = 22/208 (10%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESS------FRAEILTLGKIRHRNI 840
+G G++G VYKA+ + ++VA+K + ++E + + EI L + R I
Sbjct: 9 IGKGSFGEVYKAIDKRTNQVVAIKVI-------DLEEAEDEIEDIQQEIQFLSQCRSPYI 61
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
K YG + +GS L +I EY GS +LL L+ I GL YLH +
Sbjct: 62 TKYYG-SFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEEG 118
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
K HRDIK+ NILL ++ + + DFG++ + SK + V + ++APE
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPF-WMAPEVIKQSG 174
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQPLD 987
EK DI+S G+ +EL G P+ L
Sbjct: 175 YDEKADIWSLGITAIELAKGEPPLSDLH 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 3e-23
Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 20/204 (9%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEIL----TLGKIRHRNIVKL 843
+G G++G V+K V + K V K + N E R E + L K+ I++
Sbjct: 8 IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRE---REEAIDEARVLAKLDSSYIIRY 64
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGS-----SCNLEWPTRFMIALGAAEGLAYLHHD 898
Y +G ++ EY E G L +LL + W RF I GLA+LH
Sbjct: 65 YESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW--RFFIQ--ILLGLAHLH-- 118
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
+I HRDIKS N+ LD +GD G+AK++ + + + G+ Y++PE
Sbjct: 119 -SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVGTPYYLSPELCEDK 176
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
EK D+++ GVVL E TG+ P
Sbjct: 177 PYNEKSDVWALGVVLYECCTGKHP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 99.9 bits (249), Expect = 5e-23
Identities = 71/211 (33%), Positives = 110/211 (52%), Gaps = 22/211 (10%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN--------NIESSFRAEILTLGKIRH 837
++G G YG VY A+ + +G+++AVK++ ++ + R+EI TL + H
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDH 67
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
NIV+ GF + + EY+ GS+G L E RF EGLAYLH
Sbjct: 68 LNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE-QVLEGLAYLH- 125
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK----VIDMPQSKSMSAVAGSYGYIAPE 953
I HRD+K++N+L+D + DFG++K + D Q+ SM GS ++APE
Sbjct: 126 --SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ---GSVFWMAPE 180
Query: 954 --YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
++Y+ + K DI+S G V+LE+ GR P
Sbjct: 181 VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 6e-23
Identities = 66/203 (32%), Positives = 100/203 (49%), Gaps = 12/203 (5%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLA---SNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G GA+G VY +D+G+ +AVK++ + E ++ EI L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQ 68
Query: 843 LYGFCYHQGSNLLIY-EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
YG C L I+ EYM GS+ + L E TR EG+ YLH +
Sbjct: 69 YYG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTR-KYTRQILEGVEYLHSN--- 123
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSAVAGSYGYIAPEYAYTMK 959
I HRDIK NIL D +GDFG +K + S M +V G+ +++PE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 960 VTEKCDIYSYGVVLLELLTGRTP 982
K D++S G ++E+LT + P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 99.2 bits (248), Expect = 1e-22
Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 35/218 (16%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIE----SSFRAEILTLGKIRHRNIVK 842
+G G Y VYKA ++G+IVA+KK+ + ++ R EI L +++H NI+
Sbjct: 8 LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALR-EIKLLQELKHPNIIG 66
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE----------G 891
L + SN+ L++E+ME L +++ S I L A+ G
Sbjct: 67 LLD-VFGHKSNINLVFEFME-TDLEKVIKDKS----------IVLTPADIKSYMLMTLRG 114
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
L YLH + I HRD+K NN+L+ + DFGLA+ P K V + Y A
Sbjct: 115 LEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRW-YRA 170
Query: 952 PEYAY-TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD 988
PE + D++S G + ELL R P P D
Sbjct: 171 PELLFGARHYGVGVDMWSVGCIFAELLL-RVPFLPGDS 207
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 62/219 (28%), Positives = 93/219 (42%), Gaps = 31/219 (14%)
Query: 788 VGSGAYGTVYKAVMDSGK------IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G GA+G V+ + +VAVK L N+ F E L +H NIV
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIV 71
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPTR-----------FMIALGA 888
K YG C ++++EYME G L + L HG IA+
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS-- 946
A G+ YL HRD+ + N L+ +GDFG+++ + + V G
Sbjct: 132 ASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV---YTTDYYRVGGHTM 185
Query: 947 --YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++ PE K T + D++S+GVVL E+ T G+ P
Sbjct: 186 LPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 3e-22
Identities = 61/197 (30%), Positives = 98/197 (49%), Gaps = 9/197 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G G +G V+ + VA+K L + G +F E + K+RH +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV 70
Query: 848 YHQGSNLLIYEYMERGSLGELLHG-SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ ++ EYM +GSL + L G L P +A A G+AY+ + HR
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+++ NIL+ + V DFGLA++I+ + + + APE A + T K D+
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 967 YSYGVVLLELLT-GRTP 982
+S+G++L EL T GR P
Sbjct: 187 WSFGILLTELTTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 4e-22
Identities = 74/220 (33%), Positives = 102/220 (46%), Gaps = 26/220 (11%)
Query: 782 FHDSFI-----VGSGAYGTV----YKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILT 831
FH ++ +G G +G V Y D +G++VAVK L G S ++ EI
Sbjct: 1 FHKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRE-CGQQNTSGWKKEINI 59
Query: 832 LGKIRHRNIVKLYGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMI-ALGA 888
L + H NIVK G C QG LI EY+ GSL + L NL + ++ A
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNL---AQLLLFAQQI 116
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA---- 944
EG+AYLH HRD+ + N+LLD+ +GDFGLAK + P+ V
Sbjct: 117 CEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEYYRVREDGD 171
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
+ A E K + D++S+GV L ELLT Q
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQ 211
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 97.4 bits (243), Expect = 6e-22
Identities = 68/218 (31%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLA--SNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
G G +G VYKA + +G++VA+KK+ + ++G I ++ R EI L K++H N+V L
Sbjct: 17 GEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPI-TALR-EIKILKKLKHPNVVPLID 74
Query: 846 FCYHQGSNL--------LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
+ ++ YM+ L LL S L L EG+ YLH
Sbjct: 75 MAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLH- 132
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS---YG------ 948
+ I HRDIK+ NIL+D++ + DFGLA+ D P G Y
Sbjct: 133 --ENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTR 190
Query: 949 -YIAPEYA-----YTMKVTEKCDIYSYGVVLLELLTGR 980
Y PE YT V DI+ G V E+ T R
Sbjct: 191 WYRPPELLLGERRYTTAV----DIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 98.4 bits (245), Expect = 7e-22
Identities = 74/260 (28%), Positives = 119/260 (45%), Gaps = 32/260 (12%)
Query: 743 PVGNCGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-M 801
P + +S SS S + S ++ +GSGA GTVYK +
Sbjct: 48 PPPSSSSSSSSSSSASGSAPSAAK----SLSELERVN-------RIGSGAGGTVYKVIHR 96
Query: 802 DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861
+G++ A+K + N E + + EI L + H N+VK + H G ++ E+M+
Sbjct: 97 PTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155
Query: 862 RGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF 919
GSL G+ E +F+ +A G+AYLH + I HRDIK +N+L++
Sbjct: 156 GGSL----EGTHIADE---QFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAK 205
Query: 920 EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLL 974
+ DFG+++++ S+V G+ Y++PE T DI+S GV +L
Sbjct: 206 NVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSIL 264
Query: 975 ELLTGRTPVQPLDDGGDLAT 994
E GR P + GD A+
Sbjct: 265 EFYLGRFPF-GVGRQGDWAS 283
|
Length = 353 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 7e-22
Identities = 64/197 (32%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V+ + VAVK L + G SF E + K+RH +V+LY
Sbjct: 14 LGNGQFGEVWMGTWNGNTKVAVKTL---KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV 70
Query: 848 YHQGSNLLIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ ++ EYM +GSL + L G L+ P +A A G+AY+ + HR
Sbjct: 71 SEE-PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D++S NIL+ D + DFGLA++I+ + + + APE A + T K D+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 967 YSYGVVLLELLT-GRTP 982
+S+G++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 67/217 (30%), Positives = 99/217 (45%), Gaps = 38/217 (17%)
Query: 788 VGSGAYGTVYK------AVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G GA+G VYK S VA+K L N E ++ FR E + ++H NIV
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPK-VQQEFRQEAELMSDLQHPNIV 71
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN---------------LEWPTRFMIAL 886
L G C + +++EY+ G L E L +S + L+ IA+
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 887 GAAEGLAYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP-----QSKS 939
A G+ YL HH HRD+ + N L+ + + DFGL++ I QSKS
Sbjct: 132 QIAAGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKS 186
Query: 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 976
+ V ++ PE K T + DI+S+GVVL E+
Sbjct: 187 LLPVR----WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 2e-21
Identities = 73/276 (26%), Positives = 124/276 (44%), Gaps = 32/276 (11%)
Query: 787 IVGSGAYGTVYKA--VMDSGKIVAVKKLASNR----EGNNIESSFRAEILTLGKIRHRNI 840
+G+GA+ + Y+A V +G ++AVK++ R E + + R EI + ++ H +I
Sbjct: 7 QLGTGAFSSCYQARDVK-TGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT-RFMIALGAAEGLAYLHHDC 899
+++ G L E+M GS+ LL E + L GL+YLH +
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL--LRGLSYLHEN- 122
Query: 900 KPRIFHRDIKSNNILLDDKFE-AHVGDFGLAKVIDMPQSKS---MSAVAGSYGYIAPEYA 955
+I HRD+K N+L+D + + DFG A + + + + G+ ++APE
Sbjct: 123 --QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVL 180
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015
+ CD++S G V++E+ T + P W +H IF
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAKPP------------WNAEKHSNHLAL--IFKIASA 226
Query: 1016 VEDESIVDHMILVLK-VALMCTSISPFDRPSMREVV 1050
SI +H+ L+ V L C + P DRP RE++
Sbjct: 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELL 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 22/211 (10%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH---RNIVK 842
++G GAYG VY+ + +G++VA+K + + +++ R E+ L ++R NI K
Sbjct: 8 LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR-EVALLSQLRQSQPPNITK 66
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
YG Y +G L +I EY E GS+ L+ + +I L Y+H
Sbjct: 67 YYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGP--IAEKYISVIIREVLVALKYIHKV--- 120
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----AY 956
+ HRDIK+ NIL+ + + DFG+A +++ SK + V Y ++APE Y
Sbjct: 121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPY-WMAPEVITEGKYY 179
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQPLD 987
K DI+S G+ + E+ TG P +D
Sbjct: 180 DTKA----DIWSLGITIYEMATGNPPYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 43/222 (19%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLY 844
++G G YG VYKA +G++VA+K + + E + E L K H NI Y
Sbjct: 13 VIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFY 69
Query: 845 GFCYHQGSNL-------LIYEYMERGSLGEL-----LHGSSCNLEWPTRFMIAL---GAA 889
G + + + L+ E GS+ +L G EW IA
Sbjct: 70 G-AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEW-----IAYILRETL 123
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGY 949
GLAYLH + ++ HRDIK NILL E + DFG++ +D + + + Y +
Sbjct: 124 RGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY-W 179
Query: 950 IAPE---------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+APE +Y + D++S G+ +EL G+ P
Sbjct: 180 MAPEVIACDEQPDASYDA----RSDVWSLGITAIELADGKPP 217
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 19/206 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA VY A+ + + + VA+K++ + +++ R E+ + + H N+VK Y
Sbjct: 9 IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDE-LRKEVQAMSQCNHPNVVKYYTS 67
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCN--LEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
L+ Y+ GSL +++ S L+ + +GL YLH
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH---SNGQI 124
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMP---QSKSMSAVAGSYGYIAPE-----YAY 956
HRDIK+ NILL + + DFG++ + K G+ ++APE + Y
Sbjct: 125 HRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGY 184
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTP 982
K DI+S+G+ +EL TG P
Sbjct: 185 ----DFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 3e-21
Identities = 64/210 (30%), Positives = 109/210 (51%), Gaps = 15/210 (7%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G YGTV+KA ++ +IVA+K++ + + + SS EI L +++H+NIV+LY
Sbjct: 8 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCN--LEWPT--RFMIALGAAEGLAYLHHDCKPR 902
+ L++EY ++ L + SCN ++ FM L +GLA+ H
Sbjct: 68 LHSDKKLTLVFEYCDQ-DLKKYF--DSCNGDIDPEIVKSFMFQL--LKGLAFCHSH---N 119
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV-T 961
+ HRD+K N+L++ E + DFGLA+ +P + SA + Y P+ + K+ +
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYS 178
Query: 962 EKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
D++S G + EL P+ P +D D
Sbjct: 179 TSIDMWSAGCIFAELANAGRPLFPGNDVDD 208
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 76/294 (25%), Positives = 125/294 (42%), Gaps = 43/294 (14%)
Query: 781 NFHDSFIVGSGAYGTVYKAVM------DSGKIVAVKKLASNREGNNIESSFRAEILTLGK 834
N + +G G +G V+ A +V VK L ++ N++S FR E+ K
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRK 64
Query: 835 IRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSC--------NLEWPTRFMIAL 886
+ H+N+V+L G C + +I EY + G L + L + L + +
Sbjct: 65 LSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT 124
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAVAG 945
A G+ +L R HRD+ + N L+ + E V L+K V + K +A+
Sbjct: 125 QIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI- 180
Query: 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHS 1004
++APE + K D++S+GV++ E+ T G P L D V N ++
Sbjct: 181 PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSD-----EEVLNRLQAGK 235
Query: 1005 LTPGIFDTRLNVED---ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055
L L V + + K+ C +++P DRPS E+VS L E
Sbjct: 236 L-------ELPVPEGCPSRL-------YKLMTRCWAVNPKDRPSFSELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 92.9 bits (231), Expect = 8e-21
Identities = 58/201 (28%), Positives = 90/201 (44%), Gaps = 14/201 (6%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G G +G VYK V+ VAVK S +++ F E L + H NIVKL G C
Sbjct: 3 IGKGNFGDVYKGVLKGNTEVAVKTCRST-LPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+ ++ E + GSL L L ++L AA G+ YL HRD
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRD 118
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTMKVTE 962
+ + N L+ + + DFG+++ + + V+ I APE + T
Sbjct: 119 LAARNCLVGENNVLKISDFGMSR----EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 963 KCDIYSYGVVLLELLT-GRTP 982
+ D++SYG++L E + G TP
Sbjct: 175 ESDVWSYGILLWETFSLGDTP 195
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 1e-20
Identities = 60/197 (30%), Positives = 101/197 (51%), Gaps = 9/197 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G G +G V+ + VA+K L + G + +F E + K+RH +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTKVAIKTL---KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV 70
Query: 848 YHQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ ++ E+M +GSL + L G L+ P +A A+G+AY+ + HR
Sbjct: 71 SEE-PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+++ NIL+ D + DFGLA++I+ + + + APE A + T K D+
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186
Query: 967 YSYGVVLLELLT-GRTP 982
+S+G++L EL+T GR P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 2e-20
Identities = 58/206 (28%), Positives = 91/206 (44%), Gaps = 15/206 (7%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA G+V K + + ++ K + +++ E+ + IVK YG
Sbjct: 8 RLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGA 67
Query: 847 CY--HQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
S + EY E GSL + G E IA +GL+YLH
Sbjct: 68 FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG-EKVLG-KIAESVLKGLSYLH--- 122
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
+I HRDIK +NILL K + + DFG++ ++ S + + S+ Y+APE
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELVNSLAGTFTGTSF-YMAPERIQGKP 179
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQP 985
+ D++S G+ LLE+ R P P
Sbjct: 180 YSITSDVWSLGLTLLEVAQNRFPFPP 205
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 91.5 bits (227), Expect = 3e-20
Identities = 62/210 (29%), Positives = 105/210 (50%), Gaps = 13/210 (6%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLA---SNREGNNIE-SSFRAEILTLGKIRHRNIVK 842
++G GAYGTVY + + G+++AVK++ SN E + E+ L ++H NIV+
Sbjct: 7 VLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
G C + + E++ GS+ +L+ E P +G+AYLH++C
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE-PVFCKYTKQILDGVAYLHNNC--- 122
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-----PQSKSMSAVAGSYGYIAPEYAYT 957
+ HRDIK NN++L + DFG A+ + S + ++ G+ ++APE
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQPLD 987
K DI+S G + E+ TG+ P+ +D
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKPPLASMD 212
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 3e-20
Identities = 72/209 (34%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKK--LASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
+G G YG VYKA D+G++VA+KK L + +EG I ++ R EI L ++ HRNIV L
Sbjct: 14 QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPI-TAIR-EIKILRQLNHRNIVNL 71
Query: 844 Y----------GFCYHQGSNLLIYEYMERGSLGELLHG-SSCNLEWPTRFMIALGAAEGL 892
F +G+ L++EYM+ +G L G + + FM L EGL
Sbjct: 72 KEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL--LEGL 129
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
Y H K HRDIK +NILL++K + + DFGLA++ + +S+ + + Y P
Sbjct: 130 NYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPP 186
Query: 953 EYAY-TMKVTEKCDIYSYGVVLLELLTGR 980
E + D++S G +L EL T +
Sbjct: 187 ELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 3e-20
Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 52/290 (17%)
Query: 788 VGSGAYGTVYKAVM------DSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKIRHR 838
+G G++G VY+ + + VA+K + AS RE F E + +
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE----FLNEASVMKEFNCH 69
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG------SSCNLEWPTR---FMIALGAA 889
++V+L G L++ E M +G L L ++ L PT +A A
Sbjct: 70 HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----MPQSKSMSAVA 944
+G+AYL + HRD+ + N ++ + +GDFG+ + I K + V
Sbjct: 130 DGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDH 1003
++APE T K D++S+GVVL E+ T P Q L + V ++ D
Sbjct: 187 ----WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN-----EEVLKFVIDG 237
Query: 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
G D N D+ +L++ MC +P RP+ E+VS L
Sbjct: 238 ----GHLDLPENCPDK--------LLELMRMCWQYNPKMRPTFLEIVSSL 275
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 4e-20
Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 15/198 (7%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
I+G G +G V + +G+ VAVK N + + +F E + K+ H+N+V+L G
Sbjct: 13 IIGEGEFGAVLQGEY-TGQKVAVK----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNL-EWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
H G +++ E M +G+L L L +L AEG+ YL ++ H
Sbjct: 68 ILHNGLYIVM-ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE---SKKLVH 123
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RD+ + NIL+ + A V DFGLA+V M S V + APE K + K D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK----WTAPEALKHKKFSSKSD 179
Query: 966 IYSYGVVLLELLT-GRTP 982
++SYGV+L E+ + GR P
Sbjct: 180 VWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.2 bits (227), Expect = 5e-20
Identities = 62/199 (31%), Positives = 95/199 (47%), Gaps = 14/199 (7%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
VG GAYG V K +G+IVA+KK + + +++ + E+ L ++RH NIV L
Sbjct: 9 VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+G L++EY+ER +L ELL S L + +AY H I HR
Sbjct: 69 FRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCH---SHNIIHR 124
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYTMKVT 961
DIK NIL+ + + DFG A+ + + ++ + Y APE Y V
Sbjct: 125 DIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPV- 183
Query: 962 EKCDIYSYGVVLLELLTGR 980
D+++ G ++ ELL G
Sbjct: 184 ---DVWAIGCIMAELLDGE 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 59/200 (29%), Positives = 91/200 (45%), Gaps = 12/200 (6%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY 848
G GA+G VYKA + A K+ +E F EI L + +H NIV LY +
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELED-FMVEIDILSECKHPNIVGLYEAYF 72
Query: 849 HQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDI 908
++ ++ E+ + G+L ++ L P + E L +LH ++ HRD+
Sbjct: 73 YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDL 129
Query: 909 KSNNILLDDKFEAHVGDFGL-AKVIDMPQSKSMSAVAGSYGYIAPEYAY--TMKVTE--- 962
K+ NILL + + DFG+ AK Q + G+ ++APE T K
Sbjct: 130 KAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVACETFKDNPYDY 187
Query: 963 KCDIYSYGVVLLELLTGRTP 982
K DI+S G+ L+EL P
Sbjct: 188 KADIWSLGITLIELAQMEPP 207
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 8e-20
Identities = 61/199 (30%), Positives = 109/199 (54%), Gaps = 14/199 (7%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G Y TVYK +G+IVA+K++ + E ++ R EI + +++H NIV+L+
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIR-EISLMKELKHENIVRLHDV 66
Query: 847 CYHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPR 902
+ + +L++EYM+ L + + HG L+ T F L +G+A+ H + R
Sbjct: 67 IHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQL--LKGIAFCHEN---R 120
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV-T 961
+ HRD+K N+L++ + E + DFGLA+ +P + + V + Y AP+ + +
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLW-YRAPDVLLGSRTYS 179
Query: 962 EKCDIYSYGVVLLELLTGR 980
DI+S G ++ E++TGR
Sbjct: 180 TSIDIWSVGCIMAEMITGR 198
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 24/206 (11%)
Query: 787 IVGSGAYGTVYKA-VMDSGKIVAVK-----KLASNREGNNIESSFRAEILTLGKIRHRNI 840
++G GA+G V D+ K+ A+K K N+ E L ++ H +
Sbjct: 7 VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNV----LNERRILQELNHPFL 62
Query: 841 VKL-YGFCYHQGSNL-LIYEYMERGSLG-ELLHGSSCNLEWPTRFMIA-LGAAEGLAYLH 896
V L Y F N+ L+ + + G L L + E +F I + A L YLH
Sbjct: 63 VNLWYSFQ--DEENMYLVVDLLLGGDLRYHLSQKVKFS-EEQVKFWICEIVLA--LEYLH 117
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
I HRDIK +NILLD++ H+ DF +A + ++ +G+ GY+APE
Sbjct: 118 SK---GIIHRDIKPDNILLDEQGHVHITDFNIA--TKVTPDTLTTSTSGTPGYMAPEVLC 172
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTP 982
+ D +S GV E L G+ P
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 9e-20
Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 19/204 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
VGSG YG VYKA + +G++ AVK + G++ S + EI + + +H NIV +G
Sbjct: 17 VGSGTYGDVYKARNLHTGELAAVK-IIKLEPGDDF-SLIQQEIFMVKECKHCNIVAYFGS 74
Query: 847 CYHQGSNLLIYEYMERGSLGELLHG----SSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
+ + EY GSL ++ H S + + R + +GLAYLH K
Sbjct: 75 YLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGK-- 127
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK--- 959
HRDIK NILL D + + DFG+A I +K S + Y ++APE A K
Sbjct: 128 -MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPY-WMAPEVAAVEKNGG 185
Query: 960 VTEKCDIYSYGVVLLELLTGRTPV 983
+ CDI++ G+ +EL + P+
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 90.0 bits (224), Expect = 1e-19
Identities = 65/207 (31%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 788 VGSGAYGTVYKAVMDS-GKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+ GAYG V+ A S G I A+K + ++ N E L + + +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 846 FCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ + NL L+ EY+ G L LL E R IA L YLH I
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA-EIVLALEYLH---SNGII 115
Query: 905 HRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSA-------VAGSYGYIAPEYA 955
HRD+K +NIL+D H+ DFGL+KV + + +++ + G+ YIAPE
Sbjct: 116 HRDLKPDNILIDS--NGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
++ D +S G +L E L G P
Sbjct: 174 LGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 1e-19
Identities = 59/197 (29%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+GSG +G V+ GKI VA+K + REG E F E + K+ H N+V+LYG
Sbjct: 12 LGSGQFGVVHLG-KWRGKIDVAIKMI---REGAMSEDDFIEEAKVMMKLSHPNLVQLYGV 67
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
C Q ++ EYM G L L L + E + YL + HR
Sbjct: 68 CTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+ + N L+ + V DFGLA+ + Q S + PE + + K D+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184
Query: 967 YSYGVVLLELLT-GRTP 982
+S+GV++ E+ + G+ P
Sbjct: 185 WSFGVLMWEVFSEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 1e-19
Identities = 57/197 (28%), Positives = 100/197 (50%), Gaps = 9/197 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V+ + VA+K L ++G+ +F AE + +++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNGHTKVAIKSL---KQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ +I EYME GSL + L L +A AEG+A++ + HR
Sbjct: 71 TQE-PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHR 126
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+++ NIL+ + + DFGLA++I+ + + + APE T K D+
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 186
Query: 967 YSYGVVLLELLT-GRTP 982
+S+G++L E++T GR P
Sbjct: 187 WSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.3 bits (222), Expect = 1e-19
Identities = 78/291 (26%), Positives = 113/291 (38%), Gaps = 66/291 (22%)
Query: 788 VGSGAYGTVYKAV--MDSGKI--VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
+G G +G+V K V M SGK VAVK L + F E + ++ H IV+L
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG-KKEFLREASVMAQLDHPCIVRL 61
Query: 844 YGFCYHQGSNL-LIYEYMERGSLGELLHGSSCN-----LEWPTRFMIALGAAEGLAYLHH 897
G C +G L L+ E G L + L E A A G+AYL
Sbjct: 62 IGVC--KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKEL------AHQVAMGMAYLE- 112
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--GYIAPEYA 955
HRD+ + N+LL ++ +A + DFG+++ + + AG + + APE
Sbjct: 113 --SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECI 170
Query: 956 YTMKVTEKCDIYSYGVVLLELLT-GRTP---------VQPLDDGGDLATWVRNYIRDHSL 1005
K + K D++SYGV L E + G P + L+ G
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE--------------- 215
Query: 1006 TPGIFDTRLNVEDE---SIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
RL +E I M L C P DRP+ E+ S
Sbjct: 216 -------RLPRPEECPQEIYSIM-------LSCWKYRPEDRPTFSELESTF 252
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-19
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 19/208 (9%)
Query: 788 VGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G YG VY+ V VAVK L +E F E + +I+H N+V+L G
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 70
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCN---LEWPTRFMIALGAAEGLAYLHHDCKPRI 903
C + +I E+M G+L + L CN + +A + + YL K
Sbjct: 71 CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVNAVVLLYMATQISSAMEYLE---KKNF 125
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS---YGYIAPEYAYTMKV 960
HRD+ + N L+ + V DFGL++++ + +A AG+ + APE K
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 961 TEKCDIYSYGVVLLELLT-GRTPVQPLD 987
+ K D++++GV+L E+ T G +P +D
Sbjct: 183 SIKSDVWAFGVLLWEIATYGMSPYPGID 210
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 788 VGSGAYGTVYKAVMDS--GKI--VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
+G G++G V + + GK+ VAVK L S++ + + F E + + H N+++L
Sbjct: 3 LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIM-DDFLKEAAIMHSLDHENLIRL 61
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPR 902
YG +++ E GSL + L + T A+ A G+ YL R
Sbjct: 62 YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLE---SKR 117
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS----YGYIAPEYAYTM 958
HRD+ + NILL + +GDFGL + +PQ++ + + + APE T
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRA--LPQNEDHYVMEEHLKVPFAWCAPESLRTR 175
Query: 959 KVTEKCDIYSYGVVLLELLT-GRTP 982
+ D++ +GV L E+ T G P
Sbjct: 176 TFSHASDVWMFGVTLWEMFTYGEEP 200
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 57/214 (26%), Positives = 103/214 (48%), Gaps = 8/214 (3%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V+ ++ VAVK L + G +F E + ++H +V+LY
Sbjct: 14 LGAGQFGEVWMGYYNNSTKVAVKTL---KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV 70
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ +I EYM +GSL + L + P + AEG+AY+ + HR
Sbjct: 71 TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+++ N+L+ + + DFGLA+VI+ + + + APE T K D+
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187
Query: 967 YSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNY 999
+S+G++L E++T G+ P + + ++ R Y
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGY 221
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 67/211 (31%), Positives = 111/211 (52%), Gaps = 21/211 (9%)
Query: 787 IVGSGAYGTVYKAVMD--SGKIVAVKKLASNREGNNIESSFRA-------EILTLGKIRH 837
++GSG++G+VY M+ SG+++AVK++ + + R+ EI L +++H
Sbjct: 7 LIGSGSFGSVYLG-MNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQH 65
Query: 838 RNIVKLYGFCYHQGSNLLIY-EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH 896
NIV+ G +L I+ EY+ GS+ LL+ E R + +GL YLH
Sbjct: 66 ENIVQYLG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR-QILKGLNYLH 123
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-----VIDMPQSKSMSAVAGSYGYIA 951
+ I HRDIK NIL+D+K + DFG++K + + + ++ GS ++A
Sbjct: 124 NR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMA 180
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
PE T K DI+S G +++E+LTG+ P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 55/201 (27%), Positives = 90/201 (44%), Gaps = 17/201 (8%)
Query: 787 IVGSGAYGTVYKAVMD-SGK---IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G G +G V + + GK VA+K L + F E +G+ H NI++
Sbjct: 11 VIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQ-RLDFLTEASIMGQFDHPNIIR 69
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
L G ++I EYME GSL + L + + G A G+ YL
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN--- 126
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYT 957
HRD+ + NIL++ V DFGL++ ++ + + G I APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE----ATYTTKGGKIPIRWTAPEAIAY 182
Query: 958 MKVTEKCDIYSYGVVLLELLT 978
K T D++S+G+V+ E+++
Sbjct: 183 RKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 87.9 bits (218), Expect = 5e-19
Identities = 80/278 (28%), Positives = 124/278 (44%), Gaps = 38/278 (13%)
Query: 787 IVGSGAYGTVYKA-VMDSGKI---VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G G +G VY ++DS AVK L + +E F E + + H N++
Sbjct: 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQ-FLKEGIIMKDFSHPNVLS 60
Query: 843 LYGFCY-HQGSNLLIYEYMERGSLGELLHGSSCNLEWPT-RFMIALG--AAEGLAYLHHD 898
L G C +GS L++ YM+ G L + + N PT + +I G A+G+ YL
Sbjct: 61 LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHN---PTVKDLIGFGLQVAKGMEYL--- 114
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-----DMPQSKSMSAVAGSYGYIAPE 953
+ HRD+ + N +LD+ F V DFGLA+ I + + ++A E
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH--TGAKLPVKWMALE 172
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013
T K T K D++S+GV+L EL+T P P D D+ Y + R
Sbjct: 173 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDIT----VY---------LLQGR 219
Query: 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051
++ E D + +V L C P RP+ E+VS
Sbjct: 220 RLLQPEYCPDPL---YEVMLSCWHPKPEMRPTFSELVS 254
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 26/268 (9%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V+ A + VAVK + + G+ +F AE + ++H +VKL+
Sbjct: 14 LGAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV 70
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ +I E+M +GSL + L + P + AEG+A++ + HR
Sbjct: 71 TKE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHR 126
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+++ NIL+ + DFGLA+VI+ + + + APE T K D+
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186
Query: 967 YSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHM 1025
+S+G++L+E++T GR P + + IR +L G R E + +
Sbjct: 187 WSFGILLMEIVTYGRIPYPGMSNP--------EVIR--ALERGYRMPRPENCPEELYN-- 234
Query: 1026 ILVLKVALMCTSISPFDRPSMREVVSML 1053
+ + C P +RP+ + S+L
Sbjct: 235 -----IMMRCWKNRPEERPTFEYIQSVL 257
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-18
Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 33/220 (15%)
Query: 788 VGSGAYGTVYKA-----VMDSGK-IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G GA+G V+ A + + K +VAVK L E + AE+LT+ ++H++IV
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTV--LQHQHIV 70
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELL--HGSSCN------------LEWPTRFMIALG 887
+ YG C L+++EYM G L L HG L IA
Sbjct: 71 RFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQ 130
Query: 888 AAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS- 946
A G+ YL HRD+ + N L+ +GDFG+++ I S V G
Sbjct: 131 IASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGRT 184
Query: 947 ---YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++ PE K T + DI+S+GVVL E+ T G+ P
Sbjct: 185 MLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 86.9 bits (216), Expect = 2e-18
Identities = 69/200 (34%), Positives = 104/200 (52%), Gaps = 21/200 (10%)
Query: 791 GAYGTVYKAV-MDSGKIVAVKKLA--SNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G YG VY+A +G+IVA+KKL +EG I +S R EI L K++H NIV +
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPI-TSLR-EINILLKLQHPNIVTVKEVV 73
Query: 848 YHQGSNL----LIYEYMERG--SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
GSNL ++ EY+E SL E + E M+ L G+A+LH +
Sbjct: 74 V--GSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKC-LMLQL--LSGVAHLHDN--- 125
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TMKV 960
I HRD+K++N+LL+++ + DFGLA+ P K + + + Y APE +
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-LKPYTQLVVTLWYRAPELLLGAKEY 184
Query: 961 TEKCDIYSYGVVLLELLTGR 980
+ D++S G + ELLT +
Sbjct: 185 STAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 55/196 (28%), Positives = 87/196 (44%), Gaps = 7/196 (3%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+GSG +G V+ + VA+K + EG E F E + K+ H +V+LYG C
Sbjct: 12 LGSGQFGVVHLGKWRAQIKVAIKAI---NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC 68
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
Q ++ E+ME G L L L + EG+ YL + HRD
Sbjct: 69 TQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRD 125
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 967
+ + N L+ V DFG+ + + + S S + PE K + K D++
Sbjct: 126 LAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVW 185
Query: 968 SYGVVLLELLT-GRTP 982
S+GV++ E+ T G+ P
Sbjct: 186 SFGVLMWEVFTEGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 3e-18
Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 15/206 (7%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V VA+K + +EG+ E F E + K+ H +V+LYG C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVC 68
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
Q ++ EYM G L L + + EG+AYL + HRD
Sbjct: 69 TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRD 125
Query: 908 IKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSA---VAGSYGYIAPEYAYTMKVTEK 963
+ + N L+DD+ V DFGL++ V+D + S+ + V S PE K + K
Sbjct: 126 LAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLLYSKFSSK 181
Query: 964 CDIYSYGVVLLELLT-GRTPVQPLDD 988
D++++GV++ E+ + G+ P + ++
Sbjct: 182 SDVWAFGVLMWEVYSLGKMPYERFNN 207
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 5e-18
Identities = 62/204 (30%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIE---SSFRAEILTLGKIRHRNIVK 842
++G GA+G VY +D+G+ +A K++ + E S+ EI L ++H IV+
Sbjct: 9 LLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQ 68
Query: 843 LYGFCYHQGSNLL--IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
YG + L EYM GS+ + L E TR EG++YLH +
Sbjct: 69 YYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTR-KYTRQILEGMSYLHSN-- 125
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM--PQSKSMSAVAGSYGYIAPEYAYTM 958
I HRDIK NIL D +GDFG +K + + +V G+ +++PE
Sbjct: 126 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGE 184
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
K D++S G ++E+LT + P
Sbjct: 185 GYGRKADVWSLGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-18
Identities = 56/203 (27%), Positives = 96/203 (47%), Gaps = 11/203 (5%)
Query: 787 IVGSGAYGTVYKAVMD-SGK---IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G+G +G V++ ++ G+ VA+K L F +E +G+ H NI++
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQ-RQDFLSEASIMGQFSHHNIIR 70
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
L G ++I EYME G+L + L + G A G+ YL
Sbjct: 71 LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG--YIAPEYAYTMKV 960
HRD+ + NIL++ E V DFGL++V++ + + G + APE K
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 961 TEKCDIYSYGVVLLELLT-GRTP 982
T D++S+G+V+ E+++ G P
Sbjct: 188 TSASDVWSFGIVMWEVMSFGERP 210
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 5e-18
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 14/207 (6%)
Query: 782 FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLA-SNREGNNIESSFRAEILTLGKIRHRN 839
F D +G G++G VY A + + ++VA+KK++ S ++ N E+ L K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
++ G + + L+ EY GS +LL L+ + GA +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH- 134
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
+ HRD+K+ NILL + +GDFG A ++ + + V Y ++APE M
Sbjct: 135 --NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANXFVGTPY-WMAPEVILAMD 187
Query: 960 VTE---KCDIYSYGVVLLELLTGRTPV 983
+ K D++S G+ +EL + P+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 6e-18
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 787 IVGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++GSG +GTV+K + DS KI K +R G +L +G + H IV+
Sbjct: 14 LLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFM-IALGAAEGLAYLHHDCK 900
L G C G++L L+ + GSL + + +L+ P R + + A+G+ YL
Sbjct: 74 LLGIC--PGASLQLVTQLSPLGSLLDHVRQHRDSLD-PQRLLNWCVQIAKGMYYLEEHR- 129
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM--SAVAGSYGYIAPEYAYTM 958
+ HR++ + NILL + DFG+A ++ P K S ++A E
Sbjct: 130 --MVHRNLAARNILLKSDSIVQIADFGVADLL-YPDDKKYFYSEHKTPIKWMALESILFG 186
Query: 959 KVTEKCDIYSYGVVLLELLT 978
+ T + D++SYGV + E+++
Sbjct: 187 RYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 7e-18
Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 8/195 (4%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+VG GA+G V+ K+V +K++ + + + + E L + H NI++ Y
Sbjct: 7 VVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYE 66
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ +++ EY G+L E + CN ++ LA LHH I H
Sbjct: 67 NFLEDKALMIVMEYAPGGTLAEYIQ-KRCNSLLDEDTILHFFVQILLA-LHHVHTKLILH 124
Query: 906 RDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSKS-MSAVAGSYGYIAPEYAYTMKVTEK 963
RD+K+ NILLD K +GDFG++K++ SKS V G+ YI+PE +K
Sbjct: 125 RDLKTQNILLDKHKMVVKIGDFGISKIL---SSKSKAYTVVGTPCYISPELCEGKPYNQK 181
Query: 964 CDIYSYGVVLLELLT 978
DI++ G VL EL +
Sbjct: 182 SDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 9e-18
Identities = 61/204 (29%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN 839
NF +G G YG VYKA +G++VA+KK+ + E + S+ EI L ++ H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 840 IVKLYGFCYHQGSNLLIYEYMERG--SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
IVKL + + L++E++ + + S L ++ L +GLA+ H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAFCHS 118
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
R+ HRD+K N+L++ + + DFGLA+ +P V + Y APE
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-YRAPEILLG 174
Query: 958 MKV-TEKCDIYSYGVVLLELLTGR 980
K + DI+S G + E++T R
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-17
Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 787 IVGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++GSGA+GTVYK + ++ KI K+ + G F E L + + H ++V+
Sbjct: 14 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 73
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLH------GSSCNLEWPTRFMIALGAAEGLAYLH 896
L G C L + + M G L + +H GS L W + A+G+ YL
Sbjct: 74 LLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYLE 126
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--GYIAPEY 954
+ R+ HRD+ + N+L+ + DFGLA++++ + K +A G ++A E
Sbjct: 127 ---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE-KEYNADGGKMPIKWMALEC 182
Query: 955 AYTMKVTEKCDIYSYGVVLLELLT 978
+ K T + D++SYGV + EL+T
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 1e-17
Identities = 64/207 (30%), Positives = 95/207 (45%), Gaps = 10/207 (4%)
Query: 782 FHDSFIVGSGAYGTVYKA-VMDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRN 839
F ++G G +G V V +GK+ A KKL R + ES E L K+ R
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 840 IVKLYGFCYHQGSNL-LIYEYMERGSLG-ELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
+V L + Y L L+ M G L + H E A GL LH
Sbjct: 62 VVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQ 120
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
+ RI +RD+K NILLDD + D GLA + +P+ +++ G+ GY+APE
Sbjct: 121 E---RIVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKN 175
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQ 984
+ T D ++ G +L E++ G++P Q
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPFQ 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 2e-17
Identities = 64/207 (30%), Positives = 103/207 (49%), Gaps = 16/207 (7%)
Query: 782 FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLA-SNREGNNIESSFRAEILTLGKIRHRN 839
F D +G G++G VY A + + ++VA+KK++ S ++ N E+ L ++RH N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 840 IVKLYGFCY-HQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898
++ Y CY + + L+ EY GS ++L L+ I GA +GLAYLH
Sbjct: 77 TIE-YKGCYLREHTAWLVMEYC-LGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
+ HRDIK+ NILL + + DFG A ++ S G+ ++APE M
Sbjct: 135 ER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANS-----FVGTPYWMAPEVILAM 186
Query: 959 ---KVTEKCDIYSYGVVLLELLTGRTP 982
+ K D++S G+ +EL + P
Sbjct: 187 DEGQYDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 2e-17
Identities = 64/219 (29%), Positives = 102/219 (46%), Gaps = 44/219 (20%)
Query: 782 FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLA--SNREGNNIESSFRAEILTLGKIR-- 836
+ + +G GAYGTVYKA +++G+ VA+KK+ + EG I S EI L ++
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEG--IPLSTLREIALLKQLESF 58
Query: 837 -HRNIVKLYGFCY-HQGSN----LLIYEYMERGSLGELLHG------SSCNLEWPTRFMI 884
H NIV+L C+ + L++E++++ L L ++ R ++
Sbjct: 59 EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 885 ALGAAEGLAYLH-HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943
G+ +LH H RI HRD+K NIL+ + + DFGLA++ + S V
Sbjct: 118 R-----GVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLARIYSF-EMALTSVV 167
Query: 944 AGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLEL 976
+ Y APE YA D++S G + EL
Sbjct: 168 VTLW-YRAPEVLLQSSYATP------VDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 83.4 bits (206), Expect = 2e-17
Identities = 65/202 (32%), Positives = 95/202 (47%), Gaps = 17/202 (8%)
Query: 788 VGSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
+G G +G V D +G+ VAVK L GN+I + + EI L + H NIVK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI-ADLKKEIEILRNLYHENIVK 70
Query: 843 LYGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
G C G N LI E++ GSL E L + + + A+ +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG---S 127
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG----YIAPEYAY 956
+ HRD+ + N+L++ + + +GDFGL K I+ K V + APE
Sbjct: 128 RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE--TDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 957 TMKVTEKCDIYSYGVVLLELLT 978
K D++S+GV L ELLT
Sbjct: 186 QSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-17
Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLA-SNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G++G VY A + ++VAVKK++ S ++ N E+ L +++H N ++ G
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ + L+ EY GS +LL L+ I GA +GLAYLH H
Sbjct: 89 CYLKEHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM---IH 144
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE--- 962
RDIK+ NILL + + + DFG A S + S V Y ++APE M +
Sbjct: 145 RDIKAGNILLTEPGQVKLADFGSASKS----SPANSFVGTPY-WMAPEVILAMDEGQYDG 199
Query: 963 KCDIYSYGVVLLELLTGRTPV 983
K D++S G+ +EL + P+
Sbjct: 200 KVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 16/200 (8%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G++G V+K + + + ++VA+K + + IE + EI L + + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYG- 69
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPR 902
Y +G+ L +I EY+ GS +LL + F IA E GL YLH + K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFD-----EFQIATMLKEILKGLDYLHSEKK-- 122
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
HRDIK+ N+LL ++ + + DFG+A + Q K + V G+ ++APE
Sbjct: 123 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQSAYDS 180
Query: 963 KCDIYSYGVVLLELLTGRTP 982
K DI+S G+ +EL G P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIE---SSFRAEILTLGKIRHRNIVK 842
++G GA+G VY D+G+ +AVK++ + E ++ EI L + H IV+
Sbjct: 9 LLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQ 68
Query: 843 LYGFCYH-QGSNLLIY-EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
YG L I+ E+M GS+ + L E TR EG++YLH +
Sbjct: 69 YYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTR-KYTRQILEGVSYLHSN-- 125
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP--QSKSMSAVAGSYGYIAPEYAYTM 958
I HRDIK NIL D +GDFG +K + M +V G+ +++PE
Sbjct: 126 -MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE 184
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
K DI+S G ++E+LT + P
Sbjct: 185 GYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-17
Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 27/210 (12%)
Query: 787 IVGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
+VG G++G +A++ +S + A+K++ + + +E S R E + L K++H NIV
Sbjct: 7 VVGEGSFG---RALLVQHVNSDQKYAMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVA 62
Query: 843 LYGFCYHQGSNLLIYEYMERGSL--------GELLHGSSCNLEWPTRFMIALGAAEGLAY 894
G ++ EY + G L G+L + L+W + + G+ +
Sbjct: 63 FKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI-LQWFVQMCL------GVQH 115
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY 954
+H + R+ HRDIKS NI L + +GDFG A+++ P + + + V Y Y+ PE
Sbjct: 116 IH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPY-YVPPEI 171
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
M K DI+S G +L EL T + P Q
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 3e-17
Identities = 60/208 (28%), Positives = 90/208 (43%), Gaps = 26/208 (12%)
Query: 789 GSGAYGTVYKAVMDS-GKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
G G+YG+VYK S + A+K++ + E + EI L + H NI+
Sbjct: 9 GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPNII----- 62
Query: 847 CYHQG---SNLL--IYEYMERGSLGELLHGSSCN---LEWPTRFMIALGAAEGLAYLHHD 898
Y + N L + EY G L + + + + I + GL LH
Sbjct: 63 SYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ 122
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA--VAGSYGYIAPEYAY 956
+I HRD+KS NILL +GD G++KV+ K A G+ Y+APE
Sbjct: 123 ---KILHRDLKSANILLVANDLVKIGDLGISKVL-----KKNMAKTQIGTPHYMAPEVWK 174
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
+ K DI+S G +L E+ T P +
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH-RNIVKLYG 845
+G GA+GTV K + SG I+AVK++ S + + ++ + + IVK YG
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKE-QKRLLMDLDVVMRSSDCPYIVKFYG 70
Query: 846 FCYHQGSNLLIYEYMERGSLGEL---LHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCK 900
+ +G + E M+ SL + ++ P + IA+ + L YL + K
Sbjct: 71 ALFREGDCWICMELMDI-SLDKFYKYVYEVL-KSVIPEEILGKIAVATVKALNYLKEELK 128
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAVAGSYGYIAPEY----- 954
I HRD+K +NILLD + DFG++ +++D S + + AG Y+APE
Sbjct: 129 --IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD---SIAKTRDAGCRPYMAPERIDPSA 183
Query: 955 --AYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y + + D++S G+ L E+ TG+ P
Sbjct: 184 RDGYDV----RSDVWSLGITLYEVATGKFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 73/282 (25%), Positives = 125/282 (44%), Gaps = 42/282 (14%)
Query: 781 NFHDSFIVGSGAYGTVY--KAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR 838
+ +G G++G +Y KA DS V +K++ + + + + E++ L K++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGE-------LLHGSSCNLEWPTRFMIALGAAEG 891
NIV + G ++ EY + G L + +L L W + I+LG
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQ--ISLG---- 113
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
L H +I HRDIKS NI L + A +GDFG+A+ ++ + + V Y Y+
Sbjct: 114 ---LKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPY-YL 169
Query: 951 APEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH--SLTPG 1008
+PE K DI+S G VL EL T + P + G +L V + + ++P
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE----GNNLHQLVLKICQGYFAPISPN 225
Query: 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVV 1050
+ + S++ + +SP DRPS+ ++
Sbjct: 226 -----FSRDLRSLISQLF----------KVSPRDRPSITSIL 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 68/214 (31%), Positives = 106/214 (49%), Gaps = 20/214 (9%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLA---SNREGNNIESSFRAEILTLGKIR 836
N+ ++G GA+G VY D+G+ +AVK++ ++E + ++ EI L +R
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 837 HRNIVKLYGFCY--HQGSNLLIY-EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
H IV+ YG C + L I+ EYM GS+ + L E TR +G++
Sbjct: 63 HDRIVQYYG-CLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTR-RYTRQILQGVS 120
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-----AVAGSYG 948
YLH + I HRDIK NIL D +GDFG +K I Q+ MS +V G+
Sbjct: 121 YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRI---QTICMSGTGIKSVTGTPY 174
Query: 949 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+++PE K D++S ++E+LT + P
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 62/206 (30%), Positives = 96/206 (46%), Gaps = 29/206 (14%)
Query: 787 IVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G +G V + D G VAVK + ++ +F AE + ++RH N+V+L G
Sbjct: 13 TIGKGEFGDV--MLGDYRGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLG 66
Query: 846 FCYHQGSNLLIY-EYMERGSL-------GELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
+ L I EYM +GSL G + G C L++ +L E + YL
Sbjct: 67 VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF------SLDVCEAMEYLEA 120
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
+ HRD+ + N+L+ + A V DFGL K Q V + APE
Sbjct: 121 N---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALRE 173
Query: 958 MKVTEKCDIYSYGVVLLELLT-GRTP 982
K + K D++S+G++L E+ + GR P
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 4e-17
Identities = 58/201 (28%), Positives = 88/201 (43%), Gaps = 10/201 (4%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G +G V + +GK+ A KKL R + E E L K+ R IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 846 FCYHQGSNL-LIYEYMERGSLG-ELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
+ + +L L+ M G L + + A GL +LH RI
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RI 116
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
+RD+K N+LLDD + D GLA +++ K + AG+ GY+APE
Sbjct: 117 VYRDLKPENVLLDDHGNVRISDLGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS 174
Query: 964 CDIYSYGVVLLELLTGRTPVQ 984
D ++ G L E++ GR+P +
Sbjct: 175 VDWFALGCTLYEMIAGRSPFR 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-17
Identities = 63/206 (30%), Positives = 96/206 (46%), Gaps = 12/206 (5%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G GA+G VYKA +A K+ + +E + EI L H IVKL G
Sbjct: 20 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELED-YMVEIEILATCNHPYIVKLLGAF 78
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
Y G ++ E+ G++ ++ L P +I E L YLH +I HRD
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLH---SMKIIHRD 135
Query: 908 IKSNNILLDDKFEAHVGDFGL-AKVIDMPQSKSMSAVAGSYGYIAPEYAY--TMKVTE-- 962
+K+ N+LL + + DFG+ AK + Q + + G+ ++APE TMK T
Sbjct: 136 LKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR--DSFIGTPYWMAPEVVMCETMKDTPYD 193
Query: 963 -KCDIYSYGVVLLELLTGRTPVQPLD 987
K DI+S G+ L+E+ P L+
Sbjct: 194 YKADIWSLGITLIEMAQIEPPHHELN 219
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 6e-17
Identities = 62/211 (29%), Positives = 110/211 (52%), Gaps = 19/211 (9%)
Query: 784 DSFI-VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
D+F+ +G G+ G V A +G+ VAVKK+ R+ E F E++ + +H NIV
Sbjct: 22 DNFVKIGEGSTGIVCIATDKSTGRQVAVKKM-DLRKQQRRELLFN-EVVIMRDYQHPNIV 79
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
++Y Y G L ++ E++E G+L +++ + + + L + L++LH
Sbjct: 80 EMYS-SYLVGDELWVVMEFLEGGALTDIV--THTRMNEEQIATVCLAVLKALSFLHAQ-- 134
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYAYTM 958
+ HRDIKS++ILL + DFG + ++P+ KS+ V Y ++APE +
Sbjct: 135 -GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL--VGTPY-WMAPEVISRL 190
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP---VQPL 986
+ DI+S G++++E++ G P PL
Sbjct: 191 PYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL 221
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 60/209 (28%), Positives = 89/209 (42%), Gaps = 20/209 (9%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G +G V V + A+K + + +E L + H IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ ++ EY G L +L E+ RF IA YLH+ I +
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIA-CVVLAFEYLHNR---GIIY 116
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE------YAYTMK 959
RD+K N+LLD + DFG AK + K+ + G+ Y+APE Y ++
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAKKLK-SGQKTWTFC-GTPEYVAPEIILNKGYDFS-- 172
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQPLDD 988
D +S G++L ELLTGR P D+
Sbjct: 173 ----VDYWSLGILLYELLTGRPPFGEDDE 197
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-16
Identities = 61/204 (29%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G G V K ++ +KL I + E+ L + IV YG
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCKPRIFH 905
Y G + E+M+ GSL ++L + P + +++ GLAYL K +I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLRE--KHQIMH 127
Query: 906 RDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMS-AVAGSYGYIAPEYAYTMKVTEK 963
RD+K +NIL++ + E + DFG++ ++ID SM+ + G+ Y++PE + +
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 964 CDIYSYGVVLLELLTGRTPVQPLD 987
DI+S G+ L+EL GR P+ P D
Sbjct: 183 SDIWSMGLSLVELAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 81.7 bits (201), Expect = 1e-16
Identities = 78/283 (27%), Positives = 128/283 (45%), Gaps = 30/283 (10%)
Query: 782 FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLA-SNREGNNIESSFRAEILTLGKIRHRN 839
F D +G G++G VY A + + ++VA+KK++ S ++ N E+ L +I+H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
++ G + + L+ EY GS +LL L+ I GA +GLAYLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH- 144
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
+ HRDIK+ NILL + + + DFG A + S + S V Y ++APE M
Sbjct: 145 --NMIHRDIKAGNILLTEPGQVKLADFGSASIA----SPANSFVGTPY-WMAPEVILAMD 197
Query: 960 VTE---KCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016
+ K D++S G+ +EL + P+ ++ L +N +P + +
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------SPTLQSNEWSD 251
Query: 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059
+ VD C P DRP+ E++ + ER
Sbjct: 252 YFRNFVDS----------CLQKIPQDRPTSEELLKHMFVLRER 284
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 63/216 (29%), Positives = 98/216 (45%), Gaps = 29/216 (13%)
Query: 788 VGSGAYGTVYKAVM-----DSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G GA+G VY+ + D+ ++ VAVK L + + ES F E L + K H+NIV
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQD-ESDFLMEALIMSKFNHQNIV 72
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF------MIALGAAEGLAYL 895
+L G + + ++ E M G L L + E P+ A A+G YL
Sbjct: 73 RLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYL 132
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFE---AHVGDFGLAKVIDMPQ-----SKSMSAVAGSY 947
+ HRDI + N LL K A + DFG+A+ I ++M +
Sbjct: 133 EEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIK--- 186
Query: 948 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++ PE T K D++S+GV+L E+ + G P
Sbjct: 187 -WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 1e-16
Identities = 61/202 (30%), Positives = 100/202 (49%), Gaps = 15/202 (7%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVK--KLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+GSG YG VYKA +++G++ A+K KL + ++ EI+ + +H NIV +
Sbjct: 17 IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQ----EIIMMKDCKHSNIVAYF 72
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
G + + E+ GSL ++ H + E + ++ +GL YLH K
Sbjct: 73 GSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAY-VSRETLQGLYYLHSKGK---M 128
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK---VT 961
HRDIK NILL D + DFG++ I +K S + Y ++APE A +
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPY-WMAPEVAAVERKGGYN 187
Query: 962 EKCDIYSYGVVLLELLTGRTPV 983
+ CDI++ G+ +EL + P+
Sbjct: 188 QLCDIWAVGITAIELAELQPPM 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-16
Identities = 64/200 (32%), Positives = 96/200 (48%), Gaps = 8/200 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G G++G VYK + + K V K+ E + + EI L + I + YG
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG-S 70
Query: 848 YHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
Y +G+ L +I EY+ GS +LL LE I +GL YLH + R HR
Sbjct: 71 YLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHSE---RKIHR 125
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
DIK+ N+LL ++ + + DFG+A + Q K + V G+ ++APE K DI
Sbjct: 126 DIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQSAYDFKADI 184
Query: 967 YSYGVVLLELLTGRTPVQPL 986
+S G+ +EL G P L
Sbjct: 185 WSLGITAIELAKGEPPNSDL 204
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 31/213 (14%)
Query: 788 VGSGAYGTVYKAVM---DSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
+G G YG VYKA GK A+KK + I S EI L +++H N+V L
Sbjct: 8 IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67
Query: 844 YGFCYH--QGSNLLIYEYMERGSLGELL--HGSSCNLEWPTRFMIAL--GAAEGLAYLHH 897
S L+++Y E L +++ H + + P + +L G+ YLH
Sbjct: 68 VEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS 126
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSMSAVAG---SYGYI 950
+ + HRD+K NIL+ + +GD GLA++ + P K ++ + + Y
Sbjct: 127 NW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP-LKPLADLDPVVVTIWYR 182
Query: 951 APEYA-----YTMKVTEKCDIYSYGVVLLELLT 978
APE YT + DI++ G + ELLT
Sbjct: 183 APELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 82/287 (28%), Positives = 123/287 (42%), Gaps = 28/287 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+VG G+YG V K ++G+IVA+KK + + ++ EI L ++RH N+V L
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ L++E+++ L +L N L+ G+ + H I
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLDDLEK--YPNGLDESRVRKYLFQILRGIEFCHSH---NII 122
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TMKVTEK 963
HRDIK NIL+ + DFG A+ + P VA + Y APE K
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRW-YRAPELLVGDTKYGRA 181
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDGGD-LATWVR---NYIRDH----SLTPGIFDTRL- 1014
DI++ G ++ E+LTG P+ P D D L ++ N I H P RL
Sbjct: 182 VDIWAVGCLVTEMLTGE-PLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240
Query: 1015 ---NVE--DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056
+E ++ LVL +A C I P DRPS S L+
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHH 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 81.1 bits (201), Expect = 3e-16
Identities = 68/221 (30%), Positives = 108/221 (48%), Gaps = 53/221 (23%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLA---SNREGNNIESSFRAEILTLGKIR-HRNIVK 842
+G GAYG V+KA+ + ++VA+KK+ N + + +FR EI+ L ++ H NIVK
Sbjct: 15 LGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA--TDAQRTFR-EIMFLQELGDHPNIVK 71
Query: 843 LYGFCYHQGSN----LLIYEYME-------RGSLGELLHGSSCNLEWPTRFMI--ALGAA 889
L + N L++EYME R ++ E +H R+++ L A
Sbjct: 72 LLNV--IKAENDKDIYLVFEYMETDLHAVIRANILEDVH---------KRYIMYQLLKA- 119
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-MPQSKSMSA----VA 944
L Y+H + HRD+K +NILL+ + DFGLA+ + + ++ VA
Sbjct: 120 --LKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174
Query: 945 GSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGR 980
+ Y APE YT V D++S G +L E+L G+
Sbjct: 175 TRW-YRAPEILLGSTRYTKGV----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 3e-16
Identities = 59/197 (29%), Positives = 96/197 (48%), Gaps = 12/197 (6%)
Query: 787 IVGSGAYG--TVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
++G GA+G T+Y+ D +V K++ R EI+ L ++H NI+ Y
Sbjct: 7 VLGKGAFGEATLYRRTEDDSLVV-WKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNL---EWPTRFMIALGAAEGLAYLHHDCKP 901
+ L+ EY G+L + + L E ++ + +A ++Y+H K
Sbjct: 66 NHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSA--VSYIH---KA 120
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVT 961
I HRDIK+ NI L +GDFG++K++ S + + V Y Y++PE +K
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPY-YMSPELCQGVKYN 179
Query: 962 EKCDIYSYGVVLLELLT 978
K DI++ G VL ELLT
Sbjct: 180 FKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 3e-16
Identities = 72/281 (25%), Positives = 126/281 (44%), Gaps = 36/281 (12%)
Query: 788 VGSGAYGTVYKA--VMDSGKIVAVKK-----LASNREGNNIESSFR---AEILTLGK-IR 836
+GSGA+G VYK + ++A+K+ A ++ + S +E+ + + +R
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 837 HRNIVKLYGFCYHQGSNL-LIYEYMERGSLGEL---LHGSSCNLEWPTRFMIALGAAEGL 892
H NIV+ Y + + L ++ + +E LGE L + I + L
Sbjct: 68 HPNIVRYYK-TFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
YLH + RI HRD+ NNI+L + + + DFGLAK P+SK +++V G+ Y P
Sbjct: 127 RYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQ-KQPESK-LTSVVGTILYSCP 182
Query: 953 EYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012
E EK D++++G +L ++ T + P + LAT + + + L G++
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMCTLQPPFYS-TNMLSLATKIVEAVYE-PLPEGMYSE 240
Query: 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
V V C + RP + +V +M+
Sbjct: 241 D--------------VTDVITSCLTPDAEARPDIIQVSAMI 267
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 3e-16
Identities = 63/213 (29%), Positives = 102/213 (47%), Gaps = 28/213 (13%)
Query: 788 VGSGAYGTVYKAVMD--SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G YG VYKA D + + +A+KK+ +E + S+ EI L +++H NIV+L
Sbjct: 10 IGEGTYGVVYKA-RDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSC-----NLEWPTRFMIALGAAEGLAYLHHDCK 900
+ + L++EY++ L H S N ++ + G+AY H
Sbjct: 69 VVHSEKRLYLVFEYLD---LDLKKHMDSSPDFAKNPRLIKTYLYQI--LRGIAYCHSH-- 121
Query: 901 PRIFHRDIKSNNILLDDKFEA-HVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----Y 954
R+ HRD+K N+L+D + A + DFGLA+ +P V + Y APE
Sbjct: 122 -RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW-YRAPEILLGSR 179
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLD 987
Y+ V DI+S G + E++ + P+ P D
Sbjct: 180 HYSTPV----DIWSVGCIFAEMVNQK-PLFPGD 207
|
Length = 294 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-16
Identities = 53/169 (31%), Positives = 73/169 (43%), Gaps = 48/169 (28%)
Query: 587 LDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEI 646
L + + G +PN++ L+ L+ + LS N GNIP +LG+++ L
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE------------- 469
Query: 647 PPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLL 706
L+LSYN+ +GSIP LG+L L L LN N LSG +P+A L L
Sbjct: 470 ------------VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAA---LGGRL 514
Query: 707 GSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRP-VGNCGASPSSG 754
S+N F N GLCG P + CG S G
Sbjct: 515 LHRASFN-------------------FTDNAGLCGIPGLRACGPHLSVG 544
|
Length = 623 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 66/218 (30%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 788 VGSGAYGTV-----YKAVMDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G GA+G V Y + KI VAVK L +N F E L ++H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD--ASDNARKDFHREAELLTNLQHEHIV 70
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELL--HGSSCNL----EWPTRFM------IALGAA 889
K YG C ++++EYM+ G L + L HG L P IA A
Sbjct: 71 KFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIA 130
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG---- 945
G+ YL HRD+ + N L+ + +GDFG+++ + S V G
Sbjct: 131 AGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV---YSTDYYRVGGHTML 184
Query: 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++ PE K T + D++S GVVL E+ T G+ P
Sbjct: 185 PIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 4e-16
Identities = 64/207 (30%), Positives = 111/207 (53%), Gaps = 16/207 (7%)
Query: 781 NFHDSFI-VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR 838
+ D+FI +G G+ G V A V SGK+VAVKK+ R+ E F E++ + +H
Sbjct: 20 TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM-DLRKQQRRELLFN-EVVIMRDYQHE 77
Query: 839 NIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
N+V++Y Y G L ++ E++E G+L +++ + N E + L + L+ LH
Sbjct: 78 NVVEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--AVCLAVLKALSVLHA 134
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYA 955
+ HRDIKS++ILL + DFG + ++P+ KS+ G+ ++APE
Sbjct: 135 Q---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL---VGTPYWMAPELI 188
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + DI+S G++++E++ G P
Sbjct: 189 SRLPYGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 4e-16
Identities = 58/215 (26%), Positives = 101/215 (46%), Gaps = 24/215 (11%)
Query: 787 IVGSGAYGTVYKAVM--DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKL 843
++G G +G V +A++ D K+ A K+ N F E+ L K+ H NI+ L
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINL 68
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTRFMIALGA 888
G C ++G + EY G+L + L HG++ L A
Sbjct: 69 LGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG 948
A G+ YL + + HRD+ + N+L+ + + + DFGL++ ++ K+M +
Sbjct: 129 ATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL--PVR 183
Query: 949 YIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++A E T K D++S+GV+L E+++ G TP
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTP 218
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 4e-16
Identities = 79/297 (26%), Positives = 126/297 (42%), Gaps = 62/297 (20%)
Query: 788 VGSGAYGTVYKAVM------DSGKIVAVKKLASNREG--NNIESSFRAEILTLGKIRHRN 839
+G GA+G V++A + +VAVK L +E ++++ F+ E + + H N
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKML---KEEASADMQADFQREAALMAEFDHPN 69
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSS---------------------CNLEW 878
IVKL G C L++EYM G L E L S L
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 879 PTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMP 935
+ IA A G+AYL + HRD+ + N L+ + + DFGL++ I D
Sbjct: 130 TEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 186
Query: 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATW 995
++ A+ ++ PE + + T + D+++YGVVL E+ + +QP G
Sbjct: 187 KASENDAI--PIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS--YGMQPY--YGMAHEE 240
Query: 996 VRNYIRDHSLTPGIFDTRLNVEDE---SIVDHMILVLKVALMCTSISPFDRPSMREV 1049
V Y+RD ++ L+ D + + M L C S P DRPS +
Sbjct: 241 VIYYVRDGNV--------LSCPDNCPLELYNLMRL-------CWSKLPSDRPSFASI 282
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 66/210 (31%), Positives = 103/210 (49%), Gaps = 23/210 (10%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G YG VYKA +G+IVA+KK+ E + S+ EI L ++ H NIV+L
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTR---FMIALGAAEGLAYLHHDCKPR 902
H + L L++E+++ L + + S P ++ L +G+AY H R
Sbjct: 67 -VHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQL--LQGIAYCHSH---R 119
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----AYT 957
+ HRD+K N+L+D + + DFGLA+ +P V + Y APE Y+
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW-YRAPEILLGSRQYS 178
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQPLD 987
V DI+S G + E++ R P+ P D
Sbjct: 179 TPV----DIWSIGCIFAEMVNRR-PLFPGD 203
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-16
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 14/204 (6%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G G V+K ++ +KL I + E+ L + IV YG
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCKPRIFH 905
Y G + E+M+ GSL ++L + P + + +++ +GL YL K +I H
Sbjct: 73 YSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE--KHKIMH 127
Query: 906 RDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMS-AVAGSYGYIAPEYAYTMKVTEK 963
RD+K +NIL++ + E + DFG++ ++ID SM+ + G+ Y++PE + +
Sbjct: 128 RDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHYSVQ 182
Query: 964 CDIYSYGVVLLELLTGRTPVQPLD 987
DI+S G+ L+E+ GR P+ P D
Sbjct: 183 SDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 4e-16
Identities = 66/211 (31%), Positives = 99/211 (46%), Gaps = 22/211 (10%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYG 845
+G G YG VYK G + AVK L + ++ AE L + H N+VK YG
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYG 86
Query: 846 FCYHQ-----GSNLLIYEYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHH 897
Y G L+ E GS+ EL+ G L+ I GA GL +LH+
Sbjct: 87 MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY--- 954
+ RI HRD+K NNILL + + DFG++ + + + ++V G+ ++APE
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIAC 202
Query: 955 --AYTMKVTEKCDIYSYGVVLLELLTGRTPV 983
Y +CD++S G+ +EL G P+
Sbjct: 203 EQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 6e-16
Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 23/211 (10%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR----NIVK 842
+G G YG+VYK + +G +A+K++ + ES F I+ L I H+ IV
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLELD----ESKFNQIIMEL-DILHKAVSPYIVD 63
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCK 900
YG + +G+ + EYM+ GSL +L G P + I +GL +L +
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV 960
I HRD+K N+L++ + + DFG++ + +K+ G Y+APE +
Sbjct: 124 --IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN---IGCQSYMAPERIKSGGP 178
Query: 961 TE------KCDIYSYGVVLLELLTGRTPVQP 985
+ + D++S G+ +LE+ GR P P
Sbjct: 179 NQNPTYTVQSDVWSLGLSILEMALGRYPYPP 209
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 6e-16
Identities = 59/202 (29%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G Y TVYK + +VA+K++ E ++ R E+ L ++H NIV L+
Sbjct: 14 LGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72
Query: 847 CYHQGSNLLIYEYMERGSLGELLH--GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ + S L++EY+++ L + L G+S N+ F+ L GL Y H + ++
Sbjct: 73 IHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQL--LRGLNYCH---RRKVL 126
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TMKVTEK 963
HRD+K N+L++++ E + DFGLA+ +P +K+ S + Y P+ + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYSNEVVTLWYRPPDILLGSTDYSTQ 185
Query: 964 CDIYSYGVVLLELLTGRTPVQP 985
D++ G + E+ TGR P+ P
Sbjct: 186 IDMWGVGCIFYEMSTGR-PLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 6e-16
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA GTVY A+ + +G+ VA+K++ N + + EIL + + +H NIV Y
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQM--NLQQQPKKELIINEILVMRENKHPNIVN-YLD 83
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
Y G L ++ EY+ GSL +++ + ++ + + L +LH + ++ H
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSN---QVIH 138
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RDIKS+NILL + DFG I QSK + V Y ++APE K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVD 197
Query: 966 IYSYGVVLLELLTGRTP 982
I+S G++ +E++ G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 55/200 (27%), Positives = 86/200 (43%), Gaps = 22/200 (11%)
Query: 791 GAYGTVYKA-VMDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHR-NIVKLYGFC 847
GA+G+VY A +G A+K L S+ N ++ +AE + + KLY +
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY-YS 65
Query: 848 YHQGSNL-LIYEYMERGSLGELLHG-SSCNLEWPTRFMIALGAAE---GLAYLHHDCKPR 902
+ L L+ EY+ G L+ +W ++ AE G+ LH
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQY-----IAEVVLGVEDLHQR---G 117
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
I HRDIK N+L+D + DFGL++ + G+ Y+APE + +
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK-----FVGTPDYLAPETILGVGDDK 172
Query: 963 KCDIYSYGVVLLELLTGRTP 982
D +S G V+ E L G P
Sbjct: 173 MSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 8e-16
Identities = 63/207 (30%), Positives = 104/207 (50%), Gaps = 22/207 (10%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR----NIVKLY 844
G+G G V K + ++ +KL I+ + R +I+ K+ H IV Y
Sbjct: 10 GAGNGGVVTKVLHRPSGLIMARKLIHLE----IKPAIRNQIIRELKVLHECNSPYIVGFY 65
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCKPR 902
G Y G + E+M+ GSL ++L + P + I++ GL YL K +
Sbjct: 66 GAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENILGKISIAVLRGLTYLRE--KHK 120
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMS-AVAGSYGYIAPEYAYTMKV 960
I HRD+K +NIL++ + E + DFG++ ++ID SM+ + G+ Y++PE
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-----SMANSFVGTRSYMSPERLQGTHY 175
Query: 961 TEKCDIYSYGVVLLELLTGRTPVQPLD 987
T + DI+S G+ L+E+ GR P+ P D
Sbjct: 176 TVQSDIWSLGLSLVEMAIGRYPIPPPD 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 9e-16
Identities = 69/220 (31%), Positives = 98/220 (44%), Gaps = 32/220 (14%)
Query: 787 IVGSGAYGTVYKAVM------DSGKI-VAVKKLASNREGNNIE--SSFRAEILTLGKIRH 837
+GSGA+G VY+ SG I VAVK L R+G + F E + H
Sbjct: 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTL---RKGATDQEKKEFLKEAHLMSNFNH 58
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM------IALGAAEG 891
NIVKL G C +I E ME G L L + P I L A+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEA-----HVGDFGLAKVI---DMPQSKSMSAV 943
YL + HRD+ + N L+ +K +GDFGLA+ I D + + +
Sbjct: 119 CVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLL 175
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE K T + D++S+GV++ E+LT G+ P
Sbjct: 176 --PVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 63/213 (29%), Positives = 98/213 (46%), Gaps = 35/213 (16%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G+YG V+K ++G+IVA+KK + + I+ EI L +++H N+V L
Sbjct: 9 IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68
Query: 847 CYHQGSNLLIYEYMERGSLGEL---LHG----SSCNLEWPTRFMIALGAAEGLAYLH-HD 898
+ L++EY + L EL G + W T + + + H H+
Sbjct: 69 FRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT--------LQAVNFCHKHN 120
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY---- 954
C HRD+K NIL+ + + + DFG A+++ P VA + Y APE
Sbjct: 121 C----IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRW-YRAPELLVGD 175
Query: 955 -AYTMKVTEKCDIYSYGVVLLELLTGRTPVQPL 986
Y V D+++ G V ELLTG QPL
Sbjct: 176 TQYGPPV----DVWAIGCVFAELLTG----QPL 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 1e-15
Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 42/218 (19%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESS-------FRAEILTLGKIRHR 838
+GSGAYG V AV +G+ VA+KK+ +N+ R EI L +RH
Sbjct: 7 PIGSGAYGVVCSAVDKRTGRKVAIKKI------SNVFDDLIDAKRILR-EIKLLRHLRHE 59
Query: 839 NIVKLYGFCYHQGSN-----LLIYEYMERGSLGELLHGSSCNL--EWPTRFMIALGAAEG 891
NI+ L ++ E ME L +++ S L + F+ + G
Sbjct: 60 NIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIK-SPQPLTDDHIQYFLYQI--LRG 115
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSA-VAGSYG 948
L YLH + HRD+K +NIL++ + + DFGLA+ +D + + ++ V +
Sbjct: 116 LKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW- 171
Query: 949 YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRT 981
Y APE YT + DI+S G + ELLT +
Sbjct: 172 YRAPELLLSSSRYTKAI----DIWSVGCIFAELLTRKP 205
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-15
Identities = 64/204 (31%), Positives = 107/204 (52%), Gaps = 16/204 (7%)
Query: 784 DSFI-VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
DSFI +G G+ G V A +GK VAVKK+ R+ E F E++ + H N+V
Sbjct: 25 DSFIKIGEGSTGIVCIATEKHTGKQVAVKKM-DLRKQQRRELLFN-EVVIMRDYHHENVV 82
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
+Y Y G L ++ E++E G+L +++ + N E + L L+YLH+
Sbjct: 83 DMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA--TVCLSVLRALSYLHNQ-- 137
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYAYTM 958
+ HRDIKS++ILL + DFG + ++P+ KS+ G+ ++APE +
Sbjct: 138 -GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSL---VGTPYWMAPEVISRL 193
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
+ DI+S G++++E++ G P
Sbjct: 194 PYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 1e-15
Identities = 54/207 (26%), Positives = 90/207 (43%), Gaps = 10/207 (4%)
Query: 787 IVGSGAYGTVYKAVMDSGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
+G G +G VY+ V S + VAVK + + E F E + + H +IVK
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAYIMRQFDHPHIVK 71
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
L G ++ E G L L + +L+ + + + + LAYL R
Sbjct: 72 LIGVITENPV-WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLE---SKR 127
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
HRDI + N+L+ +GDFGL++ ++ S ++APE + T
Sbjct: 128 FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTS 187
Query: 963 KCDIYSYGVVLLELLT-GRTPVQPLDD 988
D++ +GV + E+L G P Q + +
Sbjct: 188 ASDVWMFGVCMWEILMLGVKPFQGVKN 214
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 1e-15
Identities = 72/286 (25%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 784 DSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESS-FRAEILTLGKIRHRNIV 841
+ ++G G YG VY A + + +A+K++ E ++ EI ++HRNIV
Sbjct: 12 ERVVLGKGTYGIVYAARDLSTQVRIAIKEIP---ERDSRYVQPLHEEIALHSYLKHRNIV 68
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAA--EGLAYLHHDC 899
+ G G + E + GSL LL L+ + +I EGL YLH +
Sbjct: 69 QYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN- 127
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV-------AGSYGYIAP 952
+I HRDIK +N+L++ G+ K+ D SK ++ + G+ Y+AP
Sbjct: 128 --QIVHRDIKGDNVLVNTY-------SGVVKISDFGTSKRLAGINPCTETFTGTLQYMAP 178
Query: 953 EYAYTMKVTEK--------CDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS 1004
E V +K DI+S G ++E+ TG+ P L + A + + H
Sbjct: 179 E------VIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE-PQAAMFKVGMFKIHP 231
Query: 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVV 1050
P L+ E ++ + L C P R S +++
Sbjct: 232 EIP----ESLSAEAKNFI----------LRCFEPDPDKRASAHDLL 263
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 2e-15
Identities = 60/205 (29%), Positives = 103/205 (50%), Gaps = 21/205 (10%)
Query: 789 GSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G G+Y TVYK +G++VA+K++ E ++ R E L ++H NIV L+
Sbjct: 14 GEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDII 72
Query: 848 YHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ + + L++EY++ L + + G ++ F+ L GLAY H R+ H
Sbjct: 73 HTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQL--LRGLAYCHQR---RVLH 126
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----AYTMKV 960
RD+K N+L+ ++ E + DFGLA+ +P SK+ S + Y P+ Y+ +
Sbjct: 127 RDLKPQNLLISERGELKLADFGLARAKSVP-SKTYSNEVVTLWYRPPDVLLGSTEYSTSL 185
Query: 961 TEKCDIYSYGVVLLELLTGRTPVQP 985
D++ G + E+ TGR P+ P
Sbjct: 186 ----DMWGVGCIFYEMATGR-PLFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 58/197 (29%), Positives = 97/197 (49%), Gaps = 14/197 (7%)
Query: 788 VGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
+G G++G KA++ + GK +K++ ++ R E+ L ++H NIV+
Sbjct: 8 IGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ- 63
Query: 844 YGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH-HDCKP 901
Y + + NL ++ +Y E G L + ++ L +P ++ LA H HD K
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVL-FPEDQILDWFVQICLALKHVHDRK- 121
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVT 961
I HRDIKS NI L +GDFG+A+V++ + + + Y Y++PE
Sbjct: 122 -ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPY-YLSPEICENRPYN 179
Query: 962 EKCDIYSYGVVLLELLT 978
K DI++ G VL E+ T
Sbjct: 180 NKSDIWALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 2e-15
Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 39/212 (18%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G YG VYK +G+IVA+KK+ E + S+ EI L +++H NIV L
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDV 67
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGL------AYLHHD-- 898
+ LI+E++ S +L+ +++ +L + + +YL+
Sbjct: 68 LMQESRLYLIFEFL------------SMDLK---KYLDSLPKGQYMDAELVKSYLYQILQ 112
Query: 899 ----C-KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
C R+ HRD+K N+L+D+K + DFGLA+ +P V + Y APE
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLW-YRAPE 171
Query: 954 Y-----AYTMKVTEKCDIYSYGVVLLELLTGR 980
Y+ V DI+S G + E+ T +
Sbjct: 172 VLLGSPRYSTPV----DIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 2e-15
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 24/205 (11%)
Query: 788 VGSGAYGTVYKAVMDSGKI-VAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLY 844
VGSGAYG V A VA+KKL+ R + + R E+ L + H N++ L
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS--RPFQSAIHAKRTYRELRLLKHMDHENVIGLL 80
Query: 845 GFCYHQGSNL-------LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
+ S+L L+ M L ++ + + +F++ GL Y+H
Sbjct: 81 D-VFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDD-HIQFLV-YQILRGLKYIH- 135
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
I HRD+K +NI +++ E + DFGLA+ D M+ + Y APE
Sbjct: 136 --SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLN 189
Query: 958 -MKVTEKCDIYSYGVVLLELLTGRT 981
M + DI+S G ++ ELLTG+T
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKT 214
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 787 IVGSGAYGTVYKAVM------DSGKIVAVKKLASNREGNNIESSF-RAEILT-LGKIRHR 838
+G+GA+G V +A D+ VAVK L + E+ +I++ LG H
Sbjct: 42 TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGN--HE 99
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYL-H 896
NIV L G C G L+I EY G L L + L + A+G+A+L
Sbjct: 100 NIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS 159
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS----YGYIAP 952
+C HRD+ + N+LL + DFGLA+ I + S V G+ ++AP
Sbjct: 160 KNC----IHRDLAARNVLLTHGKIVKICDFGLARDI---MNDSNYVVKGNARLPVKWMAP 212
Query: 953 EYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
E + T + D++SYG++L E+ + G P
Sbjct: 213 ESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-15
Identities = 78/309 (25%), Positives = 130/309 (42%), Gaps = 45/309 (14%)
Query: 782 FHDSFIVGSGAYGTVYKAVM--DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHR 838
F D ++G G +G V KA + D ++ A K + F E+ L K+ H
Sbjct: 11 FQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 68
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTRFM 883
NI+ L G C H+G L EY G+L + L + ++ L
Sbjct: 69 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 128
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943
A A G+ YL + + HRD+ + NIL+ + + A + DFGL++ ++ K+M +
Sbjct: 129 FAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 185
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRD 1002
++A E T D++SYGV+L E+++ G TP + T Y
Sbjct: 186 --PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM-------TCAELY--- 233
Query: 1003 HSLTPGI-FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061
L G + LN +DE V + C P++RPS +++ L E
Sbjct: 234 EKLPQGYRLEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 285
Query: 1062 RFNSSPTYD 1070
+ ++ Y+
Sbjct: 286 TYVNTTLYE 294
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (191), Expect = 3e-15
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 37/210 (17%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVK----KLASNREGNNIESSFRAEILTLGKI-RHRNIV 841
+G G +G+VY A ++G++VA+K K S E N+ E+ +L K+ H NIV
Sbjct: 7 LGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-----EVKSLRKLNEHPNIV 61
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
KL ++EYME G+L +L+ I +GLA++H
Sbjct: 62 KLKEVFRENDELYFVFEYME-GNLYQLMKDRKGKP-FSESVIRSIIYQILQGLAHIH--- 116
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA----VAGSYGYIAPEY- 954
K FHRD+K N+L+ + DFGLA+ I +S V+ + Y APE
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREI-----RSRPPYTDYVSTRW-YRAPEIL 170
Query: 955 ----AYTMKVTEKCDIYSYGVVLLELLTGR 980
+Y+ V DI++ G ++ EL T R
Sbjct: 171 LRSTSYSSPV----DIWALGCIMAELYTLR 196
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 3e-15
Identities = 70/235 (29%), Positives = 94/235 (40%), Gaps = 52/235 (22%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKL------ASNREGNNIESSFRAEILTLGKIRHRN 839
++G GA+G V+ D+G++ A+K L N+ + RAE L
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-----VRAERDILADADSPW 62
Query: 840 IVKLYGFCYHQGSNLL--IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
IVKLY Q L + EYM G L LL E RF IA E + L
Sbjct: 63 IVKLY--YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIA----ELVLALDS 116
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVI----------------------- 932
K HRDIK +NIL+D H+ DFGL K +
Sbjct: 117 VHKLGFIHRDIKPDNILIDAD--GHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVL 174
Query: 933 ----DMPQSKSMS-AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
D Q + + + G+ YIAPE +CD +S GV+L E+L G P
Sbjct: 175 VRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 4e-15
Identities = 66/220 (30%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 780 YNFHDSFIVGSGAYGTV----YKAVMDSGKIVAVK-----KLASNREGNNIESSFRAEIL 830
+ F +G+G++G V +K SGK A+K K+ ++ ++ + E
Sbjct: 3 FEFIK--TLGTGSFGRVMLVRHK---GSGKYYALKILSKAKIVKLKQVEHVLN----EKR 53
Query: 831 TLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAA 889
L IRH +V LYG + SNL L+ EY+ G L L S E RF AA
Sbjct: 54 ILQSIRHPFLVNLYG-SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY----AA 108
Query: 890 E---GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS 946
+ L YLH I +RD+K N+LLD + DFG AK + + G+
Sbjct: 109 QVVLALEYLHS-LD--IVYRDLKPENLLLDSDGYIKITDFGFAKRVK----GRTYTLCGT 161
Query: 947 YGYIAPEY----AYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y+APE Y V D ++ G+++ E+L G P
Sbjct: 162 PEYLAPEIILSKGYGKAV----DWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 4e-15
Identities = 56/200 (28%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 796 VYKAVMDSGKIVAVKKLASNREGNNIESS-FRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854
+YK + + K V ++ +G+ + EI L +I NI+K+YGF +L
Sbjct: 36 IYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94
Query: 855 ----LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH-HDCKPRIFHRDIK 909
LI EY RG L E+L +L + T+ +A+ +GL L+ + KP ++++
Sbjct: 95 PRLSLILEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKYTNKP---YKNLT 150
Query: 910 SNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM--KVTEKCDIY 967
S + L+ + ++ + GL K++ P K+++ + Y + + + + T K DIY
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMV----YFSYKMLNDIFSEYTIKDDIY 206
Query: 968 SYGVVLLELLTGRTPVQPLD 987
S GVVL E+ TG+ P + L
Sbjct: 207 SLGVVLWEIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 5e-15
Identities = 59/215 (27%), Positives = 98/215 (45%), Gaps = 24/215 (11%)
Query: 787 IVGSGAYGTVYKAVM--DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKL 843
++G G +G V KA + D ++ A K + F E+ L K+ H NI+ L
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTRFMIALGA 888
G C H+G L EY G+L + L + ++ L A
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG 948
A G+ YL + + HRD+ + NIL+ + + A + DFGL++ ++ K+M +
Sbjct: 122 ARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVR 176
Query: 949 YIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++A E T D++SYGV+L E+++ G TP
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 6e-15
Identities = 62/221 (28%), Positives = 96/221 (43%), Gaps = 34/221 (15%)
Query: 788 VGSGAYGTVYKA------VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G GA+G V+ A +VAVK L + AE+LT ++H +IV
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLT--NLQHEHIV 70
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELL--HG-------------SSCNLEWPTRFMIAL 886
K YG C ++++EYM+ G L + L HG + L IA
Sbjct: 71 KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG- 945
A G+ YL HRD+ + N L+ +GDFG+++ + S V G
Sbjct: 131 QIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVGGH 184
Query: 946 ---SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++ PE K T + D++S+GV+L E+ T G+ P
Sbjct: 185 TMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-15
Identities = 66/209 (31%), Positives = 107/209 (51%), Gaps = 17/209 (8%)
Query: 787 IVGSGAYGTVY--KAVM--DSGKIVAVK--KLASNREGNNIESSFRAEILTLGKIRHRNI 840
++G G++G V+ + + D+G++ A+K K A+ + + + + +IL ++ H I
Sbjct: 3 VLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILA--EVNHPFI 60
Query: 841 VKL-YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
VKL Y F +G LI +++ G L L E +F +A A L +LH
Sbjct: 61 VKLHYAF-QTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA-ELALALDHLH--- 115
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
I +RD+K NILLD++ + DFGL+K ID K + G+ Y+APE
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRR 173
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQPLD 987
T+ D +S+GV++ E+LTG P Q D
Sbjct: 174 GHTQSADWWSFGVLMFEMLTGSLPFQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 8e-15
Identities = 60/196 (30%), Positives = 93/196 (47%), Gaps = 8/196 (4%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G++G V+K + + + K+VA+K + + IE + EI L + + K YG
Sbjct: 12 IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYVTKYYGS 70
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+I EY+ GS +LL L+ I +GL YLH + K HR
Sbjct: 71 YLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSEKK---IHR 125
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
DIK+ N+LL + E + DFG+A + Q K + G+ ++APE K DI
Sbjct: 126 DIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIKQSAYDSKADI 184
Query: 967 YSYGVVLLELLTGRTP 982
+S G+ +EL G P
Sbjct: 185 WSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-14
Identities = 58/201 (28%), Positives = 103/201 (51%), Gaps = 11/201 (5%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G Y TV+K + +VA+K++ E ++ R E+ L ++H NIV L+
Sbjct: 13 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLHDI 71
Query: 847 CYHQGSNLLIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ + L++EY++ L + G+ ++ FM L GL+Y H +I H
Sbjct: 72 IHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL--LRGLSYCHKR---KILH 126
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TMKVTEKC 964
RD+K N+L+++K E + DFGLA+ +P +K+ S + Y P+ + + +
Sbjct: 127 RDLKPQNLLINEKGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSTEYSTPI 185
Query: 965 DIYSYGVVLLELLTGRTPVQP 985
D++ G +L E+ TGR P+ P
Sbjct: 186 DMWGVGCILYEMATGR-PMFP 205
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 65/218 (29%), Positives = 105/218 (48%), Gaps = 26/218 (11%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR----NIVKL 843
+G+G G+V K V KK+ +SS R +IL +I H IV
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHI----GAKSSVRKQILRELQIMHECRSPYIVSF 68
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF----MIALGAAEGLAYLHHDC 899
YG ++ + + E+M+ GSL + P IA+ EGL YL++
Sbjct: 69 YGAFLNENNICMCMEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYN-- 121
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
RI HRDIK +NIL++ + + + DFG++ ++I+ S + + V G+ Y++PE
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---SIADTFV-GTSTYMSPERIQGG 177
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP--VQPLDDGGDLAT 994
K T K D++S G+ ++EL G+ P +DD G
Sbjct: 178 KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP 215
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 56/220 (25%), Positives = 96/220 (43%), Gaps = 28/220 (12%)
Query: 787 IVGSGAYGTVYKA------VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRN 839
+G GA+G V KA + VAVK L + ++ S +E+ + I +H+N
Sbjct: 19 PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHKN 77
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTRFMI 884
I+ L G C +G ++ EY G+L + L L
Sbjct: 78 IINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSF 137
Query: 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAV 943
A A G+ +L + HRD+ + N+L+ + + DFGLA+ I + + +
Sbjct: 138 AYQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNG 194
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE + T + D++S+GV+L E+ T G +P
Sbjct: 195 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 1e-14
Identities = 64/207 (30%), Positives = 89/207 (42%), Gaps = 30/207 (14%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLA-----SNREGNNIESSFRAEILTLGKIRHRNIV 841
VG G YG V+ A D+G+IVA+K++ E ++ +ILT K +V
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHV--LTERDILTTTK--SEWLV 64
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMI-----ALGAAEGLAYL 895
KL + + L L EY+ G LL+ E RF + A+ A L Y+
Sbjct: 65 KLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYI 123
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H D KP N L+D + DFGL+K I + + S V GS Y+APE
Sbjct: 124 HRDLKP---------ENFLIDASGHIKLTDFGLSKGI---VTYANSVV-GSPDYMAPEVL 170
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
D +S G +L E L G P
Sbjct: 171 RGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 1e-14
Identities = 61/229 (26%), Positives = 92/229 (40%), Gaps = 35/229 (15%)
Query: 780 YNFHDSFIVGSGAYGTVYKAVMD--SGKIVAVKKLASNREGNNIESSFRA---------- 827
Y + + G G YG V KA D +GKIVA+KK+ N++ +
Sbjct: 10 YIQKGAHL-GEGTYGKVEKA-YDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 828 --EILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIA 885
E+ + +I+H NI+ L L+ + M L +++ L I
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVD-RKIRLTESQVKCIL 125
Query: 886 LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-------------KVI 932
L GL LH K HRD+ NI ++ K + DFGLA K
Sbjct: 126 LQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDE 182
Query: 933 DMPQSKSMSAVAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGR 980
M + + M++ + Y APE K D++S G + ELLTG+
Sbjct: 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-14
Identities = 63/219 (28%), Positives = 104/219 (47%), Gaps = 27/219 (12%)
Query: 782 FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNI 840
+ D +G G+ G V+ AV D K VAVKK+ + +++ + R EI + ++ H NI
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVL-TDPQSVKHALR-EIKIIRRLDHDNI 64
Query: 841 VKLYGFCYHQGSNL--------------LIYEYMERGSLGELLHGSSCNLEWPTRFMIAL 886
VK+Y GS+L ++ EYME L +L + E FM L
Sbjct: 65 VKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQL 123
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKS--MSAV 943
GL Y+H + HRD+K N+ ++ + +GDFGLA+++D S +S
Sbjct: 124 --LRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEG 178
Query: 944 AGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRT 981
+ Y +P + T+ D+++ G + E+LTG+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 2e-14
Identities = 59/210 (28%), Positives = 98/210 (46%), Gaps = 21/210 (10%)
Query: 788 VGSGAYGTVYKAV--MDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHR----NI 840
+GSG +G V K V M +I VA+K L + E S R E++ +I H+ I
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-----KSVRDEMMREAEIMHQLDNPYI 57
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
V++ G C + L L+ E G L + L G + + + G+ YL
Sbjct: 58 VRMIGVC--EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLE--- 112
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--GYIAPEYAYT 957
HRD+ + N+LL ++ A + DFGL+K + S + AG + + APE
Sbjct: 113 GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172
Query: 958 MKVTEKCDIYSYGVVLLELLT-GRTPVQPL 986
K + + D++SYG+ + E + G+ P + +
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 2e-14
Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 11/203 (5%)
Query: 787 IVGSGAYGTVYKAVMD-SGK---IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G+G +G V + GK VA+K L + F +E +G+ H NI+
Sbjct: 11 VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
L G +++ EYME GSL L + G A G+ YL
Sbjct: 70 LEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDMG 126
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG--YIAPEYAYTMKV 960
HRD+ + NIL++ V DFGL++V++ + + G + APE K
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 186
Query: 961 TEKCDIYSYGVVLLELLT-GRTP 982
T D++SYG+V+ E+++ G P
Sbjct: 187 TSASDVWSYGIVMWEVMSYGERP 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 2e-14
Identities = 63/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA GTVY A+ + +G+ VA+K++ N + + EIL + + ++ NIV Y
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQM--NLQQQPKKELIINEILVMRENKNPNIVN-YLD 83
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
Y G L ++ EY+ GSL +++ +C E + + L +LH + ++ H
Sbjct: 84 SYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIA-AVCRECLQALDFLHSN---QVIH 138
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RDIKS+NILL + DFG I QSK + V Y ++APE K D
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVD 197
Query: 966 IYSYGVVLLELLTGRTP 982
I+S G++ +E++ G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 62/219 (28%), Positives = 95/219 (43%), Gaps = 47/219 (21%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR-----NIVK 842
G GAYG V K + +G I+AVK++ + + S + +L I R V
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVKRIRAT-----VNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTRFM--IALGAAEGLAYLHHDC 899
YG + +G + E M+ SL + L P + IA+ + L YLH
Sbjct: 65 FYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFG--------LAKVIDMPQSKSMSAVAGSYGYIA 951
+ HRD+K +N+L++ + + DFG +AK ID AG Y+A
Sbjct: 124 S--VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID----------AGCKPYMA 171
Query: 952 PE--------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
PE Y + K D++S G+ ++EL TGR P
Sbjct: 172 PERINPELNQKGYDV----KSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-14
Identities = 42/116 (36%), Positives = 59/116 (50%), Gaps = 8/116 (6%)
Query: 88 PCS-----WIGVNCTSDFEPVVW---SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELT 139
PC W G +C D W L L+ G + I L HL ++L+ N +
Sbjct: 396 PCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIR 455
Query: 140 GYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLG 195
G IP +G+ + LE L L+ N F+G IP LG+L+SL LN+ N +SG +P LG
Sbjct: 456 GNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 3e-14
Identities = 60/204 (29%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 784 DSFI-VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+++I +G G+ G V A SG+ VAVK + R+ E F E++ + +H+N+V
Sbjct: 24 ENYIKIGEGSTGIVCIAREKHSGRQVAVK-MMDLRKQQRRELLFN-EVVIMRDYQHQNVV 81
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
++Y Y G L ++ E+++ G+L +++ + N E + + L YLH
Sbjct: 82 EMYK-SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIA--TVCESVLQALCYLHSQ-- 136
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYAYTM 958
+ HRDIKS++ILL + DFG I D+P+ KS+ G+ ++APE
Sbjct: 137 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL---VGTPYWMAPEVISRT 192
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
+ DI+S G++++E++ G P
Sbjct: 193 PYGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-14
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLY 844
+GSGAYG V A+ SGK VA+KK+ + + + R E+ L +H NI+ +
Sbjct: 12 NIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIR 70
Query: 845 GFCYHQGSNL----LIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDC 899
G++ ++ + ME L ++H E F+ L GL Y+H
Sbjct: 71 DILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQL--LRGLKYIHSAN 127
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---MSAVAGSYGYIAPEYAY 956
+ HRD+K +N+L+++ E +GDFG+A+ + ++ M+ + Y APE
Sbjct: 128 ---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLL 184
Query: 957 TM-KVTEKCDIYSYGVVLLELLTGRTPVQP 985
++ + T D++S G + E+L GR + P
Sbjct: 185 SLPEYTTAIDMWSVGCIFAEML-GRRQLFP 213
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 787 IVGSGAYGTVYKAVMD-SGK---IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G+G +G V + + GK VA+K L S F +E +G+ H NI+
Sbjct: 11 VIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQ-RRDFLSEASIMGQFDHPNIIH 69
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
L G ++I E+ME G+L L + + G A G+ YL +
Sbjct: 70 LEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG------YIAPEYAY 956
HRD+ + NIL++ V DFGL++ ++ S S G + APE
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRFLE--DDTSDPTYTSSLGGKIPIRWTAPEAIA 184
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTP 982
K T D++SYG+V+ E+++ G P
Sbjct: 185 YRKFTSASDVWSYGIVMWEVMSYGERP 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 59/205 (28%), Positives = 95/205 (46%), Gaps = 15/205 (7%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVK--KLASNREGNNIESSFRAEILT-LGKIRHRNIVKL 843
+G GAYGTVYKA SG VA+K ++ +N +G + + +L L H NIV+L
Sbjct: 8 IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67
Query: 844 YGFCYHQGSN-----LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898
C ++ L++E++++ L L T + GL +LH +
Sbjct: 68 MDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN 127
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
C I HRD+K NIL+ + + DFGLA++ +++ V + Y APE
Sbjct: 128 C---IVHRDLKPENILVTSGGQVKLADFGLARIYSC--QMALTPVVVTLWYRAPEVLLQS 182
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPV 983
D++S G + E+ R P+
Sbjct: 183 TYATPVDMWSVGCIFAEMFR-RKPL 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 4e-14
Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 23/207 (11%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G+Y TVYK + +G++VA+K ++ E ++ R E L ++H NIV L+
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDI 71
Query: 847 CYHQGSNLLIYEYMERGSLGEL-------LHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+ + + ++EYM L + LH N+ FM L GLAY+H
Sbjct: 72 IHTKETLTFVFEYMHT-DLAQYMIQHPGGLH--PYNVRL---FMFQL--LRGLAYIHGQ- 122
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TM 958
I HRD+K N+L+ E + DFGLA+ +P S++ S+ + Y P+
Sbjct: 123 --HILHRDLKPQNLLISYLGELKLADFGLARAKSIP-SQTYSSEVVTLWYRPPDVLLGAT 179
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQP 985
+ DI+ G + +E+L G+ P P
Sbjct: 180 DYSSALDIWGAGCIFIEMLQGQ-PAFP 205
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 5e-14
Identities = 62/197 (31%), Positives = 101/197 (51%), Gaps = 11/197 (5%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA GTVY A+ + +G+ VA++++ N + + EIL + + ++ NIV Y
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVN-YLD 84
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
Y G L ++ EY+ GSL +++ +C E + + L +LH + ++ H
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIA-AVCRECLQALEFLHSN---QVIH 139
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RDIKS+NILL + DFG I QSK + V Y ++APE K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVD 198
Query: 966 IYSYGVVLLELLTGRTP 982
I+S G++ +E++ G P
Sbjct: 199 IWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 6e-14
Identities = 62/219 (28%), Positives = 100/219 (45%), Gaps = 37/219 (16%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLY 844
+VG+G YG VYK + +G++ A+K + + E + EI L K HRNI Y
Sbjct: 23 VVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDE---EEEIKLEINMLKKYSHHRNIATYY 79
Query: 845 GFCY------HQGSNLLIYEYMERGSLGELLH---GSSCNLEWPTRFMIALGAAEGLAYL 895
G H L+ E+ GS+ +L+ G++ +W I GLA+L
Sbjct: 80 GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIA--YICREILRGLAHL 137
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
H ++ HRDIK N+LL + E + DFG++ +D + + + Y ++APE
Sbjct: 138 HAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVI 193
Query: 954 ---------YAYTMKVTEKCDIYSYGVVLLELLTGRTPV 983
Y Y + DI+S G+ +E+ G P+
Sbjct: 194 ACDENPDATYDY------RSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 8e-14
Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 18/204 (8%)
Query: 787 IVGSGAYGTVYKA-VMDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLY 844
++G G +G V V +GK+ A KKL R + E+ E L K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL- 65
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLH--GSSCNLEWPTRFMIALGAAE---GLAYLHHD 898
+ Y L L+ M G L ++ G+ E F AAE GL L
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFY----AAELCCGLEDLQ-- 119
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
+ RI +RD+K NILLDD+ + D GLA + +P+ +++ G+ GY+APE
Sbjct: 120 -RERIVYRDLKPENILLDDRGHIRISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNE 176
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
K T D + G ++ E++ G++P
Sbjct: 177 KYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 8e-14
Identities = 58/197 (29%), Positives = 102/197 (51%), Gaps = 11/197 (5%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA GTV+ A+ + +G+ VA+K++ N + + EIL + ++++ NIV
Sbjct: 27 IGQGASGTVFTAIDVATGQEVAIKQI--NLQKQPKKELIINEILVMKELKNPNIVNFLD- 83
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ G L ++ EY+ GSL +++ +C ++ + + L +LH + ++ H
Sbjct: 84 SFLVGDELFVVMEYLAGGSLTDVV-TETC-MDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RDIKS+N+LL + DFG I QSK + V Y ++APE K D
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGPKVD 197
Query: 966 IYSYGVVLLELLTGRTP 982
I+S G++ +E++ G P
Sbjct: 198 IWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 9e-14
Identities = 66/207 (31%), Positives = 99/207 (47%), Gaps = 24/207 (11%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASN--REGNNIESSF-RAEILTLGKIRHRNIVK 842
++G G++G V A + + + A+K L + E +++E + +L L H +
Sbjct: 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTH 60
Query: 843 LYGFCYHQGSNLLIY--EYMERGSLGELLHGSSCNL--EWPTRFMIALGAAE---GLAYL 895
L FC Q L + EY+ G L + H S E RF AAE GL +L
Sbjct: 61 L--FCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFY----AAEIICGLQFL 112
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H K I +RD+K +N+LLD + DFG+ K +M S G+ YIAPE
Sbjct: 113 H---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGEGKASTFCGTPDYIAPEIL 168
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
K E D +S+GV+L E+L G++P
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 9e-14
Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 10/205 (4%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G GA+G VYKA ++A K+ + +E + EI L H NIVKL
Sbjct: 13 LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELED-YMVEIDILASCDHPNIVKLLDAF 71
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
Y++ + ++ E+ G++ ++ L P ++ E L YLH + +I HRD
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRD 128
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE----- 962
+K+ NIL + + DFG++ + S + Y ++APE +
Sbjct: 129 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPY-WMAPEVVMCETSKDRPYDY 187
Query: 963 KCDIYSYGVVLLELLTGRTPVQPLD 987
K D++S G+ L+E+ P L+
Sbjct: 188 KADVWSLGITLIEMAQIEPPHHELN 212
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 2e-13
Identities = 36/82 (43%), Positives = 51/82 (62%)
Query: 570 LTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNL 629
L G IP +I LQ +++S NS G++P LG++ LE+L LS N F+G+IP +LG L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 630 SHLTELQMGGNLFSGEIPPELG 651
+ L L + GN SG +P LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)
Query: 788 VGSGAYGTVYKAVM--------DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHR 838
+G G +G V +A D VAVK L N ++ + +E+ + I +H+
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDL-ADLISEMELMKLIGKHK 78
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG---------------SSCNLEWPTRFM 883
NI+ L G C +G +I EY +G+L E L L +
Sbjct: 79 NIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSA 942
A A G+ YL R HRD+ + N+L+ + + DFGLA+ V D+ K S
Sbjct: 139 CAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195
Query: 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE + T + D++S+G+++ E+ T G +P
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 2e-13
Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 45/232 (19%)
Query: 787 IVGSGAYGTVYKAVMDSGK------IVAVKKLASNREGNNIESSFRA---EILTLGKIRH 837
+G G +G V KA K VAVK L +E + S R E L ++ H
Sbjct: 7 TLGEGEFGKVVKATAFRLKGRAGYTTVAVKML---KENAS-SSELRDLLSEFNLLKQVNH 62
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGS---------------SCNLEWPTRF 882
+++KLYG C G LLI EY + GSL L S S L+ P
Sbjct: 63 PHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDER 122
Query: 883 MIALG--------AAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-- 932
+ +G + G+ YL + ++ HRD+ + N+L+ + + + DFGL++ +
Sbjct: 123 ALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 933 -DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
D +S + ++A E + T + D++S+GV+L E++T G P
Sbjct: 180 EDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (175), Expect = 2e-13
Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLY 844
+VG+G YG VYK + +G++ A+K + + G+ E + EI L K HRNI Y
Sbjct: 13 LVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDE-EEEIKQEINMLKKYSHHRNIATYY 69
Query: 845 G-FCYHQGSNL-----LIYEYMERGSLGELLH---GSSCNLEWPTRFMIALGAAEGLAYL 895
G F + L+ E+ GS+ +L+ G++ EW I GL++L
Sbjct: 70 GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHL 127
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H ++ HRDIK N+LL + E + DFG++ +D + + + Y ++APE
Sbjct: 128 HQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY-WMAPEVI 183
Query: 956 YTMKVTE-----KCDIYSYGVVLLELLTGRTPV 983
+ + K D++S G+ +E+ G P+
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 2e-13
Identities = 70/246 (28%), Positives = 111/246 (45%), Gaps = 24/246 (9%)
Query: 782 FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNI 840
+ D VGSGAYGTV A+ +G VA+KKL + E+ L ++H N+
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76
Query: 841 VKLYGFCYHQGSNL-------LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
+ L + +L L+ +M LG+L+ + E +F++ +GL
Sbjct: 77 IGLLD-VFTPDLSLDRFHDFYLVMPFMGT-DLGKLMKHEKLS-EDRIQFLV-YQMLKGLK 132
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
Y+H I HRD+K N+ +++ E + DFGLA+ D M+ + Y APE
Sbjct: 133 YIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD----SEMTGYVVTRWYRAPE 185
Query: 954 YAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012
M T+ DI+S G ++ E+LTG+ PL G D + ++ F
Sbjct: 186 VILNWMHYTQTVDIWSVGCIMAEMLTGK----PLFKGHDHLDQLMEIMKVTGTPSKEFVQ 241
Query: 1013 RLNVED 1018
+L ED
Sbjct: 242 KLQSED 247
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 52/193 (26%), Positives = 86/193 (44%), Gaps = 6/193 (3%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
++G G +G V+K + VAVK + ++ F +E L + H NIVKL G
Sbjct: 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGV 60
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH-HDCKPRIFH 905
C + ++ E + G L L+ AL AA G+AYL +C H
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNC----IH 116
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RD+ + N L+ + + DFG+++ D S + APE + + + D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176
Query: 966 IYSYGVVLLELLT 978
++SYG++L E +
Sbjct: 177 VWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 3e-13
Identities = 69/228 (30%), Positives = 104/228 (45%), Gaps = 48/228 (21%)
Query: 788 VGSGAYGTVYKAVMD--SGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKL 843
+G GA+G V+ +V D GK VA+KK+ + + N+ S R E+ L +H N++
Sbjct: 8 IGYGAFGVVW-SVTDPRDGKRVALKKMPNVFQ--NLVSCKRVFRELKMLCFFKHDNVLSA 64
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNL------------EWPTRFMIALGAAEG 891
Q ++ +E + + EL+ +L + F+ + G
Sbjct: 65 LDIL--QPPHIDPFEEIY--VVTELMQ---SDLHKIIVSPQPLSSDHVKVFLYQI--LRG 115
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA-VAGSYGYI 950
L YLH I HRDIK N+L++ + DFGLA+V + +SK M+ V Y Y
Sbjct: 116 LKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQY-YR 171
Query: 951 APEYA-----YTMKVTEKCDIYSYGVVLLELLTGR------TPVQPLD 987
APE YT V DI+S G + ELL R +P+Q LD
Sbjct: 172 APEILMGSRHYTSAV----DIWSVGCIFAELLGRRILFQAQSPIQQLD 215
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 3e-13
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 16/209 (7%)
Query: 787 IVGSGAYGTVYKAVMD-SGKIVAVKKLASN--REGNNIESSF-RAEILTLGKIRHRNIVK 842
++G G++G V+ A + + + A+K L + +++E + +L+L H +
Sbjct: 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 843 LYGFCYHQGSNLLIY--EYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDC 899
LY C Q L + EY+ G L + H SC+ + P A GL +LH
Sbjct: 61 LY--CTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLH--- 113
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
I +RD+K +NILLD + DFG+ K + +K+ G+ YIAPE K
Sbjct: 114 SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEILLGQK 172
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQPLDD 988
D +S+GV+L E+L G++P D+
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 3e-13
Identities = 72/245 (29%), Positives = 100/245 (40%), Gaps = 51/245 (20%)
Query: 781 NFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESS----FRAEILTLGKI 835
+F ++G GA+G V D+G I A+KKL R+ +E RAE L +
Sbjct: 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKL---RKSEMLEKEQVAHVRAERDILAEA 58
Query: 836 RHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAY 894
+ +VKLY + + + L LI EY+ G + LL E TRF IA E +
Sbjct: 59 DNPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIA----ETILA 113
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK------------------------ 930
+ K HRDIK +N+LLD K + DFGL
Sbjct: 114 IDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173
Query: 931 VIDMPQSKSMSA-------------VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 977
I P S A G+ YIAPE ++CD +S GV++ E+L
Sbjct: 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML 233
Query: 978 TGRTP 982
G P
Sbjct: 234 VGYPP 238
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-13
Identities = 63/222 (28%), Positives = 97/222 (43%), Gaps = 15/222 (6%)
Query: 772 FQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEIL 830
F V E T + D VG GA+G V A +G+ VA+KK+ + E+
Sbjct: 2 FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61
Query: 831 TLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE 890
L +RH NI+ L ++ + L LL ++ F+ +
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI--LR 119
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
GL Y+H + HRD+K +NIL+++ + + DFGLA+ Q M+ + Y
Sbjct: 120 GLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLAR----IQDPQMTGYVSTRYYR 172
Query: 951 APEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
APE T K + DI+S G + E+L G+ PL G D
Sbjct: 173 APEIMLTWQKYDVEVDIWSAGCIFAEMLEGK----PLFPGKD 210
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 4e-13
Identities = 63/206 (30%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 787 IVGSGAYGTVYKA-VMDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLY 844
++G G +G V V +GK+ A KKL R + E+ E L K+ R +V L
Sbjct: 7 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL- 65
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLH--GSSCNLEWPTRFMIALGAAE---GLAYLHHD 898
+ Y L L+ M G L ++ G+ E F AAE GL LH +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFY----AAEITCGLEDLHRE 121
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
RI +RD+K NILLDD + D GLA +++P+ +++ G+ GY+APE
Sbjct: 122 ---RIVYRDLKPENILLDDYGHIRISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNE 176
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQ 984
+ T D + G ++ E++ G++P +
Sbjct: 177 RYTFSPDWWGLGCLIYEMIEGKSPFR 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 4e-13
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 14/201 (6%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLASNR---EGNNIESSFRAEILTLGKIRHRNIVKL 843
+G G +G V V ++GK+ A KKL R + + EIL K+ IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE--KVNSPFIVNL 58
Query: 844 YGFCYHQGSNL-LIYEYMERGSLG-ELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
+ + ++L L+ M G L + + LE + G+ +LH
Sbjct: 59 -AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH---SM 114
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVT 961
I +RD+K N+LLDD+ + D GLA +++ K+++ AG+ GY+APE +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGTNGYMAPEILKEEPYS 172
Query: 962 EKCDIYSYGVVLLELLTGRTP 982
D ++ G + E++ GRTP
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 4e-13
Identities = 58/204 (28%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY-- 844
VGSGAYG+V A+ +G+ VA+KKL+ + E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 845 ---GFCYHQGSNL-LIYEYMERGSLGEL--LHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898
+ + L+ YM + L ++ S +++ M+ GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHPLSEDKVQYLVYQMLC-----GLKYIH-- 134
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT- 957
I HRD+K N+ +++ E + DFGLA+ D M+ + Y APE
Sbjct: 135 -SAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD----AEMTGYVVTRWYRAPEVILNW 189
Query: 958 MKVTEKCDIYSYGVVLLELLTGRT 981
M + DI+S G ++ E+LTG+T
Sbjct: 190 MHYNQTVDIWSVGCIMAEMLTGKT 213
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-13
Identities = 83/298 (27%), Positives = 128/298 (42%), Gaps = 57/298 (19%)
Query: 787 IVGSGAYGTVYKAVM----DSGKI-VAVKKLASNREGNNIESSFRAEIL----TLGKIRH 837
++GSGA+GTVYK + ++ KI VA+K L RE N EIL + +
Sbjct: 14 VLGSGAFGTVYKGIWIPDGENVKIPVAIKVL---RE--NTSPKANKEILDEAYVMAGVGS 68
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLH------GSSCNLEWPTRFMIALGAAEG 891
+ +L G C + L+ + M G L + + GS L W + A+G
Sbjct: 69 PYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQI------AKG 121
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--GY 949
++YL + R+ HRD+ + N+L+ + DFGLA+++D+ + A G +
Sbjct: 122 MSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE-TEYHADGGKVPIKW 177
Query: 950 IAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQ--PLDDGGDLATWVRNYIRDHSLT 1006
+A E + T + D++SYGV + EL+T G P P + DL L
Sbjct: 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDL------------LE 225
Query: 1007 PGIFDTRLNVEDESIVD-HMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRF 1063
G RL +D +MI+V C I RP RE+V RF
Sbjct: 226 KG---ERLPQPPICTIDVYMIMV-----KCWMIDSECRPRFRELVDEFSRMARDPSRF 275
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 5e-13
Identities = 54/202 (26%), Positives = 106/202 (52%), Gaps = 13/202 (6%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G Y TV+K + +VA+K++ E ++ R E+ L ++H NIV L+
Sbjct: 14 LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKDLKHANIVTLHDI 72
Query: 847 CYHQGSNLLIYEYMERGSLGELLH--GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ S L++EY+++ L + + G+ ++ F+ + GLAY H + ++
Sbjct: 73 VHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQI--LRGLAYCH---RRKVL 126
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TMKVTEK 963
HRD+K N+L++++ E + DFGLA+ +P +K+ S + Y P+ + + + +
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLARAKSVP-TKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 964 CDIYSYGVVLLELLTGRTPVQP 985
D++ G + E+ +GR P+ P
Sbjct: 186 IDMWGVGCIFFEMASGR-PLFP 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 6e-13
Identities = 33/78 (42%), Positives = 49/78 (62%)
Query: 550 LPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLE 609
+P ++ L L + N+S N + G IPP + + +L+ LD+S+NSF GS+P LG L L
Sbjct: 434 IPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLR 493
Query: 610 ILKLSENKFSGNIPSTLG 627
IL L+ N SG +P+ LG
Sbjct: 494 ILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 6e-13
Identities = 59/206 (28%), Positives = 93/206 (45%), Gaps = 12/206 (5%)
Query: 782 FHDSFIVGSGAYGTVYKA-VMDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRN 839
F ++G G +G V V +GK+ A K+L R + ES E L K+ +
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 840 IVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWP--TRFMIALGAAEGLAYLH 896
+V L + Y L L+ M G L ++ N+ P AAE L L
Sbjct: 62 VVNL-AYAYETKDALCLVLTIMNGGDLKFHIY----NMGNPGFEEERALFYAAEILCGLE 116
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
+ +RD+K NILLDD + D GLA + +P+ +S+ G+ GY+APE
Sbjct: 117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLN 174
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTP 982
+ T D + G ++ E++ G++P
Sbjct: 175 NQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-13
Identities = 72/292 (24%), Positives = 125/292 (42%), Gaps = 52/292 (17%)
Query: 788 VGSGAYGTVYKAVM------DSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKIRHR 838
+G G++G VY+ + + VA+K + AS RE IE F E + +
Sbjct: 14 LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRE--RIE--FLNEASVMKEFNCH 69
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELL-------HGSSCNLEWPTRFMIALGA--A 889
++V+L G L+I E M RG L L + + MI + A
Sbjct: 70 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG- 948
+G+AYL+ + + HRD+ + N ++ + F +GDFG+ + D+ ++ G G
Sbjct: 130 DGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR--DIYETDYYR--KGGKGL 182
Query: 949 ----YIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDH 1003
+++PE T D++S+GVVL E+ T P Q + + +
Sbjct: 183 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN---------EQVLRF 233
Query: 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055
+ G+ D N D ++ ++ MC +P RPS E++S + E
Sbjct: 234 VMEGGLLDKPDNCPD--------MLFELMRMCWQYNPKMRPSFLEIISSIKE 277
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 9e-13
Identities = 66/206 (32%), Positives = 98/206 (47%), Gaps = 22/206 (10%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR--NIVKLY 844
+GSG G VYK +G ++AVK++ R GN E+ L + H IVK Y
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMR--RTGNKEENKRILMDLDVVLKSHDCPYIVKCY 80
Query: 845 GFCYHQGSNLLI-YEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHDCKP 901
G + S++ I E M L +LL P + + + + L YL K
Sbjct: 81 G-YFITDSDVFICMELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKE--KH 134
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV 960
+ HRD+K +NILLD + DFG++ +++D SK+ + AG Y+APE
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVD---SKAKTRSAGCAAYMAPERIDPPDP 191
Query: 961 TEKCDI----YSYGVVLLELLTGRTP 982
K DI +S G+ L+EL TG+ P
Sbjct: 192 NPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 9e-13
Identities = 73/295 (24%), Positives = 120/295 (40%), Gaps = 59/295 (20%)
Query: 787 IVGSGAYGTVYKAVM--DSGKI--VAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIV 841
I+G G +G+V + + D G VAVK + + IE F +E + H N++
Sbjct: 6 ILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEE-FLSEAACMKDFDHPNVM 64
Query: 842 KLYGFCYHQGSN------LLIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAE 890
KL G C+ S ++I +M+ G L L G L T + A
Sbjct: 65 KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--- 947
G+ YL + HRD+ + N +L + V DFGL+K I +G Y
Sbjct: 125 GMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKI----------YSGDYYRQ 171
Query: 948 --------GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRN 998
+IA E T K D++++GV + E+ T G+TP +++ + +
Sbjct: 172 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-----IYD 226
Query: 999 YIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
Y+R RL + E +D + + C P DRP+ ++ +L
Sbjct: 227 YLRH--------GNRLK-QPEDCLDE---LYDLMYSCWRADPKDRPTFTKLREVL 269
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 1e-12
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 41/207 (19%)
Query: 802 DSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLY--GFCYHQGSNLL--I 856
+G VA+K L ++ E + + FR E ++ H NIV L G LL +
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA---PPGLLFAV 57
Query: 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE----------GLAYLHHDCKPRIFHR 906
+EY+ +L E+L AL A E LA H+ I HR
Sbjct: 58 FEYVPGRTLREVLAADG-----------ALPAGETGRLMLQVLDALACAHNQ---GIVHR 103
Query: 907 DIKSNNILL---DDKFEAHVGDFGL------AKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
D+K NI++ + A V DFG+ + D+ + V G+ Y APE
Sbjct: 104 DLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRG 163
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQ 984
VT D+Y++G++ LE LTG+ VQ
Sbjct: 164 EPVTPNSDLYAWGLIFLECLTGQRVVQ 190
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 16/211 (7%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYG 845
+G G YG V+K + +G AVK L ++I+ AE L + H N+VK YG
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAEYNILKALSDHPNVVKFYG 82
Query: 846 FCYHQ----GSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
Y + G L L+ E GS+ +L+ G E +IA E L L H
Sbjct: 83 MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----A 955
+ HRD+K NNILL + + DFG++ + + + ++V G+ ++APE
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQQ 201
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTPVQPL 986
+CD++S G+ +EL G P+ L
Sbjct: 202 LDSTYDARCDVWSLGITAIELGDGDPPLADL 232
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-12
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 30/215 (13%)
Query: 788 VGSGAYGTVYKAVM------DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G +G VYK + + + VA+K L EG + F+ E + +++H NIV
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGP-LREEFKHEAMMRSRLQHPNIV 71
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELL-----H---GSS-------CNLEWPTRFMIAL 886
L G + +I+ Y L E L H GS+ LE I
Sbjct: 72 CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVT 131
Query: 887 GAAEGLAYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAV 943
A G+ +L HH H+D+ + N+L+ DK + D GL + V K M
Sbjct: 132 QIAAGMEFLSSHHVV-----HKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNS 186
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 978
+++PE K + DI+SYGVVL E+ +
Sbjct: 187 LLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 2e-12
Identities = 54/197 (27%), Positives = 97/197 (49%), Gaps = 13/197 (6%)
Query: 787 IVGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
I+G G GTVYKA + + +I+AVK + + ++ +E+ L K I+ YG
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYG 66
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ + + E+M+ GSL ++ + IA+ +GL YL +I H
Sbjct: 67 AFFVENRISICTEFMDGGSLD--VYRK---IPEHVLGRIAVAVVKGLTYL---WSLKILH 118
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RD+K +N+L++ + + + DFG++ + +K+ G+ Y+APE + D
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY---VGTNAYMAPERISGEQYGIHSD 175
Query: 966 IYSYGVVLLELLTGRTP 982
++S G+ +EL GR P
Sbjct: 176 VWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 2e-12
Identities = 48/153 (31%), Positives = 69/153 (45%), Gaps = 22/153 (14%)
Query: 837 HRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH 896
+ N +KLY ++LI +Y++ G L +LL E + I E L LH
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKK-IIRQLVEALNDLH 126
Query: 897 HDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
K I H DIK N+L D K ++ D+GL K+I P S G+ Y +PE
Sbjct: 127 ---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKI 178
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y + D ++ GV+ ELLTG+ P
Sbjct: 179 KGHNYDVSF------DWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 56/208 (26%), Positives = 85/208 (40%), Gaps = 43/208 (20%)
Query: 807 VAVKKLASNREGNNIES--SFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGS 864
VAVK L R + + F E+ L ++ NI +L G C +I EYME G
Sbjct: 49 VAVKVL---RPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105
Query: 865 LGELLH-------GSSCNLEWPTRFM---IALGAAEGLAYLHHDCKPRIF-HRDIKSNNI 913
L + L G +CN + + +A A G+ YL + F HRD+ + N
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYL----ESLNFVHRDLATRNC 161
Query: 914 LLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----------APEYAYTMKVTE 962
L+ + + DFG+ S + + Y + A E K T
Sbjct: 162 LVGKNYTIKIADFGM----------SRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTT 211
Query: 963 KCDIYSYGVVLLELLT--GRTPVQPLDD 988
K D++++GV L E+LT P + L D
Sbjct: 212 KSDVWAFGVTLWEILTLCREQPYEHLTD 239
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 3e-12
Identities = 32/82 (39%), Positives = 51/82 (62%), Gaps = 1/82 (1%)
Query: 279 DNQ-LTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPRE 337
DNQ L GFIP+++ LQ++ L N++ G IP +G++ L L L N NG+IP
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 338 IGNLSMVTEIDLSENSLNGEIP 359
+G L+ + ++L+ NSL+G +P
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 60/206 (29%), Positives = 96/206 (46%), Gaps = 13/206 (6%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+VG GAYG V K ++ +IVA+KK + E ++ + E+ L ++ NIV+L
Sbjct: 8 VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67
Query: 846 FCYHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
+G L++EY+E+ L ELL + E ++ L A +H K I
Sbjct: 68 AFRRRGKLYLVFEYVEKNML-ELLEEMPNGVPPEKVRSYIYQLIKA-----IHWCHKNDI 121
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
HRDIK N+L+ + DFG A+ + + + + + Y +PE +
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDG 989
D++S G +L EL G QPL G
Sbjct: 182 VDMWSVGCILGELSDG----QPLFPG 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (168), Expect = 3e-12
Identities = 59/200 (29%), Positives = 87/200 (43%), Gaps = 10/200 (5%)
Query: 787 IVGSGAYGTVYKAVMDS-GKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
++G G++G V A + GK AVK L + + + + L ++H +V L
Sbjct: 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61
Query: 844 YGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
+ + + L + +Y+ G L L E RF A A L YLH
Sbjct: 62 H-YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH---SLN 116
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
I +RD+K NILLD + + DFGL K + SK+ S G+ Y+APE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GIEHSKTTSTFCGTPEYLAPEVLRKQPYDR 175
Query: 963 KCDIYSYGVVLLELLTGRTP 982
D + G VL E+L G P
Sbjct: 176 TVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 50/203 (24%), Positives = 92/203 (45%), Gaps = 15/203 (7%)
Query: 788 VGSGAYGTVYKA--VMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR---HRNIVK 842
+G GAYG V+KA + + G+ VA+K++ + S E+ L + H N+V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 843 LYGFCYHQGSN-----LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
L+ C ++ L++E++++ L + T + GL +LH
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 128
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
R+ HRD+K NIL+ + + DFGLA++ ++++V + Y APE
Sbjct: 129 H---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQ 183
Query: 958 MKVTEKCDIYSYGVVLLELLTGR 980
D++S G + E+ +
Sbjct: 184 SSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 4e-12
Identities = 54/194 (27%), Positives = 92/194 (47%), Gaps = 8/194 (4%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G+Y TVYK +GK+VA+K + E ++ R L G ++H NIV L+
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKG-LKHANIVLLHDI 71
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ + + L++EY+ L + + L + GL+Y+H + I HR
Sbjct: 72 IHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIH---QRYILHR 127
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC-D 965
D+K N+L+ D E + DFGLA+ +P S + S + Y P+ C D
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVP-SHTYSNEVVTLWYRPPDVLLGSTEYSTCLD 186
Query: 966 IYSYGVVLLELLTG 979
++ G + +E++ G
Sbjct: 187 MWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 23/207 (11%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKL-------ASNREGNNIESSFRAEILTLGKIRHRN 839
+G G + VYKA+ + G++VA+KK+ A R+ EI L ++ H N
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQ------DCLKEIDLLKQLDHPN 63
Query: 840 IVKLY-GFCYHQGSNLLIYEYMERGSLGELL-HGSSCN--LEWPTRFMIALGAAEGLAYL 895
++K F + N+ + E + G L ++ H + T + + L ++
Sbjct: 64 VIKYLASFIENNELNI-VLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H RI HRDIK N+ + +GD GL + + + S V Y Y++PE
Sbjct: 123 H---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERI 178
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ K DI+S G +L E+ ++P
Sbjct: 179 HENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 4e-12
Identities = 60/218 (27%), Positives = 94/218 (43%), Gaps = 32/218 (14%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN-IVKLY 844
+G G YG VYKA ++GK+VA+KK + I + EI L + IV+L
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67
Query: 845 GFCYHQGSN-----LLIYEYME---RGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAY 894
+ + N L++EY++ + + G L T FM L +G+A+
Sbjct: 68 DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL--LKGVAH 125
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEA-HVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
H K + HRD+K N+L+D + + D GL + +P + + Y APE
Sbjct: 126 CH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW-YRAPE 181
Query: 954 Y-----AYTMKVTEKCDIYSYGVVLLELLTGRTPVQPL 986
Y+ V DI+S G + E+ QPL
Sbjct: 182 VLLGSTHYSTPV----DIWSVGCIFAEMSRK----QPL 211
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 4e-12
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 788 VGSGAYGTVYKAV---MDSGK-----IVAVKKLASNREGNNIESSFRAEILTLGKI-RHR 838
+G G +G V A +D K VAVK L S+ ++ S +E+ + I +H+
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDL-SDLISEMEMMKMIGKHK 84
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELL-----------HGSSC----NLEWPTRFM 883
NI+ L G C G +I EY +G+L E L + + L +
Sbjct: 85 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSA 942
A A G+ YL + HRD+ + N+L+ + + DFGLA+ I + K +
Sbjct: 145 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTN 201
Query: 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE + T + D++S+GV+L E+ T G +P
Sbjct: 202 GRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 5e-12
Identities = 68/280 (24%), Positives = 122/280 (43%), Gaps = 40/280 (14%)
Query: 788 VGSGAYGTVYKAVM---DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G +G+V + + DS VAVK + + F +E + + + H N+++L
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 845 GFCYHQGSN------LLIYEYMERGSLGELLHGS---SCNLEWPTRFMIALGA--AEGLA 893
G C + ++I +M+ G L L S C PT+ ++ A G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMPQSKSMSAVAGSYGYI 950
YL HRD+ + N +L++ V DFGL+K I D + ++ + +I
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKM--PVKWI 181
Query: 951 APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009
A E T K D++S+GV + E+ T G+TP +++ + + +Y+R
Sbjct: 182 AIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN-----SEIYDYLRQ------- 229
Query: 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
RL + D + + + C ++P DRPS +
Sbjct: 230 -GNRL----KQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 5e-12
Identities = 76/281 (27%), Positives = 129/281 (45%), Gaps = 49/281 (17%)
Query: 787 IVGSGAYGTVYKA--VMDSGKI---VAVKKLASNREGNNIESSFRAEIL----TLGKIRH 837
++GSGA+GTVYK + + K+ VA+K+L RE + +++ EIL + + +
Sbjct: 14 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKAN--KEILDEAYVMASVDN 68
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLH------GSSCNLEWPTRFMIALGAAEG 891
++ +L G C L I + M G L + + GS L W + A+G
Sbjct: 69 PHVCRLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI------AKG 121
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--GY 949
+ YL + R+ HRD+ + N+L+ + DFGLAK++ + K A G +
Sbjct: 122 MNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE-KEYHAEGGKVPIKW 177
Query: 950 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009
+A E T + D++SYGV + EL+T + +P D G A+ + + + P
Sbjct: 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGS--KPYD--GIPASEISSILEKGERLPQP 233
Query: 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVV 1050
++V +MI+V C I RP RE++
Sbjct: 234 PICTIDV-------YMIMV-----KCWMIDADSRPKFRELI 262
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 6e-12
Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 20/203 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLY 844
VGSGAYG+V A +G VAVKKL+ R +I + R E+ L ++H N++ L
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKLS--RPFQSIIHAKRTYRELRLLKHMKHENVIGLL 82
Query: 845 GF-----CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+ +++ + ++ L ++ + +F+I GL Y+H
Sbjct: 83 DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD-HVQFLI-YQILRGLKYIH--- 137
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT-M 958
I HRD+K +N+ +++ E + DFGLA+ D M+ + Y APE M
Sbjct: 138 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD----DEMTGYVATRWYRAPEIMLNWM 193
Query: 959 KVTEKCDIYSYGVVLLELLTGRT 981
+ DI+S G ++ ELLTGRT
Sbjct: 194 HYNQTVDIWSVGCIMAELLTGRT 216
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 6e-12
Identities = 80/268 (29%), Positives = 118/268 (44%), Gaps = 17/268 (6%)
Query: 455 PPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYA 514
L + +NL L+L N + P L L +L L N + S P L L NL
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKN 167
Query: 515 IELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLI 574
++L N S +P + N L L ++ N + LP E+ LS L ++S+N + +
Sbjct: 168 LDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKISD-LPPEIELLSALEELDLSNNSII-EL 224
Query: 575 PPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTE 634
+ N L L++S+N LP +G L LE L LS N+ + S+LG+L++L E
Sbjct: 225 LSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQ--ISSISSLGSLTNLRE 281
Query: 635 LQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGE 694
L + GN S +P L L++ LNL EL L +LLNNN LS
Sbjct: 282 LDLSGNSLSNALPLIALLLLLLELLLNLLLTL----KALELK----LNSILLNNNILSNG 333
Query: 695 IPSAFENLSSLLGSNFSYNNLTGPLPSI 722
S+ E LS L + +
Sbjct: 334 ETSSPEALSILE--SLNNLWTLDNALDE 359
|
Length = 394 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 9e-12
Identities = 63/214 (29%), Positives = 97/214 (45%), Gaps = 19/214 (8%)
Query: 781 NFHDSFIVGSGAYGTVY----KAVMDSGKIVAVK--KLASNREGNNIESSFRAEILTLGK 834
NF ++G+GAYG V+ + DSGK+ A+K K A+ + R E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 835 IRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFM---IALGAAE 890
IR + + + + L LI +Y+ G L +L RF + + + E
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL-------FTHLSQRERFKEQEVQIYSGE 113
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
+ L H K I +RDIK NILLD + DFGL+K + + + G+ Y+
Sbjct: 114 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYM 173
Query: 951 APEYAYTMKV--TEKCDIYSYGVVLLELLTGRTP 982
AP+ + D +S GV++ ELLTG +P
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 9e-12
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 23/207 (11%)
Query: 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNR-------EGNNIESSFRAEILTLGKIRHRN 839
+G G +G V M +GK+ A KKL R EG +E L K+ R
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI------LAKVHSRF 54
Query: 840 IVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCN---LEWPTRFMIALGAAEGLAYL 895
IV L + + ++L L+ M G L ++ P GL +L
Sbjct: 55 IVSL-AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHL 113
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H RI +RD+K N+LLD+ + D GLA + QSK+ AG+ G++APE
Sbjct: 114 HQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKT-KGYAGTPGFMAPELL 169
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ D ++ GV L E++ R P
Sbjct: 170 QGEEYDFSVDYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 59/203 (29%), Positives = 91/203 (44%), Gaps = 16/203 (7%)
Query: 787 IVGSGAYGTVYKAVMDSG------KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNI 840
++G G++G V A + K++ K + +E +I S + L ++H +
Sbjct: 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERN---VLLKNVKHPFL 58
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
V L+ F + L + +Y+ G L L C LE RF A A L YLH
Sbjct: 59 VGLH-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLH--- 113
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
I +RD+K NILLD + + DFGL K ++ + + S G+ Y+APE +
Sbjct: 114 SLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 960 VTEKCDIYSYGVVLLELLTGRTP 982
D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 1e-11
Identities = 55/217 (25%), Positives = 104/217 (47%), Gaps = 12/217 (5%)
Query: 788 VGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+GSG +GTV K + S K VAVK L ++ ++ E + ++ + IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMI 62
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
G C + S +L+ E E G L + L + ++ + + G+ YL
Sbjct: 63 GICEAE-SWMLVMELAELGPLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET---NFV 117
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY--GYIAPEYAYTMKVTE 962
HRD+ + N+LL + A + DFGL+K + ++ + G + + APE K +
Sbjct: 118 HRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS 177
Query: 963 KCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRN 998
K D++S+GV++ E + G+ P + + G ++ + +
Sbjct: 178 KSDVWSFGVLMWEAFSYGQKPYKGM-KGNEVTQMIES 213
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 1e-11
Identities = 60/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 788 VGSGAYGTVYKAV---MDSGK-----IVAVKKLASNREGNNIESSFRAEILTLGKI-RHR 838
+G G +G V A +D K VAVK L + ++ S +E+ + I +H+
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDL-SDLVSEMEMMKMIGKHK 78
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG----------SSC-----NLEWPTRFM 883
NI+ L G C G ++ EY +G+L E L +C L +
Sbjct: 79 NIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSA 942
A A G+ YL + HRD+ + N+L+ + + DFGLA+ V ++ K +
Sbjct: 139 CAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN 195
Query: 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE + T + D++S+GV+L E+ T G +P
Sbjct: 196 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSP 236
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 66.1 bits (162), Expect = 1e-11
Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 29/203 (14%)
Query: 789 GSGAYGTVYKA-VMDSGKIVAVKKL----ASNREGNNIESSFRAEILTLGKIR-HRNIVK 842
G G + V KA +GK A+K + S + NN+ EI L ++ H NI++
Sbjct: 8 GEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-----REIQALRRLSPHPNILR 62
Query: 843 LYGFCYHQ--GSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHD 898
L + + G L++E M+ +L EL+ G L +M L + L ++H +
Sbjct: 63 LIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQL--LKSLDHMHRN 119
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID--MPQSKSMSAVAGSYGYIAPEYAY 956
IFHRDIK NIL+ D + DFG + I P ++ +S + Y APE
Sbjct: 120 ---GIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIS----TRWYRAPECLL 171
Query: 957 TMKV-TEKCDIYSYGVVLLELLT 978
T K DI++ G V E+L+
Sbjct: 172 TDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 33/90 (36%), Positives = 52/90 (57%)
Query: 155 LYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPL 214
L L+N G IP ++ KL L S+N+ N I G +P LG+++SL N+ G +
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 215 PQSIGNLRNLRVFRAGQNAISGSIPAEISG 244
P+S+G L +LR+ N++SG +PA + G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGG 512
|
Length = 623 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 77/292 (26%), Positives = 120/292 (41%), Gaps = 52/292 (17%)
Query: 788 VGSGAYGTVYKAVM------DSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKIRHR 838
+G G++G VY+ ++ VAVK + AS RE IE A ++ H
Sbjct: 14 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRE--RIEFLNEASVMKGFTCHH- 70
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT-------RFMIALGA--A 889
+V+L G L++ E M G L L E + MI + A A
Sbjct: 71 -VVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-----SKSMSAVA 944
+G+AYL+ + HRD+ + N ++ F +GDFG+ + I K + V
Sbjct: 130 DGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDH 1003
+APE T D++S+GVVL E+ + P Q L + V ++ D
Sbjct: 187 W----MAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN-----EQVLKFVMDG 237
Query: 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055
G D N E + D M MC +P RP+ E+V++L +
Sbjct: 238 ----GYLDQPDNCP-ERVTDLM-------RMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 58/219 (26%), Positives = 99/219 (45%), Gaps = 38/219 (17%)
Query: 788 VGSGAYGTVYKAV-----MDSGKIVAVKKLASNREGNNIE--SSFRAEILTLGKIRHRNI 840
+G A+G +YK MD ++VA+K L ++ NN + F+ E + ++ H NI
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL---KDINNPQQWGEFQQEASLMAELHHPNI 69
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSS----------------CNLEWPTRFMI 884
V L G + +++EY+ +G L E L S +L+ I
Sbjct: 70 VCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHI 129
Query: 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP-----QSKS 939
A+ A G+ YL H+D+ + NIL+ ++ + D GL++ I Q KS
Sbjct: 130 AIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKS 186
Query: 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 978
+ + ++ PE K + DI+S+GVVL E+ +
Sbjct: 187 LLPIR----WMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-11
Identities = 52/181 (28%), Positives = 81/181 (44%), Gaps = 20/181 (11%)
Query: 766 PKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESS 824
+ F F D V + +G G +G V+KA + +IVA+KK+ E +
Sbjct: 1 DQYEFPFCDEVS---KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT 57
Query: 825 FRAEILTLGKIRHRNIVKLYGFCY--------HQGSNLLIYEYMERGSLGELLHGSSC-- 874
EI L ++H N+V L C ++GS L++E+ E L LL +
Sbjct: 58 ALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKF 116
Query: 875 NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934
L + M L GL Y+H + +I HRD+K+ NIL+ + DFGLA+ +
Sbjct: 117 TLSEIKKVMKML--LNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSL 171
Query: 935 P 935
Sbjct: 172 S 172
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 2e-11
Identities = 90/349 (25%), Positives = 136/349 (38%), Gaps = 75/349 (21%)
Query: 748 GASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVY--KAVMDSGK 805
+ + + FP E + S ++GSGA GTV K V D G+
Sbjct: 1 MMASGDAMIGRVCRT-FPDTFAKDEATAKEQAKKYWISRVLGSGATGTVLCAKRVSD-GE 58
Query: 806 IVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLY-GFCYHQGSN-------LL 855
AVK + + EG + RA E+ L +IVK + F N L
Sbjct: 59 PFAVKVV--DMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL 116
Query: 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYL------HHDCKPRIFHR 906
+ +Y G L + E +R E GL ++ HH + HR
Sbjct: 117 VLDYANAGDLRQ---------EIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR 167
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AVAGSYGYIAPEYAYTMKVTEKCD 965
DIKS NILL +GDFG +K+ S + G+ Y+APE ++K D
Sbjct: 168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227
Query: 966 IYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD--HSLTPGIFDTRLNVEDESIVD 1023
++S GV+L ELLT + P DG + + + H G +D
Sbjct: 228 MFSLGVLLYELLTLKRPF----DGEN--------MEEVMHKTLAGRYDP----------- 264
Query: 1024 HMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSSPTYDLP 1072
+ SIS P M+E+V+ L+ S+ + R +SS ++P
Sbjct: 265 ----------LPPSIS----PEMQEIVTALLSSDPKR-RPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 2e-11
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 22/208 (10%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASN--REGNNIESSF-RAEILTLGKIRHRNIVK 842
++G G++G V A + +SG++ AVK L + + +++E + IL+L + H + +
Sbjct: 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQ 60
Query: 843 LYGFCYHQGSNLL-IYEYMERGSLGELLHGSSCNL--EWPTRFMIALGAAE---GLAYLH 896
LY C+ L + E++ G L + H E RF AAE L +LH
Sbjct: 61 LY-CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFY----AAEITSALMFLH 113
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
I +RD+K +N+LLD + + DFG+ K + K+ S G+ YIAPE
Sbjct: 114 ---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
M D ++ GV+L E+L G P +
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFE 197
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-11
Identities = 33/88 (37%), Positives = 50/88 (56%)
Query: 299 LALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEI 358
L L + L G IP ++ L+ L + L N + G IP +G+++ + +DLS NS NG I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 359 PTEFSKITGLRLLFLFQNQLTGVIPNEL 386
P ++T LR+L L N L+G +P L
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 62/207 (29%), Positives = 94/207 (45%), Gaps = 19/207 (9%)
Query: 787 IVGSGAYGTVY---KAVMDSGKIVAVKKLASNR----EGNNIESSFRAEILTLGKIRHRN 839
I+G G +G VY KA D+GK+ A+K L R +G + + R +L+L
Sbjct: 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERI-MLSLVSTGDCP 57
Query: 840 IVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898
+ + +H L I + M G L L E RF A E + L H
Sbjct: 58 FIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFY----ATEIILGLEHM 113
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
+ +RD+K NILLD+ + D GLA D + K ++V G++GY+APE
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKG 170
Query: 959 KVTE-KCDIYSYGVVLLELLTGRTPVQ 984
+ D +S G +L +LL G +P +
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 35/89 (39%), Positives = 46/89 (51%)
Query: 319 FLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQL 378
F+ L L L G IP +I L + I+LS NS+ G IP IT L +L L N
Sbjct: 419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSF 478
Query: 379 TGVIPNELSSLRNLTKLDLSINYLTGPIP 407
G IP L L +L L+L+ N L+G +P
Sbjct: 479 NGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 4e-11
Identities = 38/95 (40%), Positives = 53/95 (55%), Gaps = 5/95 (5%)
Query: 365 ITGLRLLFLFQNQ-LTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFE 423
I GL L NQ L G IPN++S LR+L ++LS N + G IP +T + L L
Sbjct: 420 IDGLGL----DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSY 475
Query: 424 NSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHL 458
NS G IP LG + L +++ + N L+GR+P L
Sbjct: 476 NSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 4e-11
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 35/213 (16%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH----RNIVK 842
+G G +G VY+ D+ +I A+K L+ + EI+ ++ H RNI+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLS------------KKEIVAKKEVAHTIGERNILV 48
Query: 843 ---------LYG--FCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE 890
+ G F + S+L L+ +YM G L L E +F IA E
Sbjct: 49 RTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIA----E 104
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
+ L H K I +RD+K NILLD + DFGL+K ++ +K+ + G+ Y+
Sbjct: 105 LVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYL 163
Query: 951 APEYAYTMK-VTEKCDIYSYGVVLLELLTGRTP 982
APE K T+ D +S GV++ E+ G +P
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSP 196
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 4e-11
Identities = 66/214 (30%), Positives = 96/214 (44%), Gaps = 19/214 (8%)
Query: 781 NFHDSFIVGSGAYGTVYKAVM----DSGKIVAVKKLASNR---EGNNIESSFRAEILTLG 833
NF ++G+GAYG V+ D+GK+ A+K L + E + R E L
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHT-RTERQVLE 59
Query: 834 KIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGL 892
+R + + + + L LI +Y+ G L L+ E R IA E +
Sbjct: 60 AVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIA----EIV 115
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYI 950
L H + I +RDIK NILLD E HV DFGL+K + + + G+ Y+
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDS--EGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYM 173
Query: 951 APEYAYTMKV--TEKCDIYSYGVVLLELLTGRTP 982
APE + D +S GV+ ELLTG +P
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASP 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 5e-11
Identities = 63/207 (30%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 787 IVGSGAYGTVY---KAVMDSGKIVAVKKLASNR----EGNNIESSFRAEILTLGKIRHRN 839
I+G G +G VY KA D+GK+ A+K L R +G + + R +L+L
Sbjct: 1 IIGRGGFGEVYGCRKA--DTGKMYAMKCLDKKRIKMKQGETLALNERI-MLSLVSTGDCP 57
Query: 840 IVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898
+ + +H L I + M G L L E RF AAE + L H
Sbjct: 58 FIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFY----AAEIILGLEHM 113
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-YAYT 957
+ +RD+K NILLD+ + D GLA D + K ++V G++GY+APE
Sbjct: 114 HNRFVVYRDLKPANILLDEHGHVRISDLGLA--CDFSKKKPHASV-GTHGYMAPEVLQKG 170
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQ 984
+ D +S G +L +LL G +P +
Sbjct: 171 VAYDSSADWFSLGCMLFKLLRGHSPFR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 6e-11
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 787 IVGSGAYGTVYKAVMDSG------KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNI 840
++G G++G V A S K++ K + +E N+I + + L ++H +
Sbjct: 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAE---RNVLLKNLKHPFL 58
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
V L+ + + L + +Y+ G L L C LE RF A A + YLH
Sbjct: 59 VGLH-YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLH--- 113
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
I +RD+K NILLD + + DFGL K + ++ S G+ Y+APE
Sbjct: 114 SLNIIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEPEETTSTFCGTPEYLAPEVLRKEP 172
Query: 960 VTEKCDIYSYGVVLLELLTGRTP 982
D + G VL E+L G P
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 7e-11
Identities = 43/151 (28%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 828 EILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG 887
E + L + H +++++ ++ + L L S L +I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 888 AAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AVAGS 946
EGL YLH RI HRD+K+ NI ++D + +GD G A+ P +AG+
Sbjct: 166 ILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLAGT 219
Query: 947 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 977
APE K K DI+S G+VL E+L
Sbjct: 220 VETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 57/221 (25%), Positives = 97/221 (43%), Gaps = 30/221 (13%)
Query: 788 VGSGAYGTVYKAV---MDSGK-----IVAVKKLASNREGNNIESSFRAEILTLGKI-RHR 838
+G G +G V A +D K VAVK L + ++ S +E+ + I +H+
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDL-SDLVSEMEMMKMIGKHK 81
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG---------------SSCNLEWPTRFM 883
NI+ L G C G +I EY +G+L E L + +
Sbjct: 82 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVS 141
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSA 942
A G+ YL + HRD+ + N+L+ + + DFGLA+ V ++ K +
Sbjct: 142 CTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTN 198
Query: 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE + T + D++S+GV++ E+ T G +P
Sbjct: 199 GRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 33/208 (15%)
Query: 787 IVGSGAYGTVYKAVMDS-GKIVAVKKL----ASNREGNNIESSFRAEILTLGKIRHRNIV 841
+VG G+YG V + GK +KKL AS RE E E L +++H NIV
Sbjct: 7 VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQ----EAQLLSQLKHPNIV 62
Query: 842 KLYGFCYHQGSNLLIYEYM---ERGSL--------GELLHGSSCNLEWPTRFMIALGAAE 890
Y + +G + L+Y M E G L G+LL + +EW + +AL
Sbjct: 63 -AYRESW-EGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQV-VEWFVQIAMAL---- 115
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
YLH I HRD+K+ N+ L VGD G+A+V++ Q S + G+ Y+
Sbjct: 116 --QYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLE-NQCDMASTLIGTPYYM 169
Query: 951 APEYAYTMKVTEKCDIYSYGVVLLELLT 978
+PE K D+++ G + E+ T
Sbjct: 170 SPELFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 62/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 788 VGSGAYGTVYKAVMDSGKI---VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
VG G YG VYKA GK A+K++ EG I S EI L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALKQI----EGTGISMSACREIALLRELKHPNVIALQ 64
Query: 845 G-FCYHQGSNL-LIYEYMERGSLGELLH------GSSCN---LEWPTRFMIAL--GAAEG 891
F H + L+++Y E +L H S N ++ P + +L +G
Sbjct: 65 KVFLSHSDRKVWLLFDYAEH----DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120
Query: 892 LAYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFGLAKVIDMPQS--KSMSAVAG 945
+ YLH + + HRD+K NIL+ ++ + D G A++ + P + V
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 946 SYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLT 978
++ Y APE + T+ DI++ G + ELLT
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 8e-11
Identities = 36/89 (40%), Positives = 47/89 (52%)
Query: 347 IDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI 406
+ L L G IP + SK+ L+ + L N + G IP L S+ +L LDLS N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 407 PVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
P LT +R L L NSL+G +P LG
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 9e-11
Identities = 64/211 (30%), Positives = 100/211 (47%), Gaps = 14/211 (6%)
Query: 781 NFHDSFIVGSGAYGTVY---KAV-MDSGKIVAVK---KLASNREGNNIESSFRAEILTLG 833
NF ++G+GAYG V+ K D+GK+ A+K K A ++ +E + R E L
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHT-RTERNVLE 59
Query: 834 KIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGL 892
+R + + + + L LI +Y+ G + L+ E RF + E +
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFY----SGEII 115
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
L H K I +RDIK NILLD + + DFGL+K + + + G+ Y+AP
Sbjct: 116 LALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAP 175
Query: 953 EYAYTMKVTEKC-DIYSYGVVLLELLTGRTP 982
E K D +S G+++ ELLTG +P
Sbjct: 176 EIIRGKGGHGKAVDWWSLGILIFELLTGASP 206
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 52/204 (25%), Positives = 90/204 (44%), Gaps = 19/204 (9%)
Query: 788 VGSGAYGTVYKAVMDS-GKIVAVKKLASNREG--NNIESSFRAEILTLGKIRHRNIVKLY 844
+G G +G V+ + + VAVK S RE ++++ F E L + H NIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK---SCRETLPPDLKAKFLQEARILKQYSHPNIVRLI 59
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
G C + ++ E ++ G L L+ + AA G+ YL
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTMK 959
HRD+ + N L+ +K + DFG+++ + + A G I APE +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR----EEEDGVYASTGGMKQIPVKWTAPEALNYGR 172
Query: 960 VTEKCDIYSYGVVLLELLT-GRTP 982
+ + D++S+G++L E + G P
Sbjct: 173 YSSESDVWSFGILLWEAFSLGAVP 196
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 1e-10
Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 21/207 (10%)
Query: 787 IVGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESS--FRAEILTLGKIRHRNI 840
++G G YG V++ D+GKI A+K L N + + +AE L ++H I
Sbjct: 3 VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
V L + + G L LI EY+ G L L +E F ++ E L H
Sbjct: 63 VDLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS----EISLALEHLH 117
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA----GSYGYIAPEYA 955
+ I +RD+K NILLD + + DFGL K +S V G+ Y+APE
Sbjct: 118 QQGIIYRDLKPENILLDAQGHVKLTDFGLCK-----ESIHEGTVTHTFCGTIEYMAPEIL 172
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ D +S G ++ ++LTG P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAPP 199
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 60/218 (27%), Positives = 102/218 (46%), Gaps = 30/218 (13%)
Query: 787 IVGSGAYGTVYKAVM----DSGKIVAVKKLASN-REGNNIESSFRAEILTLGKIRHRNIV 841
++G G +G+V +A + S + VAVK L ++ ++IE R E + + H N++
Sbjct: 6 MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLR-EAACMKEFDHPNVI 64
Query: 842 KLYGFCYHQGSN------LLIYEYMERGSLGELLHGS-------SCNLEWPTRFMIALGA 888
KL G + ++I +M+ G L L S + L+ RFMI +
Sbjct: 65 KLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI-- 122
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMPQSKSMSAVAG 945
A G+ YL HRD+ + N +L++ V DFGL+K I D + S +
Sbjct: 123 ASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL-- 177
Query: 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++A E T D++++GV + E++T G+TP
Sbjct: 178 PVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 56/213 (26%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 781 NFHDSFIVGSGAYGTVYKA--VMDSGKIVAVKKLASNREGNNIESSFRA----EILTLGK 834
NF +G G + VY+A ++D G VA+KK+ + + +++ RA EI L +
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLD-GVPVALKKV---QIFDLMDAKARADCIKEIDLLKQ 58
Query: 835 IRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTR----FMIALGAA 889
+ H N++K Y ++ E + G L ++ H P + + + L +A
Sbjct: 59 LNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGY 949
L H R+ HRDIK N+ + +GD GL + + + S V Y Y
Sbjct: 119 -----LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-Y 172
Query: 950 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
++PE + K DI+S G +L E+ ++P
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 1e-10
Identities = 63/214 (29%), Positives = 94/214 (43%), Gaps = 23/214 (10%)
Query: 781 NFHDSFIVGSGAYGTVYKAV--MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR 838
+F ++G GA+G V + V S ++ A+K L+ +S+F E + + H
Sbjct: 44 DFDVIKVIGRGAFGEV-QLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDI--MAHA 100
Query: 839 N---IVKLYGFCYHQGSNLL--IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
N IV+L Q L + EYM G L L+ +W RF A L
Sbjct: 101 NSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKW-ARFYTA-EVVLALD 156
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP-QSKSMSAVAGSYGYIAP 952
+H HRD+K +N+LLD + DFG +D + +AV G+ YI+P
Sbjct: 157 AIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISP 212
Query: 953 EYAYTMKVT----EKCDIYSYGVVLLELLTGRTP 982
E + +CD +S GV L E+L G TP
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 34/214 (15%)
Query: 788 VGSGAYGTVYKAVMDSG---KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
VG G YG VYKA G + A+K++ EG I S EI L +++H N++ L
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISLQ 64
Query: 845 G-FCYHQGSNL-LIYEYMERGSLGELLH------GSSCN---LEWPTRFMIAL--GAAEG 891
F H + L+++Y E +L H S N ++ P + +L +G
Sbjct: 65 KVFLSHADRKVWLLFDYAEH----DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120
Query: 892 LAYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFGLAKVIDMPQS--KSMSAVAG 945
+ YLH + + HRD+K NIL+ ++ + D G A++ + P + V
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 946 SYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLT 978
++ Y APE + T+ DI++ G + ELLT
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGNNIESSFR-AEILTLGKIRHRNIVKLYG 845
+G G++G V + D+ +I A+K + + E + AE L ++ IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPL-K 59
Query: 846 FCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
F + L L+ ++ G L L RF A E L L + K +
Sbjct: 60 FSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTA----ELLCALENLHKFNVI 115
Query: 905 HRDIKSNNILLDDKFEAHVG--DFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
+RD+K NILLD ++ H+ DFGL K ++M + G+ Y+APE T+
Sbjct: 116 YRDLKPENILLD--YQGHIALCDFGLCK-LNMKDDDKTNTFCGTPEYLAPELLLGHGYTK 172
Query: 963 KCDIYSYGVVLLELLTGRTP 982
D ++ GV+L E+LTG P
Sbjct: 173 AVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 72/254 (28%), Positives = 106/254 (41%), Gaps = 38/254 (14%)
Query: 788 VGSGAYGTVYKAVMDS--GKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKL 843
+GSGA G V A D+ G VAVKKL+ R N + RA E++ L + H+NI+ L
Sbjct: 29 IGSGAQGIVCAA-FDTVLGINVAVKKLS--RPFQNQTHAKRAYRELVLLKCVNHKNIISL 85
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSC-----NLEWPTRFMIALGAAEGLAYLHHD 898
Q S + E+ + + EL+ + C L+ + G+ +LH
Sbjct: 86 LNVFTPQKS---LEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 140
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
I HRD+K +NI++ + DFGLA+ + M+ + Y APE M
Sbjct: 141 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGM 197
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQPLDD------------------GGDLATWVRNYI 1000
E DI+S G ++ EL+ G Q D L VRNY+
Sbjct: 198 GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYV 257
Query: 1001 RDHSLTPGIFDTRL 1014
+ PGI L
Sbjct: 258 ENRPQYPGISFEEL 271
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 2e-10
Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 30/216 (13%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKL 843
++G G+YG V A+ +G+ VA+KK+ N ++ + R EI L +RH +IV++
Sbjct: 7 VIGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLRHPDIVEI 64
Query: 844 YGFCYHQGSN-----LLIYEYMERGSLGELLH---GSSCNL--EWPTRFMIALGAAEGLA 893
+++E ME LH ++ +L E F+ L L
Sbjct: 65 KHIMLPPSRREFKDIYVVFELMESD-----LHQVIKANDDLTPEHHQFFLYQL--LRALK 117
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIA 951
Y+H +FHRD+K NIL + + + DFGLA+V D P + + + Y A
Sbjct: 118 YIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 952 PEY--AYTMKVTEKCDIYSYGVVLLELLTGRTPVQP 985
PE ++ K T DI+S G + E+LTG+ P+ P
Sbjct: 175 PELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP 209
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.7 bits (153), Expect = 3e-10
Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 23/211 (10%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G GAYG V A +G VA+KK++ + + R EI L + +H NI+ +
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGILD 70
Query: 846 FCYHQGSNL-------LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898
+ + ++ E ME L +L+ + + F+ + GL Y+H
Sbjct: 71 I--IRPPSFESFNDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQI--LRGLKYIH-- 123
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---MSAVAGSYGYIAPEYA 955
+ HRD+K +N+LL+ + + DFGLA++ D P+ ++ + Y APE
Sbjct: 124 -SANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD-PEHDHTGFLTEYVATRWYRAPEIM 181
Query: 956 YTMK-VTEKCDIYSYGVVLLELLTGRTPVQP 985
K T+ DI+S G +L E+L+ R P+ P
Sbjct: 182 LNSKGYTKAIDIWSVGCILAEMLSNR-PLFP 211
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-10
Identities = 100/344 (29%), Positives = 152/344 (44%), Gaps = 21/344 (6%)
Query: 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNL------RVFRAGQNAISGSIPAEISGCQSLQI 250
L S + + + L+ S+ NL N + +I E+ +L
Sbjct: 62 LPSSLSRLLSLDLLSPSGISSLDGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTS 120
Query: 251 LGLAQNDIGGSLPKEIGML-ESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQ 309
L L N+I +P IG+L +L E+ L DN++ +PS L N L+ L L N+L
Sbjct: 121 LDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-D 177
Query: 310 IPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLR 369
+PK + NL L L L N+++ +P EI LS + E+DLS NS+ E+ + S + L
Sbjct: 178 LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLS 235
Query: 370 LLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGG 429
L L N+L +P + +L NL LDLS N ++ +G LT +R+L L NSL+
Sbjct: 236 GLELSNNKLED-LPESIGNLSNLETLDLSNNQISSISSLG--SLTNLRELDLSGNSLS-N 291
Query: 430 IPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLL 489
P + L LL + + L NS L+ N+ N + P + E+L
Sbjct: 292 ALPLIALLLLLLELLLNLLLTL--KALELKLNSILLNNNILSNGETSS-PEALSILESLN 348
Query: 490 QLRLVGNSLTGSFPL-ELCKLENLYAIELDQNKFSGPIPPEIEN 532
L + N+L S + K N LD K E N
Sbjct: 349 NLWTLDNALDESNLNRYIVKNPNAIGSLLDLVKKHVNQLLEKVN 392
|
Length = 394 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 4e-10
Identities = 56/207 (27%), Positives = 96/207 (46%), Gaps = 34/207 (16%)
Query: 788 VGSGAYGTVY-----KAVMDSG----KIVAVKKLASNREGNNIESSFRAEILTLGKIRHR 838
+G G++GTVY KAV + K + V +L N ++++ A++L+ K+ H
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLS--KLDHP 62
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN---------LEWPTRFMIALGAA 889
IVK + + + +I EY E L L EW + ++
Sbjct: 63 AIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL----- 117
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGY 949
G+ Y+H + RI HRD+K+ NI L + +GDFG+++++ M + G+ Y
Sbjct: 118 -GVHYMH---QRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL-MGSCDLATTFTGTPYY 171
Query: 950 IAPEYAYTMKVTEKCDIYSYGVVLLEL 976
++PE K DI+S G +L E+
Sbjct: 172 MSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-10
Identities = 64/208 (30%), Positives = 97/208 (46%), Gaps = 20/208 (9%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESS-FRAEILTLGKIRHRNIVKLY 844
++G GA+G V M ++G++ A+K L E++ FR E L R I L+
Sbjct: 8 VIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLH 67
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNL-EWPTRFMIA--LGAAEGLAYLHHDCK 900
+ + +NL L+ +Y G L LL L E RF +A + A + + L +
Sbjct: 68 -YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGY--- 123
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA-GSYGYIAPEYAYTM- 958
HRDIK +N+LLD + DFG + + S VA G+ YI+PE M
Sbjct: 124 ---VHRDIKPDNVLLDKNGHIRLADFGSCLRL-LADGTVQSNVAVGTPDYISPEILQAME 179
Query: 959 ----KVTEKCDIYSYGVVLLELLTGRTP 982
+ +CD +S GV + E+L G TP
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 61/214 (28%), Positives = 103/214 (48%), Gaps = 26/214 (12%)
Query: 787 IVGSGAYGTVYKA-VMDSGKIVAVKKLASN--REGNNIESSF-RAEILTLGKIRHRNIVK 842
++G G++G V A + + ++ AVK L + + +++E + +L L +H + +
Sbjct: 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFLTQ 60
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNL--EWPTRFMIALGAAE---GLAYLH 896
L+ C+ L + EY+ G L + H E RF AAE GL +LH
Sbjct: 61 LHS-CFQTKDRLFFVMEYVNGGDL--MFHIQRSGRFDEPRARFY----AAEIVLGLQFLH 113
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY 954
+ I +RD+K +N+LLD E H+ DFG+ K + + S G+ YIAPE
Sbjct: 114 ---ERGIIYRDLKLDNVLLDS--EGHIKIADFGMCKE-GILGGVTTSTFCGTPDYIAPEI 167
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD 988
D ++ GV+L E+L G++P + D+
Sbjct: 168 LSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-10
Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 30/216 (13%)
Query: 787 IVGSGAYGTV----YKAVMDSGKIVAVKKLA-----SNREGNNIESSFRAEILTLGKIRH 837
++G G +G V YK +G++ A+K L + E ++ R T RH
Sbjct: 6 VLGRGHFGKVLLAEYK---KTGELYAIKALKKGDIIARDEVESLMCEKRI-FETANSERH 61
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGEL-LHGSSCNLEWP-TRFMIALGAAE---GL 892
+V L+ C+ + + ME + G+L +H + P F AA GL
Sbjct: 62 PFLVNLFA-CFQTEDH--VCFVMEYAAGGDLMMHIHTDVFSEPRAVFY----AACVVLGL 114
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
YLH + +I +RD+K +N+LLD + + DFGL K M S G+ ++AP
Sbjct: 115 QYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKE-GMGFGDRTSTFCGTPEFLAP 170
Query: 953 EYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD 988
E T D + GV++ E+L G +P P DD
Sbjct: 171 EVLTETSYTRAVDWWGLGVLIYEMLVGESPF-PGDD 205
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 5e-10
Identities = 55/216 (25%), Positives = 102/216 (47%), Gaps = 16/216 (7%)
Query: 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNR--EGNNIESSFRAEILTLGKIRH 837
+F+ ++G G++G V A + ++ A+K L + + +++E + + + + +
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLH--GSSCNLEWPTRFMIALGAAEGLAYL 895
+ +L+ C+ L Y ME + G+L++ + P A + GL +L
Sbjct: 61 PFLTQLHS-CFQTVDRL--YFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H + I +RD+K +N++LD + + DFG+ K M + G+ YIAPE
Sbjct: 118 H---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-HMVDGVTTRTFCGTPDYIAPEII 173
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
+ D ++YGV+L E+L G QP DG D
Sbjct: 174 AYQPYGKSVDWWAYGVLLYEMLAG----QPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 6e-10
Identities = 58/211 (27%), Positives = 91/211 (43%), Gaps = 29/211 (13%)
Query: 787 IVGSGAYGTV----YKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN-IV 841
++G GA+G V +K+ S K+ A+K L+ +S+F E + + +V
Sbjct: 50 VIGRGAFGEVQLVRHKS---SQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 842 KLYGFCYHQGSNLL--IYEYMERGSLGELLHGSSCNLEWPTRF----MIALGAAEGLAYL 895
+L FC Q L + EYM G L L+ +W + ++AL A +
Sbjct: 107 QL--FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMG-- 162
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
+ HRD+K +N+LLD + DFG +D G+ YI+PE
Sbjct: 163 -------LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVL 215
Query: 956 YTMK----VTEKCDIYSYGVVLLELLTGRTP 982
+ +CD +S GV L E+L G TP
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 1e-09
Identities = 31/80 (38%), Positives = 45/80 (56%)
Query: 236 GSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTK 295
G IP +IS + LQ + L+ N I G++P +G + SL + L N G IP LG T
Sbjct: 432 GFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTS 491
Query: 296 LQTLALYSNNLVGQIPKEVG 315
L+ L L N+L G++P +G
Sbjct: 492 LRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-09
Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 37/288 (12%)
Query: 117 SLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKL-SS 175
S ++ L+ L LDL N L I E+ + L L L+NN + IP +G L S+
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNIS-ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSN 141
Query: 176 LVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAIS 235
L L++ +N I +LP L NL +L + N+L+
Sbjct: 142 LKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS------------------------ 176
Query: 236 GSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTK 295
+P +S +L L L+ N I LP EI +L +L E+ L +N + + S L N
Sbjct: 177 -DLPKLLSNLSNLNNLDLSGNKI-SDLPPEIELLSALEELDLSNNSIIE-LLSSLSNLKN 233
Query: 296 LQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
L L L SNN + +P+ +GNL L L L N++ + +G+L+ + E+DLS NSL+
Sbjct: 234 LSGLEL-SNNKLEDLPESIGNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLS 290
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
+P + L LL L + EL L ++ N T
Sbjct: 291 NALPLIALLLLLLELLLNLLLTLKAL---ELKLNSILLNNNILSNGET 335
|
Length = 394 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-09
Identities = 51/190 (26%), Positives = 81/190 (42%), Gaps = 32/190 (16%)
Query: 816 REGNNIESSFRAEILTLGKIRHRNIVKL--------YGFCYHQGSNLLIYEYMERGSLGE 867
+ G+ EIL LG++ H NI+K+ + Q + +Y +M +
Sbjct: 201 KAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF-- 258
Query: 868 LLHGSSCNLEWPTR-FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 926
L TR M L A + Y+H ++ HRDIK NI L+ + +GDF
Sbjct: 259 --DWKDRPLLKQTRAIMKQLLCA--VEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDF 311
Query: 927 GLAKVIDMPQSKSMSAVAGSYGYI------APEYAYTMKVTEKCDIYSYGVVLLELLTGR 980
G A + + A YG++ +PE E DI+S G++LL++L+
Sbjct: 312 GTAMPFEKER------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS-- 363
Query: 981 TPVQPLDDGG 990
P+ DGG
Sbjct: 364 HDFCPIGDGG 373
|
Length = 501 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 37/107 (34%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
GL +LH I +RD+K +N++LD + DFG+ K +++ S G+ YI
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRA-STFCGTPDYI 163
Query: 951 APEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR 997
APE +K T D +S+GV+L E+L G++P DD +L +R
Sbjct: 164 APEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIR 209
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSL----GELLH-GSSCNLEWPTRFMIALGAAEGLA 893
N+V L+ + + S L+ ++ E G L + L+ C W ++AL A
Sbjct: 46 NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA----- 100
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
LH + I RD+ NNILLDD+ + F + ++ S AV Y APE
Sbjct: 101 -LHRE---GIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDGEAV--ENMYCAPE 152
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
+ TE CD +S G +L ELLTG+T V+
Sbjct: 153 VGGISEETEACDWWSLGAILFELLTGKTLVE 183
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-09
Identities = 31/82 (37%), Positives = 47/82 (57%)
Query: 210 LTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGML 269
L G +P I LR+L+ N+I G+IP + SL++L L+ N GS+P+ +G L
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 270 ESLTEIVLWDNQLTGFIPSELG 291
SL + L N L+G +P+ LG
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 2e-09
Identities = 65/241 (26%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G GA+G V +D+ + A+K L ++ N + +AE L + + +VKLY
Sbjct: 9 IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLY- 67
Query: 846 FCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIA-LGAAEGLAYLHHDCKPRI 903
+ + NL + +Y+ G + LL E RF IA L A + +H K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCA--IESVH---KMGF 122
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVI------------DMPQSKSMS---------- 941
HRDIK +NIL+D + DFGL D + SM
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 942 --------------------AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
++ G+ YIAPE T+ CD +S GV+L E+L G+
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242
Query: 982 P 982
P
Sbjct: 243 P 243
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 8/103 (7%)
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG 948
A GL +LH I +RD+K +N++LD + + DFG+ K ++ K+ G+
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKE-NIFGGKTTRTFCGTPD 166
Query: 949 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
YIAPE + D +++GV+L E+L G QP DG D
Sbjct: 167 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG----QPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESS-FRAEILTLGKIRHRNIVKLY 844
++G GA+G V + ++ K+ A+K L E++ FR E L ++ I L+
Sbjct: 8 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH 67
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNL-EWPTRFMIA--LGAAEGLAYLHHDCK 900
+ + +NL L+ +Y G L LL L E RF +A + A + + LH+
Sbjct: 68 -YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHY--- 123
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM-- 958
HRDIK +NIL+D + DFG + + S G+ YI+PE M
Sbjct: 124 ---VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180
Query: 959 ---KVTEKCDIYSYGVVLLELLTGRTP 982
K +CD +S GV + E+L G TP
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-09
Identities = 61/218 (27%), Positives = 97/218 (44%), Gaps = 40/218 (18%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLY 844
+G GAYG V A ++ + VA+KK+A+ + N + R EI L + H N++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFD--NRIDAKRTLREIKLLRHLDHENVIAIK 70
Query: 845 GF----CYHQGSNL-LIYEYME-------RGSLGELLHGSSCNLEWPTRFMIALGAAEGL 892
+++ ++YE M+ R S + L C F+ L GL
Sbjct: 71 DIMPPPHREAFNDVYIVYELMDTDLHQIIRSS--QTLSDDHCQY-----FLYQL--LRGL 121
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
Y+H + HRD+K +N+LL+ + + DFGLA+ V + Y AP
Sbjct: 122 KYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRW-YRAP 177
Query: 953 EY-----AYTMKVTEKCDIYSYGVVLLELLTGRTPVQP 985
E YT + D++S G + ELL GR P+ P
Sbjct: 178 ELLLNCSEYTTAI----DVWSVGCIFAELL-GRKPLFP 210
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 2e-09
Identities = 61/221 (27%), Positives = 84/221 (38%), Gaps = 36/221 (16%)
Query: 775 VVEATYNFHDSFIVGSGAYGTVYKAVM---DSGKIVAVKKLASNREGNNIESSFRAEILT 831
VV YN S + G+ G V+ + K V VK + G EI
Sbjct: 89 VVRMQYNILSS--LTPGSEGEVFVCTKHGDEQRKKVIVKAVTG---GKTPGR----EIDI 139
Query: 832 LGKIRHRNIVKLYGFCYHQGSNLL---------IYEYMERGSLGELLHGSSCNLEWPTRF 882
L I HR I+ L Y S + ++ Y++R L
Sbjct: 140 LKTISHRAIINLI-HAYRWKSTVCMVMPKYKCDLFTYVDRSG----------PLPLEQAI 188
Query: 883 MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-KVIDMPQSKSMS 941
I E LAYLH I HRD+K+ NI LD+ A +GDFG A K+ P +
Sbjct: 189 TIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245
Query: 942 AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+G+ +PE K DI+S G+VL E+
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286
|
Length = 392 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 34/216 (15%)
Query: 781 NFHDSFIVGSGAYGTVYKAVMDSG------KIVAVKKLASNREGNNIESSFRAEILTLGK 834
+ VG+G +G V+ K++A+ ++ ++ ++ + E L +
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHN----EKRVLKE 57
Query: 835 IRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALG---AAE 890
+ H I++L+ + H L ++ EY+ G L L S RF + G A+E
Sbjct: 58 VSHPFIIRLF-WTEHDQRFLYMLMEYVPGGELFSYLRNSG-------RFSNSTGLFYASE 109
Query: 891 ---GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAVAGS 946
L YLH I +RD+K NILLD + + DFG AK + D + + G+
Sbjct: 110 IVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT-----LCGT 161
Query: 947 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y+APE + + D ++ G+++ E+L G P
Sbjct: 162 PEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 2e-09
Identities = 18/42 (42%), Positives = 21/42 (50%), Gaps = 1/42 (2%)
Query: 57 LNSEGHYLLELKNSL-HDEFNFLKSWKSTDQTPCSWIGVNCT 97
LN + LL K+SL D L SW + PCSW GV C
Sbjct: 1 LNDDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42
|
Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-09
Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 24/204 (11%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLY 844
VGSGAYG+V A + VAVKKL+ R ++ + R E+ L ++H N++ L
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLS--RPFQSLIHARRTYRELRLLKHMKHENVIGLL 80
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNL-------EWPTRFMIALGAAEGLAYLHH 897
S I + E + L+ N+ + +F+I GL Y+H
Sbjct: 81 DVFTPATS---IENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLI-YQLLRGLKYIH- 135
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
I HRD+K +N+ +++ E + DFGLA+ D M+ + Y APE
Sbjct: 136 --SAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD----DEMTGYVATRWYRAPEIMLN 189
Query: 958 -MKVTEKCDIYSYGVVLLELLTGR 980
M + DI+S G ++ ELL G+
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 3e-09
Identities = 68/248 (27%), Positives = 106/248 (42%), Gaps = 60/248 (24%)
Query: 781 NFHDSFIVGSGAYGTVYKAVM--DSGKIVAVKKLASNREGNNIE----SSFRAEILTLGK 834
+F ++G GA+G V + V D+G I A+K L R+ + +E + RAE L +
Sbjct: 2 DFESLKVIGRGAFGEV-RLVQKKDTGHIYAMKIL---RKADMLEKEQVAHIRAERDILVE 57
Query: 835 IRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMI-----ALGA 888
+VK++ + + NL LI E++ G + LL E T+F I A+ A
Sbjct: 58 ADGAWVVKMF-YSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDA 116
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-------------KVIDMP 935
L ++H RDIK +N+LLD K + DFGL + P
Sbjct: 117 IHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNP 167
Query: 936 QS----KSMS-----------------AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLL 974
S ++M+ + G+ YIAPE + CD +S GV++
Sbjct: 168 PSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMY 227
Query: 975 ELLTGRTP 982
E+L G P
Sbjct: 228 EMLIGYPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 3e-09
Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 14/205 (6%)
Query: 787 IVGSGAYGTVYKAVMDSG-KIVAVKKLASNREGNNIESS-FRAEILTLGKIRHRNIVKLY 844
++G GA+G V M +I A+K L E++ FR E L + I L+
Sbjct: 8 VIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLH 67
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNL-EWPTRFMIALGAAEGLAYLHHDCKPR 902
+ + + L L+ +Y G L LL L E RF IA E + +H +
Sbjct: 68 -YAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIA----EMVLAIHSIHQLH 122
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM---- 958
HRDIK +N+LLD + DFG ++ + S G+ YI+PE M
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGM 182
Query: 959 -KVTEKCDIYSYGVVLLELLTGRTP 982
K +CD +S GV + E+L G TP
Sbjct: 183 GKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-09
Identities = 34/89 (38%), Positives = 46/89 (51%)
Query: 251 LGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQI 310
LGL + G +P +I L L I L N + G IP LG+ T L+ L L N+ G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 311 PKEVGNLKFLTKLYLYRNELNGTIPREIG 339
P+ +G L L L L N L+G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 5e-09
Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 40/229 (17%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNN-IESSFRAEILTLGKIRHRNIVKLY 844
++G G G VY A + VA+KK+ + N ++ F E + H IV +Y
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 845 GFC-----------YHQGSNL--LIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAE 890
C Y +G L L+ ++ SL + L +S I
Sbjct: 69 SICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSV----GAFLSIFHKICA 124
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV----------IDMPQSKSM 940
+ Y+H + HRD+K +NILL E + D+G A ID+ +
Sbjct: 125 TIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 941 SA-------VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + G+ Y+APE + +E DIY+ GV+L ++LT P
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 5e-09
Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 50/243 (20%)
Query: 781 NFHDSFIVGSGAYGTVYKAVM--DSGKIVAVKKLASNREGNNIESS----FRAEILTLGK 834
+F ++G GA+G V + V D+G + A+K L R+ + +E RAE L +
Sbjct: 2 DFESLKVIGRGAFGEV-RLVQKKDTGHVYAMKIL---RKADMLEKEQVGHIRAERDILVE 57
Query: 835 IRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
+VK++ + + NL LI E++ G + LL E T+F IA E +
Sbjct: 58 ADSLWVVKMF-YSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA----ETVL 112
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--------------DMPQSKS 939
+ + HRDIK +N+LLD K + DFGL + +P +
Sbjct: 113 AIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFT 172
Query: 940 MS--------------------AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG 979
+ G+ YIAPE + CD +S GV++ E+L G
Sbjct: 173 FQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIG 232
Query: 980 RTP 982
P
Sbjct: 233 YPP 235
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-09
Identities = 25/90 (27%), Positives = 46/90 (51%)
Query: 514 AIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGL 573
+ LD G IP +I + LQ ++++ N +P +G+++ L ++S N G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 574 IPPEIVNCMTLQRLDISHNSFVGSLPNELG 603
IP + +L+ L+++ NS G +P LG
Sbjct: 482 IPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 6e-09
Identities = 47/188 (25%), Positives = 84/188 (44%), Gaps = 22/188 (11%)
Query: 806 IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865
+VAVK L ++ + F EI + ++++ NI++L G C +I EYME G L
Sbjct: 46 LVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL 104
Query: 866 GELLH--------GSSCNLEWPTR---FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNIL 914
+ L + N+ + +A+ A G+ YL HRD+ + N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161
Query: 915 LDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS----YGYIAPEYAYTMKVTEKCDIYSYG 970
+ + + + DFG+++ + S + G ++A E K T D++++G
Sbjct: 162 VGNHYTIKIADFGMSRNL---YSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG 218
Query: 971 VVLLELLT 978
V L E+ T
Sbjct: 219 VTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 8e-09
Identities = 59/200 (29%), Positives = 94/200 (47%), Gaps = 22/200 (11%)
Query: 788 VGSGAYGTV---YKAVMDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVK 842
+GSGA G V Y AV+D + VA+KKL+ R N + RA E++ + + H+NI+
Sbjct: 25 IGSGAQGIVCAAYDAVLD--RNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIIS 80
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN-----LEWPTRFMIALGAAEGLAYLHH 897
L Q S + E+ + + EL+ + C L+ + G+ +LH
Sbjct: 81 LLNVFTPQKS---LEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH- 136
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
I HRD+K +NI++ + DFGLA+ S M+ + Y APE
Sbjct: 137 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 192
Query: 958 MKVTEKCDIYSYGVVLLELL 977
M E DI+S G ++ E++
Sbjct: 193 MGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 8e-09
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 47/203 (23%)
Query: 806 IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865
+VAVK L + N + F E+ L +++ NI++L G C + +I EYME G L
Sbjct: 48 LVAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL 106
Query: 866 GELLHGSSCNLE--------------------WPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ L SS +L+ + + +AL A G+ YL H
Sbjct: 107 NQFL--SSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVH 161
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY-----------GYIAPEY 954
RD+ + N L+ + + DFG+ S + AG Y ++A E
Sbjct: 162 RDLATRNCLVGENLTIKIADFGM----------SRNLYAGDYYRIQGRAVLPIRWMAWEC 211
Query: 955 AYTMKVTEKCDIYSYGVVLLELL 977
K T D++++GV L E+L
Sbjct: 212 ILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-08
Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 22/203 (10%)
Query: 788 VGSGAYGTV---YKAVMDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVK 842
+GSGA G V Y A+++ + VA+KKL+ R N + RA E++ + + H+NI+
Sbjct: 32 IGSGAQGIVCAAYDAILE--RNVAIKKLS--RPFQNQTHAKRAYRELVLMKCVNHKNIIG 87
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN-----LEWPTRFMIALGAAEGLAYLHH 897
L Q S + E+ + + EL+ + C L+ + G+ +LH
Sbjct: 88 LLNVFTPQKS---LEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH- 143
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
I HRD+K +NI++ + DFGLA+ S M+ + Y APE
Sbjct: 144 --SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILG 199
Query: 958 MKVTEKCDIYSYGVVLLELLTGR 980
M E DI+S G ++ E++ G
Sbjct: 200 MGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-08
Identities = 56/207 (27%), Positives = 104/207 (50%), Gaps = 26/207 (12%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
I+G+G++G VY+A+ +D+ + VA+KK+ + + N E+L + + H NI+ L
Sbjct: 73 IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN------RELLIMKNLNHINIIFLKD 126
Query: 846 FCYHQG-----SNL---LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAY 894
+ Y + N+ ++ E++ + + H + N P F++ L + + LAY
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPL-FLVKLYSYQLCRALAY 185
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEA-HVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
+H I HRD+K N+L+D + DFG AK + + +S+S + + Y APE
Sbjct: 186 IHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL-LAGQRSVSYICSRF-YRAPE 240
Query: 954 YAY-TMKVTEKCDIYSYGVVLLELLTG 979
T D++S G ++ E++ G
Sbjct: 241 LMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 59/203 (29%), Positives = 89/203 (43%), Gaps = 16/203 (7%)
Query: 787 IVGSGAYGTVYKAVMD-SGKIVAVKKLA-----SNREGNNIESSFRAEILTLGKIRHRNI 840
++G G++G V A GK AVK L + +E +I + + L ++H +
Sbjct: 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERN---VLLKNVKHPFL 58
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
V L+ + + L + +++ G L L E RF A A L YLH
Sbjct: 59 VGLH-YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLH--- 113
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
I +RD+K NILLD + + DFGL K + QS + + G+ Y+APE
Sbjct: 114 SINIVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTTFCGTPEYLAPEVIRKQP 172
Query: 960 VTEKCDIYSYGVVLLELLTGRTP 982
D + G VL E+L G P
Sbjct: 173 YDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 56/208 (26%), Positives = 90/208 (43%), Gaps = 23/208 (11%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRN-IVKLY 844
++G GA+G V S + V KL S E +S+F E + + +V+L+
Sbjct: 50 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 109
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRF-----MIALGAAEGLAYLHHD 898
+ + L ++ EYM G L L+ +W RF ++AL A + ++H
Sbjct: 110 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFYTAEVVLALDAIHSMGFIH-- 165
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
RD+K +N+LLD + DFG ++ G+ YI+PE +
Sbjct: 166 -------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 959 K----VTEKCDIYSYGVVLLELLTGRTP 982
+CD +S GV L E+L G TP
Sbjct: 219 GGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-08
Identities = 65/210 (30%), Positives = 91/210 (43%), Gaps = 31/210 (14%)
Query: 787 IVGSGAYGTVY----KAVMDSGKIVAVKKLASNREGNNIESSFRAEILT----LGKIRHR 838
++G G +G V KA +GK A+K L ++ I A LT L RH
Sbjct: 2 LLGKGTFGKVILVREKA---TGKYYAMKIL---KKEVIIAKDEVAHTLTESRVLQNTRHP 55
Query: 839 NIVKL-YGFCYHQGSNLLIYEYMERGSLGELL-HGSSCNL--EWPTRFMIALGA--AEGL 892
+ L Y F Q + L + ME + GEL H S + E RF GA L
Sbjct: 56 FLTALKYSF---QTHDRLCF-VMEYANGGELFFHLSRERVFSEDRARFY---GAEIVSAL 108
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
YLH C + +RD+K N++LD + DFGL K + +M G+ Y+AP
Sbjct: 109 GYLH-SCD--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLAP 164
Query: 953 EYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
E D + GVV+ E++ GR P
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 2e-08
Identities = 63/225 (28%), Positives = 94/225 (41%), Gaps = 19/225 (8%)
Query: 791 GAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG-FCYH 849
GA G + A +D+ V A R G E+ L I H +I++L G F Y+
Sbjct: 103 GAEGFAF-ACIDNKTCEHVVIKAGQRGGTATEAH------ILRAINHPSIIQLKGTFTYN 155
Query: 850 QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIK 909
+ + L++ Y + L L N+ I + YLH + RI HRDIK
Sbjct: 156 KFTCLILPRY--KTDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHEN---RIIHRDIK 209
Query: 910 SNNILLDDKFEAHVGDFGLAKV-IDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYS 968
+ NI ++ + +GDFG A +D+ +K AG+ APE DI+S
Sbjct: 210 AENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGTIATNAPELLARDPYGPAVDIWS 268
Query: 969 YGVVLLELLTGRTPV---QPLDDGGDLATWVRNYIRDHSLTPGIF 1010
G+VL E+ T + LD D ++ IR P F
Sbjct: 269 AGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313
|
Length = 391 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 37/195 (18%)
Query: 806 IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865
+VAVK L + N + F EI + +++ NI++L C +I EYME G L
Sbjct: 48 LVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106
Query: 866 GELL-----HGSSCNLEWPT------RFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNIL 914
+ L ++ + T FM A A G+ YL HRD+ + N L
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFM-ATQIASGMKYL---SSLNFVHRDLATRNCL 162
Query: 915 LDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY-----------GYIAPEYAYTMKVTEK 963
+ + + DFG+ S + +G Y +++ E K T
Sbjct: 163 VGKNYTIKIADFGM----------SRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTA 212
Query: 964 CDIYSYGVVLLELLT 978
D++++GV L E+LT
Sbjct: 213 SDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 2e-08
Identities = 58/216 (26%), Positives = 105/216 (48%), Gaps = 23/216 (10%)
Query: 787 IVGSGAYGTVYKAVMD-SGKIVAVKKLASNR--EGNNIESSF-RAEILTLGKIRHRNIVK 842
++G G++G V A + + ++ A+K L + + ++++ + IL L +H +
Sbjct: 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAA-KHPFLTA 60
Query: 843 LYGFCYHQGSNLLIY--EYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLH- 896
L+ C Q + L + EY+ G L + S E +RF AAE L +LH
Sbjct: 61 LH--CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFY----AAEVTLALMFLHR 114
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
H + +RD+K +NILLD + + DFG+ K + + + G+ YIAPE
Sbjct: 115 HG----VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILNGVTTTTFCGTPDYIAPEILQ 169
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992
++ D ++ GV++ E++ G+ P + D+ DL
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEA-DNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 13/205 (6%)
Query: 787 IVGSGAYGTVYKAVMD--SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+VG G +G V + V + +G I A+K + + SF E + I + +
Sbjct: 8 LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
+ + NL L+ EY G L LL+ + M AE + +H +
Sbjct: 67 QYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFD---EDMAQFYLAELVLAIHSVHQMGY 123
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
HRDIK N+L+D + DFG A + + + G+ YIAPE TM K
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183
Query: 964 ------CDIYSYGVVLLELLTGRTP 982
CD +S GV+ E++ GR+P
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-08
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 50/217 (23%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLY 844
+GSGA G V A +G+ VA+KKL+ R N+ + RA E++ + + H+NI+ L
Sbjct: 24 IGSGAQGIVCAAYDTVTGQNVAIKKLS--RPFQNVTHAKRAYRELVLMKLVNHKNIIGLL 81
Query: 845 GFCYHQGSNL-------LIYEYM--------------ERGSLGELLHGSSCNLEWPTRFM 883
+ +L L+ E M ER S LL+ C
Sbjct: 82 N-VFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSY--LLYQMLC--------- 129
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943
G+ +LH I HRD+K +NI++ + DFGLA+ S M+
Sbjct: 130 -------GIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPY 177
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR 980
+ Y APE M E DI+S G ++ E++ G
Sbjct: 178 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-08
Identities = 54/169 (31%), Positives = 75/169 (44%), Gaps = 19/169 (11%)
Query: 826 RAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIA 885
R+E+ L H IVK + LLI EY GS G+L N + R
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY---GSGGDL------NKQIKQRLKEH 163
Query: 886 LGAAE---GLAY------LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMP 935
L E GL + L ++ HRD+KS NI L +GDFG +K D
Sbjct: 164 LPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223
Query: 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
S+ G+ Y+APE + ++K D++S GV+L ELLT P +
Sbjct: 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK 272
|
Length = 478 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 3e-08
Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 12/152 (7%)
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPR 902
C+ S L L+ EY+ G L + E RF AAE L +LH +
Sbjct: 64 CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFY----AAEICIALNFLH---ERG 116
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
I +RD+K +N+LLD + D+G+ K P + S G+ YIAPE +
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTFCGTPNYIAPEILRGEEYGF 175
Query: 963 KCDIYSYGVVLLELLTGRTPVQPLDDGGDLAT 994
D ++ GV++ E++ GR+P + D D+ T
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNT 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 56/216 (25%), Positives = 94/216 (43%), Gaps = 27/216 (12%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKL-------ASNREGNNIESSFRAEILTL 832
NF +G G + VY+A + K VA+KK+ A R+ EI L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQ------DCVKEIDLL 56
Query: 833 GKIRHRNIVK-LYGFCYHQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTR----FMIAL 886
++ H N++K L F N+++ E + G L +++ + P R + + L
Sbjct: 57 KQLNHPNVIKYLDSFIEDNELNIVL-ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQL 115
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS 946
+A + H R+ HRDIK N+ + +GD GL + + + S V
Sbjct: 116 CSA-----VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170
Query: 947 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y Y++PE + K DI+S G +L E+ ++P
Sbjct: 171 Y-YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 4e-08
Identities = 51/213 (23%), Positives = 81/213 (38%), Gaps = 33/213 (15%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIE--SSFRAEILTLGKIRHRNIVKLYGF 846
+ K + +VAVKK+ N + + E + EI+T +++H NI+ Y
Sbjct: 11 EDLMIVHLAKHK-PTNTLVAVKKI--NLDSCSKEDLKLLQQEIITSRQLQHPNILP-YVT 66
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIAL---GAAEGLAYLHHDCKPR 902
+ S L ++ M GS +LL + P IA L Y+H
Sbjct: 67 SFIVDSELYVVSPLMAYGSCEDLLK-THFPEGLP-ELAIAFILKDVLNALDYIHSK---G 121
Query: 903 IFHRDIKSNNILLDDKFEAHV-----------GDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
HR +K+++ILL + + V D P+S + +++
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKS-----SVKNLPWLS 176
Query: 952 PEYAYT--MKVTEKCDIYSYGVVLLELLTGRTP 982
PE EK DIYS G+ EL G P
Sbjct: 177 PEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 7e-08
Identities = 64/220 (29%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 788 VGSGAYGTV----YKAVMDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIR-HRNI 840
+G GAYG V + VA+KK+ +N I + RA E+ L R H+NI
Sbjct: 8 LGQGAYGIVCSARNAETSEEET-VAIKKI-TNVFSKKI-LAKRALRELKLLRHFRGHKNI 64
Query: 841 VKLYGF---CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE------- 890
LY + L +YE EL+ +L R L A
Sbjct: 65 TCLYDMDIVFPGNFNELYLYE--------ELM---EADLHQIIRSGQPLTDAHFQSFIYQ 113
Query: 891 ---GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---MSAVA 944
GL Y+H + HRD+K N+L++ E + DFGLA+ ++ M+
Sbjct: 114 ILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 945 GSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPV 983
+ Y APE + + T+ D++S G +L ELL GR PV
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPV 209
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-08
Identities = 67/263 (25%), Positives = 102/263 (38%), Gaps = 63/263 (23%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLASNREGN----NIESSFRAEILTLGKIRHRNIVK 842
+G GA+G V A +D+ + A+K L R+ + N + +AE L + + +V+
Sbjct: 9 LGIGAFGEVCLARKVDTKALYAMKTL---RKKDVLLRNQVAHVKAERDILAEADNEWVVR 65
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
LY + + NL + +Y+ G + LL E RF IA E + K
Sbjct: 66 LY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIA----ELTCAVESVHKM 120
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVI------------DMPQSKSMS-------- 941
HRDIK +NIL+D + DFGL D + SM
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDP 180
Query: 942 --------------------------AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 975
++ G+ YIAPE T+ CD +S GV+L E
Sbjct: 181 ANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240
Query: 976 LLTGRTPV---QPLDDGGDLATW 995
+L G+ P PL+ + W
Sbjct: 241 MLVGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 9e-08
Identities = 68/239 (28%), Positives = 108/239 (45%), Gaps = 10/239 (4%)
Query: 117 SLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSL 176
SL + L +L LDL++N+L+ +P+ + N S L +L L+ N+ S +P E+ LS+L
Sbjct: 154 SLPSPLRNLPNLKNLDLSFNDLSD-LPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSAL 211
Query: 177 VSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG 236
L++ NN I L L NL +L N L LP+SIGNL NL N IS
Sbjct: 212 EELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS- 268
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
SI + + +L+ L L+ N + +LP + L +L + LT EL + L
Sbjct: 269 SISS-LGSLTNLRELDLSGNSLSNALPLIALL--LLLLELLLNLLLTL-KALELKLNSIL 324
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
+ +N P+ + L+ L L+ N L+ + + L +
Sbjct: 325 LNNNI-LSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLDLVKK 382
|
Length = 394 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-07
Identities = 64/257 (24%), Positives = 101/257 (39%), Gaps = 66/257 (25%)
Query: 781 NFHDSFIVGSGAYGTVYKAV--MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRH 837
+FH ++G GA+G V + V D+GKI A+K L S + + +AE L +
Sbjct: 2 DFHTVKVIGKGAFGEV-RLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 838 RNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIA-----LGAAEG 891
+V LY + + L LI E++ G L +L E TRF +A + A
Sbjct: 61 PWVVSLY-YSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHK 119
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL----------------------- 928
L ++H RDIK +NIL+D + DFGL
Sbjct: 120 LGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNK 170
Query: 929 ---------------------AKVIDMPQSKSMSAVA--GSYGYIAPEYAYTMKVTEKCD 965
++ +++ + A + G+ YIAPE ++CD
Sbjct: 171 NRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECD 230
Query: 966 IYSYGVVLLELLTGRTP 982
+S G ++ E L G P
Sbjct: 231 WWSLGAIMFECLIGWPP 247
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-07
Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 888 AAE---GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA 944
AAE GL +LH I +RD+K +N++LD + + DFG+ K +M +
Sbjct: 107 AAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NMWDGVTTKTFC 162
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD 988
G+ YIAPE + D +++GV+L E+L G+ P + D+
Sbjct: 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 206
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-07
Identities = 59/206 (28%), Positives = 92/206 (44%), Gaps = 30/206 (14%)
Query: 532 NCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISH 591
N L L + N S + + + L+ L + ++ +N +T + P + L+ LD+S
Sbjct: 91 NLLPLPSLDLNLNRLRSNISELL-ELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSD 149
Query: 592 NSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELG 651
N + SLP+ L L L+ L LS N S ++P L
Sbjct: 150 NK-IESLPSPLRNLPNLKNLDLSFNDLS-------------------------DLPKLLS 183
Query: 652 DLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFS 711
+LS+L L+LS N +S +PPE+ L LE L L+NN + E+ S+ NL +L G S
Sbjct: 184 NLSNLNN-LDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELS 240
Query: 712 YNNLTGPLPSIPQFQNMDISSFLGNE 737
N L SI N++ N+
Sbjct: 241 NNKLEDLPESIGNLSNLETLDLSNNQ 266
|
Length = 394 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 2e-07
Identities = 63/207 (30%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 787 IVGSGAYGTVY----KAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI----RHR 838
++G G +G V KA SGK A+K L ++ I A LT ++ RH
Sbjct: 2 LLGKGTFGKVILVREKA---SGKYYAMKIL---KKEVIIAKDEVAHTLTESRVLKNTRHP 55
Query: 839 NIVKL-YGFCYHQGSNLLIY--EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYL 895
+ L Y F Q + L + EY+ G L L E TRF A L YL
Sbjct: 56 FLTSLKYSF---QTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGA-EIVSALDYL 111
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H +I +RD+K N++LD + DFGL K + + +M G+ Y+APE
Sbjct: 112 HSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKE-GITDAATMKTFCGTPEYLAPEVL 167
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
D + GVV+ E++ GR P
Sbjct: 168 EDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 49/210 (23%), Positives = 89/210 (42%), Gaps = 27/210 (12%)
Query: 787 IVGSGAYGTVYKAVMD-SGK---IVAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
I+G+G +G + + + K VA+ L S+++ F AE LTLG+ H N
Sbjct: 12 ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQ----RRGFLAEALTLGQFDHSN 67
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
IV+L G + +++ EYM G+L L L + G A G+ YL
Sbjct: 68 IVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYL---S 124
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG------YIAPE 953
+ H+ + ++ +L++ + F Q A+ + + APE
Sbjct: 125 EMGYVHKGLAAHKVLVNSDLVCKISGFRRL------QEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
+ D++S+G+V+ E+++ G P
Sbjct: 179 AIQYHHFSSASDVWSFGIVMWEVMSYGERP 208
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 64/244 (26%), Positives = 96/244 (39%), Gaps = 54/244 (22%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYG 845
+G GA+G V A +D+ + A+K L N N + +AE L + + +VKLY
Sbjct: 9 LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLY- 67
Query: 846 FCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ + NL + +Y+ G + LL E RF IA E + K
Sbjct: 68 YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIA----ELTLAIESVHKMGFI 123
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLA----------------------------------- 929
HRDIK +NIL+D + DFGL
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183
Query: 930 ------KVIDMPQSKSMS-----AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 978
K ++ +K ++ G+ YIAPE T+ CD +S GV+L E+L
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243
Query: 979 GRTP 982
G+ P
Sbjct: 244 GQPP 247
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 3e-07
Identities = 46/144 (31%), Positives = 70/144 (48%), Gaps = 8/144 (5%)
Query: 791 GAYGTVYKAVM-DSGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCY 848
GA+G VY ++ K+ AVK + N N+ +AE L + IV LY +
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73
Query: 849 HQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+N+ L+ EY+ G + LLH E I+ A L YLH + I HRD
Sbjct: 74 QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYIS-EVALALDYLH---RHGIIHRD 129
Query: 908 IKSNNILLDDKFEAHVGDFGLAKV 931
+K +N+L+ ++ + DFGL+KV
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 3e-07
Identities = 58/221 (26%), Positives = 102/221 (46%), Gaps = 38/221 (17%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREG----NNIESSF-RAEILTLGKIRHRNI 840
++ +GAYG VY ++ + A+KK+ N++ N I+ F +ILT + + +
Sbjct: 8 LISNGAYGAVYLVRHKETRQRFAMKKI--NKQNLILRNQIQQVFVERDILTFAE--NPFV 63
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAE---GLAYL 895
V ++ + +L ++ EY+E G LL + + ++ M + AE L YL
Sbjct: 64 VSMFC-SFETKRHLCMVMEYVEGGDCATLLKNIGALPVD-----MARMYFAETVLALEYL 117
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM--------------S 941
H+ I HRD+K +N+L+ + DFGL+K+ M + ++
Sbjct: 118 HN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174
Query: 942 AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
V G+ YIAPE + D ++ G++L E L G P
Sbjct: 175 QVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 5e-07
Identities = 71/289 (24%), Positives = 109/289 (37%), Gaps = 47/289 (16%)
Query: 788 VGSGAYGTVYKAVMDSGKIVA---VKKL---ASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G+G +G V G A VK+L A+ E + F E+ ++ H N++
Sbjct: 3 IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDE----QLLFLQEVQPYRELNHPNVL 58
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMI----ALGAAEGLAYLHH 897
+ G C LL+ E+ G L L + + + + A A GL +LH
Sbjct: 59 QCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH- 117
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMPQSKSMSAVAGSYGYIAPEY 954
+ H D+ N L +GD+GLA D +K AV ++APE
Sbjct: 118 --QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVP--LRWLAPEL 173
Query: 955 A-------YTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNY-IRDHSLT 1006
T+K +I+S GV + EL T QP D D V +R+
Sbjct: 174 VEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAAD--QPYPDLSDEQ--VLKQVVREQ--- 226
Query: 1007 PGIFDTRLNVE--DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
D +L D D V++ + P RP+ EV +L
Sbjct: 227 ----DIKLPKPQLDLKYSDRWYEVMQFCWL----DPETRPTAEEVHELL 267
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 5e-07
Identities = 33/100 (33%), Positives = 56/100 (56%), Gaps = 13/100 (13%)
Query: 889 AEGLAYL-HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS- 946
A+G+ +L +C HRD+ + N+LL D A + DFGLA+ I + S V G+
Sbjct: 222 AQGMDFLASKNC----IHRDVAARNVLLTDGRVAKICDFGLARDI---MNDSNYVVKGNA 274
Query: 947 ---YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE + T + D++SYG++L E+ + G++P
Sbjct: 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 6e-07
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 1/103 (0%)
Query: 467 LNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPI 526
L L L G IP D+ L + L GNS+ G+ P L + +L ++L N F+G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 527 PPEIENCQKLQRLHIANNYFTSELPKEVGN-LSQLVTFNISSN 568
P + L+ L++ N + +P +G L +FN + N
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 6e-07
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 788 VGSGAYGTVYKAVMDSGKI--VAVKKLASNR--EGNNIESSFRAEILTLGKIRHRNIVKL 843
+G+G++G V A + VA+K+ ++ + ++ F +E L I H V L
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVF-SERKILNYINHPFCVNL 96
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG---AAEGLAYLHHDCK 900
YG + L+ E++ G L + RF +G AA+ + +
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFLRRNK-------RFPNDVGCFYAAQIVLIFEYLQS 149
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV 960
I +RD+K N+LLD + DFG AKV+D + G+ YIAPE +
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD----TRTYTLCGTPEYIAPEILLNVGH 205
Query: 961 TEKCDIYSYGVVLLELLTGRTP 982
+ D ++ G+ + E+L G P
Sbjct: 206 GKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 8e-07
Identities = 44/147 (29%), Positives = 69/147 (46%), Gaps = 7/147 (4%)
Query: 837 HRNIVKLYGFCYHQGSNLL-IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYL 895
H +V L+ C+ S L + EY+ G L + E RF A + L YL
Sbjct: 55 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSA-EISLALNYL 112
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H + I +RD+K +N+LLD + + D+G+ K P + S G+ YIAPE
Sbjct: 113 H---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTFCGTPNYIAPEIL 168
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTP 982
D ++ GV++ E++ GR+P
Sbjct: 169 RGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 1e-06
Identities = 30/98 (30%), Positives = 48/98 (48%), Gaps = 2/98 (2%)
Query: 659 ALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGP 718
L L L G IP ++ KL L+ + L+ N + G IP + +++SL + SYN+ G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 719 LP-SIPQFQNMDISSFLGNEGLCGRPVGNCGASPSSGS 755
+P S+ Q ++ I + GN L GR G +
Sbjct: 482 IPESLGQLTSLRILNLNGNS-LSGRVPAALGGRLLHRA 518
|
Length = 623 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 11/157 (7%)
Query: 834 KIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
++ H++IV LYG C N+++ E++E G L +H S L P +F +A A L+
Sbjct: 60 QVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALS 119
Query: 894 YLHHDCKPRIFHRDIKSNNILL-DDKFEAHVGDFGLAKVID--MPQSK-SMSAVAGSYGY 949
YL + H ++ + NILL + + G F K+ D +P + S +
Sbjct: 120 YLE---DKDLVHGNVCTKNILLAREGIDGECGPF--IKLSDPGIPITVLSRQECVERIPW 174
Query: 950 IAPEYAYTMKV-TEKCDIYSYGVVLLEL-LTGRTPVQ 984
IAPE K + D +S+G L E+ G P++
Sbjct: 175 IAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 64/289 (22%), Positives = 123/289 (42%), Gaps = 48/289 (16%)
Query: 791 GAYGTVYKAVM-----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
G +G ++ ++ + V VK + + + + E L + H+NI+ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQV-TLLLQESCLLYGLSHQNILPILH 75
Query: 846 FCYHQGSN-LLIYEYMERGSLGELL----HGSSCNLE-WPTRFMIALGA--AEGLAYLHH 897
C G ++Y YM G+L L G + N + T+ ++ + A G++YLH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH- 134
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY---GYIAPEY 954
K + H+DI + N ++D++ + + D L++ D+ ++A E
Sbjct: 135 --KRGVIHKDIAARNCVIDEELQVKITDNALSR--DLFPMDYHCLGDNENRPVKWMALES 190
Query: 955 AYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013
+ + D++S+GV+L EL+T G+TP +D + Y++D R
Sbjct: 191 LVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-----PFEMAAYLKD--------GYR 237
Query: 1014 L----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058
L N DE + V C ++ P +RPS ++V L + +
Sbjct: 238 LAQPINCPDE--------LFAVMACCWALDPEERPSFSQLVQCLTDFHA 278
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (123), Expect = 2e-06
Identities = 60/225 (26%), Positives = 94/225 (41%), Gaps = 33/225 (14%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIE-SSFRAEILTLGKIRHRNIVKLYGF 846
+G+G +G V+ + K S R E S E+ + +++H+NIV+ Y
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVR-YID 79
Query: 847 CYHQGSNLLIYEYMERGSLGELLHG-SSC-----NLEWPTRFMIALGAAEGLAYLHH--- 897
+ +N +Y ME G+L C +E I LAY H+
Sbjct: 80 RFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKD 139
Query: 898 -DCKPRIFHRDIKSNNILLDDKFE-----------------AHVGDFGLAKVIDMPQSKS 939
R+ HRD+K NI L A +GDFGL+K I + +S +
Sbjct: 140 GPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI-ESMA 198
Query: 940 MSAVAGSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLTGRTP 982
S V Y Y +PE T +K D+++ G ++ EL +G+TP
Sbjct: 199 HSCVGTPY-YWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242
|
Length = 1021 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 30/91 (32%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
L YLH + +RDIK N++LD + DFGL K + +M G+ Y+A
Sbjct: 108 LEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCGTPEYLA 163
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
PE D + GVV+ E++ GR P
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-06
Identities = 55/202 (27%), Positives = 78/202 (38%), Gaps = 15/202 (7%)
Query: 782 FHDSFIVGSGAYGTVYK-AVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNI 840
F +V A G Y ++ IVA ++A N + + R LT K
Sbjct: 8 FGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK------ 61
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
Y F H + EY G L L E RF A L YLH +
Sbjct: 62 ---YSFQTHD-RLCFVMEYANGGELFFHLSRERVFSEDRARFYGA-EIVSALDYLHSE-- 114
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV 960
+ +RD+K N++LD + DFGL K + +M G+ Y+APE
Sbjct: 115 KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVLEDNDY 173
Query: 961 TEKCDIYSYGVVLLELLTGRTP 982
D + GVV+ E++ GR P
Sbjct: 174 GRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 9e-06
Identities = 30/111 (27%), Positives = 55/111 (49%), Gaps = 11/111 (9%)
Query: 807 VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866
V +K L S+ + + F + ++ H+++VKLYG C N+++ EY++ G L
Sbjct: 33 VVLKVLGSD--HRDSLAFFET-ASLMSQLSHKHLVKLYGVCVRDE-NIMVEEYVKFGPLD 88
Query: 867 ELLH--GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL 915
LH ++ +L W + +A A L YL ++ H ++ NIL+
Sbjct: 89 VFLHREKNNVSLHW--KLDVAKQLASALHYLEDK---KLVHGNVCGKNILV 134
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 2e-05
Identities = 66/251 (26%), Positives = 91/251 (36%), Gaps = 72/251 (28%)
Query: 782 FHDSFIVGSGAYGTVYKA-VMDSGKIVAVK----KLASNREGNNIESSFRAEILTLGKIR 836
F ++G G G V+ + +GK+ A+K K R N E L +
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKR---NKVKRVLTEQEILATLD 59
Query: 837 HRNIVKLYG-----FCYHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPTRFMIALGAA 889
H + LY L+ +Y G L LL C E RF AA
Sbjct: 60 HPFLPTLYASFQTETYLC-----LVMDYCPGGELFRLLQRQPGKCLSEEVARFY----AA 110
Query: 890 E---GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAK-------------- 930
E L YLH I +RD+K NILL + H+ DF L+K
Sbjct: 111 EVLLALEYLH--LLG-IVYRDLKPENILLHE--SGHIMLSDFDLSKQSDVEPPPVSKALR 165
Query: 931 ---------------VIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSYGV 971
+ P +S S V G+ YIAPE + V D ++ G+
Sbjct: 166 KGSRRSSVNSIPSETFSEEPSFRSNSFV-GTEEYIAPEVISGDGHGSAV----DWWTLGI 220
Query: 972 VLLELLTGRTP 982
+L E+L G TP
Sbjct: 221 LLYEMLYGTTP 231
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-05
Identities = 30/89 (33%), Positives = 44/89 (49%), Gaps = 7/89 (7%)
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
YLH I +RD+K N+LLD+K V DFG AK + + G+ Y+APE
Sbjct: 133 YLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV----PDRTFTLCGTPEYLAPE 185
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + D ++ GV+L E + G P
Sbjct: 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 788 VGSGAYGTVYKA----VMDSGKI----VAVKKL-ASNREGNNIESSFRAEILTLGKIRHR 838
+G G + ++K V D G++ V +K L S+R N ES F A + + ++ H+
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHR--NYSESFFEAASM-MSQLSHK 59
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELL--HGSSCNLEWPTRFMIALGAAEGLAY-L 895
++V YG C ++++ EY++ GSL L + + N+ W L A+ LA+ L
Sbjct: 60 HLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW------KLEVAKQLAWAL 113
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---MPQSKSMSAVAGSYGYIAP 952
H + H ++ + N+LL + + G+ K+ D + ++ P
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIPWVPP 173
Query: 953 EYAYTMK-VTEKCDIYSYGVVLLELLTGRT-PVQPLD 987
E + ++ D +S+G L E+ +G P+ LD
Sbjct: 174 ECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALD 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 3e-05
Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 13/130 (10%)
Query: 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYL-HHDCKPRIFHRDIKSNNILLDD 917
Y+++ E+L L+ + A+G+++L +C HRD+ + NILL
Sbjct: 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNC----IHRDLAARNILLTH 249
Query: 918 KFEAHVGDFGLAKVIDMPQSKSMSAVAGS----YGYIAPEYAYTMKVTEKCDIYSYGVVL 973
+ DFGLA+ I ++ S V G+ ++APE + T + D++SYG++L
Sbjct: 250 GRITKICDFGLARDI---RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILL 306
Query: 974 LELLT-GRTP 982
E+ + G +P
Sbjct: 307 WEIFSLGSSP 316
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 3e-05
Identities = 38/167 (22%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSY 947
A G+ +L + HRD+ + NILL + + DFGLA+ I P +
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 948 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLT 1006
++APE + T + D++S+GV+L E+ + G +P + + +++
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD-------- 292
Query: 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
TR+ + + + + ++ L C P +RP+ +V +L
Sbjct: 293 ----GTRMRAPENATPE----IYRIMLACWQGDPKERPTFSALVEIL 331
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 4e-05
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 28/156 (17%)
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
HRD+ + NILL + + DFGLA+ I D + A ++APE + T
Sbjct: 196 HRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-PLKWMAPESIFDKVYTT 254
Query: 963 KCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIR----DHSLTPGIFDTRLNVE 1017
+ D++S+GV+L E+ + G +P + + ++ R +++ TP I+ L+
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYA-TPEIYSIMLD-- 311
Query: 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
C +P DRP+ E+V +L
Sbjct: 312 -----------------CWHNNPEDRPTFSELVEIL 330
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 4e-05
Identities = 28/91 (30%), Positives = 48/91 (52%), Gaps = 4/91 (4%)
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
L +LH + I +RD+K +N+LLD + + D+G+ K + + S G+ YIA
Sbjct: 109 LNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDTTSTFCGTPNYIA 164
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
PE D ++ GV++ E++ GR+P
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 5e-05
Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 3/90 (3%)
Query: 441 WVVD---FSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNS 497
W +D + L G IP + + +L +NL N + GNIP + + +L L L NS
Sbjct: 418 WFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNS 477
Query: 498 LTGSFPLELCKLENLYAIELDQNKFSGPIP 527
GS P L +L +L + L+ N SG +P
Sbjct: 478 FNGSIPESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 5e-05
Identities = 31/85 (36%), Positives = 43/85 (50%)
Query: 419 LQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNI 478
L L L G IP + L ++ S N + G IPP L ++L +L+L YN G+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 479 PTDVLNCETLLQLRLVGNSLTGSFP 503
P + +L L L GNSL+G P
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVP 507
|
Length = 623 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 8e-05
Identities = 28/96 (29%), Positives = 49/96 (51%), Gaps = 5/96 (5%)
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK-VIDMPQSKSMSAVAGSY 947
A+G+ +L + HRD+ + NILL + + DFGLA+ + P
Sbjct: 189 AKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245
Query: 948 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++APE + T + D++S+GV+L E+ + G +P
Sbjct: 246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 281
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 9e-05
Identities = 37/118 (31%), Positives = 55/118 (46%), Gaps = 19/118 (16%)
Query: 766 PKEG--FSFQDVVEATYNFHDSF---------IVGSGAYGTVYKAVM------DSGKIVA 808
EG ++F D + YN F +G+GA+G V +A D+ VA
Sbjct: 13 AAEGNNYTFIDPTQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVA 72
Query: 809 VKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865
VK L ++ + E+ +E+ L + +H+NIV L G C H G L+I EY G L
Sbjct: 73 VKMLKASAHTDEREA-LMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDL 129
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 40.2 bits (95), Expect = 2e-04
Identities = 20/61 (32%), Positives = 28/61 (45%), Gaps = 2/61 (3%)
Query: 127 HLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNM 185
+L LDL+ N LT IP L+ L L+ N + P L SL SL++ N
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 186 I 186
+
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 4e-04
Identities = 24/60 (40%), Positives = 29/60 (48%)
Query: 367 GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSL 426
L+ L L N+LT + L NL LDLS N LT P F L +R L L N+L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|215633 PLN03210, PLN03210, Resistant to P | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 4e-04
Identities = 76/284 (26%), Positives = 118/284 (41%), Gaps = 47/284 (16%)
Query: 365 ITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFEN 424
+TGLR + L ++ IP+ LS NL L LS +P Q+L ++ L +
Sbjct: 633 LTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRC 691
Query: 425 SLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLN 484
+P G+ L SL + N L+G C S L K F +I T N
Sbjct: 692 ENLEILPTGINLKSL-----YRLN-LSG------C--SRL--------KSFPDIST---N 726
Query: 485 CETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSG------PIPPEIENCQ-KLQ 537
L + + FP L +LENL + L + K P+ P + L
Sbjct: 727 ISWLD----LDETAIEEFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT 781
Query: 538 RLHIANNYFTSELPKEVGNLSQLVTFNISS--NMLTGLIPPEIVNCMTLQRLDISHNSFV 595
RL +++ ELP + NL +L I + N+ T P +N +L+ LD+S S +
Sbjct: 782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLET---LPTGINLESLESLDLSGCSRL 838
Query: 596 GSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGG 639
+ P+ + T + L LS +P + S+L+ L M G
Sbjct: 839 RTFPD-IST--NISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNG 878
|
syringae 6; Provisional. Length = 1153 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 5e-04
Identities = 30/91 (32%), Positives = 44/91 (48%), Gaps = 7/91 (7%)
Query: 886 LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS-AVA 944
L A + Y+H + I HRDIK+ N+L++ + +GDFG A S +A
Sbjct: 270 LSAID---YIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 975
G+ APE T DI+S G+V+ E
Sbjct: 324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 9e-04
Identities = 33/149 (22%), Positives = 53/149 (35%), Gaps = 15/149 (10%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV--KLY 844
++ G VY V +K S +G + E E+ L + + + K+
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYV-LKINPSREKGADRER----EVAILQLLARKGLPVPKVL 59
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
G + L+ E++E GE L + E L LA LH +
Sbjct: 60 ASGESDGWSYLLMEWIE----GETL--DEVSEEEKEDIAEQLAEL--LAKLHQLPLLVLC 111
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVID 933
H D+ NIL+DD + D+ A
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 19/58 (32%), Positives = 24/58 (41%), Gaps = 2/58 (3%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQF 162
SLDL+ T + GL +L LDL+ N LT P L L L+ N
Sbjct: 4 SLDLSNNRLT-VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.9 bits (89), Expect = 0.001
Identities = 24/60 (40%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 344 VTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402
+ +DLS N L IP F + L++L L N LT + P S L +L LDLS N L
Sbjct: 2 LKSLDLSNNRL-TVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 0.001
Identities = 29/83 (34%), Positives = 46/83 (55%), Gaps = 8/83 (9%)
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS----YGYIAPEYAYTMKV 960
HRD+ + N+L+ + + DFGLA+ I M S +S GS ++APE +
Sbjct: 262 HRDLAARNVLICEGKLVKICDFGLARDI-MRDSNYISK--GSTFLPLKWMAPESIFNNLY 318
Query: 961 TEKCDIYSYGVVLLELLT-GRTP 982
T D++S+G++L E+ T G TP
Sbjct: 319 TTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 44/158 (27%), Positives = 67/158 (42%), Gaps = 32/158 (20%)
Query: 788 VGSGAYGTVYKAVMDSGKIVA---VKKL---ASNREGNNIESSFRAEILTLGK----IRH 837
+G+G +G V + + + VA VK+L AS++E N E L G ++H
Sbjct: 3 IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQN--------EFLQQGDPYRILQH 54
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTR-------FMIALGAAE 890
NI++ G C LL++EY E G L L +W R +A A
Sbjct: 55 PNILQCLGQCVEAIPYLLVFEYCELGDLKSYL----SQEQWHRRNSQLLLLQRMACEIAA 110
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928
G+ ++H K H D+ N L VGD+G+
Sbjct: 111 GVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|238064 cd00116, LRR_RI, Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 63/311 (20%), Positives = 98/311 (31%), Gaps = 73/311 (23%)
Query: 341 LSMVTEIDLSENSLNGE----IPTEFSKITGLRLLFLFQNQL------TGVIPNELSSLR 390
L + + L N+L E + + L+ L L N+ + L+
Sbjct: 22 LLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81
Query: 391 NLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYL 450
L +LDLS N L + L + LQ ++N L
Sbjct: 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQEL---------------------KLNNNGL 120
Query: 451 TGRIPPHLCQ-----NSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLE 505
R L + L L LG N+L G +CE +L +
Sbjct: 121 GDRGLRLLAKGLKDLPPALEKLVLGRNRLEGA------SCE----------ALAKALR-A 163
Query: 506 LCKLENLYAIELDQNKFSGP----IPPEIENCQKLQRLHIANNYFTSE----LPKEVGNL 557
L+ L L N + ++ L+ L + NN T E L + + +L
Sbjct: 164 NRDLKEL---NLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASL 220
Query: 558 SQLVTFNISSNMLTGLIPPEIVNCM-----TLQRLDISHNSF----VGSLPNELGTLQQL 608
L N+ N LT + + + +L L +S N L L + L
Sbjct: 221 KSLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESL 280
Query: 609 EILKLSENKFS 619
L L NKF
Sbjct: 281 LELDLRGNKFG 291
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). Length = 319 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.002
Identities = 23/63 (36%), Positives = 33/63 (52%), Gaps = 5/63 (7%)
Query: 631 HLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNN 688
+L L + N + IP L +L++ L+LS NNL+ SI PE L L L L+
Sbjct: 1 NLKSLDLSNNRLT-VIPDGAFKGLPNLKV-LDLSGNNLT-SISPEAFSGLPSLRSLDLSG 57
Query: 689 NHL 691
N+L
Sbjct: 58 NNL 60
|
Length = 60 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 51/169 (30%), Positives = 75/169 (44%), Gaps = 34/169 (20%)
Query: 836 RHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAA 889
RH NI+ + + GS L +I +M GS LL G S L I GA
Sbjct: 57 RHPNIMTSWTV-FTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGN----ILFGAL 111
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG- 948
GL YLH + HR+IK+++IL+ + V GL+ + + ++ + V +
Sbjct: 112 RGLNYLHQN---GYIHRNIKASHILISG--DGLVSLSGLSHLYSLVRNGQKAKVVYDFPQ 166
Query: 949 -------YIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
+++PE Y Y +K DIYS G+ EL TGR P Q
Sbjct: 167 FSTSVLPWLSPELLRQDLYGYNVK----SDIYSVGITACELATGRVPFQ 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 39/149 (26%), Positives = 61/149 (40%), Gaps = 11/149 (7%)
Query: 788 VGSGAYGTVYKAVMDSG---KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G+G +G V ++SG V VK+L + + F E ++H N+++
Sbjct: 3 IGNGWFGKVILGEVNSGYTPAQVVVKELRVS-ASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLH----GSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
G C LL+ E+ G L L + T +A A GL +LH K
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---K 118
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLA 929
H D+ N LL +GD+GL+
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|185268 PRK15370, PRK15370, E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.003
Identities = 50/167 (29%), Positives = 76/167 (45%), Gaps = 21/167 (12%)
Query: 295 KLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSL 354
++ TL L +N L GN+K LY N+L +IP + + + E++LS N +
Sbjct: 200 QITTLILDNNELKSLPENLQGNIK---TLYANSNQLT-SIPATLPD--TIQEMELSINRI 253
Query: 355 NGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLT 414
E+P + L+ L LF N+++ + N LR L+ D SI L +P G HL
Sbjct: 254 T-ELPERLP--SALQSLDLFHNKISCLPENLPEELRYLSVYDNSIRTLPAHLPSGITHLN 310
Query: 415 QMRQLQLFENSLT---GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHL 458
+ NSLT +PPGL L + + L +PP L
Sbjct: 311 ------VQSNSLTALPETLPPGL---KTLEAGENALTSLPASLPPEL 348
|
Length = 754 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1078 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.98 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.98 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.98 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.98 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.98 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.98 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.98 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.98 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.98 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.98 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.98 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.98 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.98 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.98 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.98 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.98 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.98 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.97 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.97 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.97 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.97 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.97 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.97 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.97 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.97 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.97 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.97 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.97 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.97 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.97 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.97 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.97 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.97 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.97 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.97 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.97 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.97 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.97 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.97 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.97 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.97 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.97 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.97 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.97 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.97 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.97 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.96 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.96 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.95 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.95 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.94 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.93 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.93 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.92 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.92 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.91 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.9 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.89 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.89 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.88 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.86 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.83 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.8 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.77 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.76 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.76 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.75 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.75 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.74 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.74 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.7 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.69 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.66 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.64 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.62 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.62 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.61 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.58 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.57 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.52 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.51 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.49 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.49 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.48 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.34 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.31 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.31 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.28 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.25 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.22 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.18 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.14 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.14 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.1 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.09 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.08 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.08 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.07 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.02 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.01 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.01 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.98 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.94 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 98.93 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.86 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.86 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.83 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.79 | |
| PF08263 | 43 | LRRNT_2: Leucine rich repeat N-terminal domain; In | 98.77 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.74 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.62 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.62 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.6 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.57 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.47 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.42 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-112 Score=1099.38 Aligned_cols=900 Identities=36% Similarity=0.598 Sum_probs=646.1
Q ss_pred HHHHHHHHHHHHHHhhcCCCcchHHHHHHHHHhcccCCCCCCCccCCCCCCCcccceEeecCCCCcEEEEeCCCCccccc
Q 001434 38 VEIVGFWLVVMLLVCTTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGS 117 (1078)
Q Consensus 38 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~k~~~~~~~~~l~sW~~~~~~~C~w~Gv~C~~~~~~~v~~l~l~~~~l~g~ 117 (1078)
.+.+++++.+++..+.+...++|+.||++||+++.+|.+.+.+|... .+||.|.||+|+.. .+|+.+||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~w~~~-~~~c~w~gv~c~~~--~~v~~L~L~~~~i~~~ 84 (968)
T PLN00113 8 HCPYLIFMLFFLFLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSS-ADVCLWQGITCNNS--SRVVSIDLSGKNISGK 84 (968)
T ss_pred CCChHHHHHHHHHHHccCCCHHHHHHHHHHHHhCCCCcccCCCCCCC-CCCCcCcceecCCC--CcEEEEEecCCCcccc
Confidence 33334455555555555556789999999999999888889999754 47999999999853 5789999999999999
Q ss_pred CCCcccCCCccCeEecccCccccccCCCcc-CcCCCcEEEccCCccccccccccccCCCCceeccccccccCCCCccccC
Q 001434 118 LSPSIGGLVHLTYLDLAYNELTGYIPREIG-NCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGN 196 (1078)
Q Consensus 118 ~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~-~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~ 196 (1078)
+++.+..+++|+.|+|++|+++|.+|..+. .+++|++|+|++|.+++.+|. +.+++|++|+|++|.+++.+|..+++
T Consensus 85 ~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~ 162 (968)
T PLN00113 85 ISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGS 162 (968)
T ss_pred CChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhc
Confidence 999999999999999999999999997765 899999999999999888875 56788888888888887666555544
Q ss_pred CcchhHHhcccCcccccccccccCcccccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceee
Q 001434 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIV 276 (1078)
Q Consensus 197 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 276 (1078)
+++|++|++++|.+.+.+|..++++++|++|+|++|.+.+.+|..++.+++|++|+
T Consensus 163 ------------------------l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 218 (968)
T PLN00113 163 ------------------------FSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIY 218 (968)
T ss_pred ------------------------CCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEE
Confidence 45555555555555555555555555566666666665555666666666666666
Q ss_pred ecCCcccCCCCccccCccccceeeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCC
Q 001434 277 LWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356 (1078)
Q Consensus 277 L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~ 356 (1078)
|++|++++.+|..++++++|++|++++|++++.+|..++++++|++|+|++|.+.+.+|..+.++++|++|++++|.+.+
T Consensus 219 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~ 298 (968)
T PLN00113 219 LGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSG 298 (968)
T ss_pred CcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeecc
Confidence 66666666666666666666666666666666666666666666666666666666666666666677777777777766
Q ss_pred ccchhhhhhcccchhccccccccCCCCCccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccc
Q 001434 357 EIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGL 436 (1078)
Q Consensus 357 ~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 436 (1078)
.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|.+++.+|..+..+++|+.|++++|+
T Consensus 299 ~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~----------- 367 (968)
T PLN00113 299 EIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNN----------- 367 (968)
T ss_pred CCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCe-----------
Confidence 666667777777777777777777777777777788888887777776555544443333333332222
Q ss_pred cCcceEEEecCCCCCCCCCccccCCCccceeeeeeccccccCCcCCccccccceEEeecCCccCcccccccccccccccc
Q 001434 437 YSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIE 516 (1078)
Q Consensus 437 ~~~L~~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~ 516 (1078)
+++.+|..++.+ ++|+.|+
T Consensus 368 -------------l~~~~p~~~~~~------------------------------------------------~~L~~L~ 386 (968)
T PLN00113 368 -------------LTGEIPEGLCSS------------------------------------------------GNLFKLI 386 (968)
T ss_pred -------------eEeeCChhHhCc------------------------------------------------CCCCEEE
Confidence 222222222222 2233333
Q ss_pred cccccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccC
Q 001434 517 LDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVG 596 (1078)
Q Consensus 517 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 596 (1078)
+++|++.+.+|..+..+++|+.|++++|++++.+|..|..++.|++|++++|.+++.+|..+..+++|+.|+|++|++.+
T Consensus 387 l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~ 466 (968)
T PLN00113 387 LFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFG 466 (968)
T ss_pred CcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeee
Confidence 33333333444444444455555555555555555555555555555555555555555555556666666666666666
Q ss_pred CCCccccCcccCceeeccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccC
Q 001434 597 SLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELG 676 (1078)
Q Consensus 597 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~ 676 (1078)
.+|..++ .++|+.|++++|++++.+|..+.++++|+.|+|++|+++|.+|..++.++.|+ .|+|++|+++|.+|..++
T Consensus 467 ~~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~ 544 (968)
T PLN00113 467 GLPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLV-SLDLSHNQLSGQIPASFS 544 (968)
T ss_pred ecCcccc-cccceEEECcCCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCC-EEECCCCcccccCChhHh
Confidence 6665543 46777788888888777777777888888888888888888888888888887 688888888888888899
Q ss_pred cccccchhhcCCCcCcCCCChhhhhhcccccccccccccCCCCCCCcccCcccccccccCcCcCCCC----CCCCCCCCC
Q 001434 677 KLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRP----VGNCGASPS 752 (1078)
Q Consensus 677 ~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~p----~~~c~~s~~ 752 (1078)
.+++|+.|||++|+++|.+|..+.++++|+.+++++|+++|.+|..++|.++...++.||+++||.+ ...|.....
T Consensus 545 ~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~~~~ 624 (968)
T PLN00113 545 EMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKRVRK 624 (968)
T ss_pred CcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccCCCCCccccc
Confidence 9999999999999999999999999999999999999999999999999999999999999999864 234432110
Q ss_pred CCCC-C----------------------------CCCCcC-----CCC-------CCCCChHhHHHHhhcCCCccEEecc
Q 001434 753 SGSV-P----------------------------PLNNVY-----FPP-------KEGFSFQDVVEATYNFHDSFIVGSG 791 (1078)
Q Consensus 753 ~~~~-~----------------------------~~~~~~-----~~~-------~~~~~~~~~~~~~~~~~~~~~lG~G 791 (1078)
.... . ...... +.. ...+.+++ ....+...++||+|
T Consensus 625 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ig~G 701 (968)
T PLN00113 625 TPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSITIND---ILSSLKEENVISRG 701 (968)
T ss_pred cceeeeehhHHHHHHHHHHHHHHHHHHHHhhhcccccccccccccccccccccccchhhhHHH---HHhhCCcccEEccC
Confidence 0000 0 000000 000 00111222 23456677889999
Q ss_pred CceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHHhHhc
Q 001434 792 AYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLH 870 (1078)
Q Consensus 792 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 870 (1078)
+||.||+|++. +++.||||++...... ..+|++.+++++|||||++++++.+++..++||||+++|+|.++++
T Consensus 702 ~~g~Vy~~~~~~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~ 775 (968)
T PLN00113 702 KKGASYKGKSIKNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR 775 (968)
T ss_pred CCeeEEEEEECCCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh
Confidence 99999999974 6899999998654321 1246888999999999999999999999999999999999999996
Q ss_pred CCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccccccCcc
Q 001434 871 GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950 (1078)
Q Consensus 871 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~ 950 (1078)
.++|.++.+++.|+++|++|+|+.+.++|+||||||+||+++.++.+++. ||.+..... .....+++.|+
T Consensus 776 ----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----~~~~~~t~~y~ 845 (968)
T PLN00113 776 ----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----DTKCFISSAYV 845 (968)
T ss_pred ----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----CCCcccccccc
Confidence 37899999999999999999996656699999999999999999888875 665543221 12236789999
Q ss_pred cccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCC-CCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHH
Q 001434 951 APEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLD-DGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVL 1029 (1078)
Q Consensus 951 aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1029 (1078)
|||++.+..++.++|||||||++|||++|+.||.... .......|++....... ...+.++.+........+...++.
T Consensus 846 aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 924 (968)
T PLN00113 846 APETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH-LDMWIDPSIRGDVSVNQNEIVEVM 924 (968)
T ss_pred CcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc-hhheeCccccCCCCccHHHHHHHH
Confidence 9999999999999999999999999999999996432 33455566554332221 222334443332222234566788
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHhhcccC
Q 001434 1030 KVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 1030 ~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1060 (1078)
+++.+||+.||++||||+|+++.|+++....
T Consensus 925 ~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~ 955 (968)
T PLN00113 925 NLALHCTATDPTARPCANDVLKTLESASRSS 955 (968)
T ss_pred HHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence 9999999999999999999999999885533
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-61 Score=623.32 Aligned_cols=514 Identities=34% Similarity=0.536 Sum_probs=434.4
Q ss_pred cccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccC-cccccceeeecCCcccCCCCccccCccccceeee
Q 001434 223 NLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIG-MLESLTEIVLWDNQLTGFIPSELGNCTKLQTLAL 301 (1078)
Q Consensus 223 ~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L 301 (1078)
+++.|++++|.+++.++..|..+++|+.|+|++|++.+.+|..+. .+++|++|+|++|++++.+|. +.+++|++|+|
T Consensus 70 ~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~L 147 (968)
T PLN00113 70 RVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDL 147 (968)
T ss_pred cEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEEC
Confidence 566666666666666666666667777777777776666665543 667777777777777666653 34667777777
Q ss_pred cccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccccCC
Q 001434 302 YSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGV 381 (1078)
Q Consensus 302 s~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~ 381 (1078)
++|.+++.+|..++++++|++|+|++|.+.+.+|..++++++|++|+|++|.+.+.+|..++.+++|+.|++++|++++.
T Consensus 148 s~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 227 (968)
T PLN00113 148 SNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227 (968)
T ss_pred cCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCc
Confidence 77777777777777777777777777777777777777777777777777777777777777777777777777777777
Q ss_pred CCCccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCCCCCCCccccCC
Q 001434 382 IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN 461 (1078)
Q Consensus 382 ~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~~~~ 461 (1078)
+|..+..+++|++|++++|.+++.+|..|..+++|++|++++|++++.+|..+..++.|+.|++++|.+++.+|..+..+
T Consensus 228 ~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l 307 (968)
T PLN00113 228 IPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQL 307 (968)
T ss_pred CChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCC
Confidence 77777777778888888887777777777778888888888888877778778788888888888888888888888888
Q ss_pred CccceeeeeeccccccCCcCCccccccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccceeec
Q 001434 462 SNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHI 541 (1078)
Q Consensus 462 ~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 541 (1078)
++|+.|++++|.+.+.+|..+..+++|+.|++++|.+++.+|..++.+++|+.|++++|++++.+|..+..+++|+.|++
T Consensus 308 ~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l 387 (968)
T PLN00113 308 QNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLIL 387 (968)
T ss_pred CCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEEC
Confidence 89999999999998888888888999999999999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccCceeeccccccCCC
Q 001434 542 ANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN 621 (1078)
Q Consensus 542 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 621 (1078)
++|.+.+.+|..++.+++|+.|++++|++++.+|..+..++.|+.|++++|.+++.+|..+..+++|+.|+|++|++.|.
T Consensus 388 ~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~ 467 (968)
T PLN00113 388 FSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGG 467 (968)
T ss_pred cCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcCCCcCcCCCChhhhh
Q 001434 622 IPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFEN 701 (1078)
Q Consensus 622 ~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 701 (1078)
+|..++ .++|+.||+++|+++|.+|..+..++.|+ .|+|++|+++|.+|..++.+++|+.|+|++|+++|.+|..|.+
T Consensus 468 ~p~~~~-~~~L~~L~ls~n~l~~~~~~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 545 (968)
T PLN00113 468 LPDSFG-SKRLENLDLSRNQFSGAVPRKLGSLSELM-QLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSE 545 (968)
T ss_pred cCcccc-cccceEEECcCCccCCccChhhhhhhccC-EEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhC
Confidence 998764 58999999999999999999999999998 7999999999999999999999999999999999999999999
Q ss_pred hcccccccccccccCCCCCCC-cccCcccccccccCcCcC
Q 001434 702 LSSLLGSNFSYNNLTGPLPSI-PQFQNMDISSFLGNEGLC 740 (1078)
Q Consensus 702 l~~L~~l~ls~N~l~g~~p~~-~~~~~~~~~~~~~n~~lc 740 (1078)
++.|+.+++++|+++|.+|.. ..+..+....+.+|+..+
T Consensus 546 l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~ 585 (968)
T PLN00113 546 MPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHG 585 (968)
T ss_pred cccCCEEECCCCcccccCChhHhcCcccCEEeccCCccee
Confidence 999999999999999999953 444455555666776544
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=400.65 Aligned_cols=290 Identities=46% Similarity=0.765 Sum_probs=247.9
Q ss_pred CCCCCChHhHHHHhhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEee
Q 001434 766 PKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845 (1078)
Q Consensus 766 ~~~~~~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~ 845 (1078)
+...|++.++..++.+|...+.||+|+||.||+|...+|+.||||++....... .++|.+|++++.+++|||+|+++|
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlG 138 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLG 138 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEE
Confidence 456799999999999999999999999999999999988999999886655432 455999999999999999999999
Q ss_pred EEEecC-ceEEEEeeccCCCHHhHhcCCCC-CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEE
Q 001434 846 FCYHQG-SNLLIYEYMERGSLGELLHGSSC-NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 923 (1078)
Q Consensus 846 ~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 923 (1078)
||.+.+ +.++|||||++|+|.++++.... .++|.+|++||.++|+||+|||..+.+.|+||||||+|||+|++.++||
T Consensus 139 yC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl 218 (361)
T KOG1187|consen 139 YCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL 218 (361)
T ss_pred EEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence 999988 59999999999999999998776 8999999999999999999999998888999999999999999999999
Q ss_pred eecccccccCCCCCCccccc-ccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCC--CCCCHHHHHHHHh
Q 001434 924 GDFGLAKVIDMPQSKSMSAV-AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLD--DGGDLATWVRNYI 1000 (1078)
Q Consensus 924 ~Dfg~a~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~--~~~~~~~~~~~~~ 1000 (1078)
+|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||++.|++||+.|..... .......|+...+
T Consensus 219 sDFGLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~ 297 (361)
T KOG1187|consen 219 SDFGLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL 297 (361)
T ss_pred cCccCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence 999999765421 2222222 79999999999999999999999999999999999998887543 4445788887777
Q ss_pred hcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
... ....++|+++........+.+..+..++.+|++.+|++||+|.||++.|+.+...
T Consensus 298 ~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~ 355 (361)
T KOG1187|consen 298 EEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL 355 (361)
T ss_pred HCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence 766 4556778887632211115677799999999999999999999999999665443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=379.41 Aligned_cols=256 Identities=29% Similarity=0.437 Sum_probs=216.7
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-ceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-SNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~e~ 859 (1078)
++..+.||+|..|+||+++++ +++.+|+|++... ......+++.+|++++++.+||+||++|+.|+++. .+.|+|||
T Consensus 81 le~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 81 LERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred hhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 345567999999999999987 6888999999444 33456788999999999999999999999999998 49999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|++|+|++++...+ .+++....+++.+|++||.|||+ + +|+||||||+|||++..|.|||||||.++.+...
T Consensus 160 MDgGSLd~~~k~~g-~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRVG-RIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--- 232 (364)
T ss_pred cCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence 99999999988664 69999999999999999999996 5 9999999999999999999999999999987532
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCC-CCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPL-DDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
...+++||..|||||.+.+..|+.++||||||++++|+.+|+.||... ....+..+.+..+....++ +++..
T Consensus 233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP-------~lP~~ 305 (364)
T KOG0581|consen 233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPP-------RLPEG 305 (364)
T ss_pred hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCC-------CCCcc
Confidence 557789999999999999999999999999999999999999999865 3344555555555443221 11111
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
....++..++..|+++||.+|||+.|+++|-+-..
T Consensus 306 -----~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~ 340 (364)
T KOG0581|consen 306 -----EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK 340 (364)
T ss_pred -----cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence 23345788999999999999999999999876543
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=372.50 Aligned_cols=258 Identities=29% Similarity=0.356 Sum_probs=215.7
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCch-----hHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNN-----IESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
..|...+.+|+|+||.|-+|..+ +|+.||||++.+...... ....+.+|+++|++++||+||+++++|+..+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 35666778999999999999965 699999999987754321 223457999999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC---CceEEeeccccc
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAK 930 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~ 930 (1078)
||||||++||+|.+++-.++ .+.+.....+++|++.|+.|||++ ||+||||||+|||+..+ ..+||+|||+|+
T Consensus 252 YmVlE~v~GGeLfd~vv~nk-~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK 327 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANK-YLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAK 327 (475)
T ss_pred EEEEEEecCccHHHHHHhcc-ccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhh
Confidence 99999999999999998776 588888899999999999999999 99999999999999765 779999999999
Q ss_pred ccCCCCCCcccccccccCcccccccccCC---CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMK---VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1078)
... ....+.+.+|||.|.|||++.+.. +..+.|+||+||++|-+++|.+||..-.......+. +.
T Consensus 328 ~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ----I~------ 395 (475)
T KOG0615|consen 328 VSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ----IL------ 395 (475)
T ss_pred ccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH----Hh------
Confidence 876 566788899999999999998655 334789999999999999999999754433322222 11
Q ss_pred ccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1008 GIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
..++...+..|.+...+..++|.+|+..||++|||++|+++|-|-.
T Consensus 396 ---~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~ 441 (475)
T KOG0615|consen 396 ---KGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK 441 (475)
T ss_pred ---cCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence 2233334455566777888999999999999999999999998754
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=383.68 Aligned_cols=256 Identities=38% Similarity=0.579 Sum_probs=212.1
Q ss_pred ccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-ceEEEEeeccCC
Q 001434 785 SFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-SNLLIYEYMERG 863 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-~~~lv~e~~~~g 863 (1078)
.+.+|+|+||+||+|.++....||||++..........+.|.+|+.++.+++|||||++++++.+.. ..++||||+++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3449999999999999995555999999887655555789999999999999999999999998887 789999999999
Q ss_pred CHHhHhcC-CCCCCChhHHHHHHHHHHhhhhhhhccCCCc-eEecCCCCCcEEECCCC-ceEEeecccccccCCCCCCcc
Q 001434 864 SLGELLHG-SSCNLEWPTRFMIALGAAEGLAYLHHDCKPR-IFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 864 sL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
+|.++++. ....+++..++.|+.|||+|++|||++ + ||||||||+|||++.++ ++||+|||+++...... ...
T Consensus 126 sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~~~ 201 (362)
T KOG0192|consen 126 SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-TSM 201 (362)
T ss_pred cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeecccc-ccc
Confidence 99999988 366899999999999999999999999 7 99999999999999997 99999999998754221 344
Q ss_pred cccccccCcccccccc--cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 941 SAVAGSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
+...||+.|||||++. +..|+.|+|||||||++|||+||+.||..... ......+ .... ..+ .++..
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~~~~~~v---~~~~-~Rp-----~~p~~- 270 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-VQVASAV---VVGG-LRP-----PIPKE- 270 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-HHHHHHH---HhcC-CCC-----CCCcc-
Confidence 4478999999999999 66899999999999999999999999987655 2222222 1111 111 11111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccC
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1060 (1078)
....+..++.+||+.||++||++.+++..++.+....
T Consensus 271 -----~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~ 307 (362)
T KOG0192|consen 271 -----CPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHI 307 (362)
T ss_pred -----CCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhh
Confidence 2234678889999999999999999999999775433
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=380.89 Aligned_cols=253 Identities=28% Similarity=0.417 Sum_probs=217.7
Q ss_pred hcCCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..|..+++||+|+|+.||.+++ .+|+.||+|++.+... ....++++.+|+++.++|+|||||+++++|++.+.+|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999998 7899999999987543 3345788999999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+|+.++|.++++ .++.+++.+++.+++||+.|+.|||++ +|+|||||..|++++++.+|||+|||+|..+..+ .
T Consensus 98 ELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~-~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD-G 172 (592)
T ss_pred EecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCc-c
Confidence 9999999999998 445899999999999999999999999 9999999999999999999999999999988744 3
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
+...+.+|||.|+|||++.+..++..+||||+||++|.++.|++||+.. .+.+....+....... +..+
T Consensus 173 Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk----~vkety~~Ik~~~Y~~----P~~l--- 241 (592)
T KOG0575|consen 173 ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETK----TVKETYNKIKLNEYSM----PSHL--- 241 (592)
T ss_pred cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccc----hHHHHHHHHHhcCccc----cccc---
Confidence 4556789999999999999999999999999999999999999999743 3344444433322211 2222
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..+..+||.+++++||.+|||+++|+.+=.=
T Consensus 242 -------s~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 242 -------SAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred -------CHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 2335679999999999999999999987655
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=385.17 Aligned_cols=255 Identities=30% Similarity=0.449 Sum_probs=217.5
Q ss_pred CCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
+...+.||+|.||.||.|.++....||+|.++... ...++|.+|+++|++++|++||+++++|..++.++||||||+
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~---m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~ 284 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS---MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMP 284 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEeccc---cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecc
Confidence 34455699999999999999988899999996653 345788999999999999999999999999999999999999
Q ss_pred CCCHHhHhcC-CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 862 RGSLGELLHG-SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 862 ~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
.|+|.++++. .+..+...+.+.++.||++|++||+++ ++|||||.++||||+++..+||+|||+|+...++.....
T Consensus 285 ~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~ 361 (468)
T KOG0197|consen 285 KGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS 361 (468)
T ss_pred cCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeec
Confidence 9999999986 556899999999999999999999999 999999999999999999999999999996665555555
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
....-...|+|||.+..+.++.|+|||||||++|||+| |+.||..+...+.+..+.+++.... +.
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~--------P~------ 427 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR--------PE------ 427 (468)
T ss_pred CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC--------CC------
Confidence 55566778999999999999999999999999999999 9999987665544444433332211 11
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
.++..+++++..||+.+|++|||++.+...++++...
T Consensus 428 ---~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~ 464 (468)
T KOG0197|consen 428 ---GCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS 464 (468)
T ss_pred ---CCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence 2334578899999999999999999999999988553
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=362.86 Aligned_cols=201 Identities=30% Similarity=0.481 Sum_probs=183.7
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..+|...+.||+|+||+||+|+++ ++.+||||.+.+..-.....+.+..|+.+++.++|||||+++++++.++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 345666667999999999999976 5899999999888655666788899999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC------CceEEeecccccc
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK------FEAHVGDFGLAKV 931 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------~~~kl~Dfg~a~~ 931 (1078)
|||+||+|.+|+++.+ .+++..+..++.|++.|+++||++ +||||||||+|||++.. -.+||+|||+|+.
T Consensus 89 EyC~gGDLs~yi~~~~-~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRG-RLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EeCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 9999999999999887 799999999999999999999999 99999999999999864 4589999999998
Q ss_pred cCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQP 985 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~ 985 (1078)
+. ......+.+|++-|||||++..++|+.|+|+||+|+++|||++|+.||..
T Consensus 165 L~--~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a 216 (429)
T KOG0595|consen 165 LQ--PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDA 216 (429)
T ss_pred CC--chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccc
Confidence 86 44556778999999999999999999999999999999999999999964
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=351.76 Aligned_cols=267 Identities=22% Similarity=0.317 Sum_probs=221.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+...++|+|+||+||+|+++ +|+.||||++......+...+-..+|++++++++|+|+|.++++|......++|+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4666778999999999999977 599999999988877777778889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
++. ++.+-++......+...+.++++|+++|+.|+|++ +++||||||+|||++.+|.+|+||||+|+.+.. ....
T Consensus 83 ~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd~ 157 (396)
T KOG0593|consen 83 CDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGDN 157 (396)
T ss_pred cch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcC-Ccch
Confidence 987 77777787777899999999999999999999999 999999999999999999999999999998764 4566
Q ss_pred ccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH----------HHHhhcCCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV----------RNYIRDHSLTPG 1008 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~----------~~~~~~~~~~~~ 1008 (1078)
+...+.|.+|+|||.+.+ .+|++.+||||+||++.||++|.+-|.+..+-+++..++ .+.+...+...+
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 778889999999999887 679999999999999999999998887655444433332 223333333333
Q ss_pred cccCCC---CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRL---NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~---~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+.-+.. .+....+......+.+++++|++.||.+|++-++++.+
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H 284 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH 284 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence 221111 11223334445578899999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-46 Score=386.58 Aligned_cols=490 Identities=30% Similarity=0.437 Sum_probs=266.4
Q ss_pred CccCeEecccCccccccCCCccCcCCCcEEEccCCccccccccccccCCCCceeccccccccCCCCccccCCcchhHHhc
Q 001434 126 VHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVA 205 (1078)
Q Consensus 126 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~l 205 (1078)
.-++.|++++|.+. .+-+.+.+|..|++|++++|.++ +.|.+++.+..++.|+.++|+++ ++|+.++.+.+|+.+++
T Consensus 45 v~l~~lils~N~l~-~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~ 121 (565)
T KOG0472|consen 45 VDLQKLILSHNDLE-VLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDC 121 (565)
T ss_pred cchhhhhhccCchh-hccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhc
Confidence 34778888888887 44456778888888888888887 77888888888888888888887 66776666666666666
Q ss_pred ccCcccccccccccCcccccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCC
Q 001434 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285 (1078)
Q Consensus 206 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 285 (1078)
++|.+. ++|++++.+..|..++..+|+++ ..|+.+..+.+|..|++.+|++....|..+. ++.|++||...|-++ .
T Consensus 122 s~n~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-t 197 (565)
T KOG0472|consen 122 SSNELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-T 197 (565)
T ss_pred ccccee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-c
Confidence 666666 45555555555555555555555 4455555555555555555555533333332 555555555555554 3
Q ss_pred CCccccCccccceeeecccccccccccccccccccceeeccCCCCCCccCcccc-CcccccEEeccCCCCCCccchhhhh
Q 001434 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIG-NLSMVTEIDLSENSLNGEIPTEFSK 364 (1078)
Q Consensus 286 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~-~l~~L~~L~Ls~N~l~~~~~~~~~~ 364 (1078)
+|..++.+.+|+.|+|.+|.+. .+| .|.++..|++|+++.|+|. .+|++.+ +++++..|||..|+++ ..|+.+..
T Consensus 198 lP~~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRdNklk-e~Pde~cl 273 (565)
T KOG0472|consen 198 LPPELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICL 273 (565)
T ss_pred CChhhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccccccc-cCchHHHH
Confidence 4445555555555555555555 333 4555555555555555554 3443333 4555555555555555 34445555
Q ss_pred hcccchhccccccccCCCCCccccccccCeeeccCccccCCCCcccccc--cccceeEeeccccccCCCCcccccCcceE
Q 001434 365 ITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHL--TQMRQLQLFENSLTGGIPPGLGLYSLLWV 442 (1078)
Q Consensus 365 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l--~~L~~L~L~~N~l~~~~p~~~~~~~~L~~ 442 (1078)
+.+|++||+++|.|+ ..|.+++++ .|+.|-+.+|.+..+-.+.+..- .-|++|.= .++ .+.+... +.
T Consensus 274 LrsL~rLDlSNN~is-~Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs---~~~---~dglS~s---e~ 342 (565)
T KOG0472|consen 274 LRSLERLDLSNNDIS-SLPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRS---KIK---DDGLSQS---EG 342 (565)
T ss_pred hhhhhhhcccCCccc-cCCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHH---hhc---cCCCCCC---cc
Confidence 555555555555555 233444554 45555555554432110000000 00111100 000 0000000 00
Q ss_pred EEecCCCCCCCCCccccCCCccceeeeeeccccccCCcCCccccc---cceEEeecCCccCccccccccccccc-ccccc
Q 001434 443 VDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCET---LLQLRLVGNSLTGSFPLELCKLENLY-AIELD 518 (1078)
Q Consensus 443 Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~---L~~L~L~~N~l~~~~p~~l~~l~~L~-~L~Ls 518 (1078)
=..+.-.......+......+.+.|+++.-+++ .+|..++...+ ....+++.|++. .+|..+..+..+. .+.++
T Consensus 343 ~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt-~VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~ls 420 (565)
T KOG0472|consen 343 GTETAMTLPSESFPDIYAIITTKILDVSDKQLT-LVPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLS 420 (565)
T ss_pred cccccCCCCCCcccchhhhhhhhhhcccccccc-cCCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhh
Confidence 000000000000111122344555666655554 34444443333 555666666666 5566665555543 34444
Q ss_pred cccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCC
Q 001434 519 QNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSL 598 (1078)
Q Consensus 519 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 598 (1078)
+|.++ .+|..++.+++|..|+|++|.+. .+|.+++.+..|+.||+|.|+|. .+|..+..+..++.+-.++|++....
T Consensus 421 nn~is-fv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd 497 (565)
T KOG0472|consen 421 NNKIS-FVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVD 497 (565)
T ss_pred cCccc-cchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccC
Confidence 44443 66666666677777777666665 36666666666666666666665 45665555555666656666666444
Q ss_pred CccccCcccCceeeccccccCCCCCCccCCcccceEEeccCccCC
Q 001434 599 PNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFS 643 (1078)
Q Consensus 599 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 643 (1078)
|..+.++.+|.+|||.+|.+. .+|+.++++++|++|++++|+|.
T Consensus 498 ~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 498 PSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred hHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence 444666666666666666666 56666666666666666666666
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-46 Score=387.80 Aligned_cols=476 Identities=28% Similarity=0.393 Sum_probs=298.6
Q ss_pred cccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceeeecccccccccccccccccccc
Q 001434 242 ISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLT 321 (1078)
Q Consensus 242 l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~ 321 (1078)
+.++..|.+|++++|++. ..|.+++.+..++.|+.++|+++ .+|+.+..+.+|..|+.++|.+. .+|+.++.+-.|+
T Consensus 64 l~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~ 140 (565)
T KOG0472|consen 64 LKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLE 140 (565)
T ss_pred hhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhh
Confidence 344444444555555444 44445555555555555555555 34555555555555555555555 4444455555555
Q ss_pred eeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccccCCCCCccccccccCeeeccCcc
Q 001434 322 KLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINY 401 (1078)
Q Consensus 322 ~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~ 401 (1078)
.|+..+|+++ ..|+.+.++.+|..+++.+|++....|..+. ++.|++|+..+|-++ .+|..++.+.+|+.|+|.+|+
T Consensus 141 dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nk 217 (565)
T KOG0472|consen 141 DLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNK 217 (565)
T ss_pred hhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcc
Confidence 5555555555 4455555555555555555555533333333 555555555555554 344455555555555555555
Q ss_pred ccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCCCCCCCccccCCCccceeeeeeccccccCCcC
Q 001434 402 LTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTD 481 (1078)
Q Consensus 402 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~ 481 (1078)
+.. .| .|..+..|++|+++.|+|.....+....++++.+||+..|+++ ..|+.+|-+.+|++||+|+|.|+ ..|..
T Consensus 218 i~~-lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~s 293 (565)
T KOG0472|consen 218 IRF-LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYS 293 (565)
T ss_pred ccc-CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCccc-cCCcc
Confidence 552 23 4555555555555555555332233335555566666666665 56666666666666666666665 34555
Q ss_pred CccccccceEEeecCCccCcccccccc--cccccccc-------ccccc---c-cCCCcc----ccccccccceeecccc
Q 001434 482 VLNCETLLQLRLVGNSLTGSFPLELCK--LENLYAIE-------LDQNK---F-SGPIPP----EIENCQKLQRLHIANN 544 (1078)
Q Consensus 482 ~~~~~~L~~L~L~~N~l~~~~p~~l~~--l~~L~~L~-------Ls~N~---l-~~~~p~----~~~~l~~L~~L~L~~N 544 (1078)
++++ .|+.|.+.||.+..+--.-+.. -.-|++|. ++.-. - .+..|. ....+.+.+.|+++.-
T Consensus 294 Lgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~ 372 (565)
T KOG0472|consen 294 LGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDK 372 (565)
T ss_pred cccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhccccc
Confidence 6666 6666666666654211111111 00112221 11100 0 001111 1234567889999999
Q ss_pred ccccCCCcccCCccc---ccEEEeccccccCcCCccccccccccE-EeccCccccCCCCccccCcccCceeeccccccCC
Q 001434 545 YFTSELPKEVGNLSQ---LVTFNISSNMLTGLIPPEIVNCMTLQR-LDISHNSFVGSLPNELGTLQQLEILKLSENKFSG 620 (1078)
Q Consensus 545 ~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~~~p~~~~~l~~L~~-L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 620 (1078)
+++. +|+++..-.+ .+..+++.|++. .+|..+..+..+++ +++++|.+. -+|..++.+++|..|+|++|.+.
T Consensus 373 qlt~-VPdEVfea~~~~~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~is-fv~~~l~~l~kLt~L~L~NN~Ln- 448 (565)
T KOG0472|consen 373 QLTL-VPDEVFEAAKSEIVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKIS-FVPLELSQLQKLTFLDLSNNLLN- 448 (565)
T ss_pred cccc-CCHHHHHHhhhcceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccc-cchHHHHhhhcceeeecccchhh-
Confidence 9984 6776544444 778999999998 56888888877665 455555554 89999999999999999999998
Q ss_pred CCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcCCCcCcCCCChhhh
Q 001434 621 NIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFE 700 (1078)
Q Consensus 621 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 700 (1078)
.+|..++.+-.|+.||+|.|+|. .+|..+..+..++ .+-.++|++...-|..+.+|.+|..|||.+|.|. .||+.++
T Consensus 449 ~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE-tllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~Lg 525 (565)
T KOG0472|consen 449 DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE-TLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILG 525 (565)
T ss_pred hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH-HHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhc
Confidence 79999999999999999999999 9999999998887 5666778887444444999999999999999999 8999999
Q ss_pred hhcccccccccccccCCCCCCCcc--cCcccccccccCc
Q 001434 701 NLSSLLGSNFSYNNLTGPLPSIPQ--FQNMDISSFLGNE 737 (1078)
Q Consensus 701 ~l~~L~~l~ls~N~l~g~~p~~~~--~~~~~~~~~~~n~ 737 (1078)
++++|+++.+++|+++ .|.... -+|..+.+|.+++
T Consensus 526 nmtnL~hLeL~gNpfr--~Pr~~iLmkgT~aiL~ylrdr 562 (565)
T KOG0472|consen 526 NMTNLRHLELDGNPFR--QPRHQILMKGTAAILSYLRDR 562 (565)
T ss_pred cccceeEEEecCCccC--CCHHHHhccChHHHHHHhccc
Confidence 9999999999999998 443322 2455566666653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=350.85 Aligned_cols=251 Identities=26% Similarity=0.358 Sum_probs=211.2
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCch-hHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNN-IESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..++||+|+||+||.++.+ +++.||+|++++....+. ..+...+|..++.+++||+||+++-.|++.+..|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 35788899999999999999966 588999999988755433 4567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+.||.|...+++.+ .+++..+.-++..|+.||.|||++ ||||||+||+|||+|++|+++|+|||+++..- ...
T Consensus 105 d~~~GGeLf~hL~~eg-~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~-~~~ 179 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREG-RFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDL-KDG 179 (357)
T ss_pred eccCCccHHHHHHhcC-CcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcc-cCC
Confidence 9999999999999777 688888888889999999999999 99999999999999999999999999998543 234
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC-CCCCccccCCCCc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH-SLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 1016 (1078)
....+++||+.|||||++.+..|+.++|.||+|+++|||++|.+||.+ .+...+..++.... ...+.. +
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~----~~~~~~~~~I~~~k~~~~p~~----l-- 249 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYA----EDVKKMYDKILKGKLPLPPGY----L-- 249 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcC----ccHHHHHHHHhcCcCCCCCcc----C--
Confidence 455668999999999999999999999999999999999999999964 44555555555443 111111 1
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRP----SMREVVSML 1053 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RP----s~~ell~~L 1053 (1078)
.....+++.+.+..||++|. ++.++.+|-
T Consensus 250 --------s~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hp 282 (357)
T KOG0598|consen 250 --------SEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHP 282 (357)
T ss_pred --------CHHHHHHHHHHhccCHHHhcCCCCChHHhhcCc
Confidence 12256788999999999995 677766553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=340.66 Aligned_cols=258 Identities=22% Similarity=0.331 Sum_probs=210.5
Q ss_pred cCCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEee-EEEecC-ceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG-FCYHQG-SNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~-~~~~~~-~~~lv~ 857 (1078)
+|...+.||+|.||+||++.+ .+|..||.|.+.-.......+++...|+.++++++|||||++++ .+.++. ..+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 456667799999999999985 47999999999866566667888999999999999999999998 344444 489999
Q ss_pred eeccCCCHHhHhc---CCCCCCChhHHHHHHHHHHhhhhhhhccCCC-ceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 858 EYMERGSLGELLH---GSSCNLEWPTRFMIALGAAEGLAYLHHDCKP-RIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 858 e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~-~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
||+++|+|..+++ +..+.+++..+++++.|++.||.++|++... -|+||||||.||+++..|.||++|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 9999999999986 3445799999999999999999999994211 39999999999999999999999999999886
Q ss_pred CCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 934 MPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 934 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
.. .......+|||.||+||.+.+.+|+.|+||||+||++|||..-++||.+. .+....+++... +
T Consensus 180 s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~----n~~~L~~KI~qg----------d 244 (375)
T KOG0591|consen 180 SK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD----NLLSLCKKIEQG----------D 244 (375)
T ss_pred ch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc----cHHHHHHHHHcC----------C
Confidence 43 33455688999999999999999999999999999999999999999743 455555554332 2
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.++.++. .....+..+|..|+.+||+.||+...++..+..
T Consensus 245 ~~~~p~~--~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~ 284 (375)
T KOG0591|consen 245 YPPLPDE--HYSTDLRELINMCIAVDPEQRPDTVPYVQDIQS 284 (375)
T ss_pred CCCCcHH--HhhhHHHHHHHHHccCCcccCCCcchHHHHHHH
Confidence 2222322 345668889999999999999986555555443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=355.24 Aligned_cols=266 Identities=29% Similarity=0.387 Sum_probs=218.4
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 856 (1078)
..|+..+.||+|+||.||+|++. +|+.||+|++......++...-..+||.+|++++||||+++.+...+. ..+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 34566678999999999999964 699999999988877667777888999999999999999999998776 689999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
+|||+. +|.-++...+-.+++.++..++.|++.||+|||++ ||+|||||.+|||+|.+|.+||+|||+|+++....
T Consensus 197 FeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~ 272 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSG 272 (560)
T ss_pred Eecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCC
Confidence 999988 99999998877899999999999999999999999 99999999999999999999999999999988777
Q ss_pred CCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc-CCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD-TRL 1014 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 1014 (1078)
...+...+-|.+|.|||++.+. .|+.+.|+||+|||+.||++|++.|.+..+-+++..+.+ .-+.+.+..|. .++
T Consensus 273 ~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfk---lcGSP~e~~W~~~kL 349 (560)
T KOG0600|consen 273 SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFK---LCGSPTEDYWPVSKL 349 (560)
T ss_pred CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHH---HhCCCChhccccccC
Confidence 7778888899999999999875 599999999999999999999999987665444444321 11111111111 011
Q ss_pred C---------cch----hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1015 N---------VED----ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1015 ~---------~~~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+ ... +.+........+|+..+|..||.+|.||.++++.
T Consensus 350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 1 001 1112223447789999999999999999998864
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=325.27 Aligned_cols=267 Identities=24% Similarity=0.322 Sum_probs=214.8
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
++|...+.+|+|+||.||+|++. +|+.||||+++.....+.......+|++.++.++|+||+.++++|.+.+...+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 35667788999999999999964 79999999998887666667788999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
||+. +|...++.....++..++..++.++++|++|||++ .|+|||+||.|+|++.+|.+||+|||+|+.+..+...
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~ 157 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRI 157 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcc
Confidence 9986 99999998888999999999999999999999999 9999999999999999999999999999988644333
Q ss_pred cccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC---
Q 001434 939 SMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL--- 1014 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1014 (1078)
....+.|.+|+|||.+.+. .|+...||||+||++.|++-|.+-|.+.. ++.+...-+..-+-+.+..|+.-.
T Consensus 158 -~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s---DidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 158 -QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS---DIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred -cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc---hHHHHHHHHHHcCCCCcccCccccccc
Confidence 2333789999999998875 59999999999999999999876665433 333333322222222222211100
Q ss_pred --------C--cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1015 --------N--VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1015 --------~--~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
+ ....-+........+++.+|+..||.+|++++|++++=.
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~y 283 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPY 283 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchh
Confidence 0 000112233445689999999999999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=355.33 Aligned_cols=256 Identities=25% Similarity=0.334 Sum_probs=213.0
Q ss_pred HHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccC-CCCceeeEeeEEEecCc
Q 001434 776 VEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 776 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 852 (1078)
.....+|..++.||+|+|++|++|+.+ ++++||||++.+..... ...+-+.+|-..|.+| .||.|++++-.|+|+..
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 445567888899999999999999965 68999999997764432 2345567888889999 89999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
.|+|+||+++|+|.++|++.+ .+++..++.++.+|+.||+|||++ |||||||||+|||+|++++++|+|||.|+.+
T Consensus 149 LYFvLe~A~nGdll~~i~K~G-sfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYG-SFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhC-cchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccC
Confidence 999999999999999999886 799999999999999999999999 9999999999999999999999999999877
Q ss_pred CCCCCC----------c--ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHh
Q 001434 933 DMPQSK----------S--MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYI 1000 (1078)
Q Consensus 933 ~~~~~~----------~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 1000 (1078)
...... . ...++||..|.+||++.....++.+|+|+|||++|+|+.|++||.+..+--.+..++.-
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l-- 302 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL-- 302 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh--
Confidence 422111 1 24589999999999999999999999999999999999999999865543333322221
Q ss_pred hcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
+..+ .+.++ ..+.+|+.+.+..||.+|+|.++|.+|.
T Consensus 303 -~y~f-----p~~fp----------~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp 339 (604)
T KOG0592|consen 303 -DYEF-----PEGFP----------EDARDLIKKLLVRDPSDRLTSQQIKAHP 339 (604)
T ss_pred -cccC-----CCCCC----------HHHHHHHHHHHccCccccccHHHHhhCc
Confidence 1111 11111 3466899999999999999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=365.38 Aligned_cols=386 Identities=20% Similarity=0.212 Sum_probs=296.4
Q ss_pred cEEEcCCcccccccCCCcccc--cccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceeeec
Q 001434 225 RVFRAGQNAISGSIPAEISGC--QSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALY 302 (1078)
Q Consensus 225 ~~L~l~~n~l~~~~p~~l~~l--~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls 302 (1078)
+.|+++++.+....-..+.+. +.-+.||+++|++....+..|.++++|++++|.+|.++ .+|.......+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 346677776654433333322 34466999999999888888889999999999999998 678777777779999999
Q ss_pred ccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccccCCC
Q 001434 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVI 382 (1078)
Q Consensus 303 ~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 382 (1078)
+|.|+..-.+.+..++.|+.||||.|.|+...-..|..-.++++|+|++|+|+......|..+.+|..|.|+.|+|+...
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 99998877788888999999999999998444456777788999999999999888888999999999999999999888
Q ss_pred CCccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCCCCCCCccccCCC
Q 001434 383 PNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNS 462 (1078)
Q Consensus 383 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~~~~~ 462 (1078)
+..|.++++|+.|+|..|+|.-.--..|..+++|+.|.|..|.+.......|..+..+++|+|+.|+++..-..++.+++
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt 293 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT 293 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence 88899999999999999998844455789999999999999999988888888888888999999988888888888888
Q ss_pred ccceeeeeeccccccCCcCCccccccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccceeecc
Q 001434 463 NLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIA 542 (1078)
Q Consensus 463 ~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 542 (1078)
.|+.|+||+|.|..+-++...-+++|++|+|++|+|+...+.+|..|..|+.|.|++|+++..-...|..+++|++|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 88888888888888777777778888888888888887777788888888888888888876555667777777777777
Q ss_pred ccccccCCCc---ccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccCceee
Q 001434 543 NNYFTSELPK---EVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILK 612 (1078)
Q Consensus 543 ~N~l~~~~p~---~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 612 (1078)
+|.++..+.+ .|.+|++|+.|++.+|+|..+....|.++.+|+.|||.+|.|..+-|++|..+ .|+.|-
T Consensus 374 ~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv 445 (873)
T KOG4194|consen 374 SNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELV 445 (873)
T ss_pred CCeEEEEEecchhhhccchhhhheeecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhh
Confidence 7777765443 24455555555555555554444445555555555555555444444444444 444433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=354.99 Aligned_cols=265 Identities=21% Similarity=0.299 Sum_probs=214.2
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecC-ceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQG-SNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~-~~~lv 856 (1078)
.+|...+.||.|+||.||+|+.+ +++.||||++++.....+ ...-.||++.++++. |||||++.+++.+.+ ..|+|
T Consensus 10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 45677778999999999999955 689999999988866422 334468999999998 999999999999888 89999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
||||+. +|+++++.+++.+++..+..|+.||++||+|+|++ |+.|||+||+|||+.....+||+|||+|+.+. .
T Consensus 89 fE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~--S 162 (538)
T KOG0661|consen 89 FEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVR--S 162 (538)
T ss_pred HHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccc--c
Confidence 999975 99999998888999999999999999999999999 99999999999999988899999999999876 4
Q ss_pred CCcccccccccCcccccccc-cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc-----
Q 001434 937 SKSMSAVAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF----- 1010 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1010 (1078)
...+..++.|.+|+|||++. .+.|+.+.||||+||+++|+.+-++-|.+..+-+++..+..- + +.+....+
T Consensus 163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~V-L--GtP~~~~~~eg~~ 239 (538)
T KOG0661|consen 163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEV-L--GTPDKDSWPEGYN 239 (538)
T ss_pred CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHH-h--CCCccccchhHHH
Confidence 56677889999999999876 566999999999999999999999888766544444433211 1 00000000
Q ss_pred -----cCCCCcc-----hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1011 -----DTRLNVE-----DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1011 -----~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.-+++.. ..-+.....+..+++.+|+.+||.+||||+|++++--
T Consensus 240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pf 293 (538)
T KOG0661|consen 240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPF 293 (538)
T ss_pred HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence 1111111 1112234456789999999999999999999999863
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=345.20 Aligned_cols=261 Identities=30% Similarity=0.429 Sum_probs=208.4
Q ss_pred hcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC--ceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG--SNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~--~~~lv 856 (1078)
.++...+.||+|+||.||.+.... |+.+|||.+....... .+.+.+|+.++++++|||||++++.....+ .+++.
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEee
Confidence 456677789999999999999764 8999999997763322 667899999999999999999999754444 58999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEEeecccccccCC-
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDM- 934 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~- 934 (1078)
|||+++|+|.+++.+.+..+++..+..+.+||++||+|||++ |||||||||+|||++. ++.+||+|||.++....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 999999999999998766799999999999999999999999 9999999999999999 79999999999987652
Q ss_pred -CCCCcccccccccCcccccccccCC-CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 -PQSKSMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
..........||+.|||||++..+. ..+++||||+||++.||+||+.||... .....++-...... ..+.+ +.
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~-~~P~i-p~ 246 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGRED-SLPEI-PD 246 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccC-CCCCC-Cc
Confidence 2233345678999999999998643 345999999999999999999999753 22222222222221 11111 22
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccC
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1060 (1078)
. ......+++.+|+..+|++||||++++++........
T Consensus 247 ~----------ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 247 S----------LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred c----------cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 2 2233567899999999999999999999998765443
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=354.89 Aligned_cols=253 Identities=26% Similarity=0.333 Sum_probs=210.6
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
...|.....||+|+.|.||.|... +++.||||++..... ...+-+.+|+.+|+..+|+|||.+++.|...+..++||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q--~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQ--PKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccC--CchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 346666778999999999999854 588999999977654 33567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|||+||+|.|.+.... +++.++..|++++++||+|||.+ ||+|||||.+|||++.+|.+||+|||++..+....
T Consensus 350 Eym~ggsLTDvVt~~~--~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~- 423 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTKTR--MTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ- 423 (550)
T ss_pred eecCCCchhhhhhccc--ccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccccc-
Confidence 9999999999998765 99999999999999999999999 99999999999999999999999999998876433
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
....+.+|||+|||||++....|++|.||||+|++++||+-|++||..... + ..+.- +.....+.--..
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P---l-rAlyL-Ia~ng~P~lk~~------ 492 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP---L-RALYL-IATNGTPKLKNP------ 492 (550)
T ss_pred CccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh---H-HHHHH-HhhcCCCCcCCc------
Confidence 356678899999999999999999999999999999999999999974221 1 11111 111111111111
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
......+.+++.+|+..||++||++.|+++|-.
T Consensus 493 ----~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpF 525 (550)
T KOG0578|consen 493 ----EKLSPELKDFLDRCLVVDVEQRASAKELLEHPF 525 (550)
T ss_pred ----cccCHHHHHHHHHHhhcchhcCCCHHHHhcChh
Confidence 123345778999999999999999999998743
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=338.22 Aligned_cols=254 Identities=23% Similarity=0.360 Sum_probs=216.5
Q ss_pred hhcCCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCCCc-hhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
..+|+..+.+|+|.||+|-+|.. ..|+.||||.+.+..... ...-.+.+|+++|..+.||||+.+|++|+..+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 34555566799999999999995 679999999998876533 3455678999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||..+|.|+||+.+.+ .+++.++..+++||+.|+.|+|++ +++|||||.+|||+|+++++||+|||++-.+. .
T Consensus 132 MEYaS~GeLYDYiSer~-~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~--~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG-SLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYA--D 205 (668)
T ss_pred EEecCCccHHHHHHHhc-cccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhc--c
Confidence 99999999999999877 799999999999999999999999 99999999999999999999999999998875 5
Q ss_pred CCcccccccccCcccccccccCCCC-CcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
....++++|++-|.+||++.+.+|. +..|.||+||++|.+..|.+||++. +....++++-+.... .+.-+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~----Dhk~lvrQIs~GaYr-----EP~~P 276 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR----DHKRLVRQISRGAYR-----EPETP 276 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc----hHHHHHHHhhccccc-----CCCCC
Confidence 5667889999999999999999986 8999999999999999999999644 445555554433221 11111
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
.+ ..-+|++|+.++|++|.|..+|..|.|--+
T Consensus 277 Sd----------A~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 277 SD----------ASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ch----------HHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 11 345899999999999999999999997543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=353.69 Aligned_cols=258 Identities=24% Similarity=0.336 Sum_probs=214.9
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC---chhHHHHHHHHHHHccCC-CCceeeEeeEEEecCc
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG---NNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~ 852 (1078)
....|..++.||+|+||+|+.|.+. +++.||+|++.+.... ....+.+.+|+.++++++ ||||+++++++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 3457788889999999999999865 6899999977665221 233566779999999999 9999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC-CceEEeecccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKV 931 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~ 931 (1078)
.++||||+.||+|.+++.. ..++.+.++..+++|++.|++|||++ ||+||||||+||+++.+ +++||+|||++..
T Consensus 95 ~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAI 170 (370)
T ss_pred EEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccc
Confidence 9999999999999999998 44788899999999999999999999 99999999999999999 9999999999998
Q ss_pred cCCCCCCcccccccccCcccccccccCC-CC-CcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAYTMK-VT-EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
.. .......+.+|++.|+|||++.+.. |+ .++||||+||++|.|++|+.||.. .........+.......+..
T Consensus 171 ~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d----~~~~~l~~ki~~~~~~~p~~ 245 (370)
T KOG0583|consen 171 SP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD----SNVPNLYRKIRKGEFKIPSY 245 (370)
T ss_pred cC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC----ccHHHHHHHHhcCCccCCCC
Confidence 74 3456677889999999999999877 86 889999999999999999999975 33344444433332222111
Q ss_pred ccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
+. ..++..++.+|+..||.+|+|+.+++++=|-..
T Consensus 246 ~~-------------S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 246 LL-------------SPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred cC-------------CHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 11 234678999999999999999999997776544
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=348.78 Aligned_cols=250 Identities=24% Similarity=0.383 Sum_probs=217.3
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
++|...+.||+|.||.||+|+.+ +.+.||+|.+.+....+...+.+.+|++++++++|||||.++++|+...+.++|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 35777788999999999999976 57889999999887777778889999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+.| +|..++...+ .++++.+..++.+++.||.|||+. +|.|||+||+||+++..|.+|+||||+|+.... ...
T Consensus 82 ~a~g-~L~~il~~d~-~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~ 155 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG-KLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTS 155 (808)
T ss_pred hhhh-hHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhccc-Cce
Confidence 9987 9999998776 799999999999999999999999 999999999999999999999999999997753 334
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
....+.|||-|||||++.+++|+..+|+||+||++||+++|++||. ...+.+.++.+..+.. +++.
T Consensus 156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~----a~si~~Lv~~I~~d~v--------~~p~-- 221 (808)
T KOG0597|consen 156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFY----ARSITQLVKSILKDPV--------KPPS-- 221 (808)
T ss_pred eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCch----HHHHHHHHHHHhcCCC--------CCcc--
Confidence 4566889999999999999999999999999999999999999996 3455566666555422 1111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.....+..++...+.+||.+|.|..+++.|-
T Consensus 222 ----~~S~~f~nfl~gLL~kdP~~RltW~~Ll~Hp 252 (808)
T KOG0597|consen 222 ----TASSSFVNFLQGLLIKDPAQRLTWTDLLGHP 252 (808)
T ss_pred ----cccHHHHHHHHHHhhcChhhcccHHHHhcCh
Confidence 2233466788888999999999999999874
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=351.87 Aligned_cols=253 Identities=25% Similarity=0.355 Sum_probs=217.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEeccc-CCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASN-REGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.|+.++.+|.|+.|.|..|++. +|+.+|||++.+. ...+.....+.+|+-+|+-+.||||+++|+++++..+.|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 4566778999999999999965 7999999999877 3444556788999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|++||.|++++-.++ .+++.++++++.||+.|+.|+|+. +|+|||+||+|+|+|..+++||+|||+|..-. ...
T Consensus 93 yv~gGELFdylv~kG-~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gk 166 (786)
T KOG0588|consen 93 YVPGGELFDYLVRKG-PLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGK 166 (786)
T ss_pred ecCCchhHHHHHhhC-CCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc--CCc
Confidence 999999999998877 688899999999999999999998 99999999999999999999999999997632 455
Q ss_pred cccccccccCcccccccccCCCC-CcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
-..+.||.++|.|||++.+.+|+ .++||||+||++|.+++|+.||. ++.+.....+..+....++ -
T Consensus 167 lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd----DdNir~LLlKV~~G~f~MP----s----- 233 (786)
T KOG0588|consen 167 LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD----DDNIRVLLLKVQRGVFEMP----S----- 233 (786)
T ss_pred cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC----CccHHHHHHHHHcCcccCC----C-----
Confidence 66788999999999999999986 79999999999999999999996 4556666555544432221 1
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
....+..+|+.+|+.+||++|.|++||++|.+-..
T Consensus 234 -----~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g 268 (786)
T KOG0588|consen 234 -----NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSG 268 (786)
T ss_pred -----cCCHHHHHHHHHHhccCccccccHHHHhhCchhhc
Confidence 11233568999999999999999999999988653
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=333.03 Aligned_cols=262 Identities=22% Similarity=0.333 Sum_probs=210.3
Q ss_pred hcCCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
..|+...+||.|..++||+|+. +.++.||||++.-+..... .+.+.+|++.|+.++||||++++..|..+...|+||+
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 3566667899999999999995 4689999999987776544 6789999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 859 YMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||.+|++.+.+... ...+++..+..|.+++++||.|||++ |.+|||||+.|||++.+|.|||+|||.+..+.....
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 99999999999754 34699999999999999999999999 999999999999999999999999998765432221
Q ss_pred C---cccccccccCccccccccc--CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 938 K---SMSAVAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 938 ~---~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
+ ....+.||+.|||||++.. ..|+.|+||||||++..|+.+|..||.....-.. .... +...++.. .
T Consensus 182 R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv---Ll~t-Lqn~pp~~---~- 253 (516)
T KOG0582|consen 182 RQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV---LLLT-LQNDPPTL---L- 253 (516)
T ss_pred eeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH---HHHH-hcCCCCCc---c-
Confidence 1 1156789999999998543 4699999999999999999999999975543222 1122 11111111 1
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
......+........+.+++..|+.+||++|||+++++++-
T Consensus 254 t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~ 294 (516)
T KOG0582|consen 254 TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHA 294 (516)
T ss_pred cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccH
Confidence 11122233334455788999999999999999999999864
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=357.09 Aligned_cols=369 Identities=20% Similarity=0.179 Sum_probs=312.8
Q ss_pred ccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceeeecc
Q 001434 224 LRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303 (1078)
Q Consensus 224 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 303 (1078)
-+.|++++|+++...+..|.++++|++++|..|.++ .+|...+...+|+.|+|.+|.|+..-.+.++.++.|+.||||.
T Consensus 80 t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLSr 158 (873)
T KOG4194|consen 80 TQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLSR 158 (873)
T ss_pred eeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhhh
Confidence 356888888888888888888888888888888887 6777666667788888888888877778888888888888888
Q ss_pred cccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccccCCCC
Q 001434 304 NNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIP 383 (1078)
Q Consensus 304 N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p 383 (1078)
|.|+...-..|..-.++++|+|++|+|+......|.++.+|..|.|+.|+++...+..|.++++|+.|+|..|+|.-+--
T Consensus 159 N~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ 238 (873)
T KOG4194|consen 159 NLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEG 238 (873)
T ss_pred chhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeehh
Confidence 88885544556666778888888888887777788888888888888888887777888888888888888888875545
Q ss_pred CccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCCCCCCCccccCCCc
Q 001434 384 NELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSN 463 (1078)
Q Consensus 384 ~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~~~~~~ 463 (1078)
-.|.++++|+.|.|..|.+.......|..+.++++|+|..|+++.....++..++.|+.||+|+|.|..+-++...-.++
T Consensus 239 ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftqk 318 (873)
T KOG4194|consen 239 LTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQK 318 (873)
T ss_pred hhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhccc
Confidence 67888888888888888888887888888888999999999888888888888888999999999998888888888889
Q ss_pred cceeeeeeccccccCCcCCccccccceEEeecCCccCcccccccccccccccccccccccCCCcc---ccccccccceee
Q 001434 464 LIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPP---EIENCQKLQRLH 540 (1078)
Q Consensus 464 L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L~ 540 (1078)
|++|+|++|+|+..-+..|..+..|++|.|++|+|......+|..+++|+.|||++|.|+..+.+ .|..+++|+.|+
T Consensus 319 L~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~ 398 (873)
T KOG4194|consen 319 LKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLR 398 (873)
T ss_pred ceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhee
Confidence 99999999999888888888899999999999999888888899999999999999999876644 467799999999
Q ss_pred ccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccc
Q 001434 541 IANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSF 594 (1078)
Q Consensus 541 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 594 (1078)
+.+|++..+.-.+|.++..|++|||.+|.|..+-|..|..+ .|++|.+..-.|
T Consensus 399 l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk~Lv~nSssf 451 (873)
T KOG4194|consen 399 LTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELKELVMNSSSF 451 (873)
T ss_pred ecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhhhhhhcccce
Confidence 99999998777899999999999999999999999999998 899988765443
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=343.80 Aligned_cols=249 Identities=27% Similarity=0.388 Sum_probs=209.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.|...+.||+|.||.||+|.+. +++.||+|++.-.... ...+++.+|+.++.+++++||.++|+.+..+...+++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 4555577999999999999965 6889999999776553 4467899999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+.||++.+.++... .+++.++..++++++.|+.|+|.+ +.+|||||+.||++..+|.||++|||++..........
T Consensus 93 ~~gGsv~~lL~~~~-~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr 168 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGN-ILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR 168 (467)
T ss_pred hcCcchhhhhccCC-CCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhcc
Confidence 99999999998766 458888888999999999999999 99999999999999999999999999998876444443
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.+++||+.|||||++....|+.|+||||+|++.+||++|.+|+...+....+..+ ++..++..+
T Consensus 169 -~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI---------------pk~~PP~L~ 232 (467)
T KOG0201|consen 169 -KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI---------------PKSAPPRLD 232 (467)
T ss_pred -ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec---------------cCCCCCccc
Confidence 7889999999999999889999999999999999999999999866542211110 111111111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
. .....+.+++..|+++||+.||+|.++++|
T Consensus 233 ~--~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 233 G--DFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred c--ccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 1 333457789999999999999999999875
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=319.27 Aligned_cols=247 Identities=23% Similarity=0.325 Sum_probs=203.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.+|.|+||+|..++.+ +|..||+|++.+...- -...+...+|..+++.+.||+++++++.+.+.+..|||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4677788999999999999976 5889999999776432 2234567889999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|++||.|..++++.+ .+++..++-++.||+.|++|||+. +|++||+||+|||+|.+|.+||+|||+|+... .
T Consensus 125 yv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----~ 196 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----G 196 (355)
T ss_pred ccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEec----C
Confidence 999999999999877 689999999999999999999999 99999999999999999999999999999865 2
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
..-+.+|||.|+|||.+....|..++|.|||||++|||+.|.+||.+... ..+..++....-- ++..+.
T Consensus 197 rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~----~~iY~KI~~~~v~----fP~~fs--- 265 (355)
T KOG0616|consen 197 RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP----IQIYEKILEGKVK----FPSYFS--- 265 (355)
T ss_pred cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh----HHHHHHHHhCccc----CCcccC---
Confidence 25678999999999999999999999999999999999999999975443 3333333332211 122222
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCC-----CCHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDR-----PSMREVVSML 1053 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~R-----Ps~~ell~~L 1053 (1078)
..+.+|+.+.+++|-.+| +...+|..|-
T Consensus 266 -------~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~ 298 (355)
T KOG0616|consen 266 -------SDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHP 298 (355)
T ss_pred -------HHHHHHHHHHHhhhhHhhhcCcCCCccccccCc
Confidence 225567788888888888 3444555443
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=369.44 Aligned_cols=256 Identities=28% Similarity=0.436 Sum_probs=212.1
Q ss_pred CCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
....+.||+|+||+||+|+.. +...||||.++..... ...++|++|++++..++|||||+++|.|.+++..+|
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~-~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN-QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH-HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 344556999999999999843 3567999999877653 357899999999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCC-------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceE
Q 001434 856 IYEYMERGSLGELLHGSS-------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 922 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 922 (1078)
|+|||..|+|.+++.... ..++..+.+.||.|||.|++||-++ .+|||||..+|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEE
Confidence 999999999999996321 1378889999999999999999999 999999999999999999999
Q ss_pred EeecccccccCCCCCCccc-ccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHh
Q 001434 923 VGDFGLAKVIDMPQSKSMS-AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYI 1000 (1078)
Q Consensus 923 l~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 1000 (1078)
|+|||+++..-..+..+.. ...-..+|||||.+..++|+.++|||||||++||+++ |+.||.+..+.+.+..+..+..
T Consensus 644 IsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l 723 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL 723 (774)
T ss_pred ecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc
Confidence 9999999865433333322 4455789999999999999999999999999999999 9999987766554444322221
Q ss_pred hcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
. . .+ .+.+.++++|+..||+..|++||+++||-..|+....
T Consensus 724 -----L----~-----~P---e~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 724 -----L----S-----CP---ENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred -----c----c-----CC---CCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 1 1 11 1344568899999999999999999999999987744
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=347.26 Aligned_cols=275 Identities=29% Similarity=0.414 Sum_probs=219.9
Q ss_pred hHHHHhhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 774 DVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 774 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
++...-.++...+.||+|.||+||+|.|.+ .||||++......++..+.|+.|+..+++-+|.||+=+.|||..+..
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~- 462 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL- 462 (678)
T ss_pred ccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-
Confidence 333334455667789999999999999873 59999999888888889999999999999999999999999988776
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
.||+-+|+|-+|+.+++..+..+++.+.+.|++||++|+.|||.+ +|+|||||..||++.+++.|||+|||++..-.
T Consensus 463 AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 463 AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeee
Confidence 999999999999999998888999999999999999999999999 99999999999999999999999999996532
Q ss_pred C-CCCCcccccccccCccccccccc---CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCH-HHHHHHHhhcCCCCCc
Q 001434 934 M-PQSKSMSAVAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL-ATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 934 ~-~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~-~~~~~~~~~~~~~~~~ 1008 (1078)
. ..........|...|||||++.. .+|+..+||||||+++|||++|..||. ....+.+ ...-++
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG---------- 608 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRG---------- 608 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEeccc----------
Confidence 1 12233444567889999999863 469999999999999999999999998 3222221 111111
Q ss_pred cccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccC---CCCCCCCC
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE---GRFNSSPT 1068 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~---~~~~~~~~ 1068 (1078)
+..++.. ....+..+++.+|+..||..++++||.+.+|+..|+++.... .++++.|.
T Consensus 609 ~l~pd~s---~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~~pki~RS~S~P~ 668 (678)
T KOG0193|consen 609 YLMPDLS---KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPSLPKINRSASEPV 668 (678)
T ss_pred ccCccch---hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhcccccccCcCccc
Confidence 1111111 111244567889999999999999999999999888875533 44444443
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=318.01 Aligned_cols=267 Identities=24% Similarity=0.286 Sum_probs=215.2
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe--cCceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv 856 (1078)
.+|+..+.|++|+||+||+|+++ +++.||+|+++.........-.-.+|+.++.+.+|||||.+.++... -+.+|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 45677778999999999999976 68899999999887666666677899999999999999999998754 4678999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
||||+. +|..+++..++++...++.-++.|+++|++|||++ .|+|||||++|+|++..|.+||+|||+|+.+..+
T Consensus 156 Me~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp- 230 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSP- 230 (419)
T ss_pred HHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence 999988 99999999888999999999999999999999999 9999999999999999999999999999998744
Q ss_pred CCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC---
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT--- 1012 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 1012 (1078)
...+...+-|.+|+|||++.+. .|+.+.|+||+||++.|++++++-|.+..+-.++..+.+ ..+.+...+|+.
T Consensus 231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~---llGtPte~iwpg~~~ 307 (419)
T KOG0663|consen 231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFK---LLGTPSEAIWPGYSE 307 (419)
T ss_pred cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHH---HhCCCccccCCCccc
Confidence 4556777889999999998875 599999999999999999999998876554444443322 222222222211
Q ss_pred -------CCCcchhh-----HHH--HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1013 -------RLNVEDES-----IVD--HMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1013 -------~~~~~~~~-----~~~--~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.++..+.. +.. ....-++++...+..||++|-||+|.+++=+
T Consensus 308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~ 363 (419)
T KOG0663|consen 308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEY 363 (419)
T ss_pred cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccc
Confidence 11111100 001 1134568889999999999999999998754
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=334.71 Aligned_cols=264 Identities=23% Similarity=0.280 Sum_probs=206.6
Q ss_pred HHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC------------chhHHHHHHHHHHHccCCCCceee
Q 001434 776 VEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG------------NNIESSFRAEILTLGKIRHRNIVK 842 (1078)
Q Consensus 776 ~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------------~~~~~~~~~e~~~l~~l~h~~iv~ 842 (1078)
....++|+..+.||+|.||.|-+|++. +++.||||++.+.... -...++..+|+.+|++++|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 345678888889999999999999976 5899999999765211 112368899999999999999999
Q ss_pred EeeEEEe--cCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCc
Q 001434 843 LYGFCYH--QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE 920 (1078)
Q Consensus 843 l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 920 (1078)
++++..+ .+.+|||+|||..|.+...-.... .+...++++++++++.||+|||.+ ||+||||||+|+|++++|+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~-els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKP-ELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcc-cccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCc
Confidence 9999876 467899999999887765422221 389999999999999999999999 9999999999999999999
Q ss_pred eEEeecccccccCCC----CCCcccccccccCcccccccccCC----CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCH
Q 001434 921 AHVGDFGLAKVIDMP----QSKSMSAVAGSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992 (1078)
Q Consensus 921 ~kl~Dfg~a~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~ 992 (1078)
|||+|||.+...... ........+|||.|+|||...++. .+.+.||||+||++|+++.|+.||.+...
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~---- 324 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE---- 324 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH----
Confidence 999999999866321 122234478999999999987733 34789999999999999999999974332
Q ss_pred HHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 993 ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
.+...++... +. .++..+ +....+.++|++++.+||++|-+..+|..|.|..+..
T Consensus 325 ~~l~~KIvn~-pL-------~fP~~p----e~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 325 LELFDKIVND-PL-------EFPENP----EINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred HHHHHHHhcC-cc-------cCCCcc----cccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 2222222221 11 111111 2234467899999999999999999999999987663
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=376.34 Aligned_cols=444 Identities=30% Similarity=0.352 Sum_probs=269.0
Q ss_pred cCcccccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccce
Q 001434 219 GNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQT 298 (1078)
Q Consensus 219 ~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 298 (1078)
.+.-+|+.|++++|+++ .+|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|.|.+|++. ..|..+..+++|+.
T Consensus 42 ~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~ 118 (1081)
T KOG0618|consen 42 EKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQY 118 (1081)
T ss_pred hheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccc
Confidence 33445888888888887 77888888888888888888887 66777888888888888888887 67888888888888
Q ss_pred eeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccc
Q 001434 299 LALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQL 378 (1078)
Q Consensus 299 L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 378 (1078)
||+|.|.+. .+|..+..++.++.+..++|..... ++... ++.+++..|.+.+.++..+..++. .|+|+.|.+
T Consensus 119 LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~ 190 (1081)
T KOG0618|consen 119 LDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEM 190 (1081)
T ss_pred cccchhccC-CCchhHHhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchh
Confidence 888888887 7788888888888888888822212 22222 777888888887777777776666 678888877
Q ss_pred cCCCCCccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCCCCCCCccc
Q 001434 379 TGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHL 458 (1078)
Q Consensus 379 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~ 458 (1078)
. . -.+..+++|+.|.+..|+++... -..++|+.|+.++|.++...+. .....|+++|+|+|++++ +|+++
T Consensus 191 ~-~--~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~--p~p~nl~~~dis~n~l~~-lp~wi 260 (1081)
T KOG0618|consen 191 E-V--LDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVH--PVPLNLQYLDISHNNLSN-LPEWI 260 (1081)
T ss_pred h-h--hhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeeccc--cccccceeeecchhhhhc-chHHH
Confidence 6 2 24566777888888888776321 1235666666666666622221 122345555555555553 33555
Q ss_pred cCCCccceeeeeeccccccCCcCCccccccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccce
Q 001434 459 CQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQR 538 (1078)
Q Consensus 459 ~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 538 (1078)
+.+.+|+.|+..+|+| + .+|..+...++|+.|.+.+|.++ .+|+..+.++.|+.
T Consensus 261 ~~~~nle~l~~n~N~l------------------------~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~t 314 (1081)
T KOG0618|consen 261 GACANLEALNANHNRL------------------------V-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRT 314 (1081)
T ss_pred HhcccceEecccchhH------------------------H-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeee
Confidence 5555555555555555 2 44444445555555555555554 44555555555555
Q ss_pred eeccccccccCCCcccCCccc-ccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccCceeeccccc
Q 001434 539 LHIANNYFTSELPKEVGNLSQ-LVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENK 617 (1078)
Q Consensus 539 L~L~~N~l~~~~p~~~~~l~~-L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 617 (1078)
|+|..|+|....+..|.-+.. |..|+.+.|++....-..=.....|+.|++.+|.|+...-..+.+...|++|+|++|+
T Consensus 315 LdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNr 394 (1081)
T KOG0618|consen 315 LDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNR 394 (1081)
T ss_pred eeehhccccccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccc
Confidence 555555554322222222222 4555555555554322222234455556666666655444445555556666666666
Q ss_pred cCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcCCCcCcCC-CC
Q 001434 618 FSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGE-IP 696 (1078)
Q Consensus 618 l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~-ip 696 (1078)
|.......+.++..|++|+||+|+|+ .+|.++..+..|+ .|...+|++. ..| ++.++++|+++|||.|+|+-. +|
T Consensus 395 L~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~-tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~ 470 (1081)
T KOG0618|consen 395 LNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH-TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLP 470 (1081)
T ss_pred cccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH-HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhh
Confidence 55222234455556666666666665 5566666666665 4555556555 455 555666666666666666532 22
Q ss_pred hhhhhhcccccccccccc
Q 001434 697 SAFENLSSLLGSNFSYNN 714 (1078)
Q Consensus 697 ~~~~~l~~L~~l~ls~N~ 714 (1078)
... --+.|++||||+|.
T Consensus 471 ~~~-p~p~LkyLdlSGN~ 487 (1081)
T KOG0618|consen 471 EAL-PSPNLKYLDLSGNT 487 (1081)
T ss_pred hhC-CCcccceeeccCCc
Confidence 221 11455666666655
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=315.59 Aligned_cols=257 Identities=22% Similarity=0.269 Sum_probs=210.9
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..++||+|.|+.||++.+. +|+.+|+|.+......+...+++.+|+.+-+.++||||+++.+.+......|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 34566667999999999999865 69999999998776666678899999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC---CCceEEeecccccccCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~ 935 (1078)
+|+|++|..-|-... ..++..+-..++||++|+.|+|.+ +|||||+||+|+++-. ...+|++|||+|..+.
T Consensus 91 ~m~G~dl~~eIV~R~-~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-- 164 (355)
T KOG0033|consen 91 LVTGGELFEDIVARE-FYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-- 164 (355)
T ss_pred cccchHHHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeC--
Confidence 999999987664332 567788888999999999999999 9999999999999953 4569999999999876
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
.........|||+|||||++.+.+|+..+|||+.||++|-++.|.+||.+. +...+..++......
T Consensus 165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~----~~~rlye~I~~g~yd---------- 230 (355)
T KOG0033|consen 165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE----DQHRLYEQIKAGAYD---------- 230 (355)
T ss_pred CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhccccC----------
Confidence 445566788999999999999999999999999999999999999999743 333333333332211
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....|.....+..+++++|+..||.+|.|+.|.+.|-|-.
T Consensus 231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~ 271 (355)
T KOG0033|consen 231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWIC 271 (355)
T ss_pred CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhc
Confidence 11112223334466899999999999999999999877643
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=322.38 Aligned_cols=283 Identities=25% Similarity=0.344 Sum_probs=220.3
Q ss_pred HHHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe----
Q 001434 775 VVEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH---- 849 (1078)
Q Consensus 775 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~---- 849 (1078)
.+.....|...+.||+|+||.|+.|.++ +|+.||||++..........++..+|++.++.++|+||+.+.+.+..
T Consensus 17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~ 96 (359)
T KOG0660|consen 17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD 96 (359)
T ss_pred EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence 3344455666778999999999999976 68999999998777777778899999999999999999999998865
Q ss_pred -cCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccc
Q 001434 850 -QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 850 -~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 928 (1078)
-..+|+|+|+|+ .+|.+.++... .++..++..+++|+++|+.|+|+. +|+|||+||+|++++.+..+||+|||+
T Consensus 97 ~f~DvYiV~elMe-tDL~~iik~~~-~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 97 KFNDVYLVFELME-TDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ccceeEEehhHHh-hHHHHHHHcCc-cccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccc
Confidence 346799999995 49999988665 599999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCC-CCCcccccccccCcccccccc-cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHH-----------
Q 001434 929 AKVIDMP-QSKSMSAVAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATW----------- 995 (1078)
Q Consensus 929 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~----------- 995 (1078)
|+..+.. ....++..+.|.+|.|||+.. ...|+.+.||||+||++.||++|++-|.+.+.-.++..+
T Consensus 172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~ 251 (359)
T KOG0660|consen 172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED 251 (359)
T ss_pred eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence 9987532 234456778899999999875 457999999999999999999999988764432222221
Q ss_pred --------HHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH--HhhcccCCCCCC
Q 001434 996 --------VRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML--IESNEREGRFNS 1065 (1078)
Q Consensus 996 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L--~~~~~~~~~~~~ 1065 (1078)
++.+++..+..+.. +. ...+........+++.+|+..||.+|+|++|+++|- ...+....+|..
T Consensus 252 l~~i~s~~ar~yi~slp~~p~~-----~f-~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP~~ 325 (359)
T KOG0660|consen 252 LQKIRSEKARPYIKSLPQIPKQ-----PF-SSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEPVC 325 (359)
T ss_pred HHHhccHHHHHHHHhCCCCCCC-----CH-HHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCCCC
Confidence 12233322211111 00 111112223467899999999999999999999874 566666666544
Q ss_pred CCC
Q 001434 1066 SPT 1068 (1078)
Q Consensus 1066 ~~~ 1068 (1078)
.+.
T Consensus 326 ~~~ 328 (359)
T KOG0660|consen 326 QPI 328 (359)
T ss_pred CCC
Confidence 433
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=346.02 Aligned_cols=261 Identities=27% Similarity=0.375 Sum_probs=211.8
Q ss_pred hcCCCccEEeccCceEEEEEEECC--C---cEEEEEEeccc-CCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS--G---KIVAVKKLASN-REGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~--~---~~vavK~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.+....++||+|+||.||+|..+. + ..||||..+.. ........++.+|+++|++++|||||++||++..+...
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455789999999999999653 2 23899999863 34566788999999999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++|||+|.||+|.+++++.+..++..++..++.+.|+||+|||++ +++||||.++|+|++.++.+||+|||+++...
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 999999999999999998887899999999999999999999999 99999999999999999999999999987643
Q ss_pred CCCCCccc-ccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 934 MPQSKSMS-AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 934 ~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
...... ...-..+|+|||.+..+.|+.++|||||||++||+++ |..||.+....+....++.+.++.
T Consensus 314 --~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~--------- 382 (474)
T KOG0194|consen 314 --QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRM--------- 382 (474)
T ss_pred --ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccC---------
Confidence 111111 1235678999999999999999999999999999999 899998665442222221221111
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCC
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1061 (1078)
..+. .....+..++.+||..+|++||+|.++.+.++.+.....
T Consensus 383 -~~~~------~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~ 425 (474)
T KOG0194|consen 383 -PIPS------KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE 425 (474)
T ss_pred -CCCC------CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence 1111 122346678889999999999999999999998855544
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=333.30 Aligned_cols=258 Identities=24% Similarity=0.294 Sum_probs=208.0
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
...+|+..++||+|+||.||.|+.+ +|+.||+|++++... .....+-+..|-.+|...++|.||+++-.|++.+..|+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4467888889999999999999966 699999999988743 23345677889999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC-
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM- 934 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~- 934 (1078)
||||++||++..++.+.+ .+++..+..++.+++-||+.+|+. |++||||||+|+|+|..|++||+|||++.-+..
T Consensus 219 iMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 999999999999999877 789999999999999999999999 999999999999999999999999999853321
Q ss_pred ---------------------CCCC-----c-------------------ccccccccCcccccccccCCCCCcCcchhH
Q 001434 935 ---------------------PQSK-----S-------------------MSAVAGSYGYIAPEYAYTMKVTEKCDIYSY 969 (1078)
Q Consensus 935 ---------------------~~~~-----~-------------------~~~~~gt~~y~aPE~~~~~~~~~~~Dvwsl 969 (1078)
.... . .-..+|||.|+|||++.+..|+..+|.||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 0 012679999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC---H
Q 001434 970 GVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS---M 1046 (1078)
Q Consensus 970 Gv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~ 1046 (1078)
||++|||+.|.+||...+..+....++.... .-..+. ... ...+..++|.+|+. ||+.|.. +
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~-~l~fP~-----~~~--------~s~eA~DLI~rll~-d~~~RLG~~G~ 439 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRE-TLKFPE-----EVD--------LSDEAKDLITRLLC-DPENRLGSKGA 439 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh-hccCCC-----cCc--------ccHHHHHHHHHHhc-CHHHhcCcccH
Confidence 9999999999999986554444444333221 111111 111 11446789999999 9999985 7
Q ss_pred HHHHHHHH
Q 001434 1047 REVVSMLI 1054 (1078)
Q Consensus 1047 ~ell~~L~ 1054 (1078)
+||.+|-+
T Consensus 440 ~EIK~HPf 447 (550)
T KOG0605|consen 440 EEIKKHPF 447 (550)
T ss_pred HHHhcCCc
Confidence 77777654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=345.30 Aligned_cols=259 Identities=25% Similarity=0.421 Sum_probs=202.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec-C
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ-G 851 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~-~ 851 (1078)
.+|+..+.||+|+||.||+|.+. +++.||+|++..... ....+.+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT-ASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc-hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46777889999999999999742 356899999875432 23356788999999999 899999999988764 4
Q ss_pred ceEEEEeeccCCCHHhHhcCCC----------------------------------------------------------
Q 001434 852 SNLLIYEYMERGSLGELLHGSS---------------------------------------------------------- 873 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 873 (1078)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 5789999999999999986432
Q ss_pred ---CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-CcccccccccCc
Q 001434 874 ---CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGY 949 (1078)
Q Consensus 874 ---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y 949 (1078)
..+++.++..++.||++||+|||++ +|+||||||+||++++++.+||+|||+++....... .......+++.|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 1367788899999999999999998 999999999999999999999999999986532211 122234567889
Q ss_pred ccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHH
Q 001434 950 IAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILV 1028 (1078)
Q Consensus 950 ~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 1028 (1078)
+|||.+.+..++.++||||||+++|||++ |..||.......... ......... ..+. .....+
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~----~~~~~~~~~------~~~~------~~~~~l 306 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFC----QRLKDGTRM------RAPE------NATPEI 306 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHH----HHHhcCCCC------CCCC------CCCHHH
Confidence 99999999999999999999999999997 999997544322211 112111110 0000 112347
Q ss_pred HHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1029 LKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1029 ~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
.+++.+||+.||++|||+.++++.|+++..
T Consensus 307 ~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 307 YRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 789999999999999999999999998744
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-37 Score=366.84 Aligned_cols=255 Identities=31% Similarity=0.463 Sum_probs=211.4
Q ss_pred cCCCccEEeccCceEEEEEEEC--CCc----EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD--SGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
..+..+.||+|+||.||.|... .+. .||||.+.+... .+...+|.+|+.+|+.++|||||+++|++-+....+
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 4455667999999999999854 233 589999977654 345789999999999999999999999999999999
Q ss_pred EEEeeccCCCHHhHhcCC------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccc
Q 001434 855 LIYEYMERGSLGELLHGS------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 928 (1078)
|++|||+||+|..++++. ...++..+.+.++.|||+|+.||+++ ++|||||.++|+|++....|||+|||+
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccch
Confidence 999999999999999877 55789999999999999999999999 999999999999999999999999999
Q ss_pred ccc-cCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 929 AKV-IDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 929 a~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
|+. ++.+.........-...|||||.+..+.++.|+|||||||++||+++ |..||......+.+..+..+- ...
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg----RL~ 924 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG----RLD 924 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC----ccC
Confidence 994 33333333333344568999999999999999999999999999999 999998766554444343332 111
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.+ ..+...++++|.+||+.+|++||++..+++.+..+
T Consensus 925 ----~P---------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i 961 (1025)
T KOG1095|consen 925 ----PP---------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAI 961 (1025)
T ss_pred ----CC---------CCCChHHHHHHHHHccCChhhCccHHHHHhhhhhh
Confidence 11 12334578999999999999999999999988776
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=336.03 Aligned_cols=268 Identities=22% Similarity=0.296 Sum_probs=206.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|+||.||+|+++ +++.||+|++..........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEY 81 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEec
Confidence 5777889999999999999986 578899999977654445567788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
++++.+..+.. ....+++..+..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||.+..........
T Consensus 82 ~~~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (287)
T cd07848 82 VEKNMLELLEE-MPNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157 (287)
T ss_pred CCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence 99876665544 334689999999999999999999998 99999999999999999999999999998765333333
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH----------HhhcCCCCCcc
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN----------YIRDHSLTPGI 1009 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~----------~~~~~~~~~~~ 1009 (1078)
.....|++.|+|||.+.+..++.++||||+||++|||++|+.||............... ...........
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 44567899999999999888999999999999999999999999754322211111100 00000000000
Q ss_pred ccCCC----CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1010 FDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1010 ~~~~~----~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
..+.. .............+.+++.+|++.||++|||++++++|
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h 284 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 00000 00000011123458899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=308.98 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=216.3
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC------chhHHHHHHHHHHHccC-CCCceeeEeeEEEec
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG------NNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ 850 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~ 850 (1078)
-.+|..++.+|+|..++|.++.++ +|.++|+|++...... .+..+.-.+|+.+++++ .||+|+++.++++.+
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 346777888999999999999865 6889999998654322 22345667899999998 699999999999999
Q ss_pred CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 851 GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
...++|+|.|+.|.|+|++...- .+++.+..++++|+.+|++|+|.+ +|||||+||+|||+|++.+++|+|||+|+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V-tlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~ 171 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV-TLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFAC 171 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe-eecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceee
Confidence 99999999999999999998765 789999999999999999999999 99999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCcccccccc------cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAY------TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
.+. ...+....+|||+|+|||.+. ...|+...|+||+||++|.++.|.+||.... .-.+-..
T Consensus 172 ~l~--~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk-----QmlMLR~----- 239 (411)
T KOG0599|consen 172 QLE--PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK-----QMLMLRM----- 239 (411)
T ss_pred ccC--CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH-----HHHHHHH-----
Confidence 876 556777899999999999875 3458899999999999999999999996211 1111111
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
++..+.....+.|.+......++|.+|++.||.+|.|++|+++|-+-
T Consensus 240 ----ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff 286 (411)
T KOG0599|consen 240 ----IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF 286 (411)
T ss_pred ----HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence 22344555566677778888999999999999999999999998654
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=335.10 Aligned_cols=239 Identities=30% Similarity=0.452 Sum_probs=199.9
Q ss_pred EEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHH
Q 001434 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~ 866 (1078)
-+|.|+.|.||.|+.+ ++.||||+++.-+ ..+++-|++|+||||+.+.++|.....++||||||+.|-|.
T Consensus 131 WlGSGaQGAVF~Grl~-netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 131 WLGSGAQGAVFLGRLH-NETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhccCcccceeeeecc-CceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 3899999999999988 7899999995443 25788899999999999999999999999999999999999
Q ss_pred hHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccccc
Q 001434 867 ELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS 946 (1078)
Q Consensus 867 ~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 946 (1078)
..++..+ .+.....+.|..+||.|+.|||.+ .|||||||.=||||+.+..|||+|||-++..... .....++||
T Consensus 201 ~VLka~~-~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--STkMSFaGT 274 (904)
T KOG4721|consen 201 EVLKAGR-PITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--STKMSFAGT 274 (904)
T ss_pred HHHhccC-ccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--hhhhhhhhh
Confidence 9998765 788899999999999999999999 9999999999999999999999999999876532 334468999
Q ss_pred cCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHH
Q 001434 947 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMI 1026 (1078)
Q Consensus 947 ~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1026 (1078)
..|||||++...+.+.|+||||||||+|||+||..||.+.+....++..-.+.. .-.++ ..+.+
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL----------~LpvP------stcP~ 338 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL----------HLPVP------STCPD 338 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc----------cccCc------ccCch
Confidence 999999999999999999999999999999999999986553322221111100 01111 12223
Q ss_pred HHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1027 LVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1027 ~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
-+.-|+++||+..|..||++.+++.||+-..
T Consensus 339 GfklL~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 339 GFKLLLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 3556899999999999999999999997553
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=302.02 Aligned_cols=253 Identities=26% Similarity=0.350 Sum_probs=212.8
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
..+|+.++.+|+|.||.||.|+.+ ++-.||+|++.+.... .....++.+|+++-+.++||||.++|++|.++...|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 345788899999999999999965 6788999999776432 23467889999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 857 YEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
+||..+|++...++..+ ..+++.....++.|+|.|+.|+|.+ +|+||||||+|+|++..+..|++|||.+...+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 175 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC--
Confidence 99999999999998443 3688899999999999999999998 99999999999999999999999999998754
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
.....+.+||..|.|||+..+..++.+.|+|++|++.||++.|.+||......+....+ .+. +..++
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI----~k~--------~~~~p 242 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRI----RKV--------DLKFP 242 (281)
T ss_pred -CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHH----HHc--------cccCC
Confidence 44556789999999999999999999999999999999999999999865533332222 221 11111
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
........++|.+|+..+|.+|.+..|+.++-|-
T Consensus 243 ------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI 276 (281)
T KOG0580|consen 243 ------STISGGAADLISRLLVKNPIERLALTEVMDHPWI 276 (281)
T ss_pred ------cccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence 1122346689999999999999999999998774
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=369.96 Aligned_cols=506 Identities=28% Similarity=0.352 Sum_probs=296.0
Q ss_pred EecccCccccccCCCccCcCCCcEEEccCCccccccccccccCCCCceeccccccccCCCCccccCCcchhHHhcccCcc
Q 001434 131 LDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNL 210 (1078)
Q Consensus 131 L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~l~~n~l 210 (1078)
+|++.+++. .||..+-.-..++.|+++.|.+-...-+.+.+.-+|+.||+++|+++ .+|..+..+.+|+.|+++.|.+
T Consensus 3 vd~s~~~l~-~ip~~i~~~~~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i 80 (1081)
T KOG0618|consen 3 VDASDEQLE-LIPEQILNNEALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYI 80 (1081)
T ss_pred cccccccCc-ccchhhccHHHHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhH
Confidence 455555555 55655555455777777777654222223334445777777777765 5555555555555555555444
Q ss_pred cccccccccCcccccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccc
Q 001434 211 TGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSEL 290 (1078)
Q Consensus 211 ~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l 290 (1078)
. ..|.+++++++|++|.|..|.+. ..|..+..+.+|++|++++|++. .+ |..+
T Consensus 81 ~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~------------------------Pl~i 133 (1081)
T KOG0618|consen 81 R-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSFNHFG-PI------------------------PLVI 133 (1081)
T ss_pred h-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccchhccC-CC------------------------chhH
Confidence 4 33455555666666666655555 45555555555555555555554 34 4444
Q ss_pred cCccccceeeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccch
Q 001434 291 GNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRL 370 (1078)
Q Consensus 291 ~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~ 370 (1078)
..++.++.++.++|..... ++... ++.++|..|.+.+.++..+.+++. .|||++|.+. ...+..+.+|+.
T Consensus 134 ~~lt~~~~~~~s~N~~~~~----lg~~~-ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~---~~dls~~~~l~~ 203 (1081)
T KOG0618|consen 134 EVLTAEEELAASNNEKIQR----LGQTS-IKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME---VLDLSNLANLEV 203 (1081)
T ss_pred HhhhHHHHHhhhcchhhhh----hcccc-chhhhhhhhhcccchhcchhhhhe--eeecccchhh---hhhhhhccchhh
Confidence 4445555555555521111 11111 455555555555555544444443 4555555554 123444555555
Q ss_pred hccccccccCCCCCccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCC
Q 001434 371 LFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYL 450 (1078)
Q Consensus 371 L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l 450 (1078)
|....|++... -..-++|+.|+.++|.++...+. + .-.+|++++++.|++++ +|+++..+.+|+.++..+|+|
T Consensus 204 l~c~rn~ls~l----~~~g~~l~~L~a~~n~l~~~~~~-p-~p~nl~~~dis~n~l~~-lp~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 204 LHCERNQLSEL----EISGPSLTALYADHNPLTTLDVH-P-VPLNLQYLDISHNNLSN-LPEWIGACANLEALNANHNRL 276 (1081)
T ss_pred hhhhhcccceE----EecCcchheeeeccCcceeeccc-c-ccccceeeecchhhhhc-chHHHHhcccceEecccchhH
Confidence 55555555522 12235566666666666522111 1 12356666666666663 346677777777777777777
Q ss_pred CCCCCccccCCCccceeeeeeccccccCCcCCccccccceEEeecCCccCccccccccccc-ccccccccccccCCCcc-
Q 001434 451 TGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLEN-LYAIELDQNKFSGPIPP- 528 (1078)
Q Consensus 451 ~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~-L~~L~Ls~N~l~~~~p~- 528 (1078)
+ .+|..+....+|+.|++.+|.++ .+|....+.+.|+.|+|..|+|....+..+..+.. |..|+.+.|+++. .|.
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~-lp~~ 353 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLST-LPSY 353 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhccccc-cccc
Confidence 4 67777777788888888888886 45666677788888888888887444444444443 7777778787763 331
Q ss_pred ccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccC
Q 001434 529 EIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQL 608 (1078)
Q Consensus 529 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 608 (1078)
.=..++.|+.|++.+|.++...-..+.+...|+.|+|++|+|.......+.++..|+.|+||+|+++ .+|..+..+..|
T Consensus 354 ~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L 432 (1081)
T KOG0618|consen 354 EENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRL 432 (1081)
T ss_pred cchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhh
Confidence 1124456777778888777766666677777777777777777655556667777777777777776 667777777777
Q ss_pred ceeeccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcCC
Q 001434 609 EILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNN 688 (1078)
Q Consensus 609 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~ 688 (1078)
++|...+|++. ..| .+..++.|+.+|+|.|.|+-. .+|..... ++|++|||++
T Consensus 433 ~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~------------------------~l~~~~p~-p~LkyLdlSG 485 (1081)
T KOG0618|consen 433 HTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEV------------------------TLPEALPS-PNLKYLDLSG 485 (1081)
T ss_pred HHHhhcCCcee-ech-hhhhcCcceEEecccchhhhh------------------------hhhhhCCC-cccceeeccC
Confidence 77777777776 556 666777777777777776611 11111111 4677777777
Q ss_pred CcCcCCCChhhhhhccccccccccc
Q 001434 689 NHLSGEIPSAFENLSSLLGSNFSYN 713 (1078)
Q Consensus 689 N~l~g~ip~~~~~l~~L~~l~ls~N 713 (1078)
|.-.-.-...|..+.++..+++.-|
T Consensus 486 N~~l~~d~~~l~~l~~l~~~~i~~~ 510 (1081)
T KOG0618|consen 486 NTRLVFDHKTLKVLKSLSQMDITLN 510 (1081)
T ss_pred CcccccchhhhHHhhhhhheecccC
Confidence 7633223344555555555555544
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=334.67 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=218.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc-eEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS-NLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~-~~lv~ 857 (1078)
.+|...+++|+|+||.++.++++ ++..|++|++.-.......++...+|+.++++++|||||.+.+.|++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 35777888999999999999876 57899999998887777777789999999999999999999999999998 89999
Q ss_pred eeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 858 EYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
+|++||++.+.+.+.. ..++++++..|+.|++.|+.|||++ .|+|||||+.||+++.++.|+++|||+|+....+.
T Consensus 84 ~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~ 160 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED 160 (426)
T ss_pred eecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCch
Confidence 9999999999997655 5799999999999999999999988 99999999999999999999999999999886433
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......||+.|++||.+.+.+|+.|+||||+||++|||++-+++|.+. +....+.++.+.... +
T Consensus 161 -~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~----~m~~Li~ki~~~~~~----------P 225 (426)
T KOG0589|consen 161 -SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS----NMSELILKINRGLYS----------P 225 (426)
T ss_pred -hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc----chHHHHHHHhhccCC----------C
Confidence 3556789999999999999999999999999999999999999999744 445555554443211 1
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.+. ....++..+|..|+..+|+.||++.+++.+.
T Consensus 226 lp~---~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P 259 (426)
T KOG0589|consen 226 LPS---MYSSELRSLVKSMLRKNPEHRPSALELLRRP 259 (426)
T ss_pred CCc---cccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence 111 2334577899999999999999999999874
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=331.65 Aligned_cols=253 Identities=25% Similarity=0.315 Sum_probs=203.2
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|+..+.||+|+||+||+|.+. +++.||+|++...... ......+.+|++++++++|++|+++++++.+++..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 556778999999999999965 6899999998765332 22345678899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++|+|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||++..... ..
T Consensus 82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05631 82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE--GE 156 (285)
T ss_pred cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC--CC
Confidence 9999999887643 23688999999999999999999998 999999999999999999999999999986532 22
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|+..|+|||.+.+..++.++||||+||++|||++|+.||.................... ..+..
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~------ 226 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQ----EEYSE------ 226 (285)
T ss_pred eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhccc----ccCCc------
Confidence 23445789999999999999999999999999999999999999986544322222222211110 00011
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPS-----MREVVSML 1053 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L 1053 (1078)
.....+.+++.+||+.||++||+ +++++++-
T Consensus 227 ----~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~ 262 (285)
T cd05631 227 ----KFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHP 262 (285)
T ss_pred ----cCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCH
Confidence 11234678999999999999997 89999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=340.11 Aligned_cols=244 Identities=25% Similarity=0.331 Sum_probs=203.2
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 855 (1078)
..+|...+++|+|.||+|+.|..+ +++.||||++++... ..+..+..+.|.+++... +||.++.++..|+..++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 456788889999999999999977 588999999998754 344567788888887766 59999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+.||++..+.+. +.+++..+.-++..|+.||.|||++ ||||||||.+|||+|.+|.+||+|||+++..- .
T Consensus 447 vmey~~Ggdm~~~~~~--~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m-~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT--DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM-G 520 (694)
T ss_pred EEEecCCCcEEEEEec--ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccC-C
Confidence 9999999995444433 3599999999999999999999999 99999999999999999999999999998642 2
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
.....++++|||.|+|||++.+..|+.++|.|||||++|||+.|+.||.+.++++.+..++ .+....+.
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~----~d~~~yP~------- 589 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV----NDEVRYPR------- 589 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh----cCCCCCCC-------
Confidence 3446788999999999999999999999999999999999999999998766555444432 22222221
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSM 1046 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1046 (1078)
....+...++.+++.++|++|..+
T Consensus 590 -------~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 590 -------FLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -------cccHHHHHHHHHHhccCcccccCC
Confidence 122345678899999999999955
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=323.62 Aligned_cols=252 Identities=24% Similarity=0.316 Sum_probs=219.8
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|.|++|-.|++- +|+.||||++.+.+...-....+.+|++-|+-++|||||++|++...+...|+|+|.-
T Consensus 20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELG 99 (864)
T KOG4717|consen 20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELG 99 (864)
T ss_pred ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEec
Confidence 444556999999999999865 7999999999998876666778899999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEE-CCCCceEEeecccccccCCCCCCc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL-DDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
++|+|++||-+....+.+.-+.++++||+.|+.|+|+. .+|||||||+||.+ ..-|-||+.|||++-.+. ...+
T Consensus 100 D~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--PG~k 174 (864)
T KOG4717|consen 100 DGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--PGKK 174 (864)
T ss_pred CCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCC--Ccch
Confidence 99999999988877899999999999999999999998 99999999999877 567899999999998765 5567
Q ss_pred ccccccccCcccccccccCCCC-CcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
..+.+|+..|.|||++.+..|+ ++.||||+||++|.+.+|++||+...+.+.+..+ +|.+....
T Consensus 175 L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmI--------------mDCKYtvP- 239 (864)
T KOG4717|consen 175 LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMI--------------MDCKYTVP- 239 (864)
T ss_pred hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhh--------------hcccccCc-
Confidence 7889999999999999999998 7899999999999999999999877666554432 34444332
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+..++|..|+..||++|.+.++|...-|--
T Consensus 240 ---shvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq 274 (864)
T KOG4717|consen 240 ---SHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQ 274 (864)
T ss_pred ---hhhhHHHHHHHHHHHhcCchhhccHHHHhcccccc
Confidence 24556788999999999999999999999876643
|
|
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=346.54 Aligned_cols=371 Identities=28% Similarity=0.417 Sum_probs=315.4
Q ss_pred cccccEEeccCCCCC-CccchhhhhhcccchhccccccccCCCCCccccccccCeeeccCccccCCCCccccccccccee
Q 001434 341 LSMVTEIDLSENSLN-GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQL 419 (1078)
Q Consensus 341 l~~L~~L~Ls~N~l~-~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L 419 (1078)
++-.+-.|+++|.++ +..|.....+++++.|.|...++. .+|+.++.+.+|+.|.+++|++. .+-..+..++.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 444566677777776 456777777777777777777776 56777777777777777777776 344556777777888
Q ss_pred Eeeccccc-cCCCCcccccCcceEEEecCCCCCCCCCccccCCCccceeeeeeccccccCCcCCccccccceEEeecCCc
Q 001434 420 QLFENSLT-GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSL 498 (1078)
Q Consensus 420 ~L~~N~l~-~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l 498 (1078)
.+..|++. ..+|..+..+..|.+||||+|+++ ..|..+...+++.+|+||+|+|..+.-.-|.+++.|..|+|++|++
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence 88888775 456777778888999999999998 7899999999999999999999865555677899999999999999
Q ss_pred cCcccccccccccccccccccccccCCCccccccccccceeeccccccc-cCCCcccCCcccccEEEeccccccCcCCcc
Q 001434 499 TGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT-SELPKEVGNLSQLVTFNISSNMLTGLIPPE 577 (1078)
Q Consensus 499 ~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~ 577 (1078)
. .+|..+..|..|++|+|++|.+...--..+..+++|+.|++++.+=+ .-+|.++..+.+|..+|+|.|.+. .+|+.
T Consensus 163 e-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec 240 (1255)
T KOG0444|consen 163 E-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC 240 (1255)
T ss_pred h-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence 8 77888999999999999999987554556777889999999987644 348999999999999999999998 67999
Q ss_pred ccccccccEEeccCccccCCCCccccCcccCceeeccccccCCCCCCccCCcccceEEeccCccCCC-CCCccccCchhH
Q 001434 578 IVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG-EIPPELGDLSSL 656 (1078)
Q Consensus 578 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g-~ip~~l~~l~~l 656 (1078)
+.++.+|++|+||+|+|+ .+.-..+...+|++|+||.|+++ .+|.++..|+.|+.|++.+|+++- -||+.+|+|..|
T Consensus 241 ly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L 318 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL 318 (1255)
T ss_pred HhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence 999999999999999998 66777788899999999999999 899999999999999999999984 499999999999
Q ss_pred HHHHhcccccccCCCCcccCcccccchhhcCCCcCcCCCChhhhhhcccccccccccccCCCCCC
Q 001434 657 QIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPS 721 (1078)
Q Consensus 657 ~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~ 721 (1078)
. .+..++|++. ..|+.++.+..|+.|.|++|.|. ..|.++--|+.|+.||+..|.---.+|.
T Consensus 319 e-vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnLVMPPK 380 (1255)
T KOG0444|consen 319 E-VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNLVMPPK 380 (1255)
T ss_pred H-HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCccCCCC
Confidence 9 6999999998 89999999999999999999999 8999999999999999999986555553
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=316.04 Aligned_cols=255 Identities=21% Similarity=0.255 Sum_probs=213.2
Q ss_pred hcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..|+..+.||+|.-|+||.|..++ +..+|+|++.+.... .....+...|-++|+.++||.++.+|..|+.++..++||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 345566779999999999999874 689999999877543 334567788999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC--
Q 001434 858 EYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM-- 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~-- 934 (1078)
|||+||+|..+++++. +.+++..++-++..|+-||+|||-. |||+|||||+|||+.++|++.++||+++.....
T Consensus 157 eyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~~P 233 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP 233 (459)
T ss_pred ecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence 9999999999998664 4788899999999999999999998 999999999999999999999999998843310
Q ss_pred -------------------------------C-C---------------------CCcccccccccCcccccccccCCCC
Q 001434 935 -------------------------------P-Q---------------------SKSMSAVAGSYGYIAPEYAYTMKVT 961 (1078)
Q Consensus 935 -------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~~~ 961 (1078)
. . ......++||-+|+|||++.+..++
T Consensus 234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg 313 (459)
T KOG0610|consen 234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG 313 (459)
T ss_pred eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence 0 0 0112236799999999999999999
Q ss_pred CcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCC
Q 001434 962 EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPF 1041 (1078)
Q Consensus 962 ~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~ 1041 (1078)
.++|.|+|||++|||+.|..||.+....+.+.+++.+ +.+++..+ ..+....+||++.+.+||.
T Consensus 314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~------------~l~Fp~~~----~vs~~akDLIr~LLvKdP~ 377 (459)
T KOG0610|consen 314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ------------PLKFPEEP----EVSSAAKDLIRKLLVKDPS 377 (459)
T ss_pred chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC------------CCcCCCCC----cchhHHHHHHHHHhccChh
Confidence 9999999999999999999999988888777776555 22222222 3344577899999999999
Q ss_pred CCCC----HHHHHHHH
Q 001434 1042 DRPS----MREVVSML 1053 (1078)
Q Consensus 1042 ~RPs----~~ell~~L 1053 (1078)
+|.. ++||.+|-
T Consensus 378 kRlg~~rGA~eIK~Hp 393 (459)
T KOG0610|consen 378 KRLGSKRGAAEIKRHP 393 (459)
T ss_pred hhhccccchHHhhcCc
Confidence 9998 88988764
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=345.62 Aligned_cols=254 Identities=26% Similarity=0.435 Sum_probs=218.0
Q ss_pred CCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
....++||.|.||.|++|+.+ ....||||.++.... +..+.+|..|+.+|.+++||||+++.++....+.++||+
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt-ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc-HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 344678999999999999975 245799999987655 345789999999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|||++|+|+.+++.+...+++.+...+++.|+.|+.||-+. ++|||||.++|||++.+-.+|++|||+++.+.++..
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~ 786 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 786 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence 99999999999998888899999999999999999999998 999999999999999999999999999998754443
Q ss_pred Cccccc--ccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 938 KSMSAV--AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 938 ~~~~~~--~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
..+.+. .-..+|.|||.+...+++.++|||||||++||.++ |..||.++.+.+.+..+..++.. ++ .
T Consensus 787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL----Pp-----P- 856 (996)
T KOG0196|consen 787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL----PP-----P- 856 (996)
T ss_pred ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC----CC-----C-
Confidence 333333 33679999999999999999999999999999998 99999988766555544444322 21 1
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.+++..+++|++.||++|-.+||.+++|+..|.++
T Consensus 857 -------mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl 891 (996)
T KOG0196|consen 857 -------MDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL 891 (996)
T ss_pred -------CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence 13344588999999999999999999999999987
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.19 Aligned_cols=271 Identities=24% Similarity=0.335 Sum_probs=212.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCc-eeeEeeEEEecC------
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN-IVKLYGFCYHQG------ 851 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~------ 851 (1078)
..|...+.||+|+||+||+|+.+ +|+.||+|++.-....+.......+|+.++++++|+| |+++++++....
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555667999999999999965 6889999999877665556677899999999999999 999999998877
Q ss_pred ceEEEEeeccCCCHHhHhcCCC---CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSS---CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 928 (1078)
..++||||++. +|.+++.... ...+...+..+++||++|++|||++ +|+||||||+||++++.|.+||+|||+
T Consensus 91 ~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccch
Confidence 78899999976 9999998665 3577788999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1078)
|+...-+ .......++|..|+|||++.+. .|+...||||+||+++||++++.-|.+..+ ..+..+-+...+.+..
T Consensus 167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se---~~ql~~If~~lGtP~e 242 (323)
T KOG0594|consen 167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE---IDQLFRIFRLLGTPNE 242 (323)
T ss_pred HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH---HHHHHHHHHHcCCCCc
Confidence 9966532 2346677899999999999877 699999999999999999999988876544 2332222222222111
Q ss_pred ccccCC---------CCcc--hhhHHH----HHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhhcc
Q 001434 1008 GIFDTR---------LNVE--DESIVD----HMILVLKVALMCTSISPFDRPSMREVVSM--LIESNE 1058 (1078)
Q Consensus 1008 ~~~~~~---------~~~~--~~~~~~----~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~~~ 1058 (1078)
..|+.. ++.. +..+.. ......+++.+|++.+|.+|.|++.+++| +.+...
T Consensus 243 ~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 243 KDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred cCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 111111 1110 111111 11357789999999999999999999998 555533
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=327.01 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=201.9
Q ss_pred CCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCc-hhHHHHHHHHHHHccCCCCceeeEeeEEEe----cCceEEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNLLI 856 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~lv 856 (1078)
......||+|++|.||+|.+. |+.||||++....... ...+.+.+|+.++++++||||+++++++.+ ....++|
T Consensus 22 ~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv 100 (283)
T PHA02988 22 KYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLI 100 (283)
T ss_pred CCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEE
Confidence 333357999999999999985 8899999997654332 224678899999999999999999999876 3467899
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++|+|.+++.... .+++..+..++.|++.|++|+|+. .+++||||||+||++++++.+|++|||+++......
T Consensus 101 ~Ey~~~g~L~~~l~~~~-~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~ 177 (283)
T PHA02988 101 LEYCTRGYLREVLDKEK-DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP 177 (283)
T ss_pred EEeCCCCcHHHHHhhCC-CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence 99999999999998654 688999999999999999999973 278899999999999999999999999998654221
Q ss_pred CCcccccccccCccccccccc--CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
....|+..|+|||.+.+ ..++.++|||||||++|||++|+.||.... ...+.......... ...
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~----~~~~~~~i~~~~~~------~~~ 243 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT----TKEIYDLIINKNNS------LKL 243 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHhcCCC------CCC
Confidence 23457899999999876 679999999999999999999999997543 22222222221111 111
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
+. .....+.+++.+||+.||++|||++++++.|+.+.
T Consensus 244 ~~------~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~ 280 (283)
T PHA02988 244 PL------DCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK 280 (283)
T ss_pred CC------cCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence 10 12234778999999999999999999999998764
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=319.33 Aligned_cols=267 Identities=26% Similarity=0.332 Sum_probs=201.9
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----c
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-----S 852 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~ 852 (1078)
.-.|...+++|+|+||.||+|... +++.||||++.....-. .+|+++|+.++|||||++.-+|.... .
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 345677789999999999999965 47899999997765432 37999999999999999998886532 2
Q ss_pred eEEEEeeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC-CceEEeeccc
Q 001434 853 NLLIYEYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGL 928 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~ 928 (1078)
..+|||||+. +|+++++. .+..++...+.-+..||++|++|||+. +|+||||||+|+|+|.+ |.+||||||.
T Consensus 97 lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGS 172 (364)
T KOG0658|consen 97 LNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGS 172 (364)
T ss_pred HHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCc
Confidence 2489999987 99999874 244688889999999999999999998 99999999999999976 9999999999
Q ss_pred ccccCCCCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH-------h
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNY-------I 1000 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~-------~ 1000 (1078)
|+..... ........+..|+|||.+.+. .|+.+.||||.||++.||+.|++-|.+.....++..+++-. +
T Consensus 173 AK~L~~~--epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I 250 (364)
T KOG0658|consen 173 AKVLVKG--EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI 250 (364)
T ss_pred ceeeccC--CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 9987633 333556678899999999875 59999999999999999999999998755444444443211 0
Q ss_pred hcCCCCCccccCCCCc-chh-----hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhhccc
Q 001434 1001 RDHSLTPGIFDTRLNV-EDE-----SIVDHMILVLKVALMCTSISPFDRPSMREVVSM--LIESNER 1059 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~~~~ 1059 (1078)
...... ....+.+. ... .......+..+++.+++..+|.+|.++.|++.+ +.+++..
T Consensus 251 ~~mn~~--y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 251 KSMNPN--YTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hhcCcc--cccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 000000 00000000 000 011123457789999999999999999999965 4455444
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=338.36 Aligned_cols=244 Identities=22% Similarity=0.255 Sum_probs=199.2
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
++||+|+||.||+|.++ +|+.||+|++..... .......+.+|+.++++++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 689999999976532 2233456788999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 943 (1078)
+|.+++...+ .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.... ........
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~-~~~~~~~~ 155 (323)
T cd05571 81 ELFFHLSRER-VFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-CCCcccce
Confidence 9999987654 689999999999999999999999 999999999999999999999999999875321 22233456
Q ss_pred ccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHH
Q 001434 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023 (1078)
Q Consensus 944 ~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1078)
.||+.|+|||.+.+..++.++||||+||++|||++|+.||...+ ............. .++. .
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~----~~~~~~~~~~~~~--------~~p~------~ 217 (323)
T cd05571 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEEI--------RFPR------T 217 (323)
T ss_pred ecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCC----HHHHHHHHHcCCC--------CCCC------C
Confidence 79999999999999999999999999999999999999996432 2222222221111 1111 1
Q ss_pred HHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 001434 1024 HMILVLKVALMCTSISPFDRP-----SMREVVSM 1052 (1078)
Q Consensus 1024 ~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 1052 (1078)
....+.+++.+|++.||++|| ++.+++++
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h 251 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH 251 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence 123467899999999999999 89999876
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=330.43 Aligned_cols=262 Identities=24% Similarity=0.406 Sum_probs=201.4
Q ss_pred hcCCCccEEeccCceEEEEEEECC-----------------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-----------------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 842 (1078)
.+|...+.||+|+||.||+|.++. +..||+|.+..... ......+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN-KNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC-HHHHHHHHHHHHHHhhcCCCCeeE
Confidence 356677889999999999998532 33699999875432 334567899999999999999999
Q ss_pred EeeEEEecCceEEEEeeccCCCHHhHhcCCC------------------CCCChhHHHHHHHHHHhhhhhhhccCCCceE
Q 001434 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSS------------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904 (1078)
Q Consensus 843 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~iv 904 (1078)
+++++.+.+..++||||+++|+|.+++.... ..+++.++..++.||+.|++|||+. +|+
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~iv 160 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFV 160 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Ccc
Confidence 9999999999999999999999999885421 1367788899999999999999998 999
Q ss_pred ecCCCCCcEEECCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh--CCC
Q 001434 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRT 981 (1078)
Q Consensus 905 H~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~ 981 (1078)
||||||+||+++.++.+||+|||+++....... .......++..|+|||.+.++.++.++||||+|+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999976532221 12233456788999999988899999999999999999987 567
Q ss_pred CCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 982 PVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 982 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
||....... ....+.......... ......+ .....+.+++.+||+.||++|||++++.+.|++
T Consensus 241 p~~~~~~~~-~~~~~~~~~~~~~~~--~~~~~~~-------~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 241 PYGELTDEQ-VIENAGEFFRDQGRQ--VYLFRPP-------PCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCCcCCHHH-HHHHHHHHhhhcccc--ccccCCC-------CCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 776543322 222222222211110 0000001 112347789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=334.54 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=204.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||+|.++ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 5677788999999999999976 688999999965432 12335678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~---- 153 (291)
T cd05612 82 YVPGGELFSYLRNSG-RFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD---- 153 (291)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC----
Confidence 999999999997655 688999999999999999999998 999999999999999999999999999986542
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|++.|+|||.+.+..++.++||||+|+++|||++|+.||.... ............... +...
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~----~~~~~~~i~~~~~~~----~~~~---- 221 (291)
T cd05612 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----PFGIYEKILAGKLEF----PRHL---- 221 (291)
T ss_pred CcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCcCC----CccC----
Confidence 1223568999999999998889999999999999999999999997533 222223322221100 1111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHHh
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPS-----MREVVSMLIE 1055 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L~~ 1055 (1078)
...+.+++.+|++.||.+||+ +++++++-+-
T Consensus 222 ------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~ 257 (291)
T cd05612 222 ------DLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWF 257 (291)
T ss_pred ------CHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccc
Confidence 224678999999999999995 9999988653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=323.02 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=204.3
Q ss_pred hcCCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
.+|+..+.||+|+||.||+|.++ .+..||+|+++.... ....+.+.+|+.++++++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 45677788999999999999853 356899999976543 2335678899999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++|+|.+++......+++.+++.++.|++.|++|||++ +++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 9999999999999987655789999999999999999999998 9999999999999999999999999987654221
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.........++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ............+ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~----~~~~~~~~~~~~~-------~ 229 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQ----DVIKAVEDGFRLP-------A 229 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHHHCCCCCC-------C
Confidence 1111122345678999999999999999999999999999875 99999754322 2222221111110 0
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+ ......+.+++.+||+.+|++||+++++++.|.+.
T Consensus 230 ~------~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 230 P------RNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred C------CCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 1 01223477899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=322.35 Aligned_cols=264 Identities=26% Similarity=0.378 Sum_probs=216.0
Q ss_pred hhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+.....++.||+|.||.|..|....+..||||+++.... +..+.+|.+|+++|.+++||||++++++|..++.+++|+|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~-~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E 615 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDAT-KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE 615 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccc-hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence 445566778999999999999998889999999977654 3447899999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCC-CChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC-CCC
Q 001434 859 YMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-MPQ 936 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~-~~~ 936 (1078)
||++|+|.+++.....+ ........|+.||+.|++||.+. ++||||+.++|+|+|.++++||+|||+++.+- .+.
T Consensus 616 YmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y 692 (807)
T KOG1094|consen 616 YMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY 692 (807)
T ss_pred HHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCc
Confidence 99999999999877432 35667788999999999999999 99999999999999999999999999998543 233
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh--CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
....+..+-..+|||||.+.-++++.++|||+||+++||+++ .+.||....++.. .+-............ +....
T Consensus 693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v-ven~~~~~~~~~~~~--~l~~P 769 (807)
T KOG1094|consen 693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV-VENAGEFFRDQGRQV--VLSRP 769 (807)
T ss_pred eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH-HHhhhhhcCCCCcce--eccCC
Confidence 334445566789999999999999999999999999999876 8899987664433 333334444333221 11111
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+. +...+++++.+||..+-++||+++++..+|.+.
T Consensus 770 ~~-------cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~ 804 (807)
T KOG1094|consen 770 PA-------CPQGLYELMLRCWRRESEQRPSFEQLHLFLQED 804 (807)
T ss_pred Cc-------CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence 11 233477899999999999999999999999865
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=337.75 Aligned_cols=256 Identities=23% Similarity=0.220 Sum_probs=205.8
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||+|.+. +++.||+|++...... ......+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 5777889999999999999976 5889999999765322 2335678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~---- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG-VLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---- 153 (333)
T ss_pred CCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc----
Confidence 999999999997654 688999999999999999999999 999999999999999999999999999986542
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|++.|+|||.+.+..++.++||||+||++|||++|..||..... ............... .+... ..
T Consensus 154 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~---~~~~~-~~ 225 (333)
T cd05600 154 YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP----NETWENLKYWKETLQ---RPVYD-DP 225 (333)
T ss_pred ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH----HHHHHHHHhcccccc---CCCCC-cc
Confidence 23445799999999999998999999999999999999999999975332 222111111110000 00000 00
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.......+.+++.+|+..+|++||++++++++-+
T Consensus 226 --~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~ 259 (333)
T cd05600 226 --RFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPF 259 (333)
T ss_pred --ccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcc
Confidence 0122344678999999999999999999998854
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=326.82 Aligned_cols=264 Identities=22% Similarity=0.316 Sum_probs=202.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|...+.||+|+||+||+|.++ +++.||+|++...... .....+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE 83 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC-CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence 35777889999999999999976 5889999999755332 234567789999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++ +|.+++...+..+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ..
T Consensus 84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~-~~ 158 (288)
T cd07871 84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVP-TK 158 (288)
T ss_pred CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCC-Cc
Confidence 9985 99999876665688999999999999999999998 9999999999999999999999999998765322 22
Q ss_pred cccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc------
Q 001434 939 SMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD------ 1011 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1011 (1078)
......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||......+........ . .......++
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~ 235 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRL-L--GTPTEETWPGITSNE 235 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-h--CCCChHHhhccccch
Confidence 2334568999999998865 56889999999999999999999999754322222211111 0 000000000
Q ss_pred -------CCCCcc--hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 -------TRLNVE--DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 -------~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+..... ............+++.+|++.||.+|||++|+++|
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h 285 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH 285 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00001112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=338.73 Aligned_cols=257 Identities=25% Similarity=0.403 Sum_probs=202.4
Q ss_pred hcCCCccEEeccCceEEEEEEE------CCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCc
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVM------DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 852 (1078)
.+|+..+.||+|+||.||+|.+ .++..||||+++.... ....+.+.+|+++++.+ +||||+++++++.+.+.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 3567778899999999999974 2356899999865443 23356788999999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCC-----------------------------------------------------------
Q 001434 853 NLLIYEYMERGSLGELLHGSS----------------------------------------------------------- 873 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 873 (1078)
.++||||+++|+|.++++...
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999999986432
Q ss_pred ---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 874 ---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 874 ---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
..+++.++..++.||++|++|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 1467888999999999999999998 9999999999999999999999999999865422211
Q ss_pred -cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 939 -SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 939 -~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
......++..|+|||.+.+..++.++||||||+++|||++ |..||............+.. ..... .+. .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~----~~~~~---~~~--~ 341 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKE----GYRML---SPE--C 341 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHh----CccCC---CCC--C
Confidence 1222345678999999999999999999999999999998 88898754433222222221 11000 000 0
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
...++.+++.+||+.||++|||++++++.|++.
T Consensus 342 -------~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 342 -------APSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred -------CCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 123477899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=337.82 Aligned_cols=248 Identities=21% Similarity=0.232 Sum_probs=203.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||.||+|.++ +++.||+|++..... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 35677788999999999999976 588999999976532 2233567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 98 e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-- 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-- 171 (329)
T ss_pred cCCCCChHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--
Confidence 9999999999998655 678888999999999999999999 9999999999999999999999999999865422
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.....|++.|+|||.+.+..++.++||||+||++|||++|+.||.... ............... +..
T Consensus 172 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~----~~~~~~~i~~~~~~~----p~~---- 237 (329)
T PTZ00263 172 --TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT----PFRIYEKILAGRLKF----PNW---- 237 (329)
T ss_pred --cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCcCC----CCC----
Confidence 224578999999999999899999999999999999999999996432 222222222211110 110
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPS-----MREVVSML 1053 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L 1053 (1078)
....+.+++.+||+.||++||+ ++++++|-
T Consensus 238 ------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp 272 (329)
T PTZ00263 238 ------FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHP 272 (329)
T ss_pred ------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCC
Confidence 1123678999999999999996 78888774
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=332.84 Aligned_cols=270 Identities=26% Similarity=0.366 Sum_probs=203.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|+||.||+|.+. +++.||||++..... ....+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE-DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc-HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 3455677999999999999976 589999999965432 23456789999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+.. ...+..+..++.||+.||+|||++ +|+||||||+||++++++.+||+|||+++..... ...
T Consensus 154 ~~~~~L~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~ 224 (353)
T PLN00034 154 MDGGSLEGTH-----IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-MDP 224 (353)
T ss_pred CCCCcccccc-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccc-ccc
Confidence 9999987542 345677888999999999999998 9999999999999999999999999999865422 122
Q ss_pred ccccccccCccccccccc-----CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 940 MSAVAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.....|+..|+|||.+.. ...+.++|||||||++|||++|+.||.... ..+.............. ..
T Consensus 225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~-~~~~~~~~~~~~~~~~~-------~~ 296 (353)
T PLN00034 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWASLMCAICMSQPP-------EA 296 (353)
T ss_pred ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCC-CccHHHHHHHHhccCCC-------CC
Confidence 344578999999998743 234568999999999999999999997322 22222222222111110 00
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc--CCCCCCCCCCCCCCC
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER--EGRFNSSPTYDLPQI 1074 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~--~~~~~~~~~~~~~~~ 1074 (1078)
. ......+.+++.+||+.||++|||+.|++++-+-.... ...........+|++
T Consensus 297 ~------~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~ 352 (353)
T PLN00034 297 P------ATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPP 352 (353)
T ss_pred C------CccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCcccccCCCCccCCCCCC
Confidence 0 01223477899999999999999999999986644332 222222344555554
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=313.32 Aligned_cols=249 Identities=24% Similarity=0.368 Sum_probs=211.0
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+...++|+|+||.||+|.++ +|..+|||++..... .+++..|+.+|++++.|+||++|+.+......++|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 344567999999999999976 599999999966643 678889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
..|+..+.++.+++.+.+.++..+++..++||+|||.. .-+|||||+.|||++.+|..|++|||.|..+.+ .-.+.
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD-TMAKR 186 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD-TMAKR 186 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhh-hHHhh
Confidence 99999999998888999999999999999999999998 889999999999999999999999999987642 33445
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
.++.||+.|||||++..-.|+.++||||+|++..||..|++||.+.+.-.. ++. .+++.++....
T Consensus 187 NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-------IFM--------IPT~PPPTF~K 251 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-------IFM--------IPTKPPPTFKK 251 (502)
T ss_pred CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-------eEe--------ccCCCCCCCCC
Confidence 678999999999999999999999999999999999999999976543211 111 12222333222
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
......++.+++++|+-++|++|-|+-++++|-
T Consensus 252 PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~ 284 (502)
T KOG0574|consen 252 PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHT 284 (502)
T ss_pred hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhh
Confidence 233445677899999999999999999998874
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=329.28 Aligned_cols=267 Identities=22% Similarity=0.334 Sum_probs=203.0
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..+|+..+.||+|+||.||+|.++ +++.||+|++...... .....+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 356888889999999999999976 6889999999755432 22446778999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+. ++|.+++......+++..+..++.|++.||+|||++ +|+||||||+||++++++.+||+|||++...... .
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~ 157 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVP-S 157 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCC-C
Confidence 9996 588888876655789999999999999999999999 9999999999999999999999999998754322 2
Q ss_pred CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhc-CCCCCccc-----
Q 001434 938 KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD-HSLTPGIF----- 1010 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~----- 1010 (1078)
.......+++.|+|||.+.+ ..++.++||||+||++|||++|+.||....+ ........... .......+
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD---IQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc---HHHHHHHHHHHhCCCChhhccchhh
Confidence 23344568999999998865 4578899999999999999999999975432 22222211110 00000000
Q ss_pred -----cCCCC-cchhhHHH------HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1011 -----DTRLN-VEDESIVD------HMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1011 -----~~~~~-~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
...+. ..+..... ....+.+++.+|++.||++|||+.|+++|-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~ 290 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcc
Confidence 00000 00000000 1234678999999999999999999997543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=331.87 Aligned_cols=254 Identities=25% Similarity=0.310 Sum_probs=216.2
Q ss_pred hcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCC-chhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREG-NNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv 856 (1078)
..|...+.||+|.||+||+|+.+. |+.+|+|++.+.... ....+.+.+|+.+|+++. |||||.++++|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 345666789999999999999875 999999999877543 234678999999999998 99999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC----CceEEeeccccccc
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK----FEAHVGDFGLAKVI 932 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~kl~Dfg~a~~~ 932 (1078)
||++.||.|.+.+... ..++..+..++.|++.|+.|||+. ||+|||+||+|+|+... +.++++|||++...
T Consensus 115 mEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred EEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 9999999999999866 389999999999999999999998 99999999999999643 57999999999987
Q ss_pred CCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.. .......+||++|+|||++....|+.++||||+||++|.|++|.+||.+....+....+...
T Consensus 190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~-------------- 253 (382)
T KOG0032|consen 190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRG-------------- 253 (382)
T ss_pred cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcC--------------
Confidence 64 55677889999999999999999999999999999999999999999876554444433222
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
++....+.+........+++.+|+..||.+|+|+.++++|-|
T Consensus 254 ~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpW 295 (382)
T KOG0032|consen 254 DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPW 295 (382)
T ss_pred CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence 112222333344556778999999999999999999999865
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=318.24 Aligned_cols=250 Identities=26% Similarity=0.393 Sum_probs=202.9
Q ss_pred cCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
+|+..+.||+|+||.||+|.++++..+|+|.+..... ..+.+.+|++++++++||||+++++++..++..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~ 81 (256)
T cd05114 5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM---SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFM 81 (256)
T ss_pred HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc---cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcC
Confidence 4666778999999999999988888899998864432 2467889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++|+|.++++.....+++..+..++.|++.|++|||++ +++||||||+||++++++.++++|||.++..........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05114 82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence 99999999986555689999999999999999999998 999999999999999999999999999876542222222
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
....++..|+|||.+.+..++.++||||+|+++|||++ |+.||.... ............... .+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~----~~~~~~~i~~~~~~~----~~~~----- 225 (256)
T cd05114 159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS----NYEVVEMISRGFRLY----RPKL----- 225 (256)
T ss_pred CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHCCCCCC----CCCC-----
Confidence 23345678999999988889999999999999999999 899996433 222223322211110 0100
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
....+.+++.+||+.+|++||+++++++.|
T Consensus 226 ----~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 226 ----ASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred ----CCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 123478999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=332.52 Aligned_cols=255 Identities=24% Similarity=0.251 Sum_probs=204.2
Q ss_pred cCCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCC--CchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCce
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNRE--GNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 853 (1078)
+|+..+.||+|+||+||+|... +++.||+|++.+... .....+.+.+|+.+++++ +|++|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 3667788999999999999853 578999999975432 223345678899999999 599999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~ 156 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-NFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFL 156 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence 99999999999999987654 688999999999999999999998 99999999999999999999999999998654
Q ss_pred CCCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 934 MPQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 934 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
...........||+.|+|||.+.+. .++.++||||+||++|||++|+.||.....................
T Consensus 157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~-------- 228 (332)
T cd05614 157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-------- 228 (332)
T ss_pred ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCC--------
Confidence 3333333456799999999998765 4788999999999999999999999755444444433333332211
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSML 1053 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 1053 (1078)
.++.. ....+.+++.+|++.||++|| ++++++++-
T Consensus 229 ~~~~~------~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~ 268 (332)
T cd05614 229 PFPSF------IGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHP 268 (332)
T ss_pred CCCCC------CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCC
Confidence 11111 123367899999999999999 788888764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=335.13 Aligned_cols=256 Identities=21% Similarity=0.250 Sum_probs=205.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|...+.||+|+||+||+|.++ +++.||+|++..... .....+.+.+|+.+++.++|++|+++++++.+.+..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 5777889999999999999976 588999999976543 23345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~ 158 (330)
T cd05601 82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV 158 (330)
T ss_pred CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence 9999999999987755799999999999999999999999 9999999999999999999999999999876433322
Q ss_pred cccccccccCcccccccc------cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 939 SMSAVAGSYGYIAPEYAY------TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~------~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
......||+.|+|||++. +..++.++||||+||++|||++|+.||..... ..............
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~------ 228 (330)
T cd05601 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTS----AKTYNNIMNFQRFL------ 228 (330)
T ss_pred eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCH----HHHHHHHHcCCCcc------
Confidence 333457899999999886 45678999999999999999999999964332 22233322211110
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..+... .....+.+++.+|++ +|++||++++++++-+
T Consensus 229 ~~~~~~----~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~ 265 (330)
T cd05601 229 KFPEDP----KVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265 (330)
T ss_pred CCCCCC----CCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence 001000 112336678899998 9999999999997643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=337.62 Aligned_cols=257 Identities=26% Similarity=0.408 Sum_probs=203.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCc
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 852 (1078)
.+|+..+.||+|+||.||+|++. ++..||+|++...... ...+.+.+|+++++.+ +|+||+++++++...+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 36777888999999999999853 2457999999765432 3356788999999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCC-----------------------------------------------------------
Q 001434 853 NLLIYEYMERGSLGELLHGSS----------------------------------------------------------- 873 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~----------------------------------------------------------- 873 (1078)
.++||||+++|+|.+++....
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999885321
Q ss_pred ----------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC-cccc
Q 001434 874 ----------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSA 942 (1078)
Q Consensus 874 ----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-~~~~ 942 (1078)
..+++.++.+++.||+.||+|||++ +|+||||||+||++++++.++|+|||+++........ ....
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 1367788899999999999999998 9999999999999999999999999999765422211 1122
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESI 1021 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1021 (1078)
..++..|+|||.+.+..++.++||||+|+++|||++ |+.||............+.. .. . ...+.
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~----~~-~-----~~~~~----- 338 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKR----GY-Q-----MSRPD----- 338 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHc----cc-C-----ccCCC-----
Confidence 345678999999998899999999999999999997 99999765433222222111 10 0 00000
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1022 VDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1022 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+.+++.+||+.||++|||+.++++.|+++
T Consensus 339 -~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~ 372 (374)
T cd05106 339 -FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ 372 (374)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence 0123477899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-35 Score=336.22 Aligned_cols=262 Identities=23% Similarity=0.243 Sum_probs=202.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|...+.||+|+||.||+|.+. +++.||+|+.. ...+.+|++++++++||||+++++++......++|||
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 46888899999999999999975 58899999653 2346789999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
++. ++|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++........
T Consensus 164 ~~~-~~L~~~l~~~~-~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~ 238 (391)
T PHA03212 164 RYK-TDLYCYLAAKR-NIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN 238 (391)
T ss_pred cCC-CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence 996 58988887654 688999999999999999999998 9999999999999999999999999999754322233
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC---CCHHHHHHHHhhcCCCCCccc-----
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG---GDLATWVRNYIRDHSLTPGIF----- 1010 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~----- 1010 (1078)
......||+.|+|||++.+..++.++||||+||++|||++|+.||...... .+........+......+..+
T Consensus 239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 334567999999999999989999999999999999999999887543211 011111111111100000000
Q ss_pred ----------------cCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1011 ----------------DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1011 ----------------~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.+...............+.+++.+|++.||++|||++|++++-+
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~ 378 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAA 378 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChh
Confidence 00001112222334556889999999999999999999997655
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=324.88 Aligned_cols=266 Identities=24% Similarity=0.365 Sum_probs=198.4
Q ss_pred cCCCccEEeccCceEEEEEEEC--CCcEEEEEEecccCCCchhHHHHHHHHHHHccC---CCCceeeEeeEEEe-----c
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD--SGKIVAVKKLASNREGNNIESSFRAEILTLGKI---RHRNIVKLYGFCYH-----Q 850 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~-----~ 850 (1078)
+|+..+.||+|+||+||+|.+. +++.||+|++............+.+|+.+++.+ +||||+++++++.. .
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 5777888999999999999873 467899999876554444444566677766655 69999999998853 4
Q ss_pred CceEEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccc
Q 001434 851 GSNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 929 (1078)
...++||||++ ++|.+++.... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~ 157 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLA 157 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccce
Confidence 56799999997 59999887543 3588999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC--C---
Q 001434 930 KVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH--S--- 1004 (1078)
Q Consensus 930 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~--- 1004 (1078)
+..... .......|++.|+|||.+.+..++.++||||+||++|||++|++||....+.+............. .
T Consensus 158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~ 235 (290)
T cd07862 158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPR 235 (290)
T ss_pred EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchh
Confidence 865422 333456789999999999888999999999999999999999999976543333322222110000 0
Q ss_pred ---CCCccccCCCCcchhh-HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1005 ---LTPGIFDTRLNVEDES-IVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1005 ---~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+........+. ..+....+.+++.+|++.||++|||+.|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h 287 (290)
T cd07862 236 DVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 287 (290)
T ss_pred hhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence 0000000000000111 11223456789999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=332.48 Aligned_cols=245 Identities=22% Similarity=0.257 Sum_probs=198.9
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
+.||+|+||.||+|.++ +|+.||+|++..... .......+.+|++++++++||||+++++++...+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999975 589999999976532 2233456778999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 943 (1078)
+|.+++.... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..... ........
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~~~ 155 (323)
T cd05595 81 ELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DGATMKTF 155 (323)
T ss_pred cHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccC-CCCccccc
Confidence 9999887654 689999999999999999999998 999999999999999999999999999875321 22233446
Q ss_pred ccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHH
Q 001434 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023 (1078)
Q Consensus 944 ~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1078)
.|++.|+|||.+.+..++.++||||+||++|||++|+.||...+.. ............ ++..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~----~~~~~~~~~~~~----~p~~---------- 217 (323)
T cd05595 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE----RLFELILMEEIR----FPRT---------- 217 (323)
T ss_pred cCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH----HHHHHHhcCCCC----CCCC----------
Confidence 7999999999999989999999999999999999999999754322 222222211110 0111
Q ss_pred HHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 001434 1024 HMILVLKVALMCTSISPFDRP-----SMREVVSML 1053 (1078)
Q Consensus 1024 ~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 1053 (1078)
....+.+++.+|++.||++|| ++.+++++-
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~ 252 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHR 252 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCC
Confidence 123467899999999999998 899988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=327.80 Aligned_cols=242 Identities=22% Similarity=0.283 Sum_probs=196.9
Q ss_pred EeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
||+|+||.||+|.+. +++.||+|++..... .......+.+|+.++++++||||+++++++.+++..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999976 588999999975432 223456778899999999999999999999999999999999999999
Q ss_pred HhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccccc
Q 001434 866 GELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG 945 (1078)
Q Consensus 866 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 945 (1078)
.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++.... .........|
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~g 155 (312)
T cd05585 81 FHHLQREG-RFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMK-DDDKTNTFCG 155 (312)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCcc-CCCccccccC
Confidence 99997654 689999999999999999999998 999999999999999999999999999875432 2223345679
Q ss_pred ccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHH
Q 001434 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHM 1025 (1078)
Q Consensus 946 t~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1078)
|+.|+|||.+.+..++.++||||+||++|||++|+.||... ............... ++.. ..
T Consensus 156 t~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~----~~~~~~~~~~~~~~~----~~~~----------~~ 217 (312)
T cd05585 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE----NVNEMYRKILQEPLR----FPDG----------FD 217 (312)
T ss_pred CcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC----CHHHHHHHHHcCCCC----CCCc----------CC
Confidence 99999999999999999999999999999999999999643 233333333322110 0111 12
Q ss_pred HHHHHHHHhcCCCCCCCCCC---HHHHHHH
Q 001434 1026 ILVLKVALMCTSISPFDRPS---MREVVSM 1052 (1078)
Q Consensus 1026 ~~l~~li~~cl~~dP~~RPs---~~ell~~ 1052 (1078)
..+.+++.+||+.||++||+ +.+++.+
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~h 247 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNH 247 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence 34678999999999999985 6777665
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=334.93 Aligned_cols=248 Identities=23% Similarity=0.272 Sum_probs=202.1
Q ss_pred cCCCccEEeccCceEEEEEEECC--CcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS--GKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
+|...+.||+|+||.||+|.++. +..||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 31 ~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 110 (340)
T PTZ00426 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110 (340)
T ss_pred hcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEE
Confidence 57777889999999999998653 36899999865432 2234567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 111 Ey~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~--- 183 (340)
T PTZ00426 111 EFVIGGEFFTFLRRNK-RFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT--- 183 (340)
T ss_pred eCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCC---
Confidence 9999999999998655 688999999999999999999999 999999999999999999999999999986542
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............. ++..+
T Consensus 184 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~~~~----~p~~~--- 251 (340)
T PTZ00426 184 -RTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP----LLIYQKILEGIIY----FPKFL--- 251 (340)
T ss_pred -CcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH----HHHHHHHhcCCCC----CCCCC---
Confidence 12345799999999999988899999999999999999999999974322 2222222221110 11111
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~ 1054 (1078)
...+.+++.+|++.||++|+ ++++++++-+
T Consensus 252 -------~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~ 286 (340)
T PTZ00426 252 -------DNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286 (340)
T ss_pred -------CHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCC
Confidence 12356899999999999995 8999988743
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=328.94 Aligned_cols=245 Identities=22% Similarity=0.263 Sum_probs=199.7
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
+.||+|+||.||+|.++ +++.||+|++..... .......+.+|+++++.++||||+++++++..++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 589999999976532 2334567789999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 943 (1078)
+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.... ........
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~~~ 155 (328)
T cd05593 81 ELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT-DAATMKTF 155 (328)
T ss_pred CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCC-cccccccc
Confidence 9999887654 689999999999999999999998 999999999999999999999999999875321 12233456
Q ss_pred ccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHH
Q 001434 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023 (1078)
Q Consensus 944 ~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1078)
.|++.|+|||.+.+..++.++||||+||++|||++|+.||.... .............. ++..
T Consensus 156 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~----~~~~~~~~~~~~~~----~p~~---------- 217 (328)
T cd05593 156 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEDIK----FPRT---------- 217 (328)
T ss_pred cCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC----HHHHHHHhccCCcc----CCCC----------
Confidence 79999999999998899999999999999999999999996432 22222222211110 1111
Q ss_pred HHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 001434 1024 HMILVLKVALMCTSISPFDRP-----SMREVVSML 1053 (1078)
Q Consensus 1024 ~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 1053 (1078)
....+.+++.+|++.||++|| ++.+++++-
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 252 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHS 252 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCC
Confidence 123467899999999999997 899999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=339.25 Aligned_cols=255 Identities=27% Similarity=0.319 Sum_probs=206.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|...+.||+|+||+||+|.+. +++.||+|++...... ......+.+|++++..++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 5777889999999999999976 6899999999765332 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC--
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-- 936 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-- 936 (1078)
|+++++|.+++... ..+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 157 (350)
T cd05573 82 YMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR 157 (350)
T ss_pred CCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence 99999999999876 3689999999999999999999998 99999999999999999999999999998654322
Q ss_pred --------------------------CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 001434 937 --------------------------SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG 990 (1078)
Q Consensus 937 --------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~ 990 (1078)
........||+.|+|||.+.+..++.++||||+||++|||++|+.||.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~-- 235 (350)
T cd05573 158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL-- 235 (350)
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH--
Confidence 1123345789999999999999999999999999999999999999975432
Q ss_pred CHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHHHH
Q 001434 991 DLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS-MREVVSMLI 1054 (1078)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~L~ 1054 (1078)
............ .. ..+... .....+.+++.+|+. ||++||+ +++++++-+
T Consensus 236 --~~~~~~i~~~~~---~~---~~p~~~----~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~ 287 (350)
T cd05573 236 --QETYNKIINWKE---SL---RFPPDP----PVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287 (350)
T ss_pred --HHHHHHHhccCC---cc---cCCCCC----CCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCC
Confidence 222222221000 00 001000 022346789999997 9999999 999999754
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=329.90 Aligned_cols=267 Identities=24% Similarity=0.342 Sum_probs=206.3
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||.||+|+++ ++..||+|.+..... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 46788889999999999999976 578899998875432 2345678999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++.... .+++..+..++.|++.|+.|||++ .+|+||||||+||+++.++.++|+|||++..... .
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---~ 157 (331)
T cd06649 84 HMDGGSLDQVLKEAK-RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---S 157 (331)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccc---c
Confidence 999999999997654 588999999999999999999985 2699999999999999999999999999876532 2
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC--CCCCcc-------
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH--SLTPGI------- 1009 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~~~------- 1009 (1078)
......|++.|+|||.+.+..++.++||||+|+++|||++|+.||...+.. ............. ......
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccccc
Confidence 233457899999999999889999999999999999999999999643321 1111110000000 000000
Q ss_pred ------------------------ccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1010 ------------------------FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1010 ------------------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+... .......+.+++.+||..||++|||+.+++++.+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~ 305 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLP--NGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK 305 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCC--CccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence 000000000 001234578999999999999999999999997644
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=326.67 Aligned_cols=261 Identities=25% Similarity=0.361 Sum_probs=217.7
Q ss_pred HhHHHHhhcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC
Q 001434 773 QDVVEATYNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG 851 (1078)
Q Consensus 773 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 851 (1078)
+.+...+.++....++|-|.||.||.|.|+. .-.||||.++... ...++|..|+.+|+.++|||+|+++++|..+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 4444556677778889999999999999984 6789999995543 45789999999999999999999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCCC-CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSSC-NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
..|||+|||..|+|.+|+.+..+ ..+....+.++.||..|++||..+ +++||||.++|+|+.++..||++|||+++
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR 413 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR 413 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence 99999999999999999987643 567777889999999999999998 99999999999999999999999999999
Q ss_pred ccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
.+..+....+....-...|.|||.+....++.|+|||+|||++||+.| |..||.+.+-... .....+-++..
T Consensus 414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV-Y~LLEkgyRM~------ 486 (1157)
T KOG4278|consen 414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV-YGLLEKGYRMD------ 486 (1157)
T ss_pred hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH-HHHHhcccccc------
Confidence 987666666666667889999999999999999999999999999999 8889975442211 12222222211
Q ss_pred ccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
... .+..++++|++.||+++|.+||+++|+-+.++.+
T Consensus 487 --~Pe--------GCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtm 523 (1157)
T KOG4278|consen 487 --GPE--------GCPPKVYELMRACWNWSPSDRPSFAEIHQAFETM 523 (1157)
T ss_pred --CCC--------CCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHH
Confidence 111 2334578999999999999999999999998754
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=316.07 Aligned_cols=253 Identities=24% Similarity=0.416 Sum_probs=205.0
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY 82 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence 45777788999999999999988888999999865432 356789999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.........
T Consensus 83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 9999999998753 34688889999999999999999998 9999999999999999999999999999876432222
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||...++.++.++||||+|+++|+|++ |+.||...... ............+ ...
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~----~~~~~~~~~~~~~------~~~-- 227 (261)
T cd05072 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS----DVMSALQRGYRMP------RME-- 227 (261)
T ss_pred ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH----HHHHHHHcCCCCC------CCC--
Confidence 2233445678999999988889999999999999999998 99999643321 2222221111110 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.....+.+++.+|++.+|++||+++++.+.|++
T Consensus 228 -----~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 260 (261)
T cd05072 228 -----NCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD 260 (261)
T ss_pred -----CCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 112346789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=335.37 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=202.1
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
..+|+..+.||+|+||.||+|.++ +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv 121 (370)
T cd05621 42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV 121 (370)
T ss_pred HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence 457888889999999999999976 578999999865322 223345678999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++|+|.+++... .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.......
T Consensus 122 ~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 122 MEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 9999999999999754 478889999999999999999998 99999999999999999999999999998764333
Q ss_pred CCcccccccccCcccccccccC----CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTM----KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
........||+.|+|||++.+. .++.++||||+||++|||++|+.||..... ..............
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~i~~~~~~~------ 266 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSKIMDHKNSL------ 266 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCccc------
Confidence 3333456799999999998754 378899999999999999999999975432 22222222211100
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFD--RPSMREVVSMLI 1054 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~ 1054 (1078)
.++.. ......+.+++.+|+..++.+ ||+++|++++-+
T Consensus 267 ~~p~~----~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~ 306 (370)
T cd05621 267 NFPED----VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPF 306 (370)
T ss_pred CCCCc----ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcc
Confidence 01110 112234567888888755544 899999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=332.80 Aligned_cols=266 Identities=24% Similarity=0.366 Sum_probs=198.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----ceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-----SNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 854 (1078)
+|+..+.||+|+||.||+|.+. +++.||||++............+.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4667788999999999999976 5899999998765443344567889999999999999999999875432 479
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+. ++|.+++.... .+++..+..++.|+++||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~ 155 (338)
T cd07859 81 VVFELME-SDLHQVIKAND-DLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFN 155 (338)
T ss_pred EEEecCC-CCHHHHHHhcc-cCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence 9999995 59999887654 589999999999999999999999 999999999999999999999999999975432
Q ss_pred CC--CCcccccccccCccccccccc--CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc-
Q 001434 935 PQ--SKSMSAVAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI- 1009 (1078)
Q Consensus 935 ~~--~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1009 (1078)
.. ........|++.|+|||++.+ ..++.++||||+||++|||++|+.||.......... .+..... ......
T Consensus 156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~-~~~~~~~--~~~~~~~ 232 (338)
T cd07859 156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLD-LITDLLG--TPSPETI 232 (338)
T ss_pred ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHH-HHHHHhC--CCCHHHH
Confidence 11 112234578999999998865 678999999999999999999999996543211110 0000000 000000
Q ss_pred --------------ccCCCCc-chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1010 --------------FDTRLNV-EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1010 --------------~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
+....+. ..+........+.+++.+||+.||++|||++|++++-+
T Consensus 233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~ 292 (338)
T cd07859 233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPY 292 (338)
T ss_pred HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCch
Confidence 0000000 00001112234678999999999999999999998754
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=329.23 Aligned_cols=245 Identities=25% Similarity=0.295 Sum_probs=197.7
Q ss_pred cEEeccCceEEEEEEEC----CCcEEEEEEecccCC--CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 786 FIVGSGAYGTVYKAVMD----SGKIVAVKKLASNRE--GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+.||+|+||.||+|... .++.||+|++..... .......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 56999999999999853 578999999976432 122345678899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++.... .+.+..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ...
T Consensus 82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~ 156 (323)
T cd05584 82 LSGGELFMHLEREG-IFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTV 156 (323)
T ss_pred CCCchHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCc
Confidence 99999999997655 578888889999999999999998 9999999999999999999999999998754321 222
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.....|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... ............. ++..
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~----~~~~~~~~~~~~~----~~~~------ 222 (323)
T cd05584 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENR----KKTIDKILKGKLN----LPPY------ 222 (323)
T ss_pred ccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCC----CCCC------
Confidence 3345789999999999988899999999999999999999999974332 2222332221110 0111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRP-----SMREVVSML 1053 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 1053 (1078)
....+.+++.+|++.+|++|| ++++++++-
T Consensus 223 ----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~ 257 (323)
T cd05584 223 ----LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHP 257 (323)
T ss_pred ----CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCC
Confidence 123467899999999999999 899998864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=314.13 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=205.9
Q ss_pred hcCCCccEEeccCceEEEEEEECC----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
.+|+..+.||+|+||+||+|.++. ...||+|++..... ......+.+|+..+++++||||+++++++.+.+..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS-DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 457778889999999999999752 45789998865543 3345678899999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++++|.+++......+++.++..++.|++.|++|||++ +|+||||||+||++++++.++++|||++......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 9999999999999987665789999999999999999999998 9999999999999999999999999999876421
Q ss_pred CCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 936 QSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 936 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
... ......++..|+|||.+.+..++.++||||+|+++||+++ |..||..... .............+.
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~~------ 229 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN----QDVIKAVEDGYRLPP------ 229 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH----HHHHHHHHcCCCCCC------
Confidence 111 1112344678999999998899999999999999999998 9999964332 222222211111100
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+ ......+.+++.+|++.+|++||++.+++++|.++
T Consensus 230 -~------~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 230 -P------MDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred -C------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 01123477999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-34 Score=313.31 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=204.9
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|++|.||+|.+.+++.||+|.++.... ..+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL 82 (261)
T ss_pred hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence 45777788999999999999988788899999865432 246788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++.... ..+++.++..++.|++.|+.|||+. +++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 99999999997543 4689999999999999999999998 9999999999999999999999999999876532222
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......+..|+|||...+..++.++||||+|+++|||++ |+.||..... .............. .+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~~~~~~~~~-------~~~- 227 (261)
T cd05068 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN----AEVLQQVDQGYRMP-------CPP- 227 (261)
T ss_pred ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCC-------CCC-
Confidence 2222233468999999988899999999999999999999 9999964432 12222211111100 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+.+++.+|++.+|++||++.++++.|++.
T Consensus 228 -----~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 228 -----GCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -----cCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 1223477899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=332.00 Aligned_cols=256 Identities=22% Similarity=0.282 Sum_probs=198.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.|...+.||+|+||+||+|++. +++.||+|++..... .....+.+.+|++++++++||||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 4667788999999999999975 588999999976532 23345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 937 (1078)
|+++|+|.+++.... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 82 YIPGGDMMSLLIRME-VFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred cCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCccccccccc
Confidence 999999999997655 588888999999999999999998 999999999999999999999999998753310000
Q ss_pred ---------------------------------------------CcccccccccCcccccccccCCCCCcCcchhHHHH
Q 001434 938 ---------------------------------------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVV 972 (1078)
Q Consensus 938 ---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~ 972 (1078)
.......||+.|+|||.+.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~i 237 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVI 237 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhH
Confidence 00123579999999999998889999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHh--cCCCCCCCCCCHHHHH
Q 001434 973 LLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALM--CTSISPFDRPSMREVV 1050 (1078)
Q Consensus 973 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~--cl~~dP~~RPs~~ell 1050 (1078)
+|||++|+.||...... ............. . .+... .....+.+++.+ |+..+|..||++++++
T Consensus 238 l~elltG~~Pf~~~~~~----~~~~~i~~~~~~~-~-~~~~~--------~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 238 LFEMLVGQPPFLAPTPT----ETQLKVINWENTL-H-IPPQV--------KLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred HHHHHhCCCCCcCCCHH----HHHHHHHcccccc-C-CCCCC--------CCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999754322 1112221111000 0 01100 111235567766 5566777799999999
Q ss_pred HHHH
Q 001434 1051 SMLI 1054 (1078)
Q Consensus 1051 ~~L~ 1054 (1078)
+|-+
T Consensus 304 ~hp~ 307 (381)
T cd05626 304 AHPF 307 (381)
T ss_pred cCcc
Confidence 8754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=326.54 Aligned_cols=259 Identities=28% Similarity=0.436 Sum_probs=206.2
Q ss_pred hHHHHhhcCCCc---cEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe
Q 001434 774 DVVEATYNFHDS---FIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH 849 (1078)
Q Consensus 774 ~~~~~~~~~~~~---~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~ 849 (1078)
+..+..|+|+.. -++|+|.||+||.|++.+ ...+|||.+..... ...+-+.+|+...++++|.|||+++|.+.+
T Consensus 566 e~iefeYeyde~~ervVLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~se 643 (1226)
T KOG4279|consen 566 EKIEFEYEYDESNERVVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSE 643 (1226)
T ss_pred cceEEEeeecCCCceEEeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCC
Confidence 333444555542 269999999999999774 66789999976544 335668899999999999999999999999
Q ss_pred cCceEEEEeeccCCCHHhHhcCCCCCC--ChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEEC-CCCceEEeec
Q 001434 850 QGSNLLIYEYMERGSLGELLHGSSCNL--EWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDF 926 (1078)
Q Consensus 850 ~~~~~lv~e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~-~~~~~kl~Df 926 (1078)
++..-|.||.++||+|.+++..+=+++ .+.+.-.+-+||++||.|||+. .|||||||.+||+++ -.|.+||+||
T Consensus 644 nGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDF 720 (1226)
T KOG4279|consen 644 NGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDF 720 (1226)
T ss_pred CCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEeccc
Confidence 999999999999999999998775556 6667778889999999999999 999999999999996 5789999999
Q ss_pred ccccccCCCCCCcccccccccCcccccccccCC--CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 927 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 927 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
|-++++.. -.....++.||..|||||++..++ |++++|||||||++.||.||++||........ +....++++.++
T Consensus 721 GTsKRLAg-inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMFkVGmyKvHP 798 (1226)
T KOG4279|consen 721 GTSKRLAG-INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMFKVGMYKVHP 798 (1226)
T ss_pred ccchhhcc-CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhhhhcceecCC
Confidence 99988753 334456788999999999998664 88999999999999999999999986543321 111122222221
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
. -++ +...+...+|.+|+.+||.+||++.++++--
T Consensus 799 ~-----------iPe---elsaeak~FilrcFepd~~~R~sA~~LL~Dp 833 (1226)
T KOG4279|consen 799 P-----------IPE---ELSAEAKNFILRCFEPDPCDRPSAKDLLQDP 833 (1226)
T ss_pred C-----------CcH---HHHHHHHHHHHHHcCCCcccCccHHHhccCc
Confidence 1 122 3344566899999999999999999998743
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=333.47 Aligned_cols=255 Identities=25% Similarity=0.315 Sum_probs=201.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||+||+|.+. +++.||||++..... .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 5777889999999999999976 588999999976432 22334567899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||++.........
T Consensus 82 ~~~~g~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 157 (364)
T cd05599 82 YLPGGDMMTLLMKKD-TFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT 157 (364)
T ss_pred CCCCcHHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence 999999999997655 689999999999999999999999 9999999999999999999999999998754211100
Q ss_pred -------------------------------------cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCC
Q 001434 939 -------------------------------------SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981 (1078)
Q Consensus 939 -------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~ 981 (1078)
.....+||+.|+|||++.+..++.++||||+||++|||++|..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~ 237 (364)
T cd05599 158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP 237 (364)
T ss_pred cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence 0112469999999999999899999999999999999999999
Q ss_pred CCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHH
Q 001434 982 PVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS---MREVVSMLI 1054 (1078)
Q Consensus 982 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~L~ 1054 (1078)
||.... ............... .++... .....+.+++.+|+. +|.+|++ +++++++-+
T Consensus 238 Pf~~~~----~~~~~~~i~~~~~~~--~~~~~~--------~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~ 298 (364)
T cd05599 238 PFCSDN----PQETYRKIINWKETL--QFPDEV--------PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPF 298 (364)
T ss_pred CCCCCC----HHHHHHHHHcCCCcc--CCCCCC--------CCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCC
Confidence 997433 222222222111100 001111 112235678888986 9999998 999988753
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=339.08 Aligned_cols=362 Identities=29% Similarity=0.423 Sum_probs=235.9
Q ss_pred cEEEcCCcccc-cccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceeeecc
Q 001434 225 RVFRAGQNAIS-GSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303 (1078)
Q Consensus 225 ~~L~l~~n~l~-~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~ 303 (1078)
+-.++++|.++ +.+|.....+++++.|.|...++. .+|++++.+.+|++|.+++|++. .+-..++.++.|+.+++.+
T Consensus 10 rGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~R~ 87 (1255)
T KOG0444|consen 10 RGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIVRD 87 (1255)
T ss_pred ecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhhhc
Confidence 44455566655 445666666666666666666665 56666666666666666666666 3455566666677777776
Q ss_pred ccccc-ccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccccCCC
Q 001434 304 NNLVG-QIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVI 382 (1078)
Q Consensus 304 N~l~~-~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 382 (1078)
|++.. -+|..+..+..|+.||||+|+++ ..|..+..-+++..|+||+|+|..+....|.+++.|-.|+|++|++. ..
T Consensus 88 N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe-~L 165 (1255)
T KOG0444|consen 88 NNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE-ML 165 (1255)
T ss_pred cccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-hc
Confidence 66652 35666666777777777777776 56666666666777777777776544455666777777777777776 34
Q ss_pred CCccccccccCeeeccCccccCCCCcccccccccceeEeeccccc-cCCCCcccccCcceEEEecCCCCCCCCCccccCC
Q 001434 383 PNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT-GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN 461 (1078)
Q Consensus 383 p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~~~~ 461 (1078)
|..+..+.+|++|+|++|.+....-..+..+++|+.|.+++.+-+ .-+|.++..+.+|..+|+|+|++. ++|+.+..+
T Consensus 166 PPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l 244 (1255)
T KOG0444|consen 166 PPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKL 244 (1255)
T ss_pred CHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhh
Confidence 445666777777777777665332233344555555555554433 234555555555555555555555 455555555
Q ss_pred CccceeeeeeccccccCCcCCccccccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccceeec
Q 001434 462 SNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHI 541 (1078)
Q Consensus 462 ~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 541 (1078)
.+|+.|+||+|+|+ .+....+...+|++|+||.|+++ .+|..++.+++|+.|++
T Consensus 245 ~~LrrLNLS~N~it-------------------------eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~ 298 (1255)
T KOG0444|consen 245 RNLRRLNLSGNKIT-------------------------ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYA 298 (1255)
T ss_pred hhhheeccCcCcee-------------------------eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHh
Confidence 55555555555554 22333444566777777777776 67777777777777777
Q ss_pred cccccccC-CCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccCceeeccccccC
Q 001434 542 ANNYFTSE-LPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619 (1078)
Q Consensus 542 ~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 619 (1078)
.+|+++-+ +|+.++.|.+|+++..++|.+. .+|+.++.|..|+.|.|++|++. .+|+.+.-|+.|+.|||.+|.--
T Consensus 299 n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 299 NNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred ccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 77776533 6777788888888888888776 67888888888888888888887 67888888888888888877644
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=319.70 Aligned_cols=254 Identities=24% Similarity=0.316 Sum_probs=203.4
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|+..++||+|+||+||++.+. +++.||+|++...... ......+.+|+.++++++||+|+++++++..++..++||||
T Consensus 2 y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05605 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEec
Confidence 566788999999999999975 5889999999764332 22245677899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++|+|.+++... ...+++..+..++.|++.|+.|||+. +++||||||+||++++++.++|+|||++..... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--~~ 156 (285)
T cd05605 82 MNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE--GE 156 (285)
T ss_pred cCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCC--CC
Confidence 9999999888643 33689999999999999999999998 999999999999999999999999999886542 22
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|+..|+|||.+.+..++.++||||+|+++|||++|+.||............... ..... ...+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~-~~~~~-------~~~~--- 225 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERR-VKEDQ-------EEYS--- 225 (285)
T ss_pred ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHH-hhhcc-------cccC---
Confidence 223457899999999999888999999999999999999999999764433222222222 11110 0000
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~ 1054 (1078)
......+.+++.+||+.||++|| ++++++++-+
T Consensus 226 ---~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~ 263 (285)
T cd05605 226 ---EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPF 263 (285)
T ss_pred ---cccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcC
Confidence 01223467899999999999999 8999988744
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=316.59 Aligned_cols=250 Identities=25% Similarity=0.371 Sum_probs=201.3
Q ss_pred cCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
+|+..+.||+|++|.||+|.++++..+|+|.+..... ....+.+|++++++++||||+++++++...+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM---SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYM 81 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC---CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecC
Confidence 4667778999999999999988778899999864432 2456888999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.+|++|||.++..........
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (256)
T cd05059 82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS 158 (256)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence 99999999986655789999999999999999999998 999999999999999999999999999876542222222
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
....++..|+|||.+.+..++.++||||+|+++||+++ |+.||...... ............ ..+.
T Consensus 159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~-------~~~~--- 224 (256)
T cd05059 159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS----EVVESVSAGYRL-------YRPK--- 224 (256)
T ss_pred CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH----HHHHHHHcCCcC-------CCCC---
Confidence 22234567999999998899999999999999999999 89999654322 122221111110 0000
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.....+.+++.+||+.+|++|||+.++++.|
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 225 ---LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred ---CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 1223478899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=327.69 Aligned_cols=248 Identities=24% Similarity=0.314 Sum_probs=196.9
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHH---HccCCCCceeeEeeEEEecCceEEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILT---LGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~---l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
|+..+.||+|+||.||+|.+. +++.||||++.+... .....+.+.+|+++ +++++||||+++++++.+.+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 455678999999999999976 589999999976532 12233456666554 4667899999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++++|..+++.. .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.+||+|||+++.... .
T Consensus 81 ~E~~~~~~L~~~~~~~--~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~-~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD--VFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG-F 154 (324)
T ss_pred EcCCCCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCC-C
Confidence 9999999999988654 589999999999999999999998 999999999999999999999999999875321 2
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
........|++.|+|||.+.+..++.++||||+||++|||++|+.||.... ............... +..
T Consensus 155 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~----~~~~~~~i~~~~~~~----p~~--- 223 (324)
T cd05589 155 GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD----EEEVFDSIVNDEVRY----PRF--- 223 (324)
T ss_pred CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCC----CCC---
Confidence 223345679999999999999899999999999999999999999997433 223333332221111 111
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSML 1053 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 1053 (1078)
....+.+++.+|++.||++|| ++.+++++-
T Consensus 224 -------~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~ 258 (324)
T cd05589 224 -------LSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQP 258 (324)
T ss_pred -------CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCC
Confidence 123367899999999999999 677877764
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=312.91 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=202.2
Q ss_pred cCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
+|+..+.||+|++|+||.|.++++..||+|.+..... ..+.+.+|+.++++++||||+++++++.+.+..++||||+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM 81 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc---cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence 4666778999999999999988777899999865432 2457899999999999999999999999989999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
.+++|.+++......+++.++..++.||+.|++|||++ +++|+||||+||++++++.+|++|||.++..........
T Consensus 82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~ 158 (256)
T cd05113 82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS 158 (256)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence 99999999986555789999999999999999999998 999999999999999999999999999876543222222
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
....++..|+|||...+..++.++||||+|+++|||++ |..||..... .............. .+.
T Consensus 159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~----~~~~~~~~~~~~~~----~~~------ 224 (256)
T cd05113 159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNN----SETVEKVSQGLRLY----RPH------ 224 (256)
T ss_pred CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCH----HHHHHHHhcCCCCC----CCC------
Confidence 22345678999999988889999999999999999998 9999864432 12222222111100 000
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.....+.+++.+||+.+|++||++.++++.++
T Consensus 225 ---~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 225 ---LASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred ---CCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 01245788999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=330.42 Aligned_cols=257 Identities=21% Similarity=0.262 Sum_probs=204.0
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
..+|+..+.||+|+||.||+|.++ +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.++...++|
T Consensus 42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv 121 (370)
T cd05596 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV 121 (370)
T ss_pred HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence 456788889999999999999976 588999999965422 222345578899999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++|+|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+.......
T Consensus 122 ~Ey~~gg~L~~~l~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~ 196 (370)
T cd05596 122 MEYMPGGDLVNLMSNY--DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG 196 (370)
T ss_pred EcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC
Confidence 9999999999998754 478888899999999999999998 99999999999999999999999999998664332
Q ss_pred CCcccccccccCcccccccccC----CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTM----KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
........||+.|+|||.+.+. .++.++||||+||++|||++|+.||.... .............. .
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~----~~~~~~~i~~~~~~------~ 266 (370)
T cd05596 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYSKIMDHKNS------L 266 (370)
T ss_pred cccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC----HHHHHHHHHcCCCc------C
Confidence 2233456799999999988653 47889999999999999999999997433 22222332221110 0
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFD--RPSMREVVSMLI 1054 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~ 1054 (1078)
.++.. ......+.+++.+|+..+|++ ||++++++++-+
T Consensus 267 ~~~~~----~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~ 306 (370)
T cd05596 267 TFPDD----IEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306 (370)
T ss_pred CCCCc----CCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcc
Confidence 01110 012234678999999999988 999999998854
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=292.37 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=205.0
Q ss_pred hhcCCCccEEeccCceEEEEEE-ECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----c
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-----S 852 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~ 852 (1078)
..+|+..+.+|+|+|+-||.++ ..+++.||+|++.-.. .+..+..++|++..++++||||++++++...+. .
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3467777889999999999998 4468899999997665 245778899999999999999999999875544 3
Q ss_pred eEEEEeeccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccc
Q 001434 853 NLLIYEYMERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 929 (1078)
.|++++|...|+|.+.++.. +..+++.++++|+.+|++||+++|+. .+.++||||||.||++.+.+.+++.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCc
Confidence 89999999999999998643 44799999999999999999999998 234999999999999999999999999999
Q ss_pred cccCCCCCCc--------ccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 001434 930 KVIDMPQSKS--------MSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN 998 (1078)
Q Consensus 930 ~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~ 998 (1078)
+...-..... ......|..|+|||.+. +...+.++||||+||++|+|+.|.-||......+.....+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA-- 254 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA-- 254 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe--
Confidence 7654222111 11234688899999875 4557889999999999999999999997544333222111
Q ss_pred HhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 999 YIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+....+....+. .....+.+++++|+++||.+||++.+++..+++.
T Consensus 255 ----------v~n~q~s~P~~~--~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L 300 (302)
T KOG2345|consen 255 ----------VQNAQISIPNSS--RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL 300 (302)
T ss_pred ----------eeccccccCCCC--CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence 111111111111 1445578999999999999999999999998865
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=318.61 Aligned_cols=249 Identities=23% Similarity=0.300 Sum_probs=198.4
Q ss_pred EeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
||+|+||+||+|.++ +++.||+|++...... ....+.+..|++++++++|++|+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999976 6889999998755332 22345678899999999999999999999999999999999999999
Q ss_pred HhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 866 GELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 866 ~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
.+++.. ....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.++|+|||.+....... .....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~-~~~~~ 156 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ-SKTKG 156 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCC-ccccc
Confidence 988743 233689999999999999999999998 99999999999999999999999999997654222 22334
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+|+++|||++|+.||.................... ..++.
T Consensus 157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~---------- 222 (280)
T cd05608 157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDS----VTYPD---------- 222 (280)
T ss_pred cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccC----CCCcc----------
Confidence 5789999999999999999999999999999999999999975443322222222211110 00011
Q ss_pred HHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~ 1054 (1078)
.....+.+++.+|++.||++|| ++++++++-+
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~ 259 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPL 259 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChh
Confidence 1223467899999999999999 7888888743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=331.73 Aligned_cols=259 Identities=25% Similarity=0.340 Sum_probs=204.3
Q ss_pred hhcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecC
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQG 851 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 851 (1078)
.++|...++||+|+||.||+|.+. .+..||||++..... ....+.+.+|+++++++. ||||+++++++.+.+
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~ 114 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTAR-SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG 114 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence 457778889999999999999853 134799999965433 334567899999999996 999999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCC----------------------------------------------------------
Q 001434 852 SNLLIYEYMERGSLGELLHGSS---------------------------------------------------------- 873 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 873 (1078)
..++||||+++|+|.++++...
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (400)
T cd05105 115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI 194 (400)
T ss_pred ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence 9999999999999999886421
Q ss_pred -------------------------------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEEC
Q 001434 874 -------------------------------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD 916 (1078)
Q Consensus 874 -------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 916 (1078)
..+++.++..++.|+++|++|||+. +|+||||||+||+++
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~ 271 (400)
T cd05105 195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA 271 (400)
T ss_pred hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence 1367778889999999999999998 999999999999999
Q ss_pred CCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHH
Q 001434 917 DKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLAT 994 (1078)
Q Consensus 917 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~ 994 (1078)
.++.+|++|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |..||...........
T Consensus 272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~ 351 (400)
T cd05105 272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN 351 (400)
T ss_pred CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence 999999999999986532211 12223456788999999998899999999999999999997 9999975433222221
Q ss_pred HHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 995 WVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
. ....... ..+ ......+.+++.+||+.+|++||++.++.+.|+++.
T Consensus 352 ~----~~~~~~~------~~~------~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~ 398 (400)
T cd05105 352 K----IKSGYRM------AKP------DHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL 398 (400)
T ss_pred H----HhcCCCC------CCC------ccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence 1 1111100 000 012345778999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=318.48 Aligned_cols=248 Identities=34% Similarity=0.532 Sum_probs=193.6
Q ss_pred ccEEeccCceEEEEEEEC-----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 785 SFIVGSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+.||.|.||.||+|.+. .+..|+||.+.... .....+.+.+|++.+++++||||+++++++...+..++||||
T Consensus 4 ~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 4 IKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS-SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS-SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred eeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc-ccccceeeeecccccccccccccccccccccccccccccccc
Confidence 467999999999999976 36789999995532 233478899999999999999999999999988889999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC-CC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP-QS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~-~~ 937 (1078)
+++|+|.+++... ...+++.++..|+.||++||+|||++ +++|+||+++||++++++.+||+|||++...... ..
T Consensus 83 ~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 83 CPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp -TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence 9999999999876 55799999999999999999999999 9999999999999999999999999999876211 11
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
...........|+|||.+.+..++.++||||||+++||+++ |+.||... ....+......... . ..+.
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~----~~~~~~~~~~~~~~-~------~~~~ 228 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY----DNEEIIEKLKQGQR-L------PIPD 228 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS----CHHHHHHHHHTTEE-T------TSBT
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc----cccccccccccccc-c------eecc
Confidence 22233456788999999999999999999999999999999 78898644 23333333322111 1 0000
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.....+.+++.+||+.+|++|||++++++.|
T Consensus 229 ------~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 229 ------NCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ------TSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred ------chhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 1123467899999999999999999999875
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=327.87 Aligned_cols=245 Identities=23% Similarity=0.327 Sum_probs=196.9
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
++||+|+||+||+|.++ +++.||+|++.+... .....+.+.+|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 588999999976432 223345677888888776 699999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||++..... .......
T Consensus 81 g~L~~~i~~~~-~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (320)
T cd05590 81 GDLMFHIQKSR-RFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF-NGKTTST 155 (320)
T ss_pred chHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc-CCCcccc
Confidence 99999987655 689999999999999999999998 999999999999999999999999999875421 1222344
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ............... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~----~~~~~~~i~~~~~~~----~~~--------- 218 (320)
T cd05590 156 FCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN----EDDLFEAILNDEVVY----PTW--------- 218 (320)
T ss_pred cccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC----HHHHHHHHhcCCCCC----CCC---------
Confidence 679999999999998899999999999999999999999997433 223333332221111 111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCH------HHHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSM------REVVSML 1053 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~------~ell~~L 1053 (1078)
....+.+++.+|++.||++||++ ++++++-
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~ 254 (320)
T cd05590 219 -LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHP 254 (320)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCC
Confidence 12346789999999999999998 6777653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=329.68 Aligned_cols=245 Identities=21% Similarity=0.251 Sum_probs=198.3
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
+.||+|+||.||+|.+. +++.||+|++..... .......+.+|++++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999975 688999999976532 2233456788999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
+|.+++.... .+++.++..++.||+.||+|||+ + +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (325)
T cd05594 81 ELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK-DGATMKT 155 (325)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCC-CCccccc
Confidence 9999887654 68999999999999999999997 6 999999999999999999999999999875321 1222334
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+||++|||++|+.||.... .............. ++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~----~~~~~~~i~~~~~~----~p~~--------- 218 (325)
T cd05594 156 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD----HEKLFELILMEEIR----FPRT--------- 218 (325)
T ss_pred ccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC----HHHHHHHHhcCCCC----CCCC---------
Confidence 579999999999999999999999999999999999999996432 22222222211110 0111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRP-----SMREVVSML 1053 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L 1053 (1078)
....+.+++.+|++.||++|+ ++.+++++-
T Consensus 219 -~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~ 253 (325)
T cd05594 219 -LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHK 253 (325)
T ss_pred -CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCC
Confidence 123467899999999999996 899998774
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=324.50 Aligned_cols=249 Identities=20% Similarity=0.305 Sum_probs=196.9
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||.||+|.++ +++.||+|++.+.... ......+.+|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 5789999999865332 23345677888888776 799999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (329)
T cd05618 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-PGDTTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccC-CCCcccc
Confidence 99999887654 689999999999999999999998 999999999999999999999999999875322 1222345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC----CCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG----GDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
..||+.|+|||.+.+..++.++||||+|+++|||++|+.||...... .....+....+..... .++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~-------~~p~-- 226 (329)
T cd05618 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-------RIPR-- 226 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC-------CCCC--
Confidence 67999999999999999999999999999999999999999642211 1222222222221111 1111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPS------MREVVSM 1052 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~ell~~ 1052 (1078)
.....+.+++.+|++.||++||+ ++++++|
T Consensus 227 ----~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05618 227 ----SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH 262 (329)
T ss_pred ----CCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence 11234668999999999999998 5777766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=316.99 Aligned_cols=245 Identities=26% Similarity=0.325 Sum_probs=194.8
Q ss_pred EeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
||+|+||.||++..+ +|+.||+|++...... ......+..|++++++++||||+++++++.++...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999976 5899999999654322 12234556799999999999999999999999999999999999999
Q ss_pred HhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccc
Q 001434 866 GELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA 944 (1078)
Q Consensus 866 ~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 944 (1078)
.+++.... ..+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+...... .......
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~ 155 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA 155 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence 98886433 3588899999999999999999998 9999999999999999999999999998765422 2223456
Q ss_pred cccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHH
Q 001434 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024 (1078)
Q Consensus 945 gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1078)
|+..|+|||.+.+..++.++||||+||++|||++|+.||..................... ..... ..
T Consensus 156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----------~~~~~---~~ 222 (277)
T cd05607 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV----------KFEHQ---NF 222 (277)
T ss_pred CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccc----------ccccc---cC
Confidence 899999999999888999999999999999999999999754433332333222221110 00000 12
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHH
Q 001434 1025 MILVLKVALMCTSISPFDRPSMREVV 1050 (1078)
Q Consensus 1025 ~~~l~~li~~cl~~dP~~RPs~~ell 1050 (1078)
...+.+++.+||+.||++||+++|++
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccch
Confidence 23467899999999999999996554
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=322.86 Aligned_cols=244 Identities=23% Similarity=0.321 Sum_probs=193.2
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHcc-CCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
++||+|+||+||+|.+. +++.||+|+++.... .....+.+..|..++.. .+||||+++++++..++..++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 578899999976532 12234455566666664 4899999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++..... ......
T Consensus 81 g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~-~~~~~~ 155 (316)
T cd05592 81 GDLMFHIQSSG-RFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC-CCcccc
Confidence 99999987654 688999999999999999999998 9999999999999999999999999999754322 233345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||..... .............. +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~----~~~--------- 218 (316)
T cd05592 156 FCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE----DELFDSILNDRPHF----PRW--------- 218 (316)
T ss_pred ccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCCC----CCC---------
Confidence 6799999999999988999999999999999999999999975432 22222222211111 111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSMR-EVVSM 1052 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~~-ell~~ 1052 (1078)
....+.+++.+||+.||++||++. +++++
T Consensus 219 -~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05592 219 -ISKEAKDCLSKLFERDPTKRLGVDGDIRQH 248 (316)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 123366899999999999999875 56554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=332.13 Aligned_cols=265 Identities=23% Similarity=0.279 Sum_probs=202.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----ceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-----SNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 854 (1078)
+|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 3667788999999999999975 6899999998765443344567889999999999999999999998776 789
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+. ++|.+++.... .+++..+..++.||+.||+|||++ +++||||||+||+++.++.+||+|||+++....
T Consensus 81 lv~e~~~-~~l~~~~~~~~-~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~ 155 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSPQ-PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155 (372)
T ss_pred EEeeccc-cCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence 9999997 48888876544 689999999999999999999998 999999999999999999999999999986543
Q ss_pred CCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH-----------------
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV----------------- 996 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~----------------- 996 (1078)
..........+++.|+|||.+.+. .++.++||||+||++|||++|+.||...........+.
T Consensus 156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 235 (372)
T cd07853 156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235 (372)
T ss_pred CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence 333334445688999999988764 47899999999999999999999997544222111111
Q ss_pred -HHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 997 -RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 997 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..................... ......+.+++.+|++.||++|||++|++++-+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~ 290 (372)
T cd07853 236 ARAHILRGPHKPPSLPVLYTLS----SQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290 (372)
T ss_pred HHHHHHhCCCCCCchHHhcccC----CCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHh
Confidence 001100000000000000000 011345778999999999999999999998765
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=323.56 Aligned_cols=245 Identities=20% Similarity=0.318 Sum_probs=198.0
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
++||+|+||.||+|.++ +++.||+|++..... .....+.+..|.+++..+ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 35999999999999976 478999999976532 223345677888888765 799999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (321)
T cd05591 81 GDLMFQIQRSR-KFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL-NGVTTTT 155 (321)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceeccc-CCccccc
Confidence 99999987654 688899999999999999999999 999999999999999999999999999875432 1222344
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+|+++|||++|+.||..... .............. +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~----~~~~~~i~~~~~~~----p~~--------- 218 (321)
T cd05591 156 FCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE----DDLFESILHDDVLY----PVW--------- 218 (321)
T ss_pred cccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCH----HHHHHHHHcCCCCC----CCC---------
Confidence 6789999999999988999999999999999999999999975432 22333332221111 111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCC-------CHHHHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRP-------SMREVVSML 1053 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RP-------s~~ell~~L 1053 (1078)
....+.+++.+|++.||++|| ++++++++-
T Consensus 219 -~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp 255 (321)
T cd05591 219 -LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHP 255 (321)
T ss_pred -CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCC
Confidence 113467899999999999999 889998774
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=324.88 Aligned_cols=249 Identities=20% Similarity=0.289 Sum_probs=198.5
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
++||+|+||.||+|.++ +++.||+|++++.... ....+.+.+|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999976 5889999999765432 23345678899999888 799999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 g~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~-~~~~~~~ 155 (329)
T cd05588 81 GDLMFHMQRQR-KLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR-PGDTTST 155 (329)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCcccccccc-CCCcccc
Confidence 99999887554 689999999999999999999998 999999999999999999999999999874321 1223345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC----CCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG----GDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||...... .....+..+.+...... ++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~----- 227 (329)
T cd05588 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---IPRS----- 227 (329)
T ss_pred ccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---CCCC-----
Confidence 67999999999999999999999999999999999999999643211 12222222222222111 0111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPS------MREVVSM 1052 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs------~~ell~~ 1052 (1078)
....+.+++.+|++.||++||+ +++++++
T Consensus 228 -----~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h 262 (329)
T cd05588 228 -----LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH 262 (329)
T ss_pred -----CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence 1234678999999999999997 6788766
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=316.92 Aligned_cols=254 Identities=28% Similarity=0.444 Sum_probs=206.7
Q ss_pred hhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
..+|+..+.||.|++|.||+|.+++++.+|+|++..... .....+.+|+.+++.++|+||+++++++.+.+..++|||
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 456777788999999999999988889999999876543 235578899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 859 YMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+++++|.+++... ...+++.++..++.|++.|++|||++ +++||||+|+||++++++.+|++|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999764 34689999999999999999999998 999999999999999999999999999986643222
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
. .....++..|+|||...+..++.++||||+|+++|+|++ |+.||...... ............ ..+
T Consensus 160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~-------~~~- 226 (261)
T cd05148 160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH----EVYDQITAGYRM-------PCP- 226 (261)
T ss_pred c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH----HHHHHHHhCCcC-------CCC-
Confidence 1 223445778999999988889999999999999999998 89999654322 222222211110 000
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
......+.+++.+|++.||++|||++++++.|+.
T Consensus 227 -----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~ 260 (261)
T cd05148 227 -----AKCPQEIYKIMLECWAAEPEDRPSFKALREELDN 260 (261)
T ss_pred -----CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence 0112346789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=330.16 Aligned_cols=244 Identities=25% Similarity=0.288 Sum_probs=197.0
Q ss_pred cEEeccCceEEEEEEE----CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 786 FIVGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
+.||+|+||.||++.. .+|+.||+|++............+.+|++++++++||||+++++++.+++..|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999875 257899999997654433345567889999999999999999999999999999999999
Q ss_pred CCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccc
Q 001434 862 RGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941 (1078)
Q Consensus 862 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 941 (1078)
+|+|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++...... .....
T Consensus 82 ~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~-~~~~~ 156 (318)
T cd05582 82 GGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH-EKKAY 156 (318)
T ss_pred CCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCC-CCcee
Confidence 999999997654 689999999999999999999998 9999999999999999999999999998765322 12233
Q ss_pred ccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhH
Q 001434 942 AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESI 1021 (1078)
Q Consensus 942 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1021 (1078)
...|++.|+|||.+.+..++.++||||+|+++|||++|+.||.... .............. ++..
T Consensus 157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~----~~~~~~~i~~~~~~----~p~~-------- 220 (318)
T cd05582 157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD----RKETMTMILKAKLG----MPQF-------- 220 (318)
T ss_pred cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC----HHHHHHHHHcCCCC----CCCC--------
Confidence 4678999999999988889999999999999999999999996432 22222222221110 0111
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 001434 1022 VDHMILVLKVALMCTSISPFDRPS-----MREVVSM 1052 (1078)
Q Consensus 1022 ~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 1052 (1078)
....+.+++.+||+.||++||+ +.+++++
T Consensus 221 --~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~ 254 (318)
T cd05582 221 --LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH 254 (318)
T ss_pred --CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence 1233678999999999999999 4555544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=311.84 Aligned_cols=253 Identities=25% Similarity=0.387 Sum_probs=203.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|...+.||+|++|.||+|.++ .++.||+|++.... ...+.+.+|++.+++++|+||+++++++..++..++||||
T Consensus 7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (263)
T cd05052 7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEF 83 (263)
T ss_pred HeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEe
Confidence 4666778999999999999976 48889999986442 2356788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... ...+++..+..++.|+++|++|||++ +++||||||+||++++++.+|++|||.+.........
T Consensus 84 ~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 84 MTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999998754 33689999999999999999999998 9999999999999999999999999999876433222
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||.+.+..++.++||||+|+++|||++ |..||.... ............. ...+.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~----~~~~~~~~~~~~~-------~~~~~- 228 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYELLEKGYR-------MERPE- 228 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHHHCCCC-------CCCCC-
Confidence 2222334678999999988899999999999999999998 899986432 2222222211110 01110
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+.+++.+|++.+|++||++.++++.|+.+
T Consensus 229 -----~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 229 -----GCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred -----CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 1123477899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=328.23 Aligned_cols=269 Identities=27% Similarity=0.320 Sum_probs=202.6
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 851 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 851 (1078)
...+|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3467888899999999999999975 5889999999766544455667889999999999999999999886543
Q ss_pred -ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 852 -SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 852 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
..++||||+++ ++.+.+.. .++..++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~ 171 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIHM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 171 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHhc---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCcc
Confidence 46899999976 67776643 478888999999999999999999 99999999999999999999999999997
Q ss_pred ccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHH---------------
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATW--------------- 995 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~--------------- 995 (1078)
.... ........||+.|+|||.+.+..++.++||||+|+++|+|++|+.||...+........
T Consensus 172 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (359)
T cd07876 172 TACT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249 (359)
T ss_pred cccc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence 5432 22234457899999999999999999999999999999999999999754322111111
Q ss_pred ---HHHHhhcCCCCCccc-cC---C--CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 996 ---VRNYIRDHSLTPGIF-DT---R--LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 996 ---~~~~~~~~~~~~~~~-~~---~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
+..+....+...... .. . .+...+........+.+++.+|++.||++|||++|++++-+-
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~ 318 (359)
T cd07876 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318 (359)
T ss_pred HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence 111111111000000 00 0 000000000112447899999999999999999999998763
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=322.30 Aligned_cols=244 Identities=23% Similarity=0.297 Sum_probs=194.1
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHcc-CCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||.||+|.++ +++.||+|++..... .....+.+..|..++.. .+||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999976 588999999976532 12234556677777765 4899999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++.... .......
T Consensus 81 g~L~~~i~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (316)
T cd05620 81 GDLMFHIQDKG-RFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF-GDNRAST 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeeccc-CCCceec
Confidence 99999987654 688999999999999999999998 999999999999999999999999999874321 1223345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+||++|||++|+.||...+ ............... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~----~~~~~~~~~~~~~~~----~~~--------- 218 (316)
T cd05620 156 FCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD----EDELFESIRVDTPHY----PRW--------- 218 (316)
T ss_pred cCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCC----CCC---------
Confidence 679999999999999999999999999999999999999996433 222222222211111 110
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCH-HHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSM-REVVSM 1052 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~-~ell~~ 1052 (1078)
....+.+++.+|++.||++||++ +++++|
T Consensus 219 -~~~~~~~li~~~l~~dP~~R~~~~~~~~~h 248 (316)
T cd05620 219 -ITKESKDILEKLFERDPTRRLGVVGNIRGH 248 (316)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence 12346789999999999999997 466644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=320.21 Aligned_cols=259 Identities=24% Similarity=0.399 Sum_probs=203.9
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCc----EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||.||+|.+. +++ .||+|++..... ....+.+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 45777889999999999999864 233 489999865432 33456788999999999999999999998764 578
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+|+||+++|+|.+++......+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++....
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999999987666788999999999999999999998 999999999999999999999999999987643
Q ss_pred CCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.... ...+. .........+. +
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~----~~~~~-~~~~~~~~~~~--~- 233 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEIS-SILEKGERLPQ--P- 233 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC----HHHHH-HHHhCCCCCCC--C-
Confidence 2221 1122334678999999999999999999999999999998 999996432 22221 22221111000 0
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccC
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1060 (1078)
+ .....+.+++.+||..+|++||++.+++..+.++....
T Consensus 234 --~-------~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~ 272 (316)
T cd05108 234 --P-------ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP 272 (316)
T ss_pred --C-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence 0 01224678999999999999999999999999885544
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=319.47 Aligned_cols=254 Identities=28% Similarity=0.470 Sum_probs=203.1
Q ss_pred cCCCccEEeccCceEEEEEEECC------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
+|+..+.||+|+||.||+|.+.. ...||+|.+..... ......+.+|++.+++++||||+++++++.+.+..+
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC-HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 56677789999999999998643 25799998865433 334567899999999999999999999999999999
Q ss_pred EEEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC
Q 001434 855 LIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF 919 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~ 919 (1078)
++|||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence 9999999999999986432 3577888999999999999999998 999999999999999999
Q ss_pred ceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHH
Q 001434 920 EAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVR 997 (1078)
Q Consensus 920 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~ 997 (1078)
.++|+|||++........ .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||...... +...
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~----~~~~ 237 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ----EVIE 237 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH----HHHH
Confidence 999999999876532221 22233456788999999988899999999999999999998 99999754322 2222
Q ss_pred HHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 998 NYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
...... ... .+ ......+.+++.+||+.||++||++++++++|+.
T Consensus 238 ~i~~~~-~~~------~~------~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05048 238 MIRSRQ-LLP------CP------EDCPARVYALMIECWNEIPARRPRFKDIHTRLRS 282 (283)
T ss_pred HHHcCC-cCC------Cc------ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence 221111 110 00 1223457899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=325.77 Aligned_cols=249 Identities=21% Similarity=0.323 Sum_probs=198.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCC-CceeeEeeEEEecCceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRH-RNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~ 857 (1078)
+|+..+.||+|+||.||+|.++ +++.||+|++.+... .....+.+..|.+++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 3667788999999999999976 478899999976532 22345677889999998876 56888999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++..... ..
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~-~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-KFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-GG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC-CC
Confidence 9999999999987655 588899999999999999999998 999999999999999999999999999875321 12
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||..... ............. ++..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~----~~~~~~i~~~~~~----~~~~---- 223 (324)
T cd05587 156 KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE----DELFQSIMEHNVS----YPKS---- 223 (324)
T ss_pred CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCCC----CCCC----
Confidence 223446799999999999999999999999999999999999999974432 2222222221110 0111
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSM-----REVVSM 1052 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 1052 (1078)
....+.+++.+|++.||++|++. +++.++
T Consensus 224 ------~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h 257 (324)
T cd05587 224 ------LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH 257 (324)
T ss_pred ------CCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence 12346789999999999999976 677665
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=321.22 Aligned_cols=259 Identities=24% Similarity=0.377 Sum_probs=215.1
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC---CCc--EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD---SGK--IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~---~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 852 (1078)
.+..+...+.||.|.||.||+|... .|+ .||||.-+..... +..+.|.+|+.+|++++||||++++|+|.+ ..
T Consensus 387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~~e-~P 464 (974)
T KOG4257|consen 387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QP 464 (974)
T ss_pred ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeeeec-cc
Confidence 3445566778999999999999843 233 5788888776543 347899999999999999999999999975 57
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
.+||||.++-|.|..|++.+...++......++.||..|++|||++ .+|||||..+|||+....-||++|||+++.+
T Consensus 465 ~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ 541 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYL 541 (974)
T ss_pred eeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhc
Confidence 8999999999999999999888899999999999999999999999 9999999999999999999999999999998
Q ss_pred CCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.++.....+...-...|||||.+.-.+++.++|||.|||++||++. |..||.+..+.+.+-.+ +.+..
T Consensus 542 ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~i-----EnGeR------ 610 (974)
T KOG4257|consen 542 EDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHI-----ENGER------ 610 (974)
T ss_pred cccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEe-----cCCCC------
Confidence 8666666665566778999999999999999999999999999997 99999987655432221 11110
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
++ .+ ..++..++.++.+||..+|.+||++.++...|.++..
T Consensus 611 --lP-~P---~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 611 --LP-CP---PNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred --CC-CC---CCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 00 01 1223447789999999999999999999999987744
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=326.84 Aligned_cols=254 Identities=23% Similarity=0.318 Sum_probs=196.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||+||+|.+. +++.||+|++.+... .......+.+|+.++.+++|++|+++++.+.+....++|||
T Consensus 2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E 81 (363)
T cd05628 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME 81 (363)
T ss_pred CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence 5777889999999999999976 588999999976432 22334677889999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 937 (1078)
|++||+|.+++...+ .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~ 157 (363)
T cd05628 82 FLPGGDMMTLLMKKD-TLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT 157 (363)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence 999999999998655 689999999999999999999998 999999999999999999999999999875431110
Q ss_pred ---------------------------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 001434 938 ---------------------------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984 (1078)
Q Consensus 938 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~ 984 (1078)
......+||+.|+|||.+.+..++.++||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~ 237 (363)
T cd05628 158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (363)
T ss_pred cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence 00123579999999999999999999999999999999999999996
Q ss_pred CCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCC--CCCCCCCCHHHHHHH
Q 001434 985 PLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTS--ISPFDRPSMREVVSM 1052 (1078)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dP~~RPs~~ell~~ 1052 (1078)
.... ............ . ..+++..+. .....+++.+++. .++..||+++|++++
T Consensus 238 ~~~~----~~~~~~i~~~~~-~-~~~p~~~~~--------s~~~~~li~~l~~~~~~r~~r~~~~ei~~h 293 (363)
T cd05628 238 SETP----QETYKKVMNWKE-T-LIFPPEVPI--------SEKAKDLILRFCCEWEHRIGAPGVEEIKTN 293 (363)
T ss_pred CCCH----HHHHHHHHcCcC-c-ccCCCcCCC--------CHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence 4332 222222221110 0 001111111 1124455655443 344457999999998
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=326.25 Aligned_cols=244 Identities=26% Similarity=0.290 Sum_probs=193.2
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHH-HHccCCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEIL-TLGKIRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||+||+|.++ +++.||+|++...... ......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999976 6899999999754321 222334445544 56789999999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (323)
T cd05575 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE-HSKTTST 155 (323)
T ss_pred CCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCccccc-CCCcccc
Confidence 99999987654 688899999999999999999998 999999999999999999999999999875321 2223345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+||++|||++|+.||.... .............. ..+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~----~~~~~~~i~~~~~~----~~~~--------- 218 (323)
T cd05575 156 FCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----TAEMYDNILNKPLR----LKPN--------- 218 (323)
T ss_pred ccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCC----HHHHHHHHHcCCCC----CCCC---------
Confidence 679999999999999999999999999999999999999997432 23333333221110 0111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCH----HHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSM----REVVSM 1052 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~----~ell~~ 1052 (1078)
....+.+++.+|++.||++||++ .+++++
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~ 251 (323)
T cd05575 219 -ISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH 251 (323)
T ss_pred -CCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence 12346789999999999999987 466554
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=324.65 Aligned_cols=259 Identities=26% Similarity=0.403 Sum_probs=202.3
Q ss_pred hcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec-C
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ-G 851 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~-~ 851 (1078)
.+|+..++||+|+||.||+|.+. +++.||+|++..... ....+.+.+|+.+++++ +|+||+++++++... .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 35677788999999999999742 357899999875433 23346678899999999 799999999988654 5
Q ss_pred ceEEEEeeccCCCHHhHhcCCC----------------------------------------------------------
Q 001434 852 SNLLIYEYMERGSLGELLHGSS---------------------------------------------------------- 873 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 873 (1078)
..+++|||+++++|.+++....
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 6789999999999999985321
Q ss_pred --CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-CcccccccccCcc
Q 001434 874 --CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYI 950 (1078)
Q Consensus 874 --~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~ 950 (1078)
..+++..+..++.||+.|++|||++ +|+||||||+||++++++.++|+|||++..+..... .......++..|+
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 1578889999999999999999998 999999999999999999999999999987532221 1222345677899
Q ss_pred cccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHH
Q 001434 951 APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVL 1029 (1078)
Q Consensus 951 aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1029 (1078)
|||.+.+..++.++||||+||++|||++ |..||......+...... ...... ..+ . .....+.
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~----~~~~~~------~~~---~---~~~~~~~ 306 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRL----KEGTRM------RAP---E---YATPEIY 306 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHH----hccCCC------CCC---c---cCCHHHH
Confidence 9999999999999999999999999998 999997543332222221 111100 000 0 1123477
Q ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1030 KVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1030 ~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
+++.+||+.+|++||++.+++++|.++..
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 89999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=334.15 Aligned_cols=255 Identities=23% Similarity=0.304 Sum_probs=198.8
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||+||+|.+. +++.||||++.+... .....+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 5777889999999999999975 688999999865432 22345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||+++.+......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~ 157 (377)
T cd05629 82 FLPGGDLMTMLIKYD-TFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS 157 (377)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999997654 688889999999999999999999 9999999999999999999999999998643210000
Q ss_pred ----------------------------------------------cccccccccCcccccccccCCCCCcCcchhHHHH
Q 001434 939 ----------------------------------------------SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVV 972 (1078)
Q Consensus 939 ----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~ 972 (1078)
......||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi 237 (377)
T cd05629 158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI 237 (377)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence 0012469999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCC---CCHHHH
Q 001434 973 LLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDR---PSMREV 1049 (1078)
Q Consensus 973 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~el 1049 (1078)
+|||++|..||..... ............ .. .++.. ......+.+++.+|+. +|.+| +++.++
T Consensus 238 l~elltG~~Pf~~~~~----~~~~~~i~~~~~---~~---~~p~~----~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~ 302 (377)
T cd05629 238 MFECLIGWPPFCSENS----HETYRKIINWRE---TL---YFPDD----IHLSVEAEDLIRRLIT-NAENRLGRGGAHEI 302 (377)
T ss_pred hhhhhcCCCCCCCCCH----HHHHHHHHccCC---cc---CCCCC----CCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence 9999999999964332 222222221100 00 00100 0112346788999997 67665 599999
Q ss_pred HHHHH
Q 001434 1050 VSMLI 1054 (1078)
Q Consensus 1050 l~~L~ 1054 (1078)
+++-+
T Consensus 303 l~hp~ 307 (377)
T cd05629 303 KSHPF 307 (377)
T ss_pred hcCCC
Confidence 98853
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-34 Score=326.78 Aligned_cols=268 Identities=22% Similarity=0.287 Sum_probs=202.4
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec------
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------ 850 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 850 (1078)
...+|...+.||+|+||.||+|.+. .++.||||++..........+.+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3457888889999999999999976 588999999977655445567788999999999999999999987543
Q ss_pred CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 851 GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
...++||||+++ ++.+.+.. .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~ 174 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 174 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHHh---cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence 356999999975 78777753 478888999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH------------
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN------------ 998 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~------------ 998 (1078)
.... ........|++.|+|||.+.+..++.++||||+||++|||++|+.||...+........+..
T Consensus 175 ~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (364)
T cd07875 175 TAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 252 (364)
T ss_pred ccCC--CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence 6542 22234457899999999999999999999999999999999999999754432222211110
Q ss_pred ------HhhcCCCCCcc-----ccC-CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 999 ------YIRDHSLTPGI-----FDT-RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 999 ------~~~~~~~~~~~-----~~~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
+....+..... +.. ..+...+........+.+++.+|++.||++|||+.+++++-+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~ 320 (364)
T cd07875 253 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPY 320 (364)
T ss_pred hHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcc
Confidence 00000000000 000 000000000011235779999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=309.73 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=203.0
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|+||.||+|.++++..||+|++..... ..+.+.+|++++++++||||+++++++. ++..++||||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY 81 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc---CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence 35777788999999999999987777899999975433 2457889999999999999999998875 4567999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++|+|.+++... ...+++..+..++.|++.||+|+|+. +++||||||+||++++++.++|+|||.++........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT 158 (262)
T ss_pred CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence 9999999999753 33578999999999999999999998 9999999999999999999999999999866533322
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||...+..++.++||||+|+++||+++ |..||...... ............ ...
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~----~~~~~~~~~~~~-------~~~-- 225 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR----EVLDQVERGYRM-------PCP-- 225 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH----HHHHHHhcCCCC-------CCc--
Confidence 2233456778999999988899999999999999999999 88888644322 222221111110 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
......+.+++.+|++.+|++||+++++++.|++.
T Consensus 226 ----~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 226 ----PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred ----cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 12234577999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-34 Score=319.49 Aligned_cols=244 Identities=23% Similarity=0.343 Sum_probs=193.9
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHcc-CCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||+||+|.+. +++.||+|++..... .....+.+..|..++.. .+||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 478999999976532 12234456677777775 4899999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++..... .......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (316)
T cd05619 81 GDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENML-GDAKTCT 155 (316)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCC-CCCceee
Confidence 99999997654 688999999999999999999998 999999999999999999999999999875321 1222344
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ............... +..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~i~~~~~~~----~~~--------- 218 (316)
T cd05619 156 FCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD----EEELFQSIRMDNPCY----PRW--------- 218 (316)
T ss_pred ecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCC----Ccc---------
Confidence 678999999999998899999999999999999999999997533 222222222111110 111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHH-HHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSMR-EVVSM 1052 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~~-ell~~ 1052 (1078)
....+.+++.+|++.||++||++. ++.++
T Consensus 219 -~~~~~~~li~~~l~~~P~~R~~~~~~l~~h 248 (316)
T cd05619 219 -LTREAKDILVKLFVREPERRLGVKGDIRQH 248 (316)
T ss_pred -CCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence 123467899999999999999997 67654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=309.68 Aligned_cols=260 Identities=21% Similarity=0.305 Sum_probs=207.4
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||.||+|+++ +++.||||++..... .......+.+|++++++++||||+++++++.+.+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 35777888999999999999975 689999998865432 2334567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 858 EYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
||+++++|.+++.. ....++...+..++.|+++|++|||++ +++|+||||+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 99999999988753 233578889999999999999999998 999999999999999999999999999886542
Q ss_pred CCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.. .......+++.|+|||...+..++.++||||+|+++|||++|+.||.... .....+.... .....++ .
T Consensus 159 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~--~~~~~~~~~~-~~~~~~~------~ 228 (267)
T cd08228 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLFSLCQKI-EQCDYPP------L 228 (267)
T ss_pred hh-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc--ccHHHHHHHH-hcCCCCC------C
Confidence 21 12233568889999999988889999999999999999999999986432 1222222222 1111111 0
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
. . ......+.+++.+||+.+|++||++.++++.++.++
T Consensus 229 ~--~---~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 229 P--T---EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred C--h---hhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 0 0 122345788999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=316.60 Aligned_cols=266 Identities=24% Similarity=0.338 Sum_probs=196.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC---CCCceeeEeeEEEe-----cC
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI---RHRNIVKLYGFCYH-----QG 851 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~-----~~ 851 (1078)
+|+..+.||+|+||+||+|.++ +++.||+|.+............+.+|+.+++++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 3667788999999999999976 588999999876543333334555677666655 79999999998864 24
Q ss_pred ceEEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
..++||||+.+ +|.+++.... ..+++.++..++.|++.|++|+|++ +++||||||+||+++.++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~ 156 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLAR 156 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccc
Confidence 57899999985 8988887543 3589999999999999999999999 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhh--cCCCC--
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR--DHSLT-- 1006 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~-- 1006 (1078)
..... .......|+..|+|||.+.+..++.++||||+||++|||++|++||.................. ...++
T Consensus 157 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 157 IYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 66422 2233456899999999999889999999999999999999999999654332222222111000 00000
Q ss_pred ----CccccCCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 ----PGIFDTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ----~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...+....... .+...+....+.+++.+|++.||++|||+.|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h 285 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH 285 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00000000000 01111233457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=320.99 Aligned_cols=268 Identities=23% Similarity=0.359 Sum_probs=203.8
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||.||+|.++ ++..+|+|.+..... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 46777888999999999999987 578889998865432 3345678999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++.... .+++..+..++.|++.|++|||+. .+++||||||+||+++.++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~--- 157 (333)
T cd06650 84 HMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--- 157 (333)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh---
Confidence 999999999997654 588889999999999999999974 27999999999999999999999999998765321
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc---------
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI--------- 1009 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~--------- 1009 (1078)
......|+..|+|||.+.+..++.++||||+||++|||++|+.||...... ...................
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-ELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-HHHHHhcCcccCCccccccCcccCCccc
Confidence 223456899999999998888999999999999999999999999743321 1111100000000000000
Q ss_pred ----ccCCCCc--chhhHH--------------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1010 ----FDTRLNV--EDESIV--------------DHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1010 ----~~~~~~~--~~~~~~--------------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..+...+ ...... ....++.+++.+||+.||++|||++|++++-+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~ 302 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHH
Confidence 0000000 000000 012457899999999999999999999887664
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-34 Score=337.14 Aligned_cols=254 Identities=24% Similarity=0.285 Sum_probs=205.3
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC------
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 851 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 851 (1078)
..+|...+.||+|+||+||+|.+. +++.||||++............+.+|+..+..++|++++++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~ 110 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPEN 110 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCccc
Confidence 357888889999999999999865 6899999999776555555677889999999999999999988775432
Q ss_pred --ceEEEEeeccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeec
Q 001434 852 --SNLLIYEYMERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 926 (1078)
Q Consensus 852 --~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 926 (1078)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+||
T Consensus 111 ~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 111 VLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred ceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEec
Confidence 257999999999999998643 23688899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCC-CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCC
Q 001434 927 GLAKVIDMPQ-SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL 1005 (1078)
Q Consensus 927 g~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1078)
|+++.+.... ........||+.|+|||.+.+..++.++||||+||++|||++|+.||... ...............
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~----~~~~~~~~~~~~~~~ 263 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE----NMEEVMHKTLAGRYD 263 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHhcCCCC
Confidence 9998654222 22234567999999999999999999999999999999999999999643 333343333322110
Q ss_pred CCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1006 TPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+ ++.. ....+.+++.+||+.||++||++++++++
T Consensus 264 ~---~~~~----------~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 264 P---LPPS----------ISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred C---CCCC----------CCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 0 0111 12347789999999999999999999876
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=324.65 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=197.8
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||+||+|.++ +++.||+|++.+... .......+.+|..+++.+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 478999999976532 223345677888888877 699999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++++++.++|+|||+++.... .......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (318)
T cd05570 81 GDLMFHIQRSG-RFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL-GGVTTST 155 (318)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCc-CCCcccc
Confidence 99999987664 689999999999999999999998 999999999999999999999999999875321 1222334
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+||++|+|++|+.||.... .............. ++..
T Consensus 156 ~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~----~~~~~~~i~~~~~~----~~~~--------- 218 (318)
T cd05570 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD----EDELFQSILEDEVR----YPRW--------- 218 (318)
T ss_pred eecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC----HHHHHHHHHcCCCC----CCCc---------
Confidence 578999999999999999999999999999999999999996433 22222222221111 0111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSM-----REVVSML 1053 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~L 1053 (1078)
....+.+++.+||+.||++||++ .+++++-
T Consensus 219 -~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~ 253 (318)
T cd05570 219 -LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHP 253 (318)
T ss_pred -CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCC
Confidence 12346789999999999999999 8888763
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=308.10 Aligned_cols=250 Identities=25% Similarity=0.390 Sum_probs=205.6
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|...+.||+|++|.||+|.++ +++.|++|.+..........+.+.+|++++++++|||++++++++.+++..++||||+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 81 (256)
T cd08529 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYA 81 (256)
T ss_pred ceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeC
Confidence 566678999999999999976 5889999998765544556778899999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 861 ERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 861 ~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
++++|.+++... ...+++.++..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||.+....... ..
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~-~~ 157 (256)
T cd08529 82 ENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT-NF 157 (256)
T ss_pred CCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc-ch
Confidence 999999999764 44788999999999999999999998 99999999999999999999999999988664322 22
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.....|++.|+|||+..+..++.++||||+|+++|+|++|+.||.... ............ .. ..+ .
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~-~~------~~~---~ 223 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN----QGALILKIIRGV-FP------PVS---Q 223 (256)
T ss_pred hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCC-CC------CCc---c
Confidence 234568899999999998889999999999999999999999996443 122222222211 00 010 0
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+||+.+|++||++.+++++
T Consensus 224 ---~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 224 ---MYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred ---ccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 123447889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=291.50 Aligned_cols=249 Identities=22% Similarity=0.266 Sum_probs=206.1
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEe----cCceEEEEee
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYH----QGSNLLIYEY 859 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~----~~~~~lv~e~ 859 (1078)
++||-|-.|.|..|..+ +++.+|+|++... .+.++|++..-.. .|||||.++++|+. .+...+|||.
T Consensus 68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~ 140 (400)
T KOG0604|consen 68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMEC 140 (400)
T ss_pred hhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeec
Confidence 57999999999999976 6899999999433 3456788875444 69999999998854 3456799999
Q ss_pred ccCCCHHhHhcCCCC-CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC---CCceEEeecccccccCCC
Q 001434 860 MERGSLGELLHGSSC-NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a~~~~~~ 935 (1078)
|+||.|+..++.++. .+++.++.+|++||..|+.|||+. +|.||||||+|+|+.. +..+|++|||+|+...
T Consensus 141 meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~-- 215 (400)
T KOG0604|consen 141 MEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ-- 215 (400)
T ss_pred ccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccC--
Confidence 999999999987654 799999999999999999999999 9999999999999974 4579999999999754
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
......+.+-|+.|.|||++-..+|+...|+||+||++|-|++|.+||........... ++..++. ....
T Consensus 216 ~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg-Mk~rI~~---------gqy~ 285 (400)
T KOG0604|consen 216 EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-MKRRIRT---------GQYE 285 (400)
T ss_pred CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh-HHhHhhc---------cCcc
Confidence 34566778899999999999999999999999999999999999999987765333222 3333332 2233
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
...+.|.+..+...++|++++..+|.+|-|+.++..+-|--
T Consensus 286 FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~ 326 (400)
T KOG0604|consen 286 FPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWIN 326 (400)
T ss_pred CCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhc
Confidence 44556777888888999999999999999999999987744
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-34 Score=336.42 Aligned_cols=250 Identities=23% Similarity=0.264 Sum_probs=200.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-C-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-S-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.|...+.||+|++|.||+|... + ++.||+|.+.... ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~--~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND--ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 3777788999999999999865 3 5778888764432 2334567889999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 859 YMERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
|+++|+|.+++... ...+++.++..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~ 222 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence 99999999987532 33688899999999999999999998 9999999999999999999999999999876432
Q ss_pred CC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 936 QS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 936 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.. .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ..............+ ...
T Consensus 223 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~----~~~~~~~~~~~~~~~---~~~-- 293 (478)
T PTZ00267 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS----QREIMQQVLYGKYDP---FPC-- 293 (478)
T ss_pred cccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCC---CCc--
Confidence 21 22345679999999999999899999999999999999999999996432 233333332221100 001
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+||+.||++||++++++.+
T Consensus 294 --------~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 294 --------PVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred --------cCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 112347789999999999999999998754
|
|
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=308.11 Aligned_cols=252 Identities=29% Similarity=0.459 Sum_probs=202.2
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|++|.||+|.++++..||+|.+..... ..+.+.+|+.++++++|++++++++++. ....++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~ 81 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM---SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY 81 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC---CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence 35667788999999999999988888899999976543 2457899999999999999999999875 4568999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... ...+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence 9999999999754 33589999999999999999999998 9999999999999999999999999999865432222
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||...+..++.++||||+|+++|||++ |..||...... ............ ..+.
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~----~~~~~~~~~~~~-------~~~~- 226 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR----EVLEQVERGYRM-------PCPQ- 226 (260)
T ss_pred cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHHHcCCCC-------CCCC-
Confidence 2223345678999999988889999999999999999999 88999643322 222222111110 0110
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.....+.+++.+|++.+|++|||++++.+.|++
T Consensus 227 -----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 227 -----DCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred -----cCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 122347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=310.63 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=199.6
Q ss_pred EEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHH
Q 001434 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~ 866 (1078)
+||+|+||.||+|..+++..||+|.+..... ......+.+|++++++++||||+++++++...+..++||||+++++|.
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLP-QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 5899999999999988888999999865543 233457889999999999999999999999999999999999999999
Q ss_pred hHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccccc
Q 001434 867 ELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS 946 (1078)
Q Consensus 867 ~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt 946 (1078)
+++......+++..+..++.|++.|+.|+|++ +++||||||+||++++++.++++|||++...............++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (250)
T cd05085 81 SFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIP 157 (250)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCc
Confidence 99976655689999999999999999999998 999999999999999999999999999876542222222223446
Q ss_pred cCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHH
Q 001434 947 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHM 1025 (1078)
Q Consensus 947 ~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1078)
+.|+|||...++.++.++||||+|+++|++++ |..||...... ...... .... .. ..+. ...
T Consensus 158 ~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~----~~~~~~-~~~~-~~-----~~~~------~~~ 220 (250)
T cd05085 158 IKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQ----QAREQV-EKGY-RM-----SCPQ------KCP 220 (250)
T ss_pred ccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHH----HHHHHH-HcCC-CC-----CCCC------CCC
Confidence 78999999988889999999999999999998 99999644321 222221 1111 00 0000 112
Q ss_pred HHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1026 ILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1026 ~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..+.+++.+|++.+|++||++.++++.|.
T Consensus 221 ~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred HHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 34778999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=308.42 Aligned_cols=247 Identities=23% Similarity=0.343 Sum_probs=197.2
Q ss_pred EEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 787 IVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
.||+|+||.||+|+++ +++.||+|.+..... .+....+.+|++++++++||||+++++++...+..++||||+++++|
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLP-PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 5899999999999975 688999998865432 33456789999999999999999999999999999999999999999
Q ss_pred HhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc-ccccc
Q 001434 866 GELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS-MSAVA 944 (1078)
Q Consensus 866 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~-~~~~~ 944 (1078)
.+++......+++.++..++.|++.||+|||++ +++||||||+||+++.++.++++|||.+.......... .....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 157 (252)
T cd05084 81 LTFLRTEGPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ 157 (252)
T ss_pred HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCC
Confidence 999976655689999999999999999999998 99999999999999999999999999987543211111 11122
Q ss_pred cccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHH
Q 001434 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023 (1078)
Q Consensus 945 gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1078)
.+..|+|||.+.++.++.++||||+|+++|||++ |..||...... ............ ..+. .
T Consensus 158 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----~~~~~~~~~~~~-------~~~~------~ 220 (252)
T cd05084 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----QTREAIEQGVRL-------PCPE------L 220 (252)
T ss_pred CceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----HHHHHHHcCCCC-------CCcc------c
Confidence 3467999999998889999999999999999998 88888643321 111111111110 0000 1
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1024 HMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1024 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
....+.+++.+|++.+|++|||++++.+.|+
T Consensus 221 ~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 251 (252)
T cd05084 221 CPDAVYRLMERCWEYDPGQRPSFSTVHQELQ 251 (252)
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence 1235778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=320.44 Aligned_cols=249 Identities=27% Similarity=0.401 Sum_probs=205.3
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccC-CCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|...+.||.|+||.||.|++. +.+.||||++.... ...+...++..|+..+++++|||+|.+.++|..+...++||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 334456999999999999975 67889999986543 3344567899999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
|-| +-.|++.-..+++.+.++..|+.+.+.||+|||++ +.+|||||+.|||+++.|.||++|||.|.... .
T Consensus 108 ClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-----P 178 (948)
T KOG0577|consen 108 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA-----P 178 (948)
T ss_pred Hhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC-----c
Confidence 965 99999887777899999999999999999999999 99999999999999999999999999998654 3
Q ss_pred ccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
...++|||.|||||++. .+.|+-++||||+||+..|+.-.++|+..+..-..+..++ ....+.+ +
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIA------QNesPtL-----q- 246 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA------QNESPTL-----Q- 246 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHH------hcCCCCC-----C-
Confidence 45689999999999986 5789999999999999999999999998665322222211 1112111 1
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.. +....+..++..|+++-|.+|||.+++++|-.-
T Consensus 247 -s~---eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv 281 (948)
T KOG0577|consen 247 -SN---EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFV 281 (948)
T ss_pred -Cc---hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchh
Confidence 11 233446788899999999999999999987543
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.87 Aligned_cols=252 Identities=26% Similarity=0.420 Sum_probs=203.0
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
..|+..++||+|+||.||+|..++++.||+|.+..... ..+++.+|+.++++++|+||+++++++. ++..++||||
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM---SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY 81 (260)
T ss_pred HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC---cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence 45667788999999999999988889999999875443 2457889999999999999999999874 5678999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... +..+++.++..++.|++.|++|||+. +++||||||+||++++++.++++|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 82 MENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 9999999998653 34688999999999999999999998 9999999999999999999999999999766432222
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||.+.+..++.++||||+|+++||+++ |+.||..... ............. ..+.
T Consensus 159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~-------~~~~- 226 (260)
T cd05067 159 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN----PEVIQNLERGYRM-------PRPD- 226 (260)
T ss_pred cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh----HHHHHHHHcCCCC-------CCCC-
Confidence 2233456778999999988889999999999999999999 9999974432 2222222111110 0000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.....+.+++.+|++.+|++||+++++++.|+.
T Consensus 227 -----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 227 -----NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred -----CCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 112347889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=330.77 Aligned_cols=255 Identities=23% Similarity=0.270 Sum_probs=198.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||+|++. +++.||+|++.+... .....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 5777889999999999999976 588999999865432 12234668899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC--
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-- 936 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-- 936 (1078)
|+++|+|.+++...+ .+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~ 157 (376)
T cd05598 82 YIPGGDMMSLLIRLG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (376)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence 999999999997655 678888899999999999999998 99999999999999999999999999975321000
Q ss_pred ----------------------------------------CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHH
Q 001434 937 ----------------------------------------SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLEL 976 (1078)
Q Consensus 937 ----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~el 976 (1078)
........||+.|+|||++.+..++.++||||+||++|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel 237 (376)
T cd05598 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237 (376)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence 0011235799999999999999999999999999999999
Q ss_pred HhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCC---CHHHHHHHH
Q 001434 977 LTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRP---SMREVVSML 1053 (1078)
Q Consensus 977 ltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP---s~~ell~~L 1053 (1078)
++|+.||..... .............. ..+... .....+.+++.+|+ .+|++|+ ++.+++++-
T Consensus 238 l~G~~Pf~~~~~----~~~~~~i~~~~~~~------~~~~~~----~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~ 302 (376)
T cd05598 238 LVGQPPFLADTP----AETQLKVINWETTL------HIPSQA----KLSREASDLILRLC-CGAEDRLGKNGADEIKAHP 302 (376)
T ss_pred hhCCCCCCCCCH----HHHHHHHhccCccc------cCCCCC----CCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCC
Confidence 999999975432 22222221111000 000000 11223456777765 5999999 899999884
Q ss_pred H
Q 001434 1054 I 1054 (1078)
Q Consensus 1054 ~ 1054 (1078)
+
T Consensus 303 ~ 303 (376)
T cd05598 303 F 303 (376)
T ss_pred C
Confidence 4
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=326.15 Aligned_cols=258 Identities=21% Similarity=0.259 Sum_probs=202.1
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
...+|+..+.||+|+||.||+|.++ +++.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (371)
T cd05622 41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM 120 (371)
T ss_pred chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 4568888899999999999999976 588899999865322 22234567889999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++|+|.+++... .++...+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++......
T Consensus 121 v~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 121 VMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 99999999999998754 378888899999999999999999 9999999999999999999999999999876433
Q ss_pred CCCcccccccccCcccccccccC----CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTM----KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.........||+.|+|||++.+. .++.++||||+||++|||++|+.||.... ...............
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~----~~~~~~~i~~~~~~~----- 266 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYSKIMNHKNSL----- 266 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC----HHHHHHHHHcCCCcc-----
Confidence 32333456799999999998653 37889999999999999999999997433 222223322211100
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFD--RPSMREVVSMLI 1054 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L~ 1054 (1078)
.++.. ......+.+++.+|+...+.+ ||++++++++.+
T Consensus 267 -~~~~~----~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~ 306 (371)
T cd05622 267 -TFPDD----NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306 (371)
T ss_pred -cCCCc----CCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcc
Confidence 01100 112334667889999844433 789999999865
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=323.25 Aligned_cols=249 Identities=21% Similarity=0.318 Sum_probs=198.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
+|...+.||+|+||.||+|.++ +++.||+|++.+.... ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 3667788999999999999976 4789999999765322 22344567777877776 5899999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||++++++.+||+|||+++.... ..
T Consensus 81 E~~~~g~L~~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~-~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW-DG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC-CC
Confidence 9999999999987654 588999999999999999999998 999999999999999999999999999875431 12
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......||+.|+|||.+.+..++.++||||+||++|||++|+.||..... ............. ++..
T Consensus 156 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~----~~~~~~i~~~~~~----~p~~---- 223 (323)
T cd05616 156 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE----DELFQSIMEHNVA----YPKS---- 223 (323)
T ss_pred CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC----CCCc----
Confidence 223456789999999999999999999999999999999999999974332 2233332221110 1111
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSM-----REVVSM 1052 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 1052 (1078)
....+.+++.+|++.||++|++. .++.++
T Consensus 224 ------~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05616 224 ------MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH 257 (323)
T ss_pred ------CCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence 12346789999999999999984 676654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=333.16 Aligned_cols=262 Identities=23% Similarity=0.300 Sum_probs=208.0
Q ss_pred HhhcCCCccEEeccCceEEEEEEECCC-cEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeE-EEe-----
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMDSG-KIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGF-CYH----- 849 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~-~~~----- 849 (1078)
...++++.++|++|||+.||.|.+..+ .+||+|++... .+...+.+++|+++|+.|+ |+|||.+++. ...
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 456778888999999999999998765 99999999776 3456788999999999997 9999999993 211
Q ss_pred -cCceEEEEeeccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecc
Q 001434 850 -QGSNLLIYEYMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 927 (1078)
Q Consensus 850 -~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 927 (1078)
...+.+.||||+||.|-|++..+ ...+++.++++|++++++|+++||.. ++.|+|||||-+|||++.+|..||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccc
Confidence 23567999999999999999743 22599999999999999999999987 6789999999999999999999999999
Q ss_pred cccccCCCCCCcc--------cccccccCccccccc---ccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 001434 928 LAKVIDMPQSKSM--------SAVAGSYGYIAPEYA---YTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV 996 (1078)
Q Consensus 928 ~a~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~ 996 (1078)
.|+..-....... -....|+.|+|||++ .+...+.|+||||+||++|.++....||+... . ..
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg---~-la-- 265 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG---K-LA-- 265 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc---c-ee--
Confidence 9874321111110 013569999999986 36678999999999999999999999996321 1 11
Q ss_pred HHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCCC
Q 001434 997 RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGR 1062 (1078)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1062 (1078)
|.+.++...+ ...+...+.+||..||++||++||++.+++.++.++......
T Consensus 266 ------------Ilng~Y~~P~--~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~ 317 (738)
T KOG1989|consen 266 ------------ILNGNYSFPP--FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP 317 (738)
T ss_pred ------------EEeccccCCC--CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence 1122222111 124456688999999999999999999999999988654443
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=328.78 Aligned_cols=254 Identities=22% Similarity=0.265 Sum_probs=196.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.|...+.||+|+||+||+|++. +++.||+|++..... .....+.+.+|++++++++||||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 4677889999999999999975 588999999976432 22345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC--
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-- 936 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-- 936 (1078)
|+++|+|.+++.+.+ .+++..+..++.||+.||+|||++ +|+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 82 YIPGGDMMSLLIRMG-IFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence 999999999997654 578888999999999999999998 99999999999999999999999999975321000
Q ss_pred --------------------------------------------CCcccccccccCcccccccccCCCCCcCcchhHHHH
Q 001434 937 --------------------------------------------SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVV 972 (1078)
Q Consensus 937 --------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~ 972 (1078)
........||+.|+|||++.+..++.++||||+||+
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvi 237 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHH
Confidence 000123468999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC---HHHH
Q 001434 973 LLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS---MREV 1049 (1078)
Q Consensus 973 l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~el 1049 (1078)
+|||++|+.||..... .............. ..+... .......+++.+|+ .+|++|++ ++++
T Consensus 238 l~elltG~~Pf~~~~~----~~~~~~i~~~~~~~------~~p~~~----~~s~~~~~li~~l~-~~p~~R~~~~~~~ei 302 (382)
T cd05625 238 LYEMLVGQPPFLAQTP----LETQMKVINWQTSL------HIPPQA----KLSPEASDLIIKLC-RGPEDRLGKNGADEI 302 (382)
T ss_pred HHHHHhCCCCCCCCCH----HHHHHHHHccCCCc------CCCCcc----cCCHHHHHHHHHHc-cCHhHcCCCCCHHHH
Confidence 9999999999975332 22222222111000 001000 11123456666665 59999997 8888
Q ss_pred HHHH
Q 001434 1050 VSML 1053 (1078)
Q Consensus 1050 l~~L 1053 (1078)
++|-
T Consensus 303 ~~hp 306 (382)
T cd05625 303 KAHP 306 (382)
T ss_pred hcCC
Confidence 8763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=311.28 Aligned_cols=253 Identities=25% Similarity=0.378 Sum_probs=202.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC---chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG---NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
+|...+.||+|++|.||.|... +++.||+|.+...... ....+.+.+|++++++++||||+++++++.+++..++|
T Consensus 3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 82 (263)
T cd06625 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF 82 (263)
T ss_pred cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence 5777889999999999999965 5899999998755322 12345788999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++......
T Consensus 83 ~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~ 158 (263)
T cd06625 83 MEYMPGGSVKDQLKAYG-ALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 158 (263)
T ss_pred EEECCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence 99999999999987654 588899999999999999999998 99999999999999999999999999987654222
Q ss_pred CCcc--cccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 937 SKSM--SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 937 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.... ....++..|+|||...+..++.++||||+|+++||+++|+.||..... . ........... . ..+
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~-~~~~~~~~~~~-~-----~~~ 228 (263)
T cd06625 159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA---M-AAIFKIATQPT-N-----PQL 228 (263)
T ss_pred cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch---H-HHHHHHhccCC-C-----CCC
Confidence 1111 335678899999999998899999999999999999999999964322 1 11111111111 0 011
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
+. .....+.+++.+||..+|++|||+.+++++.
T Consensus 229 ~~------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~ 261 (263)
T cd06625 229 PS------HVSPDARNFLRRTFVENAKKRPSAEELLRHF 261 (263)
T ss_pred Cc------cCCHHHHHHHHHHhhcCcccCCCHHHHhhCC
Confidence 10 1223467899999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=327.72 Aligned_cols=269 Identities=23% Similarity=0.304 Sum_probs=203.1
Q ss_pred HHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC----
Q 001434 777 EATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG---- 851 (1078)
Q Consensus 777 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~---- 851 (1078)
....+|+..+.||+|+||.||+|.+. .++.||||++............+.+|+.+++.++||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 34567888899999999999999975 5889999999776555555677889999999999999999999886433
Q ss_pred --ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccc
Q 001434 852 --SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929 (1078)
Q Consensus 852 --~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 929 (1078)
..++||||+++ ++.+.+.. .+++..+..++.|+++||+|||++ ||+||||||+||+++.++.+||+|||++
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~---~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~ 166 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh---cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCccc
Confidence 46899999976 67776653 478888999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHH------------
Q 001434 930 KVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR------------ 997 (1078)
Q Consensus 930 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~------------ 997 (1078)
+.... ........|++.|+|||.+.+..++.++||||+||++|||++|+.||...+........+.
T Consensus 167 ~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (355)
T cd07874 167 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_pred ccCCC--ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 86542 2223445789999999999988999999999999999999999999975432211111111
Q ss_pred ------HHhhcCCCCCcc-----c-cCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 998 ------NYIRDHSLTPGI-----F-DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 998 ------~~~~~~~~~~~~-----~-~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.+....+..... + +...+............+.+++.+|++.||++|||+.|++++-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~ 313 (355)
T cd07874 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPY 313 (355)
T ss_pred hcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcc
Confidence 111110000000 0 00000000000112345679999999999999999999999854
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=324.47 Aligned_cols=240 Identities=24% Similarity=0.276 Sum_probs=189.0
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHH-HHHccCCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEI-LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~-~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||+||+|+++ +++.||+|++...... ......+..|. .+++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 36999999999999976 4778999999754321 12223344444 456788999999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+.+..+..++.||++||+|||++ ||+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~~~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~-~~~~~~~ 155 (325)
T cd05602 81 GELFYHLQRER-CFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-HNGTTST 155 (325)
T ss_pred CcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCccccc-CCCCccc
Confidence 99999997654 577888889999999999999998 999999999999999999999999999875422 2223345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+||++|||++|+.||..... ............ . .++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~~~~~i~~~~~-~---~~~~--------- 218 (325)
T cd05602 156 FCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT----AEMYDNILNKPL-Q---LKPN--------- 218 (325)
T ss_pred ccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH----HHHHHHHHhCCc-C---CCCC---------
Confidence 6799999999999999999999999999999999999999974332 222222222110 0 0111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSMRE 1048 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~~e 1048 (1078)
....+.+++.+|++.||.+||++.+
T Consensus 219 -~~~~~~~li~~~l~~~p~~R~~~~~ 243 (325)
T cd05602 219 -ITNSARHLLEGLLQKDRTKRLGAKD 243 (325)
T ss_pred -CCHHHHHHHHHHcccCHHHCCCCCC
Confidence 1234678999999999999998763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=310.02 Aligned_cols=252 Identities=26% Similarity=0.431 Sum_probs=201.0
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|...+.||+|++|.||+|.++.+..+|+|.+..... ..+.+.+|++++++++|++++++++++. .+..++||||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~ 81 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF 81 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence 34666778999999999999988777899998865432 3467889999999999999999998875 4568899999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... ...+++..+..++.|++.||+|||+. +++|+||||+||++++++.++|+|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence 9999999999754 33578999999999999999999998 9999999999999999999999999999765432222
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||...+..++.++||||+|+++|||++ |+.||...... ........... . ..+
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~----~~~~~~~~~~~-~------~~~-- 225 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR----EVLEQVERGYR-M------PCP-- 225 (260)
T ss_pred ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCC-C------CCC--
Confidence 2223446778999999988889999999999999999999 89999754322 12222111111 0 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
......+.+++.+||+++|++||+++++++.|++
T Consensus 226 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 226 ----QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred ----cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0123457889999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=313.11 Aligned_cols=254 Identities=27% Similarity=0.381 Sum_probs=200.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||.||+|.+. +++.||+|++..... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 46778889999999999999975 588899999865432 234567899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.++++... .+++..+..++.|++.|++|+|++ +|+|||++|+||+++.++.++++|||.+...... ..
T Consensus 87 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~-~~ 161 (267)
T cd06646 87 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-IA 161 (267)
T ss_pred CCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc-cc
Confidence 999999999987554 688999999999999999999998 9999999999999999999999999999865422 12
Q ss_pred cccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 939 SMSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
......|++.|+|||.+. ...++.++||||+|+++|||++|+.||...........+ ...... .+...
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~-----~~~~~~----~~~~~ 232 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM-----SKSNFQ----PPKLK 232 (267)
T ss_pred ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee-----ecCCCC----CCCCc
Confidence 223456889999999874 345788999999999999999999998643321111100 000000 01110
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
. .......+.+++.+||+.+|++|||++++++++
T Consensus 233 ~----~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 233 D----KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred c----ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 0 011234577899999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=320.77 Aligned_cols=267 Identities=21% Similarity=0.313 Sum_probs=203.3
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|...+.||+|+||.||+|.++ +++.||+|++...... .....+.+|++++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 84 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE 84 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence 45777888999999999999976 5788999998755432 234567789999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++ +|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||.+....... .
T Consensus 85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~ 159 (309)
T cd07872 85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K 159 (309)
T ss_pred CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence 9975 89998876665688999999999999999999998 99999999999999999999999999987643222 2
Q ss_pred cccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc-------
Q 001434 939 SMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF------- 1010 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1010 (1078)
......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||......+......+.. . ......+
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~ 236 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLL-G--TPTEETWPGISSND 236 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh-C--CCCHHHHhhhcchh
Confidence 2334567899999998765 458899999999999999999999997544322222211110 0 0000000
Q ss_pred ---cCCCCcc-h----hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1011 ---DTRLNVE-D----ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1011 ---~~~~~~~-~----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
+...+.. . .........+.+++.+|++.||++|||++|++++-+=
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~ 289 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYF 289 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhh
Confidence 0000000 0 0001123456789999999999999999999986653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.24 Aligned_cols=260 Identities=22% Similarity=0.311 Sum_probs=209.2
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|++|.||+|... +++.||+|.++..... ....+.+.+|++++++++|++++++++++.+++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 35777888999999999999977 7899999998754332 233678899999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 858 EYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
||+++++|.+++.. ....+++.++..++.++++|++|||+. +++||||+|+||+++.++.++++|||.+.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 99999999998853 233588999999999999999999998 999999999999999999999999999876542
Q ss_pred CCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.. .......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ............. ... ..
T Consensus 159 ~~-~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~-~~~------~~ 228 (267)
T cd08224 159 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK--MNLYSLCKKIEKC-DYP------PL 228 (267)
T ss_pred CC-cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC--ccHHHHHhhhhcC-CCC------CC
Confidence 22 22233568889999999988889999999999999999999999986432 2222322222111 100 01
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
+ . ......+.+++.+||+.+|++|||+.++++.+++++
T Consensus 229 ~---~--~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 229 P---A--DHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred C---h--hhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 1 0 122345778999999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=316.36 Aligned_cols=254 Identities=26% Similarity=0.449 Sum_probs=202.4
Q ss_pred cCCCccEEeccCceEEEEEEECC------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
+|...+.||+|+||.||+|.+.+ ++.||+|++..... .+..+.+.+|++++++++|+||+++++++......+
T Consensus 6 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 6 TIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45666789999999999998642 47899999876543 234578999999999999999999999999999999
Q ss_pred EEEeeccCCCHHhHhcCCC-------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCce
Q 001434 855 LIYEYMERGSLGELLHGSS-------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~-------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 921 (1078)
+||||+++++|.+++...+ ..+++.++..++.|++.|++|+|++ +++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeE
Confidence 9999999999999996532 2477888999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHH
Q 001434 922 HVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNY 999 (1078)
Q Consensus 922 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 999 (1078)
+++|||.+........ .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||...... ......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~----~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE----EVIECI 237 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH----HHHHHH
Confidence 9999999875432211 11233446788999999999999999999999999999998 99999654322 222222
Q ss_pred hhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1000 IRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.. ..... .+. .....+.+++.+||+.||++||++.|+++.|++
T Consensus 238 ~~-~~~~~--~~~----------~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 238 TQ-GRLLQ--RPR----------TCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred Hc-CCcCC--CCC----------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 11 11100 000 122347789999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=311.02 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=205.8
Q ss_pred hhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
..+|...+.||+|++|.||+|.++++..||+|.+..... ..+++.+|+..+++++|+||+++++++..+...++|||
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM---SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc---CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 346777788999999999999988888899999875433 34678899999999999999999999998899999999
Q ss_pred eccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 859 YMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+++++|.+++.... ..+++.++..++.|++.|++|||++ +++|+||||+||++++++.++++|||.+........
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 999999999997653 4689999999999999999999998 999999999999999999999999999876643222
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......++..|+|||.+.+..++.++||||+|+++|++++ |+.||...... ............. .+.
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~----~~~~~~~~~~~~~-------~~~ 227 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR----EVLEQVERGYRMP-------RPP 227 (261)
T ss_pred hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH----HHHHHHHcCCCCC-------CCC
Confidence 22223335678999999998889999999999999999998 99999654322 2222222111100 000
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.....+.+++.+|++.+|++||+++++++.|+.
T Consensus 228 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 228 ------NCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ------CCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 012347789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=323.34 Aligned_cols=258 Identities=22% Similarity=0.256 Sum_probs=199.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||+||+|.++ +++.||+|++.+... .....+.+.+|+.+++.++|++|+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (331)
T cd05597 2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD 81 (331)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence 5777889999999999999976 588999999975322 22334668899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++.+....+++..+..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~ 158 (331)
T cd05597 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158 (331)
T ss_pred cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence 9999999999986555789999999999999999999999 9999999999999999999999999998765432222
Q ss_pred cccccccccCccccccccc-----CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 939 SMSAVAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
......||+.|+|||++.. ..++.++||||+||++|||++|+.||.... ............... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~----~~~~~~~i~~~~~~~------~ 228 (331)
T cd05597 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKEHF------Q 228 (331)
T ss_pred cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC----HHHHHHHHHcCCCcc------c
Confidence 2233568999999999863 457889999999999999999999996432 223322222211100 0
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCC--CCCCCCHHHHHHHHH
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSIS--PFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~d--P~~RPs~~ell~~L~ 1054 (1078)
++.... .....+.+++.+|+..+ +..||++.+++++-+
T Consensus 229 ~~~~~~---~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~ 268 (331)
T cd05597 229 FPPDVT---DVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268 (331)
T ss_pred CCCccC---CCCHHHHHHHHHHccCcccccCCCCHHHHhcCCC
Confidence 111100 12233566777777543 334889999999854
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=307.26 Aligned_cols=248 Identities=23% Similarity=0.362 Sum_probs=197.7
Q ss_pred EEeccCceEEEEEEEC---CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 787 IVGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
.||+|+||.||+|.++ +++.||+|++..........+.+.+|+.++++++||||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 4899999999999753 5788999998766554455678899999999999999999999875 45678999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc--cc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MS 941 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~ 941 (1078)
+|.+++.... .+++..+..++.|++.|++|+|++ +++||||||+||++++++.++++|||.+.......... ..
T Consensus 81 ~L~~~l~~~~-~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 81 PLNKFLQKNK-HVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred cHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence 9999997554 688999999999999999999998 99999999999999999999999999998664322211 12
Q ss_pred ccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 942 AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 942 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
...++..|+|||.+....++.++||||+|+++|||++ |+.||..... ..+......... . ..+.
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~----~~~~~~i~~~~~-~------~~~~---- 221 (257)
T cd05116 157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG----NEVTQMIESGER-M------ECPQ---- 221 (257)
T ss_pred CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHCCCC-C------CCCC----
Confidence 2234578999999988889999999999999999998 9999975432 222222221111 0 0110
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+.++|.+||+.||++||++++|.+.|+..
T Consensus 222 --~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 222 --RCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred --CCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 1123467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=340.59 Aligned_cols=261 Identities=23% Similarity=0.321 Sum_probs=203.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||.||+|.+. +++.||+|++...... +...+++.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 35777889999999999999976 5899999999765332 234567899999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCC----------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecc
Q 001434 858 EYMERGSLGELLHGS----------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 927 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~----------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 927 (1078)
||++||+|.+++... ....++..+..++.||++||+|||++ +|+||||||+||+++.++.++|+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence 999999999988632 12355677889999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCC-----------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 001434 928 LAKVIDMPQS-----------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG 990 (1078)
Q Consensus 928 ~a~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~ 990 (1078)
+++....... .......||+.|+|||.+.+..++.++||||+||++|||++|+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 9986521110 11123569999999999999999999999999999999999999997532211
Q ss_pred CHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCC-CHHHHHHHHHhhcc
Q 001434 991 DLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRP-SMREVVSMLIESNE 1058 (1078)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~ell~~L~~~~~ 1058 (1078)
.. ...... . +. ... ...+....+.+++.+|++.||++|| +++++.+.|+....
T Consensus 239 i~---~~~~i~-~--P~-----~~~----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS---YRDVIL-S--PI-----EVA----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh---hhhhcc-C--hh-----hcc----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 10 011000 0 00 000 0012234467899999999999997 67778787777643
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=312.19 Aligned_cols=257 Identities=26% Similarity=0.440 Sum_probs=204.3
Q ss_pred hcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.+|...+.||+|+||+||++.+. ++..||+|.+.... ....+.+.+|++++++++||+|+++++++...+..
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 46777788999999999999852 24568899886543 23456789999999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCC------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCce
Q 001434 854 LLIYEYMERGSLGELLHGSS------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 921 (1078)
++||||+++++|.+++...+ ..+++.++..++.|++.|++|||++ +++||||||+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence 99999999999999986432 2489999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHH
Q 001434 922 HVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNY 999 (1078)
Q Consensus 922 kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 999 (1078)
+++|||.++....... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||..... .......
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~----~~~~~~i 235 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN----NEVIECI 235 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHH
Confidence 9999999976532211 11223445778999999988889999999999999999998 8999864432 2222222
Q ss_pred hhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1000 IRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
.... ... .+. .....+.+++.+||+.+|.+|||+.++.+.|+++..
T Consensus 236 ~~~~-~~~--~~~----------~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 236 TQGR-VLQ--RPR----------TCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred HcCC-cCC--CCC----------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 2211 110 000 112347889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=319.41 Aligned_cols=250 Identities=20% Similarity=0.281 Sum_probs=198.1
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||+||+|..+ +++.||+|++.+.... ....+.+.+|+.++.++ +||+|+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 36999999999999976 5789999999765432 23355678899998888 699999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~~~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (327)
T cd05617 81 GDLMFHMQRQR-KLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG-PGDTTST 155 (327)
T ss_pred CcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccC-CCCceec
Confidence 99999887554 689999999999999999999998 999999999999999999999999999875321 1222345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC--CHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG--DLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
..||+.|+|||.+.+..++.++||||+||++|||++|+.||....... ................ ++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~------- 225 (327)
T cd05617 156 FCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---IPRF------- 225 (327)
T ss_pred ccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC---CCCC-------
Confidence 679999999999999999999999999999999999999996543222 1222222222221110 0111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCC------HHHHHHHH
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRPS------MREVVSML 1053 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RPs------~~ell~~L 1053 (1078)
....+.+++.+|++.||++||+ ++++++|-
T Consensus 226 ---~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~ 261 (327)
T cd05617 226 ---LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT 261 (327)
T ss_pred ---CCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence 1123568999999999999998 46777663
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=314.55 Aligned_cols=256 Identities=24% Similarity=0.388 Sum_probs=200.2
Q ss_pred hhcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 852 (1078)
..+|+..+.||+|+||.||+|.++ .++.||+|++..... ......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 456788889999999999999854 256799999864432 2335678899999999999999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCC---------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEE
Q 001434 853 NLLIYEYMERGSLGELLHGSS---------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 923 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 923 (1078)
.++||||+++++|.+++.... ...++..+..++.|++.|++|||+. +++||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEE
Confidence 999999999999999986432 1356778899999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhh
Q 001434 924 GDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIR 1001 (1078)
Q Consensus 924 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1001 (1078)
+|||.++....... .......+++.|+|||.+.++.++.++||||+|+++|||++ |..||..... .........
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~----~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSN----EQVLRFVME 236 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHc
Confidence 99999875432211 11122345778999999998889999999999999999999 7888864332 222222111
Q ss_pred cCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.. ... ... .....+.+++.+|++.+|++|||+.|+++.+++
T Consensus 237 ~~-~~~--~~~----------~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 237 GG-LLD--KPD----------NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred CC-cCC--CCC----------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 11 110 011 112347789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=315.28 Aligned_cols=263 Identities=25% Similarity=0.411 Sum_probs=203.8
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCc--EEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGK--IVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 856 (1078)
+|+..+.||+|+||.||+|.++ ++. .+++|.+.... .....+.+.+|++++.++ +|+||+++++++.+++..++|
T Consensus 8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 5666778999999999999975 344 45777765433 233456788999999999 899999999999999999999
Q ss_pred EeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCce
Q 001434 857 YEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 921 (1078)
|||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||+++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcE
Confidence 99999999999986432 2578889999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHh
Q 001434 922 HVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYI 1000 (1078)
Q Consensus 922 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 1000 (1078)
+|+|||++..... ........++..|+|||.+.+..++.++||||+|+++|||++ |..||...... ......
T Consensus 164 kl~dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~----~~~~~~- 236 (303)
T cd05088 164 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA----ELYEKL- 236 (303)
T ss_pred EeCccccCcccch--hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH----HHHHHH-
Confidence 9999999864321 111112234668999999988889999999999999999998 99999644321 222111
Q ss_pred hcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCCCCCCC
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSS 1066 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~~~~~ 1066 (1078)
.... . ...+. .....+.+++.+||+.+|++||+++++++.+.++...+..+...
T Consensus 237 ~~~~-~-----~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~~~~~~ 290 (303)
T cd05088 237 PQGY-R-----LEKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNT 290 (303)
T ss_pred hcCC-c-----CCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhhhhhhh
Confidence 1110 0 00000 11234678999999999999999999999999887666655443
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=308.01 Aligned_cols=254 Identities=24% Similarity=0.358 Sum_probs=197.9
Q ss_pred CCccEEeccCceEEEEEEECC-Cc--EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec------Cce
Q 001434 783 HDSFIVGSGAYGTVYKAVMDS-GK--IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------GSN 853 (1078)
Q Consensus 783 ~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------~~~ 853 (1078)
...+.||+|+||.||+|.+.. +. .||+|.++.........+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 345679999999999999764 32 689999877655455567889999999999999999999987432 246
Q ss_pred EEEEeeccCCCHHhHhcC-----CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccc
Q 001434 854 LLIYEYMERGSLGELLHG-----SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~-----~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 928 (1078)
++||||+++|+|.+++.. ....+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||.
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCc
Confidence 899999999999988742 223578999999999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 929 AKVIDMPQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 929 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
++........ ......+++.|+|||...+..++.++||||+|+++|||++ |+.||..... ....... ......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~~~~~-~~~~~~ 233 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVEN----SEIYDYL-RQGNRL 233 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHH-HcCCCC
Confidence 9876422211 1123346778999999998899999999999999999999 8889864322 2222222 221110
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
. .+. .....+.+++.+||+.+|++|||++++++.|+++
T Consensus 234 ~------~~~------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 K------QPP------DCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred C------CCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 0 000 1123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=315.50 Aligned_cols=255 Identities=30% Similarity=0.427 Sum_probs=203.5
Q ss_pred CCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|+||+||+|.... ++.||+|++..............+|+..+++++||||+++++++.++...++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567789999999999999875 668999999887654444445567999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++.... .+++.++..++.|+++||++||+. +++|+||||+||+++.++.++|+|||.+... .......
T Consensus 81 ~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~-~~~~~~~ 155 (260)
T PF00069_consen 81 PGGSLQDYLQKNK-PLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKL-SENNENF 155 (260)
T ss_dssp TTEBHHHHHHHHS-SBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEES-TSTTSEB
T ss_pred ccccccccccccc-cccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-ccccccc
Confidence 9999999998333 689999999999999999999999 9999999999999999999999999998754 1233444
Q ss_pred cccccccCcccccccc-cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 941 SAVAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
....++..|+|||.+. +..++.++||||+|+++|+|++|..||........ ............ .....
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~~~~------~~~~~---- 224 (260)
T PF00069_consen 156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ-LEIIEKILKRPL------PSSSQ---- 224 (260)
T ss_dssp SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH-HHHHHHHHHTHH------HHHTT----
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccchhh-hhhhhhcccccc------ccccc----
Confidence 5667899999999988 78899999999999999999999999975411111 111111111000 00000
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
........+.+++.+|++.||++||++.+++++
T Consensus 225 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~ 257 (260)
T PF00069_consen 225 QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH 257 (260)
T ss_dssp SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence 000112568899999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=310.11 Aligned_cols=254 Identities=26% Similarity=0.347 Sum_probs=201.4
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|+..+.||+|+||.||+|.+. +++.||+|.+....... .....+.+|+.++++++|++++++++.+.+++..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 556678999999999999976 58899999987653322 2234567899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++.... ..+++.++..++.|++.|+.|+|+. +|+||||||+||++++++.++++|||++..... ..
T Consensus 82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~--~~ 156 (285)
T cd05630 82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE--GQ 156 (285)
T ss_pred cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCC--Cc
Confidence 99999999886433 3588999999999999999999998 999999999999999999999999999876432 12
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||........... ......... . ....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~-~~~~~~~~~--~-~~~~------ 226 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE-VERLVKEVQ--E-EYSE------ 226 (285)
T ss_pred cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH-HHhhhhhhh--h-hcCc------
Confidence 22345789999999999998999999999999999999999999975433221111 111111100 0 0011
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPS-----MREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L~ 1054 (1078)
.....+.+++.+||+.||++||| ++|++++-+
T Consensus 227 ----~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~ 263 (285)
T cd05630 227 ----KFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPL 263 (285)
T ss_pred ----cCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChh
Confidence 11234678999999999999999 899998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=313.63 Aligned_cols=252 Identities=23% Similarity=0.335 Sum_probs=203.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|++|.||+|.+. +++.|++|.+..... ...+.+.+|+.+++.++|+||+++++.+.+++..++|||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc--chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 46777788999999999999965 588999999876543 234678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++... .+++.++..++.|++.|++|||+. +|+||||||+||+++.++.++|+|||.+....... .
T Consensus 98 ~~~~~~L~~~~~~~--~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~-~ 171 (296)
T cd06654 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 171 (296)
T ss_pred ccCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccc-c
Confidence 99999999998754 478899999999999999999998 99999999999999999999999999987653221 2
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......+++.|+|||...+..++.++|||||||++|+|++|+.||........ + ........ . .... +
T Consensus 172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~---~-~~~~~~~~-~------~~~~-~ 239 (296)
T cd06654 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA---L-YLIATNGT-P------ELQN-P 239 (296)
T ss_pred ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh---H-HHHhcCCC-C------CCCC-c
Confidence 22334688999999999888899999999999999999999999964432111 1 11111110 0 0000 0
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
......+.+++.+||..+|++||++.+++++-+
T Consensus 240 ---~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~ 272 (296)
T cd06654 240 ---EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQF 272 (296)
T ss_pred ---cccCHHHHHHHHHHCcCCcccCcCHHHHhhChh
Confidence 112244778999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=314.77 Aligned_cols=256 Identities=25% Similarity=0.429 Sum_probs=203.5
Q ss_pred cCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
+|...+.||+|+||.||+|.+. ++..+++|.+..... ...+.+.+|++.+++++|+||+++++++..++..+
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 83 (291)
T cd05094 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL--AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI 83 (291)
T ss_pred HeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH--HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence 4566678999999999999843 345688888854432 33467889999999999999999999999999999
Q ss_pred EEEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC
Q 001434 855 LIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF 919 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~ 919 (1078)
+||||+++++|.+++.... ..+++..++.++.|++.|++|||++ +++||||||+||+++.++
T Consensus 84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL 160 (291)
T ss_pred EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence 9999999999999986432 2478899999999999999999999 999999999999999999
Q ss_pred ceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHH
Q 001434 920 EAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVR 997 (1078)
Q Consensus 920 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~ 997 (1078)
.++++|||++........ .......++..|+|||.+.+..++.++||||+|+++|||++ |+.||...... ....
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~----~~~~ 236 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT----EVIE 236 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----HHHH
Confidence 999999999976532221 12233456788999999998899999999999999999999 99998654322 2222
Q ss_pred HHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 998 NYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
.. ...... .... .....+.+++.+||+.+|++|||++++++.|.++..
T Consensus 237 ~~-~~~~~~-----~~~~-------~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 237 CI-TQGRVL-----ERPR-------VCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred HH-hCCCCC-----CCCc-------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 21 111111 0000 112347789999999999999999999999999855
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=322.64 Aligned_cols=239 Identities=24% Similarity=0.297 Sum_probs=188.9
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHH-HHccCCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEIL-TLGKIRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
++||+|+||.||+|.+. +++.||+|++.+... .......+.+|.. +++.++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 588999999975432 1222344555544 67889999999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
++|.+++.... .+++.++..++.||+.||+|||++ +|+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~ 155 (321)
T cd05603 81 GELFFHLQRER-CFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE-PEETTST 155 (321)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCC-CCCcccc
Confidence 99999887544 578888999999999999999998 999999999999999999999999999875322 1223345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+||++|||++|+.||...+ ............. .++.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~----~~~~~~~i~~~~~--------~~~~------ 217 (321)
T cd05603 156 FCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD----VSQMYDNILHKPL--------QLPG------ 217 (321)
T ss_pred ccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC----HHHHHHHHhcCCC--------CCCC------
Confidence 678999999999998889999999999999999999999997532 2233333222110 1111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSMR 1047 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~~ 1047 (1078)
.....+.+++.+|++.||++||++.
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCC
Confidence 1123467899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=310.23 Aligned_cols=252 Identities=24% Similarity=0.321 Sum_probs=201.4
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|+..+.||+|+||+||+|.+. +++.||+|++....... .....+.+|++++++++|++|+++++++.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 556678999999999999975 58899999986653322 2245577899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++.... ..+++..+..++.|++.|+.|||++ +|+||||||+||++++++.++|+|||.+..... ..
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~--~~ 156 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GE 156 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCC--CC
Confidence 99999998886543 3689999999999999999999998 999999999999999999999999999876532 12
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|+..|+|||.+.+..++.++|+||+|+++||+++|..||...........+........ ..+..
T Consensus 157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----~~~~~------ 226 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----EVYSA------ 226 (285)
T ss_pred cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----cccCc------
Confidence 22345789999999999888999999999999999999999999975443222222222211111 01111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPS-----MREVVSM 1052 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~ 1052 (1078)
.....+.+++.+|++.||++||+ +++++++
T Consensus 227 ----~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~ 261 (285)
T cd05632 227 ----KFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH 261 (285)
T ss_pred ----cCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence 11234678999999999999999 7888886
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-33 Score=306.75 Aligned_cols=255 Identities=25% Similarity=0.388 Sum_probs=200.3
Q ss_pred CCCccEEeccCceEEEEEEECC----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc-----
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS----- 852 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~----- 852 (1078)
|+..+.||+|+||.||+|.+.. +..||+|+++...........+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 3456789999999999998642 4679999997665544556778999999999999999999998866554
Q ss_pred -eEEEEeeccCCCHHhHhcCC-----CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeec
Q 001434 853 -NLLIYEYMERGSLGELLHGS-----SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 926 (1078)
Q Consensus 853 -~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 926 (1078)
.++||||+++|+|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence 68999999999999988532 23688899999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 927 GLAKVIDMPQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 927 g~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
|.++........ ......++..|+|||...+..++.++||||+|+++|||++ |..||..... .+..........
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN----HEIYDYLRHGNR 233 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHcCCC
Confidence 999865422211 1112334678999999988889999999999999999999 8888864332 222222221111
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
. ..+. .....+.+++.+||+.||++|||+.|+++.|+++
T Consensus 234 ~-------~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 234 L-------KQPE------DCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred C-------CCCc------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0 0110 1234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=307.76 Aligned_cols=257 Identities=24% Similarity=0.375 Sum_probs=200.2
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCc----EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||+||+|.+. +++ .|++|++..... .....++..|+..+++++||||+++++++. +...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSG-RQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccc-hHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 35667788999999999999975 344 467777643322 233467788888999999999999999875 45678
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+|+||+++|+|.+++......+++..+..++.||+.|++|+|++ +++||||||+||++++++.+|++|||.++....
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999999987666789999999999999999999998 999999999999999999999999999986532
Q ss_pred CCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
... .......++..|+|||.+.++.++.++||||||+++||+++ |+.||...... ............. .+
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~-----~~~~~~~~~~~~~---~~ 233 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH-----EVPDLLEKGERLA---QP 233 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-----HHHHHHHCCCcCC---CC
Confidence 221 22234456778999999988899999999999999999998 99999644321 1122222111111 11
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
.. ....+.+++.+||..+|++|||+.|+++.+..+..
T Consensus 234 ~~---------~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~ 270 (279)
T cd05111 234 QI---------CTIDVYMVMVKCWMIDENVRPTFKELANEFTRMAR 270 (279)
T ss_pred CC---------CCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence 11 11235678999999999999999999999988653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-33 Score=306.52 Aligned_cols=256 Identities=25% Similarity=0.445 Sum_probs=204.1
Q ss_pred hcCCCccEEeccCceEEEEEEECC-C---cEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-G---KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
.+|+..+.||+|++|.||+|.++. + ..+|+|++..... ....+.+.+|++++++++|+|++++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 356778899999999999999752 3 3689998865432 2345678899999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++++|.+++......+++.++..++.|++.|++|+|+. +++||||||+||++++++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 9999999999999987655789999999999999999999998 9999999999999999999999999998765422
Q ss_pred CCCccc--ccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 936 QSKSMS--AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 936 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
...... ....+..|+|||.+.+..++.++||||+|+++||+++ |+.||..... .............+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~----~~~~~~i~~~~~~~~----- 231 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSN----HEVMKAINDGFRLPA----- 231 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCH----HHHHHHHhcCCCCCC-----
Confidence 221111 1223457999999988889999999999999999998 9999964432 222222221111100
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.. +....+.+++.+||+.+|++||++.++++.|.++
T Consensus 232 -~~-------~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 232 -PM-------DCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred -CC-------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 1123467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=305.30 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=202.6
Q ss_pred cCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
+|+..+.||+|+||.||+|.+..++.+|+|.+..... ....+.+|++++++++||+++++++++......++||||+
T Consensus 5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 81 (256)
T cd05112 5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM---SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM 81 (256)
T ss_pred HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC---CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence 4566778999999999999987788999999865433 2457889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++......+++..+..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...........
T Consensus 82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999987655688999999999999999999998 999999999999999999999999999876542222222
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
....++..|+|||...++.++.++||||+|+++||+++ |+.||.... .............. ..++.
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~~~----~~~~~----- 225 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRS----NSEVVETINAGFRL----YKPRL----- 225 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCC----HHHHHHHHhCCCCC----CCCCC-----
Confidence 23345678999999988889999999999999999998 999996432 22222222211110 01111
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
....+.+++.+||+.+|++|||+.++++.|
T Consensus 226 ----~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 226 ----ASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ----CCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 124578899999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=319.71 Aligned_cols=257 Identities=22% Similarity=0.248 Sum_probs=200.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|...+.||+|+||+||++.++ +++.||+|++.+... .......+.+|..++..++|++|+++++++.+++..|+|||
T Consensus 2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E 81 (331)
T cd05624 2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD 81 (331)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5777889999999999999976 578899999875322 22234567889999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|++||+|.+++......+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 158 (331)
T cd05624 82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV 158 (331)
T ss_pred CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence 9999999999987555789999999999999999999998 9999999999999999999999999999766433322
Q ss_pred cccccccccCccccccccc-----CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 939 SMSAVAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
......|++.|+|||.+.+ +.++.++||||+|+++|||++|+.||.... ............... . ++..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~-~-~p~~ 232 (331)
T cd05624 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHEERF-Q-FPSH 232 (331)
T ss_pred eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC----HHHHHHHHHcCCCcc-c-CCCc
Confidence 3334579999999998865 467889999999999999999999996432 222222222211100 0 0111
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCC--CCCHHHHHHHH
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFD--RPSMREVVSML 1053 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~--RPs~~ell~~L 1053 (1078)
. .+....+.+++.+|+...+++ |+++++++++-
T Consensus 233 ~-------~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~ 267 (331)
T cd05624 233 I-------TDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA 267 (331)
T ss_pred c-------ccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence 1 112344677888988865544 56899998774
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=319.51 Aligned_cols=248 Identities=21% Similarity=0.305 Sum_probs=197.2
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEEEe
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
|+..+.||+|+||+||+|.++ +++.||+|++.+... .....+.+..|..++..+. |++|+++++++.+.+..++|||
T Consensus 2 f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E 81 (323)
T cd05615 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVME 81 (323)
T ss_pred ceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEc
Confidence 566788999999999999976 588999999976532 2233456778888888775 5788889999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++.... .+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++..... ..
T Consensus 82 y~~~g~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~ 156 (323)
T cd05615 82 YVNGGDLMYHIQQVG-KFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GV 156 (323)
T ss_pred CCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCC-Cc
Confidence 999999999987655 689999999999999999999998 9999999999999999999999999998754321 12
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......||+.|+|||.+.+..++.++||||+||++|||++|+.||.... ............... +..
T Consensus 157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~----~~~~~~~i~~~~~~~----p~~----- 223 (323)
T cd05615 157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED----EDELFQSIMEHNVSY----PKS----- 223 (323)
T ss_pred cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC----HHHHHHHHHhCCCCC----Ccc-----
Confidence 2334568999999999998899999999999999999999999997543 223333332221110 111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSM-----REVVSM 1052 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~-----~ell~~ 1052 (1078)
....+.+++.+|++.+|.+|++. +++.++
T Consensus 224 -----~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h 257 (323)
T cd05615 224 -----LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH 257 (323)
T ss_pred -----CCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence 12346789999999999999974 556554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=321.06 Aligned_cols=256 Identities=21% Similarity=0.237 Sum_probs=198.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||++.++ +++.||+|++.+... .......+.+|+.++..++|++|+++++++.+++..++|||
T Consensus 2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (332)
T cd05623 2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD 81 (332)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence 5777889999999999999976 478899999865322 22234557889999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++|+|.+++.+....+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||++.........
T Consensus 82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~ 158 (332)
T cd05623 82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158 (332)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence 9999999999987555789999999999999999999998 9999999999999999999999999998765322222
Q ss_pred cccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 939 SMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
......||+.|+|||++. ...++.++||||+||++|||++|+.||... ............... ..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~----~~~~~~~~i~~~~~~------~~ 228 (332)
T cd05623 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE----SLVETYGKIMNHKER------FQ 228 (332)
T ss_pred eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC----CHHHHHHHHhCCCcc------cc
Confidence 333457999999999886 346889999999999999999999999643 223333332221110 00
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCC--CCCCHHHHHHH
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPF--DRPSMREVVSM 1052 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~--~RPs~~ell~~ 1052 (1078)
++... ......+.+++.+|+..+++ .|+++++++++
T Consensus 229 ~p~~~---~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 229 FPAQV---TDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred CCCcc---ccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 11110 11223466788887765444 47899999988
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=306.96 Aligned_cols=247 Identities=23% Similarity=0.360 Sum_probs=195.8
Q ss_pred EeccCceEEEEEEEC---CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCC
Q 001434 788 VGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGS 864 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gs 864 (1078)
||+|+||.||+|.+. .+..||+|++..... ....+.+.+|+.++++++||||+++++++. .+..++||||+++++
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~-~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE-KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccC-hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 899999999999864 355799998865532 334567899999999999999999999875 457899999999999
Q ss_pred HHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc--ccc
Q 001434 865 LGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSA 942 (1078)
Q Consensus 865 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--~~~ 942 (1078)
|.+++......+++.++..++.|++.|++|+|++ +++||||||+||+++.++.+|++|||.+.......... ...
T Consensus 81 L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 157 (257)
T cd05115 81 LNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSA 157 (257)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCC
Confidence 9999986666789999999999999999999998 99999999999999999999999999997654222111 112
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESI 1021 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1021 (1078)
..++..|+|||.+.+..++.++||||||+++||+++ |..||...... .+.... ...... ..+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~-~~~~~~------~~~~----- 221 (257)
T cd05115 158 GKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGP----EVMSFI-EQGKRL------DCPA----- 221 (257)
T ss_pred CCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHH----HHHHHH-HCCCCC------CCCC-----
Confidence 233578999999988889999999999999999996 99999754322 222221 111110 0110
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1022 VDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1022 ~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+.+++.+||..+|++||++.++.+.|+.+
T Consensus 222 -~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 222 -ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred -CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 1224467899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=322.42 Aligned_cols=239 Identities=25% Similarity=0.303 Sum_probs=190.1
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHH-HHccCCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEIL-TLGKIRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~-~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||+||+|.+. +|+.||+|++..... .......+.+|.. +++.++||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 35999999999999975 588999999976532 1222344555554 56778999999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++.++..++.||+.||+|||++ ||+||||||+||+++.++.+||+|||+++.... .......
T Consensus 81 ~~L~~~l~~~~-~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~-~~~~~~~ 155 (325)
T cd05604 81 GELFFHLQRER-SFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTT 155 (325)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCC-CCCCccc
Confidence 99999887554 689999999999999999999998 999999999999999999999999999875321 1223345
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||.+.+..++.++||||+||++|||++|+.||...+ ............. .+.+.
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~----~~~~~~~~~~~~~----~~~~~--------- 218 (325)
T cd05604 156 FCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD----VAEMYDNILHKPL----VLRPG--------- 218 (325)
T ss_pred ccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC----HHHHHHHHHcCCc----cCCCC---------
Confidence 679999999999999999999999999999999999999997433 2233333322111 00111
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSMR 1047 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~~ 1047 (1078)
....+.+++.+|++.+|++||++.
T Consensus 219 -~~~~~~~ll~~ll~~~p~~R~~~~ 242 (325)
T cd05604 219 -ASLTAWSILEELLEKDRQRRLGAK 242 (325)
T ss_pred -CCHHHHHHHHHHhccCHHhcCCCC
Confidence 123356899999999999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=312.40 Aligned_cols=267 Identities=27% Similarity=0.337 Sum_probs=206.8
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.+. +++.||+|++..........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 3667788999999999999975 689999999977655445567889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+ +++|.+++......+++.++..++.|+++|++|||++ +++|+||||+||+++.++.++++|||.+..........
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~ 156 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL 156 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence 9 9999999976666799999999999999999999998 99999999999999999999999999998765433333
Q ss_pred ccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCC------------CC
Q 001434 940 MSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS------------LT 1006 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------~~ 1006 (1078)
.....++..|+|||.+.+. .++.++||||+|+++|||++|.+||....+.......... ..... ..
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 235 (286)
T cd07832 157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT-LGTPNEETWPGLTSLPDYN 235 (286)
T ss_pred cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHH-cCCCChHHHhhccCcchhh
Confidence 4456789999999988654 4689999999999999999998877643322221111111 00000 00
Q ss_pred CccccCCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 PGIFDTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...+....... .+...+....+.+++.+|++.+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h 282 (286)
T cd07832 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282 (286)
T ss_pred cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00000000000 00111233668899999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=311.17 Aligned_cols=257 Identities=24% Similarity=0.382 Sum_probs=203.0
Q ss_pred hcCCCccEEeccCceEEEEEEECC------CcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCc
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS------GKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 852 (1078)
.+|+..+.||+|+||.||++.+.. ...||+|.+..... ......+.+|+++++++ +|+||+++++++..++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 456777889999999999998642 36789999876543 23346788999999999 89999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCC---------------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC
Q 001434 853 NLLIYEYMERGSLGELLHGS---------------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD 917 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~ 917 (1078)
.++||||+++|+|.++++.. ...+++..+..++.|++.|++|||++ +|+||||||+||++++
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTE 167 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcC
Confidence 99999999999999998632 23688899999999999999999998 9999999999999999
Q ss_pred CCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001434 918 KFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATW 995 (1078)
Q Consensus 918 ~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~ 995 (1078)
++.++++|||.++.+..... .......++..|+|||...+..++.++||||||+++||+++ |..||..... .+.
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----~~~ 243 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----EEL 243 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----HHH
Confidence 99999999999986643221 11222345678999999988899999999999999999998 9999864332 222
Q ss_pred HHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 996 VRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
......... . ..+. .....+.+++.+|++.+|++|||+.++++.|+++.
T Consensus 244 ~~~~~~~~~-~------~~~~------~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 244 FKLLKEGYR-M------EKPQ------NCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHHHcCCc-C------CCCC------CCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 222111110 0 0010 11234778999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.79 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=207.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|++|.||+|.+. +++.||||.+..... ......++.+|+.+++.++|+||+++++++.+++..++|||
T Consensus 3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 82 (267)
T cd08229 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE 82 (267)
T ss_pred hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence 4666778999999999999964 689999998865433 22345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 859 YMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 859 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
|+++++|.+++.. ....+++..+..++.|+++|++|||++ +++|+||||+||+++.++.++++|||.+......
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd08229 83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159 (267)
T ss_pred ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence 9999999998863 233688999999999999999999998 9999999999999999999999999998765422
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
. .......++..|+|||...+..++.++||||+|+++|+|++|..||..... ........... ... +..+
T Consensus 160 ~-~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~-~~~------~~~~ 229 (267)
T cd08229 160 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM--NLYSLCKKIEQ-CDY------PPLP 229 (267)
T ss_pred C-cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc--hHHHHhhhhhc-CCC------CCCC
Confidence 2 222345688999999999888899999999999999999999999964321 12222222111 110 1111
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
. ......+.+++.+||+.+|++|||+.+|++.+++..
T Consensus 230 ~-----~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 230 S-----DHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred c-----ccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 0 123345788999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=311.20 Aligned_cols=267 Identities=23% Similarity=0.343 Sum_probs=203.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.++ +++.||+|++..........+.+.+|++++++++|+|++++++++..+...++||||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~ 81 (286)
T cd07847 2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEY 81 (286)
T ss_pred ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEec
Confidence 5677788999999999999987 588999999876544334456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
++++++..++.... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+....... ..
T Consensus 82 ~~~~~l~~~~~~~~-~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07847 82 CDHTVLNELEKNPR-GVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPG-DD 156 (286)
T ss_pred cCccHHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCc-cc
Confidence 99988888765443 689999999999999999999998 99999999999999999999999999998764322 12
Q ss_pred ccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhh----------cCCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR----------DHSLTPG 1008 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----------~~~~~~~ 1008 (1078)
.....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+....+...... .......
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG 236 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence 334567889999998865 45789999999999999999999999755433222222111100 0000000
Q ss_pred cccCCCC---cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRLN---VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...+... ............+.+++.+||+.+|++||++.|++.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~ 283 (286)
T cd07847 237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH 283 (286)
T ss_pred ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence 0000000 0001111224567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=306.35 Aligned_cols=256 Identities=25% Similarity=0.405 Sum_probs=203.7
Q ss_pred hcCCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
.+|+..+.||+|+||.||+|.+. .+..||+|.+..... ....+.+.+|+.++++++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 35667788999999999999864 234789999865433 3345688999999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++++|.+++......+++.++..++.|++.|++|||++ +++||||||+||+++.++.++++|||.+......
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 9999999999999987665789999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCCcc--cccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 936 QSKSM--SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 936 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
..... ....++..|+|||.+.+..++.++||||+|+++||+++ |..||...... ............+
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~----~~~~~~~~~~~~~------ 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ----DVIKAIEEGYRLP------ 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH----HHHHHHhCCCcCC------
Confidence 22111 11223568999999998889999999999999999887 99999754322 1222221111100
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.. ......+.+++.+|++.+|++||++.++++.|.++
T Consensus 230 -~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 230 -AP------MDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -CC------CCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 00 01123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=303.87 Aligned_cols=250 Identities=24% Similarity=0.337 Sum_probs=201.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|+||.||++.+. +++.||+|.+..... ....+.+.+|+.++++++|+||+++++.+.+++..++||||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS-SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc-hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 3666788999999999999976 588999999865433 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... ...++...+..++.|++.|+.|||++ +++|+||||+||++++++.++++|||.+...... ..
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-~~ 155 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP-GA 155 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccc-cc
Confidence 9999999988643 34578899999999999999999998 9999999999999999999999999998765422 22
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|++.|+|||...+..++.++||||+|+++|+|++|..||... ............... ..+
T Consensus 156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~----~~~~~~~~~~~~~~~-------~~~--- 221 (255)
T cd08219 156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN----SWKNLILKVCQGSYK-------PLP--- 221 (255)
T ss_pred ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC----CHHHHHHHHhcCCCC-------CCC---
Confidence 223456889999999998888999999999999999999999999643 222222222211110 000
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
. .....+.+++.+||+.||++||++.+++..
T Consensus 222 ~---~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 222 S---HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred c---ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 0 112346789999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-33 Score=323.35 Aligned_cols=263 Identities=21% Similarity=0.200 Sum_probs=198.9
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
...|...+.||+|+||.||+|.+. .++.||||.... ..+.+|++++++++|+||+++++++..++..++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 446778889999999999999976 478899996421 23568999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|++. ++|.+++......+++.++..++.|+++||+|||++ +|+||||||+||+++.++.++|+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~ 315 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS 315 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence 9995 599998876655799999999999999999999998 999999999999999999999999999986542221
Q ss_pred C-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC---CCCHHHHHHHHhhcCCCCCccccCC
Q 001434 938 K-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD---GGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 938 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
. ......||+.|+|||++.+..++.++|||||||++|||++|..|+..... .......+.+.+.........+...
T Consensus 316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 1 22345799999999999999999999999999999999998876543221 1111111112111111000000000
Q ss_pred ---------------------CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1014 ---------------------LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1014 ---------------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
....+..+......+.+++.+||+.||++|||+.|++++-
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp 456 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLP 456 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCc
Confidence 0000111111223577899999999999999999999873
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=311.49 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=201.4
Q ss_pred hcCCCccEEeccCceEEEEEEECC-Cc--EEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GK--IVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 855 (1078)
.+|+..++||+|+||.||+|.++. +. .+++|.++.... ....+.+.+|++++.++ +||||+++++++......++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFAS-ENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCC-HHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 356777889999999999998753 33 468887764322 23456788999999999 79999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCc
Q 001434 856 IYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE 920 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 920 (1078)
||||+++++|.+++.... ..+++..+..++.|++.|++|||++ +++||||||+||++++++.
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~ 157 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLA 157 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCe
Confidence 999999999999986432 2478889999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHH
Q 001434 921 AHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNY 999 (1078)
Q Consensus 921 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~ 999 (1078)
+||+|||++...... ........+..|+|||...+..++.++|||||||++|||++ |..||.... ........
T Consensus 158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~----~~~~~~~~ 231 (297)
T cd05089 158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT----CAELYEKL 231 (297)
T ss_pred EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHHH
Confidence 999999998643211 11111233567999999988889999999999999999997 999996433 22222222
Q ss_pred hhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCC
Q 001434 1000 IRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1061 (1078)
..... ...+. .....+.+++.+|++.+|.+||+++++++.|.++.....
T Consensus 232 ~~~~~-------~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~~ 280 (297)
T cd05089 232 PQGYR-------MEKPR------NCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEARK 280 (297)
T ss_pred hcCCC-------CCCCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence 11110 00110 112346789999999999999999999999988865543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=317.38 Aligned_cols=268 Identities=25% Similarity=0.348 Sum_probs=207.4
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-C-----CceeeEeeEEEec
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-H-----RNIVKLYGFCYHQ 850 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~l~~~~~~~ 850 (1078)
..++|...++||+|+||.|.+|.+. +++.||||+++.... -..+...|+.+|..++ | -|+|+++++|...
T Consensus 184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~---f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR---FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH---HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 3458888999999999999999965 699999999977643 3455677899998885 3 5999999999999
Q ss_pred CceEEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC--CceEEeecc
Q 001434 851 GSNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK--FEAHVGDFG 927 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~--~~~kl~Dfg 927 (1078)
++.+||+|.++. +|+++++.+. ..++...++.++.||+.||.+||+. +|||+||||+|||+.+. ..|||+|||
T Consensus 261 ~HlciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 261 NHLCIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred cceeeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence 999999999965 9999997653 4799999999999999999999998 99999999999999754 479999999
Q ss_pred cccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHH----------
Q 001434 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR---------- 997 (1078)
Q Consensus 928 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~---------- 997 (1078)
.|+..... .-...-+..|+|||++.+.+|+.+.||||||||++||++|.+-|.+..+.+.+..++.
T Consensus 337 SSc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL 412 (586)
T KOG0667|consen 337 SSCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML 412 (586)
T ss_pred cccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 99976422 2256778899999999999999999999999999999999877766544444443321
Q ss_pred -------HHhhcCCCCCc-----------------------cccCCCCcchhhH----H-HHHHHHHHHHHhcCCCCCCC
Q 001434 998 -------NYIRDHSLTPG-----------------------IFDTRLNVEDESI----V-DHMILVLKVALMCTSISPFD 1042 (1078)
Q Consensus 998 -------~~~~~~~~~~~-----------------------~~~~~~~~~~~~~----~-~~~~~l~~li~~cl~~dP~~ 1042 (1078)
.++........ ..+...+...+.+ . .....+.+++++|+..||.+
T Consensus 413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~ 492 (586)
T KOG0667|consen 413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE 492 (586)
T ss_pred HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence 11111000000 0000011011111 1 23345899999999999999
Q ss_pred CCCHHHHHHHHHhh
Q 001434 1043 RPSMREVVSMLIES 1056 (1078)
Q Consensus 1043 RPs~~ell~~L~~~ 1056 (1078)
|+|+.++++|-+--
T Consensus 493 R~tp~qal~Hpfl~ 506 (586)
T KOG0667|consen 493 RITPAQALNHPFLT 506 (586)
T ss_pred cCCHHHHhcCcccc
Confidence 99999999987644
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-33 Score=313.38 Aligned_cols=257 Identities=25% Similarity=0.391 Sum_probs=204.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCc
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 852 (1078)
.+|...+.||+|+||.||+|.+. .+..||+|++..... ....+.+.+|+.+++++ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 45777888999999999999742 355799999876533 23356789999999999 79999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
.++||||+++|+|.++++... ..+++.++..++.|++.|++|+|++ +++|+||||+||+++.++.++++|||.+..
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCccccc
Confidence 999999999999999997543 2489999999999999999999998 999999999999999999999999999976
Q ss_pred cCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 001434 932 IDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 932 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
...... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||............ .......
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~----~~~~~~~--- 263 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKL----IKEGYRM--- 263 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHH----HHcCCcC---
Confidence 542221 11223345778999999998889999999999999999998 99999754432222221 1111100
Q ss_pred ccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
..+. .....+.+++.+|++.+|++|||+.++++.|.+.
T Consensus 264 ---~~~~------~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 264 ---AQPE------HAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred ---CCCC------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000 1123478899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=312.28 Aligned_cols=262 Identities=23% Similarity=0.393 Sum_probs=200.1
Q ss_pred hcCCCccEEeccCceEEEEEEECC---------------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS---------------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~ 844 (1078)
.+|+..+.||+|+||.||+|.+.. ...||+|++..... ......+.+|++++++++|+|+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT-KTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 456777889999999999987642 23589999875432 33456789999999999999999999
Q ss_pred eEEEecCceEEEEeeccCCCHHhHhcCCC-----------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcE
Q 001434 845 GFCYHQGSNLLIYEYMERGSLGELLHGSS-----------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNI 913 (1078)
Q Consensus 845 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Ni 913 (1078)
+++......++||||+++++|.+++.... ..+++..+..++.|++.|++|||++ +++||||||+||
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Ni 160 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNC 160 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhE
Confidence 99999999999999999999999986432 1367888999999999999999998 999999999999
Q ss_pred EECCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh--CCCCCCCCCCCC
Q 001434 914 LLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRTPVQPLDDGG 990 (1078)
Q Consensus 914 ll~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~P~~~~~~~~ 990 (1078)
++++++.+|++|||++........ .......++..|+|||...++.++.++||||||+++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999876532211 11223345778999999988889999999999999999998 667876543322
Q ss_pred CHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 991 DLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.... ............ .....+ .....+.+++.+|++.+|++|||++++++.|++
T Consensus 241 ~~~~-~~~~~~~~~~~~--~~~~~~-------~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 VIEN-TGEFFRNQGRQI--YLSQTP-------LCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred HHHH-HHHhhhhccccc--cCCCCC-------CCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 2221 122111110000 000000 012357899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=312.13 Aligned_cols=262 Identities=26% Similarity=0.404 Sum_probs=202.6
Q ss_pred hcCCCccEEeccCceEEEEEEECC-----------------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-----------------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 842 (1078)
.+|+..+.||+|+||.||+|.+.. +..||+|++...... ...+.+.+|++++++++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEeE
Confidence 467778889999999999998642 245899988755432 34678899999999999999999
Q ss_pred EeeEEEecCceEEEEeeccCCCHHhHhcCCC----------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCc
Q 001434 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSS----------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNN 912 (1078)
Q Consensus 843 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 912 (1078)
+++++..++..++||||+++++|.+++.... ..+++..+..++.|++.||+|||++ +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchhc
Confidence 9999999999999999999999999986543 2588999999999999999999998 99999999999
Q ss_pred EEECCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh--CCCCCCCCCCC
Q 001434 913 ILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRTPVQPLDDG 989 (1078)
Q Consensus 913 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~P~~~~~~~ 989 (1078)
|+++.++.++++|||.++....... .......+++.|+|||.+.+..++.++||||+|+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 9999999999999999876532221 22234456788999999988889999999999999999998 67788643322
Q ss_pred CCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
... .......+........ + . + ......+.+++.+|++.||++|||++++++.|++
T Consensus 241 ~~~-~~~~~~~~~~~~~~~~-~-~-~------~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 QVI-ENAGHFFRDDGRQIYL-P-R-P------PNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred HHH-HHHHhccccccccccC-C-C-c------cCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 111 1111111111100000 0 0 0 0112457899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=310.65 Aligned_cols=264 Identities=28% Similarity=0.387 Sum_probs=198.7
Q ss_pred CCccEEeccCceEEEEEEE-----CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEE
Q 001434 783 HDSFIVGSGAYGTVYKAVM-----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLL 855 (1078)
Q Consensus 783 ~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~l 855 (1078)
...+.||+|+||+||.+.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++... ...++
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 6677899999999988653 2577899999876533 23456788999999999999999999988654 35789
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++++|.+++... .+++.++..++.|++.|++|||++ +++||||||+||++++++.++++|||+++.....
T Consensus 86 v~e~~~~~~l~~~~~~~--~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 86 IMEYVPLGSLRDYLPKH--KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred EecCCCCCCHHHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 99999999999999764 489999999999999999999998 9999999999999999999999999999866432
Q ss_pred CCC--cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHh---hcCCCCCccc
Q 001434 936 QSK--SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYI---RDHSLTPGIF 1010 (1078)
Q Consensus 936 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 1010 (1078)
... ......++..|+|||...+..++.++||||+|+++|||++|..||...... ......... ...... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~-~~~ 237 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTVVRLI-ELL 237 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccchhhhh-hhh
Confidence 211 112234566799999998888999999999999999999999998643211 000000000 000000 000
Q ss_pred cCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
+...... ........+.+++.+||+.+|++|||++++++.|+++.
T Consensus 238 ~~~~~~~--~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~ 282 (283)
T cd05080 238 ERGMRLP--CPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH 282 (283)
T ss_pred hcCCCCC--CCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence 0000000 00112345788999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=306.05 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=201.7
Q ss_pred cCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCC----chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREG----NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
+|+..+.||+|+||.||+|...+++.+|+|.+...... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 46778889999999999999888999999998754322 22345688999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC-
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP- 935 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~- 935 (1078)
|||+++++|.+++.+.. .+++..+..++.|++.|++|+|+. +++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 156 (265)
T cd06631 81 MEFVPGGSISSILNRFG-PLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG 156 (265)
T ss_pred EecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence 99999999999997654 578899999999999999999998 9999999999999999999999999998754211
Q ss_pred ----CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 936 ----QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 936 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.........|+..|+|||.+.+..++.++||||+|+++|++++|+.||.......... .........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~----~~~~~~~~~----- 227 (265)
T cd06631 157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF----YIGAHRGLM----- 227 (265)
T ss_pred ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH----HhhhccCCC-----
Confidence 1112233568899999999998889999999999999999999999997543221111 111110000
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+..+. .....+.+++.+|++.+|++||++.+++++
T Consensus 228 ~~~~~------~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 262 (265)
T cd06631 228 PRLPD------SFSAAAIDFVTSCLTRDQHERPSALQLLRH 262 (265)
T ss_pred CCCCC------CCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 11111 122346789999999999999999999864
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=301.96 Aligned_cols=252 Identities=24% Similarity=0.345 Sum_probs=207.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..++||+|+||.||.+... +++.+++|++............+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4677889999999999999865 588999999876655555567889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... ...+++.++..++.|+++|++|||+. +++||||+|+||++++++.+|++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~- 156 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS- 156 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence 9999999999765 44689999999999999999999998 999999999999999999999999999986643321
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......+++.|+|||...+..++.++||||+|+++|||++|..||... ............. ... . .
T Consensus 157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~~~~~~~~-~~~-----~----~ 222 (256)
T cd08221 157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT----NPLNLVVKIVQGN-YTP-----V----V 222 (256)
T ss_pred cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHcCC-CCC-----C----c
Confidence 234456899999999998888899999999999999999999999643 2233333332211 110 0 0
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
......+.+++.+||+.+|++||++.++++++
T Consensus 223 ---~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~ 254 (256)
T cd08221 223 ---SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254 (256)
T ss_pred ---cccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence 11234477899999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=307.42 Aligned_cols=260 Identities=24% Similarity=0.416 Sum_probs=204.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCc----EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||+||+|.+. +++ .||+|++..... ....+.+.+|+.+++.++|+||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTS-PKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCC-HHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 46777788999999999999864 343 489999865433 3345678899999999999999999998875 4578
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
++|||+++|+|.+++......+++.++..++.|++.|++|||++ +|+||||||+||++++++.+||+|||+++....
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999999987655789999999999999999999999 999999999999999999999999999987642
Q ss_pred CCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.... ......+++.|+|||...+..++.++||||||+++||+++ |..||..... .. ....+......+. +.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~----~~~~~~~~~~~~~--~~ 234 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA-RE----IPDLLEKGERLPQ--PP 234 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCH-HH----HHHHHHCCCcCCC--Cc
Confidence 2211 1122345678999999988899999999999999999998 8999864321 11 1122222111100 00
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCC
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1061 (1078)
.....+.+++.+||+.||++||++.++++.+.++....+
T Consensus 235 ----------~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05109 235 ----------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDPS 273 (279)
T ss_pred ----------cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCCc
Confidence 122347789999999999999999999999988865543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=322.58 Aligned_cols=258 Identities=26% Similarity=0.359 Sum_probs=202.2
Q ss_pred hhcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecC
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQG 851 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~ 851 (1078)
..+|...+.||+|+||.||+|++. .++.||+|++...... ...+.+.+|++++.++. ||||+++++++...+
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~ 114 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGG 114 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC
Confidence 345667788999999999999864 3468999999765432 33457889999999997 999999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCC----------------------------------------------------------
Q 001434 852 SNLLIYEYMERGSLGELLHGSS---------------------------------------------------------- 873 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 873 (1078)
..++||||+++|+|.++++..+
T Consensus 115 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (401)
T cd05107 115 PIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQD 194 (401)
T ss_pred CcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhc
Confidence 9999999999999999986432
Q ss_pred ---------------------------------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEE
Q 001434 874 ---------------------------------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNIL 914 (1078)
Q Consensus 874 ---------------------------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil 914 (1078)
..+++..+..++.|++.|++|||+. +++||||||+||+
T Consensus 195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiL 271 (401)
T cd05107 195 MKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVL 271 (401)
T ss_pred chhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEE
Confidence 1255667788999999999999998 9999999999999
Q ss_pred ECCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCH
Q 001434 915 LDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDL 992 (1078)
Q Consensus 915 l~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~ 992 (1078)
+++++.++++|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......+.
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986532211 12223456788999999988889999999999999999998 8899864432221
Q ss_pred HHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 993 ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
........... ..+. .....+.+++.+||+.+|++||+++++++.|+++
T Consensus 351 ---~~~~~~~~~~~------~~p~------~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~ 399 (401)
T cd05107 351 ---FYNAIKRGYRM------AKPA------HASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL 399 (401)
T ss_pred ---HHHHHHcCCCC------CCCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence 11211111100 0110 1123578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=302.16 Aligned_cols=248 Identities=26% Similarity=0.390 Sum_probs=197.2
Q ss_pred cEEeccCceEEEEEEECC----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 786 FIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
+.||+|+||.||+|.+.. +..||+|.+...... ...+.+.+|++++++++|+||+++++++. .+..++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 359999999999998542 368999999766543 44567899999999999999999999876 456899999999
Q ss_pred CCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccc
Q 001434 862 RGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941 (1078)
Q Consensus 862 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 941 (1078)
+++|.+++.... .+++..+..++.|++.|++|||.. +++||||||+||+++.++.+|++|||.++...........
T Consensus 79 ~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~ 154 (257)
T cd05060 79 LGPLLKYLKKRR-EIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA 154 (257)
T ss_pred CCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence 999999998665 689999999999999999999998 9999999999999999999999999999866432221111
Q ss_pred --ccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 942 --AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 942 --~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
...++..|+|||...+..++.++||||+|+++|||++ |..||...+. ...... +....... .+
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~----~~~~~~-~~~~~~~~------~~--- 220 (257)
T cd05060 155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAM-LESGERLP------RP--- 220 (257)
T ss_pred ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH----HHHHHH-HHcCCcCC------CC---
Confidence 1223467999999988899999999999999999998 9999965432 122111 11111000 00
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
......+.+++.+|++.+|++||++.++++.|+++
T Consensus 221 ---~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 255 (257)
T cd05060 221 ---EECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255 (257)
T ss_pred ---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence 01123577899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=308.09 Aligned_cols=254 Identities=25% Similarity=0.430 Sum_probs=199.8
Q ss_pred cCCCccEEeccCceEEEEEEE-----CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVM-----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
+|+..+.||+|+||+||+|.+ ..+..|++|.+..... ......+.+|+.++++++||||+++++++..++..++
T Consensus 6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 455667899999999999984 2467899999975433 2334678899999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCC----------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC
Q 001434 856 IYEYMERGSLGELLHGSS----------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF 919 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~----------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~ 919 (1078)
||||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||++++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence 999999999999985321 2477888899999999999999998 999999999999999999
Q ss_pred ceEEeecccccccCCCC-CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHH
Q 001434 920 EAHVGDFGLAKVIDMPQ-SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVR 997 (1078)
Q Consensus 920 ~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~ 997 (1078)
.+|++|||+++...... ........++..|+|||...+..++.++||||+|+++|||++ |..||..... .....
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~----~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN----QEVIE 237 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH----HHHHH
Confidence 99999999997653222 112233445678999999988889999999999999999998 9999864321 22222
Q ss_pred HHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 998 NYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
. .......+ .+. .....+.+++.+|++.||++||++.++.+++..
T Consensus 238 ~-~~~~~~~~--~~~----------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 238 M-VRKRQLLP--CSE----------DCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred H-HHcCCcCC--CCC----------CCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 2 22111110 011 112346789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=307.26 Aligned_cols=251 Identities=24% Similarity=0.364 Sum_probs=199.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..++||+|+||.||+|.+. +++.||+|++..... ....+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT-VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC-hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 4666778999999999999975 688999999865532 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|..+. .+++..+..++.|++.|++|||+. +|+|+||||+||+++.++.++|+|||.+...... .
T Consensus 81 ~~~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~ 149 (279)
T cd06619 81 MDGGSLDVYR-----KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I 149 (279)
T ss_pred CCCCChHHhh-----cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence 9999997652 367888899999999999999998 9999999999999999999999999999765322 2
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCH---HHHHHHHhhcCCCCCccccCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL---ATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.....|+..|+|||.+.+..++.++||||+|+++|+|++|+.||......... ....... .... . ...+.
T Consensus 150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~-~-----~~~~~ 222 (279)
T cd06619 150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI-VDED-P-----PVLPV 222 (279)
T ss_pred ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH-hccC-C-----CCCCC
Confidence 33457899999999999889999999999999999999999999754322211 1111111 1110 0 01100
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
. .....+.+++.+|++.+|++||++++++++-+-
T Consensus 223 ~-----~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~ 256 (279)
T cd06619 223 G-----QFSEKFVHFITQCMRKQPKERPAPENLMDHPFI 256 (279)
T ss_pred C-----cCCHHHHHHHHHHhhCChhhCCCHHHHhcCccc
Confidence 0 112346789999999999999999999988653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-33 Score=303.37 Aligned_cols=248 Identities=28% Similarity=0.441 Sum_probs=202.7
Q ss_pred cEEeccCceEEEEEEECC----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 786 FIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
+.||+|+||.||+|.+.. +..|++|.+....... ..+.+.+|++.+++++|+|++++++++.++...++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 358999999999999763 7889999997665433 46788999999999999999999999999999999999999
Q ss_pred CCCHHhHhcCC--------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 862 RGSLGELLHGS--------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 862 ~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
+++|.+++... ...+++.++..++.|++.|++|||++ +++||||+|+||++++++.++++|||.+....
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 156 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVY 156 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccc
Confidence 99999999876 35799999999999999999999998 99999999999999999999999999998765
Q ss_pred CCC-CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 934 MPQ-SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 934 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
... ........++..|+|||.+....++.++||||+|+++|||++ |..||.... ............. .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~~-~----- 226 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS----NEEVLEYLRKGYR-L----- 226 (262)
T ss_pred cccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHHcCCC-C-----
Confidence 322 122334567889999999988889999999999999999999 699997552 2222222221110 0
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..+. .....+.+++.+|++.+|++|||+.+++++|+
T Consensus 227 -~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 227 -PKPE------YCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred -CCCc------cCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0000 11345778999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=286.18 Aligned_cols=253 Identities=22% Similarity=0.346 Sum_probs=199.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+.+....+|.|+.|.||+++.+ +|..+|||.+.+....++ .+++...++++..- ++|+||++++||..+..+++.||
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee-~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe 171 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEE-NKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME 171 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHH-HHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence 3444556999999999999976 488999999988766443 45666666665544 59999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
.|.. ...+++.+-.+++++.-+-++...+++||.||.++ ++|+|||+||+|||+|+.|++|+||||.+.++- +..
T Consensus 172 lMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeK--H~viHRDvKPSNILlDe~GniKlCDFGIsGrlv--dSk 246 (391)
T KOG0983|consen 172 LMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGNIKLCDFGISGRLV--DSK 246 (391)
T ss_pred HHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHh--cceeecccCccceEEccCCCEEeecccccceee--ccc
Confidence 9954 67777776666788888888999999999999987 499999999999999999999999999998765 344
Q ss_pred cccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 939 SMSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
..+...|-+.|||||.+. ...|+.++||||+|++++|+.||+.||...+.+-+.- .+.....+ +. ++....
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~l---tkvln~eP--P~-L~~~~g 320 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVL---TKVLNEEP--PL-LPGHMG 320 (391)
T ss_pred ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHH---HHHHhcCC--CC-CCcccC
Confidence 556678999999999885 3468999999999999999999999998654332222 22222221 11 122211
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
....+.+++..|+.+|+.+||.+.+++++-
T Consensus 321 --------FSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~ 350 (391)
T KOG0983|consen 321 --------FSPDFQSFVKDCLTKDHRKRPKYNKLLEHP 350 (391)
T ss_pred --------cCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence 233467899999999999999999998764
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=327.83 Aligned_cols=264 Identities=20% Similarity=0.300 Sum_probs=193.6
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec-------
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------- 850 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------- 850 (1078)
..+|+..+.||+|+||+||+|.+. +++.||||++.... ....+|+.++++++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~ 138 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK 138 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence 346888899999999999999975 58899999885432 2235799999999999999999887432
Q ss_pred -CceEEEEeeccCCCHHhHhc---CCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-ceEEee
Q 001434 851 -GSNLLIYEYMERGSLGELLH---GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGD 925 (1078)
Q Consensus 851 -~~~~lv~e~~~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~D 925 (1078)
...++||||+++ ++.+++. .....+++..+..++.||+.||+|||++ +|+||||||+||+++.++ .+||+|
T Consensus 139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence 235689999975 7877664 2334689999999999999999999999 999999999999999664 799999
Q ss_pred cccccccCCCCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC-
Q 001434 926 FGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH- 1003 (1078)
Q Consensus 926 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~- 1003 (1078)
||+++..... .......|++.|+|||++.+. .++.++||||+||++|||++|.+||.+..........+...-...
T Consensus 215 FGla~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~ 292 (440)
T PTZ00036 215 FGSAKNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE 292 (440)
T ss_pred cccchhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9999866422 223345789999999988654 689999999999999999999999975443322222221100000
Q ss_pred ----CCCCccccCCCCc-chhhHH-----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1004 ----SLTPGIFDTRLNV-EDESIV-----DHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1004 ----~~~~~~~~~~~~~-~~~~~~-----~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
...+...+..++. ....+. ....++.+++.+||..||++|||+.|++++-+
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~ 353 (440)
T PTZ00036 293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF 353 (440)
T ss_pred HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence 0000000000000 000000 12245789999999999999999999998765
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-34 Score=315.88 Aligned_cols=250 Identities=24% Similarity=0.388 Sum_probs=201.8
Q ss_pred CCccEEeccCceEEEEEEEC--CC--cEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 783 HDSFIVGSGAYGTVYKAVMD--SG--KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 783 ~~~~~lG~G~~g~V~~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
...++||+|.||+|++|.|+ +| ..||||++....... ...+|.+|+..|.+|+|+|++++|++..+ ....||||
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 34456999999999999987 34 358999998776544 56899999999999999999999999887 67889999
Q ss_pred eccCCCHHhHhcC-CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 859 YMERGSLGELLHG-SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
.++.|+|.+.+++ ....+-......++.|||.|+.||.++ ++||||+..+|+++-....|||+|||+.+-+.....
T Consensus 191 LaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred hcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 9999999999987 444677788889999999999999999 999999999999999999999999999997753322
Q ss_pred Cc--ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 938 KS--MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 938 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.. .....-.+.|+|||.+....++.++|||+|||++|||++ |+.||.+... .++.+.+-.....+ +-
T Consensus 268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g----~qIL~~iD~~erLp------RP 337 (1039)
T KOG0199|consen 268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG----IQILKNIDAGERLP------RP 337 (1039)
T ss_pred ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH----HHHHHhccccccCC------CC
Confidence 21 122344678999999999999999999999999999999 8999975442 23333322111111 11
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
. .+.+.++++++.||..+|++|||+.++.+.+-
T Consensus 338 k-------~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 338 K-------YCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred C-------CChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 1 23455889999999999999999999985543
|
|
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=300.93 Aligned_cols=247 Identities=26% Similarity=0.402 Sum_probs=199.2
Q ss_pred EEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHH
Q 001434 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~ 866 (1078)
+||+|++|.||+|.+..++.||+|++...... ...+.+.+|++++++++|++|+++++++.+....++||||+++++|.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 58999999999999877999999998765443 34678899999999999999999999999999999999999999999
Q ss_pred hHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc-ccccc
Q 001434 867 ELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM-SAVAG 945 (1078)
Q Consensus 867 ~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~-~~~~g 945 (1078)
+++......+++..+..++.+++.|++|+|++ +++||||+|+||+++.++.++++|||.+........... ....+
T Consensus 81 ~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 81 TFLRKKKNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99976655788999999999999999999998 999999999999999999999999999876532111111 12234
Q ss_pred ccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHH
Q 001434 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024 (1078)
Q Consensus 946 t~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1078)
+..|+|||.+.++.++.++|+||+|+++|||++ |..||...... ..... ..... . ...+ + ..
T Consensus 158 ~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~----~~~~~-~~~~~-~-----~~~~---~---~~ 220 (251)
T cd05041 158 PIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ----QTRER-IESGY-R-----MPAP---Q---LC 220 (251)
T ss_pred eeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHH----HHHHH-HhcCC-C-----CCCC---c---cC
Confidence 567999999988889999999999999999999 88888654321 11111 11110 0 0000 0 12
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1025 MILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1025 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
...+.+++.+|+..+|++|||+.|+++.|.
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 235788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=302.38 Aligned_cols=252 Identities=25% Similarity=0.418 Sum_probs=202.0
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|+||.||+|.+..+..+|+|.+.... ...+.+.+|++++++++|+||+++++++.+ ...+++|||
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~ 81 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF 81 (260)
T ss_pred cceeEEeEecCccceEEEEEEecCCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence 4567778899999999999998778889999886432 235678899999999999999999999877 778999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++... ....++.++..++.|++.|++|+|+. +++||||||+||+++.++.++++|||.+.........
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 82 MAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 9999999999753 34678889999999999999999998 9999999999999999999999999998765432222
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||.+....++.++|+||+|+++|++++ |+.||..... ............ . +..
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~----~~~~~~~~~~~~-~-----~~~--- 225 (260)
T cd05073 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN----PEVIRALERGYR-M-----PRP--- 225 (260)
T ss_pred cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCH----HHHHHHHhCCCC-C-----CCc---
Confidence 2223345678999999988889999999999999999998 9999964332 122221111111 0 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
......+.+++.+|++.+|++||++.++.+.|+.
T Consensus 226 ----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~ 259 (260)
T cd05073 226 ----ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259 (260)
T ss_pred ----ccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 1122347789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=318.19 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=200.5
Q ss_pred ccEEeccCceEEEEEEEC-CCcEEEEEEecccC--CCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc--eEEEEee
Q 001434 785 SFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNR--EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS--NLLIYEY 859 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~--~~lv~e~ 859 (1078)
..+||+|+|-+||+|.+. +|.+||--.++-.. ......++|..|+.+++.|+||||+++|.++.+... ..+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 345999999999999976 47777754333222 233445899999999999999999999999987665 6799999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|..|+|..|+.+.+ ..+......|++||++||.|||++ .+.|+|||||.+||||+. .|.|||+|+|+|+.....
T Consensus 125 ~TSGtLr~Y~kk~~-~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s--- 199 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR-RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS--- 199 (632)
T ss_pred ccCCcHHHHHHHhc-cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc---
Confidence 99999999998776 688899999999999999999998 789999999999999975 589999999999987532
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
....+.|||+|||||++. ..|+..+||||||++++||.|+.+||.. -...+++.++.....++. .+..-.
T Consensus 200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE---C~n~AQIYKKV~SGiKP~------sl~kV~ 269 (632)
T KOG0584|consen 200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE---CTNPAQIYKKVTSGIKPA------ALSKVK 269 (632)
T ss_pred ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh---hCCHHHHHHHHHcCCCHH------HhhccC
Confidence 233478999999999776 7899999999999999999999999974 445556666655443221 111100
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
-.++.++|.+|+.. .++|||+.|++.+=
T Consensus 270 ------dPevr~fIekCl~~-~~~R~sa~eLL~d~ 297 (632)
T KOG0584|consen 270 ------DPEVREFIEKCLAT-KSERLSAKELLKDP 297 (632)
T ss_pred ------CHHHHHHHHHHhcC-chhccCHHHHhhCh
Confidence 12377899999999 99999999999753
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=301.95 Aligned_cols=248 Identities=27% Similarity=0.402 Sum_probs=199.0
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEE-ecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY-HQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e 858 (1078)
.+|+..+.||+|++|.||++..+ +..||+|.+.... ..+.+.+|+.++++++|++++++++++. .+...++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 80 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEE
Confidence 35677788999999999999876 7889999985432 2467889999999999999999999764 4567899999
Q ss_pred eccCCCHHhHhcCCCC-CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 859 YMERGSLGELLHGSSC-NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+++++|.+++..... .+++..+..++.|++.|++|||++ +++||||||+||++++++.+|++|||.+.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~- 156 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ- 156 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-
Confidence 9999999999876443 478899999999999999999998 99999999999999999999999999987543211
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
....++..|+|||...+..++.++||||+|+++|||++ |+.||... .............. . ...
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~~~~--~-----~~~- 221 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI----PLKDVVPRVEKGYK--M-----DAP- 221 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCCC--C-----CCC-
Confidence 22345678999999988889999999999999999998 99998633 23333333222111 0 000
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
......+.+++.+|++.+|++|||++++++.|+++
T Consensus 222 -----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 222 -----DGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred -----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 01123477899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=305.02 Aligned_cols=250 Identities=26% Similarity=0.399 Sum_probs=203.8
Q ss_pred hcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|++|.||+|.++. ++.|++|.+..... .+.+.+|++++++++|+||+++++++.+++..+++||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 457777789999999999999875 78999999865432 5788999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++......+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+....... .
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~-~ 154 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM-A 154 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc-c
Confidence 9999999999987666789999999999999999999998 99999999999999999999999999988764322 1
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......++..|+|||.+.+..++.++||||+|+++|+|++|+.||.......... .... . . .....
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~----~~~~-~--~----~~~~~--- 220 (256)
T cd06612 155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF----MIPN-K--P----PPTLS--- 220 (256)
T ss_pred ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh----hhcc-C--C----CCCCC---
Confidence 2234457889999999988899999999999999999999999997543221111 1000 0 0 00010
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
........+.+++.+|++.+|++|||+.+++++
T Consensus 221 -~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~ 253 (256)
T cd06612 221 -DPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH 253 (256)
T ss_pred -chhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence 001122457889999999999999999999874
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=304.99 Aligned_cols=258 Identities=23% Similarity=0.370 Sum_probs=204.0
Q ss_pred hcCCCccEEeccCceEEEEEEECC----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
++|...+.||+|+||.||+|.+.+ ...|+||....... ....+.+.+|+.++++++||||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 456677889999999999998643 24688898865543 2345688999999999999999999998875 56789
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++++|.+++......+++.++..++.|++.|++|+|+. +++||||||+||+++.++.++++|||.+......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999999987665689999999999999999999998 9999999999999999999999999999865433
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.........++..|+|||.+....++.++||||+|+++||+++ |..||...... ............. ...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~----~~~~~~~~~~~~~---~~~-- 231 (270)
T cd05056 161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN----DVIGRIENGERLP---MPP-- 231 (270)
T ss_pred cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHHcCCcCC---CCC--
Confidence 2222223334568999999888889999999999999999996 99999754322 1122211111110 011
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
.....+.+++.+|+..+|++|||+.++++.|.++..+
T Consensus 232 --------~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~ 268 (270)
T cd05056 232 --------NCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE 268 (270)
T ss_pred --------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence 1123477899999999999999999999999987654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=307.83 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=198.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|...+.||+|+||.||+|.+. +++.||+|+++.... .....+.+|+.+++.++||||+++++++.+++..++||||
T Consensus 10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~ 87 (267)
T cd06645 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF 87 (267)
T ss_pred HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence 5566677999999999999975 588999999865532 2345678899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++...+ .+++.++..++.|++.|++|||+. +++|+||||+||+++.++.++|+|||.+...... ...
T Consensus 88 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~-~~~ 162 (267)
T cd06645 88 CGGGSLQDIYHVTG-PLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT-IAK 162 (267)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc-ccc
Confidence 99999999987655 689999999999999999999998 9999999999999999999999999998765422 222
Q ss_pred ccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.....|+..|+|||.+. ...++.++||||+||++|+|++|..||........... ..... ..+.......
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~----~~~~~-~~~~~~~~~~-- 235 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL----MTKSN-FQPPKLKDKM-- 235 (267)
T ss_pred cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh----hhccC-CCCCcccccC--
Confidence 33457899999999874 45688999999999999999999999864432211111 11111 1100000000
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+|++.+|++||++++++++
T Consensus 236 ------~~~~~~~~li~~~l~~~P~~R~~~~~ll~~ 265 (267)
T cd06645 236 ------KWSNSFHHFVKMALTKNPKKRPTAEKLLQH 265 (267)
T ss_pred ------CCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence 112346789999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-33 Score=307.02 Aligned_cols=259 Identities=25% Similarity=0.373 Sum_probs=201.5
Q ss_pred cCCCccEEeccCceEEEEEEE-----CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--Cce
Q 001434 781 NFHDSFIVGSGAYGTVYKAVM-----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSN 853 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 853 (1078)
-|+..+.||+|+||.||.|.. .+++.||+|.+..... ....+.+.+|++++++++|||++++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG-GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 356677899999999999974 2478899999865533 33456789999999999999999999998775 567
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++||||++|++|.+++......+++.++..++.|++.|++|+|++ +++||||||+||+++.++.++++|||.++...
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccc
Confidence 899999999999999976655689999999999999999999999 99999999999999999999999999998664
Q ss_pred CCCCC--cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCC-----------CCCCHHHHHHHHh
Q 001434 934 MPQSK--SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLD-----------DGGDLATWVRNYI 1000 (1078)
Q Consensus 934 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~-----------~~~~~~~~~~~~~ 1000 (1078)
..... ......++..|+|||...+..++.++||||+|+++||+++++.|+.... ........+.. .
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV-L 239 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH-H
Confidence 32211 1223456778999999988889999999999999999999876643211 01111111111 1
Q ss_pred hcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
...... +.. ......+.+++.+|++.+|++|||++++++.++++
T Consensus 240 ~~~~~~--------~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 240 EEGKRL--------PRP----PNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HcCccC--------CCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 111100 000 11234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=338.15 Aligned_cols=256 Identities=21% Similarity=0.354 Sum_probs=200.1
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLL 855 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~l 855 (1078)
..+|...+.||+|+||+||+|.+. +++.||+|++............+.+|+.++++++||||++++++|.+. ..+|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 346788889999999999999976 477889999876655555567889999999999999999999988653 56899
Q ss_pred EEeeccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhhccCC----CceEecCCCCCcEEECC-----------
Q 001434 856 IYEYMERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCK----PRIFHRDIKSNNILLDD----------- 917 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~----~~ivH~Dlkp~Nill~~----------- 917 (1078)
||||+++|+|.+++... ...+++..++.|+.||+.||+|||+... .+||||||||+|||++.
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 99999999999998642 2368999999999999999999998511 25999999999999964
Q ss_pred ------CCceEEeecccccccCCCCCCcccccccccCccccccccc--CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC
Q 001434 918 ------KFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG 989 (1078)
Q Consensus 918 ------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~P~~~~~~~ 989 (1078)
.+.+||+|||++...... .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~-- 247 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN-- 247 (1021)
T ss_pred ccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC--
Confidence 335899999999865422 22334579999999998854 458899999999999999999999996433
Q ss_pred CCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.....+......... ... .....+.++|.+||+.+|++||++.+++.+-
T Consensus 248 -~~~qli~~lk~~p~l-------pi~-------~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~ 296 (1021)
T PTZ00266 248 -NFSQLISELKRGPDL-------PIK-------GKSKELNILIKNLLNLSAKERPSALQCLGYQ 296 (1021)
T ss_pred -cHHHHHHHHhcCCCC-------CcC-------CCCHHHHHHHHHHhcCChhHCcCHHHHhccH
Confidence 233333222211100 001 1123477899999999999999999999543
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=304.83 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=204.4
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|++|.||+|.+. +++.+++|++...... ..+.+.+|++++++++||||+++++++.+.+..+++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 45777788999999999999975 5788999999765432 45788999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++......+++.++..++.|++.|++|||++ +++||||+|+||+++.++.++++|||.+...... ..
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~-~~ 156 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT-IA 156 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhh-hh
Confidence 9999999999987645789999999999999999999998 9999999999999999999999999998765422 12
Q ss_pred cccccccccCcccccccccC---CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 939 SMSAVAGSYGYIAPEYAYTM---KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
......++..|+|||.+.+. .++.++||||+|+++|||++|+.||........ ............ ...
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~----~~~~~~~~~~~~-----~~~ 227 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA----LFLISKSNFPPP-----KLK 227 (262)
T ss_pred ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhccCCCc-----ccc
Confidence 22345688899999998776 788999999999999999999999975432211 111111100000 000
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
........+.+++.+||+.+|.+|||+++++.+
T Consensus 228 ----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 260 (262)
T cd06613 228 ----DKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH 260 (262)
T ss_pred ----chhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 011233457899999999999999999999864
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=312.42 Aligned_cols=254 Identities=24% Similarity=0.344 Sum_probs=201.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
..|+..+.||+|+||.||+|.+. +++.|++|++.... ....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 35667778999999999999976 48899999986543 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|..++.+....+++..+..++.|++.|++|||++ +++||||||+||+++.++.++|+|||.+...... ..
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~-~~ 165 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT-LQ 165 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceecccc-cc
Confidence 9999999998876655789999999999999999999998 9999999999999999999999999988754321 22
Q ss_pred cccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 939 SMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
......+++.|+|||.+. ...++.++||||+|+++|||++|+.||..... ............ + .
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~~-~------~ 234 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAKSEP-P------T 234 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH----HHHHHHHhcCCC-c------c
Confidence 223456888999999874 34577899999999999999999999964331 222222221111 0 0
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.... ......+.+++.+||+.+|++||++++++++-+
T Consensus 235 ~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 271 (292)
T cd06644 235 LSQP----SKWSMEFRDFLKTALDKHPETRPSAAQLLEHPF 271 (292)
T ss_pred CCCC----cccCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence 0000 012234678999999999999999999987644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-33 Score=308.46 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=199.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.++ +++.||+|++......+...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 3666788999999999999976 588999999876544444456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC--CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 860 MERGSLGELLHGSS--CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
++ ++|.+++.... ..+++.++..++.|++.||+|||++ +++||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 155 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence 97 58988886432 4689999999999999999999998 99999999999999999999999999987654222
Q ss_pred CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc-----
Q 001434 938 KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD----- 1011 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1011 (1078)
.......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||............... ........++
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 232 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRI---LGTPTEDVWPGVTSL 232 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH---hCCCChhhhhcchhh
Confidence 222334578899999987654 5788999999999999999999999753321111111110 0000000000
Q ss_pred ----CCCCc-----chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 ----TRLNV-----EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ----~~~~~-----~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...+. ..........++.+++.+|++.||++|||+.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~ 282 (285)
T cd07861 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH 282 (285)
T ss_pred HHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence 00000 000001123456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-33 Score=311.71 Aligned_cols=264 Identities=23% Similarity=0.353 Sum_probs=200.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.+. +|+.||+|++............+.+|++++++++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 3666778999999999999976 588999999976544344456678899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++ +|.+++......+++..+..++.||++|+.|||++ +++||||||+||+++.++.++|+|||.+....... ..
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~ 155 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-RC 155 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC-CC
Confidence 975 88888876555789999999999999999999998 99999999999999999999999999987654221 22
Q ss_pred ccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC------------
Q 001434 940 MSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT------------ 1006 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~------------ 1006 (1078)
.....+++.|+|||.+.+. .++.++||||+|+++|||++|..|+....+. ........+.....
T Consensus 156 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 156 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV---DDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCH---HHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 3345678899999988764 4789999999999999999999987543322 11111111100000
Q ss_pred CccccCCCCcc---hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 PGIFDTRLNVE---DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+..... .+........+.+++.+|++.||.+|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h 281 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH 281 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence 00000000000 00011223457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=316.83 Aligned_cols=267 Identities=18% Similarity=0.205 Sum_probs=197.0
Q ss_pred ccEEecc--CceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 785 SFIVGSG--AYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 785 ~~~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
.++||+| +|++||++.++ +|+.||+|++..........+.+.+|+++++.++||||+++++++..++..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3569999 67899999875 68999999997765544556678889999999999999999999999999999999999
Q ss_pred CCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC---
Q 001434 862 RGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS--- 937 (1078)
Q Consensus 862 ~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--- 937 (1078)
+|+|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++++||+..........
T Consensus 83 ~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 83 YGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred CCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 99999998653 33589999999999999999999998 999999999999999999999999986543221110
Q ss_pred ---CcccccccccCccccccccc--CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC----CCCCc
Q 001434 938 ---KSMSAVAGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH----SLTPG 1008 (1078)
Q Consensus 938 ---~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~----~~~~~ 1008 (1078)
.......++..|+|||.+.+ ..++.++||||+||++|||++|+.||.................... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAE 239 (327)
T ss_pred ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhh
Confidence 01122346778999999876 4588999999999999999999999975432221111111000000 00000
Q ss_pred ---------cccCCC----------C-----cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1009 ---------IFDTRL----------N-----VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1009 ---------~~~~~~----------~-----~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..+... + ............+.+++.+||+.||++|||+++++++-+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~ 309 (327)
T cd08227 240 ELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 309 (327)
T ss_pred hcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChh
Confidence 000000 0 000001122345789999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-33 Score=308.37 Aligned_cols=257 Identities=26% Similarity=0.382 Sum_probs=201.1
Q ss_pred cCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
+|+..+.||+|+||.||+|... ....+++|.+..... ....+.+.+|+.+++.++||||+++++.+..++..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 3566778999999999999853 235688888865543 233567889999999999999999999999999999
Q ss_pred EEEeeccCCCHHhHhcCCC-----------------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCC
Q 001434 855 LIYEYMERGSLGELLHGSS-----------------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSN 911 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~-----------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 911 (1078)
+||||+.+++|.+++.... ..+++.++..++.|++.|++|||+. +++||||||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~ 156 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAAR 156 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhh
Confidence 9999999999999875321 2477889999999999999999998 9999999999
Q ss_pred cEEECCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCC
Q 001434 912 NILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDG 989 (1078)
Q Consensus 912 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~ 989 (1078)
||++++++.++|+|||.++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 157 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~- 235 (290)
T cd05045 157 NVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP- 235 (290)
T ss_pred eEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH-
Confidence 99999999999999999976532221 11223345678999999988889999999999999999998 9999964321
Q ss_pred CCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
..+.. ...... . ...+. .....+.+++.+|++.+|++||+++++++.|+++-.
T Consensus 236 ---~~~~~-~~~~~~-~-----~~~~~------~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 236 ---ERLFN-LLKTGY-R-----MERPE------NCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred ---HHHHH-HHhCCC-C-----CCCCC------CCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 12111 111110 0 00010 112347789999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=308.64 Aligned_cols=252 Identities=23% Similarity=0.310 Sum_probs=199.6
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|+||.||+|.+. ++..+++|.+..... ...+.+.+|+++++.++||||+++++++..+...++||||+
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~ 84 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 84 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH--HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence 455677999999999999976 477888888854432 34567889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||++...... ....
T Consensus 85 ~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~-~~~~ 160 (282)
T cd06643 85 AGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQRR 160 (282)
T ss_pred CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEcccccccccccc-cccc
Confidence 99999998876555789999999999999999999998 9999999999999999999999999998764321 2223
Q ss_pred cccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 941 SAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
....++..|+|||.+. +..++.++||||+||++|||++|+.||...... ............. ...+.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~~~~~-~~~~~--- 232 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSEPPT-LAQPS--- 232 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHHhhcCCCC-CCCcc---
Confidence 3456899999999873 445778999999999999999999999654321 2222221111100 00010
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.....+.+++.+||+.+|++||++++++++-+
T Consensus 233 -------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 264 (282)
T cd06643 233 -------RWSSEFKDFLKKCLEKNVDARWTTTQLLQHPF 264 (282)
T ss_pred -------ccCHHHHHHHHHHccCChhhCcCHHHHhcCCC
Confidence 11234678999999999999999999987765
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-33 Score=308.47 Aligned_cols=262 Identities=24% Similarity=0.399 Sum_probs=200.4
Q ss_pred hcCCCccEEeccCceEEEEEEEC-----------------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-----------------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~ 842 (1078)
.+|+..+.||+|+||.||+|.+. +...||+|++..... ......+.+|+.++++++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN-KNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcce
Confidence 45777888999999999998643 234689998865532 334568899999999999999999
Q ss_pred EeeEEEecCceEEEEeeccCCCHHhHhcCCC----------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCc
Q 001434 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSS----------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNN 912 (1078)
Q Consensus 843 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~N 912 (1078)
+++++.+++..++||||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~N 160 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRN 160 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhe
Confidence 9999999999999999999999999987532 1366778999999999999999998 99999999999
Q ss_pred EEECCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh--CCCCCCCCCCC
Q 001434 913 ILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT--GRTPVQPLDDG 989 (1078)
Q Consensus 913 ill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt--g~~P~~~~~~~ 989 (1078)
|+++.++.++++|||.++....... .......++..|+|||...++.++.++||||+|+++|||++ |..||......
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 9999999999999999876532211 11222344678999999888889999999999999999998 77888654332
Q ss_pred CCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..... ...+....... .. .+... .....+.+++.+||+.||++||+++++++.|++
T Consensus 241 ~~~~~-~~~~~~~~~~~-~~-~~~~~-------~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 241 QVIEN-TGEFFRDQGRQ-VY-LPKPA-------LCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred HHHHH-HHHHHhhcccc-cc-CCCCC-------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 22211 11111111100 00 01001 112347789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-33 Score=312.44 Aligned_cols=195 Identities=26% Similarity=0.435 Sum_probs=160.7
Q ss_pred ccEEeccCceEEEEEEEC---CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe--cCceEEEEee
Q 001434 785 SFIVGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLIYEY 859 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~ 859 (1078)
.+.||+|+||+||+|.++ +++.||+|++..... ...+.+|++++++++||||+++++++.. +...++||||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 356999999999999865 467899999865432 3456789999999999999999998854 4567899999
Q ss_pred ccCCCHHhHhcCC--------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEE----CCCCceEEeecc
Q 001434 860 MERGSLGELLHGS--------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFG 927 (1078)
Q Consensus 860 ~~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg 927 (1078)
+.+ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++ +..+.+||+|||
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG 157 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMG 157 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecC
Confidence 965 888877522 12578889999999999999999998 99999999999999 456789999999
Q ss_pred cccccCCCCC--CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 001434 928 LAKVIDMPQS--KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLD 987 (1078)
Q Consensus 928 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~ 987 (1078)
+++....... .......||+.|+|||.+.+. .++.++||||+||++|||++|++||....
T Consensus 158 ~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 158 FARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 9987643221 223456789999999998764 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=300.68 Aligned_cols=251 Identities=24% Similarity=0.328 Sum_probs=202.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe-cCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH-QGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e 858 (1078)
+|+..+.||+|++|.||++.++ +++.||+|++..........+.+.+|++++++++|+|++++++.+.. +...++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 3667788999999999999976 47889999997655444556678899999999999999999988764 445789999
Q ss_pred eccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 859 YMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+++++|.+++... ...+++.++..++.|++.|++|+|+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~- 156 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC- 156 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccC-
Confidence 99999999998753 33589999999999999999999998 99999999999999999999999999998664222
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......+++.|+|||...+..++.++||||+|+++|++++|+.||...+ ............ .. ..+
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~----~~~~~~~~~~~~-~~------~~~-- 223 (257)
T cd08223 157 DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD----MNSLVYRIIEGK-LP------PMP-- 223 (257)
T ss_pred CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHHhcC-CC------CCc--
Confidence 22334568899999999999899999999999999999999999986332 233332222211 10 011
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
......+.+++.+|++.+|++||++.+++++
T Consensus 224 ----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 254 (257)
T cd08223 224 ----KDYSPELGELIATMLSKRPEKRPSVKSILRQ 254 (257)
T ss_pred ----cccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0122347789999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=306.79 Aligned_cols=260 Identities=27% Similarity=0.411 Sum_probs=198.7
Q ss_pred hcCCCccEEeccCceEEEEEEEC-----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe--cCc
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--QGS 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~ 852 (1078)
.+|+..+.||+|+||.||+|..+ +++.||+|++..... ...+.+.+|++++++++||||+++++++.. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA--EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH--HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 35667788999999999999742 578999999865432 345678899999999999999999998754 346
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
.++||||+++++|.+++......+++..+..++.|++.||+|||++ +++||||||+||++++++.++|+|||++...
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 7899999999999999986655789999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCCCc--ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC-----------CCHHHHHHHH
Q 001434 933 DMPQSKS--MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG-----------GDLATWVRNY 999 (1078)
Q Consensus 933 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~-----------~~~~~~~~~~ 999 (1078)
....... .....++..|+|||...+..++.++||||+|+++|||++|..|+...... ..........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIEL 238 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHH
Confidence 4322111 11223345699999998888999999999999999999987765422110 0000000111
Q ss_pred hhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1000 IRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
..... ..+. . ......+.+++.+||+.+|++|||+.++++.|+.+
T Consensus 239 ~~~~~--------~~~~-~---~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~ 283 (284)
T cd05081 239 LKNNG--------RLPA-P---PGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI 283 (284)
T ss_pred HhcCC--------cCCC-C---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence 11100 0000 0 01223578999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=317.57 Aligned_cols=264 Identities=24% Similarity=0.318 Sum_probs=199.3
Q ss_pred HHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec-----
Q 001434 777 EATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ----- 850 (1078)
Q Consensus 777 ~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~----- 850 (1078)
....+|...+.||+|+||.||+|.+. +++.||||++..........+.+.+|++++++++||||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34567888889999999999999975 588999999976544333456678999999999999999999987543
Q ss_pred -CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccc
Q 001434 851 -GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929 (1078)
Q Consensus 851 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 929 (1078)
...++++|++ +++|.+++... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||++
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ--KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccc
Confidence 3468999988 67999887643 489999999999999999999998 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC-C
Q 001434 930 KVIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT-P 1007 (1078)
Q Consensus 930 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~ 1007 (1078)
+.... ......|++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...... ............. .
T Consensus 166 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~ 237 (343)
T cd07878 166 RQADD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI----DQLKRIMEVVGTPSP 237 (343)
T ss_pred eecCC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH----HHHHHHHHHhCCCCH
Confidence 86542 2234578999999999876 56889999999999999999999999653321 1111111100000 0
Q ss_pred cccc-----------CCCCcch-hh----HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1008 GIFD-----------TRLNVED-ES----IVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1008 ~~~~-----------~~~~~~~-~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.... ..++..+ .. .......+.+++.+|++.||++|||++|++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~ 300 (343)
T cd07878 238 EVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPY 300 (343)
T ss_pred HHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcc
Confidence 0000 0000000 00 0011223678999999999999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-33 Score=320.39 Aligned_cols=254 Identities=24% Similarity=0.311 Sum_probs=198.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||+|.++ +++.||+|++..... .......+.+|+.++.+++||+|+++++++.+++..++|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 5677889999999999999976 588999999975432 23345678889999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 937 (1078)
|++||+|.+++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~ 157 (360)
T cd05627 82 FLPGGDMMTLLMKKD-TLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT 157 (360)
T ss_pred CCCCccHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence 999999999997655 688999999999999999999998 999999999999999999999999999875421110
Q ss_pred ---------------------------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCC
Q 001434 938 ---------------------------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984 (1078)
Q Consensus 938 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~ 984 (1078)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~ 237 (360)
T cd05627 158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237 (360)
T ss_pred ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCC
Confidence 00123579999999999999999999999999999999999999996
Q ss_pred CCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHH
Q 001434 985 PLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS---MREVVSML 1053 (1078)
Q Consensus 985 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~L 1053 (1078)
.... ............ ...+++..+ ....+.+++.+|+ .||++|++ ++++++|-
T Consensus 238 ~~~~----~~~~~~i~~~~~--~~~~p~~~~--------~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp 294 (360)
T cd05627 238 SETP----QETYRKVMNWKE--TLVFPPEVP--------ISEKAKDLILRFC-TDSENRIGSNGVEEIKSHP 294 (360)
T ss_pred CCCH----HHHHHHHHcCCC--ceecCCCCC--------CCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCC
Confidence 4432 222222221110 000111111 1123556777766 49999984 77887774
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=305.88 Aligned_cols=260 Identities=21% Similarity=0.338 Sum_probs=204.9
Q ss_pred hhcCCCccEEeccCceEEEEEEECC-----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe-cCc
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMDS-----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH-QGS 852 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~ 852 (1078)
..+|+..++||+|+||.||+|.+.. +..|++|++.... .....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA-SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 3466777889999999999999765 6788999886443 23446778899999999999999999998766 567
Q ss_pred eEEEEeeccCCCHHhHhcCCC-------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEee
Q 001434 853 NLLIYEYMERGSLGELLHGSS-------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 925 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~-------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 925 (1078)
.++++||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||++++++.+|++|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECC
Confidence 899999999999999986532 3588999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcC
Q 001434 926 FGLAKVIDMPQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDH 1003 (1078)
Q Consensus 926 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1003 (1078)
||+++.+...... ......++..|+|||.+.+..++.++||||+|+++||+++ |+.||.... ...+........
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~ 236 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID----PFEMAAYLKDGY 236 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC----HHHHHHHHHcCC
Confidence 9999865322211 1122345678999999988889999999999999999999 999996432 122222221111
Q ss_pred CCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 1004 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
.... .. .....+.+++.+||..+|++|||+.++++.|.++..+
T Consensus 237 ~~~~---~~----------~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~ 279 (280)
T cd05043 237 RLAQ---PI----------NCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ 279 (280)
T ss_pred CCCC---CC----------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence 1100 00 1123467899999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=317.30 Aligned_cols=262 Identities=22% Similarity=0.270 Sum_probs=195.3
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
...+|...+.||+|+||.||+|.+. +++.||+|+..... ...|+.++++++||||+++++++.+....++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 4457888999999999999999976 46789999753322 24689999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+. ++|.+++......+++.++..++.||+.||.|||++ +|+||||||+||+++.++.++|+|||.++....
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 209 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV-- 209 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc--
Confidence 99996 589998877666799999999999999999999998 999999999999999999999999999875331
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC--CH----HHHHHHHhhcCCCCCccc
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG--DL----ATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~--~~----~~~~~~~~~~~~~~~~~~ 1010 (1078)
........||+.|+|||.+.+..++.++||||+||++|||+++..|+....... .. .......+......+..+
T Consensus 210 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 289 (357)
T PHA03209 210 APAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF 289 (357)
T ss_pred CcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence 122334568999999999999999999999999999999999655543222111 00 011111111111111000
Q ss_pred cCCCC-----------------cchhh---HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1011 DTRLN-----------------VEDES---IVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1011 ~~~~~-----------------~~~~~---~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
..... ..... .........+++.+||+.||++|||+.|+++|-
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp 352 (357)
T PHA03209 290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYP 352 (357)
T ss_pred CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCc
Confidence 10000 00000 001122355689999999999999999999873
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-33 Score=304.19 Aligned_cols=255 Identities=25% Similarity=0.429 Sum_probs=201.9
Q ss_pred cCCCccEEeccCceEEEEEEECC-C---cEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS-G---KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
.|+..+.||+|+||.||+|.++. + ..||+|++..... ....+.+..|+..+++++||||+++++++.+++..++|
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 83 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII 83 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence 35667889999999999999753 3 3699999865432 33467899999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++++|.+++......+++.++..++.|++.|++|||++ +++||||||+||+++.++.++++|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 84 TEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999987666789999999999999999999998 99999999999999999999999999987653221
Q ss_pred CC-ccc-cc--ccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 937 SK-SMS-AV--AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 937 ~~-~~~-~~--~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.. ... .. ..+..|+|||.+.+..++.++||||+|+++||+++ |..||..... .............+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~----~~~~~~i~~~~~~~----- 231 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----QDVINAIEQDYRLP----- 231 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH----HHHHHHHHcCCcCC-----
Confidence 11 111 11 12457999999998899999999999999999987 9999964432 22222221111110
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.. .+....+.+++.+||+.+|++||++++++..|++.
T Consensus 232 ----~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 232 ----PP----MDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ----Cc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 01223467899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-33 Score=304.04 Aligned_cols=253 Identities=25% Similarity=0.368 Sum_probs=197.7
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
+..+.....||+|+||.||+|.+. ++..|++|.+..... ...+.+.+|+.++++++|+||+++++++..++..++||
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS--RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCH--HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 344555567999999999999965 578899998865533 34567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCC--ChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEEeecccccccCC
Q 001434 858 EYMERGSLGELLHGSSCNL--EWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l--~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~ 934 (1078)
||+++++|.+++......+ ++..+..++.|++.|++|||++ +|+||||||+||+++. .+.++|+|||.+.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999998654345 7888889999999999999998 9999999999999986 67999999999876532
Q ss_pred CCCCcccccccccCcccccccccCC--CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
. ........+++.|+|||.+.+.. ++.++||||+|+++|++++|+.||........ ..+....... .+
T Consensus 162 ~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~-~~~~~~~~~~--------~~ 231 (268)
T cd06624 162 I-NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQA-AMFKVGMFKI--------HP 231 (268)
T ss_pred C-CCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhh-hHhhhhhhcc--------CC
Confidence 2 12223345789999999886543 78899999999999999999999965332111 1111111111 01
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.++. .....+.+++.+||+.+|++|||+.+++++
T Consensus 232 ~~~~------~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 265 (268)
T cd06624 232 EIPE------SLSAEAKNFILRCFEPDPDKRASAHDLLQD 265 (268)
T ss_pred CCCc------ccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence 1110 122347789999999999999999999876
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-33 Score=321.31 Aligned_cols=265 Identities=24% Similarity=0.262 Sum_probs=201.7
Q ss_pred hhcCCCccEEeccCceEEEEEEEC---CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
..+|...+.||+|+||.||+|... .++.||+|.+.... ...+|++++++++||||+++++++......++
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~l 163 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCM 163 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEE
Confidence 346888889999999999999754 35789999885432 34579999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
|||++. ++|.+++... ..+++.++..++.|++.||+|||++ +|+||||||+||+++.++.++|+|||+++.....
T Consensus 164 v~e~~~-~~l~~~l~~~-~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 164 VMPKYK-CDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EehhcC-CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 999996 5899988544 3689999999999999999999998 9999999999999999999999999999765432
Q ss_pred CC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 936 QS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 936 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.. .......||+.|+|||++.+..++.++||||+||++|||++|+.||.+.......... ....+.....+..++...
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l-~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL-RSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHH-HHHHHHhccCccccCCcc
Confidence 22 2223457999999999999999999999999999999999999999765543322221 111111100000000000
Q ss_pred -----------------Ccc-hhhH--HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1015 -----------------NVE-DESI--VDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1015 -----------------~~~-~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+.. ++.. ......+.+++.+|+..||++|||+.|++.+-+=.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~ 379 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT 379 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence 000 0000 01123567899999999999999999999986543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=309.46 Aligned_cols=260 Identities=23% Similarity=0.382 Sum_probs=204.5
Q ss_pred hhcCCCccEEeccCceEEEEEEEC--------CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEe
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD--------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYH 849 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 849 (1078)
..+|...+.||+|+||.||+|++. ++..||+|.+..... ....+.+.+|+..++.+ +||||+++++++..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc-hHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 446677788999999999999742 245789998875433 23456788999999999 89999999999999
Q ss_pred cCceEEEEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEE
Q 001434 850 QGSNLLIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNIL 914 (1078)
Q Consensus 850 ~~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nil 914 (1078)
....++||||+++|+|.+++.... ..+++.++..++.||++|++|||++ |++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEE
Confidence 999999999999999999987532 2467788999999999999999998 9999999999999
Q ss_pred ECCCCceEEeecccccccCCCCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCH
Q 001434 915 LDDKFEAHVGDFGLAKVIDMPQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDL 992 (1078)
Q Consensus 915 l~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~ 992 (1078)
+++++.+|++|||.++........ ......+++.|+|||.+.+..++.++||||+|+++||+++ |..||... ..
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~----~~ 245 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI----PV 245 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC----CH
Confidence 999999999999999866432211 1222345678999999988889999999999999999998 78888543 23
Q ss_pred HHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 993 ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
..+.......... . .+ ......+.+++.+||+.+|++|||+.++++.|.++...
T Consensus 246 ~~~~~~~~~~~~~-----~--~~------~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~ 299 (304)
T cd05101 246 EELFKLLKEGHRM-----D--KP------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL 299 (304)
T ss_pred HHHHHHHHcCCcC-----C--CC------CCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence 3333332221110 0 00 01234477899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=300.97 Aligned_cols=251 Identities=22% Similarity=0.340 Sum_probs=205.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|+||.||++... +++.||+|++..........+.+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4667788999999999999965 588999999876544444556889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++.... ..+++.++..++.|++.|++|+|++ +++|+||+|+||+++.++.++++|||.+....... .
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~-~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV-E 156 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch-h
Confidence 99999999987543 3578899999999999999999998 99999999999999999999999999997654221 1
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|++.|+|||...+..++.++||||+|+++|++++|+.||... ................ .+
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~----~~~~~~~~~~~~~~~~-------~~--- 222 (256)
T cd08218 157 LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG----NMKNLVLKIIRGSYPP-------VS--- 222 (256)
T ss_pred hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC----CHHHHHHHHhcCCCCC-------Cc---
Confidence 223346788999999998888999999999999999999999999643 3333333333221110 00
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
......+.+++.+||+.+|++||++.+++++
T Consensus 223 ---~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~ 253 (256)
T cd08218 223 ---SHYSYDLRNLVSQLFKRNPRDRPSVNSILEK 253 (256)
T ss_pred ---ccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence 0122347789999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=304.97 Aligned_cols=254 Identities=26% Similarity=0.384 Sum_probs=199.3
Q ss_pred hcCCCccEEeccCceEEEEEEECC------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.+|...+.||+|++|.||+|.+.. +..||+|.+..... ......+.+|+.++++++|+||+++++++.+.+..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 467778889999999999999753 56788888764433 23346788999999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCC------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC---ceEEe
Q 001434 854 LLIYEYMERGSLGELLHGSS------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF---EAHVG 924 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~ 924 (1078)
++||||+++++|.+++...+ ..+++.++..++.||+.|++|||++ +++||||||+||+++.++ .+|++
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEec
Confidence 99999999999999987543 2578899999999999999999998 999999999999998754 58999
Q ss_pred ecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhc
Q 001434 925 DFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRD 1002 (1078)
Q Consensus 925 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1002 (1078)
|||+++....... ........+..|+|||.+.+..++.++||||+||++|||++ |..||..... ..........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~----~~~~~~~~~~ 237 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN----QEVMEFVTGG 237 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH----HHHHHHHHcC
Confidence 9999986532211 11112234568999999998899999999999999999997 9999964332 2222222111
Q ss_pred CCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.... .+. .....+.+++.+|++.+|++||++++++++|.
T Consensus 238 ~~~~---~~~----------~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 238 GRLD---PPK----------GCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred CcCC---CCC----------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 1110 011 11234778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-33 Score=301.73 Aligned_cols=248 Identities=26% Similarity=0.422 Sum_probs=199.3
Q ss_pred cEEeccCceEEEEEEECC--C--cEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 786 FIVGSGAYGTVYKAVMDS--G--KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
+.||+|++|.||+|.+.. + ..||+|.+...... ...+.+.+|+..+++++||||+++++++.+ ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 358999999999999753 3 36899999776553 456788999999999999999999999988 88899999999
Q ss_pred CCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC--
Q 001434 862 RGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-- 938 (1078)
Q Consensus 862 ~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~-- 938 (1078)
+++|.+++.... ..+++..+..++.|++.||+|+|++ +++||||+|+||+++.++.+|++|||.+.........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999997654 4689999999999999999999998 9999999999999999999999999999876432111
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......++..|+|||...+..++.++||||+|+++|||++ |+.||.... ..+............ ..+
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~----~~~~~~~~~~~~~~~------~~~-- 223 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLS----GSQILKKIDKEGERL------ERP-- 223 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCC----HHHHHHHHHhcCCcC------CCC--
Confidence 1123456788999999988899999999999999999998 999996432 222222222211100 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
+ .....+.+++.+|++.+|++||+++++++.|.
T Consensus 224 -~---~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 224 -E---ACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred -c---cCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 12234778999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-33 Score=312.73 Aligned_cols=267 Identities=21% Similarity=0.300 Sum_probs=202.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|...+.||+|+||.||+|.++ +++.||+|.+...... .....+.+|+.++++++||||+++++++..++..++|||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e 84 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 84 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence 45777888999999999999976 5889999998655432 224567789999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++ +|.+++......+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||.+....... .
T Consensus 85 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~ 159 (301)
T cd07873 85 YLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K 159 (301)
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence 9974 99999877666788999999999999999999998 99999999999999999999999999987643222 2
Q ss_pred cccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC-----
Q 001434 939 SMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT----- 1012 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1012 (1078)
......+++.|+|||.+.+. .++.++||||+|+++|||++|++||...+.......... .... .....++.
T Consensus 160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~ 236 (301)
T cd07873 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR-ILGT--PTEETWPGILSNE 236 (301)
T ss_pred cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH-HcCC--CChhhchhhhccc
Confidence 22334578999999987654 478899999999999999999999975432211111111 0000 00000000
Q ss_pred -----CCCcc----h-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1013 -----RLNVE----D-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1013 -----~~~~~----~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..+.. . .........+.+++.+|++.||++|||++|++++-+-
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f 289 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYF 289 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence 00000 0 0001123346789999999999999999999986553
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=300.10 Aligned_cols=248 Identities=28% Similarity=0.449 Sum_probs=202.6
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|++|.||+|... ++.||+|++..... ..+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 81 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY 81 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence 45677788999999999999876 78999999976543 356788999999999999999999999989999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++.... ..+++..+..++.|++.|+.|||++ +++||||||+||+++.++.++++|||.++.......
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 99999999997554 2689999999999999999999998 999999999999999999999999999986532211
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
...++..|+|||.+.++.++.++||||+|+++||+++ |..||.... .............. ..+.
T Consensus 158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~----~~~~~~~~~~~~~~-------~~~~- 222 (256)
T cd05039 158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP----LKDVVPHVEKGYRM-------EAPE- 222 (256)
T ss_pred ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHHHHhcCCCC-------CCcc-
Confidence 2345668999999988889999999999999999997 999986432 22222211111110 0010
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.....+.+++.+|+..+|++|||++++++.|+.
T Consensus 223 -----~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 255 (256)
T cd05039 223 -----GCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL 255 (256)
T ss_pred -----CCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence 112457789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=310.64 Aligned_cols=254 Identities=22% Similarity=0.342 Sum_probs=204.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||.|++|.||+|.+. +++.|++|.+..... ...+.+.+|+..++.++|||++++++++..++..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 35777888999999999999965 689999999865433 335678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++|+|||.+....... .
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~-~ 170 (296)
T cd06655 97 YLAGGSLTDVVTET--CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ-S 170 (296)
T ss_pred ecCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhccccc-c
Confidence 99999999998754 489999999999999999999999 99999999999999999999999999987654222 2
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......++..|+|||.+.+..++.++||||+||++|++++|+.||...+.. ........... .. .. .+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~----~~~~~~~~~~~-~~------~~-~~ 238 (296)
T cd06655 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL----RALYLIATNGT-PE------LQ-NP 238 (296)
T ss_pred cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCC-cc------cC-Cc
Confidence 223356888999999998888999999999999999999999999654321 11111111110 00 00 00
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
......+.+++.+||..||++||++.+++.+=+-.
T Consensus 239 ---~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~ 273 (296)
T cd06655 239 ---EKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273 (296)
T ss_pred ---ccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhh
Confidence 01223467899999999999999999999876643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=317.52 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=202.2
Q ss_pred CCCccEEeccCceEEEEEEECCCcE-EEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~~~~-vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|.....+|.|+||.||+|..++... .|.|++.... .+..+++.-|++++..++||+||++++.|+.++..+|..|||
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 4444568999999999999775444 4556664433 345788999999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
.||-.+..+-.-++.+.+.++..+++|++.||.|||++ +|+|||||+.|||++-+|.++++|||.+.... ......
T Consensus 112 ~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~-~t~qkR 187 (1187)
T KOG0579|consen 112 GGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNK-STRQKR 187 (1187)
T ss_pred CCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccch-hHHhhh
Confidence 99999999887778899999999999999999999999 99999999999999999999999999886432 233445
Q ss_pred cccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 941 SAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
..+.|||+|||||+.. ..+|+.++||||||+++.||..+.+|......- ..+.++....++ .+
T Consensus 188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM----RVllKiaKSePP--TL------ 255 (1187)
T KOG0579|consen 188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKIAKSEPP--TL------ 255 (1187)
T ss_pred ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH----HHHHHHhhcCCC--cc------
Confidence 6789999999999864 567999999999999999999999998644322 222222222211 11
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
..+ ......+.+++.+|+.+||+.||+++++++|-
T Consensus 256 lqP---S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hp 290 (1187)
T KOG0579|consen 256 LQP---SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHP 290 (1187)
T ss_pred cCc---chhhhHHHHHHHHHHhcCCccCCCHHHHhhCc
Confidence 111 12334577899999999999999999998875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=305.69 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=200.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.++...+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC--HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 45667788999999999999742 35678888876443 23456889999999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCC--------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC
Q 001434 854 LLIYEYMERGSLGELLHGSS--------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF 919 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~--------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~ 919 (1078)
++||||+++++|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||++++++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGL 159 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCC
Confidence 99999999999999987543 2478899999999999999999998 999999999999999999
Q ss_pred ceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHH
Q 001434 920 EAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVR 997 (1078)
Q Consensus 920 ~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~ 997 (1078)
.++|+|||++........ .......+++.|+|||...+..++.++||||||+++|||++ |..||...... ....
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~----~~~~ 235 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT----EAIE 235 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH----HHHH
Confidence 999999999875432111 11223345678999999998899999999999999999998 99998643322 2222
Q ss_pred HHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 998 NYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 998 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
......... .+. .....+.+++.+||+.||++||+++++++.|++
T Consensus 236 ~~~~~~~~~---~~~----------~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 236 CITQGRELE---RPR----------TCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred HHHcCccCC---CCC----------CCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 221111100 001 112346789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=318.70 Aligned_cols=244 Identities=24% Similarity=0.248 Sum_probs=190.1
Q ss_pred EeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccC---CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKI---RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
||+|+||+||+|.++ +++.||+|++.+... .......+..|..++.+. +||+|+++++++.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 699999999999976 589999999965432 122233445566666555 699999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.+++.... .+++..+..++.||++||+|||++ +|+||||||+||+++.++.++|+|||++..... .......
T Consensus 81 g~L~~~l~~~~-~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~-~~~~~~~ 155 (330)
T cd05586 81 GELFWHLQKEG-RFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLT-DNKTTNT 155 (330)
T ss_pred ChHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCC-CCCCccC
Confidence 99999987654 689999999999999999999999 999999999999999999999999999875432 1223345
Q ss_pred cccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhH
Q 001434 943 VAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESI 1021 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1021 (1078)
..||+.|+|||.+.+. .++.++||||+||++|||++|+.||.... ............. .++..
T Consensus 156 ~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~----~~~~~~~i~~~~~--------~~~~~---- 219 (330)
T cd05586 156 FCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED----TQQMYRNIAFGKV--------RFPKN---- 219 (330)
T ss_pred ccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC----HHHHHHHHHcCCC--------CCCCc----
Confidence 6799999999988754 48899999999999999999999996432 2233333222111 01100
Q ss_pred HHHHHHHHHHHHhcCCCCCCCCC----CHHHHHHHH
Q 001434 1022 VDHMILVLKVALMCTSISPFDRP----SMREVVSML 1053 (1078)
Q Consensus 1022 ~~~~~~l~~li~~cl~~dP~~RP----s~~ell~~L 1053 (1078)
.....+.+++.+|++.||++|| ++.+++++-
T Consensus 220 -~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~ 254 (330)
T cd05586 220 -VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHP 254 (330)
T ss_pred -cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCc
Confidence 0123356899999999999998 677777754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-33 Score=315.08 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=199.4
Q ss_pred hcCCCccEEeccCceEEEEEEE------CCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec-C
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVM------DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ-G 851 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~-~ 851 (1078)
.+|+..+.||+|+||+||+|.+ .+++.||||+++.... ......+.+|+.++.++ +||||+++++++... .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 3577788899999999999974 2467899999975543 23356788999999999 689999999987654 4
Q ss_pred ceEEEEeeccCCCHHhHhcCCC----------------------------------------------------------
Q 001434 852 SNLLIYEYMERGSLGELLHGSS---------------------------------------------------------- 873 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------- 873 (1078)
..++||||+++|+|.+++....
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 6789999999999999986421
Q ss_pred --------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-Ccccccc
Q 001434 874 --------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVA 944 (1078)
Q Consensus 874 --------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~ 944 (1078)
..+++..+..++.|+++|++|||++ +|+||||||+||++++++.+|++|||++........ .......
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 242 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDAR 242 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCC
Confidence 1357778889999999999999998 999999999999999999999999999876532211 1222334
Q ss_pred cccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHH
Q 001434 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023 (1078)
Q Consensus 945 gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1078)
+++.|+|||.+.+..++.++||||+|+++|||++ |..||.......... ......... ..+..
T Consensus 243 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~~~~-------~~~~~------ 306 (343)
T cd05103 243 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC---RRLKEGTRM-------RAPDY------ 306 (343)
T ss_pred CCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHH---HHHhccCCC-------CCCCC------
Confidence 5678999999988899999999999999999997 999986543222111 111111110 00000
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1024 HMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1024 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
....+.+++.+||+.+|++|||+.+++++|+.+..
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 11236789999999999999999999999998743
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=307.55 Aligned_cols=253 Identities=25% Similarity=0.372 Sum_probs=199.7
Q ss_pred CCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
|+..+.||+|+||.||+|.+. .+..||+|++..... ....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 455667999999999999863 247899999975543 2345678899999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCC---------------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCc
Q 001434 856 IYEYMERGSLGELLHGS---------------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE 920 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~---------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~ 920 (1078)
++||+++++|.+++... ...+++..+..++.|++.|++|+|++ +++||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCc
Confidence 99999999999998521 12477888999999999999999998 9999999999999999999
Q ss_pred eEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHH
Q 001434 921 AHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRN 998 (1078)
Q Consensus 921 ~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~ 998 (1078)
+|++|||+++....... .......+++.|+|||.+.++.++.++||||+|+++|||++ |..||.+.. ...+...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~----~~~~~~~ 238 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS----NQDVIEM 238 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCC----HHHHHHH
Confidence 99999999876532221 12233456789999999988889999999999999999998 888886432 2233333
Q ss_pred HhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 999 YIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
...... . ..+ . +....+.+++.+||+.+|++||+++++++.|+.
T Consensus 239 i~~~~~-~------~~~---~---~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 239 IRNRQV-L------PCP---D---DCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred HHcCCc-C------CCC---C---CCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 222111 0 001 0 122347789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=302.84 Aligned_cols=256 Identities=24% Similarity=0.376 Sum_probs=205.1
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||.|++|+||+|... ++..+++|++....... ..+.+.+|++.++.++|+|++++++.+..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 5777888999999999999965 57889999987654433 567889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC--CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 860 MERGSLGELLHGSS--CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
+++++|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.+..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 99999999997542 3688999999999999999999998 999999999999999999999999999876643322
Q ss_pred C---cccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 938 K---SMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 938 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
. ......|+..|+|||.+... .++.++||||+|+++|+|++|+.||............ ..... ..
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~----~~~~~-------~~ 226 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLT----LQNDP-------PS 226 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHH----hcCCC-------CC
Confidence 2 12334688999999998776 7889999999999999999999999754433222222 11111 00
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
..... ........+.+++.+|++.||++||++.+++++
T Consensus 227 ~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~ 264 (267)
T cd06610 227 LETGA-DYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH 264 (267)
T ss_pred cCCcc-ccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 11000 011233457789999999999999999999875
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=303.96 Aligned_cols=250 Identities=26% Similarity=0.410 Sum_probs=199.7
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-------hhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-------NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-------~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
|.....||+|++|.||+|.+. +++.||+|.+....... ...+.+.+|+.++++++||||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566778999999999999975 57899999887653321 1235678999999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNYG-AFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLE 157 (267)
T ss_pred EEEEEecCCCCHHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence 99999999999999997654 688889999999999999999998 99999999999999999999999999988664
Q ss_pred CCCC-----CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 001434 934 MPQS-----KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 934 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1078)
.... .......|+..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ..+...... .
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~--~--- 228 (267)
T cd06628 158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKIGEN--A--- 228 (267)
T ss_pred cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHHhcc--C---
Confidence 2111 1112345788999999998888999999999999999999999999753221 111111110 0
Q ss_pred cccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.+..+. .....+.+++.+||+.||++||++.+++++
T Consensus 229 --~~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 264 (267)
T cd06628 229 --SPEIPS------NISSEAIDFLEKTFEIDHNKRPTAAELLKH 264 (267)
T ss_pred --CCcCCc------ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence 111111 122346789999999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-33 Score=304.88 Aligned_cols=254 Identities=22% Similarity=0.313 Sum_probs=201.4
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
..|+..+.||+||.+.||++...+.+.||+|++.-...+......+.+|+..|.++ .|.+||++++|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 46777788999999999999988788899998877666666788999999999999 49999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|-+ .+|..++++.....+.-.+..+..|++.|+.++|.+ ||||.||||.|+++-. |.+||+|||.|..+..+...
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhcccCccccc
Confidence 875 499999987765444337788889999999999999 9999999999999854 59999999999877644333
Q ss_pred c-ccccccccCcccccccccCC-----------CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 939 S-MSAVAGSYGYIAPEYAYTMK-----------VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 939 ~-~~~~~gt~~y~aPE~~~~~~-----------~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
. ....+||+.||+||.+.... .++++||||+||++|+|+.|+.||. ++.....+...-..+-
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~------~~~n~~aKl~aI~~P~ 589 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG------QIINQIAKLHAITDPN 589 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH------HHHHHHHHHHhhcCCC
Confidence 2 34578999999999875322 5678999999999999999999995 2232222322222111
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
..+--+..+... ++.++++.|+..||++|||..+++++
T Consensus 590 ~~Iefp~~~~~~--------~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 590 HEIEFPDIPEND--------ELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred ccccccCCCCch--------HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 222122222221 27889999999999999999999976
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.08 Aligned_cols=248 Identities=27% Similarity=0.439 Sum_probs=194.0
Q ss_pred EEeccCceEEEEEEECC-Cc--EEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccC
Q 001434 787 IVGSGAYGTVYKAVMDS-GK--IVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+||+|+||.||+|.+++ +. .+++|.+..... ....+.+.+|++++.++ +||||+++++++......++||||+++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS-KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC-HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 58999999999999764 43 468888864432 23456788999999999 799999999999999999999999999
Q ss_pred CCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecc
Q 001434 863 GSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 927 (1078)
Q Consensus 863 gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 927 (1078)
|+|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||++++++.+|++|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 2477889999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 928 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
++...... ........+..|+|||.+.+..++.++||||||+++|||++ |..||..... .............
T Consensus 158 l~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~----~~~~~~~~~~~~~- 230 (270)
T cd05047 158 LSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC----AELYEKLPQGYRL- 230 (270)
T ss_pred Cccccchh--hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH----HHHHHHHhCCCCC-
Confidence 98643211 11112234567999999988889999999999999999997 9999964322 2222222111100
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
..+. .....+.+++.+|++.+|.+|||++++++.|.++.
T Consensus 231 ------~~~~------~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 231 ------EKPL------NCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred ------CCCC------cCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 0010 11234678999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=288.50 Aligned_cols=258 Identities=24% Similarity=0.332 Sum_probs=209.1
Q ss_pred cEEeccCceEEEEEE-ECCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 786 FIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
+++|+|+|+.|..|+ ..+|.+||||++.+.. ...+.++.+|++++.+. .|+||++++++|++++..|+|||.|.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCc
Confidence 469999999999998 5689999999998773 35678899999999999 5999999999999999999999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC---CceEEeecccccccCC--C---
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAKVIDM--P--- 935 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~~~~--~--- 935 (1078)
+|...|++.. .+++.++.++..+|+.||.+||.+ ||.|||+||+|||..+. ..||||||.++..... +
T Consensus 162 plLshI~~~~-~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 162 PLLSHIQKRK-HFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred hHHHHHHHhh-hccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 9999998776 689999999999999999999999 99999999999999654 3589999998764421 1
Q ss_pred -CCCcccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC------CCCHHHHHHHHhhcC
Q 001434 936 -QSKSMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD------GGDLATWVRNYIRDH 1003 (1078)
Q Consensus 936 -~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~------~~~~~~~~~~~~~~~ 1003 (1078)
......+.+|+.+|||||++. ...|+.+.|.||+||++|-|++|.+||.+.-+ ++.......+..-
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LF-- 315 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLF-- 315 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHH--
Confidence 122334578999999999763 34589999999999999999999999987432 2222222222111
Q ss_pred CCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1004 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..+-+.+.....++|.....+..+++...+..|+..|.++.+++.+-|
T Consensus 316 ---esIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw 363 (463)
T KOG0607|consen 316 ---ESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPW 363 (463)
T ss_pred ---HHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcc
Confidence 112244455556677777777888999999999999999999998654
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=308.85 Aligned_cols=266 Identities=24% Similarity=0.345 Sum_probs=203.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|+||.||+|.+. ++..||+|.+..... ......+.+|++++++++||||+++++++.+++..++||||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK-PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 5777888999999999999976 578888888865432 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++.... .+++..+..++.|+++|++|||+. .+++||||||+||+++.++.++++|||.+...... .
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---~ 154 (308)
T cd06615 81 MDGGSLDQVLKKAG-RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---M 154 (308)
T ss_pred cCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCccccccc---c
Confidence 99999999997664 688999999999999999999973 18999999999999999999999999998755321 2
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCc-----cccCC-
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG-----IFDTR- 1013 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~- 1013 (1078)
.....|+..|+|||...+..++.++||||+|+++|+|++|+.||...+. .....+............. .....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDA-KELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcch-hhHHHhhcCccccccccCCcccccCCCCCc
Confidence 2345788999999998888899999999999999999999999964331 1111111110000000000 00000
Q ss_pred -----------------CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1014 -----------------LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1014 -----------------~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.+..+. ......+.+++.+|++.+|++|||+.+++++.+-.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~ 291 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPS--GAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcC--cccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence 000000 01233578999999999999999999999987643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=309.13 Aligned_cols=259 Identities=25% Similarity=0.367 Sum_probs=202.8
Q ss_pred hcCCCccEEeccCceEEEEEEEC--------CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD--------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ 850 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~ 850 (1078)
.+|...+.||+|+||.||+|.+. ....||+|.+..... ......+.+|+.+++.+ +||||+++++++..+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC-hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 35777888999999999999853 235699999976532 23356788899999999 799999999999999
Q ss_pred CceEEEEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEE
Q 001434 851 GSNLLIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL 915 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill 915 (1078)
+..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEE
Confidence 99999999999999999997532 2478889999999999999999998 99999999999999
Q ss_pred CCCCceEEeecccccccCCCCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHH
Q 001434 916 DDKFEAHVGDFGLAKVIDMPQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLA 993 (1078)
Q Consensus 916 ~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~ 993 (1078)
++++.++++|||.+......... ......+++.|+|||.+.+..++.++||||+|+++|||++ |..||.... ..
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~----~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----VE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCC----HH
Confidence 99999999999998765321111 1112234568999999988889999999999999999998 888885322 22
Q ss_pred HHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 994 TWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
...... ...... ..+. .....+.+++.+|++.+|++|||+.++++.|+++...
T Consensus 250 ~~~~~~-~~~~~~------~~~~------~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~ 302 (307)
T cd05098 250 ELFKLL-KEGHRM------DKPS------NCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILAL 302 (307)
T ss_pred HHHHHH-HcCCCC------CCCC------cCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHH
Confidence 222222 111100 0010 1123567899999999999999999999999987543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=303.84 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=201.8
Q ss_pred hcCCCccEEeccCceEEEEEEECC------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.+|...+.||+|+||.||+|.++. +..||+|.+..... ......+.+|+.++++++||||+++++++......
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 467777889999999999998652 46899999865432 23356788999999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCC---------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEe
Q 001434 854 LLIYEYMERGSLGELLHGSS---------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 924 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 924 (1078)
++||||+++++|.+++.... ..+++..+..++.|++.|+.|||+. +++||||||+||+++.++.+|++
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEEC
Confidence 99999999999999986432 2367888999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhc
Q 001434 925 DFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRD 1002 (1078)
Q Consensus 925 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 1002 (1078)
|||.++....... .......++..|+|||.+.++.++.++||||+|+++||+++ |..||..... ....... ..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~----~~~~~~~-~~ 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSN----EEVLKFV-ID 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCH----HHHHHHH-hc
Confidence 9999876542221 22233456789999999988889999999999999999998 9999864322 2222222 21
Q ss_pred CCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.... ..+.. ....+.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ~~~~------~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 GGHL------DLPEN------CPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred CCCC------CCCCC------CCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 1110 01111 12357789999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-33 Score=311.60 Aligned_cols=255 Identities=23% Similarity=0.279 Sum_probs=204.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|++|.||+|.+. +++.||+|.+....... ...+.+.+|++++++++|+||+++++.+.+.+..++|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 5677788999999999999976 48999999997664432 345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 859 YMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+.+++|.+++... ...+++..+..++.|+++||+|||+. +++||||||+||+++.++.++++|||.+........
T Consensus 82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 99999999998754 34689999999999999999999998 999999999999999999999999999875432111
Q ss_pred ----------------------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC
Q 001434 938 ----------------------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG 989 (1078)
Q Consensus 938 ----------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~ 989 (1078)
.......|+..|+|||...+..++.++||||+|+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 0112346788999999999888999999999999999999999999754432
Q ss_pred CCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHHH
Q 001434 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS----MREVVSMLI 1054 (1078)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs----~~ell~~L~ 1054 (1078)
... ........ ..+.. ......+.+++.+|++.+|++||+ +++++.+-+
T Consensus 239 ~~~----~~~~~~~~--------~~~~~----~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~ 291 (316)
T cd05574 239 ETF----SNILKKEV--------TFPGS----PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291 (316)
T ss_pred HHH----HHHhcCCc--------cCCCc----cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCch
Confidence 221 11111110 01111 013345789999999999999999 888888633
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=301.00 Aligned_cols=251 Identities=27% Similarity=0.424 Sum_probs=194.1
Q ss_pred cEEeccCceEEEEEEEC----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEE-ecCceEEEEeec
Q 001434 786 FIVGSGAYGTVYKAVMD----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY-HQGSNLLIYEYM 860 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~-~~~~~~lv~e~~ 860 (1078)
+.||+|+||.||+|.+. ....||+|++..... ....+.+.+|+.+++.++||||+++++++. .+...++||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD-LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC-HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 35899999999999853 245789998854332 233567889999999999999999999775 455678999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC---
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS--- 937 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~--- 937 (1078)
.+++|.+++.......++..+..++.|+++|++|||+. +++||||||+||++++++.+|++|||+++.......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999999987655678888899999999999999998 999999999999999999999999999875432111
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhC-CCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTG-RTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......++..|+|||...+..++.++||||||+++|||++| .+||... ................. +.
T Consensus 157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~----~~~~~~~~~~~~~~~~~---~~---- 225 (262)
T cd05058 157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV----DSFDITVYLLQGRRLLQ---PE---- 225 (262)
T ss_pred cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC----CHHHHHHHHhcCCCCCC---CC----
Confidence 111233457789999999888899999999999999999995 5555432 22222222222111100 00
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
.....+.+++.+||+.+|++||++.++++.++++.
T Consensus 226 ------~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~ 260 (262)
T cd05058 226 ------YCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIF 260 (262)
T ss_pred ------cCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence 11234778999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=304.88 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=201.4
Q ss_pred hhcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 852 (1078)
..+|+..+.||+|+||.||+|..+ .+..||+|.+..... ......+.+|+..+++++||||+++++++.+.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS-LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 456778889999999999999753 245799998865432 2234567889999999999999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCC---------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEE
Q 001434 853 NLLIYEYMERGSLGELLHGSS---------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 923 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~---------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl 923 (1078)
.++||||+++|+|.+++.... ...++..+..++.|++.|++|||++ +|+||||||+||++++++.+++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEE
Confidence 999999999999999996422 2345677889999999999999998 9999999999999999999999
Q ss_pred eecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhh
Q 001434 924 GDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIR 1001 (1078)
Q Consensus 924 ~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 1001 (1078)
+|||+++....... .......++..|+|||...++.++.++||||+|+++|||++ |..||..... .........
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN----EQVLKFVMD 236 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHc
Confidence 99999875532221 11222345678999999988899999999999999999998 7888864332 222222211
Q ss_pred cCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1002 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
..... .+. .....+.+++.+|++.+|++|||+.++++.+++..
T Consensus 237 -~~~~~------~~~------~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~ 279 (288)
T cd05061 237 -GGYLD------QPD------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL 279 (288)
T ss_pred -CCCCC------CCC------CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence 11110 000 11235788999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=312.03 Aligned_cols=258 Identities=25% Similarity=0.401 Sum_probs=201.6
Q ss_pred hcCCCccEEeccCceEEEEEEEC--------CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD--------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ 850 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~ 850 (1078)
.+|...+.||+|+||.||+|.+. ....||+|++..... ......+.+|+++++++ +||||+++++++.++
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 35667788999999999999752 245689998875433 23356788999999999 699999999999999
Q ss_pred CceEEEEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEE
Q 001434 851 GSNLLIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL 915 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill 915 (1078)
+..++||||+++|+|.+++.... ..+++.++..++.|++.|++|+|++ |++||||||+||++
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill 167 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLV 167 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEE
Confidence 99999999999999999996432 2478889999999999999999998 99999999999999
Q ss_pred CCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHH
Q 001434 916 DDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLA 993 (1078)
Q Consensus 916 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~ 993 (1078)
++++.+|++|||.++....... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||..... .
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~----~ 243 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPV----E 243 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCH----H
Confidence 9999999999999986542211 11122234567999999988889999999999999999999 8889864322 2
Q ss_pred HHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 994 TWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
..... ....... ..+. .....+.+++.+|++.+|++|||+.++++.|+++..
T Consensus 244 ~~~~~-~~~~~~~------~~~~------~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 244 ELFKL-LREGHRM------DKPS------NCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHH-HHcCCCC------CCCC------CCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 22221 1111100 0010 112346789999999999999999999999998854
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=303.05 Aligned_cols=238 Identities=22% Similarity=0.393 Sum_probs=187.5
Q ss_pred EEeccCceEEEEEEECC-------------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 787 IVGSGAYGTVYKAVMDS-------------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.||+|+||.||+|+... ...|++|++..... .....+.+|+.+++.++||||+++++++..+...
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~ 79 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR--DISLAFFETASMMRQVSHKHIVLLYGVCVRDVEN 79 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh--hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCC
Confidence 58999999999998532 23578888755432 3345788899999999999999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCc-------eEEeec
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE-------AHVGDF 926 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-------~kl~Df 926 (1078)
++||||+++++|..++......+++..+..++.||++|++|||++ +|+||||||+||+++.++. ++++||
T Consensus 80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999886665789999999999999999999998 9999999999999987654 899999
Q ss_pred ccccccCCCCCCcccccccccCcccccccc-cCCCCCcCcchhHHHHHHHHH-hCCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 927 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELL-TGRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 927 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~ell-tg~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
|.+..... .....++..|+|||.+. +..++.++||||+|+++|||+ +|..||...... .. .......
T Consensus 157 g~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~----~~-~~~~~~~- 225 (262)
T cd05077 157 GIPITVLS-----RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLA----EK-ERFYEGQ- 225 (262)
T ss_pred CCCccccC-----cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchh----HH-HHHHhcC-
Confidence 99875431 22345788899999886 466889999999999999998 588887543211 11 1111111
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.. . ... ....+.+++.+||+.||++||++.++++.+
T Consensus 226 ~~--~----~~~-------~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 226 CM--L----VTP-------SCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred cc--C----CCC-------ChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 00 0 000 123467899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=309.27 Aligned_cols=252 Identities=24% Similarity=0.338 Sum_probs=202.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|++|.||+|.+. +++.||+|.+..... ...+.+.+|+.+++.++|+||+++++++..++..++|||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc--chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 56777888999999999999974 689999999865443 234668899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++.+. .+++.++..++.|++.|+.|||+. +++||||||+||+++.++.++++|||.+....... .
T Consensus 97 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~-~ 170 (297)
T cd06656 97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (297)
T ss_pred ccCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCc-c
Confidence 99999999998754 478899999999999999999998 99999999999999999999999999987653222 2
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......+++.|+|||...+..++.++||||+|+++|++++|..||...+....... ..... .+ ... .+
T Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~----~~~~~-~~------~~~-~~ 238 (297)
T cd06656 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL----IATNG-TP------ELQ-NP 238 (297)
T ss_pred CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee----eccCC-CC------CCC-Cc
Confidence 22345688899999999988899999999999999999999999965432111110 00000 00 000 00
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
......+.+++.+||..+|++||++++++++=+
T Consensus 239 ---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 271 (297)
T cd06656 239 ---ERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPF 271 (297)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence 112234678999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=298.75 Aligned_cols=250 Identities=23% Similarity=0.372 Sum_probs=203.1
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|... +++.||+|++............+.+|++++++++||+|+++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4677788999999999999975 588899999976654455567889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-ceEEeecccccccCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~ 937 (1078)
+++++|.+++.... ..+++..+..++.|+++|++|+|++ +++||||+|+||++++++ .++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-- 155 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK-- 155 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC--
Confidence 99999999997643 3588999999999999999999998 999999999999998654 5799999999876422
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ............. .++.
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~----~~~~~~~~~~~~~-------~~~~- 223 (256)
T cd08220 156 SKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANL----PALVLKIMSGTFA-------PISD- 223 (256)
T ss_pred ccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCch----HHHHHHHHhcCCC-------CCCC-
Confidence 222335688899999999888899999999999999999999999964332 2222222221110 0000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+||+.+|++|||+.|++++
T Consensus 224 -----~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~ 253 (256)
T cd08220 224 -----RYSPDLRQLILSMLNLDPSKRPQLSQIMAQ 253 (256)
T ss_pred -----CcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence 122346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=303.69 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=189.2
Q ss_pred EEeccCceEEEEEEECC---CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 787 IVGSGAYGTVYKAVMDS---GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
.||+|+||.||+|.+.+ +..+|+|.+...... .....+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 58999999999998643 467899988665432 33457888999999999999999999999999999999999999
Q ss_pred CHHhHhcCCC----CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-C
Q 001434 864 SLGELLHGSS----CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-K 938 (1078)
Q Consensus 864 sL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~ 938 (1078)
+|.+++.... ...++..+..++.|++.|++|+|++ +++||||||+||+++.++.++++|||.+........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence 9999986432 2456677888999999999999998 999999999999999999999999999875432211 1
Q ss_pred cccccccccCcccccccccC-------CCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc
Q 001434 939 SMSAVAGSYGYIAPEYAYTM-------KVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1078)
......++..|+|||++.+. .++.++||||+|+++|||++ |+.||......+.... ...... ....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~----~~~~~~--~~~~ 231 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY----TVREQQ--LKLP 231 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH----Hhhccc--CCCC
Confidence 12234577889999987532 35789999999999999996 9999965433221111 111110 1111
Q ss_pred cCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.+.+.. .....+.+++.+|+ .+|++|||+++|++.|+
T Consensus 232 ~~~~~~------~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLKL------PLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccCC------CCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 111111 11223567888998 58999999999998764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=306.15 Aligned_cols=256 Identities=28% Similarity=0.459 Sum_probs=202.1
Q ss_pred hhcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 852 (1078)
..+|+..+.||+|+||.||+|.++ +++.||+|++..... ......+.+|+.++++++||||+++++++.+++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~ 82 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP 82 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC-HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence 456777888999999999999864 467899999875433 2335678899999999999999999999999999
Q ss_pred eEEEEeeccCCCHHhHhcCCC---------------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCC
Q 001434 853 NLLIYEYMERGSLGELLHGSS---------------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSN 911 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~---------------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 911 (1078)
.++||||+++|+|.+++.... ..+++.++..++.|++.||+|+|++ +++||||||+
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~ 159 (288)
T cd05050 83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR 159 (288)
T ss_pred cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence 999999999999999986321 2467788899999999999999998 9999999999
Q ss_pred cEEECCCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCC
Q 001434 912 NILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDG 989 (1078)
Q Consensus 912 Nill~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~ 989 (1078)
||++++++.++++|||.+........ ........+..|+|||.+.+..++.++||||+||++|||++ |..||....
T Consensus 160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-- 237 (288)
T cd05050 160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-- 237 (288)
T ss_pred heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC--
Confidence 99999999999999999876532211 11222334677999999988899999999999999999998 888886432
Q ss_pred CCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..+......... .. . .+ + .....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 238 --~~~~~~~~~~~~-~~----~--~~---~---~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 238 --HEEVIYYVRDGN-VL----S--CP---D---NCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred --HHHHHHHHhcCC-CC----C--CC---C---CCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 223333222211 10 0 00 0 112447789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=301.78 Aligned_cols=260 Identities=26% Similarity=0.410 Sum_probs=205.4
Q ss_pred hcCCCccEEeccCceEEEEEEECC-Cc----EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||.||+|.++. ++ .||+|....... ......+.+|+..+++++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 356677889999999999998652 32 588898865543 3345678899999999999999999999887 7889
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+++|+|.+++......+++..+..++.|++.|++|||++ +++||||||+||++++++.++|+|||.++....
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999999987666789999999999999999999998 999999999999999999999999999986642
Q ss_pred CCCCc-ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQSKS-MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
..... .....++..|+|||.+....++.++|+||+|+++||+++ |+.||.... ...+............ +.
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~----~~~~~~~~~~~~~~~~---~~ 234 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIP----AVEIPDLLEKGERLPQ---PP 234 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCC----HHHHHHHHhCCCCCCC---CC
Confidence 22111 112223568999999988889999999999999999998 999996432 2222222222111110 00
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCC
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1061 (1078)
.....+.+++.+||..+|.+||++.++++.+.++..+.+
T Consensus 235 ----------~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~~~ 273 (279)
T cd05057 235 ----------ICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARDPQ 273 (279)
T ss_pred ----------CCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhCCc
Confidence 011236789999999999999999999999999855443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=308.51 Aligned_cols=267 Identities=25% Similarity=0.360 Sum_probs=204.1
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.++ +++.||+|++..........+.+.+|++++++++|+||+++++++.+++..++||||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 81 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEY 81 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEec
Confidence 5677788999999999999976 588999999876655445567889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
++++.+..+.... ..+++.++..++.|++.|++|||+. +++|||++|+||++++++.++|+|||.+..........
T Consensus 82 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 157 (288)
T cd07833 82 VERTLLELLEASP-GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP 157 (288)
T ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence 9986666655443 3689999999999999999999998 99999999999999999999999999998765433323
Q ss_pred ccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCC-------CCcccc
Q 001434 940 MSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL-------TPGIFD 1011 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 1011 (1078)
.....++..|+|||.+.+. .++.++||||+|+++|+|++|+.||............. ........ ....+.
T Consensus 158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07833 158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQ-KCLGPLPPSHQELFSSNPRFA 236 (288)
T ss_pred ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-HHhCCCCHHHhhhcccCcccc
Confidence 4456788999999999887 78899999999999999999999997443221111111 10000000 000000
Q ss_pred C-CCC--cchhhH----H-HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 T-RLN--VEDESI----V-DHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ~-~~~--~~~~~~----~-~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
. ... ...... . .....+.+++.+||+.+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 285 (288)
T cd07833 237 GVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH 285 (288)
T ss_pred ccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence 0 000 000000 0 114568899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=307.10 Aligned_cols=265 Identities=25% Similarity=0.344 Sum_probs=202.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC---chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG---NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
+|+..+.||+|++|.||+|.+. +++.||+|++...... ......+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3566778999999999999976 5899999999766443 33345677899999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+ +++|.+++......+++.++..++.||++||+|||++ +++||||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~ 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN 156 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence 9999 8899999986655689999999999999999999998 99999999999999999999999999998764322
Q ss_pred CCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc------
Q 001434 937 SKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI------ 1009 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1009 (1078)
.......+++.|+|||.+.+ ..++.++||||+|+++|||++|.+||....+.......... .. ......
T Consensus 157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~ 232 (298)
T cd07841 157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA-LG--TPTEENWPGVTS 232 (298)
T ss_pred -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH-cC--CCchhhhhhccc
Confidence 22333456788999998754 45789999999999999999998777643322211111111 00 000000
Q ss_pred ----cc--CCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1010 ----FD--TRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1010 ----~~--~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.. ...... ..........+.+++.+||+.+|++|||++|++++=
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~ 283 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHP 283 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCc
Confidence 00 000000 011112345688999999999999999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-33 Score=307.79 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=202.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.+. ++..||+|.+.... ....+.+.+|++++++++||||+++++++..+...++||||
T Consensus 6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC--HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 4666777999999999999975 58899999986442 23456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++...+..+++.++..++.|++.|+.|||+. +|+|+||+|+||+++.++.++++|||.+...... ...
T Consensus 84 ~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~-~~~ 159 (280)
T cd06611 84 CDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST-LQK 159 (280)
T ss_pred cCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc-ccc
Confidence 999999999987666799999999999999999999999 9999999999999999999999999988754322 222
Q ss_pred ccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 940 MSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.....+++.|+|||.+. +..++.++||||+|+++|||++|+.||...... ........... + .+
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~~~~~~~~~-~------~~ 228 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVLLKILKSEP-P------TL 228 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHHHHHhcCCC-C------Cc
Confidence 23456889999999874 344678999999999999999999999754322 22222221111 0 00
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.. +. .....+.+++.+||+.+|++||++.+++++-+
T Consensus 229 ~~-~~---~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 264 (280)
T cd06611 229 DQ-PS---KWSSSFNDFLKSCLVKDPDDRPTAAELLKHPF 264 (280)
T ss_pred CC-cc---cCCHHHHHHHHHHhccChhhCcCHHHHhcChh
Confidence 00 00 11234678999999999999999999998755
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-33 Score=309.95 Aligned_cols=246 Identities=22% Similarity=0.364 Sum_probs=197.0
Q ss_pred ccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 785 SFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
...||+|+||.||++... +++.||||++..... ...+.+.+|+..+++++|+||+++++.+..++..++||||++++
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~ 104 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ--QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGG 104 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchH--HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCC
Confidence 345999999999999975 588999999865432 34567889999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 943 (1078)
+|.+++... .+++.++..++.||+.|++|||++ +++||||||+||++++++.++|+|||++....... ......
T Consensus 105 ~L~~~~~~~--~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 178 (292)
T cd06658 105 ALTDIVTHT--RMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKRKSL 178 (292)
T ss_pred cHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccCcee
Confidence 999988644 488999999999999999999998 99999999999999999999999999987653222 222345
Q ss_pred ccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHH
Q 001434 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023 (1078)
Q Consensus 944 ~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1078)
.|+..|+|||...+..++.++||||+|+++|||++|+.||..... ........... ....... ..
T Consensus 179 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~----~~~~~~~~~~~-------~~~~~~~----~~ 243 (292)
T cd06658 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP----LQAMRRIRDNL-------PPRVKDS----HK 243 (292)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhcC-------CCccccc----cc
Confidence 688999999999888899999999999999999999999964322 11111111110 0011000 01
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1024 HMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1024 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
....+.+++.+|+..||++|||+++++++-
T Consensus 244 ~~~~~~~li~~~l~~~P~~Rpt~~~il~~~ 273 (292)
T cd06658 244 VSSVLRGFLDLMLVREPSQRATAQELLQHP 273 (292)
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhCh
Confidence 223467889999999999999999999863
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=300.83 Aligned_cols=251 Identities=26% Similarity=0.400 Sum_probs=195.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC---chhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG---NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~ 854 (1078)
+|+..+.||+|+||.||+|.+. +++.|++|++...... ....+.+.+|+.++++++||||+++++++.+. ...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 5778889999999999999975 5889999988654322 22345688999999999999999999988753 5678
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
++|||+++++|.+++.... .+++.....++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 83 l~~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG-ALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 158 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence 9999999999999997654 578899999999999999999998 999999999999999999999999999876532
Q ss_pred CC--CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQ--SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.. ........++..|+|||.+.+..++.++||||+|+++||+++|+.||..... ...+....... . .+
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~~-~-----~~ 228 (266)
T cd06651 159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQP-T-----NP 228 (266)
T ss_pred ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcCC-C-----CC
Confidence 11 1112234588899999999888899999999999999999999999974322 12222211111 0 11
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.++. .....+.+++ +||..+|++||+++|++++
T Consensus 229 ~~~~------~~~~~~~~li-~~~~~~p~~Rp~~~eil~h 261 (266)
T cd06651 229 QLPS------HISEHARDFL-GCIFVEARHRPSAEELLRH 261 (266)
T ss_pred CCch------hcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence 1110 1122345566 6888999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=303.48 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=199.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC--------chhHHHHHHHHHHHccCCCCceeeEeeEEEecC
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG--------NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG 851 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~--------~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 851 (1078)
+|...+.||+|++|.||+|... +++.||+|.+...... ....+.+.+|+.++++++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667788999999999999865 5889999988643211 112356788999999999999999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
..++||||+++++|.+++.... .+++..+..++.|++.|+.|+|+. +++||||+|+||+++.++.++++|||.+..
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~ 157 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKK 157 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeecccccc
Confidence 9999999999999999998764 688899999999999999999998 999999999999999999999999999876
Q ss_pred cCCCCCC-cccccccccCcccccccccCC--CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 001434 932 IDMPQSK-SMSAVAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 932 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1078)
....... ......|+..|+|||.+.... ++.++||||+|+++||+++|..||..... . .......... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~---~-~~~~~~~~~~-~~-~ 231 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA---I-AAMFKLGNKR-SA-P 231 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch---H-HHHHHhhccc-cC-C
Confidence 5322111 123346788999999887654 78999999999999999999999953221 1 1111111111 00 0
Q ss_pred cccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.++... .......+.+++.+|++.+|++||++++++++
T Consensus 232 ~~~~~~------~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 269 (272)
T cd06629 232 PIPPDV------SMNLSPVALDFLNACFTINPDNRPTARELLQH 269 (272)
T ss_pred cCCccc------cccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence 001111 11223457789999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=302.35 Aligned_cols=255 Identities=29% Similarity=0.441 Sum_probs=206.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.++ +++.||+|.+...... ...+.+.+|++++++++||||+++++++..+...++||||
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 4566678999999999999976 5889999998765432 4467788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++......++...+..++.|++.|++|+|+ . +++|+||||+||++++++.++++|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 156 (265)
T cd06605 81 MDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA- 156 (265)
T ss_pred cCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-
Confidence 99999999998764578999999999999999999999 7 999999999999999999999999999876532211
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCC-CCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD-GGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ................ +..+..
T Consensus 157 --~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 227 (265)
T cd06605 157 --KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-------PRLPSG 227 (265)
T ss_pred --hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC-------CCCChh
Confidence 126688899999999988999999999999999999999999975432 1222233333222111 011100
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.....+.++|.+||..+|++|||+.+++.+-+
T Consensus 228 -----~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~ 259 (265)
T cd06605 228 -----KFSPDFQDFVNLCLIKDPRERPSYKELLEHPF 259 (265)
T ss_pred -----hcCHHHHHHHHHHcCCCchhCcCHHHHhhCch
Confidence 02344778999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=299.64 Aligned_cols=254 Identities=30% Similarity=0.432 Sum_probs=204.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|...+.||+|++|.||+|.+. +++.|++|.++.........+.+.+|++++++++|+||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 3666788999999999999965 688999999977655445678899999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++.... .+++..+..++.|+++|++|||+. +++|+||+|+||++++++.+||+|||.+..........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 81 CSGGTLEELLEHGR-ILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred CCCCcHHHHHhhcC-CCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence 99999999998654 578899999999999999999998 99999999999999999999999999998764332222
Q ss_pred ---ccccccccCcccccccccCC---CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 940 ---MSAVAGSYGYIAPEYAYTMK---VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 940 ---~~~~~gt~~y~aPE~~~~~~---~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
.....++..|+|||.+.+.. ++.++||||+|+++|++++|+.||...+... ...... .. .. ...
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~---~~~~~~-~~-~~-----~~~ 226 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF---QIMFHV-GA-GH-----KPP 226 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH---HHHHHH-hc-CC-----CCC
Confidence 12356788999999988766 8899999999999999999999997543221 111111 11 11 111
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
++.. ......+.+++.+|++.+|++||++.+++.+
T Consensus 227 ~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~ 261 (264)
T cd06626 227 IPDS----LQLSPEGKDFLDRCLESDPKKRPTASELLQH 261 (264)
T ss_pred CCcc----cccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 1111 1123346789999999999999999998864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=303.86 Aligned_cols=250 Identities=25% Similarity=0.388 Sum_probs=195.6
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec------C
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ------G 851 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~------~ 851 (1078)
..|+..+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++++ +|+||+++++++... .
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 44566677999999999999976 588899999865432 245678899999998 699999999998753 4
Q ss_pred ceEEEEeeccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
..++||||+++++|.+++... ...+++..+..++.|++.|++|||++ +|+||||||+||++++++.++|+|||++.
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 578999999999999998764 34688999999999999999999998 99999999999999999999999999987
Q ss_pred ccCCCCCCcccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCC
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL 1005 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1078)
..... ........|++.|+|||++. +..++.++||||+||++|||++|+.||...... ... ..... ..
T Consensus 160 ~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~---~~~-~~~~~-~~- 232 (272)
T cd06637 160 QLDRT-VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM---RAL-FLIPR-NP- 232 (272)
T ss_pred ecccc-cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH---HHH-HHHhc-CC-
Confidence 65422 22334467899999999876 345888999999999999999999999643321 111 11111 10
Q ss_pred CCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1006 TPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+. .....+.+++.+||+.+|.+|||+++++++
T Consensus 233 ~~~~~~~----------~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 269 (272)
T cd06637 233 APRLKSK----------KWSKKFQSFIESCLVKNHSQRPTTEQLMKH 269 (272)
T ss_pred CCCCCCC----------CcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence 1111011 112347789999999999999999999875
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=303.34 Aligned_cols=259 Identities=28% Similarity=0.398 Sum_probs=204.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe--cCce
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--QGSN 853 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~ 853 (1078)
.|...+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|++.+++++|+||+++++++.. ....
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 4555678999999999999853 3688999999766543 346789999999999999999999999877 5578
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++||||+++++|.+++......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+....
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred EEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 999999999999999987665799999999999999999999998 99999999999999999999999999998764
Q ss_pred CCCCC--cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC-----------CHHHHHHHHh
Q 001434 934 MPQSK--SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG-----------DLATWVRNYI 1000 (1078)
Q Consensus 934 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~-----------~~~~~~~~~~ 1000 (1078)
..... ......++..|+|||...+..++.++||||+|+++|||++|+.|+....... ....+ ....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~ 239 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRL-LELL 239 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHH-HHHH
Confidence 22111 1112344567999999988889999999999999999999999986432211 11111 1111
Q ss_pred hcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
..... .+.. ......+.+++.+||+.+|++|||+.|++++|+.+
T Consensus 240 ~~~~~--------~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i 283 (284)
T cd05038 240 KEGER--------LPRP----PSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL 283 (284)
T ss_pred HcCCc--------CCCC----ccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence 11110 0000 01124578899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=309.32 Aligned_cols=267 Identities=26% Similarity=0.403 Sum_probs=202.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.++ +++.||+|++..........+.+.+|++++++++||||+++++++..++..++||||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 81 (286)
T cd07846 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEF 81 (286)
T ss_pred ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEec
Confidence 5667788999999999999986 588999999876654444566788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
++++++.++..... .+++.++..++.|++.|++|||+. +++||||+|+||++++++.++++|||++....... ..
T Consensus 82 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~ 156 (286)
T cd07846 82 VDHTVLDDLEKYPN-GLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV 156 (286)
T ss_pred CCccHHHHHHhccC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence 99988888766543 589999999999999999999998 99999999999999999999999999988654322 23
Q ss_pred ccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH----------HhhcCCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN----------YIRDHSLTPG 1008 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~----------~~~~~~~~~~ 1008 (1078)
.....++..|+|||...+ ..++.++||||+|+++|||++|+.||............... ..........
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence 334567899999998865 44778999999999999999999988643321111111100 0000000000
Q ss_pred cccCCCCcch---hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRLNVED---ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...+...... .........+.+++.+||+.+|++||++++++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 283 (286)
T cd07846 237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH 283 (286)
T ss_pred cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence 0000000000 0011223558899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=306.69 Aligned_cols=261 Identities=26% Similarity=0.415 Sum_probs=200.3
Q ss_pred hHhHHHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEE-
Q 001434 772 FQDVVEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCY- 848 (1078)
Q Consensus 772 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~- 848 (1078)
++.+.....+|+..+.||+|+||.||+|.+. +++.||+|++..... ....+.+|+.+++++ +||||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD---IDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc---hHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 4444456678888889999999999999975 578999998754322 235677899999998 6999999999874
Q ss_pred ----ecCceEEEEeeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCce
Q 001434 849 ----HQGSNLLIYEYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921 (1078)
Q Consensus 849 ----~~~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 921 (1078)
.++..++||||+++++|.+++.. ....+++..+..++.|+++|+.|||+. +++||||||+||++++++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCE
Confidence 34568999999999999998752 233688889999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCCcccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 001434 922 HVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV 996 (1078)
Q Consensus 922 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~ 996 (1078)
+++|||.+...... ........|++.|+|||.+. +..++.++||||+||++|||++|+.||..........
T Consensus 164 kl~dfg~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~--- 239 (286)
T cd06638 164 KLVDFGVSAQLTST-RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALF--- 239 (286)
T ss_pred EEccCCceeecccC-CCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHh---
Confidence 99999998765422 12223456899999999875 3457889999999999999999999997543221111
Q ss_pred HHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 997 RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
...... ......+. .....+.+++.+||+.||++|||+.|++++.+
T Consensus 240 -~~~~~~--~~~~~~~~---------~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~ 285 (286)
T cd06638 240 -KIPRNP--PPTLHQPE---------LWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF 285 (286)
T ss_pred -hccccC--CCcccCCC---------CcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence 111110 00110110 01234778999999999999999999998753
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=305.72 Aligned_cols=259 Identities=25% Similarity=0.433 Sum_probs=201.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCc----EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||.||+|.+. +++ .||+|.+..... ......+.+|+.++++++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 35667788999999999999864 343 468888765432 23345688999999999999999999988654 567
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+++||+++|+|.+++......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||.++....
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999999987665788999999999999999999998 999999999999999999999999999986642
Q ss_pred CCCC-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.... ......++..|+|||.+.+..++.++||||||+++||+++ |+.||.... ... ...........+ .+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~----~~~-~~~~~~~~~~~~---~~ 233 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP----TRE-IPDLLEKGERLP---QP 233 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC----HHH-HHHHHHCCCCCC---CC
Confidence 2221 1222345678999999988889999999999999999997 899986432 111 122222111110 00
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccC
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1060 (1078)
. .....+.+++.+||..+|++||+++++++.+.++....
T Consensus 234 --~-------~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~ 272 (303)
T cd05110 234 --P-------ICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP 272 (303)
T ss_pred --C-------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence 0 01234678999999999999999999999999875443
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-32 Score=303.89 Aligned_cols=264 Identities=24% Similarity=0.371 Sum_probs=199.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|++|.||+|.++ +++.||+|.+...... .....+.+|++++++++|+||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE 83 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence 46777889999999999999976 5889999998765432 223456789999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++ +|.+++......+++..+..++.|++.||.|||+. +++||||||+||+++.++.++++|||.++...... .
T Consensus 84 ~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-~ 158 (291)
T cd07844 84 YLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-K 158 (291)
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCC-c
Confidence 9985 99999877665789999999999999999999998 99999999999999999999999999987543221 1
Q ss_pred cccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC-CCCCccc------
Q 001434 939 SMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH-SLTPGIF------ 1010 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-~~~~~~~------ 1010 (1078)
......++..|+|||...+ ..++.++||||+|+++|||++|+.||...... ........... ...+..+
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDV---EDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccH---HHHHHHHHHhcCCCChhhhhhhhhc
Confidence 2223356889999998865 45889999999999999999999999644321 11111111100 0000000
Q ss_pred ----cCCCCcc-hhhH------HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1011 ----DTRLNVE-DESI------VDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1011 ----~~~~~~~-~~~~------~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
....... .... ......+.+++.+|++.+|++|||+++++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~ 288 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH 288 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence 0000000 0000 0111456789999999999999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=299.62 Aligned_cols=250 Identities=28% Similarity=0.411 Sum_probs=201.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC---CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE---GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
+|+..+.||+|++|+||+|..+ +++.|++|.+..... .+...+.+.+|++++++++|++|+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666788999999999999976 689999999865432 233456789999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++++|.+++.... .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.+||+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-SFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEecCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence 99999999999997654 588999999999999999999998 99999999999999999999999999987654222
Q ss_pred CCcccccccccCcccccccccCC-CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
......++..|+|||.+.... ++.++|+||+|+++|++++|+.||..... ............ .+.+ +.
T Consensus 157 --~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~-~~~~-~~--- 225 (258)
T cd06632 157 --FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSKE-LPPI-PD--- 225 (258)
T ss_pred --cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhccc-CCCc-CC---
Confidence 234456889999999987766 88999999999999999999999965431 111111111010 1100 11
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+||+.+|++||++.+++++
T Consensus 226 -------~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 255 (258)
T cd06632 226 -------HLSDEAKDFILKCLQRDPSLRPTAAELLEH 255 (258)
T ss_pred -------CcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence 112346789999999999999999999865
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=308.86 Aligned_cols=257 Identities=25% Similarity=0.400 Sum_probs=202.2
Q ss_pred cCCCccEEeccCceEEEEEEECC--------CcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecC
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS--------GKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQG 851 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~ 851 (1078)
+|...+.||+|+||.||+|.+.. +..||+|.+..... ....+.+.+|+++++++ +||||+++++++..++
T Consensus 13 ~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT-DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred HeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC-HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 56777889999999999997531 23689998865432 23456788999999999 7999999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEEC
Q 001434 852 SNLLIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD 916 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 916 (1078)
..++||||+++|+|.+++.... ..+++.++..++.|++.|++|||++ +++||||||+||+++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEc
Confidence 9999999999999999986432 2477888999999999999999998 999999999999999
Q ss_pred CCCceEEeecccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHH
Q 001434 917 DKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLAT 994 (1078)
Q Consensus 917 ~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~ 994 (1078)
+++.+||+|||.++....... .......++..|+|||.+.+..++.++||||+|+++|||++ |..||.... ...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~----~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEE 244 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC----HHH
Confidence 999999999999976542211 11222334567999999999899999999999999999998 888886432 233
Q ss_pred HHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 995 WVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
........... ..+. .....+.+++.+||+.+|++||++.++++.|+++..
T Consensus 245 ~~~~~~~~~~~-------~~~~------~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~ 295 (334)
T cd05100 245 LFKLLKEGHRM-------DKPA------NCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT 295 (334)
T ss_pred HHHHHHcCCCC-------CCCC------CCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence 33222211110 0000 112347789999999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=302.90 Aligned_cols=256 Identities=27% Similarity=0.441 Sum_probs=202.8
Q ss_pred hcCCCccEEeccCceEEEEEEEC------CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.+|+..+.||+|+||.||+|+.+ +.+.|++|.+..... ....+.+.+|++++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 46777788999999999999964 246788888865432 22456789999999999999999999999998999
Q ss_pred EEEEeeccCCCHHhHhcCCC--------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEee
Q 001434 854 LLIYEYMERGSLGELLHGSS--------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 925 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~--------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 925 (1078)
++||||+++|+|.+++.... ..+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~ 160 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL 160 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence 99999999999999997543 1588999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 926 FGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 926 fg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
||++...............++..|+|||.+.+..++.++||||+|+++|++++ |..||...... ........ ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~----~~~~~~~~-~~ 235 (275)
T cd05046 161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE----EVLNRLQA-GK 235 (275)
T ss_pred cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH----HHHHHHHc-CC
Confidence 99987543333333344566788999999988888999999999999999998 88898643322 12222111 11
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.. ..... .....+.+++.+|++.+|++|||+.|+++.|++
T Consensus 236 ~~-~~~~~----------~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~ 275 (275)
T cd05046 236 LE-LPVPE----------GCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE 275 (275)
T ss_pred cC-CCCCC----------CCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence 00 00000 112347789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=306.97 Aligned_cols=194 Identities=27% Similarity=0.438 Sum_probs=159.4
Q ss_pred cEEeccCceEEEEEEEC---CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe--cCceEEEEeec
Q 001434 786 FIVGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLIYEYM 860 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~e~~ 860 (1078)
..||+|+||+||+|..+ +++.||+|.+..... ...+.+|++++++++||||+++++++.. +...++||||+
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~ 82 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYA 82 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeee
Confidence 57999999999999965 357899999865432 3457789999999999999999998854 45678999998
Q ss_pred cCCCHHhHhcCC--------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEE----CCCCceEEeeccc
Q 001434 861 ERGSLGELLHGS--------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL----DDKFEAHVGDFGL 928 (1078)
Q Consensus 861 ~~gsL~~~l~~~--------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill----~~~~~~kl~Dfg~ 928 (1078)
++ +|.+++... ...+++..+..++.|++.||+|||++ +|+||||||+||++ +.++.+||+|||+
T Consensus 83 ~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 83 EH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred CC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 75 887776421 22578888999999999999999998 99999999999999 5667899999999
Q ss_pred ccccCCCCC--CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCC
Q 001434 929 AKVIDMPQS--KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLD 987 (1078)
Q Consensus 929 a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~ 987 (1078)
++....... .......||+.|+|||.+.+. .++.++||||+|+++|||++|++||....
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 987643221 223345789999999988764 58899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-32 Score=299.09 Aligned_cols=255 Identities=25% Similarity=0.439 Sum_probs=201.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC----chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG----NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
+|+..+.||+|++|.||+|... +++.||+|++...... ....+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 3667788999999999999964 6889999998754422 1235678999999999999999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-ceEEeecccccccCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDM 934 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~ 934 (1078)
||||+++++|.+++.... .+++..+..++.|++.|++|||++ +++|+||+|+||+++.++ .++++|||.+.....
T Consensus 81 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~ 156 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-AFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156 (268)
T ss_pred EEeccCCCcHHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence 999999999999997654 688899999999999999999998 999999999999998776 599999999876643
Q ss_pred CCC---CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 935 PQS---KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 935 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
... .......++..|+|||.+.+..++.++||||+|+++|++++|..||.......... .......... .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~~~~~~~~~~------~ 229 (268)
T cd06630 157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA-LIFKIASATT------A 229 (268)
T ss_pred ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH-HHHHHhccCC------C
Confidence 211 11223467889999999988889999999999999999999999996443222222 1111111100 1
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+..+ ......+.+++.+|+..+|++||++.+++++
T Consensus 230 ~~~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~ 264 (268)
T cd06630 230 PSIP------EHLSPGLRDVTLRCLELQPEDRPPSRELLKH 264 (268)
T ss_pred CCCc------hhhCHHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence 1111 1223457789999999999999999999865
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=296.43 Aligned_cols=250 Identities=29% Similarity=0.456 Sum_probs=200.2
Q ss_pred CCccEEeccCceEEEEEEECC-----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 783 HDSFIVGSGAYGTVYKAVMDS-----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 783 ~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
...+.||+|+||.||+|.+.. +..||+|++..... ....+.+.+|+..+++++|+||+++++++.+.+..+++|
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~ 80 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM 80 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence 345679999999999999763 37899999965543 224678899999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCC-CChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 858 EYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~-l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
||+++++|.+++...... +++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+.......
T Consensus 81 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 81 EYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred eccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 999999999999765544 89999999999999999999999 99999999999999999999999999998665332
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
........+++.|+|||...+..++.++||||+|+++|+|++ |..||... ................ .+
T Consensus 158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~----~~~~~~~~~~~~~~~~-------~~ 226 (258)
T smart00219 158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM----SNEEVLEYLKKGYRLP-------KP 226 (258)
T ss_pred ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC----CHHHHHHHHhcCCCCC-------CC
Confidence 222212346789999999988889999999999999999998 78888642 2222222222211100 00
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
. .....+.+++.+|++.+|++|||+.++++.|
T Consensus 227 ~------~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 227 E------NCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred C------cCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 0 1233477899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=302.58 Aligned_cols=238 Identities=20% Similarity=0.330 Sum_probs=186.3
Q ss_pred EEeccCceEEEEEEECC-------------------------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCcee
Q 001434 787 IVGSGAYGTVYKAVMDS-------------------------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv 841 (1078)
.||+|+||.||+|.... ...|++|++..... .....+.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR--DIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH--HHHHHHHHHHHHHhcCCCCCee
Confidence 48999999999997421 23578888855432 3346788899999999999999
Q ss_pred eEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC--
Q 001434 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-- 919 (1078)
Q Consensus 842 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-- 919 (1078)
++++++.++...++||||+++|+|..++......+++..+..++.|+++||+|||++ +|+||||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGLA 156 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcc
Confidence 999999999999999999999999999976655789999999999999999999998 999999999999997643
Q ss_pred -----ceEEeecccccccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHH-hCCCCCCCCCCCCCH
Q 001434 920 -----EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELL-TGRTPVQPLDDGGDL 992 (1078)
Q Consensus 920 -----~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~ell-tg~~P~~~~~~~~~~ 992 (1078)
.++++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||........
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~- 230 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK- 230 (274)
T ss_pred cCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-
Confidence 3899999988643211 22356788999998865 56889999999999999995 69999865432211
Q ss_pred HHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 993 ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
. ......... +... ...+.+++.+||+.+|++|||+.++++.|
T Consensus 231 ~----~~~~~~~~~----~~~~----------~~~~~~li~~cl~~~p~~Rps~~~il~~L 273 (274)
T cd05076 231 E----RFYEKKHRL----PEPS----------CKELATLISQCLTYEPTQRPSFRTILRDL 273 (274)
T ss_pred H----HHHHhccCC----CCCC----------ChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence 1 111111000 1100 12367899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-32 Score=302.11 Aligned_cols=251 Identities=27% Similarity=0.407 Sum_probs=203.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|...+.||.|++|.||+|.+. +++.||+|++..... ......+.+|+++++.++|+||+++++++.++...++|+||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 4566678999999999999976 588999999865542 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++... .+++..+..++.|++.|+.|+|+. +++||||+|+||++++++.++++|||.++...... ..
T Consensus 81 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~ 154 (274)
T cd06609 81 CGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM-SK 154 (274)
T ss_pred eCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc-cc
Confidence 9999999999865 589999999999999999999998 99999999999999999999999999998765332 22
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.....+++.|+|||...+..++.++||||+|+++|+|++|+.||...... .......... .+. ....
T Consensus 155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~~~~~~~~--~~~-----~~~~-- 221 (274)
T cd06609 155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVLFLIPKNN--PPS-----LEGN-- 221 (274)
T ss_pred cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHHHHhhhcC--CCC-----Cccc--
Confidence 33456888999999999888999999999999999999999999654321 1111111111 111 1100
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.....+.+++.+|+..+|++|||+++++++-+
T Consensus 222 ---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~ 253 (274)
T cd06609 222 ---KFSKPFKDFVSLCLNKDPKERPSAKELLKHKF 253 (274)
T ss_pred ---ccCHHHHHHHHHHhhCChhhCcCHHHHhhChh
Confidence 02234678999999999999999999988644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=324.90 Aligned_cols=262 Identities=19% Similarity=0.257 Sum_probs=191.3
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC------CCceeeEeeEEEec
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR------HRNIVKLYGFCYHQ 850 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~l~~~~~~~ 850 (1078)
...+|+..+.||+|+||+||+|.+. .++.||||++..... ....+..|+++++.++ |.+++++++++..+
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~---~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK---YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh---hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 4567888889999999999999975 578899999964321 2234455666665554 45689999988764
Q ss_pred -CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCC---------
Q 001434 851 -GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKF--------- 919 (1078)
Q Consensus 851 -~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~--------- 919 (1078)
.+.++|||++ |++|.+++.+.+ .+++.++..++.||+.||+|||+ . ||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~ 278 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHG-PFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNR 278 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccccccccc
Confidence 4678999988 668999887654 68999999999999999999997 5 999999999999998765
Q ss_pred -------ceEEeecccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCH
Q 001434 920 -------EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992 (1078)
Q Consensus 920 -------~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~ 992 (1078)
.+||+|||.+.... .......||+.|+|||++.+..|+.++||||+||++|||++|+.||......+..
T Consensus 279 ~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~ 354 (467)
T PTZ00284 279 ALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHL 354 (467)
T ss_pred ccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 49999999876432 2234567999999999999999999999999999999999999999754432211
Q ss_pred HHHHHHHhhcCCCCCc------------cccC----CCCcchhhH-----------HHHHHHHHHHHHhcCCCCCCCCCC
Q 001434 993 ATWVRNYIRDHSLTPG------------IFDT----RLNVEDESI-----------VDHMILVLKVALMCTSISPFDRPS 1045 (1078)
Q Consensus 993 ~~~~~~~~~~~~~~~~------------~~~~----~~~~~~~~~-----------~~~~~~l~~li~~cl~~dP~~RPs 1045 (1078)
..+ ..... ..+.. +++. .....+..+ ......+.+++.+||+.||++|||
T Consensus 355 ~~i-~~~~g--~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 355 HLM-EKTLG--RLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHH-HHHcC--CCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 111 11100 00000 0000 000000000 001234679999999999999999
Q ss_pred HHHHHHHHH
Q 001434 1046 MREVVSMLI 1054 (1078)
Q Consensus 1046 ~~ell~~L~ 1054 (1078)
++|+++|-+
T Consensus 432 a~e~L~Hp~ 440 (467)
T PTZ00284 432 ARQMTTHPY 440 (467)
T ss_pred HHHHhcCcc
Confidence 999999654
|
|
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=301.69 Aligned_cols=252 Identities=23% Similarity=0.358 Sum_probs=203.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.|+..+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.+++++.||+|+++++++.++...++||||
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY 83 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence 4556677999999999999976 588999999875433 23457788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++... .+++.++..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+....... ..
T Consensus 84 ~~~~~L~~~i~~~--~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~ 157 (277)
T cd06640 84 LGGGSALDLLRAG--PFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK 157 (277)
T ss_pred CCCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence 9999999998754 488889999999999999999998 99999999999999999999999999997654222 22
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.....++..|+|||...+..++.++||||+|+++|||++|..||....... ......... . +.+
T Consensus 158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~----~~~~~~~~~--~-----~~~----- 221 (277)
T cd06640 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR----VLFLIPKNN--P-----PTL----- 221 (277)
T ss_pred cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh----HhhhhhcCC--C-----CCC-----
Confidence 233467889999999988889999999999999999999999996543211 111110000 0 011
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.......+.+++.+||+.+|++||++++++.+-+-.
T Consensus 222 -~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 257 (277)
T cd06640 222 -TGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV 257 (277)
T ss_pred -chhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence 112345678999999999999999999999885543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=301.20 Aligned_cols=251 Identities=26% Similarity=0.398 Sum_probs=202.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe--cCceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv~ 857 (1078)
+|+..+.+|.|+||.||+|.+. +++.||+|++..........+.+.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 3666778999999999999865 57899999997665555556778899999999999999999998754 44578999
Q ss_pred eeccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhh-----ccCCCceEecCCCCCcEEECCCCceEEeecccc
Q 001434 858 EYMERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLH-----HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH-----~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 929 (1078)
||+++++|.+++... ...+++..++.++.|++.|++|+| +. +++|+||+|+||+++.++.++++|||.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~ 157 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA 157 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence 999999999998643 346899999999999999999999 66 9999999999999999999999999999
Q ss_pred cccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 001434 930 KVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 930 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
........ ......+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... ....... .......
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~-~~~~~~~--- 228 (265)
T cd08217 158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN----QLQLASK-IKEGKFR--- 228 (265)
T ss_pred ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC----HHHHHHH-HhcCCCC---
Confidence 87653221 1234568999999999998889999999999999999999999997543 2222222 2211110
Q ss_pred ccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.++. .....+.+++.+|++.+|++||++.+++++
T Consensus 229 ---~~~~------~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 229 ---RIPY------RYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred ---CCcc------ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 1110 123457789999999999999999999976
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=299.92 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=211.4
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
..|++-..+++|.|.||+||-|+++ +|+.||||++.+.+........+++|+.++++++||.||.+.-.|+..+.+++|
T Consensus 562 tvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVV 641 (888)
T KOG4236|consen 562 TVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVV 641 (888)
T ss_pred HHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEE
Confidence 4466666788999999999999965 799999999998877777778999999999999999999999999999999999
Q ss_pred EeeccCCCHHhHh-cCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC---CceEEeeccccccc
Q 001434 857 YEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK---FEAHVGDFGLAKVI 932 (1078)
Q Consensus 857 ~e~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~---~~~kl~Dfg~a~~~ 932 (1078)
||.+.| +..++| ......+++.....++.||+.||.|||.+ +|||+|+||+|||+... -++|+||||+|+++
T Consensus 642 MEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiI 717 (888)
T KOG4236|consen 642 MEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARII 717 (888)
T ss_pred ehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeec
Confidence 999976 555554 44445788888888999999999999999 99999999999999653 46999999999998
Q ss_pred CCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
+. ......++||+.|+|||++..+.|...-|+||+||++|--+.|..||. +++++.+.+.+..-..
T Consensus 718 gE--ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN---EdEdIndQIQNAaFMy--------- 783 (888)
T KOG4236|consen 718 GE--KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN---EDEDINDQIQNAAFMY--------- 783 (888)
T ss_pred ch--hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC---CccchhHHhhcccccc---------
Confidence 73 344567899999999999999999999999999999999999999996 4555555444321111
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.+..|.+.....+++|...+++.-++|.|++.-+.+.|
T Consensus 784 ----Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~W 821 (888)
T KOG4236|consen 784 ----PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPW 821 (888)
T ss_pred ----CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchh
Confidence 11223344455678888899999999999998877654
|
|
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-32 Score=298.82 Aligned_cols=237 Identities=26% Similarity=0.430 Sum_probs=188.9
Q ss_pred cEEeccCceEEEEEEECCCc-----------EEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceE
Q 001434 786 FIVGSGAYGTVYKAVMDSGK-----------IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~-----------~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
+.||+|+||.||+|.++... .|++|.+..... ....+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 35899999999999976432 467776654432 15788899999999999999999999988 7789
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-------ceEEeecc
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-------EAHVGDFG 927 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-------~~kl~Dfg 927 (1078)
+||||+++|+|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++ .++++|||
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999999987665789999999999999999999998 999999999999999887 79999999
Q ss_pred cccccCCCCCCcccccccccCcccccccccC--CCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 928 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
.+..... .....++..|+|||.+.+. .++.++||||+|+++||+++ |..||...... .....+.....
T Consensus 154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~----~~~~~~~~~~~ 224 (259)
T cd05037 154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS----EKERFYQDQHR 224 (259)
T ss_pred ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch----hHHHHHhcCCC
Confidence 9986542 2234567789999998776 78899999999999999999 57777654321 11111111100
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
. . .+ . ...+.+++.+||..+|++|||+.++++.|
T Consensus 225 ~-----~--~~-~-------~~~~~~li~~~l~~~p~~Rpt~~~il~~l 258 (259)
T cd05037 225 L-----P--MP-D-------CAELANLINQCWTYDPTKRPSFRAILRDL 258 (259)
T ss_pred C-----C--CC-C-------chHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 0 0 00 0 04577899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=304.67 Aligned_cols=249 Identities=27% Similarity=0.390 Sum_probs=199.9
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+.+|++++++++||||+++++++..+...++||||+
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 344566999999999999875 578899998865433 234567899999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++... .+++..+..++.|+++|+.|||++ +++|+||+|+||++++++.++++|||++....... ...
T Consensus 85 ~~~~L~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~~ 158 (277)
T cd06642 85 GGGSALDLLKPG--PLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKR 158 (277)
T ss_pred CCCcHHHHhhcC--CCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcc-hhh
Confidence 999999998653 588899999999999999999998 99999999999999999999999999987654221 122
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
....++..|+|||.+.+..++.++||||+|+++|||++|+.||.......... ...... .+.+.
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~-----~~~~~~------~~~~~----- 222 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF-----LIPKNS------PPTLE----- 222 (277)
T ss_pred hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh-----hhhcCC------CCCCC-----
Confidence 33467889999999998889999999999999999999999986433221111 111110 01111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
......+.+++.+|++.+|++||++.+++++-+
T Consensus 223 -~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~ 255 (277)
T cd06642 223 -GQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF 255 (277)
T ss_pred -cccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence 012344778999999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=301.68 Aligned_cols=259 Identities=24% Similarity=0.353 Sum_probs=206.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||+||+|.+. +++.||+|++..... ....+.+.+|+++++.++||||+++++++......++|||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK-SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc-chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 35666778999999999999976 588899998865432 3346788999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++...+ .+++..+..++.+++.|+.|||+. .+++||||+|+||+++.++.++++|||++......
T Consensus 84 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--- 157 (284)
T cd06620 84 FMDCGSLDRIYKKGG-PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--- 157 (284)
T ss_pred cCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhh---
Confidence 999999999987654 689999999999999999999963 28999999999999999999999999998654211
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC-------CHHHHHHHHhhcCCCCCcccc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG-------DLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
......|+..|+|||.+.+..++.++||||+||++|++++|+.||....... ....+.........
T Consensus 158 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 230 (284)
T cd06620 158 IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------- 230 (284)
T ss_pred ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC-------
Confidence 1224578999999999988889999999999999999999999997544321 11122222222111
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
+.++. ......+.+++.+|++.||++|||++|++++.+-+.
T Consensus 231 ~~~~~-----~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~ 271 (284)
T cd06620 231 PRLPS-----SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271 (284)
T ss_pred CCCCc-----hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence 11110 012345788999999999999999999999865443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=303.88 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=200.2
Q ss_pred hHhHHHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEe
Q 001434 772 FQDVVEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYH 849 (1078)
Q Consensus 772 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~ 849 (1078)
++++.....+|...+.||+|+||.||+|..+ +++.||+|++.... .....+.+|+.+++++ +|||++++++++..
T Consensus 14 ~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred cccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 3444445677888889999999999999975 58899999986542 2245677899999988 79999999999875
Q ss_pred c-----CceEEEEeeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCce
Q 001434 850 Q-----GSNLLIYEYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921 (1078)
Q Consensus 850 ~-----~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 921 (1078)
. +..++||||+++++|.++++. ....+++..+..++.|++.|++|||+. +++||||||+||+++.++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCE
Confidence 4 357999999999999998863 234688999999999999999999998 99999999999999999999
Q ss_pred EEeecccccccCCCCCCcccccccccCcccccccccC-----CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 001434 922 HVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM-----KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV 996 (1078)
Q Consensus 922 kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~ 996 (1078)
+++|||.+....... .......|+..|+|||.+... .++.++||||+||++|||++|+.||.........
T Consensus 168 kl~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~---- 242 (291)
T cd06639 168 KLVDFGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL---- 242 (291)
T ss_pred EEeecccchhccccc-ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH----
Confidence 999999987654222 122335688999999987543 3678999999999999999999999754322211
Q ss_pred HHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 997 RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 997 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
....+.. ...+.+ .+ .....+.+++.+|++.+|++||++.+++++
T Consensus 243 ~~~~~~~--~~~~~~------~~---~~~~~l~~li~~~l~~~p~~Rps~~~il~~ 287 (291)
T cd06639 243 FKIPRNP--PPTLLH------PE---KWCRSFNHFISQCLIKDFEARPSVTHLLEH 287 (291)
T ss_pred HHHhcCC--CCCCCc------cc---ccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1111111 111100 01 122347889999999999999999999976
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-32 Score=304.62 Aligned_cols=264 Identities=25% Similarity=0.364 Sum_probs=200.1
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||.|++|.||+|.++ +++.||||++............+.+|++++++++||||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 3667788999999999999976 588999999876554444556788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+. ++|.+++... ...+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+....... .
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-R 155 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc-c
Confidence 96 5899988654 34688999999999999999999998 99999999999999999999999999987654221 2
Q ss_pred cccccccccCcccccccccCC-CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc-------
Q 001434 939 SMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF------- 1010 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1010 (1078)
......++..|+|||.+.+.. ++.++||||+|+++|||+||+.||....+.......... ........+
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT---LGTPDEVVWPGVTSLP 232 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH---hCCCChhhhhhhhHHH
Confidence 223345688999999876644 688999999999999999999999754322222111111 000000000
Q ss_pred ------cCCCCcchhh-HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1011 ------DTRLNVEDES-IVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1011 ------~~~~~~~~~~-~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
........+. .......+.+++.+|++.||++|||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~ 281 (284)
T cd07860 233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH 281 (284)
T ss_pred HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence 0000000000 01122346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-32 Score=305.60 Aligned_cols=256 Identities=23% Similarity=0.262 Sum_probs=199.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||++.++ +++.|++|.+...... ....+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5677788999999999999976 4789999998765321 2334677899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS- 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~- 937 (1078)
|++|++|.+++...+ .+++..+..++.|++.|++|+|++ +++||||||+||+++.++.++++|||.++.......
T Consensus 82 ~~~g~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~ 157 (305)
T cd05609 82 YVEGGDCATLLKNIG-ALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT 157 (305)
T ss_pred cCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence 999999999997654 688899999999999999999998 999999999999999999999999998864211000
Q ss_pred -------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 938 -------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 938 -------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
.......++..|+|||.+.+..++.++|+||+|+++||+++|..||.+.. ..+..........
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~----~~~~~~~~~~~~~ 233 (305)
T cd05609 158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT----PEELFGQVISDDI 233 (305)
T ss_pred cccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHhccc
Confidence 01112457889999999988889999999999999999999999996432 2233322222111
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..+. .. ......+.+++.+||+.+|++||++.++.+.++.
T Consensus 234 ~~~~-----~~------~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~ 273 (305)
T cd05609 234 EWPE-----GD------EALPADAQDLISRLLRQNPLERLGTGGAFEVKQH 273 (305)
T ss_pred CCCC-----cc------ccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence 1000 00 0122346789999999999999985555444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-32 Score=302.12 Aligned_cols=255 Identities=24% Similarity=0.357 Sum_probs=200.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|+||.||+|.++ +++.||+|.+..... ......+.+|++++++++|+||+++++++..++..++||||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD-ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC-HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 4666778999999999999976 689999998865432 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC--CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 860 MERGSLGELLHGS--SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
+++++|.+++... ...+++..+..++.|++.|+.|||+. .+++||||||+||+++.++.++++|||.+......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 9999999998764 23689999999999999999999963 28999999999999999999999999998765321
Q ss_pred CcccccccccCcccccccccCC------CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMK------VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~------~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
......+++.|+|||.+.+.. ++.++||||+||++|+|++|+.||........ ......... .. .
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~-~~-~----- 227 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI-FAQLSAIVD-GD-P----- 227 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH-HHHHHHHhh-cC-C-----
Confidence 223346788999999885443 57899999999999999999999965332211 111111111 11 0
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..++. .....+.+++.+|++.+|++||++++++.+-+-
T Consensus 228 ~~~~~------~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~ 265 (286)
T cd06622 228 PTLPS------GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265 (286)
T ss_pred CCCCc------ccCHHHHHHHHHHcccCcccCCCHHHHhcChhh
Confidence 11111 123446789999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=282.82 Aligned_cols=274 Identities=24% Similarity=0.335 Sum_probs=208.5
Q ss_pred HHHhhcCCCccEEeccCceEEEEEEECC-----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe-
Q 001434 776 VEATYNFHDSFIVGSGAYGTVYKAVMDS-----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH- 849 (1078)
Q Consensus 776 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~- 849 (1078)
++....|+....||+|+||.||+|..++ .+.||||+++.++..........+|+..++.++||||+.+..++..
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence 4455678888899999999999996432 3479999999887766767788899999999999999999998876
Q ss_pred cCceEEEEeeccCCCHHhHhcCC----CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC----Cce
Q 001434 850 QGSNLLIYEYMERGSLGELLHGS----SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK----FEA 921 (1078)
Q Consensus 850 ~~~~~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~----~~~ 921 (1078)
+..+++++||.+. +|...|+-. .+.++...+..++.||+.|+.|||++ =|+|||+||.|||+..+ |.|
T Consensus 100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V 175 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV 175 (438)
T ss_pred CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence 8889999999987 999988632 24688899999999999999999999 79999999999999877 999
Q ss_pred EEeecccccccCCCCCC--cccccccccCcccccccccCC-CCCcCcchhHHHHHHHHHhCCCCCCCCCCCC-----CHH
Q 001434 922 HVGDFGLAKVIDMPQSK--SMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGG-----DLA 993 (1078)
Q Consensus 922 kl~Dfg~a~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~P~~~~~~~~-----~~~ 993 (1078)
||+|||+++.+..+-.. ....++-|..|.|||++.+.+ |+++.||||+||++.||+|-++-|....... -..
T Consensus 176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~ 255 (438)
T KOG0666|consen 176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH 255 (438)
T ss_pred EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence 99999999988644332 334577899999999998764 8999999999999999999988887543211 111
Q ss_pred HHHHHHhhcCCC-CCccccCCCCcchhh-------------------HHHH----HHHHHHHHHhcCCCCCCCCCCHHHH
Q 001434 994 TWVRNYIRDHSL-TPGIFDTRLNVEDES-------------------IVDH----MILVLKVALMCTSISPFDRPSMREV 1049 (1078)
Q Consensus 994 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~-------------------~~~~----~~~l~~li~~cl~~dP~~RPs~~el 1049 (1078)
+.+.+++.--.. ....| +.+...++. +.+. ...-.+++.+++..||.+|.|++++
T Consensus 256 dQl~rIf~vLG~Pt~~~W-p~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qA 334 (438)
T KOG0666|consen 256 DQLDRIFEVLGTPTDKDW-PDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQA 334 (438)
T ss_pred HHHHHHHHHcCCCccccc-hhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHH
Confidence 122222221111 11111 111111100 0010 1126789999999999999999999
Q ss_pred HHHHH
Q 001434 1050 VSMLI 1054 (1078)
Q Consensus 1050 l~~L~ 1054 (1078)
+++.-
T Consensus 335 leh~y 339 (438)
T KOG0666|consen 335 LEHPY 339 (438)
T ss_pred hcccc
Confidence 88764
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-32 Score=307.23 Aligned_cols=249 Identities=20% Similarity=0.316 Sum_probs=199.0
Q ss_pred ccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 785 SFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
...||+|+||.||+|.+. +++.||+|++..... ...+.+.+|+..++.++|||++++++++..++..++||||++++
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~ 103 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGG 103 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCC
Confidence 345999999999999975 588999999865433 23566889999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 943 (1078)
+|.+++... .+++..+..++.|++.|++|||+. +++||||||+||+++.++.++|+|||++....... ......
T Consensus 104 ~L~~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~~~~ 177 (297)
T cd06659 104 ALTDIVSQT--RLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKRKSL 177 (297)
T ss_pred CHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccccce
Confidence 999987653 488999999999999999999998 99999999999999999999999999987554222 222345
Q ss_pred ccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHH
Q 001434 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023 (1078)
Q Consensus 944 ~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1023 (1078)
.|+..|+|||.+.+..++.++||||+|+++|||++|+.||..... ......... ..... .... ..
T Consensus 178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~----~~~~~~~~~-~~~~~---~~~~-------~~ 242 (297)
T cd06659 178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAMKRLRD-SPPPK---LKNA-------HK 242 (297)
T ss_pred ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHhc-cCCCC---cccc-------CC
Confidence 688999999999888899999999999999999999999974332 111221111 11000 0000 01
Q ss_pred HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1024 HMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1024 ~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
....+.+++.+|++.+|++||++++++++-+-.
T Consensus 243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~ 275 (297)
T cd06659 243 ISPVLRDFLERMLTREPQERATAQELLDHPFLL 275 (297)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhhChhhc
Confidence 123467899999999999999999999975544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-32 Score=295.25 Aligned_cols=246 Identities=28% Similarity=0.443 Sum_probs=196.7
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|...+.||+|+||.||++.. .++.||+|++.... ..+.+.+|+.++++++|||++++++++..+ ..++||||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEEC
Confidence 4577788999999999999875 47889999986542 246788999999999999999999998654 57999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++.... ..+++..+..++.|++.|+.|+|+. +++||||||+||+++.++.++|+|||.+......
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 99999999997543 3588999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......+..|+|||.+.++.++.++||||+|+++|||++ |+.||..... ............. ...
T Consensus 154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~----~~~~~~~~~~~~~-------~~~-- 219 (254)
T cd05083 154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL----KEVKECVEKGYRM-------EPP-- 219 (254)
T ss_pred -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH----HHHHHHHhCCCCC-------CCC--
Confidence 122334578999999988899999999999999999998 9999964432 2222222111110 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
+ .....+.+++.+||+.+|++||+++++++.+++
T Consensus 220 -~---~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 220 -E---GCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred -C---cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 0 122346789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-32 Score=301.92 Aligned_cols=265 Identities=23% Similarity=0.333 Sum_probs=198.5
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..+|...+.||+|+||.||+|.+. +++.||+|++...... .....+.+|+.+++.++|+||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE-GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC-CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 457788889999999999999875 5889999998665432 23446678999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+. +++.+++......+.+.++..++.|++.||+|||+. +|+|+||||+||+++.++.++|+|||.++......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPS- 157 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence 9996 588777765544678888999999999999999998 99999999999999999999999999987543221
Q ss_pred CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCC------------
Q 001434 938 KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS------------ 1004 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~------------ 1004 (1078)
.......+++.|+|||.+.+. .++.++||||+|+++|||++|+.||....+. .+..........
T Consensus 158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~ 234 (291)
T cd07870 158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV---FEQLEKIWTVLGVPTEDTWPGVSK 234 (291)
T ss_pred CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhH---HHHHHHHHHHcCCCChhhhhhhhh
Confidence 222334578899999988754 5788999999999999999999999754321 111111111000
Q ss_pred ---CCCccccCCCCcchhhH---HHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1005 ---LTPGIFDTRLNVEDESI---VDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1005 ---~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
..........+...... ......+.+++.+|+..||++|||++|++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h 288 (291)
T cd07870 235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH 288 (291)
T ss_pred cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence 00000000000000000 0113457789999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=298.23 Aligned_cols=248 Identities=28% Similarity=0.449 Sum_probs=195.0
Q ss_pred EEeccCceEEEEEEECC-------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 787 IVGSGAYGTVYKAVMDS-------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.||+|+||.||+|.+.+ ++.||+|.+..... ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 58999999999998642 25789998865432 23356788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-----ceEEeeccc
Q 001434 860 MERGSLGELLHGS------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-----EAHVGDFGL 928 (1078)
Q Consensus 860 ~~~gsL~~~l~~~------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-----~~kl~Dfg~ 928 (1078)
+++++|.+++... ...+++.++..++.|++.|++|+|+. +++|+||||+||+++.++ .++++|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence 9999999998642 22478899999999999999999998 999999999999999877 899999999
Q ss_pred ccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 929 AKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 929 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
+........ .......++..|+|||.+.++.++.++||||||+++|||++ |+.||..... .............
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~----~~~~~~~~~~~~~- 232 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN----QEVLQHVTAGGRL- 232 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH----HHHHHHHhcCCcc-
Confidence 876532211 12223345788999999999999999999999999999998 9999964322 1222221111100
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..+ ......+.+++.+||..+|++||+++++++.|.+
T Consensus 233 ------~~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 233 ------QKP------ENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------CCc------ccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 000 1123457789999999999999999999998863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.35 Aligned_cols=238 Identities=21% Similarity=0.384 Sum_probs=187.2
Q ss_pred EEeccCceEEEEEEECC--------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 787 IVGSGAYGTVYKAVMDS--------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.||+|+||.||+|.++. ...|++|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 79 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQE 79 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEe
Confidence 58999999999998642 2347777775432 2335678889999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCc--------eEEeeccccc
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE--------AHVGDFGLAK 930 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--------~kl~Dfg~a~ 930 (1078)
|+++|+|.++++..+..+++..+..++.||+.|++|||++ +|+||||||+||+++.++. ++++|||.+.
T Consensus 80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999999987766789999999999999999999998 9999999999999987765 6999999886
Q ss_pred ccCCCCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCC-CCCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGR-TPVQPLDDGGDLATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1078)
.... .....++..|+|||.+.+. .++.++||||+|+++|||++|. .||..... .... .......
T Consensus 157 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~----~~~~-~~~~~~~---- 222 (258)
T cd05078 157 TVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS----QKKL-QFYEDRH---- 222 (258)
T ss_pred ccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH----HHHH-HHHHccc----
Confidence 5431 2234678899999998764 5789999999999999999985 55543221 1111 1111110
Q ss_pred cccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.++.. ...++.+++.+||+.+|++|||++++++.|
T Consensus 223 ----~~~~~------~~~~~~~li~~~l~~~p~~Rps~~~il~~l 257 (258)
T cd05078 223 ----QLPAP------KWTELANLINQCMDYEPDFRPSFRAIIRDL 257 (258)
T ss_pred ----cCCCC------CcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence 01100 113467899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=338.65 Aligned_cols=256 Identities=31% Similarity=0.450 Sum_probs=205.7
Q ss_pred HhhcCCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
...+|..+..||.|.||.||.|.. .+|+-.|+|.++-........+.+.+|..++..+.|||+|+++++-.+.+..+|.
T Consensus 1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence 345677778899999999999995 4688999998877665555567788999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
||||++|+|.+.++..+ ..++.....+..|++.|++|||++ |||||||||.||+++..|.+|.+|||.|..+....
T Consensus 1313 MEyC~~GsLa~ll~~gr-i~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~ 1388 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHGR-IEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA 1388 (1509)
T ss_pred HHHhccCcHHHHHHhcc-hhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCch
Confidence 99999999999998655 456666667778999999999999 99999999999999999999999999998775332
Q ss_pred ---CCcccccccccCcccccccccC---CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc
Q 001434 937 ---SKSMSAVAGSYGYIAPEYAYTM---KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 937 ---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1078)
........||+.|||||++.+. ....++||||+|||+.||+||+.||...+.. |+.-+.-.....+.+
T Consensus 1389 ~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-----~aIMy~V~~gh~Pq~- 1462 (1509)
T KOG4645|consen 1389 QTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-----WAIMYHVAAGHKPQI- 1462 (1509)
T ss_pred hcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-----hHHHhHHhccCCCCC-
Confidence 2234457899999999999754 3667999999999999999999999866543 322222222222222
Q ss_pred cCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
++++. .+=.+++.+|+..||++|.++.|++++=
T Consensus 1463 P~~ls----------~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1463 PERLS----------SEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred chhhh----------HhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence 22222 2234788899999999999999988764
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=305.10 Aligned_cols=269 Identities=29% Similarity=0.370 Sum_probs=202.9
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 856 (1078)
.+|+..+.||+|+||.||+|.++ +|+.||+|++............+.+|+.++++++|+||+++++++... +..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 46777888999999999999976 589999999876544333344567899999999999999999998765 467999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+.+ +|.+++......+++.++..++.|+++|++|||+. +++||||||+||+++.++.++|+|||.+.......
T Consensus 87 ~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 87 MEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999975 89988876556789999999999999999999999 99999999999999999999999999998765322
Q ss_pred CCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc-----
Q 001434 937 SKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF----- 1010 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1010 (1078)
.......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||............... ... .....+
T Consensus 163 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~ 238 (309)
T cd07845 163 -KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQL-LGT--PNESIWPGFSD 238 (309)
T ss_pred -CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCC--CChhhchhhhc
Confidence 22233446788999998865 45789999999999999999999999754432222221111 000 000000
Q ss_pred -------c---CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1011 -------D---TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1011 -------~---~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
. ................+.+++.+|++.||++|||+.+++++-+=.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~ 294 (309)
T cd07845 239 LPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294 (309)
T ss_pred ccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0 000000000111244577899999999999999999999876543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-32 Score=303.84 Aligned_cols=268 Identities=24% Similarity=0.302 Sum_probs=201.6
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv 856 (1078)
.+|+..+.||+|++|.||+|.++ +++.||+|.++.....+.....+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 35677778999999999999986 588999999976654444445677899999999999999999998877 889999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++ +|.+++......+++.++..++.|++.||+|||+. +++||||||+||+++.++.++++|||.+.......
T Consensus 85 ~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 85 MEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred ehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 999975 99999877665789999999999999999999998 99999999999999999999999999998765322
Q ss_pred CCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHh----------hcCCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYI----------RDHSL 1005 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~----------~~~~~ 1005 (1078)
.......+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||................. .....
T Consensus 161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 223345678899999988654 468899999999999999999999975432221111111000 00000
Q ss_pred CC-cccc-CCCCcchhhHHH--HHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1006 TP-GIFD-TRLNVEDESIVD--HMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1006 ~~-~~~~-~~~~~~~~~~~~--~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.. ..+. .......+.+.. ....+.+++.+|++.+|++|||+.|++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~ 290 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH 290 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence 00 0000 000000000111 13457789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=298.03 Aligned_cols=250 Identities=22% Similarity=0.296 Sum_probs=203.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||+|.+. +++.||+|++....... ...+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3667788999999999999976 58999999997654322 446788999999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++... ..+++.++..++.|+++|+.|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-- 154 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCc--
Confidence 99999999999766 3689999999999999999999998 99999999999999999999999999987654221
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||...... ............ ....+..
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---~~~~~~~----- 224 (258)
T cd05578 155 LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETA---DVLYPAT----- 224 (258)
T ss_pred cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccc---cccCccc-----
Confidence 233456888999999998888999999999999999999999999755432 122222222210 0001111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCH--HHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSM--REVVS 1051 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~--~ell~ 1051 (1078)
....+.+++.+||+.||.+||++ +|+++
T Consensus 225 -----~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~ 254 (258)
T cd05578 225 -----WSTEAIDAINKLLERDPQKRLGDNLKDLKN 254 (258)
T ss_pred -----CcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence 12457789999999999999999 66654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=305.22 Aligned_cols=255 Identities=22% Similarity=0.291 Sum_probs=214.1
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
....|...+.||+|.|++|..|++. ++..||||.+.+..-.....+.+.+|+++|+.+.|||||+++.+.+.+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3456677788999999999999965 699999999998877666677799999999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+.+|.+++++.+.++ +...++..++.|+++|++|||++ .|||||||++|++++.+.++||+|||++..+. .
T Consensus 134 ~eya~~ge~~~yl~~~gr-~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGR-MKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD--Y 207 (596)
T ss_pred EEeccCchhHHHHHhccc-chhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec--c
Confidence 999999999999998875 44488889999999999999999 99999999999999999999999999999886 5
Q ss_pred CCcccccccccCcccccccccCCCC-CcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
.....+.+|++.|.|||++.+..|. +.+|+||+|+++|.++.|..||++..-.+.....+.+ ++.
T Consensus 208 ~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--------------k~r 273 (596)
T KOG0586|consen 208 GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--------------KYR 273 (596)
T ss_pred cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--------------eec
Confidence 5667789999999999999988876 8999999999999999999999754322222211111 111
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.... -..+.-+++++++-.+|.+|++.+++-++-|.-
T Consensus 274 Ip~~----ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n 310 (596)
T KOG0586|consen 274 IPFY----MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRN 310 (596)
T ss_pred ccce----eechhHHHHHHhhccCccccCCHHHhhhhcccc
Confidence 1111 112245688899999999999999999887754
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=303.46 Aligned_cols=248 Identities=24% Similarity=0.305 Sum_probs=203.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|++|.||+|.+. +++.||+|++...... ....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 5677788999999999999976 5889999998765332 2345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++.... .+++..+..++.|++.||+|||+. +++||||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~-~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG-RFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--- 154 (290)
T ss_pred cCCCCCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC---
Confidence 999999999997664 689999999999999999999998 9999999999999999999999999999875432
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
.....+++.|+|||.+.+..++.++||||+|+++|+|++|+.||.... .............. ++..+
T Consensus 155 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~~----~~~~~---- 221 (290)
T cd05580 155 -TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN----PIQIYEKILEGKVR----FPSFF---- 221 (290)
T ss_pred -CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCcc----CCccC----
Confidence 234568899999999988888999999999999999999999996433 12222222211110 01111
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~ 1054 (1078)
...+.+++.+||..+|.+|| +++|++++-+
T Consensus 222 ------~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~ 256 (290)
T cd05580 222 ------SPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPW 256 (290)
T ss_pred ------CHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcc
Confidence 23467899999999999999 8888887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=298.49 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=200.0
Q ss_pred CCCccEEeccCceEEEEEEECC--CcEEEEEEecccC--------CCchhHHHHHHHHHHHcc-CCCCceeeEeeEEEec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDS--GKIVAVKKLASNR--------EGNNIESSFRAEILTLGK-IRHRNIVKLYGFCYHQ 850 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~--------~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~ 850 (1078)
|+..+.||+|+||.||+|.++. ++.+|+|.+.... .......++.+|+.++.+ ++||||+++++++.++
T Consensus 2 y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 81 (269)
T cd08528 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN 81 (269)
T ss_pred chhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC
Confidence 5666789999999999999764 6889999885432 122334567788888765 7999999999999999
Q ss_pred CceEEEEeeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCCceEEeec
Q 001434 851 GSNLLIYEYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDF 926 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 926 (1078)
+..++||||+++++|.+++.. ....+++..++.++.|++.|+.|||+ . +++|+||+|+||+++.++.++++||
T Consensus 82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 82 DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEecc
Confidence 999999999999999998743 33468899999999999999999996 5 8999999999999999999999999
Q ss_pred ccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 927 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 927 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
|.+....... ......|+..|+|||...+..++.++||||+|+++|++++|+.||.... ..............+
T Consensus 159 g~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~ 232 (269)
T cd08528 159 GLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN----MLSLATKIVEAVYEP 232 (269)
T ss_pred cceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC----HHHHHHHHhhccCCc
Confidence 9998765332 3345568899999999998889999999999999999999999996432 222222222111100
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.. + ......+.+++.+||+.||++||++.|+.+++++
T Consensus 233 -------~~---~--~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~ 269 (269)
T cd08528 233 -------LP---E--GMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269 (269)
T ss_pred -------CC---c--ccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence 00 0 0112347789999999999999999999998763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-32 Score=301.78 Aligned_cols=252 Identities=24% Similarity=0.352 Sum_probs=201.8
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|...+.||+|+||.||++... +++.||+|.+..... ...+.+.+|+.++++++||||+++++++...+..++|||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQ--PKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccc--hHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 45677788999999999999865 578899999864432 234678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++++|.+++.+. .+++.++..++.|++.|++|||++ +++||||+|+||+++.++.++|+|||.+....... .
T Consensus 97 ~~~~~~L~~~~~~~--~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-~ 170 (293)
T cd06647 97 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-S 170 (293)
T ss_pred cCCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc-c
Confidence 99999999998754 478899999999999999999999 99999999999999999999999999887554222 2
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......+++.|+|||.+.+..++.++||||||+++|++++|+.||............ ..... +... ..
T Consensus 171 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~----~~~~~-------~~~~-~~ 238 (293)
T cd06647 171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI----ATNGT-------PELQ-NP 238 (293)
T ss_pred ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeeh----hcCCC-------CCCC-Cc
Confidence 233456888999999998888999999999999999999999999754322111110 00000 0000 00
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
......+.+++.+||..+|++||++++++.+-+
T Consensus 239 ---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~ 271 (293)
T cd06647 239 ---EKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPF 271 (293)
T ss_pred ---cccCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence 112234778999999999999999999998854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-32 Score=300.26 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=186.8
Q ss_pred EEeccCceEEEEEEECC---CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 787 IVGSGAYGTVYKAVMDS---GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
.||+|+||+||+|.... ...+|+|.+..... ......+.+|+..++.++|+||+++++++.+....++||||+++|
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT-PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC-hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 48999999999997543 45678887754432 333567889999999999999999999999999999999999999
Q ss_pred CHHhHhcCCCC----CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-C
Q 001434 864 SLGELLHGSSC----NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-K 938 (1078)
Q Consensus 864 sL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-~ 938 (1078)
+|.+++..... ..++.....++.|++.|++|||++ +|+||||||+||++++++.+|++|||.+........ .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence 99999875432 346777889999999999999999 999999999999999999999999999865422111 1
Q ss_pred cccccccccCccccccccc-------CCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc
Q 001434 939 SMSAVAGSYGYIAPEYAYT-------MKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1078)
......++..|+|||+... ..++.++||||+|+++|||++ |..||....+.. ............ ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~----~~~~~~~~~~~~--~~ 231 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ----VLKQVVREQDIK--LP 231 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH----HHHHHhhccCcc--CC
Confidence 1223446778999998642 356789999999999999999 788886443221 222222221110 00
Q ss_pred cCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.+... ......+.+++..|| .||++|||+++|++.+.
T Consensus 232 ~~~~~------~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQLD------LKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCccc------ccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 11111 012233556778888 59999999999998863
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-31 Score=294.21 Aligned_cols=254 Identities=29% Similarity=0.475 Sum_probs=207.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.++ +++.|++|++...... ...+.+.+|+..+.+++|+|++++++++..++..++||||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 4667788999999999999977 4899999998766442 4467889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++++|.+++.... .+++..+..++.|+++|++|+|+ . +++||||+|+||+++.++.++++|||.+....... .
T Consensus 81 ~~~~~L~~~l~~~~-~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-~ 155 (264)
T cd06623 81 MDGGSLADLLKKVG-KIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-D 155 (264)
T ss_pred cCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCC-C
Confidence 99999999997653 68999999999999999999999 8 99999999999999999999999999988664222 2
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......++..|+|||...+..++.++||||+|+++|+|++|+.||..... ....+.......... . .....
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~-~~~~~~~~~~~~~~~-~------~~~~~- 226 (264)
T cd06623 156 QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQ-PSFFELMQAICDGPP-P------SLPAE- 226 (264)
T ss_pred cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccc-cCHHHHHHHHhcCCC-C------CCCcc-
Confidence 22345688999999999988899999999999999999999999975542 133333333322111 0 11100
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.....+.+++.+|++.+|++||++.+++++=
T Consensus 227 ----~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~ 257 (264)
T cd06623 227 ----EFSPEFRDFISACLQKDPKKRPSAAELLQHP 257 (264)
T ss_pred ----cCCHHHHHHHHHHccCChhhCCCHHHHHhCH
Confidence 0234578899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=302.86 Aligned_cols=266 Identities=24% Similarity=0.356 Sum_probs=199.7
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||.|++|.||+|.+. +|+.||+|++..........+.+.+|++.+++++|||++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 455678999999999999975 6899999999766544444567889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 861 ERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 861 ~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+ ++|.+++.... ..+++..+..++.|+++||+|||++ +++||||+|+||+++.++.++++|||.+....... ..
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~-~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV-RT 155 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc-cc
Confidence 5 59999987654 3689999999999999999999998 99999999999999999999999999997654221 22
Q ss_pred ccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCC-----------CCC
Q 001434 940 MSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS-----------LTP 1007 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-----------~~~ 1007 (1078)
.....+++.|+|||.+.+. .++.++||||+|+++|+|++|+.||....+........+....... ...
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKP 235 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhh
Confidence 2233568899999987654 5788999999999999999999999754322211111111000000 000
Q ss_pred ccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1008 GIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
....................+.+++.+|++.+|++|||++|++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 280 (283)
T cd07835 236 TFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH 280 (283)
T ss_pred hcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 000000000000011122457789999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-32 Score=296.71 Aligned_cols=252 Identities=26% Similarity=0.341 Sum_probs=196.7
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC---chhHHHHHHHHHHHccCCCCceeeEeeEEEec--Cce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG---NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 853 (1078)
.+|+..+.||+|+||.||.|.++ +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 35777889999999999999975 5889999988643221 22346788999999999999999999988764 457
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+. +++|+||||+||+++.++.++|+|||.+....
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~ 157 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-ALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQ 157 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence 89999999999999987654 578888999999999999999998 99999999999999999999999999987653
Q ss_pred CCC--CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 934 MPQ--SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 934 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
... ........++..|+|||.+.+..++.++||||+|+++||+++|+.||...... ......... .. .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~~-----~ 227 (265)
T cd06652 158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQ-PT-----N 227 (265)
T ss_pred cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHHhcC-CC-----C
Confidence 211 11223356888999999998888999999999999999999999999643211 111111111 10 0
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+..+ ......+.+++.+|+. +|++||++++++++
T Consensus 228 ~~~~------~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~ 261 (265)
T cd06652 228 PVLP------PHVSDHCRDFLKRIFV-EAKLRPSADELLRH 261 (265)
T ss_pred CCCc------hhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence 1111 1223446678888985 99999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-31 Score=295.83 Aligned_cols=255 Identities=26% Similarity=0.381 Sum_probs=198.8
Q ss_pred CCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC------
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 851 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 851 (1078)
|...+.||+|+||.||+|.++ +++.||+|++..........+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 345667999999999999854 3688999999776555555677889999999999999999999886542
Q ss_pred ceEEEEeeccCCCHHhHhcCC-----CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeec
Q 001434 852 SNLLIYEYMERGSLGELLHGS-----SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 926 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 926 (1078)
..++++||+.+|+|.+++... ...++...+..++.|++.|++|||++ +|+||||||+||+++.++.+|++||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence 237889999999999887422 22478888999999999999999998 9999999999999999999999999
Q ss_pred ccccccCCCCC-CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCC
Q 001434 927 GLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 927 g~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
|.++....... .......+++.|++||......++.++||||+|+++|||++ |+.||..... ............
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~----~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN----SEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH----HHHHHHHHcCCc
Confidence 99886532221 11223345678999999988889999999999999999999 8888864322 222222221111
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.. .+. .....+.+++.+|++.+|++|||+.++++.|+++
T Consensus 234 ~~-------~~~------~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 LK-------QPP------DCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred CC-------CCC------CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 10 000 1223578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=298.37 Aligned_cols=251 Identities=24% Similarity=0.375 Sum_probs=186.6
Q ss_pred EEeccCceEEEEEEECCC---cEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 787 IVGSGAYGTVYKAVMDSG---KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
.||+|+||+||+|...++ ..+++|.+..... ....+.+.+|+..++.++||||+++++.+.+....++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 489999999999975433 3456666654432 234578899999999999999999999999999999999999999
Q ss_pred CHHhHhcCCC---CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC-CCc
Q 001434 864 SLGELLHGSS---CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-SKS 939 (1078)
Q Consensus 864 sL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~-~~~ 939 (1078)
+|.+++.... ...+...+..++.||+.||+|||+. +++||||||+||+++.++.++++|||.+....... ...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 9999997542 2456677789999999999999998 99999999999999999999999999886432111 112
Q ss_pred ccccccccCccccccccc-------CCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 940 MSAVAGSYGYIAPEYAYT-------MKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.....++..|+|||+... ..++.++||||+|+++|||++ |..||..... ............ ...++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~----~~~~~~~~~~~~--~~~~~ 231 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD----REVLNHVIKDQQ--VKLFK 231 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCH----HHHHHHHHhhcc--cccCC
Confidence 234567889999998743 245789999999999999997 5678754332 222222222211 11112
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
+.+... ....+.+++.+|| .+|++||+++++++.|.
T Consensus 232 ~~~~~~------~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 232 PQLELP------YSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CccCCC------CcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 222211 1234667888999 67999999999998763
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.4e-32 Score=299.92 Aligned_cols=249 Identities=21% Similarity=0.348 Sum_probs=200.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.|...+.||+|++|.||+|.+. +++.|++|++..... ...+.+.+|+.++++++||||+++++++...+..++|+||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 3455568999999999999965 688999998854332 3355688999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++... .+++.++..++.|++.|++|+|++ +++||||+|+||+++.++.++++|||.+....... ..
T Consensus 98 ~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~-~~ 171 (285)
T cd06648 98 LEGGALTDIVTHT--RMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV-PR 171 (285)
T ss_pred cCCCCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCC-cc
Confidence 9999999998873 588999999999999999999998 99999999999999999999999999887543222 22
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.....|++.|+|||...+..++.++||||+|+++|||++|+.||.... ............ .... .. .
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~----~~~~~~~~~~~~--~~~~-~~----~-- 238 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP----PLQAMKRIRDNL--PPKL-KN----L-- 238 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC----HHHHHHHHHhcC--CCCC-cc----c--
Confidence 234568899999999988889999999999999999999999996432 222222222211 1110 00 0
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
......+.+++.+||+.+|++||++.+++++
T Consensus 239 --~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~ 269 (285)
T cd06648 239 --HKVSPRLRSFLDRMLVRDPAQRATAAELLNH 269 (285)
T ss_pred --ccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence 0122347889999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-32 Score=309.90 Aligned_cols=271 Identities=25% Similarity=0.353 Sum_probs=208.6
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC------c
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG------S 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------~ 852 (1078)
+-|...+.+|+|+||.||+++.+ +|+.||||.+..... ...+++..+|++++++++|+|||+++++-++.. .
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~-~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESS-LRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhcc-cchHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 44555667999999999999954 799999999987653 234678889999999999999999998755433 4
Q ss_pred eEEEEeeccCCCHHhHhcCCC--CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEEC--CCC--ceEEeec
Q 001434 853 NLLIYEYMERGSLGELLHGSS--CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD--DKF--EAHVGDF 926 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Df 926 (1078)
..+|||||.||+|..++++.. ..+++.+.+.++.++..|+.|||++ ||+||||||.||++- ++| -.||+||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf 168 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF 168 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence 579999999999999998654 3799999999999999999999998 999999999999983 334 3699999
Q ss_pred ccccccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCC
Q 001434 927 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL 1005 (1078)
Q Consensus 927 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1078)
|+|+..+ +.......+||..|.+||++.. +.|+..+|.|||||++|++.||..||.+..........+.......+-
T Consensus 169 G~Arel~--d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 169 GAARELD--DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred cccccCC--CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 9999886 3447778999999999999984 789999999999999999999999998766554322232222222111
Q ss_pred C-----------CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCC--CHHHHHHHHHhh
Q 001434 1006 T-----------PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRP--SMREVVSMLIES 1056 (1078)
Q Consensus 1006 ~-----------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP--s~~ell~~L~~~ 1056 (1078)
. +..+...++....-.......+...+..++..+|++|. .+.+....+.++
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dI 310 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDI 310 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHH
Confidence 0 11122233332222233334455666778889999999 777777766665
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=297.47 Aligned_cols=261 Identities=25% Similarity=0.346 Sum_probs=201.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 857 (1078)
+|+..+.||.|++|.||+|.+. +++.||+|.+...... .....+.+|++++++++||||+++++++.+. ...++||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 4667788999999999999985 5888999988755332 3457789999999999999999999988654 4679999
Q ss_pred eeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 858 EYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
||+++++|.+++.. ....++...+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 99999999987652 334688889999999999999999998 999999999999999999999999999875432
Q ss_pred CCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC-CCHHHHHHHHhhcCCCCCccccCC
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG-GDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
. ......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ....+.. ........ ... ...
T Consensus 158 ~---~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~-~~~-~~~ 231 (287)
T cd06621 158 S---LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELL-SYIVNMPN-PEL-KDE 231 (287)
T ss_pred c---ccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHH-HHHhcCCc-hhh-ccC
Confidence 1 122345788999999998889999999999999999999999999755321 1112222 21111110 000 111
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.... ......+.+++.+||+.+|++|||+.|++++-+-
T Consensus 232 ~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~ 269 (287)
T cd06621 232 PGNG----IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269 (287)
T ss_pred CCCC----CchHHHHHHHHHHHcCCCcccCCCHHHHHhCccc
Confidence 1000 1123457899999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.9e-33 Score=283.85 Aligned_cols=242 Identities=24% Similarity=0.267 Sum_probs=199.4
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
++|+..+++|+|.||+|-.++.+ +++.||+|++++...-+ +....-..|-++++..+||.+..+.-.|+..+..++||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 45677788999999999999966 69999999998886432 33445568999999999999999998999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||..||.|+-.+.+.+ .+++....-+-..|+.||.|||++ +||+||+|.+|.++|.+|++||+|||+++.-- ...
T Consensus 248 eyanGGeLf~HLsrer-~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-~~g 322 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER-VFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEI-KYG 322 (516)
T ss_pred EEccCceEeeehhhhh-cccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcc-ccc
Confidence 9999999999988765 677777777888999999999999 99999999999999999999999999997532 345
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
...++++|||+|+|||++....|+.+.|.|.+||++|||++|+.||...+.+.-+.-+...-++ ++..+.++
T Consensus 323 ~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k--------FPr~ls~e 394 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK--------FPRTLSPE 394 (516)
T ss_pred ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc--------CCccCCHH
Confidence 6678899999999999999999999999999999999999999999866544433333222111 23333322
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCC
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRP 1044 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RP 1044 (1078)
...++.-.+.+||.+|.
T Consensus 395 ----------AktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 395 ----------AKTLLSGLLKKDPKKRL 411 (516)
T ss_pred ----------HHHHHHHHhhcChHhhc
Confidence 23466677889999997
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=298.17 Aligned_cols=252 Identities=27% Similarity=0.398 Sum_probs=198.4
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecC-----
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQG----- 851 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~----- 851 (1078)
..+|+..+.||+|++|.||+|.++ +++.|++|++..... ..+.+.+|+.+++++ .|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 457788889999999999999986 578899999865432 346788999999999 7999999999997644
Q ss_pred -ceEEEEeeccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecc
Q 001434 852 -SNLLIYEYMERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 927 (1078)
Q Consensus 852 -~~~lv~e~~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 927 (1078)
..++||||+++++|.+++... ...+++..+..++.|++.|+.|||++ +++|+||+|+||++++++.++++|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence 479999999999999988643 34689999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccccccc-----CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhc
Q 001434 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYT-----MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD 1002 (1078)
Q Consensus 928 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1002 (1078)
.+...... ........|+..|+|||.+.. ..++.++||||+|+++|+|++|+.||........ .......
T Consensus 159 ~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~ 233 (275)
T cd06608 159 VSAQLDST-LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA----LFKIPRN 233 (275)
T ss_pred cceecccc-hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHH----HHHhhcc
Confidence 98765422 222334568899999998753 3467889999999999999999999964332211 1111111
Q ss_pred CCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
. . +.+.. . ......+.+++.+|+..||++|||+.+++++
T Consensus 234 ~--~-----~~~~~-~---~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~ 272 (275)
T cd06608 234 P--P-----PTLKS-P---ENWSKKFNDFISECLIKNYEQRPFMEELLEH 272 (275)
T ss_pred C--C-----CCCCc-h---hhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence 1 1 01111 0 1233457789999999999999999999875
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=9.8e-32 Score=298.87 Aligned_cols=256 Identities=26% Similarity=0.376 Sum_probs=205.8
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
...|...+.||+|++|.||+|.++ +++.|++|++..... ..+.+.+|++.+++++|+|++++++++..++..++|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 345666678999999999999987 688999999965533 4567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++++|.+++......+++.++..++.|++.|++|||+. |++|+||+|+||+++.++.++|+|||.+.......
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~- 170 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK- 170 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccch-
Confidence 99999999999987655689999999999999999999998 99999999999999999999999999887654222
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ......... ... .. .
T Consensus 171 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~~~~~-~~~-~~-----~-- 237 (286)
T cd06614 171 SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFLITTK-GIP-PL-----K-- 237 (286)
T ss_pred hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhc-CCC-CC-----c--
Confidence 2223445788999999998888999999999999999999999999643222 111111111 110 00 0
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
........+.+++.+|++.+|.+||++.+++++-+-.
T Consensus 238 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~ 274 (286)
T cd06614 238 --NPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274 (286)
T ss_pred --chhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence 0011234577899999999999999999999765544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=319.79 Aligned_cols=271 Identities=20% Similarity=0.243 Sum_probs=191.0
Q ss_pred hhcCCCccEEeccCceEEEEEEECC--CcEEEEEEe--------------ccc-CCCchhHHHHHHHHHHHccCCCCcee
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMDS--GKIVAVKKL--------------ASN-REGNNIESSFRAEILTLGKIRHRNIV 841 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~--------------~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv 841 (1078)
..+|+..+.||+|+||+||+|..+. ++.+++|.+ .+. .........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4578888899999999999987542 222222211 111 11223345678999999999999999
Q ss_pred eEeeEEEecCceEEEEeeccCCCHHhHhcCCC----CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC
Q 001434 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSS----CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD 917 (1078)
Q Consensus 842 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~ 917 (1078)
++++++.+.+..|+|+|++.+ ++.+++.... ......++..++.|++.||+|||++ +|+||||||+|||++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNC 302 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence 999999999999999999964 7887765332 1233556778999999999999998 9999999999999999
Q ss_pred CCceEEeecccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001434 918 KFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR 997 (1078)
Q Consensus 918 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~ 997 (1078)
++.+||+|||+++.+............||..|+|||++.+..++.++||||+||++|||++|..++........... ..
T Consensus 303 ~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~-~~ 381 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ-LL 381 (501)
T ss_pred CCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH-HH
Confidence 99999999999987654333333446799999999999999999999999999999999998765433222221122 11
Q ss_pred HHhhcCCCCCccccC------------CCCcchhhHHH------HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 998 NYIRDHSLTPGIFDT------------RLNVEDESIVD------HMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 998 ~~~~~~~~~~~~~~~------------~~~~~~~~~~~------~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..+........-++. .+......... ....+.+++.+|++.||++|||+.|++++-+
T Consensus 382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~ 456 (501)
T PHA03210 382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPL 456 (501)
T ss_pred HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChh
Confidence 211111100000000 00000000000 1123567789999999999999999998754
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=291.64 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=204.1
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|++|.||++.+. +++.|++|++..... ...+.+.+|++.+++++|++++++++++..+...++++||+
T Consensus 2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 79 (253)
T cd05122 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFC 79 (253)
T ss_pred ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecC
Confidence 566778999999999999986 688999999976654 34678899999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++......+++..+..++.|++.|++|||+. +++||||+|+||++++++.++|+|||.+........ .
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~ 154 (253)
T cd05122 80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R 154 (253)
T ss_pred CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence 99999999987655789999999999999999999998 999999999999999999999999999887653221 3
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+. ......... .. .... ...
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~-~~~~-----~~~--- 220 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP----MKALFKIAT-NG-PPGL-----RNP--- 220 (253)
T ss_pred cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch----HHHHHHHHh-cC-CCCc-----Ccc---
Confidence 455788999999999888899999999999999999999999964331 111111111 11 1110 000
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
......+.+++.+|++.||++|||+.+++++
T Consensus 221 -~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~ 251 (253)
T cd05122 221 -EKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH 251 (253)
T ss_pred -cccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0113447889999999999999999999875
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=296.52 Aligned_cols=263 Identities=23% Similarity=0.283 Sum_probs=195.2
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEec--CceEEEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQ--GSNLLIY 857 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~~~lv~ 857 (1078)
|+..+.||+|+||.||+|.+. +++.||+|+++....... .....+|+..+.++. |+|++++++++.++ +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 455678999999999999965 588999999876543222 234457888888885 99999999999887 8899999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++ ++.+.+......+++.++..++.|++.||+|||+. +++||||+|+||+++. +.+||+|||.+......
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~-- 152 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK-- 152 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC--
Confidence 99975 88888876555789999999999999999999998 9999999999999999 99999999999865422
Q ss_pred CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHH----------HHhhcCCCC
Q 001434 938 KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR----------NYIRDHSLT 1006 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~----------~~~~~~~~~ 1006 (1078)
.......++..|+|||.+.+ ..++.++||||+||++|||++|..||...+..+....... .........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07831 153 PPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHM 232 (282)
T ss_pred CCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccc
Confidence 22233567889999997654 5578899999999999999999999965432111111110 000000000
Q ss_pred CccccCCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 PGIFDTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...++...... ..........+.+++.+|++.+|++||++++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~ 279 (282)
T cd07831 233 NYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH 279 (282)
T ss_pred cccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence 00000000000 00011235678899999999999999999999876
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=304.73 Aligned_cols=269 Identities=22% Similarity=0.292 Sum_probs=202.4
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec------
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------ 850 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------ 850 (1078)
...+|+..+.||+|+||.||+|.+. +++.||+|++.+..........+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4567888889999999999999975 689999999876544444456778899999999999999999988643
Q ss_pred CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 851 GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
...++||||+.+ +|.+.+... ++..++..++.|++.||+|||++ +++||||||+||+++.++.+|++|||.+.
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 166 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLAR 166 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccce
Confidence 346999999965 888887643 78889999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHH-------------
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR------------- 997 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~------------- 997 (1078)
..... .......++..|+|||.+.+..++.++||||+|+++|+|++|+.||...+..........
T Consensus 167 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (353)
T cd07850 167 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRL 244 (353)
T ss_pred eCCCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence 65422 223345678899999999999999999999999999999999999975432111111110
Q ss_pred -----HHhhcCCCCC-----ccccCC-CCcch-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 998 -----NYIRDHSLTP-----GIFDTR-LNVED-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 998 -----~~~~~~~~~~-----~~~~~~-~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.+........ ..+... .+... +........+.+++.+|++.||++|||+.|++++-+-
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~ 314 (353)
T cd07850 245 QPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI 314 (353)
T ss_pred hhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence 0000000000 000000 00000 0001123456799999999999999999999988653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.5e-32 Score=299.27 Aligned_cols=263 Identities=25% Similarity=0.365 Sum_probs=204.6
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|++|.||+|... +++.+++|++............+.+|++++++++|++|+++++++.+++..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 445678999999999999975 6889999998776554455678889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++ ++.+++......+++.++..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+....... ...
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~~ 155 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPY 155 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-ccc
Confidence 76 89888877655789999999999999999999998 99999999999999999999999999997765332 223
Q ss_pred cccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc--------
Q 001434 941 SAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD-------- 1011 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------- 1011 (1078)
....++..|+|||...+. .++.++||||+|+++|+|++|+.||......+......... .......+.
T Consensus 156 ~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~ 232 (283)
T cd05118 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTL---GTPDPEVWPKFTSLARN 232 (283)
T ss_pred cCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc---CCCchHhcccchhhhhh
Confidence 345678899999998776 78899999999999999999999996543221111111110 000000000
Q ss_pred ------C-CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 ------T-RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ------~-~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
. ......+...+....+.+++.+||+.||.+||++.+++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~ 280 (283)
T cd05118 233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH 280 (283)
T ss_pred hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence 0 0000011122345678899999999999999999999875
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-32 Score=294.15 Aligned_cols=251 Identities=24% Similarity=0.377 Sum_probs=202.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|+||.||+|.++ +|..||+|.+..........+.+.+|++++++++|+||+++++++.++...++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 3666788999999999999976 488899999876544334456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCc-eEEeecccccccCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE-AHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~-~kl~Dfg~a~~~~~~~~ 937 (1078)
+++++|.+++.... ..+++..+..++.|+++|++|||+. +++|+||||+||++++++. ++++|||.+...... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~-~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS-M 156 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC-c
Confidence 99999999987543 3578999999999999999999998 9999999999999998864 699999998766422 2
Q ss_pred CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......|++.|+|||...+..++.++||||+|+++|||++|..||.... ............. .+ ...
T Consensus 157 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~----~~~~~~~~~~~~~------~~-~~~- 224 (257)
T cd08225 157 ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN----LHQLVLKICQGYF------AP-ISP- 224 (257)
T ss_pred ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHHhcccC------CC-CCC-
Confidence 22233568899999999988889999999999999999999999996432 2333333222110 10 000
Q ss_pred hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+|+..+|++|||+.+++++
T Consensus 225 -----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~ 254 (257)
T cd08225 225 -----NFSRDLRSLISQLFKVSPRDRPSITSILKR 254 (257)
T ss_pred -----CCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence 112347789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-31 Score=295.92 Aligned_cols=246 Identities=23% Similarity=0.247 Sum_probs=189.5
Q ss_pred EEeccCceEEEEEEEC-CCcEEEEEEecccCCCch-hHHHHHHHHHH---HccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 787 IVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNN-IESSFRAEILT---LGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~---l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
+||+|+||.||++.+. +++.||+|.+........ ....+.+|..+ +...+||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999975 588999999876543222 12233444433 334479999999999999999999999999
Q ss_pred CCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccc
Q 001434 862 RGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941 (1078)
Q Consensus 862 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 941 (1078)
+++|.+++.... .+++..+..++.|++.|++|||+. +++||||||+||++++++.++++|||++...... ...
T Consensus 81 ~~~L~~~i~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~ 153 (279)
T cd05633 81 GGDLHYHLSQHG-VFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH 153 (279)
T ss_pred CCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceecccc---Ccc
Confidence 999999987655 589999999999999999999998 9999999999999999999999999998755322 122
Q ss_pred ccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 942 AVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 942 ~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
...|+..|+|||...+ ..++.++||||+|+++|||++|..||....... ........... +..++.
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~--------~~~~~~---- 220 (279)
T cd05633 154 ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KHEIDRMTLTV--------NVELPD---- 220 (279)
T ss_pred CcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcC-HHHHHHHhhcC--------CcCCcc----
Confidence 3468999999998864 558899999999999999999999997543322 11111111110 111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHH
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~ 1054 (1078)
.....+.+++.+|++.||++|| ++++++++.+
T Consensus 221 --~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~ 257 (279)
T cd05633 221 --SFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVF 257 (279)
T ss_pred --ccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcc
Confidence 1223477899999999999999 6999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-31 Score=293.29 Aligned_cols=248 Identities=25% Similarity=0.399 Sum_probs=200.0
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|+||.||+|.+. +++.||+|++..... ....+.+.+|+..+++++||||+++++++..++..++||||+
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 556678999999999999875 588999998865433 234567889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++... .+++..+..++.|++.|+.|||+. +++|+||+|+||+++.++.++++|||++...... ....
T Consensus 85 ~~~~l~~~i~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~-~~~~ 158 (277)
T cd06641 85 GGGSALDLLEPG--PLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT-QIKR 158 (277)
T ss_pred CCCcHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccc-hhhh
Confidence 999999998754 488999999999999999999998 9999999999999999999999999998765422 1222
Q ss_pred cccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
....++..|+|||...+..++.++||||+|+++|+|++|..||..... ....... .... .+. ++.
T Consensus 159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~-~~~~-~~~-~~~-------- 223 (277)
T cd06641 159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVLFLI-PKNN-PPT-LEG-------- 223 (277)
T ss_pred ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHHHHH-hcCC-CCC-CCc--------
Confidence 335678899999999888889999999999999999999999964321 1111111 1111 000 011
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.....+.+++.+|++.+|++||++.+++++-
T Consensus 224 --~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~ 254 (277)
T cd06641 224 --NYSKPLKEFVEACLNKEPSFRPTAKELLKHK 254 (277)
T ss_pred --ccCHHHHHHHHHHccCChhhCcCHHHHHhCH
Confidence 1223467899999999999999999999963
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-31 Score=296.41 Aligned_cols=263 Identities=26% Similarity=0.356 Sum_probs=202.6
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEEEEe
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLIYE 858 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~e 858 (1078)
|+..+.||+|++|.||+|.+. +++.||+|++............+.+|++++++++|+|++++++++.+. +..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 455678999999999999977 488999999987654444456788999999999999999999999887 78999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+++ +|.+++......+++.++..++.|+++|++|||+. +++|+||+|+||++++++.++++|||.+.........
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~ 156 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA 156 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence 9975 99998877655799999999999999999999998 9999999999999999999999999999876543322
Q ss_pred cccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC-Ccccc-----
Q 001434 939 SMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT-PGIFD----- 1011 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----- 1011 (1078)
......++..|+|||.+.+ ..++.++||||||+++|||++|+.||....... ...........+ ...+.
T Consensus 157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE----QLEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH----HHHHHHHHhCCCchhhccccccc
Confidence 3344467888999997764 457899999999999999999999997544222 222211110000 00000
Q ss_pred ---------CCCCcch-hhHHHH-HHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 ---------TRLNVED-ESIVDH-MILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ---------~~~~~~~-~~~~~~-~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
....... +..... ...+.+++.+|++.+|++||++.+++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 284 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH 284 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence 0000000 011111 4567899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=297.43 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=199.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.|...+.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+++++.++||||+++++++.+++..++|||
T Consensus 16 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e 95 (307)
T cd06607 16 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVME 95 (307)
T ss_pred hhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHH
Confidence 3666678999999999999975 588999999865432 23345678899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+.+ ++.+++......+++..+..++.|++.|+.|||+. +++||||+|+||++++++.++|+|||++......
T Consensus 96 ~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--- 168 (307)
T cd06607 96 YCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--- 168 (307)
T ss_pred hhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCCC---
Confidence 9974 88887765555789999999999999999999998 9999999999999999999999999998764321
Q ss_pred cccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 939 SMSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
....+++.|+|||.+. ...++.++||||+|+++|||++|+.||..... ........... .. ...
T Consensus 169 --~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~----~~~~~~~~~~~--~~-----~~~ 235 (307)
T cd06607 169 --NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQND--SP-----TLS 235 (307)
T ss_pred --CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH----HHHHHHHhcCC--CC-----CCC
Confidence 2346788999999874 45688999999999999999999999964321 11111111111 00 010
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
. ......+.+++.+||+.+|++||++.+++.+.+-.
T Consensus 236 --~---~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~ 271 (307)
T cd06607 236 --S---NDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL 271 (307)
T ss_pred --c---hhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence 0 11234578899999999999999999999876533
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.3e-32 Score=298.81 Aligned_cols=252 Identities=26% Similarity=0.393 Sum_probs=195.3
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEe------
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYH------ 849 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~------ 849 (1078)
....|+..+.||+|+||.||+|.+. +++.||+|++.... .....+..|+.+++++ +|+||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 4456777788999999999999975 58889999885542 2345678899999988 69999999998853
Q ss_pred cCceEEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccc
Q 001434 850 QGSNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 850 ~~~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 928 (1078)
....++||||+++|+|.+++.... ..+++..+..++.|++.|++|||++ +++||||+|+||++++++.++|+|||.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~ 167 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV 167 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcc
Confidence 456799999999999999987533 3578888899999999999999998 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH 1003 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1003 (1078)
+....... .......|++.|+|||.+. +..++.++||||+|+++|||++|..||......... ......
T Consensus 168 ~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~~~~~~- 241 (282)
T cd06636 168 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----FLIPRN- 241 (282)
T ss_pred hhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----hhHhhC-
Confidence 87653221 2233456899999999875 346788999999999999999999999643321111 111111
Q ss_pred CCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1004 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
........ .....+.+++.+||+.||.+||++.|++++
T Consensus 242 -~~~~~~~~----------~~~~~~~~li~~cl~~~p~~Rp~~~ell~~ 279 (282)
T cd06636 242 -PPPKLKSK----------KWSKKFIDFIEGCLVKNYLSRPSTEQLLKH 279 (282)
T ss_pred -CCCCCccc----------ccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence 01111000 122357889999999999999999999865
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=296.73 Aligned_cols=255 Identities=22% Similarity=0.362 Sum_probs=194.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHH-HccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILT-LGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|+..+.||+|+||.||+|.++ +|+.||+|++......+. ...+..|+.. ++..+||||+++++++..++..++|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 5677788999999999999976 589999999976544333 3445556554 666789999999999999999999999
Q ss_pred eccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 859 YMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 859 ~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
|++ |+|.+++.. ....+++..+..++.|++.|++|||++ .+++||||||+||+++.++.+||+|||.+......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 997 588887753 234689999999999999999999974 28999999999999999999999999998865321
Q ss_pred CCCcccccccccCccccccccc----CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYT----MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||..... .... ........ .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~--~~~~-~~~~~~~~--~----- 225 (283)
T cd06617 158 --VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT--PFQQ-LKQVVEEP--S----- 225 (283)
T ss_pred --cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc--CHHH-HHHHHhcC--C-----
Confidence 12223467889999998754 4568899999999999999999999964322 1111 11211111 0
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
...+.. .....+.+++.+||..+|++||++++++++-+-.
T Consensus 226 ~~~~~~-----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~ 265 (283)
T cd06617 226 PQLPAE-----KFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265 (283)
T ss_pred CCCCcc-----ccCHHHHHHHHHHccCChhhCcCHHHHhcCchhh
Confidence 111100 1224477899999999999999999999865543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=305.83 Aligned_cols=264 Identities=25% Similarity=0.338 Sum_probs=198.4
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec--CceE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ--GSNL 854 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~~~~ 854 (1078)
..+|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.+++++ +||||+++++++... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 345667778999999999999976 588999999876543334455677899999999 999999999988654 3579
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+++ +|.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++++|||.+.....
T Consensus 86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~ 159 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159 (337)
T ss_pred EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence 99999975 999988765 578889999999999999999998 999999999999999999999999999986543
Q ss_pred CCC----CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC--
Q 001434 935 PQS----KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP-- 1007 (1078)
Q Consensus 935 ~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 1007 (1078)
... .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........... .........
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~----~~~~~~~~~~~ 235 (337)
T cd07852 160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK----IIEVIGPPSAE 235 (337)
T ss_pred ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH----HHHHhCCCCHH
Confidence 221 12234568899999998764 4578899999999999999999999964332211111 111000000
Q ss_pred ---------------ccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1008 ---------------GIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1008 ---------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.+.........+........+.+++.+||+.+|++|||+.+++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 000000000011111124557899999999999999999999987
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-31 Score=300.90 Aligned_cols=268 Identities=26% Similarity=0.344 Sum_probs=201.8
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC------
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 851 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 851 (1078)
..+|+..+.||+|++|.||+|.++ +++.||+|++......+.....+.+|++++++++||||+++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 456777888999999999999986 5889999999766544444567789999999999999999999987654
Q ss_pred ----ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecc
Q 001434 852 ----SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 927 (1078)
Q Consensus 852 ----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg 927 (1078)
..++||||+++ ++.+.+......+++..+..++.|++.||+|||+. +|+||||||+||++++++.+||+|||
T Consensus 86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCccc
Confidence 78999999986 78887776655789999999999999999999998 99999999999999999999999999
Q ss_pred cccccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 928 ~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
.+...............++..|+|||.+.+ ..++.++||||+|+++|||++|++||............. ..... ...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~-~~~~~-~~~ 239 (302)
T cd07864 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS-RLCGS-PCP 239 (302)
T ss_pred ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH-HHhCC-CCh
Confidence 998765333233333456788999998764 457899999999999999999999997433221111111 11110 000
Q ss_pred Ccc--------c---cCCCC---cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 PGI--------F---DTRLN---VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ~~~--------~---~~~~~---~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
... + +.... ............+.+++.+||+.+|.+||++.+++++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 299 (302)
T cd07864 240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS 299 (302)
T ss_pred hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 000 0 00000 0000011123557899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.3e-31 Score=294.32 Aligned_cols=249 Identities=25% Similarity=0.295 Sum_probs=198.1
Q ss_pred EeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
||+|+||+||+|.+. +|+.||+|++...... ....+.+..|++++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 5889999998754322 22345667899999999999999999999999999999999999999
Q ss_pred HhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccc
Q 001434 866 GELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA 944 (1078)
Q Consensus 866 ~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 944 (1078)
.+++.... ..+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+..... ........
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~ 155 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA 155 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence 99987544 3688999999999999999999998 999999999999999999999999999876542 22233456
Q ss_pred cccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHH
Q 001434 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024 (1078)
Q Consensus 945 gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1078)
++..|+|||...+..++.++||||+|+++|+|++|+.||................... ....+. ..
T Consensus 156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~------~~ 221 (277)
T cd05577 156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEM--------AVEYPD------KF 221 (277)
T ss_pred CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccc--------cccCCc------cC
Confidence 7889999999988889999999999999999999999997654332322222221111 001110 11
Q ss_pred HHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHHh
Q 001434 1025 MILVLKVALMCTSISPFDRP-----SMREVVSMLIE 1055 (1078)
Q Consensus 1025 ~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~~ 1055 (1078)
...+.+++.+||+.+|++|| ++.+++++-+=
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~ 257 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence 23467899999999999999 88888876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=296.53 Aligned_cols=265 Identities=25% Similarity=0.388 Sum_probs=200.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|++. +++.||||++...... ...+.+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 4677788999999999999986 5889999999765432 2345677899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC--CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 860 MERGSLGELLHGSS--CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
+++ +|.+++.... ..+++..+..++.|++.|++|||+. +++||||+|+||++++++.++++|||.+.......
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~- 154 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV- 154 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc-
Confidence 985 8988886543 4689999999999999999999998 99999999999999999999999999997654221
Q ss_pred CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC-------CCCCcc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH-------SLTPGI 1009 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~-------~~~~~~ 1009 (1078)
.......++..|+|||.+.+. .++.++||||+|+++|++++|+.||......+............. ...+..
T Consensus 155 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (284)
T cd07836 155 NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY 234 (284)
T ss_pred cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchh
Confidence 222334578899999987654 478899999999999999999999975543322222211100000 000000
Q ss_pred ccCCCCcch-----hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1010 FDTRLNVED-----ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1010 ~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
....+... .........+.+++.+|++.||++||++++++++
T Consensus 235 -~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 281 (284)
T cd07836 235 -KPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH 281 (284)
T ss_pred -cccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence 01111100 0011223557899999999999999999999865
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-31 Score=304.59 Aligned_cols=269 Identities=22% Similarity=0.315 Sum_probs=203.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe----cCceE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~ 854 (1078)
.+|+..+.||+|++|.||+|.++ +++.||+|++..........+.+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 56777888999999999999976 58999999997654444445677889999999999999999998753 34679
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+. ++|.+++.... .+++..+..++.|++.||+|||++ +++||||||+||++++++.+||+|||.+.....
T Consensus 85 lv~e~~~-~~l~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 159 (334)
T cd07855 85 VVMDLME-SDLHHIIHSDQ-PLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSS 159 (334)
T ss_pred EEEehhh-hhHHHHhccCC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence 9999996 59999987655 589999999999999999999998 999999999999999999999999999976542
Q ss_pred CCC---CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc-
Q 001434 935 PQS---KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI- 1009 (1078)
Q Consensus 935 ~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1009 (1078)
... .......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...+.......+... ....+...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~---~g~~~~~~~ 236 (334)
T cd07855 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSV---LGSPSEEVL 236 (334)
T ss_pred cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHH---hCCChhHhh
Confidence 221 11234578899999998765 45889999999999999999999999653321111111000 00000000
Q ss_pred --------------ccCCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1010 --------------FDTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1010 --------------~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+....... .+........+.+++.+|++.+|++||++++++.+-+-.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~ 298 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence 00000000 011122345688999999999999999999999977644
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=298.30 Aligned_cols=264 Identities=23% Similarity=0.310 Sum_probs=197.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecCc-----e
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGS-----N 853 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~-----~ 853 (1078)
+|+..+.||+|+||.||+|.+. +++.||+|++............+.+|+.++++++ ||||+++++++...+. .
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~ 81 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL 81 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence 5777888999999999999976 5889999998766544444567888999999995 6999999999887666 7
Q ss_pred EEEEeeccCCCHHhHhcCC----CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEEeeccc
Q 001434 854 LLIYEYMERGSLGELLHGS----SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGL 928 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~ 928 (1078)
++||||+++ +|.+++... ...+++..+..++.||+.||+|||++ +++||||+|+||+++. ++.++++|||.
T Consensus 82 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~ 157 (295)
T cd07837 82 YLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGL 157 (295)
T ss_pred EEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeeccc
Confidence 999999986 898887643 23579999999999999999999998 9999999999999998 88999999999
Q ss_pred ccccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1078)
+....... .......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||....+........... .....
T Consensus 158 ~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~---~~~~~ 233 (295)
T cd07837 158 GRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL---GTPTE 233 (295)
T ss_pred ceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh---CCCCh
Confidence 87653221 22223356888999998765 457899999999999999999999997533222111111110 00000
Q ss_pred cccc-----------CCCCc-c-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1008 GIFD-----------TRLNV-E-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1008 ~~~~-----------~~~~~-~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
..+. +.... . ..........+.++|.+|++.||++||+++|++.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~ 291 (295)
T cd07837 234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291 (295)
T ss_pred hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence 0000 00000 0 00011234557899999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.7e-31 Score=299.73 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=200.1
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|...+.||+|+||.||+|.+. +++.||+|++..... .......+.+|++++++++|||++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 555677999999999999975 588999999865432 223456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+.| ++.+.+......+++.++..++.|++.|+.|||++ +++||||+|+||+++.++.++++|||.+.....
T Consensus 107 ~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 107 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred CCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 975 88888766555789999999999999999999998 999999999999999999999999998875432
Q ss_pred ccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.....+++.|+|||.+. ++.++.++||||+|+++|||++|+.||...... ............. ..
T Consensus 178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~~~~~-------~~- 245 (317)
T cd06635 178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNESPT-------LQ- 245 (317)
T ss_pred cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHHHHHHhccCCC-------CC-
Confidence 22346888999999874 456889999999999999999999998653222 1122222111100 00
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
. ......+.+++.+|++.+|++||++.+++++.+...
T Consensus 246 -~---~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 282 (317)
T cd06635 246 -S---NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLR 282 (317)
T ss_pred -C---ccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhc
Confidence 0 012234778999999999999999999999887654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-31 Score=297.10 Aligned_cols=265 Identities=22% Similarity=0.327 Sum_probs=198.0
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.++ +++.||+|++..........+.+.+|++++++++||||+++++++.++...++||||
T Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 82 (294)
T PLN00009 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEY 82 (294)
T ss_pred ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEec
Confidence 5777788999999999999976 688999999876544334456788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEEeecccccccCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
+++ ++.+++.... ...++..+..++.||+.|++|||++ +++||||+|+||+++. ++.+|++|||.+...... .
T Consensus 83 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-~ 157 (294)
T PLN00009 83 LDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-V 157 (294)
T ss_pred ccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCC-c
Confidence 965 8888775433 2467888889999999999999998 9999999999999985 457999999999765422 2
Q ss_pred CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc-----
Q 001434 938 KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD----- 1011 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 1011 (1078)
.......+++.|+|||.+.+ ..++.++||||+|+++|+|++|+.||......+........ ........++
T Consensus 158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (294)
T PLN00009 158 RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRI---LGTPNEETWPGVTSL 234 (294)
T ss_pred cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH---hCCCChhhccccccc
Confidence 22233467889999998765 45789999999999999999999999754332222111110 0000000000
Q ss_pred -------CCCCcc-h-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1012 -------TRLNVE-D-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1012 -------~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
...... . .........+.+++.+|++.+|++||++.+++++-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~ 285 (294)
T PLN00009 235 PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHE 285 (294)
T ss_pred hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCc
Confidence 000000 0 00011234477899999999999999999999863
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=289.72 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=207.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||++.+. +++.|++|++......+...+.+.+|++.+++++|+|++++++.+..++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 3666788999999999999976 588999999987665556677889999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 860 MERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 860 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
+++++|.+++... ...+++.++..++.+++.|++|||+. +++|+||+|+||++++++.++++|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 9999999999764 35799999999999999999999998 99999999999999999999999999998765332
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......|++.|+|||...+..++.++||||+|+++++|++|+.||.... ............. . .++.
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~~-~------~~~~ 225 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN----LLELALKILKGQY-P------PIPS 225 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc----HHHHHHHHhcCCC-C------CCCC
Confidence 22334578899999999988889999999999999999999999996432 2333333222111 0 1110
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+||+.+|++|||+.+++++
T Consensus 226 ------~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 255 (258)
T cd08215 226 ------QYSSELRNLVSSLLQKDPEERPSIAQILQS 255 (258)
T ss_pred ------CCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 112346789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=288.81 Aligned_cols=253 Identities=28% Similarity=0.426 Sum_probs=206.8
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~lv~ 857 (1078)
+|+..+.||+|++|.||+|.+. +++.|++|++..........+.+.+|++.+++++|++|+++++.+.+. ...++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3666788999999999999977 688999999977655445567889999999999999999999999988 8899999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++++|.+++.... .+++.++..++.|+++|++|||+. +++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 156 (260)
T cd06606 81 EYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156 (260)
T ss_pred EecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence 9999999999998765 789999999999999999999998 999999999999999999999999999987653322
Q ss_pred C-cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 938 K-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
. ......++..|+|||...+..++.++||||+|+++|++++|..||.... ........... ..... .++
T Consensus 157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~-~~~~~-----~~~- 226 (260)
T cd06606 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG---NPMAALYKIGS-SGEPP-----EIP- 226 (260)
T ss_pred cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---chHHHHHhccc-cCCCc-----CCC-
Confidence 1 1334568899999999988889999999999999999999999997544 11222212111 00000 111
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+ .....+.+++.+|++.+|++||++.+++.+
T Consensus 227 --~---~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~ 257 (260)
T cd06606 227 --E---HLSEEAKDFLRKCLRRDPKKRPTADELLQH 257 (260)
T ss_pred --c---ccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence 1 113457889999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=295.87 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=199.9
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC---CCceeeEeeEEEecCceEEEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR---HRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
|+..+.||+|+||.||+|.+. +++.||+|.+..... ....+.+.+|+.++++++ ||+++++++++.++...++||
T Consensus 3 y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 556678999999999999974 688999999865433 233567888999999886 999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++++|.+++... .+++..+..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~--~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 82 EYAEGGSVRTLMKAG--PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred ecCCCCcHHHHHHcc--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 999999999998754 588999999999999999999998 99999999999999999999999999998765332
Q ss_pred CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 938 KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......|+..|+|||.+.++ .++.++||||+|+++|+|++|..||...... ...... ... . .+.+..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~~~~-~~~-~-----~~~~~~ 224 (277)
T cd06917 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAMMLI-PKS-K-----PPRLED 224 (277)
T ss_pred cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhhhcc-ccC-C-----CCCCCc
Confidence 223345688999999988654 4688999999999999999999999643321 111111 100 0 111111
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
. .....+.+++.+||+.||++||++.+++++-+-
T Consensus 225 ~-----~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~ 258 (277)
T cd06917 225 N-----GYSKLLREFVAACLDEEPKERLSAEELLKSKWI 258 (277)
T ss_pred c-----cCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence 1 123457789999999999999999999886443
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=289.83 Aligned_cols=247 Identities=23% Similarity=0.292 Sum_probs=200.4
Q ss_pred EeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
||.|++|.||+|.+. +++.||+|++...... ....+.+.+|++++++++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999976 4889999999765432 33457789999999999999999999999999999999999999999
Q ss_pred HhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccccc
Q 001434 866 GELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG 945 (1078)
Q Consensus 866 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 945 (1078)
.+++.+.. .+++..+..++.|++.|++|+|+. +++|+||+|+||+++.++.++++|||.+....... ......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~ 154 (262)
T cd05572 81 WTILRDRG-LFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCG 154 (262)
T ss_pred HHHHhhcC-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccC
Confidence 99998654 588999999999999999999998 99999999999999999999999999998764321 2233568
Q ss_pred ccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHH
Q 001434 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHM 1025 (1078)
Q Consensus 946 t~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1078)
+..|+|||.+.+..++.++|+||+|+++|+|++|..||..... +............. . ...+.. ..
T Consensus 155 ~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~-~-----~~~~~~------~~ 220 (262)
T cd05572 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE--DPMEIYNDILKGNG-K-----LEFPNY------ID 220 (262)
T ss_pred CcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC--CHHHHHHHHhccCC-C-----CCCCcc------cC
Confidence 8999999998888899999999999999999999999975442 22233333221110 0 001100 12
Q ss_pred HHHHHHHHhcCCCCCCCCCC-----HHHHHHHHH
Q 001434 1026 ILVLKVALMCTSISPFDRPS-----MREVVSMLI 1054 (1078)
Q Consensus 1026 ~~l~~li~~cl~~dP~~RPs-----~~ell~~L~ 1054 (1078)
..+.+++.+||+.+|++||+ ++|++++-+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~ 254 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhcChh
Confidence 34788999999999999999 888888544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-31 Score=293.96 Aligned_cols=265 Identities=25% Similarity=0.343 Sum_probs=199.6
Q ss_pred CCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccC---CCCceeeEeeEEEecCc-----
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKI---RHRNIVKLYGFCYHQGS----- 852 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~~~~----- 852 (1078)
|+..+.||+|++|.||+|.++. ++.||+|++............+.+|+.+++++ +|+|++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 4556789999999999999874 89999999976554444445666787776655 69999999999988776
Q ss_pred eEEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
.+++|||+.+ +|.+++.... ..+++..+..++.|+++|++|||+. +++|+||+|+||++++++.++++|||.+..
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~ 156 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI 156 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCccee
Confidence 8999999975 8999887543 3689999999999999999999998 999999999999999999999999999977
Q ss_pred cCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC--CCC---
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH--SLT--- 1006 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~--- 1006 (1078)
.... .......++..|+|||.+.+..++.++||||+|+++|||++|++||......+....+........ ...
T Consensus 157 ~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 157 YSFE--MALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred ccCC--cccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 6422 222334578899999999988899999999999999999999999875433222222221110000 000
Q ss_pred ---CccccCCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 ---PGIFDTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ---~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...+....... .....+....+.+++.+||+.||++||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~ 284 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH 284 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence 00001111111 11122334567899999999999999999999865
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=290.82 Aligned_cols=279 Identities=24% Similarity=0.263 Sum_probs=215.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCch-hHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNN-IESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..|..-++||+|+||.||-++.+ +|+.||.|++.+...... .......|-.++.++..+.||.+--.|+..+..++|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45666778999999999999865 699999998876644222 2445678999999999999999998999999999999
Q ss_pred eeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 858 EYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
..|.||+|.-+|...+ ..+++..++-++.+|+.||++||++ +||+||+||+|||+|+.|+++|+|.|+|..+. .
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~--~ 339 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIP--E 339 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecC--C
Confidence 9999999999887654 3799999999999999999999999 99999999999999999999999999999775 4
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......+||.+|||||++..+.|+...|.||+||++|||+.|+.||....+.....++-+....+. .+++
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~--------~ey~- 410 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP--------EEYS- 410 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch--------hhcc-
Confidence 4445556899999999999999999999999999999999999999986544433323222222211 1111
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHH--HhhcccCCCCCCCCCCCCCCCccC
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSML--IESNEREGRFNSSPTYDLPQIHET 1077 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L--~~~~~~~~~~~~~~~~~~~~~~~~ 1077 (1078)
+. ...+..++....+++||++|. .++++.+|- .++.-+.-....-+|.-+|.++||
T Consensus 411 --~k---FS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aV 473 (591)
T KOG0986|consen 411 --DK---FSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAV 473 (591)
T ss_pred --cc---cCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCcccc
Confidence 11 223345677788899999987 566777653 233222222233445556666654
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-32 Score=323.63 Aligned_cols=253 Identities=26% Similarity=0.415 Sum_probs=193.4
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec-------
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------- 850 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------- 850 (1078)
..+|+..+++|+||||.||+++.+ +|+.||||++.... +......+.+|+..+.++.|||||+++..+.+.
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 346677788999999999999977 89999999998876 556678899999999999999999987422100
Q ss_pred --------------------------------------------------------------------------------
Q 001434 851 -------------------------------------------------------------------------------- 850 (1078)
Q Consensus 851 -------------------------------------------------------------------------------- 850 (1078)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhcc
Q 001434 851 --------------------------------GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898 (1078)
Q Consensus 851 --------------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 898 (1078)
...||-||||+..++.++++++...-.....++++++|+.|++|+|++
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~ 716 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQ 716 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhC
Confidence 012678999998777777776653336788899999999999999999
Q ss_pred CCCceEecCCCCCcEEECCCCceEEeecccccccC-----------------CCCCCcccccccccCcccccccccCC--
Q 001434 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----------------MPQSKSMSAVAGSYGYIAPEYAYTMK-- 959 (1078)
Q Consensus 899 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~-- 959 (1078)
|||||||||.||++|+++.|||+|||+|+... .......+..+||.-|+|||++.+..
T Consensus 717 ---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~ 793 (1351)
T KOG1035|consen 717 ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN 793 (1351)
T ss_pred ---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence 99999999999999999999999999998621 11122345578999999999987654
Q ss_pred -CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCC
Q 001434 960 -VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSI 1038 (1078)
Q Consensus 960 -~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 1038 (1078)
|+.|+|+||+||+++||+. ||....+ ....+.+.. ....+ ..+..+.+.+..=.++|.+|+++
T Consensus 794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsME---Ra~iL~~LR-~g~iP---------~~~~f~~~~~~~e~slI~~Ll~h 857 (1351)
T KOG1035|consen 794 KYNSKIDMYSLGIVLFEMLY---PFGTSME---RASILTNLR-KGSIP---------EPADFFDPEHPEEASLIRWLLSH 857 (1351)
T ss_pred cccchhhhHHHHHHHHHHhc---cCCchHH---HHHHHHhcc-cCCCC---------CCcccccccchHHHHHHHHHhcC
Confidence 9999999999999999985 5653322 233333322 22221 11111222333345789999999
Q ss_pred CCCCCCCHHHHHH
Q 001434 1039 SPFDRPSMREVVS 1051 (1078)
Q Consensus 1039 dP~~RPs~~ell~ 1051 (1078)
||.+||||.|++.
T Consensus 858 dP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 858 DPSKRPTATELLN 870 (1351)
T ss_pred CCccCCCHHHHhh
Confidence 9999999999985
|
|
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=298.43 Aligned_cols=266 Identities=23% Similarity=0.363 Sum_probs=198.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc------
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS------ 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~------ 852 (1078)
.+|+..+.||+|+||.||+|.+. +++.||+|++......+.....+.+|++++++++||||+++++++...+.
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 35777888999999999999976 58899999987654444444566789999999999999999999876543
Q ss_pred --eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 853 --NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 853 --~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
.++||||+.+ ++.+++......+++.++..++.|++.|++|||++ +++|+||||+||+++.++.+||+|||.+.
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 4999999965 89888876655789999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCC---cccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 931 VIDMPQSK---SMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 931 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
........ ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||......... ..+..... ..+
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~-~~~~~~~~--~~~ 244 (310)
T cd07865 168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL-TLISQLCG--SIT 244 (310)
T ss_pred cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhC--CCC
Confidence 65432211 12234578889999987654 3788999999999999999999999754322111 11111111 001
Q ss_pred CccccC----------CCCcchh-hHH------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1007 PGIFDT----------RLNVEDE-SIV------DHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1007 ~~~~~~----------~~~~~~~-~~~------~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
..+++. ..+.... ... .....+.+++.+|++.||++|||+++++++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h 307 (310)
T cd07865 245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH 307 (310)
T ss_pred hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence 000000 0000000 000 011346689999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=252.48 Aligned_cols=263 Identities=24% Similarity=0.366 Sum_probs=206.5
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+.-++||+|.||+||+|+.+ +++.||+|.+.-....+.......+|+-+++.++|.|||++++....++...+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 4555677999999999999954 688999999988877777788899999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
|.. +|.++...-...++.+.+..++.|+++|+.++|++ ++.|||+||.|.+++.+|+.|++|||+++.++-+. .-
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv-rc 157 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RC 157 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce-Ee
Confidence 976 99999988777899999999999999999999999 99999999999999999999999999999876433 33
Q ss_pred ccccccccCcccccccccCC-CCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCC-CCccccC----
Q 001434 940 MSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSL-TPGIFDT---- 1012 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---- 1012 (1078)
++..+-|..|.+|+++.+.. |+...|+||.||++.|+.. |++-|.+.+ ..+..+++++.... ...-++.
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~d----vddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND----VDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCc----HHHHHHHHHHHhCCCccccCCccccC
Confidence 45567799999999998765 8899999999999999998 555564333 33333333332211 1111110
Q ss_pred -C-----CCcchhhHHHHH----HHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1013 -R-----LNVEDESIVDHM----ILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1013 -~-----~~~~~~~~~~~~----~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+ +.+....+.... ..=.+++.+.+.-+|..|.++++.+++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh 283 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH 283 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence 0 001111111111 123567778888899999999998875
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=292.89 Aligned_cols=249 Identities=23% Similarity=0.287 Sum_probs=203.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||++.+. +++.||+|++......+.....+.+|++++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 3566778999999999999865 578999999977655445567788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCC---CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 860 MERGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 860 ~~~gsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
+++++|.+++... ...+++..+..++.|++.|++|||+. +++|+||+|+||++++++.++++|||.+......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 9999999998652 23688899999999999999999998 9999999999999999999999999999876533
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
......+++.|+|||...+..++.++|+||+|+++|++++|+.||...+. ....... ...... .
T Consensus 157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~-~~~~~~---------~ 220 (256)
T cd08530 157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM----QDLRYKV-QRGKYP---------P 220 (256)
T ss_pred --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHH-hcCCCC---------C
Confidence 22334678899999999988899999999999999999999999964432 2222221 111111 0
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
... .....+.+++.+|++.+|++||++.+++++
T Consensus 221 ~~~---~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~ 253 (256)
T cd08530 221 IPP---IYSQDLQNFIRSMLQVKPKLRPNCDKILAS 253 (256)
T ss_pred Cch---hhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence 111 223457889999999999999999999875
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=298.43 Aligned_cols=246 Identities=22% Similarity=0.355 Sum_probs=196.5
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGS 864 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gs 864 (1078)
..||+|+||.||++..+ +++.||+|++..... .....+.+|+.++++++|+|++++++++..++..++||||+++++
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 103 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccch--hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence 46999999999999875 688999998854332 345678899999999999999999999999999999999999999
Q ss_pred HHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccc
Q 001434 865 LGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA 944 (1078)
Q Consensus 865 L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 944 (1078)
|.+++... .+++..+..++.|++.|++|||+. |++||||+|+||+++.++.++++|||.+....... .......
T Consensus 104 L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~~ 177 (292)
T cd06657 104 LTDIVTHT--RMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSLV 177 (292)
T ss_pred HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceeccccc-ccccccc
Confidence 99987643 478899999999999999999998 99999999999999999999999999887654221 2223456
Q ss_pred cccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHH
Q 001434 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024 (1078)
Q Consensus 945 gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1078)
|++.|+|||.+.+..++.++||||+|+++|+|++|..||..... ...........+ ..+.. ....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~----~~~~~~~~~~~~-------~~~~~----~~~~ 242 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAMKMIRDNLP-------PKLKN----LHKV 242 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhhCC-------cccCC----cccC
Confidence 88999999999888899999999999999999999999964322 111111111110 00000 0111
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1025 MILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1025 ~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
...+.+++.+|++.+|.+||++.+++++=+
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~~~ 272 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPF 272 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence 234678899999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=296.55 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=195.6
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
+|...+.||+|+||.||++.+. +++.||+|++...... .....+.+|+.++.++. |+||+++++++..++..+++||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e 83 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME 83 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence 3445567999999999999976 5889999998765433 34567889999999996 9999999999999999999999
Q ss_pred eccCCCHHhHh---cC-CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 859 YMERGSLGELL---HG-SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 859 ~~~~gsL~~~l---~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
|+.. ++.++. .. ....+++..+..++.|++.|++|||+. .+++||||||+||+++.++.++++|||++.....
T Consensus 84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9865 655543 22 234689999999999999999999963 2899999999999999999999999999976542
Q ss_pred CCCCcccccccccCcccccccccC---CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTM---KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
. .......|+..|+|||.+.+. .++.++||||+|+++|||++|+.||.... .............. +
T Consensus 161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~--~---- 229 (288)
T cd06616 161 S--IAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVKGDP--P---- 229 (288)
T ss_pred C--CccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcCCCC--C----
Confidence 2 122334678899999998766 68899999999999999999999996432 11122222211111 0
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.+... ........+.+++.+||+.+|++|||+++++++-+
T Consensus 230 -~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~ 269 (288)
T cd06616 230 -ILSNS--EEREFSPSFVNFINLCLIKDESKRPKYKELLEHPF 269 (288)
T ss_pred -cCCCc--CCCccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence 11110 00123345789999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=294.35 Aligned_cols=253 Identities=25% Similarity=0.287 Sum_probs=200.8
Q ss_pred CCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCC--CchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNRE--GNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 854 (1078)
|+..+.||+|+||.||.|.+. +|+.||+|++..... .....+.+.+|+++++++ +|++|++++++++.+...+
T Consensus 2 y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~ 81 (290)
T cd05613 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLH 81 (290)
T ss_pred ceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEE
Confidence 566778999999999999863 688999999875432 122346678899999999 5999999999999999999
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+++++|.+++.... .+++..+..++.|++.|++|||+. +++||||+|+||+++.++.++|+|||++.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 157 (290)
T cd05613 82 LILDYINGGELFTHLSQRE-RFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHE 157 (290)
T ss_pred EEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence 9999999999999987654 588889999999999999999998 999999999999999999999999999986643
Q ss_pred CCCCcccccccccCcccccccccC--CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
..........|+..|+|||.+.+. .++.++||||+|+++|+|++|+.||...........+........... +.
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~ 233 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY----PQ 233 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC----Cc
Confidence 333333345688999999988753 467899999999999999999999975433334344433332221111 11
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHH
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSM 1052 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~ 1052 (1078)
.....+.+++.+|++.+|++|| ++.+++.+
T Consensus 234 ----------~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~ 268 (290)
T cd05613 234 ----------EMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH 268 (290)
T ss_pred ----------cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence 1123467899999999999997 78888776
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-31 Score=300.22 Aligned_cols=267 Identities=22% Similarity=0.306 Sum_probs=196.5
Q ss_pred CCCccEEeccCceEEEEEEECC---CcEEEEEEecccC-CCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--CceEE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDS---GKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSNLL 855 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~---~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~~l 855 (1078)
|+..+.||+|++|.||+|.++. ++.||+|.+.... ......+.+.+|+.++++++||||+++++++.+. +..++
T Consensus 2 y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 81 (316)
T cd07842 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYL 81 (316)
T ss_pred ceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEE
Confidence 5667789999999999999754 7899999998743 2223346678899999999999999999999888 78999
Q ss_pred EEeeccCCCHHhHhcCC----CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC----CCceEEeecc
Q 001434 856 IYEYMERGSLGELLHGS----SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD----KFEAHVGDFG 927 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~Dfg 927 (1078)
||||+++ ++.+++... ...+++..+..++.|++.|++|||++ +++||||||+||+++. ++.+|++|||
T Consensus 82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg 157 (316)
T cd07842 82 LFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLG 157 (316)
T ss_pred EEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCc
Confidence 9999975 777766422 12578899999999999999999998 9999999999999999 8999999999
Q ss_pred cccccCCCCC--CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCH-----HHHHHHH
Q 001434 928 LAKVIDMPQS--KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL-----ATWVRNY 999 (1078)
Q Consensus 928 ~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~-----~~~~~~~ 999 (1078)
++........ .......+++.|+|||.+.+. .++.++||||+|+++|+|++|++||......... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (316)
T cd07842 158 LARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERI 237 (316)
T ss_pred cccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHH
Confidence 9986543222 122345678899999987664 5789999999999999999999999765433200 0000000
Q ss_pred hhcCC--------------CCC----ccccCCCC-cchhhHH----HHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1000 IRDHS--------------LTP----GIFDTRLN-VEDESIV----DHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1000 ~~~~~--------------~~~----~~~~~~~~-~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
..... ... .......+ ....... .....+.+++.+|++.||++|||+.|++++
T Consensus 238 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~ 313 (316)
T cd07842 238 FEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH 313 (316)
T ss_pred HHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 00000 000 00000011 0000111 123457899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-31 Score=294.82 Aligned_cols=257 Identities=23% Similarity=0.246 Sum_probs=201.5
Q ss_pred CCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCC--CchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceE
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNRE--GNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~--~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~ 854 (1078)
|+..+.||+|++|.||+|.+. +++.||||+++.... .....+.+.+|++++.++ +||+|+++++.+..++..+
T Consensus 2 ~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~ 81 (288)
T cd05583 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLH 81 (288)
T ss_pred ceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEE
Confidence 566778999999999999853 468899999875432 122345678999999999 5999999999999999999
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+++++|.+++.... .+++..+..++.|+++||+|||+. +++||||+|+||+++.++.++++|||++.....
T Consensus 82 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 157 (288)
T cd05583 82 LILDYVNGGELFTHLYQRE-HFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEecCCCCcHHHHHhhcC-CcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence 9999999999999987554 688899999999999999999998 999999999999999999999999999876543
Q ss_pred CCCCcccccccccCcccccccccCC--CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMK--VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
..........|+..|+|||...+.. ++.++||||+|+++|||++|..||.......................
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~------ 231 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF------ 231 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC------
Confidence 3222223356889999999987665 78899999999999999999999964433323333333332221111
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+. .....+.+++.+||+.+|++|||+.++.+.+...
T Consensus 232 --~~------~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~ 267 (288)
T cd05583 232 --PK------TMSAEARDFIQKLLEKDPKKRLGANGADEIKNHP 267 (288)
T ss_pred --Cc------ccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCc
Confidence 10 1123467899999999999999988777666544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-33 Score=323.82 Aligned_cols=281 Identities=22% Similarity=0.221 Sum_probs=219.2
Q ss_pred hHHHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecC
Q 001434 774 DVVEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG 851 (1078)
Q Consensus 774 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 851 (1078)
++.....+|...++||+|+||.|..++++ +++.||.|++.+.... ......|..|-++|..-..+=|+.++-.|+++.
T Consensus 69 ~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~ 148 (1317)
T KOG0612|consen 69 ELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDER 148 (1317)
T ss_pred HHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCcc
Confidence 33445678999999999999999999976 5888999999774322 223467889999999889999999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
+.|+|||||+||+|-.++.+.+ .+++..+..++..|+-||+-+|+. |+|||||||+|||+|..|++|++|||.+..
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClk 224 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLK 224 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHh
Confidence 9999999999999999999887 799999999999999999999999 999999999999999999999999999988
Q ss_pred cCCCCCCcccccccccCcccccccc----c-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAY----T-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
++.+........+|||.|++||++. + +.|++.+|.||+||++|||+.|..||.... +.....++.....
T Consensus 225 m~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~hk~-- 298 (1317)
T KOG0612|consen 225 MDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNHKE-- 298 (1317)
T ss_pred cCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhchhh--
Confidence 8766666667789999999999886 2 679999999999999999999999997433 3333333322210
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC---HHHHHHHHHhhcccCCCCCCCCCCCCCC
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS---MREVVSMLIESNEREGRFNSSPTYDLPQ 1073 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs---~~ell~~L~~~~~~~~~~~~~~~~~~~~ 1073 (1078)
.+...+ ..+......++|.+.+. +|+.|-. ++++..|..=....|..-....+..+|.
T Consensus 299 ------~l~FP~--~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 299 ------SLSFPD--ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred ------hcCCCc--ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 111110 01122334456655554 8888887 9999988765544554444444444443
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=289.18 Aligned_cols=250 Identities=28% Similarity=0.435 Sum_probs=204.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+|+..+.||+|++|.||+|.+. +++.|++|.+......+...+.+.+|++++++++|++++++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 3566788999999999999876 578999999987765445567899999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++++|.+++.... .+++..+..++.|++.|+.|+|+. |++||||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-~ 155 (254)
T cd06627 81 AENGSLRQIIKKFG-PFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK-D 155 (254)
T ss_pred CCCCcHHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcc-c
Confidence 99999999987664 689999999999999999999998 999999999999999999999999999987653222 2
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.....++..|+|||...+..++.++||||+|+++|+|++|+.||..... ..... ...... . ..++.
T Consensus 156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~---~~~~~-~~~~~~--~-----~~~~~--- 221 (254)
T cd06627 156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP---MAALF-RIVQDD--H-----PPLPE--- 221 (254)
T ss_pred ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH---HHHHH-HHhccC--C-----CCCCC---
Confidence 2345688999999998888889999999999999999999999974431 11111 111100 0 01110
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.....+.+++.+|++.+|++|||+.+++.+
T Consensus 222 ---~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~ 251 (254)
T cd06627 222 ---GISPELKDFLMQCFQKDPNLRPTAKQLLKH 251 (254)
T ss_pred ---CCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence 112346789999999999999999999854
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=284.00 Aligned_cols=265 Identities=27% Similarity=0.355 Sum_probs=207.9
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHcc--CCCCceeeEeeEEEecC----ce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGK--IRHRNIVKLYGFCYHQG----SN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~--l~h~~iv~l~~~~~~~~----~~ 853 (1078)
.++...+.||+|.||.||+|.|+ |+.||||++.... ++.+.+|.++.+. ++|+||..+++.-..+. +.
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred heeEEEEEecCccccceeecccc-CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 35566778999999999999999 8999999996553 3456677777665 49999999998765543 56
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhc-----cCCCceEecCCCCCcEEECCCCceEEeeccc
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-----DCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-----~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 928 (1078)
++|++|.+.|||+||+.+. .++.+...+++..+|.||+|||. +.++.|+|||||..||||..++.+.|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r~--tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN--TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhhc--cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 8999999999999999984 59999999999999999999995 3578999999999999999999999999999
Q ss_pred ccccCCCC---CCcccccccccCcccccccccCC----C--CCcCcchhHHHHHHHHHhC----------CCCCCCCCCC
Q 001434 929 AKVIDMPQ---SKSMSAVAGSYGYIAPEYAYTMK----V--TEKCDIYSYGVVLLELLTG----------RTPVQPLDDG 989 (1078)
Q Consensus 929 a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DvwslGv~l~elltg----------~~P~~~~~~~ 989 (1078)
|...+... .......+||.+|||||++...- + -..+||||||.++||+.-. +.||.+..+.
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 98765332 22344578999999999886431 2 2468999999999999762 4788877655
Q ss_pred CCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 990 GDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 990 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
+...+.+++..-..+..+. ++..+.. .+.+..+.++++.||..+|..|-|+-.+.+.+.++..
T Consensus 443 DPs~eeMrkVVCv~~~RP~-----ipnrW~s-~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~ 505 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPN-----IPNRWKS-DPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN 505 (513)
T ss_pred CCCHHHHhcceeecccCCC-----CCccccc-CHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence 5444444444433333322 2222221 3567778999999999999999999999999998863
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=300.56 Aligned_cols=268 Identities=24% Similarity=0.341 Sum_probs=202.1
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec-----Cce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ-----GSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~~ 853 (1078)
.+|...+.||+|+||+||+|.+. +++.||||++............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 46777889999999999999975 589999999876543334456678899999999999999999987654 347
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++||||+. ++|.+++...+ .+++..+..++.|++.|+.|||++ +++||||||+||+++.++.+||+|||++....
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 159 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQ-TLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTS 159 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence 99999996 58999887654 689999999999999999999998 99999999999999999999999999998664
Q ss_pred CCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH----------------
Q 001434 934 MPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV---------------- 996 (1078)
Q Consensus 934 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~---------------- 996 (1078)
... .......++..|+|||.+.. ..++.++||||+|+++|+|++|+.||...+.........
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 321 22334567889999998764 468899999999999999999999996432111111000
Q ss_pred ---HHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhhccc
Q 001434 997 ---RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM--LIESNER 1059 (1078)
Q Consensus 997 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~~~~ 1059 (1078)
..+........ +... ..........+.+++.+|++.+|++|||+++++++ +......
T Consensus 239 ~~~~~~~~~~~~~~---~~~~---~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 239 EKARRYIRSLPYTP---RQSF---ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300 (337)
T ss_pred hhhhHHHHhcCccc---ccCH---HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence 00000000000 0000 00111234557899999999999999999999998 5554333
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=299.21 Aligned_cols=279 Identities=23% Similarity=0.302 Sum_probs=211.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----ceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-----SNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~~~ 854 (1078)
+|+..+.||+|++|.||+|.+. +++.||+|++..........+.+.+|+.++++++|+||+++++++...+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4667788999999999999976 4899999999776543445678899999999999999999999988775 789
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+++ +|.+++.... .+++..+..++.|++.|++|||++ |++||||||+||+++.++.++++|||.+.....
T Consensus 81 lv~e~~~~-~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~ 155 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQ-PLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155 (330)
T ss_pred EEecchhh-hHHHHHhCCC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence 99999975 8999987655 789999999999999999999998 999999999999999999999999999987653
Q ss_pred CCC--CcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCC-CCccc
Q 001434 935 PQS--KSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL-TPGIF 1010 (1078)
Q Consensus 935 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 1010 (1078)
... .......++..|+|||.+.+. .++.++||||+|+++|+|++|..||...... ............ ....+
T Consensus 156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~----~~~~~i~~~~~~~~~~~~ 231 (330)
T cd07834 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI----DQLNLIVEVLGTPSEEDL 231 (330)
T ss_pred cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH----HHHHHHHHhcCCCChhHh
Confidence 321 223345678899999999887 7899999999999999999999999754322 111111111100 00000
Q ss_pred c---------------CCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhhcccCCCCCCCCC
Q 001434 1011 D---------------TRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM--LIESNEREGRFNSSPT 1068 (1078)
Q Consensus 1011 ~---------------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~~~~~~~~~~~~~ 1068 (1078)
. ...... .+........+.+++.+||+.+|++||++++++++ ++..........+..+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~~ 307 (330)
T cd07834 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPP 307 (330)
T ss_pred hhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcccccCCCCCCc
Confidence 0 000000 00001123457899999999999999999999996 5565554444433333
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=299.70 Aligned_cols=268 Identities=27% Similarity=0.343 Sum_probs=198.6
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-------
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG------- 851 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------- 851 (1078)
.+|+..+.||+|+||.||+|.++ +++.||+|++............+.+|++++++++||||+++++++.+..
T Consensus 8 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 87 (311)
T cd07866 8 RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKR 87 (311)
T ss_pred ccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccC
Confidence 56788889999999999999976 5889999998765443333456788999999999999999999875433
Q ss_pred -ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 852 -SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 852 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
..++||||+.+ ++...+......+++.++..++.|+++||+|||++ +++||||||+||++++++.++++|||++.
T Consensus 88 ~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 88 GSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred ceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccch
Confidence 45899999975 78888776666799999999999999999999998 99999999999999999999999999997
Q ss_pred ccCCCCCC----------cccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHH
Q 001434 931 VIDMPQSK----------SMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNY 999 (1078)
Q Consensus 931 ~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~ 999 (1078)
........ ......+++.|+|||.+.+. .++.++||||+|+++|||++|++||...........+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~- 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL- 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH-
Confidence 65422211 11234568889999987654 5789999999999999999999999643322211111110
Q ss_pred hhcC-----------CC-CCccccCCCCcch-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1000 IRDH-----------SL-TPGIFDTRLNVED-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1000 ~~~~-----------~~-~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.... .. .........+... +........+.+++.+|++.+|++|||+.+++.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~ 308 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH 308 (311)
T ss_pred hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence 0000 00 0000001111110 1111222457899999999999999999999865
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=300.46 Aligned_cols=269 Identities=23% Similarity=0.327 Sum_probs=198.3
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----c
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG-----S 852 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~-----~ 852 (1078)
..+|...+.||+|+||.||+|.+. +++.||+|++..... ......+.+|+.++++++|+||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 356788889999999999999975 689999999864322 234567788999999999999999999876543 4
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
.++||||+++ ++.+++... .+++..+..++.|++.||+|||+. +|+||||||+||+++.++.++|+|||++...
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~--~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 156 (336)
T cd07849 83 VYIVQELMET-DLYKLIKTQ--HLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIA 156 (336)
T ss_pred EEEEehhccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeec
Confidence 7999999975 888887654 489999999999999999999998 9999999999999999999999999998765
Q ss_pred CCCCC--CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC--
Q 001434 933 DMPQS--KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP-- 1007 (1078)
Q Consensus 933 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~-- 1007 (1078)
..... .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...+.......+ ....... ...
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~-~~~~~~~-~~~~~ 234 (336)
T cd07849 157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI-LGVLGTP-SQEDL 234 (336)
T ss_pred cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HHHcCCC-CHHHH
Confidence 42221 11233568899999998654 46889999999999999999999999643311111111 0000000 000
Q ss_pred ------------ccccCCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhh
Q 001434 1008 ------------GIFDTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSM--LIES 1056 (1078)
Q Consensus 1008 ------------~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~ 1056 (1078)
...+...... ..........+.+++.+||+.+|++|||+.+++++ ++..
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~ 298 (336)
T cd07849 235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298 (336)
T ss_pred HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence 0000000000 00011223457899999999999999999999998 4444
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-31 Score=300.57 Aligned_cols=268 Identities=23% Similarity=0.310 Sum_probs=200.2
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC------c
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG------S 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------~ 852 (1078)
.+|...+.||+|+||.||+|.+. +++.||+|++......+.....+.+|++++++++||||+++++++.... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 57777889999999999999975 5899999999765444444567889999999999999999999987543 4
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
.++|+||+.. ++.+++. ..+++..+..++.|++.|++|||++ +++||||||+||+++.++.++++|||+++..
T Consensus 95 ~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~ 167 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG---HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHA 167 (342)
T ss_pred EEEEeccccc-CHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence 5899999965 7777653 2578899999999999999999998 9999999999999999999999999998764
Q ss_pred CCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccc-
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF- 1010 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1010 (1078)
.. ......++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.+.... ..........+.+...+
T Consensus 168 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~~~ 239 (342)
T cd07879 168 DA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL----DQLTQILKVTGVPGPEFV 239 (342)
T ss_pred CC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCHHHH
Confidence 32 2234467889999998876 45889999999999999999999999753321 11111111100000000
Q ss_pred --------------cCCCCcc-h-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH--HHhhcccCCC
Q 001434 1011 --------------DTRLNVE-D-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM--LIESNEREGR 1062 (1078)
Q Consensus 1011 --------------~~~~~~~-~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~--L~~~~~~~~~ 1062 (1078)
.+..+.. . .........+.+++.+|++.||++||++++++.+ +++.......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~~~~ 309 (342)
T cd07879 240 QKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEE 309 (342)
T ss_pred HHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccccccc
Confidence 0000000 0 0001123447799999999999999999999976 7776554333
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=295.62 Aligned_cols=259 Identities=23% Similarity=0.294 Sum_probs=195.1
Q ss_pred EEecc--CceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 787 IVGSG--AYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 787 ~lG~G--~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
.||+| +||+||.|.+. +++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++||||+.++
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 36666 99999999975 6899999999766544445678899999999999999999999999999999999999999
Q ss_pred CHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc---
Q 001434 864 SLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--- 939 (1078)
Q Consensus 864 sL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--- 939 (1078)
++.+++.... ..+++..+..++.|++.||+|||+. +++||||||+||+++.++.++++||+.+..........
T Consensus 85 ~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (328)
T cd08226 85 SANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVV 161 (328)
T ss_pred CHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccc
Confidence 9999987542 3588899999999999999999998 99999999999999999999999998654322111100
Q ss_pred ---ccccccccCcccccccccC--CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC-------
Q 001434 940 ---MSAVAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP------- 1007 (1078)
Q Consensus 940 ---~~~~~gt~~y~aPE~~~~~--~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~------- 1007 (1078)
.....++..|+|||.+.+. .++.++||||+|+++|||++|+.||.......... .........+
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~----~~~~~~~~~~~~~~~~~ 237 (328)
T cd08226 162 YDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL----QKLKGPPYSPLDITTFP 237 (328)
T ss_pred ccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH----HHhcCCCCCCccccccc
Confidence 0112345679999998764 47899999999999999999999997543221111 1111100000
Q ss_pred ----------------------------ccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1008 ----------------------------GIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1008 ----------------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
....... ...........+.+++.+||+.||++|||++|++++-+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~ 310 (328)
T cd08226 238 CEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERL--RTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAF 310 (328)
T ss_pred hhhhhhccchhhhhcccccchhccccccccccccc--cchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHH
Confidence 0000000 01111234456889999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7e-31 Score=288.33 Aligned_cols=252 Identities=25% Similarity=0.353 Sum_probs=197.8
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccC---CCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--Cce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNR---EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ--GSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~--~~~ 853 (1078)
.+|+..+.||+|++|.||+|.+. +++.||+|++.... ........+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 36777889999999999999975 58899999875432 1233456788999999999999999999998764 457
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
++||||+++++|.+++.... .+++..+..++.|++.|+.|||+. +++|+||||+||+++.++.++++|||.++...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 157 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-ALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQ 157 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence 89999999999999987654 478889999999999999999998 99999999999999999999999999998653
Q ss_pred CCC--CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcccc
Q 001434 934 MPQ--SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 934 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
... ........++..|+|||.+.+..++.++||||+|+++|++++|+.||..... ... +...... +..
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~---~~~-~~~~~~~-~~~----- 227 (264)
T cd06653 158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA---MAA-IFKIATQ-PTK----- 227 (264)
T ss_pred cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH---HHH-HHHHHcC-CCC-----
Confidence 211 1122345688999999999888899999999999999999999999964321 121 2222111 111
Q ss_pred CCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
+.++ ......+.+++.+|+. +|..||++.+++.+
T Consensus 228 ~~~p------~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~ 261 (264)
T cd06653 228 PMLP------DGVSDACRDFLKQIFV-EEKRRPTAEFLLRH 261 (264)
T ss_pred CCCC------cccCHHHHHHHHHHhc-CcccCccHHHHhcC
Confidence 1111 1122447789999999 57999999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.8e-31 Score=292.01 Aligned_cols=258 Identities=19% Similarity=0.259 Sum_probs=184.8
Q ss_pred hcCCCccEEeccCceEEEEEEECC----CcEEEEEEecccCCCchh---------HHHHHHHHHHHccCCCCceeeEeeE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNI---------ESSFRAEILTLGKIRHRNIVKLYGF 846 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~----~~~vavK~~~~~~~~~~~---------~~~~~~e~~~l~~l~h~~iv~l~~~ 846 (1078)
.+|...+.||+|+||+||+|.+.+ +..+|+|+.......... ......+...+..++|+++++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 467778899999999999999764 345566654322211100 0112334455667789999999987
Q ss_pred EEecC----ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceE
Q 001434 847 CYHQG----SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 922 (1078)
Q Consensus 847 ~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 922 (1078)
+.... ..++++|++.. ++.+.+.... ..++..+..++.|++.|++|+|++ +|+||||||+||+++.++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-CKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhhc-cCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCcEE
Confidence 76543 33678887744 6776665433 356788899999999999999998 999999999999999999999
Q ss_pred EeecccccccCCCCC------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH
Q 001434 923 VGDFGLAKVIDMPQS------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV 996 (1078)
Q Consensus 923 l~Dfg~a~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~ 996 (1078)
|+|||+|+....... .......||+.|+|||...+..++.++||||+||++|||++|+.||.............
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~ 246 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA 246 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence 999999986532111 11223469999999999999999999999999999999999999998664333222211
Q ss_pred H-HHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 997 R-NYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 997 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
. .+..... .... ..+ .....+.+++..|+..+|++||+++++++.+
T Consensus 247 ~~~~~~~~~-~~~~---~~~-------~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 247 KCDFIKRLH-EGKI---KIK-------NANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred HHHHHHHhh-hhhh---ccC-------CCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 1111100 0000 011 1134577899999999999999999999876
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=287.82 Aligned_cols=246 Identities=23% Similarity=0.235 Sum_probs=189.3
Q ss_pred EEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHH---HHHHccCCCCceeeEeeEEEecCceEEEEeecc
Q 001434 787 IVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAE---ILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e---~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~ 861 (1078)
+||+|+||.||+|.+. +++.||+|.+....... .....+..| ...++...||+|+++++++.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999875 58899999987653321 112223333 334555689999999999999999999999999
Q ss_pred CCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccc
Q 001434 862 RGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941 (1078)
Q Consensus 862 ~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 941 (1078)
|++|.+++.... .+++.++..++.|++.|++|||+. +++||||||+||+++.++.++++|||.+...... ...
T Consensus 81 g~~L~~~l~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~ 153 (278)
T cd05606 81 GGDLHYHLSQHG-VFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPH 153 (278)
T ss_pred CCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCc
Confidence 999999887554 689999999999999999999998 9999999999999999999999999998755322 122
Q ss_pred ccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 942 AVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 942 ~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
...|+..|+|||.+.++ .++.++||||+|+++|||++|+.||........ .......... ...++..
T Consensus 154 ~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~--------~~~~~~~--- 221 (278)
T cd05606 154 ASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTM--------AVELPDS--- 221 (278)
T ss_pred CcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch-HHHHHHhhcc--------CCCCCCc---
Confidence 34689999999998754 688999999999999999999999975432221 1111111110 1111111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCC-----CHHHHHHHHH
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RP-----s~~ell~~L~ 1054 (1078)
....+.+++.+|+..+|.+|| ++.+++++-+
T Consensus 222 ---~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~ 257 (278)
T cd05606 222 ---FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPF 257 (278)
T ss_pred ---CCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcc
Confidence 123477899999999999999 9999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=285.49 Aligned_cols=243 Identities=22% Similarity=0.256 Sum_probs=187.4
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHH-HccCCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILT-LGKIRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||.||+|.+. +++.||+|++.+.... ......+..|... ....+|+|++++++++..++..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 45899999999999975 5889999998654321 1222334445444 4455899999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
++|.+++.... .+++..+..++.|++.||.|+|+. +++||||+|+||++++++.++++|||.+..... ...
T Consensus 82 ~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~ 152 (260)
T cd05611 82 GDCASLIKTLG-GLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKK 152 (260)
T ss_pred CCHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----ccc
Confidence 99999997654 688999999999999999999998 999999999999999999999999999875432 233
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..++..|+|||...+..++.++||||+|+++|+|++|..||..... .............. ..... .
T Consensus 153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~----~~~~~------~ 218 (260)
T cd05611 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP----DAVFDNILSRRINW----PEEVK------E 218 (260)
T ss_pred CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhcccCC----CCccc------c
Confidence 4688899999999888889999999999999999999999964332 22222211111000 00010 0
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSMREVVS 1051 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~~ell~ 1051 (1078)
.....+.+++.+||+.+|++||++.++.+
T Consensus 219 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~ 247 (260)
T cd05611 219 FCSPEAVDLINRLLCMDPAKRLGANGYQE 247 (260)
T ss_pred cCCHHHHHHHHHHccCCHHHccCCCcHHH
Confidence 12344788999999999999997654433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=295.97 Aligned_cols=261 Identities=20% Similarity=0.219 Sum_probs=192.0
Q ss_pred CceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHHhHhc
Q 001434 792 AYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLH 870 (1078)
Q Consensus 792 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 870 (1078)
++|.||.++.. +++.||+|++..........+.+.+|++++++++|+||+++++++.+++..+++|||+++++|.+++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44455555533 58999999997764444556789999999999999999999999999999999999999999999997
Q ss_pred CC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC------Cccccc
Q 001434 871 GS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS------KSMSAV 943 (1078)
Q Consensus 871 ~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~------~~~~~~ 943 (1078)
.. ...+++..+..++.|+++||+|||++ +|+||||||+||+++.++.++++|||.+........ ......
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~ 168 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSS 168 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccc
Confidence 54 33688899999999999999999998 999999999999999999999999998865532111 112234
Q ss_pred ccccCccccccccc--CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhh----cCCCCC---c------
Q 001434 944 AGSYGYIAPEYAYT--MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR----DHSLTP---G------ 1008 (1078)
Q Consensus 944 ~gt~~y~aPE~~~~--~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~----~~~~~~---~------ 1008 (1078)
.++..|+|||.+.+ ..++.++||||+|+++|||++|+.||.................. ....+. .
T Consensus 169 ~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (314)
T cd08216 169 VKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRS 248 (314)
T ss_pred cccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccc
Confidence 56778999998865 35889999999999999999999999754432211111110000 000000 0
Q ss_pred -cccCC--CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1009 -IFDTR--LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1009 -~~~~~--~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..... ..............+.+++.+||+.||++|||+++++++-+-
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~ 298 (314)
T cd08216 249 SNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF 298 (314)
T ss_pred cccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence 00000 000011112233567889999999999999999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=296.88 Aligned_cols=262 Identities=26% Similarity=0.361 Sum_probs=198.0
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecC-----
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG----- 851 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----- 851 (1078)
...+|+..+.||+|+||.||+|.+. +++.||||++..........+.+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3456888889999999999999865 6899999998765443344567889999999999999999999887654
Q ss_pred -ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 852 -SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 852 -~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
..++||||+ +++|.+++... .+++..+..++.|++.|++|||+. +|+||||||+||+++.++.++++|||.+.
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~ 166 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKHE--KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLAR 166 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeccccc
Confidence 358999999 67999888653 588999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
.... ......+++.|+|||.+.+ ..++.++|+||+|+++|++++|+.||...... ................
T Consensus 167 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~~~~ 238 (343)
T cd07880 167 QTDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHL----DQLMEIMKVTGTPSKE 238 (343)
T ss_pred cccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHHhcCCCCHH
Confidence 6542 2233467889999998876 45889999999999999999999999754321 1111111111000000
Q ss_pred ccCCCCc-------------chhh----HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1010 FDTRLNV-------------EDES----IVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1010 ~~~~~~~-------------~~~~----~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
+...+.. .... .......+.+++.+|++.||++|||+.+++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~ 299 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHP 299 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCc
Confidence 0000000 0000 011223477999999999999999999999543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=284.82 Aligned_cols=250 Identities=23% Similarity=0.291 Sum_probs=191.9
Q ss_pred hHhHHHHhhcCCCccEE--eccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHcc-CCCCceeeEeeEE
Q 001434 772 FQDVVEATYNFHDSFIV--GSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGK-IRHRNIVKLYGFC 847 (1078)
Q Consensus 772 ~~~~~~~~~~~~~~~~l--G~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~ 847 (1078)
..+......+|+..+.+ |+|+||.||++..+ +++.+|+|.+........ |+..... .+||||+++++++
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~ 78 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSV 78 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEE
Confidence 34444444555555555 99999999999965 588899999865432211 1111111 2799999999999
Q ss_pred EecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-ceEEeec
Q 001434 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDF 926 (1078)
Q Consensus 848 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Df 926 (1078)
..++..++||||+++++|.+++.... .+++.++..++.|+++|+.|+|+. +++||||||+||+++.++ .++++||
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 79 TTLKGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred ecCCeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence 99999999999999999999998765 789999999999999999999998 999999999999999988 9999999
Q ss_pred ccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC-CHHHHHHHHhhcCCC
Q 001434 927 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG-DLATWVRNYIRDHSL 1005 (1078)
Q Consensus 927 g~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~ 1005 (1078)
|.+...... ....++..|+|||.+.+..++.++||||+|+++|||++|+.||....... ....+.... . ..
T Consensus 155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~-~~- 226 (267)
T PHA03390 155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-Q-KK- 226 (267)
T ss_pred ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-c-cc-
Confidence 998765422 23468899999999998899999999999999999999999997443322 122222221 1 00
Q ss_pred CCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCC-HHHHHHH
Q 001434 1006 TPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPS-MREVVSM 1052 (1078)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-~~ell~~ 1052 (1078)
. ... ......+.+++.+|++.+|.+||+ +++++++
T Consensus 227 ~-----~~~-------~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h 262 (267)
T PHA03390 227 L-----PFI-------KNVSKNANDFVQSMLKYNINYRLTNYNEIIKH 262 (267)
T ss_pred C-----Ccc-------cccCHHHHHHHHHHhccChhhCCchHHHHhcC
Confidence 0 000 012234778999999999999995 6998865
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-31 Score=298.94 Aligned_cols=270 Identities=25% Similarity=0.343 Sum_probs=201.7
Q ss_pred hHHHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe-cC
Q 001434 774 DVVEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH-QG 851 (1078)
Q Consensus 774 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~ 851 (1078)
++.....+|+..+.||+|+||.||+|.+. +++.||+|++..........+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 44556778888999999999999999966 68999999987654444445678899999999999999999998865 55
Q ss_pred ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
..++||||+ +++|.+++... .+++..+..++.|+++|++|||+. +++||||+|+||++++++.++++|||.+..
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~~--~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTSR--PLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred cEEEEeehh-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccc
Confidence 789999999 55999888754 477888889999999999999998 999999999999999999999999999875
Q ss_pred cCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH-----------HHH
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV-----------RNY 999 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~-----------~~~ 999 (1078)
... ......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...........+. ...
T Consensus 158 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (328)
T cd07856 158 QDP----QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI 233 (328)
T ss_pred cCC----CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 432 2233457889999998765 568899999999999999999999996433211111110 000
Q ss_pred hhcCC--CCCccccCCCCcc-hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1000 IRDHS--LTPGIFDTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1000 ~~~~~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..... ..... ....... .+........+.+++.+|++.+|++||++++++.+-+
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~ 290 (328)
T cd07856 234 CSENTLRFVQSL-PKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290 (328)
T ss_pred cchhhHHHHhhc-cccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCc
Confidence 00000 00000 0000000 0111112356789999999999999999999988743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-31 Score=283.38 Aligned_cols=262 Identities=25% Similarity=0.380 Sum_probs=197.1
Q ss_pred ccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHc--cCCCCceeeEeeEEEecC----ceEEEEe
Q 001434 785 SFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLG--KIRHRNIVKLYGFCYHQG----SNLLIYE 858 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~--~l~h~~iv~l~~~~~~~~----~~~lv~e 858 (1078)
.++||+|.||.||+|... ++.||||++... ..+.|..|-++.+ .++|+||++++++-...+ .+++|+|
T Consensus 215 ~eli~~Grfg~V~KaqL~-~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~ 288 (534)
T KOG3653|consen 215 LELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTE 288 (534)
T ss_pred HHHhhcCccceeehhhcc-CceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEee
Confidence 456999999999999987 689999999544 2455666655544 568999999998876655 7899999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhcc------CCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
|.+.|+|.+|+..+. ++|....+++..+++||+|||+. ++++|+|||||.+|||+..+++..|+|||+|.++
T Consensus 289 fh~kGsL~dyL~~nt--isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 289 FHPKGSLCDYLKANT--ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred eccCCcHHHHHHhcc--ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 999999999998775 99999999999999999999964 3678999999999999999999999999999887
Q ss_pred CCCC-CCcccccccccCcccccccccCC-CC-----CcCcchhHHHHHHHHHhCCCCC------------CCC-CCCCCH
Q 001434 933 DMPQ-SKSMSAVAGSYGYIAPEYAYTMK-VT-----EKCDIYSYGVVLLELLTGRTPV------------QPL-DDGGDL 992 (1078)
Q Consensus 933 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DvwslGv~l~elltg~~P~------------~~~-~~~~~~ 992 (1078)
.... .......+||.+|||||++.+.. +. .+.||||+|.++|||++.-..+ +.. .....+
T Consensus 367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~ 446 (534)
T KOG3653|consen 367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL 446 (534)
T ss_pred cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence 5322 22333478999999999987542 21 4689999999999999854322 211 111222
Q ss_pred HHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCC
Q 001434 993 ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 993 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1061 (1078)
.+. +...-..+. .+.++..+... ..+..+.+.+..||+.||+.|.|+.=+-+.++++.....
T Consensus 447 e~m-q~~VV~kK~-----RP~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~ 508 (534)
T KOG3653|consen 447 EEM-QELVVRKKQ-----RPKIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE 508 (534)
T ss_pred HHH-HHHHHhhcc-----CCCChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence 222 222221221 22222222222 345668899999999999999999999999988855443
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-31 Score=294.34 Aligned_cols=251 Identities=27% Similarity=0.400 Sum_probs=197.8
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|+..+.||+|++|.||+|++. +++.||+|.+..... ......++.+|+++++.++|+|++++++++..+...++||||
T Consensus 17 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 96 (308)
T cd06634 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96 (308)
T ss_pred HHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEc
Confidence 445567999999999999976 578899999865322 223346788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+. |++.+.+......+++.++..++.|++.|+.|||+. +++||||+|+||+++.++.++++|||.+......
T Consensus 97 ~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---- 168 (308)
T cd06634 97 CL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---- 168 (308)
T ss_pred cC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecCc----
Confidence 97 588887765555689999999999999999999998 9999999999999999999999999998765321
Q ss_pred ccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
....+++.|+|||.+. ...++.++||||+|+++|+|++|..||...... ........... + ...
T Consensus 169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~~~-~------~~~- 235 (308)
T cd06634 169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNES-P------ALQ- 235 (308)
T ss_pred -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----HHHHHHhhcCC-C------CcC-
Confidence 2345788999999874 356788999999999999999999998643221 11111111110 0 000
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
. ......+.+++.+||+.+|++||++++++++.+...
T Consensus 236 -~---~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~ 272 (308)
T cd06634 236 -S---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR 272 (308)
T ss_pred -c---ccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence 0 012344678999999999999999999999876554
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=292.57 Aligned_cols=248 Identities=27% Similarity=0.408 Sum_probs=196.2
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|...+.||+|+||+||+|.+. +++.|++|++..... .....+.+.+|++++++++|||++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 444566999999999999975 588999999865433 223346788999999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+. +++.+++......+++.++..++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+.... .
T Consensus 103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~ 173 (313)
T cd06633 103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P 173 (313)
T ss_pred CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence 96 488888876655789999999999999999999998 99999999999999999999999999886432 1
Q ss_pred ccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 940 MSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.....|+..|+|||.+. +..++.++||||+|+++|||++|..||...... ........... +.....
T Consensus 174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~~~~--~~~~~~---- 243 (313)
T cd06633 174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQNDS--PTLQSN---- 243 (313)
T ss_pred CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHhcCC--CCCCcc----
Confidence 23456888999999874 456888999999999999999999999654321 12222211111 111011
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.....+.+++.+|++.+|++||++.+++++-+
T Consensus 244 ------~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~ 275 (313)
T cd06633 244 ------EWTDSFRGFVDYCLQKIPQERPASAELLRHDF 275 (313)
T ss_pred ------ccCHHHHHHHHHHccCChhhCcCHHHHhcCcc
Confidence 11133678999999999999999999997733
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.8e-31 Score=290.37 Aligned_cols=263 Identities=24% Similarity=0.321 Sum_probs=196.9
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|+..+.||+|++|+||+|... +++.|+||++...... .......+|+..+++++ |++++++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc-hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 455678999999999999976 4788999998765432 22334567999999998 99999999999999999999999
Q ss_pred ccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+ +|+|.+++.... ..+++.++..++.|++.|+.|||++ +++|+||+|+||++++++.++|+|||.+...... .
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--~ 153 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--P 153 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCC--C
Confidence 9 779999887654 4689999999999999999999998 9999999999999999999999999999865422 2
Q ss_pred cccccccccCcccccccc-cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH------------HHHhhcCCC
Q 001434 939 SMSAVAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV------------RNYIRDHSL 1005 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~------------~~~~~~~~~ 1005 (1078)
......++..|+|||.+. ...++.++|+||||++++||++|+.||............. .........
T Consensus 154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd07830 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKL 233 (283)
T ss_pred CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccc
Confidence 233456788999999875 4457899999999999999999999986443221111110 000000000
Q ss_pred CCccccCCCCcch-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1006 TPGIFDTRLNVED-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1006 ~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
...+........ +........+.+++.+||+.+|++|||+.|++.+
T Consensus 234 -~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 280 (283)
T cd07830 234 -GFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH 280 (283)
T ss_pred -cccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence 000000000000 0011113558899999999999999999999875
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.4e-31 Score=287.26 Aligned_cols=247 Identities=26% Similarity=0.339 Sum_probs=197.2
Q ss_pred EeccCceEEEEEEECC-CcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 788 VGSGAYGTVYKAVMDS-GKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
||+|+||.||+|.+.. ++.|++|++..... .....+.+.+|++++++++||||+++++.+..+...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 5899999999999874 89999999866533 234457788999999999999999999999999999999999999999
Q ss_pred HhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC-------C
Q 001434 866 GELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-------K 938 (1078)
Q Consensus 866 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-------~ 938 (1078)
.+++.+.+ .+++..+..++.|++.||+|||+. +++||||+|+||++++++.++++|||++........ .
T Consensus 81 ~~~l~~~~-~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 81 ASLLENVG-SLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred HHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccc
Confidence 99998655 689999999999999999999998 999999999999999999999999999876532211 1
Q ss_pred cccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcch
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......++..|+|||...+..++.++||||+|+++|++++|..||.... ............... ....
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~----~~~~~~~~~~~~~~~----~~~~---- 224 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET----PEEIFQNILNGKIEW----PEDV---- 224 (265)
T ss_pred cccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHhcCCcCC----Cccc----
Confidence 2334567889999999988889999999999999999999999996443 222222222111100 0000
Q ss_pred hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.....+.+++.+|++.+|++|||+.++.+.+.
T Consensus 225 ----~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~ 256 (265)
T cd05579 225 ----EVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN 256 (265)
T ss_pred ----cCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence 01344678999999999999999955555444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-31 Score=292.34 Aligned_cols=255 Identities=23% Similarity=0.345 Sum_probs=196.6
Q ss_pred hcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|++|.||+|.++. ++.||||.+...... .....+.+|+.++.+. .||||+++++++.++...++||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 456777889999999999999875 889999999765432 2344566677766666 5999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
||+.+ ++.+++......+++..+..++.|++.|++|||+ . +|+||||+|+||++++++.++|+|||.+.......
T Consensus 94 e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 94 ELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred eccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 99854 8888776655578999999999999999999996 5 89999999999999999999999999987654222
Q ss_pred CCcccccccccCcccccccccCC----CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccC
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMK----VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
......++..|+|||.+.+.. ++.++||||+|+++|+|++|+.||...... .+...........
T Consensus 170 --~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~---~~~~~~~~~~~~~------- 237 (296)
T cd06618 170 --AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE---FEVLTKILQEEPP------- 237 (296)
T ss_pred --cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH---HHHHHHHhcCCCC-------
Confidence 223345788999999887543 788999999999999999999999643211 1222222221110
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
..+... .....+.+++.+||+.||++||++.+++++-+-
T Consensus 238 ~~~~~~----~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~ 276 (296)
T cd06618 238 SLPPNE----GFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFI 276 (296)
T ss_pred CCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHhcChhh
Confidence 000000 122347889999999999999999999988663
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-31 Score=292.41 Aligned_cols=250 Identities=24% Similarity=0.375 Sum_probs=202.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
+|...+.||+|++|.||+|.++ +++.||+|++..... .....+.+.+|++++++++ ||||+++++++.+++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 5677788999999999999976 689999999876432 2233567889999999998 999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++++|.+++.+.+ .+++..+..++.|++.|++|||+. +++|+||+|+||+++.++.++++|||.+........
T Consensus 82 e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 82 EYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157 (280)
T ss_pred cCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence 9999999999998765 699999999999999999999998 999999999999999999999999999876543221
Q ss_pred -------------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 001434 938 -------------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN 998 (1078)
Q Consensus 938 -------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~ 998 (1078)
.......++..|+|||...+..++.++||||+|++++++++|+.||..... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~ 233 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLTFQK 233 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHH
Confidence 222345678999999998888899999999999999999999999975432 111222
Q ss_pred HhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCH----HHHHHH
Q 001434 999 YIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSM----REVVSM 1052 (1078)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~----~ell~~ 1052 (1078)
....... +... ....+.+++.+||+.+|++||++ ++++++
T Consensus 234 ~~~~~~~----~~~~----------~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~ 277 (280)
T cd05581 234 ILKLEYS----FPPN----------FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH 277 (280)
T ss_pred HHhcCCC----CCCc----------cCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence 2111100 0111 12346789999999999999999 888765
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=302.89 Aligned_cols=260 Identities=24% Similarity=0.379 Sum_probs=209.7
Q ss_pred cCCCccEEeccCceEEEEEEEC-C----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-S----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
..+..++||+|+||+||+|.|- . ..+||||++..... .....++.+|+-+|.+++|||++++++++.... ..+
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~-~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS-PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC-chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 3455678999999999999963 3 34688888866544 334578899999999999999999999998765 889
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
|++||++|+|.++++..+..+-....+.|..||++|+.|||.+ ++|||||.++||||..-..+|+.|||+++....+
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 9999999999999998888899999999999999999999998 9999999999999999999999999999987543
Q ss_pred CCCc-ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 936 QSKS-MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 936 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
.... .....-.+.|||-|.+....|+.++|||||||++||++| |..||.+...+ .+...++.... .-.+
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-----eI~dlle~geR---LsqP- 922 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-----EIPDLLEKGER---LSQP- 922 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-----HhhHHHhcccc---CCCC-
Confidence 3222 222344668999999999999999999999999999999 99999765432 23333332211 1011
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCCC
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGR 1062 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1062 (1078)
......++-++.+||..|++.||+++++.+.+.+....-.+
T Consensus 923 --------piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardpqr 963 (1177)
T KOG1025|consen 923 --------PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDPQR 963 (1177)
T ss_pred --------CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCcce
Confidence 12234477789999999999999999999999887544433
|
|
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-31 Score=291.10 Aligned_cols=265 Identities=27% Similarity=0.359 Sum_probs=202.2
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|++|.||+|... +++.||+|++......+...+.+.+|+.++++++|++++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 344567999999999999976 4899999999876544444567889999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++ +|.+++......+++..+..++.|++.|++|||++ +++||||+|+||++++++.++|+|||.+....... ...
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~-~~~ 155 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPL-RTY 155 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCc-ccc
Confidence 85 99999987645799999999999999999999998 99999999999999999999999999987654322 223
Q ss_pred cccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC---------CC--CCc
Q 001434 941 SAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH---------SL--TPG 1008 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~---------~~--~~~ 1008 (1078)
....++..|+|||.+.+. .++.++||||+|+++||+++|+.||.............. ..... .. ...
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 234 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ-ILGTPTEESWPGVTKLPDYKP 234 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHH-HhCCCcHHHHHhhcccccccc
Confidence 334567889999988766 788999999999999999999999965432211111111 00000 00 000
Q ss_pred cccCCCCcch-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRLNVED-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.+........ +........+.+++.+|+..+|++||++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~ 279 (282)
T cd07829 235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH 279 (282)
T ss_pred cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence 0000000000 1111224568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=293.53 Aligned_cols=269 Identities=25% Similarity=0.323 Sum_probs=202.5
Q ss_pred hHhHHHHhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec
Q 001434 772 FQDVVEATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ 850 (1078)
Q Consensus 772 ~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~ 850 (1078)
.+++.....+|...+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+.++++++||||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455567788998999999999999999864 688999999976544333456778899999999999999999988643
Q ss_pred ------CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEe
Q 001434 851 ------GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 924 (1078)
Q Consensus 851 ------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 924 (1078)
...+++++++ +++|.+++... .+++..+..++.|+++|++|||+. +|+||||||+||+++.++.++++
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~ 162 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKIL 162 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEe
Confidence 3467888887 67999887654 488999999999999999999998 99999999999999999999999
Q ss_pred ecccccccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcC
Q 001434 925 DFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH 1003 (1078)
Q Consensus 925 Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 1003 (1078)
|||++..... ......++..|+|||...+ ..++.++||||+|+++|||++|+.||............... .
T Consensus 163 dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~----~ 234 (345)
T cd07877 163 DFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL----V 234 (345)
T ss_pred cccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH----h
Confidence 9999876432 2234567889999998766 56888999999999999999999999654322211111111 0
Q ss_pred CCCCccccCCCCcc----------------h-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1004 SLTPGIFDTRLNVE----------------D-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1004 ~~~~~~~~~~~~~~----------------~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..........+... . +........+.+++.+|++.||++||++.+++++-+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~ 302 (345)
T cd07877 235 GTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 302 (345)
T ss_pred CCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChh
Confidence 00000000000000 0 000011334779999999999999999999998865
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=295.93 Aligned_cols=263 Identities=24% Similarity=0.311 Sum_probs=196.6
Q ss_pred ccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCch------------hHHHHHHHHHHHccCCCCceeeEeeEEEecC
Q 001434 785 SFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNN------------IESSFRAEILTLGKIRHRNIVKLYGFCYHQG 851 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~------------~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 851 (1078)
.+.||+|+||+||+|.++ +++.||+|++........ ....+.+|++++++++|+||+++++++..++
T Consensus 14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 93 (335)
T PTZ00024 14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93 (335)
T ss_pred hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence 457999999999999976 589999999865432211 1125678999999999999999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
..++||||+. |+|.+++.... .++......++.|++.|++|||+. +++||||+|+||+++.++.++++|||.+..
T Consensus 94 ~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~ 168 (335)
T PTZ00024 94 FINLVMDIMA-SDLKKVVDRKI-RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARR 168 (335)
T ss_pred cEEEEEeccc-cCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceee
Confidence 9999999997 59999987544 588999999999999999999998 999999999999999999999999999876
Q ss_pred cCCC-------------CCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHH
Q 001434 932 IDMP-------------QSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR 997 (1078)
Q Consensus 932 ~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~ 997 (1078)
.... .........++..|+|||.+.+. .++.++||||+|+++|||++|+.||....+.+.......
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~ 248 (335)
T PTZ00024 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFE 248 (335)
T ss_pred cccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 5411 11112234567889999988764 468899999999999999999999975543222221111
Q ss_pred HHhhcCCCCCcccc------------CCCCcch-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 998 NYIRDHSLTPGIFD------------TRLNVED-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 998 ~~~~~~~~~~~~~~------------~~~~~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
.... .....+. ...+... .........+.+++.+|++.+|++|||+++++.+-+-
T Consensus 249 -~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~ 316 (335)
T PTZ00024 249 -LLGT--PNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYF 316 (335)
T ss_pred -HhCC--CchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCccc
Confidence 1110 0000000 0000000 0011123457899999999999999999999986654
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=279.02 Aligned_cols=242 Identities=22% Similarity=0.310 Sum_probs=197.0
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 856 (1078)
.+|....+||+|+||+|-.|..+ +.+.||||++++...-+ ...+.-+.|-+++.-- +-|.+++++.+|+.-+..|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 45677788999999999999877 46789999998875432 3344456677776655 578999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+.||+|--.|++-+ .+.+..++-+|..|+-||-+||++ ||++||||.+|||+|.+|++||+|||+++.-- -.
T Consensus 429 MEyvnGGDLMyhiQQ~G-kFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~ 503 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVG-KFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FD 503 (683)
T ss_pred EEEecCchhhhHHHHhc-ccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccc-cC
Confidence 99999999999998776 577788888999999999999999 99999999999999999999999999997432 23
Q ss_pred CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.....+++|||.|+|||++...+|+.++|.||+||++|||+.|++||.+.++++.+..+...-. .+++.+
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------syPKsl-- 573 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------SYPKSL-- 573 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC--------cCcccc--
Confidence 4556789999999999999999999999999999999999999999987665544444332211 112222
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCC
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRP 1044 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RP 1044 (1078)
..+...+++..+.+.|.+|.
T Consensus 574 --------SkEAv~ickg~ltK~P~kRL 593 (683)
T KOG0696|consen 574 --------SKEAVAICKGLLTKHPGKRL 593 (683)
T ss_pred --------cHHHHHHHHHHhhcCCcccc
Confidence 23455677788889999986
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=298.78 Aligned_cols=262 Identities=25% Similarity=0.334 Sum_probs=200.1
Q ss_pred HhhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCc----
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS---- 852 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~---- 852 (1078)
...+|...+.||+|++|.||+|.+. +++.||+|++..........+.+.+|+.++++++|||++++++++..++.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 3456778889999999999999976 57899999987654434445667889999999999999999998876654
Q ss_pred --eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 853 --NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 853 --~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
.++|+||+ +++|.+++... .+++.++..++.|++.|++|||+. ||+||||+|+||+++.++.++|+|||.+.
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~ 166 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ--KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLAR 166 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccccccc
Confidence 89999999 56999998764 589999999999999999999998 99999999999999999999999999998
Q ss_pred ccCCCCCCcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCcc
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
..... .....++..|+|||...+ ..++.++||||+|+++||+++|+.||...... ............+...
T Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~----~~~~~i~~~~~~~~~~ 238 (343)
T cd07851 167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI----DQLKRIMNLVGTPDEE 238 (343)
T ss_pred ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHHhcCCCCHH
Confidence 65422 234467889999998765 36788999999999999999999999644322 1222111111000000
Q ss_pred ccCCCC----------------cch-hhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1010 FDTRLN----------------VED-ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1010 ~~~~~~----------------~~~-~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
+..++. ... +........+.+++.+|++.+|++|||+.+++++-
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~ 299 (343)
T cd07851 239 LLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHP 299 (343)
T ss_pred HHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCC
Confidence 000000 000 00111245688999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-30 Score=312.75 Aligned_cols=254 Identities=28% Similarity=0.420 Sum_probs=205.8
Q ss_pred CCccEEeccCceEEEEEEEC----C----CcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCce
Q 001434 783 HDSFIVGSGAYGTVYKAVMD----S----GKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 783 ~~~~~lG~G~~g~V~~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~ 853 (1078)
...+.+|+|+||.|++|... . ...||||..+..... ...+.+..|+++|+.+ +|+||+.++++|...+..
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 34447999999999999832 1 457999999887765 5678999999999999 599999999999999999
Q ss_pred EEEEeeccCCCHHhHhcCCC---------------CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC
Q 001434 854 LLIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK 918 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~---------------~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~ 918 (1078)
++|+||++.|+|.++++..+ ..+...+...++.|||.|++||++. ++||||+.++|||+.++
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~ 454 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKN 454 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCC
Confidence 99999999999999998776 3488889999999999999999999 99999999999999999
Q ss_pred CceEEeecccccccCCCCCCcccccc--cccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHH
Q 001434 919 FEAHVGDFGLAKVIDMPQSKSMSAVA--GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATW 995 (1078)
Q Consensus 919 ~~~kl~Dfg~a~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~ 995 (1078)
..+||+|||+|+.............. -...|||||.+....|+.++|||||||++||+++ |..||.+.....++.+
T Consensus 455 ~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~- 533 (609)
T KOG0200|consen 455 KVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLE- 533 (609)
T ss_pred CEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHH-
Confidence 99999999999865433322212222 2456999999999999999999999999999999 9999976332222222
Q ss_pred HHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 996 VRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 996 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+.+.+.... .+ ..+..+++++++.||+.+|++||+++++.+.+...
T Consensus 534 ---~l~~G~r~~----~P--------~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 534 ---FLKEGNRME----QP--------EHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred ---HHhcCCCCC----CC--------CCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 333322111 00 11234577899999999999999999999999984
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-32 Score=288.75 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=211.0
Q ss_pred CCCccEEeccCceEEEEEEECCCc-EEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDSGK-IVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~~~-~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+.....+|-|+||.|-.+..++.+ .+|+|++++... .....+.+..|-.+|...+.|.||++|..|.+++.+||.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344456999999999998866433 489999877643 233455677899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
|-||.++..+..++ .++..++.-++..+++|++|||++ |||+|||||+|+++|.+|-+|+.|||+|+.+. ...+
T Consensus 502 ClGGElWTiLrdRg-~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~--~g~K 575 (732)
T KOG0614|consen 502 CLGGELWTILRDRG-SFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG--SGRK 575 (732)
T ss_pred hcCchhhhhhhhcC-CcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhc--cCCc
Confidence 99999999998777 688888888888899999999999 99999999999999999999999999999886 5566
Q ss_pred ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchh
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.-+++|||+|.|||++....++.++|.||+|+++||+++|.+||.+.+.-.....+.+++-... + +.++.
T Consensus 576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~-~-----Pr~I~---- 645 (732)
T KOG0614|consen 576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIE-F-----PRRIT---- 645 (732)
T ss_pred eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhh-c-----ccccc----
Confidence 7789999999999999999999999999999999999999999998776655555555533221 1 22222
Q ss_pred hHHHHHHHHHHHHHhcCCCCCCCCCC-----HHHHHHHHHhh
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPS-----MREVVSMLIES 1056 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs-----~~ell~~L~~~ 1056 (1078)
+...++|++....+|.+|.. +.+|.+|-|=.
T Consensus 646 ------k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~ 681 (732)
T KOG0614|consen 646 ------KTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFE 681 (732)
T ss_pred ------hhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhh
Confidence 23456888888999999986 88999988755
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=289.17 Aligned_cols=263 Identities=25% Similarity=0.320 Sum_probs=195.4
Q ss_pred cCCCccEEeccCceEEEEEEEC-C--CcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEec----Cc
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-S--GKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ----GS 852 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~----~~ 852 (1078)
+|+..+.||+|+||.||+|.+. . +..||+|++..........+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 3566778999999999999976 3 67899999876544444456788999999999 599999999875432 45
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
.++++||+. ++|.+++.... .+++.++..++.|++.||+|||+. +++||||||+||+++.++.++|+|||.+...
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~ 155 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSGQ-PLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGF 155 (332)
T ss_pred EEEEEeccc-CCHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence 688999986 59999887544 689999999999999999999998 9999999999999999999999999999865
Q ss_pred CCCCC---CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH----------
Q 001434 933 DMPQS---KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN---------- 998 (1078)
Q Consensus 933 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~---------- 998 (1078)
..... .......|+..|+|||...+ ..++.++||||+|+++|++++|++||...+........+..
T Consensus 156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (332)
T cd07857 156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS 235 (332)
T ss_pred ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence 42211 12234568999999998765 46889999999999999999999999754321111111100
Q ss_pred ---------HhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 999 ---------YIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 999 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
........+ ...+. .........+.+++.+|++.||++|||+.+++++=+
T Consensus 236 ~~~~~~~~~~~~~~~~~~---~~~~~---~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~ 294 (332)
T cd07857 236 RIGSPKAQNYIRSLPNIP---KKPFE---SIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPY 294 (332)
T ss_pred hhhhhhHHHHHHhccccC---CcchH---hhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 000000000 00000 000011245788999999999999999999998765
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=289.89 Aligned_cols=243 Identities=23% Similarity=0.257 Sum_probs=195.9
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 856 (1078)
...|.....+|.|+|+.|..+.+. +++.+++|++.+.... ..+|+.++... +||||+++.+.+.++.+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeee
Confidence 345555556999999999999865 5888999999777332 22455444444 799999999999999999999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEE-CCCCceEEeecccccccCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL-DDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill-~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||.+.|+-+.+.+...+. .. .++..|+++|+.|+.|||++ ||||||+||+|||+ ++.++++|+|||.++.....
T Consensus 395 ~e~l~g~ell~ri~~~~~-~~-~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKPE-FC-SEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred ehhccccHHHHHHHhcch-hH-HHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 999999988888876653 22 77888999999999999998 99999999999999 68999999999999876533
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
....+-|..|.|||+....+|+.++|+||+|+++|+|++|+.||.....+ .+ +...+...++.
T Consensus 470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e-i~~~i~~~~~s--------- 532 (612)
T KOG0603|consen 470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE-IHTRIQMPKFS--------- 532 (612)
T ss_pred ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH-HHHhhcCCccc---------
Confidence 44456788999999999999999999999999999999999999866554 12 22222221111
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
........+|+.+|++.||.+||+++++..+-|-
T Consensus 533 ------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 ------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 1223446689999999999999999999998887
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=271.95 Aligned_cols=252 Identities=27% Similarity=0.384 Sum_probs=193.3
Q ss_pred ccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHH-HccCCCCceeeEeeEEEecCceEEEEeeccC
Q 001434 785 SFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILT-LGKIRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~-l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
...||.|+||+|++..++ +|+..|||++...... ...+++..|.+. ++.=++|+||++|+.+..++..+|.||.|+-
T Consensus 69 lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~-keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd~ 147 (361)
T KOG1006|consen 69 LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIE-KEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMDI 147 (361)
T ss_pred HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccch-HHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHhh
Confidence 345999999999999976 6999999999877663 334566677765 4445799999999999999999999999965
Q ss_pred CCHHhHhc----CCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 863 GSLGELLH----GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 863 gsL~~~l~----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++.+-. .+...+++.-.-.|....++||.||-.. ..|+|||+||+|||++..|.+|+||||.+..+.. +-
T Consensus 148 -SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~--Si 222 (361)
T KOG1006|consen 148 -SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD--SI 222 (361)
T ss_pred -hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHH--HH
Confidence 7766532 1223578888888888889999999876 4899999999999999999999999999987642 22
Q ss_pred cccccccccCcccccccc--cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCc
Q 001434 939 SMSAVAGSYGYIAPEYAY--TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~--~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
..+.-.|-..|||||.+. +..|+.++||||+|+++||+.||..||...+. ..+.+....... ++.-.
T Consensus 223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv~gd--------pp~l~ 291 (361)
T KOG1006|consen 223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVVIGD--------PPILL 291 (361)
T ss_pred HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHHcCC--------CCeec
Confidence 223346788899999885 34589999999999999999999999986543 222222222221 11111
Q ss_pred chhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.+....+....+.++|..|+-+|-..||.+++++++-
T Consensus 292 ~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~ 328 (361)
T KOG1006|consen 292 FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFP 328 (361)
T ss_pred CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCc
Confidence 2222234566788999999999999999999998753
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=277.85 Aligned_cols=242 Identities=27% Similarity=0.324 Sum_probs=196.6
Q ss_pred EeccCceEEEEEEEC-CCcEEEEEEecccCCC-chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCH
Q 001434 788 VGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL 865 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL 865 (1078)
||+|+||.||++.+. +++.||+|++...... ......+..|++++++++|++|+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 4889999998766432 23456788999999999999999999999999999999999999999
Q ss_pred HhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCccccccc
Q 001434 866 GELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG 945 (1078)
Q Consensus 866 ~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 945 (1078)
.+++.... .+++..+..++.|++.|+.|+|+. +++|+||+|+||+++.++.++++|||.+....... .......+
T Consensus 81 ~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~ 155 (250)
T cd05123 81 FSHLSKEG-RFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCG 155 (250)
T ss_pred HHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcC
Confidence 99998665 589999999999999999999998 99999999999999999999999999987654221 22344568
Q ss_pred ccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHH
Q 001434 946 SYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHM 1025 (1078)
Q Consensus 946 t~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1025 (1078)
+..|+|||...+..++.++|+||+|+++|++++|+.||...+. ........... .. ++... .
T Consensus 156 ~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~----~~~~~~~~~~~-~~---~~~~~----------~ 217 (250)
T cd05123 156 TPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR----KEIYEKILKDP-LR---FPEFL----------S 217 (250)
T ss_pred CccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH----HHHHHHHhcCC-CC---CCCCC----------C
Confidence 8899999999888889999999999999999999999964332 22222222211 10 01111 2
Q ss_pred HHHHHHHHhcCCCCCCCCCCH---HHHHHH
Q 001434 1026 ILVLKVALMCTSISPFDRPSM---REVVSM 1052 (1078)
Q Consensus 1026 ~~l~~li~~cl~~dP~~RPs~---~ell~~ 1052 (1078)
..+.+++.+|+..||++||++ .+++.+
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~ 247 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGGAEEIKAH 247 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccHHHHHhC
Confidence 346789999999999999999 555543
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=291.55 Aligned_cols=266 Identities=23% Similarity=0.315 Sum_probs=193.8
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec--------
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ-------- 850 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-------- 850 (1078)
.+|...+.||+|+||.||+|.+. +++.||+|++..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 46777888999999999999975 588999999866543 3356788999999999999999999876543
Q ss_pred ------CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEE
Q 001434 851 ------GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHV 923 (1078)
Q Consensus 851 ------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl 923 (1078)
...++||||+++ +|.+++... .+++..+..++.||+.|+.|||+. +++||||||+||+++. ++.+++
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQG--PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEE
Confidence 357899999974 999888643 488999999999999999999998 9999999999999984 557899
Q ss_pred eecccccccCCCCC--CcccccccccCccccccccc-CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHh
Q 001434 924 GDFGLAKVIDMPQS--KSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYI 1000 (1078)
Q Consensus 924 ~Dfg~a~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 1000 (1078)
+|||.+........ .......++..|+|||.+.+ ..++.++||||+||++|+|++|+.||.................
T Consensus 157 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~ 236 (342)
T cd07854 157 GDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVP 236 (342)
T ss_pred CCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999976532211 11123457889999997654 4578899999999999999999999975432221111111100
Q ss_pred hcC---------CCCCc----cccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1001 RDH---------SLTPG----IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1001 ~~~---------~~~~~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
... ..... ......+ ..+........+.+++.+|++.||++|||+++++++-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~ 302 (342)
T cd07854 237 VVREEDRNELLNVIPSFVRNDGGEPRRP-LRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPY 302 (342)
T ss_pred CCChHHhhhhhhhhhhhhhhcccccCCC-HHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCc
Confidence 000 00000 0000000 00000112345778999999999999999999997644
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.5e-30 Score=279.49 Aligned_cols=250 Identities=23% Similarity=0.276 Sum_probs=194.6
Q ss_pred cCCCccEEeccCceEEEEEEECC-CcEEEEEEecccC---CCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNR---EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~---~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
+|...+.||+|+||.||++.+.. +..+++|+++... ........+.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 35666789999999999998763 4445566554322 2223345677899999999999999999999999999999
Q ss_pred EeeccCCCHHhHhcC---CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 857 YEYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
|||+++++|.+++.. ....+++.++..++.|++.|+.|||+. +++|+||+|+||++++ +.++++|||.+....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence 999999999998863 334689999999999999999999998 9999999999999975 579999999987653
Q ss_pred CCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCC
Q 001434 934 MPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 934 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
.. ........|++.|+|||...+..++.++|+||+|+++|++++|..||... ............. .+ .
T Consensus 157 ~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~----~~~~~~~~~~~~~-~~------~ 224 (260)
T cd08222 157 GS-CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ----NFLSVVLRIVEGP-TP------S 224 (260)
T ss_pred CC-cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHHHHHcCC-CC------C
Confidence 22 22233456788999999988888899999999999999999999998532 2223333322211 10 1
Q ss_pred CCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.+ ......+.+++.+|++.+|++||++.+++++
T Consensus 225 ~~------~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 257 (260)
T cd08222 225 LP------ETYSRQLNSIMQSMLNKDPSLRPSAAEILRN 257 (260)
T ss_pred Cc------chhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence 11 1223457789999999999999999999876
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=311.72 Aligned_cols=147 Identities=29% Similarity=0.377 Sum_probs=131.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|...+.||+|+||.||+|.+. +++.||||++..... .......+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 46777889999999999999977 688999999976432 2334567889999999999999999999999999999999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccc
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~ 930 (1078)
||+.+++|.+++.... .+++..++.++.||+.||+|||++ +|+||||||+|||++.++.++|+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-YFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997654 578899999999999999999998 99999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-32 Score=267.01 Aligned_cols=269 Identities=22% Similarity=0.356 Sum_probs=205.2
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe--------cC
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--------QG 851 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--------~~ 851 (1078)
.|....+||+|.||.||+|+.+ +|+.||+|++......+.-.....+|++++..++|+|++.+++.|.. ..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 3445567999999999999966 57888998876655555556678899999999999999999998754 23
Q ss_pred ceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
..|+||.+++. +|+-++......++..++.+++.++..||.|+|+. .|+|||+||.|++++.+|.+|++|||+++.
T Consensus 98 t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~ 173 (376)
T KOG0669|consen 98 TFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARA 173 (376)
T ss_pred eeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccc
Confidence 46899999987 99999988877899999999999999999999999 999999999999999999999999999976
Q ss_pred cCCCC---CCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC
Q 001434 932 IDMPQ---SKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007 (1078)
Q Consensus 932 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1078)
+.... ...+...+-|..|.+||.+.+. .|+++.|||..||++.||.||.+-+.+..+...+..+ ..... ....
T Consensus 174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~I-s~LcG--s~tk 250 (376)
T KOG0669|consen 174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLI-SQLCG--SITK 250 (376)
T ss_pred eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHH-HHHhc--cCCc
Confidence 54222 1223345568999999998865 5999999999999999999999888765544333322 11111 1111
Q ss_pred ccccC-------------CCCc-chhhHHHHHH------HHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1008 GIFDT-------------RLNV-EDESIVDHMI------LVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1008 ~~~~~-------------~~~~-~~~~~~~~~~------~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.+|+. .++. ......+..+ +..+++.+++..||.+|+++++++.+-+=-
T Consensus 251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~ 319 (376)
T KOG0669|consen 251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW 319 (376)
T ss_pred ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence 11111 0111 1111222333 567899999999999999999999876533
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=291.30 Aligned_cols=250 Identities=25% Similarity=0.378 Sum_probs=200.8
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEe-----cCce
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYH-----QGSN 853 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~-----~~~~ 853 (1078)
.|+..++||.|.+|.||+++.+ +++.+|+|+....... .+++..|+++++.. .|||++.++++|.. ++..
T Consensus 20 ~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~---deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqL 96 (953)
T KOG0587|consen 20 IFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE---EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQL 96 (953)
T ss_pred ccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc---cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeE
Confidence 3556678999999999999954 5888889988666543 34567788888877 69999999999864 5678
Q ss_pred EEEEeeccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 854 LLIYEYMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
++|||||.|||..|+++.. +..+.|+.+..|++.++.|+.+||.. .++|||||-.|||++.++.||++|||++..+
T Consensus 97 WLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 97 WLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred EEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 9999999999999998743 55799999999999999999999998 9999999999999999999999999999887
Q ss_pred CCCCCCcccccccccCcccccccccC-----CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCC
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTM-----KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 1007 (1078)
+. ......+..||+.|||||++... .|+..+|+||+|++..||.-|.+|+.+++....+.. +.+ .+++
T Consensus 174 ds-T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~----IpR--NPPP 246 (953)
T KOG0587|consen 174 DS-TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFL----IPR--NPPP 246 (953)
T ss_pred ec-ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhcc----CCC--CCCc
Confidence 63 34556678999999999998643 477899999999999999999999976653221111 111 1111
Q ss_pred ccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1008 GIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1008 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.. ........++.++|..|+.+|.+.||++.++++|
T Consensus 247 kL---------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h 282 (953)
T KOG0587|consen 247 KL---------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH 282 (953)
T ss_pred cc---------cchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence 11 1112334567889999999999999999998865
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=271.68 Aligned_cols=258 Identities=27% Similarity=0.348 Sum_probs=196.1
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCch-----hHHHHHHHHHHHccCCCCceeeEeeEEEe-cCce
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNN-----IESSFRAEILTLGKIRHRNIVKLYGFCYH-QGSN 853 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~-----~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~ 853 (1078)
+|-...++|+|+|+.||+|.+- ..+.||||+-...+...+ -.+...+|.++.+.++||.||++|+||.- .+.+
T Consensus 464 RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsF 543 (775)
T KOG1151|consen 464 RYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSF 543 (775)
T ss_pred HHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccc
Confidence 4445567999999999999965 477889997654433222 23456799999999999999999999964 5667
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEEC---CCCceEEeeccccc
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD---DKFEAHVGDFGLAK 930 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~---~~~~~kl~Dfg~a~ 930 (1078)
+-|+|||+|.+|+-|+.... .+++.++..|+.||+.||.||.+. ++.|+|-||||.|||+. ..|.+||+|||+++
T Consensus 544 CTVLEYceGNDLDFYLKQhk-lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK 621 (775)
T KOG1151|consen 544 CTVLEYCEGNDLDFYLKQHK-LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK 621 (775)
T ss_pred eeeeeecCCCchhHHHHhhh-hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence 89999999999999998766 789999999999999999999997 77899999999999994 45889999999999
Q ss_pred ccCCCCCCc------ccccccccCcccccccccC----CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHh
Q 001434 931 VIDMPQSKS------MSAVAGSYGYIAPEYAYTM----KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYI 1000 (1078)
Q Consensus 931 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~----~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~ 1000 (1078)
+++++.... .+...||++|++||.+.-+ ..+.|+||||+||++|+++.|+.||.......++.+. ..++
T Consensus 622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqe-NTIl 700 (775)
T KOG1151|consen 622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQE-NTIL 700 (775)
T ss_pred hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhh-hchh
Confidence 987554432 2346899999999987533 3678999999999999999999999754333222111 0011
Q ss_pred hcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
. ....-|+++.... -+...+|++|++.--++|..+.++...
T Consensus 701 k---AtEVqFP~KPvVs--------seAkaFIRRCLaYRKeDR~DV~qLA~d 741 (775)
T KOG1151|consen 701 K---ATEVQFPPKPVVS--------SEAKAFIRRCLAYRKEDRIDVQQLACD 741 (775)
T ss_pred c---ceeccCCCCCccC--------HHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence 1 1111122221111 124568999999999999998887654
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-30 Score=268.38 Aligned_cols=269 Identities=19% Similarity=0.318 Sum_probs=213.0
Q ss_pred ChHhHHHHhhcCCCccEEeccCceEEEEEEECC------CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEe
Q 001434 771 SFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDS------GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844 (1078)
Q Consensus 771 ~~~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~ 844 (1078)
..+++.-.+.+++...++-+|.||.||.|+|++ .+.|.+|.++.... +-....+.+|.-.+....|||+..+.
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS-~iQv~~~L~es~lly~~sH~nll~V~ 353 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHAS-QIQVNLLLQESMLLYGASHPNLLSVL 353 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhccc-HHHHHHHHHHHHHHhcCcCCCcccee
Confidence 345555566677777789999999999998753 35577788866654 33456788999999999999999999
Q ss_pred eEEE-ecCceEEEEeeccCCCHHhHhcC-----C--CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEEC
Q 001434 845 GFCY-HQGSNLLIYEYMERGSLGELLHG-----S--SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD 916 (1078)
Q Consensus 845 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~-----~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~ 916 (1078)
+++. +.+..+++|+++.-|+|..++.. . .+..+..+...++.|++.|++|||++ +|||.||..+|+++|
T Consensus 354 ~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvId 430 (563)
T KOG1024|consen 354 GVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVID 430 (563)
T ss_pred EEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceeh
Confidence 9874 55678999999999999999972 2 23577788899999999999999999 999999999999999
Q ss_pred CCCceEEeecccccccCCCCCCccc-ccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHH
Q 001434 917 DKFEAHVGDFGLAKVIDMPQSKSMS-AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLAT 994 (1078)
Q Consensus 917 ~~~~~kl~Dfg~a~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~ 994 (1078)
+.-+||++|=.+++.....+....+ .......||+||.+....|+.++|||||||++||++| |+.||...+..+
T Consensus 431 d~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE---- 506 (563)
T KOG1024|consen 431 DQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE---- 506 (563)
T ss_pred hheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH----
Confidence 9999999999999876544433322 2334668999999999999999999999999999999 999997554332
Q ss_pred HHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccC
Q 001434 995 WVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 995 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~ 1060 (1078)
+..+++++..... + .+++.+++.++..||...|++||+++|++.-|.+.....
T Consensus 507 -m~~ylkdGyRlaQ----P--------~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql 559 (563)
T KOG1024|consen 507 -MEHYLKDGYRLAQ----P--------FNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL 559 (563)
T ss_pred -HHHHHhccceecC----C--------CCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence 3333333322111 1 234556889999999999999999999999999876543
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-30 Score=269.42 Aligned_cols=261 Identities=21% Similarity=0.281 Sum_probs=201.6
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-C-----CceeeEeeEEEecC
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-H-----RNIVKLYGFCYHQG 851 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~iv~l~~~~~~~~ 851 (1078)
..+|.....+|+|+||.|-.+.+. .+..||+|+++.-. .-++..+-|++++.++. + --+|.+.+||...+
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg 164 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG 164 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence 567777888999999999999876 47899999985442 23556778999999983 2 25788889999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-------------
Q 001434 852 SNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD------------- 917 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~------------- 917 (1078)
+.+||+|.+ |-|+++++..+. .+++..++..+++|+++++++||+. +++|.||||+||++.+
T Consensus 165 hiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 165 HICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred ceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCcc
Confidence 999999998 559999998754 4789999999999999999999999 9999999999999941
Q ss_pred -------CCceEEeecccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCC
Q 001434 918 -------KFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG 990 (1078)
Q Consensus 918 -------~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~ 990 (1078)
.-.++++|||.|+... ......+.|..|.|||++.+-.++.++||||+||+++|+.+|..-|+..++.+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~----e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDH----EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred ceeccCCCcceEEEecCCcceec----cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2358999999998743 33467789999999999999999999999999999999999999998766555
Q ss_pred CHHHHHHHHhhcCCCCCccccCC----------------------------CCcchhh---HHHHHHHHHHHHHhcCCCC
Q 001434 991 DLATWVRNYIRDHSLTPGIFDTR----------------------------LNVEDES---IVDHMILVLKVALMCTSIS 1039 (1078)
Q Consensus 991 ~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~---~~~~~~~l~~li~~cl~~d 1039 (1078)
.++ .+..+ .. +.+..+.... ..+.... .......+++|+.+|+..|
T Consensus 317 HLa-MMerI-lG-p~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 317 HLA-MMERI-LG-PIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred HHH-HHHHh-hC-CCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 432 11111 11 1111111111 0000000 0123345999999999999
Q ss_pred CCCCCCHHHHHHHH
Q 001434 1040 PFDRPSMREVVSML 1053 (1078)
Q Consensus 1040 P~~RPs~~ell~~L 1053 (1078)
|.+|+|+.|++.+-
T Consensus 394 P~~RiTl~EAL~Hp 407 (415)
T KOG0671|consen 394 PARRITLREALSHP 407 (415)
T ss_pred ccccccHHHHhcCH
Confidence 99999999998763
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.76 Aligned_cols=219 Identities=26% Similarity=0.258 Sum_probs=174.1
Q ss_pred cCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHHhHh
Q 001434 791 GAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL 869 (1078)
Q Consensus 791 G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l 869 (1078)
|.+|.||+|.++ +++.||+|++..... +.+|...+....||||+++++++.+.+..++||||+++|+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 899999999976 588999999965432 223444445557999999999999999999999999999999998
Q ss_pred cCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccccccCc
Q 001434 870 HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGY 949 (1078)
Q Consensus 870 ~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y 949 (1078)
.... .+++..+..++.|+++|++|+|++ +++||||||+||+++.++.++++|||.+...... .....++..|
T Consensus 77 ~~~~-~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y 148 (237)
T cd05576 77 SKFL-NIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY 148 (237)
T ss_pred HHhc-CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence 7654 589999999999999999999998 9999999999999999999999999987655321 2233457789
Q ss_pred ccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHH
Q 001434 950 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVL 1029 (1078)
Q Consensus 950 ~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 1029 (1078)
+|||...+..++.++||||+|+++|||++|+.|+........ .. . ...++. .....+.
T Consensus 149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~----------~~--~----~~~~~~------~~~~~~~ 206 (237)
T cd05576 149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN----------TH--T----TLNIPE------WVSEEAR 206 (237)
T ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc----------cc--c----ccCCcc------cCCHHHH
Confidence 999999888899999999999999999999988753211100 00 0 000110 1123467
Q ss_pred HHHHhcCCCCCCCCCCH
Q 001434 1030 KVALMCTSISPFDRPSM 1046 (1078)
Q Consensus 1030 ~li~~cl~~dP~~RPs~ 1046 (1078)
+++.+|++.||++||++
T Consensus 207 ~li~~~l~~dp~~R~~~ 223 (237)
T cd05576 207 SLLQQLLQFNPTERLGA 223 (237)
T ss_pred HHHHHHccCCHHHhcCC
Confidence 89999999999999996
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-30 Score=258.30 Aligned_cols=269 Identities=24% Similarity=0.296 Sum_probs=203.9
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec-----CceE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ-----GSNL 854 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~~~ 854 (1078)
+++..+.||-|+||+||.+.+. +|+.||.|++..-...-...+++.+|.+++..++|.||...+++..-. ...|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 4556778999999999999975 799999999977655445567889999999999999999988876533 2457
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+|+|.|.. +|.+.|-... .++.+++..+.+||++|+.|||+. +|.||||||.|.+++.+...||||||+++..+.
T Consensus 134 V~TELmQS-DLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQ-ALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHHHHh-hhhheeccCC-CCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccch
Confidence 88999865 8888776544 789999999999999999999998 999999999999999999999999999998776
Q ss_pred CCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH-----------------
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV----------------- 996 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~----------------- 996 (1078)
.+...+...+-|..|.|||.+.+. .|+.+.||||+||++.|++..+.-|+....-+.+.-+.
T Consensus 209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG 288 (449)
T KOG0664|consen 209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG 288 (449)
T ss_pred hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence 666666777889999999999875 58999999999999999999988887543222222110
Q ss_pred -HHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 997 -RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 997 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
+..+......+..+..-...... ...-.+...+..+++..||++|.+.++.+.+...-
T Consensus 289 Ak~H~LR~~~k~Ps~~vLYtlsS~--~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~ 347 (449)
T KOG0664|consen 289 AKNHVLRAGLRAPDTQRLYKIASP--DDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE 347 (449)
T ss_pred hHHHhhccCCCCCCccceeeecCC--cccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence 11111111111000000000110 01222345677889999999999999999887654
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.3e-29 Score=238.73 Aligned_cols=198 Identities=25% Similarity=0.387 Sum_probs=165.0
Q ss_pred CCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHcc-CCCCceeeEeeEEEecCceEEEEeec
Q 001434 783 HDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGK-IRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 783 ~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
.....||+|+||.|-+.++. +|...|+|.+......+. .++...|+++..+ ..+|.+|.+|+...+...+++.||.|
T Consensus 49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~-q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M 127 (282)
T KOG0984|consen 49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQE-QKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM 127 (282)
T ss_pred hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHH-HHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh
Confidence 33445999999999888865 689999999988766444 4566677776554 47999999999999999999999999
Q ss_pred cCCCHHhHhc---CCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC
Q 001434 861 ERGSLGELLH---GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 861 ~~gsL~~~l~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
+- +|..+-. ..+...++.-.-+|+..+..|+.|||++ ..++|||+||+|||++.+|+||+||||.+..+.+.
T Consensus 128 ~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dS-- 202 (282)
T KOG0984|consen 128 DT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDS-- 202 (282)
T ss_pred hh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhh--
Confidence 75 8877653 4555789999999999999999999997 58999999999999999999999999999876522
Q ss_pred CcccccccccCccccccccc----CCCCCcCcchhHHHHHHHHHhCCCCCCCC
Q 001434 938 KSMSAVAGSYGYIAPEYAYT----MKVTEKCDIYSYGVVLLELLTGRTPVQPL 986 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~DvwslGv~l~elltg~~P~~~~ 986 (1078)
-..+.-.|...|||||.+.. ..|+.++||||+|+++.||.++++||...
T Consensus 203 iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 203 IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 22223467788999998753 36899999999999999999999999743
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=262.09 Aligned_cols=240 Identities=28% Similarity=0.403 Sum_probs=194.7
Q ss_pred CceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHHhHhc
Q 001434 792 AYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLH 870 (1078)
Q Consensus 792 ~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~ 870 (1078)
+||.||+|.+.. ++.+|+|++........ .+.+.+|++.+++++|++++++++++......+++|||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 589999999874 89999999976654332 5788999999999999999999999999999999999999999999987
Q ss_pred CCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccccccCcc
Q 001434 871 GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950 (1078)
Q Consensus 871 ~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~ 950 (1078)
... .+++..+..++.+++.++.|||+. +++|+||+|+||++++++.++++|||.+...... .......++..|+
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~~ 153 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG--GLLTTFVGTPEYM 153 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc--cccccccCCcCCC
Confidence 655 388999999999999999999998 9999999999999999999999999999876532 2344566888999
Q ss_pred cccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHH
Q 001434 951 APEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLK 1030 (1078)
Q Consensus 951 aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 1030 (1078)
+||...+..++.++||||+|++++++++|..||....+. ............ .. ... . ......+.+
T Consensus 154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~---~~~~~~~~~~~~-~~---~~~----~---~~~~~~~~~ 219 (244)
T smart00220 154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL---LELFKKIGKPKP-PF---PPP----E---WKISPEAKD 219 (244)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHhccCC-CC---ccc----c---ccCCHHHHH
Confidence 999998888999999999999999999999999653222 222222211111 10 000 0 002245778
Q ss_pred HHHhcCCCCCCCCCCHHHHHHH
Q 001434 1031 VALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1031 li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
++.+|+..+|++||++.+++++
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~ 241 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQH 241 (244)
T ss_pred HHHHHccCCchhccCHHHHhhC
Confidence 9999999999999999999873
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=289.57 Aligned_cols=262 Identities=18% Similarity=0.187 Sum_probs=169.0
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-C----CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeE------E
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-S----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF------C 847 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~------~ 847 (1078)
..+|...+.||+|+||.||+|.+. + +..||+|++..... .+....| .+++..+.++..+... .
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA----VEIWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch----hHHHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 346778889999999999999975 4 68999998864332 1111111 1111122222221111 2
Q ss_pred EecCceEEEEeeccCCCHHhHhcCCCCC-------------------CChhHHHHHHHHHHhhhhhhhccCCCceEecCC
Q 001434 848 YHQGSNLLIYEYMERGSLGELLHGSSCN-------------------LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDI 908 (1078)
Q Consensus 848 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~-------------------l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl 908 (1078)
..+...++||||+++++|.+++...... .....+..++.|++.||+|||++ +|+||||
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL 281 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV 281 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence 4566789999999999999998754311 11234567999999999999998 9999999
Q ss_pred CCCcEEECC-CCceEEeecccccccCCCCCCcccccccccCcccccccccC----------------------CCCCcCc
Q 001434 909 KSNNILLDD-KFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM----------------------KVTEKCD 965 (1078)
Q Consensus 909 kp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 965 (1078)
||+|||+++ ++.+||+|||+|+..............+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 57999999999986543333344556789999999965322 2345679
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCc---cccCCCCcc----hhhHHHHHHHHHHHHHhcCCC
Q 001434 966 IYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG---IFDTRLNVE----DESIVDHMILVLKVALMCTSI 1038 (1078)
Q Consensus 966 vwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~ 1038 (1078)
|||+||++|||+++..|+.. .................. ........+ .+..........+++.+|++.
T Consensus 362 VwSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~ 436 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF 436 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence 99999999999997765431 111111111100000000 000000000 000000112245799999999
Q ss_pred CCCCCCCHHHHHHHHH
Q 001434 1039 SPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1039 dP~~RPs~~ell~~L~ 1054 (1078)
||++|||++++++|-+
T Consensus 437 dP~kR~ta~e~L~Hpf 452 (566)
T PLN03225 437 KGRQRISAKAALAHPY 452 (566)
T ss_pred CcccCCCHHHHhCCcC
Confidence 9999999999999754
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-28 Score=251.33 Aligned_cols=248 Identities=20% Similarity=0.285 Sum_probs=193.3
Q ss_pred hhcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCc-hhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-NIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 855 (1078)
..+|+..++||+|+|++|..++++ +.+.||+|++++.-..+ +...=...|-.+..+- .||.+|.++.+|+.+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 356788889999999999999965 57889999998774322 2223334555555544 69999999999999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCC
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
|.||++||+|--.+++++ +++++++..+...|.-||.|||++ ||++||+|.+||++|.+|.+|++|+|+++.-- .
T Consensus 329 vieyv~ggdlmfhmqrqr-klpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l-~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-KLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-G 403 (593)
T ss_pred EEEEecCcceeeehhhhh-cCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCC-C
Confidence 999999999988888776 688888888889999999999999 99999999999999999999999999997543 2
Q ss_pred CCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCC---CCCCHHHHHHHHhhcCCCCCccccC
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLD---DGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.....++++|||.|+|||.+.+..|+...|.|++||+++||+.|+.||.-.. .+....+..-+.+....+. .+.
T Consensus 404 ~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---ipr 480 (593)
T KOG0695|consen 404 PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---IPR 480 (593)
T ss_pred CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---ccc
Confidence 3455678999999999999999999999999999999999999999997432 2222222222222211110 011
Q ss_pred CCCcchhhHHHHHHHHHHHHHhcCCCCCCCCC
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRP 1044 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP 1044 (1078)
.+. .+...+++.-+++||.+|.
T Consensus 481 sls----------vkas~vlkgflnkdp~erl 502 (593)
T KOG0695|consen 481 SLS----------VKASHVLKGFLNKDPKERL 502 (593)
T ss_pred eee----------hhhHHHHHHhhcCCcHHhc
Confidence 121 1233566777899999985
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=265.29 Aligned_cols=206 Identities=26% Similarity=0.359 Sum_probs=172.4
Q ss_pred CCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|...+.||-|+||+|.+++. ++...||.|.+.+... ......-++.|-++|..-+.+-||++|-.|.+.+..|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 34556799999999999984 3467789998876532 233345678899999999999999999999999999999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccC------
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID------ 933 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~------ 933 (1078)
++||++-.++.+.+ -+++.-++.++..++.|+++.|+. |+|||||||+|||||.+|++||+|||+++-+.
T Consensus 711 IPGGDmMSLLIrmg-IFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdsk 786 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 786 (1034)
T ss_pred cCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccc
Confidence 99999999998877 577777777788999999999998 99999999999999999999999999985331
Q ss_pred ---CCC-C-------------------------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh
Q 001434 934 ---MPQ-S-------------------------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT 978 (1078)
Q Consensus 934 ---~~~-~-------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt 978 (1078)
... . ......+||+.|+|||++....|+..+|.||.||++|||+.
T Consensus 787 YYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 787 YYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLV 866 (1034)
T ss_pred cccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhh
Confidence 000 0 00112579999999999999999999999999999999999
Q ss_pred CCCCCCCCCCCCC
Q 001434 979 GRTPVQPLDDGGD 991 (1078)
Q Consensus 979 g~~P~~~~~~~~~ 991 (1078)
|++||.+....+.
T Consensus 867 g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 867 GQPPFLADTPGET 879 (1034)
T ss_pred CCCCccCCCCCcc
Confidence 9999987665443
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-28 Score=280.06 Aligned_cols=244 Identities=28% Similarity=0.355 Sum_probs=188.3
Q ss_pred CCCccEEeccCce-EEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYG-TVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g-~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|...+++|.|+.| .||+|... |+.||||++-... .....+|++.++.- +|||||++++.-.++...||+.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~-----~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF-----FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh-----HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 4445568999888 57999987 8899999985543 34567899999887 599999999988889999999999
Q ss_pred ccCCCHHhHhcCCCC---CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC---C--CceEEeecccccc
Q 001434 860 MERGSLGELLHGSSC---NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD---K--FEAHVGDFGLAKV 931 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~--~~~kl~Dfg~a~~ 931 (1078)
|.. +|.+++..... .......+.+..|+++|+++||+. +||||||||.|||++. + .+++|+|||+++.
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk 660 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK 660 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence 965 99999987421 111145678899999999999998 9999999999999975 3 5789999999998
Q ss_pred cCCCCC--CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 001434 932 IDMPQS--KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 932 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1078)
.+.... .......||.+|+|||.+....-+.++||||+||++|+.++ |.+||...-.+ ..++........
T Consensus 661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R------~~NIl~~~~~L~- 733 (903)
T KOG1027|consen 661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER------QANILTGNYTLV- 733 (903)
T ss_pred cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh------hhhhhcCcccee-
Confidence 764332 23456789999999999998888889999999999999999 58999643221 112222211111
Q ss_pred cccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.+....+ . +..+||.+|++++|..||+|.+|+.|
T Consensus 734 ----~L~~~~d----~--eA~dLI~~ml~~dP~~RPsa~~VL~H 767 (903)
T KOG1027|consen 734 ----HLEPLPD----C--EAKDLISRMLNPDPQLRPSATDVLNH 767 (903)
T ss_pred ----eeccCch----H--HHHHHHHHhcCCCcccCCCHHHHhCC
Confidence 1111111 1 46789999999999999999999865
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=274.53 Aligned_cols=260 Identities=20% Similarity=0.267 Sum_probs=177.7
Q ss_pred hhcCCCccEEeccCceEEEEEEE-----------------CCCcEEEEEEecccCCCc------------hhHHHHHHHH
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVM-----------------DSGKIVAVKKLASNREGN------------NIESSFRAEI 829 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~-----------------~~~~~vavK~~~~~~~~~------------~~~~~~~~e~ 829 (1078)
..+|+..++||+|+||+||+|.+ ..++.||||++....... ...+....|+
T Consensus 144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~ 223 (507)
T PLN03224 144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA 223 (507)
T ss_pred ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence 45788889999999999999964 235689999986542210 1112334567
Q ss_pred HHHccCCCCce-----eeEeeEEEe--------cCceEEEEeeccCCCHHhHhcCCC-----------------------
Q 001434 830 LTLGKIRHRNI-----VKLYGFCYH--------QGSNLLIYEYMERGSLGELLHGSS----------------------- 873 (1078)
Q Consensus 830 ~~l~~l~h~~i-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~----------------------- 873 (1078)
.++.+++|.++ ++++++|.. .+..++||||+++++|.++++...
T Consensus 224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~ 303 (507)
T PLN03224 224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ 303 (507)
T ss_pred HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence 77777766544 666776643 356799999999999999987431
Q ss_pred CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccccccCccccc
Q 001434 874 CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953 (1078)
Q Consensus 874 ~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE 953 (1078)
...++..+..++.|++.|++|+|+. +|+||||||+||+++.++.+||+|||++...............+++.|+|||
T Consensus 304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE 380 (507)
T PLN03224 304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380 (507)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence 1245677889999999999999998 9999999999999999999999999999765322222222234578999999
Q ss_pred ccccCC--------------------CC--CcCcchhHHHHHHHHHhCCC-CCCCCCC--------CCCHHHHHHHHhhc
Q 001434 954 YAYTMK--------------------VT--EKCDIYSYGVVLLELLTGRT-PVQPLDD--------GGDLATWVRNYIRD 1002 (1078)
Q Consensus 954 ~~~~~~--------------------~~--~~~DvwslGv~l~elltg~~-P~~~~~~--------~~~~~~~~~~~~~~ 1002 (1078)
.+.... |+ .+.||||+||++|||++|.. ||..... ..+...|... ..
T Consensus 381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~--~~ 458 (507)
T PLN03224 381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMY--KG 458 (507)
T ss_pred hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhh--cc
Confidence 875322 11 24699999999999999875 6643211 0111111110 00
Q ss_pred CCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCC---CCCCCHHHHHHHHH
Q 001434 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISP---FDRPSMREVVSMLI 1054 (1078)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP---~~RPs~~ell~~L~ 1054 (1078)
. ...+. .+........+++.+++..+| .+|+|++|+++|-+
T Consensus 459 ~-------~~~~~----~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~ 502 (507)
T PLN03224 459 Q-------KYDFS----LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRF 502 (507)
T ss_pred c-------CCCcc----cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCC
Confidence 0 00111 011123345678889998766 68999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-27 Score=251.81 Aligned_cols=268 Identities=23% Similarity=0.292 Sum_probs=194.5
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCC--------CCceeeEeeEEEe-
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR--------HRNIVKLYGFCYH- 849 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~--------h~~iv~l~~~~~~- 849 (1078)
.+|...++||.|.|++||.|.+. ..+.||+|+++.. +.-.+....|++++++++ ..+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 46777888999999999999975 5778999999554 234567789999999883 3589999999976
Q ss_pred ---cCceEEEEeeccCCCHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC-------
Q 001434 850 ---QGSNLLIYEYMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK------- 918 (1078)
Q Consensus 850 ---~~~~~lv~e~~~~gsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~------- 918 (1078)
+.+++||+|++ |.+|..+|... .+.++...+.+|++||+.||.|||++| ||+|.||||+|||+...
T Consensus 155 GpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~ 231 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD 231 (590)
T ss_pred CCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence 45789999999 66999988754 347999999999999999999999987 99999999999999300
Q ss_pred --------------------------------------------------------------------------------
Q 001434 919 -------------------------------------------------------------------------------- 918 (1078)
Q Consensus 919 -------------------------------------------------------------------------------- 918 (1078)
T Consensus 232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~ 311 (590)
T KOG1290|consen 232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING 311 (590)
T ss_pred hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence
Q ss_pred -------------------------------------------------------------------------------C
Q 001434 919 -------------------------------------------------------------------------------F 919 (1078)
Q Consensus 919 -------------------------------------------------------------------------------~ 919 (1078)
.
T Consensus 312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di 391 (590)
T KOG1290|consen 312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI 391 (590)
T ss_pred cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence 0
Q ss_pred ceEEeecccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC------CCHH
Q 001434 920 EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG------GDLA 993 (1078)
Q Consensus 920 ~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~------~~~~ 993 (1078)
+|||+|||-|+.+. .....-..|..|+|||++.+..|+..+||||++|+++|++||.+-|.+.... ..++
T Consensus 392 ~vKIaDlGNACW~~----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA 467 (590)
T KOG1290|consen 392 RVKIADLGNACWVH----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA 467 (590)
T ss_pred eEEEeeccchhhhh----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence 13344444443321 1111223577899999999999999999999999999999999988764422 2222
Q ss_pred HHH-------HHHhhcCCCCCccccCC--------CCc--c-------hhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHH
Q 001434 994 TWV-------RNYIRDHSLTPGIFDTR--------LNV--E-------DESIVDHMILVLKVALMCTSISPFDRPSMREV 1049 (1078)
Q Consensus 994 ~~~-------~~~~~~~~~~~~~~~~~--------~~~--~-------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el 1049 (1078)
.++ +.+...++.....|+.. +.+ - .+-..+....+.+++.-|++.+|++||||++.
T Consensus 468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c 547 (590)
T KOG1290|consen 468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC 547 (590)
T ss_pred HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence 222 11222222222222211 110 0 01112455678899999999999999999999
Q ss_pred HHHHHhhc
Q 001434 1050 VSMLIESN 1057 (1078)
Q Consensus 1050 l~~L~~~~ 1057 (1078)
+++-|--.
T Consensus 548 l~hPwLn~ 555 (590)
T KOG1290|consen 548 LKHPWLNP 555 (590)
T ss_pred hcCccccC
Confidence 99877553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.6e-28 Score=246.87 Aligned_cols=262 Identities=26% Similarity=0.331 Sum_probs=201.3
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEec------Cc
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------GS 852 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------~~ 852 (1078)
.+|...+.+|.|+- .|..|.+. .++.||+|++..+.......++..+|...+..+.|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 35555667888888 66666654 588999999987766566678889999999999999999999988543 35
Q ss_pred eEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
.|+|||+|.. +|...++ ..++..+...+..|++.|+.|+|+. ||+||||||+||++..++.+||.|||+|+..
T Consensus 96 ~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 96 VYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhccc
Confidence 6899999975 9999888 2478889999999999999999999 9999999999999999999999999999875
Q ss_pred CCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH----------------
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV---------------- 996 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~---------------- 996 (1078)
+. .-..+..+.+..|.|||++.+..|...+||||+||++.||++|..-|.+.+ .+.+|.
T Consensus 169 ~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~~q 243 (369)
T KOG0665|consen 169 DT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFMKQ 243 (369)
T ss_pred Cc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHHHH
Confidence 42 245677889999999999999889999999999999999999998887432 222321
Q ss_pred -----HHHhhcCC------CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 997 -----RNYIRDHS------LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 997 -----~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
+.+.+..+ ......|..++...+.-.-......+++.+|+-.+|++|.+++++++|--
T Consensus 244 L~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY 312 (369)
T KOG0665|consen 244 LQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPY 312 (369)
T ss_pred hhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCe
Confidence 22222111 00111111111111111112233678999999999999999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=261.35 Aligned_cols=198 Identities=26% Similarity=0.355 Sum_probs=172.6
Q ss_pred hcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCC------chhHHHHHHHHHHHccCC---CCceeeEeeEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREG------NNIESSFRAEILTLGKIR---HRNIVKLYGFCYH 849 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~ 849 (1078)
..|...+.+|.|+||.|+.|+++. ...|+||.+.+.+.- +...-.+--|+++|..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357777889999999999999875 667899999877531 111234567999999996 9999999999999
Q ss_pred cCceEEEEeec-cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccc
Q 001434 850 QGSNLLIYEYM-ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 850 ~~~~~lv~e~~-~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 928 (1078)
++.+|++||-. +|.+|+++|..++ .+++.++..|++||+.|+++||+. ||||||||-+||.++.+|-+|++|||.
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp-~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgs 716 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKP-RMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGS 716 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccC-ccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccc
Confidence 99999999975 4559999999777 699999999999999999999999 999999999999999999999999999
Q ss_pred ccccCCCCCCcccccccccCcccccccccCCCC-CcCcchhHHHHHHHHHhCCCCCC
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVT-EKCDIYSYGVVLLELLTGRTPVQ 984 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGv~l~elltg~~P~~ 984 (1078)
|.... ......++||..|.|||++.+..|- ..-|||++|+++|.+.....||.
T Consensus 717 aa~~k---sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 717 AAYTK---SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhhc---CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 98753 4556678999999999999988874 67899999999999999998885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-28 Score=266.82 Aligned_cols=253 Identities=27% Similarity=0.375 Sum_probs=201.7
Q ss_pred hcCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|.....+|.|+||.||+|+++ +++..|+|+++-... +......+|+-+++..+|||||.+++.+...+..+++||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~--dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG--DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC--ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 45666778999999999999976 688999999987654 335667899999999999999999999999999999999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+.||+|.+.-+..+ .+++.++..+++..++|++|+|+. |-+|||||-.||++++.|.+|++|||.+..+. ..-.
T Consensus 93 ycgggslQdiy~~Tg-plselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqit-ati~ 167 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTG-PLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQIT-ATIA 167 (829)
T ss_pred ecCCCcccceeeecc-cchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhh-hhhh
Confidence 999999999877666 799999999999999999999999 99999999999999999999999999987664 2334
Q ss_pred cccccccccCcccccccc---cCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 939 SMSAVAGSYGYIAPEYAY---TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
+...+.||+.|||||+.. .+.|...+|||+.|++..|+---++|-..........- .-+....++..
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~L----mTkS~~qpp~l------ 237 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFL----MTKSGFQPPTL------ 237 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHH----hhccCCCCCcc------
Confidence 556789999999999764 66799999999999999999887777653332111110 00111111111
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
.+...+ ...+.++++.|+.++|++||+++.++.|
T Consensus 238 kDk~kw---s~~fh~fvK~altknpKkRptaeklL~h 271 (829)
T KOG0576|consen 238 KDKTKW---SEFFHNFVKGALTKNPKKRPTAEKLLQH 271 (829)
T ss_pred cCCccc---hHHHHHHHHHHhcCCCccCCChhhheec
Confidence 111112 2346789999999999999999887653
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-25 Score=237.08 Aligned_cols=212 Identities=37% Similarity=0.564 Sum_probs=184.8
Q ss_pred EeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHH
Q 001434 788 VGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~ 866 (1078)
||+|.+|.||++.... ++.+++|++....... ..+.+.+|++.++.++|++++++++++......+++|||+++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 6899999999999764 8899999997665422 3567899999999999999999999999989999999999999999
Q ss_pred hHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEEeecccccccCCCCCCccccccc
Q 001434 867 ELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAKVIDMPQSKSMSAVAG 945 (1078)
Q Consensus 867 ~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~g 945 (1078)
+++.......++..+..++.+++++++++|+. +++|+||+|.||+++. ++.++++|||.+........ ......+
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~ 155 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG 155 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence 99986634689999999999999999999998 9999999999999999 89999999999986643221 2334567
Q ss_pred ccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHH
Q 001434 946 SYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024 (1078)
Q Consensus 946 t~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1024 (1078)
...|++||..... .++.++|+|++|++++++
T Consensus 156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------ 187 (215)
T cd00180 156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------ 187 (215)
T ss_pred CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence 8899999998877 788999999999999999
Q ss_pred HHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1025 MILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1025 ~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
..+.+++.+|++.+|++||+++++++++
T Consensus 188 -~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 -PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred -HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 2366899999999999999999998753
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=228.81 Aligned_cols=262 Identities=19% Similarity=0.268 Sum_probs=193.7
Q ss_pred HhhcCCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEec--Cce
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQ--GSN 853 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~~ 853 (1078)
...+|+..+.+|+|.|+.||.|.. .+.+.++||+++.-+ .+.+.+|+.+++.+. ||||+++++...+. ...
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 345677778899999999999984 457889999985443 467899999999997 99999999998775 456
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC-CceEEeeccccccc
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKVI 932 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~ 932 (1078)
.+|+||+.+.+...+-. .++...+...+.++++||.|+|++ ||.|||+||.|+++|.. ..++++|||+|.++
T Consensus 111 aLiFE~v~n~Dfk~ly~----tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP----TLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred hhHhhhhccccHHHHhh----hhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhc
Confidence 79999999876666544 577788899999999999999999 99999999999999965 56999999999988
Q ss_pred CCCCCCcccccccccCcccccccccC-CCCCcCcchhHHHHHHHHHhCCCCCCCCCC-CCCHHHHHH--------HHhhc
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDD-GGDLATWVR--------NYIRD 1002 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGv~l~elltg~~P~~~~~~-~~~~~~~~~--------~~~~~ 1002 (1078)
.. .......+.+..|.-||++..- .|+..-|+|||||++..|+..+.||....+ .+++..+++ .+...
T Consensus 184 Hp--~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~K 261 (338)
T KOG0668|consen 184 HP--GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNK 261 (338)
T ss_pred CC--CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHH
Confidence 63 3334445667788999988654 588899999999999999999999865432 223333221 11111
Q ss_pred CC--C---CCccccCCCCcchhhHH------HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1003 HS--L---TPGIFDTRLNVEDESIV------DHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1003 ~~--~---~~~~~~~~~~~~~~~~~------~~~~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.. . ...++..-....++.+. -...+..+++.+.+..|..+|||+.|..+|-
T Consensus 262 Y~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp 323 (338)
T KOG0668|consen 262 YQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP 323 (338)
T ss_pred HccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence 00 0 00110011111111110 0124567889999999999999999998764
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2e-26 Score=248.61 Aligned_cols=264 Identities=21% Similarity=0.249 Sum_probs=203.5
Q ss_pred hhcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCC------CCceeeEeeEEEecC
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIR------HRNIVKLYGFCYHQG 851 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~------h~~iv~l~~~~~~~~ 851 (1078)
..+|.+....|+|-|++|..|.+.. |..||||++...... .+.=..|+++|++|. --|+++++..|.+..
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn 507 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN 507 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence 3456666678999999999999764 789999999776442 334468999999994 358999999999999
Q ss_pred ceEEEEeeccCCCHHhHhcCCCC--CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-ceEEeeccc
Q 001434 852 SNLLIYEYMERGSLGELLHGSSC--NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGL 928 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~--~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~ 928 (1078)
+.|+|||-+.- +|.+.+.+-+. .+...++..++.|+.-||..|-.. ||+|.||||.||||++.. .+||||||.
T Consensus 508 HLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 508 HLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred eeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCcc
Confidence 99999999865 99999976544 688889999999999999999988 999999999999998764 579999999
Q ss_pred ccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHH-------HHHhh
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV-------RNYIR 1001 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~-------~~~~~ 1001 (1078)
|..... ....++.-+..|.|||++.+-+|+...|+||+||++||+.||+.-|.+..+...+...+ .+.++
T Consensus 584 A~~~~e---neitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR 660 (752)
T KOG0670|consen 584 ASFASE---NEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR 660 (752)
T ss_pred cccccc---ccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence 987642 23344556678999999999999999999999999999999999997755443333221 11222
Q ss_pred cCCCCCccccCCCCc-----------------------------------chhhHHHHHHHHHHHHHhcCCCCCCCCCCH
Q 001434 1002 DHSLTPGIFDTRLNV-----------------------------------EDESIVDHMILVLKVALMCTSISPFDRPSM 1046 (1078)
Q Consensus 1002 ~~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~ 1046 (1078)
...+....||..+.. .++.-......+.+|+.+|+..||++|.|.
T Consensus 661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~ 740 (752)
T KOG0670|consen 661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV 740 (752)
T ss_pred hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence 222222222322221 111223445568899999999999999999
Q ss_pred HHHHHH
Q 001434 1047 REVVSM 1052 (1078)
Q Consensus 1047 ~ell~~ 1052 (1078)
.++++|
T Consensus 741 nqAL~H 746 (752)
T KOG0670|consen 741 NQALKH 746 (752)
T ss_pred HHHhcC
Confidence 999876
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.9e-26 Score=228.17 Aligned_cols=251 Identities=20% Similarity=0.308 Sum_probs=189.3
Q ss_pred cCCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeE-EEecCceEEEE
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGF-CYHQGSNLLIY 857 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~-~~~~~~~~lv~ 857 (1078)
.|...+.+|+|.||.+-.|.++ +.+.+++|.+.+... ..++|.+|...--.+ .|.||+..|+. |+..+.+++++
T Consensus 25 ~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 25 VYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 4666778999999999999987 477899999977754 356889998876666 58999998874 77888889999
Q ss_pred eeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEEC--CCCceEEeecccccccCCC
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||++.|+|..-+...+ +-+....+++.|+++|+.|+|++ ++||||||.+|||+- +..+||+||||.++..+
T Consensus 102 E~aP~gdL~snv~~~G--igE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-- 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVEAAG--IGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-- 174 (378)
T ss_pred ccCccchhhhhcCccc--ccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccC--
Confidence 9999999999888765 78888999999999999999999 999999999999993 34589999999987654
Q ss_pred CCCcccccccccCcccccccccC-----CCCCcCcchhHHHHHHHHHhCCCCCCCCC-CCCCHHHHHHHHhhcCCCCCcc
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTM-----KVTEKCDIYSYGVVLLELLTGRTPVQPLD-DGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DvwslGv~l~elltg~~P~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
.......-+..|.+||..... ...+.+|||.||+++|.++||..||+..- .+....+|..-.-+...
T Consensus 175 --~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~----- 247 (378)
T KOG1345|consen 175 --TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP----- 247 (378)
T ss_pred --ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-----
Confidence 222223345678999976422 35688999999999999999999998432 23334444333222211
Q ss_pred ccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCC---CCHHHHHHHHH
Q 001434 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDR---PSMREVVSMLI 1054 (1078)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R---Ps~~ell~~L~ 1054 (1078)
+.+ +.+........++.++-+.++|++| .+++.....+|
T Consensus 248 ---~~P---~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w 289 (378)
T KOG1345|consen 248 ---ALP---KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW 289 (378)
T ss_pred ---cCc---hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence 122 2222233446778889999999999 55555555444
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.1e-27 Score=247.06 Aligned_cols=416 Identities=23% Similarity=0.253 Sum_probs=292.2
Q ss_pred eeecCCcccCCCCccccCccccceeeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccC-CC
Q 001434 275 IVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSE-NS 353 (1078)
Q Consensus 275 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~-N~ 353 (1078)
.+-++-.++ .+|..+. +.-..++|..|+|+...|..|+.+++|+.|||++|.|+.+-|++|.++.+|..|-+-+ |+
T Consensus 51 VdCr~~GL~-eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~Nk 127 (498)
T KOG4237|consen 51 VDCRGKGLT-EVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNK 127 (498)
T ss_pred EEccCCCcc-cCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCc
Confidence 344555566 5676665 3667899999999988888999999999999999999988899999999988776655 99
Q ss_pred CCCccchhhhhhcccchhccccccccCCCCCccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCc
Q 001434 354 LNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPG 433 (1078)
Q Consensus 354 l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~ 433 (1078)
|+......|+++.+|+.|.+.-|++..+..+.|..+++|..|.+-+|.+..+.-..|..+..++.+.+..|.+-.
T Consensus 128 I~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~ic----- 202 (498)
T KOG4237|consen 128 ITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFIC----- 202 (498)
T ss_pred hhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCcccc-----
Confidence 998777889999999999999999999989999999999999999999986666689999999999999988431
Q ss_pred ccccCcceEEEecCCCCCCCCCccccCCCccceeeeeeccccccCCcCCccc-cccceEEeecCCccCccc-cccccccc
Q 001434 434 LGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNC-ETLLQLRLVGNSLTGSFP-LELCKLEN 511 (1078)
Q Consensus 434 ~~~~~~L~~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~-~~L~~L~L~~N~l~~~~p-~~l~~l~~ 511 (1078)
..+++.+.. ++. ..|..+.......-..+.++++..+-+..|... .++..=..+.+...+.-| ..|..|++
T Consensus 203 dCnL~wla~-~~a------~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~ 275 (498)
T KOG4237|consen 203 DCNLPWLAD-DLA------MNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPN 275 (498)
T ss_pred ccccchhhh-HHh------hchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhccc
Confidence 111111110 011 122334444444455555666654444333221 122211222222333334 35888889
Q ss_pred ccccccccccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccC
Q 001434 512 LYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISH 591 (1078)
Q Consensus 512 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 591 (1078)
|+.|+|++|+|+++-+.+|....++++|+|..|+|...-...|.++..|++|+|++|+|+...|..|..+..|.+|.|-.
T Consensus 276 L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~ 355 (498)
T KOG4237|consen 276 LRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLS 355 (498)
T ss_pred ceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehcc
Confidence 99999999999888888898888999999999988876677888888999999999999888888888888899988888
Q ss_pred ccccCC-----CCcccc-----------CcccCceeeccccccCC---CCCCccCC---------cccc-eEEeccCccC
Q 001434 592 NSFVGS-----LPNELG-----------TLQQLEILKLSENKFSG---NIPSTLGN---------LSHL-TELQMGGNLF 642 (1078)
Q Consensus 592 N~l~~~-----~p~~~~-----------~l~~L~~L~Ls~N~l~~---~~p~~~~~---------l~~L-~~L~Ls~N~l 642 (1078)
|.+.-. +-+++. .-..++.++++.+.+.. ..|++.+- ++-+ ++..-|++.+
T Consensus 356 Np~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~l 435 (498)
T KOG4237|consen 356 NPFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLL 435 (498)
T ss_pred CcccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccch
Confidence 877521 001110 01134445555544431 12322221 2223 2334455555
Q ss_pred CCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcCCCcCcCCCChhhhhhccccccccccc
Q 001434 643 SGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYN 713 (1078)
Q Consensus 643 ~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N 713 (1078)
. .+|..+-.-.. .|+|.+|.++ .+|.+ .+.+| .+|||+|+++-.-...|.++++|..|-+|||
T Consensus 436 k-~lp~~iP~d~t---elyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 436 K-LLPRGIPVDVT---ELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred h-hcCCCCCchhH---HHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 4 56655543322 6788888888 78877 66777 8888888888777778888888888888887
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=231.46 Aligned_cols=200 Identities=36% Similarity=0.484 Sum_probs=173.6
Q ss_pred CCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
|+..+.||+|++|.||++.... ++.+++|.+...... ...+.+.+|++.+++++|++++++++++...+..++++||+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 3456789999999999999875 889999999766443 24678899999999999999999999999999999999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~ 940 (1078)
++++|.+++......+++..+..++.+++.++.++|+. +++|+|++|+||+++.++.++++|||.+...........
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence 99999999986653378999999999999999999998 999999999999999999999999999987654321233
Q ss_pred cccccccCccccccc-ccCCCCCcCcchhHHHHHHHHHhCCCCCCC
Q 001434 941 SAVAGSYGYIAPEYA-YTMKVTEKCDIYSYGVVLLELLTGRTPVQP 985 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~-~~~~~~~~~DvwslGv~l~elltg~~P~~~ 985 (1078)
....++..|++||.. ....++.++|||++|++++||++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 445678899999988 666788899999999999999999999953
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.5e-25 Score=237.55 Aligned_cols=270 Identities=27% Similarity=0.368 Sum_probs=201.3
Q ss_pred HhHHHHhhcCCCccEEeccCceEEEEEEEC----CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEE
Q 001434 773 QDVVEATYNFHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFC 847 (1078)
Q Consensus 773 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~ 847 (1078)
+++......|...++||+|.|++||+|.+. .++.||+|.+..... ..++.+|++++..+ .+.||+++.+++
T Consensus 29 q~~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~ 104 (418)
T KOG1167|consen 29 QDIPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCF 104 (418)
T ss_pred hhhhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhh
Confidence 344556678888999999999999999854 467899999966544 45688999999999 599999999999
Q ss_pred EecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-CCceEEeec
Q 001434 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDF 926 (1078)
Q Consensus 848 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-~~~~kl~Df 926 (1078)
...+.+.+|+||++.....++.. .++..++..+++.++.||.++|+. |||||||||+|++++. .+.-.|+||
T Consensus 105 rnnd~v~ivlp~~~H~~f~~l~~----~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDF 177 (418)
T KOG1167|consen 105 RNNDQVAIVLPYFEHDRFRDLYR----SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDF 177 (418)
T ss_pred ccCCeeEEEecccCccCHHHHHh----cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEec
Confidence 99999999999999988888876 466888999999999999999999 9999999999999985 577899999
Q ss_pred ccccccCCCC-------------------------------------------CCcccccccccCcccccccccC-CCCC
Q 001434 927 GLAKVIDMPQ-------------------------------------------SKSMSAVAGSYGYIAPEYAYTM-KVTE 962 (1078)
Q Consensus 927 g~a~~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~ 962 (1078)
|+|..++... ........||++|.|||++.+. ..++
T Consensus 178 gLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtt 257 (418)
T KOG1167|consen 178 GLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTT 257 (418)
T ss_pred hhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCC
Confidence 9997321000 0001125699999999998754 4788
Q ss_pred cCcchhHHHHHHHHHhCCCCCCCCCC-CCCHHHHHH-----HHhhcCCCCCc--ccc-------------------CCCC
Q 001434 963 KCDIYSYGVVLLELLTGRTPVQPLDD-GGDLATWVR-----NYIRDHSLTPG--IFD-------------------TRLN 1015 (1078)
Q Consensus 963 ~~DvwslGv~l~elltg~~P~~~~~~-~~~~~~~~~-----~~~~~~~~~~~--~~~-------------------~~~~ 1015 (1078)
+.||||.||++.-++++++||....+ -+.+.+++. ...+.-..... ++. +.+.
T Consensus 258 aiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~ 337 (418)
T KOG1167|consen 258 AIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIY 337 (418)
T ss_pred ccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcc
Confidence 99999999999999999999875443 333333321 00000000000 111 0000
Q ss_pred c------chhhHHHHH-HHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1016 V------EDESIVDHM-ILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1016 ~------~~~~~~~~~-~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
. ..+.+.+.. ..+++++.+|+..||.+|-|++++++|-
T Consensus 338 ~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp 382 (418)
T KOG1167|consen 338 KSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP 382 (418)
T ss_pred cccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence 1 111222222 2588999999999999999999999874
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-26 Score=242.35 Aligned_cols=289 Identities=23% Similarity=0.265 Sum_probs=198.6
Q ss_pred ccCeEecccCccccccCCCccCcCCCcEEEccCCccccccccccccCCCCceecccc-ccccCCCCccccCCcchhHHhc
Q 001434 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN-NMISGALPEGLGNLSSLVDFVA 205 (1078)
Q Consensus 127 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~-n~i~~~~p~~l~~l~~L~~L~l 205 (1078)
.-+.++|..|+|+..-|.+|+.+.+|+.||||+|+|+-.-|++|.++.+|..|-+.+ |+|+..-...|.+|..|+.|.+
T Consensus 68 ~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~l~k~~F~gL~slqrLll 147 (498)
T KOG4237|consen 68 ETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITDLPKGAFGGLSSLQRLLL 147 (498)
T ss_pred cceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhhhhhhHhhhHHHHHHHhc
Confidence 446677777777755556777777777777777777777777777777776666655 7776444456677777777777
Q ss_pred ccCcccccccccccCcccccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCC
Q 001434 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285 (1078)
Q Consensus 206 ~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~ 285 (1078)
.-|++.-...+.|..|++|..|.+.+|.+...--..|..+.+++.+.+..|.+- ...+++.+.. +...
T Consensus 148 Nan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~i-----cdCnL~wla~-------~~a~ 215 (498)
T KOG4237|consen 148 NANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFI-----CDCNLPWLAD-------DLAM 215 (498)
T ss_pred ChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccc-----cccccchhhh-------HHhh
Confidence 777777666666777777777777777766443446666677777777666532 0112222211 1112
Q ss_pred CCccccCccccceeeeccccccccccccccc-ccccceeeccCCCCCCccC-ccccCcccccEEeccCCCCCCccchhhh
Q 001434 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGN-LKFLTKLYLYRNELNGTIP-REIGNLSMVTEIDLSENSLNGEIPTEFS 363 (1078)
Q Consensus 286 ~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~-l~~L~~L~L~~N~l~~~~p-~~l~~l~~L~~L~Ls~N~l~~~~~~~~~ 363 (1078)
.|..++...-..-..|.++++..+-+..|.. +..+..=..+.+...+.-| ..|..+++|+.|+|++|+|++.-+.+|.
T Consensus 216 ~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe 295 (498)
T KOG4237|consen 216 NPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFE 295 (498)
T ss_pred chhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhhhhhhc
Confidence 3344555555566666777776554444432 2222222223333333444 4688899999999999999988888899
Q ss_pred hhcccchhccccccccCCCCCccccccccCeeeccCccccCCCCcccccccccceeEeeccccc
Q 001434 364 KITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427 (1078)
Q Consensus 364 ~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 427 (1078)
++..++.|+|..|+|..+-...|.++..|+.|+|.+|+|+...|..|..+.+|.+|+|-.|++.
T Consensus 296 ~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~ 359 (498)
T KOG4237|consen 296 GAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFN 359 (498)
T ss_pred chhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCccc
Confidence 9999999999999998777788888999999999999999888889999999999999888876
|
|
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=269.50 Aligned_cols=336 Identities=21% Similarity=0.277 Sum_probs=165.6
Q ss_pred cccCccccceeeecccc------ccccccccccccc-ccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchh
Q 001434 289 ELGNCTKLQTLALYSNN------LVGQIPKEVGNLK-FLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE 361 (1078)
Q Consensus 289 ~l~~l~~L~~L~Ls~N~------l~~~~p~~l~~l~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 361 (1078)
.|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.+. .+|..| ...+|++|++++|++. .++..
T Consensus 553 aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~ 629 (1153)
T PLN03210 553 AFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDG 629 (1153)
T ss_pred HHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccc
Confidence 44555555555554432 2223444444442 3555555555554 445444 3455555666555554 33444
Q ss_pred hhhhcccchhccccccccCCCCCccccccccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcce
Q 001434 362 FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLW 441 (1078)
Q Consensus 362 ~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~ 441 (1078)
+..+++|+.|+|++|...+.+|. +..+++|+.|+|++|.....+|..+..+++|+.|++++|..-..+|..+ .+++|+
T Consensus 630 ~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~ 707 (1153)
T PLN03210 630 VHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLY 707 (1153)
T ss_pred cccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCC
Confidence 45555555555555443334442 4555556666665555444555555555556666555544333444433 445555
Q ss_pred EEEecCCCCCCCCCccccCCCccceeeeeeccccccCCcCCccccccceEEeecCCcc-------Ccccccccccccccc
Q 001434 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT-------GSFPLELCKLENLYA 514 (1078)
Q Consensus 442 ~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~-------~~~p~~l~~l~~L~~ 514 (1078)
.|++++|...+.+|.. ..+|++|+|++|.+. .+|..+ .+++|.+|.+.++... ...+......++|+.
T Consensus 708 ~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~ 782 (1153)
T PLN03210 708 RLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTR 782 (1153)
T ss_pred EEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccchh
Confidence 5555555444344332 245555666665553 233332 3445555555442211 111111222345555
Q ss_pred cccccccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccc
Q 001434 515 IELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSF 594 (1078)
Q Consensus 515 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 594 (1078)
|+|++|...+.+|..++++++|+.|++++|...+.+|..+ ++++|++|++++|..-..+|.. ..+|+.|+|++|.+
T Consensus 783 L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i 858 (1153)
T PLN03210 783 LFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTGI 858 (1153)
T ss_pred eeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCCC
Confidence 5555555444555555555555555555544333344443 4555555555554433333321 23455555555555
Q ss_pred cCCCCccccCcccCceeeccc-cccCCCCCCccCCcccceEEeccCc
Q 001434 595 VGSLPNELGTLQQLEILKLSE-NKFSGNIPSTLGNLSHLTELQMGGN 640 (1078)
Q Consensus 595 ~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N 640 (1078)
+ .+|..+..+++|+.|+|++ |+++ .+|..+..+++|+.|+++++
T Consensus 859 ~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C 903 (1153)
T PLN03210 859 E-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDC 903 (1153)
T ss_pred c-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCC
Confidence 5 4555555555555555554 3333 34555555555555555554
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=270.08 Aligned_cols=338 Identities=19% Similarity=0.220 Sum_probs=212.7
Q ss_pred CCcccccccceeeeeccc------cCCCCCCccCccc-ccceeeecCCcccCCCCccccCccccceeeeccccccccccc
Q 001434 240 AEISGCQSLQILGLAQND------IGGSLPKEIGMLE-SLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPK 312 (1078)
Q Consensus 240 ~~l~~l~~L~~L~L~~n~------l~~~~~~~l~~l~-~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 312 (1078)
.+|.++++|+.|.+..+. +...+|..+..++ +|+.|++.++.++ .+|..| ...+|++|++++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345556666666665442 2223455554443 4666666666665 445554 3456666666666665 4555
Q ss_pred ccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccccCCCCCcccccccc
Q 001434 313 EVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNL 392 (1078)
Q Consensus 313 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L 392 (1078)
.+..+++|+.|+|++|...+.+|. ++.+++|+.|+|++|.....+|..+..+++|+.|++++|...+.+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 556666666666666543334442 5556666666666665545566666666666666666654333444433 56666
Q ss_pred CeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCC-------CCCCCccccCCCccc
Q 001434 393 TKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYL-------TGRIPPHLCQNSNLI 465 (1078)
Q Consensus 393 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l-------~~~~p~~~~~~~~L~ 465 (1078)
+.|++++|...+.+|.. ..+|+.|++++|.++ .+|..+ .+++|..|+++++.. ....+..+...++|+
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~ 781 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFPSNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLT 781 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCccc-cccccc-cccccccccccccchhhccccccccchhhhhccccch
Confidence 66666666544344432 345666666666664 334333 345555566555321 111222233456788
Q ss_pred eeeeeeccccccCCcCCccccccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccceeeccccc
Q 001434 466 MLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNY 545 (1078)
Q Consensus 466 ~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 545 (1078)
.|+|++|...+.+|..+.++++|+.|++++|...+.+|..+ .+++|+.|+|++|.....+|.. .++|++|+|++|.
T Consensus 782 ~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~ 857 (1153)
T PLN03210 782 RLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPDI---STNISDLNLSRTG 857 (1153)
T ss_pred heeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCcccccccc---ccccCEeECCCCC
Confidence 88888887777788888888888888888876555667665 6888888899887554455543 3578899999999
Q ss_pred cccCCCcccCCcccccEEEecc-ccccCcCCccccccccccEEeccCcc
Q 001434 546 FTSELPKEVGNLSQLVTFNISS-NMLTGLIPPEIVNCMTLQRLDISHNS 593 (1078)
Q Consensus 546 l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~ 593 (1078)
++ .+|.++..+++|++|++++ |++. .+|..+..++.|+.++++++.
T Consensus 858 i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 858 IE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred Cc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 87 5788899999999999988 5555 467778889999999998773
|
syringae 6; Provisional |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.9e-23 Score=247.90 Aligned_cols=229 Identities=30% Similarity=0.375 Sum_probs=147.3
Q ss_pred CcceEEEecCCCCCCCCCccccCCCccceeeeeeccccccCCcCCccccccceEEeecCCccCccccccccccccccccc
Q 001434 438 SLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIEL 517 (1078)
Q Consensus 438 ~~L~~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~L 517 (1078)
+.|++|++++|+|+. +|.. .++|+.|+|++|.|+. +|.. ..+|+.|++++|+|+. +|.. .++|+.|+|
T Consensus 242 ~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~-Lp~l---p~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdL 309 (788)
T PRK15387 242 PELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTH-LPAL---PSGLCKLWIFGNQLTS-LPVL---PPGLQELSV 309 (788)
T ss_pred CCCcEEEecCCccCc-ccCc---ccccceeeccCCchhh-hhhc---hhhcCEEECcCCcccc-cccc---ccccceeEC
Confidence 344455555555552 2321 2455666666666542 2321 1345666666776663 3332 356777777
Q ss_pred ccccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCC
Q 001434 518 DQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGS 597 (1078)
Q Consensus 518 s~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~ 597 (1078)
++|+|++ +|... .+|+.|++++|.+++ +|.. ..+|++|+|++|+|+++ |.. ..+|+.|++++|+|+ .
T Consensus 310 S~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~-~ 376 (788)
T PRK15387 310 SDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLT-S 376 (788)
T ss_pred CCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccCCC-CCC---Ccccceehhhccccc-c
Confidence 7777774 44422 356777788888774 4431 24678888888888753 432 246777888888887 4
Q ss_pred CCccccCcccCceeeccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCc
Q 001434 598 LPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGK 677 (1078)
Q Consensus 598 ~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~ 677 (1078)
+|... .+|+.|+|++|+|+ .+|... ++|+.|++++|+|+ .+|... ..|. .|+|++|+|+ .+|.++++
T Consensus 377 LP~l~---~~L~~LdLs~N~Lt-~LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~~L~-~L~Ls~NqLt-~LP~sl~~ 443 (788)
T PRK15387 377 LPALP---SGLKELIVSGNRLT-SLPVLP---SELKELMVSGNRLT-SLPMLP---SGLL-SLSVYRNQLT-RLPESLIH 443 (788)
T ss_pred Ccccc---cccceEEecCCccc-CCCCcc---cCCCEEEccCCcCC-CCCcch---hhhh-hhhhccCccc-ccChHHhh
Confidence 66533 46788888888888 456543 56788888888888 577643 3455 5788888887 68888888
Q ss_pred ccccchhhcCCCcCcCCCChhhhhhcc
Q 001434 678 LDLLEFLLLNNNHLSGEIPSAFENLSS 704 (1078)
Q Consensus 678 l~~L~~L~Ls~N~l~g~ip~~~~~l~~ 704 (1078)
+++|+.|+|++|+|+|.+|..+.++.+
T Consensus 444 L~~L~~LdLs~N~Ls~~~~~~L~~l~s 470 (788)
T PRK15387 444 LSSETTVNLEGNPLSERTLQALREITS 470 (788)
T ss_pred ccCCCeEECCCCCCCchHHHHHHHHhc
Confidence 888888888888888888777755543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.8e-23 Score=211.79 Aligned_cols=171 Identities=23% Similarity=0.190 Sum_probs=129.9
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|+|.++++..+..+++.++..++.|++.||+|||++ + ||+||+++.++.+++ ||.+.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc------
Confidence 689999987666799999999999999999999998 5 999999999999999 99988654221
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
..|++.|+|||++.+..++.++||||+||++|||++|+.||....... ............. .......... .
T Consensus 64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~~-~ 135 (176)
T smart00750 64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS---AILEILLNGMPAD----DPRDRSNLES-V 135 (176)
T ss_pred CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc---HHHHHHHHHhccC----CccccccHHH-H
Confidence 258899999999999999999999999999999999999996443222 2222221111100 0000011111 1
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcc
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~ 1058 (1078)
.....+.+++.+||+.+|++||++.+++++++....
T Consensus 136 ~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~ 171 (176)
T smart00750 136 SAARSFADFMRVCASRLPQRREAANHYLAHCRALFA 171 (176)
T ss_pred HhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence 111258899999999999999999999999987643
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=264.71 Aligned_cols=197 Identities=16% Similarity=0.159 Sum_probs=140.9
Q ss_pred CCC-CceeeEeeEE-------EecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEec
Q 001434 835 IRH-RNIVKLYGFC-------YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906 (1078)
Q Consensus 835 l~h-~~iv~l~~~~-------~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 906 (1078)
++| +||++++++| .+++..+.+|||+ +++|.+++......+++.++..++.||++||+|||++ ||+||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~---gIvHr 104 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQ---GIVVH 104 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhC---Ceeec
Confidence 345 5777777776 3335667889988 4599999987666799999999999999999999998 99999
Q ss_pred CCCCCcEEECCC-------------------CceEEeecccccccCCCCC---------------CcccccccccCcccc
Q 001434 907 DIKSNNILLDDK-------------------FEAHVGDFGLAKVIDMPQS---------------KSMSAVAGSYGYIAP 952 (1078)
Q Consensus 907 Dlkp~Nill~~~-------------------~~~kl~Dfg~a~~~~~~~~---------------~~~~~~~gt~~y~aP 952 (1078)
||||+|||++.. +.+|++|||+++....... .......||+.|+||
T Consensus 105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP 184 (793)
T PLN00181 105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP 184 (793)
T ss_pred cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence 999999999654 4556666666653211000 001124578899999
Q ss_pred cccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHH
Q 001434 953 EYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVA 1032 (1078)
Q Consensus 953 E~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 1032 (1078)
|++.+..|+.++|||||||++|||++|..|+.... ......... .. ++.. .........++
T Consensus 185 E~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~------~~~~~~~~~-~~-----~~~~-------~~~~~~~~~~~ 245 (793)
T PLN00181 185 EEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS------RTMSSLRHR-VL-----PPQI-------LLNWPKEASFC 245 (793)
T ss_pred hhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH------HHHHHHHHh-hc-----Chhh-------hhcCHHHHHHH
Confidence 99999999999999999999999999988764211 111111110 00 1100 01112245778
Q ss_pred HhcCCCCCCCCCCHHHHHHHHH
Q 001434 1033 LMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1033 ~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
.+||+++|.+||++.|++++-+
T Consensus 246 ~~~L~~~P~~Rps~~eil~h~~ 267 (793)
T PLN00181 246 LWLLHPEPSCRPSMSELLQSEF 267 (793)
T ss_pred HHhCCCChhhCcChHHHhhchh
Confidence 8999999999999999998765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=207.58 Aligned_cols=266 Identities=21% Similarity=0.303 Sum_probs=203.0
Q ss_pred hhcCCCccEEeccCceEEEEEE-ECCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 856 (1078)
.-.|+++++||+|.||+++.|. .-++++||||.-..... ..++..|+...+.| ..+.|+.+|-+...+.+..+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 3468889999999999999998 34699999998766544 34566777777777 579999999888888899999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC-----CceEEeecccccc
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK-----FEAHVGDFGLAKV 931 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~Dfg~a~~ 931 (1078)
+|.+ |-+|.|++.-+++.++..+++.+|.|++.-++|+|++ .+|+|||||+|+||... ..+.++|||+|+.
T Consensus 103 idLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 9998 7799999999988999999999999999999999999 99999999999999743 4589999999998
Q ss_pred cCCCCCCc------ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCC
Q 001434 932 IDMPQSKS------MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL 1005 (1078)
Q Consensus 932 ~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~ 1005 (1078)
+.++.... .....||.+||+-....+.+.+.+.|+-|+|-++++.+-|..||++......-... +.+.+.+.
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kY--eKIGe~Kr 256 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKY--EKIGETKR 256 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHH--HHhccccc
Confidence 86554433 34567999999999999999999999999999999999999999987654332221 11111111
Q ss_pred CCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCCC
Q 001434 1006 TPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGR 1062 (1078)
Q Consensus 1006 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~~ 1062 (1078)
.+.+..-.+ ..+.++..-+.-.-..+-++-|..+-+...+.++.++.+.
T Consensus 257 -----~T~i~~Lc~---g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~ 305 (449)
T KOG1165|consen 257 -----STPIEVLCE---GFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE 305 (449)
T ss_pred -----cCCHHHHHh---cCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence 011100011 1122222222233355778899999988888877554443
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-23 Score=246.16 Aligned_cols=240 Identities=29% Similarity=0.347 Sum_probs=189.3
Q ss_pred ceEEEecCCCCCCCCCccccCCCccceeeeeeccccccCCcCCccccccceEEeecCCccCccccccccccccccccccc
Q 001434 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ 519 (1078)
Q Consensus 440 L~~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~ 519 (1078)
|+.|++++|+|+. +|. ..++|++|+|++|+|+. +|.. .++|+.|++++|.|+ .+|..+ ++|+.|++++
T Consensus 224 L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~-~Lp~lp---~~L~~L~Ls~ 291 (788)
T PRK15387 224 ITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLT-HLPALP---SGLCKLWIFG 291 (788)
T ss_pred CCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccCCchh-hhhhch---hhcCEEECcC
Confidence 4445555555553 443 24789999999999985 4543 468999999999998 445432 5688899999
Q ss_pred ccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCC
Q 001434 520 NKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLP 599 (1078)
Q Consensus 520 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 599 (1078)
|+++ .+|.. .++|+.|+|++|+|++ +|... .+|+.|++++|+|++ +|.. ..+|+.|+|++|+|+ .+|
T Consensus 292 N~Lt-~LP~~---p~~L~~LdLS~N~L~~-Lp~lp---~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls-~LP 358 (788)
T PRK15387 292 NQLT-SLPVL---PPGLQELSVSDNQLAS-LPALP---SELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLA-SLP 358 (788)
T ss_pred Cccc-ccccc---ccccceeECCCCcccc-CCCCc---ccccccccccCcccc-cccc---ccccceEecCCCccC-CCC
Confidence 9998 45653 3689999999999996 45432 468889999999986 4532 257999999999999 566
Q ss_pred ccccCcccCceeeccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCccc
Q 001434 600 NELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLD 679 (1078)
Q Consensus 600 ~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~ 679 (1078)
... .+|+.|++++|+|+ .+|... ++|+.|+|++|+|+ .+|.... .|. .|++++|+|+ .+|... .
T Consensus 359 ~lp---~~L~~L~Ls~N~L~-~LP~l~---~~L~~LdLs~N~Lt-~LP~l~s---~L~-~LdLS~N~Ls-sIP~l~---~ 422 (788)
T PRK15387 359 TLP---SELYKLWAYNNRLT-SLPALP---SGLKELIVSGNRLT-SLPVLPS---ELK-ELMVSGNRLT-SLPMLP---S 422 (788)
T ss_pred CCC---cccceehhhccccc-cCcccc---cccceEEecCCccc-CCCCccc---CCC-EEEccCCcCC-CCCcch---h
Confidence 533 57888999999999 477643 57899999999999 5786554 455 6899999999 588654 4
Q ss_pred ccchhhcCCCcCcCCCChhhhhhcccccccccccccCCCCCC
Q 001434 680 LLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPS 721 (1078)
Q Consensus 680 ~L~~L~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~ 721 (1078)
+|+.|+|++|+|+ .+|..+.+++.|..+++++|+|+|.+|.
T Consensus 423 ~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~ 463 (788)
T PRK15387 423 GLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQ 463 (788)
T ss_pred hhhhhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHH
Confidence 6889999999999 8999999999999999999999998874
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-21 Score=219.64 Aligned_cols=262 Identities=21% Similarity=0.256 Sum_probs=197.1
Q ss_pred cCCCccEEeccCceEEEEEEECCC--cEEEEEEecccCCCchhHHHHHHHHHHHccCC----CCceeeEeeEE-EecCce
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSG--KIVAVKKLASNREGNNIESSFRAEILTLGKIR----HRNIVKLYGFC-YHQGSN 853 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~~--~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~----h~~iv~l~~~~-~~~~~~ 853 (1078)
+|...+.||+|+||.||.|.+... +.+|+|.......... ..+..|+.++..+. .+++.++++.+ ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 788889999999999999997653 4788888766543222 15677888888775 36999999999 577788
Q ss_pred EEEEeeccCCCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC-----CceEEeecc
Q 001434 854 LLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK-----FEAHVGDFG 927 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-----~~~kl~Dfg 927 (1078)
++||+.+ |.+|.++..... +.++..++..++.|++.+|+++|+. |++||||||.|+++... ..+.+.|||
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG 172 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG 172 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence 9999988 779999886544 6899999999999999999999999 99999999999999865 469999999
Q ss_pred ccc--ccCCCCC------Cc-ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHH
Q 001434 928 LAK--VIDMPQS------KS-MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN 998 (1078)
Q Consensus 928 ~a~--~~~~~~~------~~-~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~ 998 (1078)
+++ .+..... .. .....||..|++++...+.+.+++.|+||+++++.|+..|..||...............
T Consensus 173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~ 252 (322)
T KOG1164|consen 173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKD 252 (322)
T ss_pred CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHH
Confidence 998 4321111 11 23456999999999999999999999999999999999999999766544333322222
Q ss_pred HhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhcccCC
Q 001434 999 YIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 999 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~~~ 1061 (1078)
...... .. ... .....+.++...+-..+..++|....+...+++.....+
T Consensus 253 ~~~~~~-~~------~~~------~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~~ 302 (322)
T KOG1164|consen 253 PRKLLT-DR------FGD------LKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSEG 302 (322)
T ss_pred hhhhcc-cc------ccC------CChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhcC
Confidence 111110 00 000 011223344444445899999999999999988866553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.5e-22 Score=193.72 Aligned_cols=203 Identities=24% Similarity=0.317 Sum_probs=170.9
Q ss_pred hhcCCCccEEeccCceEEEEEEE-CCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCC-CceeeEeeEEEecCceEEE
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH-RNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 779 ~~~~~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~lv 856 (1078)
..+|...+.||.|+||.+|.|.. .+|++||||+-..... ...+..|..+.+.+++ ..|+.+..++.+.+...+|
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~----hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV 89 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK----HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV 89 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC----CcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence 35678888999999999999984 5799999999866544 2346678888888864 6777778888888889999
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC---CCceEEeecccccccC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVID 933 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~---~~~~kl~Dfg~a~~~~ 933 (1078)
|+.. |.+|.+++.-..+.++..++..++-|++.-++|+|.+ +++||||||+|+|+.- ...+.++|||+|+.+.
T Consensus 90 MdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 90 MDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9998 7799999988777899999999999999999999999 9999999999999963 4568999999998875
Q ss_pred CCCCCc------ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCC
Q 001434 934 MPQSKS------MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG 989 (1078)
Q Consensus 934 ~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~ 989 (1078)
+..... .....||.+|.+-....+.+.+.+.|+-|+|.++.+.--|..||++....
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~ 227 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA 227 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh
Confidence 433222 23467999999988888888889999999999999999999999976543
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3e-21 Score=215.29 Aligned_cols=164 Identities=23% Similarity=0.222 Sum_probs=127.4
Q ss_pred hcCCCccEEeccCceEEEEEEEC--CCcEEEEEEecccCC---CchhHHHHHHHHHHHccCCCCceee-EeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD--SGKIVAVKKLASNRE---GNNIESSFRAEILTLGKIRHRNIVK-LYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~-l~~~~~~~~~~ 853 (1078)
.+|...+.||+|+||+||+|.++ +++.||||++..... .....+.+.+|++++++++|+++++ +++ .+..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCc
Confidence 45777888999999999999875 477789998753321 2234567899999999999999985 443 2467
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCC-CCCcEEECCCCceEEeeccccccc
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDI-KSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
++||||++|++|... .... ...++.|+++||+|+|++ ||+|||| ||+||+++.++.++|+|||+|+.+
T Consensus 94 ~LVmE~~~G~~L~~~-~~~~-------~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RPHG-------DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred EEEEEccCCCCHHHh-Cccc-------hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 999999999999732 2111 146788999999999998 9999999 999999999999999999999876
Q ss_pred CCCCC-------CcccccccccCcccccccccC
Q 001434 933 DMPQS-------KSMSAVAGSYGYIAPEYAYTM 958 (1078)
Q Consensus 933 ~~~~~-------~~~~~~~gt~~y~aPE~~~~~ 958 (1078)
..... .......+++.|+|||.+...
T Consensus 163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 43221 112346788889999987643
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=235.02 Aligned_cols=202 Identities=27% Similarity=0.438 Sum_probs=92.6
Q ss_pred ccCeEecccCccccccCCCccCcCCCcEEEccCCccccccccccccCCCCceeccccccccCCCCccccCCcchhHHhcc
Q 001434 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAY 206 (1078)
Q Consensus 127 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~l~ 206 (1078)
+.+.|++++++++ .+|..+. +.|+.|+|++|.++ .+|..+. ++|++|++++|.++ .+|..+. .+|+.|+++
T Consensus 179 ~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls 249 (754)
T PRK15370 179 NKTELRLKILGLT-TIPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS 249 (754)
T ss_pred CceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence 3455666666655 3454443 35666666666665 4454443 35666666666655 3444332 244455555
Q ss_pred cCcccccccccccCcccccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCC
Q 001434 207 TNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFI 286 (1078)
Q Consensus 207 ~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~ 286 (1078)
+|++. .+|..+. ++|+.|++++|+++ .+|..+. ++|+.|++++|+|++ +|..+. ++|+.|++++|+++. +
T Consensus 250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp--~sL~~L~Ls~N~Lt~-L 319 (754)
T PRK15370 250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-LPAHLP--SGITHLNVQSNSLTA-L 319 (754)
T ss_pred CCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-Ccccch--hhHHHHHhcCCcccc-C
Confidence 55544 3444332 24455555555544 2343332 344555555554442 232221 234444444444442 2
Q ss_pred CccccCccccceeeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCC
Q 001434 287 PSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355 (1078)
Q Consensus 287 p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~ 355 (1078)
|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|+|++|+++
T Consensus 320 P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt 380 (754)
T PRK15370 320 PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT 380 (754)
T ss_pred Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC
Confidence 32221 344444444444442 333332 34444444444444 2333221 34444444444444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-22 Score=197.95 Aligned_cols=244 Identities=22% Similarity=0.320 Sum_probs=188.4
Q ss_pred EEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHH
Q 001434 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~ 866 (1078)
+|.+...|..|+|+|+ |..+++|++..........++|..|.-.++-+.||||..+++.|.......++..||+.|+|+
T Consensus 197 kl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsly 275 (448)
T KOG0195|consen 197 KLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLY 275 (448)
T ss_pred hhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHH
Confidence 4888999999999998 556777888777666667789999999999999999999999999999999999999999999
Q ss_pred hHhcCCCC-CCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEe--ecccccccCCCCCCccccc
Q 001434 867 ELLHGSSC-NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG--DFGLAKVIDMPQSKSMSAV 943 (1078)
Q Consensus 867 ~~l~~~~~-~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~ 943 (1078)
..+++... ..+..++++++.++++|++|||+. .+-|.---+....|++|++.+.+|. |--++.+. . ..
T Consensus 276 nvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe---~-----gr 346 (448)
T KOG0195|consen 276 NVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE---V-----GR 346 (448)
T ss_pred HHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeec---c-----cc
Confidence 99997643 577789999999999999999997 3334555688999999999887764 32222111 1 11
Q ss_pred ccccCcccccccccCCCC---CcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhh
Q 001434 944 AGSYGYIAPEYAYTMKVT---EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020 (1078)
Q Consensus 944 ~gt~~y~aPE~~~~~~~~---~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1020 (1078)
.-.|.|++||.++..+-+ .++|+|||++++||+-|...||.....-+.--.++-.-.+ ..+++
T Consensus 347 ~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr----------v~ipp---- 412 (448)
T KOG0195|consen 347 AYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR----------VHIPP---- 412 (448)
T ss_pred ccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc----------ccCCC----
Confidence 246889999998876543 5899999999999999999999866543322222211111 11111
Q ss_pred HHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhh
Q 001434 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1021 ~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~ 1056 (1078)
.....+.+++.-|++.||.+||.++.++-.|++.
T Consensus 413 --gis~hm~klm~icmnedpgkrpkfdmivpilekm 446 (448)
T KOG0195|consen 413 --GISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM 446 (448)
T ss_pred --CccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence 1223356788889999999999999999988875
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.5e-21 Score=233.18 Aligned_cols=266 Identities=29% Similarity=0.432 Sum_probs=167.5
Q ss_pred ccCeeeccCccccCCCCcccccccccceeEeeccccccCCCCcccccCcceEEEecCCCCCCCCCccccCCCccceeeee
Q 001434 391 NLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLG 470 (1078)
Q Consensus 391 ~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~Ldls~N~l~~~~p~~~~~~~~L~~L~Ls 470 (1078)
+...|+++++.++. +|..+. +.++.|+|++|+|+. +|..+. .+|+.|++++|+|+. +|..
T Consensus 179 ~~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lts-LP~~------------- 238 (754)
T PRK15370 179 NKTELRLKILGLTT-IPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLTS-IPAT------------- 238 (754)
T ss_pred CceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCcccc-CChh-------------
Confidence 45778888888874 444332 356666666666663 232221 244555555555442 2322
Q ss_pred eccccccCCcCCccccccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccceeeccccccccCC
Q 001434 471 YNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSEL 550 (1078)
Q Consensus 471 ~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 550 (1078)
+. .+|+.|+|++|++. .+|..+. ++|+.|++++|+|+ .+|..+. .+|+.|++++|+|++ +
T Consensus 239 -----------l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~-L 298 (754)
T PRK15370 239 -----------LP--DTIQEMELSINRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRT-L 298 (754)
T ss_pred -----------hh--ccccEEECcCCccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCcccc-C
Confidence 21 24555555555555 3444433 35666677777666 3555443 367777777777764 4
Q ss_pred CcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccCceeeccccccCCCCCCccCCcc
Q 001434 551 PKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLS 630 (1078)
Q Consensus 551 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 630 (1078)
|..+. ++|+.|++++|+++. +|..+. ++|+.|++++|.+++ +|..+. ++|+.|+|++|+|+ .+|..+. +
T Consensus 299 P~~lp--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~ 367 (754)
T PRK15370 299 PAHLP--SGITHLNVQSNSLTA-LPETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--P 367 (754)
T ss_pred cccch--hhHHHHHhcCCcccc-CCcccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--C
Confidence 44332 367777888887775 343332 578888888888874 666554 58888888888887 5676553 6
Q ss_pred cceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccC----cccccchhhcCCCcCcCCCChhhhhhcccc
Q 001434 631 HLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELG----KLDLLEFLLLNNNHLSGEIPSAFENLSSLL 706 (1078)
Q Consensus 631 ~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~----~l~~L~~L~Ls~N~l~g~ip~~~~~l~~L~ 706 (1078)
+|+.|+|++|+|+ .+|..+. ..|+ .|++++|+|+ .+|..+. .++.+..|+|.+|+|+. ..+..|+
T Consensus 368 ~L~~LdLs~N~Lt-~LP~~l~--~sL~-~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~ 436 (754)
T PRK15370 368 TITTLDVSRNALT-NLPENLP--AALQ-IMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQ 436 (754)
T ss_pred CcCEEECCCCcCC-CCCHhHH--HHHH-HHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHH
Confidence 8889999999998 6787764 3566 7899999998 5666543 34778889999999982 3444444
Q ss_pred cccccccccCCCC
Q 001434 707 GSNFSYNNLTGPL 719 (1078)
Q Consensus 707 ~l~ls~N~l~g~~ 719 (1078)
.+ ++.+.+.|++
T Consensus 437 ~L-l~s~~~~gp~ 448 (754)
T PRK15370 437 RL-MSSVGYQGPR 448 (754)
T ss_pred Hh-hhcccccCCc
Confidence 44 4556666543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.5e-21 Score=230.42 Aligned_cols=256 Identities=20% Similarity=0.243 Sum_probs=190.5
Q ss_pred ccEEeccCceEEEEEEEC-CCcEEEEEEecc---cCCCchh-HHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 785 SFIVGSGAYGTVYKAVMD-SGKIVAVKKLAS---NREGNNI-ESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~---~~~~~~~-~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
..++|.|++|.|+.+... ..+.++.|.+.. ....... ...+..|+-+-.+++|++++.....+.+.....-+|||
T Consensus 323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~ 402 (601)
T KOG0590|consen 323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY 402 (601)
T ss_pred cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence 456999999988877643 234444444331 1111111 12256677788889999999988887776666666999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCC--
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-- 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~-- 937 (1078)
+++ +|+.++.... .+...++-.++.|++.|+.|+|+. |+.|||+|++|++++..|.+||+|||.+.....+..
T Consensus 403 ~~~-Dlf~~~~~~~-~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~ 477 (601)
T KOG0590|consen 403 CPY-DLFSLVMSNG-KLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN 477 (601)
T ss_pred ccH-HHHHHHhccc-ccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence 999 9999988763 588889999999999999999999 999999999999999999999999999987654333
Q ss_pred -CcccccccccCcccccccccCCCCC-cCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCC
Q 001434 938 -KSMSAVAGSYGYIAPEYAYTMKVTE-KCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 938 -~~~~~~~gt~~y~aPE~~~~~~~~~-~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
......+|+..|+|||++.+.+|++ ..||||.|++++.|.+|+.||.......+... ...... . .....
T Consensus 478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~----~~~~~~-~----~~~~~ 548 (601)
T KOG0590|consen 478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFK----TNNYSD-Q----RNIFE 548 (601)
T ss_pred hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchh----hhcccc-c----ccccc
Confidence 3455678999999999999999985 68999999999999999999986553333210 000000 0 11111
Q ss_pred cchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHH
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
....-+.........++.+|++++|.+|.|+++|++.=|
T Consensus 549 ~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W 587 (601)
T KOG0590|consen 549 GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW 587 (601)
T ss_pred ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence 122233445566788999999999999999999987543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.7e-19 Score=200.48 Aligned_cols=261 Identities=32% Similarity=0.420 Sum_probs=201.0
Q ss_pred CCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCch-hHHHHHHHHHHHccCCCC-ceeeEeeEEEecCceEEEEee
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNN-IESSFRAEILTLGKIRHR-NIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~h~-~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
|...+.+|.|+||.||.+.+. ..+++|.+........ ....+.+|+..++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 455677999999999999987 7889999987766543 577899999999999988 799999999777778999999
Q ss_pred ccCCCHHhHhcCCC--CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC-ceEEeecccccccCCCC
Q 001434 860 MERGSLGELLHGSS--CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~ 936 (1078)
+.++++.+++.... ..+.......++.|++.++.|+|+. +++|||+||+||+++..+ .++++|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 99999997776554 2688899999999999999999999 999999999999999998 79999999998654332
Q ss_pred CC-----cccccccccCccccccccc---CCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCc
Q 001434 937 SK-----SMSAVAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 937 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1078)
.. ......|+..|+|||...+ ..+....|+|++|++++++++|..||..................... .
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~-- 233 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPT-P-- 233 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCC-c--
Confidence 22 3466789999999999987 57889999999999999999999997644331112222222221111 1
Q ss_pred cccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
........... ......+.+++.+|+..+|..|.+..+....
T Consensus 234 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 SLASPLSPSNP--ELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccccccCcccc--chhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00000100000 1222446788899999999999999988876
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.9e-20 Score=219.62 Aligned_cols=247 Identities=22% Similarity=0.246 Sum_probs=184.3
Q ss_pred cCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchh--HHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNI--ESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~--~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
++...+.+|.+.|=+|.+|+++.|. |+||++.+....... ..+...|++ ...+++||++++..+.+.++..|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5666778999999999999999776 899999877643331 222333444 455589999999988888888899999
Q ss_pred eccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc--CCCC
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQ 936 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~--~~~~ 936 (1078)
|... +|+|++..++ .+...+...|+.|++.|+..+|+. ||+|||||.+|||++.-.-+.++||..-+-. ..+.
T Consensus 102 yvkh-nLyDRlSTRP-FL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDN 176 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-FLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDN 176 (1431)
T ss_pred HHhh-hhhhhhccch-HHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCC
Confidence 9977 9999999776 788889999999999999999999 9999999999999999999999999876532 2222
Q ss_pred CCccc----ccccccCcccccccccC-----------CCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHh
Q 001434 937 SKSMS----AVAGSYGYIAPEYAYTM-----------KVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYI 1000 (1078)
Q Consensus 937 ~~~~~----~~~gt~~y~aPE~~~~~-----------~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~ 1000 (1078)
..... +......|+|||.+... ..+++.||||+||+++|+++ |++||. +.+... |.
T Consensus 177 Padf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~-------LSQL~a-Yr 248 (1431)
T KOG1240|consen 177 PADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT-------LSQLLA-YR 248 (1431)
T ss_pred cccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc-------HHHHHh-Hh
Confidence 22222 23345579999987531 15678999999999999999 788884 222211 11
Q ss_pred hcCCCCCccccCCCCcchhhHHHHH--HHHHHHHHhcCCCCCCCCCCHHHHHHHH
Q 001434 1001 RDHSLTPGIFDTRLNVEDESIVDHM--ILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1001 ~~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~li~~cl~~dP~~RPs~~ell~~L 1053 (1078)
.... ...+...+.+ ..++.++..|++.||++|-++++.++.-
T Consensus 249 ~~~~-----------~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~y 292 (1431)
T KOG1240|consen 249 SGNA-----------DDPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQKY 292 (1431)
T ss_pred ccCc-----------cCHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHhh
Confidence 1100 0111111111 1367899999999999999999999873
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-19 Score=184.40 Aligned_cols=141 Identities=16% Similarity=0.124 Sum_probs=109.5
Q ss_pred cEEeccCceEEEEEEECCCcEEEEEEecccCCCchh------------------------HHHHHHHHHHHccCCCCcee
Q 001434 786 FIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNI------------------------ESSFRAEILTLGKIRHRNIV 841 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~------------------------~~~~~~e~~~l~~l~h~~iv 841 (1078)
..||+|++|.||+|.+++|+.||||+++........ .....+|++.+.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 469999999999999888999999999765321111 11234599999999887764
Q ss_pred eEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhh-hccCCCceEecCCCCCcEEECCCCc
Q 001434 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYL-HHDCKPRIFHRDIKSNNILLDDKFE 920 (1078)
Q Consensus 842 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlkp~Nill~~~~~ 920 (1078)
....+.. ...++||||++|+++....... ..++..++..++.|++.++.|+ |+. ||+||||||+||+++ ++.
T Consensus 83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~-~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILL--KSHVLVMEFIGDDGWAAPRLKD-APLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEe--cCCEEEEEEeCCCCCcchhhhc-CCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCc
Confidence 4333222 2348999999988776553322 3688899999999999999999 677 999999999999998 478
Q ss_pred eEEeecccccccC
Q 001434 921 AHVGDFGLAKVID 933 (1078)
Q Consensus 921 ~kl~Dfg~a~~~~ 933 (1078)
++++|||+|...+
T Consensus 156 v~LiDFG~a~~~~ 168 (190)
T cd05147 156 LYIIDVSQSVEHD 168 (190)
T ss_pred EEEEEccccccCC
Confidence 9999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-19 Score=185.95 Aligned_cols=173 Identities=14% Similarity=0.158 Sum_probs=134.2
Q ss_pred HhhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchh-HHH------HHHHHHHHccCCCCceeeEeeEEEec
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNI-ESS------FRAEILTLGKIRHRNIVKLYGFCYHQ 850 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~-~~~------~~~e~~~l~~l~h~~iv~l~~~~~~~ 850 (1078)
..++|+..+++|.|+||.||.+.. ++..+|+|++.......+. ... +.+|++.+.++.|++|+.+.+++.+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 367888899999999999999766 5778999999766443221 122 57999999999999999999986643
Q ss_pred --------CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceE
Q 001434 851 --------GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 922 (1078)
Q Consensus 851 --------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~k 922 (1078)
...++||||++|.+|.++.. .+. ....+++.++..+|+. |++|||++|+||+++.+| ++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~ 174 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LR 174 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EE
Confidence 35789999999999988732 222 2455899999999999 999999999999999988 99
Q ss_pred EeecccccccCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHH
Q 001434 923 VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 977 (1078)
Q Consensus 923 l~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ell 977 (1078)
++|||........... ........|..++|+|++|+++....
T Consensus 175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence 9999988755311111 11334455677999999999886654
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.7e-20 Score=175.36 Aligned_cols=184 Identities=31% Similarity=0.566 Sum_probs=110.2
Q ss_pred cccccccccccccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEe
Q 001434 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLD 588 (1078)
Q Consensus 509 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 588 (1078)
+++.+.|.||+|+++ .+|+.+..+.+|+.|++++|++. .+|..+..+++|+.|+++-|++. ..|..|+.++.|+.||
T Consensus 32 ~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levld 108 (264)
T KOG0617|consen 32 MSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLD 108 (264)
T ss_pred hhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhh
Confidence 344555555555555 45555555555556666555555 35555555555555655555554 3455555566666666
Q ss_pred ccCccccC-CCCccccCcccCceeeccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccc
Q 001434 589 ISHNSFVG-SLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNL 667 (1078)
Q Consensus 589 Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l 667 (1078)
|++|++.. .+|..|..++.|+.|+|+.|.+. .+|..++++++|+.|.+.+|.+- ++|.+++.+..|+ .|.+.+|++
T Consensus 109 ltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lr-elhiqgnrl 185 (264)
T KOG0617|consen 109 LTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLR-ELHIQGNRL 185 (264)
T ss_pred ccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHH-HHhccccee
Confidence 66555542 35666666666666666666665 56666666666666666666666 6666666666666 566666666
Q ss_pred cCCCCcccCcccc---cchhhcCCCcCcCCCChhh
Q 001434 668 SGSIPPELGKLDL---LEFLLLNNNHLSGEIPSAF 699 (1078)
Q Consensus 668 ~g~ip~~~~~l~~---L~~L~Ls~N~l~g~ip~~~ 699 (1078)
+ .+|++++++.- =+.+.+.+|.+-..|.+.|
T Consensus 186 ~-vlppel~~l~l~~~k~v~r~E~NPwv~pIaeQf 219 (264)
T KOG0617|consen 186 T-VLPPELANLDLVGNKQVMRMEENPWVNPIAEQF 219 (264)
T ss_pred e-ecChhhhhhhhhhhHHHHhhhhCCCCChHHHHH
Confidence 6 56666665432 2345666777766665544
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.1e-20 Score=176.77 Aligned_cols=185 Identities=29% Similarity=0.531 Sum_probs=161.4
Q ss_pred ccccccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccceeeccccccccCCCcccCCcccccE
Q 001434 483 LNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVT 562 (1078)
Q Consensus 483 ~~~~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 562 (1078)
++++....|.|++|+++ .+|..+..+.+|+.|++++|+++ .+|..++.+++|+.|+++-|++. .+|..|+.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 44556667777888887 67778999999999999999998 78999999999999999999997 68999999999999
Q ss_pred EEeccccccC-cCCccccccccccEEeccCccccCCCCccccCcccCceeeccccccCCCCCCccCCcccceEEeccCcc
Q 001434 563 FNISSNMLTG-LIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNL 641 (1078)
Q Consensus 563 L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 641 (1078)
|||++|++.. ..|..|..++.|+.|+|+.|.|. .+|..++++++|+.|.+..|.+- .+|.+++.++.|++|.+.+|+
T Consensus 107 ldltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnr 184 (264)
T KOG0617|consen 107 LDLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNR 184 (264)
T ss_pred hhccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccce
Confidence 9999999974 57999999999999999999998 89999999999999999999998 799999999999999999999
Q ss_pred CCCCCCccccCchhHH--HHHhcccccccCCCCc
Q 001434 642 FSGEIPPELGDLSSLQ--IALNLSYNNLSGSIPP 673 (1078)
Q Consensus 642 l~g~ip~~l~~l~~l~--~~L~Ls~N~l~g~ip~ 673 (1078)
++ .+|++++.+.-.. ..+-+.+|.....|.+
T Consensus 185 l~-vlppel~~l~l~~~k~v~r~E~NPwv~pIae 217 (264)
T KOG0617|consen 185 LT-VLPPELANLDLVGNKQVMRMEENPWVNPIAE 217 (264)
T ss_pred ee-ecChhhhhhhhhhhHHHHhhhhCCCCChHHH
Confidence 99 8999998764321 2356677777655544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.3e-18 Score=175.92 Aligned_cols=140 Identities=19% Similarity=0.174 Sum_probs=111.1
Q ss_pred cEEeccCceEEEEEEECCCcEEEEEEecccCCCch------------------------hHHHHHHHHHHHccCCCCcee
Q 001434 786 FIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNN------------------------IESSFRAEILTLGKIRHRNIV 841 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~iv 841 (1078)
..||+|++|.||+|.+.+|+.||||++........ ....+.+|++.+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 56999999999999987899999999876532100 012246789999999998875
Q ss_pred eEeeEEEecCceEEEEeeccCCCHHhH-hcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCC
Q 001434 842 KLYGFCYHQGSNLLIYEYMERGSLGEL-LHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKF 919 (1078)
Q Consensus 842 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~ 919 (1078)
....+... ..++||||++|+++... +.. ..++..+...++.|++.++.++|+ . ||+||||||+||+++ ++
T Consensus 83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~ 154 (190)
T cd05145 83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CceEEEec--CCEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CC
Confidence 54444332 34899999998865443 332 247788899999999999999999 8 999999999999999 78
Q ss_pred ceEEeecccccccC
Q 001434 920 EAHVGDFGLAKVID 933 (1078)
Q Consensus 920 ~~kl~Dfg~a~~~~ 933 (1078)
.++++|||++...+
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.9e-19 Score=186.71 Aligned_cols=232 Identities=20% Similarity=0.237 Sum_probs=148.9
Q ss_pred CCCccEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCC----------CCceeeEeeEEEe
Q 001434 782 FHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIR----------HRNIVKLYGFCYH 849 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~----------h~~iv~l~~~~~~ 849 (1078)
+..++.||.|+++.||.+++. +++++|+|++..... .....+.+++|.-....+. |-.++-.++....
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 455678999999999999987 489999998866543 2334567777765555432 2233333333321
Q ss_pred ---------cC--------ceEEEEeeccCCCHHhHhc---CCCC---CCChhHHHHHHHHHHhhhhhhhccCCCceEec
Q 001434 850 ---------QG--------SNLLIYEYMERGSLGELLH---GSSC---NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906 (1078)
Q Consensus 850 ---------~~--------~~~lv~e~~~~gsL~~~l~---~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~ 906 (1078)
.. ..+++|+-+.+ +|.+++. .... ......+..+..|+++.++++|+. |+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEES
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEec
Confidence 11 22578888854 8988764 1111 234455666778999999999999 99999
Q ss_pred CCCCCcEEECCCCceEEeecccccccCCCCCCcccccccccCcccccccccC--------CCCCcCcchhHHHHHHHHHh
Q 001434 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM--------KVTEKCDIYSYGVVLLELLT 978 (1078)
Q Consensus 907 Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DvwslGv~l~ellt 978 (1078)
||+|+|++++++|.++++||+.....+.. ......+..|.|||..... .++.+.|.|++|+++|.+.+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999999988765421 1113455789999976442 47889999999999999999
Q ss_pred CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCC
Q 001434 979 GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDR 1043 (1078)
Q Consensus 979 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R 1043 (1078)
|+.||........... .+... .+....+..+|..+++.+|++|
T Consensus 246 ~~lPf~~~~~~~~~~~------------------~f~~C----~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW------------------DFSRC----RDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG------------------GGTTS----S---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc------------------cchhc----CCcCHHHHHHHHHHccCCcccC
Confidence 9999975432211100 11111 1233457789999999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.4e-18 Score=171.83 Aligned_cols=188 Identities=15% Similarity=0.065 Sum_probs=138.3
Q ss_pred CccEEeccCceEEEEEEECCCcEEEEEEecccCCC--chhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEEEeec
Q 001434 784 DSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREG--NNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 784 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
....+++|+||+||.+.. .+.+++.+.+...... ......+.+|+++++++. |+++++++++ ...+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 345799999999997766 4777887777544321 111235789999999995 5889999886 3469999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCC-CCCcEEECCCCceEEeecccccccCCCCCC-
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDI-KSNNILLDDKFEAHVGDFGLAKVIDMPQSK- 938 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dl-kp~Nill~~~~~~kl~Dfg~a~~~~~~~~~- 938 (1078)
+|.+|.+.+.. ....++.|+++++.++|++ ||+|||| ||+||+++.++.++|+|||+|.........
T Consensus 81 ~G~~L~~~~~~--------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 81 AGAAMYQRPPR--------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred cCccHHhhhhh--------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 99999765321 1235778999999999999 9999999 799999999999999999999865422210
Q ss_pred ---c--------ccccccccCccccccccc-CCCC-CcCcchhHHHHHHHHHhCCCCCCCCC
Q 001434 939 ---S--------MSAVAGSYGYIAPEYAYT-MKVT-EKCDIYSYGVVLLELLTGRTPVQPLD 987 (1078)
Q Consensus 939 ---~--------~~~~~gt~~y~aPE~~~~-~~~~-~~~DvwslGv~l~elltg~~P~~~~~ 987 (1078)
. ......++.|++|+...- ...+ .+.+.++-|.-+|.++|+..+.....
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 001235677777774321 1222 56788999999999999998876543
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.75 E-value=2.3e-20 Score=210.96 Aligned_cols=275 Identities=21% Similarity=0.238 Sum_probs=139.6
Q ss_pred EeCCCCcccc-cCCCcccCCCccCeEecccCccccc----cCCCccCcCCCcEEEccCCccc------cccccccccCCC
Q 001434 107 LDLNAMNFTG-SLSPSIGGLVHLTYLDLAYNELTGY----IPREIGNCSRLEHLYLNNNQFS------GKIPAELGKLSS 175 (1078)
Q Consensus 107 l~l~~~~l~g-~~~~~l~~l~~L~~L~L~~n~l~~~----~p~~~~~l~~L~~L~Ls~n~l~------~~~p~~l~~l~~ 175 (1078)
|+|.++.+++ .....+..+++|+.|++++|.+++. ++..+...++|++|+++++.+. ..++..+..+++
T Consensus 3 l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~~ 82 (319)
T cd00116 3 LSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGCG 82 (319)
T ss_pred cccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcCc
Confidence 5666667663 3445566777788888888887533 5556667777888888888776 234456667778
Q ss_pred CceeccccccccCCCCccccCCcc---hhHHhcccCcccc----cccccccCc-ccccEEEcCCcccccc----cCCCcc
Q 001434 176 LVSLNICNNMISGALPEGLGNLSS---LVDFVAYTNNLTG----PLPQSIGNL-RNLRVFRAGQNAISGS----IPAEIS 243 (1078)
Q Consensus 176 L~~L~Ls~n~i~~~~p~~l~~l~~---L~~L~l~~n~l~~----~~p~~l~~l-~~L~~L~l~~n~l~~~----~p~~l~ 243 (1078)
|++|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+.
T Consensus 83 L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~ 162 (319)
T cd00116 83 LQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKALR 162 (319)
T ss_pred eeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHHH
Confidence 888888888876555544444433 5555555555542 222233444 5555555555555422 122233
Q ss_pred cccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceeeecccccccc----cccccccccc
Q 001434 244 GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQ----IPKEVGNLKF 319 (1078)
Q Consensus 244 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~ 319 (1078)
.+++|++|++++|.+++.... .++..+..+++|++|++++|.+++. ++..+..+++
T Consensus 163 ~~~~L~~L~l~~n~l~~~~~~--------------------~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~ 222 (319)
T cd00116 163 ANRDLKELNLANNGIGDAGIR--------------------ALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKS 222 (319)
T ss_pred hCCCcCEEECcCCCCchHHHH--------------------HHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCC
Confidence 344455555555544421110 1112223333444445544444322 1222333444
Q ss_pred cceeeccCCCCCCccCcccc-----CcccccEEeccCCCCCC----ccchhhhhhcccchhccccccccCC----CCCcc
Q 001434 320 LTKLYLYRNELNGTIPREIG-----NLSMVTEIDLSENSLNG----EIPTEFSKITGLRLLFLFQNQLTGV----IPNEL 386 (1078)
Q Consensus 320 L~~L~L~~N~l~~~~p~~l~-----~l~~L~~L~Ls~N~l~~----~~~~~~~~l~~L~~L~L~~N~l~~~----~p~~l 386 (1078)
|++|++++|.+++.....+. ..+.|++|++++|.++. .+...+..+++|+++++++|.++.. ....+
T Consensus 223 L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~ 302 (319)
T cd00116 223 LEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESL 302 (319)
T ss_pred CCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHH
Confidence 55555555554432111111 12455555555555541 1122333344555555555555532 22222
Q ss_pred ccc-cccCeeeccCcc
Q 001434 387 SSL-RNLTKLDLSINY 401 (1078)
Q Consensus 387 ~~l-~~L~~L~Ls~N~ 401 (1078)
... +.|++|++.+|.
T Consensus 303 ~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 303 LEPGNELESLWVKDDS 318 (319)
T ss_pred hhcCCchhhcccCCCC
Confidence 233 456666666654
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.4e-19 Score=200.59 Aligned_cols=226 Identities=25% Similarity=0.284 Sum_probs=177.4
Q ss_pred EeccCceEEEEEE----ECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEEEeeccC
Q 001434 788 VGSGAYGTVYKAV----MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 788 lG~G~~g~V~~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+|+|+||.|+.+. .+.|.-||.|+.++.............|..++...+ ||.++++...++.+...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 6899999999876 234778999988776544333335566777777776 99999999999999999999999999
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 942 (1078)
|.+...+.... .++..........++-|++++|+. +++|||+|++||+++.+|++++.|||.++..-... .
T Consensus 82 g~lft~l~~~~-~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~ 152 (612)
T KOG0603|consen 82 GDLFTRLSKEV-MFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----I 152 (612)
T ss_pred chhhhccccCC-chHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhh-----h
Confidence 99999888766 456666666667788899999999 99999999999999999999999999998653111 1
Q ss_pred cccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHH
Q 001434 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022 (1078)
Q Consensus 943 ~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1022 (1078)
.+||..|||||++. .+..++|.||+|++.+||++|..||.. +.++.+.+.....+ .
T Consensus 153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~~~~~~p--------------~ 208 (612)
T KOG0603|consen 153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILKAELEMP--------------R 208 (612)
T ss_pred cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhhhccCCc--------------h
Confidence 28999999999987 567899999999999999999999974 33444433221111 1
Q ss_pred HHHHHHHHHHHhcCCCCCCCCCCH
Q 001434 1023 DHMILVLKVALMCTSISPFDRPSM 1046 (1078)
Q Consensus 1023 ~~~~~l~~li~~cl~~dP~~RPs~ 1046 (1078)
+......+++.+++..+|..|--.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhcc
Confidence 223335567778888899998854
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1e-17 Score=189.76 Aligned_cols=219 Identities=25% Similarity=0.419 Sum_probs=169.6
Q ss_pred HccCCCCceeeEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCC
Q 001434 832 LGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSN 911 (1078)
Q Consensus 832 l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 911 (1078)
|+.+.|.|+.++++.+.++...++|.+|+..|+|.|.+......+++.....++++|+.|++|+|+- +-.+|+.++.+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l~s~ 78 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGALKSS 78 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeeeccc
Confidence 4678999999999999999999999999999999999998777899999999999999999999986 23399999999
Q ss_pred cEEECCCCceEEeecccccccCC-CCCCcccccccccCcccccccccC-------CCCCcCcchhHHHHHHHHHhCCCCC
Q 001434 912 NILLDDKFEAHVGDFGLAKVIDM-PQSKSMSAVAGSYGYIAPEYAYTM-------KVTEKCDIYSYGVVLLELLTGRTPV 983 (1078)
Q Consensus 912 Nill~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DvwslGv~l~elltg~~P~ 983 (1078)
|+++|....+|++|||+...... ..........-..-|.|||.+... ..+.++||||+|++++|+++.+.||
T Consensus 79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~ 158 (484)
T KOG1023|consen 79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF 158 (484)
T ss_pred cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence 99999999999999999876642 111222223345679999988653 1467899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhccc
Q 001434 984 QPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 984 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~~~ 1059 (1078)
..........+++....... ...+.+.+.... +....+..++..||..+|++||+++++-..++.+...
T Consensus 159 ~~~~~~~~~~eii~~~~~~~---~~~~rP~i~~~~----e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~ 227 (484)
T KOG1023|consen 159 DLRNLVEDPDEIILRVKKGG---SNPFRPSIELLN----ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG 227 (484)
T ss_pred ccccccCChHHHHHHHHhcC---CCCcCcchhhhh----hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence 87555554444444432211 111122222111 2233578899999999999999999999999887554
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-20 Score=210.75 Aligned_cols=279 Identities=22% Similarity=0.236 Sum_probs=207.1
Q ss_pred eEecccCccc-cccCCCccCcCCCcEEEccCCccccc----cccccccCCCCceeccccccccCCCCccccCCcchhHHh
Q 001434 130 YLDLAYNELT-GYIPREIGNCSRLEHLYLNNNQFSGK----IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFV 204 (1078)
Q Consensus 130 ~L~L~~n~l~-~~~p~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~ 204 (1078)
.|+|..++++ +..+..+..+.+|++|+|+++.+++. ++..+...++|++|+++++.+.+ .+..
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~-~~~~----------- 69 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGR-IPRG----------- 69 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCC-cchH-----------
Confidence 5788888887 44556677888899999999998543 56667778889999999887753 1111
Q ss_pred cccCcccccccccccCcccccEEEcCCcccccccCCCcccccc---cceeeeeccccCC----CCCCccCcc-cccceee
Q 001434 205 AYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQS---LQILGLAQNDIGG----SLPKEIGML-ESLTEIV 276 (1078)
Q Consensus 205 l~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~---L~~L~L~~n~l~~----~~~~~l~~l-~~L~~L~ 276 (1078)
...++..+..+++|+.|++++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|++|+
T Consensus 70 ------~~~~~~~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~ 143 (319)
T cd00116 70 ------LQSLLQGLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLV 143 (319)
T ss_pred ------HHHHHHHHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEE
Confidence 1234456667888888888888887666666665555 9999999998873 233345566 8999999
Q ss_pred ecCCcccCC----CCccccCccccceeeecccccccc----cccccccccccceeeccCCCCCCcc----CccccCcccc
Q 001434 277 LWDNQLTGF----IPSELGNCTKLQTLALYSNNLVGQ----IPKEVGNLKFLTKLYLYRNELNGTI----PREIGNLSMV 344 (1078)
Q Consensus 277 L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~~----p~~l~~l~~L 344 (1078)
+++|.+++. ++..+..+++|++|++++|.+++. ++..+..+++|++|+|++|.+++.. +..+..+++|
T Consensus 144 L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L 223 (319)
T cd00116 144 LGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSL 223 (319)
T ss_pred cCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCC
Confidence 999999843 344566778999999999999853 3344556679999999999997443 3456778999
Q ss_pred cEEeccCCCCCCccchhhhh-----hcccchhccccccccCC----CCCccccccccCeeeccCccccCC----CCcccc
Q 001434 345 TEIDLSENSLNGEIPTEFSK-----ITGLRLLFLFQNQLTGV----IPNELSSLRNLTKLDLSINYLTGP----IPVGFQ 411 (1078)
Q Consensus 345 ~~L~Ls~N~l~~~~~~~~~~-----l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~~~~~~ 411 (1078)
++|++++|.+++.....+.. .++|+.|++++|.++.. +...+..+++|+++++++|.++.. ....+.
T Consensus 224 ~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~~~ 303 (319)
T cd00116 224 EVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAESLL 303 (319)
T ss_pred CEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHHHh
Confidence 99999999998754444433 27999999999999722 234456678999999999999955 333344
Q ss_pred cc-cccceeEeecccc
Q 001434 412 HL-TQMRQLQLFENSL 426 (1078)
Q Consensus 412 ~l-~~L~~L~L~~N~l 426 (1078)
.. +.|+.|++.+|++
T Consensus 304 ~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 304 EPGNELESLWVKDDSF 319 (319)
T ss_pred hcCCchhhcccCCCCC
Confidence 44 6889999888864
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.1e-17 Score=198.14 Aligned_cols=248 Identities=21% Similarity=0.221 Sum_probs=182.4
Q ss_pred HhhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCC---CCceeeEeeEEEecCceE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR---HRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~ 854 (1078)
....|...+.+|+|+||+||+|...+|+.||+|+-+.....+ |.-=-+++.||+ -+.|..+..++.-.+..+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 445677777899999999999998889999999987665422 111222333333 244555555556677889
Q ss_pred EEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-------CCceEEeecc
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-------KFEAHVGDFG 927 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~~kl~Dfg 927 (1078)
+|+||.+.|+|.+++...+ .+++.-++.+..|+++.+++||.. +||||||||+|+++.. .-.++|+|||
T Consensus 771 lv~ey~~~Gtlld~~N~~~-~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG 846 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLINTNK-VMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFG 846 (974)
T ss_pred eeeeccccccHHHhhccCC-CCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecc
Confidence 9999999999999999554 799999999999999999999998 9999999999999942 3458999999
Q ss_pred cccccC-CCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCC
Q 001434 928 LAKVID-MPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 928 ~a~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
.+..+. .+........++|-.+-.+|+..+..++..+|.|.++-++|-|+.|++-- . ..+...
T Consensus 847 ~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--~-~~g~~~------------- 910 (974)
T KOG1166|consen 847 RSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--V-KNGSSW------------- 910 (974)
T ss_pred cceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--h-cCCcce-------------
Confidence 997543 22334667788999999999999999999999999999999999998522 0 000000
Q ss_pred CccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
..+..++ +.+ ....+.+++..+|+.|-..=|...++...+++..
T Consensus 911 --~~~~~~~---Ry~--~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~ 954 (974)
T KOG1166|consen 911 --MVKTNFP---RYW--KRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVL 954 (974)
T ss_pred --eccccch---hhh--hHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHH
Confidence 0011111 111 1122556777777877777778888887777663
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=6e-17 Score=170.83 Aligned_cols=197 Identities=24% Similarity=0.309 Sum_probs=135.7
Q ss_pred CCCceeeEeeEEEec---------------------------CceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHH
Q 001434 836 RHRNIVKLYGFCYHQ---------------------------GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGA 888 (1078)
Q Consensus 836 ~h~~iv~l~~~~~~~---------------------------~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi 888 (1078)
+|||||++..+|.+. ...|+||...+. +|.+++..+. .+...+..++.|+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~--~s~r~~~~~laQl 350 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH--RSYRTGRVILAQL 350 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC--CchHHHHHHHHHH
Confidence 599999998877542 234799988865 9999998664 5667777888999
Q ss_pred HhhhhhhhccCCCceEecCCCCCcEEEC--CCC--ceEEeecccccccCC-----CCCCcccccccccCcccccccccCC
Q 001434 889 AEGLAYLHHDCKPRIFHRDIKSNNILLD--DKF--EAHVGDFGLAKVIDM-----PQSKSMSAVAGSYGYIAPEYAYTMK 959 (1078)
Q Consensus 889 ~~~L~~LH~~~~~~ivH~Dlkp~Nill~--~~~--~~kl~Dfg~a~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~~~ 959 (1078)
++|+.|||++ ||.|||+|.+||++. +++ ...++|||++-..+. +-....-...|...-||||+....+
T Consensus 351 LEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 351 LEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999 999999999999993 333 478899998743221 0011112245677889999876432
Q ss_pred ------CCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHH
Q 001434 960 ------VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVAL 1033 (1078)
Q Consensus 960 ------~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 1033 (1078)
--.|+|.|+.|.+.||+++...||....+ ..-..+.+...+- +. ++.. ....+.+++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe---m~L~~r~Yqe~qL-Pa--lp~~----------vpp~~rqlV~ 491 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE---MLLDTRTYQESQL-PA--LPSR----------VPPVARQLVF 491 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccch---heechhhhhhhhC-CC--Cccc----------CChHHHHHHH
Confidence 12489999999999999999999975221 1111112222111 10 0111 1223567888
Q ss_pred hcCCCCCCCCCCHHHHHHHHH
Q 001434 1034 MCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1034 ~cl~~dP~~RPs~~ell~~L~ 1054 (1078)
..++.||.+|++..-....+.
T Consensus 492 ~lL~r~pskRvsp~iAANvl~ 512 (598)
T KOG4158|consen 492 DLLKRDPSKRVSPNIAANVLN 512 (598)
T ss_pred HHhcCCccccCCccHHHhHHH
Confidence 889999999998776655543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=164.04 Aligned_cols=137 Identities=18% Similarity=0.183 Sum_probs=105.8
Q ss_pred CCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-----CCCceeeEeeEEEecC---ce
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-----RHRNIVKLYGFCYHQG---SN 853 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~iv~l~~~~~~~~---~~ 853 (1078)
+...++||+|++|.||. ++.....+||++..... ...+.+.+|+..++++ +||||++++++++++. ..
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 34556899999999995 54333447998866433 2356789999999999 5799999999998874 33
Q ss_pred E-EEEee--ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhh-hhhhccCCCceEecCCCCCcEEECC----CCceEEee
Q 001434 854 L-LIYEY--MERGSLGELLHGSSCNLEWPTRFMIALGAAEGL-AYLHHDCKPRIFHRDIKSNNILLDD----KFEAHVGD 925 (1078)
Q Consensus 854 ~-lv~e~--~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L-~~LH~~~~~~ivH~Dlkp~Nill~~----~~~~kl~D 925 (1078)
+ +|||| +.+++|.+++.+.. +++. ..++.+++.++ +|||++ +|+||||||+||+++. ++.++|+|
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~--~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiD 152 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCR--YEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCD 152 (210)
T ss_pred EEEEecCCCCcchhHHHHHHccc--ccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence 3 78999 55789999997642 4544 35577888777 999999 9999999999999974 34799999
Q ss_pred cccc
Q 001434 926 FGLA 929 (1078)
Q Consensus 926 fg~a 929 (1078)
|+.+
T Consensus 153 g~G~ 156 (210)
T PRK10345 153 NIGE 156 (210)
T ss_pred CCCC
Confidence 5443
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.66 E-value=4.5e-16 Score=165.61 Aligned_cols=150 Identities=19% Similarity=0.163 Sum_probs=115.0
Q ss_pred HHHHhhcCCCccEEeccCceEEEEEE--ECCCcEEEEEEecccCCCc----------------------hhHHHHHHHHH
Q 001434 775 VVEATYNFHDSFIVGSGAYGTVYKAV--MDSGKIVAVKKLASNREGN----------------------NIESSFRAEIL 830 (1078)
Q Consensus 775 ~~~~~~~~~~~~~lG~G~~g~V~~~~--~~~~~~vavK~~~~~~~~~----------------------~~~~~~~~e~~ 830 (1078)
+.....-|...+.||+|++|.||+|. ..+|+.||+|++....... .....+.+|+.
T Consensus 23 ~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 23 LLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred HHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 34455567777889999999999998 4579999999987543110 01234578999
Q ss_pred HHccCCC--CceeeEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCc-eEecC
Q 001434 831 TLGKIRH--RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR-IFHRD 907 (1078)
Q Consensus 831 ~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~-ivH~D 907 (1078)
.++++.+ ..+++++++ ...++||||++|+++........ .....+...++.|++.+++++|++ | ++|||
T Consensus 103 ~L~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~D 174 (237)
T smart00090 103 NLQRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-EPEEEEEFELYDDILEEMRKLYKE---GELVHGD 174 (237)
T ss_pred HHHHHHhcCCCCCeeeEe----cCceEEEEEecCCcccccccccC-CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCC
Confidence 9999975 334444443 23589999999988877653332 455666788999999999999998 9 99999
Q ss_pred CCCCcEEECCCCceEEeecccccccC
Q 001434 908 IKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 908 lkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
|||+||+++ ++.++++|||.+...+
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999987644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=3.1e-16 Score=184.84 Aligned_cols=216 Identities=23% Similarity=0.293 Sum_probs=147.9
Q ss_pred HhhcCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEE
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 778 ~~~~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
...+|..++.|..|+||.||.++++. .+++|. ++.++.. +.+- ++.....|.+|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~l-------ilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQNL-------ILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhh-cccccch-------hhhc--cccccCCccee---------------
Confidence 34578888999999999999999874 567787 4433321 0111 33333445444
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|+-.+.+...+ .++... +.+++|+|+. ||||||+||+|.+++.-|.+|+.|||+++..-+..
T Consensus 136 ------gDc~tllk~~g-~lPvdm--------vla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~ 197 (1205)
T KOG0606|consen 136 ------GDCATLLKNIG-PLPVDM--------VLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSL 197 (1205)
T ss_pred ------chhhhhcccCC-CCcchh--------hHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhc
Confidence 34445544433 222222 6789999999 99999999999999999999999999986542111
Q ss_pred C--------------CcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhc
Q 001434 937 S--------------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD 1002 (1078)
Q Consensus 937 ~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~ 1002 (1078)
. -..+.++||+.|+|||++....|+..+|.|++|+++||.+-|..||.+...++-+...+..
T Consensus 198 atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd---- 273 (1205)
T KOG0606|consen 198 ATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD---- 273 (1205)
T ss_pred cchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh----
Confidence 0 0122368999999999999999999999999999999999999999765544434433333
Q ss_pred CCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 001434 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051 (1078)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 1051 (1078)
....+.- +...+ .+..+++.+.+..+|.+|--.....+
T Consensus 274 ~i~wpE~-dea~p----------~Ea~dli~~LL~qnp~~Rlgt~ga~e 311 (1205)
T KOG0606|consen 274 DIEWPEE-DEALP----------PEAQDLIEQLLRQNPLCRLGTGGALE 311 (1205)
T ss_pred hcccccc-CcCCC----------HHHHHHHHHHHHhChHhhcccchhhh
Confidence 2211111 22222 23456778888999999984444443
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.7e-15 Score=158.08 Aligned_cols=146 Identities=19% Similarity=0.132 Sum_probs=112.5
Q ss_pred hHHHHhhcCCCccEEeccCceEEEEEEECCCcEEEEEEecccCCCc--------------------hhHHHHHHHHHHHc
Q 001434 774 DVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGN--------------------NIESSFRAEILTLG 833 (1078)
Q Consensus 774 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~--------------------~~~~~~~~e~~~l~ 833 (1078)
.+......|...+.||+|+||.||+|.+++|+.||||++....... .....+.+|+..+.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 3444444466678899999999999998889999999876532110 01223677888888
Q ss_pred cCCCC--ceeeEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCC
Q 001434 834 KIRHR--NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSN 911 (1078)
Q Consensus 834 ~l~h~--~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~ 911 (1078)
.+.|+ .++++++ ....++||||++|++|.+.... .....++.+++.++.++|+. +++||||||+
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcc
Confidence 88776 4444443 2455899999999998776431 34567889999999999998 9999999999
Q ss_pred cEEECCCCceEEeecccccccC
Q 001434 912 NILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 912 Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
||++++++.++++|||.+....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEcCCCcEEEEECCccccCC
Confidence 9999999999999999997554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.3e-15 Score=159.03 Aligned_cols=136 Identities=19% Similarity=0.281 Sum_probs=114.8
Q ss_pred cEEeccCceEEEEEEECCCcEEEEEEecccCCCch------hHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEee
Q 001434 786 FIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNN------IESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~------~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
+.||+|++|.||+|.+ .|..|++|+......... ....+.+|+..+..+.|++++....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 4689999999999988 477899998764432211 124578899999999999988888777778888999999
Q ss_pred ccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
++|++|.+++.... . ++..++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999987543 2 7889999999999999998 999999999999999 78999999998864
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.61 E-value=1.3e-15 Score=184.84 Aligned_cols=138 Identities=36% Similarity=0.597 Sum_probs=118.3
Q ss_pred cCCCcchHHHHHHHHHhcccCCCCCCCccCCCCCCC-----cccceEeecCC---CCcEEEEeCCCCcccccCCCcccCC
Q 001434 54 TEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPC-----SWIGVNCTSDF---EPVVWSLDLNAMNFTGSLSPSIGGL 125 (1078)
Q Consensus 54 ~~~~~~~~~~ll~~k~~~~~~~~~l~sW~~~~~~~C-----~w~Gv~C~~~~---~~~v~~l~l~~~~l~g~~~~~l~~l 125 (1078)
.+....|..||+++|.++.++.. .+|.+ ++| .|.||.|+.+. ..+|+.|+|+++++.|.+|+.+++|
T Consensus 367 ~~t~~~~~~aL~~~k~~~~~~~~--~~W~g---~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L 441 (623)
T PLN03150 367 SKTLLEEVSALQTLKSSLGLPLR--FGWNG---DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKL 441 (623)
T ss_pred cccCchHHHHHHHHHHhcCCccc--CCCCC---CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCC
Confidence 34567899999999999977642 58975 334 79999996322 1358899999999999999999999
Q ss_pred CccCeEecccCccccccCCCccCcCCCcEEEccCCccccccccccccCCCCceeccccccccCCCCccccC
Q 001434 126 VHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGN 196 (1078)
Q Consensus 126 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~ 196 (1078)
++|+.|+|++|.+.|.+|..++.+++|++|+|++|+++|.+|..+++|++|++|+|++|.++|.+|..+..
T Consensus 442 ~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~ 512 (623)
T PLN03150 442 RHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGG 512 (623)
T ss_pred CCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhh
Confidence 99999999999999999999999999999999999999999999999999999999999999888877654
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.8e-15 Score=155.72 Aligned_cols=132 Identities=19% Similarity=0.268 Sum_probs=108.1
Q ss_pred EEeccCceEEEEEEECCCcEEEEEEecccCCCc------hhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGN------NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~------~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
.||+|++|.||+|.+. +..|++|+........ ...+++.+|+++++.++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 3899999999999864 7789999865432211 11356778999999998887666665666677789999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
+|++|.+++..... .++.+++.++.++|+. +++|||++|.||+++ ++.++++|||.+..
T Consensus 80 ~g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 80 EGKPLKDVIEEGND--------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCccHHHHHhhcHH--------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 99999998764321 7889999999999998 999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.58 E-value=1e-14 Score=175.39 Aligned_cols=139 Identities=19% Similarity=0.210 Sum_probs=112.4
Q ss_pred hcCCCccEEeccCceEEEEEEECCCcEEEEEEe-cccCCC-----chhHHHHHHHHHHHccCCCCceeeEeeEEEecCce
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKL-ASNREG-----NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~~~~~~vavK~~-~~~~~~-----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
..|...+.||+|+||+||++.+... .+++|+. .+.... ....+.+.+|++++++++|++++....++.+....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~ 411 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK 411 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence 3445577899999999999987644 3444433 222111 11235688999999999999999888888777788
Q ss_pred EEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
++||||++|++|.+++. ....++.++++++.|+|+. +++|||+||+||++ +++.++++|||+++..
T Consensus 412 ~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 412 TIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 99999999999999875 3567899999999999998 99999999999999 6779999999998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.1e-15 Score=169.36 Aligned_cols=174 Identities=28% Similarity=0.358 Sum_probs=130.5
Q ss_pred ceEEEEeeccCCCHHhHhcCC--CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccc
Q 001434 852 SNLLIYEYMERGSLGELLHGS--SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 929 (1078)
..||.|++++..+|.+++.++ ....++.....++.|++.|++| + +.+|+|+||.||+...+..+||.|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999644 3468888999999999999999 5 8999999999999999999999999999
Q ss_pred cccCCCC-----CCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcC
Q 001434 930 KVIDMPQ-----SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDH 1003 (1078)
Q Consensus 930 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 1003 (1078)
....... ...+....||..||+||.+.+..|+.++||||+|++++|++. =..++... . ...-++..
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~-------~-t~~d~r~g 475 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI-------A-TLTDIRDG 475 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-------H-hhhhhhcC
Confidence 8765333 335566789999999999999999999999999999999997 22222110 0 01111211
Q ss_pred CCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Q 001434 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051 (1078)
Q Consensus 1004 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~ 1051 (1078)
.+++..- .+... =+.++.+++++.|.+||++.+...
T Consensus 476 -----~ip~~~~------~d~p~-e~~ll~~lls~~p~~RP~~~~~~~ 511 (516)
T KOG1033|consen 476 -----IIPPEFL------QDYPE-EYTLLQQLLSPSPEERPSAIEVAL 511 (516)
T ss_pred -----CCChHHh------hcCcH-HHHHHHHhcCCCcccCchHHHHhh
Confidence 2221111 11111 235788999999999995555443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.52 E-value=4.7e-16 Score=171.51 Aligned_cols=183 Identities=32% Similarity=0.530 Sum_probs=141.2
Q ss_pred ccccccccccccccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEE
Q 001434 508 KLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRL 587 (1078)
Q Consensus 508 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 587 (1078)
.+..-...||+.|++. .+|..++.+-.|+.+.|..|.+. .+|..+.++..|++|||+.|+++ ..|..++.| -|+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~l-pLkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDL-PLKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcC-cceeE
Confidence 3555667788888887 67888888888888888888887 47777888888888888888887 456666665 47888
Q ss_pred eccCccccCCCCccccCcccCceeeccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccc
Q 001434 588 DISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNL 667 (1078)
Q Consensus 588 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l 667 (1078)
-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|++++.|+-. .||+|.|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~LpLi--~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLPLI--RLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCcee--eeecccCce
Confidence 88888887 77888887778888888888887 67778888888888888888887 778887766543 478888888
Q ss_pred cCCCCcccCcccccchhhcCCCcCcCCCChhhhh
Q 001434 668 SGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFEN 701 (1078)
Q Consensus 668 ~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~ 701 (1078)
+ .||.+|.+|..|++|-|.+|.|. ..|..++.
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqIC~ 255 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQICE 255 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCC-CChHHHHh
Confidence 7 78888888888888888888887 66665543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=4.9e-14 Score=145.73 Aligned_cols=137 Identities=22% Similarity=0.228 Sum_probs=98.3
Q ss_pred cEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHH----------------------HHHHHHHHccCCCC--cee
Q 001434 786 FIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESS----------------------FRAEILTLGKIRHR--NIV 841 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~----------------------~~~e~~~l~~l~h~--~iv 841 (1078)
+.||+|+||+||+|.+.+++.||||++............ ...|.+.+.++.+. .++
T Consensus 3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~ 82 (187)
T cd05119 3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP 82 (187)
T ss_pred cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence 569999999999999888999999998754322111111 13455556555433 244
Q ss_pred eEeeEEEecCceEEEEeeccCCCHHhH-hcCCCCCCChhHHHHHHHHHHhhhhhhhc-cCCCceEecCCCCCcEEECCCC
Q 001434 842 KLYGFCYHQGSNLLIYEYMERGSLGEL-LHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKF 919 (1078)
Q Consensus 842 ~l~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~l~~~~~~~i~~qi~~~L~~LH~-~~~~~ivH~Dlkp~Nill~~~~ 919 (1078)
+++++ ...++||||++++++... +.... . ..++..++.+++.++.++|+ . +|+||||||+||+++ ++
T Consensus 83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DG 151 (187)
T ss_pred ceEec----CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CC
Confidence 44433 245899999999543221 11111 1 15678899999999999998 7 999999999999999 88
Q ss_pred ceEEeecccccccC
Q 001434 920 EAHVGDFGLAKVID 933 (1078)
Q Consensus 920 ~~kl~Dfg~a~~~~ 933 (1078)
.++++|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.49 E-value=5.3e-15 Score=176.50 Aligned_cols=259 Identities=24% Similarity=0.255 Sum_probs=191.7
Q ss_pred CCCccEEeccCceEEEEEEECC--CcEEEEEEecccCCCchhHHHHHHHHHHHccCC-CCceeeEeeEEEecCceEEEEe
Q 001434 782 FHDSFIVGSGAYGTVYKAVMDS--GKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 782 ~~~~~~lG~G~~g~V~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
|...+.||+|+++.|-.+.... ...+|+|.+...............|..+-+.+. |+|++++++...+.+..++++|
T Consensus 22 ~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~ 101 (601)
T KOG0590|consen 22 YKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLS 101 (601)
T ss_pred ccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccC
Confidence 4444559999999998887543 344555655444322333455566777777776 9999999999999999999999
Q ss_pred eccCCCHHhHh-cCCCCCCChhHHHHHHHHHHhhhhhhh-ccCCCceEecCCCCCcEEECCCC-ceEEeecccccccCC-
Q 001434 859 YMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLH-HDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDM- 934 (1078)
Q Consensus 859 ~~~~gsL~~~l-~~~~~~l~~~~~~~i~~qi~~~L~~LH-~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~- 934 (1078)
|.+|+++.+.+ +......+...+-..+.|+..++.|+| .. +++|+|+||+|.+++..+ ..+++|||+|..+..
T Consensus 102 ~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 102 YSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred cccccccccccccCCccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999 544335667777888999999999999 77 999999999999999999 999999999987754
Q ss_pred -CCCCccccccc-ccCcccccccccCC-CCCcCcchhHHHHHHHHHhCCCCCCCCCCCC-CHHHHHHHHhhcCCCCCccc
Q 001434 935 -PQSKSMSAVAG-SYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGG-DLATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 935 -~~~~~~~~~~g-t~~y~aPE~~~~~~-~~~~~DvwslGv~l~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 1010 (1078)
.........+| ++.|+|||...+.. ..+..|+||.|+++.-+++|..||....... ....|...... .
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~----~---- 250 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGR----F---- 250 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccc----c----
Confidence 33344555678 99999999988854 4578999999999999999999997544322 22222211100 0
Q ss_pred cCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
.. ..+........++..+++..+|..|.+.+++...-+-..
T Consensus 251 --~~----~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 251 --TQ----LPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred --cc----CccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00 001112233556788888899999999999877665443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.49 E-value=2.5e-15 Score=165.79 Aligned_cols=180 Identities=31% Similarity=0.477 Sum_probs=165.2
Q ss_pred cccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccCcee
Q 001434 532 NCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEIL 611 (1078)
Q Consensus 532 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 611 (1078)
.+..-...||+.|++. ++|..+..+-.|+.+.|+.|.+. .+|..+.++..|+.|||+.|+++ .+|..++.|+ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 4455678899999998 68999999999999999999998 57999999999999999999999 8898888776 9999
Q ss_pred eccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcCCCcC
Q 001434 612 KLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHL 691 (1078)
Q Consensus 612 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l 691 (1078)
-+++|+++ .+|+.++.+.+|..||.+.|.+. .+|..++.+.+|+ .|++..|++. .+|++++.|+ |..||+|+|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr-~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR-DLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHH-HHHHhhhhhh-hCCHHHhCCc-eeeeecccCce
Confidence 99999998 89999999999999999999999 9999999999999 7999999999 8999999775 99999999999
Q ss_pred cCCCChhhhhhcccccccccccccCCCCCC
Q 001434 692 SGEIPSAFENLSSLLGSNFSYNNLTGPLPS 721 (1078)
Q Consensus 692 ~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~ 721 (1078)
+ .||-+|.+|+.|+++-|-+|.|+-++-+
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 9 8999999999999999999999855443
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.48 E-value=2e-13 Score=135.62 Aligned_cols=134 Identities=23% Similarity=0.192 Sum_probs=113.0
Q ss_pred ccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCC--CceeeEeeEEEecCceEEEEeeccC
Q 001434 785 SFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH--RNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
.+.+|+|.++.||++...+ ..+++|....... ...+.+|+..++.++| .++++++.+...++..+++|||+++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred ceecccccccceEEEEecC-CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 3569999999999999864 7899999865533 4578889999999976 5899999888888889999999998
Q ss_pred CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 863 gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
+.+..+ +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4566777889999999999986334799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=2.5e-13 Score=144.94 Aligned_cols=138 Identities=18% Similarity=0.181 Sum_probs=106.9
Q ss_pred ccEEe-ccCceEEEEEEECCCcEEEEEEecccCC-----------CchhHHHHHHHHHHHccCCCCce--eeEeeEEEec
Q 001434 785 SFIVG-SGAYGTVYKAVMDSGKIVAVKKLASNRE-----------GNNIESSFRAEILTLGKIRHRNI--VKLYGFCYHQ 850 (1078)
Q Consensus 785 ~~~lG-~G~~g~V~~~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~e~~~l~~l~h~~i--v~l~~~~~~~ 850 (1078)
...|| .|+.|+||.+... ++.+++|.+..... .......+.+|++.+.++.|+++ ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 45688 8999999999876 77899998854210 11234567899999999988774 6777765433
Q ss_pred Cc----eEEEEeeccC-CCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEee
Q 001434 851 GS----NLLIYEYMER-GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 925 (1078)
Q Consensus 851 ~~----~~lv~e~~~~-gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 925 (1078)
.. .++|||+++| .+|.+++... .++.. .+.+++.++.++|+. ||+||||||.|||++.++.++++|
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~--~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LID 185 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA--PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLID 185 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC--CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEE
Confidence 22 2599999997 6999988653 23433 356899999999999 999999999999999989999999
Q ss_pred ccccccc
Q 001434 926 FGLAKVI 932 (1078)
Q Consensus 926 fg~a~~~ 932 (1078)
||.+...
T Consensus 186 fg~~~~~ 192 (239)
T PRK01723 186 FDRGELR 192 (239)
T ss_pred CCCcccC
Confidence 9988753
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=152.32 Aligned_cols=240 Identities=32% Similarity=0.397 Sum_probs=148.8
Q ss_pred CccceeeeeeccccccCCcCCcccc-ccceEEeecCCccCcccccccccccccccccccccccCCCccccccccccceee
Q 001434 462 SNLIMLNLGYNKLFGNIPTDVLNCE-TLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLH 540 (1078)
Q Consensus 462 ~~L~~L~Ls~N~l~~~~p~~~~~~~-~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 540 (1078)
+.++.|++.+|.++ .++....... .|++|++++|++. .+|..+..+++|+.|++++|+++ .+|......+.|+.|+
T Consensus 116 ~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L~ 192 (394)
T COG4886 116 TNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLD 192 (394)
T ss_pred cceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhee
Confidence 44555555555554 2333333332 5556666666655 34455667777777777777777 4555555667777788
Q ss_pred ccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCccccCCCCccccCcccCceeeccccccCC
Q 001434 541 IANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSG 620 (1078)
Q Consensus 541 L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~ 620 (1078)
+++|+++. +|.....+..|++|++++|.+. ..+..+.++.++..+.+++|++. .++..++.+++++.|++++|+++
T Consensus 193 ls~N~i~~-l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~~~~~l~~l~~L~~s~n~i~- 268 (394)
T COG4886 193 LSGNKISD-LPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS- 268 (394)
T ss_pred ccCCcccc-CchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccchhccccccceecccccccc-
Confidence 88877773 5555555666788888888533 34566777788888888888886 44777888888888888888888
Q ss_pred CCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcCCCcCcCCCChhhh
Q 001434 621 NIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFE 700 (1078)
Q Consensus 621 ~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls~N~l~g~ip~~~~ 700 (1078)
.++. ++.+.+++.||+++|.++..+|.......... .... +.++ ..+........+...++..|... ..|..+.
T Consensus 269 ~i~~-~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~--~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 342 (394)
T COG4886 269 SISS-LGSLTNLRELDLSGNSLSNALPLIALLLLLLE--LLLN-LLLT-LKALELKLNSILLNNNILSNGET-SSPEALS 342 (394)
T ss_pred cccc-ccccCccCEEeccCccccccchhhhccchhHH--hhhh-hhhh-ccccccccccccccccccccccc-ccchhhc
Confidence 4444 88888888899998888866665544433332 1222 3333 23333343444444555555555 4555555
Q ss_pred hhcccccccccccc
Q 001434 701 NLSSLLGSNFSYNN 714 (1078)
Q Consensus 701 ~l~~L~~l~ls~N~ 714 (1078)
....+..++...+.
T Consensus 343 ~~~~~~~~~~~~~~ 356 (394)
T COG4886 343 ILESLNNLWTLDNA 356 (394)
T ss_pred ccccccCceecccc
Confidence 55555555444443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.31 E-value=2.5e-12 Score=149.67 Aligned_cols=199 Identities=35% Similarity=0.504 Sum_probs=122.8
Q ss_pred EEEccCCccccccccccccCCCCceeccccccccCCCCccccCCc-chhHHhcccCcccccccccccCcccccEEEcCCc
Q 001434 154 HLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLS-SLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQN 232 (1078)
Q Consensus 154 ~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~-~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n 232 (1078)
.|+++.|.+. ..+..+..++.++.|++.+|.++ .+|.....++ +|+.|++++|.+. .+|..++.+++|+.|++++|
T Consensus 97 ~l~~~~~~~~-~~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLR-SNISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeeccccccc-cCchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 3455555443 12223334455555555555554 3444444442 4444555444444 33455666777777777777
Q ss_pred ccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceeeeccccccccccc
Q 001434 233 AISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPK 312 (1078)
Q Consensus 233 ~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~ 312 (1078)
+++ .+|...+.+++|+.|++++|++. .+|..++.+..|++|.+++|++. ..+..+.+++++..|.+.+|++. .++.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~-~~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee-eccc
Confidence 776 44544446677777777777777 55655556666777777777544 34566777777777777777776 3466
Q ss_pred ccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchh
Q 001434 313 EVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE 361 (1078)
Q Consensus 313 ~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~ 361 (1078)
.++.++++++|++++|.++ .++. ++.+.++++|++++|.+....+..
T Consensus 250 ~~~~l~~l~~L~~s~n~i~-~i~~-~~~~~~l~~L~~s~n~~~~~~~~~ 296 (394)
T COG4886 250 SIGNLSNLETLDLSNNQIS-SISS-LGSLTNLRELDLSGNSLSNALPLI 296 (394)
T ss_pred hhccccccceecccccccc-cccc-ccccCccCEEeccCccccccchhh
Confidence 6777777888888888877 3333 777777888888887777555543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.31 E-value=7.5e-12 Score=145.30 Aligned_cols=142 Identities=21% Similarity=0.244 Sum_probs=100.3
Q ss_pred ccEEeccCceEEEEEEECCCcEEEEEEecccCCCch--------------------------------------hHHHHH
Q 001434 785 SFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNN--------------------------------------IESSFR 826 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~--------------------------------------~~~~~~ 826 (1078)
.+.||.|++|.||+|+.++|+.||||+.+......- .+-++.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 467999999999999999999999999854421000 001244
Q ss_pred HHHHHHccC----C-CCceeeEeeEE-EecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHh-hhhhhhccC
Q 001434 827 AEILTLGKI----R-HRNIVKLYGFC-YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE-GLAYLHHDC 899 (1078)
Q Consensus 827 ~e~~~l~~l----~-h~~iv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~-~L~~LH~~~ 899 (1078)
+|+..+.++ + +++| .+-..+ ......++||||++|++|.++........ .+.+++.++++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~- 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRD- 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhC-
Confidence 566555555 2 3333 322222 33456799999999999988765322122 23456666665 46788887
Q ss_pred CCceEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 900 ~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
|++|+|++|.||+++++++++++|||++..+.
T Consensus 277 --g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 --GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred --CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 99999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.28 E-value=7e-12 Score=142.42 Aligned_cols=247 Identities=24% Similarity=0.161 Sum_probs=184.0
Q ss_pred CCCccEEec--cCceEEEEEEE--C-CCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEE
Q 001434 782 FHDSFIVGS--GAYGTVYKAVM--D-SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 782 ~~~~~~lG~--G~~g~V~~~~~--~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 855 (1078)
+....-+|. |.+|.||.+.. . ++..+|+|+-+...........=.+|+...+.+ .|++.++.+..++..+..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 334455899 99999999986 3 578899998655544333333445677777776 49999998889999999999
Q ss_pred EEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHh----hhhhhhccCCCceEecCCCCCcEEECCC-CceEEeeccccc
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE----GLAYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAK 930 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~----~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~ 930 (1078)
-+|++. .++.++.+.....++....+....+..+ |+.++|.. +++|-|+||.||+...+ ...+++|||+..
T Consensus 196 qtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~ 271 (524)
T KOG0601|consen 196 QTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVS 271 (524)
T ss_pred eecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeE
Confidence 999995 6999998877767888888888888888 99999999 99999999999999999 889999999988
Q ss_pred ccCCCCCCc----ccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCC--CCCCCHHHHHHHHhhcCC
Q 001434 931 VIDMPQSKS----MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPL--DDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 931 ~~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~--~~~~~~~~~~~~~~~~~~ 1004 (1078)
.+....... .....|...|++||.. .+-++.++|+|++|.++.+..+|..+.... ........+
T Consensus 272 ~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~--------- 341 (524)
T KOG0601|consen 272 KISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG--------- 341 (524)
T ss_pred EccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---------
Confidence 775433111 1223577889999965 456789999999999999999988766533 111111100
Q ss_pred CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~ 1052 (1078)
....+........+...+..|++.+|..|++.+.+..+
T Consensus 342 ----------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l 379 (524)
T KOG0601|consen 342 ----------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL 379 (524)
T ss_pred ----------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence 01111111222334558889999999999999887654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.25 E-value=5.3e-12 Score=131.05 Aligned_cols=208 Identities=22% Similarity=0.286 Sum_probs=142.4
Q ss_pred HHHHHHccCCCCceeeEeeEEEecC-----ceEEEEeeccCCCHHhHhcCCC---CCCChhHHHHHHHHHHhhhhhhhcc
Q 001434 827 AEILTLGKIRHRNIVKLYGFCYHQG-----SNLLIYEYMERGSLGELLHGSS---CNLEWPTRFMIALGAAEGLAYLHHD 898 (1078)
Q Consensus 827 ~e~~~l~~l~h~~iv~l~~~~~~~~-----~~~lv~e~~~~gsL~~~l~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~ 898 (1078)
.-..-+-++.|.|+|+++.|+.+.+ ...+++|||..|++..++++.. ..+....-.+|+.||+.||.|||+.
T Consensus 116 ~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~ 195 (458)
T KOG1266|consen 116 AVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc
Confidence 3344455667999999999886543 4679999999999999997543 3677788889999999999999995
Q ss_pred CCCceEecCCCCCcEEECCCCceEEeeccccccc---CCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHH
Q 001434 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI---DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLE 975 (1078)
Q Consensus 899 ~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~e 975 (1078)
.+.|+|+++..+-|++..+|-+|+.--.-...- ............+-++|.+||.-.....+.++|||+||....|
T Consensus 196 -~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAle 274 (458)
T KOG1266|consen 196 -DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALE 274 (458)
T ss_pred -CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHH
Confidence 889999999999999999988887421111000 0000111122346788999997776677789999999999999
Q ss_pred HHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHh
Q 001434 976 LLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 976 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~ 1055 (1078)
|..+..--............+.+.+. ..+.. .=.+++.+|++..|..||+|.+++.|.-.
T Consensus 275 mailEiq~tnseS~~~~ee~ia~~i~-------------~len~-------lqr~~i~kcl~~eP~~rp~ar~llfHpll 334 (458)
T KOG1266|consen 275 MAILEIQSTNSESKVEVEENIANVII-------------GLENG-------LQRGSITKCLEGEPNGRPDARLLLFHPLL 334 (458)
T ss_pred HHHheeccCCCcceeehhhhhhhhee-------------eccCc-------cccCcCcccccCCCCCCcchhhhhcCcee
Confidence 99877532211111111111111000 00000 01246789999999999999999987643
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.22 E-value=4e-12 Score=154.50 Aligned_cols=117 Identities=41% Similarity=0.767 Sum_probs=65.4
Q ss_pred CceeeccccccCCCCCCccCCcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchhhcC
Q 001434 608 LEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLN 687 (1078)
Q Consensus 608 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L~Ls 687 (1078)
++.|+|++|.++|.+|..++.+++|+.|+|++|.|+|.+|..++.++.|+ .|+|++|+++|.+|..++++++|+.|+|+
T Consensus 420 v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~-~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls 498 (623)
T PLN03150 420 IDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE-VLDLSYNSFNGSIPESLGQLTSLRILNLN 498 (623)
T ss_pred EEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCC-EEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence 45555566666555555555555566555555555555555555555555 45555555555555555555555555555
Q ss_pred CCcCcCCCChhhhhhcccccccccccccCCCCCCCcccCcccccccccCcCcCCCC-CCCC
Q 001434 688 NNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRP-VGNC 747 (1078)
Q Consensus 688 ~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~~~~~~~~~~~~~~~n~~lcg~p-~~~c 747 (1078)
+|+|+|.+|..+.++ +.......+.+|+.+|+.| ...|
T Consensus 499 ~N~l~g~iP~~l~~~----------------------~~~~~~l~~~~N~~lc~~p~l~~C 537 (623)
T PLN03150 499 GNSLSGRVPAALGGR----------------------LLHRASFNFTDNAGLCGIPGLRAC 537 (623)
T ss_pred CCcccccCChHHhhc----------------------cccCceEEecCCccccCCCCCCCC
Confidence 555555555544322 1112234577888899865 3455
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.8e-10 Score=117.10 Aligned_cols=138 Identities=14% Similarity=0.105 Sum_probs=99.4
Q ss_pred cEEeccCceEEEEEEECC-------CcEEEEEEecccCC--------------------CchhHHHHH----HHHHHHcc
Q 001434 786 FIVGSGAYGTVYKAVMDS-------GKIVAVKKLASNRE--------------------GNNIESSFR----AEILTLGK 834 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~-------~~~vavK~~~~~~~--------------------~~~~~~~~~----~e~~~l~~ 834 (1078)
..||.|.-+.||.|...+ +..+|||+.+.... .....+.+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 358999999999998553 47999998753310 011123333 89999998
Q ss_pred CCC--CceeeEeeEEEecCceEEEEeeccCCCHHh-HhcCCCCCCChhHHHHHHHHHHhhhhhh-hccCCCceEecCCCC
Q 001434 835 IRH--RNIVKLYGFCYHQGSNLLIYEYMERGSLGE-LLHGSSCNLEWPTRFMIALGAAEGLAYL-HHDCKPRIFHRDIKS 910 (1078)
Q Consensus 835 l~h--~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~l~~~~~~~i~~qi~~~L~~L-H~~~~~~ivH~Dlkp 910 (1078)
+.. -.+++++++ ...++||||+.+..+.. .+... .++..+...+..+++.++.++ |+. |+||||+++
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~--~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGDLs~ 153 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA--KLNDEEMKNAYYQVLSMMKQLYKEC---NLVHADLSE 153 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc--ccCHHHHHHHHHHHHHHHHHHHHhC---CeecCCCCH
Confidence 853 456666654 46789999997653322 22221 244456677889999999999 777 999999999
Q ss_pred CcEEECCCCceEEeecccccccC
Q 001434 911 NNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 911 ~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
+||+++ ++.+.++|||.+...+
T Consensus 154 ~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 154 YNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HHEEEE-CCcEEEEECCCceeCC
Confidence 999997 4689999999987654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.1e-10 Score=118.60 Aligned_cols=131 Identities=21% Similarity=0.123 Sum_probs=95.7
Q ss_pred ccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCc-eeeEeeEEEecCceEEEEeeccCC
Q 001434 785 SFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN-IVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
.+.++.|.++.||++... ++.|++|....... ....+.+|+..++.+.+.. +++++.+. .+..++||||++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCC
Confidence 356889999999999876 77899999865432 1234567888888875444 34455433 34468999999998
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccC--CCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC--KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~--~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
++.+. . ......+.+++++++.||+.. ..+++|||++|.||+++ ++.++++|||.+..
T Consensus 77 ~l~~~----~-----~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 77 ELLTE----D-----FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc----c-----ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 77653 0 112345678999999999872 12369999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.14 E-value=3.8e-12 Score=133.82 Aligned_cols=249 Identities=18% Similarity=0.233 Sum_probs=142.5
Q ss_pred CcccCCCccCeEecccCcccc----ccCCCccCcCCCcEEEccCC---ccccccccc-------cccCCCCceecccccc
Q 001434 120 PSIGGLVHLTYLDLAYNELTG----YIPREIGNCSRLEHLYLNNN---QFSGKIPAE-------LGKLSSLVSLNICNNM 185 (1078)
Q Consensus 120 ~~l~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~n---~l~~~~p~~-------l~~l~~L~~L~Ls~n~ 185 (1078)
+.+-.+..+++++||+|.|.. .+-..+.+.++|+.-++|.- +...++|.. +..+++|++||||+|-
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~~l~~aL~~~~~L~~ldLSDNA 103 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALKMLSKALLGCPKLQKLDLSDNA 103 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHHHHHHHHhcCCceeEeeccccc
Confidence 445566777788888887752 24455666777777777753 223345543 3456688888888888
Q ss_pred ccCCCCcc----ccCCcchhHHhcccCcccccccccccCcccccEEEcCCcccccccCCCcccccccceeeeeccccCCC
Q 001434 186 ISGALPEG----LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGS 261 (1078)
Q Consensus 186 i~~~~p~~----l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~ 261 (1078)
+....+.. +..++.|++|.|.+|.+.-.-...++. .|..|. .|+ ....-++|+++..++|++...
T Consensus 104 ~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~k-------k~~~~~~Lrv~i~~rNrlen~ 172 (382)
T KOG1909|consen 104 FGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNK-------KAASKPKLRVFICGRNRLENG 172 (382)
T ss_pred cCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHh-------ccCCCcceEEEEeeccccccc
Confidence 87555543 345777888888888766322222211 111111 010 011124555555555555432
Q ss_pred CC----CccCcccccceeeecCCcccCC----CCccccCccccceeeecccccccc----cccccccccccceeeccCCC
Q 001434 262 LP----KEIGMLESLTEIVLWDNQLTGF----IPSELGNCTKLQTLALYSNNLVGQ----IPKEVGNLKFLTKLYLYRNE 329 (1078)
Q Consensus 262 ~~----~~l~~l~~L~~L~L~~n~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~ 329 (1078)
.. ..|...+.|+.+.+..|.|... +...|..+++|++|||..|-++.. +.+.+..+++|+.|++++|.
T Consensus 173 ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~LakaL~s~~~L~El~l~dcl 252 (382)
T KOG1909|consen 173 GATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAKALSSWPHLRELNLGDCL 252 (382)
T ss_pred cHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHHHhcccchheeecccccc
Confidence 21 2233445566666666655421 223456667777777777776632 33445556677777777777
Q ss_pred CCCccCccc-----cCcccccEEeccCCCCCCc----cchhhhhhcccchhcccccccc
Q 001434 330 LNGTIPREI-----GNLSMVTEIDLSENSLNGE----IPTEFSKITGLRLLFLFQNQLT 379 (1078)
Q Consensus 330 l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 379 (1078)
+......+| ...++|+.|.+.+|.|+.. +...+...+.|+.|+|++|++.
T Consensus 253 l~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 253 LENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred cccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 764433322 2356778888888877632 2233455678888888888883
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.12 E-value=8.3e-11 Score=137.76 Aligned_cols=142 Identities=17% Similarity=0.220 Sum_probs=93.2
Q ss_pred cCCCccEEeccCceEEEEEEECC-CcEEEEEEecccCCC----------------------------c----hhHH----
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNREG----------------------------N----NIES---- 823 (1078)
Q Consensus 781 ~~~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~----------------------------~----~~~~---- 823 (1078)
.|+. +.||+|++|.||+|+.++ |+.||||+....... . +..+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 3555 679999999999999887 999999999754210 0 0011
Q ss_pred --HHHHHHHHHccC----CCCceeeEeeEEEe-cCceEEEEeeccCCCHHhH--hcCCCC---CCChhHHHHHHHHHHhh
Q 001434 824 --SFRAEILTLGKI----RHRNIVKLYGFCYH-QGSNLLIYEYMERGSLGEL--LHGSSC---NLEWPTRFMIALGAAEG 891 (1078)
Q Consensus 824 --~~~~e~~~l~~l----~h~~iv~l~~~~~~-~~~~~lv~e~~~~gsL~~~--l~~~~~---~l~~~~~~~i~~qi~~~ 891 (1078)
++.+|+..+.++ .+...+.+-+++.+ ....++||||++|+.+.++ +...+. .+....+..++.|+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi--- 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV--- 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH---
Confidence 234454444444 23333443333332 4567899999999999874 222221 12222223333333
Q ss_pred hhhhhccCCCceEecCCCCCcEEECCCC----ceEEeecccccccC
Q 001434 892 LAYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLAKVID 933 (1078)
Q Consensus 892 L~~LH~~~~~~ivH~Dlkp~Nill~~~~----~~kl~Dfg~a~~~~ 933 (1078)
... |++|+|+||.||+++.++ +++++|||++...+
T Consensus 277 ----f~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 ----FRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ----HhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 345 999999999999999888 99999999998764
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.3e-11 Score=126.32 Aligned_cols=136 Identities=27% Similarity=0.304 Sum_probs=97.5
Q ss_pred ccccCccccceeeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcc
Q 001434 288 SELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITG 367 (1078)
Q Consensus 288 ~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~ 367 (1078)
........|++||||+|.|+ .+.++..-+++++.|++|+|.|... ..+..+++|++||||+|.++ .+..+-..+-+
T Consensus 278 ~~~dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGN 353 (490)
T KOG1259|consen 278 VSADTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGN 353 (490)
T ss_pred EecchHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcC
Confidence 33444566888888888887 6666777778888888888888732 33777888888888888877 44455566677
Q ss_pred cchhccccccccCCCCCccccccccCeeeccCccccCCC-CcccccccccceeEeeccccccC
Q 001434 368 LRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI-PVGFQHLTQMRQLQLFENSLTGG 429 (1078)
Q Consensus 368 L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~ 429 (1078)
.+.|.|+.|.|... ..+..+-+|..||+++|+|.... -..+++++-|+.+.|.+|++.+.
T Consensus 354 IKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~ 414 (490)
T KOG1259|consen 354 IKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGS 414 (490)
T ss_pred EeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCcccc
Confidence 78888888887644 45667778888888888887432 23577778888888888877743
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1e-09 Score=125.70 Aligned_cols=167 Identities=17% Similarity=0.251 Sum_probs=128.1
Q ss_pred ECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhH
Q 001434 801 MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT 880 (1078)
Q Consensus 801 ~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~ 880 (1078)
..++.+|.|.+.+.... ...+...+.++.++.++||+|+++++.++.++..|+|+|.+. .|..++.+.+ ...
T Consensus 34 k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEE 105 (690)
T ss_pred eccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHH
Confidence 34578888888876654 445677889999999999999999999999999999999884 6777776433 566
Q ss_pred HHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCcccccccccCcccccccccCCC
Q 001434 881 RFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV 960 (1078)
Q Consensus 881 ~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~ 960 (1078)
...-++||+.||.+||+.| +++|++|.-..|+++..|..||++|.++........ ......--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~- 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE- 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence 6777899999999999664 899999999999999999999999998865432111 111112223455666443222
Q ss_pred CCcCcchhHHHHHHHHHhCC
Q 001434 961 TEKCDIYSYGVVLLELLTGR 980 (1078)
Q Consensus 961 ~~~~DvwslGv~l~elltg~ 980 (1078)
-..|.|-||++++|++.|.
T Consensus 182 -~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 182 -WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred -cchhhhhHHHHHHHHhCcc
Confidence 3469999999999999993
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.3e-11 Score=126.17 Aligned_cols=206 Identities=21% Similarity=0.179 Sum_probs=100.3
Q ss_pred cCCCccCcCCCcEEEccCCccccccccccccCCCCceeccccccccCCCCccccCCcchhHHhcc-cCcccccccccccC
Q 001434 142 IPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAY-TNNLTGPLPQSIGN 220 (1078)
Q Consensus 142 ~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~l~-~n~l~~~~p~~l~~ 220 (1078)
+|-.+.-+.+|+.+.+|++.-. .|-+-...-+.|+++.+.+..++.. +++--.+.+....-. ..-..|..-..+..
T Consensus 206 l~f~l~~f~~l~~~~~s~~~~~-~i~~~~~~kptl~t~~v~~s~~~~~--~~l~pe~~~~D~~~~E~~t~~G~~~~~~dT 282 (490)
T KOG1259|consen 206 LSFNLNAFRNLKTLKFSALSTE-NIVDIELLKPTLQTICVHNTTIQDV--PSLLPETILADPSGSEPSTSNGSALVSADT 282 (490)
T ss_pred cccchHHhhhhheeeeeccchh-heeceeecCchhheeeeeccccccc--ccccchhhhcCccCCCCCccCCceEEecch
Confidence 3444455666777777666433 1222222235666666665544311 112112222221111 11123333334444
Q ss_pred cccccEEEcCCcccccccCCCcccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceee
Q 001434 221 LRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLA 300 (1078)
Q Consensus 221 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 300 (1078)
.+.|+.++|++|.|+ .+.+++.-+|.++.|++++|.|.. ...+..+++|+.|||++|.++ .+..+-..+.+.++|.
T Consensus 283 Wq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~--v~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~ 358 (490)
T KOG1259|consen 283 WQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRT--VQNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLK 358 (490)
T ss_pred Hhhhhhccccccchh-hhhhhhhhccceeEEeccccceee--ehhhhhcccceEeecccchhH-hhhhhHhhhcCEeeee
Confidence 556666666666665 455555555666666666666652 122555566666666666555 2333333445555566
Q ss_pred ecccccccccccccccccccceeeccCCCCCCc-cCccccCcccccEEeccCCCCCC
Q 001434 301 LYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGT-IPREIGNLSMVTEIDLSENSLNG 356 (1078)
Q Consensus 301 Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls~N~l~~ 356 (1078)
|++|.|... ..++.+-+|.+||+++|+|... ....+++++.|+++.|.+|.+.+
T Consensus 359 La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 359 LAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 666655422 3344555555555655555421 12345555555555555555553
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2.5e-12 Score=135.13 Aligned_cols=256 Identities=21% Similarity=0.258 Sum_probs=140.4
Q ss_pred CCccCcCCCcEEEccCCccccc----cccccccCCCCceecccccc---ccCCCCccccCCcchhHHhcccCcccccccc
Q 001434 144 REIGNCSRLEHLYLNNNQFSGK----IPAELGKLSSLVSLNICNNM---ISGALPEGLGNLSSLVDFVAYTNNLTGPLPQ 216 (1078)
Q Consensus 144 ~~~~~l~~L~~L~Ls~n~l~~~----~p~~l~~l~~L~~L~Ls~n~---i~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 216 (1078)
+.+.....+++++||+|.|..+ +...+.+.++|+.-++|+=- ...++|+++. .| .+
T Consensus 24 ~~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd~ftGR~~~Ei~e~L~------~l-----------~~ 86 (382)
T KOG1909|consen 24 EELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSDMFTGRLKDEIPEALK------ML-----------SK 86 (382)
T ss_pred HHhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHhhhcCCcHHHHHHHHH------HH-----------HH
Confidence 4456678899999999998643 44556677788888877521 1123333221 11 13
Q ss_pred cccCcccccEEEcCCcccccccCCCc----ccccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccC
Q 001434 217 SIGNLRNLRVFRAGQNAISGSIPAEI----SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGN 292 (1078)
Q Consensus 217 ~l~~l~~L~~L~l~~n~l~~~~p~~l----~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~ 292 (1078)
.+-..++|++++||+|.+....+..| ..+++|++|.|.+|.++-.--..++. .|.+|. .|+.. +.
T Consensus 87 aL~~~~~L~~ldLSDNA~G~~g~~~l~~ll~s~~~L~eL~L~N~Glg~~ag~~l~~--al~~l~--~~kk~-------~~ 155 (382)
T KOG1909|consen 87 ALLGCPKLQKLDLSDNAFGPKGIRGLEELLSSCTDLEELYLNNCGLGPEAGGRLGR--ALFELA--VNKKA-------AS 155 (382)
T ss_pred HHhcCCceeEeeccccccCccchHHHHHHHHhccCHHHHhhhcCCCChhHHHHHHH--HHHHHH--HHhcc-------CC
Confidence 34556688888888888876666554 46788899999988886221112111 122221 11111 11
Q ss_pred ccccceeeecccccccc----cccccccccccceeeccCCCCCCc----cCccccCcccccEEeccCCCCCCc----cch
Q 001434 293 CTKLQTLALYSNNLVGQ----IPKEVGNLKFLTKLYLYRNELNGT----IPREIGNLSMVTEIDLSENSLNGE----IPT 360 (1078)
Q Consensus 293 l~~L~~L~Ls~N~l~~~----~p~~l~~l~~L~~L~L~~N~l~~~----~p~~l~~l~~L~~L~Ls~N~l~~~----~~~ 360 (1078)
-++|+++..++|++... +...|...+.|+.+.++.|.|... +...|..+++|+.|||..|.++.. +..
T Consensus 156 ~~~Lrv~i~~rNrlen~ga~~~A~~~~~~~~leevr~~qN~I~~eG~~al~eal~~~~~LevLdl~DNtft~egs~~Lak 235 (382)
T KOG1909|consen 156 KPKLRVFICGRNRLENGGATALAEAFQSHPTLEEVRLSQNGIRPEGVTALAEALEHCPHLEVLDLRDNTFTLEGSVALAK 235 (382)
T ss_pred CcceEEEEeeccccccccHHHHHHHHHhccccceEEEecccccCchhHHHHHHHHhCCcceeeecccchhhhHHHHHHHH
Confidence 23455555555555422 122233445555555555555411 112344555566666666655432 223
Q ss_pred hhhhhcccchhccccccccCCCCCcc-----ccccccCeeeccCccccCC----CCcccccccccceeEeeccccc
Q 001434 361 EFSKITGLRLLFLFQNQLTGVIPNEL-----SSLRNLTKLDLSINYLTGP----IPVGFQHLTQMRQLQLFENSLT 427 (1078)
Q Consensus 361 ~~~~l~~L~~L~L~~N~l~~~~p~~l-----~~l~~L~~L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~ 427 (1078)
.++.+++|+.|++++|.+......+| ...++|+.|.|.+|.++.. +.......+.|+.|+|++|.+.
T Consensus 236 aL~s~~~L~El~l~dcll~~~Ga~a~~~al~~~~p~L~vl~l~gNeIt~da~~~la~~~~ek~dL~kLnLngN~l~ 311 (382)
T KOG1909|consen 236 ALSSWPHLRELNLGDCLLENEGAIAFVDALKESAPSLEVLELAGNEITRDAALALAACMAEKPDLEKLNLNGNRLG 311 (382)
T ss_pred HhcccchheeecccccccccccHHHHHHHHhccCCCCceeccCcchhHHHHHHHHHHHHhcchhhHHhcCCccccc
Confidence 34455556666666666554332222 1356777777777777632 1222344677777888888773
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.09 E-value=7.2e-10 Score=107.90 Aligned_cols=133 Identities=23% Similarity=0.281 Sum_probs=102.9
Q ss_pred EEeccCceEEEEEEECCCcEEEEEEecccCC-Cch-----hHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeec
Q 001434 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNRE-GNN-----IESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM 860 (1078)
Q Consensus 787 ~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~-----~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~ 860 (1078)
.+++|+-+.||.+.+. |.++++|.-.+... .+. ..++..+|+.++.+++-..|...+-+..+.+...|+|||+
T Consensus 3 ~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 3 LIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred hhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 5789999999999775 55566775433322 111 2345678999999887767766666777888889999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeeccccccc
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~ 932 (1078)
+|..|.+++... ...++..+=.-+.-||.. ||+|+|+.++||.+..++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~--------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA--------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc--------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999888765 244556666777889998 999999999999998775 999999998753
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.8e-11 Score=142.60 Aligned_cols=127 Identities=31% Similarity=0.365 Sum_probs=63.0
Q ss_pred cccceeeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhcc
Q 001434 294 TKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFL 373 (1078)
Q Consensus 294 ~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L 373 (1078)
..++.+++..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|.|+.. ..+..++.|+.|++
T Consensus 72 ~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L~l 147 (414)
T KOG0531|consen 72 TSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKELNL 147 (414)
T ss_pred HhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhhee
Confidence 334444444444442 22234444555555555555542 222244455555555555555533 22344445666666
Q ss_pred ccccccCCCCCccccccccCeeeccCccccCCCC-cccccccccceeEeeccccc
Q 001434 374 FQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIP-VGFQHLTQMRQLQLFENSLT 427 (1078)
Q Consensus 374 ~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~ 427 (1078)
.+|.|+.. ..+..+++|+.+++++|+++...+ . ...+.+++.+++.+|.+.
T Consensus 148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~ 199 (414)
T KOG0531|consen 148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIR 199 (414)
T ss_pred ccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchh
Confidence 66666543 334446666666666666664332 1 344555555555555554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.08 E-value=4.6e-09 Score=113.20 Aligned_cols=262 Identities=14% Similarity=0.106 Sum_probs=166.6
Q ss_pred CccEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeE------E-EecCceEE
Q 001434 784 DSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGF------C-YHQGSNLL 855 (1078)
Q Consensus 784 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~------~-~~~~~~~l 855 (1078)
.+..+|+|+-+.+|..-.- +.. +.|++........ .+.+..|... .||-+-.-+.| . ..+....+
T Consensus 15 ~gr~LgqGgea~ly~l~e~-~d~-VAKIYh~Pppa~~-----aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGf 87 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEV-RDQ-VAKIYHAPPPAAQ-----AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGF 87 (637)
T ss_pred CCccccCCccceeeecchh-hch-hheeecCCCchHH-----HHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEE
Confidence 3456999999999975322 222 4477766644211 1223333333 56544331211 1 12333688
Q ss_pred EEeeccCC-CHHhHhc-----CCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccc
Q 001434 856 IYEYMERG-SLGELLH-----GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929 (1078)
Q Consensus 856 v~e~~~~g-sL~~~l~-----~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a 929 (1078)
.|+.+.|. ...++.. +.-...+|...+++++.++.+.+.||.. |.+-||++++|+|+++++.|.+.|=+.-
T Consensus 88 lmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 88 LMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred ecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcccce
Confidence 99998775 2222221 1122588999999999999999999998 9999999999999999999999986644
Q ss_pred cccCCCCCCcccccccccCcccccccc-----cCCCCCcCcchhHHHHHHHHHhC-CCCCCCCCCC----CCHH-HHHHH
Q 001434 930 KVIDMPQSKSMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTG-RTPVQPLDDG----GDLA-TWVRN 998 (1078)
Q Consensus 930 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DvwslGv~l~elltg-~~P~~~~~~~----~~~~-~~~~~ 998 (1078)
... .....+...+|..+|++||... +...+...|.|.+|+++++++.| ++||.+.... .-.. .+..+
T Consensus 165 qi~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 165 QIN--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eec--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 433 2445566778999999999754 34456789999999999999985 9999875421 1112 23333
Q ss_pred HhhcCC-CCCccccCCCCcchhhHHHHHHHHHHHHHhcCCC--CCCCCCCHHHHHHHHHhhcccC
Q 001434 999 YIRDHS-LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSI--SPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 999 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dP~~RPs~~ell~~L~~~~~~~ 1060 (1078)
.+...+ ...+...+...+..+.+. ..+..++.+|+.. ++.-|||++.++..|..+....
T Consensus 243 ~f~ya~~~~~g~~p~P~~~P~~~Lp---p~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L 304 (637)
T COG4248 243 RFAYASDQRRGLKPPPRSIPLSMLP---PDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL 304 (637)
T ss_pred eeeechhccCCCCCCCCCCChhhcC---HHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence 222211 111222222222222222 2345566677776 3678999999999998775543
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.5e-11 Score=141.35 Aligned_cols=151 Identities=27% Similarity=0.319 Sum_probs=87.5
Q ss_pred cccccceeeeeccccCCCCCCccCcccccceeeecCCcccCCCCccccCccccceeeeccccccccccccccccccccee
Q 001434 244 GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKL 323 (1078)
Q Consensus 244 ~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L 323 (1078)
.+..++.+++..|.+.. +-..+..+++|+.|++.+|+|.. +...+..+++|++|++++|.|+.. ..+..++.|+.|
T Consensus 70 ~l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~-i~~~l~~~~~L~~L~ls~N~I~~i--~~l~~l~~L~~L 145 (414)
T KOG0531|consen 70 SLTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEK-IENLLSSLVNLQVLDLSFNKITKL--EGLSTLTLLKEL 145 (414)
T ss_pred HhHhHHhhccchhhhhh-hhcccccccceeeeeccccchhh-cccchhhhhcchheeccccccccc--cchhhccchhhh
Confidence 34555555566665552 23335566666666666666663 232356666777777777777644 234555667777
Q ss_pred eccCCCCCCccCccccCcccccEEeccCCCCCCccc-hhhhhhcccchhccccccccCCCCCccccccccCeeeccCccc
Q 001434 324 YLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIP-TEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402 (1078)
Q Consensus 324 ~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~-~~~~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l 402 (1078)
++++|.|+.. ..+..+..|+.+++++|.+...-+ . ...+.+++.+++.+|.+..+ ..+..+..+..+++..|.+
T Consensus 146 ~l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~i--~~~~~~~~l~~~~l~~n~i 220 (414)
T KOG0531|consen 146 NLSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIREI--EGLDLLKKLVLLSLLDNKI 220 (414)
T ss_pred eeccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhcc--cchHHHHHHHHhhcccccc
Confidence 7777776622 344446667777777777664333 1 35566666677777666533 2344444555556666666
Q ss_pred c
Q 001434 403 T 403 (1078)
Q Consensus 403 ~ 403 (1078)
+
T Consensus 221 ~ 221 (414)
T KOG0531|consen 221 S 221 (414)
T ss_pred e
Confidence 5
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.4e-09 Score=105.01 Aligned_cols=144 Identities=20% Similarity=0.218 Sum_probs=108.9
Q ss_pred ccEEeccCceEEEEEEECCCcEEEEEEecccCCC------chhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEe
Q 001434 785 SFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREG------NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 785 ~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~------~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
..++-+|+-+.|+++.+. |+.++||.-...... +-..++..+|++.+.++.--.|.-..-++.+.....++||
T Consensus 12 l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 12 LELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred ceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 456889999999999987 777778765433221 2234677899999998875555555556777778899999
Q ss_pred eccC-CCHHhHhcCCCCCCChhHH-HHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC---ceEEeeccccccc
Q 001434 859 YMER-GSLGELLHGSSCNLEWPTR-FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF---EAHVGDFGLAKVI 932 (1078)
Q Consensus 859 ~~~~-gsL~~~l~~~~~~l~~~~~-~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~ 932 (1078)
|++| .++.+++...-.....++. ...+..|=+.+.-||.. +|+||||..+||++..++ .+.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 4788888654333333333 67888899999999999 999999999999996544 4689999998653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.02 E-value=1.8e-10 Score=131.01 Aligned_cols=250 Identities=20% Similarity=0.157 Sum_probs=176.1
Q ss_pred hcCCCccEEeccCceEEEEEEE--CCCcEEEEEEecccCCCchhHHHHHHHHHHHccC-CCCceeeEeeEEEecCceEEE
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVM--DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~lG~G~~g~V~~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~lv 856 (1078)
.+|.....||.|.|+.|+.... .++..|++|...+..........-..|+.+...+ .|.++++.+..+...+..|+-
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 3566677899999999998773 3588899998877655433333334666666666 588999988888777888899
Q ss_pred EeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCC-CceEEeecccccccCCC
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK-FEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~-~~~kl~Dfg~a~~~~~~ 935 (1078)
-||+++++....+. -...+++..++.+..|++.++.++|+. .++|+|++|+||++..+ +..++.|||.+..+...
T Consensus 345 ~e~~~~~s~~l~~~-~~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~ 420 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSV-TSQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS 420 (524)
T ss_pred hhhhcCcchhhhhH-HHHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhcccccccccccee
Confidence 99999998888773 223678888999999999999999998 99999999999999886 77899999988643211
Q ss_pred CCCcccccccccCc-ccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCC
Q 001434 936 QSKSMSAVAGSYGY-IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
......++..| .+++......+..++|+|++|..+.|..+|..--.... +|.. ++ ....
T Consensus 421 ---~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~------~~~~--i~---------~~~~ 480 (524)
T KOG0601|consen 421 ---SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV------QSLT--IR---------SGDT 480 (524)
T ss_pred ---cccccccccccccchhhccccccccccccccccccccccccCcccCcccc------ccee--ee---------cccc
Confidence 11111122333 35555556678899999999999999999874322111 1100 00 0101
Q ss_pred CcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHhhc
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ell~~L~~~~ 1057 (1078)
+..+ .....+..+.+.+..+++..||.+.++..+...++
T Consensus 481 p~~~----~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 481 PNLP----GLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred cCCC----chHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 1011 11133556777888999999999999887766543
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4.6e-11 Score=129.02 Aligned_cols=208 Identities=23% Similarity=0.210 Sum_probs=122.0
Q ss_pred CcccccEEEcCCcccccccC-CCcccccccceeeeeccccCCC--CCCccCcccccceeeecCCcccCCCCccc-cCccc
Q 001434 220 NLRNLRVFRAGQNAISGSIP-AEISGCQSLQILGLAQNDIGGS--LPKEIGMLESLTEIVLWDNQLTGFIPSEL-GNCTK 295 (1078)
Q Consensus 220 ~l~~L~~L~l~~n~l~~~~p-~~l~~l~~L~~L~L~~n~l~~~--~~~~l~~l~~L~~L~L~~n~l~~~~p~~l-~~l~~ 295 (1078)
++++|+...|.+..+....- .....|++++.|||+.|-|... +..-...|++|+.|+|+.|++.....+.. ..+++
T Consensus 119 n~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~~ 198 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLSH 198 (505)
T ss_pred hHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhhh
Confidence 44455555555554442111 2344566666666666655532 12223456677777777776653222211 14567
Q ss_pred cceeeecccccccc-cccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCcc-chhhhhhcccchhcc
Q 001434 296 LQTLALYSNNLVGQ-IPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEI-PTEFSKITGLRLLFL 373 (1078)
Q Consensus 296 L~~L~Ls~N~l~~~-~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L 373 (1078)
|+.|.|+.|.++.. +-..+..+++|+.|+|..|..-.........+..|++|||++|++-... -...+.++.|+.|++
T Consensus 199 lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Lnl 278 (505)
T KOG3207|consen 199 LKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLNL 278 (505)
T ss_pred hheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhhc
Confidence 77888888877732 2223445677888888888533233334455677888888888776322 134567788888888
Q ss_pred ccccccCC-CCCc-----cccccccCeeeccCccccCCC-CcccccccccceeEeeccccc
Q 001434 374 FQNQLTGV-IPNE-----LSSLRNLTKLDLSINYLTGPI-PVGFQHLTQMRQLQLFENSLT 427 (1078)
Q Consensus 374 ~~N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~L~~N~l~ 427 (1078)
+.+.++.+ .|+. ...+++|++|+++.|++.... -..+..+.+|+.|.+..|.++
T Consensus 279 s~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~~~n~ln 339 (505)
T KOG3207|consen 279 SSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRITLNYLN 339 (505)
T ss_pred cccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhccccccc
Confidence 88887754 2322 345678888888888886321 112444566666666666665
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.01 E-value=3.8e-11 Score=129.66 Aligned_cols=210 Identities=20% Similarity=0.187 Sum_probs=110.3
Q ss_pred cCcCCCcEEEccCCccccccc--cccccCCCCceeccccccccCCCC--ccccCCcchhHHhcccCcccccccccc-cCc
Q 001434 147 GNCSRLEHLYLNNNQFSGKIP--AELGKLSSLVSLNICNNMISGALP--EGLGNLSSLVDFVAYTNNLTGPLPQSI-GNL 221 (1078)
Q Consensus 147 ~~l~~L~~L~Ls~n~l~~~~p--~~l~~l~~L~~L~Ls~n~i~~~~p--~~l~~l~~L~~L~l~~n~l~~~~p~~l-~~l 221 (1078)
+++.+|++..|.++.+. ..+ .....|++++.||||+|-+..-.| .-...|++|+.|+++.|++........ ..+
T Consensus 118 sn~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l 196 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLL 196 (505)
T ss_pred hhHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhh
Confidence 46788888888888775 223 356678888888888887763211 222345666666666665553322221 233
Q ss_pred ccccEEEcCCcccccccCCCcccccccceeeeeccccCCCC-CCccCcccccceeeecCCcccCCCCccccCccccceee
Q 001434 222 RNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSL-PKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLA 300 (1078)
Q Consensus 222 ~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~-~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 300 (1078)
+ .|+.|.|+.|.++..- -.....+++|+.|+|..|..-..-......+..|+.||
T Consensus 197 ~------------------------~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~Ld 252 (505)
T KOG3207|consen 197 S------------------------HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELD 252 (505)
T ss_pred h------------------------hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhcc
Confidence 4 4444445544444111 11122345555555555532222222333445555566
Q ss_pred eccccccccc-ccccccccccceeeccCCCCCCc-cCcc-----ccCcccccEEeccCCCCCCcc-chhhhhhcccchhc
Q 001434 301 LYSNNLVGQI-PKEVGNLKFLTKLYLYRNELNGT-IPRE-----IGNLSMVTEIDLSENSLNGEI-PTEFSKITGLRLLF 372 (1078)
Q Consensus 301 Ls~N~l~~~~-p~~l~~l~~L~~L~L~~N~l~~~-~p~~-----l~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ 372 (1078)
|++|++.... -...+.++.|+.|+++.|.+... +|+. ...+++|++|+++.|++...- -..+..+.+|+.|.
T Consensus 253 Ls~N~li~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~ 332 (505)
T KOG3207|consen 253 LSNNNLIDFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLR 332 (505)
T ss_pred ccCCcccccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhh
Confidence 6655554211 12344555666666666655521 2222 234566777777777764211 13345556677777
Q ss_pred cccccccCC
Q 001434 373 LFQNQLTGV 381 (1078)
Q Consensus 373 L~~N~l~~~ 381 (1078)
+..|.++..
T Consensus 333 ~~~n~ln~e 341 (505)
T KOG3207|consen 333 ITLNYLNKE 341 (505)
T ss_pred ccccccccc
Confidence 777777643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.7e-09 Score=113.57 Aligned_cols=143 Identities=20% Similarity=0.248 Sum_probs=109.8
Q ss_pred cEEeccCceEEEEEEECCCcEEEEEEecccCCCchhHHHHHHHHHHHccCCC--CceeeEeeEEEec---CceEEEEeec
Q 001434 786 FIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH--RNIVKLYGFCYHQ---GSNLLIYEYM 860 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~---~~~~lv~e~~ 860 (1078)
+.++.|.++.||++...+|+.|++|........ .....+.+|+++++.+.+ ..+++++.+.... +..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 458999999999998876689999998654332 234567899999999865 3456777766553 2568999999
Q ss_pred cCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhcc------------------------------------------
Q 001434 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD------------------------------------------ 898 (1078)
Q Consensus 861 ~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~------------------------------------------ 898 (1078)
+|.++.+.+.. ..++..++..++.++++++.++|+.
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888876532 2467777778888888888888852
Q ss_pred -----------CCCceEecCCCCCcEEECC--CCceEEeecccccc
Q 001434 899 -----------CKPRIFHRDIKSNNILLDD--KFEAHVGDFGLAKV 931 (1078)
Q Consensus 899 -----------~~~~ivH~Dlkp~Nill~~--~~~~kl~Dfg~a~~ 931 (1078)
....++|+|++|.||+++. ++.+.++||+.+..
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 0246899999999999998 66789999998864
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.94 E-value=6e-10 Score=110.98 Aligned_cols=107 Identities=27% Similarity=0.391 Sum_probs=31.3
Q ss_pred cccccceeeeeccccCCCCCCccC-cccccceeeecCCcccCCCCccccCccccceeeeccccccccccccc-ccccccc
Q 001434 244 GCQSLQILGLAQNDIGGSLPKEIG-MLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLT 321 (1078)
Q Consensus 244 ~l~~L~~L~L~~n~l~~~~~~~l~-~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l-~~l~~L~ 321 (1078)
+..++++|+|++|+|+. + +.++ .+.+|+.|+|++|+|+.. +.+..+++|++|++++|+|+. +...+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S----TT----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 33456666666666652 2 2344 456677777777777643 246666777777777777763 33333 3466777
Q ss_pred eeeccCCCCCCcc-CccccCcccccEEeccCCCCC
Q 001434 322 KLYLYRNELNGTI-PREIGNLSMVTEIDLSENSLN 355 (1078)
Q Consensus 322 ~L~L~~N~l~~~~-p~~l~~l~~L~~L~Ls~N~l~ 355 (1078)
+|+|++|+|.... -..+..+++|+.|+|.+|.++
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 7777777776321 134555666666777666665
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=98.93 E-value=5.8e-10 Score=111.10 Aligned_cols=102 Identities=24% Similarity=0.259 Sum_probs=28.8
Q ss_pred ccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccccccccCCC-CCccccccccCee
Q 001434 317 LKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVI-PNELSSLRNLTKL 395 (1078)
Q Consensus 317 l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~-p~~l~~l~~L~~L 395 (1078)
+.+|+.|+|++|.|+.. +.+..++.|++|++++|+|+...+.....+++|++|++++|+|.... -..+..+++|+.|
T Consensus 41 l~~L~~L~Ls~N~I~~l--~~l~~L~~L~~L~L~~N~I~~i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L 118 (175)
T PF14580_consen 41 LDKLEVLDLSNNQITKL--EGLPGLPRLKTLDLSNNRISSISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVL 118 (175)
T ss_dssp -TT--EEE-TTS--S----TT----TT--EEE--SS---S-CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EE
T ss_pred hcCCCEEECCCCCCccc--cCccChhhhhhcccCCCCCCccccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCccee
Confidence 33444444444444421 12333444444444444444221111123444444444444444221 1234456666666
Q ss_pred eccCccccCCCC---cccccccccceeE
Q 001434 396 DLSINYLTGPIP---VGFQHLTQMRQLQ 420 (1078)
Q Consensus 396 ~Ls~N~l~~~~~---~~~~~l~~L~~L~ 420 (1078)
+|.+|.++.... ..+..+|+|+.||
T Consensus 119 ~L~~NPv~~~~~YR~~vi~~lP~Lk~LD 146 (175)
T PF14580_consen 119 SLEGNPVCEKKNYRLFVIYKLPSLKVLD 146 (175)
T ss_dssp E-TT-GGGGSTTHHHHHHHH-TT-SEET
T ss_pred eccCCcccchhhHHHHHHHHcChhheeC
Confidence 666666653311 1134455555554
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=5.8e-09 Score=107.72 Aligned_cols=137 Identities=23% Similarity=0.188 Sum_probs=100.9
Q ss_pred CccEEeccCceEEEEEEECCCcEEEEEEecccC------------------CC--chhHHHHHHHHHHHccCCCC--cee
Q 001434 784 DSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNR------------------EG--NNIESSFRAEILTLGKIRHR--NIV 841 (1078)
Q Consensus 784 ~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~------------------~~--~~~~~~~~~e~~~l~~l~h~--~iv 841 (1078)
.+..||-|.-+.||.|.++.|.++|||.=..-. .+ .-.+....+|.+.|.++... .|+
T Consensus 95 iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP 174 (304)
T COG0478 95 IGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVP 174 (304)
T ss_pred hccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCC
Confidence 346799999999999999999999999432110 00 12345678999999999655 788
Q ss_pred eEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCce
Q 001434 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921 (1078)
Q Consensus 842 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~ 921 (1078)
+.+++ +..++||||++|-.|.+.-- +......++..|+.-+..+-+. ||||||+++.||+++++|.+
T Consensus 175 ~P~~~----nRHaVvMe~ieG~eL~~~r~------~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV~~dg~~ 241 (304)
T COG0478 175 KPIAW----NRHAVVMEYIEGVELYRLRL------DVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILVTEDGDI 241 (304)
T ss_pred Ccccc----ccceeeeehcccceeecccC------cccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEEecCCCE
Confidence 87765 45579999999977766431 2233344555555555555566 99999999999999999999
Q ss_pred EEeecccccccC
Q 001434 922 HVGDFGLAKVID 933 (1078)
Q Consensus 922 kl~Dfg~a~~~~ 933 (1078)
.++||-.+....
T Consensus 242 ~vIDwPQ~v~~~ 253 (304)
T COG0478 242 VVIDWPQAVPIS 253 (304)
T ss_pred EEEeCcccccCC
Confidence 999999876543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=1.2e-09 Score=135.59 Aligned_cols=267 Identities=22% Similarity=0.252 Sum_probs=135.6
Q ss_pred ccCeEecccCc--cccccCCCccCcCCCcEEEccCCccccccccccccCCCCceeccccccccCCCCccccCCcchhHHh
Q 001434 127 HLTYLDLAYNE--LTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFV 204 (1078)
Q Consensus 127 ~L~~L~L~~n~--l~~~~p~~~~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~L~~L~ 204 (1078)
.|+.|-+..|. +....+..|..++.|++||||+|.=-+++|..|++|-+|++|+|+++.+. .+|.++.+|++|.+|+
T Consensus 546 ~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~Ln 624 (889)
T KOG4658|consen 546 KLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIYLN 624 (889)
T ss_pred ccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhheec
Confidence 46666666664 33222334556777777777776655677777777777777777777766 6677777777777777
Q ss_pred cccCcccccccccccCcccccEEEcCCcc--cccccCCCcccccccceeeeeccccCCCCCCccCcccccc----eeeec
Q 001434 205 AYTNNLTGPLPQSIGNLRNLRVFRAGQNA--ISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLT----EIVLW 278 (1078)
Q Consensus 205 l~~n~l~~~~p~~l~~l~~L~~L~l~~n~--l~~~~p~~l~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~----~L~L~ 278 (1078)
+..+.-...+|..+..|.+|++|.+.... .+...-..+.++.+|+.+....... .+-..+..+..|. .+.+.
T Consensus 625 l~~~~~l~~~~~i~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~--~~~e~l~~~~~L~~~~~~l~~~ 702 (889)
T KOG4658|consen 625 LEVTGRLESIPGILLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSV--LLLEDLLGMTRLRSLLQSLSIE 702 (889)
T ss_pred cccccccccccchhhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchh--HhHhhhhhhHHHHHHhHhhhhc
Confidence 76666555555555667777777665543 1222223334444444444432222 0111122222222 33322
Q ss_pred CCcccCCCCccccCccccceeeeccccccccccccccc------ccccceeeccCCCCCCccCccccCcccccEEeccCC
Q 001434 279 DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGN------LKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSEN 352 (1078)
Q Consensus 279 ~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~------l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N 352 (1078)
.+... ..+..+..+.+|+.|.+.++.+.......... ++++..+...++... ..+.+..-.++|+.|++..+
T Consensus 703 ~~~~~-~~~~~~~~l~~L~~L~i~~~~~~e~~~~~~~~~~~~~~f~~l~~~~~~~~~~~-r~l~~~~f~~~L~~l~l~~~ 780 (889)
T KOG4658|consen 703 GCSKR-TLISSLGSLGNLEELSILDCGISEIVIEWEESLIVLLCFPNLSKVSILNCHML-RDLTWLLFAPHLTSLSLVSC 780 (889)
T ss_pred ccccc-eeecccccccCcceEEEEcCCCchhhcccccccchhhhHHHHHHHHhhccccc-cccchhhccCcccEEEEecc
Confidence 23322 33455666677777777777665332222111 112222222222211 12222234466777777766
Q ss_pred CCCCccchhhhhhcccchhccccccccCC-CCCccccccccCeeecc
Q 001434 353 SLNGEIPTEFSKITGLRLLFLFQNQLTGV-IPNELSSLRNLTKLDLS 398 (1078)
Q Consensus 353 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~-~p~~l~~l~~L~~L~Ls 398 (1078)
.....+......+..+..+-+..+.+.+. .-...+.++++..+.++
T Consensus 781 ~~~e~~i~~~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~ 827 (889)
T KOG4658|consen 781 RLLEDIIPKLKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLS 827 (889)
T ss_pred cccccCCCHHHHhhhcccEEecccccccceeeecCCCCceeEecccC
Confidence 66555555555555555555555555544 22333444444444433
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.2e-09 Score=133.09 Aligned_cols=133 Identities=23% Similarity=0.298 Sum_probs=95.9
Q ss_pred ccCCCccCeEecccCccccccCCCccCcCCCcEEEccCCc--cccccccccccCCCCceeccccccccCCCCccccCCcc
Q 001434 122 IGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQ--FSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSS 199 (1078)
Q Consensus 122 l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~--l~~~~p~~l~~l~~L~~L~Ls~n~i~~~~p~~l~~l~~ 199 (1078)
..+....+...+-+|.+. .++... ..+.|+.|-+..|. +.......|..++.|++|||++|.--+.+|.++++|-+
T Consensus 519 ~~~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~ 596 (889)
T KOG4658|consen 519 VKSWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVH 596 (889)
T ss_pred ccchhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhh
Confidence 444567778888777765 333332 23478889888886 54333445788999999999998777788888888888
Q ss_pred hhHHhcccCcccccccccccCcccccEEEcCCcccccccCCCcccccccceeeeeccc
Q 001434 200 LVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQND 257 (1078)
Q Consensus 200 L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~L~~n~ 257 (1078)
|++|+++.+.+. .+|..+++|+.|.+|++..+.-...+|..+..|++|++|.+....
T Consensus 597 LryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 597 LRYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hhcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 888888888877 777778888888888887776555556666667777777776543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.83 E-value=3e-08 Score=100.64 Aligned_cols=128 Identities=27% Similarity=0.329 Sum_probs=85.6
Q ss_pred EEEEEEECCCcEEEEEEecccCCC------------------------chhHHHHHHHHHHHccCCCC--ceeeEeeEEE
Q 001434 795 TVYKAVMDSGKIVAVKKLASNREG------------------------NNIESSFRAEILTLGKIRHR--NIVKLYGFCY 848 (1078)
Q Consensus 795 ~V~~~~~~~~~~vavK~~~~~~~~------------------------~~~~~~~~~e~~~l~~l~h~--~iv~l~~~~~ 848 (1078)
.||.|...+|..+|+|........ ........+|++.|.++... ++++++++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 489999988999999987543110 01124567899999999765 566666442
Q ss_pred ecCceEEEEeecc--CCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhh-hhccCCCceEecCCCCCcEEECCCCceEEee
Q 001434 849 HQGSNLLIYEYME--RGSLGELLHGSSCNLEWPTRFMIALGAAEGLAY-LHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 925 (1078)
Q Consensus 849 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~-LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~D 925 (1078)
..++||||++ |..+..+.... ++......++.+++..+.. +|.. |++|||+.+.||+++++ .+.++|
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEe
Confidence 4579999998 65555544322 1245566777888886655 4676 99999999999999988 999999
Q ss_pred cccccccC
Q 001434 926 FGLAKVID 933 (1078)
Q Consensus 926 fg~a~~~~ 933 (1078)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.3e-09 Score=130.02 Aligned_cols=243 Identities=23% Similarity=0.253 Sum_probs=160.4
Q ss_pred cEEeccCceEEEEEEEC-CCcEEEEEEecccCC-CchhHHHHHHHHHHHccCCCCceeeEeeEEEecCceEEEEeeccCC
Q 001434 786 FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
+.+-+|.++.++.+.-. .|...++|+...... .....+...++-.+.-..++|.+++....+.-....++|++|..++
T Consensus 810 ~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~ 889 (1205)
T KOG0606|consen 810 KPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGG 889 (1205)
T ss_pred ccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccC
Confidence 34677888888877644 243444444322211 0111222223333333345677776665555567789999999999
Q ss_pred CHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCC---------
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM--------- 934 (1078)
Q Consensus 864 sL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~--------- 934 (1078)
+|...++..+. .+.+........+..+.+|||.. .+.|+|++|.|.+...++..++.|||.......
T Consensus 890 ~~~Skl~~~~~-~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg 965 (1205)
T KOG0606|consen 890 DLPSKLHNSGC-LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSG 965 (1205)
T ss_pred CchhhhhcCCC-cccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCccccccccccccCcCCccc
Confidence 99999998773 44444444555678899999997 799999999999999999999999983322110
Q ss_pred ---------------------CCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCCCCCCCCCCCCHH
Q 001434 935 ---------------------PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLA 993 (1078)
Q Consensus 935 ---------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~P~~~~~~~~~~~ 993 (1078)
..........||+.|.+||...+.....++|.|+.|++++|.++|.+||......
T Consensus 966 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq---- 1041 (1205)
T KOG0606|consen 966 PSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ---- 1041 (1205)
T ss_pred ccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh----
Confidence 0001123467899999999999999999999999999999999999999754433
Q ss_pred HHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhcCCCCCCCCCCHH
Q 001434 994 TWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMR 1047 (1078)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1047 (1078)
+...++.......+ .-+. .......+++.+.+..+|.+|-.+.
T Consensus 1042 ~~f~ni~~~~~~~p--------~g~~---~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWP--------EGPE---EGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred hhhhccccCCCCCC--------CCcc---ccChhhhhhhhhhhccCchhccCcc
Confidence 22233332221111 1111 1122345677778888999998776
|
|
| >PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] | Back alignment and domain information |
|---|
Probab=98.77 E-value=5.7e-09 Score=78.10 Aligned_cols=40 Identities=43% Similarity=0.896 Sum_probs=30.9
Q ss_pred cchHHHHHHHHHhcc-cCCCCCCCccCCC-CCCCcccceEee
Q 001434 58 NSEGHYLLELKNSLH-DEFNFLKSWKSTD-QTPCSWIGVNCT 97 (1078)
Q Consensus 58 ~~~~~~ll~~k~~~~-~~~~~l~sW~~~~-~~~C~w~Gv~C~ 97 (1078)
++|++||++||+++. +|.+.+.+|+... .+||.|.||+|+
T Consensus 2 ~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C~W~GV~Cd 43 (43)
T PF08263_consen 2 NQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPCSWSGVTCD 43 (43)
T ss_dssp HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CCCSTTEEE-
T ss_pred cHHHHHHHHHHHhcccccCcccccCCCcCCCCCeeeccEEeC
Confidence 579999999999998 5668999999863 689999999996
|
LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.9e-08 Score=103.71 Aligned_cols=142 Identities=15% Similarity=0.071 Sum_probs=100.3
Q ss_pred cEEeccCceEEEEEEECCCcEEEEEEecccCCCc---------hhHHHHHHHHHHHccCCCCc--eeeEeeEEEe-----
Q 001434 786 FIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGN---------NIESSFRAEILTLGKIRHRN--IVKLYGFCYH----- 849 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---------~~~~~~~~e~~~l~~l~h~~--iv~l~~~~~~----- 849 (1078)
+.+-......|+++... |+.|.||......... .....+.+|+..+.++...+ +++++++++.
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 44555555567776664 7889999774432110 01124778888888774333 3344555543
Q ss_pred cCceEEEEeeccCC-CHHhHhcCC-CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECC-------CCc
Q 001434 850 QGSNLLIYEYMERG-SLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-------KFE 920 (1078)
Q Consensus 850 ~~~~~lv~e~~~~g-sL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~-------~~~ 920 (1078)
....++|||++++. +|.+++... ....+...+..++.+++..+..||.. ||+|+|++++|||++. +..
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCce
Confidence 23468999999886 899987532 22455667778999999999999999 9999999999999975 468
Q ss_pred eEEeecccccc
Q 001434 921 AHVGDFGLAKV 931 (1078)
Q Consensus 921 ~kl~Dfg~a~~ 931 (1078)
+.++||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998753
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.62 E-value=7.1e-10 Score=126.21 Aligned_cols=127 Identities=29% Similarity=0.313 Sum_probs=84.4
Q ss_pred ccceeeecccccccccccccccccccceeeccCCCCCCccCccccCcccccEEeccCCCCCCccchhhhhhcccchhccc
Q 001434 295 KLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLF 374 (1078)
Q Consensus 295 ~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 374 (1078)
+|.+-+.++|.++ ....++.-++.|+.|+|++|+++.. +.+..++.|++|||++|.+....--....+ .|..|.++
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc-~L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLRHVPQLSMVGC-KLQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhccccccchhhh-hheeeeec
Confidence 4666777777776 4555666677777777777777643 266777777777777777763221222233 37777778
Q ss_pred cccccCCCCCccccccccCeeeccCccccCCCCc-ccccccccceeEeeccccc
Q 001434 375 QNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPV-GFQHLTQMRQLQLFENSLT 427 (1078)
Q Consensus 375 ~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~~~-~~~~l~~L~~L~L~~N~l~ 427 (1078)
+|.++.. ..+.++++|+.||+++|-|.+.-.- -++.+..|+.|+|.+|++.
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 8777744 3467778888888888877753221 2456677788888888775
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=3e-08 Score=81.17 Aligned_cols=58 Identities=36% Similarity=0.434 Sum_probs=23.9
Q ss_pred cceeeecCCcccCCCCccccCccccceeeecccccccccccccccccccceeeccCCC
Q 001434 272 LTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNE 329 (1078)
Q Consensus 272 L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~L~L~~N~ 329 (1078)
|++|++++|+++...+..|.++++|++|++++|.++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 3444444444443333344444444444444444443333334444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.62 E-value=2.7e-08 Score=81.45 Aligned_cols=58 Identities=36% Similarity=0.522 Sum_probs=26.2
Q ss_pred cceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEeccCcc
Q 001434 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNS 593 (1078)
Q Consensus 536 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 593 (1078)
|++|++++|+++...+..|.++++|++|++++|+++...|..|.++++|++|++++|+
T Consensus 3 L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 3 LESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp ESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred CcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 4444444444443333444444444444444444444444444444444444444443
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.1e-06 Score=98.09 Aligned_cols=167 Identities=20% Similarity=0.293 Sum_probs=125.9
Q ss_pred CceEEEEEEEC-CCcEEEEEEecccCCCchhHHHHHHHHHHHccCCCCceeeEeeEEEe----cCceEEEEeeccCC-CH
Q 001434 792 AYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNLLIYEYMERG-SL 865 (1078)
Q Consensus 792 ~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~e~~~~g-sL 865 (1078)
-..+.|+|... +|..|++|+++..+... ......-+++++++.|+|||++.+++.. +-..++||+|.++. +|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 34577888854 79999999995443321 1123456888999999999999998863 44678999998774 78
Q ss_pred HhHhcCC--------------CCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccc
Q 001434 866 GELLHGS--------------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 866 ~~~l~~~--------------~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~ 931 (1078)
.++-... +...++...+.++.|++.||.++|+. |+..+-+.+.+|+++.+.+++|+..|....
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv 442 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV 442 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence 7764321 12466788999999999999999999 999999999999999999999998888766
Q ss_pred cCCCCCCcccccccccCcccccccccCCCCCcCcchhHHHHHHHHHhCCC
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGv~l~elltg~~ 981 (1078)
...+. . |.+.. -.+-|.-.+|.++..+.||..
T Consensus 443 l~~d~-------------~--~~le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 443 LQEDP-------------T--EPLES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred ecCCC-------------C--cchhH---HhhhhHHHHHHHHHHHhhccc
Confidence 54222 0 11111 135688899999999999964
|
|
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.57 E-value=7.6e-09 Score=94.58 Aligned_cols=111 Identities=25% Similarity=0.337 Sum_probs=64.7
Q ss_pred ccCceeeccccccCCCCCCccC-CcccceEEeccCccCCCCCCccccCchhHHHHHhcccccccCCCCcccCcccccchh
Q 001434 606 QQLEILKLSENKFSGNIPSTLG-NLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFL 684 (1078)
Q Consensus 606 ~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~g~ip~~l~~l~~l~~~L~Ls~N~l~g~ip~~~~~l~~L~~L 684 (1078)
..|+..+|++|.+. ..|..|. .++.++.|+|++|.|+ .+|.++..++.|+ .||++.|.|. ..|..+..|.+|-.|
T Consensus 53 ~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr-~lNl~~N~l~-~~p~vi~~L~~l~~L 128 (177)
T KOG4579|consen 53 YELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALR-SLNLRFNPLN-AEPRVIAPLIKLDML 128 (177)
T ss_pred ceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhh-hcccccCccc-cchHHHHHHHhHHHh
Confidence 34444555555555 3333332 3345666666666666 6666666666666 5666666666 566666666677777
Q ss_pred hcCCCcCcCCCChhhhhhcccccccccccccCCCCCC
Q 001434 685 LLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPS 721 (1078)
Q Consensus 685 ~Ls~N~l~g~ip~~~~~l~~L~~l~ls~N~l~g~~p~ 721 (1078)
|..+|.+. +||..+-.-+......+.+|.+.+.-|.
T Consensus 129 ds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 129 DSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred cCCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 77777776 6665544434444445555555554443
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.1e-09 Score=122.55 Aligned_cols=127 Identities=25% Similarity=0.321 Sum_probs=64.2
Q ss_pred cccccccccccccCCCccccccccccceeeccccccccCCCcccCCcccccEEEeccccccCcCCccccccccccEEecc
Q 001434 511 NLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDIS 590 (1078)
Q Consensus 511 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 590 (1078)
.|...++++|.+. .+...+.-++.|+.|+|++|+++... .+..++.|++|||++|++....--....+. |+.|.|+
T Consensus 165 ~L~~a~fsyN~L~-~mD~SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~~vp~l~~~gc~-L~~L~lr 240 (1096)
T KOG1859|consen 165 KLATASFSYNRLV-LMDESLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLRHVPQLSMVGCK-LQLLNLR 240 (1096)
T ss_pred hHhhhhcchhhHH-hHHHHHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhccccccchhhhh-heeeeec
Confidence 3445555555554 33444445555555555555555321 445555566666666665532111222222 6666666
Q ss_pred CccccCCCCccccCcccCceeeccccccCCCC-CCccCCcccceEEeccCccCC
Q 001434 591 HNSFVGSLPNELGTLQQLEILKLSENKFSGNI-PSTLGNLSHLTELQMGGNLFS 643 (1078)
Q Consensus 591 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~ 643 (1078)
+|.++.. ..+.+|++|+.||+++|-|++.- -..++.|..|+.|+|.+|++-
T Consensus 241 nN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 241 NNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred ccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 6665522 23445566666666666655421 122344556666666666664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.47 E-value=7.3e-07 Score=93.21 Aligned_cols=125 Identities=22% Similarity=0.202 Sum_probs=91.0
Q ss_pred CcEEEEEEecccCCC-----chhHHHHHHHHHHHccCCC--CceeeEeeEEEecC----ceEEEEeeccCC-CHHhHhcC
Q 001434 804 GKIVAVKKLASNREG-----NNIESSFRAEILTLGKIRH--RNIVKLYGFCYHQG----SNLLIYEYMERG-SLGELLHG 871 (1078)
Q Consensus 804 ~~~vavK~~~~~~~~-----~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~ 871 (1078)
++.|.+|........ ........+|...+.++.. =.+++++++.+... ..++|+|++++. +|.+++..
T Consensus 32 ~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~ 111 (206)
T PF06293_consen 32 GRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQ 111 (206)
T ss_pred ceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHh
Confidence 556666654322111 1223467788887777742 33555566655422 347999999885 89999876
Q ss_pred CCCCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCC---ceEEeeccccccc
Q 001434 872 SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF---EAHVGDFGLAKVI 932 (1078)
Q Consensus 872 ~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~---~~kl~Dfg~a~~~ 932 (1078)
... .+......++.++++.++-||.. ||+|+|+++.|||++.++ .+.++||+.++..
T Consensus 112 ~~~-~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 112 WEQ-LDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred hcc-cchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 432 56677888999999999999999 999999999999999887 8999999987753
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.2e-07 Score=109.53 Aligned_cols=151 Identities=18% Similarity=0.289 Sum_probs=100.8
Q ss_pred HHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCceEEeecccccccCCCCCCc--------ccccccccCcccccccc
Q 001434 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--------MSAVAGSYGYIAPEYAY 956 (1078)
Q Consensus 885 ~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~--------~~~~~gt~~y~aPE~~~ 956 (1078)
+.+++.|+.|+|.. +++||+.|.|++|.++..+..|++.|+.+.....+.... .........|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34556999999986 699999999999999999999999999886554311111 01123456899999999
Q ss_pred cCCCCCcCcchhHHHHHHHHHh-CCCCCCCCCCCCCHHHHHHHHhhcCCCCCccccCCCCcchhhHHHHHHHHHHHHHhc
Q 001434 957 TMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMC 1035 (1078)
Q Consensus 957 ~~~~~~~~DvwslGv~l~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 1035 (1078)
....+.++|+||+|+++|.+.. |+.-+.... .............. ....... +...++.+=+.++
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~-~~~~~~~~~~~~~~---~~~~~s~----------~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANG-GLLSYSFSRNLLNA---GAFGYSN----------NLPSELRESLKKL 248 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccC-Ccchhhhhhccccc---ccccccc----------cCcHHHHHHHHHH
Confidence 9888899999999999999995 554443322 11111111111110 0000011 2233456677889
Q ss_pred CCCCCCCCCCHHHHHH
Q 001434 1036 TSISPFDRPSMREVVS 1051 (1078)
Q Consensus 1036 l~~dP~~RPs~~ell~ 1051 (1078)
+..++..||++.++..
T Consensus 249 l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLLS 264 (700)
T ss_pred hcCCcccCcchhhhhc
Confidence 9999999997776653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=6.3e-07 Score=104.64 Aligned_cols=143 Identities=22% Similarity=0.277 Sum_probs=95.1
Q ss_pred cEEeccCceEEEEEEECCCcEEEEEEecccCC----------------------C----------chh------HHHHHH
Q 001434 786 FIVGSGAYGTVYKAVMDSGKIVAVKKLASNRE----------------------G----------NNI------ESSFRA 827 (1078)
Q Consensus 786 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~----------------------~----------~~~------~~~~~~ 827 (1078)
+.||.++-|.||+|+.++|+.||||+...... . ++. +-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999999999999998754421 0 000 112345
Q ss_pred HHHHHccC-----CCCceeeEeeEEEecCceEEEEeeccCCCHHhHhcCCCCCCChhHHHHHHHHHHhhhhhhhccCCCc
Q 001434 828 EILTLGKI-----RHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902 (1078)
Q Consensus 828 e~~~l~~l-----~h~~iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ 902 (1078)
|+..+.++ ..+.+.-..-|.+-.....++|||++|..+.+...-.....+.........++. +..+=.. |
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~d---g 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRD---G 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhc---C
Confidence 55555554 234433333233445677999999999988887432223455444333322222 2222223 9
Q ss_pred eEecCCCCCcEEECCCCceEEeecccccccC
Q 001434 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 903 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~ 933 (1078)
+.|.|.+|.||+++.+|++.+.|||+....+
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 9999999999999999999999999987764
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.42 E-value=2e-06 Score=87.67 Aligned_cols=139 Identities=14% Similarity=0.069 Sum_probs=102.3
Q ss_pred EeccCceEEEEEEECCCcEEEEEEecccCC-C---chhHHHHHHHHHHHccCCC--CceeeEeeEEEec-----CceEEE
Q 001434 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNRE-G---NNIESSFRAEILTLGKIRH--RNIVKLYGFCYHQ-----GSNLLI 856 (1078)
Q Consensus 788 lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~---~~~~~~~~~e~~~l~~l~h--~~iv~l~~~~~~~-----~~~~lv 856 (1078)
-|+|+.+.|+..... |+.|-+|+-..... + ......|.+|+..+.++.. -.++++. ++... ...++|
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 567888889987766 45788887652211 1 2245789999999988843 2255555 33221 234799
Q ss_pred EeeccC-CCHHhHhcCCC-CCCChhHHHHHHHHHHhhhhhhhccCCCceEecCCCCCcEEECCCCc--eEEeecccccc
Q 001434 857 YEYMER-GSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE--AHVGDFGLAKV 931 (1078)
Q Consensus 857 ~e~~~~-gsL~~~l~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~~~~ivH~Dlkp~Nill~~~~~--~kl~Dfg~a~~ 931 (1078)
+|-++| .+|.+++.... ...+...+..++.+++++++-||+. |+.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 998864 38998876532 2457777889999999999999999 9999999999999986667 99999987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 1078 | ||||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 3e-68 | ||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 4e-68 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-59 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-59 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 1e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 2e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-33 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-33 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-32 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 8e-31 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-26 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-26 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 2e-24 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 2e-24 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-23 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-22 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 4e-22 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-19 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-18 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 3e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 5e-22 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-21 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-21 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-21 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 9e-21 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 9e-21 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-20 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-20 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-20 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-20 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-20 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 3e-20 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-20 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-20 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-20 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 5e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-20 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 5e-20 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-20 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 6e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 7e-20 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-19 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-19 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-19 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-19 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 2e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 2e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-19 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-19 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-19 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-19 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-19 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-19 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-19 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-19 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 3e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-19 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-19 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-19 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-19 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 4e-19 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-19 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-19 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-19 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 6e-19 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-19 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-19 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-19 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-19 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-19 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-19 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 7e-19 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-19 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-19 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-19 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-19 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-19 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 9e-19 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-18 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-18 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-18 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-18 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-18 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-18 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-18 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-18 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-18 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-18 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-18 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-18 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-18 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-18 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-18 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-18 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 4e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-18 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 4e-18 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 6e-18 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-18 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-18 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-17 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-17 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-17 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-17 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-17 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-17 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-17 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-17 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-17 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-17 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-17 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-17 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-17 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-17 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-17 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-17 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-17 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 3e-17 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-17 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-17 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-17 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-17 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 4e-17 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-17 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-17 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 5e-17 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 5e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 5e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 5e-17 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 6e-17 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 6e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-17 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 6e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-17 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 6e-17 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 6e-17 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 6e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 6e-17 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 6e-17 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 7e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-17 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-17 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 7e-17 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 7e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 7e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 7e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 7e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 7e-17 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-17 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-17 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 8e-17 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-17 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-16 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-16 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-16 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-16 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-16 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-16 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-16 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-16 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-16 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-16 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-16 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-16 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-16 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-16 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-16 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-16 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-16 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-16 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-16 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-16 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-16 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-16 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 2e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-16 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-16 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-16 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 3e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-16 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-16 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-16 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 4e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-16 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 5e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-16 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 6e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-16 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 7e-16 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-16 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 7e-16 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 7e-16 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-16 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-15 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-15 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-15 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-15 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-15 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-15 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-15 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-15 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-15 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 5e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 5e-15 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-15 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-15 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-15 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 7e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-15 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 9e-15 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-14 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-14 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 1e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-14 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-14 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-14 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 2e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 2e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-14 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 3e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 3e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 3e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-14 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-14 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 3e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-14 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-14 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 4e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 6e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 7e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 7e-14 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-14 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 7e-14 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 7e-14 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 7e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-14 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 8e-14 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 8e-14 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-14 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 8e-14 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-13 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-13 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-13 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-13 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-13 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 1e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-13 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 2e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-13 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 2e-13 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-13 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 3e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-13 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 3e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-13 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 3e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-13 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 3e-13 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-13 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 3e-13 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 4e-13 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-13 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 4e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 4e-13 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 5e-13 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-13 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 5e-13 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 5e-13 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-13 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-13 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-13 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-13 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 6e-13 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 6e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 6e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 6e-13 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-13 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-13 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 8e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 9e-13 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-13 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 9e-13 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 9e-13 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 9e-13 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 9e-13 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-13 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-12 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-12 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-12 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-12 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-12 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 2e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-12 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-12 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-12 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-12 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-12 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 3e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 4e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 4e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-12 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 4e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 5e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-12 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 6e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 6e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 6e-12 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 6e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 7e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-12 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-12 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 7e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 7e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 8e-12 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 8e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-12 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 8e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 8e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 9e-12 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 9e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 9e-12 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 9e-12 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 9e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 9e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 9e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 9e-12 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-11 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-11 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-11 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 1e-11 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-11 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-11 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-11 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-11 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-11 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-11 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-11 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-11 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-11 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-11 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-11 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-11 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 2e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-11 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-11 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 3e-11 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-11 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 4e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-11 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 5e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 5e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 5e-11 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 5e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 6e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 6e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 6e-11 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-11 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-11 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 6e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 7e-11 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 7e-11 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 7e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 8e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 8e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 8e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 8e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 8e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 8e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 8e-11 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 8e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 8e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 8e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-11 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 8e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 8e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 8e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 9e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 9e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-10 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-10 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-10 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-10 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-10 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 1e-10 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-10 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 1e-10 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-10 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-10 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 1e-10 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-10 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 1e-10 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 1e-10 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-10 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-10 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-10 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-10 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 2e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-10 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-10 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-10 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-10 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-10 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 3e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-10 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-10 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-10 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 4e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 4e-10 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 4e-10 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-10 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 4e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 4e-10 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-10 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 5e-10 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-10 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-10 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-10 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 6e-10 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 7e-10 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 7e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 7e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-10 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 7e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-10 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 9e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-09 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-09 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 1e-09 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-09 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-09 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 1e-09 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-09 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-09 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-09 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-09 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-09 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-09 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-09 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-09 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-09 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 3e-09 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-09 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-09 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 4e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-09 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-09 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 4e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 5e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 6e-09 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-09 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-09 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-09 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 7e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 7e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-09 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 8e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-09 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-09 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 9e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-09 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 1e-08 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-08 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 1e-08 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 1e-08 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 1e-08 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-08 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 1e-08 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-08 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 1e-08 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-08 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 1e-08 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-08 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-08 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-08 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-08 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-08 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 2e-08 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 2e-08 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-08 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-08 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-08 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-08 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-08 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-08 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-08 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-08 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-08 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 2e-08 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-08 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-08 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 3e-08 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-08 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-08 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 3e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-08 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-08 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-08 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 7e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-08 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-08 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 5e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-08 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 5e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 6e-08 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-04 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 6e-08 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-08 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 7e-08 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 8e-08 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 8e-08 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 8e-08 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 1e-04 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 8e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 9e-08 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 9e-08 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 9e-08 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-07 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 1e-07 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 1e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-07 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 1e-07 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-07 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-07 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-07 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-07 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-07 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-07 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 3e-07 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-07 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-07 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-07 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-07 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 6e-07 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-07 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-07 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-07 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 7e-07 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 8e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 8e-07 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 8e-07 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-07 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-07 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-07 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 8e-07 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 9e-07 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-07 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 9e-07 | ||
| 3rfs_A | 272 | Design Of A Binding Scaffold Based On Variable Lymp | 9e-07 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-06 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-06 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-06 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-06 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-06 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-06 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 2e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 2e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 2e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-06 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 1w8a_A | 192 | Third Lrr Domain Of Drosophila Slit Length = 192 | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-06 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-06 | ||
| 3zyj_A | 440 | Netring1 In Complex With Ngl1 Length = 440 | 3e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 3e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 4e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 4e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 4e-06 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 5e-06 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-06 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-06 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 7e-06 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 7e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 7e-06 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 8e-06 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 8e-06 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 8e-06 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-06 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-06 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 9e-06 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-05 | ||
| 3g3a_A | 178 | Structure Of A Lamprey Variable Lymphocyte Receptor | 1e-05 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-05 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-05 | ||
| 3g39_A | 170 | Structure Of A Lamprey Variable Lymphocyte Receptor | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-05 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-05 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-05 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-05 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-05 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 2e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-05 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-05 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-05 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-05 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-05 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-05 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 3e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-05 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-05 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-05 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-05 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-05 | ||
| 3e6j_A | 229 | Crystal Structure Of Variable Lymphocyte Receptor ( | 4e-05 | ||
| 3g3b_A | 170 | Structure Of A Lamprey Variable Lymphocyte Receptor | 4e-05 |
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3RFS|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 272 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|1W8A|A Chain A, Third Lrr Domain Of Drosophila Slit Length = 192 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3G3A|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor In Complex With A Protein Antigen Length = 178 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3G39|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Length = 170 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3E6J|A Chain A, Crystal Structure Of Variable Lymphocyte Receptor (Vlr) Rbc36 In Complex With H-Trisaccharide Length = 229 | Back alignment and structure |
|
| >pdb|3G3B|A Chain A, Structure Of A Lamprey Variable Lymphocyte Receptor Mutant In Complex With A Protein Antigen Length = 170 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 1078 | |||
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 0.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 0.0 | |
| 3rgz_A | 768 | Protein brassinosteroid insensitive 1; phytohormon | 5e-86 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-121 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-79 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 2e-37 | |
| 4eco_A | 636 | Uncharacterized protein; leucine-rich repeats, pro | 1e-18 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 1e-119 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-117 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-94 | |
| 1ziw_A | 680 | TOLL-like receptor 3; innate immunity, immune syst | 1e-85 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 1e-108 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-103 | |
| 3fxi_A | 605 | TLR4, htoll, TOLL-like receptor 4; leucine rich re | 1e-98 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 3e-96 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-64 | |
| 4ecn_A | 876 | Leucine-rich repeat protein; leucine-rich repeats, | 1e-12 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 1e-86 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 7e-85 | |
| 1ogq_A | 313 | PGIP-2, polygalacturonase inhibiting protein; inhi | 4e-75 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 5e-86 | |
| 3t6q_A | 606 | CD180 antigen; protein-protein complex, leucine ri | 2e-80 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-76 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 5e-76 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-73 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 2e-66 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 4e-56 | |
| 3vq2_A | 606 | TLR4, TOLL-like receptor 4; leucine rich repeat MD | 1e-04 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-65 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 3e-64 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 4e-63 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 5e-62 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 6e-62 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 4e-61 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 2e-60 | |
| 1o6v_A | 466 | Internalin A; bacterial infection, extracellular r | 8e-59 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 2e-60 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-59 | |
| 2z63_A | 570 | TOLL-like receptor 4, variable lymphocyte recepto; | 5e-59 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-59 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 4e-57 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 2e-52 | |
| 1jl5_A | 454 | Outer protein YOPM; leucine-rich repeat, molecular | 3e-41 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 4e-59 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-58 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 8e-58 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-55 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-55 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-55 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 5e-54 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 6e-49 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 3e-46 | |
| 2z81_A | 549 | CD282 antigen, TOLL-like receptor 2, variable lymp | 1e-43 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 2e-53 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 5e-52 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 3e-51 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 9e-51 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 4e-50 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-49 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 1e-48 | |
| 4fmz_A | 347 | Internalin; leucine rich repeat, structural genomi | 2e-46 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-50 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 1e-41 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 4e-35 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 2e-31 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 3e-22 | |
| 3j0a_A | 844 | TOLL-like receptor 5; membrane protein, leucine-ri | 8e-19 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 7e-50 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-45 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-44 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 3e-42 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-41 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 8e-22 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 9e-14 | |
| 4fcg_A | 328 | Uncharacterized protein; structural genomics, PSI- | 2e-08 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-45 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-44 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-44 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-43 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 2e-25 | |
| 3oja_A | 487 | Leucine-rich immune molecule 1; coiled-coil, helix | 3e-13 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 8e-43 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-42 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 3e-40 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 4e-39 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 9e-37 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 2e-36 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 1e-30 | |
| 3g06_A | 622 | SSPH2 (leucine-rich repeat protein); E3 ubiquitin | 6e-08 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 1e-42 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 9e-41 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-39 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 3e-38 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 1e-35 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 2e-32 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-19 | |
| 3o6n_A | 390 | APL1; leucine-rich repeat, protein binding; HET: N | 4e-16 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 6e-40 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-38 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 2e-36 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 7e-32 | |
| 3oja_B | 597 | Anopheles plasmodium-responsive leucine-rich REPE | 4e-20 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-39 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 1e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 3e-38 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-36 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 6e-36 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-35 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 2e-26 | |
| 3jqh_A | 167 | C-type lectin domain family 4 member M; DC-signr, | 4e-24 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 4e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 5e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 6e-39 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 3e-37 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 7e-32 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-29 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 2e-15 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 1e-13 | |
| 3o53_A | 317 | Protein LRIM1, AGAP006348-PA; leucine-rich repeat, | 9e-07 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 2e-38 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 3e-31 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 1e-29 | |
| 2z7x_B | 520 | TOLL-like receptor 1, variable lymphocyte recepto; | 6e-19 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-38 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 5e-37 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-35 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-34 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 1e-33 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-31 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 6e-29 | |
| 2id5_A | 477 | Lingo-1, leucine rich repeat neuronal 6A; CNS-spec | 2e-16 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 2e-36 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 6e-36 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-35 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-34 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-34 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 4e-34 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-33 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-31 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-22 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 1e-17 | |
| 3bz5_A | 457 | Internalin-J, INLJ; leucine rich repeat (LRR), cys | 2e-17 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-35 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 4e-35 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-35 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 6e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 6e-35 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 7e-35 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 7e-35 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 8e-35 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-34 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 1e-34 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 2e-34 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-34 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-34 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 3e-34 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 9e-34 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 1e-33 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-33 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 1e-33 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-33 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-30 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 3e-29 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 2e-27 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-26 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-19 | |
| 3a79_B | 562 | TLR6, VLRB.59, TOLL-like receptor 6, variable lymp | 1e-15 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-33 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 1e-33 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-33 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-33 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-33 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 3e-33 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 3e-33 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 3e-33 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 3e-33 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-33 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 5e-33 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 6e-33 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 6e-33 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 7e-32 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 9e-32 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-31 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 3e-27 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-12 | |
| 3v47_A | 455 | TOLL-like receptor 5B and variable lymphocyte REC | 2e-10 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 9e-33 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 1e-32 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-32 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 1e-32 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 2e-32 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 2e-32 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 2e-32 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 3e-32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-32 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 3e-32 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 3e-32 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 3e-32 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 4e-32 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 9e-32 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 1e-31 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 1e-31 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 2e-31 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 3e-31 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 3e-31 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 3e-31 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 3e-31 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-31 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 4e-31 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 4e-31 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 4e-31 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 5e-31 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 6e-31 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 6e-31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 7e-31 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 5e-29 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 4e-28 | |
| 3cvr_A | 571 | Invasion plasmid antigen; leucine rich repeat and | 9e-09 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 7e-31 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 7e-31 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-31 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 1e-30 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 1e-30 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-30 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-30 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 2e-30 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 2e-30 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 2e-30 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 2e-30 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 3e-30 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 3e-30 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 3e-30 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 4e-30 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 5e-30 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 6e-30 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 8e-30 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 7e-29 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-28 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-27 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 1e-23 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 4e-15 | |
| 1xku_A | 330 | Decorin; proteoglycan, leucine-rich repeat, struct | 9e-15 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 1e-29 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-29 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 2e-29 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-29 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 5e-29 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 5e-29 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 5e-29 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 5e-29 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 6e-29 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 7e-29 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-29 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 8e-29 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 1e-28 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 1e-28 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-28 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-28 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-28 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 2e-28 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 3e-28 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-28 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 3e-28 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-28 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 4e-28 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 4e-28 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-28 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 7e-28 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 8e-28 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 9e-28 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 1e-27 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-27 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-27 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-27 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 1e-27 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-27 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 1e-27 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-27 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 2e-27 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-27 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-27 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 3e-27 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-27 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 4e-27 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-27 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 4e-27 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 5e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 5e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 6e-27 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 4e-24 | |
| 2ft3_A | 332 | Biglycan; proteoglycan, dimer interface, structura | 2e-13 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 5e-27 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 5e-27 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 6e-27 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-27 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 7e-27 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-26 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 1e-26 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-26 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-26 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-26 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 2e-26 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 2e-26 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 3e-26 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 6e-26 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 6e-26 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 1e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 1e-25 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 9e-24 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 7e-20 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 8e-18 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-15 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 6e-12 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-10 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 2e-05 | |
| 2z80_A | 353 | TOLL-like receptor 2, variable lymphocyte recepto; | 4e-04 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 1e-25 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-25 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 1e-25 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 3e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-25 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-23 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 1e-21 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 4e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 5e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 9e-20 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 2e-16 | |
| 1ozn_A | 285 | Reticulon 4 receptor; NOGO receptor, MAD, myelinat | 3e-16 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-25 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 2e-24 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 3e-21 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-19 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-18 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-15 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 4e-14 | |
| 3zyj_A | 440 | Leucine-rich repeat-containing protein 4C; cell ad | 1e-07 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 1e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-24 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-22 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-21 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 6e-19 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 2e-15 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 3e-14 | |
| 3zyi_A | 452 | Leucine-rich repeat-containing protein 4; cell adh | 1e-07 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 2e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-24 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 8e-23 | |
| 2z66_A | 306 | Variable lymphocyte receptor B, TOLL-like recepto; | 1e-21 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-23 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 6e-23 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-23 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 1e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 2e-22 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 4e-18 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 8e-16 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 5e-12 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 3e-08 | |
| 1wwl_A | 312 | Monocyte differentiation antigen CD14; LPS, immune | 6e-04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-22 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 5e-16 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 2e-14 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 1e-12 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-11 | |
| 1p9a_G | 290 | Platelet glycoprotein IB alpha chain precursor; pl | 3e-08 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 3e-22 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 3e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 6e-22 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 6e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-22 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 6e-21 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 1e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 2e-20 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 8e-19 | |
| 1h6u_A | 308 | Internalin H; cell adhesion, leucine rich repeat, | 9e-04 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 2e-21 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-21 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 3e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 4e-21 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-21 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-20 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-18 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-16 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 2e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 3e-15 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 4e-12 | |
| 2z62_A | 276 | TOLL-like receptor 4, variable lymphocyte recepto; | 1e-04 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-20 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 1e-17 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 2e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 4e-16 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-15 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 3e-12 | |
| 4ay9_X | 350 | Follicle-stimulating hormone receptor; hormone-rec | 7e-05 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 3e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 6e-20 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 2e-18 | |
| 1m9s_A | 605 | Internalin B; cell invasion, GW domains, SH3 domai | 5e-17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 2e-20 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-20 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 3e-20 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 5e-20 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 2e-19 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-19 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 2e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-19 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 3e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 9e-13 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 2e-12 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 5e-11 | |
| 2o6q_A | 270 | Variable lymphocyte receptor A; leucine-rich repea | 4e-10 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 4e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 5e-19 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-18 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-17 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 6e-16 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 9e-15 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 4e-13 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 3e-12 | |
| 4ezg_A | 197 | Putative uncharacterized protein; internalin-A, le | 1e-10 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 5e-19 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-18 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-15 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 1e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 4e-12 | |
| 2xwt_C | 239 | Thyrotropin receptor; signaling protein-immune sys | 2e-10 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 1e-18 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 1e-18 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-18 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 2e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-18 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 9e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 9e-17 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 4e-16 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 3e-15 | |
| 1h6t_A | 291 | Internalin B; cell adhesion, leucine rich repeat, | 2e-14 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-18 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 3e-18 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 4e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 5e-18 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 8e-18 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 1e-17 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-17 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-17 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 4e-17 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 5e-17 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 5e-17 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 6e-17 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 6e-17 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-16 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 2e-16 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 2e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 3e-16 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 6e-15 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 8e-13 | |
| 1z7x_W | 461 | Ribonuclease inhibitor; leucine-rich repeat, enzym | 9e-09 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 4e-16 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 3e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 6e-10 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-08 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-06 | |
| 3rfs_A | 272 | Internalin B, repeat modules, variable lymphocyte | 2e-04 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 5e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 8e-16 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 9e-16 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 9e-16 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 1e-15 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-13 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-11 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 2e-09 | |
| 2xot_A | 361 | Amphoterin-induced protein 1; cell adhesion, neuro | 3e-09 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 1e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 2e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 2e-15 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 5e-13 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 1e-12 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 4e-11 | |
| 1xeu_A | 263 | Internalin C; cellular invasion, leucine-rich repe | 9e-09 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-15 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-12 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 4e-11 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-10 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 1e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-09 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 3e-07 | |
| 1dce_A | 567 | Protein (RAB geranylgeranyltransferase alpha subun | 5e-04 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 4e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 4e-15 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-11 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 3e-09 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 1e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-07 | |
| 2v9t_B | 220 | SLIT homolog 2 protein N-product; structural prote | 2e-07 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 7e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-15 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 9e-08 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-07 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 1e-06 | |
| 3m19_A | 251 | Variable lymphocyte receptor A diversity region; a | 3e-04 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 1e-14 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 2e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-14 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 1e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 2e-11 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 6e-10 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 9e-09 | |
| 2ca6_A | 386 | RAN GTPase-activating protein 1; GAP, GTPase activ | 7e-05 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 7e-14 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 1e-13 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-12 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 3e-11 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 8e-09 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 1e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 2e-06 | |
| 2v70_A | 220 | SLIT-2, SLIT homolog 2 protein N-product; neurogen | 4e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-10 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-08 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 1e-06 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 5e-05 | |
| 2o6s_A | 208 | Variable lymphocyte receptor B; leucine-rich repea | 8e-04 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 3e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 1e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 8e-10 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-08 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-07 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 4e-06 | |
| 2wfh_A | 193 | SLIT homolog 2 protein C-product; developmental pr | 2e-05 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-10 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 5e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-09 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-08 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 3e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 7e-06 | |
| 3e6j_A | 229 | Variable lymphocyte receptor diversity region; var | 2e-05 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 6e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 1e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 4e-10 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-08 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 8e-07 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 1e-04 | |
| 1w8a_A | 192 | SLIT protein; signaling protein, secreted protein, | 2e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 5e-10 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 5e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 8e-10 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 2e-09 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 3e-07 | |
| 2p1m_B | 594 | Transport inhibitor response 1 protein; F-BOX, leu | 5e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 4e-09 | |
| 3ogk_B | 592 | Coronatine-insensitive protein 1; leucine rich rep | 5e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 6e-09 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 7e-09 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 8e-09 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 9e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 9e-09 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-08 | |
| 3goz_A | 362 | Leucine-rich repeat-containing protein; LEGL7, NES | 2e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 1e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 5e-08 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-07 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 8e-06 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 3e-05 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 2e-04 | |
| 2ifg_A | 347 | High affinity nerve growth factor receptor; TRK, T | 7e-04 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 3e-08 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 6e-07 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 2e-06 | |
| 2o6r_A | 177 | Variable lymphocyte receptor B; leucine-rich repea | 4e-04 | |
| 2ast_B | 336 | S-phase kinase-associated protein 2; SCF-substrate | 1e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 2e-07 | |
| 3g39_A | 170 | Variable lymphocyte receptor VLRB.2D; antibody, X- | 4e-06 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 4e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 5e-07 | |
| 2r9u_A | 174 | Variable lymphocyte receptor; adaptive immunity, V | 4e-06 | |
| 3un9_A | 372 | NLR family member X1; leucine rich repeat (LRR), a | 7e-07 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-06 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-05 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 1e-04 | |
| 2je0_A | 149 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 2e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 6e-06 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 4e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 7e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 9e-05 | |
| 1ds9_A | 198 | Outer arm dynein; leucine-rich repeat, beta-BETA-a | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 6e-06 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 1e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 3e-04 | |
| 1a9n_A | 176 | U2A', U2A'; complex (nuclear protein/RNA), RNA, sn | 4e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 3e-05 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 2e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 4e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 5e-04 | |
| 2ell_A | 168 | Acidic leucine-rich nuclear phosphoprotein 32 FAM | 6e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 5e-05 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 1e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-04 | |
| 2ra8_A | 362 | Uncharacterized protein Q64V53_bacfr; WGR domain, | 8e-04 |
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 644 bits (1663), Expect = 0.0
Identities = 210/663 (31%), Positives = 308/663 (46%), Gaps = 23/663 (3%)
Query: 106 SLDLNAMNFTGSLSP--SIGGLVHLTYLDLAYNELTGYIPREIG-NCSRLEHLYLNNNQF 162
SLDL+ + +G ++ S+G L +L+++ N L G + LE L L+ N
Sbjct: 104 SLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSI 163
Query: 163 SGKIPAEL---GKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIG 219
SG L L I N ISG + + +L +NN + +P +G
Sbjct: 164 SGANVVGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLG 220
Query: 220 NLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWD 279
+ L+ N +SG IS C L++L ++ N G +P L+SL + L +
Sbjct: 221 DCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAE 278
Query: 280 NQLTGFIPSEL-GNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPRE- 337
N+ TG IP L G C L L L N+ G +P G+ L L L N +G +P +
Sbjct: 279 NKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDT 338
Query: 338 IGNLSMVTEIDLSENSLNGEIPTEFSKITG-LRLLFLFQNQLTGVIPNEL--SSLRNLTK 394
+ + + +DLS N +GE+P + ++ L L L N +G I L + L +
Sbjct: 339 LLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQE 398
Query: 395 LDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRI 454
L L N TG IP + +++ L L N L+G IP LG S L + N L G I
Sbjct: 399 LYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEI 458
Query: 455 PPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYA 514
P L L L L +N L G IP+ + NC L + L N LTG P + +LENL
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 515 IELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLI 574
++L N FSG IP E+ +C+ L L + N F +P + S I++N + G
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKR 574
Query: 575 PPEIVNCMTLQRLDISHN--SFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHL 632
I N + + N F G +L L ++ + G+ T N +
Sbjct: 575 YVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSM 634
Query: 633 TELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLS 692
L M N+ SG IP E+G + L I LNL +N++SGSIP E+G L L L L++N L
Sbjct: 635 MFLDMSYNMLSGYIPKEIGSMPYLFI-LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLD 693
Query: 693 GEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPS 752
G IP A L+ L + S NNL+GP+P + QF+ + FL N GLCG P+ C S +
Sbjct: 694 GRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNA 753
Query: 753 SGS 755
G
Sbjct: 754 DGY 756
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 552 bits (1426), Expect = 0.0
Identities = 193/697 (27%), Positives = 294/697 (42%), Gaps = 78/697 (11%)
Query: 53 TTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAM 112
++ L E H L+ K+ L D+ N L W S ++ PC++ GV C D V S+DL++
Sbjct: 6 PSQSLYREIHQLISFKDVLPDK-NLLPDWSS-NKNPCTFDGVTCRDDK---VTSIDLSSK 60
Query: 113 NFT---GSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPA- 168
++S S+ L L L L+ + + G + + L L L+ N SG +
Sbjct: 61 PLNVGFSAVSSSLLSLTGLESLFLSNSHINGSVS-GFKCSASLTSLDLSRNSLSGPVTTL 119
Query: 169 -ELGKLSSLVSLNICNNMISGALP-EGLGNLSSLVDFVAYTNNLTGPLPQSI---GNLRN 223
LG S L LN+ +N + G L+SL N+++G
Sbjct: 120 TSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGE 179
Query: 224 LRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLT 283
L+ N ISG + +S C +L+ L ++ N+ +P +G +L + + N+L+
Sbjct: 180 LKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSALQHLDISGNKLS 236
Query: 284 GFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI-GNLS 342
G + CT+L+ L + SN VG IP LK L L L N+ G IP + G
Sbjct: 237 GDFSRAISTCTELKLLNISSNQFVGPIPPL--PLKSLQYLSLAENKFTGEIPDFLSGACD 294
Query: 343 MVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE-LSSLRNLTKLDLSINY 401
+T +DLS N G +P F + L L L N +G +P + L +R L LDLS N
Sbjct: 295 TLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNE 354
Query: 402 LTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN 461
+G +P +L+ + L +D S N +G I P+LCQN
Sbjct: 355 FSGELPESLTNLS-----------------------ASLLTLDLSSNNFSGPILPNLCQN 391
Query: 462 SNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK 521
TL +L L N TG P L L ++ L N
Sbjct: 392 PK----------------------NTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNY 429
Query: 522 FSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNC 581
SG IP + + KL+ L + N E+P+E+ + L T + N LTG IP + NC
Sbjct: 430 LSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 582 MTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNL 641
L + +S+N G +P +G L+ L ILKLS N FSGNIP+ LG+ L L + NL
Sbjct: 490 TNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNL 549
Query: 642 FSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLL--NNNHLSGEIPSAF 699
F+G IP + S ++ N ++G + + + N G
Sbjct: 550 FNGTIPAAMFKQSGK-----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQL 604
Query: 700 ENLSSLLGSNFSYNNLTGPLPS----IPQFQNMDISS 732
LS+ N + G +D+S
Sbjct: 605 NRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 294 bits (754), Expect = 5e-86
Identities = 97/338 (28%), Positives = 157/338 (46%), Gaps = 19/338 (5%)
Query: 90 SWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNC 149
+ NC+ + SL L+ +G++ S+G L L L L N L G IP+E+
Sbjct: 412 PTLS-NCSE-----LVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYV 465
Query: 150 SRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNN 209
LE L L+ N +G+IP+ L ++L +++ NN ++G +P+ +G L +L N+
Sbjct: 466 KTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNS 525
Query: 210 LTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGML 269
+G +P +G+ R+L N +G+IPA + +A N I G I
Sbjct: 526 FSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKND 581
Query: 270 ESLTEIVLWDN--QLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYR 327
E N + G +L + + S G N + L +
Sbjct: 582 GMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSY 641
Query: 328 NELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELS 387
N L+G IP+EIG++ + ++L N ++G IP E + GL +L L N+L G IP +S
Sbjct: 642 NMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMS 701
Query: 388 SLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENS 425
+L LT++DLS N L+GPIP Q + F +
Sbjct: 702 ALTMLTEIDLSNNNLSGPIPEM-------GQFETFPPA 732
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 385 bits (990), Expect = e-121
Identities = 103/686 (15%), Positives = 189/686 (27%), Gaps = 97/686 (14%)
Query: 55 EGLNSEGHYLLELKNSLHDEFNFLKS-WKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMN 113
++ L ++ LK W + + S G W+ +
Sbjct: 12 LTDDAIVPIKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQ---PGANWNFNKELDM 68
Query: 114 FTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG----KIPAE 169
+ S+ +T L L +G +P IG + LE L L ++ P
Sbjct: 69 WGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKG 128
Query: 170 LGKLSSLVSLNICNNMISGALPEGLG--NLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVF 227
+ S + + S L+ ++ + +S
Sbjct: 129 ISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQI 188
Query: 228 RAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIP 287
N I+ + + L+ + + E E+ Q
Sbjct: 189 GQLSNNIT-FVSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEY-----AQQYKTED 242
Query: 288 SELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNEL--------NGTIPREIG 339
+ N L + +Y+ + ++P + L + + + N + +
Sbjct: 243 LKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAP 302
Query: 340 NLSMVTEIDLSENSL-NGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLS 398
+ I + N+L + T K+ L +L NQL G +P S L L+L+
Sbjct: 303 VGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA 361
Query: 399 INYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHL 458
N +T Q+ L N L IP S+
Sbjct: 362 YNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSV------------------- 401
Query: 459 CQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELD 518
S + ++ YN++ K N+ +I L
Sbjct: 402 ---SVMSAIDFSYNEIGSVDG-----------------KNFDPLDPTPFKGINVSSINLS 441
Query: 519 QNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEI 578
N+ S L +++ N T E+PK
Sbjct: 442 NNQISKFPKELFSTGSPLSSINLMGNMLT-EIPKNSL----------------KDENENF 484
Query: 579 VNCMTLQRLDISHNSFVGSLPNEL--GTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQ 636
N L +D+ N L ++ TL L + LS N FS P+ N S L
Sbjct: 485 KNTYLLTSIDLRFNKL-TKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFG 542
Query: 637 MGGNL------FSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNH 690
+ E P + SL L + N++ + ++ + L + +N
Sbjct: 543 IRNQRDAQGNRTLREWPEGITLCPSLTQ-LQIGSNDIR-KVNEKI--TPNISVLDIKDNP 598
Query: 691 LSGEIPSAFENLSSLLGSNFSYNNLT 716
S Y+
Sbjct: 599 NISIDLSYVCPYIEAGMYMLFYDKTQ 624
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 271 bits (696), Expect = 2e-79
Identities = 67/463 (14%), Positives = 136/463 (29%), Gaps = 49/463 (10%)
Query: 289 ELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNG----TIPREIGNLSMV 344
L + ++ L+L G++P +G L L L L + P+ I
Sbjct: 76 SLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSD 135
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRL--LFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402
+ + L + + I T++ N +
Sbjct: 136 EQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNI 195
Query: 403 TGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNS 462
T + LT++RQ + + +
Sbjct: 196 TF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLK 249
Query: 463 NLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKF 522
+L + + +PT + + + + N +Q K
Sbjct: 250 DLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGIS----------------GEQLKD 293
Query: 523 SGPIPPEIENCQKLQRLHIANNYFTS-ELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNC 581
+ +K+Q ++I N + + + + +L N L G P +
Sbjct: 294 DWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEG-KLPAFGSE 352
Query: 582 MTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTL--GNLSHLTELQMGG 639
+ L L++++N N G +Q+E L + NK IP+ ++S ++ +
Sbjct: 353 IKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDAKSVSVMSAIDFSY 411
Query: 640 NLFSG-------EIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLS 692
N + P ++ +NLS N +S L + L N L+
Sbjct: 412 NEIGSVDGKNFDPLDPTPFKGINVSS-INLSNNQISKFPKELFSTGSPLSSINLMGNMLT 470
Query: 693 G-------EIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNM 728
+ F+N L + +N LT L + +
Sbjct: 471 EIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRATTL 512
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-37
Identities = 30/232 (12%), Positives = 67/232 (28%), Gaps = 13/232 (5%)
Query: 511 NLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT----SELPKEVGNLSQLVTFNIS 566
+ + L+ SG +P I +L+ L + ++ PK +
Sbjct: 82 RVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKM 141
Query: 567 SNMLTGLIPPEI--VNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS 624
+ L + I+ + S+ + + N + +
Sbjct: 142 RMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSK 200
Query: 625 TLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFL 684
+ L+ L + MG + F E E + N Y + + L L +
Sbjct: 201 AVMRLTKLRQFYMGNSPFVAENICEAWEN------ENSEYAQQYKTEDLKWDNLKDLTDV 254
Query: 685 LLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGN 736
+ N ++P+ + L + N + N +Q + +
Sbjct: 255 EVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEK 306
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-18
Identities = 20/146 (13%), Positives = 44/146 (30%), Gaps = 7/146 (4%)
Query: 588 DISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG--- 644
+ + + L + ++ L L SG +P +G L+ L L +G +
Sbjct: 63 NKELDMWGAQPGVSLNSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNER 122
Query: 645 -EIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDL--LEFLLLNNNHLSGEIPSAFEN 701
P + S + + + + D L +N++ I +
Sbjct: 123 LFGPKGISANMSDEQ-KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRI 181
Query: 702 LSSLLGSNFSYNNLTGPLPSIPQFQN 727
NN+T ++ +
Sbjct: 182 TLKDTQIGQLSNNITFVSKAVMRLTK 207
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 369 bits (949), Expect = e-119
Identities = 123/291 (42%), Positives = 173/291 (59%), Gaps = 11/291 (3%)
Query: 770 FSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEI 829
FS +++ A+ NF + I+G G +G VYK + G +VAVK+L R E F+ E+
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEV 78
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG---SSCNLEWPTRFMIAL 886
+ HRN+++L GFC LL+Y YM GS+ L S L+WP R IAL
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS 946
G+A GLAYLH C P+I HRD+K+ NILLD++FEA VGDFGLAK++D + +AV G+
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGT 198
Query: 947 YGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPV----QPLDDGGDLATWVRNYIRD 1002
G+IAPEY T K +EK D++ YGV+LLEL+TG+ DD L WV+ +++
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
L + D L + + + +++VAL+CT SP +RP M EVV ML
Sbjct: 259 KKL-EALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 377 bits (970), Expect = e-117
Identities = 135/665 (20%), Positives = 220/665 (33%), Gaps = 62/665 (9%)
Query: 104 VWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFS 163
+ L+L + + LT LD+ +N ++ P L+ L L +N+ S
Sbjct: 27 ITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELS 86
Query: 164 GKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRN 223
++L L++ +N I +L+ N L+ + L N
Sbjct: 87 QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146
Query: 224 LRVFRAGQNAISGSIPAEISGCQ--SLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQ 281
L+ N I E+ SL+ L L+ N I P + L + L + Q
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQ 206
Query: 282 LTGFIPSELG---NCTKLQTLALYSNNLVGQIPKEVGNLKF--LTKLYLYRNELNGTIPR 336
L + +L T ++ L+L ++ L LK+ LT L L N LN
Sbjct: 207 LGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGND 266
Query: 337 EIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQN---------QLTGVIPNELS 387
L + L N++ + +R L L ++ L +
Sbjct: 267 SFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQ 326
Query: 388 SLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSH 447
L+ L L++ N + G F L ++ L L + + SL
Sbjct: 327 WLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL-------- 378
Query: 448 NYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFP-LEL 506
+S L +LNL NK+ L L L N + E
Sbjct: 379 ------------AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEW 426
Query: 507 CKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTS--ELPKEVGNLSQLVTFN 564
LEN++ I L NK+ LQRL + + P L L +
Sbjct: 427 RGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTILD 486
Query: 565 ISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS 624
+S+N + + + L+ LD+ HN+ + +L ++ G
Sbjct: 487 LSNNNIANINDDMLEGLEKLEILDLQHNN----------------LARLWKHANPGGPIY 530
Query: 625 TLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFL 684
L LSHL L + N F DL L+I ++L NNL+ L+ L
Sbjct: 531 FLKGLSHLHILNLESNGFDEIPVEVFKDLFELKI-IDLGLNNLNTLPASVFNNQVSLKSL 589
Query: 685 LLNNNHLSGEIPSAFE-NLSSLLGSNFSYNNLTGPLPSIPQFQNM-----DISSFLGNEG 738
L N ++ F +L + +N SI F N L +
Sbjct: 590 NLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHY 649
Query: 739 LCGRP 743
LC P
Sbjct: 650 LCNTP 654
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 315 bits (808), Expect = 1e-94
Identities = 117/553 (21%), Positives = 188/553 (33%), Gaps = 39/553 (7%)
Query: 208 NNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIG 267
LT +P + N+ V N + A + L L + N I P+
Sbjct: 14 LKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQ 70
Query: 268 MLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYR 327
L L + L N+L+ CT L L L SN++ K L L L
Sbjct: 71 KLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSH 130
Query: 328 NELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFS--KITGLRLLFLFQNQLTGVIPNE 385
N L+ T L + E+ LS N + E + L+ L L NQ+ P
Sbjct: 131 NGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGC 190
Query: 386 LSSLRNLTKLDLSINYLTGPIPVGFQ---HLTQMRQLQLFENSLTGGIPP---GLGLYSL 439
++ L L L+ L + T +R L L + L+ GL +L
Sbjct: 191 FHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNL 250
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRL------ 493
++D S+N L L L YN + + + L L
Sbjct: 251 T-MLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTK 309
Query: 494 ---VGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT-SE 549
SL L+ L + ++ N G L+ L ++N++ +
Sbjct: 310 QSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRT 369
Query: 550 LPKEVG---NLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLP-NELGTL 605
L E S L N++ N ++ + L+ LD+ N L E L
Sbjct: 370 LTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWRGL 429
Query: 606 QQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG--EIPPELGDLSSLQIALNLS 663
+ + + LS NK+ ++ + L L + P L +L I L+LS
Sbjct: 430 ENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRNLTI-LDLS 488
Query: 664 YNNLSGSIPPELGKLDLLEFLLLNNNHLS--------GEIPSAFENLSSLLGSNFSYNNL 715
NN++ L L+ LE L L +N+L+ G + LS L N N
Sbjct: 489 NNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGF 548
Query: 716 TGPLPSIPQFQNM 728
+ F+++
Sbjct: 549 DEIPVEV--FKDL 559
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 290 bits (744), Expect = 1e-85
Identities = 104/499 (20%), Positives = 182/499 (36%), Gaps = 27/499 (5%)
Query: 247 SLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNL 306
S ++ + + +P ++ ++T + L NQL + ++L +L + N +
Sbjct: 5 SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTI 61
Query: 307 VGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKIT 366
P+ L L L L NEL+ + + +TE+ L NS+ F K
Sbjct: 62 SKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQK 121
Query: 367 GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQ--HLTQMRQLQLFEN 424
L L L N L+ L NL +L LS N + + +++L+L N
Sbjct: 122 NLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSN 181
Query: 425 SLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLC---QNSNLIMLNLGYNKLFGNIPT- 480
+ P L+ + ++ L + LC N+++ L+L ++L T
Sbjct: 182 QIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTT 241
Query: 481 -DVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRL 539
L L L L N+L L L L+ N + ++ L
Sbjct: 242 FLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYL 301
Query: 540 HIANNYFTSEL---------PKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDIS 590
++ ++ + L L N+ N + G+ + L+ L +S
Sbjct: 302 NLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLS 361
Query: 591 HNSF-VGSLPNELG---TLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEI 646
++ + +L NE L IL L++NK S L HL L +G N E+
Sbjct: 362 NSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQEL 421
Query: 647 PP-ELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSG--EIPSAFENLS 703
E L ++ + LSYN + L+ L+L L PS F+ L
Sbjct: 422 TGQEWRGLENIFE-IYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLR 480
Query: 704 SLLGSNFSYNNLTGPLPSI 722
+L + S NN+ +
Sbjct: 481 NLTILDLSNNNIANINDDM 499
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-108
Identities = 114/318 (35%), Positives = 166/318 (52%), Gaps = 16/318 (5%)
Query: 744 VGNCGASPSSGSVPPLNNVYFPPKEG--FSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM 801
+G+ + ++ L++ Y P E D+ EAT NF F++G G +G VYK V+
Sbjct: 1 MGSKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL 60
Query: 802 DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYME 861
G VA+K+ E + F EI TL RH ++V L GFC + +LIY+YME
Sbjct: 61 RDGAKVALKRR--TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 862 RGSLGELLHGS---SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK 918
G+L L+GS + ++ W R I +GAA GL YLH I HRD+KS NILLD+
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDEN 175
Query: 919 FEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 977
F + DFG++K ++ Q+ + V G+ GYI PEY ++TEK D+YS+GVVL E+L
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 978 TGRTPVQPLDDGGD--LATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMC 1035
R+ + LA W + L I D L D+ + + A+ C
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQL-EQIVDPNL--ADKIRPESLRKFGDTAVKC 292
Query: 1036 TSISPFDRPSMREVVSML 1053
++S DRPSM +V+ L
Sbjct: 293 LALSSEDRPSMGDVLWKL 310
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 324 bits (834), Expect = e-103
Identities = 100/295 (33%), Positives = 144/295 (48%), Gaps = 19/295 (6%)
Query: 770 FSFQDVVEATYNFHDSF------IVGSGAYGTVYKAVMDSGKIVAVKKLAS--NREGNNI 821
FSF ++ T NF + +G G +G VYK ++ VAVKKLA+ + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEEL 73
Query: 822 ESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG--SSCNLEWP 879
+ F EI + K +H N+V+L GF L+Y YM GSL + L + L W
Sbjct: 74 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133
Query: 880 TRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939
R IA GAA G+ +LH + HRDIKS NILLD+ F A + DFGLA+ +
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190
Query: 940 MS-AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRN 998
M+ + G+ Y+APE ++T K DIYS+GVVLLE++TG V + L
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249
Query: 999 YIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ D ++N D + V+ M VA C RP +++V +L
Sbjct: 250 IEDEEKTIEDYIDKKMNDADSTSVEAMY---SVASQCLHEKKNKRPDIKKVQQLL 301
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 324 bits (832), Expect = 1e-98
Identities = 113/644 (17%), Positives = 203/644 (31%), Gaps = 71/644 (11%)
Query: 105 WSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG 164
+ +NF + ++ LDL++N L + L+ L L+ +
Sbjct: 10 ITYQCMELNFY-KIPDNL--PFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 165 KIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNL 224
LS L +L + N + + L +L
Sbjct: 67 IEDGAYQSLSHLSTLILTG------------------------NPIQSLALGAFSGLSSL 102
Query: 225 RVFRAGQNAISGSIPAEISGCQSLQILGLAQNDI-GGSLPKEIGMLESLTEIVLWDNQLT 283
+ A + ++ I ++L+ L +A N I LP+ L +L + L N++
Sbjct: 103 QKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ 162
Query: 284 GFIPSELGNCTKLQTLALY---SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPRE-IG 339
++L ++ L L S N + I L KL L N + + + I
Sbjct: 163 SIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQ 222
Query: 340 NLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSI 399
L+ + L + L + L L NLT + +
Sbjct: 223 GLAGLEVHRLVLGEFRN------------------EGNLEKFDKSALEGLCNLTIEEFRL 264
Query: 400 NYL---TGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPP 456
YL I F LT + L ++ + + ++ +
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVKDFSYNFGWQ-HLELVNCKFG----- 317
Query: 457 HLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT--GSFPLELCKLENLYA 514
+ L + G ++ +L L L N L+ G +L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKY 377
Query: 515 IELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGL 573
++L N + ++L+ L ++ V +L L+ +IS
Sbjct: 378 LDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVA 436
Query: 574 IPPEIVNCMTLQRLDISHNSFVGSL-PNELGTLQQLEILKLSENKFSGNIPSTLGNLSHL 632
+L+ L ++ NSF + P+ L+ L L LS+ + P+ +LS L
Sbjct: 437 FNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSL 496
Query: 633 TELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKL-DLLEFLLLNNNHL 691
L M N F L+SLQ+ L+ S N++ S EL L FL L N
Sbjct: 497 QVLNMSHNNFFSLDTFPYKCLNSLQV-LDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
Query: 692 SGEIPSA--FENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSF 733
+ + + + P Q M + S
Sbjct: 556 ACTCEHQSFLQWIKDQRQLLVEVERMECATP--SDKQGMPVLSL 597
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 324 bits (833), Expect = 3e-96
Identities = 102/656 (15%), Positives = 203/656 (30%), Gaps = 79/656 (12%)
Query: 64 LLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIG 123
L E + D W++ D + + + W+ + + +
Sbjct: 261 LKETAEYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLD 320
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN 183
+T L LA G +P IG + L+ L + + + +
Sbjct: 321 NNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERK 380
Query: 184 NMISGAL-------PEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG 236
+ I + L L D + + S +L++ + N I+
Sbjct: 381 HRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQ-IGNLTNRIT- 438
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
I I LQI+ A + + ++ + N L
Sbjct: 439 FISKAIQRLTKLQIIYFANSPFTY-DNIAVDWEDAN----SDYAKQYENEELSWSNLKDL 493
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
+ LY+ + Q+P + +L L L + N + + +
Sbjct: 494 TDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGIS-AAQLKADWT-------------- 538
Query: 357 EIPTEFSKITGLRLLFLFQNQLTGVIPN-ELSSLRNLTKLDLSINYLTGPIPVGFQHLTQ 415
+ + +++ ++ N L + L + L LD N + F +
Sbjct: 539 RLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKVRHLEA--FGTNVK 596
Query: 416 MRQLQLFENSLTGGIPPGLG-LYSLLWVVDFSHNYLTGRIPP--HLCQNSNLIMLNLGYN 472
+ L+L N + IP + + FSHN L IP + + ++ YN
Sbjct: 597 LTDLKLDYNQIEE-IPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSVYVMGSVDFSYN 654
Query: 473 KLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIEN 532
K+ G+ ++ ++ K N + L N+
Sbjct: 655 KI-GSEGRNISC------------------SMDDYKGINASTVTLSYNEIQKFPTELFAT 695
Query: 533 CQKLQRLHIANNYFTS-------ELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCM--T 583
+ + ++NN TS N L T ++ N LT + +
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY 754
Query: 584 LQRLDISHNSFVGSLPNELGTLQQLEILKLSE------NKFSGNIPSTLGNLSHLTELQM 637
L +D+S+N F S P + QL+ + N+ P+ + L +LQ+
Sbjct: 755 LSNMDVSYNCF-SSFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQI 813
Query: 638 GGNLFSGEIPPELGDLSSLQIALNLSYNNL-SGSIPPELGKLDL-LEFLLLNNNHL 691
G N ++ +L L I L+++ N S + ++ + LL +
Sbjct: 814 GSNDIR-KVDEKL--TPQLYI-LDIADNPNISIDVTSVCPYIEAGMYVLLYDKTQD 865
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-64
Identities = 78/598 (13%), Positives = 170/598 (28%), Gaps = 53/598 (8%)
Query: 171 GKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAG 230
+ L + + S +D T + LP + +
Sbjct: 168 RVTTELKGMKVTYKEDSKEHQNPDNANDKYMDIGVATCDSAVWLPAGTYQVVAYTTYSQS 227
Query: 231 QNAISGSIPAEISGCQ---------SLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQ 281
S + G + + + + + + + +
Sbjct: 228 GIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKAIWEALDGKNWR 287
Query: 282 LTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNL 341
+ + + Q ++ N +T L L G +P IG L
Sbjct: 288 YYSGTINNTIHSLNWNFNKEL-DMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQL 346
Query: 342 SMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE-LSSLRNLTKLDLSIN 400
+ + + +S + + ++++ L + L DL +
Sbjct: 347 TELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQD 406
Query: 401 YLT-----GPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIP 455
+ PI + + Q+ N +T I + + L ++ F+++ T
Sbjct: 407 AINRNPEMKPIKKDSRISLKDTQIGNLTNRITF-ISKAIQRLTKLQIIYFANSPFTYDNI 465
Query: 456 PHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAI 515
+ N Y K + N N + L + L P L L L ++
Sbjct: 466 A-----VDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSL 520
Query: 516 ELDQNKFSGP---------IPPEIENCQKLQRLHIANNYFTSELPKEV--GNLSQLVTFN 564
+ N+ + + + K+Q ++ N P + +L +
Sbjct: 521 NIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEE-FPASASLQKMVKLGLLD 579
Query: 565 ISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGT-LQQLEILKLSENKFSGNIP 623
N + L + L L + +N +P + Q+E L S NK IP
Sbjct: 580 CVHNKVRHL--EAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLKY-IP 635
Query: 624 ST--LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQ----IALNLSYNNLSGSIPPELGK 677
+ ++ + + N E + + + LSYN +
Sbjct: 636 NIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFAT 695
Query: 678 LDLLEFLLLNNNHLS-------GEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNM 728
+ ++L+NN ++ ++N L + +N LT L + +
Sbjct: 696 GSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTL 752
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 71.1 bits (174), Expect = 1e-12
Identities = 21/149 (14%), Positives = 48/149 (32%), Gaps = 7/149 (4%)
Query: 587 LDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEI 646
LD + + N K + + L N +T L + G G +
Sbjct: 281 LDGKNWRYYSGTINNTIHSLNWNFNK-ELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRV 339
Query: 647 PPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAF-ENLSSL 705
P +G L+ L++ L+ ++ + S + + + + F + L
Sbjct: 340 PDAIGQLTELKV-LSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRL 398
Query: 706 LGSNFSYNNLTGPLPSIPQFQNMDISSFL 734
S+ + + P+ + + S +
Sbjct: 399 NLSDLLQDAIN----RNPEMKPIKKDSRI 423
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 281 bits (721), Expect = 1e-86
Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 7/285 (2%)
Query: 467 LNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSF--PLELCKLENLYAIEL-DQNKFS 523
+ G + + L L G +L + P L L L + + N
Sbjct: 31 TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLV 90
Query: 524 GPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT 583
GPIPP I +L L+I + + +P + + LVT + S N L+G +PP I +
Sbjct: 91 GPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPN 150
Query: 584 LQRLDISHNSFVGSLPNELGTLQQL-EILKLSENKFSGNIPSTLGNLSHLTELQMGGNLF 642
L + N G++P+ G+ +L + +S N+ +G IP T NL+ L + + N+
Sbjct: 151 LVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLN-LAFVDLSRNML 209
Query: 643 SGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENL 702
G+ G + Q ++L+ N+L+ + ++G L L L NN + G +P L
Sbjct: 210 EGDASVLFGSDKNTQK-IHLAKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQL 267
Query: 703 SSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNC 747
L N S+NNL G +P Q D+S++ N+ LCG P+ C
Sbjct: 268 KFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 7e-85
Identities = 88/302 (29%), Positives = 145/302 (48%), Gaps = 10/302 (3%)
Query: 58 NSEGHYLLELKNSLHDEFNFLKSWK-STDQTPCSWIGVNCTSDFEPV-VWSLDLNAMNFT 115
+ LL++K L + L SW +TD +W+GV C +D + V +LDL+ +N
Sbjct: 5 PQDKQALLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLP 63
Query: 116 GS--LSPSIGGLVHLTYLDLA-YNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGK 172
+ S+ L +L +L + N L G IP I ++L +LY+ + SG IP L +
Sbjct: 64 KPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQ 123
Query: 173 LSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVF-RAGQ 231
+ +LV+L+ N +SG LP + +L +LV N ++G +P S G+ L +
Sbjct: 124 IKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISR 183
Query: 232 NAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELG 291
N ++G IP + +L + L++N + G G ++ +I L N L + +G
Sbjct: 184 NRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VG 241
Query: 292 NCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSE 351
L L L +N + G +P+ + LKFL L + N L G IP + GNL +
Sbjct: 242 LSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYAN 300
Query: 352 NS 353
N
Sbjct: 301 NK 302
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 249 bits (639), Expect = 4e-75
Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 7/281 (2%)
Query: 231 QNAISGSIPAEISGCQSLQILGLAQNDIGGS--LPKEIGMLESLTEIVLWD-NQLTGFIP 287
G + + + L L+ ++ +P + L L + + N L G IP
Sbjct: 35 NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIP 94
Query: 288 SELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEI 347
+ T+L L + N+ G IP + +K L L N L+GT+P I +L + I
Sbjct: 95 PAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI 154
Query: 348 DLSENSLNGEIPTEFSKITGL-RLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI 406
N ++G IP + + L + + +N+LTG IP ++L NL +DLS N L G
Sbjct: 155 TFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDA 213
Query: 407 PVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIM 466
V F +++ L +NSL + +GL L +D +N + G +P L Q L
Sbjct: 214 SVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHS 272
Query: 467 LNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELC 507
LN+ +N L G IP N + N PL C
Sbjct: 273 LNVSFNNLCGEIPQG-GNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 5e-86
Identities = 110/609 (18%), Positives = 191/609 (31%), Gaps = 62/609 (10%)
Query: 95 NCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEH 154
+ + V + + + + ++ L+ ++N L L
Sbjct: 5 DQKCIEKEVNKTYNCENLGLN-EIPGTL--PNSTECLEFSFNVLPTIQNTTFSRLINLTF 61
Query: 155 LYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPL 214
L L Q L +L + N + L +L ++
Sbjct: 62 LDLTRCQIYWIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSID 121
Query: 215 PQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTE 274
+ N + L G N IS + + L++L N I +++ L+ T
Sbjct: 122 FIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATN 181
Query: 275 IVLW--DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKF--LTKLYLYRNEL 330
+ L N + G I + Q+L + I K + N L +
Sbjct: 182 LSLNLNGNDIAG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDD 240
Query: 331 NGTIPREIGNLSM--VTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSS 388
P L V I+L ++ F +GL+ L L L+ +P+ L
Sbjct: 241 EDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVG 299
Query: 389 LRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHN 448
L L KL LS N + + + L + N+ + G
Sbjct: 300 LSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTG--------------- 344
Query: 449 YLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCK 508
L NL L+L ++ + + L+L
Sbjct: 345 --------CLENLENLRELDLSHDDI----------------------ETSDCCNLQLRN 374
Query: 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISS 567
L +L ++ L N+ + C +L+ L +A + + NL L N+S
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSH 434
Query: 568 NMLTGLIPPEIVNCMTLQRLDISHNSFVG---SLPNELGTLQQLEILKLSENKFSGNIPS 624
++L LQ L++ N F N L TL +LEIL LS S
Sbjct: 435 SLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQH 494
Query: 625 TLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFL 684
+L + + + N + L L + LNL+ N++S +P L L +
Sbjct: 495 AFTSLKMMNHVDLSHNRLTSSSIEALSHLKGIY--LNLASNHISIILPSLLPILSQQRTI 552
Query: 685 LLNNNHLSG 693
L N L
Sbjct: 553 NLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 274 bits (702), Expect = 2e-80
Identities = 107/505 (21%), Positives = 175/505 (34%), Gaps = 20/505 (3%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
IP + S + L + N + L +LT + L Q+ + +L
Sbjct: 26 EIPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRL 83
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
TL L +N L+ + K L L+ + ++ + N + + L N ++
Sbjct: 84 DTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISS 143
Query: 357 EIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT--KLDLSINYLTGPIPVGFQHLT 414
+ L++L N + + ++SSL+ T L+L+ N + G I G
Sbjct: 144 IKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG-IEPGAFDSA 202
Query: 415 QMRQLQLFENSLTGGIPPGLGLYSL--LWVVDFSHNYLTG--RIPPHLCQNSNLIMLNLG 470
+ L I GL ++ LW+ F ++ +NL
Sbjct: 203 VFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEMSVESINLQ 262
Query: 471 YNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI 530
+ F L +L L L+ P L L L + L NKF
Sbjct: 263 KHYFFNISSNTFHCFSGLQELDLTATHLS-ELPSGLVGLSTLKKLVLSANKFENLCQISA 321
Query: 531 ENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLT--GLIPPEIVNCMTLQRL 587
N L L I N EL NL L ++S + + ++ N LQ L
Sbjct: 322 SNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSL 381
Query: 588 DISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP-STLGNLSHLTELQMGGNLFSGEI 646
++S+N + QLE+L L+ + S NL L L + +L
Sbjct: 382 NLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISS 441
Query: 647 PPELGDLSSLQIALNLSYNNLSGSI---PPELGKLDLLEFLLLNNNHLSGEIPSAFENLS 703
L +LQ LNL N+ L L LE L+L+ LS AF +L
Sbjct: 442 EQLFDGLPALQH-LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLK 500
Query: 704 SLLGSNFSYNNLTGPLPSIPQFQNM 728
+ + S+N LT ++
Sbjct: 501 MMNHVDLSHNRLTSSSIEA--LSHL 523
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 4e-76
Identities = 76/307 (24%), Positives = 119/307 (38%), Gaps = 28/307 (9%)
Query: 769 GFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAE 828
+++ + + G +G V+KA + + VAVK ++ + + E
Sbjct: 13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIF-PIQDKQSWQ--NEYE 68
Query: 829 ILTLGKIRHRNIVKLYGFCYHQGSN----LLIYEYMERGSLGELLHGSSCNLEWPTRFMI 884
+ +L ++H NI++ G S LI + E+GSL + L + + W I
Sbjct: 69 VYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV--VSWNELCHI 126
Query: 885 ALGAAEGLAYLHHD-------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937
A A GLAYLH D KP I HRDIKS N+LL + A + DFGLA + +S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 938 K-SMSAVAGSYGYIAPEYA-----YTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
G+ Y+APE + + D+Y+ G+VL EL + T D
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 992 L----ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVL-KVALMCTSISPFDRPSM 1046
L + D R + D + +L + C R S
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 1047 REVVSML 1053
V +
Sbjct: 307 GCVGERI 313
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 5e-76
Identities = 112/579 (19%), Positives = 177/579 (30%), Gaps = 44/579 (7%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
+DL++N L N S L+ L L+ + L L +L + N I
Sbjct: 33 STKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPI 92
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG-SIPAEISGC 245
P L+SL + VA L IG L L+ N I +PA S
Sbjct: 93 QSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNL 152
Query: 246 QSLQILGLAQNDIGGSLPKEIGMLESLT----EIVLWDNQLTGFIPSELGNCTKLQTLAL 301
+L + L+ N I ++ L + + N + FI + KL L L
Sbjct: 153 TNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAFQGIKLHELTL 211
Query: 302 YSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPT 360
N I K NL L L E E +L P+
Sbjct: 212 RGNFNSSNIMKTCLQNLAGLHVHRLILGEF------------------KDERNLEIFEPS 253
Query: 361 EFSKITGLRL--LFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQ 418
+ + + L + L N++ + L+ + V + +
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK--HFKWQS 311
Query: 419 LQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL--FG 476
L + L P L L L + + N + I +L L+L N L G
Sbjct: 312 LSIIRCQLKQ--FPTLDLPFLK-SLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSG 366
Query: 477 NIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPE-IENCQK 535
L +L L L N LE L ++ + + +K
Sbjct: 367 CCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEK 425
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSF 594
L L I+ + L+ L T ++ N + T L LD+S
Sbjct: 426 LLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQL 485
Query: 595 VGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLS 654
TL +L++L +S N S L L+ L N
Sbjct: 486 EQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPK 545
Query: 655 SLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSG 693
SL NL+ N+++ I L+++ L
Sbjct: 546 SLAF-FNLTNNSVA-CICEH---QKFLQWVKEQKQFLVN 579
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 255 bits (653), Expect = 1e-73
Identities = 100/534 (18%), Positives = 181/534 (33%), Gaps = 33/534 (6%)
Query: 208 NNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIG 267
L+ +P I + + N + S LQ L L++ +I K
Sbjct: 21 QKLSK-VPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWH 77
Query: 268 MLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYR 327
L L+ ++L N + F P T L+ L L +G L L KL +
Sbjct: 78 GLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAH 137
Query: 328 NELNG-TIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRL----LFLFQNQLTGVI 382
N ++ +P NL+ + +DLS N + + + L + N + +
Sbjct: 138 NFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDFIQ 197
Query: 383 PNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLTG---------GIPP 432
+ L +L L N+ + I Q+L + +L I
Sbjct: 198 DQAFQGI-KLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIME 256
Query: 433 GLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLR 492
GL ++ ++ +N+ ++L + DV L
Sbjct: 257 GLCDVTID-EFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSI--KYLEDVPKHFKWQSLS 313
Query: 493 LVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT--SEL 550
++ L L+L L++L L NK S I + L L ++ N +
Sbjct: 314 IIRCQLKQFPTLDLPFLKSLT---LTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCC 368
Query: 551 PKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNE-LGTLQQLE 609
+ L ++S N ++ + LQ LD H++ +L++L
Sbjct: 369 SYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLL 427
Query: 610 ILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLS 668
L +S + L+ L L+M GN F + ++L L+LS L
Sbjct: 428 YLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTF-LDLSKCQLE 486
Query: 669 GSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSI 722
L L+ L +++N+L S + L SL + S+N + +
Sbjct: 487 QISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGIL 540
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 234 bits (600), Expect = 2e-66
Identities = 94/505 (18%), Positives = 161/505 (31%), Gaps = 46/505 (9%)
Query: 261 SLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFL 320
+P +I S I L N L N ++LQ L L + K L L
Sbjct: 25 KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHL 82
Query: 321 TKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTG 380
+ L L N + P L+ + + E L ++ L+ L + N +
Sbjct: 83 SNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHS 142
Query: 381 V-IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQ----LQLFENSLTGGIPPGLG 435
+P S+L NL +DLS NY+ Q L + Q L + N + I
Sbjct: 143 CKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQAF 201
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVLNCETL------ 488
L + N+ + I QN + L + L + ++ +
Sbjct: 202 QGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDV 261
Query: 489 --LQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYF 546
+ RL + ++ L N+ A+ L ++ K Q L I
Sbjct: 262 TIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKY--LEDVPKHFKWQSLSIIRCQL 319
Query: 547 TS-------------------ELPKEVGNLSQLVTFNISSNMLTGLIP--PEIVNCMTLQ 585
+ + L L ++S N L+ + +L+
Sbjct: 320 KQFPTLDLPFLKSLTLTMNKGSISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLR 379
Query: 586 RLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP-STLGNLSHLTELQMGGNLFSG 644
LD+S N + + L++L+ L + S +L L L +
Sbjct: 380 HLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKI 438
Query: 645 EIPPELGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLS 703
+ L+SL L ++ N+ + L FL L+ L F+ L
Sbjct: 439 DFDGIFLGLTSLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLH 497
Query: 704 SLLGSNFSYNNLTGPLPSIPQFQNM 728
L N S+NNL S + +
Sbjct: 498 RLQLLNMSHNNLLFLDSSH--YNQL 520
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 4e-56
Identities = 80/479 (16%), Positives = 142/479 (29%), Gaps = 55/479 (11%)
Query: 284 GFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSM 343
G + + + T L ++P ++ + + L N L N S
Sbjct: 2 GSLNPCIEVVPNI-TYQCMDQKLS-KVPDDIPS--STKNIDLSFNPLKILKSYSFSNFSE 57
Query: 344 VTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
+ +DLS + + + L L L N + P S L +L L L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 404 GPIPVGFQHLTQMRQLQLFENSLTGGIPPGL----------------------------- 434
L +++L + N + P
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLR 177
Query: 435 GLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRL 493
+ +D S N + I Q L L L N NI L N L RL
Sbjct: 178 ENPQVNLSLDMSLNPIDF-IQDQAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRL 236
Query: 494 VGNSLTGSFPLE------LCKLENLYAIELD--QNKFSGPIPPEIENCQKLQRLHIANNY 545
+ LE + L ++ E + + + +A
Sbjct: 237 ILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVS 296
Query: 546 FTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTL 605
++V + + +I L ++ L+ L ++ N GS+ + L
Sbjct: 297 IKY--LEDVPKHFKWQSLSIIRCQLKQF---PTLDLPFLKSLTLTMNK--GSISFKKVAL 349
Query: 606 QQLEILKLSENKFSGNIPSTLGNL--SHLTELQMGGNLFSGEIPPELGDLSSLQIALNLS 663
L L LS N S + + +L + L L + N + L LQ L+
Sbjct: 350 PSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH-LDFQ 407
Query: 664 YNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPS 721
++ L L+ L +L ++ + + F L+SL + N+ S
Sbjct: 408 HSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 1e-04
Identities = 12/59 (20%), Positives = 20/59 (33%)
Query: 105 WSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFS 163
L+++ N S L L+ LD ++N + L L NN +
Sbjct: 500 QLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-65
Identities = 88/311 (28%), Positives = 139/311 (44%), Gaps = 33/311 (10%)
Query: 750 SPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFI---VGSGAYGTVYKAVMDSGKI 806
S +P N+YF D+ + D I +G+G++GTV++A G
Sbjct: 9 PMSDYDIPTTENLYFQGAMDGDDMDI-----PWCDLNIKEKIGAGSFGTVHRAEWH-GSD 62
Query: 807 VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866
VAVK L + F E+ + ++RH NIV G + ++ EY+ RGSL
Sbjct: 63 VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLY 122
Query: 867 ELLHGSSCN--LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 924
LLH S L+ R +A A+G+ YLH+ P I HR++KS N+L+D K+ V
Sbjct: 123 RLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVC 181
Query: 925 DFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
DFGL+++ S + AG+ ++APE EK D+YS+GV+L EL T + P
Sbjct: 182 DFGLSRLKAS-TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWG 240
Query: 985 PLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALM--CTSISPFD 1042
L + + V I + + ++ C + P+
Sbjct: 241 NL-NPAQVVAAVGF----KCKRLEIPRN----LNPQVAA---------IIEGCWTNEPWK 282
Query: 1043 RPSMREVVSML 1053
RPS ++ +L
Sbjct: 283 RPSFATIMDLL 293
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 3e-64
Identities = 77/282 (27%), Positives = 122/282 (43%), Gaps = 38/282 (13%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIES-----SFRAEILTLGKIRHRNI 840
+G G +G V+K + +VA+K L E F+ E+ + + H NI
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
VKLYG ++ ++ E++ G L L + ++W + + L A G+ Y+ +
Sbjct: 86 VKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QN 142
Query: 901 PRIFHRDIKSNNILLDDKFE-----AHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
P I HRD++S NI L E A V DFGL++ S+S + G++ ++APE
Sbjct: 143 PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWMAPETI 198
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013
A TEK D YS+ ++L +LTG P N IR+ L P
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFDEYSY---GKIKFINMIREEGLRP------ 249
Query: 1014 LNVEDESIVDHMILVLKVALM--CTSISPFDRPSMREVVSML 1053
+I + L+ ++ C S P RP +V L
Sbjct: 250 ------TIPEDCPPRLR-NVIELCWSGDPKKRPHFSYIVKEL 284
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 216 bits (551), Expect = 4e-63
Identities = 82/270 (30%), Positives = 126/270 (46%), Gaps = 29/270 (10%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+VG GA+G V KA K VA+K++ S E +F E+ L ++ H NIVKLYG
Sbjct: 15 VVGRGAFGVVCKAKWR-AKDVAIKQIESESE----RKAFIVELRQLSRVNHPNIVKLYGA 69
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGS--SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
C + L+ EY E GSL +LHG+ L ++G+AYLH +
Sbjct: 70 CLNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 905 HRDIKSNNILLDDKFE-AHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
HRD+K N+LL + DFG A I M+ GS ++APE +EK
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTACDIQT----HMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023
CD++S+G++L E++T R P + W + + P + +++
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH----NGTRPPL--------IKNLPK 231
Query: 1024 HMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ ++ C S P RPSM E+V ++
Sbjct: 232 PIESLMT---RCWSKDPSQRPSMEEIVKIM 258
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 5e-62
Identities = 81/277 (29%), Positives = 122/277 (44%), Gaps = 32/277 (11%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
I+G G +G VY+A G VAVK + + + + R E ++H NI+ L
Sbjct: 14 IIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
G C + + L+ E+ G L +L G + A+ A G+ YLH + I
Sbjct: 73 GVCLKEPNLCLVMEFARGGPLNRVLSGK--RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 905 HRDIKSNNILLDDKFEAH--------VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
HRD+KS+NIL+ K E + DFGLA+ + + AG+Y ++APE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH---RTTKMSAAGAYAWMAPEVIR 187
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016
++ D++SYGV+L ELLTG P + + DG +A V + L I T
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGI-DGLAVAYGVAM----NKLALPIPST---- 238
Query: 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
E M C + P RPS ++ L
Sbjct: 239 CPEPFAKLM-------EDCWNPDPHSRPSFTNILDQL 268
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 6e-62
Identities = 70/338 (20%), Positives = 123/338 (36%), Gaps = 50/338 (14%)
Query: 770 FSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAE- 828
+ + N ++G G YG VYK +D + VAVK + +F E
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLD-ERPVAVKVFSFANR-----QNFINEK 56
Query: 829 -ILTLGKIRHRNIVKLYGFCYHQGSN-----LLIYEYMERGSLGELLHGSSCNLEWPTRF 882
I + + H NI + ++ LL+ EY GSL + L + +W +
Sbjct: 57 NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSC 114
Query: 883 MIALGAAEGLAYLHHD------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID--- 933
+A GLAYLH + KP I HRD+ S N+L+ + + DFGL+ +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 934 ----MPQSKSMSAVAGSYGYIAPEYA-------YTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + + G+ Y+APE ++ D+Y+ G++ E+ T
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234
Query: 983 VQPLDDGGDLATWVRNYIRDHSLTPGIFD---------TRLNVEDESIVDHMILVLKVAL 1033
+ P G + + + + P D R + + + +
Sbjct: 235 LFP---GESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291
Query: 1034 M--CTSISPFDRPSMREVVSMLIE-SNEREGRFNSSPT 1068
+ C R + + + E E + SPT
Sbjct: 292 IEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVSPT 329
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 4e-61
Identities = 60/273 (21%), Positives = 102/273 (37%), Gaps = 30/273 (10%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+ G ++K G + VK L F E L H N++ + G
Sbjct: 17 KLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA 75
Query: 847 CYHQ-GSNL-LIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
C + LI +M GSL +LH G++ ++ AL A G+A+LH +P I
Sbjct: 76 CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLI 134
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE---YAYTMKV 960
+ S ++++D+ A + + S + ++APE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPEALQKKPEDTN 188
Query: 961 TEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020
D++S+ V+L EL+T P L ++ V L P I
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADL-SNMEIGMKVAL----EGLRPTI--------PPG 235
Query: 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
I H+ ++K +C + P RP +V +L
Sbjct: 236 ISPHVSKLMK---ICMNEDPAKRPKFDMIVPIL 265
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 2e-60
Identities = 111/505 (21%), Positives = 183/505 (36%), Gaps = 62/505 (12%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSL 179
+ L L +T + + ++ L + + L++L +
Sbjct: 18 FTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLTQI 73
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
N NN ++ L NL+ LVD + N + P + NL NL N I+ P
Sbjct: 74 NFSNNQLTD--ITPLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 240 AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTL 299
+ +L L L+ N I S + L SL ++ NQ+T P L N T L+ L
Sbjct: 130 --LKNLTNLNRLELSSNTI--SDISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERL 182
Query: 300 ALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIP 359
+ SN + + L L L N+++ P +G L+ + E+ L+ N L
Sbjct: 183 DISSNKVSD--ISVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236
Query: 360 TEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQL 419
+ +T L L L NQ++ + P LS L LT+L L N ++ P LT + L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 420 QLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIP 479
+L EN L + L + N ++ P + + L L NK+
Sbjct: 293 ELNENQLED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKV----- 343
Query: 480 TDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRL 539
S L L N+ + N+ S P + N ++ +L
Sbjct: 344 ---------------------SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQL 380
Query: 540 HIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPP-EIVNCMTLQRLDISHNSFVGSL 598
+ + +T+ N+S N N+ LI P I + + DI+ N
Sbjct: 381 GLNDQAWTNAPVNYKANVSIP---NTVKNVTGALIAPATISDGGSYTEPDITWNL-PSYT 436
Query: 599 PNELGTLQQLEILKLSENKFSGNIP 623
T Q + FSG +
Sbjct: 437 NEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 8e-59
Identities = 105/505 (20%), Positives = 185/505 (36%), Gaps = 63/505 (12%)
Query: 217 SIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIV 276
+ L G+ ++ ++ + + L + I + L +LT+I
Sbjct: 19 TDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGI--KSIDGVEYLNNLTQIN 74
Query: 277 LWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPR 336
+NQLT P L N TKL + + +N + P + NL LT L L+ N++ P
Sbjct: 75 FSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP- 129
Query: 337 EIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLD 396
+ NL+ + ++LS N+++ + S +T L+ L NQ+T + P L++L L +LD
Sbjct: 130 -LKNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLD 183
Query: 397 LSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPP 456
+S N ++ LT + L N ++ LG+ + L + + N L
Sbjct: 184 ISSNKVSDISV--LAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IG 237
Query: 457 HLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIE 516
L +NL L+L N++ P L L L ++
Sbjct: 238 TLASLTNLTDLDLANNQISNLAP--------------------------LSGLTKLTELK 271
Query: 517 LDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPP 576
L N+ S P + L L + N + NL L + N ++ + P
Sbjct: 272 LGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDISP- 326
Query: 577 EIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQ 636
+ + LQRL +N S + L L + L N+ S P L NL+ +T+L
Sbjct: 327 -VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLG 381
Query: 637 MGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPP-ELGKLDLLEFLLLNNNHLSGEI 695
+ ++ ++S N N I P + + N S
Sbjct: 382 LNDQAWTNAPVNYKANVSI----PNTVKNVTGALIAPATISDGGSYTEPDITWNLPS-YT 436
Query: 696 PSAFENLSSLLGSNFSYNNLTGPLP 720
S + +G +
Sbjct: 437 NEVSYTFSQPVTIGKGTTTFSGTVT 461
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 2e-60
Identities = 80/276 (28%), Positives = 120/276 (43%), Gaps = 34/276 (12%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+GSG++GTVYK G VAVK L +F+ E+ L K RH NI+ G+
Sbjct: 32 IGSGSFGTVYKGKWH-GD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 848 YHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
L ++ ++ E SL LH S E IA A G+ YLH I HR
Sbjct: 90 TAP--QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHR 144
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPE---YAYTMKVTE 962
D+KSNNI L + +GDFGLA S ++GS ++APE + +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 963 KCDIYSYGVVLLELLTGRTP---VQPLDDGGDLATWV--RNYIRDHSLTPGIFDTRLNVE 1017
+ D+Y++G+VL EL+TG+ P + D + R + P + R N
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIEMVGRGSLS-----PDLSKVRSNC- 254
Query: 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ + M C +RPS +++ +
Sbjct: 255 PKRMKRLM-------AECLKKKRDERPSFPRILAEI 283
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 2e-59
Identities = 113/589 (19%), Positives = 196/589 (33%), Gaps = 52/589 (8%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSL 179
P + + ++TY IP + ++L L+ N L L
Sbjct: 2 PCVEVVPNITY-QCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVL 57
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
++ I +LS L + N + + L +L+ A + ++
Sbjct: 58 DLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLEN 117
Query: 240 AEISGCQSLQILGLAQNDIG-GSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQT 298
I ++L+ L +A N I LP+ L +L + L N++ ++L ++
Sbjct: 118 FPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPL 177
Query: 299 LALY---SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPRE-IGNLSMVTEIDLSENSL 354
L L S N + I L KL L N + + + I L+ + L
Sbjct: 178 LNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGE- 236
Query: 355 NGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG---PIPVGFQ 411
F + L + L L NLT + + YL I F
Sbjct: 237 -----------------FRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFN 279
Query: 412 HLTQMRQLQLFENSLTGGIPPGLGLYSL--LWVVDFSHNYLTGRIPPHLCQNSNLIMLNL 469
LT + L ++ + + L +V+ +L L
Sbjct: 280 CLTNVSSFSLVSVTIER-VKDFSYNFGWQHLELVNCKFGQFPTLKLK------SLKRLTF 332
Query: 470 GYNKLFGNIPTDVLNCETLLQLRLVGNSLT--GSFPLELCKLENLYAIELDQNKFSGPIP 527
NK GN ++V + +L L L N L+ G +L ++L N +
Sbjct: 333 TSNKG-GNAFSEV-DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MS 389
Query: 528 PEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGLIPPEIVNCMTLQR 586
++L+ L ++ V +L L+ +IS +L+
Sbjct: 390 SNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEV 449
Query: 587 LDISHNSFVGSLPNE-LGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGE 645
L ++ NSF + + L+ L L LS+ + P+ +LS L L M N
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK-S 508
Query: 646 IPPE-LGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSG 693
+P L+SLQ + L N S P L +L N+ G
Sbjct: 509 VPDGIFDRLTSLQK-IWLHTNPWDCSCP---RIDYLSRWLNKNSQKEQG 553
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 5e-59
Identities = 103/531 (19%), Positives = 179/531 (33%), Gaps = 49/531 (9%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
IP + S + L L+ N + L + L ++ + + L
Sbjct: 21 KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHL 78
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN- 355
TL L N + L L KL L IG+L + E++++ N +
Sbjct: 79 STLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQS 138
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT----KLDLSINYLTGPIPVGFQ 411
++P FS +T L L L N++ + +L L + LDLS+N + I G
Sbjct: 139 FKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAF 197
Query: 412 HLTQMRQLQLFENSLTGGIPPG-------LGLYSLLWVVDFSHNYLTGRIPPHL--CQNS 462
++ +L L N + + L ++ L+ + L L N
Sbjct: 198 KEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNL 257
Query: 463 NLIMLNLGYNKLFGNIPTDVLNC-ETLLQLRLVGNSLT----GSFPLELCKLE------- 510
+ L Y + + D+ NC + LV ++ S+ LE
Sbjct: 258 TIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFG 317
Query: 511 --------NLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT--SELPKEVGNLSQL 560
+L + NK + L+ L ++ N + + + L
Sbjct: 318 QFPTLKLKSLKRLTFTSNKGGNA--FSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSL 375
Query: 561 VTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNE--LGTLQQLEILKLSENKF 618
++S N + + + L+ LD H++ + +L+ L L +S
Sbjct: 376 KYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHT 433
Query: 619 SGNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LG 676
LS L L+M GN F P+ +L +L L+LS L + P
Sbjct: 434 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLE-QLSPTAFN 491
Query: 677 KLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQN 727
L L+ L + +N L F+ L+SL N P I
Sbjct: 492 SLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCPRIDYLSR 542
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 3e-59
Identities = 105/526 (19%), Positives = 174/526 (33%), Gaps = 77/526 (14%)
Query: 167 PAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRV 226
P + L +N+ +P N+ S ++ + P G R + V
Sbjct: 5 PRNVSNTFLQEPLRHSSNLTE--MPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 227 FRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFI 286
R + L L + SLP+ LESL N LT +
Sbjct: 63 SRLRDCL-----------DRQAHELELNNLGLS-SLPELPPHLESLV---ASCNSLT-EL 106
Query: 287 PSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTE 346
P + L L P L L + N+L +P E+ N S +
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPPL-------LEYLGVSNNQLE-KLP-ELQNSSFLKI 157
Query: 347 IDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI 406
ID+ NSL ++P L + NQL +P EL +L LT + N L +
Sbjct: 158 IDVDNNSLK-KLPDL---PPSLEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLKK-L 210
Query: 407 PVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIM 466
P + + N L P L L + +N L +P +L
Sbjct: 211 P---DLPLSLESIVAGNNILE--ELPELQNLPFLTTIYADNNLLK-TLPDLPP---SLEA 261
Query: 467 LNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPI 526
LN+ N L ++P + L + + L+ NLY + N+ +
Sbjct: 262 LNVRDNYL-TDLPELPQSLTFLDVSENIFSGLSEL-------PPNLYYLNASSNEIRS-L 312
Query: 527 PPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQR 586
+ L+ L+++NN LP L +L S N L + P N L++
Sbjct: 313 CDLPPS---LEELNVSNNKLIE-LPALPPRLERL---IASFNHLAEV-PELPQN---LKQ 361
Query: 587 LDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEI 646
L + +N P+ +++ L + N +P NL +L + N E
Sbjct: 362 LHVEYNPLR-EFPDIPESVEDLRM-----NSHLAEVPELPQNL---KQLHVETNPLR-EF 411
Query: 647 PPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLS 692
P + L ++ + D LE + ++H
Sbjct: 412 PDIPESVEDL----RMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 4e-57
Identities = 117/515 (22%), Positives = 191/515 (37%), Gaps = 77/515 (14%)
Query: 118 LSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLS--- 174
++P L + LT +P E N Y +++ P G+
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 175 ----------SLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNL 224
L + N +S +LPE +L SL VA N+LT LP+ +L++L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSL 116
Query: 225 RVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTG 284
V A+S P L+ LG++ N + LP E+ L I + +N L
Sbjct: 117 LVDNNNLKALSDLPP-------LLEYLGVSNNQL-EKLP-ELQNSSFLKIIDVDNNSLK- 166
Query: 285 FIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMV 344
+P + L+ +A +N L ++P E+ NL FLT +Y N L +P +L
Sbjct: 167 KLPDLPPS---LEFIAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPLSL--- 217
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
I N L E E + L ++ N L +P+ SL L D + L
Sbjct: 218 ESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPSLEALNVRDNYLTDL-- 272
Query: 405 PIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNL 464
P Q LT + + + L+ P LY L + S N + + +L
Sbjct: 273 --PELPQSLTFLDVSENIFSGLSELPP---NLYYL----NASSNEIR-SLCDLP---PSL 319
Query: 465 IMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSG 524
LN+ NKL +P L +L N L P L+ L+ ++ N
Sbjct: 320 EELNVSNNKL-IELPA---LPPRLERLIASFNHLA-EVPELPQNLKQLH---VEYNPLRE 371
Query: 525 PIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTL 584
P E+ + L+ N++ +P+ NL QL ++ +N L P + +
Sbjct: 372 -FPDIPESVEDLR----MNSHLAE-VPELPQNLKQL---HVETNPLREF-PDIPES---V 418
Query: 585 QRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
+ L ++ V T +LE +
Sbjct: 419 EDLRMNSERVVDPYEFAHETTDKLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-52
Identities = 106/486 (21%), Positives = 173/486 (35%), Gaps = 81/486 (16%)
Query: 263 PKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTK 322
P+ + L E + + LT +P E N + P G + +
Sbjct: 5 PRNVS-NTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAV 62
Query: 323 LYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVI 382
L E++L+ L+ +P L L N LT +
Sbjct: 63 SRLRDCLDRQ-----------AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-EL 106
Query: 383 PNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWV 442
P SL++L + ++ L+ P + L + N L +P L S L +
Sbjct: 107 PELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLEK-LPE-LQNSSFLKI 157
Query: 443 VDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSF 502
+D +N L ++P +L + G N+L +P ++ N L + NSL
Sbjct: 158 IDVDNNSLK-KLPDLP---PSLEFIAAGNNQL-EELP-ELQNLPFLTAIYADNNSLK-KL 210
Query: 503 PLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVT 562
P LE++ N PE++N L ++ NN + LP +L L
Sbjct: 211 PDLPLSLESIV---AGNNILE--ELPELQNLPFLTTIYADNNLLKT-LPDLPPSLEAL-- 262
Query: 563 FNISSNMLTGLIPPEIVNCMTLQRLDISHNSF--VGSLPNELGTL--------------Q 606
N+ N LT L P + L LD+S N F + LP L L
Sbjct: 263 -NVRDNYLTDL-PELPQS---LTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPP 317
Query: 607 QLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNN 666
LE L +S NK +P+ L L N + E+P +L L ++ YN
Sbjct: 318 SLEELNVSNNKLI-ELPALPPRL---ERLIASFNHLA-EVPELPQNLKQL----HVEYNP 368
Query: 667 LSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQ 726
L P + E L +N++ E+P +NL L + N L +
Sbjct: 369 LR-EFPDIPESV---EDLRMNSH--LAEVPELPQNLKQL---HVETNPLREFPDIPESVE 419
Query: 727 NMDISS 732
++ ++S
Sbjct: 420 DLRMNS 425
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-41
Identities = 90/443 (20%), Positives = 151/443 (34%), Gaps = 85/443 (19%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
SL + + T L L L + L+ P LE+L ++NNQ K
Sbjct: 95 SLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-K 145
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+P EL S L +++ NN + LP +L +
Sbjct: 146 LP-ELQNSSFLKIIDVDNNSLKK-------------------------LPDLPPSLEFIA 179
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
N + +P E+ L + N + LP LES+ V +N L
Sbjct: 180 AGN---NQLE-ELP-ELQNLPFLTAIYADNNSL-KKLPDLPLSLESI---VAGNNILE-- 228
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
EL N L T+ +N L +P +L+ L + N L +P +L T
Sbjct: 229 ELPELQNLPFLTTIYADNNLLK-TLPDLPPSLE---ALNVRDNYLT-DLPELPQSL---T 280
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
+D+SEN + + L L N++ + + +L +L++S N L
Sbjct: 281 FLDVSENIFS-GLS---ELPPNLYYLNASSNEIR-SLCDLPP---SLEELNVSNNKLIE- 331
Query: 406 IPVGFQHLTQMRQLQLFENSLTGGIPPGLG-LYSLLWVVDFSHNYLTGRIPPHLCQNSNL 464
+P ++ +L N L +P L L +N L P +L
Sbjct: 332 LP---ALPPRLERLIASFNHLA-EVPELPQNLKQL----HVEYNPLR-EFPDIPESVEDL 382
Query: 465 IMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSG 524
M + +P N + L + N L FP +E+L ++ +
Sbjct: 383 RMNS-----HLAEVPELPQNLKQ---LHVETNPLR-EFPDIPESVEDLR---MNSERVVD 430
Query: 525 PIPPEIENCQKLQRLHIANNYFT 547
P E KL+ +++
Sbjct: 431 PYEFAHETTDKLEDDVFEHHHHH 453
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-59
Identities = 58/298 (19%), Positives = 115/298 (38%), Gaps = 40/298 (13%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
++G G +G VY G+ VA++ + R+ + +F+ E++ + RH N+V G
Sbjct: 40 LIGKGRFGQVYHGRWH-GE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA 97
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
C +I + +L ++ + L+ IA +G+ YLH I H+
Sbjct: 98 CMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVID----MPQSKSMSAVAGSYGYIAPE--------- 953
D+KS N+ D+ + + DFGL + + + G ++APE
Sbjct: 155 DLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWV--RNYIRDHSLTPGIFD 1011
+ ++ D+++ G + EL P + + W
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP--AEAIIWQMGTGM------------ 259
Query: 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSSPTY 1069
+ N+ + + +L C + +RP+ +++ ML E + R S P +
Sbjct: 260 -KPNLSQIGMGKEISDILL---FCWAFEQEERPTFTKLMDML-EKLPKRNRRLSHPGH 312
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-58
Identities = 69/284 (24%), Positives = 113/284 (39%), Gaps = 42/284 (14%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G K ++G+++ +K+L R + +F E+ + + H N++K G
Sbjct: 18 LGKGCFGQAIKVTHRETGEVMVMKEL--IRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
Y I EY++ G+L ++ W R A A G+AYLH I HR
Sbjct: 76 LYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHR 132
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVID-------------MPQSKSMSAVAGSYGYIAPE 953
D+ S+N L+ + V DFGLA+++ P K V G+ ++APE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013
EK D++S+G+VL E++ D P D
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGRVNA-------------------DPDYLPRTMDFG 233
Query: 1014 LNVEDE---SIVDHM-ILVLKVALMCTSISPFDRPSMREVVSML 1053
LNV + + + C + P RPS ++ L
Sbjct: 234 LNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 195 bits (497), Expect = 2e-55
Identities = 68/292 (23%), Positives = 108/292 (36%), Gaps = 34/292 (11%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFR--AEILTLGKIRHRNIVKLY 844
+G G YG V+ G+ VAVK + E +S+ EI +RH NI+
Sbjct: 44 QIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE-----ASWFRETEIYQTVLMRHENILGFI 97
Query: 845 GFCYHQGSN----LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH---- 896
+ LI +Y E GSL + L ++ L+ + +A + GL +LH
Sbjct: 98 AADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIF 155
Query: 897 -HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---MPQSKSMSAVAGSYGYIAP 952
KP I HRD+KS NIL+ + D GLA + G+ Y+ P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215
Query: 953 E------YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG---DLATWVRNYIRDH 1003
E + D+YS+G++L E+ +++ D
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275
Query: 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALM--CTSISPFDRPSMREVVSML 1053
I R + + D + + LM C + +P R + V L
Sbjct: 276 REIVCIKKLRPSFPNRWSSDECLRQMG-KLMTECWAHNPASRLTALRVKKTL 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-55
Identities = 75/297 (25%), Positives = 115/297 (38%), Gaps = 44/297 (14%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAE--ILTLGKIRHRNIVKLY 844
VG G YG V++ G+ VAVK S+R+ E S+ E + +RH NI+
Sbjct: 15 CVGKGRYGEVWRGSWQ-GENVAVKIF-SSRD----EKSWFRETELYNTVMLRHENILGFI 68
Query: 845 GFCYHQGSN----LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD-- 898
+ LI Y E GSL + L ++ L+ + I L A GLA+LH +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHLHIEIF 126
Query: 899 ---CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---MPQSKSMSAVAGSYGYIAP 952
KP I HRD+KS NIL+ + + D GLA + + G+ Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186
Query: 953 E------YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006
E ++ DI+++G+VL E+ ++D + +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED------YKPPFYDVVPND 240
Query: 1007 PGIFDTRLNVEDE--------SIVDHMILVLKVALM--CTSISPFDRPSMREVVSML 1053
P D R V + L LM C +P R + + L
Sbjct: 241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 5e-54
Identities = 97/505 (19%), Positives = 185/505 (36%), Gaps = 40/505 (7%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
SIP+ ++ +++ L L+ N I ++ +L ++L +++ + L
Sbjct: 19 SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSL 76
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNG-TIPREIGNLSMVTEIDLSENSL 354
+ L L N+L + G L L L L N + NL+ + + +
Sbjct: 77 EHLDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVET 135
Query: 355 NGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHL 413
EI F+ +T L L + L L S+R++ L L ++ + + L
Sbjct: 136 FSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADIL 195
Query: 414 TQMRQLQLFENSLTG---GIPPGLGLYSLLWVVDFSHNYLTG-------RIPPHLCQNSN 463
+ +R L+L + +L P + S + + F + LT ++ ++ + S
Sbjct: 196 SSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSE 255
Query: 464 LIMLNLGYNKLFGNIPTDV--------LNCETLLQLRLVGNSLTGSFPLELCKLENLYAI 515
+ + N L P++ + T+ +L + L LE + I
Sbjct: 256 VEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRI 315
Query: 516 ELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKE---VGNLSQLVTFNISSNMLTG 572
++ +K ++ + L+ L ++ N E K G L T +S N L
Sbjct: 316 TVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRS 375
Query: 573 L-IPPEIVNCMT-LQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLS 630
+ EI+ + L LDIS N+F +P+ +++ L LS + +
Sbjct: 376 MQKTGEILLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIR-VVKT--CIPQ 431
Query: 631 HLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNH 690
L L + N L L L +S N L ++P +L + ++ N
Sbjct: 432 TLEVLDVSNNNLD-SFSLFLPRLQEL----YISRNKLK-TLPDA-SLFPVLLVMKISRNQ 484
Query: 691 LSGEIPSAFENLSSLLGSNFSYNNL 715
L F+ L+SL N
Sbjct: 485 LKSVPDGIFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 6e-49
Identities = 93/558 (16%), Positives = 196/558 (35%), Gaps = 59/558 (10%)
Query: 94 VNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLE 153
++C + D + +FT S+ + + LDL++N++T ++ C+ L+
Sbjct: 2 LSCDASG-----VCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQ 53
Query: 154 HLYLNNNQFSGKIPAE-LGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTG 212
L L +++ + I + L SL L++ +N +S G LSSL N
Sbjct: 54 VLILKSSRIN-TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQT 112
Query: 213 -PLPQSIGNLRNLRVFR-AGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLE 270
+ NL NL+ R S + +G SL L + + + + +
Sbjct: 113 LGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIR 172
Query: 271 SLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNEL 330
+ + L ++ + + ++ L L NL + + + +
Sbjct: 173 DIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRG 232
Query: 331 NGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLR 390
+ L + L + + EF T L ++ V
Sbjct: 233 SVLTDESFNELLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETV 286
Query: 391 NLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYL 450
+ +L + YL + + L +++++ ++ +
Sbjct: 287 TIRRLHIPQFYLFYDLSTVYSLLEKVKRI------------------------TVENSKV 322
Query: 451 TGRIPPHLCQN-SNLIMLNLGYNKL---FGNIPTDVLNCETLLQLRLVGNSLT--GSFPL 504
+P Q+ +L L+L N + + +L L L N L
Sbjct: 323 F-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGE 381
Query: 505 ELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFN 564
L L+NL ++++ +N F P+P + +K++ L++++ + L +
Sbjct: 382 ILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRV-VKT--CIPQTLEVLD 437
Query: 565 ISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS 624
+S+N L + LQ L IS N +LP+ L ++K+S N+
Sbjct: 438 VSNNNLDS-FSLFLPR---LQELYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDG 491
Query: 625 TLGNLSHLTELQMGGNLF 642
L+ L ++ + N +
Sbjct: 492 IFDRLTSLQKIWLHTNPW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-46
Identities = 92/498 (18%), Positives = 163/498 (32%), Gaps = 25/498 (5%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
SLDL+ T + +L L L + + + LEHL L++N S
Sbjct: 30 SLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS-S 88
Query: 166 IPAE-LGKLSSLVSLNICNNMISGALPEGL-GNLSSLVD-FVAYTNNLTGPLPQSIGNLR 222
+ + G LSSL LN+ N L NL++L + + L
Sbjct: 89 LSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLT 148
Query: 223 NLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQL 282
+L ++ + + + L L ++ L +L S+ + L D L
Sbjct: 149 SLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNL 208
Query: 283 TGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLS 342
F S L + + + L L + L +E+ E + +
Sbjct: 209 ARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEV------EFDDCT 262
Query: 343 MVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402
+ D + + + + +R L + Q L + S L + ++ + + +
Sbjct: 263 LNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKV 322
Query: 403 TGPIPVGFQHLTQMRQLQLFENSLTGGIPPG---LGLYSLLWVVDFSHNYLT--GRIPPH 457
QHL + L L EN + G + L + S N+L +
Sbjct: 323 FLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEI 382
Query: 458 LCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIEL 517
L NL L++ N +P E + L L + LE L +
Sbjct: 383 LLTLKNLTSLDISRNTF-HPMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLD---V 438
Query: 518 DQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPE 577
N + LQ L+I+ N + LP L+ IS N L +
Sbjct: 439 SNNNLDS-FSLFLPR---LQELYISRNKLKT-LPDAS-LFPVLLVMKISRNQLKSVPDGI 492
Query: 578 IVNCMTLQRLDISHNSFV 595
+LQ++ + N +
Sbjct: 493 FDRLTSLQKIWLHTNPWD 510
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 1e-43
Identities = 74/434 (17%), Positives = 142/434 (32%), Gaps = 22/434 (5%)
Query: 292 NCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSE 351
+C S + IP + + L L N++ ++ + + + L
Sbjct: 3 SCDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKS 59
Query: 352 NSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG-PIPVGF 410
+ +N F + L L L N L+ + + L +L L+L N + F
Sbjct: 60 SRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLF 119
Query: 411 QHLTQMRQLQLFENSLTGGIPPG--LGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLN 468
+LT ++ L++ I GL SL ++ L L ++ L
Sbjct: 120 PNLTNLQTLRIGNVETFSEIRRIDFAGLTSLN-ELEIKALSLRNYQSQSLKSIRDIHHLT 178
Query: 469 LGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPP 528
L ++ + ++ L L +L L E ++ + S
Sbjct: 179 LHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDE 238
Query: 529 EIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLD 588
KL R + + + + + + + + + V +T++RL
Sbjct: 239 SFNELLKLLRYILELSEVEFD------DCTLNGLGDFNPSESDVVSELGKVETVTIRRLH 292
Query: 589 ISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPP 648
I L L++++ + + +K S +L L L + NL E
Sbjct: 293 IPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLK 352
Query: 649 E---LGDLSSLQIALNLSYNNLSGSIPPELG---KLDLLEFLLLNNNHLSGEIPSAFENL 702
G SLQ L LS N+L S+ L L L ++ N +P + +
Sbjct: 353 NSACKGAWPSLQT-LVLSQNHLR-SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWP 409
Query: 703 SSLLGSNFSYNNLT 716
+ N S +
Sbjct: 410 EKMRFLNLSSTGIR 423
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-53
Identities = 73/307 (23%), Positives = 119/307 (38%), Gaps = 48/307 (15%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAE--ILTLGKIRHRNIVKLY 844
+G G +G V++ G+ VAVK +S E S+ E I +RH NI+
Sbjct: 49 SIGKGRFGEVWRGKWR-GEEVAVKIFSSREE-----RSWFREAEIYQTVMLRHENILGFI 102
Query: 845 GFCYHQGSN----LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD-- 898
L+ +Y E GSL + L+ + + +AL A GLA+LH +
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIV 160
Query: 899 ---CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID---MPQSKSMSAVAGSYGYIAP 952
KP I HRD+KS NIL+ + D GLA D + + G+ Y+AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220
Query: 953 E------YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDD---------GGDLATW-V 996
E + ++ DIY+ G+V E+ + +D D + +
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 280
Query: 997 RNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALM--CTSISPFDRPSMREVVSMLI 1054
R + + L P I L + +M C + R + + L
Sbjct: 281 RKVVCEQKLRPNI--------PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332
Query: 1055 ESNEREG 1061
+ +++EG
Sbjct: 333 QLSQQEG 339
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 5e-52
Identities = 80/373 (21%), Positives = 148/373 (39%), Gaps = 28/373 (7%)
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
L +N P +L+ L + S+ + ++ + L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL 439
+ + L NL L+L+ N +T P +L ++ L + N +T L +
Sbjct: 58 SI--QGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
L + + + ++ L + + LNLG N ++ + N L L + + +
Sbjct: 112 LRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLSDLSP-LSNMTGLNYLTVTESKVK 168
Query: 500 GSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQ 559
P+ L +LY++ L+ N+ P + + L N T V N+++
Sbjct: 169 DVTPIA--NLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTR 222
Query: 560 LVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
L + I +N +T L P + N L L+I N S N + L +L++L + N+ S
Sbjct: 223 LNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQIS 278
Query: 620 GNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLD 679
S L NLS L L + N E +G L++L L LS N+++ P L L
Sbjct: 279 D--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTT-LFLSQNHITDIRP--LASLS 333
Query: 680 LLEFLLLNNNHLS 692
++ N +
Sbjct: 334 KMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 3e-51
Identities = 73/396 (18%), Positives = 141/396 (35%), Gaps = 51/396 (12%)
Query: 128 LTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMIS 187
L + P + + L + + +L S+ L + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57
Query: 188 GALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQS 247
Q I L NL N I+ P +S
Sbjct: 58 S--------------------------IQGIEYLTNLEYLNLNGNQITDISP--LSNLVK 89
Query: 248 LQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLV 307
L L + N I + + L +L E+ L ++ ++ P L N TK+ +L L +N+ +
Sbjct: 90 LTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP--LANLTKMYSLNLGANHNL 145
Query: 308 GQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITG 367
+ N+ L L + +++ P I NL+ + + L+ N + P + +T
Sbjct: 146 S-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDISP--LASLTS 200
Query: 368 LRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
L + NQ+T + P ++++ L L + N +T P +L+Q+ L++ N ++
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256
Query: 428 GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCET 487
+ + L +++ N ++ L S L L L N+L +
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312
Query: 488 LLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFS 523
L L L N +T PL L + + +
Sbjct: 313 LTTLFLSQNHITDIRPLA--SLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 181 bits (463), Expect = 9e-51
Identities = 71/354 (20%), Positives = 137/354 (38%), Gaps = 25/354 (7%)
Query: 121 SIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLN 180
L L +T + + L + + + I + L++L LN
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA-SIQG-IEYLTNLEYLN 72
Query: 181 ICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPA 240
+ N I+ L NL L + TN +T ++ NL NLR ++ IS P
Sbjct: 73 LNGNQITD--ISPLSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP- 127
Query: 241 EISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLA 300
++ + L L N S + + L + + ++++ P + N T L +L+
Sbjct: 128 -LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 301 LYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPT 360
L N + P + +L L Y N++ P + N++ + + + N + P
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP- 238
Query: 361 EFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQ 420
+ ++ L L + NQ++ + N + L L L++ N ++ +L+Q+ L
Sbjct: 239 -LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLF 293
Query: 421 LFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
L N L +G + L + S N++T I P L S + + +
Sbjct: 294 LNNNQLGNEDMEVIGGLTNLTTLFLSQNHITD-IRP-LASLSKMDSADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 4e-50
Identities = 75/322 (23%), Positives = 134/322 (41%), Gaps = 23/322 (7%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L + S+ I L +L YL+L N++T P + N +L +LY+ N+ +
Sbjct: 48 KLVVAGEKVA-SIQG-IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT-- 101
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+ L L++L L + + IS L NL+ + N+ + N+ L
Sbjct: 102 DISALQNLTNLRELYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLN 158
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
++ + P I+ L L L N I + L SL + NQ+T
Sbjct: 159 YLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI--SPLASLTSLHYFTAYVNQITDI 214
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
P + N T+L +L + +N + P + NL LT L + N++ + + +L+ +
Sbjct: 215 TP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLK 268
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
+++ N ++ + + ++ L LFL NQL + L NLT L LS N++T
Sbjct: 269 MLNVGSNQISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDI 326
Query: 406 IPVGFQHLTQMRQLQLFENSLT 427
P L++M +
Sbjct: 327 RP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 1e-49
Identities = 79/397 (19%), Positives = 154/397 (38%), Gaps = 52/397 (13%)
Query: 272 LTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELN 331
+ + P + + L ++ + +E L+ +TKL + ++
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVTQE--ELESITKLVVAGEKVA 57
Query: 332 GTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRN 391
+I I L+ + ++L+ N + P S + L L++ N++T + L +L N
Sbjct: 58 -SIQ-GIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT--DISALQNLTN 111
Query: 392 LTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLT 451
L +L L+ + ++ P +LT+M L L N L + L + + + +
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVK 168
Query: 452 GRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLEN 511
+ P + ++L L+L YN++ P L L +
Sbjct: 169 D-VTP-IANLTDLYSLSLNYNQIEDISP--------------------------LASLTS 200
Query: 512 LYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLT 571
L+ N+ + P + N +L L I NN T + NLSQL I +N ++
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--LSPLANLSQLTWLEIGTNQIS 256
Query: 572 GLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSH 631
+ + + L+ L++ N + + L L QL L L+ N+ +G L++
Sbjct: 257 DI--NAVKDLTKLKMLNVGSNQ-ISDISV-LNNLSQLNSLFLNNNQLGNEDMEVIGGLTN 312
Query: 632 LTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLS 668
LT L + N + P L LS + + + +
Sbjct: 313 LTTLFLSQNHITDIRP--LASLSKMDS-ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 1e-49
Identities = 85/346 (24%), Positives = 142/346 (41%), Gaps = 25/346 (7%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L + T + L +T L +A ++ I I + LE+L LN NQ +
Sbjct: 26 RAVLQKASVTDV--VTQEELESITKLVVAGEKVAS-IQ-GIEYLTNLEYLNLNGNQITDI 81
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
P L L L +L I N I+ L NL++L + +N++ P + NL +
Sbjct: 82 SP--LSNLVKLTNLYIGTNKITD--ISALQNLTNLRELYLNEDNISDISP--LANLTKMY 135
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
G N S + +S L L + ++ + P I L L + L NQ+
Sbjct: 136 SLNLGANHNL-SDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLSLNYNQIEDI 192
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
P L + T L Y N + P V N+ L L + N++ P + NLS +T
Sbjct: 193 SP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLT 246
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
+++ N ++ +T L++L + NQ++ + L++L L L L+ N L
Sbjct: 247 WLEIGTNQISD--INAVKDLTKLKMLNVGSNQISDISV--LNNLSQLNSLFLNNNQLGNE 302
Query: 406 IPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLT 451
LT + L L +N +T I P L + DF++ +
Sbjct: 303 DMEVIGGLTNLTTLFLSQNHIT-DIRPLASLSKMDS-ADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 1e-48
Identities = 78/376 (20%), Positives = 149/376 (39%), Gaps = 49/376 (13%)
Query: 217 SIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIV 276
+L + +++ + +S+ L +A + + I L +L +
Sbjct: 17 PDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVAS--IQGIEYLTNLEYLN 72
Query: 277 LWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPR 336
L NQ+T P L N KL L + +N + + NL L +LYL + ++ P
Sbjct: 73 LNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP- 127
Query: 337 EIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLD 396
+ NL+ + ++L N + S +TGL L + ++++ V P +++L +L L
Sbjct: 128 -LANLTKMYSLNLGANHN-LSDLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSLS 183
Query: 397 LSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPP 456
L+ N + P LT + + N +T I P + L + +N +T + P
Sbjct: 184 LNYNQIEDISP--LASLTSLHYFTAYVNQITD-ITPVANMTRLN-SLKIGNNKITD-LSP 238
Query: 457 HLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIE 516
L S L L +G N++ +I + L L +
Sbjct: 239 -LANLSQLTWLEIGTNQI-SDIN-------------------------AVKDLTKLKMLN 271
Query: 517 LDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPP 576
+ N+ S + N +L L + NN +E + +G L+ L T +S N +T + P
Sbjct: 272 VGSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP- 328
Query: 577 EIVNCMTLQRLDISHN 592
+ + + D ++
Sbjct: 329 -LASLSKMDSADFANQ 343
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 2e-46
Identities = 82/368 (22%), Positives = 147/368 (39%), Gaps = 28/368 (7%)
Query: 367 GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSL 426
G L + + P + L + L +T + + L + +L + +
Sbjct: 1 GAATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV 56
Query: 427 TGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCE 486
G+ + L ++ + N +T P L L L +G NK+ + + N
Sbjct: 57 AS--IQGIEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLT 110
Query: 487 TLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYF 546
L +L L ++++ PL L +Y++ L N + N L L + +
Sbjct: 111 NLRELYLNEDNISDISPLA--NLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKV 167
Query: 547 TSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQ 606
+ NL+ L + +++ N + + P + + +L N P + +
Sbjct: 168 KD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITDITP--VANMT 221
Query: 607 QLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNN 666
+L LK+ NK + P L NLS LT L++G N S + DL+ L++ LN+ N
Sbjct: 222 RLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD--INAVKDLTKLKM-LNVGSNQ 276
Query: 667 LSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTG--PLPSIPQ 724
+S L L L L LNNN L E L++L S N++T PL S+ +
Sbjct: 277 ISD--ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSK 334
Query: 725 FQNMDISS 732
+ D ++
Sbjct: 335 MDSADFAN 342
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 2e-50
Identities = 118/607 (19%), Positives = 199/607 (32%), Gaps = 59/607 (9%)
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLVSLNIC 182
L L L++N + +L+ L L + I E L +L L++
Sbjct: 22 VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLG 81
Query: 183 NNMISGALPEGLGNLSSLVDFVAYTNNLTGPL--PQSIGNLRNLRVFRAGQNAISG-SIP 239
++ I P+ L L + Y L+ + NL+ L +N I +
Sbjct: 82 SSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLH 141
Query: 240 AEISGCQSLQILGLAQNDIGGSLPKEIGMLE--SLTEIVLWDNQLTGFIPSELGNCTK-- 295
SL+ + + N I E+ L+ +L+ L N L + + G C
Sbjct: 142 PSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 296 ----LQTLALYSNNLVGQIPKEVGN------------LKFLTKLYLYRNELNGTIPREIG 339
L+ L + N I N + + +
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 340 NL--SMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDL 397
L S V +DLS + F + L++L L N++ + L NL L+L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 398 SINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIP 455
S N L F L ++ + L +N + I L L +D N LT
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTFKFLEKLQ-TLDLRDNALT---- 375
Query: 456 PHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT----GSFPLELCKLEN 511
+ ++ + L NKL +P L + L N L F L + L+
Sbjct: 376 -TIHFIPSIPDIFLSGNKL-VTLPKINLT---ANLIHLSENRLENLDILYFLLRVPHLQI 430
Query: 512 LYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-----GNLSQLVTFNI 565
L L+QN+FS + L++L + N E+ LS L +
Sbjct: 431 LI---LNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYL 487
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
+ N L L P + L+ L ++ N L + LEIL +S N+ P
Sbjct: 488 NHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPANLEILDISRNQLLAPNPDV 545
Query: 626 LGNLSHLTELQMGGNLFSGEIPPE--LGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEF 683
L+ L + N F E + L+ + + ++ P + L
Sbjct: 546 ---FVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPADIYCVYPDSFSGVSLFSL 602
Query: 684 LLLNNNH 690
+
Sbjct: 603 STEGCDE 609
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-41
Identities = 80/454 (17%), Positives = 157/454 (34%), Gaps = 46/454 (10%)
Query: 293 CTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSEN 352
C+ +A Y + Q+P+ + +L L N + L + ++L
Sbjct: 2 CSFDGRIAFYRFCNLTQVPQVLNT---TERLLLSFNYIRTVTASSFPFLEQLQLLELGSQ 58
Query: 353 SLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI--PVG 409
I E F + LR+L L +++ + P+ L +L +L L L+ +
Sbjct: 59 YTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGY 118
Query: 410 FQHLTQMRQLQLFENSLTGGIPPGLGLYSL--LWVVDFSHNYLTGRIPPHL---CQNSNL 464
F++L + +L L +N + + L L +DFS N + + H Q L
Sbjct: 119 FRNLKALTRLDLSKNQIR-SLYLHPSFGKLNSLKSIDFSSNQIF-LVCEHELEPLQGKTL 176
Query: 465 IMLNLGYNKLFGNIPTDVLNC------------------ETLLQLRLVGNSLTGSFPLEL 506
+L N L+ + D C T+ N+++ S L
Sbjct: 177 SFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSL 236
Query: 507 CKLENLYAIELDQNKFSGPIPPEIENCQK--LQRLHIANNYFTSELPKEVGNLSQLVTFN 564
++ + P + ++ L +++ + S + L L N
Sbjct: 237 ILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLN 296
Query: 565 ISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS 624
++ N + + LQ L++S+N + L ++ + L +N +
Sbjct: 297 LAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQ 356
Query: 625 TLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDL-LEF 683
T L L L + N + + + S+ + LS N L L K++L
Sbjct: 357 TFKFLEKLQTLDLRDNALT-----TIHFIPSIPD-IFLSGNKLV-----TLPKINLTANL 405
Query: 684 LLLNNNHLSG-EIPSAFENLSSLLGSNFSYNNLT 716
+ L+ N L +I + L + N +
Sbjct: 406 IHLSENRLENLDILYFLLRVPHLQILILNQNRFS 439
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 4e-35
Identities = 80/429 (18%), Positives = 145/429 (33%), Gaps = 54/429 (12%)
Query: 348 DLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIP 407
+L ++P + L L F N + V + L L L+L Y I
Sbjct: 10 FYRFCNLT-QVPQVLNTTERLLLSF---NYIRTVTASSFPFLEQLQLLELGSQYTPLTID 65
Query: 408 VG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGR-IPPHLCQN-S 462
F++L +R L L + + + P GL+ L + L+ + +N
Sbjct: 66 KEAFRNLPNLRILDLGSSKIY-FLHPDAFQGLFHLF-ELRLYFCGLSDAVLKDGYFRNLK 123
Query: 463 NLIMLNLGYNKLFG-NIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLE--NLYAIELDQ 519
L L+L N++ + +L + N + EL L+ L L
Sbjct: 124 ALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAA 183
Query: 520 NKFSGPIPPEIENCQK------LQRLHIANNYFTSELPKEVGN------------LSQLV 561
N + + C L+ L ++ N +T ++ N ++
Sbjct: 184 NSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIM 243
Query: 562 TFNISSNMLTGLIPPEIVN--CMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
+ + +++ LD+SH TL+ L++L L+ NK +
Sbjct: 244 GAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKIN 303
Query: 620 GNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPELGKL 678
L +L L + NL E+ L + ++L N+++ L
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLG-ELYSSNFYGLPKVAY-IDLQKNHIAIIQDQTFKFL 361
Query: 679 DLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIP-----------QFQN 727
+ L+ L L +N L + + S+ S N L LP I + +N
Sbjct: 362 EKLQTLDLRDNAL-----TTIHFIPSIPDIFLSGNKLVT-LPKINLTANLIHLSENRLEN 415
Query: 728 MDISSFLGN 736
+DI FL
Sbjct: 416 LDILYFLLR 424
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-31
Identities = 75/396 (18%), Positives = 132/396 (33%), Gaps = 63/396 (15%)
Query: 369 RLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTG 428
R+ F LT V L +L LS NY+ F L Q++ L
Sbjct: 7 RIAFYRFCNLTQVPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQLL--------- 53
Query: 429 GIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVL-NCE 486
+ Y I +N NL +L+LG +K+ + D
Sbjct: 54 ---------------ELGSQYTPLTIDKEAFRNLPNLRILDLGSSKI-YFLHPDAFQGLF 97
Query: 487 TLLQLRLVGNSLTGSF--PLELCKLENLYAIELDQNKFSG-PIPPEIENCQKLQRLHIAN 543
L +LRL L+ + L+ L ++L +N+ + P L+ + ++
Sbjct: 98 HLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSS 157
Query: 544 NYFTSELPKEVGNLSQ--LVTFNISSNMLTGLIPPEIVNC------MTLQRLDISHNSFV 595
N E+ L L F++++N L + + C M L+ LD+S N +
Sbjct: 158 NQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWT 217
Query: 596 GSLPN------------ELGTLQQLEILKLSENKFSGNIPSTLGNL--SHLTELQMGGNL 641
+ L + + +T L S + L +
Sbjct: 218 VDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGF 277
Query: 642 FSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFE 700
+ L L++ LNL+YN ++ LD L+ L L+ N L S F
Sbjct: 278 VF-SLNSRVFETLKDLKV-LNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFY 335
Query: 701 NLSSLLGSNFSYNNLT----GPLPSIPQFQNMDISS 732
L + + N++ + + Q +D+
Sbjct: 336 GLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRD 371
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-22
Identities = 76/318 (23%), Positives = 117/318 (36%), Gaps = 42/318 (13%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
LDL+ S L L L+LAYN++ L+ L L+ N
Sbjct: 270 HLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGEL 329
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+ L + +++ N I+ + + + L L+
Sbjct: 330 YSSNFYGLPKVAYIDLQKNHIA-IIQDQ-----------------------TFKFLEKLQ 365
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
NA++ I S+ + L+ N + +LPK + I L +N+L
Sbjct: 366 TLDLRDNALT-----TIHFIPSIPDIFLSGNKL-VTLPKI---NLTANLIHLSENRLENL 416
Query: 286 -IPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI----- 338
I L LQ L L N + L +L+L N L E+
Sbjct: 417 DILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVF 476
Query: 339 GNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLS 398
LS + + L+ N LN P FS +T LR L L N+LT + N+L + NL LD+S
Sbjct: 477 EGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPA--NLEILDIS 534
Query: 399 INYLTGPIPVGFQHLTQM 416
N L P P F L+ +
Sbjct: 535 RNQLLAPNPDVFVSLSVL 552
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 8e-19
Identities = 54/328 (16%), Positives = 110/328 (33%), Gaps = 46/328 (14%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L+L + GL +L L+L+YN L ++ ++ L N +
Sbjct: 294 VLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAII 353
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
L L +L++ +N ++ +I + ++
Sbjct: 354 QDQTFKFLEKLQTLDLRDNALT-----------------------------TIHFIPSIP 384
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGM-LESLTEIVLWDNQLTG 284
N + ++P + ++ L++N + + + L ++L N+ +
Sbjct: 385 DIFLSGNKLV-TLP---KINLTANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFSS 440
Query: 285 FIPSEL-GNCTKLQTLALYSNNLVGQIPKEV-----GNLKFLTKLYLYRNELNGTIPREI 338
+ L+ L L N L E+ L L LYL N LN P
Sbjct: 441 CSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVF 500
Query: 339 GNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLS 398
+L+ + + L+ N L + L +L + +NQL P+ +L+ LD++
Sbjct: 501 SHLTALRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPD---VFVSLSVLDIT 555
Query: 399 INYLTGPIPVG-FQHLTQMRQLQLFENS 425
N + F + + +
Sbjct: 556 HNKFICECELSTFINWLNHTNVTIAGPP 583
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 178 bits (455), Expect = 7e-50
Identities = 48/286 (16%), Positives = 106/286 (37%), Gaps = 22/286 (7%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVH--LTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFS 163
++ + + + L+L L P + S L+H+ ++
Sbjct: 59 QIETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM 117
Query: 164 GKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRN 223
++P + + + L +L + N + ALP + +L+ L + LP+ + +
Sbjct: 118 -ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST-- 173
Query: 224 LRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLT 283
E G +LQ L L I SLP I L++L + + ++ L+
Sbjct: 174 -------------DASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS 219
Query: 284 GFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSM 343
+ + + KL+ L L + P G L +L L T+P +I L+
Sbjct: 220 A-LGPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQ 278
Query: 344 VTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSL 389
+ ++DL +P+ +++ ++ + + + + +
Sbjct: 279 LEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-45
Identities = 58/371 (15%), Positives = 109/371 (29%), Gaps = 53/371 (14%)
Query: 289 ELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEID 348
+ + + L + + + + R N +
Sbjct: 7 HHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIET 62
Query: 349 LSENSLNGEIPTEFSKIT--GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI 406
+ +L T G L L L P++ L +L + + L +
Sbjct: 63 RTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLME-L 119
Query: 407 PVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIM 466
P Q + L L N L +P + + L
Sbjct: 120 PDTMQQFAGLETLTLARNPLR-------------------------ALPASIASLNRLRE 154
Query: 467 LNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPI 526
L++ +P + + E L NL ++ L+ +
Sbjct: 155 LSIRACPELTELPEPLAST---------------DASGEHQGLVNLQSLRLEWTGIRS-L 198
Query: 527 PPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISS-NMLTGLIPPEIVNCMTLQ 585
P I N Q L+ L I N+ ++ L + +L +L ++ L PP L+
Sbjct: 199 PASIANLQNLKSLKIRNSPLSA-LGPAIHHLPKLEELDLRGCTALRNY-PPIFGGRAPLK 256
Query: 586 RLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGE 645
RL + S + +LP ++ L QLE L L +PS + L + + +L +
Sbjct: 257 RLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQL 316
Query: 646 IPPELGDLSSL 656
+
Sbjct: 317 DQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-44
Identities = 58/337 (17%), Positives = 103/337 (30%), Gaps = 28/337 (8%)
Query: 389 LRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHN 448
L + P L+Q ++ + + + + +
Sbjct: 11 SSGRENLYFQGSTALRPYH---DVLSQWQRHYNADRNRWH-SAWRQANSNNPQIETRTGR 66
Query: 449 YLTGRIPPHL--CQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLEL 506
L L + L L L P L + + L P +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPL-PQFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 507 CKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNIS 566
+ L + L +N +P I + +L+ L I +ELP+ + +
Sbjct: 124 QQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTD-------- 174
Query: 567 SNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTL 626
E + LQ L + SLP + LQ L+ LK+ + S + +
Sbjct: 175 -------ASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAI 225
Query: 627 GNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLL 686
+L L EL + G PP G + L+ L L + ++P ++ +L LE L L
Sbjct: 226 HHLPKLEELDLRGCTALRNYPPIFGGRAPLKR-LILKDCSNLLTLPLDIHRLTQLEKLDL 284
Query: 687 NNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIP 723
+PS L + + P
Sbjct: 285 RGCVNLSRLPSLIAQLPANCIILVPPHLQAQLDQHRP 321
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-42
Identities = 45/328 (13%), Positives = 100/328 (30%), Gaps = 24/328 (7%)
Query: 143 PREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVD 202
+ S E+LY + L + + + N ++
Sbjct: 5 HHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNNPQI 60
Query: 203 FVAYTNNLTGPLPQSIGNLR--NLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGG 260
L + + + P + LQ + + +
Sbjct: 61 ETRTGRALKA-TADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGL-M 117
Query: 261 SLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKF- 319
LP + L + L N L +P+ + + +L+ L++ + + ++P+ + +
Sbjct: 118 ELPDTMQQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDAS 176
Query: 320 --------LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLL 371
L L L + ++P I NL + + + + L+ + + L L
Sbjct: 177 GEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEEL 234
Query: 372 FLFQNQLTGVIPNELSSLRNLTKLDLS-INYLTGPIPVGFQHLTQMRQLQLFENSLTGGI 430
L P L +L L + L +P+ LTQ+ +L L +
Sbjct: 235 DLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLT-LPLDIHRLTQLEKLDLRGCVNLSRL 293
Query: 431 PPGLGLYSLLWVVDFSHNYLTGRIPPHL 458
P + ++ + L ++ H
Sbjct: 294 PSLIAQLPANCIILVPPH-LQAQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 8e-41
Identities = 55/390 (14%), Positives = 107/390 (27%), Gaps = 75/390 (19%)
Query: 188 GALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQS 247
G+ + S + + P + + + + +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRW----HSAWRQANSNN 57
Query: 248 LQILGLAQNDIGGSLPKEIGML--ESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNN 305
QI + + + + L L P + + LQ + + +
Sbjct: 58 PQIETRTGRAL-KATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAG 115
Query: 306 LVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKI 365
L+ ++P + L L L RN L +P I +L+ + E+ + E+P +
Sbjct: 116 LM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLAST 173
Query: 366 TGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENS 425
E L NL L L + +P +L ++ L++ +
Sbjct: 174 D---------------ASGEHQGLVNLQSLRLEWTGIRS-LPASIANLQNLKSLKIRNSP 217
Query: 426 LTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNC 485
L+ + P + L L+L N P
Sbjct: 218 LSA-------------------------LGPAIHHLPKLEELDLRGCTALRNYPPIFGGR 252
Query: 486 ETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNY 545
L +L L S L L P +I +L++L +
Sbjct: 253 APLKRLILKDCS----------NLLTL--------------PLDIHRLTQLEKLDLRGCV 288
Query: 546 FTSELPKEVGNLSQLVTFNISSNMLTGLIP 575
S LP + L + ++ L
Sbjct: 289 NLSRLPSLIAQLPANCIILVPPHLQAQLDQ 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 8e-22
Identities = 29/244 (11%), Positives = 63/244 (25%), Gaps = 46/244 (18%)
Query: 484 NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIAN 543
+ L G++ + L + + Y + ++ N Q
Sbjct: 10 HSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTG 65
Query: 544 NYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELG 603
+ + +Q L++ P++
Sbjct: 66 RALK-ATADLLEDATQP----------------------GRVALELRSVPLP-QFPDQAF 101
Query: 604 TLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLS 663
L L+ + + +P T+ + L L + N +P + L+ L+ L++
Sbjct: 102 RLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRE-LSIR 158
Query: 664 YNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIP 723
+P L D + L +L + + SI
Sbjct: 159 ACPELTELPEPLASTDA---------------SGEHQGLVNLQSLRLEWTGIRSLPASIA 203
Query: 724 QFQN 727
QN
Sbjct: 204 NLQN 207
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 72.7 bits (179), Expect = 9e-14
Identities = 18/95 (18%), Positives = 36/95 (37%), Gaps = 2/95 (2%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLA-YNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
LDL + P GG L L L + L +P +I ++LE L L +
Sbjct: 234 LDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSR 292
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSL 200
+P+ + +L + + + ++ + +
Sbjct: 293 LPSLIAQLPANCIILVPPHLQAQLDQHRPVARPAE 327
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 2e-08
Identities = 20/142 (14%), Positives = 36/142 (25%), Gaps = 22/142 (15%)
Query: 595 VGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG---------- 644
+GS + E L + L +
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQI 60
Query: 645 ---------EIPPELGDLSSLQ-IALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGE 694
L D + +AL L L P + +L L+ + ++ L E
Sbjct: 61 ETRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-E 118
Query: 695 IPSAFENLSSLLGSNFSYNNLT 716
+P + + L + N L
Sbjct: 119 LPDTMQQFAGLETLTLARNPLR 140
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 170 bits (431), Expect = 3e-45
Identities = 68/525 (12%), Positives = 151/525 (28%), Gaps = 48/525 (9%)
Query: 117 SLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSL 176
++ + + L + + ++ L L+ N S A+L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 177 VSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG 236
LN+ +N++ + +L LR N +
Sbjct: 61 ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ- 93
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
E+ S++ L A N+I + + I L +N++T + G +++
Sbjct: 94 ----ELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 297 QTLALYSNNLVG-QIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
Q L L N + + + L L L N + + ++ + + +DLS N L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL-TGPIPVGFQHLT 414
+ EF G+ + L N+L +I L +NL DL N G + F
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 415 QMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
+++ + ++ ++ + + P + L
Sbjct: 263 RVQTVAK--QTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320
Query: 475 FGN----IPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI 530
G+ + + N ++ + + + +E + +
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 531 ENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLT-GLIPPEIVNCMTLQRLDI 589
+L EL S L + + V ++ D+
Sbjct: 381 RAHAELDGTLQQAV-GQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDM 439
Query: 590 SHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTE 634
+ + L+ + + + +L
Sbjct: 440 YQHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLAS 484
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-44
Identities = 75/504 (14%), Positives = 156/504 (30%), Gaps = 38/504 (7%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI 166
+ + +L+ ++ LDL+ N L+ ++ ++LE L L++N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72
Query: 167 PAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRV 226
+L LS+L +L++ NN + L S+ A NN++ + + +
Sbjct: 73 TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VS--CSRGQGKKN 124
Query: 227 FRAGQNAISGSIPAEISGCQSLQILGLAQNDIGG-SLPKEIGMLESLTEIVLWDNQLTGF 285
N I+ + +Q L L N+I + + ++L + L N +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD- 183
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
+ ++ KL+TL L SN L + E + +T + L N+L I + + +
Sbjct: 184 VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
DL N + +F R+ + + + + T
Sbjct: 241 HFDLRGNGFHCGTLRDF-FSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCEDL 299
Query: 406 IPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLI 465
L +++ + S G R+ +
Sbjct: 300 PAPFADRLIALKRKEHALLSGQGSET--------------------ERLECERENQARQR 339
Query: 466 MLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGP 525
++ + I L + + L +L L
Sbjct: 340 EIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVG-QIE 398
Query: 526 IPPEIENCQKLQRL-HIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTL 584
+ E LQ L I Y + ++ + + +++ + T L
Sbjct: 399 LQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMYQHKETQLAEENARLKKLN 458
Query: 585 QRLDISHNSFVGSLPNELGTLQQL 608
D++ S +L + Q L
Sbjct: 459 GEADLALASANATLQELVVREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-44
Identities = 64/425 (15%), Positives = 127/425 (29%), Gaps = 24/425 (5%)
Query: 315 GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLF 374
N + + L + + V E+DLS N L+ + + T L LL L
Sbjct: 7 QNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLS 66
Query: 375 QNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL 434
N L + L SL L LDL+ NY+ + L N+++ +
Sbjct: 67 SNVLYETLD--LESLSTLRTLDLNNNYVQE-----LLVGPSIETLHAANNNISR-VSCSR 118
Query: 435 GLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFG-NIPTDVLNCETLLQLRL 493
G + ++N +T S + L+L N++ N + +TL L L
Sbjct: 119 G--QGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNL 176
Query: 494 VGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKE 553
N + ++ L ++L NK + + PE ++ + + + NN + K
Sbjct: 177 QYNFIY-DVKGQVV-FAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL-IEKA 232
Query: 554 VGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKL 613
+ L F++ N + + + ++ + +
Sbjct: 233 LRFSQNLEHFDLRGNGFHCGTLRDFFS-KNQRVQTVAKQTVKKLTGQNEEECTVPTLGHY 291
Query: 614 SENKFSGNIPSTLGNLSHLT----ELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSG 669
L L L G + + E + + + ++
Sbjct: 292 GAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQRE-IDALKEQYRT 350
Query: 670 SIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNF---SYNNLTGPLPSIPQFQ 726
I + L L ++ + + L G+ L Q
Sbjct: 351 VIDQVTLRKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQ 410
Query: 727 NMDIS 731
+
Sbjct: 411 LLRAI 415
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 3e-43
Identities = 60/388 (15%), Positives = 126/388 (32%), Gaps = 21/388 (5%)
Query: 334 IPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT 393
I N + ++++SL + + ++ L L N L+ + +L+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 394 KLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGR 453
L+LS N L + + L+ +R L L N + + G + +L ++N ++ R
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-ELLVGPSIETL----HAANNNIS-R 113
Query: 454 IPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTG-SFPLELCKLENL 512
+ Q + L NK+ D + L L N + +F + L
Sbjct: 114 VSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 513 YAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTG 572
+ L N + ++ KL+ L +++N + E + + + ++ +N L
Sbjct: 172 EHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLVL 228
Query: 573 LIPPEIVNCMTLQRLDISHNSFV-GSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSH 631
I + L+ D+ N F G+L + Q++ +++ +
Sbjct: 229 -IEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRV--QTVAKQTVKKLTGQNEEECTV 285
Query: 632 LTELQMGGNL---FSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNN 688
T G L L + AL + + + E +
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALK 345
Query: 689 NHLSGEIPSAFENLSSLLGSNFSYNNLT 716
I + + L
Sbjct: 346 EQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-25
Identities = 43/366 (11%), Positives = 104/366 (28%), Gaps = 14/366 (3%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTG-YIPREIGNCSRLEHLYLNNNQFSG 164
++ L T G + YLDL NE+ + LEHL L N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 165 KIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNL 224
+ ++ + L +L++ +N ++ + + + + N L + +++ +NL
Sbjct: 183 DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL 239
Query: 225 RVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTG 284
F N ++ ++ +A+ + + T
Sbjct: 240 EHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLGHYGAYCCED 298
Query: 285 FIPSELGNCTKLQTLALY----SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGN 340
L+ + ++ E N ++ + + I +
Sbjct: 299 LPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTLR 358
Query: 341 LSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGV--IPNELSSLRNLTKLDLS 398
++ + +L+ ++ L + E S L+ L +
Sbjct: 359 KQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKR 418
Query: 399 INYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHL 458
+ +R ++++ T L L D + + +
Sbjct: 419 YEEMYVEQQ--SVQNNAIRDWDMYQHKETQLAEENARLKKLNGEADLALASANATLQELV 476
Query: 459 CQNSNL 464
+ NL
Sbjct: 477 VREQNL 482
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 72.2 bits (177), Expect = 3e-13
Identities = 28/137 (20%), Positives = 55/137 (40%), Gaps = 21/137 (15%)
Query: 597 SLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSL 656
++ + +I K++++ + S + ++ EL + GN S +L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 657 QIALNLSYNNLSGSIP----PELGKLDL-------------LEFLLLNNNHLSGEIPSAF 699
++ LNLS N L ++ L LDL +E L NN++S S
Sbjct: 61 EL-LNLSSNVLYETLDLESLSTLRTLDLNNNYVQELLVGPSIETLHAANNNISRVSCSRG 119
Query: 700 ENLSSLLGSNFSYNNLT 716
+ ++ + N +T
Sbjct: 120 QGKKNI---YLANNKIT 133
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 8e-43
Identities = 83/386 (21%), Positives = 140/386 (36%), Gaps = 48/386 (12%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
L++ + LT +P + + L + +N + +PA + L +L + N +
Sbjct: 41 GNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQL 93
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQ 246
+ +LP L L F + LP L L +F N ++ S+P
Sbjct: 94 T-SLPVLPPGLLELSIFSNPLTH----LPALPSGLCKLWIFG---NQLT-SLPVLPP--- 141
Query: 247 SLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNL 306
LQ L ++ N + SLP L L ++NQLT +P LQ L++ N L
Sbjct: 142 GLQELSVSDNQL-ASLPALPSELCKLW---AYNNQLT-SLPMLPSG---LQELSVSDNQL 193
Query: 307 VGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKIT 366
+P L KL+ Y N L ++P L E+ +S N L +P +
Sbjct: 194 A-SLPTLPSE---LYKLWAYNNRLT-SLPALPSGL---KELIVSGNRLT-SLPVL---PS 241
Query: 367 GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSL 426
L+ L + N+LT +P S L L + N LT +P HL+ + L N L
Sbjct: 242 ELKELMVSGNRLTS-LPMLPS---GLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGNPL 296
Query: 427 TGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCE 486
+ L + +S + + + + L + +
Sbjct: 297 S--ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPAD 354
Query: 487 TLLQLRLVGNSLTGSFPLELCKLENL 512
N+ +F L L +L
Sbjct: 355 RWHMFGQEDNA--DAFSLFLDRLSET 378
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-42
Identities = 83/362 (22%), Positives = 130/362 (35%), Gaps = 46/362 (12%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L++ T +L + H+T L + N LT +P L L ++ NQ +
Sbjct: 44 VLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPE---LRTLEVSGNQLT-S 95
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+P L L + + ALP GL L + N LT LP L+ L
Sbjct: 96 LPVLPPGLLELSIFSNPLTHLP-ALPSGLCKLW------IFGNQLTS-LPVLPPGLQELS 147
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
V N ++ S+PA S L N + SLP L+ L+ + DNQL
Sbjct: 148 V---SDNQLA-SLPALPSELCKLWAYN---NQL-TSLPMLPSGLQELS---VSDNQLA-S 195
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
+P+ L L Y+N L +P L +L + N L ++P L
Sbjct: 196 LPTLPSE---LYKLWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVLPSEL---K 244
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
E+ +S N L +P +GL L +++NQLT +P L L + T ++L N L+
Sbjct: 245 ELMVSGNRLT-SLPML---PSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299
Query: 406 IPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLI 465
+ +T L + ++L
Sbjct: 300 TLQALREITSAPGYSGPIIRFDMAGASAPRETRALH--LAAADWLVPAREGEPAPADRWH 357
Query: 466 ML 467
M
Sbjct: 358 MF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 3e-40
Identities = 77/401 (19%), Positives = 123/401 (30%), Gaps = 71/401 (17%)
Query: 293 CTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSEN 352
L + + L +P + +T L + N L ++P L +++S N
Sbjct: 39 NNGNAVLNVGESGL-TTLPDCLPAH--ITTLVIPDNNLT-SLPALPPEL---RTLEVSGN 91
Query: 353 SLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQH 412
L +P + L + L + L KL + N LT +PV
Sbjct: 92 QLT-SLPVLPPGLLELSIFSNPLTHLP-------ALPSGLCKLWIFGNQLTS-LPVLPPG 142
Query: 413 LTQMRQLQLFENSLTGGIPPGLG-LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGY 471
L + L + +N L +P L L +N LT +P S L L++
Sbjct: 143 LQE---LSVSDNQLAS-LPALPSELCKL----WAYNNQLT-SLPMLP---SGLQELSVSD 190
Query: 472 NKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIE 531
N+L S P +L L+ N+ + +P
Sbjct: 191 NQL-------------------------ASLPTLPSELYKLW---AYNNRLT-SLPALPS 221
Query: 532 NCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISH 591
L+ L ++ N TS LP L +L +S N LT L P L L +
Sbjct: 222 G---LKELIVSGNRLTS-LPVLPSELKEL---MVSGNRLTSL-PMLPSG---LLSLSVYR 270
Query: 592 NSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELG 651
N LP L L + L N S L ++ F
Sbjct: 271 NQLT-RLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
Query: 652 DLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLS 692
+ +L +A P + + N + S
Sbjct: 330 ETRALHLAAADWLVPAREGEPAPADRWHMFG-QEDNADAFS 369
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-39
Identities = 80/337 (23%), Positives = 129/337 (38%), Gaps = 47/337 (13%)
Query: 389 LRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG-LYSLLWVVDFSH 447
L++ + LT +P + L + +N+LT +P L +L + S
Sbjct: 39 NNGNAVLNVGESGLTT-LPDCL--PAHITTLVIPDNNLTS-LPALPPELRTL----EVSG 90
Query: 448 NYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELC 507
N LT +P L + + L +P+ L +L + GN LT S P+
Sbjct: 91 NQLT-SLPVLPPGLLELSIFSNPLTHL-PALPSG------LCKLWIFGNQLT-SLPVLPP 141
Query: 508 KLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISS 567
L+ L + N+ + +P L +L NN TS LP L +L ++S
Sbjct: 142 GLQELS---VSDNQLAS-LPALPSE---LCKLWAYNNQLTS-LPMLPSGLQEL---SVSD 190
Query: 568 NMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLG 627
N L L P L +L +N SLP L++L +S N+ + ++P
Sbjct: 191 NQLASL-PTLPSE---LYKLWAYNNRLT-SLPALPSGLKELI---VSGNRLT-SLPVLPS 241
Query: 628 NLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLN 687
L EL + GN + +P L SL ++ N L+ +P L L + L
Sbjct: 242 EL---KELMVSGNRLT-SLPMLPSGLLSL----SVYRNQLT-RLPESLIHLSSETTVNLE 292
Query: 688 NNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQ 724
N LS A ++S G + S P+
Sbjct: 293 GNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPR 329
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 4e-39
Identities = 78/372 (20%), Positives = 130/372 (34%), Gaps = 46/372 (12%)
Query: 149 CSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTN 208
+ L + + + +P L + +L I +N ++ +LP L +L N
Sbjct: 39 NNGNAVLNVGESGLT-TLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTL---EVSGN 91
Query: 209 NLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGM 268
LT LP L L +F + L L + N + SLP
Sbjct: 92 QLTS-LPVLPPGLLELSIFSNPLTHLPALPS-------GLCKLWIFGNQL-TSLPVLPPG 142
Query: 269 LESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRN 328
L+ L+ + DNQL +P+ L L Y+N L +P L +L + N
Sbjct: 143 LQELS---VSDNQLAS-LPALPSE---LCKLWAYNNQLT-SLPMLPSG---LQELSVSDN 191
Query: 329 ELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSS 388
+L ++P L ++ N L +P +GL+ L + N+LT +P S
Sbjct: 192 QLA-SLPTLPSEL---YKLWAYNNRLT-SLPAL---PSGLKELIVSGNRLTS-LPVLPS- 241
Query: 389 LRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHN 448
L +L +S N LT +P + + L ++ N LT +P L S V+ N
Sbjct: 242 --ELKELMVSGNRLTS-LP---MLPSGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEGN 294
Query: 449 YLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCK 508
L+ + G F L L + L + E
Sbjct: 295 PLS-ERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHL-AAADWLVPAREGEPAP 352
Query: 509 LENLYAIELDQN 520
+ + + N
Sbjct: 353 ADRWHMFGQEDN 364
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 9e-37
Identities = 83/372 (22%), Positives = 135/372 (36%), Gaps = 49/372 (13%)
Query: 366 TGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENS 425
G +L + ++ LT +P+ L ++T L + N LT +P ++R L++ N
Sbjct: 40 NGNAVLNVGESGLT-TLPDCL--PAHITTLVIPDNNLTS-LP---ALPPELRTLEVSGNQ 92
Query: 426 LTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNC 485
LT +P L + +L S L L + N+L ++P
Sbjct: 93 LTS-LPVLPPGLLELSIFSNPLTHLPALP-------SGLCKLWIFGNQL-TSLPVLPPG- 142
Query: 486 ETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNY 545
L +L + N L S P +L L+ N+ + +P LQ L +++N
Sbjct: 143 --LQELSVSDNQLA-SLPALPSELCKLW---AYNNQLTS-LPMLPSG---LQELSVSDNQ 192
Query: 546 FTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTL 605
S LP L +L +N LT L P L+ L +S N SLP
Sbjct: 193 LAS-LPTLPSELYKL---WAYNNRLTSL-PALPSG---LKELIVSGNRL-TSLPVLPS-- 241
Query: 606 QQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYN 665
+L+ L +S N+ + ++P L L + N + +P L LSS +NL N
Sbjct: 242 -ELKELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETT-VNLEGN 294
Query: 666 NLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQF 725
LS L ++ SA +L + + L +
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRAL--HLAAADWLVPAREG--EP 350
Query: 726 QNMDISSFLGNE 737
D G E
Sbjct: 351 APADRWHMFGQE 362
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-36
Identities = 73/319 (22%), Positives = 119/319 (37%), Gaps = 42/319 (13%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
+L+++ T SL GL+ L+ L P L L++ NQ +
Sbjct: 85 TLEVSGNQLT-SLPVLPPGLLELSIFSNPLTHL----PALPSG---LCKLWIFGNQLT-S 135
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+P L L++ +N ++ +LP L L AY N LT LP L+ L
Sbjct: 136 LPVLPP---GLQELSVSDNQLA-SLPALPSELCKL---WAYNNQLTS-LPMLPSGLQELS 187
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
V N ++ S+P S L L N + SLP L E+++ N+LT
Sbjct: 188 V---SDNQLA-SLPTLPS---ELYKLWAYNNRL-TSLPALPS---GLKELIVSGNRLTS- 235
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
+P L+ L + N L +P L L +YRN+L +P + +LS T
Sbjct: 236 LPVLPSE---LKELMVSGNRLT-SLPMLPSG---LLSLSVYRNQLT-RLPESLIHLSSET 287
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
++L N L+ E + + + + + S+ R L L+ P
Sbjct: 288 TVNLEGNPLS-ERTLQ--ALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVP 344
Query: 406 IPVGFQHLTQMRQLQLFEN 424
G + +F
Sbjct: 345 AREG--EPAPADRWHMFGQ 361
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 1e-30
Identities = 62/274 (22%), Positives = 99/274 (36%), Gaps = 40/274 (14%)
Query: 459 CQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELD 518
C N+ +LN+G + L +P + + L + N+LT S P +L L +
Sbjct: 37 CLNNGNAVLNVGESGL-TTLPDCLPA--HITTLVIPDNNLT-SLPALPPELRTLE---VS 89
Query: 519 QNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEI 578
N+ + +P +L LP L +L I N LT L P
Sbjct: 90 GNQLTS-LPVLPPGLLELSIFSNPLT----HLPALPSGLCKL---WIFGNQLTSL-PVLP 140
Query: 579 VNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMG 638
LQ L +S N SLP L + L N+ + ++P L EL +
Sbjct: 141 PG---LQELSVSDNQL-ASLPALPSELCK---LWAYNNQLT-SLPMLPSG---LQELSVS 189
Query: 639 GNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSA 698
N + +P +L L N L+ S+P L+ L+++ N L+ +P
Sbjct: 190 DNQLA-SLPTLPSELYK----LWAYNNRLT-SLPALPSG---LKELIVSGNRLT-SLPVL 239
Query: 699 FENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISS 732
L L S N LT ++ +
Sbjct: 240 PSELKEL---MVSGNRLTSLPMLPSGLLSLSVYR 270
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 23/128 (17%), Positives = 42/128 (32%), Gaps = 7/128 (5%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L ++ T SL GL L + N+LT +P + + S + L N S +
Sbjct: 245 ELMVSGNRLT-SLPMLPSGL---LSLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSER 299
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
L +++S + +I + + +A + L
Sbjct: 300 TLQALREITSAPGYS--GPIIRFDMAGASAPRETRALHLAAADWLVPAREGEPAPADRWH 357
Query: 226 VFRAGQNA 233
+F NA
Sbjct: 358 MFGQEDNA 365
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 1e-42
Identities = 63/270 (23%), Positives = 113/270 (41%), Gaps = 31/270 (11%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G++ TVYK + ++ VA +L + + F+ E L ++H NIV+ Y
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 846 FCYH---QGSNLLIY-EYMERGSLGELL--HGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+++ E M G+L L ++ +GL +L H
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---MKIKVLRSWCRQILKGLQFL-HTR 148
Query: 900 KPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
P I HRD+K +NI + +GD GLA + +K++ G+ ++APE Y
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV---IGTPEFMAPEM-YEE 204
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018
K E D+Y++G+ +LE+ T P + + V + + P FD E
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-----GVKPASFDKVAIPEV 259
Query: 1019 ESIVDHMILVLKVALMCTSISPFDRPSMRE 1048
+ I++ C + +R S+++
Sbjct: 260 KEIIE----------GCIRQNKDERYSIKD 279
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 9e-41
Identities = 63/364 (17%), Positives = 135/364 (37%), Gaps = 27/364 (7%)
Query: 333 TIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNL 392
I + + ++ + + + E + +++ + + + L S R +
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 393 TKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYL 450
L+L+ + F + +++L + N++ +PP + + L + N L
Sbjct: 72 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV-LVLERNDL 129
Query: 451 TGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCK 508
+ +P + N L L++ N L I D +L L+L N LT L L
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-- 184
Query: 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSN 568
+ +L+ + N S + ++ L ++N + V +L + N
Sbjct: 185 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHN 236
Query: 569 MLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGN 628
LT ++N L +D+S+N + + +Q+LE L +S N+ +
Sbjct: 237 NLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 293
Query: 629 LSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNN 688
+ L L + N + L+ L L +N++ ++ L+ L L++
Sbjct: 294 IPTLKVLDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIV-TLKL--STHHTLKNLTLSH 348
Query: 689 NHLS 692
N
Sbjct: 349 NDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-39
Identities = 78/407 (19%), Positives = 147/407 (36%), Gaps = 50/407 (12%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
I + + + + E L + + ++ + + L + ++
Sbjct: 12 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 71
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSL 354
+ L L + +I + KLY+ N + +P + N+ ++T + L N L
Sbjct: 72 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 129
Query: 355 NGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHL 413
+ +P F L L + N L + + + +L L LS N LT V +
Sbjct: 130 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLI 185
Query: 414 TQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNK 473
+ + N L+ + + + L D SHN + + + L +L L +N
Sbjct: 186 PSLFHANVSYNLLS-TLAIPIAVEEL----DASHNSIN-VVRGPVNV--ELTILKLQHNN 237
Query: 474 LFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENC 533
L + +LN L+++ L N L ++ + F
Sbjct: 238 L-TDTAW-LLNYPGLVEVDLSYNELE----------------KIMYHPFV--------KM 271
Query: 534 QKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNS 593
Q+L+RL+I+NN + L + L ++S N L + L+ L + HNS
Sbjct: 272 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 329
Query: 594 FVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGN 640
V +L L T L+ L LS N + N L ++ +
Sbjct: 330 IV-TLK--LSTHHTLKNLTLSHNDWDCNSLRAL--FRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 3e-38
Identities = 75/380 (19%), Positives = 134/380 (35%), Gaps = 35/380 (9%)
Query: 103 VVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQ 161
V + + ++ L + + + + +P + + ++E L LN+ Q
Sbjct: 22 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ 80
Query: 162 FSGKIPAE-LGKLSSLVSLNICNNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIG 219
+I ++ L + N I LP N+ L V N+L+
Sbjct: 81 IE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFH 138
Query: 220 NLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLW 278
N L N + I + SLQ L L+ N + + + ++ SL +
Sbjct: 139 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVS 194
Query: 279 DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI 338
N L+ L ++ L N++ + V LT L L N L T +
Sbjct: 195 YNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWL 244
Query: 339 GNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDL 397
N + E+DLS N L +I F K+ L L++ N+L + + L LDL
Sbjct: 245 LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 302
Query: 398 SINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPH 457
S N+L + ++ L L NS+ + ++L + SHN
Sbjct: 303 SHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST-HHTLKN-LTLSHNDWD------ 352
Query: 458 LCQNSNLIMLNLGYNKLFGN 477
C + + N+ +
Sbjct: 353 -CNSLRALFRNVARPAVDDA 371
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 64/385 (16%), Positives = 127/385 (32%), Gaps = 26/385 (6%)
Query: 125 LVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLVSLNICN 183
+ + Y E + + + N+ K+PA L + LN+ +
Sbjct: 20 DCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLND 78
Query: 184 NMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI- 242
I ++ N + P N+ L V +N +S S+P I
Sbjct: 79 LQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF 137
Query: 243 SGCQSLQILGLAQNDIGGSLPKEIGM-LESLTEIVLWDNQLTGFIPSELGNCTKLQTLAL 301
L L ++ N++ + + SL + L N+LT +L L +
Sbjct: 138 HNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANV 193
Query: 302 YSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE 361
N L + + +L N +N + + +T + L N+L +
Sbjct: 194 SYNLL-----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTAW- 243
Query: 362 FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQL 421
GL + L N+L ++ + ++ L +L +S N L + + Q + ++ L L
Sbjct: 244 LLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDL 302
Query: 422 FENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTD 481
N L + + L + HN + + + L L L +N N
Sbjct: 303 SHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHNDWDCNSLRA 358
Query: 482 VLNCETLLQLRLVGNSLTGSFPLEL 506
+ + + + +L
Sbjct: 359 LFR--NVARPAVDDADQHCKIDYQL 381
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 2e-32
Identities = 81/446 (18%), Positives = 150/446 (33%), Gaps = 82/446 (18%)
Query: 190 LPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSL 248
+ L D L N ++ + + +PA + + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 249 QILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVG 308
++L L D Q+ +Q L + N +
Sbjct: 72 ELLNLN------------------------DLQIEEIDTYAFAYAHTIQKLYMGFNAIR- 106
Query: 309 QIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSLNGEIPTE-FSKI 365
+P V N+ LT L L RN+L+ ++PR I N +T + +S N+L I + F
Sbjct: 107 YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQAT 164
Query: 366 TGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENS 425
T L+ L L N+LT V +LS + +L ++S N L+ + +L NS
Sbjct: 165 TSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIAVEELDASHNS 216
Query: 426 LTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL 483
+ + + L L HN LT L L+ ++L YN+L I
Sbjct: 217 IN-VVRGPVNVELTIL----KLQHNNLTD--TAWLLNYPGLVEVDLSYNEL-EKIMYHPF 268
Query: 484 -NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIA 542
+ L +L + N L + + L+ L ++
Sbjct: 269 VKMQRLERLYISNNRLVA-------------------------LNLYGQPIPTLKVLDLS 303
Query: 543 NNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNEL 602
+N+ + + +L + N + + + TL+ L +SHN + + L
Sbjct: 304 HNHLLH-VERNQPQFDRLENLYLDHNSIVT-LKLSTHH--TLKNLTLSHNDWDCNSLRAL 359
Query: 603 GTLQQLEILKLSENKFSGNIPSTLGN 628
+ + + + I L +
Sbjct: 360 --FRNVARPAVDDADQHCKIDYQLEH 383
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 4e-19
Identities = 39/209 (18%), Positives = 72/209 (34%), Gaps = 9/209 (4%)
Query: 526 IPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQ 585
I ++ +HI E L+ ++ + L + + ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 586 RLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGE 645
L+++ ++ L + N P N+ LT L + N S
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-S 131
Query: 646 IPPEL-GDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLS 703
+P + + L L++S NNL I + L+ L L++N L+ S +L
Sbjct: 132 LPRGIFHNTPKLTT-LSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLF 189
Query: 704 SLLGSNFSYNNLTGPLPSIPQFQNMDISS 732
N SYN L+ L + +D S
Sbjct: 190 HA---NVSYNLLST-LAIPIAVEELDASH 214
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 4e-16
Identities = 33/176 (18%), Positives = 63/176 (35%), Gaps = 5/176 (2%)
Query: 543 NNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNEL 602
+ + +I E + + + +++ L
Sbjct: 6 RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALL 65
Query: 603 GTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALN 661
+ +Q+E+L L++ + + +L MG N +PP ++ L + L
Sbjct: 66 DSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV-LV 123
Query: 662 LSYNNLSGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
L N+LS S+P + L L ++NN+L F+ +SL S N LT
Sbjct: 124 LERNDLS-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT 178
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 6e-40
Identities = 106/618 (17%), Positives = 194/618 (31%), Gaps = 54/618 (8%)
Query: 103 VVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQ 161
V + + ++ L + + + + +P + + ++E L LN+ Q
Sbjct: 28 VFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQ 86
Query: 162 FSGKIPAE-LGKLSSLVSLNICNNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIG 219
+I ++ L + N I LP N+ L V N+L+
Sbjct: 87 IE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLSSLPRGIFH 144
Query: 220 NLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLW 278
N L N + I + SLQ L L+ N + + + ++ SL +
Sbjct: 145 NTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRL-THVD--LSLIPSLFHANVS 200
Query: 279 DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI 338
N L+ L ++ L N++ + V LT L L N L T +
Sbjct: 201 YNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNL--TDTAWL 250
Query: 339 GNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDL 397
N + E+DLS N L +I F K+ L L++ N+L + + L LDL
Sbjct: 251 LNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDL 308
Query: 398 SINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPH 457
S N+L + ++ L L NS+ + ++L + SHN
Sbjct: 309 SHNHLLH-VERNQPQFDRLENLYLDHNSIV-TLKLST-HHTLKN-LTLSHNDWD------ 358
Query: 458 LCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIEL 517
C + + N+ + +C+ QL Y
Sbjct: 359 -CNSLRALFRNVARPAVDDAD----QHCKIDYQLE--HGLCCKESDKPYLDRLLQYIALT 411
Query: 518 DQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQL-VTFNISSNMLTGLIPP 576
+ + + ++Y T + + QL N + L
Sbjct: 412 SVVEKVQRAQGRCSATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELRAEVQQLTNE 471
Query: 577 EIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQ 636
+I LQ L ++ + L + + + S+N L E Q
Sbjct: 472 QIQQEQLLQGLHAEIDTNLRRY-----RLPKDGLARSSDNLNKVFTHLKERQAFKLRETQ 526
Query: 637 MGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIP 696
+ E DL IAL +N + +L + L +
Sbjct: 527 ARRTEADAKQ-KETEDLEQENIALEKQLDNKRAK------QAELRQETSLKRQKVKQLEA 579
Query: 697 SAFENLSSLLGSNFSYNN 714
N + S+ +++
Sbjct: 580 KKNRNPDTRRVSHHHHHH 597
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 2e-38
Identities = 63/364 (17%), Positives = 135/364 (37%), Gaps = 27/364 (7%)
Query: 333 TIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNL 392
I + + ++ + + + E + +++ + + + L S R +
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 393 TKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYL 450
L+L+ + F + +++L + N++ +PP + + L + N L
Sbjct: 78 ELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTV-LVLERNDL 135
Query: 451 TGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCK 508
+ +P + N L L++ N L I D +L L+L N LT L L
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL-- 190
Query: 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSN 568
+ +L+ + N S + ++ L ++N + V +L + N
Sbjct: 191 IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINV-VRGPV--NVELTILKLQHN 242
Query: 569 MLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGN 628
LT ++N L +D+S+N + + +Q+LE L +S N+ +
Sbjct: 243 NLTDT--AWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQP 299
Query: 629 LSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNN 688
+ L L + N + L+ L L +N++ ++ L+ L L++
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLEN-LYLDHNSIV-TLKL--STHHTLKNLTLSH 354
Query: 689 NHLS 692
N
Sbjct: 355 NDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 87/492 (17%), Positives = 166/492 (33%), Gaps = 60/492 (12%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
I + + + + E L + + ++ + + L + ++
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQV 77
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSL 354
+ L L + +I + KLY+ N + +P + N+ ++T + L N L
Sbjct: 78 ELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDL 135
Query: 355 NGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHL 413
+ +P F L L + N L + + + +L L LS N LT V +
Sbjct: 136 S-SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLI 191
Query: 414 TQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNK 473
+ + N L+ + + + L D SHN + + + L +L L +N
Sbjct: 192 PSLFHANVSYNLLS-TLAIPIAVEEL----DASHNSIN-VVRGPVNV--ELTILKLQHNN 243
Query: 474 LFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENC 533
L + +LN L+++ L N L ++ + F
Sbjct: 244 LT-DTAW-LLNYPGLVEVDLSYNELE----------------KIMYHPFVK--------M 277
Query: 534 QKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNS 593
Q+L+RL+I+NN + L + L ++S N L + L+ L + HNS
Sbjct: 278 QRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDRLENLYLDHNS 335
Query: 594 FVGSLPNELGTLQQLEILKLSENKFSGNIPSTL-----------GNLSHLTELQMGGNLF 642
V +L L T L+ L LS N + N L + + Q+ L
Sbjct: 336 IV-TLK--LSTHHTLKNLTLSHNDWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLC 392
Query: 643 SGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENL 702
E D IAL + D + + +++++ + +
Sbjct: 393 CKESDKPYLDRLLQYIALTSVVEKVQ-RAQGRCSATDTINSVQSLSHYITQQGGVPLQGN 451
Query: 703 SSLLGSNFSYNN 714
L
Sbjct: 452 EQLEAEVNELRA 463
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 7e-32
Identities = 88/521 (16%), Positives = 163/521 (31%), Gaps = 41/521 (7%)
Query: 190 LPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSL 248
+ L D L N ++ + + +PA + + +
Sbjct: 19 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 77
Query: 249 QILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLV 307
++L L I + ++ ++ + N + P N L L L N+L
Sbjct: 78 ELLNLNDLQI-EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 308 GQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSLNGEIPTEFSKI 365
+P+ + N LT L + N L I + + + + LS N L + S I
Sbjct: 137 -SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLI 191
Query: 366 TGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENS 425
L + N L+ L+ + +LD S N + LT L+L N+
Sbjct: 192 PSLFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELT---ILKLQHNN 243
Query: 426 LTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVLN 484
LT L Y L VD S+N L +I H L L + N+L +
Sbjct: 244 LTD--TAWLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRL-VALNLYGQP 299
Query: 485 CETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANN 544
TL L L N L + + L + LD N + L+ L +++N
Sbjct: 300 IPTLKVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKNLTLSHN 355
Query: 545 YFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGT 604
+ + N+ + +C +L+ P
Sbjct: 356 -----------DWDCNSLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL 404
Query: 605 LQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSY 664
LQ + + + E + + +Q + + + L L+ +N
Sbjct: 405 LQYIALTSVVEKVQRAQGRCS--ATDTINSVQSLSHYITQQGGVPLQGNEQLEAEVNELR 462
Query: 665 NNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
+ ++ + LL+ L + + L+
Sbjct: 463 AEVQQLTNEQIQQEQLLQGLHAEIDTNLRRYRLPKDGLARS 503
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 94.6 bits (235), Expect = 4e-20
Identities = 47/246 (19%), Positives = 79/246 (32%), Gaps = 28/246 (11%)
Query: 501 SFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQ 559
L Y + +D E + + N+ LP + + Q
Sbjct: 18 CIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRK-LPAALLDSFRQ 76
Query: 560 LVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
+ N++ + + T+Q+L + N+ P+ + L +L L N S
Sbjct: 77 VELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 136
Query: 620 GNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSG---SIPPEL 675
N LT L M N I + +SLQ L LS N L+ S+ P L
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQN-LQLSSNRLTHVDLSLIPSL 194
Query: 676 GKLDL-------------LEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSI 722
++ +E L ++N ++ L+ L +NNLT
Sbjct: 195 FHANVSYNLLSTLAIPIAVEELDASHNSINVVRGPVNVELTIL---KLQHNNLT----DT 247
Query: 723 PQFQNM 728
N
Sbjct: 248 AWLLNY 253
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 4e-39
Identities = 64/287 (22%), Positives = 106/287 (36%), Gaps = 62/287 (21%)
Query: 789 GSGAYGTVYKAVMDSGKI-VAVKKLASNREGNNIE--SSFRAEILTLGKIRHRNIVKLYG 845
G G +G V+ + + VAVK RE + + F E L + H NIV+L G
Sbjct: 123 GRGNFGEVFSGRLRADNTLVAVKSC---RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
C + ++ E ++ G L L T + AA G+ YL H
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIH 236
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTMKV 960
RD+ + N L+ +K + DFG+++ + A +G + APE +
Sbjct: 237 RDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 961 TEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGI--FDTRLNVE 1017
+ + D++S+G++L E + G +P Y P + TR VE
Sbjct: 293 SSESDVWSFGILLWETFSLGASP----------------Y-------PNLSNQQTREFVE 329
Query: 1018 D-----------ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+++ M C + P RPS + L
Sbjct: 330 KGGRLPCPELCPDAVFRLM-------EQCWAYEPGQRPSFSTIYQEL 369
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 5e-39
Identities = 59/345 (17%), Positives = 114/345 (33%), Gaps = 46/345 (13%)
Query: 117 SLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSL 176
++ + + L + + ++ L L+ N S A+L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 177 VSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG 236
LN+ +N++ + +L LR N +
Sbjct: 61 ELLNLSSNVLYE--------------------------TLDLESLSTLRTLDLNNNYVQ- 93
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
E+ S++ L A N+I + + I L +N++T + G +++
Sbjct: 94 ----ELLVGPSIETLHAANNNI-SRVSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRV 146
Query: 297 QTLALYSNNLVG-QIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
Q L L N + + + L L L N + + ++ + + +DLS N L
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA 204
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT-GPIPVGFQHLT 414
+ EF G+ + L N+L +I L +NL DL N G + F
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 415 QMRQLQLFENS-LTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHL 458
+++ + LTG + +L + P
Sbjct: 263 RVQTVAKQTVKKLTGQNEEECTVPTLG-----HYGAYCCEDLPAP 302
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 6e-39
Identities = 59/361 (16%), Positives = 118/361 (32%), Gaps = 48/361 (13%)
Query: 334 IPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT 393
I N + ++++SL + + ++ L L N L+ + +L+ L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 394 KLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGR 453
L+LS N L + + L+ +R L D ++NY+
Sbjct: 62 LLNLSSNVLYETLD--LESLSTLRTL------------------------DLNNNYVQ-- 93
Query: 454 IPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLY 513
L ++ L+ N + + + L N +T L+ +
Sbjct: 94 ---ELLVGPSIETLHAANNNI-SRVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQ 147
Query: 514 AIELDQNKFSG-PIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTG 572
++L N+ + L+ L++ N+ + +V ++L T ++SSN L
Sbjct: 148 YLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQV-VFAKLKTLDLSSNKLAF 205
Query: 573 LIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS-GNIPSTLGNLSH 631
+ PE + + + + +N V + L Q LE L N F G +
Sbjct: 206 -MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQR 263
Query: 632 LTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHL 691
+ + E + +L Y P L+ L ++H
Sbjct: 264 VQTVAKQTVKKLTGQNEEECTVPTL-----GHYGAYCCEDLPAPFADRLIA---LGHHHH 315
Query: 692 S 692
Sbjct: 316 H 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-37
Identities = 57/298 (19%), Positives = 113/298 (37%), Gaps = 24/298 (8%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI 166
+ + +L+ ++ LDL+ N L+ ++ ++LE L L++N
Sbjct: 15 EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVLYE-- 72
Query: 167 PAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRV 226
+L LS+L +L++ NN + L S+ A NN++ + S + +
Sbjct: 73 TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSR--GQGKKN 124
Query: 227 FRAGQNAISGSIPAEISGCQSLQILGLAQNDIGG-SLPKEIGMLESLTEIVLWDNQLTGF 285
N I+ + +Q L L N+I + + ++L + L N +
Sbjct: 125 IYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD- 183
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
+ ++ KL+TL L SN L + E + +T + L N+L I + + +
Sbjct: 184 VKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLE 240
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
DL N + LR F ++ V + L + + ++ L
Sbjct: 241 HFDLRGNGFH---------CGTLRDFFSKNQRVQTVAKQTVKKLTGQNEEECTVPTLG 289
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 45/277 (16%), Positives = 98/277 (35%), Gaps = 18/277 (6%)
Query: 462 SNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQN 520
+ + + + L + + + +L L GN L+ +L L + L N
Sbjct: 10 NRYKIEKVTDSSL-KQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSN 68
Query: 521 KFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVN 580
++E+ L+ L + NNY E+ + T + ++N ++ +
Sbjct: 69 VLYET--LDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR-VSCSRGQ 120
Query: 581 CMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSG-NIPSTLGNLSHLTELQMGG 639
+ + +++N + G +++ L L N+ N + L L +
Sbjct: 121 --GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQY 178
Query: 640 NLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAF 699
N ++ ++ + L+ L+LS N L+ + PE + ++ L NN L I A
Sbjct: 179 NFIY-DVKGQVV-FAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKAL 233
Query: 700 ENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGN 736
+L + N +N + +
Sbjct: 234 RFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQ 270
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-29
Identities = 42/240 (17%), Positives = 97/240 (40%), Gaps = 15/240 (6%)
Query: 478 IPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQ 537
I N ++ +SL + N+ ++L N S ++ KL+
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 538 RLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGS 597
L++++N ++ +LS L T ++++N + E++ +++ L ++N+
Sbjct: 62 LLNLSSNVLYE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SR 113
Query: 598 LPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGN-LFSGEIPPELGDLSSL 656
+ Q + + L+ NK + G S + L + N + + +L
Sbjct: 114 VS--CSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 657 QIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
+ LNL YN + + ++ L+ L L++N L+ + F++ + + + N L
Sbjct: 172 EH-LNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 2e-15
Identities = 26/176 (14%), Positives = 62/176 (35%), Gaps = 7/176 (3%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTG-YIPREIGNCSRLEHLYLNNNQFSG 164
++ L T G + YLDL NE+ + LEHL L N
Sbjct: 124 NIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY- 182
Query: 165 KIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNL 224
+ ++ + L +L++ +N ++ + + + + N L + +++ +NL
Sbjct: 183 DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLVL-IEKALRFSQNL 239
Query: 225 RVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDN 280
F N ++ ++ +A+ + L + ++ + +
Sbjct: 240 EHFDLRGNGFH-CGTLRDFFSKNQRVQTVAKQTV-KKLTGQNEEECTVPTLGHYGA 293
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 1e-13
Identities = 27/120 (22%), Positives = 52/120 (43%), Gaps = 8/120 (6%)
Query: 597 SLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSL 656
++ + +I K++++ + S + ++ EL + GN S +L + L
Sbjct: 1 AIHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 657 QIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
++ LNLS N L +L L L L LNNN++ S+ + + NN++
Sbjct: 61 EL-LNLSSNVLYE--TLDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS 112
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 9e-07
Identities = 13/83 (15%), Positives = 30/83 (36%), Gaps = 5/83 (6%)
Query: 646 IPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
I + + +I ++ ++L ++ ++ L L+ N LS + + L
Sbjct: 2 IHEIKQNGNRYKI-EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 706 LGSNFSYNNLTGPLPSIPQFQNM 728
N S N L +++
Sbjct: 61 ELLNLSSNVLY----ETLDLESL 79
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 2e-38
Identities = 88/483 (18%), Positives = 172/483 (35%), Gaps = 28/483 (5%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
+P ++S Q IL ++QN I +I L L +++ N++ S +L
Sbjct: 14 HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQEL 71
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPR--EIGNLSMVTEIDLSENSL 354
+ L L N LV I L L L N + +P E GN+S + + LS L
Sbjct: 72 EYLDLSHNKLVK-ISC--HPTVNLKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHL 127
Query: 355 NGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLT 414
+ + ++L + + L++ L I + T ++
Sbjct: 128 EKSSVLPIAHLNISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVS 185
Query: 415 QMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
L +++ + Y L + N + +N+ + ++
Sbjct: 186 VKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNL-----TLNNIETTWNSFIRI 240
Query: 475 FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQ 534
+ + ++ ++L G F L+ L ++ + F P E
Sbjct: 241 LQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFS 300
Query: 535 KLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSF 594
+ + + +S + + S+N+LT + + L+ L + N
Sbjct: 301 NMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQL 360
Query: 595 VGSLPNELG---TLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGGNLFSGEIPPEL 650
L ++ L+ L +S+N S + L L M N+ + I L
Sbjct: 361 K-ELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL 419
Query: 651 GDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL----L 706
+++ L+L N + SIP ++ KL+ L+ L + +N L F+ L+SL L
Sbjct: 420 --PPRIKV-LDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWL 475
Query: 707 GSN 709
+N
Sbjct: 476 HTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-31
Identities = 78/492 (15%), Positives = 163/492 (33%), Gaps = 57/492 (11%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
T L+++ N ++ +I + S+L L +++N+ + L L++ +N +
Sbjct: 22 KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKL 81
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTG-PLPQSIGNLRNLRVFRAGQNAISGSIPAEISGC 245
NL L N P+ + GN+ L+ + S I+
Sbjct: 82 VKISCHPTVNLKHL---DLSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 246 QSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNN 305
++L + ++ L+ L T + + + L +N
Sbjct: 139 NISKVLLVLGETY--GEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSN 196
Query: 306 LVG-----------QIPKEVGNLKFLTKLYLYRNELNGTIPREIGNL---SMVTEIDLSE 351
+ I ++ L+ L L E I L + V +S
Sbjct: 197 IKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISN 256
Query: 352 NSLNGEIPTE-----FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI 406
L G++ + + L + + + N+ + +++
Sbjct: 257 VKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVH 316
Query: 407 PVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLI 465
+ ++ L DFS+N LT C + + L
Sbjct: 317 MLCPSKISPFLHL------------------------DFSNNLLT-DTVFENCGHLTELE 351
Query: 466 MLNLGYNKL--FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELC-KLENLYAIELDQNKF 522
L L N+L I ++L QL + NS++ C ++L ++ + N
Sbjct: 352 TLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNIL 411
Query: 523 SGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCM 582
+ I + +++ L + +N S +PK+V L L N++SN L +
Sbjct: 412 TDTIFRCLP--PRIKVLDLHSNKIKS-IPKQVVKLEALQELNVASNQLKSVPDGIFDRLT 468
Query: 583 TLQRLDISHNSF 594
+LQ++ + N +
Sbjct: 469 SLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-29
Identities = 73/443 (16%), Positives = 132/443 (29%), Gaps = 46/443 (10%)
Query: 280 NQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI- 338
N L +P +L K L + N + ++ +L L L + N + + +
Sbjct: 10 NGLI-HVPKDLS--QKTTILNISQNYISELWTSDILSLSKLRILIISHNRIQ-YLDISVF 65
Query: 339 GNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGV-IPNELSSLRNLTKLDL 397
+ +DLS N L +I L+ L L N + I E ++ L L L
Sbjct: 66 KFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALPICKEFGNMSQLKFLGL 122
Query: 398 SINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPH 457
S +L + HL + L + + P + T +
Sbjct: 123 STTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGL--QDFNTESLHIVFPTNKEFHF 180
Query: 458 LCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIEL 517
+ S + NL + + + + + + +L N + L + I +
Sbjct: 181 ILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRI 240
Query: 518 DQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPE 577
Q + + I+N +L F+ S L
Sbjct: 241 LQLVWHTT----------VWYFSISNVKLQGQLDFR--------DFDYSGTSLK------ 276
Query: 578 IVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQM 637
L + + F + I + + +S L
Sbjct: 277 -----ALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDF 331
Query: 638 GGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELG---KLDLLEFLLLNNNHL-SG 693
NL + + G L+ L+ L L N L + ++ L+ L ++ N +
Sbjct: 332 SNNLLTDTVFENCGHLTELET-LILQMNQLK-ELSKIAEMTTQMKSLQQLDISQNSVSYD 389
Query: 694 EIPSAFENLSSLLGSNFSYNNLT 716
E SLL N S N LT
Sbjct: 390 EKKGDCSWTKSLLSLNMSSNILT 412
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 90.7 bits (225), Expect = 6e-19
Identities = 57/345 (16%), Positives = 106/345 (30%), Gaps = 43/345 (12%)
Query: 65 LELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGG 124
L + + EF+F+ + C L+ N ++ S+ +
Sbjct: 168 LHIVFPTNKEFHFILDVSVKTVANLELSNIKCV---------LEDNKCSYFLSILAKLQT 218
Query: 125 LVHLTYLDLAYNELTGYIPREIGNC---SRLEHLYLNNNQFSGKIPAELG-----KLSSL 176
L+ L L E T I + + + ++N + G++ L +L
Sbjct: 219 NPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKAL 278
Query: 177 VSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG 236
+ +++ S++ + + N ++
Sbjct: 279 SIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
++ L+ L L N + L K M + L
Sbjct: 339 TVFENCGHLTELETLILQMNQL-KELSKIAEMTTQM---------------------KSL 376
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
Q L + N++ K K L L + N L TI R + + +DL N +
Sbjct: 377 QQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
IP + K+ L+ L + NQL V L +L K+ L N
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 8e-38
Identities = 64/236 (27%), Positives = 104/236 (44%), Gaps = 37/236 (15%)
Query: 767 KEGFSFQDVVEATYNFHDS---FIVGSGAYGTVYKAV-MDSGKIVAVK--KLASNREGNN 820
+EG D++E Y + ++ ++G G YG VY + + +A+K +R
Sbjct: 6 EEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQP 65
Query: 821 IESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY-EYMERGSLGELL---HGSSCNL 876
+ EI ++H+NIV+ G + I+ E + GSL LL G +
Sbjct: 66 LHE----EIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVPGGSLSALLRSKWGPLKDN 120
Query: 877 EWPTRFMIA--LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVI 932
E F L EGL YLH + +I HRDIK +N+L++ + DFG +K +
Sbjct: 121 EQTIGFYTKQIL---EGLKYLHDN---QIVHRDIKGDNVLINTY-SGVLKISDFGTSKRL 173
Query: 933 DMPQSKSMSAVAGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + G+ Y+APE Y DI+S G ++E+ TG+ P
Sbjct: 174 AGINPCTET-FTGTLQYMAPEIIDKGPRGYGKAA----DIWSLGCTIIEMATGKPP 224
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 5e-37
Identities = 71/307 (23%), Positives = 115/307 (37%), Gaps = 14/307 (4%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLVSLNICNNM 185
LDL N + E + LE L LN N S + L +L +L + +N
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVS-AVEPGAFNNLFNLRTLGLRSNR 91
Query: 186 ISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-S 243
+ +P G LS+L N + L +L NL+ G N + I S
Sbjct: 92 LK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS 149
Query: 244 GCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALY 302
G SL+ L L + ++ S+P E L L + L + +L+ L +
Sbjct: 150 GLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEIS 208
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPRE-IGNLSMVTEIDLSENSLNGEIPTE 361
+ + LT L + L +P + +L + ++LS N ++ I
Sbjct: 209 HWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266
Query: 362 -FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQL 419
++ L+ + L QL V P L L L++S N LT + F + + L
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-LEESVFHSVGNLETL 325
Query: 420 QLFENSL 426
L N L
Sbjct: 326 ILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 1e-35
Identities = 73/337 (21%), Positives = 122/337 (36%), Gaps = 40/337 (11%)
Query: 267 GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYL 325
G+ + L N++ E + L+ L L + N+V + NL L L L
Sbjct: 29 GIPTETRLLDLGKNRIKTLNQDEFASFPHLEELEL-NENIVSAVEPGAFNNLFNLRTLGL 87
Query: 326 YRNELNGTIPREI-GNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPN 384
N L IP + LS +T++D+SEN + + F + L+ L + N L +
Sbjct: 88 RSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHR 146
Query: 385 ELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLW 441
S L +L +L L LT IP HL + L+L ++ I LY L
Sbjct: 147 AFSGLNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKV 204
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGS 501
+ + SH + P+ NL L++ + L +P +
Sbjct: 205 L-EISHWPYLDTMTPNCLYGLNLTSLSITHCNL-TAVPYLAVR----------------- 245
Query: 502 FPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-GNLSQ 559
L L + L N S I + +LQ + + + L+
Sbjct: 246 ------HLVYLRFLNLSYNPIST-IEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNY 297
Query: 560 LVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSFV 595
L N+S N LT + + + + L+ L + N
Sbjct: 298 LRVLNVSGNQLT-TLEESVFHSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-34
Identities = 75/378 (19%), Positives = 135/378 (35%), Gaps = 66/378 (17%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+ +P T RLL L +N++ + +E +S +L +L+L+ N ++
Sbjct: 14 RAVLCHRKRFV-AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-S 462
+ G F +L +R L L N L IP + S
Sbjct: 71 -VEPGAFNNLFNLRTLGLRSNRLK-------------------------LIPLGVFTGLS 104
Query: 463 NLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK 521
NL L++ NK+ + + + L L + N L +
Sbjct: 105 NLTKLDISENKI-VILLDYMFQDLYNLKSLEVGDNDLV----------------YISHRA 147
Query: 522 FSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGLIPPEIVN 580
FSG L++L + TS +P E +L L+ + + +
Sbjct: 148 FSG--------LNSLEQLTLEKCNLTS-IPTEALSHLHGLIVLRLRHLNINAIRDYSFKR 198
Query: 581 CMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGG 639
L+ L+ISH ++ ++ L L ++ + +P + +L +L L +
Sbjct: 199 LYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSY 257
Query: 640 NLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPS 697
N S I L +L LQ + L L+ + P L+ L L ++ N L+ S
Sbjct: 258 NPIS-TIEGSMLHELLRLQ-EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEES 314
Query: 698 AFENLSSLLGSNFSYNNL 715
F ++ +L N L
Sbjct: 315 VFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 75/316 (23%), Positives = 127/316 (40%), Gaps = 14/316 (4%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
++P I ++L L +N I E L E+ L +N ++ P N L
Sbjct: 25 AVPEGIP--TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNL 82
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSL 354
+TL L SN L IP V L LTKL + N++ + + +L + +++ +N L
Sbjct: 83 RTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDL 140
Query: 355 NGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHL 413
I FS + L L L + LT + LS L L L L + F+ L
Sbjct: 141 V-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRL 199
Query: 414 TQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYN 472
+++ L++ + P L + +H LT +P ++ L LNL YN
Sbjct: 200 YRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYN 258
Query: 473 KLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI- 530
+ I +L L +++LVG L P L L + + N+ + + +
Sbjct: 259 PI-STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLTT-LEESVF 316
Query: 531 ENCQKLQRLHIANNYF 546
+ L+ L + +N
Sbjct: 317 HSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-31
Identities = 64/327 (19%), Positives = 109/327 (33%), Gaps = 17/327 (5%)
Query: 131 LDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGAL 190
+ +P I + L L N+ E L L + N++S
Sbjct: 16 VLCHRKRFVA-VPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVE 72
Query: 191 PEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQ 249
P NL +L +N L L NL +N I + + +L+
Sbjct: 73 PGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLK 131
Query: 250 ILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVG 308
L + ND+ + L SL ++ L LT L + L L L N+
Sbjct: 132 SLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN- 189
Query: 309 QIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE-FSKIT 366
I L L L + T+ +T + ++ +L +P +
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLV 248
Query: 367 GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENS 425
LR L L N ++ + + L L L ++ L L + F+ L +R L + N
Sbjct: 249 YLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAV-VEPYAFRGLNYLRVLNVSGNQ 307
Query: 426 LTGGIPPGL--GLYSLLWVVDFSHNYL 450
LT + + + + L + N L
Sbjct: 308 LT-TLEESVFHSVGN-LETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 6e-29
Identities = 59/283 (20%), Positives = 101/283 (35%), Gaps = 32/283 (11%)
Query: 124 GLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNIC 182
L +L L L N L IP + S L L ++ N+ + L +L SL +
Sbjct: 78 NLFNLRTLGLRSNRLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVG 136
Query: 183 NNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAE 241
+N + + L+SL NLT +++ +L L V R I+ +I
Sbjct: 137 DNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNIN-AIRDY 194
Query: 242 I-SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLA 300
L++L ++ ++ +LT + + LT + + L+ L
Sbjct: 195 SFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLN 254
Query: 301 LYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIP 359
L N + I + L L ++ L +L +
Sbjct: 255 LSYNPIS-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYA--------------------- 291
Query: 360 TEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402
F + LR+L + NQLT + + S+ NL L L N L
Sbjct: 292 --FRGLNYLRVLNVSGNQLTTLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 82.8 bits (205), Expect = 2e-16
Identities = 48/206 (23%), Positives = 71/206 (34%), Gaps = 8/206 (3%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
SL++ + +S GL L L L LT IP E + L L L + +
Sbjct: 132 SLEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNIN 189
Query: 164 GKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRN 223
+L L L I + + +L NLT ++ +L
Sbjct: 190 AIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVY 249
Query: 224 LRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQ 281
LR N IS +I + LQ + L + + L L + + NQ
Sbjct: 250 LRFLNLSYNPIS-TIEGSMLHELLRLQEIQLVGGQL-AVVEPYAFRGLNYLRVLNVSGNQ 307
Query: 282 LTGFIPSELGNCTKLQTLALYSNNLV 307
LT S + L+TL L SN L
Sbjct: 308 LTTLEESVFHSVGNLETLILDSNPLA 333
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 66/293 (22%), Positives = 119/293 (40%), Gaps = 52/293 (17%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
++GSG +G V+KA GK +K++ N E E+ L K+ H NIV G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE------KAEREVKALAKLDHVNIVHYNG 71
Query: 846 F---------------CYHQGSNLLIY-EYMERGSLGELLHGSSCN-LEWPTRFMIALGA 888
+ L I E+ ++G+L + + L+ +
Sbjct: 72 CWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQI 131
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG 948
+G+ Y+H ++ +RD+K +NI L D + +GDFGL + + G+
Sbjct: 132 TKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLK--NDGKRTRSKGTLR 186
Query: 949 YIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG 1008
Y++PE + ++ D+Y+ G++L ELL + T +R+ I
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELL---HVCDTAFETSKFFTDLRDGI-----ISD 238
Query: 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML-IESNERE 1060
IFD + +++ ++ S P DRP+ E++ L + E
Sbjct: 239 IFDKKEK----TLLQKLL----------SKKPEDRPNTSEILRTLTVWKKSPE 277
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-36
Identities = 60/202 (29%), Positives = 92/202 (45%), Gaps = 19/202 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
VG G++G V++ +G AVKK+ +E E++ + IV LYG
Sbjct: 66 VGRGSFGEVHRMKDKQTGFQCAVKKV-------RLEVFRVEELVACAGLSSPRIVPLYG- 117
Query: 847 CYHQGSNLLIY-EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+G + I+ E +E GSLG+L+ C E + A EGL YLH RI H
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALY-YLGQALEGLEYLHTR---RILH 173
Query: 906 RDIKSNNILLDDK-FEAHVGDFGLAKVIDMPQSK----SMSAVAGSYGYIAPEYAYTMKV 960
D+K++N+LL A + DFG A + + + G+ ++APE
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233
Query: 961 TEKCDIYSYGVVLLELLTGRTP 982
K DI+S ++L +L G P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-35
Identities = 77/457 (16%), Positives = 156/457 (34%), Gaps = 47/457 (10%)
Query: 270 ESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNE 329
++ V ++ L +L +++++ + L LTKL N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI--TDMTGIEKLTGLTKLICTSNN 75
Query: 330 LNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSL 389
+ T+ + + +T + N L + + +T L L N+LT + ++S
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLTKL---DVSQN 126
Query: 390 RNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNY 449
LT L+ + N LT + H TQ+ +L N + + L +D S N
Sbjct: 127 PLLTYLNCARNTLT---EIDVSHNTQLTELDCHLNKKIT--KLDVTPQTQLTTLDCSFNK 181
Query: 450 LTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKL 509
+T + + QN L LN N + + D+ L L N LT +++ L
Sbjct: 182 ITE-LD--VSQNKLLNRLNCDTNNIT-KL--DLNQNIQLTFLDCSSNKLTE---IDVTPL 232
Query: 510 ENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNM 569
L + N + + + KL LH ++ + +QL+ F
Sbjct: 233 TQLTYFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQAEGC- 285
Query: 570 LTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNL 629
+ ++ + L LD L L +L L L+ + + + + +
Sbjct: 286 -RKIKELDVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHN 338
Query: 630 SHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNN- 688
+ L L + +G + +L + ++P E + L + +
Sbjct: 339 TKLKSLSCVNAHIQ-DFSS-VGKIPALNN-NFEAEGQTI-TMPKETLTNNSLTIAVSPDL 394
Query: 689 ---NHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSI 722
I + + ++ NL+ P++
Sbjct: 395 LDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAV 431
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-34
Identities = 93/478 (19%), Positives = 161/478 (33%), Gaps = 69/478 (14%)
Query: 223 NLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQL 282
N A + + +L L + I + I L LT+++ N +
Sbjct: 19 NFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSI-TDMT-GIEKLTGLTKLICTSNNI 76
Query: 283 TGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLS 342
T +L T L LA SN L + V L LT L N+L + +
Sbjct: 77 TTL---DLSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNP 127
Query: 343 MVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402
++T ++ + N+L EI S T L L N+ + ++ LT LD S N +
Sbjct: 128 LLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI 182
Query: 403 TGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNS 462
T + + +L N++T + L L +D S N LT I + +
Sbjct: 183 TE---LDVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLT 233
Query: 463 NLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKF 522
L + N L DV L L + L E+D
Sbjct: 234 QLTYFDCSVNPL---TELDVSTLSKLTTLHCIQTDLL----------------EID---- 270
Query: 523 SGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCM 582
+ + +L EL +V + +QL + + +T L ++
Sbjct: 271 -------LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITEL---DLSQNP 318
Query: 583 TLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLF 642
L L +++ L + +L+ L + S +G + L
Sbjct: 319 KLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQT 373
Query: 643 SGEIPPELGDLSSLQIALNLSYNNLSG---SIPPELGKLDLLEFLLLNNNHLSGEIPS 697
+P E +SL IA++ + G +I P G + + +LS + P+
Sbjct: 374 I-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPA 430
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 1e-34
Identities = 87/425 (20%), Positives = 149/425 (35%), Gaps = 42/425 (9%)
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
E+ T L+ +T +D +S+ T K+TGL L N +T
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD--MTGIEKLTGLTKLICTSNNIT 77
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL 439
+ +LS NLT L N LT + V LT++ L N LT L
Sbjct: 78 TL---DLSQNTNLTYLACDSNKLTN-LDVT--PLTKLTYLNCDTNKLTKLDVSQN---PL 128
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
L ++ + N LT I + N+ L L+ NK + DV L L N +T
Sbjct: 129 LTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKIT 183
Query: 500 GSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQ 559
L++ + + L + D N + ++ +L L ++N T + V L+Q
Sbjct: 184 E---LDVSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTE-ID--VTPLTQ 234
Query: 560 LVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
L F+ S N LT L ++ L L + + L QL + +
Sbjct: 235 LTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEGCRKI 288
Query: 620 GNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLD 679
+ + + + L L + E+ L L L L+ L+ + +
Sbjct: 289 KELD--VTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY-LYLNNTELT-ELD--VSHNT 339
Query: 680 LLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGL 739
L+ L N H+ + S + +L + + ++ I+
Sbjct: 340 KLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDLLDQ 397
Query: 740 CGRPV 744
G P+
Sbjct: 398 FGNPM 402
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 4e-34
Identities = 78/408 (19%), Positives = 137/408 (33%), Gaps = 42/408 (10%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
S A + + S L LT LD + +T + I + L L +N +
Sbjct: 22 SEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNNIT-T 78
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+ L + ++L L +N ++ L + L+ L TN LT + L
Sbjct: 79 LD--LSQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT---KLDVSQNPLLT 130
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
+N ++ I +S L L N L + LT + N++T
Sbjct: 131 YLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKITEL 185
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
++ L L +NN+ ++ + LT L N+L I + L+ +T
Sbjct: 186 ---DVSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLT 236
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
D S N L E+ S ++ L L Q L + +L+ L
Sbjct: 237 YFDCSVNPLT-ELD--VSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKE 290
Query: 406 IPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLI 465
+ V H TQ+ L +T + L L + ++ LT + + N+ L
Sbjct: 291 LDVT--HNTQLYLLDCQAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLK 342
Query: 466 MLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLY 513
L+ + + + V L + P E +L
Sbjct: 343 SLSCVNAHI-QDFSS-VGKIPALNNNFEAEGQTI-TMPKETLTNNSLT 387
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-33
Identities = 76/465 (16%), Positives = 154/465 (33%), Gaps = 67/465 (14%)
Query: 128 LTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMIS 187
A E+ + L L +N+ + + + KL+ L L +N
Sbjct: 20 FASEVAAAFEMQATDTISEEQLATLTSLDCHNSSIT-DMT-GIEKLTGLTKLICTSN--- 74
Query: 188 GALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQS 247
N+++L + NL N ++ ++ ++
Sbjct: 75 --------NITTL----------------DLSQNTNLTYLACDSNKLT-NLD--VTPLTK 107
Query: 248 LQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLV 307
L L N + L + LT + N LT ++ + T+L L + N +
Sbjct: 108 LTYLNCDTNKL-TKLD--VSQNPLLTYLNCARNTLTEI---DVSHNTQLTELDCHLNKKI 161
Query: 308 GQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITG 367
++ V LT L N++ + + ++ ++ N++ ++ ++
Sbjct: 162 TKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQ 213
Query: 368 LRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
L L N+LT + +++ L LT D S+N LT + V L+++ L + L
Sbjct: 214 LTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELDVS--TLSKLTTLHCIQTDLL 267
Query: 428 GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCET 487
+ L ++ F + N+ L +L+ + D+
Sbjct: 268 -----EIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGI---TELDLSQNPK 319
Query: 488 LLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT 547
L+ L L LT L++ L ++ + L A
Sbjct: 320 LVYLYLNNTELTE---LDVSHNTKLKSLSCVNAHIQD--FSSVGKIPALNNNFEAEGQTI 374
Query: 548 SELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHN 592
+ +PKE + L T +S ++L P + D + N
Sbjct: 375 T-MPKETLTNNSL-TIAVSPDLLDQFGNPMNIEPGDGGVYDQATN 417
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-31
Identities = 66/385 (17%), Positives = 128/385 (33%), Gaps = 42/385 (10%)
Query: 104 VWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFS 163
+ SLD + + T ++ I L LT L N +T ++ + L +L ++N+ +
Sbjct: 44 LTSLDCHNSSIT-DMTG-IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLT 98
Query: 164 GKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRN 223
+ + L+ L LN N ++ L + L N LT + +
Sbjct: 99 -NLD--VTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLT---EIDVSHNTQ 149
Query: 224 LRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLT 283
L N + ++ L L + N I L + + L + N +T
Sbjct: 150 LTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKI-TELD--VSQNKLLNRLNCDTNNIT 204
Query: 284 GFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSM 343
+L +L L SN L +I V L LT N L + + LS
Sbjct: 205 KL---DLNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD--VSTLSK 255
Query: 344 VTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
+T + + L E +L++ + +++ L LD +T
Sbjct: 256 LTTLHCIQTDL-----LEIDLTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLDCQAAGIT 310
Query: 404 GPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSN 463
+ ++ L L LT + + + L + + ++ + +
Sbjct: 311 -ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQD-FSS-VGKIPA 362
Query: 464 LIMLNLGYNKLFGNIPTDVLNCETL 488
L + +P + L +L
Sbjct: 363 LNNNFEAEGQTI-TMPKETLTNNSL 386
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 71/375 (18%), Positives = 133/375 (35%), Gaps = 39/375 (10%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L + N T + + +LTYL N+LT + + ++L +L + N+ + K
Sbjct: 68 KLICTSNNIT---TLDLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLT-K 120
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+ + + L LN N ++ + + + + L + + N L + L
Sbjct: 121 LD--VSQNPLLTYLNCARNTLT-EID--VSHNTQLTELDCHLNKKITKLD--VTPQTQLT 173
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
N I+ + +S + L L N+I L + LT + N+LT
Sbjct: 174 TLDCSFNKIT-ELD--VSQNKLLNRLNCDTNNI-TKLD--LNQNIQLTFLDCSSNKLTEI 227
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVT 345
++ T+L N L ++ V L LT L+ + +L I + + + +
Sbjct: 228 ---DVTPLTQLTYFDCSVNPL-TELD--VSTLSKLTTLHCIQTDLL-EID--LTHNTQLI 278
Query: 346 EIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP 405
E+ + + T L LL +T + +LS L L L+ LT
Sbjct: 279 YFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELTE- 332
Query: 406 IPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLI 465
+ V H T+++ L + + +L + L NS I
Sbjct: 333 LDVS--HNTKLKSLSCVNAHIQ-DFSSVGKIPALNN-NFEAEGQTITMPKETLTNNSLTI 388
Query: 466 MLNLGYNKLFGNIPT 480
++ FGN
Sbjct: 389 AVSPDLLDQFGNPMN 403
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-22
Identities = 49/296 (16%), Positives = 93/296 (31%), Gaps = 29/296 (9%)
Query: 109 LNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPA 168
L+ + LT LD ++N++T ++ L L + N + K+
Sbjct: 153 LDCHLNKKITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNIT-KLD- 207
Query: 169 ELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFR 228
L + L L+ +N ++ + + L+ L F N LT + L L
Sbjct: 208 -LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT---ELDVSTLSKLTTLH 260
Query: 229 AGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPS 288
Q + I ++ L L ++ L + +T
Sbjct: 261 CIQTDLL-EID--LTHNTQLIYFQAEGCRKIKEL--DVTHNTQLYLLDCQAAGITEL--- 312
Query: 289 ELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEID 348
+L KL L L + L ++ V + L L + +G + +
Sbjct: 313 DLSQNPKLVYLYLNNTELT-ELD--VSHNTKLKSLSCVNAHIQ-DFS-SVGKIPALNNNF 367
Query: 349 LSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSL-RNLTKLDLSINYLT 403
+E +P E +T L L N ++ + D + N +T
Sbjct: 368 EAEGQTI-TMPKE--TLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTIT 420
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 86.3 bits (214), Expect = 1e-17
Identities = 53/275 (19%), Positives = 89/275 (32%), Gaps = 43/275 (15%)
Query: 461 NSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT-----GSFP------------ 503
+ N ++ TL L +S+T
Sbjct: 17 DDNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTGIEKLTGLTKLICTSNNI 76
Query: 504 --LELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLV 561
L+L + NL + D NK + + + KL L+ N T +V L
Sbjct: 77 TTLDLSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNCDTNKLTK---LDVSQNPLLT 130
Query: 562 TFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN 621
N + N LT + ++ + L LD N + L + QL L S NK +
Sbjct: 131 YLNCARNTLTEI---DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-E 184
Query: 622 IPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLL 681
+ + L L N + ++ L L L+ S N L+ I + L L
Sbjct: 185 LD--VSQNKLLNRLNCDTNNIT-KLD--LNQNIQLTF-LDCSSNKLT-EID--VTPLTQL 235
Query: 682 EFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
+ + N L+ S L++L + +L
Sbjct: 236 TYFDCSVNPLTELDVSTLSKLTTL---HCIQTDLL 267
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-17
Identities = 40/246 (16%), Positives = 84/246 (34%), Gaps = 24/246 (9%)
Query: 119 SPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVS 178
+ + LT+LD + N+LT ++ ++L + + N + ++ + LS L +
Sbjct: 205 KLDLNQNIQLTFLDCSSNKLTEI---DVTPLTQLTYFDCSVNPLT-ELD--VSTLSKLTT 258
Query: 179 LNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSI 238
L+ + + L + + L+ F A L + + L + I+ +
Sbjct: 259 LHCIQTDLL-EID--LTHNTQLIYFQAEGCRKIKELD--VTHNTQLYLLDCQAAGIT-EL 312
Query: 239 PAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQT 298
+S L L L ++ L + L + + + F S +G L
Sbjct: 313 D--LSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNN 365
Query: 299 LALYSNNLVGQIPKEVGNLKFLTKL----YLYRNELNGTIPREIGNLSMVTEIDLSENSL 354
+ +PKE LT L + I G + ++ +L
Sbjct: 366 NFEAEGQTI-TMPKETLTNNSLTIAVSPDLLDQFGNPMNIEPGDGGVYDQATNTITWENL 424
Query: 355 NGEIPT 360
+ + P
Sbjct: 425 STDNPA 430
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-35
Identities = 68/235 (28%), Positives = 109/235 (46%), Gaps = 22/235 (9%)
Query: 750 SPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVA 808
SP +P + N+ P+E F+ + + G G++G V+K + + K+VA
Sbjct: 4 SPVQSGLPGMQNLKADPEELFTKLEKI------------GKGSFGEVFKGIDNRTQKVVA 51
Query: 809 VKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGE 867
+K + + IE + EI L + + K YG Y + + L +I EY+ GS +
Sbjct: 52 IKIIDLEEAEDEIED-IQQEITVLSQCDSPYVTKYYG-SYLKDTKLWIIMEYLGGGSALD 109
Query: 868 LLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 927
LL L+ I +GL YLH + + HRDIK+ N+LL + E + DFG
Sbjct: 110 LLE--PGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFG 164
Query: 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+A + Q K + V + ++APE K DI+S G+ +EL G P
Sbjct: 165 VAGQLTDTQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 4e-35
Identities = 49/213 (23%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN--IVKLYG 845
+GSG V++ + + +I A+K + N S+R EI L K++ + I++LY
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 846 FCYHQGSNLLIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ ++ E L L S + + + E + +H + I
Sbjct: 96 YEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIH---QHGIV 149
Query: 905 HRDIKSNNILLDD---KFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPE------- 953
H D+K N L+ D K + DFG+A + S + G+ Y+ PE
Sbjct: 150 HSDLKPANFLIVDGMLK----LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
K++ K D++S G +L + G+TP
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 4e-35
Identities = 75/310 (24%), Positives = 119/310 (38%), Gaps = 55/310 (17%)
Query: 789 GSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
G G +G+V D +G +VAVK+L + G + + F+ EI L + IVK
Sbjct: 32 GKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKY 89
Query: 844 YGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
G Y G L+ EY+ G L + L L+ + + +G+ YL
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SR 146
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAY 956
R HRD+ + NIL++ + + DFGLAK++ + + V G APE
Sbjct: 147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY---YVVREPGQSPIFWYAPESLS 203
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL- 1014
+ + D++S+GVVL EL T P + + R +RL
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER---------DVPALSRLL 254
Query: 1015 -NVED-----------ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML-----IESN 1057
+E+ + + M +C + SP DRPS + L
Sbjct: 255 ELLEEGQRLPAPPACPAEVHELM-------KLCWAPSPQDRPSFSALGPQLDMLWSGSRG 307
Query: 1058 EREGRFNSSP 1067
F + P
Sbjct: 308 CETHAFTAHP 317
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 6e-35
Identities = 52/249 (20%), Positives = 95/249 (38%), Gaps = 31/249 (12%)
Query: 773 QDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILT 831
Q + D I+G GA V++ +G + A+K + ++ R E
Sbjct: 4 QSTSNHLWLLSD--ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEV 60
Query: 832 LGKIRHRNIVKLYGFCYHQGSNLLIY---EYMERGSLGELL--HGSSCNLEWPT--RFMI 884
L K+ H+NIVKL+ + + E+ GSL +L ++ L +
Sbjct: 61 LKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSM 940
+ G+ +L + I HR+IK NI+ + + DFG A+ ++ +
Sbjct: 120 DV--VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQF 172
Query: 941 SAVAGSYGYIAPE--------YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992
++ G+ Y+ P+ + K D++S GV TG P +P +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 993 ATWVRNYIR 1001
+ I
Sbjct: 233 KEVMYKIIT 241
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 6e-35
Identities = 56/200 (28%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+GSG +G V+ + VA+K + REG E F E + K+ H +V+LYG
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
C Q L+ E+ME G L + L T + L EG+AYL + + HR
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL---EEACVIHR 128
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI---APEYAYTMKVTEK 963
D+ + N L+ + V DFG+ + + ++ G+ + +PE + + K
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185
Query: 964 CDIYSYGVVLLELLT-GRTP 982
D++S+GV++ E+ + G+ P
Sbjct: 186 SDVWSFGVLMWEVFSEGKIP 205
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 65/288 (22%), Positives = 112/288 (38%), Gaps = 49/288 (17%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G V++A A+K++ E R E+ L K+ H IV+ +
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMR-EVKALAKLEHPGIVRYFNA 71
Query: 847 CYHQGS---------NLLIY---EYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGL 892
+ + + +Y + + +L + ++G E I L AE +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----------MPQSKSMS 941
+LH + HRD+K +NI VGDFGL +D MP +
Sbjct: 132 EFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 942 AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR 1001
G+ Y++PE + + K DI+S G++L ELL P + + + +R
Sbjct: 189 GQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY------PFSTQMERVRTLTD-VR 241
Query: 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
+ P +F + E +V M+ S SP +RP +
Sbjct: 242 NLKFPP-LFTQKYPCE-YVMVQDML----------SPSPMERPEAINI 277
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 7e-35
Identities = 64/210 (30%), Positives = 93/210 (44%), Gaps = 20/210 (9%)
Query: 789 GSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
G G +G V D +G+ VAVK L GN+I + EI L + H NIVK
Sbjct: 30 GEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRNLYHENIVKY 88
Query: 844 YGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
G C G N LI E++ GSL E L + + + A+ +G+ YL
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAY 956
+ HRD+ + N+L++ + + +GDFGL K I ++ APE
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAI---ETDKEYYTVKDDRDSPVFWYAPECLM 202
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTPVQP 985
K D++S+GV L ELLT + P
Sbjct: 203 QSKFYIASDVWSFGVTLHELLTYCDSDSSP 232
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-35
Identities = 61/208 (29%), Positives = 93/208 (44%), Gaps = 17/208 (8%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G+G+YG K GKI+ K+L + +E+ L +++H NIV+ Y
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 846 -FCYHQGSNLLIY-EYMERGSLGELLHGSSCNLE-------WPTRFMIALGAAEGLAYLH 896
+ L I EY E G L ++ + + R M L L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL--RVMTQL--TLALKECH 128
Query: 897 --HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY 954
D + HRD+K N+ LD K +GDFGLA++++ S + + V G+ Y++PE
Sbjct: 129 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQ 187
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTP 982
M EK DI+S G +L EL P
Sbjct: 188 MNRMSYNEKSDIWSLGCLLYELCALMPP 215
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-34
Identities = 72/296 (24%), Positives = 122/296 (41%), Gaps = 60/296 (20%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
++G GA+G V KA + A+KK+ E S+ +E++ L + H+ +V+ Y
Sbjct: 13 VLGQGAFGQVVKARNALDSRYYAIKKIRHTEE---KLSTILSEVMLLASLNHQYVVRYYA 69
Query: 846 F----------CYHQGSNLLIY---EYMERGSLGELLHGSSCNLE----WPTRFMIALGA 888
++ EY E G+L +L+H + N + W R +
Sbjct: 70 AWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW--RLFRQI-- 125
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-------------MP 935
E L+Y+H I HRD+K NI +D+ +GDFGLAK +
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 936 QSKSMSAVAGSYGYIAPE-YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLAT 994
S ++++ G+ Y+A E T EK D+YS G++ E++ P G +
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY------PFSTGMERVN 236
Query: 995 WVRNYIRDHSLT-PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
++ +R S+ P FD ++ I+ +I P RP R +
Sbjct: 237 ILKK-LRSVSIEFPPDFDDNKMKVEKKIIRLLI----------DHDPNKRPGARTL 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-34
Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 20/205 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLA----SNREGNNIESSFRAEILTLGKIRHRNIV 841
+G G++G + G+ +K++ S++E E+ L ++H NIV
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRR----EVAVLANMKHPNIV 86
Query: 842 KLYGFCYHQGSNLLIY-EYMERGSLGELLHGSSCNL---EWPTRFMIALGAAEGLAYLHH 897
+ + + +L I +Y E G L + ++ L + + + + L ++H
Sbjct: 87 QYRE-SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI--CLALKHVH- 142
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
+I HRDIKS NI L +GDFG+A+V++ + + + G+ Y++PE
Sbjct: 143 --DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICEN 199
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTP 982
K DI++ G VL EL T +
Sbjct: 200 KPYNNKSDIWALGCVLYELCTLKHA 224
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-34
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+GSG +G V VAVK + +EG+ E F E T+ K+ H +VK YG
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMI---KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
C + ++ EY+ G L L LE + EG+A+L + HR
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI---APEYAYTMKVTEK 963
D+ + N L+D V DFG+ + + + G+ + APE + K + K
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKWSAPEVFHYFKYSSK 185
Query: 964 CDIYSYGVVLLELLT-GRTP 982
D++++G+++ E+ + G+ P
Sbjct: 186 SDVWAFGILMWEVFSLGKMP 205
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 75/245 (30%), Positives = 107/245 (43%), Gaps = 29/245 (11%)
Query: 752 SSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIV-----GSGAYGTVYKAVMD---- 802
+P N+YF G +F+D F + + G G +G+V D
Sbjct: 10 HDYDIPTTENLYFQGAMGSAFEDRDP--TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQD 67
Query: 803 -SGKIVAVKKLASNREGNNIESS-FRAEILTLGKIRHRNIVKLYGFCYHQGSN--LLIYE 858
+G++VAVKKL + F EI L ++H NIVK G CY G LI E
Sbjct: 68 NTGEVVAVKKL---QHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124
Query: 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK 918
Y+ GSL + L ++ +G+ YL R HRD+ + NIL++++
Sbjct: 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENE 181
Query: 919 FEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVL 973
+GDFGL KV+ PQ K G APE K + D++S+GVVL
Sbjct: 182 NRVKIGDFGLTKVL--PQDKEY-YKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 238
Query: 974 LELLT 978
EL T
Sbjct: 239 YELFT 243
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 2e-34
Identities = 47/210 (22%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH--RNIVKLYG 845
+GSG V++ + + +I A+K + N S+R EI L K++ I++LY
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 76
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTR-FMIALGAAEGLAYLHHDCKPRIF 904
+ ++ E L L W + + + E + +H + I
Sbjct: 77 YEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIH---QHGIV 130
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM-SAVAGSYGYIAPE---------- 953
H D+K N L+ D + DFG+A + + + + G+ Y+ PE
Sbjct: 131 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRE 189
Query: 954 -YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
K++ K D++S G +L + G+TP
Sbjct: 190 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 3e-34
Identities = 53/198 (26%), Positives = 88/198 (44%), Gaps = 13/198 (6%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY 848
G+G +G V VA+K + +EG+ E F E + + H +V+LYG C
Sbjct: 33 GTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 849 HQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDI 908
Q +I EYM G L L + + E + YL + HRD+
Sbjct: 90 KQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDL 146
Query: 909 KSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI---APEYAYTMKVTEKCD 965
+ N L++D+ V DFGL++ + ++ GS + PE K + K D
Sbjct: 147 AARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 966 IYSYGVVLLELLT-GRTP 982
I+++GV++ E+ + G+ P
Sbjct: 204 IWAFGVLMWEIYSLGKMP 221
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 9e-34
Identities = 52/249 (20%), Positives = 95/249 (38%), Gaps = 31/249 (12%)
Query: 773 QDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILT 831
Q + D I+G GA V++ +G + A+K + ++ R E
Sbjct: 4 QSTSNHLWLLSD--ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMR-EFEV 60
Query: 832 LGKIRHRNIVKLYGFCYHQGSNLLIY---EYMERGSLGELL--HGSSCNLEWPT--RFMI 884
L K+ H+NIVKL+ + + E+ GSL +L ++ L +
Sbjct: 61 LKKLNHKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119
Query: 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSM 940
+ G+ +L + I HR+IK NI+ + + DFG A+ ++ +
Sbjct: 120 DV--VGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQF 172
Query: 941 SAVAGSYGYIAPE--------YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992
++ G+ Y+ P+ + K D++S GV TG P +P +
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 993 ATWVRNYIR 1001
+ I
Sbjct: 233 KEVMYKIIT 241
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 1e-33
Identities = 91/376 (24%), Positives = 142/376 (37%), Gaps = 47/376 (12%)
Query: 714 NLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPSSGSVPPLNNVYFPPKEGFSFQ 773
G L I S + G+ + ++ P+ + Q
Sbjct: 21 VAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQ 80
Query: 774 DVVEATYNFHDSF--IVGSGAYGTVYKAVM---DSGKI-VAVKKL---ASNREGNNIESS 824
VV + F ++G G +G VY + D KI AVK L E S
Sbjct: 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQ 136
Query: 825 FRAEILTLGKIRHRNIVKLYGFCYH-QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM 883
F E + + H N++ L G C +GS L++ YM+ G L + + N
Sbjct: 137 FLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943
L A+G+ +L + HRD+ + N +LD+KF V DFGLA+ DM + S
Sbjct: 197 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR--DMYDKEFDSVH 251
Query: 944 AGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVR 997
+ + A E T K T K D++S+GV+L EL+T G P ++ +
Sbjct: 252 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----IT 306
Query: 998 NYIRDHSLTPGIFDTRLNV-EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML--- 1053
Y+ RL E + ++ L C RPS E+VS +
Sbjct: 307 VYLLQ--------GRRLLQPEYCPDPLYEVM-----LKCWHPKAEMRPSFSELVSRISAI 353
Query: 1054 IESNEREGRFNSSPTY 1069
+ E + + TY
Sbjct: 354 FSTFIGEHYVHVNATY 369
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 1e-33
Identities = 50/208 (24%), Positives = 84/208 (40%), Gaps = 25/208 (12%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKK-----LASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G G + VY+A + G VA+KK L + + EI L ++ H N++
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIK----EIDLLKQLNHPNVI 95
Query: 842 KLYGFCYHQGSNLLIY-EYMERGSLGELLHGSSCNLEWPTRF------MIALGAAEGLAY 894
K Y L I E + G L ++ + + L +
Sbjct: 96 KYYASFIEDNE-LNIVLELADAGDLSRMIKHFK---KQKRLIPERTVWKYFVQLCSALEH 151
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY 954
+H R+ HRDIK N+ + +GD GL + + + S V G+ Y++PE
Sbjct: 152 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 207
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ K DI+S G +L E+ ++P
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSP 235
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 76/290 (26%), Positives = 115/290 (39%), Gaps = 47/290 (16%)
Query: 789 GSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
G G +G+V D +G++VAVKKL + E + + F EI L ++H NIVK
Sbjct: 19 GKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRD--FEREIEILKSLQHDNIVKY 76
Query: 844 YGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
G CY G LI EY+ GSL + L ++ +G+ YL
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TK 133
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAY 956
R HRD+ + NIL++++ +GDFGL KV+ PQ K G APE
Sbjct: 134 RYIHRDLATRNILVENENRVKIGDFGLTKVL--PQDKEF-FKVKEPGESPIFWYAPESLT 190
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL-- 1014
K + D++S+GVVL EL T + + L
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQ-------GQMIVFHLIE 243
Query: 1015 NVED-----------ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+++ + I M C + + RPS R++ +
Sbjct: 244 LLKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALRV 286
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-33
Identities = 84/488 (17%), Positives = 162/488 (33%), Gaps = 56/488 (11%)
Query: 261 SLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKF 319
+PK++ + L N ++ ++ ++L+ L L N + + V +
Sbjct: 45 HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSLDFHVFLFNQD 101
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPT--EFSKITGLRLLFLFQNQ 377
L L + N L I ++ + +DLS N + +P EF +T L L L +
Sbjct: 102 LEYLDVSHNRL-QNISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAK 157
Query: 378 LTGVIPNELSSLR-NLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGL 436
+ ++ L + LDL ++ G + L L + +
Sbjct: 158 FRQLDLLPVAHLHLSCILLDLVSYHIKG-GETESLQIPNTTVLHLVFHPNSLFSVQVNMS 216
Query: 437 YSLLWVVDFSHNYLTGR-------IPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNC---E 486
+ L + S+ L L + L+ + L + + +
Sbjct: 217 VNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPR 276
Query: 487 TLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYF 546
+ L + ++T E + L H+ N F
Sbjct: 277 PVEYLNIYNLTITERIDREEFTYSET-------------------ALKSLMIEHVKNQVF 317
Query: 547 TSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQ 606
+++ +S + + + + L+ + N F S+ TL+
Sbjct: 318 LFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLK 377
Query: 607 QLEILKLSENKFSGNIPSTLGNLSHLTELQMGGN----LFSGEIPPELGDLSSLQIALNL 662
+L+ L L N N +++ L+ L S S+ + LNL
Sbjct: 378 RLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILV-LNL 435
Query: 663 SYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSI 722
S N L+GS+ L ++ L L+NN + IP +L +L N + N L S+
Sbjct: 436 SSNMLTGSVFRCLPPK--VKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK----SV 488
Query: 723 PQ--FQNM 728
P F +
Sbjct: 489 PDGVFDRL 496
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-30
Identities = 79/464 (17%), Positives = 154/464 (33%), Gaps = 37/464 (7%)
Query: 106 SLDLNAMNFTGSLSPS-IGGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
+L L+ + + L I L L L L++N + + + LE+L +++N+
Sbjct: 56 ALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ 113
Query: 164 GKIPAELGKLSSLVSLNICNNMISGALPEG--LGNLSSLVDFVAYTNNLTGPLPQSIGNL 221
I ++SL L++ N LP GNL+ L + +L
Sbjct: 114 -NISC--CPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHL 169
Query: 222 RNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQ 281
+ + E + +L L + + + +L + L + +
Sbjct: 170 HLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIK 229
Query: 282 LT-----GFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKF-----LTKLYLYRNELN 331
L + L + ++ V +F + L +Y +
Sbjct: 230 LNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTIT 289
Query: 332 GTIPREIGN-----LSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNEL 386
I RE L + + +S + + L + +
Sbjct: 290 ERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCP 349
Query: 387 SSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL--LWVVD 444
S + T L+ + N T + G L +++ L L N L L ++ L +D
Sbjct: 350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLD 409
Query: 445 FSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVLNC--ETLLQLRLVGNSLTGS 501
S N L C ++++LNL N L V C + L L N + S
Sbjct: 410 VSLNSLNSHAYDRTCAWAESILVLNLSSNML----TGSVFRCLPPKVKVLDLHNNRIM-S 464
Query: 502 FPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANN 544
P ++ L+ L + + N+ +P + + LQ + + +N
Sbjct: 465 IPKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 3e-29
Identities = 81/477 (16%), Positives = 166/477 (34%), Gaps = 38/477 (7%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
+P ++ + L L+QN I +I L L + L N++ L
Sbjct: 45 HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDL 102
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPR--EIGNLSMVTEIDLSENSL 354
+ L + N L I + L L L N+ + +P E GNL+ +T + LS
Sbjct: 103 EYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKF 158
Query: 355 NGEIPTEFSKITGLRLLFLFQNQLTGVIPN------ELSSLRNLTKLDLSINYLTGPIPV 408
+ + L L + + ++ I ++ + L + + + + +
Sbjct: 159 RQ---LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNM 215
Query: 409 GFQHLT--QMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPP-----HLCQN 461
L Q+ ++L + + + L +++ + ++
Sbjct: 216 SVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWP 275
Query: 462 SNLIMLNLGYNKLFGNIPTDV-----LNCETLLQLRLVGNSLTGSFPLELCKLENLYAIE 516
+ LN+ + I + ++L+ + S +
Sbjct: 276 RPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKM 335
Query: 517 LDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGL--I 574
L + + L+ N FT + + L +L T + N L +
Sbjct: 336 LSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKV 395
Query: 575 PPEIVNCMTLQRLDISHNSFVGSLPNEL-GTLQQLEILKLSENKFSGNIPSTLGNLSHLT 633
N +L+ LD+S NS + + + +L LS N +G++ L +
Sbjct: 396 ALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--PPKVK 453
Query: 634 ELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNN 689
L + N IP ++ L +LQ LN++ N L S+P +L L+++ L++N
Sbjct: 454 VLDLHNNRIM-SIPKDVTHLQALQE-LNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-27
Identities = 87/489 (17%), Positives = 161/489 (32%), Gaps = 36/489 (7%)
Query: 129 TYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISG 188
+ +D + LT ++P+++ R + L L+ N S ++ LS L L + +N I
Sbjct: 34 SMVDYSNRNLT-HVPKDL--PPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIR- 89
Query: 189 ALPEGL-GNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP--AEISGC 245
+L + L N L + + +LR N +P E
Sbjct: 90 SLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNL 145
Query: 246 QSLQILGLAQNDI-GGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSN 304
L LGL+ L + S + L + G L L L +
Sbjct: 146 TKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSYHIKGGETESL-QIPNTTVLHLVFH 204
Query: 305 NLVGQIPKEVGNLKFLTKLYLYRNELNG-------TIPREIGNLSMVTEIDLSENSLNGE 357
+ ++ L L L +LN T E+ + + L +
Sbjct: 205 PNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWK 264
Query: 358 IPTE---FSKITGLRLLFLFQNQLTGVIPNEL-----SSLRNLTKLDLSINYLTGPIPVG 409
+ F + L ++ +T I E ++L++L +
Sbjct: 265 CSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEAL 324
Query: 410 FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNL 469
+ +M L + S ++F+ N T + L L L
Sbjct: 325 YSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLIL 384
Query: 470 GYNKLFGNIPTDVLNCETLLQLRLVGNSLT----GSFPLELCKLENLYAIELDQNKFSGP 525
N L N L + + L + SL ++ E++ + L N +G
Sbjct: 385 QRNGL-KNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGS 443
Query: 526 IPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQ 585
+ + K++ L + NN S +PK+V +L L N++SN L + +LQ
Sbjct: 444 VFRCLP--PKVKVLDLHNNRIMS-IPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQ 500
Query: 586 RLDISHNSF 594
+ + N +
Sbjct: 501 YIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-26
Identities = 81/460 (17%), Positives = 153/460 (33%), Gaps = 33/460 (7%)
Query: 206 YTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPK 264
N+++ I L LRV R N I S+ + Q L+ L ++ N + ++
Sbjct: 60 SQNSISELRMPDISFLSELRVLRLSHNRIR-SLDFHVFLFNQDLEYLDVSHNRLQ-NIS- 116
Query: 265 EIGMLESLTEIVLWDNQLTGF-IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTK- 322
+ SL + L N + E GN TKL L L + V +L
Sbjct: 117 -CCPMASLRHLDLSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCIL 175
Query: 323 LYLYRNELNGTIPREIGNL-SMVTEIDLSENSLNGEI------PTEFSKITGLRLLFLFQ 375
L L + G + + V + NSL +++ ++L
Sbjct: 176 LDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENC 235
Query: 376 NQLTGVIPNEL--SSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPG 433
+L + +L N+T + + F + L ++ ++T I
Sbjct: 236 QRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDRE 295
Query: 434 LGLYSL-----LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLN-CET 487
YS L + + + + + L + I +
Sbjct: 296 EFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIKMLSISDT-PFIHMVCPPSPSS 354
Query: 488 LLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT 547
L N T S L+ L + L +N + + L +
Sbjct: 355 FTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN-FFKVALMTKNMSSLETLDVSLN 413
Query: 548 S----ELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELG 603
S + ++ N+SSNMLTG + + ++ LD+ +N S+P ++
Sbjct: 414 SLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP--KVKVLDLHNNRI-MSIPKDVT 470
Query: 604 TLQQLEILKLSENKFSGNIP-STLGNLSHLTELQMGGNLF 642
LQ L+ L ++ N+ ++P L+ L + + N +
Sbjct: 471 HLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDNPW 509
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 1e-19
Identities = 66/382 (17%), Positives = 115/382 (30%), Gaps = 35/382 (9%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+ +D S +L +P + + L L QN ++ + ++S L L L LS N +
Sbjct: 34 SMVDYSNRNLT-HVPKDLP--PRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRIRS 90
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLC--QN 461
+ F + L + N L I + SL +D S N +P
Sbjct: 91 -LDFHVFLFNQDLEYLDVSHNRLQN-ISCC-PMASL-RHLDLSFNDFD-VLPVCKEFGNL 145
Query: 462 SNLIMLNLGYNKL----FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIEL 517
+ L L L K + L+C + L LV + G L N + L
Sbjct: 146 TKLTFLGLSAAKFRQLDLLPVAHLHLSC---ILLDLVSYHIKGGETESLQIP-NTTVLHL 201
Query: 518 DQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPE 577
+ S + L L ++N E + + +T + +T
Sbjct: 202 VFHPNSLFSVQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVT------ 255
Query: 578 IVNCMTLQRLDISHNSFVGSLPN-ELGTLQQLEI--LKLSENKFSGNIPSTLGNLSHLTE 634
LQ ++ + V ++ L I L ++E + L L
Sbjct: 256 ------LQHIETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMI 309
Query: 635 LQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGE 694
+ +F + + I LS ++ FL N +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNI-KMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDS 368
Query: 695 IPSAFENLSSLLGSNFSYNNLT 716
+ L L N L
Sbjct: 369 VFQGCSTLKRLQTLILQRNGLK 390
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 1e-15
Identities = 34/203 (16%), Positives = 69/203 (33%), Gaps = 8/203 (3%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI 166
+ F S + L+ ++ + S L N F+ +
Sbjct: 310 EHVKNQVFLFSKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSV 369
Query: 167 PAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLT----GPLPQSIGNLR 222
L L +L + N + + ++ +L ++
Sbjct: 370 FQGCSTLKRLQTLILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAE 428
Query: 223 NLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQL 282
++ V N ++GS+ + +++L L N I S+PK++ L++L E+ + NQL
Sbjct: 429 SILVLNLSSNMLTGSVFRCLP--PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQL 485
Query: 283 TGFIPSELGNCTKLQTLALYSNN 305
T LQ + L+ N
Sbjct: 486 KSVPDGVFDRLTSLQYIWLHDNP 508
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 1e-33
Identities = 48/210 (22%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH--RNIVKLYG 845
+GSG V++ + + +I A+K + N S+R EI L K++ I++LY
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 123
Query: 846 FCYHQGSNLLIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ ++ E L L S + + + E + +H I
Sbjct: 124 YEITDQYIYMVMECGN-IDLNSWLKKKKSIDPWERKSYWKNM--LEAVHTIHQH---GIV 177
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPE---------- 953
H D+K N L+ D + DFG+A + S + G+ Y+ PE
Sbjct: 178 HSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRE 236
Query: 954 -YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
K++ K D++S G +L + G+TP
Sbjct: 237 NGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-33
Identities = 59/197 (29%), Positives = 103/197 (52%), Gaps = 11/197 (5%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G+YG+VYKA+ ++G+IVA+K++ + I EI + + ++VK YG
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEII----KEISIMQQCDSPHVVKYYG- 91
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
Y + ++L ++ EY GS+ +++ + L I +GL YLH R H
Sbjct: 92 SYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM---RKIH 148
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RDIK+ NILL+ + A + DFG+A + +K + + + ++APE + D
Sbjct: 149 RDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYNCVAD 207
Query: 966 IYSYGVVLLELLTGRTP 982
I+S G+ +E+ G+ P
Sbjct: 208 IWSLGITAIEMAEGKPP 224
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-33
Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 17/200 (8%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G+ G V A SG+ VAVK + + E++ + +H N+V++Y
Sbjct: 53 IGEGSTGIVCLAREKHSGRQVAVKMM--DLRKQQRRELLFNEVVIMRDYQHFNVVEMYK- 109
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPR 902
Y G L ++ E+++ G+L +++ N E IA LAYLH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ-----IATVCEAVLQALAYLH---AQG 161
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
+ HRDIKS++ILL + DFG I K S V Y ++APE
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEVISRSLYAT 220
Query: 963 KCDIYSYGVVLLELLTGRTP 982
+ DI+S G++++E++ G P
Sbjct: 221 EVDIWSLGIMVIEMVDGEPP 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 2e-33
Identities = 67/260 (25%), Positives = 98/260 (37%), Gaps = 41/260 (15%)
Query: 740 CGRPVG---NCGASPSSGSVPPLNNVY-FPPK--EGFSFQDVVEATYNFHDSFIVGSGAY 793
CGRPVG + S G P + Y F P+ G D+V Y + G
Sbjct: 40 CGRPVGRSDSETKGASEGWCPYCGSPYSFLPQLNPG----DIVAGQYEVKG--CIAHGGL 93
Query: 794 GTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ 850
G +Y A+ D +G+ V +K L + + AE L ++ H +IV+++ F H
Sbjct: 94 GWIYLAL-DRNVNGRPVVLKGLVHSGDAEAQAM-AMAERQFLAEVVHPSIVQIFNFVEHT 151
Query: 851 GSNLLIYEY--MER---GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ Y ME SL L L L+YLH + +
Sbjct: 152 DRHGDPVGYIVMEYVGGQSLKRSKGQK---LPVAEAIAYLLEILPALSYLHSI---GLVY 205
Query: 906 RDIKSNNILLDD---KFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
D+K NI+L + K + D G I+ S + G+ G+ APE T T
Sbjct: 206 NDLKPENIMLTEEQLK----LIDLGAVSRIN-----SFGYLYGTPGFQAPEIVRT-GPTV 255
Query: 963 KCDIYSYGVVLLELLTGRTP 982
DIY+ G L L
Sbjct: 256 ATDIYTVGRTLAALTLDLPT 275
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 76/291 (26%), Positives = 113/291 (38%), Gaps = 51/291 (17%)
Query: 789 GSGAYGTVYKAVMD-----SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
G G +G V D +G++VAVK L ++ G S ++ EI L + H +I+K
Sbjct: 40 GEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 844 YGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
G C G+ L+ EY+ GSL + L S + + A EG+AYLH
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS--IGLAQLLLFAQQICEGMAYLH---AQ 153
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAY 956
HRD+ + N+LLD+ +GDFGLAK + P+ G APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV--PEGHEY-YRVREDGDSPVFWYAPECLK 210
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL- 1014
K D++S+GV L ELLT + P +L + RL
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG--IAQ-------GQMTVLRLT 261
Query: 1015 -NVED-----------ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+E + M C RP+ ++ +L
Sbjct: 262 ELLERGERLPRPDKCPAEVYHLM-------KNCWETEASFRPTFENLIPIL 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 58/245 (23%), Positives = 93/245 (37%), Gaps = 34/245 (13%)
Query: 750 SPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSF----IVGSGAYGTVYKAV-MDSG 804
S + L + + P SF F SF +G G+YG V+K + G
Sbjct: 32 SFRGEASETLQSPGYDPSRPESF---------FQQSFQRLSRLGHGSYGEVFKVRSKEDG 82
Query: 805 KIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIY-EYMER 862
++ AVK+ S G + AE+ + K+ +H V+L + +G L + E
Sbjct: 83 RLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ-AWEEGGILYLQTELCG- 140
Query: 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 922
SL + +L + LA+LH + H D+K NI L +
Sbjct: 141 PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197
Query: 923 VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELL 977
+GDFGL + + G Y+APE Y D++S G+ +LE+
Sbjct: 198 LGDFGLLVELGTAG--AGEVQEGDPRYMAPELLQGSY------GTAADVFSLGLTILEVA 249
Query: 978 TGRTP 982
Sbjct: 250 CNMEL 254
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 62/198 (31%), Positives = 87/198 (43%), Gaps = 8/198 (4%)
Query: 788 VGSGAYGTVYKAVMDS--GKIVAVKKLASN-REGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G TVY A D+ VA+K + RE F E+ ++ H+NIV +
Sbjct: 19 LGGGGMSTVYLAE-DTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
L+ EY+E +L E + L T +G+ + H RI
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP-LSVDTAINFTNQILDGIKHAHDM---RIV 133
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRDIK NIL+D + DFG+AK + + V G+ Y +PE A E
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 965 DIYSYGVVLLELLTGRTP 982
DIYS G+VL E+L G P
Sbjct: 194 DIYSIGIVLYEMLVGEPP 211
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 53/198 (26%), Positives = 83/198 (41%), Gaps = 8/198 (4%)
Query: 788 VGSGAYGTVYKAVMDS--GKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLY 844
VG G G VY+A D+ +IVA+K ++ + + + E T G+++ ++V ++
Sbjct: 42 VGRGGMGDVYEAE-DTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
F G + + L +L L P I L H
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGP-LAPPRAVAIVRQIGSALDAAHAA---GAT 156
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRD+K NIL+ A++ DFG+A + + G+ Y+APE T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRA 216
Query: 965 DIYSYGVVLLELLTGRTP 982
DIY+ VL E LTG P
Sbjct: 217 DIYALTCVLYECLTGSPP 234
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 17/200 (8%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA GTVY A+ + +G+ VA++++ N + + EIL + + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLD- 84
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPR 902
Y G L ++ EY+ GSL +++ + + IA E L +LH + +
Sbjct: 85 SYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ-----IAAVCRECLQALEFLHSN---Q 136
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
+ HRDIKS+NILL + DFG I QSK + V Y ++APE
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEVVTRKAYGP 195
Query: 963 KCDIYSYGVVLLELLTGRTP 982
K DI+S G++ +E++ G P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 4e-33
Identities = 70/293 (23%), Positives = 118/293 (40%), Gaps = 39/293 (13%)
Query: 789 GSGAYGTVYKAVMDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G G YG VY+ V + VAVK L +E F E + +I+H N+V+L G C
Sbjct: 229 GGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ +I E+M G+L + L + + +A + + YL K HR
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHR 342
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
++ + N L+ + V DFGL++++ + + + APE K + K D+
Sbjct: 343 NLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDV 402
Query: 967 YSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED---ESIV 1022
+++GV+L E+ T G +P +D ++Y R+ + E +
Sbjct: 403 WAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-------------RMERPEGCPEKVY 449
Query: 1023 DHMILVLKVALMCTSISPFDRPSMREVVSMLIE-------SNEREGRFNSSPT 1068
+ M C +P DRPS E+ S+E E T
Sbjct: 450 ELM-------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELGKRGT 495
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-33
Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 14/202 (6%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA+G VYKA ++G + A K + + + EI L H IVKL G
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYIVEIEILATCDHPYIVKLLG- 83
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
Y+ L ++ E+ G++ ++ L P ++ E L +LH RI H
Sbjct: 84 AYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK---RIIH 140
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE--- 962
RD+K+ N+L+ + + + DFG++ K S + Y ++APE + +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPY-WMAPEVVMCETMKDTPY 199
Query: 963 --KCDIYSYGVVLLELLTGRTP 982
K DI+S G+ L+E+ P
Sbjct: 200 DYKADIWSLGITLIEMAQIEPP 221
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 6e-33
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 15/202 (7%)
Query: 787 IVGSGAYGTVYKAVMDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G YG VY+ V + VAVK L +E F E + +I+H N+V+L G
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
C + +I E+M G+L + L + + +A + + YL K
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 133
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS---YGYIAPEYAYTMKVT 961
HRD+ + N L+ + V DFGL++++ + +A AG+ + APE K +
Sbjct: 134 HRDLAARNCLVGENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 962 EKCDIYSYGVVLLELLT-GRTP 982
K D++++GV+L E+ T G +P
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSP 212
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-33
Identities = 73/413 (17%), Positives = 138/413 (33%), Gaps = 66/413 (15%)
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQL 378
+ + L N + L + + + + + I F ++ L +L L NQ
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQF 91
Query: 379 TGVIPNELSSLRNLTKLDLSINYLTG-PIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGL 436
+ + L NL L L+ L G + F+ LT + L L +N++ I P
Sbjct: 92 LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKK-IQPASFF 150
Query: 437 YSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDV---LNCETLLQLRL 493
++ +L+L +NK+ +I + + LRL
Sbjct: 151 LNM----------------------RRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRL 187
Query: 494 VGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKE 553
+L ++++ + L ++ N F +
Sbjct: 188 SSITLQ----------------DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMA-- 229
Query: 554 VGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKL 613
+ +++ + D + +F G + ++ L
Sbjct: 230 -KRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS------GVKTCDL 282
Query: 614 SENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNLSGSIP 672
S++K + S + + L +L + N + +I L+ L LNLS N L SI
Sbjct: 283 SKSKIFALLKSVFSHFTDLEQLTLAQNEIN-KIDDNAFWGLTHLLK-LNLSQNFLG-SID 339
Query: 673 PEL-GKLDLLEFLLLNNNHLSGEIPS-AFENLSSLLGSNFSYNNLTGPLPSIP 723
+ LD LE L L+ NH+ + +F L +L N L S+P
Sbjct: 340 SRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK----SVP 387
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 7e-32
Identities = 68/398 (17%), Positives = 138/398 (34%), Gaps = 51/398 (12%)
Query: 271 SLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNE 329
+ + L N + + LQ L + I L L L L N+
Sbjct: 31 HVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQ 90
Query: 330 LNGTIPREI-GNLSMVTEIDLSENSLNG-EIPTE-FSKITGLRLLFLFQNQLTGVIPNEL 386
+ L+ + + L++ +L+G + F +T L +L L N + + P
Sbjct: 91 F-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASF 149
Query: 387 -SSLRNLTKLDLSINYLTGPIPVG-FQHLT--QMRQLQLFENSLTGGIPPGLGLYSLLWV 442
++R LDL+ N + I + L+L +L
Sbjct: 150 FLNMRRFHVLDLTFNKVKS-ICEEDLLNFQGKHFTLLRLSSITLQ--------------- 193
Query: 443 VDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL-------------FGNIPTDVLNCETLL 489
D + +L + +N+++ L+L N I + +L+ +
Sbjct: 194 -DMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 490 QLRLVGNSLTGSFPLELCKLE--NLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYF 546
+ LE + +L ++K + + + L++L +A N
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLTLAQNEI 311
Query: 547 TSELPKEV-GNLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSFVGSLPNEL-G 603
+ L+ L+ N+S N L + + + L+ LD+S+N +L ++
Sbjct: 312 NK-IDDNAFWGLTHLLKLNLSQNFLGSI-DSRMFENLDKLEVLDLSYNHI-RALGDQSFL 368
Query: 604 TLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGGN 640
L L+ L L N+ ++P L+ L ++ + N
Sbjct: 369 GLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 9e-32
Identities = 72/403 (17%), Positives = 140/403 (34%), Gaps = 48/403 (11%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
L+ ++P + + + L N + + S L++L L +
Sbjct: 13 YNAICINRGLH-QVPELPAHVNYVDL---SLNSIAELNETSFSRLQDLQFLKVEQQTPGL 68
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPH--LC 459
I F+ L+ + L+L N + G GL + L V+ + L G +
Sbjct: 69 VIRNNTFRGLSSLIILKLDYNQFL-QLETGAFNGLAN-LEVLTLTQCNLDGAVLSGNFFK 126
Query: 460 QNSNLIMLNLGYNKLFGNIPTDVLNCETLLQ-LRLVGNSLT----------GSFPLELCK 508
++L ML L N + P L L N + L +
Sbjct: 127 PLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLR 186
Query: 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLV-----TF 563
L ++ ++++ + L ++ N F + K +
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 564 NISSNMLTGLIPPEIVNC----------MTLQRLDISHNSFVGSLPNEL-GTLQQLEILK 612
+ S NM + + ++ D+S + +L + LE L
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKI-FALLKSVFSHFTDLEQLT 305
Query: 613 LSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNLSGSI 671
L++N+ + + L+HL +L + N I + + L L++ L+LSYN++ ++
Sbjct: 306 LAQNEINKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEV-LDLSYNHIR-AL 362
Query: 672 PPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSL----LGSN 709
+ L L+ L L+ N L F+ L+SL L +N
Sbjct: 363 GDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-31
Identities = 86/391 (21%), Positives = 142/391 (36%), Gaps = 43/391 (10%)
Query: 106 SLDLNAMNFTGSLSP-SIGGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
+DL+ + L+ S L L +L + I S L L L+ NQF
Sbjct: 34 YVDLSLNSIA-ELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL 92
Query: 164 GKIPAE-LGKLSSLVSLNICNNMI-SGALPEGL-GNLSSLVDFVAYTNNLTGPLPQSI-G 219
++ L++L L + + L L+SL V NN+ P S
Sbjct: 93 -QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFL 151
Query: 220 NLRNLRVFRAGQNAISGSIPAEI---SGCQSLQILGLAQNDIGGSLPKEIGM-------- 268
N+R V N + SI E + +L L+ + +G
Sbjct: 152 NMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFK 210
Query: 269 LESLTEIVLWDNQLTGFIPS---ELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
S+T + L N + + TK+Q+L L ++ +G N K
Sbjct: 211 NTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGH-TNFKDPDNFTF 269
Query: 326 YRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE 385
E +G DLS++ + + + FS T L L L QN++ + N
Sbjct: 270 KGLEASGV-----------KTCDLSKSKIFALLKSVFSHFTDLEQLTLAQNEINKIDDNA 318
Query: 386 LSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWV 442
L +L KL+LS N+L I F++L ++ L L N + + GL +L
Sbjct: 319 FWGLTHLLKLNLSQNFLGS-IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKE- 375
Query: 443 VDFSHNYLTGRIPPHLCQN-SNLIMLNLGYN 472
+ N L +P + ++L + L N
Sbjct: 376 LALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-27
Identities = 82/407 (20%), Positives = 133/407 (32%), Gaps = 67/407 (16%)
Query: 152 LEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLT 211
+ ++ L+ N + +L L L + +
Sbjct: 32 VNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNT----------------- 74
Query: 212 GPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDI-GGSLPKEI-GM 268
L +L + + N + +G +L++L L Q ++ G L
Sbjct: 75 ------FRGLSSLIILKLDYNQFL-QLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKP 127
Query: 269 LESLTEIVLWDNQLTGFIPSEL-GNCTKLQTLALYSNNLVGQIPKEV---GNLKFLTKLY 324
L SL +VL DN + P+ N + L L N + I +E K T L
Sbjct: 128 LTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK-SICEEDLLNFQGKHFTLLR 186
Query: 325 LYRNEL-----NGTIPREIGN---LSMVTEIDLSENSLNGEIPTEFSKITGLR-----LL 371
L L + GN + +T +DLS N + F +L
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLIL 246
Query: 372 FLFQNQLTGVIPNELSSLRN----------LTKLDLSINYLTGPIPVG-FQHLTQMRQLQ 420
N + N + DLS + + + F H T + QL
Sbjct: 247 SNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIFA-LLKSVFSHFTDLEQLT 305
Query: 421 LFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGN 477
L +N + I GL LL ++ S N+L I + +N L +L+L YN +
Sbjct: 306 LAQNEIN-KIDDNAFWGLTHLL-KLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHI-RA 361
Query: 478 IPTDVL-NCETLLQLRLVGNSLTGSFPLE-LCKLENLYAIELDQNKF 522
+ L +L L N L S P +L +L I L N +
Sbjct: 362 LGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTNPW 407
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 2e-12
Identities = 34/183 (18%), Positives = 60/183 (32%), Gaps = 9/183 (4%)
Query: 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNEL-GTLQQLEILKLSENKFSGNI 622
++S N + L LQ L + + + N L L ILKL N+F +
Sbjct: 36 DLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFL-QL 94
Query: 623 PS-TLGNLSHLTELQMGGN-LFSGEIPPEL-GDLSSLQIALNLSYNNLSGSIPPE--LGK 677
+ L++L L + L + L+SL++ L L NN+ I P
Sbjct: 95 ETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEM-LVLRDNNIK-KIQPASFFLN 152
Query: 678 LDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNE 737
+ L L N + N + +++T + + N
Sbjct: 153 MRRFHVLDLTFNKVKSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNT 212
Query: 738 GLC 740
+
Sbjct: 213 SIT 215
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 63.2 bits (154), Expect = 2e-10
Identities = 41/218 (18%), Positives = 79/218 (36%), Gaps = 21/218 (9%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREI---GNCSRLEHLYLNNNQ-- 161
D+N + +T LDL+ N + + ++++ L L+N+
Sbjct: 193 QDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNM 252
Query: 162 ---FSGKIPAELGKL-------SSLVSLNICNNMISGALPEGL-GNLSSLVDFVAYTNNL 210
F + S + + ++ + I AL + + + + L N +
Sbjct: 253 GSSFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEI 311
Query: 211 TGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI-GM 268
+ L +L QN + SI + + L++L L+ N I +L +
Sbjct: 312 NKIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLG 369
Query: 269 LESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNL 306
L +L E+ L NQL T LQ + L++N
Sbjct: 370 LPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPW 407
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 27/213 (12%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+GSGA V A + VA+K++ + +++ EI + + H NIV Y
Sbjct: 23 IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDE-LLKEIQAMSQCHHPNIVSYYT- 80
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFM----IALGAAE---GLAYLHHD 898
+ L L+ + + GS+ +++ E + + IA E GL YLH +
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFG----LAKVIDMPQSKSMSAVAGSYGYIAPE- 953
HRD+K+ NILL + + DFG LA D+ ++K G+ ++APE
Sbjct: 141 ---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y K DI+S+G+ +EL TG P
Sbjct: 198 MEQVRGY----DFKADIWSFGITAIELATGAAP 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-32
Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 10/238 (4%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G+G G V+K SG ++A K + + R E+ L + IV YG
Sbjct: 41 LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR-ELQVLHECNSPYIVGFYG- 98
Query: 847 CYHQGSNLLIY-EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
++ + I E+M+ GSL ++L + E +++ +GL YL K I H
Sbjct: 99 AFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK-VSIAVIKGLTYLREKHK--IMH 155
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RD+K +NIL++ + E + DFG++ + + S G+ Y++PE + + D
Sbjct: 156 RDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS---FVGTRSYMSPERLQGTHYSVQSD 212
Query: 966 IYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023
I+S G+ L+E+ GR P+ P D + D + TP T ++ +D
Sbjct: 213 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMD 270
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 74/284 (26%), Positives = 115/284 (40%), Gaps = 46/284 (16%)
Query: 787 IVGSGAYGTVYKAVMDSGK----IVAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
++G G +G VY + AVK L E S F E + + H N
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGE----VSQFLTEGIIMKDFSHPN 87
Query: 840 IVKLYGFCYH-QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD 898
++ L G C +GS L++ YM+ G L + + N L A+G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLA-- 145
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APE 953
+ HRD+ + N +LD+KF V DFGLA+ + + S + + A E
Sbjct: 146 -SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMY--DKEYYSVHNKTGAKLPVKWMALE 202
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012
T K T K D++S+GV+L EL+T G P ++ + Y+
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD-----ITVYLLQ--------GR 249
Query: 1013 RLNVED---ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
RL + + + + M L C RPS E+VS +
Sbjct: 250 RLLQPEYCPDPLYEVM-------LKCWHPKAEMRPSFSELVSRI 286
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 31/302 (10%), Positives = 70/302 (23%), Gaps = 55/302 (18%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+ G V+ ++ + A+K + ++ + +
Sbjct: 69 PLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEAR 128
Query: 845 GFC--------------------------YHQGSNLLIYEYM--ERGSLGELLHGSSCN- 875
Y + LL+ + L L
Sbjct: 129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR 188
Query: 876 --LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933
++ A L + H +N+ + +GD
Sbjct: 189 GDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALW--- 242
Query: 934 MPQSKSMSAVAGSYGYIAPEY--AYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
A + Y E+ A T T + + G+ + + P + G
Sbjct: 243 -KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIK 301
Query: 992 LATWVRNYIRDHSLTPGIFDTRLNVEDE--SIVDHMILVLKVALMCTSISPFDRPSMREV 1049
+W R +R F + + D +++ + + R E
Sbjct: 302 -GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFL----------NFDRRRRLLPLEA 350
Query: 1050 VS 1051
+
Sbjct: 351 ME 352
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 2e-32
Identities = 66/295 (22%), Positives = 112/295 (37%), Gaps = 36/295 (12%)
Query: 766 PKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSF 825
E S V + ++ D ++G GA GT+ M + VAVK++ +
Sbjct: 12 GDEETSVVIVGKISFCPKD--VLGHGAEGTIVYRGMFDNRDVAVKRILP----ECFSFAD 65
Query: 826 RAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMI 884
R E+ L + H N+++ + + + E +L E + +
Sbjct: 66 R-EVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITL 123
Query: 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE-----AHVGDFGLAKVIDMPQS-- 937
GLA+LH I HRD+K +NIL+ A + DFGL K + + +
Sbjct: 124 LQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSF 180
Query: 938 KSMSAVAGSYGYIAPEY---AYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLAT 994
S V G+ G+IAPE T DI+S G V +++ + P
Sbjct: 181 SRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH--PFGKSLQRQA 238
Query: 995 WVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
+ + SL + +V +++ MI ++ P RPS + V
Sbjct: 239 NIL--LGACSLDCLHPEKHEDVIARELIEKMI----------AMDPQKRPSAKHV 281
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-32
Identities = 58/215 (26%), Positives = 97/215 (45%), Gaps = 36/215 (16%)
Query: 787 IVGSGAYGTVYKAV----MDSGKI-VAVKKLASNREGNNIESS--FRAEILTLGKIRHRN 839
++GSGA+GTVYK + + KI VA+K+L RE + +++ E + + + +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASVDNPH 78
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+ +L G C + LI + M G L + + N+ + A+G+ YL
Sbjct: 79 VCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGY---------- 949
R+ HRD+ + N+L+ + DFGLAK++ A Y
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG----------AEEKEYHAEGGKVPIK 184
Query: 950 -IAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
+A E T + D++SYGV + EL+T G P
Sbjct: 185 WMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 47/215 (21%), Positives = 83/215 (38%), Gaps = 26/215 (12%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G + V + G A+K++ + + + E H NI++L +
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQ--QDREEAQREADMHRLFNHPNILRLVAY 94
Query: 847 CYHQGSN----LLIYEYMERGSLGELLHGSSCN---LEWPTRFMIALGAAEGLAYLHHDC 899
C + L+ + +RG+L + L + LG GL +H
Sbjct: 95 CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIH--- 151
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA--------GSYGYIA 951
HRD+K NILL D+ + + D G + S A+ + Y A
Sbjct: 152 AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 952 PE----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
PE ++ + + E+ D++S G VL ++ G P
Sbjct: 212 PELFSVQSHCV-IDERTDVWSLGCVLYAMMFGEGP 245
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 56/203 (27%), Positives = 93/203 (45%), Gaps = 17/203 (8%)
Query: 789 GSGAYGTVYKAV--MDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
G G +G+V + V M +I VA+K L E + E E + ++ + IV+L G
Sbjct: 19 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIG 77
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
C + + +L+ E G L + L G + + + G+ YL + H
Sbjct: 78 VCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 133
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTMKV 960
RD+ + N+LL ++ A + DFGL+K + + A S G APE K
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKAL---GADDSYYTARSAGKWPLKWYAPECINFRKF 190
Query: 961 TEKCDIYSYGVVLLELLT-GRTP 982
+ + D++SYGV + E L+ G+ P
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKP 213
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 3e-32
Identities = 73/272 (26%), Positives = 119/272 (43%), Gaps = 32/272 (11%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY 848
G G +G V+ + VA+K L + G +F E + K+RH +V+LY
Sbjct: 193 GQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 849 HQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+ ++ EYM +GSL + L + L P +A A G+AY+ + HRD
Sbjct: 250 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 305
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 967
+++ NIL+ + V DFGLA++I+ + + + APE A + T K D++
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 968 SYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED---ESIVD 1023
S+G++L EL T GR P + + L R Y R+ ES+ D
Sbjct: 366 SFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPECPESLHD 412
Query: 1024 HMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055
M C P +RP+ + + L +
Sbjct: 413 LM-------CQCWRKEPEERPTFEYLQAFLED 437
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 49/236 (20%), Positives = 88/236 (37%), Gaps = 47/236 (19%)
Query: 781 NFHDSF----IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI 835
+ F +GSG +G+V+K V G I A+K+ G+ E + E+ +
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 836 -RHRNIVKLYGFCYHQGSNLLIY-EYMERGSLGELL---HGSSCNLEWPTRFMIALGAAE 890
+H ++V+ + + + ++LI EY GSL + + + + + L
Sbjct: 68 GQHSHVVRYFS-AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGR 126
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLD-------------------DKFEAHVGDFGLAKV 931
GL Y+H + H DIK +NI + +K +GD G
Sbjct: 127 GLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR 183
Query: 932 IDMPQSKSMSAVAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
I PQ G ++A E Y + K DI++ + ++
Sbjct: 184 ISSPQV-----EEGDSRFLANEVLQENYTH----LPKADIFALALTVVCAAGAEPL 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 70/281 (24%), Positives = 114/281 (40%), Gaps = 40/281 (14%)
Query: 787 IVGSGAYGTVYKAVMDSGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G G +G VY A+K L+ E +E+ F E L + + H N++
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEA-FLREGLLMRGLNHPNVLA 86
Query: 843 LYGFCYH-QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
L G +G ++ YM G L + + N L A G+ YL +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA---EQ 143
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAY 956
+ HRD+ + N +LD+ F V DFGLA+ I + S + + A E
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDIL--DREYYSVQQHRHARLPVKWTALESLQ 201
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015
T + T K D++S+GV+L ELLT G P + +D + +++ RL
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD-----LTHFLAQ--------GRRLP 248
Query: 1016 VED---ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ +S+ M C P RP+ R +V +
Sbjct: 249 QPEYCPDSLYQVM-------QQCWEADPAVRPTFRVLVGEV 282
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-32
Identities = 58/208 (27%), Positives = 89/208 (42%), Gaps = 21/208 (10%)
Query: 787 IVGSGAYGTVYKAVM---DSGKI-VAVKKLASNREG--NNIESSFRAEILTLGKIRHRNI 840
I+GSG G V + + VA+K L + G F +E +G+ H NI
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKAL---KAGYTERQRRDFLSEASIMGQFDHPNI 112
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
++L G +++ EYME GSL L + G G+ YL
Sbjct: 113 IRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---D 169
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYA 955
HRD+ + N+L+D V DFGL++V+ + +A + G I APE
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWTAPEAI 226
Query: 956 YTMKVTEKCDIYSYGVVLLELLT-GRTP 982
+ D++S+GVV+ E+L G P
Sbjct: 227 AFRTFSSASDVWSFGVVMWEVLAYGERP 254
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 4e-32
Identities = 65/211 (30%), Positives = 93/211 (44%), Gaps = 22/211 (10%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLY--- 844
G+G +G V + + D+G+ VA+K+ N E EI + K+ H N+V
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVP 81
Query: 845 ---GFCYHQGSNLLIYEYMERGSLGELL--HGSSCNL-EWPTR-FMIALGAAEGLAYLHH 897
LL EY E G L + L + C L E P R + + +A L YLH
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA--LRYLH- 138
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY 954
+ RI HRD+K NI+L + + D G AK +D V G+ Y+APE
Sbjct: 139 --ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTEFV-GTLQYLAPEL 194
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTPVQP 985
K T D +S+G + E +TG P P
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 789 GSGAYGTVYKAVMDSGKI---VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
GSG +GTV K K+ VAVK L + ++ AE + ++ + IV++ G
Sbjct: 26 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
C + S +L+ E E G L + L + +++ + + G+ YL + H
Sbjct: 86 ICEAE-SWMLVMEMAELGPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLE---ESNFVH 140
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTMKV 960
RD+ + N+LL + A + DFGL+K + ++ A ++G APE K
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADEN---YYKAQTHGKWPVKWYAPECINYYKF 197
Query: 961 TEKCDIYSYGVVLLELLT-GRTP 982
+ K D++S+GV++ E + G+ P
Sbjct: 198 SSKSDVWSFGVLMWEAFSYGQKP 220
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 62/201 (30%), Positives = 104/201 (51%), Gaps = 15/201 (7%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G+G +G V+ + VAVK L ++G+ +F AE + +++H+ +V+LY
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAV 76
Query: 847 CYHQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ +I EYME GSL + L S L +A AEG+A++ + H
Sbjct: 77 VTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE---ERNYIH 132
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS---YGYIAPEYAYTMKVTE 962
RD+++ NIL+ D + DFGLA++I + +A G+ + APE T
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 963 KCDIYSYGVVLLELLT-GRTP 982
K D++S+G++L E++T GR P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-31
Identities = 74/272 (27%), Positives = 119/272 (43%), Gaps = 32/272 (11%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY 848
G G +G V+ + VA+K L + G +F E + K+RH +V+LY
Sbjct: 276 GQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 849 HQGSNLLIYEYMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+ ++ EYM +GSL + L G L P +A A G+AY+ + HRD
Sbjct: 333 EEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 388
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 967
+++ NIL+ + V DFGLA++I+ + + + APE A + T K D++
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 968 SYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED---ESIVD 1023
S+G++L EL T GR P + + L R Y R+ ES+ D
Sbjct: 449 SFGILLTELTTKGRVPYPGMVNREVLDQVERGY-------------RMPCPPECPESLHD 495
Query: 1024 HMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055
M C P +RP+ + + L +
Sbjct: 496 LM-------CQCWRKEPEERPTFEYLQAFLED 520
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 58/205 (28%), Positives = 87/205 (42%), Gaps = 27/205 (13%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G V G VAVK + + +F AE + ++RH N+V+L G
Sbjct: 28 TIGKGEFGDVMLGDYR-GNKVAVKCI---KNDAT-AQAFLAEASVMTQLRHSNLVQLLGV 82
Query: 847 CYHQGSNLLI-YEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ L I EYM +GSL + L + L +L E + YL
Sbjct: 83 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 139
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS------MSAVAGSYGYIAPEYAYTM 958
HRD+ + N+L+ + A V DFGL K Q APE
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----------APEALREK 189
Query: 959 KVTEKCDIYSYGVVLLELLT-GRTP 982
K + K D++S+G++L E+ + GR P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-31
Identities = 67/309 (21%), Positives = 112/309 (36%), Gaps = 53/309 (17%)
Query: 771 SFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEIL 830
+F+ ++ I+G G+ GTV G+ VAVK++ + EI
Sbjct: 8 NFEQSLKNLVVSEK--ILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIK 60
Query: 831 TLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM------ 883
L + H N+++ Y + E +L +L+ + + E
Sbjct: 61 LLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 884 IALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG-------------DFGLAK 930
+ A G+A+LH +I HRD+K NIL+ DFGL K
Sbjct: 120 LLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 931 VIDMPQS---KSMSAVAGSYGYIAPE-------YAYTMKVTEKCDIYSYGVVLLELLTGR 980
+D QS +++ +G+ G+ APE ++T DI+S G V +L+
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKG 236
Query: 981 TPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISP 1040
P D + + I + D L E ++ MI P
Sbjct: 237 KH--PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMI----------DHDP 284
Query: 1041 FDRPSMREV 1049
RP+ +V
Sbjct: 285 LKRPTAMKV 293
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-31
Identities = 71/236 (30%), Positives = 100/236 (42%), Gaps = 45/236 (19%)
Query: 767 KEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSF 825
+E FQ YN ++G G++G V K + + AVK + N S+
Sbjct: 11 RENLYFQGTFAERYNIVC--MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTI 68
Query: 826 RAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIA 885
E+ L K+ H NI+KL+ S ++ E G GEL +I
Sbjct: 69 LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT-G--GELFD----------E-IIK 114
Query: 886 LG------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLA 929
AA G+ Y+H K I HRD+K NILL+ K + + DFGL+
Sbjct: 115 RKRFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
Query: 930 KVIDMPQSKSMSAVAGSYGYIAPE---YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Q+ M G+ YIAPE Y EKCD++S GV+L LL+G P
Sbjct: 172 TCFQ--QNTKMKDRIGTAYYIAPEVLRGTY----DEKCDVWSAGVILYILLSGTPP 221
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-31
Identities = 65/252 (25%), Positives = 101/252 (40%), Gaps = 34/252 (13%)
Query: 738 GLCGRPVGNCGASPSSGSVPPLNNVYFP----PKEGFSFQDVVEATYNFHDSFIVGSGAY 793
GLC R + G+V + Y + + G G +
Sbjct: 162 GLCTRLIKPK---VMEGTVAAQDEFYRSGWALNMKELKLLQTI------------GKGEF 206
Query: 794 GTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853
G V G VAVK + ++ +F AE + ++RH N+V+L G +
Sbjct: 207 GDVMLGDY-RGNKVAVKCIKND----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261
Query: 854 L-LIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSN 911
L ++ EYM +GSL + L L +L E + YL HRD+ +
Sbjct: 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAAR 318
Query: 912 NILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGV 971
N+L+ + A V DFGL K Q V + APE K + K D++S+G+
Sbjct: 319 NVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK----WTAPEALREKKFSTKSDVWSFGI 374
Query: 972 VLLELLT-GRTP 982
+L E+ + GR P
Sbjct: 375 LLWEIYSFGRVP 386
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 3e-31
Identities = 60/208 (28%), Positives = 92/208 (44%), Gaps = 21/208 (10%)
Query: 787 IVGSGAYGTVYKAVM---DSGKI-VAVKKLASNREGNNIES--SFRAEILTLGKIRHRNI 840
+VG+G +G V + +I VA+K L + G + F E +G+ H NI
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTL---KVGYTEKQRRDFLGEASIMGQFDHPNI 108
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
++L G +++ EYME GSL L + G A G+ YL
Sbjct: 109 IRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---D 165
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYA 955
HRD+ + NIL++ V DFGL +V++ +A G I +PE
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLE---DDPEAAYTTRGGKIPIRWTSPEAI 222
Query: 956 YTMKVTEKCDIYSYGVVLLELLT-GRTP 982
K T D++SYG+VL E+++ G P
Sbjct: 223 AYRKFTSASDVWSYGIVLWEVMSYGERP 250
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 63/209 (30%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 787 IVGSGAYGTVYKAV--MDSGKI---VAVKKLASNREG--NNIESSFRAEILTLGKIRHRN 839
++G+G +G VYK + SGK VA+K L + G F E +G+ H N
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTL---KAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
I++L G ++I EYME G+L + L + G A G+ YL
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLA--- 164
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEY 954
HRD+ + NIL++ V DFGL++V+ + + S G I APE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL---EDDPEATYTTSGGKIPIRWTAPEA 221
Query: 955 AYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
K T D++S+G+V+ E++T G P
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERP 250
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 4e-31
Identities = 63/201 (31%), Positives = 104/201 (51%), Gaps = 16/201 (7%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIE-SSFRAEILTLGKIRHRNIVKLYG 845
+G G++G VY A + + ++VA+KK++ + + +N + E+ L K+RH N ++ G
Sbjct: 62 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 121
Query: 846 FCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
CY + L+ EY GS +LL L+ + GA +GLAYLH +
Sbjct: 122 -CYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMI 176
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE-- 962
HRD+K+ NILL + +GDFG A ++ + + S V Y ++APE M +
Sbjct: 177 HRDVKAGNILLSEPGLVKLGDFGSASIM----APANSFVGTPY-WMAPEVILAMDEGQYD 231
Query: 963 -KCDIYSYGVVLLELLTGRTP 982
K D++S G+ +EL + P
Sbjct: 232 GKVDVWSLGITCIELAERKPP 252
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 57/207 (27%), Positives = 87/207 (42%), Gaps = 18/207 (8%)
Query: 787 IVGSGAYGTVYKAV--MDSGKI--VAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G G++G V + SGK VAVK L F E+ + + HRN++
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
+LYG ++ E GSL + L + T A+ AEG+ YL
Sbjct: 85 RLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE---SK 140
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAY 956
R HRD+ + N+LL + +GDFGL + + V + + APE
Sbjct: 141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH---YVMQEHRKVPFAWCAPESLK 197
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTP 982
T + D + +GV L E+ T G+ P
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 4e-31
Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 787 IVGSGAYGTVYKAVM---DSGKI-VAVKKLASNREGNNIESS--FRAEILTLGKIRHRNI 840
I+G G +G VY+ V KI VAVK ++ +++ F +E + + + H +I
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTC---KKDCTLDNKEKFMSEAVIMKNLDHPHI 75
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
VKL G + +I E G LG L + +L+ T + +L + +AYL
Sbjct: 76 VKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 131
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYA 955
HRDI NIL+ +GDFGL++ I+ S + +PE
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIE-----DEDYYKASVTRLPIKWMSPESI 186
Query: 956 YTMKVTEKCDIYSYGVVLLELLT-GRTP 982
+ T D++ + V + E+L+ G+ P
Sbjct: 187 NFRRFTTASDVWMFAVCMWEILSFGKQP 214
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 5e-31
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 15/199 (7%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCY 848
G+G +G V+ A + VAVK + + G+ +F AE + ++H +VKL+
Sbjct: 197 GAGQFGEVWMATYNKHTKVAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 849 HQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+ +I E+M +GSL + L P + AEG+A++ + HRD
Sbjct: 254 KE-PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRD 309
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI---APEYAYTMKVTEKC 964
+++ NIL+ + DFGLA+VI+ +A G+ I APE T K
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIE---DNEYTAREGAKFPIKWTAPEAINFGSFTIKS 366
Query: 965 DIYSYGVVLLELLT-GRTP 982
D++S+G++L+E++T GR P
Sbjct: 367 DVWSFGILLMEIVTYGRIP 385
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 6e-31
Identities = 61/215 (28%), Positives = 104/215 (48%), Gaps = 33/215 (15%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYG 845
VG+G YG VYK + +G++ A+K + + G+ E + EI L K HRNI YG
Sbjct: 32 VGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEEE-IKQEINMLKKYSHHRNIATYYG 88
Query: 846 FCYHQGSNL-------LIYEYMERGSLGELLHGSSCNL---EWPTRFMIAL---GAAEGL 892
+ + + L+ E+ GS+ +L+ + N EW IA GL
Sbjct: 89 -AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGL 142
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
++LH + ++ HRDIK N+LL + E + DFG++ +D + + + G+ ++AP
Sbjct: 143 SHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAP 198
Query: 953 EYAYTMKVTE-----KCDIYSYGVVLLELLTGRTP 982
E + + K D++S G+ +E+ G P
Sbjct: 199 EVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 6e-31
Identities = 42/209 (20%), Positives = 74/209 (35%), Gaps = 23/209 (11%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G TV A +G+ V V+++ N + + + E+ H NIV
Sbjct: 36 GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA-T 94
Query: 848 YHQGSNL-LIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ + L ++ +M GS +L+ + I G + L Y+HH H
Sbjct: 95 FIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVH 151
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI------APE------ 953
R +K+++IL+ + ++ + + + +PE
Sbjct: 152 RSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNL 211
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y K DIYS G+ EL G P
Sbjct: 212 QGY----DAKSDIYSVGITACELANGHVP 236
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 7e-31
Identities = 50/308 (16%), Positives = 101/308 (32%), Gaps = 36/308 (11%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSL 179
+ + L L L+ +P + ++ L + N +P SL L
Sbjct: 53 LKECLINQFSELQLNRLNLSS-LPDNLP--PQITVLEITQNALI-SLPELPA---SLEYL 105
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+ C+N +S LPE +L L N LT LP+ L + N ++ +P
Sbjct: 106 DACDNRLS-TLPELPASLKHLD---VDNNQLTM-LPELPALLEYINA---DNNQLT-MLP 156
Query: 240 AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTL 299
SL++L + N + LP+ SL + + N L +P+ +
Sbjct: 157 ELP---TSLEVLSVRNNQLT-FLPELPE---SLEALDVSTNLLES-LPAVPVRNHHSEET 208
Query: 300 ALY---SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
++ N + IP+ + +L + L N L+ I + + + +
Sbjct: 209 EIFFRCRENRITHIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSM 268
Query: 357 EIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQM 416
+ + L +++S + + + + N L ++
Sbjct: 269 SDGQQNTLH--RPLADAVTAWFPENKQSDVSQIWHAFEHEEHANTF-------SAFLDRL 319
Query: 417 RQLQLFEN 424
N
Sbjct: 320 SDTVSARN 327
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 5e-29
Identities = 51/297 (17%), Positives = 104/297 (35%), Gaps = 33/297 (11%)
Query: 444 DFSHNYLTG---RIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTG 500
+ +N ++G + + N+ + ++N +L+L +L+
Sbjct: 16 NSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ--FSELQLNRLNLS- 72
Query: 501 SFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQL 560
S P L + +E+ QN +P + L+ L +N ++ LP+ +L L
Sbjct: 73 SLPDNLPP--QITVLEITQNALI-SLPELPAS---LEYLDACDNRLST-LPELPASLKHL 125
Query: 561 VTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSG 620
++ +N LT L P L+ ++ +N LP LE+L + N+ +
Sbjct: 126 ---DVDNNQLTML-PELPAL---LEYINADNNQLT-MLPELPT---SLEVLSVRNNQLTF 174
Query: 621 NIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQ---IALNLSYNNLSGSIPPELGK 677
+P +L L + NL +P + I N ++ IP +
Sbjct: 175 -LPELPESL---EALDVSTNLLE-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILS 228
Query: 678 LDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFL 734
LD ++L +N LS I + ++ + + +
Sbjct: 229 LDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT 285
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 4e-28
Identities = 59/329 (17%), Positives = 112/329 (34%), Gaps = 37/329 (11%)
Query: 371 LFLFQNQLTGV---IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
F N ++G + + N + + Q +LQL +L+
Sbjct: 15 QNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECL--INQFSELQLNRLNLS 72
Query: 428 GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCET 487
+P L + V++ + N L +P ++L L+ N+L +P + +
Sbjct: 73 S-LPDNLP--PQITVLEITQNALI-SLPELP---ASLEYLDACDNRL-STLPELPASLK- 123
Query: 488 LLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT 547
L + N LT P LE + D N+ + +P + L+ L + NN T
Sbjct: 124 --HLDVDNNQLT-MLPELPALLEYIN---ADNNQLTM-LPELPTS---LEVLSVRNNQLT 173
Query: 548 SELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQR----LDISHNSFVGSLPNELG 603
LP+ +L L ++S+N+L L P V + N +P +
Sbjct: 174 -FLPELPESLEAL---DVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRIT-HIPENIL 227
Query: 604 TLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLS 663
+L + L +N S I +L + + FS + L A+
Sbjct: 228 SLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVT-- 285
Query: 664 YNNLSGSIPPELGKLDLLEFLLLNNNHLS 692
+ ++ ++ + N S
Sbjct: 286 -AWFPENKQSDVSQIWHAFEHEEHANTFS 313
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 9e-09
Identities = 26/179 (14%), Positives = 53/179 (29%), Gaps = 10/179 (5%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLT----YLDLAYNELTGYIPREIGNCSRLEHLYLNNNQF 162
LD++ N SL H + N +T +IP I + + L +N
Sbjct: 185 LDVST-NLLESLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPL 242
Query: 163 SGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLR 222
S +I L + ++ + S +G N A T + +
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYFSM--SDGQQNTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 223 NLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQ 281
+ N S + +S S + + + + +++ L +
Sbjct: 301 HAFEHEEHANTFS-AFLDRLSDTVSARNTSGFREQV-AAWLEKLSASAELRQQSFAVAA 357
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 7e-31
Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 787 IVGSGAYGTVYKAV----MDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
++GSG +GTV+K V +S KI V +K + G + +L +G + H +IV
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK-SGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
+L G C S L+ +Y+ GSL + + L + A+G+ YL +
Sbjct: 79 RLLGLCPGS-SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLE---EH 134
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAY 956
+ HR++ + N+LL + V DFG+A ++ + S A E +
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLP----PDDKQLLYSEAKTPIKWMALESIH 190
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTP 982
K T + D++SYGV + EL+T G P
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEP 217
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 7e-31
Identities = 65/197 (32%), Positives = 93/197 (47%), Gaps = 11/197 (5%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
G G +G VY A S I+A+K L + E +E R E+ +RH NI++LYG+
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+H + + LI EY G++ L S E T I A L+Y H R+ H
Sbjct: 78 -FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITE-LANALSYCH---SKRVIH 132
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCD 965
RDIK N+LL E + DFG + S + + G+ Y+ PE EK D
Sbjct: 133 RDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVD 189
Query: 966 IYSYGVVLLELLTGRTP 982
++S GV+ E L G+ P
Sbjct: 190 LWSLGVLCYEFLVGKPP 206
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 9e-31
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 788 VGSGAYGTVYKAVMDS--GKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLY 844
+G G V+ A D + VAVK L ++ + + FR E + H IV +Y
Sbjct: 20 LGFGGMSEVHLAR-DLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 845 GFCYHQGSNLLIY----EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
+ + EY++ +L +++H + + A + L + H +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFSHQN-- 135
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK--SMSAVAGSYGYIAPEYAYTM 958
I HRD+K NI++ V DFG+A+ I + +AV G+ Y++PE A
Sbjct: 136 -GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
V + D+YS G VL E+LTG P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 1e-30
Identities = 67/232 (28%), Positives = 99/232 (42%), Gaps = 30/232 (12%)
Query: 765 PPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIES 823
+E FQ ++ + F +GSGA+G V+ SG +K + +R +E
Sbjct: 9 SGRENLYFQGTIDDLFIFKR--KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ 66
Query: 824 SFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRF 882
AEI L + H NI+K++ + N+ ++ E E G GELL
Sbjct: 67 -IEAEIEVLKSLDHPNIIKIFEV-FEDYHNMYIVMETCE-G--GELLERIVSAQARGKAL 121
Query: 883 ------MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVID 933
+ LAY H + H+D+K NIL D + DFGLA++
Sbjct: 122 SEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178
Query: 934 MPQSKSMSAVAGSYGYIAPE---YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + AG+ Y+APE T KCDI+S GVV+ LLTG P
Sbjct: 179 --SDEHSTNAAGTALYMAPEVFKRDV----TFKCDIWSAGVVMYFLLTGCLP 224
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 80/318 (25%), Positives = 130/318 (40%), Gaps = 63/318 (19%)
Query: 787 IVGSGAYGTVYKAVM-----DSGKI-VAVKKL---ASNREGNNIESSFRAEILTLGKIRH 837
+G G++G VY+ V D + VA+K + AS RE F E + +
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE----FLNEASVMKEFNC 87
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELL------HGSSCNLEWPTR---FMIALGA 888
++V+L G L+I E M RG L L ++ L P+ +A
Sbjct: 88 HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 147
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG 948
A+G+AYL+ + HRD+ + N ++ + F +GDFG+ + I ++ G G
Sbjct: 148 ADGMAYLN--ANKFV-HRDLAARNCMVAEDFTVKIGDFGMTRDIY----ETDYYRKGGKG 200
Query: 949 YI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRD 1002
+ +PE T D++S+GVVL E+ T P Q L + V ++ +
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN-----EQVLRFVME 255
Query: 1003 HSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML---IE 1055
L N D + ++ MC +P RPS E++S + +E
Sbjct: 256 --------GGLLDKPDNCPDM--------LFELMRMCWQYNPKMRPSFLEIISSIKEEME 299
Query: 1056 SNEREGRFNSSPTYDLPQ 1073
RE F S LP+
Sbjct: 300 PGFREVSFYYSEENKLPE 317
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 42/218 (19%), Positives = 81/218 (37%), Gaps = 40/218 (18%)
Query: 789 GSGAYGTVYKAVM-------DSGKI-VAVKKLASNREGN-NIESSFRAEILTLGKIRHRN 839
G G + ++K V + V +K L + + N SF + K+ H++
Sbjct: 17 GQGTFTKIFKGVRREVGDYGQLHETEVLLKVL---DKAHRNYSESFFEAASMMSKLSHKH 73
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+V YG C N+L+ E+++ GSL L + + + +A A + +L
Sbjct: 74 LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLE--- 130
Query: 900 KPRIFHRDIKSNNILLDDKFEAH--------VGDFGLAKVIDMPQSKSMSAVAGSYGYI- 950
+ + H ++ + NILL + + + D G++ +
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVL----------PKDILQER 180
Query: 951 ----APE-YAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
PE + D +S+G L E+ + G P
Sbjct: 181 IPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 11/198 (5%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
G G + ++ D+ ++ A K + + + EI + H+++V +G
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG- 82
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTR-FMIALGAAEGLAYLHHDCKPRIF 904
+ + ++ E R SL EL E R ++ + G YLH + R+
Sbjct: 83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH---RNRVI 137
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRD+K N+ L++ E +GDFGLA ++ + + G+ YIAPE + +
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEV 196
Query: 965 DIYSYGVVLLELLTGRTP 982
D++S G ++ LL G+ P
Sbjct: 197 DVWSIGCIMYTLLVGKPP 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-30
Identities = 55/200 (27%), Positives = 94/200 (47%), Gaps = 11/200 (5%)
Query: 789 GSGAYGTVYKAV--MDSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
G G +G+V + V M +I VA+K L E + E E + ++ + IV+L G
Sbjct: 345 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIG 403
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
C + + +L+ E G L + L G + + + G+ YL + H
Sbjct: 404 VCQAE-ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVH 459
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGY--IAPEYAYTMKVTEK 963
R++ + N+LL ++ A + DFGL+K + S + AG + APE K + +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 964 CDIYSYGVVLLELLT-GRTP 982
D++SYGV + E L+ G+ P
Sbjct: 520 SDVWSYGVTMWEALSYGQKP 539
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 55/199 (27%), Positives = 91/199 (45%), Gaps = 12/199 (6%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
G G++ VY+A + +G VA+K + + + E+ +++H +I++LY
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN- 78
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNL-EWPTR-FMIALGAAEGLAYLHHDCKPRI 903
+ + + L+ E G + L E R FM + G+ YLH I
Sbjct: 79 YFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQI--ITGMLYLH---SHGI 133
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
HRD+ +N+LL + DFGLA + MP K + + G+ YI+PE A +
Sbjct: 134 LHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT-LCGTPNYISPEIATRSAHGLE 192
Query: 964 CDIYSYGVVLLELLTGRTP 982
D++S G + LL GR P
Sbjct: 193 SDVWSLGCMFYTLLIGRPP 211
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 787 IVGSGAYGTVYKAV----MDSGKI-VAVKKLASNREGNNIESS--FRAEILTLGKIRHRN 839
++GSGA+GTVYK + + KI VA+K+L RE + +++ E + + + +
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL---REATSPKANKEILDEAYVMASVDNPH 78
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+ +L G C + LI + M G L + + N+ + A+G+ YL
Sbjct: 79 VCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE--- 134
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEY 954
R+ HRD+ + N+L+ + DFGLAK++ + + + G + A E
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA----EGGKVPIKWMALES 190
Query: 955 AYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
T + D++SYGV + EL+T G P
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELMTFGSKP 219
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-30
Identities = 49/198 (24%), Positives = 89/198 (44%), Gaps = 11/198 (5%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
G G + ++ D+ ++ A K + + + EI + H+++V +G
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG- 108
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTR-FMIALGAAEGLAYLHHDCKPRIF 904
+ + ++ E R SL EL E R ++ + G YLH + R+
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI--VLGCQYLH---RNRVI 163
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRD+K N+ L++ E +GDFGLA ++ + + G+ YIAPE + +
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV-LCGTPNYIAPEVLSKKGHSFEV 222
Query: 965 DIYSYGVVLLELLTGRTP 982
D++S G ++ LL G+ P
Sbjct: 223 DVWSIGCIMYTLLVGKPP 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-30
Identities = 70/319 (21%), Positives = 121/319 (37%), Gaps = 56/319 (17%)
Query: 787 IVGSGAYGTVYKAVM---DSGKI-VAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
++G G +G+V +A + D + VAVK L ++ ++ F E + + H ++ K
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 843 LYGFCYHQGSN------LLIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAEG 891
L G + ++I +M+ G L L + NL T + A G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI- 950
+ YL HRD+ + N +L + V DFGL++ I G +
Sbjct: 150 MEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIY----SGDYYRQGCASKLP 202
Query: 951 ----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSL 1005
A E T D++++GV + E++T G+TP +++ + NY+
Sbjct: 203 VKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE-----IYNYLIG--- 254
Query: 1006 TPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML--IESNER 1059
G RL +E V + C S P RPS + L I +
Sbjct: 255 --GN---RLKQPPECMEE--------VYDLMYQCWSADPKQRPSFTCLRMELENILGHLS 301
Query: 1060 EGRFNSSPTY-DLPQIHET 1077
+ P Y ++ + H
Sbjct: 302 VLSTSQDPLYINIERAHHH 320
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 66/212 (31%), Positives = 93/212 (43%), Gaps = 15/212 (7%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGK 834
+ Y +GSGAYG V + A+K + + S E+ L
Sbjct: 35 LSEMYQRVK--KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKL 92
Query: 835 IRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
+ H NI+KLY F + N L+ E + G L + + E +I G+
Sbjct: 93 LDHPNIMKLYDF-FEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA-VIIKQVLSGVT 150
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
YLH I HRD+K N+LL+ K + + DFGL+ V + K M G+ YI
Sbjct: 151 YLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE--NQKKMKERLGTAYYI 205
Query: 951 APEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
APE K EKCD++S GV+L LL G P
Sbjct: 206 APE-VLRKKYDEKCDVWSIGVILFILLAGYPP 236
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-30
Identities = 69/235 (29%), Positives = 98/235 (41%), Gaps = 39/235 (16%)
Query: 765 PPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIES 823
+E FQ YN ++G G++G V K + + AVK + N S
Sbjct: 9 SGRENLYFQGTFAERYNIVC--MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTS 66
Query: 824 SFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM 883
+ E+ L K+ H NI+KL+ S ++ E G GEL +
Sbjct: 67 TILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYT-G--GELFD----------E-I 112
Query: 884 IALG------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFG 927
I AA G+ Y+H I HRD+K NILL+ K + + DFG
Sbjct: 113 IKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFG 169
Query: 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
L+ Q+ M G+ YIAPE EKCD++S GV+L LL+G P
Sbjct: 170 LSTCFQ--QNTKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 4e-30
Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 787 IVGSGAYGTVYKAVM---DSGKI-VAVKKLASNREG--NNIESSFRAEILTLGKIRHRNI 840
+G G +G V++ + ++ + VA+K + +++ F E LT+ + H +I
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHI 78
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
VKL G +I E G L L +L+ + + A + LAYL
Sbjct: 79 VKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 134
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID----MPQSKSMSAVAGSYGYIAPEYAY 956
R HRDI + N+L+ +GDFGL++ ++ SK + ++APE
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK----WMAPESIN 190
Query: 957 TMKVTEKCDIYSYGVVLLELLT-GRTP 982
+ T D++ +GV + E+L G P
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKP 217
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 5e-30
Identities = 54/248 (21%), Positives = 99/248 (39%), Gaps = 34/248 (13%)
Query: 752 SSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVK 810
S G + + F+DV Y + ++G G + V + + ++G+ AVK
Sbjct: 2 SPGISGGGGGILDMADDDVLFEDV----YELCE--VIGKGPFSVVRRCINRETGQQFAVK 55
Query: 811 ----KLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLG 866
++ G + E + E ++H +IV+L G +++E+M+
Sbjct: 56 IVDVAKFTSSPGLSTED-LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGA--- 111
Query: 867 ELL-----HGSSCNL--EWPTRFMIA--LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD 917
+L + + E + L A L Y H + I HRD+K + +LL
Sbjct: 112 DLCFEIVKRADAGFVYSEAVASHYMRQILEA---LRYCHDN---NIIHRDVKPHCVLLAS 165
Query: 918 KFEAH---VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLL 974
K + +G FG+A + G+ ++APE + D++ GV+L
Sbjct: 166 KENSAPVKLGGFGVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILF 224
Query: 975 ELLTGRTP 982
LL+G P
Sbjct: 225 ILLSGCLP 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 119 bits (302), Expect = 6e-30
Identities = 64/202 (31%), Positives = 105/202 (51%), Gaps = 22/202 (10%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKK--LASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G YG VYKA + G+ A+KK L EG ++ R EI L +++H NIVKLY
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPS-TTIR-EISILKELKHSNIVKLYD 67
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPRI 903
+ + +L++E++++ L +LL LE T F++ L G+AY H R+
Sbjct: 68 VIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQL--LNGIAYCHDR---RV 121
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYTM 958
HRD+K N+L++ + E + DFGLA+ +P + + + Y AP+ Y+
Sbjct: 122 LHRDLKPQNLLINREGELKIADFGLARAFGIP-VRKYTHEIVTLWYRAPDVLMGSKKYST 180
Query: 959 KVTEKCDIYSYGVVLLELLTGR 980
+ DI+S G + E++ G
Sbjct: 181 TI----DIWSVGCIFAEMVNGT 198
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 8e-30
Identities = 57/205 (27%), Positives = 102/205 (49%), Gaps = 23/205 (11%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKK--LASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G YGTV+KA ++ +IVA+K+ L + EG S+ R EI L +++H+NIV+L+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-SALR-EICLLKELKHKNIVRLH 67
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPR 902
+ L++E+ ++ L + + +L+ F+ L +GL + H
Sbjct: 68 DVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQL--LKGLGFCHSR---N 121
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----AYT 957
+ HRD+K N+L++ E + +FGLA+ +P + SA + Y P+ Y+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTP 982
+ D++S G + EL P
Sbjct: 181 TSI----DMWSAGCIFAELANAGRP 201
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-29
Identities = 61/310 (19%), Positives = 120/310 (38%), Gaps = 24/310 (7%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
HL + + L +P+++ L L NN+ + + L +L +L + NN I
Sbjct: 32 HLRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGC 245
S P L L N L LP+ + + L+ R +N I+ + + +G
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 246 QSLQILGLAQNDIG-GSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
+ ++ L N + + ++ L+ I + D +T IP L L L L
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDG 201
Query: 304 NNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEF 362
N + ++ L L KL L N ++ + N + E+ L+ N L ++P
Sbjct: 202 NKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 259
Query: 363 SKITGLRLLFLFQNQLTGV------IPNELSSLRNLTKLDLSINYLT-GPIPVG-FQHLT 414
+ +++++L N ++ + P + + + + L N + I F+ +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 415 QMRQLQLFEN 424
+QL
Sbjct: 320 VRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 7e-29
Identities = 66/310 (21%), Positives = 126/310 (40%), Gaps = 26/310 (8%)
Query: 296 LQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
L+ + L ++PK++ L L N++ + NL + + L N ++
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLT 414
P F+ + L L+L +NQL +P ++ + L +L + N +T + F L
Sbjct: 90 KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITK-VRKSVFNGLN 145
Query: 415 QMRQLQLFENSLT-GGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGY 471
QM ++L N L GI G G+ L + + + +T IP L +L L+L
Sbjct: 146 QMIVVELGTNPLKSSGIENGAFQGMKKLSY-IRIADTNIT-TIPQGLP--PSLTELHLDG 201
Query: 472 NKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI 530
NK+ + L L +L L NS++ L +L + L+ NK +P +
Sbjct: 202 NKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGL 259
Query: 531 ENCQKLQRLHIANNYFTS------ELPKEVGNLSQLVTFNISSNMLTGL-IPPEIVNCMT 583
+ + +Q +++ NN ++ P + ++ SN + I P C+
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 319
Query: 584 -LQRLDISHN 592
+ + +
Sbjct: 320 VRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 4e-28
Identities = 59/278 (21%), Positives = 107/278 (38%), Gaps = 21/278 (7%)
Query: 208 NNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI 266
N +T NL+NL N IS I + L+ L L++N + LP+
Sbjct: 62 NKITEIKDGDFKNLKNLHTLILINNKIS-KISPGAFAPLVKLERLYLSKNQLK-ELPE-- 117
Query: 267 GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNL-VGQIPKEV-GNLKFLTKLY 324
M ++L E+ + +N++T S ++ + L +N L I +K L+ +
Sbjct: 118 KMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIR 177
Query: 325 LYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIP 383
+ + TIP+ G +TE+ L N + ++ + L L L N ++ V
Sbjct: 178 IADTNIT-TIPQ--GLPPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDN 233
Query: 384 NELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT----GGIPPGLGLYSL 439
L++ +L +L L+ N L +P G ++ + L N+++ P
Sbjct: 234 GSLANTPHLRELHLNNNKLVK-VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK 292
Query: 440 --LWVVDFSHNYLT-GRIPPHLCQN-SNLIMLNLGYNK 473
V N + I P + + LG K
Sbjct: 293 ASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 77/381 (20%), Positives = 126/381 (33%), Gaps = 97/381 (25%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+ S+ L ++P + LL L N++T + + +L+NL L L N ++
Sbjct: 34 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 90
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSN 463
I G F L ++ +L L +N L +P +
Sbjct: 91 -ISPGAFAPLVKLERLYLSKNQLKE-LPEKM----------PK----------------T 122
Query: 464 LIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKF- 522
L L + N++ + V N L + +EL N
Sbjct: 123 LQELRVHENEIT-KVRKSVFN-----------------------GLNQMIVVELGTNPLK 158
Query: 523 SGPIPPEI-ENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNC 581
S I + +KL + IA+ T+ +P+ G L ++ N +T
Sbjct: 159 SSGIENGAFQGMKKLSYIRIADTNITT-IPQ--GLPPSLTELHLDGNKIT---------- 205
Query: 582 MTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNL 641
+ S G L L L LS N S +L N HL EL + N
Sbjct: 206 ------KVDAASLKG--------LNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNK 251
Query: 642 FSGEIPPELGDLSSLQIALNLSYNNLSGSIPPE-------LGKLDLLEFLLLNNNHLS-G 693
++P L D +Q+ + L NN+S +I K + L +N +
Sbjct: 252 LV-KVPGGLADHKYIQV-VYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308
Query: 694 EI-PSAFENLSSLLGSNFSYN 713
EI PS F +
Sbjct: 309 EIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 65/287 (22%), Positives = 117/287 (40%), Gaps = 27/287 (9%)
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTG 500
VV S L ++P L + +L+L NK+ I N + L L L+ N ++
Sbjct: 35 VVQCSDLGLE-KVPKDL--PPDTALLDLQNNKI-TEIKDGDFKNLKNLHTLILINNKISK 90
Query: 501 SFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQ 559
P L L + L +N+ +P ++ + LQ L + N T + K V L+Q
Sbjct: 91 ISPGAFAPLVKLERLYLSKNQLKE-LPEKM--PKTLQELRVHENEITK-VRKSVFNGLNQ 146
Query: 560 LVTFNISSNMLT-GLIPPEI-VNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENK 617
++ + +N L I L + I+ + ++P G L L L NK
Sbjct: 147 MIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNK 203
Query: 618 FSGNIPS-TLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPEL 675
+ + + +L L++L +L + N S + L + L+ L+L+ N L +P L
Sbjct: 204 IT-KVDAASLKGLNNLAKLGLSFNSIS-AVDNGSLANTPHLRE-LHLNNNKLV-KVPGGL 259
Query: 676 GKLDLLEFLLLNNNHLSG------EIPSAFENLSSLLGSNFSYNNLT 716
++ + L+NN++S P +S G + N +
Sbjct: 260 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 306
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 4e-15
Identities = 39/211 (18%), Positives = 79/211 (37%), Gaps = 18/211 (8%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELT-GYIPREI-GNCSRLEHLYLNNNQF 162
L ++ T + S+ GL + ++L N L I +L ++ + +
Sbjct: 125 ELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNI 183
Query: 163 SGKIPAELGKLSSLVSLNICNNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNL 221
+ IP L SL L++ N I+ + L L++L N+++ S+ N
Sbjct: 184 T-TIPQGL--PPSLTELHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANT 239
Query: 222 RNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGG------SLPKEIGMLESLTEI 275
+LR N + +P ++ + +Q++ L N+I P S + +
Sbjct: 240 PHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGV 298
Query: 276 VLWDNQLTGF-IPSELGNC-TKLQTLALYSN 304
L+ N + + I C + L +
Sbjct: 299 SLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 9e-15
Identities = 36/161 (22%), Positives = 60/161 (37%), Gaps = 11/161 (6%)
Query: 559 QLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKF 618
L S L +P ++ LD+ +N + L+ L L L NK
Sbjct: 32 HLRVVQCSDLGLEK-VPKDLPP--DTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKI 88
Query: 619 SGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPE-LGK 677
S P L L L + N E+P ++ +LQ L + N ++ +
Sbjct: 89 SKISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQE-LRVHENEIT-KVRKSVFNG 143
Query: 678 LDLLEFLLLNNNHL-SGEIPS-AFENLSSLLGSNFSYNNLT 716
L+ + + L N L S I + AF+ + L + N+T
Sbjct: 144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT 184
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 68/225 (30%), Positives = 111/225 (49%), Gaps = 25/225 (11%)
Query: 765 PPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKK--LASNREGNNIE 822
+E FQ ++E + VG G YG VYKA G+IVA+K+ L + EG
Sbjct: 9 SGRENLYFQGLME---KYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPS- 64
Query: 823 SSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT-- 880
++ R EI L ++ H NIV L + + L++E+ME+ L ++L + L+
Sbjct: 65 TAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIK 122
Query: 881 RFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSM 940
++ L G+A+ H RI HRD+K N+L++ + DFGLA+ +P +S
Sbjct: 123 IYLYQL--LRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP-VRSY 176
Query: 941 SAVAGSYGYIAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGR 980
+ + Y AP+ Y+ V DI+S G + E++TG+
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSV----DIWSIGCIFAEMITGK 217
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-29
Identities = 60/222 (27%), Positives = 96/222 (43%), Gaps = 42/222 (18%)
Query: 789 GSGAYGTVYKAVMDSGK---IVAVKKL---ASNREGNNIESSFRAEILTLGKI-RHRNIV 841
G G +G V KA + A+K++ AS + F E+ L K+ H NI+
Sbjct: 34 GEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLGHHPNII 89
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTRFMIAL 886
L G C H+G L EY G+L + L + ++ L A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGS 946
A G+ YL + + HRD+ + NIL+ + + A + DFGL++ ++ V +
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV-------YVKKT 199
Query: 947 YGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
G + A E T D++SYGV+L E+++ G TP
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-29
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 24/219 (10%)
Query: 781 NFHDSFIV----GSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGN-NIESSFRAEI 829
D +I+ GSGA G V A + K VA++ K A + + EI
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAA 889
L K+ H I+K+ F + ++ E ME G L + + G+ E +
Sbjct: 192 EILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYF-YQML 249
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAVAGS 946
+ YLH + I HRD+K N+LL + E + DFG +K++ ++ M + G+
Sbjct: 250 LAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMRTLCGT 304
Query: 947 YGYIAPE---YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y+APE T D +S GV+L L+G P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 58/201 (28%), Positives = 92/201 (45%), Gaps = 19/201 (9%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
G G +G VY A + I+A+K L ++ E +E R EI +RH NI+++Y +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+H + L+ E+ RG L + L E + + A+ L Y H + ++ H
Sbjct: 83 -FHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE-LADALHYCH---ERKVIH 137
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVT 961
RDIK N+L+ K E + DFG + S + G+ Y+ PE + KV
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRTMCGTLDYLPPEMIEGKTHDEKV- 193
Query: 962 EKCDIYSYGVVLLELLTGRTP 982
D++ GV+ E L G P
Sbjct: 194 ---DLWCAGVLCYEFLVGMPP 211
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 5e-29
Identities = 58/253 (22%), Positives = 102/253 (40%), Gaps = 46/253 (18%)
Query: 751 PSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAV 809
P S+ + + + Y+ + +G GA+ V + V +G A
Sbjct: 2 PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKE--ELGKGAFSVVRRCVHKTTGLEFAA 59
Query: 810 KKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL 869
K + + + E K++H NIV+L+ + + L+++ + G EL
Sbjct: 60 KIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG---ELF 116
Query: 870 HGSSCNLEWPTRFMIALG------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLD 916
++A A+ E +AY H I HR++K N+LL
Sbjct: 117 E-----------DIVAREFYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLA 162
Query: 917 DKFEAH---VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSY 969
K + + DFGLA ++ S++ AG+ GY++PE Y ++ DI++
Sbjct: 163 SKAKGAAVKLADFGLAIEVN--DSEAWHGFAGTPGYLSPEVLKKDPY----SKPVDIWAC 216
Query: 970 GVVLLELLTGRTP 982
GV+L LL G P
Sbjct: 217 GVILYILLVGYPP 229
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-29
Identities = 74/308 (24%), Positives = 123/308 (39%), Gaps = 67/308 (21%)
Query: 789 GSGAYGTVYKAVM------DSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-RHR 838
G+GA+G V +A D+ VAVK L A E + + +E+ + + +H
Sbjct: 55 GAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE----KEALMSELKIMSHLGQHE 110
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELL-------------HGSSCNLEWPTRFMIA 885
NIV L G C H G L+I EY G L L ++ +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170
Query: 886 LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG 945
A+G+A+L HRD+ + N+LL + A +GDFGLA+ I + +
Sbjct: 171 SQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM----NDSNYIVK 223
Query: 946 SYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNY 999
+ APE + T + D++SYG++L E+ + G P G + +
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYP----GILVNSKFYKL 279
Query: 1000 IRDHSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML-- 1053
++D G ++ I M C ++ P RP+ +++ S L
Sbjct: 280 VKD-----G---YQMAQPAFAPKN-IYSIM-------QACWALEPTHRPTFQQICSFLQE 323
Query: 1054 -IESNERE 1060
+ + RE
Sbjct: 324 QAQEDRRE 331
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 45/226 (19%)
Query: 779 TYNFHDSFIV----GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLG 833
T N +FI GSGA+ V+ +GK+ A+K + + +SS EI L
Sbjct: 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR--DSSLENEIAVLK 61
Query: 834 KIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALG----- 887
KI+H NIV L Y ++ L+ + + G GEL ++ G
Sbjct: 62 KIKHENIVTLEDI-YESTTHYYLVMQLVS-G--GELFD-----------RILERGVYTEK 106
Query: 888 -AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQ 936
A+ + YLH + I HRD+K N+L E + DFGL+K+
Sbjct: 107 DASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ--- 160
Query: 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ MS G+ GY+APE ++ D +S GV+ LL G P
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 5e-29
Identities = 65/291 (22%), Positives = 108/291 (37%), Gaps = 52/291 (17%)
Query: 787 IVGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
I+G G +G+V + + + VAVK + + F +E + H N+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 843 LYGFCYHQGSN-----LLIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAEGL 892
L G C S ++I +M+ G L L ++ T + A G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-- 950
YL HRD+ + N +L D V DFGL+K I G +
Sbjct: 161 EYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIY----SGDYYRQGRIAKMPV 213
Query: 951 ---APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLT 1006
A E T K D++++GV + E+ T G TP + + + +Y+
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE-----MYDYLLH---- 264
Query: 1007 PGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
G RL + DE + ++ C P DRP+ + L
Sbjct: 265 -G---HRLKQPEDCLDE--------LYEIMYSCWRTDPLDRPTFSVLRLQL 303
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 6e-29
Identities = 62/224 (27%), Positives = 93/224 (41%), Gaps = 34/224 (15%)
Query: 781 NFHDSFIV----GSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGN-NIESSFRAEI 829
D +I+ GSGA G V A + K VA+K K A + + EI
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRFMI 884
L K+ H I+K+ F + ++ E ME G GEL + E +
Sbjct: 67 EILKKLNHPCIIKIKNF-FDAEDYYIVLELME-G--GELFDKVVGNKRLK--EATCKLYF 120
Query: 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMS 941
+ YLH + I HRD+K N+LL + E + DFG +K++ ++ M
Sbjct: 121 -YQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG--ETSLMR 174
Query: 942 AVAGSYGYIAPE---YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ G+ Y+APE T D +S GV+L L+G P
Sbjct: 175 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 7e-29
Identities = 61/232 (26%), Positives = 111/232 (47%), Gaps = 30/232 (12%)
Query: 764 FPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVK----KLASNREG 818
F + + Q V + Y + I+G G +G V+K +G +A K + ++E
Sbjct: 73 FDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE- 131
Query: 819 NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNL- 876
+ EI + ++ H N+++LY + +++ L+ EY++ G L + + S NL
Sbjct: 132 -----EVKNEISVMNQLDHANLIQLYDA-FESKNDIVLVMEYVDGGELFDRIIDESYNLT 185
Query: 877 EWPT-RFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVID 933
E T FM + EG+ ++H + I H D+K NIL ++ + DFGLA+
Sbjct: 186 ELDTILFMKQI--CEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYK 240
Query: 934 MPQSKSMSAVAGSYGYIAPE---YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + G+ ++APE Y + V+ D++S GV+ LL+G +P
Sbjct: 241 --PREKLKVNFGTPEFLAPEVVNYDF---VSFPTDMWSVGVIAYMLLSGLSP 287
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 8e-29
Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 14/212 (6%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIE-SSFRAEILTLG 833
Y ++G G++G V +G+ AVK ++ + + S E+ L
Sbjct: 24 FSDRYKGQR--VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK 81
Query: 834 KIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
++ H NI+KLY F +G L+ E G L + + E I G+
Sbjct: 82 QLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA-RIIRQVLSGIT 140
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
Y+H + +I HRD+K N+LL+ K + + DFGL+ + SK M G+ YI
Sbjct: 141 YMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--ASKKMKDKIGTAYYI 195
Query: 951 APEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
APE EKCD++S GV+L LL+G P
Sbjct: 196 APE-VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 8e-29
Identities = 63/220 (28%), Positives = 87/220 (39%), Gaps = 39/220 (17%)
Query: 789 GSGAYGTVYKAV------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
G GA+G VY+ S VAVK L S ++ E F E L + K H+N
Sbjct: 39 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD----ELDFLMEALIISKFNHQN 94
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF------MIALGAAEGLA 893
IV+ G ++ E M G L L + P+ +A A G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 894 YL--HHDCKPRIFHRDIKSNNILLDDKFEAHV---GDFGLAKVIDM-----PQSKSMSAV 943
YL +H HRDI + N LL V GDFG+A+ I +M V
Sbjct: 155 YLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPV 209
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
++ PE T K D +S+GV+L E+ + G P
Sbjct: 210 K----WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-28
Identities = 66/235 (28%), Positives = 94/235 (40%), Gaps = 50/235 (21%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVK-----KLASNREGNNI------ES 823
+ +Y +GSGAYG V + A+K + R ++
Sbjct: 34 IGESYFKVR--KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHE 91
Query: 824 SFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM 883
EI L + H NI+KL+ + L+ E+ E G GEL + +
Sbjct: 92 EIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYE-G--GELFE----------Q-I 137
Query: 884 IALG------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFG 927
I AA G+ YLH I HRDIK NILL++K + DFG
Sbjct: 138 INRHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFG 194
Query: 928 LAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
L+ + + G+ YIAPE K EKCD++S GV++ LL G P
Sbjct: 195 LSSFFS--KDYKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-28
Identities = 58/249 (23%), Positives = 97/249 (38%), Gaps = 30/249 (12%)
Query: 752 SSGSVPPLNNVYFPP-KEGFSFQDVVEATYNFHDSFIV-----GSGAYGTVYKAVM---D 802
S + Y E ++ Y I G G +G V++ + +
Sbjct: 356 SHTVSVSETDDYAEIIDEEDTYTMPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPE 415
Query: 803 SGKI-VAVKKLASNREGNNIE--SSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859
+ + VA+K + + F E LT+ + H +IVKL G + +I E
Sbjct: 416 NPAMAVAIKTC---KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMEL 471
Query: 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF 919
G L L +L+ + + A + LAYL R HRDI + N+L+
Sbjct: 472 CTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSND 528
Query: 920 EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLL 974
+GDFGL++ ++ + S G + APE + T D++ +GV +
Sbjct: 529 CVKLGDFGLSRYME-----DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMW 583
Query: 975 ELLT-GRTP 982
E+L G P
Sbjct: 584 EILMHGVKP 592
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-28
Identities = 64/206 (31%), Positives = 105/206 (50%), Gaps = 26/206 (12%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKL-----ASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G G + TVYKA ++ +IVA+KK+ + ++G N ++ R EI L ++ H NI+
Sbjct: 18 LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINR-TALR-EIKLLQELSHPNII 75
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDC 899
L H+ + L++++ME L ++ +S L +M+ +GL YLH
Sbjct: 76 GLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMT--LQGLEYLHQH- 131
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY----- 954
I HRD+K NN+LLD+ + DFGLAK P +++ + + Y APE
Sbjct: 132 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGAR 188
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGR 980
Y + V D+++ G +L ELL
Sbjct: 189 MYGVGV----DMWAVGCILAELLLRV 210
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-28
Identities = 34/235 (14%), Positives = 65/235 (27%), Gaps = 42/235 (17%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIR-------- 836
++G +A ++G+ V + R +N + E+L L +R
Sbjct: 85 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 144
Query: 837 --HRNIVKLYGFCYHQGSNLLI-------------------YEYMERGSLGELLHGSSCN 875
H + + +I + GE+L S
Sbjct: 145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 204
Query: 876 ---LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932
L R + L LA LHH + H ++ +I+LD + + F
Sbjct: 205 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 261
Query: 933 DMPQSKSMSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTP 982
+ A +T D ++ G+ + + P
Sbjct: 262 GASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 61/205 (29%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGK-IRHRNIVKLYG 845
+G GAYG+V K V SG+I+AVK++ S + + ++ + + IV+ YG
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM-DLDVVMRSSDCPYIVQFYG 88
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM----IALGAAEGLAYLHHDCKP 901
+ +G + E M S + L+ I L + L +L + K
Sbjct: 89 ALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK- 146
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE----YAYT 957
I HRDIK +NILLD + DFG++ + S + + AG Y+APE A
Sbjct: 147 -IIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSIAKTRDAGCRPYMAPERIDPSASR 203
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTP 982
+ D++S G+ L EL TGR P
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFP 228
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 68/307 (22%), Positives = 113/307 (36%), Gaps = 83/307 (27%)
Query: 789 GSGAYGTVYKAV------MDSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNI 840
G GA+G V+ A +VAVK L + F+ E L ++H +I
Sbjct: 24 GEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA----RKDFQREAELLTNLQHEHI 79
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTRFMIA 885
VK YG C ++++EYM+ G L + L + L IA
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 886 LGAAEGLAYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAV 943
A G+ YL H HRD+ + N L+ +GDFG+++ + +
Sbjct: 140 SQIASGMVYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVY----STDYYR 190
Query: 944 AGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP---------VQPLDD 988
G + + PE K T + D++S+GV+L E+ T G+ P ++ +
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250
Query: 989 GGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALM--CTSISPFDRPSM 1046
G L R ++D +M C P R ++
Sbjct: 251 GRVLE-------RPRVCPKEVYD---------------------VMLGCWQREPQQRLNI 282
Query: 1047 REVVSML 1053
+E+ +L
Sbjct: 283 KEIYKIL 289
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 3e-28
Identities = 61/229 (26%), Positives = 100/229 (43%), Gaps = 48/229 (20%)
Query: 779 TYNFHDSFIV----GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLG 833
+ F D++ V G GA+ V + V +G A K + + + E
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 834 KIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG------ 887
K++H NIV+L+ + + L+++ + G GEL ++A
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVT-G--GELFE-----------DIVAREFYSEAD 106
Query: 888 AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFE-AHV--GDFGLAKVIDMPQS 937
A+ E +AY H I HR++K N+LL K + A V DFGLA ++ S
Sbjct: 107 ASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN--DS 161
Query: 938 KSMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
++ AG+ GY++PE Y ++ DI++ GV+L LL G P
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPY----SKPVDIWACGVILYILLVGYPP 206
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-28
Identities = 72/303 (23%), Positives = 112/303 (36%), Gaps = 70/303 (23%)
Query: 789 GSGAYGTVYKAV------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-RHR 838
G+GA+G V +A D+ VAVK L A E + +E+ L + H
Sbjct: 32 GAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE----REALMSELKVLSYLGNHM 87
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELL-----------------HGSSCNLEWPTR 881
NIV L G C G L+I EY G L L L+
Sbjct: 88 NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147
Query: 882 FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941
+ A+G+A+L HRD+ + NILL + DFGLA+ I +
Sbjct: 148 LSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIK----NDSN 200
Query: 942 AVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATW 995
V + APE + T + D++SYG+ L EL + G +P +
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 996 VRN-YIRDHSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVV 1050
++ + R+ + E + D M C P RP+ +++V
Sbjct: 261 IKEGF-------------RMLSPEHAPAE-MYDIM-------KTCWDADPLKRPTFKQIV 299
Query: 1051 SML 1053
++
Sbjct: 300 QLI 302
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-28
Identities = 62/220 (28%), Positives = 88/220 (40%), Gaps = 39/220 (17%)
Query: 789 GSGAYGTVYKAVM-----DSGKI-VAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
G GA+G VY+ + D + VAVK L S ++ E F E L + K H+N
Sbjct: 80 GHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD----ELDFLMEALIISKFNHQN 135
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF------MIALGAAEGLA 893
IV+ G ++ E M G L L + P+ +A A G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 894 YL--HHDCKPRIFHRDIKSNNILLDDKFEAHV---GDFGLAKVIDMPQSKSMSAVAGSYG 948
YL +H HRDI + N LL V GDFG+A+ I ++ G
Sbjct: 196 YLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI----YRAGYYRKGGCA 246
Query: 949 YI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
+ PE T K D +S+GV+L E+ + G P
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 57/239 (23%), Positives = 95/239 (39%), Gaps = 53/239 (22%)
Query: 777 EATYNFHDSFIV----GSGAYGTVYKAV-MDSGKIVAVK-------KLASNREGNNIESS 824
+T+ F++++ G G V + + + K AVK S E + +
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 825 FRAEILTLGKI-RHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRF 882
E+ L K+ H NI++L Y + L+++ M++G EL +
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDT-YETNTFFFLVFDLMKKG---ELFD-----------Y 114
Query: 883 MIALG------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929
+ E + LH K I HRD+K NILLDD + DFG +
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
Query: 930 KVIDMPQSKSMSAVAGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+D + + V G+ Y+APE ++ D++S GV++ LL G P
Sbjct: 172 CQLD--PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-28
Identities = 69/300 (23%), Positives = 106/300 (35%), Gaps = 68/300 (22%)
Query: 789 GSGAYGTVYKAVM------DSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
G +G VYK + + + VA+K L A FR E + +++H N
Sbjct: 18 GEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL----REEFRHEAMLRARLQHPN 73
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTRFMI 884
+V L G +I+ Y G L E L LE P +
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 885 ALGAAEGLAYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942
A G+ YL HH + H+D+ + N+L+ DK + D GL + + +
Sbjct: 134 VAQIAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVY----AADYY 184
Query: 943 VAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWV 996
+ APE K + DI+SYGVVL E+ + G P + V
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN-----QDV 239
Query: 997 RNYIRDHSLTPGIFDTRLNVED---ESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
IR+ L D + M + C + P RP +++ S L
Sbjct: 240 VEMIRN--------RQVLPCPDDCPAWVYALM-------IECWNEFPSRRPRFKDIHSRL 284
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 6e-28
Identities = 44/219 (20%), Positives = 79/219 (36%), Gaps = 32/219 (14%)
Query: 789 GSGAYGTVYKAVMDSGKIVAVKKL---------------ASNREGNNIESSFRAEILTLG 833
G + + K A+KK + F+ E+ +
Sbjct: 40 NQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT 98
Query: 834 KIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE-- 890
I++ + G + +IYEYME S+ + + T F+
Sbjct: 99 DIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157
Query: 891 -----GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAG 945
+Y+H+ + I HRD+K +NIL+D + DFG ++ + K + G
Sbjct: 158 KSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIKGSRG 212
Query: 946 SYGYIAPEYAYTMKVT--EKCDIYSYGVVLLELLTGRTP 982
+Y ++ PE+ K DI+S G+ L + P
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 7e-28
Identities = 52/203 (25%), Positives = 87/203 (42%), Gaps = 23/203 (11%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKK--LASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G+YG V+K D+G+IVA+KK + + + R EI L +++H N+V L
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKK-IALR-EIRMLKQLKHPNLVNLL 68
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPR 902
+ L++EY + ++ L + + + + H K
Sbjct: 69 EVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQT--LQAVNFCH---KHN 122
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYT 957
HRD+K NIL+ + DFG A+++ P S + Y +PE Y
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGP-SDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 958 MKVTEKCDIYSYGVVLLELLTGR 980
V D+++ G V ELL+G
Sbjct: 182 PPV----DVWAIGCVFAELLSGV 200
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 45/230 (19%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRAEI 829
VE Y + +GSG + V K +GK A K +L+S+R G + E E+
Sbjct: 3 VEDHYEMGE--ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREE-IEREV 59
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG-- 887
L +IRH NI+ L+ ++ +LI E + G GEL F+
Sbjct: 60 NILREIRHPNIITLHDIFENKTDVVLILELVS-G--GELFD-----------FLAEKESL 105
Query: 888 ----AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVI 932
A +G+ YLH RI H D+K NI+L DK + + DFG+A I
Sbjct: 106 TEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162
Query: 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 163 E--AGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 9e-28
Identities = 53/228 (23%), Positives = 96/228 (42%), Gaps = 45/228 (19%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGK 834
Y + +G GA+ V + V + +G+ A + + + E
Sbjct: 9 FTEEYQLFE--ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 835 IRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG------A 888
++H NIV+L+ +G + LI++ + G GEL ++A A
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVT-G--GELFE-----------DIVAREYYSEADA 112
Query: 889 A-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSK 938
+ E + + H + + HR++K N+LL K + + DFGLA ++ Q +
Sbjct: 113 SHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ-Q 168
Query: 939 SMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ AG+ GY++PE Y + D+++ GV+L LL G P
Sbjct: 169 AWFGFAGTPGYLSPEVLRKDPY----GKPVDLWACGVILYILLVGYPP 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 58/258 (22%), Positives = 86/258 (33%), Gaps = 57/258 (22%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVK----KLASNREGNNIESSFRAEIL 830
++ Y+ +G G+YG V A+ + I A+K ++E E+
Sbjct: 24 LQKKYHLKG--AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVR 80
Query: 831 TLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSL-------GELLHGSSCNLEWPTRFM 883
+ K+ H NI +LY + L+ E G L + G T+
Sbjct: 81 LMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQIC 140
Query: 884 IALGAA--------------------------------EGLAYLHHDCKPRIFHRDIKSN 911
L YLH I HRDIK
Sbjct: 141 PCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIKPE 197
Query: 912 NILLDDKFEAHV--GDFGLAKVI---DMPQSKSMSAVAGSYGYIAPE--YAYTMKVTEKC 964
N L + DFGL+K + + M+ AG+ ++APE KC
Sbjct: 198 NFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC 257
Query: 965 DIYSYGVVLLELLTGRTP 982
D +S GV+L LL G P
Sbjct: 258 DAWSAGVLLHLLLMGAVP 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-27
Identities = 54/236 (22%), Positives = 103/236 (43%), Gaps = 26/236 (11%)
Query: 760 NNVYFPPKEGFSFQDVVEATYNFHDSFIV----GSGAYGTVYKAV-MDSGKIVAVKKLAS 814
+ Y + + Q V + +D + + GSGA+G V++ V +G++ K + +
Sbjct: 27 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINT 86
Query: 815 NREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELL---- 869
+ + + + EI + ++ H ++ L+ + + LI E++ G GEL
Sbjct: 87 PYPLD--KYTVKNEISIMNQLHHPKLINLHDA-FEDKYEMVLILEFLS-G--GELFDRIA 140
Query: 870 -HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDF 926
+ +M EGL ++H + I H DIK NI+ + K + V DF
Sbjct: 141 AEDYKMSEAEVINYMRQA--CEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDF 195
Query: 927 GLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
GLA ++ + + + + APE V D+++ GV+ LL+G +P
Sbjct: 196 GLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 1e-27
Identities = 67/302 (22%), Positives = 115/302 (38%), Gaps = 69/302 (22%)
Query: 789 GSGAYGTVYKAV--------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-R 836
G G +G V A VAVK L A+ ++ S +E+ + I +
Sbjct: 90 GEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----LSDLVSEMEMMKMIGK 145
Query: 837 HRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTR 881
H+NI+ L G C G +I EY +G+L E L + +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205
Query: 882 FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941
A G+ YL + HRD+ + N+L+ + + DFGLA+ I+
Sbjct: 206 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN----NIDY 258
Query: 942 AVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATW 995
+ G + APE + T + D++S+GV++ E+ T G +P G
Sbjct: 259 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP-----GIPVEE 313
Query: 996 VRNYIRDHSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051
+ +++ G R+ N +E + + C P RP+ +++V
Sbjct: 314 LFKLLKE-----G---HRMDKPANCTNE--------LYMMMRDCWHAVPSQRPTFKQLVE 357
Query: 1052 ML 1053
L
Sbjct: 358 DL 359
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/215 (24%), Positives = 95/215 (44%), Gaps = 37/215 (17%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEIL-----TLGKIRHRNIV 841
+G GAYG V K + SG+I+AVK++ + + S + +L ++ + V
Sbjct: 15 LGRGAYGVVEKMRHVPSGQIMAVKRIRAT-----VNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF------MIALGAAEGLAYL 895
YG + +G + E M+ SL + ++ IA+ + L +L
Sbjct: 70 TFYGALFREGDVWICMELMD-TSLDKFYKQV---IDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
H + HRD+K +N+L++ + + DFG++ + + AG Y+APE
Sbjct: 126 HSKLS--VIHRDVKPSNVLINALGQVKMCDFGISG--YLVDDVAKDIDAGCKPYMAPERI 181
Query: 954 ------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y++ K DI+S G+ ++EL R P
Sbjct: 182 NPELNQKGYSV----KSDIWSLGITMIELAILRFP 212
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 72/312 (23%), Positives = 120/312 (38%), Gaps = 72/312 (23%)
Query: 789 GSGAYGTVYKAV------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-RHR 838
G GA+G V +A + + VAVK L A++ E + +E+ L I H
Sbjct: 36 GRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE----HRALMSELKILIHIGHHL 91
Query: 839 NIVKLYGFCYHQGS-NLLIYEYMERGSLGELL---------------HGSSCNLEWPTRF 882
N+V L G C G ++I E+ + G+L L L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 883 MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942
+ A+G+ +L + HRD+ + NILL +K + DFGLA+ I K
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIY----KDPDY 204
Query: 943 VAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWV 996
V + APE + T + D++S+GV+L E+ + G +P + + +
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 997 RN-YIRDHSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051
+ R+ E + M L C P RP+ E+V
Sbjct: 265 KEGT-------------RMRAPDYTTPE-MYQTM-------LDCWHGEPSQRPTFSELVE 303
Query: 1052 ML---IESNERE 1060
L +++N ++
Sbjct: 304 HLGNLLQANAQQ 315
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-27
Identities = 57/227 (25%), Positives = 93/227 (40%), Gaps = 44/227 (19%)
Query: 789 GSGAYGTVYKAV--------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-R 836
G GA+G V A VAVK L A+ ++ S +E+ + I +
Sbjct: 44 GEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----LSDLVSEMEMMKMIGK 99
Query: 837 HRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTR 881
H+NI+ L G C G +I EY +G+L E L + +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159
Query: 882 FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941
A G+ YL + HRD+ + N+L+ + + DFGLA+ I+
Sbjct: 160 VSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDIN----NIDY 212
Query: 942 AVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
+ G + APE + T + D++S+GV++ E+ T G +P
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-27
Identities = 60/302 (19%), Positives = 110/302 (36%), Gaps = 55/302 (18%)
Query: 716 TGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPSSGSVPPLNNVYFPPKEGFSFQDV 775
+ +P +F+ + N A + + +D
Sbjct: 23 RREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDE 82
Query: 776 V---EATYNFHDSF----IVGSGAYGTVYKAV-MDSGKIVAVK------KLASNREGNNI 821
+ A F+ + ++G G V + V +G AVK + S + +
Sbjct: 83 LPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEV 142
Query: 822 ESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWP 879
+ R E L ++ H +I+ L Y S + L+++ M +G EL
Sbjct: 143 REATRRETHILRQVAGHPHIITLIDS-YESSSFMFLVFDLMRKG---ELFD--------- 189
Query: 880 TRFMIALG------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDF 926
++ E +++LH I HRD+K NILLDD + + DF
Sbjct: 190 --YLTEKVALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDF 244
Query: 927 GLAKVIDMPQSKSMSAVAGSYGYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGR 980
G + ++ + + + G+ GY+APE ++ D+++ GV+L LL G
Sbjct: 245 GFSCHLE--PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGS 302
Query: 981 TP 982
P
Sbjct: 303 PP 304
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-27
Identities = 54/203 (26%), Positives = 94/203 (46%), Gaps = 23/203 (11%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKK--LASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
VG G+YG V K D+G+IVA+KK + + + + R EI L ++RH N+V L
Sbjct: 33 VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKK-IAMR-EIKLLKQLRHENLVNLL 90
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPR 902
C + L++E+++ ++ + L L++ +++ + G+ + H
Sbjct: 91 EVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQI--INGIGFCHSH---N 144
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYT 957
I HRDIK NIL+ + DFG A+ + P + + Y APE Y
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYG 203
Query: 958 MKVTEKCDIYSYGVVLLELLTGR 980
V D+++ G ++ E+ G
Sbjct: 204 KAV----DVWAIGCLVTEMFMGE 222
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 56/202 (27%), Positives = 101/202 (50%), Gaps = 22/202 (10%)
Query: 788 VGSGAYGTVYKA-VMDSGKIVAVKKLA-SNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G Y TVYK + +VA+K++ + EG ++ R E+ L ++H NIV L+
Sbjct: 10 LGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPC-TAIR-EVSLLKDLKHANIVTLHD 67
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPRI 903
+ + S L++EY+++ L + L + F+ L GLAY H ++
Sbjct: 68 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQL--LRGLAYCHR---QKV 121
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-----AYTM 958
HRD+K N+L++++ E + DFGLA+ +P +K+ + Y P+ Y+
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLARAKSIP-TKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 959 KVTEKCDIYSYGVVLLELLTGR 980
++ D++ G + E+ TGR
Sbjct: 181 QI----DMWGVGCIFYEMATGR 198
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 58/237 (24%), Positives = 91/237 (38%), Gaps = 54/237 (22%)
Query: 769 GFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRA 827
G + D+ Y + +G G++G V AV + A KK+ + F+
Sbjct: 1 GSTKGDI-NQYYTLEN--TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQ 55
Query: 828 EILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIAL 886
EI + + H NI++LY + +++ L+ E G GEL ++
Sbjct: 56 EIEIMKSLDHPNIIRLYET-FEDNTDIYLVMELCT-G--GELFE-----------RVVHK 100
Query: 887 G------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAK 930
AA +AY H K + HRD+K N L + DFGLA
Sbjct: 101 RVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAA 157
Query: 931 VIDMPQSKSMSAVAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
K M G+ Y++P+ Y +CD +S GV++ LL G P
Sbjct: 158 RFK--PGKMMRTKVGTPYYVSPQVLEGLY------GPECDEWSAGVMMYVLLCGYPP 206
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 42/260 (16%), Positives = 78/260 (30%), Gaps = 31/260 (11%)
Query: 788 VGSGAYGTVYKAV------MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNI 840
+G GA+ VY+A + + +K +N I + L
Sbjct: 73 LGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG---TQLMERLKPSMQHMF 129
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELL----HGSSCNLEWPTRFMIALGAAEGLAYLH 896
+K Y Q ++L+ E G+L + + + A+ + +H
Sbjct: 130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH 189
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVG-----------DFGLAKVIDM-PQSKSMSAVA 944
I H DIK +N +L + F D G + + + P+ +A
Sbjct: 190 ---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKC 246
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG-GDLATWVRNYIRDH 1003
+ G+ E + D + + +L G + G R
Sbjct: 247 ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLD 306
Query: 1004 SLTPGIFDTRLNVEDESIVD 1023
F LN+ D +
Sbjct: 307 MWNE-FFHVMLNIPDCHHLP 325
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 71/304 (23%), Positives = 112/304 (36%), Gaps = 78/304 (25%)
Query: 789 GSGAYGTVYKAV------MDSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNI 840
G GA+G V+ A +VAVK L AS F+ E L ++H++I
Sbjct: 50 GEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA----RQDFQREAELLTMLQHQHI 105
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTR--------------FMIAL 886
V+ +G C L+++EYM G L L + + +A
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 887 GAAEGLAYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA 944
A G+ YL H HRD+ + N L+ +GDFG+++ I +
Sbjct: 166 QVAAGMVYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSRDIY----STDYYRV 216
Query: 945 GSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRN 998
G + PE K T + D++S+GVVL E+ T G+ P L + T +
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-----TEAID 271
Query: 999 YIRD-HSL------TPGIFDTRLNVEDESIVDHMILVLKVALM--CTSISPFDRPSMREV 1049
I L P ++ +M C P R S+++V
Sbjct: 272 CITQGRELERPRACPPEVYA---------------------IMRGCWQREPQQRHSIKDV 310
Query: 1050 VSML 1053
+ L
Sbjct: 311 HARL 314
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-27
Identities = 57/208 (27%), Positives = 93/208 (44%), Gaps = 29/208 (13%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKK--LASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G YG VYKA+ + + VA+K+ L EG ++ R E+ L +++HRNI++L
Sbjct: 42 LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPG-TAIR-EVSLLKELQHRNIIELK 99
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPR 902
+H LI+EY E L + + + ++ F+ L G+ + H R
Sbjct: 100 SVIHHNHRLHLIFEYAEN-DLKKYMD-KNPDVSMRVIKSFLYQL--INGVNFCHS---RR 152
Query: 903 IFHRDIKSNNILLDDKFEAHVG-----DFGLAKVIDMPQSKSMSAVAGSYGYIAPEY--- 954
HRD+K N+LL + DFGLA+ +P + + + Y PE
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP-IRQFTHEIITLWYRPPEILLG 211
Query: 955 --AYTMKVTEKCDIYSYGVVLLELLTGR 980
Y+ V DI+S + E+L
Sbjct: 212 SRHYSTSV----DIWSIACIWAEMLMKT 235
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 4e-27
Identities = 66/232 (28%), Positives = 99/232 (42%), Gaps = 49/232 (21%)
Query: 789 GSGAYGTVYKAVM-----DSGKI-VAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
G G +G V KA +G VAVK L AS E +E L ++ H +
Sbjct: 32 GEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE----LRDLLSEFNVLKQVNHPH 87
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELL-----------------------HGSSCNL 876
++KLYG C G LLI EY + GSL L H L
Sbjct: 88 VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147
Query: 877 EWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936
A ++G+ YL + ++ HRD+ + NIL+ + + + DFGL++ +
Sbjct: 148 TMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKISDFGLSRDVY--- 201
Query: 937 SKSMSAVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTP 982
+ S V S G I A E + T + D++S+GV+L E++T G P
Sbjct: 202 -EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 38/241 (15%), Positives = 74/241 (30%), Gaps = 53/241 (21%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLA-SNREGNNIESSFRAEILTLGKIR-------- 836
++G +A ++G+ V + R +N + E+L L +R
Sbjct: 80 VLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA 139
Query: 837 -----------------HRNIVKLYGFCYHQGSN--LLIYEYME--RGSLGELLHGSSCN 875
+ ++++ +Y M+ + GE+L S
Sbjct: 140 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST 199
Query: 876 ---LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932
L R + L LA LHH + H ++ +I+LD + + F
Sbjct: 200 HKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD 256
Query: 933 DMPQSKSMSAVAGSYGYIAPEY-----------AYTMKVTEKCDIYSYGVVLLELLTGRT 981
+ S G+ PE +T D ++ G+V+ +
Sbjct: 257 GARVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADL 311
Query: 982 P 982
P
Sbjct: 312 P 312
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 4e-27
Identities = 57/218 (26%), Positives = 94/218 (43%), Gaps = 41/218 (18%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKK--LASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G +G V+KA +G+ VA+KK + + +EG I ++ R EI L ++H N+V L
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPI-TALR-EIKILQLLKHENVVNLI 82
Query: 845 GFCYHQGSNL--------LIYEYMERGSLGELLHGSSCNLEWPT--RFMIALGAAEGLAY 894
C + S L++++ E L LL R M L GL Y
Sbjct: 83 EICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQML--LNGLYY 139
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG------ 948
+H + +I HRD+K+ N+L+ + DFGLA+ + ++ Y
Sbjct: 140 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQ----PNRYTNRVVTL 192
Query: 949 -YIAPEY-----AYTMKVTEKCDIYSYGVVLLELLTGR 980
Y PE Y + D++ G ++ E+ T
Sbjct: 193 WYRPPELLLGERDYGPPI----DLWGAGCIMAEMWTRS 226
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-27
Identities = 48/207 (23%), Positives = 86/207 (41%), Gaps = 13/207 (6%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGK-IRHRNIVKLYG 845
+GSG G V+K +G ++AVK++ + + ++ + K IV+ +G
Sbjct: 33 MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM-DLDVVLKSHDCPYIVQCFG 91
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
+ E M + E + + + L YL + H
Sbjct: 92 TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGK-MTVAIVKALYYLKEKHG--VIH 148
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYTMKV 960
RD+K +NILLD++ + + DFG++ + K+ AG Y+APE
Sbjct: 149 RDVKPSNILLDERGQIKLCDFGISG--RLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY 206
Query: 961 TEKCDIYSYGVVLLELLTGRTPVQPLD 987
+ D++S G+ L+EL TG+ P +
Sbjct: 207 DIRADVWSLGISLVELATGQFPYKNCK 233
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-27
Identities = 78/381 (20%), Positives = 129/381 (33%), Gaps = 98/381 (25%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+ S+ L +P E S LL L N ++ + ++ L++L L L N ++
Sbjct: 36 RVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISK 92
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSN 463
I F L ++++L + +N L IPP L S +
Sbjct: 93 -IHEKAFSPLRKLQKLYISKNHLVE-IPPNL----------PS----------------S 124
Query: 464 LIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKF- 522
L+ L + N++ +P V + L N+ IE+ N
Sbjct: 125 LVELRIHDNRIR-KVPKGVFS-----------------------GLRNMNCIEMGGNPLE 160
Query: 523 SGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCM 582
+ P + KL L I+ T I ++
Sbjct: 161 NSGFEPGAFDGLKLNYLRISEAKLTG----------------IPKDLPE----------- 193
Query: 583 TLQRLDISHNSFVGSLPNE-LGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNL 641
TL L + HN ++ E L +L L L N+ +L L L EL + N
Sbjct: 194 TLNELHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNK 252
Query: 642 FSGEIPPELGDLSSLQIALNLSYNNLSGSIPPE-------LGKLDLLEFLLLNNNHLS-G 693
S +P L DL LQ+ + L NN++ + K + L NN +
Sbjct: 253 LS-RVPAGLPDLKLLQV-VYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYW 309
Query: 694 EI-PSAFENLSSLLGSNFSYN 713
E+ P+ F ++ L F
Sbjct: 310 EVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-27
Identities = 71/358 (19%), Positives = 117/358 (32%), Gaps = 71/358 (19%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
HL + + L +P+EI L L NN S + L L +L + NN I
Sbjct: 34 HLRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQ 246
S + L L N+L IP +
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-------------------------EIPPNLP--S 123
Query: 247 SLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLT-GFIPSELGNCTKLQTLALYSN 304
SL L + N I +PK + L ++ I + N L + KL L +
Sbjct: 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEA 182
Query: 305 NLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSK 364
L IPK + L +L+L N++ I E +
Sbjct: 183 KLT-GIPK--DLPETLNELHLDHNKIQ-AIELED-----------------------LLR 215
Query: 365 ITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFEN 424
+ L L L NQ+ + LS L L +L L N L+ +P G L ++ + L N
Sbjct: 216 YSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR-VPAGLPDLKLLQVVYLHTN 274
Query: 425 SLTGGIPPG-------LGLYSLLWVVDFSHNYLT-GRIPPHLCQN-SNLIMLNLGYNK 473
++T + + + +N + + P + ++ + + G K
Sbjct: 275 NIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 4e-24
Identities = 66/287 (22%), Positives = 105/287 (36%), Gaps = 28/287 (9%)
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTG 500
VV S L +P + + + +L+L N + + D + L L LV N ++
Sbjct: 37 VVQCSDLGLK-AVPKEI--SPDTTLLDLQNNDI-SELRKDDFKGLQHLYALVLVNNKISK 92
Query: 501 SFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQ 559
L L + + +N IPP + L L I +N +PK V L
Sbjct: 93 IHEKAFSPLRKLQKLYISKNHLVE-IPPNL--PSSLVELRIHDNRIRK-VPKGVFSGLRN 148
Query: 560 LVTFNISSNMLTGL-IPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKF 618
+ + N L P + + L L IS +P + L L L NK
Sbjct: 149 MNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHNKI 205
Query: 619 SGNIPS-TLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPELG 676
I L S L L +G N I L L +L+ L+L N LS +P L
Sbjct: 206 Q-AIELEDLLRYSKLYRLGLGHNQIR-MIENGSLSFLPTLRE-LHLDNNKLS-RVPAGLP 261
Query: 677 KLDLLEFLLLNNNHLSGEIPS-------AFENLSSLLGSNFSYNNLT 716
L LL+ + L+ N+++ ++ + G + N +
Sbjct: 262 DLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 45/169 (26%), Positives = 61/169 (36%), Gaps = 12/169 (7%)
Query: 559 QLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKF 618
L S L +P EI LD+ +N ++ LQ L L L NK
Sbjct: 34 HLRVVQCSDLGLKA-VPKEISP--DTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKI 90
Query: 619 SGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPE-LGK 677
S L L +L + N EIPP L SSL L + N + +P
Sbjct: 91 SKIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVE-LRIHDNRIR-KVPKGVFSG 145
Query: 678 LDLLEFLLLNNNHLSGEI--PSAFENLSSLLGSNFSYNNLTGPLPSIPQ 724
L + + + N L P AF+ L L S LTG +P+
Sbjct: 146 LRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTGIPKDLPE 193
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-27
Identities = 59/242 (24%), Positives = 103/242 (42%), Gaps = 18/242 (7%)
Query: 750 SPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIV----GSGAYGTVYKAV-MDSG 804
+N F + + Q V + D + + G+GA+G V++ +G
Sbjct: 123 RGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATG 182
Query: 805 KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGS 864
A K + ++ E+ R EI T+ +RH +V L+ ++IYE+M G
Sbjct: 183 NNFAAKFV-MTPHESDKET-VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 240
Query: 865 LGELLHGSSCNL--EWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 922
L E + + + +M + +GL ++H + H D+K NI+ K
Sbjct: 241 LFEKVADEHNKMSEDEAVEYMRQV--CKGLCHMH---ENNYVHLDLKPENIMFTTKRSNE 295
Query: 923 V--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR 980
+ DFGL +D +S+ G+ + APE A V D++S GV+ LL+G
Sbjct: 296 LKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGL 353
Query: 981 TP 982
+P
Sbjct: 354 SP 355
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 5e-27
Identities = 73/331 (22%), Positives = 125/331 (37%), Gaps = 73/331 (22%)
Query: 789 GSGAYGTVYKAV--------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-R 836
G GA+G V A + VAVK L A+ ++ S +E+ + I +
Sbjct: 78 GEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD----LSDLISEMEMMKMIGK 133
Query: 837 HRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL---------------HGSSCNLEWPTR 881
H+NI+ L G C G +I EY +G+L E L H L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 882 FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMS 941
A A G+ YL + HRD+ + N+L+ + + DFGLA+ I
Sbjct: 194 VSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDI----HHIDY 246
Query: 942 AVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATW 995
+ G + APE + T + D++S+GV+L E+ T G +P +
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-----VEE 301
Query: 996 VRNYIRDHSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051
+ +++ R+ N +E + M C P RP+ +++V
Sbjct: 302 LFKLLKE--------GHRMDKPSNCTNE-LYMMM-------RDCWHAVPSQRPTFKQLVE 345
Query: 1052 ----MLIESNEREGRFNSSPTYDLPQIHETR 1078
++ ++ +E + + I T
Sbjct: 346 DLDRIVALTSNQEMGYYHHHHHHDYDIPTTE 376
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-27
Identities = 60/227 (26%), Positives = 99/227 (43%), Gaps = 39/227 (17%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRAEI 829
VE Y+ + +GSG + V K +G A K + ++R G E E+
Sbjct: 10 VEDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE-IEREV 66
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM----------ERGSLGELLHGSSCNLEWP 879
L ++ H NI+ L+ ++ +LI E + ++ SL E E
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---------EEA 117
Query: 880 TRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMP 935
T F+ + +G+ YLH +I H D+K NI+L DK + DFGLA I+
Sbjct: 118 TSFIKQI--LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-- 170
Query: 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-27
Identities = 60/230 (26%), Positives = 97/230 (42%), Gaps = 45/230 (19%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRAEI 829
V+ Y+ + +GSG + V K +G A K + S+R G + E E+
Sbjct: 9 VDDYYDTGE--ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED-IEREV 65
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG-- 887
L +I+H N++ L+ ++ +LI E + G GEL F+
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVA-G--GELFD-----------FLAEKESL 111
Query: 888 ----AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVI 932
A G+ YLH +I H D+K NI+L D+ + DFGLA I
Sbjct: 112 TEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168
Query: 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
D + G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 169 D--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 7e-27
Identities = 67/266 (25%), Positives = 108/266 (40%), Gaps = 48/266 (18%)
Query: 735 GNEGLCGRPVGNCGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYG 794
G E L + + + AS + G+ + + + + D + +G GA
Sbjct: 14 GTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSD----FFEVES--ELGRGATS 67
Query: 795 TVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853
VY+ + K A+K L + + R EI L ++ H NI+KL + +
Sbjct: 68 IVYRCKQKGTQKPYALKVLKKTVD----KKIVRTEIGVLLRLSHPNIIKLKEI-FETPTE 122
Query: 854 L-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALG------AA-------EGLAYLHHDC 899
+ L+ E + G GEL ++ G AA E +AYLH
Sbjct: 123 ISLVLELVT-G--GELFD-----------RIVEKGYYSERDAADAVKQILEAVAYLH--- 165
Query: 900 KPRIFHRDIKSNNILLDDKFE-AHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
+ I HRD+K N+L A + DFGL+K+++ M V G+ GY APE
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILR 223
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTP 982
+ D++S G++ LL G P
Sbjct: 224 GCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 59/227 (25%), Positives = 100/227 (44%), Gaps = 39/227 (17%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRAEI 829
VE Y+ + +GSG + V K +G A K + ++R G + E E+
Sbjct: 10 VEDFYDIGE--ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREE-IEREV 66
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSNLLIYEYM----------ERGSLGELLHGSSCNLEWP 879
L ++ H N++ L+ ++ +LI E + ++ SL E E
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---------EEA 117
Query: 880 TRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMP 935
T F+ + +G+ YLH +I H D+K NI+L DK + DFGLA I+
Sbjct: 118 TSFIKQI--LDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE-- 170
Query: 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ G+ ++APE + + D++S GV+ LL+G +P
Sbjct: 171 DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 54/218 (24%), Positives = 92/218 (42%), Gaps = 26/218 (11%)
Query: 781 NFHDSFIV-----GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGK 834
NF++ +I+ G G + V + + +G+ A K L R G + + EI L
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 835 IRHR-NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAA---- 889
+ ++ L+ + +LI EY G GE+ C E
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAA-G--GEIFS--LCLPELAEMVSENDVIRLIKQ 139
Query: 890 --EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAVA 944
EG+ YLH + I H D+K NILL + + DFG+++ I + + +
Sbjct: 140 ILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG--HACELREIM 194
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
G+ Y+APE +T D+++ G++ LLT +P
Sbjct: 195 GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-26
Identities = 81/279 (29%), Positives = 120/279 (43%), Gaps = 40/279 (14%)
Query: 731 SSFLGNEGLCGRPVGNCGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGS 790
+SF + +P S G E +Y ++G+
Sbjct: 8 TSFAESCKPVQQPSAFGSMKVSRDK-DGSKVTTVVATPGQGPDRPQEVSYTDTK--VIGN 64
Query: 791 GAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH 849
G++G VY+A DSG++VA+KK+ ++ N R E+ + K+ H NIV+L F Y
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-----R-ELQIMRKLDHCNIVRLRYFFYS 118
Query: 850 QGSNL------LIYEYMERGSLGELL-HGSSCNLEWPTR----FMIALGAAEGLAYLHHD 898
G L+ +Y+ ++ + H S P +M L LAY+H
Sbjct: 119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIH-- 173
Query: 899 CKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE---- 953
I HRDIK N+LLD D + DFG AK + ++S + Y Y APE
Sbjct: 174 -SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRY-YRAPELIFG 230
Query: 954 -YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
YT + D++S G VL ELL G+ P+ P D G D
Sbjct: 231 ATDYTSSI----DVWSAGCVLAELLLGQ-PIFPGDSGVD 264
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 64/258 (24%), Positives = 104/258 (40%), Gaps = 28/258 (10%)
Query: 771 SFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEI 829
SF E Y + + G GA+ V + + + + AVK + + G+ FR E+
Sbjct: 5 SFSGRFEDVYQLQEDVL-GEGAHARVQTCINLITSQEYAVKII-EKQPGHIRSRVFR-EV 61
Query: 830 LTLGKIR-HRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALG 887
L + + HRN+++L F + + L++E M GS+ +H E ++
Sbjct: 62 EMLYQCQGHRNVLELIEF-FEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQD- 119
Query: 888 AAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVID------MPQSK 938
A L +LH I HRD+K NIL + + + DF L I +
Sbjct: 120 VASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTP 176
Query: 939 SMSAVAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLA 993
+ GS Y+APE ++CD++S GV+L LL+G P G
Sbjct: 177 ELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV--GRCGSDC 234
Query: 994 TWVRNYIRDHSLTPGIFD 1011
W R +F+
Sbjct: 235 GWDRGEACPAC-QNMLFE 251
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 2e-26
Identities = 77/316 (24%), Positives = 120/316 (37%), Gaps = 58/316 (18%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYG 845
+ G + VY+A + SG+ A+K+L SN E + E+ + K+ H NIV+
Sbjct: 36 LAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK--NRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 846 FCYHQGSN-------LLIYEYMERGSLGELLHGSSCNLEWPTRF------MIALGAAEGL 892
L+ + +G L E L +E I +
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLK----KMESRGPLSCDTVLKIFYQTCRAV 149
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA-------- 944
++H KP I HRD+K N+LL ++ + DFG A I S SA
Sbjct: 150 QHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 945 ---GSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR 997
+ Y PE Y+ + EK DI++ G +L L + P +DG L
Sbjct: 209 TRNTTPMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQH---PFEDGAKLR---- 260
Query: 998 NYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057
I + + DT+ S++ M L+V +P +R S+ EVV L E
Sbjct: 261 --IVNGKYSIPPHDTQ-YTVFHSLIRAM---LQV-------NPEERLSIAEVVHQLQEIA 307
Query: 1058 EREGRFNSSPTYDLPQ 1073
SP +L +
Sbjct: 308 AARNVNPKSPITELLE 323
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-26
Identities = 48/215 (22%), Positives = 88/215 (40%), Gaps = 23/215 (10%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGK 834
+ Y + +G G +G V++ V S K K + +G + + EI L
Sbjct: 3 LYEKYMIAE--DLGRGEFGIVHRCVETSSKKTYMAKFV--KVKGTDQVL-VKKEISILNI 57
Query: 835 IRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAA 889
RHRNI+ L+ ++I+E++ G ++ N ++ +
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFIS-G--LDIFERINTSAFELNEREIVSYVHQV--C 112
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSY 947
E L +LH I H DI+ NI+ + + + +FG A+ + + + +
Sbjct: 113 EALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--PGDNFRLLFTAP 167
Query: 948 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y APE V+ D++S G ++ LL+G P
Sbjct: 168 EYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINP 202
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 3e-26
Identities = 60/206 (29%), Positives = 108/206 (52%), Gaps = 25/206 (12%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLA-SNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G+G Y TVYK + +G VA+K++ + EG ++ R EI + +++H NIV+LY
Sbjct: 13 LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPS-TAIR-EISLMKELKHENIVRLYD 70
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAA------EGLAYLHHDC 899
+ + L++E+M+ L + + S P + L +GLA+ H +
Sbjct: 71 VIHTENKLTLVFEFMDN-DLKKYMD-SRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN- 127
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY----- 954
+I HRD+K N+L++ + + +GDFGLA+ +P + S+ + Y AP+
Sbjct: 128 --KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP-VNTFSSEVVTLWYRAPDVLMGSR 184
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGR 980
Y+ + DI+S G +L E++TG+
Sbjct: 185 TYSTSI----DIWSCGCILAEMITGK 206
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-26
Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 36/222 (16%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
++G+G++G V++A + VA+KK+ ++ N R E+ + ++H N+V L F
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN-----R-ELQIMRIVKHPNVVDLKAF 100
Query: 847 CYHQGSNL------LIYEYMERGSLGELL-HGSSCNLEWPTR----FMIALGAAEGLAYL 895
Y G L+ EY+ ++ H + P +M L LAY+
Sbjct: 101 FYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQL--LRSLAYI 157
Query: 896 HHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE- 953
H I HRDIK N+LLD + DFG AK++ ++S + Y Y APE
Sbjct: 158 H---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI-AGEPNVSYICSRY-YRAPEL 212
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
YT + DI+S G V+ EL+ G+ P+ P + G D
Sbjct: 213 IFGATNYTTNI----DIWSTGCVMAELMQGQ-PLFPGESGID 249
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-26
Identities = 69/308 (22%), Positives = 106/308 (34%), Gaps = 75/308 (24%)
Query: 789 GSGAYGTVYKAV------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-RHR 838
GSGA+G V A VAVK L A + E + +E+ + ++ H
Sbjct: 54 GSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE----REALMSELKMMTQLGSHE 109
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF---------------- 882
NIV L G C G LI+EY G L L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 883 ------MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936
A A+G+ +L HRD+ + N+L+ + DFGLA+ I
Sbjct: 170 TFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM--- 223
Query: 937 SKSMSAVAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGG 990
+ V + APE + T K D++SYG++L E+ + G P +
Sbjct: 224 -SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA 282
Query: 991 DLATWVRN-YIRDHSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPS 1045
+ ++N + ++ +E I M C + RPS
Sbjct: 283 NFYKLIQNGF-------------KMDQPFYATEE-IYIIM-------QSCWAFDSRKRPS 321
Query: 1046 MREVVSML 1053
+ S L
Sbjct: 322 FPNLTSFL 329
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-25
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 39/230 (16%)
Query: 776 VEATYNFHDSFIVGSGAYGTVYKAV---MDSGKIVAVKKLASNREGNNIESSFRAEILTL 832
VE + + + G G YG VYKA K A+K++ G ++ S+ R EI L
Sbjct: 18 VEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYALKQI--EGTGISM-SACR-EIALL 72
Query: 833 GKIRHRNIVKLYG-FCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAA- 889
+++H N++ L F H + L+++Y E L ++ + + G
Sbjct: 73 RELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 890 -------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSK 938
+G+ YLH + + HRD+K NIL+ + + D G A++ + P K
Sbjct: 132 SLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP-LK 187
Query: 939 SMSAVAGS---YGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGR 980
++ + + Y APE YT + DI++ G + ELLT
Sbjct: 188 PLADLDPVVVTFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLTSE 233
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 56/287 (19%), Positives = 98/287 (34%), Gaps = 39/287 (13%)
Query: 126 VHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNN 184
+ LDL+ N +T ++ C L+ L L +N + I + L SL L++ N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYN 110
Query: 185 MISGALPEGL-GNLSSLVDFVAYTNNLTGPLPQSI-GNLRNLRVFRAGQNAISGSIPAEI 242
+S L LSSL N S+ +L L++ R G I
Sbjct: 111 YLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQR-- 167
Query: 243 SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALY 302
L L E+ + + L + P L + + L L+
Sbjct: 168 -----------------KDFAG----LTFLEELEIDASDLQSYEPKSLKSIQNVSHLILH 206
Query: 303 SNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI--------GNLSMVTEIDLSENS 353
+ + + + L L +L+ E+ + +++ S
Sbjct: 207 MKQHI-LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDES 265
Query: 354 LNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
L ++ ++I+GL L +NQL V L +L K+ L N
Sbjct: 266 LF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 9e-24
Identities = 53/275 (19%), Positives = 104/275 (37%), Gaps = 17/275 (6%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
SIP+ ++ ++++ L L+ N I ++ +L +VL N + + L
Sbjct: 45 SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSL 102
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSL 354
+ L L N L + L LT L L N + +L+ + + +
Sbjct: 103 EHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDT 161
Query: 355 NGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHL 413
+I + F+ +T L L + + L P L S++N++ L L + + +
Sbjct: 162 FTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVT 221
Query: 414 TQMRQLQLFEN--------SLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLI 465
+ + L+L + L+ G L V + L ++ L Q S L+
Sbjct: 222 SSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLL 280
Query: 466 MLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLT 499
L N+L ++P + +L ++ L N
Sbjct: 281 ELEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPWD 314
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 6e-20
Identities = 59/356 (16%), Positives = 104/356 (29%), Gaps = 91/356 (25%)
Query: 348 DLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIP 407
S SLN IP+ + ++ L L N++T + ++L NL L L+ N + I
Sbjct: 37 KGSSGSLN-SIPSGLT--EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IE 92
Query: 408 VG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLI 465
F L + L L S+NYL+ + + S+L
Sbjct: 93 EDSFSSLGSLEHLDL------------------------SYNYLS-NLSSSWFKPLSSLT 127
Query: 466 MLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGP 525
LNL N T + + L L + +
Sbjct: 128 FLNLLGNPYKTLGETSLFS-----------------------HLTKLQILRVGNMDTFTK 164
Query: 526 IPPEI-ENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTL 584
I + L+ L I + S L + +
Sbjct: 165 IQRKDFAGLTFLEELEIDASDLQS----------------YEPKSLKSIQ--------NV 200
Query: 585 QRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN--------IPSTLGNLSHLTELQ 636
L + + L + +E L+L + ++L ++
Sbjct: 201 SHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVK 260
Query: 637 MGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHL 691
+ ++ L +S L L S N L S+P +L L+ + L+ N
Sbjct: 261 ITDESLF-QVMKLLNQISGLLE-LEFSRNQLK-SVPDGIFDRLTSLQKIWLHTNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 7e-20
Identities = 52/288 (18%), Positives = 100/288 (34%), Gaps = 31/288 (10%)
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLT- 499
+ S L IP L + L+L N++ I L C L L L N +
Sbjct: 35 ICKGSSGSLN-SIPSGL--TEAVKSLDLSNNRI-TYISNSDLQRCVNLQALVLTSNGINT 90
Query: 500 ---GSFPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV- 554
SF L +L ++L N S + + L L++ N + + +
Sbjct: 91 IEEDSF----SSLGSLEHLDLSYNYLSN-LSSSWFKPLSSLTFLNLLGNPYKTLGETSLF 145
Query: 555 GNLSQLVTFNISSNMLTGLIPPEI-VNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKL 613
+L++L + + I + L+ L+I + P L ++Q + L L
Sbjct: 146 SHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLIL 205
Query: 614 SENKFSGNIPSTLGNLSHLTELQMGGNLFSG----EIPP----ELGDLSSLQIALNLSYN 665
+ + + S + L++ E+ L + + + ++
Sbjct: 206 HMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRN-VKITDE 264
Query: 666 NLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL----LGSN 709
+L + L ++ L L + N L F+ L+SL L +N
Sbjct: 265 SLF-QVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 85.6 bits (212), Expect = 8e-18
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 17/218 (7%)
Query: 124 GLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNI 181
L L +LDL+YN L+ + S L L L N + L L+ L L +
Sbjct: 98 SLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRV 156
Query: 182 CNNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPA 240
N + L+ L + ++L P+S+ +++N+ +
Sbjct: 157 GNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLE 215
Query: 241 EI-SGCQSLQILGLAQNDIGGSLPKEI--------GMLESLTEIVLWDNQLTGFIPSELG 291
S++ L L D+ E+ + + + D L + L
Sbjct: 216 IFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQ-VMKLLN 274
Query: 292 NCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
+ L L N L +P + L L K++L+ N
Sbjct: 275 QISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 2e-15
Identities = 37/194 (19%), Positives = 77/194 (39%), Gaps = 10/194 (5%)
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSF 594
++ L ++NN T ++ L ++SN + I + + + L+ LD+S+N
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSLEHLDLSYNY- 111
Query: 595 VGSLPNEL-GTLQQLEILKLSENKFSGNIP-STLGNLSHLTELQMGGNLFSGEIPPE-LG 651
+ +L + L L L L N + S +L+ L L++G +I +
Sbjct: 112 LSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 652 DLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNF 710
L+ L+ L + ++L S P+ L + + L+L+ + + SS+
Sbjct: 172 GLTFLE-ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLEL 229
Query: 711 SYNNLTG-PLPSIP 723
+L +
Sbjct: 230 RDTDLDTFHFSELS 243
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 6e-12
Identities = 39/177 (22%), Positives = 64/177 (36%), Gaps = 14/177 (7%)
Query: 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP 623
SS L IP + ++ LD+S+N ++L L+ L L+ N +
Sbjct: 37 KGSSGSLNS-IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 624 STLGNLSHLTELQMGGNLFSGEIPPEL-GDLSSLQIALNLSYNNLSGSIPPE--LGKLDL 680
+ +L L L + N S + LSSL LNL N ++ L
Sbjct: 94 DSFSSLGSLEHLDLSYNYLS-NLSSSWFKPLSSLTF-LNLLGNPYK-TLGETSLFSHLTK 150
Query: 681 LEFLLLNNNHLSGEIPS-AFENLSSLLGSNFSYNNLT----GPLPSIPQFQNMDISS 732
L+ L + N +I F L+ L ++L L SI ++ +
Sbjct: 151 LQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHM 207
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 62.8 bits (153), Expect = 2e-10
Identities = 27/184 (14%), Positives = 56/184 (30%), Gaps = 43/184 (23%)
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNIC 182
GL L L++ ++L Y P+ + + + HL L+ Q + SS+ L +
Sbjct: 172 GLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI-LLLEIFVDVTSSVECLELR 230
Query: 183 NNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI 242
+ + T + + +L
Sbjct: 231 DTDLD-------------------TFHFSELSTGETNSLIKK------------------ 253
Query: 243 SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALY 302
+ + + + + + K + + L E+ NQL T LQ + L+
Sbjct: 254 ---FTFRNVKITDESL-FQVMKLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLH 309
Query: 303 SNNL 306
+N
Sbjct: 310 TNPW 313
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 23/136 (16%), Positives = 52/136 (38%), Gaps = 11/136 (8%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L+++A + S+ + ++++L L + + + S +E L L +
Sbjct: 178 ELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF 237
Query: 166 IPAEL--------GKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQS 217
+EL K + ++ I + + + + L +S L++ N L +P
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDG 295
Query: 218 I-GNLRNLRVFRAGQN 232
I L +L+ N
Sbjct: 296 IFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 16/97 (16%), Positives = 35/97 (36%), Gaps = 11/97 (11%)
Query: 124 GLVHLTYLDLAYNELTGYIPREI--------GNCSRLEHLYLNNNQFSGKIPAELGKLSS 175
+ L+L +L + E+ ++ + + ++ L ++S
Sbjct: 220 VTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278
Query: 176 LVSLNICNNMISGALPEG-LGNLSSLVDFVAYTNNLT 211
L+ L N + +P+G L+SL +TN
Sbjct: 279 LLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD 314
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 79/317 (24%), Positives = 116/317 (36%), Gaps = 94/317 (29%)
Query: 789 GSGAYGTVYKAVMDSGK------IVAVKKL---ASNREGNNIESSFRAEILTLGKIRHRN 839
G GA+G V++A +VAVK L AS ++ F+ E + + + N
Sbjct: 56 GEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QADFQREAALMAEFDNPN 111
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF----------------- 882
IVKL G C L++EYM G L E L S +
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 883 ------MIALGAAEGLAYL--HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934
IA A G+AYL HRD+ + N L+ + + DFGL++ I
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSRNI-- 224
Query: 935 PQSKSMSA---VAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQP 985
SA A I PE + + T + D+++YGVVL E+ + G P
Sbjct: 225 -----YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279
Query: 986 LDDGGDLATWVRNYIRD-HSL------TPGIFDTRLNVEDESIVDHMILVLKVALM--CT 1036
+ V Y+RD + L +++ LM C
Sbjct: 280 MAH-----EEVIYYVRDGNILACPENCPLELYN---------------------LMRLCW 313
Query: 1037 SISPFDRPSMREVVSML 1053
S P DRPS + +L
Sbjct: 314 SKLPADRPSFCSIHRIL 330
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 57/236 (24%), Positives = 96/236 (40%), Gaps = 56/236 (23%)
Query: 771 SFQDVVEATYNFHDSF-IVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAE 828
F Y+ +G G++ K V S + AVK ++ E ++ + E
Sbjct: 5 PFYQH----YDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME-----ANTQKE 55
Query: 829 ILTLGKIR-HRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIAL 886
I L H NIVKL+ +H + L+ E + G GEL R +
Sbjct: 56 ITALKLCEGHPNIVKLHEV-FHDQLHTFLVMELLN-G--GELFE----------R-IKKK 100
Query: 887 G------AA-------EGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAK 930
A+ ++++H + HRD+K N+L D+ + + DFG A+
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR 157
Query: 931 VIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ P ++ + + Y APE Y E CD++S GV+L +L+G+ P
Sbjct: 158 LKP-PDNQPLKTPCFTLHYAAPELLNQNGYD----ESCDLWSLGVILYTMLSGQVP 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-25
Identities = 55/221 (24%), Positives = 92/221 (41%), Gaps = 35/221 (15%)
Query: 779 TYNFHDSFIV----GSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLG 833
+ F D + V G G+Y + + + AVK + ++ EI L
Sbjct: 17 SIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILL 70
Query: 834 K-IRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEG 891
+ +H NI+ L Y G + ++ E M+ G L + + E ++ +
Sbjct: 71 RYGQHPNIITLKDV-YDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFT-ITKT 128
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAH----VGDFGLAKVIDMPQSKSMSAVAGSY 947
+ YLH + HRD+K +NIL D+ + DFG AK + ++ + +
Sbjct: 129 VEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR-AENGLLMTPCYTA 184
Query: 948 GYIAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
++APE Y CDI+S GV+L +LTG TP
Sbjct: 185 NFVAPEVLERQGY------DAACDIWSLGVLLYTMLTGYTP 219
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 3e-25
Identities = 58/240 (24%), Positives = 96/240 (40%), Gaps = 33/240 (13%)
Query: 771 SFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEI 829
+ + + F + G G +GTV +G VA+KK+ + N E +
Sbjct: 14 ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IM 70
Query: 830 LTLGKIRHRNIVKLYGFCYHQGSN-------LLIYEYMERGSLGELL-HGSSCNLEWPTR 881
L + H NIV+L + Y G ++ EY+ +L + + P
Sbjct: 71 QDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129
Query: 882 ----FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQ 936
F+ L + LH + HRDIK +N+L++ + DFG AK + P
Sbjct: 130 LIKVFLFQL--IRSIGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS-PS 185
Query: 937 SKSMSAVAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
+++ + Y Y APE YT V DI+S G + E++ G P+ D+
Sbjct: 186 EPNVAYICSRY-YRAPELIFGNQHYTTAV----DIWSVGCIFAEMMLGE-PIFRGDNSAG 239
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 5e-25
Identities = 49/218 (22%), Positives = 87/218 (39%), Gaps = 13/218 (5%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
++P I + Q + L N I +LT + L N L + L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSL 354
+ L L N + + L L L+L R L + + L+ + + L +N+L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNAL 141
Query: 355 NGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQH 412
+P + F + L LFL N+++ V L +L +L L N + + F+
Sbjct: 142 Q-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH-VHPHAFRD 199
Query: 413 LTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHN 448
L ++ L LF N+L+ +P L +L + + + N
Sbjct: 200 LGRLMTLYLFANNLS-ALPTEALAPLRALQY-LRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 50/218 (22%), Positives = 82/218 (37%), Gaps = 13/218 (5%)
Query: 261 SLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKF 319
++P I + I L N+++ + C L L L+SN L +I L
Sbjct: 25 AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLAL 81
Query: 320 LTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQ 377
L +L L N ++ L + + L L E+ F + L+ L+L N
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNA 140
Query: 378 LTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL--G 435
L + + L NLT L L N ++ F+ L + +L L +N + + P
Sbjct: 141 LQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRD 199
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYN 472
L L+ + N L+ +P L L L N
Sbjct: 200 LGRLM-TLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 1e-21
Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 14/225 (6%)
Query: 208 NNLTGPLPQSI-GNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEI 266
L +P I + + + N IS A C++L IL L N +
Sbjct: 21 QGLQA-VPVGIPAASQRIFLHG---NRISHVPAASFRACRNLTILWLHSNVLARIDAAAF 76
Query: 267 GMLESLTEIVLWDNQLTGFIPSE-LGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLY 324
L L ++ L DN + +L TL L L ++ + L L LY
Sbjct: 77 TGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLY 135
Query: 325 LYRNELNGTIPREI-GNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVI 382
L N L +P + +L +T + L N ++ +P F + L L L QN++ V
Sbjct: 136 LQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVH 193
Query: 383 PNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSL 426
P+ L L L L N L+ +P L ++ L+L +N
Sbjct: 194 PHAFRDLGRLMTLYLFANNLSA-LPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 3e-20
Identities = 55/237 (23%), Positives = 90/237 (37%), Gaps = 15/237 (6%)
Query: 459 CQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELD 518
C N + + L +P + ++ L GN ++ NL + L
Sbjct: 8 CYNEPKVTTSCPQQGL-QAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 519 QNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGLIPP 576
N + I L++L +++N + L +L T ++ L + P
Sbjct: 65 SNVLAR-IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGP 122
Query: 577 EI-VNCMTLQRLDISHNSFVGSLPNE-LGTLQQLEILKLSENKFSGNIPSTLGNLSHLTE 634
+ LQ L + N+ +LP++ L L L L N+ S L L
Sbjct: 123 GLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDR 181
Query: 635 LQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNN 689
L + N + + P DL L L L NNLS ++P E L L L++L LN+N
Sbjct: 182 LLLHQNRVA-HVHPHAFRDLGRLMT-LYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 4e-20
Identities = 47/201 (23%), Positives = 78/201 (38%), Gaps = 16/201 (7%)
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSF 594
QR+ + N + L + SN+L I + L++LD+S N+
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 595 VGSLPNE-LGTLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGGNLFSGEIPPE-LG 651
+ S+ L +L L L + L+ L L + N +P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFR 150
Query: 652 DLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNF 710
DL +L L L N +S S+P L L+ LLL+ N ++ P AF +L L+
Sbjct: 151 DLGNLTH-LFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYL 208
Query: 711 SYNNLTGPLPSIPQ--FQNMD 729
NNL+ ++P +
Sbjct: 209 FANNLS----ALPTEALAPLR 225
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 52/276 (18%), Positives = 90/276 (32%), Gaps = 58/276 (21%)
Query: 129 TYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISG 188
L +P I + + ++L+ N+ S A +L L + +N+++
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA- 69
Query: 189 ALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQS 247
+ F L L NA S+ G
Sbjct: 70 RIDAAA--------F---------------TGLALLEQLDLSDNAQLRSVDPATFHGLGR 106
Query: 248 LQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSE-LGNCTKLQTLALYSNN 305
L L L + + L + L +L + L DN L +P + + L L L+ N
Sbjct: 107 LHTLHLDRCGL-QELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNR 164
Query: 306 LVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSK 364
+ +P+ L L +L L++N + + F
Sbjct: 165 IS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHA-----------------------FRD 199
Query: 365 ITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
+ L L+LF N L+ + L+ LR L L L+ N
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 9e-20
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 9/206 (4%)
Query: 128 LTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLVSLNICNNMI 186
+ L N ++ C L L+L++N + +I A L+ L L++ +N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQ 92
Query: 187 SGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SG 244
++ L L L P L L+ NA+ ++P +
Sbjct: 93 LRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ-ALPDDTFRD 151
Query: 245 CQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
+L L L N I S+P+ L SL ++L N++ P + +L TL L++
Sbjct: 152 LGNLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 304 NNLVGQIPKEV-GNLKFLTKLYLYRN 328
NNL +P E L+ L L L N
Sbjct: 211 NNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 2e-16
Identities = 50/208 (24%), Positives = 73/208 (35%), Gaps = 11/208 (5%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
+ L+ N + + +LT L L N L I + LE L L++N
Sbjct: 36 RIFLH-GNRISHVPAASFRACRNLTILWLHSNVLA-RIDAAAFTGLALLEQLDLSDNAQL 93
Query: 164 GKIPAE-LGKLSSLVSLNICNNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNL 221
+ L L +L++ + L G L++L N L + +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDL 152
Query: 222 RNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWD 279
NL N IS S+P G SL L L QN + + L L + L+
Sbjct: 153 GNLTHLFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFA 210
Query: 280 NQLTGFIPSELGNCTKLQTLALYSNNLV 307
N L+ L LQ L L N V
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWV 238
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 33/154 (21%), Positives = 53/154 (34%), Gaps = 9/154 (5%)
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
L +P I QR+ + N + L IL L N + +
Sbjct: 19 PQQGLQA-VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAA 75
Query: 626 LGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEF 683
L+ L +L + N + P L L L+L L + P L L++
Sbjct: 76 FTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHT-LHLDRCGLQ-ELGPGLFRGLAALQY 133
Query: 684 LLLNNNHLSGEIPS-AFENLSSLLGSNFSYNNLT 716
L L +N L +P F +L +L N ++
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRIS 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 8e-25
Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 33/212 (15%)
Query: 788 VGSGAYGTVYKA--VMDSGKIVAVKK--LASNREGNNIESSFRAEI---LTLGKIRHRNI 840
+G GAYG V+KA + + G+ VA+K+ + + EG + S+ R E+ L H N+
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIR-EVAVLRHLETFEHPNV 76
Query: 841 VKLY----GFCYHQGSNL-LIYEYMERGSLGELL-HGSSCNLEWPT--RFMIALGAAEGL 892
V+L+ + + L L++E++++ L L + T M L GL
Sbjct: 77 VRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQL--LRGL 133
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
+LH R+ HRD+K NIL+ + + DFGLA++ ++++V + Y AP
Sbjct: 134 DFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVVTLWYRAP 188
Query: 953 EY----AYTMKVTEKCDIYSYGVVLLELLTGR 980
E +Y V D++S G + E+ +
Sbjct: 189 EVLLQSSYATPV----DLWSVGCIFAEMFRRK 216
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-24
Identities = 73/258 (28%), Positives = 110/258 (42%), Gaps = 18/258 (6%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+++ +L E+P S T RLL L +NQ+ + N LR+L L LS N++
Sbjct: 46 SKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT 102
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLCQN 461
I +G F L + L+LF+N LT IP G L L + +N + IP +
Sbjct: 103 -IEIGAFNGLANLNTLELFDNRLT-TIPNGAFVYLSKLK-ELWLRNNPIE-SIPSYAFNR 158
Query: 462 -SNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ 519
+L L+LG K I L L L +L P L L L ++L
Sbjct: 159 IPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSG 216
Query: 520 NKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEI 578
N S I P + LQ+L + + NL LV N++ N LT L P ++
Sbjct: 217 NHLSA-IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLL-PHDL 274
Query: 579 VNCMT-LQRLDISHNSFV 595
+ L+R+ + HN +
Sbjct: 275 FTPLHHLERIHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 2e-24
Identities = 55/277 (19%), Positives = 93/277 (33%), Gaps = 34/277 (12%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
+ + L +P I + L L+ NQ L L L + N I
Sbjct: 44 QFSKVICVRKNLR-EVPDGIS--TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI 100
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGC 245
L++L + N LT + L L+ N I SIP+ +
Sbjct: 101 RTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRI 159
Query: 246 QSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNN 305
SL+ L L + +L+ + L+ L L N
Sbjct: 160 PSLRRLDLGEL-----------------------KRLSYISEGAFEGLSNLRYLNLAMCN 196
Query: 306 LVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSLNGEIPTE-FS 363
L +IP + L L +L L N L+ I L + ++ + ++ + I F
Sbjct: 197 LR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFD 252
Query: 364 KITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
+ L + L N LT + + + L +L ++ L N
Sbjct: 253 NLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 3e-21
Identities = 66/297 (22%), Positives = 103/297 (34%), Gaps = 23/297 (7%)
Query: 431 PPGLG---LYSLLWVVDFSHNYLTGRIP--PHLCQ-NSNLIMLNLGYNKLFGNIPTDVLN 484
PG+ L SLL V+ TG P +C ++ + L +P +
Sbjct: 6 SPGMPALLLVSLLSVLLMGCVAETGSAQTCPSVCSCSNQFSKVICVRKNL-REVPDGIS- 63
Query: 485 CETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIAN 543
L L N + L +L ++L +N I L L + +
Sbjct: 64 -TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFD 121
Query: 544 NYFTSELPKEV-GNLSQLVTFNISSNMLTGLIPPEI-VNCMTLQRLDISHNSFVGSLPNE 601
N T+ +P LS+L + +N + IP +L+RLD+ + +
Sbjct: 122 NRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEG 179
Query: 602 -LGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIA 659
L L L L+ IP L L L EL + GN S I P L LQ
Sbjct: 180 AFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQK- 235
Query: 660 LNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNL 715
L + + + I L L + L +N+L+ F L L + +N
Sbjct: 236 LWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 57/270 (21%), Positives = 102/270 (37%), Gaps = 23/270 (8%)
Query: 407 PVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLI 465
P Q ++ +L +P G+ + +++ N + I + ++ +L
Sbjct: 36 PSVCSCSNQFSKVICVRKNLRE-VPDGI--STNTRLLNLHENQIQ-IIKVNSFKHLRHLE 91
Query: 466 MLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLT----GSFPLELCKLENLYAIELDQN 520
+L L N + I L L L N LT G+F + L KL+ L+ L N
Sbjct: 92 ILQLSRNHI-RTIEIGAFNGLANLNTLELFDNRLTTIPNGAF-VYLSKLKELW---LRNN 146
Query: 521 KFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGLIPPEI 578
IP L+RL + S + + LS L N++ L + P +
Sbjct: 147 PIES-IPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLREI--PNL 203
Query: 579 VNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMG 638
+ L LD+S N P L L+ L + +++ + NL L E+ +
Sbjct: 204 TPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLA 263
Query: 639 GNLFSGEIPPE-LGDLSSLQIALNLSYNNL 667
N + +P + L L+ ++L +N
Sbjct: 264 HNNLT-LLPHDLFTPLHHLE-RIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 1e-18
Identities = 50/231 (21%), Positives = 87/231 (37%), Gaps = 17/231 (7%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
L+L+ N + + L HL L L+ N + I + L L L +N+ +
Sbjct: 68 LLNLH-ENQIQIIKVNSFKHLRHLEILQLSRNHIR-TIEIGAFNGLANLNTLELFDNRLT 125
Query: 164 GKIPAE-LGKLSSLVSLNICNN---MISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIG 219
IP LS L L + NN I + +L L + L+ +
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRL--DLGELKRLSYISEGAFE 182
Query: 220 NLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLW 278
L NLR + IP ++ L L L+ N + ++ L L ++ +
Sbjct: 183 GLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMI 239
Query: 279 DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
+Q+ + N L + L NNL +P ++ L L +++L+ N
Sbjct: 240 QSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 1e-15
Identities = 52/189 (27%), Positives = 75/189 (39%), Gaps = 11/189 (5%)
Query: 124 GLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNI 181
GL +L L+L N LT IP S+L+ L+L NN IP+ ++ SL L++
Sbjct: 110 GLANLNTLELFDNRLT-TIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL 167
Query: 182 C-NNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+S + EG LS+L NL ++ L L N +S +I
Sbjct: 168 GELKRLS-YISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLS-AIR 223
Query: 240 AEI-SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQT 298
G LQ L + Q+ I L+SL EI L N LT L+
Sbjct: 224 PGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLER 283
Query: 299 LALYSNNLV 307
+ L+ N
Sbjct: 284 IHLHHNPWN 292
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 4e-14
Identities = 43/197 (21%), Positives = 65/197 (32%), Gaps = 36/197 (18%)
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFV 595
+ L++ N +L L +S N + I +F
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIR----------------TIEIGAFN 109
Query: 596 GSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPEL-GDLS 654
G L L L+L +N+ + LS L EL + N IP +
Sbjct: 110 G--------LANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIP 160
Query: 655 SLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYN 713
SL+ L+L I L L +L L +L EIP L L + S N
Sbjct: 161 SLRR-LDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDELDLSGN 217
Query: 714 NLTGPLPSIPQ--FQNM 728
+L+ +I FQ +
Sbjct: 218 HLS----AIRPGSFQGL 230
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 24/94 (25%), Positives = 39/94 (41%), Gaps = 6/94 (6%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLV 177
P++ L+ L LDL+ N L+ I L+ L++ +Q I L SLV
Sbjct: 201 PNLTPLIKLDELDLSGNHLS-AIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLV 258
Query: 178 SLNICNNMISGALPEG-LGNLSSLVDFVAYTNNL 210
+N+ +N ++ LP L L + N
Sbjct: 259 EINLAHNNLT-LLPHDLFTPLHHLERIHLHHNPW 291
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-24
Identities = 55/223 (24%), Positives = 86/223 (38%), Gaps = 36/223 (16%)
Query: 779 TYNFHDSFIV-----GSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTL 832
Y D + + G G G V + +G+ A+K L + + R E+
Sbjct: 23 KYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-------ARQEVDHH 75
Query: 833 GKI-RHRNIVKLYGFC---YHQGSNL-LIYEYMERGSLGELL-----HGSSCNLEWPTRF 882
+ +IV + +H L +I E ME G GEL G E
Sbjct: 76 WQASGGPHIVCILDVYENMHHGKRCLLIIMECME-G--GELFSRIQERGDQAFTEREAAE 132
Query: 883 MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKS 939
++ + +LH I HRD+K N+L K + + DFG AK +
Sbjct: 133 IM-RDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETT---QNA 185
Query: 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ + Y+APE K + CD++S GV++ LL G P
Sbjct: 186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-24
Identities = 57/277 (20%), Positives = 91/277 (32%), Gaps = 34/277 (12%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
+ + L+ +P+ I S +L L N L L L + N I
Sbjct: 55 QFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI 111
Query: 187 SGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SG 244
+ G L+SL + N LT + L LR N I SIP+ +
Sbjct: 112 R-QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNR 169
Query: 245 CQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSN 304
SL L L + +L L+ L L
Sbjct: 170 VPSLMRLDLGEL-----------------------KKLEYISEGAFEGLFNLKYLNLGMC 206
Query: 305 NLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE-FS 363
N+ +P + L L +L + N P LS + ++ + + ++ I F
Sbjct: 207 NIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFD 263
Query: 364 KITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
+ L L L N L+ + + + LR L +L L N
Sbjct: 264 GLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 66/261 (25%), Positives = 114/261 (43%), Gaps = 24/261 (9%)
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
+K+ R L+ +P+ I S ++L EN++ F + L +L L +N +
Sbjct: 56 FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GL 436
+ + L +L L+L N+LT IP G F++L+++R+L L N + IP +
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170
Query: 437 YSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
SL+ + L I + NL LNLG + ++P L +L + G
Sbjct: 171 PSLMRLDLGELKKLE-YISEGAFEGLFNLKYLNLGMCNIK-DMPNLT-PLVGLEELEMSG 227
Query: 496 NSLT----GSFPLELCKLENLYAIELDQNKFSGPIPPE-IENCQKLQRLHIANNYFTSEL 550
N GSF L L+ L+ + ++ S I + L L++A+N +S L
Sbjct: 228 NHFPEIRPGSFH-GLSSLKKLW---VMNSQVSL-IERNAFDGLASLVELNLAHNNLSS-L 281
Query: 551 PKEV-GNLSQLVTFNISSNML 570
P ++ L LV ++ N
Sbjct: 282 PHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-21
Identities = 62/267 (23%), Positives = 100/267 (37%), Gaps = 18/267 (6%)
Query: 456 PHLCQ-NSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYA 514
P +C ++ + L +P + L L+ N++ L +L
Sbjct: 47 PSVCSCSNQFSKVVCTRRGLS-EVPQGIP--SNTRYLNLMENNIQMIQADTFRHLHHLEV 103
Query: 515 IELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTG 572
++L +N I L L + +N+ T +P LS+L + +N +
Sbjct: 104 LQLGRNSIRQ-IEVGAFNGLASLNTLELFDNWLTV-IPSGAFEYLSKLRELWLRNNPIE- 160
Query: 573 LIPPEI-VNCMTLQRLDISHNSFVGSLPNE-LGTLQQLEILKLSENKFSGNIPSTLGNLS 630
IP +L RLD+ + + L L+ L L ++P L L
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLV 218
Query: 631 HLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNN 688
L EL+M GN F EI P LSSL+ L + + +S I L L L L +
Sbjct: 219 GLEELEMSGNHFP-EIRPGSFHGLSSLKK-LWVMNSQVS-LIERNAFDGLASLVELNLAH 275
Query: 689 NHLSGEIPSAFENLSSLLGSNFSYNNL 715
N+LS F L L+ + +N
Sbjct: 276 NNLSSLPHDLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 1e-19
Identities = 69/326 (21%), Positives = 107/326 (32%), Gaps = 85/326 (26%)
Query: 368 LRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
+ + L+ +P + S N L+L N + F+HL + LQL NS+
Sbjct: 56 FSKVVCTRRGLS-EVPQGIPS--NTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR 112
Query: 428 GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCET 487
I G F+ ++L L L N L IP+
Sbjct: 113 Q-IEVGA----------FNGL-------------ASLNTLELFDNWL-TVIPSGAFE--- 144
Query: 488 LLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYF 546
L KL L+ L N IP L RL +
Sbjct: 145 -----------------YLSKLRELW---LRNNPIES-IPSYAFNRVPSLMRLDLGELKK 183
Query: 547 TSELPKEV-GNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTL 605
+ + L L N+ + + P + + L+ L++S N
Sbjct: 184 LEYISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGN------------- 228
Query: 606 QQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSY 664
++ F G LS L +L + + S I L+SL LNL++
Sbjct: 229 ---HFPEIRPGSFHG--------LSSLKKLWVMNSQVS-LIERNAFDGLASLVE-LNLAH 275
Query: 665 NNLSGSIPPE-LGKLDLLEFLLLNNN 689
NNLS S+P + L L L L++N
Sbjct: 276 NNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 6e-19
Identities = 51/230 (22%), Positives = 88/230 (38%), Gaps = 15/230 (6%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSG 164
L+L N + + L HL L L N + I + L L L +N +
Sbjct: 79 YLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLASLNTLELFDNWLT- 136
Query: 165 KIPAE-LGKLSSLVSLNICNN---MISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGN 220
IP+ LS L L + NN I + +L L + L +
Sbjct: 137 VIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRL--DLGELKKLEYISEGAFEG 194
Query: 221 LRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKE-IGMLESLTEIVLWD 279
L NL+ G I +P ++ L+ L ++ N + L SL ++ + +
Sbjct: 195 LFNLKYLNLGMCNIK-DMPN-LTPLVGLEELEMSGNHF-PEIRPGSFHGLSSLKKLWVMN 251
Query: 280 NQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
+Q++ + L L L NNL +P ++ L++L +L+L+ N
Sbjct: 252 SQVSLIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 2e-15
Identities = 45/189 (23%), Positives = 67/189 (35%), Gaps = 11/189 (5%)
Query: 124 GLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLVSLNI 181
GL L L+L N LT IP S+L L+L NN IP+ ++ SL+ L++
Sbjct: 121 GLASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDL 178
Query: 182 -CNNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+ + EG L +L N+ ++ L L N I
Sbjct: 179 GELKKLE-YISEGAFEGLFNLKYLNLGMCNIKDM--PNLTPLVGLEELEMSGNHFP-EIR 234
Query: 240 AE-ISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQT 298
G SL+ L + + + L SL E+ L N L+ L
Sbjct: 235 PGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVE 294
Query: 299 LALYSNNLV 307
L L+ N
Sbjct: 295 LHLHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 75.6 bits (186), Expect = 3e-14
Identities = 40/198 (20%), Positives = 61/198 (30%), Gaps = 38/198 (19%)
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFV 595
+ L++ N +L L + N + I +F
Sbjct: 77 TRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSIR----------------QIEVGAFN 120
Query: 596 GSLPNELGTLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGGNLFSGEIPPE-LGDL 653
G L L L+L +N + IPS LS L EL + N IP +
Sbjct: 121 G--------LASLNTLELFDNWLT-VIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRV 170
Query: 654 SSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSY 712
SL L+L I L L++L L ++ ++P L L S
Sbjct: 171 PSLMR-LDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSG 227
Query: 713 NNLTGPLPSIPQ--FQNM 728
N+ I F +
Sbjct: 228 NHFP----EIRPGSFHGL 241
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 54.4 bits (131), Expect = 1e-07
Identities = 28/93 (30%), Positives = 44/93 (47%), Gaps = 4/93 (4%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLVS 178
P++ LV L L+++ N P S L+ L++ N+Q S I L+SLV
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVE 270
Query: 179 LNICNNMISGALPEG-LGNLSSLVDFVAYTNNL 210
LN+ +N +S +LP L LV+ + N
Sbjct: 271 LNLAHNNLS-SLPHDLFTPLRYLVELHLHHNPW 302
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-24
Identities = 60/213 (28%), Positives = 92/213 (43%), Gaps = 33/213 (15%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKK--LASNREGNNI--ESSFRAEI---LTLGKIRHRN 839
+G GAYGTVYKA SG VA+K + + G S+ R E+ L H N
Sbjct: 17 IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPN 75
Query: 840 IVKLYGFCYHQGSNL-----LIYEYMERGSLGELL-HGSSCNLEWPT--RFMIALGAAEG 891
+V+L C ++ L++E++++ L L L T M G
Sbjct: 76 VVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQF--LRG 132
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
L +LH + I HRD+K NIL+ + DFGLA++ +++ V + Y A
Sbjct: 133 LDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--MALTPVVVTLWYRA 187
Query: 952 PEY----AYTMKVTEKCDIYSYGVVLLELLTGR 980
PE Y V D++S G + E+ +
Sbjct: 188 PEVLLQSTYATPV----DMWSVGCIFAEMFRRK 216
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 8e-24
Identities = 50/234 (21%), Positives = 96/234 (41%), Gaps = 15/234 (6%)
Query: 490 QLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANN--YF 546
++R LT S P + + +EL+ NK +P + + +L +L +++N F
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 547 TSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNE--LGT 604
+ + L ++S N + + + L+ LD H++ + +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLS 124
Query: 605 LQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLS 663
L+ L L +S LS L L+M GN F P+ +L +L L+LS
Sbjct: 125 LRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLS 183
Query: 664 YNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
L + P L L+ L +++N+ ++ L+SL ++S N++
Sbjct: 184 QCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-23
Identities = 59/247 (23%), Positives = 95/247 (38%), Gaps = 16/247 (6%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLT--GFIPSELGNCT 294
S+P I S L L N + L LT++ L N L+ G T
Sbjct: 21 SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78
Query: 295 KLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENS 353
L+ L L N ++ + L+ L L + L + +L + +D+S
Sbjct: 79 SLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 137
Query: 354 LNGEIPTE-FSKITGLRLLFLFQNQ-LTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQ 411
F+ ++ L +L + N +P+ + LRNLT LDLS L P F
Sbjct: 138 TR-VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFN 196
Query: 412 HLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLCQN--SNLIML 467
L+ ++ L + N+ + L SL +D+S N++ Q+ S+L L
Sbjct: 197 SLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQV-LDYSLNHIM-TSKKQELQHFPSSLAFL 253
Query: 468 NLGYNKL 474
NL N
Sbjct: 254 NLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 55/301 (18%), Positives = 91/301 (30%), Gaps = 59/301 (19%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
+ N+ T S+ I T L+L N+L ++L L L++N S K
Sbjct: 11 EIRCNSKGLT-SVPTGI--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFK 67
Query: 166 --IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSI-GNLR 222
+SL L++ N + + L L +NL S+ +LR
Sbjct: 68 GCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 126
Query: 223 NLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQ 281
NL I +G SL++L +A N +
Sbjct: 127 NLIYLDISHTHTR-VAFNGIFNGLSSLEVLKMAGN-----------------------SF 162
Query: 282 LTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGN 340
F+P L L L L Q+ +L L L + N ++
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFP-- 218
Query: 341 LSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSL-RNLTKLDLSI 399
+ + L++L N + EL +L L+L+
Sbjct: 219 ---------------------YKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQ 257
Query: 400 N 400
N
Sbjct: 258 N 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-23
Identities = 57/235 (24%), Positives = 91/235 (38%), Gaps = 12/235 (5%)
Query: 478 IPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK--FSGPIPPEIENCQK 535
+PT + + +L L N L KL L + L N F G
Sbjct: 22 VPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTS 79
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEI-VNCMTLQRLDISHNSF 594
L+ L ++ N + + L QL + + L + + ++ L LDISH
Sbjct: 80 LKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHT 138
Query: 595 VGSLPNELGTLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGGNLFSGEIPPE-LGD 652
+ L LE+LK++ N F N L +LT L + ++ P
Sbjct: 139 RVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNS 197
Query: 653 LSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLL 706
LSSLQ+ LN+S+NN S+ L+ L+ L + NH+ ++ S L
Sbjct: 198 LSSLQV-LNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSL 250
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 1e-21
Identities = 58/329 (17%), Positives = 92/329 (27%), Gaps = 82/329 (24%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT- 403
TEI + L +PT + L L N+L + L LTKL LS N L+
Sbjct: 10 TEIRCNSKGLT-SVPTGIP--SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSF 66
Query: 404 GPIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNS 462
T ++ L L N + + +
Sbjct: 67 KGCCSQSDFGTTSLKYLDLSFNGVI-------------------------TMSSNFLGLE 101
Query: 463 NLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK 521
L L+ ++ L V + L+ L +
Sbjct: 102 QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR----------------VAFNGI 145
Query: 522 FSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGLIPPEIVN 580
F+G L+ L +A N F ++ L L ++S L
Sbjct: 146 FNG--------LSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE--------- 188
Query: 581 CMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGN 640
+S +F L L++L +S N F L+ L L N
Sbjct: 189 -------QLSPTAFNS--------LSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLN 233
Query: 641 LFSGEIPPE-LGDLSSLQIALNLSYNNLS 668
+ L S LNL+ N+ +
Sbjct: 234 HIM-TSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 27/198 (13%), Positives = 53/198 (26%), Gaps = 38/198 (19%)
Query: 788 VGSGAYGTVYKAVMDS--GKIVAVKKLASNREGNNIESS-FRAEILTLGKIRHRNIVKLY 844
G ++A+ D+ + VA+ + + + L L +I + ++
Sbjct: 39 HGGVPPLQFWQAL-DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ + L++ E++ GSL E+ S A H +
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVADTS---PSPVGAIRAMQSLAAAADAAHRA---GVA 151
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
+ + V G + + +
Sbjct: 152 LSIDHPSRVR--------VSIDGDVVL-------------AYPATMPD-------ANPQD 183
Query: 965 DIYSYGVVLLELLTGRTP 982
DI G L LL R P
Sbjct: 184 DIRGIGASLYALLVNRWP 201
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 6e-23
Identities = 60/265 (22%), Positives = 98/265 (36%), Gaps = 40/265 (15%)
Query: 742 RPVGNCGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIV----------GSG 791
P P + ++P PP Q V++ + I+ G G
Sbjct: 14 FPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLG 73
Query: 792 AYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFC-- 847
G V + + + A+K L + + R E+ + + +IV++
Sbjct: 74 INGKVLQIFNKRTQEKFALKML------QDCPKARR-EVELHWRASQCPHIVRIVDVYEN 126
Query: 848 -YHQGSNL-LIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
Y L ++ E ++ G GEL G E ++ E + YLH
Sbjct: 127 LYAGRKCLLIVMECLD-G--GELFSRIQDRGDQAFTEREASEIM-KSIGEAIQYLH---S 179
Query: 901 PRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
I HRD+K N+L K + DFG AK S++ + Y+APE
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGP 237
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTP 982
K + CD++S GV++ LL G P
Sbjct: 238 EKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 6e-23
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 31/210 (14%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVK-----KLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G G++G V D+ K+ A+K K E N+ E+ + + H +V
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNV----FKELQIMQGLEHPFLV 78
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIA-LGAAEGLAYLHHDC 899
L+ + + ++ ++ + + G L L + E + I L A L YL
Sbjct: 79 NLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA--LDYLQ--- 132
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE------ 953
RI HRD+K +NILLD+ H+ DF +A +P+ ++ +AG+ Y+APE
Sbjct: 133 NQRIIHRDMKPDNILLDEHGHVHITDFNIAA--MLPRETQITTMAGTKPYMAPEMFSSRK 190
Query: 954 -YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y+ V D +S GV ELL GR P
Sbjct: 191 GAGYSFAV----DWWSLGVTAYELLRGRRP 216
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 1e-22
Identities = 52/276 (18%), Positives = 89/276 (32%), Gaps = 25/276 (9%)
Query: 461 NSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFP---LELCKLENLYAIEL 517
S +L + TD++ +L +L + + L + + L + L
Sbjct: 43 RSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTL 102
Query: 518 DQNKFSGPIPPEIENCQ--KLQRLHIANNYFTSELPKEVGNLSQ-----LVTFNISSNML 570
+ + +G PP + L L++ N + + + L Q L +I+
Sbjct: 103 ENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHS 161
Query: 571 TGLIPPEIVNCMTLQRLDISHNSFVGSL-------PNELGTLQQLEILKLSENKFSGNIP 623
++ L LD+S N +G P + TLQ L + SG
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221
Query: 624 STLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEF 683
+ L L + N D S +LNLS+ L +P L L
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSV 278
Query: 684 LLLNNNHLSG-EIPSAFENLSSLLGSNFSYNNLTGP 718
L L+ N L P + +L + N
Sbjct: 279 LDLSYNRLDRNPSPDELPQVGNL---SLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 2e-22
Identities = 56/281 (19%), Positives = 93/281 (33%), Gaps = 32/281 (11%)
Query: 267 GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPK---EVGNLKFLTKL 323
G + D + +++ L+ L + + + +I V + L +L
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 324 YLYRNELNGTIPREIGNLSM--VTEIDLSENSLNGEIPTEFSKI-----TGLRLLFLFQN 376
L E+ GT P + + + ++L S +++ GL++L + Q
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLKPGLKVLSIAQA 159
Query: 377 QLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG----FQHLTQMRQLQLFEN---SLTGG 429
++ L+ LDLS N G + ++ L L + +G
Sbjct: 160 HSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGV 219
Query: 430 IPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKL---FGNIPTDVLNC 485
L +D SHN L C S L LNL + L +P
Sbjct: 220 CSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPA----- 274
Query: 486 ETLLQLRLVGNSLTG-SFPLELCKLENLYAIELDQNKFSGP 525
L L L N L P EL ++ NL L N F
Sbjct: 275 -KLSVLDLSYNRLDRNPSPDELPQVGNLS---LKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 85.7 bits (212), Expect = 4e-18
Identities = 52/263 (19%), Positives = 87/263 (33%), Gaps = 31/263 (11%)
Query: 480 TDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRL 539
+ NC + L G L L E D +F+ +I L+RL
Sbjct: 25 SSAFNCLGAADVELYGGGR------SLEYLLKRVDTEADLGQFT-----DIIKSLSLKRL 73
Query: 540 HIANNYFTSELPK---EVGNLSQLVTFNISSNMLTGLIPPEIVNCM--TLQRLDISHNSF 594
+ S + V +S L + + +TG PP ++ L L++ + S+
Sbjct: 74 TVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSW 133
Query: 595 VGSLPNELGTLQQ-----LEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPE 649
L LQQ L++L +++ + L+ L + N GE
Sbjct: 134 AT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLI 192
Query: 650 ----LGDLSSLQIALNLSYNN---LSGSIPPELGKLDLLEFLLLNNNHLSGEIP-SAFEN 701
+LQ+ L L SG L+ L L++N L + +
Sbjct: 193 SALCPLKFPTLQV-LALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 702 LSSLLGSNFSYNNLTGPLPSIPQ 724
S L N S+ L +P
Sbjct: 252 PSQLNSLNLSFTGLKQVPKGLPA 274
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 8e-16
Identities = 58/319 (18%), Positives = 87/319 (27%), Gaps = 80/319 (25%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPR---EIGNCSRLEHLYLNNNQFSGKIPAELGKL--S 174
I + L L + + I + S L+ L L N + +G P L +
Sbjct: 62 TDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGP 121
Query: 175 SLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAI 234
L LN+ N + L L +
Sbjct: 122 DLNILNLRNVSWAT-RDAWLAELQQWLK-------------------------------- 148
Query: 235 SGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNC- 293
L++L +AQ +++ + +L+ + L DN G C
Sbjct: 149 -----------PGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP 197
Query: 294 ---TKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLS 350
LQ LAL + + +G + +DLS
Sbjct: 198 LKFPTLQVLALRNAGM---------------------ETPSGVCSALAAARVQLQGLDLS 236
Query: 351 ENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG 409
NSL + L L L L V L+ LDLS N L P
Sbjct: 237 HNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKG---LPAKLSVLDLSYNRLDR-NPS- 291
Query: 410 FQHLTQMRQLQLFENSLTG 428
L Q+ L L N
Sbjct: 292 PDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 67.2 bits (164), Expect = 5e-12
Identities = 30/214 (14%), Positives = 64/214 (29%), Gaps = 35/214 (16%)
Query: 104 VWSLDLNAMNFTG--SLSPSIGGLV--HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNN 159
+ L+L +++ + + + L L +A + ++ L L L++
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 160 NQFSGKIP----AELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLP 215
N G+ K +L L + N + +G
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGM---------------------ETPSGVCS 221
Query: 216 QSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEIGMLESLTE 274
L+ N++ + A L L L+ + +PK + L+
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGL-KQVPKGL--PAKLSV 278
Query: 275 IVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVG 308
+ L N+L ++ L+L N +
Sbjct: 279 LDLSYNRLDRN--PSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 27/183 (14%), Positives = 51/183 (27%), Gaps = 26/183 (14%)
Query: 555 GNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLS 614
G S +I+ ++L+RL + +
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGA------------ 88
Query: 615 ENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQI-ALNLSYNNLSG--SI 671
+ +S L EL + +G PP L + + + LNL + + +
Sbjct: 89 ---------LRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAW 139
Query: 672 PPELGKLDL--LEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMD 729
EL + L+ L + H +L + S N G I +
Sbjct: 140 LAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLK 199
Query: 730 ISS 732
+
Sbjct: 200 FPT 202
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 16/85 (18%), Positives = 35/85 (41%), Gaps = 6/85 (7%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG 164
LDL+ + + L L+L++ L +P+ + ++L L L+ N+
Sbjct: 232 GLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQ-VPKGLP--AKLSVLDLSYNRLDR 288
Query: 165 KIPAELGKLSSLVSLNICNNMISGA 189
P+ L + +L++ N +
Sbjct: 289 -NPSPDE-LPQVGNLSLKGNPFLDS 311
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-22
Identities = 81/305 (26%), Positives = 125/305 (40%), Gaps = 43/305 (14%)
Query: 701 NLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASPSSGSVPP-- 758
L NF + +P +P+ + + L + SV P
Sbjct: 100 ACGRNLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGPCKDLFQELTRLTHEYLSVAPFA 159
Query: 759 --LNNVYFPPKEGFSFQDVVEATYN-FHDSFIVGSGAYGTVYKA-VMDSGKIVAVKKLAS 814
L+++YF + + + T N F ++G G +G V V +GK+ A KKL
Sbjct: 160 DYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEK 219
Query: 815 NR--EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGSLGELL-- 869
R + + E L K+ R +V L + Y L L+ M G G+L
Sbjct: 220 KRIKKRKGEAMA-LNEKQILEKVNSRFVVSLA-YAYETKDALCLVLTLM-NG--GDLKFH 274
Query: 870 ---HGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV 923
G + E F AAE GL LH + RI +RD+K NILLDD H+
Sbjct: 275 IYHMGQAGFPEARAVFY----AAEICCGLEDLH---RERIVYRDLKPENILLDD--HGHI 325
Query: 924 --GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLELL 977
D GLA +P+ +++ G+ GY+APE YT D ++ G +L E++
Sbjct: 326 RISDLGLAV--HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP----DWWALGCLLYEMI 379
Query: 978 TGRTP 982
G++P
Sbjct: 380 AGQSP 384
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 58/205 (28%), Positives = 82/205 (40%), Gaps = 13/205 (6%)
Query: 271 SLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNEL 330
S E+ LT +P +L L L N L + LT+L L R EL
Sbjct: 11 SHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67
Query: 331 NGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLR 390
T + G L ++ +DLS N L +P + L +L + N+LT + L L
Sbjct: 68 --TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLG 124
Query: 391 NLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSH 447
L +L L N L +P G ++ +L L N+LT +P GL GL L +
Sbjct: 125 ELQELYLKGNELKT-LPPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGL-ENLDTLLLQE 181
Query: 448 NYLTGRIPPHLCQNSNLIMLNLGYN 472
N L IP + L L N
Sbjct: 182 NSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 5e-16
Identities = 49/170 (28%), Positives = 71/170 (41%), Gaps = 8/170 (4%)
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFV 595
LH++ N + + ++L N+ LT L L LD+SHN
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ 90
Query: 596 GSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD-LS 654
SLP TL L +L +S N+ + L L L EL + GN +PP L
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK-TLPPGLLTPTP 148
Query: 655 SLQIALNLSYNNLSGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLS 703
L+ L+L+ NNL+ +P L L+ L+ LLL N L F +
Sbjct: 149 KLEK-LSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYTIPKGFFGSHL 196
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 50/205 (24%), Positives = 77/205 (37%), Gaps = 32/205 (15%)
Query: 126 VHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNM 185
T L L+ N L + + +RL L L+ + + K+ + G L L +L++ +N
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHNQ 88
Query: 186 ISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SG 244
+ +LP L +L N LT S+P G
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT-------------------------SLPLGALRG 122
Query: 245 CQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
LQ L L N++ +LP + L ++ L +N LT L L TL L
Sbjct: 123 LGELQELYLKGNEL-KTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 304 NNLVGQIPKEVGNLKFLTKLYLYRN 328
N+L IPK L +L+ N
Sbjct: 182 NSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 46/163 (28%), Positives = 70/163 (42%), Gaps = 14/163 (8%)
Query: 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP 623
++S N+L ++ L +L++ + L GTL L L LS N+ ++P
Sbjct: 37 HLSENLLYTFSLATLMPYTRLTQLNLDRAE-LTKLQ-VDGTLPVLGTLDLSHNQLQ-SLP 93
Query: 624 STLGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNLSGSIPPEL-GKLDLL 681
L LT L + N + +P L LQ L L N L ++PP L L
Sbjct: 94 LLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQE-LYLKGNELK-TLPPGLLTPTPKL 150
Query: 682 EFLLLNNNHLSGEIPS-AFENLSSLLGSNFSYNNLTGPLPSIP 723
E L L NN+L+ E+P+ L +L N+L +IP
Sbjct: 151 EKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY----TIP 188
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 52/201 (25%), Positives = 82/201 (40%), Gaps = 13/201 (6%)
Query: 443 VDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSF 502
V+ LT +PP L + +L+L N L+ ++ L QL L LT
Sbjct: 15 VNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KL 70
Query: 503 PLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLV 561
++ L L ++L N+ +P + L L ++ N TS LP L +L
Sbjct: 71 QVDG-TLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLDVSFNRLTS-LPLGALRGLGELQ 127
Query: 562 TFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSFVGSLPNEL-GTLQQLEILKLSENKFS 619
+ N L L PP ++ L++L +++N+ LP L L+ L+ L L EN
Sbjct: 128 ELYLKGNELKTL-PPGLLTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY 185
Query: 620 GNIPSTLGNLSHLTELQMGGN 640
IP L + GN
Sbjct: 186 -TIPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 3e-08
Identities = 32/116 (27%), Positives = 45/116 (38%), Gaps = 8/116 (6%)
Query: 608 LEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNL 667
IL LSEN +TL + LT+L + + G L L L+LS+N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT--KLQVDGTLPVLGT-LDLSHNQL 89
Query: 668 SGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIP 723
S+P L L L ++ N L+ A L L N L ++P
Sbjct: 90 Q-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELK----TLP 140
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 98.4 bits (245), Expect = 3e-22
Identities = 47/282 (16%), Positives = 94/282 (33%), Gaps = 39/282 (13%)
Query: 781 NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNI 840
+ ++++ + L+S + +I + +N
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSP----MDAPSVKIRRMDPFSTKNT 123
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFM--IALGAAEGLAYLHHD 898
V + + + + +L + ++ + I + AE + +LH
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH-- 181
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID-----------MPQSKSMSAVAGSY 947
+ HRD+K +NI VGDFGL +D MP + + G+
Sbjct: 182 -SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 948 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007
Y++PE + + K DI+S G++L ELL + + +R+
Sbjct: 241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLY------SFSTQMERVR-IITDVRNLKFPL 293
Query: 1008 GIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
+F + E + S SP +RP ++
Sbjct: 294 -LFTQKYPQEHMMV-----------QDMLSPSPTERPEATDI 323
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 3e-22
Identities = 55/208 (26%), Positives = 88/208 (42%), Gaps = 23/208 (11%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNR--EGNNIESSFRAEILTLGKIRHRNIVKLYG 845
G G+YG V + + ++ AVK L + N E++ + EI L ++RH+N+++L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVD 73
Query: 846 FCYHQGSNLLIYEYME--RGSLGELLHGSSCN--LEWPTRF----MIALGAAEGLAYLHH 897
Y++ +Y ME + E+L +I GL YLH
Sbjct: 74 VLYNE-EKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID-----GLEYLHS 127
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVA-GSYGYIAPEYAY 956
I H+DIK N+LL + G+A+ + + + GS + PE A
Sbjct: 128 Q---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 957 TMKVTE--KCDIYSYGVVLLELLTGRTP 982
+ K DI+S GV L + TG P
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYP 212
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-22
Identities = 61/217 (28%), Positives = 93/217 (42%), Gaps = 29/217 (13%)
Query: 781 NFHDSFIVGSGAYGTVYKA-VMDSGKIVAVKKLASNR-EGNNIESSFRAEILTLGKIRHR 838
F D ++G G +G V+ + +GK+ A KKL R + E L K+ R
Sbjct: 186 WFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSR 245
Query: 839 NIVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALG---AAE---G 891
IV L + + ++L L+ M G G++ + E F A+ G
Sbjct: 246 FIVSLA-YAFETKTDLCLVMTIM-NG--GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG 301
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGY 949
L +LH + I +RD+K N+LLDD + +V D GLA AG+ G+
Sbjct: 302 LEHLH---QRNIIYRDLKPENVLLDD--DGNVRISDLGLAV-ELKAGQTKTKGYAGTPGF 355
Query: 950 IAPE----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+APE Y V D ++ GV L E++ R P
Sbjct: 356 MAPELLLGEEYDFSV----DYFALGVTLYEMIAARGP 388
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 6e-22
Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 39/221 (17%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G GAYG V AV + + VAVK + R + E+ + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG-- 72
Query: 848 YHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRF----MIALGAAEGLAYLHHD 898
H+ + Y ++E S GEL E + ++A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRIEPDIGMP--EPDAQRFFHQLMA-----GVVYLHGI 124
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPE---- 953
I HRDIK N+LLD++ + DFGLA V + + ++ + G+ Y+APE
Sbjct: 125 ---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 954 --YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992
+ E D++S G+VL +L G P D D
Sbjct: 182 REFH-----AEPVDVWSCGIVLTAMLAGEL---PWDQPSDS 214
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 96.3 bits (240), Expect = 8e-22
Identities = 59/343 (17%), Positives = 120/343 (34%), Gaps = 52/343 (15%)
Query: 376 NQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
+ + P +L N K+ + +T + L + L F +T G+
Sbjct: 7 TAINVIFP--DPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQ 60
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
+ L ++ N +T + P L + + L L N L +V
Sbjct: 61 YLNNLIGLELKDNQIT-DLAP-LKNLTKITELELSGNPL-----KNVSA----------- 102
Query: 496 NSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVG 555
+ L+++ ++L + + P + LQ L++ N T+ P +
Sbjct: 103 ----------IAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LA 148
Query: 556 NLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSE 615
L+ L +I + ++ L P + N L L N + + L +L L + L
Sbjct: 149 GLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNK-ISDISP-LASLPNLIEVHLKN 204
Query: 616 NKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEL 675
N+ S ++ L N S+L + + + + +L N+ I P
Sbjct: 205 NQIS-DVSP-LANTSNLFIVTLTNQTITNQPVFYNNNLVV----PNVVKGPSGAPIAP-- 256
Query: 676 GKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGP 718
+ + + +L+ + S N+S + ++ N T P
Sbjct: 257 --ATISDNGTYASPNLTWNLTSFINNVSYTFNQSVTFKNTTVP 297
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 6e-21
Identities = 53/252 (21%), Positives = 98/252 (38%), Gaps = 18/252 (7%)
Query: 104 VWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFS 163
+ +L T ++ + L +L L+L N++T P + N +++ L L+ N
Sbjct: 43 ITTLSAFGTGVT-TIEG-VQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98
Query: 164 GKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRN 223
+ A + L S+ +L++ + I+ L LS+L N +T P + L N
Sbjct: 99 -NVSA-IAGLQSIKTLDLTSTQITD--VTPLAGLSNLQVLYLDLNQITNISP--LAGLTN 152
Query: 224 LRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLT 283
L+ G +S + ++ L L N I S + L +L E+ L +NQ++
Sbjct: 153 LQYLSIGNAQVS-DLTP-LANLSKLTTLKADDNKI--SDISPLASLPNLIEVHLKNNQIS 208
Query: 284 GFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSM 343
S L N + L + L + + Q NL + P I +
Sbjct: 209 DV--SPLANTSNLFIVTLTNQTITNQPVFYNNNLVVP--NVVKGPSGAPIAPATISDNGT 264
Query: 344 VTEIDLSENSLN 355
+L+ N +
Sbjct: 265 YASPNLTWNLTS 276
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 1e-20
Identities = 70/308 (22%), Positives = 117/308 (37%), Gaps = 23/308 (7%)
Query: 316 NLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQ 375
L K+ ++ + T+ +L +T + + I + L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVT-TIE-GVQYLNNLIGLELKD 72
Query: 376 NQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
NQ+T + P L +L +T+L+LS N L L ++ L L +T L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITD--VTPLA 126
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
S L V+ N +T I P L +NL L++G ++ ++ + N L L+
Sbjct: 127 GLSNLQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQV-SDLT-PLANLSKLTTLKADD 182
Query: 496 NSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVG 555
N ++ PL L NL + L N+ S P + N L + + N T++
Sbjct: 183 NKISDISPLA--SLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNN 238
Query: 556 NLSQLVTFNISSNMLTGLIPP-EIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLS 614
NL N+ I P I + T +++ N + N T Q K +
Sbjct: 239 NLVVP---NVVKGPSGAPIAPATISDNGTYASPNLTWNL-TSFINNVSYTFNQSVTFKNT 294
Query: 615 ENKFSGNI 622
FSG +
Sbjct: 295 TVPFSGTV 302
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 49/291 (16%), Positives = 109/291 (37%), Gaps = 42/291 (14%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSL 179
+ L +T L +T + + L L L +NQ + + L L+ + L
Sbjct: 35 VTQADLDGITTLSAFGTGVTTIEG--VQYLNNLIGLELKDNQIT-DLA-PLKNLTKITEL 90
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+ N + N+S++ L++++ I+ P
Sbjct: 91 ELSGNPLK--------NVSAI------------------AGLQSIKTLDLTSTQITDVTP 124
Query: 240 AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTL 299
++G +LQ+L L N I + + L +L + + + Q++ + L N +KL TL
Sbjct: 125 --LAGLSNLQVLYLDLNQI--TNISPLAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTL 178
Query: 300 ALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIP 359
+N + I + +L L +++L N+++ P + N S + + L+ ++ +
Sbjct: 179 KA-DDNKISDIS-PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 360 TEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGF 410
+ + + + P +S +L+ N + V +
Sbjct: 235 FYNNNLV--VPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFINNVSY 283
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 8e-19
Identities = 61/291 (20%), Positives = 115/291 (39%), Gaps = 25/291 (8%)
Query: 340 NLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSI 399
L+ +I ++++ + + + G+ L F +T + + L NL L+L
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 400 NYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLC 459
N +T P ++LT++ +L+L N L + + +D + +T + P L
Sbjct: 73 NQITDLAP--LKNLTKITELELSGNPLK--NVSAIAGLQSIKTLDLTSTQITD-VTP-LA 126
Query: 460 QNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ 519
SNL +L L N++ NI + L L + ++ PL L L ++ D
Sbjct: 127 GLSNLQVLYLDLNQI-TNIS-PLAGLTNLQYLSIGNAQVSDLTPLA--NLSKLTTLKADD 182
Query: 520 NKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIV 579
NK S I P + + L +H+ NN + P + N S L +++ +T P
Sbjct: 183 NKISD-ISP-LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ--PVFY 236
Query: 580 NCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLS 630
N + + S P + + + N+ S + N+S
Sbjct: 237 NNNLVVPNVVKGPSGAPIAPATISDN-----GTYASPNLTWNLTSFINNVS 282
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 21/125 (16%), Positives = 40/125 (32%), Gaps = 13/125 (10%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSL 179
+ L +L + L N+++ P + N S L + L N + + L +
Sbjct: 189 SPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPVFYNNNLVVPNVV 246
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+ P + + + NLT L I N+ + Q+ +
Sbjct: 247 K--GPSGAPIAPATISDNGTYAS-----PNLTWNLTSFINNV----SYTFNQSVTFKNTT 295
Query: 240 AEISG 244
SG
Sbjct: 296 VPFSG 300
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 2e-21
Identities = 65/212 (30%), Positives = 93/212 (43%), Gaps = 33/212 (15%)
Query: 787 IVGSGAYGTVYKA-VMDSGKIVAVKKLASNR-EGNNIESSFRAE--ILTLGK-IRHRNIV 841
I+G G +G VY D+GK+ A+K L R + E+ E +L+L IV
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHH 897
+ + +H L I + M G L L E RF AAE GL ++H
Sbjct: 256 CMS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY----AAEIILGLEHMH- 309
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
+ +RD+K NILLD+ HV D GLA + + G++GY+APE
Sbjct: 310 --NRFVVYRDLKPANILLDE--HGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPEVL 362
Query: 954 ---YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
AY D +S G +L +LL G +P
Sbjct: 363 QKGVAYDSSA----DWFSLGCMLFKLLRGHSP 390
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 61/245 (24%), Positives = 99/245 (40%), Gaps = 30/245 (12%)
Query: 749 ASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIV 807
A P G+ + P +D F I+G G++ TV A + +
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPED-------FKFGKILGEGSFSTVVLARELATSREY 58
Query: 808 AVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGS 864
A+K L + N + E + ++ H VKLY F + L Y + G
Sbjct: 59 AIKILEKRHIIKENKVPYV-TRERDVMSRLDHPFFVKLY-FTFQDDEKLYFGLSYAKNGE 116
Query: 865 LGELLHGSSCNLEWPTRFMIALGAAE---GLAYLH-HDCKPRIFHRDIKSNNILLDDKFE 920
L + + E TRF AE L YLH I HRD+K NILL++ +
Sbjct: 117 LLKYIRKIGSFDETCTRFY----TAEIVSALEYLHGKG----IIHRDLKPENILLNE--D 166
Query: 921 AHV--GDFGLAK-VIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 977
H+ DFG AK + + ++ G+ Y++PE + D+++ G ++ +L+
Sbjct: 167 MHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLV 226
Query: 978 TGRTP 982
G P
Sbjct: 227 AGLPP 231
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-21
Identities = 55/242 (22%), Positives = 92/242 (38%), Gaps = 41/242 (16%)
Query: 767 KEGFSFQDVVEATYNFHDSF----IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIE 822
K + +D++ + + + SG+YG V V G VA+K++ +
Sbjct: 5 KGEAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTV 64
Query: 823 SSF-------RA--EILTLGKIRHRNIVKLYGFCYHQGSNL-----LIYEYMERGSLGEL 868
+ R EI L H NI+ L H L+ E M L ++
Sbjct: 65 NILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQV 123
Query: 869 LHGSSCNL-EWPTRFMI--ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGD 925
+H + ++ + L GL LH + + HRD+ NILL D + + D
Sbjct: 124 IHDQRIVISPQHIQYFMYHIL---LGLHVLH---EAGVVHRDLHPGNILLADNNDITICD 177
Query: 926 FGLAKVIDMPQSKSMSA-VAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTG 979
F LA+ + + V + Y APE +T V D++S G V+ E+
Sbjct: 178 FNLAREDT--ADANKTHYVTHRW-YRAPELVMQFKGFTKLV----DMWSAGCVMAEMFNR 230
Query: 980 RT 981
+
Sbjct: 231 KA 232
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 67/222 (30%), Positives = 100/222 (45%), Gaps = 41/222 (18%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G GAYG V AV + + VAVK + R + E+ + EI + H N+VK YG
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKK-EICINKMLNHENVVKFYG-- 72
Query: 848 YHQGSNLLIYEYMERGSLGELL-----HGSSCNL-EWPTRF----MIALGAAEGLAYLHH 897
H+ + Y ++E S GEL + E + ++A G+ YLH
Sbjct: 73 -HRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA-----GVVYLHG 123
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIAPE--- 953
I HRDIK N+LLD++ + DFGLA V + + ++ + G+ Y+APE
Sbjct: 124 I---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 954 ---YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992
+ E D++S G+VL +L G P D D
Sbjct: 181 RREFH-----AEPVDVWSCGIVLTAMLAGEL---PWDQPSDS 214
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 4e-21
Identities = 55/255 (21%), Positives = 104/255 (40%), Gaps = 39/255 (15%)
Query: 748 GASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKI 806
G P + P N+++ ++ +E+ Y ++GSG +G+VY + +
Sbjct: 13 GLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGP--LLGSGGFGSVYSGIRVSDNLP 70
Query: 807 VAVK-----KLASNREGNNIESSFRAEILTLGKIRHR--NIVKLYGFCYHQGSNLLIYEY 859
VA+K +++ E N E++ L K+ +++L + S +LI E
Sbjct: 71 VAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILER 129
Query: 860 MERGSLGELL-----HGSSCNLEWPT--RFMIALGAAEGLAYLHHDCKPRIFHRDIKSNN 912
E +L G L+ F + E + + H + HRDIK N
Sbjct: 130 PEPV--QDLFDFITERG---ALQEELARSFFWQV--LEAVRHCH---NCGVLHRDIKDEN 179
Query: 913 ILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY----AYTMKVTEKCDIY 967
IL+D ++ E + DFG + + + G+ Y PE+ Y + ++
Sbjct: 180 ILIDLNRGELKLIDFGSG---ALLKDTVYTDFDGTRVYSPPEWIRYHRYHGR---SAAVW 233
Query: 968 SYGVVLLELLTGRTP 982
S G++L +++ G P
Sbjct: 234 SLGILLYDMVCGDIP 248
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 46/234 (19%), Positives = 83/234 (35%), Gaps = 36/234 (15%)
Query: 271 SLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNE 329
S + L N L + +LQ L L + I +L L+ L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTGNP 87
Query: 330 LNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSL 389
+ ++ FS ++ L+ L + L + + L
Sbjct: 88 IQ-SLALGA-----------------------FSGLSSLQKLVAVETNLASLENFPIGHL 123
Query: 390 RNLTKLDLSINYLTG-PIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVV--- 443
+ L +L+++ N + +P F +LT + L L N + I L+ + +
Sbjct: 124 KTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSL 182
Query: 444 DFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGN 496
D S N + I P + L L L N+L ++P + +L ++ L N
Sbjct: 183 DLSLNPMN-FIQPGAFKEIRLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 2e-18
Identities = 48/235 (20%), Positives = 77/235 (32%), Gaps = 21/235 (8%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
E + +IP + L L N L + S L LDLS +
Sbjct: 10 ITYQCMELNFY-KIPDNLP--FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT 66
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLCQN 461
I G +Q L+ + L L N + + G GL SL + L + +
Sbjct: 67 -IEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQK-LVAVETNLA-SLENFPIGH 122
Query: 462 -SNLIMLNLGYNKLFGNIPTDVL--NCETLLQLRLVGNSLT----GSFPLELCKLENLYA 514
L LN+ +N + + N L L L N + L ++ L
Sbjct: 123 LKTLKELNVAHNLI-QSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLR-VLHQMPLLNL 180
Query: 515 -IELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSN 568
++L N + I P +L+ L + N S L+ L + +N
Sbjct: 181 SLDLSLNPMNF-IQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 59/254 (23%), Positives = 90/254 (35%), Gaps = 54/254 (21%)
Query: 152 LEHLYLNNNQFSGKIPAE-LGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNL 210
++L L+ N + + L L++ I + +G +
Sbjct: 30 TKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGA--------YQ------ 73
Query: 211 TGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI-GM 268
+L +L N I S+ SG SLQ L + ++ SL G
Sbjct: 74 ---------SLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL-ASLENFPIGH 122
Query: 269 LESLTEIVLWDNQLTGFIPSEL-GNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYR 327
L++L E+ + N + F E N T L+ L L SN + I L+ L ++ L
Sbjct: 123 LKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTD--LRVLHQMPLLN 179
Query: 328 NELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNEL 386
L DLS N +N I F +I L+ L L NQL V
Sbjct: 180 LSL-----------------DLSLNPMN-FIQPGAFKEIR-LKELALDTNQLKSVPDGIF 220
Query: 387 SSLRNLTKLDLSIN 400
L +L K+ L N
Sbjct: 221 DRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 2e-15
Identities = 54/230 (23%), Positives = 80/230 (34%), Gaps = 34/230 (14%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
+LDL+ N L L LDL+ E+ I + S L L L N
Sbjct: 32 NLDLS-FNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 164 GKIPAEL-GKLSSLVSLNICNNMISGALPEGL-GNLSSLVDFVAYTNNLTG-PLPQSIGN 220
+ LSSL L ++ +L G+L +L + N + LP+ N
Sbjct: 90 -SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 221 LRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWD 279
L NL N I SI + +L L + L
Sbjct: 148 LTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNL--------------------SLDLSL 186
Query: 280 NQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
N + FI +L+ LAL +N L +P + L L K++L+ N
Sbjct: 187 NPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 50/214 (23%), Positives = 86/214 (40%), Gaps = 18/214 (8%)
Query: 509 LENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNIS 566
+NL L N + + +LQ L ++ + + +LS L T ++
Sbjct: 30 TKNLD---LSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSHLSTLILT 84
Query: 567 SNMLTGLIPPEIVNCMT-LQRLDISHNSFVGSLPNEL-GTLQQLEILKLSENKF-SGNIP 623
N + + + ++ LQ+L + SL N G L+ L+ L ++ N S +P
Sbjct: 85 GNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 624 STLGNLSHLTELQMGGNLFSGEIPPE----LGDLSSLQIALNLSYNNLSGSIPPELGKLD 679
NL++L L + N I L + L ++L+LS N ++ I P K
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 680 LLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYN 713
L+ L L+ N L F+ L+SL N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 4e-12
Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 8/138 (5%)
Query: 583 TLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGGNL 641
+ + LD+S N + +L++L LS + I +LSHL+ L + GN
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNP 87
Query: 642 FSGEIPPEL-GDLSSLQIALNLSYNNLSGSIPPEL-GKLDLLEFLLLNNNHL-SGEIPSA 698
+ LSSLQ L NL+ S+ G L L+ L + +N + S ++P
Sbjct: 88 IQ-SLALGAFSGLSSLQK-LVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLPEY 144
Query: 699 FENLSSLLGSNFSYNNLT 716
F NL++L + S N +
Sbjct: 145 FSNLTNLEHLDLSSNKIQ 162
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 25/106 (23%), Positives = 37/106 (34%), Gaps = 14/106 (13%)
Query: 621 NIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPEL-GKL 678
N+P + L + N + LQ+ L+LS + +I L
Sbjct: 25 NLPFST------KNLDLSFNPLR-HLGSYSFFSFPELQV-LDLSRCEIQ-TIEDGAYQSL 75
Query: 679 DLLEFLLLNNNHLSGEIPS-AFENLSSLLGSNFSYNNLTGPLPSIP 723
L L+L N + + AF LSSL NL L + P
Sbjct: 76 SHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLAS-LENFP 119
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 2e-20
Identities = 47/264 (17%), Positives = 89/264 (33%), Gaps = 14/264 (5%)
Query: 287 PSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTE 346
+ +C+ + + + +IP ++ + +L +L + +
Sbjct: 3 HHRICHCS-NRVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 347 IDLSENSLNGEIPTE-FSKITGLRLLFLFQ-NQLTGVIPNELSSLRNLTKLDLSINYLTG 404
I++S+N + I + FS + L + + + N L + P +L NL L +S +
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 118
Query: 405 PIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLCQNS 462
V H Q L + +N I GL ++ + N + I +
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGT 177
Query: 463 NLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK 521
L LNL N +P DV + L + + L L+ L A K
Sbjct: 178 QLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK 237
Query: 522 FSGPIPPEIENCQKLQRLHIANNY 545
+P +E L +
Sbjct: 238 K---LPT-LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 84.9 bits (210), Expect = 1e-17
Identities = 60/266 (22%), Positives = 102/266 (38%), Gaps = 19/266 (7%)
Query: 455 PPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYA 514
+C SN + +K+ IP+D+ ++LR V L +L
Sbjct: 3 HHRICHCSNRV-FLCQESKV-TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEK 58
Query: 515 IELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTG 572
IE+ QN I ++ N KL + I + E NL L IS+ +
Sbjct: 59 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 118
Query: 573 LIPPEIVNCMTLQRLDISHNSFVGSLPNEL--GTLQQLEILKLSENKFSGNIPSTLGNLS 630
L ++ + LDI N + ++ G + IL L++N I ++ N +
Sbjct: 119 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGT 177
Query: 631 HLTEL-QMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLN 687
L EL N E+P + S I L++S + S+P L L L
Sbjct: 178 QLDELNLSDNNNLE-ELPNDVFHGASGPVI-LDISRTRIH-SLPSYGLENLKKLRARSTY 234
Query: 688 NNHLSGEIPSAFENLSSLLGSNFSYN 713
N ++P+ E L +L+ ++ +Y
Sbjct: 235 NLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 50/274 (18%), Positives = 92/274 (33%), Gaps = 24/274 (8%)
Query: 208 NNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI 266
+ +T +P + RN R + I SG L+ + ++QND+ + ++
Sbjct: 19 SKVTE-IPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADV 74
Query: 267 -GMLESLTEIVLWD-NQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKL 323
L L EI + N L P N LQ L + + + +P + L
Sbjct: 75 FSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLL 133
Query: 324 YLYRNELNGTIPREI--GNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTG 380
+ N TI R G + L++N + EI F+ L N L
Sbjct: 134 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEE 192
Query: 381 VIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLL 440
+ + LD+S + G ++L ++R + +P L +L+
Sbjct: 193 LPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLKK---LPTLEKLVALM 249
Query: 441 WVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
++ H C +N + +
Sbjct: 250 -EASLTYPS-------HCCAFANWRRQISELHPI 275
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 35/187 (18%), Positives = 60/187 (32%), Gaps = 9/187 (4%)
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEI-VNCMTLQRLDISHNSF 594
L L IS N + +I ++ N L + I +
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 595 VGSLPNE-LGTLQQLEILKLSENKFSGNIPS-TLGNLSHLTELQMGGNLFSGEIPPE-LG 651
+ + E L L+ L +S ++P + L + N+ I
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 652 DLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPS-AFENLSSLLGSN 709
LS + L L+ N + I L E L +NN+L E+P+ F S + +
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208
Query: 710 FSYNNLT 716
S +
Sbjct: 209 ISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.3 bits (198), Expect = 4e-16
Identities = 44/279 (15%), Positives = 78/279 (27%), Gaps = 56/279 (20%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
+ L +L LE + ++ N I A
Sbjct: 31 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEA------------------ 72
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGC 245
L L + + NNL P++ NL NL+ I +P
Sbjct: 73 -DVF-SNLPKLHEI--RIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 246 QSLQILGLAQNDIGGSLPKEI--GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
+L + N ++ + G+ + L N + I + N T+L L L
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSD 186
Query: 304 NNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEF 362
NN + ++P +V L + R ++ ++P
Sbjct: 187 NNNLEELPNDVFHGASGPVILDISRTRIH-SLPSYG-----------------------L 222
Query: 363 SKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINY 401
+ LR L + L L L + L+
Sbjct: 223 ENLKKLRARST--YNLKKLPT--LEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 77.9 bits (192), Expect = 3e-15
Identities = 51/246 (20%), Positives = 80/246 (32%), Gaps = 22/246 (8%)
Query: 491 LRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSE 549
+ +T P +L N + K I L+++ I+ N
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRV-IQKGAFSGFGDLEKIEISQNDVLEV 69
Query: 550 LPKEV-GNLSQLVTFNIS-SNMLTGLIPPEI-VNCMTLQRLDISHNSFVGSLPNELGT-L 605
+ +V NL +L I +N L I PE N LQ L IS+ LP+
Sbjct: 70 IEADVFSNLPKLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHS 127
Query: 606 QQLEILKLSENKFSGNIPS-TLGNLSH-LTELQMGGNLFSGEIPPELGDLSSLQIALNLS 663
Q +L + +N I + LS L + N EI + + L
Sbjct: 128 LQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSD 186
Query: 664 YNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSI 722
NNL +P + L ++ + ENL L S NL +
Sbjct: 187 NNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKL--RARSTYNLK----KL 239
Query: 723 PQFQNM 728
P + +
Sbjct: 240 PTLEKL 245
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 68.3 bits (167), Expect = 3e-12
Identities = 38/229 (16%), Positives = 77/229 (33%), Gaps = 18/229 (7%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYL-NNNQF 162
L + G L ++++ N++ I ++ N +L + + N
Sbjct: 34 ELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNL 92
Query: 163 SGKIPAE-LGKLSSLVSLNICNNMISGALPEG--LGNLSSLVDFVAYTNNLTGPLPQSIG 219
I E L +L L I N I LP+ + +L ++ + N+ S
Sbjct: 93 L-YINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 220 NLR-NLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIV 276
L + +N I I +G Q ++ N++ LP ++ +
Sbjct: 151 GLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNL-EELPNDVFHGASGPVILD 208
Query: 277 LWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
+ ++ L N KL+ + Y+ + + L L + L
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRARSTYNLKKLPTL----EKLVALMEASL 253
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 45.2 bits (107), Expect = 7e-05
Identities = 26/122 (21%), Positives = 44/122 (36%), Gaps = 16/122 (13%)
Query: 609 EILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNL 667
+ E+K + IPS L + EL+ I L+ + +S N++
Sbjct: 12 RVFLCQESKVT-EIPSDL--PRNAIELRFVLTKLR-VIQKGAFSGFGDLEK-IEISQNDV 66
Query: 668 SGSIPPE----LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIP 723
I + L KL + + N+L P AF+NL +L S + +P
Sbjct: 67 LEVIEADVFSNLPKLHEIR--IEKANNLLYINPEAFQNLPNLQYLLISNTGIK----HLP 120
Query: 724 QF 725
Sbjct: 121 DV 122
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.9 bits (238), Expect = 2e-20
Identities = 45/235 (19%), Positives = 98/235 (41%), Gaps = 16/235 (6%)
Query: 192 EGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQIL 251
+ + ++T + Q+ L ++ A + I S+ I ++ L
Sbjct: 15 FPDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 70
Query: 252 GLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIP 311
L N + + K + L++L + L +N++ L + KL++L+L N +
Sbjct: 71 FLNGNKL--TDIKPLTNLKNLGWLFLDENKIKDLSS--LKDLKKLKSLSLEHNGI--SDI 124
Query: 312 KEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLL 371
+ +L L LYL N++ + L+ + + L +N ++ +I + +T L+ L
Sbjct: 125 NGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 180
Query: 372 FLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSL 426
+L +N ++ + L+ L+NL L+L +L ++ + SL
Sbjct: 181 YLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 233
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 95.2 bits (236), Expect = 3e-20
Identities = 50/278 (17%), Positives = 99/278 (35%), Gaps = 28/278 (10%)
Query: 368 LRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
+ + + P + K +L +T + L + Q+ + +
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK 56
Query: 428 GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCET 487
G+ + + + N LT I P L NL L L NK+ D+ + +
Sbjct: 57 --SVQGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWLFLDENKI-----KDLSSLKD 107
Query: 488 LLQLR---LVGNSLTGSFPLE-LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIAN 543
L +L+ L N ++ L L +LE+LY L NK + + KL L + +
Sbjct: 108 LKKLKSLSLEHNGISDINGLVHLPQLESLY---LGNNKITDITV--LSRLTKLDTLSLED 162
Query: 544 NYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELG 603
N + +P + L++L +S N ++ L + L L++ + N
Sbjct: 163 NQISDIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQS 218
Query: 604 TLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNL 641
L +K ++ P + + + + +L
Sbjct: 219 NLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHL 254
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 94.4 bits (234), Expect = 6e-20
Identities = 52/278 (18%), Positives = 95/278 (34%), Gaps = 18/278 (6%)
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN 183
+L +T + + ++ + NN+ + + L ++ L +
Sbjct: 19 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 74
Query: 184 NMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEIS 243
N ++ + L NL +L N + S+ +L+ L+ N IS I +
Sbjct: 75 NKLTDI--KPLTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGIS-DING-LV 128
Query: 244 GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
L+ L L N I + + L L + L DNQ++ L TKLQ L L S
Sbjct: 129 HLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYL-S 183
Query: 304 NNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFS 363
N + + + + LK L L L+ E NL + + ++ SL P S
Sbjct: 184 KNHISDL-RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV--TPEIIS 240
Query: 364 KITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINY 401
+ + + +T +
Sbjct: 241 DDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARF 278
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 2e-18
Identities = 43/238 (18%), Positives = 80/238 (33%), Gaps = 20/238 (8%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSL 179
+ L + + +++ + I + L+LN N+ + I L L +L L
Sbjct: 37 VTQNELNSIDQIIANNSDIKSV--QGIQYLPNVTKLFLNGNKLT-DIKP-LTNLKNLGWL 92
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+ N I L +L L N ++ + +L L G N I+ I
Sbjct: 93 FLDENKIKDL--SSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT-DIT 147
Query: 240 AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTL 299
+S L L L N I + + L L + L N ++ L L L
Sbjct: 148 V-LSRLTKLDTLSLEDNQI-SDIV-PLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVL 202
Query: 300 ALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTI--PREIGNLSMVTEIDLSENSLN 355
L+S + + NL + +G++ P I + + ++ +
Sbjct: 203 ELFSQECLNKPINHQSNLVVPNTVKN----TDGSLVTPEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.2 bits (210), Expect = 5e-17
Identities = 57/266 (21%), Positives = 97/266 (36%), Gaps = 18/266 (6%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
+ N + S+ I L ++T L L N+LT P + N L L+L+ N+
Sbjct: 47 QIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LTNLKNLGWLFLDENKIK-D 101
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+ + L L L SL++ +N IS GL +L L N +T + L L
Sbjct: 102 LSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLD 156
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
N IS I ++G LQ L L++N I S + + L++L + L+ +
Sbjct: 157 TLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNK 212
Query: 286 IPSELGNCTKLQTLALYSNNLVG----QIPKEVGNLKFLTKLYLYRNELNGTIPREIGNL 341
+ N T+ +LV + L + NE++ + +
Sbjct: 213 PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIG 272
Query: 342 SMVTEIDLSENSLNGEIPTEFSKITG 367
E+ T + G
Sbjct: 273 KAKARFHGRVTQPLKEVYTVSYDVDG 298
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 58/214 (27%), Positives = 88/214 (41%), Gaps = 30/214 (14%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
++G GA+ V M +G++ A+K + + + FR E L R I +L
Sbjct: 68 VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC-FREERDVLVNGDRRWITQL 126
Query: 844 YGFCYHQGSNL-LIYEYMERGSLGELL--HGSSCNLEWPTRFMIALGAAE---GLAYLHH 897
+ F + + L L+ EY G L LL G E RF AE + +H
Sbjct: 127 H-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM-ARFY----LAEIVMAIDSVH- 179
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
+ HRDIK +NILLD H+ DFG + + G+ Y++PE
Sbjct: 180 --RLGYVHRDIKPDNILLDR--CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEIL 235
Query: 954 -----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
T +CD ++ GV E+ G+TP
Sbjct: 236 QAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-20
Identities = 59/213 (27%), Positives = 86/213 (40%), Gaps = 35/213 (16%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVK-----KLASNR--EGNNIESSFRAEILTLGKIRHRNI 840
GSGA+G V+ AV + K V VK K+ + E + EI L ++ H NI
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL-EIAILSRVEHANI 91
Query: 841 VKLYGFCYHQGSNLLIYEYMERGSLGEL-----LHGSSCNLEWPTRFMIALGAAEGLAYL 895
+K+ +QG L+ E G +L H L+ P I + YL
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSG--LDLFAFIDRHP---RLDEPLASYIFRQLVSAVGYL 146
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
I HRDIK NI++ + F + DFG A + + K G+ Y APE
Sbjct: 147 R---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY--LERGKLFYTFCGTIEYCAPEVL 201
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y + +++S GV L L+ P
Sbjct: 202 MGNPYR-----GPELEMWSLGVTLYTLVFEENP 229
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 3e-20
Identities = 44/216 (20%), Positives = 81/216 (37%), Gaps = 39/216 (18%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRAEILTLGKIR----HR 838
G G +GTV+ + VA+K ++ ++ + E+ L K+ H
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHP 98
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPT--RFMIALGAAEG 891
+++L + Q +L+ E +L G L F +
Sbjct: 99 GVIRLLDWFETQEGFMLVLERPLPA--QDLFDYITEKG---PLGEGPSRCFFGQV--VAA 151
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYI 950
+ + H + HRDIK NIL+D + A + DFG + + + G+ Y
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSG---ALLHDEPYTDFDGTRVYS 205
Query: 951 APEY----AYTMKVTEKCDIYSYGVVLLELLTGRTP 982
PE+ Y ++S G++L +++ G P
Sbjct: 206 PPEWISRHQYHAL---PATVWSLGILLYDMVCGDIP 238
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 5e-20
Identities = 53/266 (19%), Positives = 95/266 (35%), Gaps = 65/266 (24%)
Query: 773 QDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILT 831
+ Y+ +G+G++G V + ++SGK A+KK+ + N R E+
Sbjct: 2 LETSSKKYSLGK--TLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-----R-ELDI 53
Query: 832 LGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPT----------- 880
+ + H NI+KL + Y G + N +
Sbjct: 54 MKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYL 113
Query: 881 ------------RFMIALGAAE-----------------GLAYLHHDCKPRIFHRDIKSN 911
+ + + + + ++H I HRDIK
Sbjct: 114 NVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQ 170
Query: 912 NILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYTMKVTEKCD 965
N+L++ + DFG AK + P S++ + + Y APE YT + D
Sbjct: 171 NLLVNSKDNTLKLCDFGSAKKLI-PSEPSVAYICSRF-YRAPELMLGATEYTPSI----D 224
Query: 966 IYSYGVVLLELLTGRTPVQPLDDGGD 991
++S G V EL+ G+ P+ + D
Sbjct: 225 LWSIGCVFGELILGK-PLFSGETSID 249
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 26/211 (12%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
++G GA+G V + ++ K+ A+K L + FR E L + I L
Sbjct: 81 VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC-FREERDVLVNGDSKWITTL 139
Query: 844 YGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNL-EWPTRFMIALGAAE---GLAYLHHD 898
+ + + +NL L+ +Y G L LL L E RF AE + +H
Sbjct: 140 H-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY----LAEMVIAIDSVH-- 192
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
+ HRDIK +NIL+D H+ DFG + + S G+ YI+PE
Sbjct: 193 -QLHYVHRDIKPDNILMDM--NGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 249
Query: 957 TMKVTEK-----CDIYSYGVVLLELLTGRTP 982
M+ + CD +S GV + E+L G TP
Sbjct: 250 AMEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 60/233 (25%), Positives = 102/233 (43%), Gaps = 30/233 (12%)
Query: 765 PPKEGFSFQDVVEATYN----FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN 819
F ++ ++T+ + + +GSGA G V A + VA+KKL +R
Sbjct: 6 KRDNNFYSVEIGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL--SRPFQ 63
Query: 820 NIESSFRA--EILTLGKIRHRNIVKLYGFCYHQGSNL------LIYEYMERGSLGELLHG 871
N + RA E++ + + H+NI+ L Q S ++ E M+ +L +++
Sbjct: 64 NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM 122
Query: 872 SSCNLEWPTR--FMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA 929
L+ + + G+ +LH I HRD+K +NI++ + DFGLA
Sbjct: 123 ---ELDHERMSYLLYQM--LCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
Query: 930 KVIDMPQSKSMSA-VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
+ S M+ V Y Y APE M E DI+S G ++ E++ G
Sbjct: 175 RTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGV 224
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 50/228 (21%), Positives = 86/228 (37%), Gaps = 44/228 (19%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRA--------------- 827
G G+YG V A + A+K KL
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 828 ----EILTLGKIRHRNIVKLYGFCYHQGSNLLIY---EYMERGSLGELLHGSSCNLEWPT 880
EI L K+ H N+VKL + +Y E + +G + E+ + +
Sbjct: 82 QVYQEIAILKKLDHPNVVKLVEV-LDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQAR 140
Query: 881 RF---MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937
+ +I G+ YLH+ +I HRDIK +N+L+ + + DFG++
Sbjct: 141 FYFQDLIK-----GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSD 191
Query: 938 KSMSAVAGSYGYIAPEYAYTMKVT---EKCDIYSYGVVLLELLTGRTP 982
+S G+ ++APE + + D+++ GV L + G+ P
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 59/192 (30%), Positives = 85/192 (44%), Gaps = 10/192 (5%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
+IP+ I + L L N + K L L + L DN+L L
Sbjct: 30 AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNL 87
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSENSL 354
+TL + N L +P V L L +L L RN+L ++P + +L+ +T + L N L
Sbjct: 88 ETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNEL 145
Query: 355 NGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQH 412
+P F K+T L+ L L+ NQL V L L L L N L +P G F
Sbjct: 146 Q-SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDS 203
Query: 413 LTQMRQLQLFEN 424
L +++ LQL EN
Sbjct: 204 LEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 58/205 (28%), Positives = 88/205 (42%), Gaps = 11/205 (5%)
Query: 128 LTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMIS 187
+D + +LT IP I + + L L +N+ S +L+ L L + +N +
Sbjct: 18 KNSVDCSSKKLT-AIPSNIP--ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ 74
Query: 188 GALPEGL-GNLSSLVDFVAYTNNLTGPLPQSI-GNLRNLRVFRAGQNAISGSIPAEI-SG 244
LP G+ L +L N L LP + L NL R +N + S+P +
Sbjct: 75 -TLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDS 131
Query: 245 CQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
L L L N++ SLPK + L SL E+ L++NQL T+L+TL L +
Sbjct: 132 LTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDN 190
Query: 304 NNLVGQIPKEVGNLKFLTKLYLYRN 328
N L +L+ L L L N
Sbjct: 191 NQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 9e-13
Identities = 50/175 (28%), Positives = 82/175 (46%), Gaps = 11/175 (6%)
Query: 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSF 594
++L + +N +S K L++L ++ N L L P I + L+ L ++ N
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTL-PAGIFKELKNLETLWVTDNKL 97
Query: 595 VGSLPNELGT-LQQLEILKLSENKFSGNIPSTL-GNLSHLTELQMGGNLFSGEIPPELGD 652
+LP + L L L+L N+ ++P + +L+ LT L +G N +P + D
Sbjct: 98 Q-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFD 154
Query: 653 -LSSLQIALNLSYNNLSGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
L+SL+ L L N L +P KL L+ L L+NN L AF++L L
Sbjct: 155 KLTSLKE-LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKL 207
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 34/204 (16%)
Query: 106 SLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
LDL + + SL L L L L N+L +P I LE L++ +N+
Sbjct: 41 KLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKNLETLWVTDNKLQ 98
Query: 164 GKIPAEL-GKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLR 222
+P + +L +L L + N + +LP + F ++LT L
Sbjct: 99 -ALPIGVFDQLVNLAELRLDRNQLK-SLPPRV--------F----DSLT--------KLT 136
Query: 223 NLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDN 280
L + G N + S+P + SL+ L L N + +P+ L L + L +N
Sbjct: 137 YLSL---GYNELQ-SLPKGVFDKLTSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNN 191
Query: 281 QLTGFIPSELGNCTKLQTLALYSN 304
QL + KL+ L L N
Sbjct: 192 QLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 50/187 (26%), Positives = 77/187 (41%), Gaps = 18/187 (9%)
Query: 391 NLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHN 448
+ KLDL N L+ F LT++R L L +N L +P G+ L +L + + N
Sbjct: 38 DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLET-LWVTDN 95
Query: 449 YLTGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTDVLNCETLLQ-LRLVGNSLT----GSF 502
L +P + NL L L N+L ++P V + T L L L N L G F
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQL-KSLPPRVFDSLTKLTYLSLGYNELQSLPKGVF 153
Query: 503 PLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEVGNLSQLV 561
KL +L + L N+ +P + +L+ L + NN +L +L
Sbjct: 154 D----KLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLK 208
Query: 562 TFNISSN 568
+ N
Sbjct: 209 MLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 4e-10
Identities = 46/169 (27%), Positives = 70/169 (41%), Gaps = 16/169 (9%)
Query: 559 QLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKF 618
+ + SS LT IP I ++LD+ N L +L +L L++NK
Sbjct: 17 NKNSVDCSSKKLTA-IPSNIPA--DTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL 73
Query: 619 SGNIPSTL-GNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNLSGSIPPEL- 675
+P+ + L +L L + N +P + D L +L L L N L S+PP +
Sbjct: 74 Q-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAE-LRLDRNQLK-SLPPRVF 129
Query: 676 GKLDLLEFLLLNNNHLSGEIPS-AFENLSSLLGSNFSYNNLTGPLPSIP 723
L L +L L N L +P F+ L+SL N L +P
Sbjct: 130 DSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQLK----RVP 173
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 4e-19
Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 22/203 (10%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
G G + V A + +G+ VA+K + + E+ + + H NIVKL+
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI 83
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTR--F--MIALGAAEGLAYLHHDCKPRI 903
+ + LI EY G + + L E R F +++ + Y H I
Sbjct: 84 ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS-----AVQYCHQKR---I 135
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY----AYTMK 959
HRD+K+ N+LLD + DFG + + A G+ Y APE Y
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNE--FTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193
Query: 960 VTEKCDIYSYGVVLLELLTGRTP 982
+ D++S GV+L L++G P
Sbjct: 194 ---EVDVWSLGVILYTLVSGSLP 213
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 5e-19
Identities = 32/186 (17%), Positives = 61/186 (32%), Gaps = 11/186 (5%)
Query: 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSN 568
+ L Q+ + L + +AN T + + I++
Sbjct: 22 FKAYLNGLLGQSSTA---NITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 569 MLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGN 628
T P I L+RL I L L L +L +S + +I + +
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 629 LSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNN 688
L + + + N +I P L L L+ LN+ ++ + + L L +
Sbjct: 135 LPKVNSIDLSYNGAITDIMP-LKTLPELKS-LNIQFDGVH-DYRG-IEDFPKLNQLYAFS 190
Query: 689 NHLSGE 694
+ G+
Sbjct: 191 QTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-18
Identities = 26/185 (14%), Positives = 67/185 (36%), Gaps = 10/185 (5%)
Query: 173 LSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQN 232
+ ++ + + + + +L+ + N+T I N++
Sbjct: 22 FKAYLNGLLGQSSTANITEAQMNSLTYIT---LANINVTDL--TGIEYAHNIKDLTINNI 76
Query: 233 AISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGN 292
+ P ISG +L+ L + D+ + L SLT + + + I +++
Sbjct: 77 HATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 293 CTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSEN 352
K+ ++ L N + I + L L L + + ++ I + + ++
Sbjct: 135 LPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYAFSQ 191
Query: 353 SLNGE 357
++ G+
Sbjct: 192 TIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 9e-17
Identities = 32/183 (17%), Positives = 66/183 (36%), Gaps = 10/183 (5%)
Query: 463 NLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKF 522
+ LG + +L + L ++T +E N+ + ++
Sbjct: 24 AYLNGLLGQSS---TANITEAQMNSLTYITLANINVTDLTGIE--YAHNIKDLTINNIHA 78
Query: 523 SGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCM 582
+ P I L+RL I TS+ + L+ L +IS + I +I
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLP 136
Query: 583 TLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLF 642
+ +D+S+N + + L TL +L+ L + + + + + L +L
Sbjct: 137 KVNSIDLSYNGAITDIMP-LKTLPELKSLNIQFDGVH-DY-RGIEDFPKLNQLYAFSQTI 193
Query: 643 SGE 645
G+
Sbjct: 194 GGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 6e-16
Identities = 32/186 (17%), Positives = 64/186 (34%), Gaps = 31/186 (16%)
Query: 121 SIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLN 180
+ + LTY+ LA +T I ++ L +NN + P + LS+L L
Sbjct: 39 TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--ISGLSNLERLR 94
Query: 181 ICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPA 240
I ++ L L+ +L L + +A SI
Sbjct: 95 IMGKDVTSDKIPNLSGLT---------------------SLTLLDI---SHSAHDDSILT 130
Query: 241 EISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLA 300
+I+ + + L+ N + + L L + + + + + + + KL L
Sbjct: 131 KINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLY 187
Query: 301 LYSNNL 306
+S +
Sbjct: 188 AFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 28/172 (16%), Positives = 54/172 (31%), Gaps = 9/172 (5%)
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEF 362
+ I + + LT + L + I + ++ ++ P
Sbjct: 31 GQSSTANITEA--QMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHATNYNP--I 84
Query: 363 SKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLF 422
S ++ L L + +T LS L +LT LD+S + I L ++ + L
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144
Query: 423 ENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL 474
N I P L L ++ + + + L L +
Sbjct: 145 YNGAITDIMP-LKTLPELKSLNIQFDGVHD-YRG-IEDFPKLNQLYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 4e-13
Identities = 31/209 (14%), Positives = 62/209 (29%), Gaps = 34/209 (16%)
Query: 316 NLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQ 375
K L ++ T ++ +T I L+ ++ ++ T ++ L +
Sbjct: 21 TFKAYLNGLLGQSS---TANITEAQMNSLTYITLANINVT-DL-TGIEYAHNIKDLTINN 75
Query: 376 NQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
T P +S L NL +L + +T LT + L +
Sbjct: 76 IHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI-------------- 119
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
SH+ I + + ++L YN +I + L L +
Sbjct: 120 ----------SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQF 168
Query: 496 NSLTGSFPLELCKLENLYAIELDQNKFSG 524
+ + +E L + G
Sbjct: 169 DGVHDYRGIE--DFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 3e-12
Identities = 25/132 (18%), Positives = 50/132 (37%), Gaps = 7/132 (5%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L +N ++ T + +P I GL +L L + ++T + + L L ++++
Sbjct: 70 DLTINNIHAT-NYNP-ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDS 127
Query: 166 IPAELGKLSSLVSLNIC-NNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNL 224
I ++ L + S+++ N I+ L L L + + I + L
Sbjct: 128 ILTKINTLPKVNSIDLSYNGAITD--IMPLKTLPELKSLNIQFDGVHDYRG--IEDFPKL 183
Query: 225 RVFRAGQNAISG 236
A I G
Sbjct: 184 NQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 22/180 (12%), Positives = 61/180 (33%), Gaps = 35/180 (19%)
Query: 556 NLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSE 615
+ + + + ++ + L + +++ + V L + ++ L ++
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNS---LTYITLANIN-VTDLTG-IEYAHNIKDLTINN 75
Query: 616 NKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEL 675
+ +S L+ L+ L + +++ P L
Sbjct: 76 IHAT-----NYNPISGLSNLER----------------------LRIMGKDVTSDKIPNL 108
Query: 676 GKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTG---PLPSIPQFQNMDISS 732
L L L ++++ I + L + + SYN PL ++P+ ++++I
Sbjct: 109 SGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQF 168
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 5e-19
Identities = 72/242 (29%), Positives = 112/242 (46%), Gaps = 34/242 (14%)
Query: 755 SVPPLNNVYFPPKEGFSFQDVVEATYN----FHDSFIVGSGAYGTVYKAV-MDSGKIVAV 809
S PP P + GF Q+V + + + D VGSGAYG V AV +G VA+
Sbjct: 2 SSPP------PARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAI 55
Query: 810 KKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLYGFCYHQGSNL------LIYEYME 861
KKL R + + RA E+ L +RH N++ L + L+ +M
Sbjct: 56 KKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMG 113
Query: 862 RGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921
LG+L+ + + + +GL Y+H I HRD+K N+ +++ E
Sbjct: 114 T-DLGKLMKHEKLGEDRIQFLVYQM--LKGLRYIH---AAGIIHRDLKPGNLAVNEDCEL 167
Query: 922 HVGDFGLAKVIDMPQSKSMSA-VAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTG 979
+ DFGLA+ D M+ V + Y APE M+ T+ DI+S G ++ E++TG
Sbjct: 168 KILDFGLARQAD----SEMTGYVVTRW-YRAPEVILNWMRYTQTVDIWSVGCIMAEMITG 222
Query: 980 RT 981
+T
Sbjct: 223 KT 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 1e-18
Identities = 37/213 (17%), Positives = 75/213 (35%), Gaps = 14/213 (6%)
Query: 267 GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYL 325
+ S + L + L N + + + + + Q+ NL +T + +
Sbjct: 28 SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEI 87
Query: 326 YRNELNGTIPREI-GNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQ----NQLTG 380
I + L ++ + + L P + +K+ + F+ + +T
Sbjct: 88 RNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFP-DLTKVYSTDIFFILEITDNPYMTS 145
Query: 381 VIPNELSSLRNLTK-LDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLY 437
+ N L N T L L N T + + T++ + L +N I G+Y
Sbjct: 146 IPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVY 204
Query: 438 SLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNL 469
S ++D S +T +P ++ LI N
Sbjct: 205 SGPSLLDVSQTSVT-ALPSKGLEHLKELIARNT 236
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 1e-15
Identities = 40/238 (16%), Positives = 84/238 (35%), Gaps = 40/238 (16%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+ ++ + IP S + L L + L + + S+L N++++ +SI+
Sbjct: 14 EDFRVTCKDIQ-RIP---SLPPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQ 69
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPH--LC 459
+ F +L+++ +++ I P L L + + + L P +
Sbjct: 70 QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF-LGIFNTGLK-MFPDLTKVY 127
Query: 460 QNSNLIMLNLGYNKLFGNIPTDVLN--CETLLQLRLVGNSLTGSFPLELCKLENLYAIEL 517
+L + N +IP + C L L+L N T +
Sbjct: 128 STDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT----------------SV 171
Query: 518 DQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV--GNLSQLVTFNISSNMLTGL 573
F+G KL +++ N + + + K+ G S ++S +T L
Sbjct: 172 QGYAFNGT---------KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVTAL 220
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 31/189 (16%), Positives = 65/189 (34%), Gaps = 11/189 (5%)
Query: 536 LQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGLIPPEI-VNCMTLQRLDISHNS 593
Q L + + + +P NL + +S ++ + N + ++I +
Sbjct: 33 TQTLKLIETHLRT-IPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTR 91
Query: 594 FVGSLPNE-LGTLQQLEILKLSENKFSGNIP--STLGNLSHLTELQMGGNLFSGEIPPE- 649
+ + + L L L+ L + P + + + L++ N + IP
Sbjct: 92 NLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNA 150
Query: 650 LGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGS 708
L + + L L N + S+ L L N +L+ AF + S
Sbjct: 151 FQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSL 209
Query: 709 -NFSYNNLT 716
+ S ++T
Sbjct: 210 LDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 29/167 (17%), Positives = 62/167 (37%), Gaps = 16/167 (9%)
Query: 558 SQLVTFNISSNMLTGL--IPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSE 615
Q F ++ + + +PP + Q L + + L + + +S
Sbjct: 11 HQEEDFRVTCKDIQRIPSLPP------STQTLKLIETHLRTIPSHAFSNLPNISRIYVSI 64
Query: 616 NKFSGNIPS-TLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPP 673
+ + S + NLS +T +++ I P+ L +L L+ L + L P
Sbjct: 65 DVTLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKF-LGIFNTGLK-MFPD 122
Query: 674 E--LGKLDLLEFL-LLNNNHLSGEIPSAFENLSSLLGS-NFSYNNLT 716
+ D+ L + +N +++ +AF+ L + + N T
Sbjct: 123 LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT 169
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 4e-12
Identities = 38/226 (16%), Positives = 70/226 (30%), Gaps = 35/226 (15%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVS 178
PS+ L L L N + +Y++ + ++ + LS +
Sbjct: 27 PSL--PPSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTH 84
Query: 179 LNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSI 238
+ I N NLT P ++ L L+ +
Sbjct: 85 IEIRNT-----------------------RNLTYIDPDALKELPLLKFLGIFNTGLK-MF 120
Query: 239 PAE--ISGCQSLQILGLAQNDIGGSLPKEI--GMLESLTEIVLWDNQLTGFIPSELGNCT 294
P + IL + N S+P G+ + L++N T + N T
Sbjct: 121 PDLTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGT 179
Query: 295 KLQTLALYSNNLVGQIPKEV--GNLKFLTKLYLYRNELNGTIPREI 338
KL + L N + I K+ G + L + + + +P +
Sbjct: 180 KLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT-ALPSKG 224
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 29/207 (14%), Positives = 71/207 (34%), Gaps = 12/207 (5%)
Query: 106 SLDLNAMNFTGSLSP-SIGGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
+L L + ++ + L +++ + ++ + + N S++ H+ + N +
Sbjct: 35 TLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSKVTHIEIRNTRNL 93
Query: 164 GKIPAE-LGKLSSLVSLNICNNMISGALPEG--LGNLSSLVDFVAYTNNLTGPLP-QSIG 219
I + L +L L L I N + P+ + + N +P +
Sbjct: 94 TYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQ 152
Query: 220 NLRN-LRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEI--GMLESLTEIV 276
L N + N + S+ L + L +N + K+ G+ + +
Sbjct: 153 GLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLTVIDKDAFGGVYSGPSLLD 211
Query: 277 LWDNQLTGFIPSELGNCTKLQTLALYS 303
+ +T L + +L ++
Sbjct: 212 VSQTSVTALPSKGLEHLKELIARNTWT 238
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 56/213 (26%), Positives = 87/213 (40%), Gaps = 33/213 (15%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKL 843
++G GA+G V + K+ A+K L + ++ F E + +V+L
Sbjct: 76 VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF-FWEERDIMAFANSPWVVQL 134
Query: 844 YGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDC 899
+ + + L ++ EYM G L L+ +W RF AE L +H
Sbjct: 135 F-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-ARFY----TAEVVLALDAIH--- 185
Query: 900 KPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE---- 953
HRD+K +N+LLD H+ DFG ++ G+ YI+PE
Sbjct: 186 SMGFIHRDVKPDNMLLDK--SGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y +CD +S GV L E+L G TP
Sbjct: 244 QGGDGYYGR----ECDWWSVGVFLYEMLVGDTP 272
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-18
Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 788 VGSGAYGTVY----KAVMDSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G G++G V+ + D+ ++ A+K L A+ + + + + + E L ++ H IV
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRT--KMERDILVEVNHPFIV 89
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHH 897
KL+ + + L LI +++ G L L E +F AE L +LH
Sbjct: 90 KLH-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY----LAELALALDHLH- 143
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
I +RD+K NILLD+ E H+ DFGL+K + K + G+ Y+APE
Sbjct: 144 --SLGIIYRDLKPENILLDE--EGHIKLTDFGLSKE-SIDHEKKAYSFCGTVEYMAPEVV 198
Query: 954 --YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+T D +S+GV++ E+LTG P
Sbjct: 199 NRRGHTQSA----DWWSFGVLMFEMLTGTLP 225
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 2e-18
Identities = 60/231 (25%), Positives = 101/231 (43%), Gaps = 26/231 (11%)
Query: 765 PPKEGFSFQDVVEATYN----FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN 819
F +V ++T+ + + +GSGA G V A + VA+KKL+ R
Sbjct: 43 KVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLS--RPFQ 100
Query: 820 NIESSFRA--EILTLGKIRHRNIVKLYGFCYHQGSNL------LIYEYMERGSLGELLHG 871
N + RA E++ + + H+NI+ L Q + L+ E M+ +L +++
Sbjct: 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM 159
Query: 872 SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931
L+ + G+ +LH I HRD+K +NI++ + DFGLA+
Sbjct: 160 ---ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213
Query: 932 IDMPQSKSMSA-VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
S M+ V Y Y APE M E DI+S G ++ E++ +
Sbjct: 214 AG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-18
Identities = 60/249 (24%), Positives = 94/249 (37%), Gaps = 35/249 (14%)
Query: 747 CGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGK 805
G+ + + PK + + F ++G G +G V +G+
Sbjct: 122 SGSPSDNSGAEEMEVSLAKPKHRVTMNE-------FEYLKLLGKGTFGKVILVKEKATGR 174
Query: 806 IVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMER 862
A+K L + + + E L RH + L + + L + EY
Sbjct: 175 YYAMKILKKEVIVAKDEVAHT-LTENRVLQNSRHPFLTALK-YSFQTHDRLCFVMEYANG 232
Query: 863 GSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPRIFHRDIKSNNILLDDKF 919
G L L E RF AE L YLH + + +RD+K N++LD
Sbjct: 233 GELFFHLSRERVFSEDRARFY----GAEIVSALDYLHSEKN--VVYRDLKLENLMLDK-- 284
Query: 920 EAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVL 973
+ H+ DFGL K + +M G+ Y+APE Y V D + GVV+
Sbjct: 285 DGHIKITDFGLCKE-GIKDGATMKTFCGTPEYLAPEVLEDNDYGRAV----DWWGLGVVM 339
Query: 974 LELLTGRTP 982
E++ GR P
Sbjct: 340 YEMMCGRLP 348
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-18
Identities = 47/236 (19%), Positives = 100/236 (42%), Gaps = 16/236 (6%)
Query: 192 EGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQIL 251
+ + ++T + Q+ L ++ A + I S+ I ++ L
Sbjct: 18 FSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIK-SVQG-IQYLPNVTKL 73
Query: 252 GLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIP 311
L N + + K + L++L + L +N++ S L + KL++L+L N +
Sbjct: 74 FLNGNKL--TDIKPLANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGI--SDI 127
Query: 312 KEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLL 371
+ +L L LYL N++ T + L+ + + L +N ++ +I + +T L+ L
Sbjct: 128 NGLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS-DIV-PLAGLTKLQNL 183
Query: 372 FLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
+L +N ++ + L+ L+NL L+L +L ++ + SL
Sbjct: 184 YLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLV 237
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 4e-18
Identities = 48/280 (17%), Positives = 96/280 (34%), Gaps = 42/280 (15%)
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN 183
+L +T + + ++ + NN+ + + L ++ L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK-SVQG-IQYLPNVTKLFLNG 77
Query: 184 NMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEIS 243
N ++ ++ L NL+NL +N + + + +
Sbjct: 78 NKLT--------DIKPL------------------ANLKNLGWLFLDENKVK-DLSS-LK 109
Query: 244 GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
+ L+ L L N I S + L L + L +N++T L TKL TL+L
Sbjct: 110 DLKKLKSLSLEHNGI--SDINGLVHLPQLESLYLGNNKITDITV--LSRLTKLDTLSLED 165
Query: 304 NNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFS 363
N + I + L L LYL +N + + R + L + ++L + S
Sbjct: 166 NQIS-DIV-PLAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQS 221
Query: 364 KITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
+ + L V P +S + K ++ +
Sbjct: 222 NLVVPNTVKNTDGSL--VTPEIISDDGDYEKPNVKWHLPE 259
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 51/224 (22%), Positives = 86/224 (38%), Gaps = 19/224 (8%)
Query: 493 LVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPK 552
V + F + L + + + + ++ N+ S +
Sbjct: 9 TVPTPIKQIFSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSV--Q 62
Query: 553 EVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILK 612
+ L + ++ N LT + P + N L L + N V L + L L++L+ L
Sbjct: 63 GIQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENK-VKDLSS-LKDLKKLKSLS 118
Query: 613 LSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIP 672
L N S +I L +L L L +G N + +I L L+ L L+L N +S I
Sbjct: 119 LEHNGIS-DING-LVHLPQLESLYLGNNKIT-DITV-LSRLTKLDT-LSLEDNQIS-DIV 172
Query: 673 PELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
P L L L+ L L+ NH+S ++ A L +L
Sbjct: 173 P-LAGLTKLQNLYLSKNHIS-DL-RALAGLKNLDVLELFSQECL 213
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 9e-17
Identities = 45/251 (17%), Positives = 83/251 (33%), Gaps = 22/251 (8%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSL 179
+ L + + +++ I + L+LN N+ + I L L +L L
Sbjct: 40 VTQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLT-DIK-PLANLKNLGWL 95
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+ N + L +L L N ++ + +L L G N I+ I
Sbjct: 96 FLDENKVKDL--SSLKDLKKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT-DIT 150
Query: 240 AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTL 299
+S L L L N I S + L L + L N ++ L L L
Sbjct: 151 V-LSRLTKLDTLSLEDNQI--SDIVPLAGLTKLQNLYLSKNHISDL--RALAGLKNLDVL 205
Query: 300 ALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTI--PREIGNLSMVTEIDLSEN--SLN 355
L+S + + NL + +G++ P I + + ++ +
Sbjct: 206 ELFSQECLNKPINHQSNLVVPNTVKN----TDGSLVTPEIISDDGDYEKPNVKWHLPEFT 261
Query: 356 GEIPTEFSKIT 366
E+ F +
Sbjct: 262 NEVSFIFYQPV 272
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 4e-16
Identities = 47/267 (17%), Positives = 94/267 (35%), Gaps = 22/267 (8%)
Query: 371 LFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGI 430
+ + + K +L +T + L + Q+ + +
Sbjct: 7 TITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIK--S 60
Query: 431 PPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQ 490
G+ + + + N LT I P L NL L L NK+ ++ + + + + L
Sbjct: 61 VQGIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKV-KDL-SSLKDLKKLKS 116
Query: 491 LRLVGNSLTGSFPLE-LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSE 549
L L N ++ L L +LE+LY L NK + + KL L + +N +
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLY---LGNNKITDITV--LSRLTKLDTLSLEDNQISDI 171
Query: 550 LPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLE 609
+P + L++L +S N ++ L + L L++ + N L
Sbjct: 172 VP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFSQECLNKPINHQSNLVVPN 227
Query: 610 ILKLSENKFSGNIPSTLGNLSHLTELQ 636
+K ++ P + + +
Sbjct: 228 TVKNTDGSLVT--PEIISDDGDYEKPN 252
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 54/228 (23%), Positives = 91/228 (39%), Gaps = 16/228 (7%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
+ N + S+ I L ++T L L N+LT P + N L L+L+ N+
Sbjct: 50 QIIANNSDIK-SVQG-IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK-D 104
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+ + L L L SL++ +N IS GL +L L N +T + L L
Sbjct: 105 LSS-LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITD--ITVLSRLTKLD 159
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
N IS I ++G LQ L L++N I S + + L++L + L+ +
Sbjct: 160 TLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELFSQECLNK 215
Query: 286 IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGT 333
+ N T+ +LV P+ + + K + + T
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVT--PEIISDDGDYEKPNVKWHLPEFT 261
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 45/255 (17%), Positives = 96/255 (37%), Gaps = 19/255 (7%)
Query: 462 SNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK 521
+ I NL + + + ++ Q+ + + ++ L N+ + L+ NK
Sbjct: 24 AETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNK 79
Query: 522 FSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNC 581
+ I P + N + L L + N + +L +L + ++ N ++ + +V+
Sbjct: 80 LTD-IKP-LANLKNLGWLFLDENKVKD--LSSLKDLKKLKSLSLEHNGISDING--LVHL 133
Query: 582 MTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNL 641
L+ L + +N + + L L +L+ L L +N+ S +I L L+ L L + N
Sbjct: 134 PQLESLYLGNNK-ITDITV-LSRLTKLDTLSLEDNQIS-DIVP-LAGLTKLQNLYLSKNH 189
Query: 642 FSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFEN 701
S ++ L L +L + L L L + + + L P +
Sbjct: 190 IS-DLRA-LAGLKNLDV-LELFSQECLNKPINHQSNLVVPNTVKNTDGSLVT--PEIISD 244
Query: 702 LSSLLGSNFSYNNLT 716
N ++
Sbjct: 245 DGDYEKPNVKWHLPE 259
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 3e-18
Identities = 69/239 (28%), Positives = 116/239 (48%), Gaps = 35/239 (14%)
Query: 761 NVYFPPKEGFSFQDVVEATYN----FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASN 815
++ K+GF QDV + + + VGSGAYG+V A+ SG+ VA+KKL +
Sbjct: 1 SLSLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--S 58
Query: 816 REGNNIESSFRA--EILTLGKIRHRNIVKLYGFCYHQGSNL------LIYEYMERGSLGE 867
R + + RA E+L L ++H N++ L S L+ +M+ L +
Sbjct: 59 RPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQT-DLQK 117
Query: 868 LLHGSSCNL-EWPTRFMI--ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 924
++ E ++++ L +GL Y+H + HRD+K N+ +++ E +
Sbjct: 118 IMG---LKFSEEKIQYLVYQML---KGLKYIH---SAGVVHRDLKPGNLAVNEDCELKIL 168
Query: 925 DFGLAKVIDMPQSKSMSA-VAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRT 981
DFGLA+ D M+ V + Y APE + M + DI+S G ++ E+LTG+T
Sbjct: 169 DFGLARHAD----AEMTGYVVTRW-YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT 222
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-18
Identities = 63/221 (28%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKL 843
+G G G V+ AV D K VA+KK+ + +S A EI + ++ H NIVK+
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLT----DPQSVKHALREIKIIRRLDHDNIVKV 73
Query: 844 YGFCYHQGSNL--------------LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAA 889
+ GS L ++ EYME L +L E FM L
Sbjct: 74 FEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQL--L 130
Query: 890 EGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDMPQSKS--MSA-VAG 945
GL Y+H + HRD+K N+ ++ + +GDFGLA+++D S +S +
Sbjct: 131 RGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 946 SYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRT 981
+ Y +P YT + D+++ G + E+LTG+T
Sbjct: 188 KW-YRSPRLLLSPNNYTKAI----DMWAAGCIFAEMLTGKT 223
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 65/212 (30%), Positives = 91/212 (42%), Gaps = 39/212 (18%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNR--EGNNIESSFRAEILTLGKIRHRNIVKLYG 845
G G +G V +G VAVK L + + + R EI L RH +I+KLY
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR-EIQNLKLFRHPHIIKLY- 77
Query: 846 FCYHQ--GSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRF--MIALGAAEGLAYLH 896
Q + + ME S GEL HG +E F +++ + Y H
Sbjct: 78 ----QVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS-----AVDYCH 128
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE--- 953
+ + HRD+K N+LLD A + DFGL+ + M + + GS Y APE
Sbjct: 129 ---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPEVIS 183
Query: 954 ---YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
YA + DI+S GV+L LL G P
Sbjct: 184 GRLYA-----GPEVDIWSCGVILYALLCGTLP 210
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 5e-18
Identities = 58/219 (26%), Positives = 84/219 (38%), Gaps = 55/219 (25%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
GSG +G + ++VAVK + R E+ R EI+ +RH NIV+
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYI--ERGAAIDENVQR-EIINHRSLRHPNIVRFKEVI 85
Query: 848 YHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRF-----------MIALGAAEG 891
+ + ME S GEL G RF +++ G
Sbjct: 86 ---LTPTHLAIIMEYASGGELYERICNAG---------RFSEDEARFFFQQLLS-----G 128
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAH--VGDFGLAKVIDMPQSKSMSAVAGSYGY 949
++Y H +I HRD+K N LLD + DFG +K + G+ Y
Sbjct: 129 VSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKS--SVLHSQPKSTVGTPAY 183
Query: 950 IAPE------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
IAPE Y + D++S GV L +L G P
Sbjct: 184 IAPEVLLRQEYD-----GKIADVWSCGVTLYVMLVGAYP 217
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 8e-18
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 788 VGSGAYGTVY----KAVMDSGKIVAVK---KLASNREGNNIESSFRAEILTLGKIRHRNI 840
+G G YG V+ ++GKI A+K K R + + +AE L +++H I
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHT-KAERNILEEVKHPFI 83
Query: 841 VKLYGFCYHQGSNL-LIYEYMERGSLGEL---LHGSSCNLEWPTRFMIALGAAE---GLA 893
V L + + G L LI EY+ G GEL L +E F AE L
Sbjct: 84 VDLI-YAFQTGGKLYLILEYL-SG--GELFMQLEREGIFMEDTACFY----LAEISMALG 135
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIA 951
+LH + I +RD+K NI+L+ + HV DFGL K + G+ Y+A
Sbjct: 136 HLH---QKGIIYRDLKPENIMLNH--QGHVKLTDFGLCKE-SIHDGTVTHTFCGTIEYMA 189
Query: 952 PE----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
PE + V D +S G ++ ++LTG P
Sbjct: 190 PEILMRSGHNRAV----DWWSLGALMYDMLTGAPP 220
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 1e-17
Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 36/224 (16%)
Query: 777 EATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA-----EIL 830
+ + + +G GAYG V A + VA+KK+ + E EI
Sbjct: 24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKI------SPFEHQTYCQRTLREIK 77
Query: 831 TLGKIRHRNIVKLYGFCYHQGSNL-----LIYEYMERGSLGELLHGSSCNLEWPTRFMIA 885
L + RH NI+ + ++ + ME L +LL + + F+
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQ 136
Query: 886 LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSA- 942
+ GL Y+H + HRD+K +N+LL+ + + DFGLA+V D + ++
Sbjct: 137 I--LRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEY 191
Query: 943 VAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRT 981
VA + Y APE YT + DI+S G +L E+L+ R
Sbjct: 192 VATRW-YRAPEIMLNSKGYTKSI----DIWSVGCILAEMLSNRP 230
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 2e-17
Identities = 47/208 (22%), Positives = 73/208 (35%), Gaps = 51/208 (24%)
Query: 789 GSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGF 846
G G G V + + + A+K L + R E+ + + +IV++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKML-QDCP------KARREVELHWRASQCPHIVRIVDV 79
Query: 847 C---YHQGSNL-LIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAEGLAYLHH 897
Y L ++ E ++ G GEL G E ++ E + YLH
Sbjct: 80 YENLYAGRKCLLIVMECLD-G--GELFSRIQDRGDQAFTEREASEIMKS-IGEAIQYLH- 134
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAH---VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY 954
I HRD+K N+L K + DFG AK Y
Sbjct: 135 --SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET----------TGEKYD------ 176
Query: 955 AYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ CD++S GV++ LL G P
Sbjct: 177 -------KSCDMWSLGVIMYILLCGYPP 197
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 3e-17
Identities = 53/218 (24%), Positives = 95/218 (43%), Gaps = 36/218 (16%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYG 845
+G G Y V++A+ + + + V VK L ++ + R EI L +R NI+ L
Sbjct: 44 LGRGKYSEVFEAINITNNEKVVVKILKPVKK----KKIKR-EIKILENLRGGPNIITLAD 98
Query: 846 FCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMI--ALGAAEGLAYLHHDCKP 901
S L++E++ +L + ++ RF + L + L Y H
Sbjct: 99 IVKDPVSRTPALVFEHVNNTDFKQLYQTLT---DYDIRFYMYEIL---KALDYCH---SM 149
Query: 902 RIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE------- 953
I HRD+K +N+++D + + + D+GLA+ P + VA Y + PE
Sbjct: 150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH-PGQEYNVRVASRY-FKGPELLVDYQM 207
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD 991
Y Y++ D++S G +L ++ + P D D
Sbjct: 208 YDYSL------DMWSLGCMLASMIFRKEPFFHGHDNYD 239
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 4e-17
Identities = 56/211 (26%), Positives = 82/211 (38%), Gaps = 35/211 (16%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G +G V +G+ A+K L + + + E L RH + L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHT-VTESRVLQNTRHPFLTALK 71
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALG---AAE---GLAYLHH 897
+ + L + EY G L H L F AE L YLH
Sbjct: 72 -YAFQTHDRLCFVMEYANGGEL--FFH-----LSRERVFTEERARFYGAEIVSALEYLH- 122
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
+ +RDIK N++LD + H+ DFGL K + +M G+ Y+APE
Sbjct: 123 --SRDVVYRDIKLENLMLDK--DGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVL 177
Query: 954 --YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y V D + GVV+ E++ GR P
Sbjct: 178 EDNDYGRAV----DWWGLGVVMYEMMCGRLP 204
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 5e-17
Identities = 68/215 (31%), Positives = 92/215 (42%), Gaps = 45/215 (20%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
G G +G V +G VAVK K+ S I R EI L RH +I+K
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR---R-EIQNLKLFRHPHIIK 80
Query: 843 LYGFCYHQ--GSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRF--MIALGAAEGLA 893
LY Q + I+ ME S GEL +G E F +++ G+
Sbjct: 81 LY-----QVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS-----GVD 130
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
Y H + + HRD+K N+LLD A + DFGL+ + M + + GS Y APE
Sbjct: 131 YCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNM--MSDGEFLRTSCGSPNYAAPE 185
Query: 954 ------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
YA + DI+S GV+L LL G P
Sbjct: 186 VISGRLYAGP-----EVDIWSSGVILYALLCGTLP 215
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 47/222 (21%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA-----EILTLGKIRHRNI 840
++G GAYG V A +G+IVA+KK+ + A EI L +H NI
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKI------EPFDKPLFALRTLREIKILKHFKHENI 71
Query: 841 VKLYGFCYHQGSNL-----LIYEYMERGSLGELLHGSSCNL-EWPTRFMI--ALGAAEGL 892
+ ++ +I E M+ L ++ S+ L + ++ I L +
Sbjct: 72 ITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI--STQMLSDDHIQYFIYQTL---RAV 125
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG---- 948
LH + HRD+K +N+L++ + V DFGLA++ID + + G
Sbjct: 126 KVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEF 182
Query: 949 -----YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGR 980
Y APE Y+ + D++S G +L EL R
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAM----DVWSCGCILAELFLRR 220
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 6e-17
Identities = 62/213 (29%), Positives = 90/213 (42%), Gaps = 42/213 (19%)
Query: 789 GSGAYGTVYKAV-MDSGKIVAVK-----KLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
G G++G V A + + VA+K L + +E R EI L +RH +I+K
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE---R-EISYLKLLRHPHIIK 73
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRF--MIALGAAEGLAYL 895
LY +++ EY GEL E F +I + Y
Sbjct: 74 LYDVITTPTDIVMVIEYAG----GELFDYIVEKKRMTEDEGRRFFQQIIC-----AIEYC 124
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPE-- 953
H + +I HRD+K N+LLDD + DFGL+ + M + GS Y APE
Sbjct: 125 H---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNI--MTDGNFLKTSCGSPNYAAPEVI 179
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
YA + D++S G+VL +L GR P
Sbjct: 180 NGKLYA-----GPEVDVWSCGIVLYVMLVGRLP 207
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 82.0 bits (203), Expect = 1e-16
Identities = 65/215 (30%), Positives = 97/215 (45%), Gaps = 35/215 (16%)
Query: 788 VGSGAYGTVY----KAVMDSGKIVAVKKLASN---REGNNIESSFRAEILTLGKIRHRN- 839
+G+GAYG V+ + D+GK+ A+K L ++ E + R E L IR
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT-RTERQVLEHIRQSPF 120
Query: 840 IVKLYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYL 895
+V L+ + + + L LI +Y+ G L L E + E L +L
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY----VGEIVLALEHL 175
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
H K I +RDIK NILLD HV DFGL+K +++ G+ Y+AP+
Sbjct: 176 H---KLGIIYRDIKLENILLDS--NGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 230
Query: 954 ------YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
+ V D +S GV++ ELLTG +P
Sbjct: 231 IVRGGDSGHDKAV----DWWSLGVLMYELLTGASP 261
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 82.6 bits (204), Expect = 2e-16
Identities = 56/291 (19%), Positives = 98/291 (33%), Gaps = 59/291 (20%)
Query: 745 GNCGASPSSGSVPPLNNVYFPPKEGFSFQD---VVEATYNFHDSFIVGSGAYGTVYKAV- 800
G S + K S + + ++G+G+YG V +A
Sbjct: 15 GTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEAYD 74
Query: 801 MDSGKIVAVKKLASNREGNNIESSFRA--EILTLGKIRHRNIVKLYGFCYHQGSNL---- 854
++VA+KK+ R ++ R EI L ++ H ++VK+ +
Sbjct: 75 KLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132
Query: 855 -LIYEYMERGSLGELLHGSSCNLEWP-TRFMI--ALGAAEGLAYLHHDCKPRIFHRDIKS 910
++ E + +L + L + ++ L G+ Y+H I HRD+K
Sbjct: 133 YVVLEIADS-DFKKLFR-TPVYLTELHIKTLLYNLL---VGVKYVH---SAGILHRDLKP 184
Query: 911 NNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG---------------------- 948
N L++ V DFGLA+ +D P++ +
Sbjct: 185 ANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHV 244
Query: 949 ----YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGG 990
Y APE YT + D++S G + ELL
Sbjct: 245 VTRWYRAPELILLQENYTEAI----DVWSIGCIFAELLNMIKENVAYHADR 291
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 2e-16
Identities = 64/232 (27%), Positives = 103/232 (44%), Gaps = 28/232 (12%)
Query: 765 PPKEGFSFQDVVEATYN----FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN 819
+ F Q++ + + + + VGSGAYG+V A +G VAVKKL+ +
Sbjct: 10 QERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-- 67
Query: 820 NIESSFRA--EILTLGKIRHRNIVKLYGFCYHQGSNL------LIYEYMERGSLGELLHG 871
+I + R E+ L ++H N++ L S L+ M L ++
Sbjct: 68 SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKC 126
Query: 872 SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931
+ + + GL Y+H I HRD+K +N+ +++ E + DFGLA+
Sbjct: 127 QKLTDDHVQFLIYQI--LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARH 181
Query: 932 IDMPQSKSMSA-VAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRT 981
M+ VA + Y APE M + DI+S G ++ ELLTGRT
Sbjct: 182 TAD----EMTGYVATRW-YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-16
Identities = 76/439 (17%), Positives = 139/439 (31%), Gaps = 87/439 (19%)
Query: 124 GLVHLTYLDLAYNELT----GYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKL-----S 174
L + L LT I + L L L +N+ + +
Sbjct: 26 LLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTPSC 85
Query: 175 SLVSLNICNNMIS----GALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLR-----NLR 225
+ L++ N ++ G L L L +L + N L Q + L
Sbjct: 86 KIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLE 145
Query: 226 VFRAGQNAIS----GSIPAEISGCQSLQILGLAQNDIGGSLPKEIG-MLE----SLTEIV 276
+ ++S + + + + L ++ NDI + + + L+ L +
Sbjct: 146 KLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALK 205
Query: 277 LWDNQLT----GFIPSELGNCTKLQTLALYSNNL----VGQIPKEVGN-LKFLTKLYLYR 327
L +T + + + L+ LAL SN L + ++ + + L L+++
Sbjct: 206 LESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWE 265
Query: 328 NELN----GTIPREIGNLSMVTEIDLSENSLNGE-----IPTEFSKITGLRLLFLFQNQL 378
+ G + R + + E+ L+ N L E T L L++
Sbjct: 266 CGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSF 325
Query: 379 TGV----IPNELSSLRNLTKLDLSINYLTGPIPVGFQHL--------TQMRQLQLFENSL 426
T + L+ R L +L +S N L G + L + +R L L + +
Sbjct: 326 TAACCSHFSSVLAQNRFLLELQISNNRLED---AGVRELCQGLGQPGSVLRVLWLADCDV 382
Query: 427 TGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL--- 483
+ SL L N +L L+L N L G+ L
Sbjct: 383 SDS-----SCSSLAAT---------------LLANHSLRELDLSNNCL-GDAGILQLVES 421
Query: 484 ---NCETLLQLRLVGNSLT 499
L QL L +
Sbjct: 422 VRQPGCLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 3e-16
Identities = 99/514 (19%), Positives = 166/514 (32%), Gaps = 112/514 (21%)
Query: 246 QSLQILGLAQNDIGGSLPKEIG-MLESLTEIVLWDNQLT----GFIPSELGNCTKLQTLA 300
+Q L + ++ + E+ +L+ + L D LT I S L L L
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 301 LYSNNLVGQIPKEVGN-LKF----LTKLYLYRNELNGT----IPREIGNLSMVTEIDLSE 351
L SN L V L+ + KL L L G + + L + E+ LS+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 352 NSLNGEIPTEFSKI-----TGLRLLFLFQNQLT----GVIPNELSSLRNLTKLDLSINYL 402
N L + L L L L+ + + L + + +L +S N +
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 403 TGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGR----IPPHL 458
G + L Q L ++ L + +T + +
Sbjct: 183 N---EAGVRVLCQG----LKDSPCQ------------LEALKLESCGVTSDNCRDLCGIV 223
Query: 459 CQNSNLIMLNLGYNKL----FGNIPTDVLNCE-TLLQLRLVGNSLTGSFPLELCKLENLY 513
++L L LG NKL + +L+ L L + +T +LC++
Sbjct: 224 ASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRV---- 279
Query: 514 AIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNL-----SQLVTFNISSN 568
+ + L+ L +A N E + + QL + + S
Sbjct: 280 ----------------LRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSC 323
Query: 569 MLTGL----IPPEIVNCMTLQRLDISHNSF----VGSLPNELGTLQ-QLEILKLSENKFS 619
T + L L IS+N V L LG L +L L++ S
Sbjct: 324 SFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS 383
Query: 620 ----GNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPEL 675
++ +TL L EL + N LGD LQ+ ++
Sbjct: 384 DSSCSSLAATLLANHSLRELDLSNN--------CLGDAGILQLVESVRQPGC-------- 427
Query: 676 GKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSN 709
LLE L+L + + S E+ L +L
Sbjct: 428 ----LLEQLVLYDIYWSEEMEDR---LQALEKDK 454
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 6e-15
Identities = 74/460 (16%), Positives = 157/460 (34%), Gaps = 84/460 (18%)
Query: 152 LEHLYLNNNQFSGKIPAELGK-LSSLVSLNICNNMIS----GALPEGLGNLSSLVDFVAY 206
++ L + + S AEL L + + + ++ + L +L +
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 207 TNNLTGPLPQSIGNL-----RNLRVFRAGQNAIS----GSIPAEISGCQSLQILGLAQND 257
+N L + ++ ++ G + + + +LQ L L+ N
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNL 124
Query: 258 IGGSLPKEI--GMLE---SLTEIVLWDNQLT----GFIPSELGNCTKLQTLALYSNNLVG 308
+G + + + G+L+ L ++ L L+ + S L + L + +N++
Sbjct: 125 LGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINE 184
Query: 309 QIPKEVG-----NLKFLTKLYLYRNELN----GTIPREIGNLSMVTEIDLSENSLNGE-- 357
+ + + L L L + + + + + + E+ L N L
Sbjct: 185 AGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGM 244
Query: 358 ---IPTEFSKITGLRLLFLFQNQLTGV----IPNELSSLRNLTKLDLSINYLTGPIPVGF 410
P + LR L++++ +T + L + +L +L L+ N L G
Sbjct: 245 AELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDE---GA 301
Query: 411 QHL--------TQMRQLQLFENSLTG----GIPPGLGLYSLLWVVDFSHNYLTGRIPPHL 458
+ L Q+ L + S T L L + S+N L L
Sbjct: 302 RLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVREL 361
Query: 459 CQ-----NSNLIMLNLGYNKL----FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKL 509
CQ S L +L L + ++ +L +L +L L N L + L+L +
Sbjct: 362 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVE- 420
Query: 510 ENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSE 549
++ + L++L + + Y++ E
Sbjct: 421 ----SVR--------------QPGCLLEQLVLYDIYWSEE 442
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 8e-13
Identities = 70/374 (18%), Positives = 121/374 (32%), Gaps = 74/374 (19%)
Query: 106 SLDLNAMNFT----GSLSPSIGGLVHLTYLDLAYNELTGYIPREIG-----NCSRLEHLY 156
L L T G LS ++ L L L L+ N L + + RLE L
Sbjct: 89 KLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQ 148
Query: 157 LNNNQFSGK----IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTG 212
L S + + L L + NN I+ G+ L
Sbjct: 149 LEYCSLSAASCEPLASVLRAKPDFKELTVSNNDIN---EAGVRVLCQG------------ 193
Query: 213 PLPQSIGNLRNLRVFRAGQNAIS----GSIPAEISGCQSLQILGLAQNDIGGSLPKEIG- 267
L S L L++ ++ + ++ SL+ L L N +G E+
Sbjct: 194 -LKDSPCQLEALKL---ESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAELCP 249
Query: 268 ----MLESLTEIVLWDNQLT----GFIPSELGNCTKLQTLALYSNNL----VGQIPKEVG 315
L + +W+ +T G + L L+ L+L N L + + +
Sbjct: 250 GLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCETLL 309
Query: 316 N-LKFLTKLYLYRNELNGTIPREIGNL----SMVTEIDLSENSLNGEIPTEFSKI----- 365
L L++ ++ + E+ +S N L E +
Sbjct: 310 EPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPG 369
Query: 366 TGLRLLFLFQNQLTGV----IPNELSSLRNLTKLDLSINYLTGPIPVGFQHL-------- 413
+ LR+L+L ++ + L + +L +LDLS N L G L
Sbjct: 370 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG---DAGILQLVESVRQPG 426
Query: 414 TQMRQLQLFENSLT 427
+ QL L++ +
Sbjct: 427 CLLEQLVLYDIYWS 440
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 9e-09
Identities = 48/300 (16%), Positives = 100/300 (33%), Gaps = 48/300 (16%)
Query: 461 NSNLIMLNLGYNKL----FGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKL----ENL 512
+ ++ L++ +L + + + C+ +RL LT + ++ L
Sbjct: 2 SLDIQSLDIQCEELSDARWAELLPLLQQCQV---VRLDDCGLTEARCKDISSALRVNPAL 58
Query: 513 YAIELDQNKFSGP----IPPEIENCQ-KLQRLHIANNYFTSE----LPKEVGNLSQLVTF 563
+ L N+ + ++ K+Q+L + N T L + L L
Sbjct: 59 AELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 118
Query: 564 NISSNMLTG-----LIPPEIVNCMTLQRLDISHNSF----VGSLPNELGTLQQLEILKLS 614
++S N+L L + L++L + + S L + L + L +S
Sbjct: 119 HLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVS 178
Query: 615 ENKFSG----NIPSTLG-NLSHLTELQMGGNLFSGE----IPPELGDLSSLQIALNLSYN 665
N + + L + L L++ + + + + +SL+ L L N
Sbjct: 179 NNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRE-LALGSN 237
Query: 666 NLSGSIPPELGKLDL-----LEFLLLNNNHLSGE----IPSAFENLSSLLGSNFSYNNLT 716
L EL L L L + ++ + + SL + + N L
Sbjct: 238 KLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELG 297
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 56/204 (27%), Positives = 87/204 (42%), Gaps = 23/204 (11%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF--IPSELGNCT 294
P + L + + + L S+ +I+ ++ + I
Sbjct: 12 IFPDDAFA--ETIKANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSVQGIQY----LP 63
Query: 295 KLQTLALYSNNLVGQIPKEVG---NLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLS 350
++ LAL N L ++ L LT L L N+L ++P + L+ + E+ L
Sbjct: 64 NVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLV 117
Query: 351 ENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG- 409
EN L F K+T L L L NQL + L NLT+LDLS N L +P G
Sbjct: 118 ENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQS-LPEGV 176
Query: 410 FQHLTQMRQLQLFENSLTGGIPPG 433
F LTQ++ L+L++N L +P G
Sbjct: 177 FDKLTQLKDLRLYQNQLK-SVPDG 199
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 3e-10
Identities = 50/159 (31%), Positives = 71/159 (44%), Gaps = 12/159 (7%)
Query: 247 SLQILGLAQNDIGGSLPKEIGM---LESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
+++ L L N + +I L +LT ++L NQL T L+ L L
Sbjct: 64 NVRYLALGGNKL-----HDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVE 118
Query: 304 NNLVGQIPKEVGN-LKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE- 361
N L +P V + L LT L L N+L L+ +TE+DLS N L +P
Sbjct: 119 NQLQ-SLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGV 176
Query: 362 FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
F K+T L+ L L+QNQL V L +L + L N
Sbjct: 177 FDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 6e-10
Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 36/215 (16%)
Query: 321 TKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT- 379
K L + + + + L+ + +I + + + + +R L L N+L
Sbjct: 22 IKANLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVRYLALGGNKLHD 77
Query: 380 -GVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLT---GGIPPGL 434
L L NLT L L+ N L +P G F LT +++L L EN L G+ L
Sbjct: 78 ISA----LKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELVLVENQLQSLPDGVFDKL 132
Query: 435 GLYSLLWVVDFSHNYLTGRIPP----HLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQ 490
+ L + +HN L +P L +NL L+L YN+L ++P V + T L+
Sbjct: 133 TNLTYLNL---AHNQLQ-SLPKGVFDKL---TNLTELDLSYNQL-QSLPEGVFDKLTQLK 184
Query: 491 -LRLVGNSLT----GSFPLELCKLENLYAIELDQN 520
LRL N L G F +L +L I L N
Sbjct: 185 DLRLYQNQLKSVPDGVFD----RLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 2e-08
Identities = 60/257 (23%), Positives = 89/257 (34%), Gaps = 71/257 (27%)
Query: 86 QTPCSWIGVNCTSD-------FEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNEL 138
I N + + A N I L ++ YL L N+L
Sbjct: 16 DAFAETIKANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQYLPNVRYLALGGNKL 75
Query: 139 TGYIPREIG---NCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMISGALPEGL 194
+I + L +L L NQ +P + KL++L L + N + +LP+G+
Sbjct: 76 H-----DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGV 128
Query: 195 GNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLA 254
F TN L L LA
Sbjct: 129 --------FDKLTN---------------------------------------LTYLNLA 141
Query: 255 QNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSEL-GNCTKLQTLALYSNNLVGQIPK 312
N + SLPK + L +LTE+ L NQL +P + T+L+ L LY N L +P
Sbjct: 142 HNQL-QSLPKGVFDKLTNLTELDLSYNQLQS-LPEGVFDKLTQLKDLRLYQNQLKS-VPD 198
Query: 313 EV-GNLKFLTKLYLYRN 328
V L L ++L+ N
Sbjct: 199 GVFDRLTSLQYIWLHDN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 51/236 (21%), Positives = 86/236 (36%), Gaps = 51/236 (21%)
Query: 477 NIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKL 536
+ + + L S+T +L ++ I + + I+ +
Sbjct: 16 DAFAETIK------ANLKKKSVT-DAV-TQNELNSIDQIIANNSDIKSV--QGIQYLPNV 65
Query: 537 QRLHIANNYFTSELPKEVG---NLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHN 592
+ L + N + L+ L ++ N L L P + + +T L+ L + N
Sbjct: 66 RYLALGGNKLHD-----ISALKELTNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVEN 119
Query: 593 SFVGSLPNEL-GTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELG 651
SLP+ + L L L L+ N+ ++P G LT L
Sbjct: 120 QLQ-SLPDGVFDKLTNLTYLNLAHNQLQ-SLPK--GVFDKLTNLTE-------------- 161
Query: 652 DLSSLQIALNLSYNNLSGSIPPEL-GKLDLLEFLLLNNNHLSGEIPS-AFENLSSL 705
L+LSYN L S+P + KL L+ L L N L +P F+ L+SL
Sbjct: 162 --------LDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKS-VPDGVFDRLTSL 207
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 42/167 (25%), Positives = 68/167 (40%), Gaps = 21/167 (12%)
Query: 562 TFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN 621
N+ +T + +N + + S V + L + L L NK
Sbjct: 23 KANLKKKSVTDAVTQNELNSIDQIIANNSDIKSVQGIQ----YLPNVRYLALGGNKLH-- 76
Query: 622 IPSTLG---NLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNLSGSIPPEL-G 676
+ L++LT L + GN +P + D L++L+ L L N L S+P +
Sbjct: 77 ---DISALKELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKE-LVLVENQLQ-SLPDGVFD 130
Query: 677 KLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIP 723
KL L +L L +N L F+ L++L + SYN L S+P
Sbjct: 131 KLTNLTYLNLAHNQLQSLPKGVFDKLTNLTELDLSYNQLQ----SLP 173
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 5e-16
Identities = 56/240 (23%), Positives = 92/240 (38%), Gaps = 51/240 (21%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIES--SFRAEILTLGKIRHRNIVKL 843
++G G+YG VY A ++ K VA+KK+ + + I+ R EI L +++ I++L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV-NRMFEDLIDCKRILR-EITILNRLKSDYIIRL 90
Query: 844 YGFCYHQGSNL-----LIYEYMERGSLGELLHGSSCNL-EWPTRFMI--ALGAAEGLAYL 895
Y ++ E + L +L + L E + ++ L G ++
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIADS-DLKKLFK-TPIFLTEEHIKTILYNLL---LGENFI 145
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG------- 948
H + I HRD+K N LL+ V DFGLA+ I+ + ++
Sbjct: 146 H---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 949 --------------YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDG 989
Y APE YT + DI+S G + ELL
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI----DIWSTGCIFAELLNMLQSHINDPTN 258
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 8e-16
Identities = 65/213 (30%), Positives = 93/213 (43%), Gaps = 38/213 (17%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAE--ILTLGKIRHRNIVK 842
+G G++G V A AVK L + + + +E +L ++H +V
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHI-MSERNVLLK-NVKHPFLVG 103
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGEL---LHGSSCNLEWPTRFMIALGAAE---GLAYL 895
L+ F + L + +Y+ G GEL L C LE RF AAE L YL
Sbjct: 104 LH-FSFQTADKLYFVLDYI-NG--GELFYHLQRERCFLEPRARFY----AAEIASALGYL 155
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
H I +RD+K NILLD + H+ DFGL K ++ + + S G+ Y+APE
Sbjct: 156 H---SLNIVYRDLKPENILLDS--QGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPE 209
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y V D + G VL E+L G P
Sbjct: 210 VLHKQPYDRTV----DWWCLGAVLYEMLYGLPP 238
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 9e-16
Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 43/242 (17%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR--------- 836
+G G + TV+ A M + VA+K + ++ + EI L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNTKEDS 82
Query: 837 --HRNIVKLYGFCYHQGSNL----LIYEYMERGSLGELL---HGSSCNLEWPTRFMIALG 887
+I+KL H+G N +++E + +L L+ L + + L
Sbjct: 83 MGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQL- 140
Query: 888 AAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH------VGDFGLAKVIDMPQSKSMS 941
GL Y+H C I H DIK N+L++ + D G A + +
Sbjct: 141 -LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYT 193
Query: 942 AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR 1001
+ Y +PE DI+S ++ EL+TG L + + ++ ++
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG----DFLFEPDEGHSYTKDD-- 247
Query: 1002 DH 1003
DH
Sbjct: 248 DH 249
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 9e-16
Identities = 63/256 (24%), Positives = 101/256 (39%), Gaps = 37/256 (14%)
Query: 745 GNCGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFH-DSF----IVGSGAYGTVYKA 799
GN A+ + KE F + + D F +G+G++G V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 800 VM-DSGKIVAVKKLASNR--EGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL-L 855
+SG A+K L + + IE + E L + +VKL F + SNL +
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHT-LNEKRILQAVNFPFLVKLE-FSFKDNSNLYM 118
Query: 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPRIFHRDIKSNN 912
+ EY+ G + L E RF AA+ YLH + +RD+K N
Sbjct: 119 VMEYVAGGEMFSHLRRIGRFSEPHARFY----AAQIVLTFEYLHSL---DLIYRDLKPEN 171
Query: 913 ILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVTEKCDI 966
+L+D + ++ DFG AK + + G+ +APE Y V D
Sbjct: 172 LLIDQ--QGYIQVTDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAV----DW 221
Query: 967 YSYGVVLLELLTGRTP 982
++ GV++ E+ G P
Sbjct: 222 WALGVLIYEMAAGYPP 237
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 79.1 bits (195), Expect = 1e-15
Identities = 47/163 (28%), Positives = 66/163 (40%), Gaps = 16/163 (9%)
Query: 279 DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV--GNLKFLTKLYLYRNELNGTIPR 336
QL +P L + T L L NNL ++ E L L L L N LN I
Sbjct: 27 KQQLP-NVPQSLPSYT--ALLDLSHNNL-SRLRAEWTPTRLTNLHSLLLSHNHLN-FISS 81
Query: 337 EI-GNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTK 394
E + + +DLS N L+ + FS + L +L L+ N + V N + L K
Sbjct: 82 EAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQK 140
Query: 395 LDLSINYLTGPIPVG----FQHLTQMRQLQLFENSLTGGIPPG 433
L LS N ++ PV L ++ L L N L +P
Sbjct: 141 LYLSQNQISR-FPVELIKDGNKLPKLMLLDLSSNKLK-KLPLT 181
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 71.8 bits (176), Expect = 2e-13
Identities = 39/159 (24%), Positives = 63/159 (39%), Gaps = 13/159 (8%)
Query: 564 NISSNMLTGLIPPEIVNCMT-LQRLDISHNSFVGSLPNE-LGTLQQLEILKLSENKFSGN 621
++S N L+ L +T L L +SHN + + +E + L L LS N
Sbjct: 45 DLSHNNLSRLRAEWTPTRLTNLHSLLLSHNH-LNFISSEAFVPVPNLRYLDLSSNHLH-T 102
Query: 622 IPS-TLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE----L 675
+ +L L L + N + D++ LQ L LS N +S P E
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQK-LYLSQNQIS-RFPVELIKDG 159
Query: 676 GKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNN 714
KL L L L++N L + + L + + + +N
Sbjct: 160 NKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHN 198
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 66.4 bits (162), Expect = 2e-11
Identities = 38/183 (20%), Positives = 71/183 (38%), Gaps = 28/183 (15%)
Query: 222 RNLRVFRAGQNAISGSIPAEI--SGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLW 278
+ N +S + AE + +L L L+ N + + E + +L + L
Sbjct: 39 SYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLS 96
Query: 279 DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPRE 337
N L + L+ L LY+N++V + + ++ L KLYL +N+++ P E
Sbjct: 97 SNHLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVE 154
Query: 338 IGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDL 397
+ + +K+ L LL L N+L + +L L K L
Sbjct: 155 LI--------------------KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
Query: 398 SIN 400
++
Sbjct: 195 YLH 197
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 2e-09
Identities = 43/228 (18%), Positives = 68/228 (29%), Gaps = 59/228 (25%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE-LSSLRNLTKLDLSINYLT 403
+ S+ L +P + LL L N L+ + + L NL L LS N+L
Sbjct: 21 NILSCSKQQLP-NVPQSLP--SYTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN 77
Query: 404 GPIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNS 462
I F + +R L L N L + L FS
Sbjct: 78 F-ISSEAFVPVPNLRYLDLSSNHLHT-LDEFL----------FSDL-------------Q 112
Query: 463 NLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKF 522
L +L L N + + + + L + L QN+
Sbjct: 113 ALEVLLLYNNHI-VVVDRNAFE-----------------------DMAQLQKLYLSQNQI 148
Query: 523 SGPIPPEI----ENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNIS 566
S P E+ KL L +++N ++ L V +
Sbjct: 149 SR-FPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLY 195
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 31/156 (19%), Positives = 55/156 (35%), Gaps = 14/156 (8%)
Query: 107 LDLNAMNFTGSLSPSI--GGLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFS 163
LDL+ N + L L +L L L++N L +I E L +L L++N
Sbjct: 44 LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH 101
Query: 164 GKIPAE-LGKLSSLVSLNICNNMISGALPEG-LGNLSSLVDFVAYTNNLTGPLP----QS 217
+ L +L L + NN I + +++ L N ++ P +
Sbjct: 102 -TLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKD 158
Query: 218 IGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGL 253
L L + N + ++ + GL
Sbjct: 159 GNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGL 194
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 80.5 bits (198), Expect = 1e-15
Identities = 64/307 (20%), Positives = 120/307 (39%), Gaps = 40/307 (13%)
Query: 692 SGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASP 751
S + + + G + G ++P + + +G +P
Sbjct: 259 SLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFERAKIGQGTKAP 318
Query: 752 SSGSVPPLNNVYFPP-KEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAVM-DSGKIVAV 809
+ ++ ++ D F+ ++G G++G V + + ++ AV
Sbjct: 319 EEKTANTISKFDNNGNRDRMKLTD-------FNFLMVLGKGSFGKVMLSERKGTDELYAV 371
Query: 810 KKL--ASNREGNNIESSFRAE--ILTLGKIRHRNIVKLYGFCYHQGSNL-LIYEYMERGS 864
K L + +++E + E +L L + + +L+ C+ L + EY+ G
Sbjct: 372 KILKKDVVIQDDDVECT-MVEKRVLAL-PGKPPFLTQLH-SCFQTMDRLYFVMEYVNGGD 428
Query: 865 LGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHDCKPRIFHRDIKSNNILLDDKFEA 921
L + E F AAE GL +L I +RD+K +N++LD E
Sbjct: 429 LMYHIQQVGRFKEPHAVFY----AAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDS--EG 479
Query: 922 HV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE----YAYTMKVTEKCDIYSYGVVLLE 975
H+ DFG+ K ++ + G+ YIAPE Y V D +++GV+L E
Sbjct: 480 HIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSV----DWWAFGVLLYE 534
Query: 976 LLTGRTP 982
+L G+ P
Sbjct: 535 MLAGQAP 541
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-15
Identities = 59/210 (28%), Positives = 95/210 (45%), Gaps = 32/210 (15%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAE--ILTLGKIRHRNIVK 842
+G G++G V+ A + + A+K L +++E + E +L+L H +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-MVEKRVLSLA-WEHPFLTH 82
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLHHD 898
++ + NL + EY+ G L + F AAE GL +LH
Sbjct: 83 MF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFY----AAEIILGLQFLH-- 135
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE--- 953
I +RD+K +NILLD + H+ DFG+ K +M + G+ YIAPE
Sbjct: 136 -SKGIVYRDLKLDNILLDK--DGHIKIADFGMCK-ENMLGDAKTNTFCGTPDYIAPEILL 191
Query: 954 -YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y V D +S+GV+L E+L G++P
Sbjct: 192 GQKYNHSV----DWWSFGVLLYEMLIGQSP 217
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 42/251 (16%), Positives = 85/251 (33%), Gaps = 23/251 (9%)
Query: 122 IGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNI 181
GL + +L +T + S +++ +N+ + + ++L L++
Sbjct: 15 DPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQ-SLAG-MQFFTNLKELHL 70
Query: 182 CNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAE 241
+N IS L +L+ L + N L L L + N + +
Sbjct: 71 SHNQISD--LSPLKDLTKLEELSVNRNRLKNLNGIPSACLSRLFL---DNNELR-DTDS- 123
Query: 242 ISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLAL 301
+ ++L+IL + N + +G L L + L N++T L K+ + L
Sbjct: 124 LIHLKNLEILSIRNNKL--KSIVMLGFLSKLEVLDLHGNEITNT--GGLTRLKKVNWIDL 179
Query: 302 YSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTI--PREIGNLSMVTEIDLSENSLN--GE 357
V + K L + +G P I N + + E
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKD----PDGRWISPYYISNGGSYVDGCVLWELPVYTDE 235
Query: 358 IPTEFSKITGL 368
+ +FS+ +
Sbjct: 236 VSYKFSEYINV 246
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 42/235 (17%), Positives = 83/235 (35%), Gaps = 25/235 (10%)
Query: 269 LESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRN 328
L + + L +T + + +Q ++N+ Q + L +L+L N
Sbjct: 18 LANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGMQFFTNLKELHLSHN 73
Query: 329 ELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRL--LFLFQNQLTGVIPNEL 386
+++ P + +L+ + E+ ++ N L + I L LFL N+L L
Sbjct: 74 QISDLSP--LKDLTKLEELSVNRNRL-----KNLNGIPSACLSRLFLDNNELRDTDS--L 124
Query: 387 SSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFS 446
L+NL L + N L I L+++ L L N +T L + +D +
Sbjct: 125 IHLKNLEILSIRNNKLKS-IV-MLGFLSKLEVLDLHGNEIT-NTGGLTRLKK-VNWIDLT 180
Query: 447 HNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNI--PTDVLNCETLLQLRLVGNSLT 499
+ L + N + G P + N + + ++
Sbjct: 181 GQKCV---NEPVKYQPELYITNTVKD-PDGRWISPYYISNGGSYVDGCVLWELPV 231
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 49/260 (18%), Positives = 84/260 (32%), Gaps = 31/260 (11%)
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEF 362
+ Q+ L K L + + + LS V + +++ +
Sbjct: 5 RPTPINQV-FPDPGLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNI--QSLAGM 59
Query: 363 SKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLF 422
T L+ L L NQ++ + P L L L +L ++ N L + L+ +L L
Sbjct: 60 QFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLS---RLFLD 114
Query: 423 ENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDV 482
N L L L ++ +N L I L S L +L+L N++ T+
Sbjct: 115 NNELRD--TDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEVLDLHGNEI-----TNT 165
Query: 483 LNCETLLQLR---LVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPE-IENCQKLQR 538
L ++ L G + LY ++ I P I N
Sbjct: 166 GGLTRLKKVNWIDLTGQKCV---NEPVKYQPELYITNTVKDPDGRWISPYYISNGGSYVD 222
Query: 539 LHIANNYFTSELPKEVGNLS 558
+ LP +S
Sbjct: 223 GCVLWE-----LPVYTDEVS 237
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 41/228 (17%), Positives = 74/228 (32%), Gaps = 24/228 (10%)
Query: 495 GNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV 554
+ FP L N L + + + + +Q + N+ S +
Sbjct: 6 PTPINQVFPDP--GLANAVKQNLGKQSVTDLVS--QKELSGVQNFNGDNSNIQS--LAGM 59
Query: 555 GNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLS 614
+ L ++S N ++ L P + + L+ L ++ N L L + LS
Sbjct: 60 QFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRN--------RLKNLNGIPSACLS 109
Query: 615 ENKFSGNIPSTLGNLSHLTELQ---MGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSI 671
N +L HL L+ + N I LG LS L++ L+L N ++ +
Sbjct: 110 RLFLDNNELRDTDSLIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEV-LDLHGNEIT-NT 165
Query: 672 PPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPL 719
L +L + ++ L E L P
Sbjct: 166 GG-LTRLKKVNWIDLTGQKCVNEPVKYQPELYITNTVKDPDGRWISPY 212
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 9e-09
Identities = 29/153 (18%), Positives = 61/153 (39%), Gaps = 13/153 (8%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
+ + + N SL+ + +L L L++N+++ P + + ++LE L +N N+
Sbjct: 45 NFNGDNSNIQ-SLAG-MQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLK-N 99
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
+ + L L + NN + + L +L +L N L +G L L
Sbjct: 100 L--NGIPSACLSRLFLDNNELRD--TDSLIHLKNLEILSIRNNKLKS--IVMLGFLSKLE 153
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDI 258
V N I+ + ++ + + + L
Sbjct: 154 VLDLHGNEIT-NTG-GLTRLKKVNWIDLTGQKC 184
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 3e-15
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 38/213 (17%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAE--ILTLGKIRHRNIVK 842
+G G++G V A + ++G + AVK L + +++E + E IL+L H + +
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECT-MTEKRILSLA-RNHPFLTQ 88
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGEL---LHGSSCNLEWPTRFMIALGAAE---GLAYL 895
L+ C+ L + E++ G G+L + S E RF AAE L +L
Sbjct: 89 LF-CCFQTPDRLFFVMEFV-NG--GDLMFHIQKSRRFDEARARFY----AAEIISALMFL 140
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
H I +RD+K +N+LLD E H DFG+ K + + + G+ YIAPE
Sbjct: 141 H---DKGIIYRDLKLDNVLLDH--EGHCKLADFGMCK-EGICNGVTTATFCGTPDYIAPE 194
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y V D ++ GV+L E+L G P
Sbjct: 195 ILQEMLYGPAV----DWWAMGVLLYEMLCGHAP 223
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 79.0 bits (194), Expect = 3e-15
Identities = 64/339 (18%), Positives = 109/339 (32%), Gaps = 39/339 (11%)
Query: 367 GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSL 426
+L + + R L + + P+ VG + T + + S+
Sbjct: 229 WFYHRWLLGRAEPHDVLCCVHVSREEACLSVCFSR---PLTVGSRMGTLLLMVDEAPLSV 285
Query: 427 TGGIPPGLGLYSLLWVVDFSHNYLTGRIP-----PHLCQNSNLIMLNLGYNKLFGNIPTD 481
P G S +W+ D L ++P + + L ++ D
Sbjct: 286 EWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPE-CWCRD 344
Query: 482 VLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ----------NKFSGPIPPEIE 531
E L + L T EL + L +E + + P+ E E
Sbjct: 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKE 403
Query: 532 NCQKLQRL-----------HIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVN 580
Q L + F E + + +++ LT L +
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQ 461
Query: 581 CMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGN 640
+ + LD+SHN +LP L L+ LE+L+ S+N N+ + NL L EL + N
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 518
Query: 641 LFSG-EIPPELGDLSSLQIALNLSYNNLSGSIPPELGKL 678
L L + LNL N+L +L
Sbjct: 519 RLQQSAAIQPLVSCPRLVL-LNLQGNSLC-QEEGIQERL 555
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 70.9 bits (173), Expect = 1e-12
Identities = 59/297 (19%), Positives = 102/297 (34%), Gaps = 39/297 (13%)
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
+ +LL +VD + + R P + S++ + +L L +P
Sbjct: 271 MGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKE 330
Query: 496 NSLTGSFPLELCK----LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELP 551
L P C+ E L+ EL K S + E+E+C++LQ L N + +
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEK-STVLQSELESCKELQELEPENKWCLLTII 389
Query: 552 KEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEIL 611
+ L L+ + + L + V+ M LD + F+ + +L
Sbjct: 390 LLMRALDPLLYEKETLQYFSTL---KAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446
Query: 612 KLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSI 671
L+ + L +L L + L+LS+N L ++
Sbjct: 447 HLAHKDLT-----VLCHLEQLLLVTH----------------------LDLSHNRLR-AL 478
Query: 672 PPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNM 728
PP L L LE L ++N L + NL L N L +I +
Sbjct: 479 PPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRLQQ-SAAIQPLVSC 532
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 69.8 bits (170), Expect = 3e-12
Identities = 51/291 (17%), Positives = 88/291 (30%), Gaps = 38/291 (13%)
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
L L T E L ++ + + L L + T
Sbjct: 304 LPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECWCR-DSATDEQLFRCELSVEKST 362
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL 439
V+ +EL S + L +L+ + + MR L L +S
Sbjct: 363 -VLQSELESCKELQELEPENKWCL------LTIILLMRALDPLLYEKET-----LQYFST 410
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
L VD + +K + + L L LT
Sbjct: 411 LKAVDPMRAAYLDDL----------------RSKFLLENSVLKMEYADVRVLHLAHKDLT 454
Query: 500 GSFPLE-LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLS 558
LE L + +L L N+ +PP + + L+ L ++N + + V NL
Sbjct: 455 VLCHLEQLLLVTHLD---LSHNRLRA-LPPALAALRCLEVLQASDNALEN-VD-GVANLP 508
Query: 559 QLVTFNISSNMLTGL-IPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQL 608
+L + +N L +V+C L L++ NS L ++
Sbjct: 509 RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 65.9 bits (160), Expect = 4e-11
Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 30/214 (14%)
Query: 261 SLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS----------NNLVGQI 310
++ E L L + T + SEL +C +LQ L + + +
Sbjct: 340 CWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPL 398
Query: 311 PKEVGNLKFLTKL-----------YLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIP 359
E L++ + L R++ + V + L+ L +
Sbjct: 399 LYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--TVL 456
Query: 360 TEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQL 419
++ + L L N+L +P L++LR L L S N L + G +L ++++L
Sbjct: 457 CHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQEL 513
Query: 420 QLFENSLTG--GIPPGLGLYSLLWVVDFSHNYLT 451
L N L I P L L +++ N L
Sbjct: 514 LLCNNRLQQSAAIQP-LVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 62.5 bits (151), Expect = 5e-10
Identities = 25/95 (26%), Positives = 42/95 (44%), Gaps = 6/95 (6%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI 166
L L + T L + L+ +T+LDL++N L +P + LE L ++N +
Sbjct: 446 LHLAHKDLT-VL-CHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQASDNALE-NV 501
Query: 167 PAELGKLSSLVSLNICNNMISG-ALPEGLGNLSSL 200
+ L L L +CNN + A + L + L
Sbjct: 502 D-GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRL 535
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 61.3 bits (148), Expect = 1e-09
Identities = 23/101 (22%), Positives = 42/101 (41%), Gaps = 6/101 (5%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
+ L LA+ +LT + + + HL L++N+ +P L L L L +N +
Sbjct: 442 DVRVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNAL 498
Query: 187 SGALPEGLGNLSSLVDFVAYTNNLTG-PLPQSIGNLRNLRV 226
+G+ NL L + + N L Q + + L +
Sbjct: 499 ENV--DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVL 537
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 59.0 bits (142), Expect = 5e-09
Identities = 29/162 (17%), Positives = 56/162 (34%), Gaps = 16/162 (9%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLD--------LAYNELTGYIPREIGNCSRLEHLYLN 158
L + A++ ++ L +D ++ + + L+L
Sbjct: 390 LLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLA 449
Query: 159 NNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSI 218
+ + + L +L + L++ +N + ALP L L L A N L + +
Sbjct: 450 HKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GV 504
Query: 219 GNLRNLRVFRAGQNAISGSIPA--EISGCQSLQILGLAQNDI 258
NL L+ N + A + C L +L L N +
Sbjct: 505 ANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 53.2 bits (127), Expect = 3e-07
Identities = 23/82 (28%), Positives = 34/82 (41%), Gaps = 4/82 (4%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG-K 165
LDL+ +L P++ L L L + N L + + N RL+ L L NN+
Sbjct: 468 LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVD-GVANLPRLQELLLCNNRLQQSA 524
Query: 166 IPAELGKLSSLVSLNICNNMIS 187
L LV LN+ N +
Sbjct: 525 AIQPLVSCPRLVLLNLQGNSLC 546
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 42.8 bits (100), Expect = 5e-04
Identities = 13/58 (22%), Positives = 21/58 (36%), Gaps = 2/58 (3%)
Query: 120 PSIGGLVHLTYLDLAYNELTGY-IPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSL 176
+ L L L L N L + + +C RL L L N + +L+ +
Sbjct: 502 DGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAE--ILTLGKIRHRNIV 841
++G G+Y V + + +I A+K + + +I+ + E + H +V
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWV-QTEKHVFEQA-SNHPFLV 73
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGEL---LHGSSCNLEWPTRFMIALGAAE---GLAY 894
L+ C+ S L + EY+ G G+L + E RF +AE L Y
Sbjct: 74 GLH-SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFY----SAEISLALNY 125
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
LH + I +RD+K +N+LLD E H+ D+G+ K + + S G+ YIAP
Sbjct: 126 LH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCK-EGLRPGDTTSTFCGTPNYIAP 179
Query: 953 E----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
E Y V D ++ GV++ E++ GR+P
Sbjct: 180 EILRGEDYGFSV----DWWALGVLMFEMMAGRSP 209
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 4e-15
Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 38/213 (17%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAE--ILTLGKIRHRNIVK 842
+G G++G V + + ++ AVK L + +++E + E +L L + + +
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECT-MVEKRVLALP-GKPPFLTQ 85
Query: 843 LYGFCYHQGSNL-LIYEYMERGSLGEL---LHGSSCNLEWPTRFMIALGAAE---GLAYL 895
L+ C+ L + EY+ G G+L + E F AAE GL +L
Sbjct: 86 LH-SCFQTMDRLYFVMEYV-NG--GDLMYHIQQVGRFKEPHAVFY----AAEIAIGLFFL 137
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE 953
I +RD+K +N++LD E H+ DFG+ K ++ + G+ YIAPE
Sbjct: 138 Q---SKGIIYRDLKLDNVMLDS--EGHIKIADFGMCKE-NIWDGVTTKTFCGTPDYIAPE 191
Query: 954 ----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y V D +++GV+L E+L G+ P
Sbjct: 192 IIAYQPYGKSV----DWWAFGVLLYEMLAGQAP 220
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 35/156 (22%), Positives = 61/156 (39%), Gaps = 26/156 (16%)
Query: 270 ESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
E++TEI L N + P KL+ + L +N + ++ + L+ L L LY N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGN 90
Query: 329 ELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSS 388
++ +P+ + F + L+LL L N++ + +
Sbjct: 91 KIT-ELPKSL-----------------------FEGLFSLQLLLLNANKINCLRVDAFQD 126
Query: 389 LRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFEN 424
L NL L L N L F L ++ + L +N
Sbjct: 127 LHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 38/150 (25%), Positives = 60/150 (40%), Gaps = 12/150 (8%)
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPST 625
LT IP + T+ + + N+ P ++L + LS N+ S P
Sbjct: 19 RGKGLTE-IPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDA 75
Query: 626 LGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNLSGSIPPEL-GKLDLLEF 683
L L L + GN + E+P L + L SLQ+ L L+ N ++ + + L L
Sbjct: 76 FQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQL-LLLNANKIN-CLRVDAFQDLHNLNL 132
Query: 684 LLLNNNHLSGEIPSAFENLSSL----LGSN 709
L L +N L F L ++ L N
Sbjct: 133 LSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 2e-09
Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 8/126 (6%)
Query: 231 QNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPS 288
QN I IP S + L+ + L+ N I L + L SL +VL+ N++T S
Sbjct: 41 QNTIK-VIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITELPKS 98
Query: 289 ELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTE 346
LQ L L +N + + + +L L L LY N+L TI + L +
Sbjct: 99 LFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPLRAIQT 156
Query: 347 IDLSEN 352
+ L++N
Sbjct: 157 MHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 29/110 (26%), Positives = 46/110 (41%), Gaps = 5/110 (4%)
Query: 609 EILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNL 667
++L +N P L + + N S E+ P+ L SL L L N +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNS-LVLYGNKI 92
Query: 668 SGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
+ +P L L L+ LLLN N ++ AF++L +L + N L
Sbjct: 93 T-ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ 141
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-07
Identities = 32/156 (20%), Positives = 55/156 (35%), Gaps = 16/156 (10%)
Query: 89 CSWIGVNCTS--------DFEPVVWSLDLNAMNFTGSLSPSI-GGLVHLTYLDLAYNELT 139
CS V+C + + + L + P L +DL+ N+++
Sbjct: 11 CSNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQIS 69
Query: 140 GYIPREI-GNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMISGALPEGL-GN 196
+ + L L L N+ + ++P L L SL L + N I+ L +
Sbjct: 70 -ELAPDAFQGLRSLNSLVLYGNKIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQD 126
Query: 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQN 232
L +L Y N L + LR ++ QN
Sbjct: 127 LHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 37/169 (21%), Positives = 59/169 (34%), Gaps = 38/169 (22%)
Query: 382 IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLW 441
IP L +T++ L N + P F ++R++ L N ++ + P
Sbjct: 26 IPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDA------- 75
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQ-LRLVGNSLT- 499
F L +L L L NK+ +P + LQ L L N +
Sbjct: 76 ---FQG--LR-----------SLNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKINC 118
Query: 500 ---GSFPLELCKLENLYAIELDQNKFSGPIPPEI-ENCQKLQRLHIANN 544
+F L NL + L NK I + +Q +H+A N
Sbjct: 119 LRVDAFQ----DLHNLNLLSLYDNKLQT-IAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 6/131 (4%)
Query: 129 TYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMIS 187
T + L N + P +L + L+NNQ S ++ + L SL SL + N I+
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKIT 93
Query: 188 GALPEGL-GNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGC 245
LP+ L L SL + N + + +L NL + N + +I S
Sbjct: 94 -ELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGTFSPL 151
Query: 246 QSLQILGLAQN 256
+++Q + LAQN
Sbjct: 152 RAIQTMHLAQN 162
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 7e-15
Identities = 61/209 (29%), Positives = 95/209 (45%), Gaps = 34/209 (16%)
Query: 788 VGSGAYGTVYKAVM-DSGKIVAVKKLASNR--EGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G+G++G V+ +G+ A+K L +E + E L L + H I++++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHT-NDERLMLSIVTHPFIIRMW 72
Query: 845 GFCYHQGSNL-LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAE---GLAYLH-HDC 899
+ + +I +Y+E G L LL S +F AAE L YLH D
Sbjct: 73 -GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY----AAEVCLALEYLHSKD- 126
Query: 900 KPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPE---- 953
I +RD+K NILLD H+ DFG AK + + G+ YIAPE
Sbjct: 127 ---IIYRDLKPENILLDK--NGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVST 177
Query: 954 YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
Y + D +S+G+++ E+L G TP
Sbjct: 178 KPYNKSI----DWWSFGILIYEMLAGYTP 202
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 9e-15
Identities = 44/155 (28%), Positives = 67/155 (43%), Gaps = 6/155 (3%)
Query: 273 TEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELN 331
++ L L + TKL L L N L + V +L L L L N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLA 96
Query: 332 GTIPREI-GNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLR 390
++P + +L+ + ++ L N L F ++T L+ L L NQL + L
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLT 155
Query: 391 NLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFEN 424
NL L LS N L +P G F L +++ + LF N
Sbjct: 156 NLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 44/172 (25%), Positives = 68/172 (39%), Gaps = 31/172 (18%)
Query: 537 QRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSFV 595
++L + + + L++L N+ N L L + + +T L L +++N
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTL-SAGVFDDLTELGTLGLANNQLA 96
Query: 596 GSLPNEL-GTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLS 654
SLP + L QL+ L L N+ +PS G LT+L+
Sbjct: 97 -SLPLGVFDHLTQLDKLYLGGNQLKS-LPS--GVFDRLTKLKE----------------- 135
Query: 655 SLQIALNLSYNNLSGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
L L+ N L SIP KL L+ L L+ N L AF+ L L
Sbjct: 136 -----LRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKL 181
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 40/149 (26%), Positives = 60/149 (40%), Gaps = 6/149 (4%)
Query: 232 NAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSEL 290
++ A G L L L N + +L + L L + L +NQL
Sbjct: 45 TGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGTLGLANNQLASLPLGVF 103
Query: 291 GNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEID 348
+ T+L L L N L +P V L L +L L N+L +IP L+ + +
Sbjct: 104 DHLTQLDKLYLGGNQLKS-LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLS 161
Query: 349 LSENSLNGEIPTEFSKITGLRLLFLFQNQ 377
LS N L F ++ L+ + LF NQ
Sbjct: 162 LSTNQLQSVPHGAFDRLGKLQTITLFGNQ 190
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 47/202 (23%), Positives = 72/202 (35%), Gaps = 54/202 (26%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNC-SRLEHLYLNNNQFSG 164
LDL + + GL LT+L+L YN+L + + + + L L L NNQ +
Sbjct: 39 KLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLA- 96
Query: 165 KIPAEL-GKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRN 223
+P + L+ L L + N + +LP G+ F + LT
Sbjct: 97 SLPLGVFDHLTQLDKLYLGGNQLK-SLPSGV--------F----DRLT------------ 131
Query: 224 LRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQL 282
L+ L L N + S+P L +L + L NQL
Sbjct: 132 -----------------------KLKELRLNTNQL-QSIPAGAFDKLTNLQTLSLSTNQL 167
Query: 283 TGFIPSELGNCTKLQTLALYSN 304
KLQT+ L+ N
Sbjct: 168 QSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-06
Identities = 45/160 (28%), Positives = 68/160 (42%), Gaps = 16/160 (10%)
Query: 393 TKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYL 450
KLDL L F+ LT++ L L N L + G+ L L + ++N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ-TLSAGVFDDLTELGT-LGLANNQL 95
Query: 451 TGRIPPHL-CQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQ-LRLVGNSLT----GSFPL 504
+P + + L L LG N+L ++P+ V + T L+ LRL N L G+F
Sbjct: 96 A-SLPLGVFDHLTQLDKLYLGGNQL-KSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFD- 152
Query: 505 ELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANN 544
KL NL + L N+ + KLQ + + N
Sbjct: 153 ---KLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 32/117 (27%), Positives = 47/117 (40%), Gaps = 9/117 (7%)
Query: 609 EILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNL 667
E L L + +T L+ LT L + N + + D L+ L L L+ N L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQT-LSAGVFDDLTELGT-LGLANNQL 95
Query: 668 SGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIP 723
+ S+P + L L+ L L N L F+ L+ L + N L SIP
Sbjct: 96 A-SLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKELRLNTNQLQ----SIP 147
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 1e-14
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 38/214 (17%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKL--ASNREGNNIESSFRAE--ILTLGKIRHRNIV 841
++G G+Y V + + +I A++ + + +I+ + E + H +V
Sbjct: 59 VIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWV-QTEKHVFEQA-SNHPFLV 116
Query: 842 KLYGFCYHQGSNL-LIYEYMERGSLGEL---LHGSSCNLEWPTRFMIALGAAE---GLAY 894
L+ C+ S L + EY+ G G+L + E RF +AE L Y
Sbjct: 117 GLH-SCFQTESRLFFVIEYV-NG--GDLMFHMQRQRKLPEEHARFY----SAEISLALNY 168
Query: 895 LHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
LH + I +RD+K +N+LLD E H+ D+G+ K + + S G+ YIAP
Sbjct: 169 LH---ERGIIYRDLKLDNVLLDS--EGHIKLTDYGMCKE-GLRPGDTTSTFCGTPNYIAP 222
Query: 953 E----YAYTMKVTEKCDIYSYGVVLLELLTGRTP 982
E Y V D ++ GV++ E++ GR+P
Sbjct: 223 EILRGEDYGFSV----DWWALGVLMFEMMAGRSP 252
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 59/225 (26%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIES--SFRAEILTLGKIR-HRNIVK 842
+G GAYG V+K++ +G++VAVKK+ + N+ ++ +FR EI+ L ++ H NIV
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKI-FDAFQNSTDAQRTFR-EIMILTELSGHENIVN 73
Query: 843 LYGFCYHQGSN--LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
L L+++YME L ++ + + L + + YLH
Sbjct: 74 LLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQL--IKVIKYLH---S 127
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG------------ 948
+ HRD+K +NILL+ + V DFGL++ + + +
Sbjct: 128 GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPIL 187
Query: 949 --------YIAPE-----YAYTMKVTEKCDIYSYGVVLLELLTGR 980
Y APE YT + D++S G +L E+L G+
Sbjct: 188 TDYVATRWYRAPEILLGSTKYTKGI----DMWSLGCILGEILCGK 228
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 2e-14
Identities = 44/325 (13%), Positives = 94/325 (28%), Gaps = 63/325 (19%)
Query: 128 LTYLDLAYNELTG----YIPREIGNCSRLEHLYLNNNQFSGK----IPAELGKLSSLVSL 179
+ L + +T + + ++ + L+ N + + + L
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 180 NICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG--- 236
+ E L L+ Q++ L R NA
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLL--------------QALLKCPKLHTVRLSDNAFGPTAQ 111
Query: 237 -SIPAEISGCQSLQILGLAQNDIG-------------GSLPKEIGMLESLTEIVLWDNQL 282
+ +S L+ L L N +G ++ K+ L I+ N+L
Sbjct: 112 EPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL 171
Query: 283 TG----FIPSELGNCTKLQTLALYSNNL-----VGQIPKEVGNLKFLTKLYLYRNELNGT 333
+ L T+ + N + + + + + L L L N
Sbjct: 172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHL 231
Query: 334 ----IPREIGNLSMVTEIDLSENSLNGEIPTEFSKI------TGLRLLFLFQNQLTGVIP 383
+ + + + E+ L++ L+ GL+ L L N++
Sbjct: 232 GSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAV 291
Query: 384 NELSS-----LRNLTKLDLSINYLT 403
L + + +L L+L+ N +
Sbjct: 292 RTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 1e-11
Identities = 48/285 (16%), Positives = 82/285 (28%), Gaps = 58/285 (20%)
Query: 117 SLSPSIGGLVHLTYLDLAYNELTG----YIPREIGNCSRLEHLYLNNNQFS--------- 163
L ++ L + L+ N + + + LEHLYL+NN
Sbjct: 85 LLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIAR 144
Query: 164 ----GKIPAELGKLSSLVSLNICNNMISG----ALPEGLGNLSSLVDFVAYTNNLTGPLP 215
+ + L S+ N + + + L N +
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI----- 199
Query: 216 QSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGG----SLPKEIGMLES 271
I + ++ CQ L++L L N +L + +
Sbjct: 200 --------------RPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 245
Query: 272 LTEIVLWDNQLTG----FIPSELGNC--TKLQTLALYSNNL----VGQIPKEVG-NLKFL 320
L E+ L D L+ + LQTL L N + V + + + L
Sbjct: 246 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 305
Query: 321 TKLYLYRNELN--GTIPREIGN-LSMVTEIDLSENSLNGEIPTEF 362
L L N + + EI S +L E E+ E
Sbjct: 306 LFLELNGNRFSEEDDVVDEIREVFSTRGRGELDELDDMEELTDEE 350
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 2e-11
Identities = 47/285 (16%), Positives = 90/285 (31%), Gaps = 59/285 (20%)
Query: 127 HLTYLDLAYNELTG----YIPREIGNCSRLEHLYLNNNQFSGKIPAE-----------LG 171
+ + L+ N + ++ I + LE ++ F+G++ E L
Sbjct: 33 SVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDI-FTGRVKDEIPEALRLLLQALL 91
Query: 172 KLSSLVSLNICNNMISG----ALPEGLGNLSSLVDFVAYTNNLT-------------GPL 214
K L ++ + +N L + L + L + N L +
Sbjct: 92 KCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAV 151
Query: 215 PQSIGNLRNLRVFRAGQNAISG----SIPAEISGCQSLQILGLAQNDIG-----GSLPKE 265
+ N LR G+N + + L + + QN I L +
Sbjct: 152 NKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 266 IGMLESLTEIVLWDNQLTG----FIPSELGNCTKLQTLALYSNNL-------VGQIPKEV 314
+ + L + L DN T + L + L+ L L L V ++
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKL 271
Query: 315 GNLKFLTKLYLYRNELNGTIPREIG-----NLSMVTEIDLSENSL 354
N+ L L L NE+ R + + + ++L+ N
Sbjct: 272 ENIG-LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 6e-10
Identities = 58/338 (17%), Positives = 93/338 (27%), Gaps = 97/338 (28%)
Query: 238 IPAEISGCQSLQILGLAQNDIGGSLPKEIG-MLE---SLTEIVLWDNQL----------T 283
+ A + S++ + L+ N IG + + + L D
Sbjct: 24 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 83
Query: 284 GFIPSELGNCTKLQTLALYSNNL----VGQIPKEVGNLKFLTKLYLYRNEL--------- 330
+ L C KL T+ L N + + L LYL+ N L
Sbjct: 84 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 143
Query: 331 ----NGTIPREIGNLSMVTEIDLSENSLNGE----IPTEFSKITGLRLLFLFQNQLT--- 379
+ ++ N + I N L F L + + QN +
Sbjct: 144 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 203
Query: 380 --GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLY 437
++ L+ + L LDL N T +G L
Sbjct: 204 IEHLLLEGLAYCQELKVLDLQDNTFT---HLGSSALAIA--------------------- 239
Query: 438 SLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL-------FGNIPTDVLNCETLLQ 490
L NL L L L + + + N L
Sbjct: 240 --------------------LKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENI-GLQT 278
Query: 491 LRLVGNSLTGSFPLELC-----KLENLYAIELDQNKFS 523
LRL N + L K+ +L +EL+ N+FS
Sbjct: 279 LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 316
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 7e-09
Identities = 53/390 (13%), Positives = 110/390 (28%), Gaps = 85/390 (21%)
Query: 271 SLTEIVLWDNQLTG----FIPSELGNCTKLQTLALYSNNL----VGQIPKEVGNLKFLTK 322
S+ L + +T + + L ++ + L N + + + + + K L
Sbjct: 5 SIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEI 64
Query: 323 LYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT--G 380
L ++ + L + L + L N
Sbjct: 65 AEFSDIFTGRVKDEIPEALRLLLQA-LLKC-------------PKLHTVRLSDNAFGPTA 110
Query: 381 VIP--NELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYS 438
P + LS L L L N L P + + L E ++ L S
Sbjct: 111 QEPLIDFLSKHTPLEHLYLHNNGLG---PQAGAKIARA----LQELAVNKKAKNAPPLRS 163
Query: 439 LLWVVDFSHNYLTGRIPPHLCQ----NSNLIMLNLGYNKL----FGNIPTDVL-NCETLL 489
+ N L + + L + + N + ++ + L C+ L
Sbjct: 164 I----ICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELK 219
Query: 490 QLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT-- 547
L L N+ T L +++ L+ L + + +
Sbjct: 220 VLDLQDNTFTHLGSSALAIA--------------------LKSWPNLRELGLNDCLLSAR 259
Query: 548 -----SELPKEVGNLSQLVTFNISSNMLT-----GLIPPEIVNCMTLQRLDISHNSF--- 594
+ ++ N+ L T + N + L L L+++ N F
Sbjct: 260 GAAAVVDAFSKLENIG-LQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 318
Query: 595 ---VGSLPNELGTLQQLEILKLSENKFSGN 621
V + T + E+ +L + + +
Sbjct: 319 DDVVDEIREVFSTRGRGELDELDDMEELTD 348
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 58/413 (14%), Positives = 129/413 (31%), Gaps = 74/413 (17%)
Query: 338 IGNLSMVTEIDLSENSLNGE----IPTEFSKITGLRLLFLFQNQLTG----VIPNELSSL 389
+ S + L +++ E + + ++ + L N + + ++S
Sbjct: 1 MARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASK 59
Query: 390 RNLTKLDLS---INYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFS 446
++L + S + IP + L Q L + L V S
Sbjct: 60 KDLEIAEFSDIFTGRVKDEIPEALRLLLQA----LLKCPK-------------LHTVRLS 102
Query: 447 HNYLTGR----IPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSF 502
N + L +++ L L L N L G + L +L + +
Sbjct: 103 DNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGL-GPQAGAKI-ARALQELAVNKKAKNAP- 159
Query: 503 PLELCKLENLYAIELDQNKFSGP----IPPEIENCQKLQRLHIANNYFTSE-----LPKE 553
L ++ +N+ ++ + L + + N E L +
Sbjct: 160 -----PLRSII---CGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEG 211
Query: 554 VGNLSQLVTFNISSNMLTG----LIPPEIVNCMTLQRLDISHN--------SFVGSLPNE 601
+ +L ++ N T + + + L+ L ++ + V +
Sbjct: 212 LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAF--S 269
Query: 602 LGTLQQLEILKLSENKFSGNIPSTLG-----NLSHLTELQMGGNLFS--GEIPPELGDLS 654
L+ L+L N+ + TL + L L++ GN FS ++ E+ ++
Sbjct: 270 KLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVF 329
Query: 655 SLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLG 707
S + L + + E + + E + + E + L+ L
Sbjct: 330 STRGRGELDELDDMEELTDEEEEDEEEEAESQSPEPETSEEEKEDKELADELS 382
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 45.5 bits (108), Expect = 7e-05
Identities = 35/237 (14%), Positives = 66/237 (27%), Gaps = 47/237 (19%)
Query: 525 PIPPEIENCQKLQRLHIANNYFTSE----LPKEVGNLSQLVTFNISSNMLTGLIPPEIV- 579
+ + ++ + ++ N +E L + + + L S TG + EI
Sbjct: 23 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIF-TGRVKDEIPE 81
Query: 580 ----------NCMTLQRLDISHNSF----VGSLPNELGTLQQLEILKLSENKFS------ 619
C L + +S N+F L + L LE L L N
Sbjct: 82 ALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAK 141
Query: 620 -------GNIPSTLGNLSHLTELQMGGNLFSGE----IPPELGDLSSLQIALNLSYNNL- 667
+ N L + G N L + + N +
Sbjct: 142 IARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH-TVKMVQNGIR 200
Query: 668 ----SGSIPPELGKLDLLEFLLLNNNHLSGE----IPSAFENLSSLLGSNFSYNNLT 716
+ L L+ L L +N + + A ++ +L + L+
Sbjct: 201 PEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 7e-14
Identities = 56/217 (25%), Positives = 84/217 (38%), Gaps = 45/217 (20%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA---EILTLGKIRHR---- 838
++G G++G V KA + VA+K + N + R EI L +R +
Sbjct: 104 VIGKGSFGQVVKAYDHKVHQHVALKMV------RNEKRFHRQAAEEIRILEHLRKQDKDN 157
Query: 839 --NIVKLYGFCYHQG----------SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIAL 886
N++ + + NL YE +++ G S L R A
Sbjct: 158 TMNVIHMLENFTFRNHICMTFELLSMNL--YELIKKNKF----QGFSLPL---VR-KFAH 207
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILL--DDKFEAHVGDFGLAKVIDMPQSKSMSAVA 944
+ L LH K RI H D+K NILL + V DFG + + + +
Sbjct: 208 SILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYI 260
Query: 945 GSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
S Y APE + D++S G +L ELLTG
Sbjct: 261 QSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 1e-13
Identities = 51/214 (23%), Positives = 84/214 (39%), Gaps = 37/214 (17%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA---EILTLGKIRHR---- 838
++G G++G V KA + VA+K + N ++ E+ L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQIEVRLLELMNKHDTEM 114
Query: 839 --NIVKLYGFCYHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAEG 891
IV L + L++E + +L +LL G S NL TR A
Sbjct: 115 KYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNL---TR-KFAQQMCTA 169
Query: 892 LAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID----MPQSKSMSAVAGSY 947
L +L + I H D+K NILL + + + K++D + + S
Sbjct: 170 LLFLATP-ELSIIHCDLKPENILLCNPKRSAI------KIVDFGSSCQLGQRIYQYIQSR 222
Query: 948 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
Y +PE M D++S G +L+E+ TG
Sbjct: 223 FYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEP 256
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 6e-12
Identities = 41/244 (16%), Positives = 66/244 (27%), Gaps = 62/244 (25%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLA------SNREGNNIESSFRAEILTLGKI------ 835
+G G +G V++ + VA+K +A N EI+ ++
Sbjct: 28 IGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGE 86
Query: 836 ---RHRNIVKLYGFCYHQGSNL------------------------------LIYEYMER 862
R + L QGS ++ E+
Sbjct: 87 VCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146
Query: 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAH 922
G L + T I LA R HRD+ N+LL
Sbjct: 147 GID--LEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVLLKKTSLKK 202
Query: 923 VGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK--CDIYSYGVVLLELLTGR 980
+ K +P S G YT+ E+ ++ + +L TG
Sbjct: 203 LHYTLNGKSSTIP----------SCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGD 252
Query: 981 TPVQ 984
Q
Sbjct: 253 GDYQ 256
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 2e-11
Identities = 35/151 (23%), Positives = 58/151 (38%), Gaps = 13/151 (8%)
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPN-ELGTLQQLEILKLSENKFSGNIPS 624
S+ L IP I L +++N F L QL + S NK +
Sbjct: 19 SNQKLNK-IPEHIPQ--YTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEG 75
Query: 625 TLGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYNNLSGSIPPEL-GKLDLLE 682
S + E+ + N + ++ L SL+ L L N ++ + + L +
Sbjct: 76 AFEGASGVNEILLTSNRLE-NVQHKMFKGLESLKT-LMLRSNRIT-CVGNDSFIGLSSVR 132
Query: 683 FLLLNNNHLSGEIPSAFENLSSL----LGSN 709
L L +N ++ P AF+ L SL L +N
Sbjct: 133 LLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 30/134 (22%), Positives = 52/134 (38%), Gaps = 9/134 (6%)
Query: 344 VTEIDLSENSLNGEIPT-EFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYL 402
E+ L+ N T F K+ LR + N++T + + ++ L+ N L
Sbjct: 34 TAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL 93
Query: 403 TGPIPVG-FQHLTQMRQLQLFENSLTGGIPPGL--GLYSLLWVVDFSHNYLTGRIPPHLC 459
+ F+ L ++ L L N +T + GL S+ + N +T + P
Sbjct: 94 EN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRL-LSLYDNQIT-TVAPGAF 149
Query: 460 QN-SNLIMLNLGYN 472
+L LNL N
Sbjct: 150 DTLHSLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-09
Identities = 25/128 (19%), Positives = 45/128 (35%), Gaps = 7/128 (5%)
Query: 232 NAISGSIP--AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSE 289
N + + L+ + + N I + EI+L N+L
Sbjct: 42 NEFT-VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKM 100
Query: 290 LGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEI 347
L+TL L SN + + + L + L LY N++ T+ L ++ +
Sbjct: 101 FKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLSTL 158
Query: 348 DLSENSLN 355
+L N N
Sbjct: 159 NLLANPFN 166
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 19/83 (22%), Positives = 38/83 (45%), Gaps = 9/83 (10%)
Query: 124 GLVHLTYLDLAYNELTGYIPREI-GNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNI 181
G + + L N L + ++ L+ L L +N+ + + + LSS+ L++
Sbjct: 79 GASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSL 136
Query: 182 CNNMISGALPEG----LGNLSSL 200
+N I+ + G L +LS+L
Sbjct: 137 YDNQIT-TVAPGAFDTLHSLSTL 158
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 27/135 (20%), Positives = 50/135 (37%), Gaps = 15/135 (11%)
Query: 89 CSWIGVNCTS--------DFEPVVWSLDLNAMNFTGSLSPSIG--GLVHLTYLDLAYNEL 138
C V+C++ L LN N L + L L ++ + N++
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNN-NEFTVLEATGIFKKLPQLRKINFSNNKI 69
Query: 139 TGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMISGALPEGL-GN 196
T S + + L +N+ + ++ L SL +L + +N I+ +
Sbjct: 70 TDIEEGAFEGASGVNEILLTSNRLEN-VQHKMFKGLESLKTLMLRSNRIT-CVGNDSFIG 127
Query: 197 LSSLVDFVAYTNNLT 211
LSS+ Y N +T
Sbjct: 128 LSSVRLLSLYDNQIT 142
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-06
Identities = 26/132 (19%), Positives = 57/132 (43%), Gaps = 7/132 (5%)
Query: 515 IELDQNKFSGPIPPEI-ENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTG 572
+ L+ N+F+ I + +L++++ +NN T + + S + ++SN L
Sbjct: 37 LRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITD-IEEGAFEGASGVNEILLTSNRLEN 95
Query: 573 LIPPEIVNCMT-LQRLDISHNSFVGSLPNELGT-LQQLEILKLSENKFSGNIPSTLGNLS 630
+ ++ + L+ L + N + N+ L + +L L +N+ + P L
Sbjct: 96 V-QHKMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 631 HLTELQMGGNLF 642
L+ L + N F
Sbjct: 154 SLSTLNLLANPF 165
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-10
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 3/114 (2%)
Query: 321 TKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTG 380
T L L N L L+ +T++ L N L F+K+T L L L NQL
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS 90
Query: 381 VIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPG 433
+ L L +L L+ N L +P G F LTQ++ L+L++N L +P G
Sbjct: 91 LPNGVFDKLTQLKELALNTNQLQS-LPDGVFDKLTQLKDLRLYQNQLK-SVPDG 142
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 43/154 (27%), Positives = 57/154 (37%), Gaps = 28/154 (18%)
Query: 273 TEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGN-LKFLTKLYLYRNELN 331
T + L N L T L L L N L +P V N L LT L L N+L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 332 GTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRN 391
++P + F K+T L+ L L NQL + L
Sbjct: 90 -SLPNGV-----------------------FDKLTQLKELALNTNQLQSLPDGVFDKLTQ 125
Query: 392 LTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFEN 424
L L L N L +P G F LT ++ + L +N
Sbjct: 126 LKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 1e-06
Identities = 38/124 (30%), Positives = 55/124 (44%), Gaps = 6/124 (4%)
Query: 232 NAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSEL 290
N++ SL L L N + SLP + L SLT + L NQL
Sbjct: 38 NSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVF 96
Query: 291 GNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEID 348
T+L+ LAL +N L +P V L L L LY+N+L ++P + L+ + I
Sbjct: 97 DKLTQLKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLK-SVPDGVFDRLTSLQYIW 154
Query: 349 LSEN 352
L +N
Sbjct: 155 LHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 5e-05
Identities = 33/128 (25%), Positives = 48/128 (37%), Gaps = 15/128 (11%)
Query: 86 QTPCSWIGVNCTSDFEPVVWS--------LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNE 137
+ CS V C S V + LDL + + L LT L L N+
Sbjct: 4 RCSCSGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK 63
Query: 138 LTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMISGALPEG--- 193
L + L +L L+ NQ +P + KL+ L L + N + +LP+G
Sbjct: 64 LQSLPNGVFNKLTSLTYLNLSTNQLQ-SLPNGVFDKLTQLKELALNTNQLQ-SLPDGVFD 121
Query: 194 -LGNLSSL 200
L L L
Sbjct: 122 KLTQLKDL 129
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 8e-04
Identities = 44/178 (24%), Positives = 62/178 (34%), Gaps = 52/178 (29%)
Query: 129 TYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMIS 187
TYLDL N L + L LYL N+ +P + KL+SL LN+ N +
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQ 89
Query: 188 GALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQS 247
+LP G+ F + LT
Sbjct: 90 -SLPNGV--------F----DKLT-----------------------------------Q 101
Query: 248 LQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSN 304
L+ L L N + SLP + L L ++ L+ NQL T LQ + L+ N
Sbjct: 102 LKELALNTNQL-QSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDN 158
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 44/181 (24%), Positives = 72/181 (39%), Gaps = 37/181 (20%)
Query: 883 MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942
+ A+G+ +L + HRD+ + NILL +K + DFGLA+ I K
Sbjct: 197 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI----YKDPDY 249
Query: 943 VAGSYGYI-----APEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWV 996
V + APE + T + D++S+GV+L E+ + G +P + + +
Sbjct: 250 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 309
Query: 997 RNYIRDHSLTPGIFDTRL----NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSM 1052
+ G TR+ E + M L C P RP+ E+V
Sbjct: 310 KE---------G---TRMRAPDYTTPE-MYQTM-------LDCWHGEPSQRPTFSELVEH 349
Query: 1053 L 1053
L
Sbjct: 350 L 350
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 56.1 bits (135), Expect = 3e-08
Identities = 28/95 (29%), Positives = 43/95 (45%), Gaps = 15/95 (15%)
Query: 787 IVGSGAYGTVYKAV------MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKI-R 836
+G GA+G V +A + + VAVK L A++ E +E+ L I
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRA----LMSELKILIHIGH 84
Query: 837 HRNIVKLYGFCYHQ-GSNLLIYEYMERGSLGELLH 870
H N+V L G C G ++I E+ + G+L L
Sbjct: 85 HLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR 119
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-10
Identities = 29/91 (31%), Positives = 42/91 (46%), Gaps = 4/91 (4%)
Query: 344 VTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
VTE+ L N +P E S L L+ L N+++ + S++ L L LS N L
Sbjct: 33 VTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
Query: 404 GPIPVG-FQHLTQMRQLQLFENSLTGGIPPG 433
IP F L +R L L N ++ +P G
Sbjct: 92 C-IPPRTFDGLKSLRLLSLHGNDIS-VVPEG 120
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 8e-10
Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 7/118 (5%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
+P I + + L L N +PKE+ + LT I L +N+++ N T+L
Sbjct: 24 VLPKGIP--RDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQL 80
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSEN 352
TL L N L IP LK L L L+ N+++ +P +LS ++ + + N
Sbjct: 81 LTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-08
Identities = 33/129 (25%), Positives = 50/129 (38%), Gaps = 27/129 (20%)
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
L L N +PKE+ N K LT + L N ++ T+
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLS--------------------- 70
Query: 357 EIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQ 415
FS +T L L L N+L + P L++L L L N ++ +P G F L+
Sbjct: 71 --NQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRLLSLHGNDISV-VPEGAFNDLSA 127
Query: 416 MRQLQLFEN 424
+ L + N
Sbjct: 128 LSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 37/133 (27%), Positives = 57/133 (42%), Gaps = 34/133 (25%)
Query: 583 TLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLF 642
+ L + N F +P EL + L ++ LS N+ S + + + S++T+L
Sbjct: 32 DVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSN--QSFSNMTQLL------ 81
Query: 643 SGEIPPELGDLSSLQIALNLSYNNLSGSIPPEL-GKLDLLEFLLLNNNHLSGEIP-SAFE 700
L LSYN L IPP L L L L+ N +S +P AF
Sbjct: 82 ----------------TLILSYNRLR-CIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFN 123
Query: 701 NLSSL----LGSN 709
+LS+L +G+N
Sbjct: 124 DLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 4e-06
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 5/105 (4%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
L L+ FT + + HLT +DL+ N ++ + N ++L L L+ N+
Sbjct: 35 ELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRC- 92
Query: 166 IPAEL-GKLSSLVSLNICNNMISGALPEGL-GNLSSLVDFVAYTN 208
IP L SL L++ N IS +PEG +LS+L N
Sbjct: 93 IPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 2e-05
Identities = 32/107 (29%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 537 QRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT-LQRLDISHNSFV 595
L++ N FT PKE+ N L ++S+N ++ L + + MT L L +S+N
Sbjct: 34 TELYLDGNQFTLV-PKELSNYKHLTLIDLSNNRISTL-SNQSFSNMTQLLTLILSYNRL- 90
Query: 596 GSLPNEL-GTLQQLEILKLSENKFSGNIP-STLGNLSHLTELQMGGN 640
+P L+ L +L L N S +P +LS L+ L +G N
Sbjct: 91 RCIPPRTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 63.0 bits (153), Expect = 2e-10
Identities = 55/291 (18%), Positives = 88/291 (30%), Gaps = 85/291 (29%)
Query: 781 NFHDSFIV----GSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI 835
F+ + V G G + TV+ + + K VA+K + S + EI L +
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYT---ETALDEIRLLKSV 90
Query: 836 R--------HRNIVKLYGFCYHQGSN----LLIYEYMERGSLGELLHGSSCNLEWPTRFM 883
R +V+L G N +++E + L + + S+ P +
Sbjct: 91 RNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQG-LPLPCV 148
Query: 884 --IALGAAEGLAYLHHDCKPRIFHRDIKSNNILL-------------------------- 915
I +GL YLH C+ I H DIK NILL
Sbjct: 149 KKIIQQVLQGLDYLHTKCR--IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 916 -----------------------DDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAP 952
+K + + D G A + ++ + Y +
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ----YRSL 262
Query: 953 EYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH 1003
E DI+S + EL TG +P DH
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD------EDH 307
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 60.9 bits (148), Expect = 2e-10
Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 3/129 (2%)
Query: 273 TEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELN 331
+ L DNQ+T P + L+ L L SN L +P V +L LT L L N+L
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 332 GTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRN 391
L + E+ + N L E+P ++T L L L QNQL + L +
Sbjct: 102 VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSS 160
Query: 392 LTKLDLSIN 400
LT L N
Sbjct: 161 LTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 5e-10
Identities = 43/133 (32%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 294 TKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSEN 352
T Q L L+ N + P +L L +LYL N+L +P + +L+ +T +DL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTN 98
Query: 353 SLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQ 411
L F ++ L+ LF+ N+LT +P + L +LT L L N L IP G F
Sbjct: 99 QLTVLPSAVFDRLVHLKELFMCCNKLTE-LPRGIERLTHLTHLALDQNQLKS-IPHGAFD 156
Query: 412 HLTQMRQLQLFEN 424
L+ + LF N
Sbjct: 157 RLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 5e-09
Identities = 44/142 (30%), Positives = 65/142 (45%), Gaps = 5/142 (3%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
S+PA I + QIL L N I P L +L E+ L NQL + T+L
Sbjct: 33 SVPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQL 90
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
L L +N L +P V L L +L++ N+L +PR I L+ +T + L +N L
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK 148
Query: 356 GEIPTEFSKITGLRLLFLFQNQ 377
F +++ L +LF N
Sbjct: 149 SIPHGAFDRLSSLTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 7e-09
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 3/107 (2%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+ L +N + P F + L+ L+L NQL + SL LT LDL N LT
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV 102
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYL 450
+P F L +++L + N LT +P G+ + L + N L
Sbjct: 103 -LPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 2e-08
Identities = 51/184 (27%), Positives = 67/184 (36%), Gaps = 44/184 (23%)
Query: 345 TEIDLSENSLN---GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINY 401
T +D IPT L+L NQ+T + P SL NL +L L N
Sbjct: 22 TTVDCRSKRHASVPAGIPTNAQI------LYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75
Query: 402 LTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQ 460
L +PVG F LTQ+ L L N LT +P + F L
Sbjct: 76 LGA-LPVGVFDSLTQLTVLDLGTNQLTV-LPSAV----------FDR--LV--------- 112
Query: 461 NSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT----GSFPLELCKLENLYAIE 516
+L L + NKL +P + L L L N L G+F +L +L
Sbjct: 113 --HLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFD----RLSSLTHAY 165
Query: 517 LDQN 520
L N
Sbjct: 166 LFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-08
Identities = 40/146 (27%), Positives = 59/146 (40%), Gaps = 9/146 (6%)
Query: 562 TFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN 621
T + S +P I Q L + N P +L L+ L L N+
Sbjct: 23 TVDCRSKRHAS-VPAGIP--TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGAL 79
Query: 622 IPSTLGNLSHLTELQMGGN-LFSGEIPPELGD-LSSLQIALNLSYNNLSGSIPPELGKLD 679
+L+ LT L +G N L +P + D L L+ L + N L+ +P + +L
Sbjct: 80 PVGVFDSLTQLTVLDLGTNQLTV--LPSAVFDRLVHLKE-LFMCCNKLT-ELPRGIERLT 135
Query: 680 LLEFLLLNNNHLSGEIPSAFENLSSL 705
L L L+ N L AF+ LSSL
Sbjct: 136 HLTHLALDQNQLKSIPHGAFDRLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 36/148 (24%), Positives = 57/148 (38%), Gaps = 11/148 (7%)
Query: 86 QTPCSWIGVNCTSDFEPVVWS--------LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNE 137
Q CS V+C S V + L L+ T L++L L L N+
Sbjct: 16 QCSCSGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQ 75
Query: 138 LTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMISGALPEGLGN 196
L + ++L L L NQ + +P+ + +L L L +C N ++ LP G+
Sbjct: 76 LGALPVGVFDSLTQLTVLDLGTNQLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIER 133
Query: 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNL 224
L+ L N L + L +L
Sbjct: 134 LTHLTHLALDQNQLKSIPHGAFDRLSSL 161
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 33/127 (25%), Positives = 56/127 (44%), Gaps = 5/127 (3%)
Query: 516 ELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTFNISSNMLTGLI 574
L N+ + P ++ L+ L++ +N + LP V +L+QL ++ +N LT L
Sbjct: 46 YLHDNQITKLEPGVFDSLINLKELYLGSNQLGA-LPVGVFDSLTQLTVLDLGTNQLTVL- 103
Query: 575 PPEIVNCMT-LQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT 633
P + + + L+ L + N LP + L L L L +N+ LS LT
Sbjct: 104 PSAVFDRLVHLKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLT 162
Query: 634 ELQMGGN 640
+ GN
Sbjct: 163 HAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 2e-05
Identities = 36/177 (20%), Positives = 57/177 (32%), Gaps = 51/177 (28%)
Query: 129 TYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAEL-GKLSSLVSLNICNNMIS 187
L L N++T P + L+ LYL +NQ +P + L+ L L++ N ++
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQLTVLDLGTNQLT 101
Query: 188 GALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQS 247
LP + F + L
Sbjct: 102 -VLPSAV--------F----DRLV-----------------------------------H 113
Query: 248 LQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSN 304
L+ L + N + LP+ I L LT + L NQL + L L+ N
Sbjct: 114 LKELFMCCNKL-TELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFGN 169
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 63.3 bits (153), Expect = 4e-10
Identities = 104/659 (15%), Positives = 194/659 (29%), Gaps = 244/659 (37%)
Query: 22 RDIK-MLKKLKSRRVLEVEIVG-----------FWLVVMLLVCTTEGLNSEGHYLLE--L 67
+D++ M K + S+ ++ I+ FW L S+ +++ +
Sbjct: 36 KDVQDMPKSILSKEEID-HIIMSKDAVSGTLRLFWT-----------LLSKQEEMVQKFV 83
Query: 68 KNSLHDEFNFLKS-WKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLV 126
+ L + FL S K+ + PS+ +
Sbjct: 84 EEVLRINYKFLMSPIKTEQR--------------------------------QPSMMTRM 111
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLE-------HLY-LNNNQF--------SGKIPAEL 170
++ D YN+ + N SRL+ L L + SGK
Sbjct: 112 YIEQRDRLYNDNQVFAKY---NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGK----- 163
Query: 171 GKLSSLVSLNICNNM-ISGALPEG-----LGNLSSLVDFVAYTNNL-------------- 210
+ + L++C + + + L N +S + L
Sbjct: 164 ---TWVA-LDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDH 219
Query: 211 TGPLPQSIGN----LRNLRVFRAGQNAI--------SGSIPA-EISGCQSLQILGLAQ-- 255
+ + I + LR L + +N + + + A + C+ L Q
Sbjct: 220 SSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNL-SCKILLTTRFKQVT 278
Query: 256 NDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVG 315
+ + + I + D+ P E+ L Y + +P+EV
Sbjct: 279 DFLSAATTTHISL----------DHHSMTLTPDEV-----KSLLLKYLDCRPQDLPREV- 322
Query: 316 NLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQ 375
T PR + S++ E + + T +
Sbjct: 323 ---------------LTTNPRRL---SIIAES-IRDG-----------LATWDNWKHVNC 352
Query: 376 NQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
++LT +I + S+N L P ++ + +L +F S IP L
Sbjct: 353 DKLTTII-------------ESSLNVLE---PAEYRKM--FDRLSVFPPSAH--IPTIL- 391
Query: 436 LYSLLW----------VVDFSHNYL-------TGRIPPH------LCQNSNLIMLNLGYN 472
SL+W VV+ H Y I + N L+
Sbjct: 392 -LSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH---R 447
Query: 473 KLFG--NIPTDVLNCETLLQLRL-------VGNSLTGSFPLELCKL-ENLYAIELD---- 518
+ NIP + + L+ L +G+ L E L ++ LD
Sbjct: 448 SIVDHYNIP-KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVF---LDFRFL 503
Query: 519 QNK-----FSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTF--NISSNML 570
+ K + I N LQ+L Y PK ++ ++ F I N++
Sbjct: 504 EQKIRHDSTAWNASGSILNT--LQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLI 560
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.6 bits (151), Expect = 6e-10
Identities = 99/544 (18%), Positives = 169/544 (31%), Gaps = 153/544 (28%)
Query: 64 LLELKNS----LHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLS 119
LLEL+ + + K+W + D C V C DF+ + W +N S
Sbjct: 144 LLELRPAKNVLIDGVLGSGKTWVALDV--CLSYKVQCKMDFK-IFW------LNLKNCNS 194
Query: 120 PS--IGGLVHLTY-LDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSL 176
P + L L Y +D + + + ++ L S L L
Sbjct: 195 PETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQA-ELRRLLKSKPYENCL-----L 248
Query: 177 VSLNICNNMISGALPEGLGNLSS--LVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAI 234
V LN+ N A NLS L+ T R +V A
Sbjct: 249 VLLNVQNAKAWNAF-----NLSCKILL--------TT----------RFKQVTDFLSAAT 285
Query: 235 SGSIPAE-----ISGCQSLQILGLAQNDIGGSLPKE--------IGML-ESLTE-IVLWD 279
+ I + ++ + +L + LP+E + ++ ES+ + + WD
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 280 N-------QLTGFI--------PSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLY 324
N +LT I P+E L+++ + IP + L
Sbjct: 346 NWKHVNCDKLTTIIESSLNVLEPAEYRKM--FDRLSVFPPSA--HIPTIL--------LS 393
Query: 325 LYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFS-KITGLRLLFLFQN----QLT 379
L ++ + + N L + SL + P E + I + L + L
Sbjct: 394 LIWFDVIKSDVMVVVN-------KLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALH 446
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQ----HLTQMRQLQLFENSLTGGIPPGLG 435
I + + + DL YL + HL + +
Sbjct: 447 RSIVDHYNIPKTFDSDDLIPPYLDQYF---YSHIGHHLKNIEHPERMT------------ 491
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
L+ +++ +DF +L +I + N +LN TL QL+
Sbjct: 492 LFRMVF-LDF--RFLEQKI------------RHDSTAW---NASGSILN--TLQQLKFYK 531
Query: 496 NSLTGSFPLELCKLENL-YAIELDQNKFSGPIPPEIENCQKLQRLHIA----NNYFTSEL 550
+ + P K E L AI F I + + L IA + E
Sbjct: 532 PYICDNDP----KYERLVNAIL----DFLPKIEENLICSKYTDLLRIALMAEDEAIFEEA 583
Query: 551 PKEV 554
K+V
Sbjct: 584 HKQV 587
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.2 bits (132), Expect = 1e-07
Identities = 109/696 (15%), Positives = 203/696 (29%), Gaps = 239/696 (34%)
Query: 313 EVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGE----IPTEFSKITGL 368
E G + Y Y++ L+ + N D+ ++ L+ E I ++G
Sbjct: 10 ETGEHQ-----YQYKDILSVFEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGT 64
Query: 369 RLLF--LFQNQLTGVIPNELSSLRNLTKLDLSINY--LTGPIPVGFQHLTQMRQLQLFE- 423
LF L Q V + + L INY L PI + + M ++ + +
Sbjct: 65 LRLFWTLLSKQEEMV--------QKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQR 116
Query: 424 NSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPH------LCQ---NSNLI---MLNLGY 471
+ L F+ ++ R+ P+ L + N++ +L G
Sbjct: 117 DRLYNDNQV------------FAKYNVS-RLQPYLKLRQALLELRPAKNVLIDGVL--GS 161
Query: 472 NKLFGNIPTDVLNCETLLQLRL------------VGNSLTGSFPLELCKLENLYAIELDQ 519
K + + L ++ + N + LE L+ L ++D
Sbjct: 162 GK-------TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLE--MLQKLLY-QIDP 211
Query: 520 N-----KFSGPIPPEIENCQ-KLQRLHIANNYFTSELP-KEVGNLSQLVTFNISSNMLTG 572
N S I I + Q +L+RL + Y L V N FN+S +L
Sbjct: 212 NWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKIL-- 269
Query: 573 LIPPEIVNCMTLQRLDISHNSFVG-------SLPNELGTLQQLEILKLSENKFSGNIPST 625
+T + F+ SL + TL E+ L K+ P
Sbjct: 270 ---------LTTR--FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLL-KYLDCRPQD 317
Query: 626 LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLL 685
L P E+ + ++++ + + + + L
Sbjct: 318 L--------------------PREVLTTNPRRLSI--------------IAES-IRDGLA 342
Query: 686 LNNN--HLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQ--FQNMDISSFLGNEGLCG 741
+N H++ + L++++ S S N L P+ + F + + F
Sbjct: 343 TWDNWKHVN------CDKLTTIIES--SLNVLE---PAEYRKMFDRLSV--F-------- 381
Query: 742 RPVGNCGASPSSGSVPPLNNVYFPPK------EGFSFQDVVEATYNFHD-SFIVGSGAYG 794
PP + + P DV+ H S +
Sbjct: 382 ---------------PP--SAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKES 424
Query: 795 TVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF--CYHQGS 852
T+ + I + ++ + HR+IV Y +
Sbjct: 425 TIS--IPS------------------IYLELKVKLENEYAL-HRSIVDHYNIPKTFDSDD 463
Query: 853 NLL------IYEY-------MERGSLGELLHGSSCNLEWPTRFM--------IALGAAEG 891
+ Y + +E L + RF+ A A+
Sbjct: 464 LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF----RFLEQKIRHDSTAWNASGS 519
Query: 892 LAYLHHDCKPRIFHRD-IKSNNILLDDKFEAHVGDF 926
+ K F++ I N D K+E V
Sbjct: 520 ILNTLQQLK---FYKPYICDN----DPKYERLVNAI 548
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 4e-10
Identities = 28/91 (30%), Positives = 46/91 (50%), Gaps = 4/91 (4%)
Query: 345 TEIDLSENSLNGEIPT-EFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
TE+ L++N L F ++ L L L +NQLTG+ PN ++ +L L N +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 404 GPIPVG-FQHLTQMRQLQLFENSLTGGIPPG 433
I F L Q++ L L++N ++ + PG
Sbjct: 92 E-ISNKMFLGLHQLKTLNLYDNQIS-CVMPG 120
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 36/106 (33%), Positives = 51/106 (48%), Gaps = 3/106 (2%)
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
L L N L + G L L KL L RN+L G P S + E+ L EN +
Sbjct: 32 TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 356 GEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
EI + F + L+ L L+ NQ++ V+P L +LT L+L+ N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 34/109 (31%), Positives = 53/109 (48%), Gaps = 12/109 (11%)
Query: 609 EILKLSENKFSGNIPST--LGNLSHLTELQMGGNLFSGEIPPELGD-LSSLQIALNLSYN 665
L L++N+ I S G L HL +L++ N + I P + S +Q L L N
Sbjct: 32 TELLLNDNELG-RISSDGLFGRLPHLVKLELKRNQLT-GIEPNAFEGASHIQE-LQLGEN 88
Query: 666 NLSGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSL----LGSN 709
+ I ++ L L+ L L +N +S +P +FE+L+SL L SN
Sbjct: 89 KIK-EISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 34/107 (31%), Positives = 50/107 (46%), Gaps = 7/107 (6%)
Query: 106 SLDLNAMNFTGSLSPS--IGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFS 163
L LN N G +S G L HL L+L N+LTG P S ++ L L N+
Sbjct: 33 ELLLN-DNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIK 91
Query: 164 GKIPAEL-GKLSSLVSLNICNNMISGALPEG-LGNLSSLVDFVAYTN 208
+I ++ L L +LN+ +N IS + G +L+SL +N
Sbjct: 92 -EISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 20/84 (23%), Positives = 36/84 (42%), Gaps = 6/84 (7%)
Query: 248 LQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSEL-GNCTKLQTLALYSNN 305
L L L +N + + + E+ L +N++ I +++ +L+TL LY N
Sbjct: 56 LVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKIKE-ISNKMFLGLHQLKTLNLYDNQ 113
Query: 306 LVGQIPKEV-GNLKFLTKLYLYRN 328
+ + +L LT L L N
Sbjct: 114 ISC-VMPGSFEHLNSLTSLNLASN 136
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 5e-10
Identities = 42/231 (18%), Positives = 78/231 (33%), Gaps = 55/231 (23%)
Query: 787 IVGSGAYGTVYKAV--MDSGKIVAVKKLASNREGNNIESSFRA---EILTLGKIRHR--- 838
+G G +G V + + VA+K + N+ A EI L KI+ +
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKII------RNVGKYREAARLEINVLKKIKEKDKE 79
Query: 839 ---NIVKLYGFCYHQ----------GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIA 885
V + + G N +E+++ + R +A
Sbjct: 80 NKFLCVLMSDWFNFHGHMCIAFELLGKNT--FEFLKENNF----QPYPLPH---VR-HMA 129
Query: 886 LGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-----------KVID- 933
L +LH + ++ H D+K NIL + + + + +V D
Sbjct: 130 YQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186
Query: 934 ---MPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
+ + + + Y PE + + CD++S G +L E G T
Sbjct: 187 GSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFT 237
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 5e-10
Identities = 34/157 (21%), Positives = 60/157 (38%), Gaps = 13/157 (8%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G + + + + VA+K + +R I ++Y F
Sbjct: 17 IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGD---GIPQVYYF 73
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
N ++ E + SL +L T MIA+ + Y+H + +R
Sbjct: 74 GPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYR 129
Query: 907 DIKSNNILL-----DDKFEAHVGDFGLAKVIDMPQSK 938
D+K N L+ + H+ DF LAK P++K
Sbjct: 130 DVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETK 166
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 45/208 (21%), Positives = 78/208 (37%), Gaps = 19/208 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH-RNIVKLYG 845
+GSG++G +Y + +G+ VA+K + E ++ I +
Sbjct: 17 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRW 72
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
N+++ E + SL +L + S T ++A + Y+H H
Sbjct: 73 CGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIH 128
Query: 906 RDIKSNNILL---DDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA-PEYA--YTMK 959
RD+K +N L+ ++ DFGLAK ++ + YA T
Sbjct: 129 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 188
Query: 960 VTEKC---DIYSYGVVLLELLTGRTPVQ 984
E+ D+ S G VL+ G P Q
Sbjct: 189 GIEQSRRDDLESLGYVLMYFNLGSLPWQ 216
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 60.3 bits (146), Expect = 2e-09
Identities = 76/426 (17%), Positives = 135/426 (31%), Gaps = 47/426 (11%)
Query: 106 SLDLNAMNFT-GSLSPSIGGLVHLTYLDLAY-NELTGYIPREIG-NCSRLEHLYLNNNQF 162
+ L M T L + L L+ + I C L+ L L +
Sbjct: 109 EIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDV 168
Query: 163 SGKIPAELGKLS----SLVSLNI--CNNMISG----ALPEGLGNLSSLVDFVAYTNNLTG 212
L SLVSLNI + +S L NL SL A
Sbjct: 169 DDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLA 228
Query: 213 PLPQSIGNLRNLRV---FRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGML 269
L Q L L + + + +SGC+ L+ L + + LP +
Sbjct: 229 TLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVC 288
Query: 270 ESLTEIVLWDNQLTGF-IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRN 328
LT + L + + + L C KLQ L + + K L +L ++
Sbjct: 289 SRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFP- 347
Query: 329 ELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELS- 387
+ L+ + +S L + F Q+T ++
Sbjct: 348 -SEPFVMEPNVALTEQGLVSVSMGCPK------------LESVLYFCRQMTNAALITIAR 394
Query: 388 SLRNLTKLDLSINYLTGPIPV-------GFQHLTQ----MRQLQLFENSLTGGIPPGLGL 436
+ N+T+ L I P + GF + + +R+L L LT + +G
Sbjct: 395 NRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSL-SGLLTDKVFEYIGT 453
Query: 437 YS-LLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGN-IPTDVLNCETLLQLRL 493
Y+ + ++ + + H+ +L L + + + ET+ L +
Sbjct: 454 YAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSLWM 513
Query: 494 VGNSLT 499
S++
Sbjct: 514 SSCSVS 519
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 3e-07
Identities = 71/483 (14%), Positives = 150/483 (31%), Gaps = 48/483 (9%)
Query: 148 NCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSL-VDFVAY 206
++ + L GK L I A+ L + + +
Sbjct: 64 RFPKVRSVEL-----KGKPHFADFNLVPDGWGGYVYPWIE-AMSSSYTWLEEIRLKRMVV 117
Query: 207 TNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGGSLPKE 265
T++ + +S N + L + S A I + C++L+ L L ++D+
Sbjct: 118 TDDCLELIAKSFKNFKVLVLSSCEG--FSTDGLAAIAATCRNLKELDLRESDVDDVSGHW 175
Query: 266 IGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLAL--YSNNLVGQ-IPKEVGNLKFLTK 322
+ T L +L + ++ + + + V L
Sbjct: 176 LSHFPD--------------------TYTSLVSLNISCLASEVSFSALERLVTRCPNLKS 215
Query: 323 LYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGE------IPTEFSKITGLRLLFLFQN 376
L L R + + + E+ + + S LR L F +
Sbjct: 216 LKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSGFWD 275
Query: 377 QLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGF-QHLTQMRQLQLFENSLTGGIPPGLG 435
+ +P S LT L+LS + V ++++L + + G+
Sbjct: 276 AVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLCQCPKLQRLWVLDYIEDAGLEVLAS 335
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCE--TLLQLRL 493
L + + P L+ +++G KL + + C T L
Sbjct: 336 TCKDLRELRVFPSEPFVMEPNVALTEQGLVSVSMGCPKL----ESVLYFCRQMTNAALIT 391
Query: 494 VGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKE 553
+ + LC +E L +E+C+ L+RL ++
Sbjct: 392 IARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYI 451
Query: 554 VGNLSQLVTFNISSNMLTGLIPPEIV-NCMTLQRLDISHNSFVG-SLPNELGTLQQLEIL 611
++ +++ + L ++ C +L++L+I F +L L+ + L
Sbjct: 452 GTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPFGDKALLANASKLETMRSL 511
Query: 612 KLS 614
+S
Sbjct: 512 WMS 514
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 43.0 bits (101), Expect = 5e-04
Identities = 30/151 (19%), Positives = 49/151 (32%), Gaps = 14/151 (9%)
Query: 531 ENCQKLQRLHIANNYFTSE----LPKEVGNLSQLVTFNIS--SNMLTGLIPPEIV-NCMT 583
C+ L+ L + + L + LV+ NIS ++ ++ +V C
Sbjct: 153 ATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNISCLASEVSFSALERLVTRCPN 212
Query: 584 LQRLDISHNSFVGSLPNELGTLQQLEILKLS------ENKFSGNIPSTLGNLSHLTELQM 637
L+ L ++ + L L QLE L + L L L
Sbjct: 213 LKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRPDVYSGLSVALSGCKELRCLSG 272
Query: 638 GGNLFSGEIPPELGDLSSLQIALNLSYNNLS 668
+ +P S L LNLSY +
Sbjct: 273 FWDAVPAYLPAVYSVCSRLTT-LNLSYATVQ 302
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 4e-09
Identities = 57/235 (24%), Positives = 88/235 (37%), Gaps = 59/235 (25%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRA---EILTLGKIRHR---- 838
+G G +G V +D+ K AVK + NI+ R+ E L KI++
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVV------RNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 839 -NIVKLYGFCYHQ----------GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG 887
NIVK +G + G +L YE + R + +G + + +
Sbjct: 96 NNIVKYHGKFMYYDHMCLIFEPLGPSL--YEIITRNNY----NGFHIED---IK-LYCIE 145
Query: 888 AAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-----------------K 930
+ L YL K + H D+K NILLDD + K
Sbjct: 146 ILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 931 VID----MPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
+ID +S ++ + Y APE + D++S+G VL EL TG
Sbjct: 203 LIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 5e-09
Identities = 59/538 (10%), Positives = 139/538 (25%), Gaps = 84/538 (15%)
Query: 102 PVVWSLDLNAMNFTGSLSPSI----GGLVHLTYLDLAYNELTGYIPREI--GNCSRLEHL 155
P +L N+ G ++P + L L + ++ + LE L
Sbjct: 84 PRAAMFNLIPENWGGYVTPWVTEISNNLRQLKSVHFRRMIVSDLDLDRLAKARADDLETL 143
Query: 156 YLNN-NQFSGKIPAELGK-LSSLVSLNICNNMIS-------GALPEGLGNLSSLVDFVAY 206
L+ + F+ + + +L + + S L + +L L ++
Sbjct: 144 KLDKCSGFTTDGLLSIVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTE 203
Query: 207 TNNLTGPLPQSIG-NLRNLRVFRAGQNAIS--GSIPAEISGCQSLQILGLAQNDIGGSLP 263
++ ++I N R+L + G I + + L ++
Sbjct: 204 FAKISPKDLETIARNCRSLVSVKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKY 263
Query: 264 KEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVG-QIPKEVGNLKFLTK 322
+ L + L +P +++ L L L + L
Sbjct: 264 MNLVFPRKLCRLGLSYMGPNE-MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEV 322
Query: 323 LYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVI 382
L + + + + + + + E ++ L+ L Q
Sbjct: 323 LETRNVIGDRGLEVLAQYCKQLKRLRIERGADEQGMEDEEGLVSQRGLIALAQG------ 376
Query: 383 PNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWV 442
+ L + + ++ +T + + + +L L L
Sbjct: 377 ------CQELEYMAVYVSDIT---NESLESIGTYLK------NLCD-----FRLVLLDRE 416
Query: 443 VDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDV------LNCETLLQLRLVGN 496
+ L + L L + G + TD+ + + L
Sbjct: 417 ERITDLPLDNGVRSLLIGCKKLRRFAFYLRQ--GGL-TDLGLSYIGQYSPNVRWMLLGYV 473
Query: 497 SLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSE-LPKEVG 555
+ +E + C LQ+L + F+ + V
Sbjct: 474 GESDEGLMEFSR-----------------------GCPNLQKLEMRGCCFSERAIAAAVT 510
Query: 556 NLSQLVTFNISSNMLTGLIPPEIV---NCMTLQRLDISHNSFVG--SLPNELGTLQQL 608
L L + + + ++ + V E+ +
Sbjct: 511 KLPSLRYLWVQGYRASMTGQDLMQMARPYWNIELIPSRRVPEVNQQGEIREMEHPAHI 568
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 37/166 (22%), Positives = 71/166 (42%), Gaps = 29/166 (17%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVK-----KLASNREGN-NIESSF---------RAEILTL 832
+G G +G +Y A M+S + V K+ + G E F + +
Sbjct: 43 IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102
Query: 833 GKIRHRNIVKLYGFCYHQGS----NLLIYEYMER-G-SLGELLHGSSCNLEWPTRFMIAL 886
K+++ + K +G H + +I M+R G L ++ ++ T ++L
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMI---MDRFGSDLQKIYEANAKRFSRKTVLQLSL 159
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDFGLAK 930
+ L Y+H H DIK++N+LL+ + + ++ D+GLA
Sbjct: 160 RILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 7e-09
Identities = 46/226 (20%), Positives = 85/226 (37%), Gaps = 45/226 (19%)
Query: 787 IVGSGAYGTVYKAV--MDSGKIVAVKKLASNREGNNIESSFRA---EILTLGKIRHR--- 838
+G GA+G V + + G+ VAVK + N++ A EI L +
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIV------KNVDRYCEAARSEIQVLEHLNTTDPN 74
Query: 839 ---NIVKLYGFCYHQGSNLLIYEYMERGSLGELL-----HGSSCNLEWPTRFMIALGAAE 890
V++ + H G +++E + S + + + R +A +
Sbjct: 75 STFRCVQMLEWFEHHGHICIVFELLGL-STYDFIKENGFLPFRLDH---IR-KMAYQICK 129
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLA-----------KVID----MP 935
+ +LH ++ H D+K NIL + + KV+D
Sbjct: 130 SVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT 981
+ S + + Y APE + ++ CD++S G +L+E G T
Sbjct: 187 DDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFT 232
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 8e-09
Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 19/208 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYG 845
+GSG++G +Y + + + VA+K + E ++ I +
Sbjct: 15 IGSGSFGEIYLGTNIQTNEEVAIKLENVKTK----HPQLLYESKIYRILQGGTGIPNVRW 70
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
F N+L+ + + SL +L + S L T M+A + ++H H
Sbjct: 71 FGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLH 126
Query: 906 RDIKSNNILL---DDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIA-PEYA--YTMK 959
RDIK +N L+ + ++ DFGLAK + + YA T
Sbjct: 127 RDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHL 186
Query: 960 VTEKC---DIYSYGVVLLELLTGRTPVQ 984
E+ D+ S G VL+ L G P Q
Sbjct: 187 GIEQSRRDDLESLGYVLMYFLRGSLPWQ 214
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 9e-09
Identities = 45/209 (21%), Positives = 77/209 (36%), Gaps = 19/209 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G++G +++ + + + VA+K + + +R L G I +Y F
Sbjct: 18 IGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCT---GIPNVYYF 74
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
N+L+ + + SL +LL T M A + +H + +R
Sbjct: 75 GQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYR 130
Query: 907 DIKSNNILLDDKFEA-----HVGDFGLAKVIDMPQSKSMSAVAGSYGYIA-PEYA--YTM 958
DIK +N L+ +V DFG+ K P +K Y T
Sbjct: 131 DIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTH 190
Query: 959 KVTEKC---DIYSYGVVLLELLTGRTPVQ 984
E+ D+ + G V + L G P Q
Sbjct: 191 LGREQSRRDDLEALGHVFMYFLRGSLPWQ 219
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 9e-09
Identities = 60/366 (16%), Positives = 103/366 (28%), Gaps = 82/366 (22%)
Query: 320 LTKLYLYRNELNGTIPREIG-----NLSMVTEIDLSENSLNGEIPTEFSKI-----TGLR 369
+T L L N L E+ + VT ++LS NSL + E +I +
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 370 LLFLFQNQLTGVIPNELSSL-----RNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFEN 424
L L N L+ +EL +T LDL N + Q
Sbjct: 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS---SKSSSEFKQA--FSNLPA 138
Query: 425 SLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQ-----NSNLIMLNLGYNKLFGNIP 479
S+T ++ N L + L Q +N+ LNL N L +
Sbjct: 139 SIT--------------SLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNL-ASKN 183
Query: 480 TDVL------NCETLLQLRLVGNSLTGSFPLELCKL-----ENLYAIELDQNKFSGP--- 525
L ++ L L N L EL + ++ ++ L N GP
Sbjct: 184 CAELAKFLASIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLE 243
Query: 526 -IPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTL 584
+ ++ + LQ +++ + + ++ L N +
Sbjct: 244 NLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFP-----------------NIQKI 286
Query: 585 QRLDISHNSF--------VGSLPNELGTLQQLEILKLS--ENKFSGNIPSTLGNLSHLTE 634
+D + + G +L + L L E
Sbjct: 287 ILVDKNGKEIHPSHSIPISNLIRELSGKADVPSLLNQCLIFAQKHQTNIEDLNIPDELRE 346
Query: 635 LQMGGN 640
Sbjct: 347 SIQTCK 352
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 2e-08
Identities = 57/379 (15%), Positives = 116/379 (30%), Gaps = 78/379 (20%)
Query: 127 HLTYLDLAYNELTGYIPREIG-----NCSRLEHLYLNNNQFSGKIPAELGKL-----SSL 176
+T LDL+ N L E+ + + L L+ N K EL ++ +++
Sbjct: 23 GVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANV 82
Query: 177 VSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISG 236
SLN+ N +S + L + + +T + +L +
Sbjct: 83 TSLNLSGNFLS---YKSSDELVKTLAAIPFTI-------TVL-DLGWNDFSSKSSSEFKQ 131
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIG-MLE----SLTEIVLWDNQLTGFIPSELG 291
+ + S+ L L ND+G E+ +L ++ + L N L
Sbjct: 132 AF---SNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA-------S 181
Query: 292 NCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIG-----NLSMVTE 346
L S +T L L N L E+ + V
Sbjct: 182 KNCAELAKFLASIP------------ASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVS 229
Query: 347 IDLSENSLNGE----IPTEFSKITGLRLLFLFQNQLTGV-------IPNELSSLRNLTKL 395
++L N L+G + + L+ ++L + + + + +++ + +
Sbjct: 230 LNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKALGAAFPNIQKIILV 289
Query: 396 DLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIP 455
D + + P ++ + ++ P L L++ N IP
Sbjct: 290 DKNGKEIH---PSHSIPISNL--IRELSGKAD---VPSLLNQCLIFAQKHQTNIEDLNIP 341
Query: 456 PHLCQNSNLIMLNLGYNKL 474
L + L
Sbjct: 342 DELRE------SIQTCKPL 354
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 2e-04
Identities = 50/289 (17%), Positives = 90/289 (31%), Gaps = 59/289 (20%)
Query: 458 LCQNSNLIMLNLGYNKLFGNIPTDVL------NCETLLQLRLVGNSLTGSFPLELCKL-- 509
+ L+L N L +I T L ++ L L GNSL EL ++
Sbjct: 18 TSIPHGVTSLDLSLNNL-YSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 510 ---ENLYAIELDQNKFSGPIPPEI-----ENCQKLQRLHIANNYFTSELPKEVGNL---- 557
N+ ++ L N S E+ + L + N F+S+ E
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNL 136
Query: 558 -SQLVTFNISSNMLT---------GLIPPEIVNCMTLQRLDISHNSF----VGSLPNELG 603
+ + + N+ N L L + + L++ N+ L L
Sbjct: 137 PASITSLNLRGNDLGIKSSDELIQIL---AAIPA-NVNSLNLRGNNLASKNCAELAKFLA 192
Query: 604 TL-QQLEILKLSENKFSGNIPSTLG-----NLSHLTELQMGGNLFSGEIPPELGDL---- 653
++ + L LS N + L +H+ L + N G L L
Sbjct: 193 SIPASVTSLDLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSL 252
Query: 654 SSLQIALNLSYNNLSGSIPPE--------LGKLDLLEFLLLNNNHLSGE 694
LQ + L Y+ + ++ E + + + N +
Sbjct: 253 KHLQT-VYLDYDIV-KNMSKEQCKALGAAFPNIQKIILVDKNGKEIHPS 299
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 57.1 bits (137), Expect = 1e-08
Identities = 18/85 (21%), Positives = 29/85 (34%), Gaps = 4/85 (4%)
Query: 621 NIPSTLGNLSHLTELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPE-LGKL 678
+ L +LTEL + + L L L+ L + + L + P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRN-LTIVKSGLR-FVAPDAFHFT 79
Query: 679 DLLEFLLLNNNHLSGEIPSAFENLS 703
L L L+ N L + LS
Sbjct: 80 PRLSRLNLSFNALESLSWKTVQGLS 104
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 20/96 (20%), Positives = 37/96 (38%), Gaps = 2/96 (2%)
Query: 333 TIPREIGNLSMVTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRN 391
+ +TE+ + + + LR L + ++ L V P+
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPR 81
Query: 392 LTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
L++L+LS N L Q L+ +++L L N L
Sbjct: 82 LSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 4/94 (4%)
Query: 120 PSIGGLVHLTYLDLAYNELTGYIPRE-IGNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLV 177
+ G +LT L + + ++ + L +L + + + + L
Sbjct: 25 HHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTPRLS 83
Query: 178 SLNICNNMISGALPEGLGNLSSLVDFVAYTNNLT 211
LN+ N + +L SL + V N L
Sbjct: 84 RLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 51.7 bits (123), Expect = 7e-07
Identities = 21/101 (20%), Positives = 32/101 (31%), Gaps = 10/101 (9%)
Query: 645 EIPPELGDLSSLQIALNLSYNNLSGSIPPE-LGKLDLLEFLLLNNNHLSGEIPSAFENLS 703
+ L +L L + + L L L L + + L P AF
Sbjct: 22 DSLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTP 80
Query: 704 SLLGSNFSYNNLTGPLPSIPQ--FQNMDISSFL--GNEGLC 740
L N S+N L S+ Q + + + GN C
Sbjct: 81 RLSRLNLSFNALE----SLSWKTVQGLSLQELVLSGNPLHC 117
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 3/112 (2%)
Query: 485 CETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPE-IENCQKLQRLHIAN 543
LR + L ENL + ++ + + + +L+ L I
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 544 NYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFV 595
+ P +L N+S N L L + V ++LQ L +S N
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALESL-SWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 48.2 bits (114), Expect = 8e-06
Identities = 19/103 (18%), Positives = 39/103 (37%), Gaps = 4/103 (3%)
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPRE-IGNLSMVTEIDLSENSLNGEIPTE 361
+ + + + LT+LY+ + + + L + + + ++ L + +
Sbjct: 16 TRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPD 74
Query: 362 -FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
F L L L N L + + L +L +L LS N L
Sbjct: 75 AFHFTPRLSRLNLSFNALESLSWKTVQGL-SLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 46.7 bits (110), Expect = 3e-05
Identities = 22/119 (18%), Positives = 36/119 (30%), Gaps = 27/119 (22%)
Query: 574 IPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLT 633
+ L L I + + L L L L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELR-----------------------DLRGLGELR 59
Query: 634 ELQMGGNLFSGEIPPE-LGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHL 691
L + + + P+ L LNLS+N L S+ + + L+ L+L+ N L
Sbjct: 60 NLTIVKSGLR-FVAPDAFHFTPRLSR-LNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 2e-04
Identities = 18/97 (18%), Positives = 33/97 (34%), Gaps = 4/97 (4%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKE-IGMLESLTEIVLWDNQLTGFIPSE-LGNCT 294
+ G ++L L + L + L L + + + L F+ +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 295 KLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELN 331
+L L L N L + + L +L L N L+
Sbjct: 81 RLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 42.0 bits (98), Expect = 7e-04
Identities = 14/71 (19%), Positives = 21/71 (29%), Gaps = 1/71 (1%)
Query: 142 IPREIGNCSRLEHLYLNNNQFSGKIPAE-LGKLSSLVSLNICNNMISGALPEGLGNLSSL 200
+ L LY+ N Q + L L L +L I + + P+ L
Sbjct: 23 SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRL 82
Query: 201 VDFVAYTNNLT 211
N L
Sbjct: 83 SRLNLSFNALE 93
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 30/166 (18%), Positives = 54/166 (32%), Gaps = 29/166 (17%)
Query: 788 VGSGAYGTVYKAVMDSGKI---------VAVKKLASNREGNNIESSFRAEIL-------- 830
G +Y+A S ++K A + N ++ F+
Sbjct: 50 QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109
Query: 831 TLGKIRHRNIVKLYGFCYHQGS-NLLIYEYMERGSLGELLHGSSCN---LEWPTRFMIAL 886
L I GF HQ L+ + R SL L L + +A
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSAL--DVSPKHVLSERSVLQVAC 166
Query: 887 GAAEGLAYLHHDCKPRIFHRDIKSNNILL--DDKFEAHVGDFGLAK 930
+ L +LH + H ++ + NI + +D+ + + +G A
Sbjct: 167 RLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 3e-08
Identities = 32/90 (35%), Positives = 42/90 (46%), Gaps = 3/90 (3%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
T ++L N L F K+T L L L QNQ+ + L LT L L N L
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENKLQS 90
Query: 405 PIPVG-FQHLTQMRQLQLFENSLTGGIPPG 433
+P G F LTQ+++L L N L +P G
Sbjct: 91 -LPNGVFDKLTQLKELALDTNQLK-SVPDG 118
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 4e-07
Identities = 34/118 (28%), Positives = 48/118 (40%), Gaps = 6/118 (5%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKL 296
S+P I S L L N + L LT++ L NQ+ TKL
Sbjct: 21 SVPTGIPS--SATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKL 78
Query: 297 QTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLSEN 352
L L+ N L +P V L L +L L N+L ++P I L+ + +I L N
Sbjct: 79 TILYLHENKL-QSLPNGVFDKLTQLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 6e-07
Identities = 30/93 (32%), Positives = 39/93 (41%), Gaps = 12/93 (12%)
Query: 345 TEIDLSENSLN---GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINY 401
TEI + L IP+ L L N+L + L LTKL LS N
Sbjct: 10 TEIRCNSKGLTSVPTGIPSS------ATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ 63
Query: 402 LTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPG 433
+ +P G F LT++ L L EN L +P G
Sbjct: 64 IQS-LPDGVFDKLTKLTILYLHENKLQ-SLPNG 94
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 2e-06
Identities = 34/108 (31%), Positives = 46/108 (42%), Gaps = 2/108 (1%)
Query: 294 TKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENS 353
+ L L SN L L LTKL L +N++ L+ +T + L EN
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILYLHENK 87
Query: 354 LNGEIPTE-FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSIN 400
L +P F K+T L+ L L NQL V L +L K+ L N
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 134
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 32/100 (32%), Positives = 46/100 (46%), Gaps = 7/100 (7%)
Query: 609 EILKLSENKFSGNIPSTLGNLSHLTELQMGGN-LFSGEIPPELGD-LSSLQIALNLSYNN 666
L+L NK L+ LT+L + N + S +P + D L+ L I L L N
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS--LPDGVFDKLTKLTI-LYLHENK 87
Query: 667 LSGSIPPEL-GKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
L S+P + KL L+ L L+ N L F+ L+SL
Sbjct: 88 LQ-SLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSL 126
|
| >2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 | Back alignment and structure |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 41/236 (17%), Positives = 79/236 (33%), Gaps = 16/236 (6%)
Query: 81 WKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELT- 139
W++ D T + V + L+ + ++DL+ + +
Sbjct: 49 WQTLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPF-RVQHMDLSNSVIEV 107
Query: 140 GYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN-----NMISGALPEGL 194
+ + CS+L++L L + S I L K S+LV LN+ L
Sbjct: 108 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 167
Query: 195 GNLSSLVDFVAYTNNLTGP-----LPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQ 249
L L +++ + T + + L + +N + + C +L
Sbjct: 168 SRLDEL--NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV 225
Query: 250 ILGLAQ-NDIGGSLPKEIGMLESLTEIVLWD-NQLTGFIPSELGNCTKLQTLALYS 303
L L+ + +E L L + L + ELG L+TL ++
Sbjct: 226 HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFG 281
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 37/93 (39%), Positives = 48/93 (51%), Gaps = 12/93 (12%)
Query: 345 TEIDLSENSLN---GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINY 401
T +D S SL IPT ++L+L+ NQ+T + P L LT+LDL N
Sbjct: 12 TTVDCSGKSLASVPTGIPTT------TQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQ 65
Query: 402 LTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPG 433
LT +P G F LTQ+ QL L +N L IP G
Sbjct: 66 LTV-LPAGVFDKLTQLTQLSLNDNQLK-SIPRG 96
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 32/94 (34%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTK 295
S+P I + Q+L L N I L + L LT + L +NQLT T+
Sbjct: 23 SVPTGIPT--TTQVLYLYDNQIT-KLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQ 79
Query: 296 LQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
L L+L N L IP+ NLK LT ++L N
Sbjct: 80 LTQLSLNDNQLKS-IPRGAFDNLKSLTHIWLLNN 112
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 4e-07
Identities = 36/206 (17%), Positives = 72/206 (34%), Gaps = 30/206 (14%)
Query: 746 NCGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSG 804
+ +S L P EG D+ + +GSG +G +Y A +
Sbjct: 5 HHHSSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKK--IGSGGFGLIYLAFPTNKP 62
Query: 805 KIVAVKKLASNREGNN---IESSF---------RAEILTLGKIRHRNIVKLYGFCYHQGS 852
+ A + + N E F + + ++ + I YG +
Sbjct: 63 EKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFK 122
Query: 853 ----NLLIYEYMERGSLGELLHGSSCNLEWP--TRFMIALGAAEGLAYLHHDCKPRIFHR 906
++ E + L ++ N + T + + + L Y+H + H
Sbjct: 123 GRSYRFMVMERLGI-DLQKIS---GQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHG 175
Query: 907 DIKSNNILLD--DKFEAHVGDFGLAK 930
DIK+ N+LL + + ++ D+GL+
Sbjct: 176 DIKAANLLLGYKNPDQVYLADYGLSY 201
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 5e-07
Identities = 33/93 (35%), Positives = 44/93 (47%), Gaps = 12/93 (12%)
Query: 345 TEIDLSENSLN---GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINY 401
T ++ L IPT+ + L+L NQ+T + P L NL +L + N
Sbjct: 15 TLVNCQNIRLASVPAGIPTD------KQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNK 68
Query: 402 LTGPIPVG-FQHLTQMRQLQLFENSLTGGIPPG 433
LT IP G F LTQ+ QL L +N L IP G
Sbjct: 69 LTA-IPTGVFDKLTQLTQLDLNDNHLK-SIPRG 99
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 4e-06
Identities = 32/94 (34%), Positives = 42/94 (44%), Gaps = 6/94 (6%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTK 295
S+PA I Q L L N I L + L +L ++ N+LT T+
Sbjct: 26 SVPAGIPT--DKQRLWLNNNQIT-KLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQ 82
Query: 296 LQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
L L L N+L IP+ NLK LT +YLY N
Sbjct: 83 LTQLDLNDNHL-KSIPRGAFDNLKSLTHIYLYNN 115
|
| >3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Length = 372 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 7e-07
Identities = 47/302 (15%), Positives = 84/302 (27%), Gaps = 55/302 (18%)
Query: 127 HLTYLDLAYNELTGYIPREIG-----NCSRLEHLYLNNNQFSGKIPAELGK-LSSLVSLN 180
L L+LA +T + L+ + L + Q L L
Sbjct: 73 SLRQLNLAGVRMTPVKCTVVAAVLGSGRHALDEVNLASCQLDPAGLRTLLPVFLRARKLG 132
Query: 181 ICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGS--- 237
+ N + PE +L L L + LR+ N ++ +
Sbjct: 133 LQLNSLG---PEACKDLRDL-------------LLHDQCQITTLRL---SNNPLTAAGVA 173
Query: 238 -IPAEISGCQSLQILGLAQNDIGGSLPKEIG-MLE---SLTEIVLWDNQLTG----FIPS 288
+ ++G S+ L L +G + + L+ L E+ + N +
Sbjct: 174 VLMEGLAGNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALAR 233
Query: 289 ELGNCTKLQTLALYSNNL----VGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMV 344
L+ L LY N L + G + ++ + E +S
Sbjct: 234 AAREHPSLELLHLYFNELSSEGRQVLRDLGGAAEGGARVVVSLTEGT--------AVSEY 285
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLF--LFQNQLT----GVIPNELSSLRNLTKLDLS 398
+ LSE N L LL L ++ L + L
Sbjct: 286 WSVILSEVQRNLNSWDRARVQRHLELLLRDLEDSRGATLNPWRKAQLLRVEGEVRALLEQ 345
Query: 399 IN 400
+
Sbjct: 346 LG 347
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 23/113 (20%), Positives = 43/113 (38%), Gaps = 4/113 (3%)
Query: 148 NCSRLEHLYLNNNQFS-GKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAY 206
S ++ L L+N++ + GK+ + L L+ N ++ L L+ L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 207 TNNLTGPLPQSIGNLRNLRVFRAGQNAISG-SIPAEISGCQSLQILGLAQNDI 258
N ++G L NL N I S + ++L+ L L ++
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEV 125
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 19/61 (31%), Positives = 29/61 (47%), Gaps = 1/61 (1%)
Query: 125 LVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG-KIPAELGKLSSLVSLNICN 183
L L L+L+ N ++G + C L HL L+ N+ L KL +L SL++ N
Sbjct: 63 LNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFN 122
Query: 184 N 184
Sbjct: 123 C 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 6e-05
Identities = 24/114 (21%), Positives = 43/114 (37%), Gaps = 4/114 (3%)
Query: 316 NLKFLTKLYLYRNELN-GTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLF 374
+ +L L + N G + + + L I K+ L+ L L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SI-ANLPKLNKLKKLELS 72
Query: 375 QNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLT 427
N+++G + NLT L+LS N + + + L ++ L LF +T
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 1e-04
Identities = 22/112 (19%), Positives = 39/112 (34%), Gaps = 4/112 (3%)
Query: 531 ENCQKLQRLHIANNYFTS-ELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDI 589
++ L + N+ +L +L + + LT + + L++L++
Sbjct: 14 RTPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLEL 71
Query: 590 SHNSFVGSLPNELGTLQQLEILKLSENKFSG-NIPSTLGNLSHLTELQMGGN 640
S N G L L L LS NK + L L +L L +
Sbjct: 72 SDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 20/79 (25%), Positives = 31/79 (39%), Gaps = 10/79 (12%)
Query: 125 LVHLTYLDLAYNELTGYIPREIGN---CSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNI 181
L +L LT I N ++L+ L L++N+ SG + K +L LN+
Sbjct: 41 FEELEFLSTINVGLT-----SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNL 95
Query: 182 CNNMISGALPEGLGNLSSL 200
N I + L L
Sbjct: 96 SGNKIKD--LSTIEPLKKL 112
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 2e-06
Identities = 39/193 (20%), Positives = 72/193 (37%), Gaps = 46/193 (23%)
Query: 131 LDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGAL 190
L + + + +HL L+ N KI + L + +L L++ N+I
Sbjct: 30 LHGMIPPIEK-MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK--- 83
Query: 191 PEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQI 250
+ NL ++ D L L + N I+ S+ + I +L++
Sbjct: 84 --KIENLDAVAD-----------------TLEELWIS---YNQIA-SL-SGIEKLVNLRV 119
Query: 251 LGLAQNDIGGSLPKEIGMLE---SLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLV 307
L ++ N I + EI L L +++L N L + + + Y +V
Sbjct: 120 LYMSNNKI--TNWGEIDKLAALDKLEDLLLAGNPLY-------NDYKENNATSEYRIEVV 170
Query: 308 GQIPKEVGNLKFL 320
++P NLK L
Sbjct: 171 KRLP----NLKKL 179
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 33/172 (19%), Positives = 62/172 (36%), Gaps = 33/172 (19%)
Query: 264 KEIGMLESLTEIVLW--DNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLT 321
++ + ++ L + + + L + LAL S N + +I + ++ L
Sbjct: 17 RKSVVATEAEKVELHGMIPPIEK-MDATLSTLKACKHLAL-STNNIEKI-SSLSGMENLR 73
Query: 322 KLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGV 381
L L RN + ++I NL V + L L++ NQ+ +
Sbjct: 74 ILSLGRNLI-----KKIENLDAVAD--------------------TLEELWISYNQIASL 108
Query: 382 IPNELSSLRNLTKLDLSINYLTGPIPVGF-QHLTQMRQLQLFENSLTGGIPP 432
+ + L NL L +S N +T + L ++ L L N L
Sbjct: 109 --SGIEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKE 158
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 27/116 (23%), Positives = 46/116 (39%), Gaps = 8/116 (6%)
Query: 601 ELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIAL 660
+++E L + +TL L L + N +I L + +L+I L
Sbjct: 21 VATEAEKVE-LHGMIPPIE-KMDATLSTLKACKHLALSTNNIE-KISS-LSGMENLRI-L 75
Query: 661 NLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLT 716
+L N + I D LE L ++ N ++ + S E L +L S N +T
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 7e-05
Identities = 20/79 (25%), Positives = 37/79 (46%), Gaps = 5/79 (6%)
Query: 122 IGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNI 181
+ G+ +L L L N + I LE L+++ NQ + + + + KL +L L +
Sbjct: 66 LSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIA-SL-SGIEKLVNLRVLYM 122
Query: 182 CNNMISGALPEGLGNLSSL 200
NN I+ + L++L
Sbjct: 123 SNNKITN--WGEIDKLAAL 139
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 9e-05
Identities = 30/108 (27%), Positives = 52/108 (48%), Gaps = 8/108 (7%)
Query: 598 LPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQ 657
+ L TL+ + L LS N I S+L + +L L +G NL +I +L+
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 658 IALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
L +SYN ++ S+ + KL L L ++NN ++ + L++L
Sbjct: 97 E-LWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITN--WGEIDKLAAL 139
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 1e-04
Identities = 29/119 (24%), Positives = 47/119 (39%), Gaps = 6/119 (5%)
Query: 382 IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLW 441
+ LS+L+ L LS N + I + +R L L N + I + L
Sbjct: 40 MDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILSLGRNLIK-KIENLDAVADTLE 96
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVL-NCETLLQLRLVGNSLT 499
+ S+N + + + + NL +L + NK+ D L + L L L GN L
Sbjct: 97 ELWISYNQIA-SLSG-IEKLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 47.0 bits (112), Expect = 6e-06
Identities = 26/126 (20%), Positives = 50/126 (39%), Gaps = 5/126 (3%)
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEF 362
+ L+ Q + N +L L ++ I L ID S+N + ++ F
Sbjct: 5 TAELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-F 60
Query: 363 SKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGF-QHLTQMRQLQL 421
+ L+ L + N++ + +L +LT+L L+ N L + L + L +
Sbjct: 61 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 120
Query: 422 FENSLT 427
N +T
Sbjct: 121 LRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 24/139 (17%), Positives = 36/139 (25%), Gaps = 32/139 (23%)
Query: 148 NCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYT 207
N R L L + I L +++ +N I L
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRK-----LDGFP--------- 61
Query: 208 NNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIG 267
LR L+ N I L L L N + ++
Sbjct: 62 ------------LLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSL--VELGDLD 107
Query: 268 MLE---SLTEIVLWDNQLT 283
L SLT + + N +T
Sbjct: 108 PLASLKSLTYLCILRNPVT 126
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 19/80 (23%), Positives = 27/80 (33%), Gaps = 4/80 (5%)
Query: 109 LNAMNFTGSLSPSIGG---LVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG- 164
+A++F+ + + G L L L + N + L L L NN
Sbjct: 44 FDAIDFSDNEIRKLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVEL 103
Query: 165 KIPAELGKLSSLVSLNICNN 184
L L SL L I N
Sbjct: 104 GDLDPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 21/129 (16%), Positives = 41/129 (31%), Gaps = 30/129 (23%)
Query: 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP 623
+++ ++ + N + + LD+ + + N TL Q + + S+N+
Sbjct: 3 KLTAELIEQA--AQYTNAVRDRELDLRGYK-IPVIENLGATLDQFDAIDFSDNEIR---- 55
Query: 624 STLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEF 683
L L L+ L ++ N + L L
Sbjct: 56 -KLDGFPLLRRLKT----------------------LLVNNNRICRIGEGLDQALPDLTE 92
Query: 684 LLLNNNHLS 692
L+L NN L
Sbjct: 93 LILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 3e-04
Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 8/114 (7%)
Query: 556 NLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSE 615
N + ++ + +I +D S N L L++L+ L ++
Sbjct: 17 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTLLVNN 73
Query: 616 NKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSG 669
N+ L LTEL + N ELGDL L +L+Y +
Sbjct: 74 NRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASLKSLTYLCILR 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 4e-04
Identities = 15/66 (22%), Positives = 25/66 (37%), Gaps = 8/66 (12%)
Query: 125 LVHLTYLDLAYNELTGYIPREIGN---CSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNI 181
L +D + NE+ ++ RL+ L +NNN+ L L L +
Sbjct: 41 LDQFDAIDFSDNEIR-----KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELIL 95
Query: 182 CNNMIS 187
NN +
Sbjct: 96 TNNSLV 101
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 3e-05
Identities = 18/61 (29%), Positives = 26/61 (42%), Gaps = 1/61 (1%)
Query: 125 LVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSG-KIPAELGKLSSLVSLNICN 183
L L L+L+ N + G + L HL L+ N+ L KL L SL++ N
Sbjct: 70 LPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFN 129
Query: 184 N 184
Sbjct: 130 C 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 27/114 (23%), Positives = 45/114 (39%), Gaps = 4/114 (3%)
Query: 316 NLKFLTKLYLYRNELN-GTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLF 374
+ +L L + N G I + + L L + K+ L+ L L
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SVSN-LPKLPKLKKLELS 79
Query: 375 QNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG-FQHLTQMRQLQLFENSLT 427
+N++ G + L NLT L+LS N L + + L ++ L LF +T
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNCEVT 133
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 4e-04
Identities = 21/111 (18%), Positives = 37/111 (33%), Gaps = 4/111 (3%)
Query: 532 NCQKLQRLHIANNYFTSELPKEVG-NLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDIS 590
++ L + N + + L ++ + L + + L++L++S
Sbjct: 22 TPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELS 79
Query: 591 HNSFVGSLPNELGTLQQLEILKLSENKFSG-NIPSTLGNLSHLTELQMGGN 640
N G L L L L LS NK + L L L L +
Sbjct: 80 ENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 5e-04
Identities = 20/79 (25%), Positives = 31/79 (39%), Gaps = 10/79 (12%)
Query: 125 LVHLTYLDLAYNELTGYIPREIGNCS---RLEHLYLNNNQFSGKIPAELGKLSSLVSLNI 181
V+L +L L L + N +L+ L L+ N+ G + KL +L LN+
Sbjct: 48 FVNLEFLSLINVGLI-----SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNL 102
Query: 182 CNNMISGALPEGLGNLSSL 200
N + L L L
Sbjct: 103 SGNKLKD--ISTLEPLKKL 119
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 6e-04
Identities = 23/106 (21%), Positives = 33/106 (31%), Gaps = 28/106 (26%)
Query: 587 LDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEI 646
LD ++ G + LE L L ++ NL L +L+
Sbjct: 31 LDNCKSN-DGKIEGLTAEFVNLEFLSLINVGLI-----SVSNLPKLPKLKK--------- 75
Query: 647 PPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLS 692
L LS N + G + KL L L L+ N L
Sbjct: 76 -------------LELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 45.7 bits (107), Expect = 5e-05
Identities = 21/167 (12%), Positives = 60/167 (35%), Gaps = 21/167 (12%)
Query: 268 MLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVG--NLKFLTKLYL 325
+L+++ + + T + L++L + S L + +++ +L L KL L
Sbjct: 167 VLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVL 226
Query: 326 YRNELNGTIPREIGNLS---------MVTEIDLSENSLNGEIPTEFSK---ITGLRLLFL 373
Y + ++ + + + + + F + + L + +
Sbjct: 227 YVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDI 286
Query: 374 FQNQLTGV----IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQM 416
LT + + + +++L +++ NYL+ + L +
Sbjct: 287 SAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS---DEMKKELQKS 330
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 44.2 bits (103), Expect = 1e-04
Identities = 29/192 (15%), Positives = 63/192 (32%), Gaps = 26/192 (13%)
Query: 508 KLENLYAIELDQNKFS----GPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTF 563
+ I+ ++ + S + P ++ L L I T+ L L +
Sbjct: 142 EGLFWGDIDFEEQEISWIEQVDLSPVLDAMPLLNNLKI---KGTNNLSIGKKPRPNLKSL 198
Query: 564 NISSNMLTGLIPPEIVNCM--TLQRLDISH-------NSFVGSLPNEL--GTLQQLEILK 612
I S L + +I+ L++L + + + L+ L
Sbjct: 199 EIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLG 258
Query: 613 LSENKFSGNIPSTLGN---LSHLTELQMGGNLFSGE----IPPELGDLSSLQIALNLSYN 665
+ + + + L L + + + + E + + + L+ +N+ YN
Sbjct: 259 IVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKF-INMKYN 317
Query: 666 NLSGSIPPELGK 677
LS + EL K
Sbjct: 318 YLSDEMKKELQK 329
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 8e-04
Identities = 14/114 (12%), Positives = 37/114 (32%), Gaps = 18/114 (15%)
Query: 107 LDLNAMNFTGSLSPSI-------GGLVHLTYLDLAYNELTGYIPREIGNC---SRLEHLY 156
L + ++ ++ +L +L + E + +LE +
Sbjct: 226 LYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMD 285
Query: 157 LNNNQFSGK----IPAELGKLSSLVSLNICNNMISG----ALPEGLGNLSSLVD 202
++ + + + + K+ L +N+ N +S L + L + D
Sbjct: 286 ISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSD 339
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 42.2 bits (98), Expect = 8e-04
Identities = 21/173 (12%), Positives = 52/173 (30%), Gaps = 22/173 (12%)
Query: 486 ETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQ--KLQRLHI-- 541
+ + L + T + + NL ++E+ + +I L++L +
Sbjct: 169 DAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYV 228
Query: 542 -ANNYFTSELPKEV------GNLSQLVTFNISSNMLTGLIPPEIVNCM---TLQRLDISH 591
+Y L I ++ + L+ +DIS
Sbjct: 229 GVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISA 288
Query: 592 NSF----VGSLPNELGTLQQLEILKLSENKFSGN----IPSTLGNLSHLTELQ 636
L + + ++ L+ + + N S + +L +++ Q
Sbjct: 289 GVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 1078 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 4e-68 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 3e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-60 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 6e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 7e-60 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-59 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-58 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-57 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 6e-57 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-57 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-56 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-56 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-56 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-55 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-54 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-54 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 4e-53 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 6e-53 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-53 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-52 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-52 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-52 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 9e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-49 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-49 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 9e-49 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-47 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 9e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-46 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 5e-46 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-45 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-45 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-45 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-45 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 8e-45 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 1e-44 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 8e-44 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-43 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-43 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-40 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 8e-40 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-39 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-39 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-39 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 6e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-38 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-34 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-33 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-29 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-26 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-22 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 5e-21 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 9e-13 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 4e-11 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-05 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-26 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 6e-23 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-19 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-18 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 3e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 4e-16 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-13 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 1e-25 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-22 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-16 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 2e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 0.002 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 1e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-19 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 4e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-15 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-13 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-11 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 4e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-08 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-06 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 3e-05 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 8e-08 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 4e-07 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 1e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-06 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 5e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-06 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-07 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 9e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 1e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 3e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 6e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 5e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 1e-06 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 3e-05 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 7e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-06 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-04 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.002 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 7e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 5e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.001 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 0.004 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-06 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 9e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 4e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 6e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 8e-04 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 0.002 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-05 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 3e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 2e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 3e-04 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.003 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.001 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (580), Expect = 4e-68
Identities = 75/270 (27%), Positives = 118/270 (43%), Gaps = 22/270 (8%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+GSG++GTVYK VAVK L +F+ E+ L K RH NI+ G+
Sbjct: 16 IGSGSFGTVYKGKWHGD--VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
++ ++ E SL LH E IA A+G+ YLH I HRD
Sbjct: 74 -TAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA---KSIIHRD 129
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVID-MPQSKSMSAVAGSYGYIAPEYAYTMK---VTEK 963
+KSNNI L + +GDFGLA V S ++GS ++APE + +
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023
D+Y++G+VL EL+TG+ P + + + L+P + R N
Sbjct: 190 SDVYAFGIVLYELMTGQLPY----SNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA---- 241
Query: 1024 HMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ ++ C +RP ++++ +
Sbjct: 242 ----MKRLMAECLKKKRDERPLFPQILASI 267
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (542), Expect = 4e-63
Identities = 62/266 (23%), Positives = 110/266 (41%), Gaps = 22/266 (8%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+GSG +G V+ + VA+K + REG E F E + K+ H +V+LYG C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
Q L++E+ME G L + L T + L EG+ + + + HRD
Sbjct: 70 LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEEACVIHRD 126
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 967
+ + N L+ + V DFG+ + + Q S + + +PE + + K D++
Sbjct: 127 LAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 968 SYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMIL 1027
S+GV++ E+ + ++ + R ++ RL
Sbjct: 187 SFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR-------LYKPRLASTH--------- 230
Query: 1028 VLKVALMCTSISPFDRPSMREVVSML 1053
V ++ C P DRP+ ++ L
Sbjct: 231 VYQIMNHCWKERPEDRPAFSRLLRQL 256
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 213 bits (543), Expect = 5e-63
Identities = 68/267 (25%), Positives = 121/267 (45%), Gaps = 24/267 (8%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V+ + VAVK L ++G+ +F AE + +++H+ +V+LY
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSL---KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77
Query: 848 YHQGSNLLIYEYMERGSLGELLHG-SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
Q +I EYME GSL + L S L +A AEG+A++ HR
Sbjct: 78 -TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+++ NIL+ D + DFGLA++I+ + + + APE T K D+
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 967 YSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMI 1026
+S+G++L E++T P ++ + R V ++ + +
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRM-------------VRPDNCPEELY 240
Query: 1027 LVLKVALMCTSISPFDRPSMREVVSML 1053
++ +C P DRP+ + S+L
Sbjct: 241 ---QLMRLCWKERPEDRPTFDYLRSVL 264
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-61
Identities = 58/268 (21%), Positives = 107/268 (39%), Gaps = 22/268 (8%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G+G +G V VA+K + +EG+ E F E + + H +V+LYG C
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
Q +I EYM G L L + + E + YL + HRD
Sbjct: 69 TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRD 125
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 967
+ + N L++D+ V DFGL++ + + S + PE K + K DI+
Sbjct: 126 LAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIW 185
Query: 968 SYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMIL 1027
++GV++ E+ + + A + G+ R ++ E +
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQ---------GLRLYRPHLASEKVYT---- 232
Query: 1028 VLKVALMCTSISPFDRPSMREVVSMLIE 1055
+ C +RP+ + ++S +++
Sbjct: 233 ---IMYSCWHEKADERPTFKILLSNILD 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 1e-60
Identities = 66/296 (22%), Positives = 120/296 (40%), Gaps = 34/296 (11%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN 839
+F +G+G G V+K SG ++A K + + I + E+ L +
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPY 65
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
IV YG Y G + E+M+ GSL ++L + + +++ +GL YL
Sbjct: 66 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH 124
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
+I HRD+K +NIL++ + E + DFG++ + + S G+ Y++PE
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF---VGTRSYMSPERLQGTH 179
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019
+ + DI+S G+ L+E+ GR P+ P D + D + TP T
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 1020 SIVDHMILVLKVALM--------------------------CTSISPFDRPSMREV 1049
+D + L+ C +P +R ++++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 6e-60
Identities = 69/296 (23%), Positives = 119/296 (40%), Gaps = 28/296 (9%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G G +G V++ G+ VAVK +S E + AEI +RH NI+
Sbjct: 11 IGKGRFGEVWRGK-WRGEEVAVKIFSSREERSWF---REAEIYQTVMLRHENILGFIAAD 66
Query: 848 YHQGSNL----LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC---- 899
L+ +Y E GSL + L+ + + +AL A GLA+LH +
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 900 -KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ---SKSMSAVAGSYGYIAPEYA 955
KP I HRD+KS NIL+ + D GLA D + + G+ Y+APE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 956 YTM------KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGD-LATWVRNYIRDHSLTPG 1008
+ ++ DIY+ G+V E+ + +D V + +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244
Query: 1009 IFDTRLN---VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061
+ + +L + + ++ K+ C + R + + L + +++EG
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 7e-60
Identities = 69/291 (23%), Positives = 118/291 (40%), Gaps = 26/291 (8%)
Query: 765 PPKEGFSFQDVVEATY-NFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIES 823
P +G + +D E + +G G +G V+ + VA+K L + G
Sbjct: 2 PQTQGLA-KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL---KPGTMSPE 57
Query: 824 SFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLE-WPTRF 882
+F E + K+RH +V+LY ++ EYM +GSL + L G + P
Sbjct: 58 AFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLV 116
Query: 883 MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942
+A A G+AY+ HRD+++ NIL+ + V DFGLA++I+ + +
Sbjct: 117 DMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 173
Query: 943 VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD 1002
+ APE A + T K D++S+G++L EL T P ++ V R
Sbjct: 174 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR- 232
Query: 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ + + C P +RP+ + + L
Sbjct: 233 -------MPCPPECPES--------LHDLMCQCWRKEPEERPTFEYLQAFL 268
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 203 bits (517), Expect = 3e-59
Identities = 68/309 (22%), Positives = 115/309 (37%), Gaps = 40/309 (12%)
Query: 762 VYFPPKEGFSFQDVVEATYNFHDSF---------IVGSGAYGTVYKAVM----DSGKIVA 808
++ P F+F+D EA F ++G+G +G V + VA
Sbjct: 2 IFIDP---FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVA 58
Query: 809 VKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGEL 868
+K L S F +E +G+ H N++ L G ++I E+ME GSL
Sbjct: 59 IKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSF 117
Query: 869 LHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928
L + + G A G+ YL HRD+ + NIL++ V DFGL
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGL 174
Query: 929 AKVID----MPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQ 984
++ ++ P S + APE K T D++SYG+V+ E+++
Sbjct: 175 SRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY 234
Query: 985 PLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRP 1044
D+ + R ++ + ++ L C RP
Sbjct: 235 WDMTNQDVINAIEQDYR--------LPPPMDCPSA--------LHQLMLDCWQKDRNHRP 278
Query: 1045 SMREVVSML 1053
++V+ L
Sbjct: 279 KFGQIVNTL 287
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 3e-58
Identities = 75/302 (24%), Positives = 125/302 (41%), Gaps = 33/302 (10%)
Query: 779 TYNFHDSFIVGSGAYGTVYKAVMDSGK----IVAVKKLASNREGNNIESSFRAEILTLGK 834
+F++ ++G G +G VY + AVK L + + F E + +
Sbjct: 28 IVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKD 84
Query: 835 IRHRNIVKLYGFCYH-QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLA 893
H N++ L G C +GS L++ YM+ G L + + N L A+G+
Sbjct: 85 FSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM- 143
Query: 894 YLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS---MSAVAGSYGYI 950
+ HRD+ + N +LD+KF V DFGLA+ + + S + ++
Sbjct: 144 --KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWM 201
Query: 951 APEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF 1010
A E T K T K D++S+GV+L EL+T P P + D+ ++ R
Sbjct: 202 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL-------- 253
Query: 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML---IESNEREGRFNSSP 1067
++ E D + +V L C RPS E+VS + + E + +
Sbjct: 254 -----LQPEYCPDPLY---EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305
Query: 1068 TY 1069
TY
Sbjct: 306 TY 307
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (505), Expect = 5e-58
Identities = 67/276 (24%), Positives = 110/276 (39%), Gaps = 32/276 (11%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G V G VAVK + ++ +F AE + ++RH N+V+L G
Sbjct: 14 TIGKGEFGDVMLGD-YRGNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGV 68
Query: 847 CYHQGSNL-LIYEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ L ++ EYM +GSL + L + L +L E + YL
Sbjct: 69 IVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFV 125
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRD+ + N+L+ + A V DFGL K S + + APE K + K
Sbjct: 126 HRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTKS 181
Query: 965 DIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024
D++S+G++L E+ + P D+ V + D
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPDGCPPA----- 228
Query: 1025 MILVLKVALMCTSISPFDRPSMREVVSML--IESNE 1058
V +V C + RPS ++ L I+++E
Sbjct: 229 ---VYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE 261
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (501), Expect = 3e-57
Identities = 60/270 (22%), Positives = 102/270 (37%), Gaps = 26/270 (9%)
Query: 789 GSGAYGTVYKAVM---DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
G G +G+V + V VA+K L E + E E + ++ + IV+L G
Sbjct: 18 GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEE-MMREAQIMHQLDNPYIVRLIG 76
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
C + +L+ E G L + L G + + + G+ YL H
Sbjct: 77 VCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 132
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
RD+ + N+LL ++ A + DFGL+K + D + SA + APE K + +
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023
D++SYGV + E L+ G ++ ++ R + E
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------MECPPECPPE---- 240
Query: 1024 HMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ + C DRP V +
Sbjct: 241 ----LYALMSDCWIYKWEDRPDFLTVEQRM 266
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 6e-57
Identities = 62/274 (22%), Positives = 112/274 (40%), Gaps = 27/274 (9%)
Query: 787 IVGSGAYGTVYKAVMDSG-----KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
++G+G +G VYK ++ + VA+K L + F E +G+ H NI+
Sbjct: 14 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNII 72
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
+L G ++I EYME G+L + L + G A G + +
Sbjct: 73 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG---MKYLANM 129
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYAYTMK 959
HRD+ + NIL++ V DFGL++V+ D + + S + APE K
Sbjct: 130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK 189
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019
T D++S+G+V+ E++T ++ + + R
Sbjct: 190 FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFR----------------LP 233
Query: 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ +D + ++ + C RP ++VS+L
Sbjct: 234 TPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 8e-57
Identities = 61/270 (22%), Positives = 107/270 (39%), Gaps = 26/270 (9%)
Query: 789 GSGAYGTVYKAVM---DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
GSG +GTV K K VAVK L + ++ AE + ++ + IV++ G
Sbjct: 16 GSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG 75
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
C + S +L+ E E G L + L + +++ + + G+ YL H
Sbjct: 76 ICEAE-SWMLVMEMAELGPLNKYLQ-QNRHVKDKNIIELVHQVSMGMKYLEE---SNFVH 130
Query: 906 RDIKSNNILLDDKFEAHVGDFGLAKVI--DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
RD+ + N+LL + A + DFGL+K + D K+ + + APE K + K
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023
D++S+GV++ E + G ++ + R E
Sbjct: 191 SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------MGCPAGCPRE---- 238
Query: 1024 HMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ + +C + +RP V L
Sbjct: 239 ----MYDLMNLCWTYDVENRPGFAAVELRL 264
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 1e-56
Identities = 62/271 (22%), Positives = 113/271 (41%), Gaps = 27/271 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G++ TVYK + ++ VA +L + + F+ E L ++H NIV+ Y
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 846 FCYHQGSN----LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
+L+ E M G+L L ++ +GL +LH P
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-MKIKVLRSWCRQILKGLQFLHT-RTP 133
Query: 902 RIFHRDIKSNNILLDDK-FEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV 960
I HRD+K +NI + +GD GLA + +K+ V G+ ++APE Y K
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA---VIGTPEFMAPEM-YEEKY 189
Query: 961 TEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020
E D+Y++G+ +LE+ T P + + V + ++ S
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE-------- 241
Query: 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVS 1051
V ++ C + +R S++++++
Sbjct: 242 -------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (492), Expect = 3e-56
Identities = 69/267 (25%), Positives = 103/267 (38%), Gaps = 27/267 (10%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
+G G +G VY A S I+A+K L + E +E R E+ +RH NI++LY
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
G+ + LI EY G++ L S + A L+Y H R+
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLSK-FDEQRTATYITELANALSYCH---SKRVI 128
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRDIK N+LL E + DFG + S + + G+ Y+ PE EK
Sbjct: 129 HRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGRMHDEKV 185
Query: 965 DIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024
D++S GV+ E L G+ P + + R P
Sbjct: 186 DLWSLGVLCYEFLVGKPPF----EANTYQETYKRISRVEFTFPDFVTEGA---------- 231
Query: 1025 MILVLKVALMCTSISPFDRPSMREVVS 1051
+ +P RP +REV+
Sbjct: 232 ----RDLISRLLKHNPSQRPMLREVLE 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (492), Expect = 5e-56
Identities = 64/269 (23%), Positives = 108/269 (40%), Gaps = 24/269 (8%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G G YG VY+ V VAVK L +E F E + +I+H N+V+L G
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 80
Query: 846 FCYHQGSNLLIYEYMERGSLGELLH-GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
C + +I E+M G+L + L + + +A + + YL K
Sbjct: 81 VCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE---KKNFI 137
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
HRD+ + N L+ + V DFGL++++ + + + APE K + K
Sbjct: 138 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 197
Query: 965 DIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024
D++++GV+L E+ T P D + + R E +
Sbjct: 198 DVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------PEGCPEK 244
Query: 1025 MILVLKVALMCTSISPFDRPSMREVVSML 1053
+ ++ C +P DRPS E+
Sbjct: 245 VY---ELMRACWQWNPSDRPSFAEIHQAF 270
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 5e-56
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 26/272 (9%)
Query: 787 IVGSGAYGTVYKAVM-DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G+G+YG K GKI+ K+L + +E+ L +++H NIV+ Y
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 846 FCYHQGSNLL--IYEYMERGSLGELLHGSS---CNLEWPTRFMIALGAAEGLAYLH--HD 898
+ + L + EY E G L ++ + L+ + L H D
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 899 CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM 958
+ HRD+K N+ LD K +GDFGLA++++ S A G+ Y++PE M
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF-AKAFVGTPYYMSPEQMNRM 189
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018
EK DI+S G +L EL P R P + LN
Sbjct: 190 SYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYSDELN--- 243
Query: 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVV 1050
++ ++ + RPS+ E++
Sbjct: 244 -----------EIITRMLNLKDYHRPSVEEIL 264
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 192 bits (488), Expect = 2e-55
Identities = 73/296 (24%), Positives = 120/296 (40%), Gaps = 50/296 (16%)
Query: 788 VGSGAYGTVYKAV------MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G GA+G V++A + +VAVK L ++++ F+ E + + + NIV
Sbjct: 21 IGEGAFGRVFQARAPGLLPYEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIV 79
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN-----------------------LEW 878
KL G C L++EYM G L E L S + L
Sbjct: 80 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 139
Query: 879 PTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-S 937
+ IA A G+AYL + HRD+ + N L+ + + DFGL++ I
Sbjct: 140 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 196
Query: 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR 997
K+ A ++ PE + + T + D+++YGVVL E+ + G V
Sbjct: 197 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY----GMAHEEVI 252
Query: 998 NYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
Y+RD ++ E+ + + +C S P DRPS + +L
Sbjct: 253 YYVRDGNILA---------CPENCPLELY---NLMRLCWSKLPADRPSFCSIHRIL 296
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (481), Expect = 3e-54
Identities = 68/275 (24%), Positives = 117/275 (42%), Gaps = 30/275 (10%)
Query: 782 FHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRN 839
F D +G G++G VY A + + ++VA+KK+ S ++ N E+ L K+RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
++ G + + L+ EY + L L+ + GA +GLAYLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKP-LQEVEIAAVTHGALQGLAYLH--- 132
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM- 958
+ HRD+K+ NILL + +GDFG A ++ ++ G+ ++APE M
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMAPEVILAMD 187
Query: 959 --KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016
+ K D++S G+ +EL + P+ ++ L +N +L G +
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--ESPALQSGHWSEYF-- 243
Query: 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051
C P DRP+ ++
Sbjct: 244 ------------RNFVDSCLQKIPQDRPTSEVLLK 266
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 6e-54
Identities = 61/271 (22%), Positives = 104/271 (38%), Gaps = 25/271 (9%)
Query: 787 IVGSGAYGTVYKAVM----DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVK 842
+G G +G V++ + + VA+K N +++ F E LT+ + H +IVK
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
L G + +I E G L L +L+ + + A + LAYL R
Sbjct: 73 LIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---SKR 128
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTE 962
HRDI + N+L+ +GDFGL++ ++ S ++APE + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTS 188
Query: 963 KCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIV 1022
D++ +GV + E+L D+ + N R N
Sbjct: 189 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER--------LPMPPNCPPT--- 237
Query: 1023 DHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ + C + P RP E+ + L
Sbjct: 238 -----LYSLMTKCWAYDPSRRPRFTELKAQL 263
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-53
Identities = 70/326 (21%), Positives = 117/326 (35%), Gaps = 60/326 (18%)
Query: 768 EGFSFQDVVEATYNF-----HDSF----IVGSGAYGTVYKAVM------DSGKIVAVKKL 812
+ + D E Y+ ++ ++GSGA+G V A VAVK L
Sbjct: 16 NEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKML 75
Query: 813 ASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHG 871
+ + E+ +E+ + ++ H NIV L G C G LI+EY G L L
Sbjct: 76 KEKADSSEREA-LMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 872 ----------------------SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIK 909
L + A A+G+ +L HRD+
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLA 191
Query: 910 SNNILLDDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYS 968
+ N+L+ + DFGLA+ I + ++APE + T K D++S
Sbjct: 192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 969 YGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMIL 1027
YG++L E+ + G P + + ++N + D +E
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFK--------MDQPFYATEE-------- 295
Query: 1028 VLKVALMCTSISPFDRPSMREVVSML 1053
+ + C + RPS + S L
Sbjct: 296 IYIIMQSCWAFDSRKRPSFPNLTSFL 321
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (470), Expect = 6e-53
Identities = 55/268 (20%), Positives = 104/268 (38%), Gaps = 27/268 (10%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA+G VYKA ++ + A K + + + + EI L H NIVKL
Sbjct: 20 LGDGAFGKVYKAQNKETSVLAAAKVI--DTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
Y++ + ++ E+ G++ ++ L ++ + L YLH +I HR
Sbjct: 78 FYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHR 134
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTM-----KVT 961
D+K+ NIL + + DFG++ + + G+ ++APE
Sbjct: 135 DLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 962 EKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESI 1021
K D++S G+ L+E+ P L+ L ++ + +
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW--------SSNF 245
Query: 1022 VDHMILVLKVALMCTSISPFDRPSMREV 1049
D + K C + R + ++
Sbjct: 246 KD---FLKK----CLEKNVDARWTTSQL 266
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 6e-53
Identities = 70/277 (25%), Positives = 112/277 (40%), Gaps = 27/277 (9%)
Query: 782 FHDSF----IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR 836
F + + +G GAYG V AV + + VAVK + R + E + + EI +
Sbjct: 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLN 61
Query: 837 HRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLH 896
H N+VK YG L EY G L + + + P G+ YLH
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIE-PDIGMPEPDAQRFFHQLMAGVVYLH 120
Query: 897 HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP-QSKSMSAVAGSYGYIAPEYA 955
I HRDIK N+LLD++ + DFGLA V + + ++ + G+ Y+APE
Sbjct: 121 G---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 956 YTMKV-TEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014
+ E D++S G+VL +L G P D + + + I
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKI----- 232
Query: 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVS 1051
D + + L+ K +P R ++ ++
Sbjct: 233 ---DSAPLA---LLHK----ILVENPSARITIPDIKK 259
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 1e-52
Identities = 61/276 (22%), Positives = 102/276 (36%), Gaps = 26/276 (9%)
Query: 788 VGSGAYGTVYKAVMDS----GKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVK 842
+G G++G V + D+ VAVK L + F E+ + + HRN+++
Sbjct: 16 LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
LYG ++ E GSL + L + T A+ AEG+ YL R
Sbjct: 76 LYGVV-LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KR 131
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS--MSAVAGSYGYIAPEYAYTMKV 960
HRD+ + N+LL + +GDFGL + + + + APE T
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191
Query: 961 TEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020
+ D + +GV L E+ T +G + +
Sbjct: 192 SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQD-------- 243
Query: 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056
+ V + C + P DRP+ + L+E+
Sbjct: 244 -------IYNVMVQCWAHKPEDRPTFVALRDFLLEA 272
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 3e-52
Identities = 71/303 (23%), Positives = 122/303 (40%), Gaps = 41/303 (13%)
Query: 787 IVGSGAYGTVYKAVMDSG---KIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVK 842
++G G +G V KA + A+K++ ++ F E+ L K+ H NI+
Sbjct: 17 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNIIN 75
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN---------------LEWPTRFMIALG 887
L G C H+G L EY G+L + L S L A
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 888 AAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSY 947
A G+ YL + + HRD+ + NIL+ + + A + DFGL++ ++ K+M
Sbjct: 136 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM--GRLPV 190
Query: 948 GYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007
++A E T D++SYGV+L E+++ +L + R
Sbjct: 191 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR------ 244
Query: 1008 GIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSSP 1067
+ LN +DE V + C P++RPS +++ L E + ++
Sbjct: 245 --LEKPLNCDDE--------VYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTT 294
Query: 1068 TYD 1070
Y+
Sbjct: 295 LYE 297
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 4e-52
Identities = 63/263 (23%), Positives = 111/263 (42%), Gaps = 24/263 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G GA GTVY A+ + +G+ VA++++ N + + EIL + + ++ NIV
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNPNIVNYLDS 85
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
++ EY+ GSL +++ + + + + L +LH ++ HR
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMD--EGQIAAVCRECLQALEFLH---SNQVIHR 140
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
DIKS+NILL + DFG I QSK S + G+ ++APE K DI
Sbjct: 141 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 967 YSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMI 1026
+S G++ +E++ G P + L N + + D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL--------SAIFRD--- 248
Query: 1027 LVLKVALMCTSISPFDRPSMREV 1049
+ + C + R S +E+
Sbjct: 249 FLNR----CLDMDVEKRGSAKEL 267
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-52
Identities = 69/292 (23%), Positives = 111/292 (38%), Gaps = 44/292 (15%)
Query: 787 IVGSGAYGTVYKAVM------DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRN 839
+G+GA+G V +A D+ VAVK L + E+ +E+ L + H N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREA-LMSELKVLSYLGNHMN 88
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGS-----------------SCNLEWPTRF 882
IV L G C G L+I EY G L L L+
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 883 MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942
+ A+G+A+L HRD+ + NILL + DFGLA+ I + +
Sbjct: 149 SFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205
Query: 943 -VAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR 1001
++APE + T + D++SYG+ L EL + + P G + + I+
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP---GMPVDSKFYKMIK 262
Query: 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+ E M + C P RP+ +++V ++
Sbjct: 263 EGFRML---------SPEHAPAEMY---DIMKTCWDADPLKRPTFKQIVQLI 302
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 179 bits (454), Expect = 3e-50
Identities = 68/295 (23%), Positives = 118/295 (40%), Gaps = 27/295 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G+GA+G V++ +G A K + + E + + + R EI T+ +RH +V L+
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHD 90
Query: 846 FCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFH 905
++IYE+M G L E + + +GL ++H + H
Sbjct: 91 AFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH---ENNYVH 147
Query: 906 RDIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
D+K NI+ K + DFGL +D +S+ G+ + APE A V
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLD--PKQSVKVTTGTAEFAAPEVAEGKPVGYY 205
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR-NYIRDHSLTPGIFDTRLNVEDESIV 1022
D++S GV+ LL+G +P +D L ++ D S GI E
Sbjct: 206 TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI--------SEDGK 257
Query: 1023 DHMILVLKVALMCTSISPFDRPSMREVVSM-LIESNEREGRFNSSPTYDLPQIHE 1076
D + K P R ++ + + + GR + P+ +I +
Sbjct: 258 D---FIRK----LLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTKIRD 305
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-49
Identities = 56/266 (21%), Positives = 104/266 (39%), Gaps = 25/266 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLY 844
I+G G++ TV A + + + A+K L N E + ++ H VKLY
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
Y + G L + + E TRF A E ++ L + I
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTA----EIVSALEYLHGKGII 130
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS-MSAVAGSYGYIAPEYAYTMKVTEK 963
HRD+K NILL++ + DFG AKV+ ++ ++ G+ Y++PE +
Sbjct: 131 HRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190
Query: 964 CDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVD 1023
D+++ G ++ +L+ G P + G+ + I+ F + + +V+
Sbjct: 191 SDLWALGCIIYQLVAGLPPFR----AGNEYLIFQKIIKL----EYDFPEKFFPKARDLVE 242
Query: 1024 HMILVLKVALMCTSISPFDRPSMREV 1049
++ + R E+
Sbjct: 243 KLL----------VLDATKRLGCEEM 258
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-49
Identities = 61/273 (22%), Positives = 111/273 (40%), Gaps = 27/273 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
++GSGA+GTVYK + + G+ VA+K+L E + + + ++
Sbjct: 16 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVC 74
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
+L G C + LI + M G L + + N+ + A+G+ YL
Sbjct: 75 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED---R 130
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAVAGSYGYIAPEYAYTMKV 960
R+ HRD+ + N+L+ + DFGLAK++ + + ++A E
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190
Query: 961 TEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDES 1020
T + D++SYGV + EL+T + ++++ + RL
Sbjct: 191 THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------GERLPQPPIC 238
Query: 1021 IVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
+D V + + C I RP RE++
Sbjct: 239 TID----VYMIMVKCWMIDADSRPKFRELIIEF 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 176 bits (447), Expect = 4e-49
Identities = 60/297 (20%), Positives = 121/297 (40%), Gaps = 28/297 (9%)
Query: 760 NNVYFPPKEGFSFQDVVEATYNFHDSF----IVGSGAYGTVYKAV-MDSGKIVAVKKLAS 814
+ Y + + Q V + +D + +GSGA+G V++ V +G++ K +
Sbjct: 5 DKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI-- 62
Query: 815 NREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSC 874
N + + + EI + ++ H ++ L+ + +LI E++ G L + +
Sbjct: 63 NTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDY 122
Query: 875 NLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHV--GDFGLAKVI 932
+ A EGL ++H + I H DIK NI+ + K + V DFGLA +
Sbjct: 123 KMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKL 179
Query: 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL 992
+ + + + + APE V D+++ GV+ LL+G +P G D
Sbjct: 180 N--PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFA----GEDD 233
Query: 993 ATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
++N R + ++ E + + +++ P R ++ +
Sbjct: 234 LETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL----------QKEPRKRLTVHDA 280
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 9e-49
Identities = 67/299 (22%), Positives = 114/299 (38%), Gaps = 39/299 (13%)
Query: 788 VGSGAYGTVYKAV------MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIV 841
+G G++G VY+ V + VA+K + + F E + + ++V
Sbjct: 28 LGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVV 86
Query: 842 KLYGFCYHQGSNLLIYEYMERGSLGELLH---------GSSCNLEWPTRFMIALGAAEGL 892
+L G L+I E M RG L L +A A+G+
Sbjct: 87 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 146
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAVAGSYGYIA 951
AYL+ + HRD+ + N ++ + F +GDFG+ + I + + +++
Sbjct: 147 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMS 203
Query: 952 PEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011
PE T D++S+GVVL E+ T + +V G+ D
Sbjct: 204 PESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--------GGLLD 255
Query: 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML---IESNEREGRFNSSP 1067
N D + ++ MC +P RPS E++S + +E RE F S
Sbjct: 256 KPDNCPDM--------LFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSE 306
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 5e-47
Identities = 53/265 (20%), Positives = 97/265 (36%), Gaps = 25/265 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G V++ V S K K + + + EI L RHRNI+ L+
Sbjct: 13 LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHRNILHLHES 69
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
++I+E++ + E ++ S+ L E L +LH I H
Sbjct: 70 FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 907 DIKSNNILLDDKFEAHV--GDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
DI+ NI+ + + + +FG A+ + + + + Y APE V+
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 965 DIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDH 1024
D++S G ++ LL+G P + N + +++E VD
Sbjct: 185 DMWSLGTLVYVLLSGINPF----LAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240
Query: 1025 MILVLKVALMCTSISPFDRPSMREV 1049
++ R + E
Sbjct: 241 LL----------VKERKSRMTASEA 255
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 166 bits (422), Expect = 9e-47
Identities = 64/277 (23%), Positives = 118/277 (42%), Gaps = 27/277 (9%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLY 844
I+G G V+ A + + VAVK L ++ + + FR E + H IV +Y
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 845 GFCYHQGSNL----LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCK 900
+ ++ EY++ +L +++H + + A + L + +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-MTPKRAIEVIADACQALNFS---HQ 129
Query: 901 PRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS--KSMSAVAGSYGYIAPEYAYTM 958
I HRD+K NI++ V DFG+A+ I + +AV G+ Y++PE A
Sbjct: 130 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 189
Query: 959 KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018
V + D+YS G VL E+LTG P G + ++R+ + P L+ +
Sbjct: 190 SVDARSDVYSLGCVLYEVLTGEPPFT----GDSPVSVAYQHVREDPIPPSARHEGLSADL 245
Query: 1019 ESIVDHMILVLKVALMCTSISPFDRP-SMREVVSMLI 1054
+++V + +P +R + E+ + L+
Sbjct: 246 DAVVLK----------ALAKNPENRYQTAAEMRADLV 272
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 167 bits (423), Expect = 2e-46
Identities = 57/274 (20%), Positives = 102/274 (37%), Gaps = 23/274 (8%)
Query: 781 NFHDSF----IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI 835
+ D + ++G+GA+ V A + K+VA+K + + + E S EI L KI
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCI-AKKALEGKEGSMENEIAVLHKI 64
Query: 836 RHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYL 895
+H NIV L G LI + + G L + + + + + YL
Sbjct: 65 KHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYL 123
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H + LD+ + + DFGL+K+ D +S G+ GY+APE
Sbjct: 124 HDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED--PGSVLSTACGTPGYVAPEVL 181
Query: 956 YTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015
++ D +S GV+ LL G P + A ++ + ++
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFY----DENDAKLFEQILKAEYEFDSPYWDDIS 237
Query: 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
+ + H++ P R + +
Sbjct: 238 DSAKDFIRHLM----------EKDPEKRFTCEQA 261
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 165 bits (417), Expect = 5e-46
Identities = 68/273 (24%), Positives = 115/273 (42%), Gaps = 15/273 (5%)
Query: 788 VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFC 847
+G G YG VYKA + G+ A+KK+ +E I S+ EI L +++H NIVKLY
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRD 907
+ + +L++E++ L +LL LE T L G+AY H R+ HRD
Sbjct: 70 HTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 908 IKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIY 967
+K N+L++ + E + DFGLA+ +P K + + + K + DI+
Sbjct: 126 LKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 968 SYGVVLLELLTGRTPVQPLDDGGDLATWVR----------NYIRDHSLTPGIFDTRLNVE 1017
S G + E++ G + + L R + + F +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 1018 DESIVDHMILVLKVALM-CTSISPFDRPSMREV 1049
ES + + L + P R + ++
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-46
Identities = 65/297 (21%), Positives = 114/297 (38%), Gaps = 44/297 (14%)
Query: 787 IVGSGAYGTVYKAVM------DSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNI 840
+G GA+G V +A + + VAVK L + + + + H N+
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 841 VKLYGFCYHQGSNLLI-YEYMERGSLGELLHGSSCN---------------LEWPTRFMI 884
V L G C G L++ E+ + G+L L L
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 885 ALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI-DMPQSKSMSAV 943
+ A+G+ +L + HRD+ + NILL +K + DFGLA+ I P
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 196
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH 1003
++APE + T + D++S+GV+L E+ + G + +++
Sbjct: 197 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG---ASPYPGVKIDEEFCRRLKE- 252
Query: 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML---IESN 1057
TR+ D + + + + L C P RP+ E+V L +++N
Sbjct: 253 -------GTRMRAPDYTTPE----MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN 298
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-45
Identities = 68/292 (23%), Positives = 112/292 (38%), Gaps = 45/292 (15%)
Query: 787 IVGSGAYGTVYKAVM--------DSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RH 837
+G GA+G V A + VAVK L S+ ++ +E+ + I +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSD-LISEMEMMKMIGKH 78
Query: 838 RNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCN---------------LEWPTRF 882
+NI+ L G C G +I EY +G+L E L L
Sbjct: 79 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138
Query: 883 MIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA 942
A A G+ YL + HRD+ + N+L+ + + DFGLA+ I +
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195
Query: 943 V-AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR 1001
++APE + T + D++S+GV+L E+ T P +L ++ R
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHR 255
Query: 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053
D N +E + + C P RP+ +++V L
Sbjct: 256 --------MDKPSNCTNE--------LYMMMRDCWHAVPSQRPTFKQLVEDL 291
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (413), Expect = 3e-45
Identities = 54/293 (18%), Positives = 105/293 (35%), Gaps = 28/293 (9%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+GSG++G +Y + +G+ VA+K + E ++ + +
Sbjct: 15 IGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRW 70
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
C +G ++ + SL +L + S T ++A + Y+H HR
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIH---SKNFIHR 127
Query: 907 DIKSNNIL---LDDKFEAHVGDFGLAKVIDMPQSKSM------SAVAGSYGYIAPEYAYT 957
D+K +N L ++ DFGLAK ++ + G+ Y +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017
++ + + D+ S G VL+ G P Q L + R + S + E
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSE 247
Query: 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSSPTYD 1070
+ ++ C S+ D+P + + R+G F+ +D
Sbjct: 248 FATYLNF----------CRSLRFDDKPDYSYLRQLFRNLFHRQG-FSYDYVFD 289
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 3e-45
Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 10/198 (5%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGN-NIESSFRAEILTLGKIRHRNIVKLY 844
+G+G++G V+ +G+ A+K L E L L + H I++++
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
G +I +Y+E G L LL S +F A E L + I
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAA----EVCLALEYLHSKDII 126
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
+RD+K NILLD + DFG AK + + G+ YIAPE T +
Sbjct: 127 YRDLKPENILLDKNGHIKITDFGFAKYVP----DVTYTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 965 DIYSYGVVLLELLTGRTP 982
D +S+G+++ E+L G TP
Sbjct: 183 DWWSFGILIYEMLAGYTP 200
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 7e-45
Identities = 65/287 (22%), Positives = 106/287 (36%), Gaps = 39/287 (13%)
Query: 782 FHDSF----IVGSGAYGTVYKAV-MDSGKIVAVKKL-------ASNREGNNIESSFRAEI 829
F++++ I+G G V + + + K AVK + S E + + E+
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 830 LTLGKIR-HRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGA 888
L K+ H NI++L L+++ M++G L + L L I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT-EKVTLSEKETRKIMRAL 119
Query: 889 AEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYG 948
E + LH K I HRD+K NILLDD + DFG + +D + + V G+
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD--PGEKLREVCGTPS 174
Query: 949 YIAPEYAYTM------KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD 1002
Y+APE ++ D++S GV++ LL G P +R
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF----WHRKQMLMLRM---- 226
Query: 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
I D+ V + + P R + E
Sbjct: 227 ------IMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 161 bits (409), Expect = 8e-45
Identities = 51/309 (16%), Positives = 106/309 (34%), Gaps = 32/309 (10%)
Query: 774 DVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTL 832
+VV Y +G G++G +++ + + + VA+K + R E T
Sbjct: 1 NVVGVHYKVGR--RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD----APQLRDEYRTY 54
Query: 833 GKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGL 892
+ + + +G + ++ + SL +LL T M A +
Sbjct: 55 KLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114
Query: 893 AYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG-----DFGLAKVIDMPQSKS------MS 941
+H + +RDIK +N L+ + DFG+ K P +K
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 942 AVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIR 1001
++G+ Y++ + + + D+ + G V + L G P Q L + + R I
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER--IG 229
Query: 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061
+ + + + +E K +++ P + + + ER
Sbjct: 230 EKKQSTPLRELCAGFPEE--------FYKYMHYARNLAFDATPDYDYLQGLFSKVLERLN 281
Query: 1062 RFNSSPTYD 1070
+D
Sbjct: 282 TTEDEN-FD 289
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (407), Expect = 1e-44
Identities = 59/281 (20%), Positives = 105/281 (37%), Gaps = 15/281 (5%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN 839
NF +G G YG VYKA +G++VA+KK+ + E + S+ EI L ++ H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
IVKL + + L++E++ + + + + P +GLA+ H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR 122
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
+ HRD+K N+L++ + + DFGLA+ +P V +
Sbjct: 123 ---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLA-------TWVRNYIRDHSLTPGIFDT 1012
+ DI+S G + E++T R + L T + P +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 1013 RLNVEDESIVDHMILVLKVAL----MCTSISPFDRPSMREV 1049
+ + + + P R S +
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 161 bits (407), Expect = 8e-44
Identities = 58/235 (24%), Positives = 90/235 (38%), Gaps = 13/235 (5%)
Query: 781 NFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKL----ASNREGNNIESSFRAEILTLGKI 835
+F I+G G +G VY D+GK+ A+K L ++G + + R + +
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 836 RHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYL 895
IV + + I + M G L L E RF A GL ++
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF-YAAEIILGLEHM 123
Query: 896 HHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYA 955
H+ + +RD+K NILLD+ + D GLA K A G++GY+APE
Sbjct: 124 HN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFS---KKKPHASVGTHGYMAPEVL 177
Query: 956 YT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009
+ D +S G +L +LL G +P + L
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSF 232
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 2e-43
Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 34/285 (11%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKL---ASNREGNNIESSFRAEILTLGKIRHRNIVK 842
+G G + TVYKA ++ +IVA+KK+ + + I + EI L ++ H NI+
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 843 LYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR 902
L H+ + L++++ME + S + + L L + +
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYML----MTLQGLEYLHQHW 120
Query: 903 IFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKV-T 961
I HRD+K NN+LLD+ + DFGLAK P ++ + + Y APE + ++
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYG 179
Query: 962 EKCDIYSYGVVLLELLTGRTPVQ-----------------PLDDGGDLATWVRNYIRDHS 1004
D+++ G +L ELL + P ++ + +Y+ S
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239
Query: 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
+ + ++D L+ +P R + +
Sbjct: 240 FPGIPLHHIFSAAGDDLLD---LIQG----LFLFNPCARITATQA 277
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (400), Expect = 2e-43
Identities = 63/281 (22%), Positives = 116/281 (41%), Gaps = 24/281 (8%)
Query: 788 VGSGAYGTVYKA--VMDSGKIVAVKKLASNREGNNIESSFRAEIL---TLGKIRHRNIVK 842
+G GAYG V+KA + + G+ VA+K++ + S E+ L H N+V+
Sbjct: 15 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 74
Query: 843 LYGFCYHQGSN-----LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH 897
L+ C ++ L++E++++ L + T + GL +LH
Sbjct: 75 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS 134
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYT 957
+ HRD+K NIL+ + + DFGLA++ + +++V + Y APE
Sbjct: 135 HR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA--LTSVVVTLWYRAPEVLLQ 189
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR--------NYIRDHSLTPGI 1009
D++S G + E+ + + D L + ++ RD +L
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249
Query: 1010 FDTRLNVEDESIVDHMILVLKVALM-CTSISPFDRPSMREV 1049
F ++ E V + + K L+ C + +P R S
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 3e-43
Identities = 57/275 (20%), Positives = 108/275 (39%), Gaps = 17/275 (6%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G YGTV+KA ++ +IVA+K++ + + + SS EI L +++H+NIV+L+
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 847 CYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHR 906
+ L++E+ ++ + + + + L L + HR
Sbjct: 70 LHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLF----QLLKGLGFCHSRNVLHR 125
Query: 907 DIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDI 966
D+K N+L++ E + +FGLA+ +P + V + + D+
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 967 YSYGVVLLELLTGRTPVQPLDDGGD--------LATWVRNYIRDHSLTPGIFDTRLNVED 1018
+S G + EL P+ P +D D L T + P +
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 1019 ESIVDHMILVLKVAL----MCTSISPFDRPSMREV 1049
S+V+ + + +P R S E
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 6e-43
Identities = 49/199 (24%), Positives = 88/199 (44%), Gaps = 8/199 (4%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNN--IESSFRAEILTLGKIRHRNIVKL 843
++G G++G V+ A + + A+K L + + +E + + + H + +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 844 YGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRI 903
+ + + + EY+ G L + S + A GL +L I
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFYAAEIILGLQFL---HSKGI 124
Query: 904 FHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEK 963
+RD+K +NILLD + DFG+ K + +K + G+ YIAPE K
Sbjct: 125 VYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNTFCGTPDYIAPEILLGQKYNHS 183
Query: 964 CDIYSYGVVLLELLTGRTP 982
D +S+GV+L E+L G++P
Sbjct: 184 VDWWSFGVLLYEMLIGQSP 202
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 1e-42
Identities = 57/286 (19%), Positives = 110/286 (38%), Gaps = 31/286 (10%)
Query: 773 QDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKL----ASNREGNNIESSFRA 827
Q+ V+ Y+ + +GSG + V K +G A K + +
Sbjct: 5 QENVDDYYDTGE--ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 828 EILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALG 887
E+ L +I+H N++ L+ ++ +LI E + G L + L E +
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL--- 119
Query: 888 AAEGLAYLHHDCKPRIFHRDIKSNNILLDD----KFEAHVGDFGLAKVIDMPQSKSMSAV 943
+ L +++ +I H D+K NI+L D K + DFGLA ID +
Sbjct: 120 -KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID--FGNEFKNI 176
Query: 944 AGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDH 1003
G+ ++APE + + D++S GV+ LL+G +P G + N +
Sbjct: 177 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFL----GDTKQETLANVSAVN 232
Query: 1004 SLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
+ + + + + ++ P R ++++
Sbjct: 233 YEFEDEYFSNTSALAKDFIRRLL----------VKDPKKRMTIQDS 268
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 6e-41
Identities = 73/291 (25%), Positives = 112/291 (38%), Gaps = 31/291 (10%)
Query: 780 YNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHR 838
++ D+ ++G+G++G VY+A DSG++VA+KK+ ++ E+ + K+ H
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHC 73
Query: 839 NIVKLYGFCYHQGSN------LLIYEYMERGSLGELLHGSSCN--LEWPTRFMIALGAAE 890
NIV+L F Y G L+ +Y+ H S L +
Sbjct: 74 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133
Query: 891 GLAYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGY 949
LAY+H I HRDIK N+LLD D + DFG AK + ++S + Y
Sbjct: 134 SLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYR 189
Query: 950 IAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLA-------TWVRNYIRD 1002
T D++S G VL ELL G+ L T R IR+
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249
Query: 1003 HS--LTPGIFDTRLNVEDESIVDHMILVLKVALM--CTSISPFDRPSMREV 1049
+ T F + +AL +P R + E
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEA 300
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (378), Expect = 4e-40
Identities = 62/228 (27%), Positives = 98/228 (42%), Gaps = 22/228 (9%)
Query: 767 KEGFSFQDVVEATYNFHDSF----IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNI 821
+ GF Q+V + + + VGSGAYG V AV +G VA+KKL +
Sbjct: 1 RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60
Query: 822 ESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN------LLIYEYMERGSLGELLHGSSCN 875
E+ L +RH N++ L + L+ +M + H
Sbjct: 61 AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--- 117
Query: 876 LEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935
L + +GL Y+H I HRD+K N+ +++ E + DFGLA+ D
Sbjct: 118 LGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-- 172
Query: 936 QSKSMSAVAGSYGYIAPEYAY-TMKVTEKCDIYSYGVVLLELLTGRTP 982
M+ + Y APE M+ T+ DI+S G ++ E++TG+T
Sbjct: 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 218
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 8e-40
Identities = 56/204 (27%), Positives = 88/204 (43%), Gaps = 14/204 (6%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+G GAYG V A + VA+KK+ S E EI L + RH NI+ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKI-SPFEHQTYCQRTLREIKILLRFRHENIIGIND 73
Query: 846 FC----YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKP 901
Q ++ + ++ L +LL + +L GL Y+H
Sbjct: 74 IIRAPTIEQMKDVYLVTHLMGADLYKLLK--TQHLSNDHICYFLYQILRGLKYIH---SA 128
Query: 902 RIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK--SMSAVAGSYGYIAPEYAYT-M 958
+ HRD+K +N+LL+ + + DFGLA+V D ++ + Y APE
Sbjct: 129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 959 KVTEKCDIYSYGVVLLELLTGRTP 982
T+ DI+S G +L E+L+ R
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPI 212
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 61/290 (21%), Positives = 105/290 (36%), Gaps = 33/290 (11%)
Query: 788 VGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGF 846
+G G +G V+KA +G+ VA+KK+ E + EI L ++H N+V L
Sbjct: 18 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 77
Query: 847 CY--------HQGSNLLIYEYMERGSLGELL-HGSSCNLEWPTRFMIALGAAEGLAYLHH 897
C +GS L++++ E G L L R M L L L++
Sbjct: 78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML-----LNGLYY 132
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS---KSMSAVAGSYGYIAPEY 954
+ +I HRD+K+ N+L+ + DFGLA+ + ++ + + Y PE
Sbjct: 133 IHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192
Query: 955 AYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013
+ D++ G ++ E+ T +Q + LA + D
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252
Query: 1014 LNVEDESIVDHMILVLKVALM--------------CTSISPFDRPSMREV 1049
E +V +K L + P R +
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (367), Expect = 2e-39
Identities = 56/272 (20%), Positives = 102/272 (37%), Gaps = 39/272 (14%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIE----SSFRAEILTLGKIR--HRN 839
++GSG +G+VY + + VA+K + +R + E + E++ L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+++L + S +LI E E L+ E + +
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC---H 127
Query: 900 KPRIFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEY-AYT 957
+ HRDIK NIL+D ++ E + DFG ++ + G+ Y PE+ Y
Sbjct: 128 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYH 184
Query: 958 MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017
++S G++L +++ G P + D + G R V
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIP----------------FEHDEEIIRGQVFFRQRVS 228
Query: 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
E + C ++ P DRP+ E+
Sbjct: 229 SE--------CQHLIRWCLALRPSDRPTFEEI 252
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-39
Identities = 53/273 (19%), Positives = 97/273 (35%), Gaps = 32/273 (11%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLY 844
++G G G V + + + A+K L R E+ + + +IV++
Sbjct: 19 VLGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIV 71
Query: 845 GFCYHQGSN----LLIYEYMERGSLGELLHGSSCN-LEWPTRFMIALGAAEGLAYLHHDC 899
+ + L++ E ++ G L + I E + YLH
Sbjct: 72 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 128
Query: 900 KPRIFHRDIKSNNILLDDKFE---AHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAY 956
I HRD+K N+L K + DFG AK + S++ + Y+APE
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLG 186
Query: 957 TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016
K + CD++S GV++ LL G P P + ++
Sbjct: 187 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE 246
Query: 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREV 1049
E + ++ +++ P R ++ E
Sbjct: 247 EVKMLIRNLL----------KTEPTQRMTITEF 269
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-39
Identities = 49/198 (24%), Positives = 75/198 (37%), Gaps = 7/198 (3%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKL-ASNREGNNIESSFRAEILTLGKIRHRNIVKLY 844
++G G +G V +G+ A+K L + + E L RH + L
Sbjct: 12 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 71
Query: 845 GFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIF 904
+ EY G L L E RF A E ++ L + +
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGA----EIVSALEYLHSRDVV 127
Query: 905 HRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKC 964
+RDIK N++LD + DFGL K + + G+ Y+APE
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEVLEDNDYGRAV 186
Query: 965 DIYSYGVVLLELLTGRTP 982
D + GVV+ E++ GR P
Sbjct: 187 DWWGLGVVMYEMMCGRLP 204
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 6e-38
Identities = 63/230 (27%), Positives = 97/230 (42%), Gaps = 13/230 (5%)
Query: 787 IVGSGAYGTVYKAV----MDSGKIVAVKKL--ASNREGNNIESSFRAEILTLGKIRHR-N 839
++G+GAYG V+ D+GK+ A+K L A+ + R E L IR
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 840 IVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
+V L+ + LI +Y+ G L L E + + E + L H
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG----EIVLALEHLH 146
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
K I +RDIK NILLD + DFGL+K +++ G+ Y+AP+
Sbjct: 147 KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGD 206
Query: 960 --VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTP 1007
+ D +S GV++ ELLTG +P + A R ++ P
Sbjct: 207 SGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP 256
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 2e-35
Identities = 53/245 (21%), Positives = 89/245 (36%), Gaps = 15/245 (6%)
Query: 745 GNCGASPSSGSVPPLNNVYFPPKEGFSFQDVVEATYNFH-DSF----IVGSGAYGTVYKA 799
GN A+ + KE F + + D F +G+G++G V
Sbjct: 1 GNAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLV 60
Query: 800 V-MDSGKIVAVKKLASNREGNNIE-SSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857
+SG A+K L + + E L + +VKL + ++
Sbjct: 61 KHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120
Query: 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD 917
EY+ G + L P A YLH + +RD+K N+L+D
Sbjct: 121 EYVAGGEMFSHLR-RIGRFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQ 176
Query: 918 KFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELL 977
+ V DFG AK + + G+ +APE + + D ++ GV++ E+
Sbjct: 177 QGYIQVTDFGFAKRVKGR----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 978 TGRTP 982
G P
Sbjct: 233 AGYPP 237
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 4e-34
Identities = 70/313 (22%), Positives = 116/313 (37%), Gaps = 45/313 (14%)
Query: 767 KEGFSFQDVVEATYNFHDSF----IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNI 821
+ F Q++ + + + + VGSGAYG+V A +G VAVKKL+ +
Sbjct: 1 RPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIH 60
Query: 822 ESSFRAEILTLGKIRHRNIVKLYGFCYHQGS-----NLLIYEYMERGSLGELLHGSSCNL 876
E+ L ++H N++ L S ++ + ++ L ++ L
Sbjct: 61 AKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK--CQKL 118
Query: 877 EWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936
+ GL Y+H I HRD+K +N+ +++ E + DFGLA+ D
Sbjct: 119 TDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175
Query: 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLA--- 993
VA + M + DI+S G ++ ELLTGRT D L
Sbjct: 176 ---TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232
Query: 994 ----------------TWVRNYIRDHSLTPGI-FDTRLNVEDESIVDHMILVLKVALMCT 1036
RNYI+ + P + F + VD L+ K
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD---LLEK----ML 285
Query: 1037 SISPFDRPSMREV 1049
+ R + +
Sbjct: 286 VLDSDKRITAAQA 298
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 1e-33
Identities = 63/294 (21%), Positives = 104/294 (35%), Gaps = 40/294 (13%)
Query: 787 IVGSGAYGTVYKAV-MDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYG 845
+GSGA G V A + VA+KKL+ + E++ + + H+NI+ L
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 846 FCYHQGSN------LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC 899
Q + L+ E M+ + + G+ +LH
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD----HERMSYLLYQMLCGIKHLHSAG 139
Query: 900 KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK 959
I HRD+K +NI++ + DFGLA+ S M+ + Y APE M
Sbjct: 140 ---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 960 VTEKCDIYSYGVVLLELLTGRTPVQ------------------PLDDGGDLATWVRNYIR 1001
E DI+S G ++ E++ + + L VRNY+
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 1002 DHSLTPGIFDTRLNVEDESIVDHMILVLKVALM------CTSISPFDRPSMREV 1049
+ G+ +L + D LK + I P R S+ +
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 308
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (325), Expect = 2e-33
Identities = 54/262 (20%), Positives = 100/262 (38%), Gaps = 30/262 (11%)
Query: 754 GSVPPLNNVYFP-----PKEGFSFQDVVEATYNFHDSF----IVGSGAYGTVYKAV-MDS 803
G VP VY P+E + ++ V + D + +G G Y V++A+ + +
Sbjct: 1 GPVPSRARVYTDVNTHRPREYWDYESHVV-EWGNQDDYQLVRKLGRGKYSEVFEAINITN 59
Query: 804 GKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNL--LIYEYM 860
+ V VK L ++ + EI L +R NI+ L S L++E++
Sbjct: 60 NEKVVVKILKPVKK-----KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114
Query: 861 ERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD-DKF 919
+L L + L Y H I HRD+K +N+++D +
Sbjct: 115 NNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHR 167
Query: 920 EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLT 978
+ + D+GLA+ + + S + PE + D++S G +L ++
Sbjct: 168 KLRLIDWGLAEFYH--PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 979 GRTPVQPLDDGGDLATWVRNYI 1000
+ P D D + +
Sbjct: 226 RKEPFFHGHDNYDQLVRIAKVL 247
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 117 bits (294), Expect = 4e-29
Identities = 50/241 (20%), Positives = 93/241 (38%), Gaps = 22/241 (9%)
Query: 763 YFPPKEGFSFQDVVEATYNFHDSFIVGSGAYGTVYKAV-MDSGKIVAVKKLASN------ 815
Y P +G ++D A Y +G G + TV+ A M + VA+K + +
Sbjct: 1 YHPAFKGEPYKD---ARYILVR--KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEA 55
Query: 816 --REGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL----LIYEYMERGSLGELL 869
E ++ A+ + +I+KL H+G N +++E + L +
Sbjct: 56 AEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIK 115
Query: 870 HGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD-DKFEAHVGDFGL 928
+ I+ GL Y+H C I H DIK N+L++ ++ +
Sbjct: 116 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKI 173
Query: 929 AKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLD 987
A + + + + + Y +PE DI+S ++ EL+TG +P +
Sbjct: 174 ADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233
Query: 988 D 988
Sbjct: 234 G 234
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 108 bits (271), Expect = 8e-26
Identities = 68/382 (17%), Positives = 124/382 (32%), Gaps = 50/382 (13%)
Query: 340 NLSMVTEIDLSENSLNGEIP-TEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLS 398
L+ + L + ++ + T+ ++T L+ L + G + L NLT+++ S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 399 INYLTGPIPVG----FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRI 454
N LT P+ + L + D +
Sbjct: 75 NNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 455 PPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQL-------RLVGNSLTGSFPLELC 507
++ + ++ + L L RL +S S L
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 508 KLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISS 567
KL NL ++ N+ S P I L L + N + +L+ L ++++
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 568 NMLTGLIPPEIVNCMTLQRLDISHNSFVGSLP--------------------NELGTLQQ 607
N ++ L P + L L + N P + + L+
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKN 308
Query: 608 LEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNL 667
L L L N S P + +L+ L L N S L +L+++ L+ +N +
Sbjct: 309 LTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINW-LSAGHNQI 363
Query: 668 SGSIPPELGKLDLLEFLLLNNN 689
S P L L + L LN+
Sbjct: 364 SDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 105 bits (262), Expect = 1e-24
Identities = 82/387 (21%), Positives = 139/387 (35%), Gaps = 37/387 (9%)
Query: 220 NLRNLRVFRAGQNAISGSIP-AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLW 278
L G+ ++ ++ ++ +LQ L I G + L +LT+I
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSIDG-----VEYLNNLTQINFS 74
Query: 279 DNQLTGFIPSELGNCTKLQTLAL------------YSNNLVGQIPKEVGNLKFLTKLYLY 326
+NQLT P L N TKL + + NL G L
Sbjct: 75 NNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 327 RNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFL-FQNQLTGVIPNE 385
I ++S ++ + + G T+ + L L + +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 386 LSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDF 445
L+ L NL L + N ++ P LT + +L L N L L + L +D
Sbjct: 193 LAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 446 SHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLE 505
++N ++ P L + L L LG N++ P L T L+ N
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLEDISP 302
Query: 506 LCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNI 565
+ L+NL + L N S P + + KLQRL ANN + + NL+ + +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSA 358
Query: 566 SSNMLTGLIPPEIVNCMTLQRLDISHN 592
N ++ L P + N + +L ++
Sbjct: 359 GHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 97.4 bits (241), Expect = 5e-22
Identities = 60/395 (15%), Positives = 130/395 (32%), Gaps = 33/395 (8%)
Query: 246 QSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNN 305
L + ++ ++ + L+ +T + + + L + +N
Sbjct: 22 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQ 77
Query: 306 LVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKI 365
L P + NL L + + N++ P + ++ + + +
Sbjct: 78 LTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLN 135
Query: 366 TGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENS 425
L N ++ + + + L + + ++ + S
Sbjct: 136 RL----ELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDIS 191
Query: 426 LTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNC 485
+ + + ++N ++ P + +NL L+L N+L + +
Sbjct: 192 VLAKLTNL-------ESLIATNNQISDITPLGIL--TNLDELSLNGNQLKD--IGTLASL 240
Query: 486 ETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNY 545
L L L N ++ P L L L ++L N+ S P + L L + N
Sbjct: 241 TNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQ 296
Query: 546 FTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTL 605
+ NL L + N ++ + P + + LQRL ++N + L L
Sbjct: 297 LED--ISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANL 350
Query: 606 QQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGN 640
+ L N+ S P L NL+ +T+L +
Sbjct: 351 TNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 96.6 bits (239), Expect = 9e-22
Identities = 77/379 (20%), Positives = 141/379 (37%), Gaps = 35/379 (9%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI 166
L N T ++S + L +T L + + + L + +NNQ +
Sbjct: 27 TVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDIT 82
Query: 167 PAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIG------- 219
P L L+ LV + + NN I+ P + + PL
Sbjct: 83 P--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 140
Query: 220 --NLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGM----LESLT 273
+ ++ + S +++ + L L + S L +L
Sbjct: 141 SNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLE 200
Query: 274 EIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGT 333
++ +NQ++ P T L L+L N L + +L LT L L N+++
Sbjct: 201 SLIATNNQISDITPLG--ILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNL 256
Query: 334 IPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT 393
P + L+ +TE+ L N ++ P + +T L L L +NQL + P +L+NLT
Sbjct: 257 AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISPIS--NLKNLT 310
Query: 394 KLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGR 453
L L N ++ P LT++++L N ++ L + + + HN ++
Sbjct: 311 YLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDL 366
Query: 454 IPPHLCQNSNLIMLNLGYN 472
P L + + L L
Sbjct: 367 TP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 94.3 bits (233), Expect = 5e-21
Identities = 68/385 (17%), Positives = 130/385 (33%), Gaps = 35/385 (9%)
Query: 173 LSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQN 232
L+ + + ++ + + +L + A + + L NL N
Sbjct: 21 LAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNN 76
Query: 233 AISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIP----- 287
++ P + L + + N I P + + +
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 288 -------SELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELN-GTIPREIG 339
+ + + + L L G ++ L LT L N + +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 340 NLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSI 399
L+ + + + N ++ P +T L L L NQL L+SL NLT LDL+
Sbjct: 195 KLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 400 NYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLC 459
N ++ P LT++ +L+L N ++ P L L + + N +
Sbjct: 251 NQISNLAP--LSGLTKLTELKLGANQISNISP----LAGLTALTNLELNENQLEDISPIS 304
Query: 460 QNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ 519
NL L L +N + P V + L +L N ++ L L N+ +
Sbjct: 305 NLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGH 360
Query: 520 NKFSGPIPPEIENCQKLQRLHIANN 544
N+ S P + N ++ +L + +
Sbjct: 361 NQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 68.9 bits (167), Expect = 9e-13
Identities = 42/177 (23%), Positives = 66/177 (37%), Gaps = 30/177 (16%)
Query: 100 FEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNN 159
+ L LN ++ L +LT LDLA N+++ P + ++L L L
Sbjct: 217 ILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGA 272
Query: 160 NQFSGKIP--------------------AELGKLSSLVSLNICNNMISGALPEGLGNLSS 199
NQ S P + + L +L L + N IS P + +L+
Sbjct: 273 NQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTK 330
Query: 200 LVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQN 256
L N ++ S+ NL N+ AG N IS P ++ + LGL
Sbjct: 331 LQRLFFANNKVSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.0 bits (157), Expect = 2e-11
Identities = 30/143 (20%), Positives = 57/143 (39%), Gaps = 6/143 (4%)
Query: 58 NSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGS 117
+ L+L N+ L + ++ S + +L
Sbjct: 239 SLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLE 298
Query: 118 LSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLV 177
I L +LTYL L +N ++ P + + ++L+ L+ NN+ S + L L+++
Sbjct: 299 DISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--VSSLANLTNIN 354
Query: 178 SLNICNNMISGALPEGLGNLSSL 200
L+ +N IS P L NL+ +
Sbjct: 355 WLSAGHNQISDLTP--LANLTRI 375
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 63.5 bits (153), Expect = 4e-11
Identities = 17/105 (16%), Positives = 36/105 (34%), Gaps = 6/105 (5%)
Query: 80 SWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELT 139
+ + + + + + L L N + + L L L A N+++
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFANNKVS 342
Query: 140 GYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNN 184
+ N + + L +NQ S P L L+ + L + +
Sbjct: 343 D--VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 45.8 bits (107), Expect = 2e-05
Identities = 42/263 (15%), Positives = 83/263 (31%), Gaps = 48/263 (18%)
Query: 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSN 568
L L + + + + ++ L S V L+ L N S+N
Sbjct: 21 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 76
Query: 569 MLTGLIPPEIVNCMTLQRLDISHNSFVGSLP----------------------------- 599
LT + P + N L + +++N P
Sbjct: 77 QLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNL 134
Query: 600 -------NELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD 652
N + + L L + GN + L L++LT L+ + +
Sbjct: 135 NRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLA 194
Query: 653 LSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSY 712
+ +L + N +S P + L+ L LN N L +L++L + +
Sbjct: 195 KLTNLESLIATNNQISDITPLGILT--NLDELSLNGNQLKD--IGTLASLTNLTDLDLAN 250
Query: 713 NNLTG--PLPSIPQFQNMDISSF 733
N ++ PL + + + + +
Sbjct: 251 NQISNLAPLSGLTKLTELKLGAN 273
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 106 bits (265), Expect = 9e-26
Identities = 53/301 (17%), Positives = 107/301 (35%), Gaps = 16/301 (5%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+ S+ L ++P + LL L N++T + + +L+NL L L N ++
Sbjct: 13 RVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 405 PIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNL 464
P F L ++ +L L +N L L V + + + L Q +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV 129
Query: 465 IMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSG 524
+ K G + L +R+ ++T L L+ LD NK +
Sbjct: 130 ELGT-NPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSLTELH---LDGNKITK 185
Query: 525 PIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTL 584
++ L +L ++ N ++ + N L ++++N L +P + + +
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK-VPGGLADHKYI 244
Query: 585 QRLDISHNSF------VGSLPNELGTLQQLEILKLSENK--FSGNIPSTLGNLSHLTELQ 636
Q + + +N+ P + L N + PST + +Q
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
Query: 637 M 637
+
Sbjct: 305 L 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 98.6 bits (244), Expect = 6e-23
Identities = 65/301 (21%), Positives = 109/301 (36%), Gaps = 21/301 (6%)
Query: 89 CSWIGVNCTS--------DFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTG 140
C V C+ D P LDL T L +L L L N+++
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISK 69
Query: 141 YIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSL 200
P +LE LYL+ NQ L L + ++ GL N +
Sbjct: 70 ISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIV 128
Query: 201 VDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGG 260
V+ +G + ++ L R I+ +IP + SL L L N I
Sbjct: 129 VELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTELHLDGNKITK 185
Query: 261 SLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFL 320
+ L +L ++ L N ++ L N L+ L L +N LV ++P + + K++
Sbjct: 186 VDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYI 244
Query: 321 TKLYLYRNELNG------TIPREIGNLSMVTEIDLSENSLN-GEI-PTEFSKITGLRLLF 372
+YL+ N ++ P + + + L N + EI P+ F + +
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQ 304
Query: 373 L 373
L
Sbjct: 305 L 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 93.9 bits (232), Expect = 2e-21
Identities = 59/303 (19%), Positives = 115/303 (37%), Gaps = 18/303 (5%)
Query: 293 CTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSEN 352
C + S+ + ++PK++ L L N++ + NL + + L N
Sbjct: 8 CQCHLRVVQCSDLGLEKVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINN 65
Query: 353 SLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQH 412
++ P F+ + L L+L +NQL + + L +L + N +T F
Sbjct: 66 KISKISPGAFAPLVKLERLYLSKNQLKELPE---KMPKTLQELRVHENEITKVRKSVFNG 122
Query: 413 LTQMRQLQL--FENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLG 470
L QM ++L +G L + + +T IP L +L L+L
Sbjct: 123 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLP--PSLTELHLD 179
Query: 471 YNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEI 530
NK+ + L +L L NS++ L +L + L+ NK +P +
Sbjct: 180 GNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGL 238
Query: 531 ENCQKLQRLHIANNYFTS------ELPKEVGNLSQLVTFNISSNMLTGL-IPPEIVNCMT 583
+ + +Q +++ NN ++ P + ++ SN + I P C+
Sbjct: 239 ADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVY 298
Query: 584 LQR 586
++
Sbjct: 299 VRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 87.4 bits (215), Expect = 4e-19
Identities = 62/284 (21%), Positives = 95/284 (33%), Gaps = 16/284 (5%)
Query: 430 IPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLL 489
+P L ++D +N +T NL L L NK+ P L
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 490 QLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSE 549
+L L N L L+ L E + K + + ++ L +
Sbjct: 83 RLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTNPLKSSGI 141
Query: 550 LPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLE 609
+ +L I+ +T IP + +L L + N L L L
Sbjct: 142 ENGAFQGMKKLSYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLA 198
Query: 610 ILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSG 669
L LS N S +L N HL EL + N ++P L D +Q+ + L NN+S
Sbjct: 199 KLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQV-VYLHNNNISA 256
Query: 670 ------SIPPELGKLDLLEFLLLNNNHLS-GEI-PSAFENLSSL 705
P K + L +N + EI PS F +
Sbjct: 257 IGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVR 300
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 84.7 bits (208), Expect = 3e-18
Identities = 51/281 (18%), Positives = 99/281 (35%), Gaps = 15/281 (5%)
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGS 501
VV S L ++P L + +L+L NK+ D N + L L L+ N ++
Sbjct: 14 VVQCSDLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKI 70
Query: 502 FPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLV 561
P L L + L +N+ + Q+L+ + + + +
Sbjct: 71 SPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE 130
Query: 562 TFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN 621
+G+ L + I+ + ++P G L L L NK +
Sbjct: 131 LGTNP-LKSSGIENGAFQGMKKLSYIRIADTNI-TTIPQ--GLPPSLTELHLDGNKITKV 186
Query: 622 IPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLL 681
++L L++L +L + N S L + L+ + +P L +
Sbjct: 187 DAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL--VKVPGGLADHKYI 244
Query: 682 EFLLLNNNHLSGEIPSAF------ENLSSLLGSNFSYNNLT 716
+ + L+NN++S + F +S G + N +
Sbjct: 245 QVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQ 285
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.5 bits (192), Expect = 3e-16
Identities = 56/310 (18%), Positives = 111/310 (35%), Gaps = 26/310 (8%)
Query: 182 CNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAE 241
C+++ +P+ L ++L+D N +T NL+NL N IS P
Sbjct: 17 CSDLGLEKVPKDLPPDTALLDL--QNNKITEIKDGDFKNLKNLHTLILINNKISKISPGA 74
Query: 242 ISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLAL 301
+ L+ L L++N + K L+ L ++ + + L ++ L
Sbjct: 75 FAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGT 133
Query: 302 YSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTE 361
G +K L+ + + + TIP+ G +TE+ L N +
Sbjct: 134 NPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDGNKITKVDAAS 190
Query: 362 FSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQL 421
+ L L L N ++ V L++ +L +L L+ N L +P G ++ + L
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYL 249
Query: 422 FENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKL-FGNIPT 480
N+++ I P + + ++ ++L N + + I
Sbjct: 250 HNNNIS-AIGSN-----------------DFCPPGYNTKKASYSGVSLFSNPVQYWEIQP 291
Query: 481 DVLNCETLLQ 490
C +
Sbjct: 292 STFRCVYVRA 301
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 78.2 bits (191), Expect = 4e-16
Identities = 48/243 (19%), Positives = 85/243 (34%), Gaps = 8/243 (3%)
Query: 495 GNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV 554
L P +L + ++L NK + + +N + L L + NN + P
Sbjct: 19 DLGLE-KVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75
Query: 555 GNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLS 614
L +L +S N L L L+ + S+ N L + +E L +
Sbjct: 76 APLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVE-LGTN 134
Query: 615 ENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPE 674
K SG + L+ +++ + IP L SL L+L N ++
Sbjct: 135 PLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGL--PPSLTE-LHLDGNKITKVDAAS 190
Query: 675 LGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFL 734
L L+ L L L+ N +S + N L + + N L + + + +
Sbjct: 191 LKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLH 250
Query: 735 GNE 737
N
Sbjct: 251 NNN 253
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 68.1 bits (165), Expect = 8e-13
Identities = 39/229 (17%), Positives = 84/229 (36%), Gaps = 11/229 (4%)
Query: 524 GPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMT 583
GP+ P C L+ + ++ +PK++ ++ +N +T + + N
Sbjct: 1 GPVCPFRCQCH-LRVVQCSDLGLEK-VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKN 56
Query: 584 LQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFS 643
L L + +N P L +LE L LS+N+ +P + L EL++ N +
Sbjct: 57 LHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK-ELPEKMPK--TLQELRVHENEIT 113
Query: 644 GEIPPELGDLSS-LQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENL 702
L+ + + L + SG + L ++ + + +++ +L
Sbjct: 114 KVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITTIPQGLPPSL 173
Query: 703 SSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNEGLCGRPVGNCGASP 751
+ L + N +T + + N L + G+ +P
Sbjct: 174 TEL---HLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTP 219
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 106 bits (265), Expect = 1e-25
Identities = 77/301 (25%), Positives = 129/301 (42%), Gaps = 8/301 (2%)
Query: 64 LLELKNSLHDEFNFLKSWK-STDQTPCSWIGVNCTSDFEPV-VWSLDLNAMNFTG--SLS 119
LL++K L + L SW +TD +W+GV C +D + V +LDL+ +N +
Sbjct: 11 LLQIKKDLGNP-TTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIP 69
Query: 120 PSIGGLVHLTYLDLAYNE-LTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVS 178
S+ L +L +L + L G IP I ++L +LY+ + SG IP L ++ +LV+
Sbjct: 70 SSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVT 129
Query: 179 LNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSI 238
L+ N +SG LP + +L +LV N ++G +P S G+ L +
Sbjct: 130 LDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN-RLTG 188
Query: 239 PAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQT 298
+ ++ + + T+ + F ++G L
Sbjct: 189 KIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNG 248
Query: 299 LALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEI 358
L L +N + G +P+ + LKFL L + N L G IP + GNL + N
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307
Query: 359 P 359
P
Sbjct: 308 P 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.0 bits (237), Expect = 5e-22
Identities = 64/273 (23%), Positives = 106/273 (38%), Gaps = 7/273 (2%)
Query: 379 TGVIPNELSSLRNLTKLDLSINYLTG--PIPVGFQHLTQMRQLQLFEN-SLTGGIPPGLG 435
GV+ + + + LDLS L PIP +L + L + +L G IPP +
Sbjct: 39 LGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIA 98
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVG 495
+ L + +H ++G IP L Q L+ L+ YN L G +P + + L+ + G
Sbjct: 99 KLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDG 158
Query: 496 NSLTGSFPLELCKLENLYA-IELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV 554
N ++G+ P L+ + + +N+ +G IPP N N
Sbjct: 159 NRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFG 218
Query: 555 GNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLS 614
+ + +++ L + + D+ +N G+LP L L+ L L +S
Sbjct: 219 SDKNTQKIHLAKNSLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVS 276
Query: 615 ENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIP 647
N G IP GNL N P
Sbjct: 277 FNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 96.0 bits (237), Expect = 6e-22
Identities = 64/263 (24%), Positives = 103/263 (39%), Gaps = 5/263 (1%)
Query: 488 LLQLRLVGNSLTGSFPL--ELCKLENLYAIELDQN-KFSGPIPPEIENCQKLQRLHIANN 544
+ L L G +L +P+ L L L + + GPIPP I +L L+I +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 545 YFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGT 604
+ +P + + LVT + S N L+G +PP I + L + N G++P+ G+
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 605 LQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSY 664
+L +L + + N+ G+ G + Q
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKN 231
Query: 665 NNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQ 724
+ L K L NN + G +P L L N S+NNL G +P
Sbjct: 232 SLAFDLGKVGLSKNLNGL--DLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGN 289
Query: 725 FQNMDISSFLGNEGLCGRPVGNC 747
Q D+S++ N+ LCG P+ C
Sbjct: 290 LQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 79.0 bits (193), Expect = 2e-16
Identities = 61/268 (22%), Positives = 96/268 (35%), Gaps = 5/268 (1%)
Query: 243 SGCQSLQILGLAQNDIGG--SLPKEIGMLESLTEIVLWDN-QLTGFIPSELGNCTKLQTL 299
+ + L L+ ++ +P + L L + + L G IP + T+L L
Sbjct: 47 TQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYL 106
Query: 300 ALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIP 359
+ N+ G IP + +K L L N L+GT+P I +L + I N ++G IP
Sbjct: 107 YITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIP 166
Query: 360 TEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQL 419
+ + L + NL +DLS N + Q
Sbjct: 167 DSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNM-LEGDASVLFGSDKNTQK 225
Query: 420 QLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIP 479
+ +GL L +D +N + G +P L Q L LN+ +N L G IP
Sbjct: 226 IHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP 285
Query: 480 TDVLNCETLLQLRLVGNSLTGSFPLELC 507
N + N PL C
Sbjct: 286 -QGGNLQRFDVSAYANNKCLCGSPLPAC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 58.2 bits (139), Expect = 2e-09
Identities = 35/152 (23%), Positives = 58/152 (38%), Gaps = 5/152 (3%)
Query: 67 LKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLV 126
+ ++ D + ++ + + F + + + N + + G
Sbjct: 161 ISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSD 220
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186
T + ++G L L L NN+ G +P L +L L SLN+ N +
Sbjct: 221 KNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNL 280
Query: 187 SGALPEGLGNLSSLVDFVAYTNN--LTG-PLP 215
G +P+ GNL D AY NN L G PLP
Sbjct: 281 CGEIPQ-GGNLQRF-DVSAYANNKCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 39.0 bits (89), Expect = 0.002
Identities = 38/136 (27%), Positives = 65/136 (47%), Gaps = 2/136 (1%)
Query: 588 DISHNSFVGSLPNELGTLQQLEILKLSENKFSGN--IPSTLGNLSHLTELQMGGNLFSGE 645
D + +++G L + ++ L LS IPS+L NL +L L +GG
Sbjct: 32 DCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVG 91
Query: 646 IPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
P + L +++ N+SG+IP L ++ L L + N LSG +P + +L +L
Sbjct: 92 PIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNL 151
Query: 706 LGSNFSYNNLTGPLPS 721
+G F N ++G +P
Sbjct: 152 VGITFDGNRISGAIPD 167
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 94.8 bits (235), Expect = 1e-22
Identities = 31/200 (15%), Positives = 60/200 (30%), Gaps = 26/200 (13%)
Query: 787 IVGSGAYGTVYKAVMDSGKIVAVKKLASNREG--------NNIESSFRAEILTLGKIRHR 838
++G G V+ + VK + + F + + R
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 839 NIVKLYGFCYHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRF-MIALGAAEGLAYLHH 897
+ KL G + +Y + L EL+ + E +A +H
Sbjct: 67 ALQKLQGLAVPK-----VYAWEGNAVLMELIDAKELYRVRVENPDEVLDMILEEVAKFYH 121
Query: 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKSMSA--VAGSYGYIAPEYA 955
I H D+ N+L+ + + DF + + + + V Y + Y
Sbjct: 122 RG---IVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRTYR 177
Query: 956 YTMKVTEKCDIYSYGVVLLE 975
+ DI S +L+
Sbjct: 178 T------EKDINSAIDRILQ 191
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (229), Expect = 3e-21
Identities = 53/261 (20%), Positives = 87/261 (33%), Gaps = 6/261 (2%)
Query: 382 IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLW 441
+P + + ++ L N ++ F+ + L L N L +LL
Sbjct: 26 VPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 442 VVDFSHNYLTGRIPP-HLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTG 500
+D S N + P L L+L L P L L L N+L
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA 143
Query: 501 SFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQL 560
L NL + L N+ S L RL + N P +L +L
Sbjct: 144 LPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRL 203
Query: 561 VTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSG 620
+T + +N L+ L + LQ L ++ N +V L+ + S ++
Sbjct: 204 MTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEVPC 262
Query: 621 NIPSTLGN--LSHLTELQMGG 639
++P L L L + G
Sbjct: 263 SLPQRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (216), Expect = 1e-19
Identities = 53/276 (19%), Positives = 88/276 (31%), Gaps = 8/276 (2%)
Query: 154 HLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGP 213
+P + ++ + + N IS +L ++N L
Sbjct: 15 TTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 214 LPQSIGNLRNLRVFRAGQNAISGSI-PAEISGCQSLQILGLAQNDIGGSLPKEIGMLESL 272
+ L L NA S+ PA G L L L + + P L +L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 273 TEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNG 332
+ L DN L + L L L+ N + + L L +L L++N +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 333 TIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNL 392
P +L + + L N+L+ + + L+ L L N L
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWL 250
Query: 393 TKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTG 428
K S + + +P Q L +L N L G
Sbjct: 251 QKFRGSSSEVPCSLP---QRLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.9 bits (216), Expect = 2e-19
Identities = 58/265 (21%), Positives = 89/265 (33%), Gaps = 7/265 (2%)
Query: 261 SLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFL 320
++P I + I L N+++ + C L L L+SN L L L
Sbjct: 25 AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 321 TKLYLYRNELNGTI-PREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
+L L N ++ P L + + L L P F + L+ L+L N L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL 439
+ + L NLT L L N ++ F+ L + +L L +N + P
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
L + N L+ L L L L N + L L + R + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPL-WAWLQKFRGSSSEVP 261
Query: 500 GSFPLELCKLENLYAIELDQNKFSG 524
S P L L N G
Sbjct: 262 CSLPQR---LAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.9 bits (203), Expect = 7e-18
Identities = 50/277 (18%), Positives = 81/277 (29%), Gaps = 9/277 (3%)
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGS 501
L +P + + + L N++ C L L L N L
Sbjct: 15 TTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARI 71
Query: 502 FPLELCKLENLYAIELDQNKFSGPIPP-EIENCQKLQRLHIANNYFTSELPKEVGNLSQL 560
L L ++L N + P +L LH+ P L+ L
Sbjct: 72 DAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAAL 131
Query: 561 VTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSG 620
+ N L L + L L + N L L+ L L +N+ +
Sbjct: 132 QYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAH 191
Query: 621 NIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDL 680
P +L L L + N S L L +LQ L L+ N
Sbjct: 192 VHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY-LRLNDNPWVCDCRA-RPLWAW 249
Query: 681 LEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTG 717
L+ +++ + +P + N+L G
Sbjct: 250 LQKFRGSSSEVPCSLPQRLAGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.8 bits (182), Expect = 4e-15
Identities = 50/289 (17%), Positives = 85/289 (29%), Gaps = 31/289 (10%)
Query: 309 QIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGL 368
+P + +++L+ N ++ +T + L N L F+ + L
Sbjct: 25 AVPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 369 RLLFLFQNQLTGVI-PNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLT 427
L L N + P L L L L L P F+ L
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA------------ 130
Query: 428 GGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCET 487
L + N L NL L L N++ +
Sbjct: 131 ------------LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
Query: 488 LLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFT 547
L +L L N + P L L + L N S + + LQ L + +N +
Sbjct: 179 LDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238
Query: 548 SELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVG 596
+ + + L F SS+ + +P + ++ N G
Sbjct: 239 CD-CRARPLWAWLQKFRGSSSEVPCSLPQRLAG---RDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (181), Expect = 5e-15
Identities = 57/280 (20%), Positives = 93/280 (33%), Gaps = 8/280 (2%)
Query: 459 CQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELD 518
C N + + L +P + ++ L GN ++ NL + L
Sbjct: 8 CYNEPKVTTSCPQQGL-QAVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 519 QNKFSGPIPPEIENCQKLQRLHIANNYFTSEL-PKEVGNLSQLVTFNISSNMLTGLIPPE 577
N + L++L +++N + P L +L T ++ L L P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 578 IVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQM 637
LQ L + N+ + L L L L N+ S L L L +
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLL 184
Query: 638 GGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPS 697
N + P DL L L NNLS L L L++L LN+N + +
Sbjct: 185 HQNRVAHVHPHAFRDLGRLMTL-YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA 243
Query: 698 AFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISSFLGNE 737
+ L S + + LP + D+ N+
Sbjct: 244 R-PLWAWLQKFRGSSSEVPCSLP--QRLAGRDLKRLAAND 280
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (167), Expect = 3e-13
Identities = 43/256 (16%), Positives = 77/256 (30%), Gaps = 5/256 (1%)
Query: 53 TTEGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAM 112
++ + G+ + + + L T L +
Sbjct: 33 ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLS-DNA 91
Query: 113 NFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGK 172
+ GL L L L L P + L++LYL +N
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 173 LSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQN 232
L +L L + N IS L SL + + N + P + +L L N
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFAN 211
Query: 233 AISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGN 292
+S ++ ++LQ L L N + + L + +++ +P L
Sbjct: 212 NLSALPTEALAPLRALQYLRLNDNPWVCD-CRARPLWAWLQKFRGSSSEVPCSLPQRLAG 270
Query: 293 CTKLQTLALYSNNLVG 308
L +N+L G
Sbjct: 271 ---RDLKRLAANDLQG 283
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.7 bits (161), Expect = 2e-12
Identities = 46/210 (21%), Positives = 73/210 (34%), Gaps = 7/210 (3%)
Query: 337 EIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLD 396
E+ ++ E++ + +L +P + K +L L +N L L LT+L+
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 397 LSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPP 456
L + + ++ +P L V+D S N LT
Sbjct: 62 LDRAE---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 457 HLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIE 516
L L L L N+L P + L +L L N+LT L LENL +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 517 LDQNKFSGPIPPEIENCQKLQRLHIANNYF 546
L +N IP L + N +
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.4 bits (155), Expect = 1e-11
Identities = 44/200 (22%), Positives = 71/200 (35%), Gaps = 7/200 (3%)
Query: 443 VDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSF 502
V+ LT +PP L + +L+L N L+ ++ L QL L LT
Sbjct: 15 VNCDKRNLT-ALPPDL--PKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQ 71
Query: 503 PLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVT 562
L L ++L N+ ++ N TS + L +L
Sbjct: 72 VD--GTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALRGLGELQE 128
Query: 563 FNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNI 622
+ N L L P + L++L +++N+ L L+ L+ L L EN I
Sbjct: 129 LYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187
Query: 623 PSTLGNLSHLTELQMGGNLF 642
P L + GN +
Sbjct: 188 PKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (153), Expect = 2e-11
Identities = 42/211 (19%), Positives = 68/211 (32%), Gaps = 7/211 (3%)
Query: 121 SIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLN 180
+ + ++ LT +P ++ L+L+ N A L + L LN
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 181 ICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPA 240
+ ++ + G L L N L V N ++
Sbjct: 62 LDRAELTK--LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPAL-TVLDVSFNRLTSLPLG 118
Query: 241 EISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLA 300
+ G LQ L L N++ P + L ++ L +N LT L L TL
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 301 LYSNNLVGQIPKEVGNLKFLTKLYLYRNELN 331
L N + IPK L +L+ N
Sbjct: 179 L-QENSLYTIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.9 bits (146), Expect = 1e-10
Identities = 40/209 (19%), Positives = 75/209 (35%), Gaps = 7/209 (3%)
Query: 410 FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNL 469
+ ++ + +LT +PP L ++ S N L L + L LNL
Sbjct: 6 VSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 470 GYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPE 529
+L L +L + ++ S PL L L +++ N+ +
Sbjct: 63 DRAELTKLQVDGTL---PVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGA 119
Query: 530 IENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDI 589
+ +LQ L++ N + P + +L ++++N LT L + L L +
Sbjct: 120 LRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLL 179
Query: 590 SHNSFVGSLPNELGTLQQLEILKLSENKF 618
NS ++P L L N +
Sbjct: 180 QENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.7 bits (143), Expect = 4e-10
Identities = 40/211 (18%), Positives = 70/211 (33%), Gaps = 7/211 (3%)
Query: 145 EIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFV 204
E+ + + + + +P +L K L++ N++ L + L
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQL- 60
Query: 205 AYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPK 264
+ Q G L L N + + + ++ N +
Sbjct: 61 -NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLG 118
Query: 265 EIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLY 324
+ L L E+ L N+L P L KL+ L+L +NNL + L+ L L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 325 LYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
L N L TIP+ ++ L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.3 bits (142), Expect = 4e-10
Identities = 43/201 (21%), Positives = 76/201 (37%), Gaps = 7/201 (3%)
Query: 106 SLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK 165
++ + N T +L P + T L L+ N L + + +RL L L+ + +
Sbjct: 14 EVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL 70
Query: 166 IPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLR 225
L L +L++ +N + G L +L N LT ++ L L+
Sbjct: 71 QVDG--TLPVLGTLDLSHNQLQSLPLLG-QTLPALTVLDVSFNRLTSLPLGALRGLGELQ 127
Query: 226 VFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGF 285
N + P ++ L+ L LA N++ + LE+L ++L +N L
Sbjct: 128 ELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-T 186
Query: 286 IPSELGNCTKLQTLALYSNNL 306
IP L L+ N
Sbjct: 187 IPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 47/206 (22%), Positives = 75/206 (36%), Gaps = 8/206 (3%)
Query: 484 NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIAN 543
+ L++ +LT + P +L K + + L +N + +L +L++
Sbjct: 8 KVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDR 64
Query: 544 NYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELG 603
T + G L L T ++S N L L D+S N L
Sbjct: 65 AELTK--LQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVL-DVSFNRLTSLPLGALR 121
Query: 604 TLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLS 663
L +L+ L L N+ P L L +L + N + L L +L L L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDT-LLLQ 180
Query: 664 YNNLSGSIPPELGKLDLLEFLLLNNN 689
N+L +IP LL F L+ N
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.3 bits (129), Expect = 2e-08
Identities = 46/210 (21%), Positives = 72/210 (34%), Gaps = 7/210 (3%)
Query: 289 ELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEID 348
E+ + NL +P ++ T L+L N L + + +T+++
Sbjct: 5 EVSKVASHLEVNCDKRNLT-ALPPDLPKD--TTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 349 LSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPV 408
L L + + +P +L LT LD+S N LT
Sbjct: 62 LDRAELTKLQVDGTLP---VLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLG 118
Query: 409 GFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLN 468
+ L ++++L L N L P L L + ++N LT L NL L
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 469 LGYNKLFGNIPTDVLNCETLLQLRLVGNSL 498
L N L+ IP L L GN
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.0 bits (110), Expect = 5e-06
Identities = 35/206 (16%), Positives = 63/206 (30%), Gaps = 16/206 (7%)
Query: 89 CSWIG----VNCT--------SDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYN 136
S + VNC D L L+ ++ LT L+L
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRA 65
Query: 137 ELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGN 196
E ++ + ++ +P L +L L++ N ++ L
Sbjct: 66 E---LTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRG 122
Query: 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQN 256
L L + N L P + L N ++ ++G ++L L L +N
Sbjct: 123 LGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQEN 182
Query: 257 DIGGSLPKEIGMLESLTEIVLWDNQL 282
+ ++PK L L N
Sbjct: 183 SL-YTIPKGFFGSHLLPFAFLHGNPW 207
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.3 bits (103), Expect = 3e-05
Identities = 40/208 (19%), Positives = 56/208 (26%), Gaps = 23/208 (11%)
Query: 553 EVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILK 612
EV ++ + N LT +PP++ L +S N L +L L
Sbjct: 5 EVSKVASHLEVNCDKRNLTA-LPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61
Query: 613 LS-ENKFSGNIPSTLGNLSHLTELQMGGNLFSG-------------------EIPPELGD 652
L + TL L L +P
Sbjct: 62 LDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALR 121
Query: 653 LSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSY 712
L L N L P L LE L L NN+L+ L +L
Sbjct: 122 GLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQE 181
Query: 713 NNLTGPLPSIPQFQNMDISSFLGNEGLC 740
N+L + + GN LC
Sbjct: 182 NSLYTIPKGFFGSHLLPFAFLHGNPWLC 209
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.7 bits (148), Expect = 1e-10
Identities = 50/271 (18%), Positives = 95/271 (35%), Gaps = 16/271 (5%)
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
QTL L NL + + + + R+ ++ + V +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQGVIA-FRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 357 E-IPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQ 415
+ S+ + L+ L L +L+ I N L+ NL +L+LS + +
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 416 MR--------QLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIML 467
R E + + + L + + N + + + NL+ L
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHL 180
Query: 468 NLGYNKLFGNIPTDVLNCETLLQ-LRLVG-NSLTGSFPLELCKLENLYAIELDQNKFSGP 525
+L + + N LQ L L + LEL ++ L +++ G
Sbjct: 181 DLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240
Query: 526 IPPEIENCQKLQRLHIANNYFTSELPKEVGN 556
+ E LQ I ++FT+ +GN
Sbjct: 241 LQLLKEALPHLQ---INCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.1 bits (144), Expect = 3e-10
Identities = 40/286 (13%), Positives = 89/286 (31%), Gaps = 22/286 (7%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
+DL+ +L+ ++ G+ ++ + + S R + +DLS + +
Sbjct: 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 405 -PIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSN 463
+ ++++ L L L+ I L S L ++ S +S
Sbjct: 61 STLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSC 120
Query: 464 LIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFS 523
+ L + F V + + +L+G S
Sbjct: 121 SRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQK---------------S 165
Query: 524 GPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISS-NMLTGLIPPEIVNCM 582
+ + ++ +E L+ L ++S + E+
Sbjct: 166 DLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIP 225
Query: 583 TLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGN 628
TL+ L + G+L L L +++ + F+ T+GN
Sbjct: 226 TLKTLQVFGIVPDGTLQLLKEALPHL---QINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 3e-09
Identities = 40/239 (16%), Positives = 71/239 (29%), Gaps = 14/239 (5%)
Query: 113 NFTGSLSPSIGGLVHLTYLDLAYNELTGY-IPREIGNCSRLEHLYLNNNQFSGKIPAELG 171
+F + ++DL+ + + + + CS+L++L L + S I L
Sbjct: 33 SFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLA 92
Query: 172 KLSSLVSLNI--CNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRA 229
K S+LV LN+ C+ AL L + S L + +
Sbjct: 93 KNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQ 152
Query: 230 GQ-------NAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWD-NQ 281
S + + + +E L L + L
Sbjct: 153 LNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYD 212
Query: 282 LTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGN 340
+ ELG L+TL ++ G + L L + + IGN
Sbjct: 213 IIPETLLELGEIPTLKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.8 bits (125), Expect = 8e-08
Identities = 48/269 (17%), Positives = 92/269 (34%), Gaps = 17/269 (6%)
Query: 419 LQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNI 478
L L +L + L ++ +++ + H + ++L + + +
Sbjct: 5 LDLTGKNLHPDVTGRLLSQGVI-AFRCPRSFMDQPLAEHFS-PFRVQHMDLSNSVIEVST 62
Query: 479 PTDVL-NCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQ--NKFSGPIPPEIENCQK 535
+L C L L L G L+ L K NL + L + + +C +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 536 LQRLHIANNYFTS------ELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDI 589
L L+++ + + + ++QL N+ + + C L LD+
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 590 SHN-SFVGSLPNELGTLQQLEILKLSE-NKFSGNIPSTLGNLSHLTELQMGGNLFSGEIP 647
S + E L L+ L LS LG + L LQ+ G + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 648 PELGDLSSLQIALNLSYNNLSGSIPPELG 676
L LQI + ++ + P +G
Sbjct: 243 LLKEALPHLQI----NCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.5 bits (119), Expect = 4e-07
Identities = 36/284 (12%), Positives = 79/284 (27%), Gaps = 22/284 (7%)
Query: 154 HLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGP 213
L L + L +++ + + L E ++ +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVST 62
Query: 214 LPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLT 273
L + L+ +S I ++ +L L L+
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCS---------------- 106
Query: 274 EIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGT 333
+ Q S L ++ + + L +N
Sbjct: 107 GFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSD 166
Query: 334 IPREIGNLSMVTEIDLSENSL-NGEIPTEFSKITGLRLLFLFQ-NQLTGVIPNELSSLRN 391
+ + + +DLS++ + + EF ++ L+ L L + + EL +
Sbjct: 167 LSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPT 226
Query: 392 LTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
L L + G + + + L LQ+ + T P +G
Sbjct: 227 LKTLQVFGIVPDGTLQLLKEALP---HLQINCSHFTTIARPTIG 267
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 2e-05
Identities = 18/101 (17%), Positives = 32/101 (31%), Gaps = 4/101 (3%)
Query: 585 QRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG 644
Q LD++ + + L Q + + + + + + + ++
Sbjct: 3 QTLDLTGKNLHPDVTGRL-LSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEV 60
Query: 645 EIPPE-LGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFL 684
L S LQ L+L LS I L K L L
Sbjct: 61 STLHGILSQCSKLQ-NLSLEGLRLSDPIVNTLAKNSNLVRL 100
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 58.7 bits (140), Expect = 1e-09
Identities = 58/339 (17%), Positives = 102/339 (30%), Gaps = 27/339 (7%)
Query: 320 LTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLT 379
+L L L+ ++P +L + S NSL E+P + L +
Sbjct: 40 AHELELNNLGLS-SLPELPPHL---ESLVASCNSLT-ELPELPQSLKSLLVDN------- 87
Query: 380 GVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSL 439
N L +L +L L L ++ L L++ + SL
Sbjct: 88 ----NNLKALSDLPPL-LEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSL 142
Query: 440 LWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
++ ++ +L + + N KL + L +
Sbjct: 143 EFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQN 202
Query: 500 GSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQ 559
F L +N L S +N + F LS+
Sbjct: 203 LPF-LTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSE 261
Query: 560 LVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFS 619
L N + I +L+ L++S+N + LP +LE L S N +
Sbjct: 262 LPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA 317
Query: 620 GNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQI 658
+P N L +L + N E P + L++
Sbjct: 318 -EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 58/340 (17%), Positives = 99/340 (29%), Gaps = 28/340 (8%)
Query: 366 TGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENS 425
L L L+ +P +L L S N LT +P Q L + +
Sbjct: 38 RQAHELELNNLGLS-SLPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92
Query: 426 LTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNC 485
L+ L LL + S+N L +I ++ ++
Sbjct: 93 LS-------DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVD------NNSLKKLPDLP 139
Query: 486 ETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNY 545
+L + N L L+ + + K +P +E+ +
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 546 FTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTL 605
+ + + + N +T +F+ N L
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 606 QQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYN 665
+L N S I S L EL + N E+P L L S+N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER----LIASFN 314
Query: 666 NLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
+L+ +P L+ L + N L E P E++ L
Sbjct: 315 HLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.1 bits (128), Expect = 4e-08
Identities = 57/343 (16%), Positives = 97/343 (28%), Gaps = 27/343 (7%)
Query: 390 RNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNY 449
R +L+L+ L+ +P + + L NSLT +P L + +N
Sbjct: 38 RQAHELELNNLGLSS-LP---ELPPHLESLVASCNSLTE-LPELPQS---LKSLLVDNNN 89
Query: 450 LTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKL 509
L L L+ N + + + S
Sbjct: 90 L-----KALSDLPPLLEYLGVSNNQLEKL-----PELQNSSFLKIIDVDNNSLKKLPDLP 139
Query: 510 ENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNM 569
+L I N+ + + +LP + ++
Sbjct: 140 PSLEFIAAGNNQLEELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPE 199
Query: 570 LTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNL 629
L L + + N F + L
Sbjct: 200 LQNLPFLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGL 259
Query: 630 SHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNN 689
S L N S EI SL+ LN+S N L +P +L E L+ + N
Sbjct: 260 SELPPNLYYLNASSNEIRSLCDLPPSLEE-LNVSNNKLI-ELPALPPRL---ERLIASFN 314
Query: 690 HLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNMDISS 732
HL+ E+P +NL L + YN L +++ ++S
Sbjct: 315 HLA-EVPELPQNLKQL---HVEYNPLREFPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.0 bits (120), Expect = 4e-07
Identities = 32/157 (20%), Positives = 54/157 (34%), Gaps = 10/157 (6%)
Query: 70 SLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLT 129
L + K+ P S +N ++ + L ++ F GL L
Sbjct: 205 FLTTIYADNNLLKTLPDLPPSLEALNVRDNYLTDLPELP-QSLTFLDVSENIFSGLSELP 263
Query: 130 YLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGA 189
N + I LE L ++NN+ ++PA +L L N ++
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLE---RLIASFNHLA-E 318
Query: 190 LPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRV 226
+PE NL L N L P ++ +LR+
Sbjct: 319 VPELPQNLKQL---HVEYNPLRE-FPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 47.5 bits (111), Expect = 5e-06
Identities = 48/329 (14%), Positives = 96/329 (29%), Gaps = 26/329 (7%)
Query: 271 SLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNEL 330
E+ L + L+ +P + L++L N+L ++P+ +LK L L
Sbjct: 39 QAHELELNNLGLSS-LPELPPH---LESLVASCNSLT-ELPELPQSLKSLLVDNNNLKAL 93
Query: 331 NGTIP---REIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELS 387
+ P + + + ++ +NS +I + + N+L
Sbjct: 94 SDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLE 153
Query: 388 SLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSH 447
L L L + + + + P L L + +
Sbjct: 154 ELPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADN 213
Query: 448 NYLTGRIPPHLCQNSNLIMLNL--------GYNKLFGNIPTDVLNCETLLQLRLVGNSLT 499
N L + + N L N+ +
Sbjct: 214 NLLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASS 273
Query: 500 GSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQ 559
+L + + NK +P L+RL + N+ +P+ NL Q
Sbjct: 274 NEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHLAE-VPELPQNLKQ 328
Query: 560 LVTFNISSNMLTGLIPPEIVNCMTLQRLD 588
L ++ N L P+I + R++
Sbjct: 329 L---HVEYNPLREF--PDIPESVEDLRMN 352
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 46.0 bits (107), Expect = 2e-05
Identities = 22/91 (24%), Positives = 40/91 (43%), Gaps = 10/91 (10%)
Query: 255 QNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV 314
N + + SL E+ + +N+L +P+ L+ L N+L ++P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPR---LERLIASFNHL-AEVPELP 323
Query: 315 GNLKFLTKLYLYRNELNG--TIPREIGNLSM 343
NLK +L++ N L IP + +L M
Sbjct: 324 QNLK---QLHVEYNPLREFPDIPESVEDLRM 351
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 54.7 bits (130), Expect = 1e-08
Identities = 36/219 (16%), Positives = 71/219 (32%), Gaps = 18/219 (8%)
Query: 373 LFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPP 432
++ +T + + L +T L +T I G Q+L + L+L +N +T P
Sbjct: 26 AGKSNVTDTVT--QADLDGITTLSAFGTGVTT-IE-GVQYLNNLIGLELKDNQITDLAPL 81
Query: 433 GLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLR 492
+ + I + + T + L L
Sbjct: 82 KNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTST------QITDVTPLAGLSNLQVLY 135
Query: 493 LVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPK 552
L N +T PL L + N KL L +N + P
Sbjct: 136 LDLNQITNISPLAGLT----NLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 553 EVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISH 591
+ +L L+ ++ +N ++ + P + N L + +++
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 5e-08
Identities = 35/227 (15%), Positives = 69/227 (30%), Gaps = 18/227 (7%)
Query: 388 SLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSH 447
+L N K+ + +T + L + L F +T G+ + L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKD 72
Query: 448 NYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELC 507
N +T P + L+ K I L + + + L
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 508 KLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISS 567
L + + +G + + Q + NLS+L T
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSD----------LTPLANLSKLTTLKADD 182
Query: 568 NMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLS 614
N ++ + P + + L + + +N P L L I+ L+
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 30/217 (13%), Positives = 67/217 (30%), Gaps = 22/217 (10%)
Query: 148 NCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYT 207
+ + + + + L + +L+ ++ EG+ L++L+
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 208 NNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIG 267
N +T P +I S + + +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 268 MLESLTEIVLWDNQLTGFI--------------PSELGNCTKLQTLALYSNNLVGQIPKE 313
+L + + L G + L N +KL TL N + P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 314 VGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLS 350
+ +L L +++L N+++ P + N S + + L+
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLT 225
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 27/216 (12%), Positives = 61/216 (28%), Gaps = 22/216 (10%)
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN 183
L + + + +T + + + + L + I + L++L+ L + +
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 184 NMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQ------------ 231
N I+ P + ++ +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 232 --NAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSE 289
I + L+ + S + L LT + DN+++ P
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP-- 190
Query: 290 LGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYL 325
L + L + L +N + P + N L + L
Sbjct: 191 LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 35/226 (15%), Positives = 76/226 (33%), Gaps = 18/226 (7%)
Query: 196 NLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQ 255
L++ + A +N+T + Q+ +L + A ++ +I + +L L L
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVT-TIEG-VQYLNNLIGLELKD 72
Query: 256 NDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVG 315
N I P + + E+ + I T T ++ +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 316 NLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQ 375
L + L G + ++ T + ++ L L
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNA----------QVSDLTPLANLSKLTTLKADD 182
Query: 376 NQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQL 421
N+++ + P L+SL NL ++ L N ++ P + + + + L
Sbjct: 183 NKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 46.9 bits (110), Expect = 4e-06
Identities = 22/112 (19%), Positives = 38/112 (33%), Gaps = 4/112 (3%)
Query: 72 HDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYL 131
+ L + + S + L+ N S + L LT L
Sbjct: 119 ITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTL 178
Query: 132 DLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN 183
N+++ P + + L ++L NNQ S P L S+L + + N
Sbjct: 179 KADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 44.6 bits (104), Expect = 2e-05
Identities = 38/218 (17%), Positives = 63/218 (28%), Gaps = 25/218 (11%)
Query: 502 FPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLV 561
FP L N I ++ + + + + L T+ + V L+ L+
Sbjct: 13 FPDP--ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLI 66
Query: 562 TFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGN 621
+ N +T L P + + +T L + V ++ +
Sbjct: 67 GLELKDNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLA 126
Query: 622 IPSTLGNLSHLTELQMGGNLF--------------SGEIPPELGDLSSLQIALNLSYNNL 667
S L L + L +LS L N +
Sbjct: 127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA-DDNKI 185
Query: 668 SGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSL 705
S P L L L + L NN +S P N S+L
Sbjct: 186 SDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 50.0 bits (118), Expect = 3e-07
Identities = 38/217 (17%), Positives = 67/217 (30%), Gaps = 22/217 (10%)
Query: 333 TIPREIG------NLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNEL 386
T+P I + + +L + S+ + +++ + + + + V +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--I 64
Query: 387 SSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFS 446
L N+TKL L+ N LT P+ L + L L + S
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKV------KDLSSLKDLKKLKSLS 118
Query: 447 HNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLEL 506
+ L L L LG NK+ L L S + L
Sbjct: 119 LEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLS----LEDNQISDIVPL 174
Query: 507 CKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIAN 543
L L + L +N S + + L L + +
Sbjct: 175 AGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.7 bits (112), Expect = 2e-06
Identities = 27/195 (13%), Positives = 61/195 (31%), Gaps = 16/195 (8%)
Query: 373 LFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPP 432
L + +T + + L ++ ++ + + + G Q+L + +L L N LT P
Sbjct: 31 LKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQ--GIQYLPNVTKLFLNGNKLTDIKP- 85
Query: 433 GLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLR 492
+ L + + ++ + + +I V +
Sbjct: 86 ----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESLYL 141
Query: 493 LVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPK 552
+ L KL+ L + KLQ L+++ N+ + +
Sbjct: 142 GNNKITDITVLSRLTKLDTLS-----LEDNQISDIVPLAGLTKLQNLYLSKNHISD--LR 194
Query: 553 EVGNLSQLVTFNISS 567
+ L L + S
Sbjct: 195 ALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.4 bits (106), Expect = 1e-05
Identities = 29/207 (14%), Positives = 57/207 (27%), Gaps = 28/207 (13%)
Query: 237 SIPAEIS------GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSEL 290
++P I L + + ++ + L S+ +I+ ++ + +
Sbjct: 9 TVPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--I 64
Query: 291 GNCTKLQTLALYSNNLVGQIP---------------KEVGNLKFLTKLYLYRNELNGTIP 335
+ L L N L P K L L
Sbjct: 65 QYLPNVTKLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 336 REIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKL 395
+I L + +++ N ++ I L+ L L L
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNL 183
Query: 396 DLSINYLTGPIPVGFQHLTQMRQLQLF 422
LS N+++ L + L+LF
Sbjct: 184 YLSKNHISDLRA--LAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 45.0 bits (105), Expect = 2e-05
Identities = 26/204 (12%), Positives = 63/204 (30%), Gaps = 16/204 (7%)
Query: 387 SSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFS 446
+ K +L +T + L + Q+ + + G+ + + +
Sbjct: 21 DAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKS--VQGIQYLPNVTKLFLN 76
Query: 447 HNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLEL 506
N LT P +N + L+ K ++ SL + ++
Sbjct: 77 GNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKS---------LSLEHNGISDI 127
Query: 507 CKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNIS 566
L +L +E + + + + S++ + L++L +S
Sbjct: 128 NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLS 186
Query: 567 SNMLTGLIPPEIVNCMTLQRLDIS 590
N ++ L + L L++
Sbjct: 187 KNHISDL--RALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.7 bits (99), Expect = 9e-05
Identities = 32/203 (15%), Positives = 66/203 (32%), Gaps = 16/203 (7%)
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN 183
+L +T + + + ++ + NN+ + L ++ L +
Sbjct: 22 AFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNG 77
Query: 184 NMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEIS 243
N ++ L++L + + S + ++ I +
Sbjct: 78 NKLTDI-----KPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 244 GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
Q + + L L + L DNQ++ +P L TKLQ L L
Sbjct: 133 LPQLESLYLGNNKITD---ITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQNLYLSK 187
Query: 304 NNLVGQIPKEVGNLKFLTKLYLY 326
N++ + + LK L L L+
Sbjct: 188 NHISD--LRALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 1e-04
Identities = 27/191 (14%), Positives = 62/191 (32%), Gaps = 22/191 (11%)
Query: 462 SNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK 521
+ I NL + + + LN ++ Q+ + + ++ L N+ + L+ NK
Sbjct: 24 AETIKDNLKKKSVTDAVTQNELN--SIDQIIANNSDIKSVQGIQ--YLPNVTKLFLNGNK 79
Query: 522 FSGPIP---------------PEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNIS 566
+ P + + + ++ L L
Sbjct: 80 LTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 567 SNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTL 626
+ +++ +T ++ + + L L +L+ L LS+N S L
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLAGLTKLQNLYLSKNHISD--LRAL 196
Query: 627 GNLSHLTELQM 637
L +L L++
Sbjct: 197 AGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 30/202 (14%), Positives = 60/202 (29%), Gaps = 25/202 (12%)
Query: 502 FPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLV 561
F + L + + + + ++ N+ S + L +
Sbjct: 18 FSDD--AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVT 71
Query: 562 TFNISSNMLTGLIP---------------PEIVNCMTLQRLDISHNSFVGSLPNELGTLQ 606
++ N LT + P + S + +++ L
Sbjct: 72 KLFLNGNKLTDIKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLV 131
Query: 607 QLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNN 666
L L+ + T+ + + + +I P L L+ LQ L LS N+
Sbjct: 132 HLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQN-LYLSKNH 189
Query: 667 LSGSIPPELGKLDLLEFLLLNN 688
+S L L L+ L L +
Sbjct: 190 ISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.0 bits (92), Expect = 6e-04
Identities = 25/197 (12%), Positives = 66/197 (33%), Gaps = 16/197 (8%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI 166
+L + T +++ + L + + +++ I + L+LN N+ +
Sbjct: 29 DNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIK 84
Query: 167 PAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRV 226
P L++L +L + + ++ +N + + + +
Sbjct: 85 P-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLPQLESL 139
Query: 227 FRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFI 286
+ ++ + ++ +L + +DI + L L + L N ++
Sbjct: 140 YLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLSKNHISDL- 193
Query: 287 PSELGNCTKLQTLALYS 303
L L L L+S
Sbjct: 194 -RALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.8 bits (89), Expect = 0.001
Identities = 31/215 (14%), Positives = 67/215 (31%), Gaps = 22/215 (10%)
Query: 142 IPREIG------NCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLG 195
+P I + L + + +L+S+ + N+ I +G+
Sbjct: 10 VPTPIKQIFSDDAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKS--VQGIQ 65
Query: 196 NLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQ 255
L ++ N LT + + NL+NL +N + +
Sbjct: 66 YLPNVTKLFLNGNKLTDI--KPLANLKNLGWLFLDENKVKDLSSLKDLKKLK-------S 116
Query: 256 NDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVG 315
+ + +I L L ++ + + +N + I +
Sbjct: 117 LSLEHNGISDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIV-PLA 175
Query: 316 NLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLS 350
L L LYL +N + + R + L + ++L
Sbjct: 176 GLTKLQNLYLSKNHI--SDLRALAGLKNLDVLELF 208
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 9e-07
Identities = 18/91 (19%), Positives = 32/91 (35%), Gaps = 6/91 (6%)
Query: 584 LQRLDISHNSFVGSLPNEL-GTLQQLEILKLSENKFSG----NIPSTLGNLSHLTELQMG 638
+Q LDI + EL LQQ ++++L + + +I S L L EL +
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 639 GNLFSGEIPPELGDLSSLQIALNLSYNNLSG 669
N + + + +L
Sbjct: 64 SNELGDVGVHCVLQGLQTP-SCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.0 bits (117), Expect = 1e-06
Identities = 17/83 (20%), Positives = 24/83 (28%), Gaps = 9/83 (10%)
Query: 580 NCMTLQRLDISHNSF----VGSLPNELGTLQQLEILKLSENKFSGNIPSTLG-----NLS 630
L+ L ++ SL L L L LS N L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 631 HLTELQMGGNLFSGEIPPELGDL 653
L +L + +S E+ L L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 49.2 bits (115), Expect = 2e-06
Identities = 15/80 (18%), Positives = 27/80 (33%), Gaps = 9/80 (11%)
Query: 127 HLTYLDLAYNELTG----YIPREIGNCSRLEHLYLNNNQFSGKIPAELGK-----LSSLV 177
L L LA +++ + + L L L+NN +L + L
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 178 SLNICNNMISGALPEGLGNL 197
L + + S + + L L
Sbjct: 430 QLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.0 bits (112), Expect = 5e-06
Identities = 17/77 (22%), Positives = 29/77 (37%), Gaps = 9/77 (11%)
Query: 106 SLDLNAMNFTG----SLSPSIGGLVHLTYLDLAYNELTGYIPREIG-----NCSRLEHLY 156
L L + + SL+ ++ L LDL+ N L ++ LE L
Sbjct: 373 VLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLV 432
Query: 157 LNNNQFSGKIPAELGKL 173
L + +S ++ L L
Sbjct: 433 LYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 47.3 bits (110), Expect = 7e-06
Identities = 11/77 (14%), Positives = 28/77 (36%), Gaps = 5/77 (6%)
Query: 126 VHLTYLDLAYNELT-GYIPREIGNCSRLEHLYLNNNQFSGK----IPAELGKLSSLVSLN 180
+ + LD+ EL+ + + + + L++ + I + L +L LN
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 181 ICNNMISGALPEGLGNL 197
+ +N + +
Sbjct: 62 LRSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 1e-05
Identities = 14/90 (15%), Positives = 28/90 (31%), Gaps = 10/90 (11%)
Query: 106 SLDLNAMNFTGS-LSPSIGGLVHLTYLDLAYNELTG----YIPREIGNCSRLEHLYLNNN 160
SLD+ + + + + L + L LT I + L L L +N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 161 QFSGKIPAELGKL-----SSLVSLNICNNM 185
+ + + + L++ N
Sbjct: 66 ELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 2e-05
Identities = 16/90 (17%), Positives = 30/90 (33%), Gaps = 5/90 (5%)
Query: 344 VTEIDLSENSLNGEIPTE-FSKITGLRLLFLFQNQLTGV----IPNELSSLRNLTKLDLS 398
+ +D+ L+ E + +++ L LT I + L L +L+L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 399 INYLTGPIPVGFQHLTQMRQLQLFENSLTG 428
N L Q ++ + SL
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 3e-05
Identities = 21/84 (25%), Positives = 33/84 (39%), Gaps = 10/84 (11%)
Query: 628 NLSHLTELQMGGNLFSGE----IPPELGDLSSLQIALNLSYNNLSGSIPPELGK-----L 678
S L L + S + L SL+ L+LS N L + +L +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRE-LDLSNNCLGDAGILQLVESVRQPG 425
Query: 679 DLLEFLLLNNNHLSGEIPSAFENL 702
LLE L+L + + S E+ + L
Sbjct: 426 CLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 16/89 (17%), Positives = 31/89 (34%), Gaps = 10/89 (11%)
Query: 391 NLTKLDLSINYLT-GPIPVGFQHLTQMRQLQLFENSLTG----GIPPGLGLYSLLWVVDF 445
++ LD+ L+ L Q + ++L + LT I L + L ++
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 446 SHNYLTGRIPPHLCQ-----NSNLIMLNL 469
N L + Q + + L+L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSL 91
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.4 bits (100), Expect = 1e-04
Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 9/97 (9%)
Query: 278 WDNQLTGFIPSELGNCTKLQTLALYSNNL----VGQIPKEVGNLKFLTKLYLYRNELNGT 333
D + + L+ L L ++ + + L +L L N L
Sbjct: 353 EDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDA 412
Query: 334 IPREIG-----NLSMVTEIDLSENSLNGEIPTEFSKI 365
++ ++ ++ L + + E+ +
Sbjct: 413 GILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 2e-04
Identities = 18/91 (19%), Positives = 30/91 (32%), Gaps = 5/91 (5%)
Query: 247 SLQILGLAQNDIGGS-LPKEIGMLESLTEIVLWDNQLTG----FIPSELGNCTKLQTLAL 301
+Q L + ++ + + + +L+ + L D LT I S L L L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 302 YSNNLVGQIPKEVGNLKFLTKLYLYRNELNG 332
SN L V + + L
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.3 bits (97), Expect = 3e-04
Identities = 17/93 (18%), Positives = 37/93 (39%), Gaps = 13/93 (13%)
Query: 556 NLSQLVTFNISSNMLTGL----IPPEIVNCMTLQRLDISHNSFVGSLPNELG-TLQQ--- 607
S L ++ ++ + ++ +L+ LD+S+N + +L +++Q
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 608 -LEILKLSENKFSGNIPSTLGNLS----HLTEL 635
LE L L + +S + L L L +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.9 bits (96), Expect = 4e-04
Identities = 21/93 (22%), Positives = 31/93 (33%), Gaps = 13/93 (13%)
Query: 148 NCSRLEHLYLNNNQFSGK----IPAELGKLSSLVSLNICNNMISGALPEGLG-----NLS 198
S L L+L + S + A L SL L++ NN + A L
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 199 SLVDFVAYTNNLTGPLPQSIGNLR----NLRVF 227
L V Y + + + L +LRV
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDKPSLRVI 459
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 15/63 (23%), Positives = 24/63 (38%), Gaps = 5/63 (7%)
Query: 660 LNLSYNNLSGSIPPEL-GKLDLLEFLLLNNNHLSGE----IPSAFENLSSLLGSNFSYNN 714
L++ LS + EL L + + L++ L+ I SA +L N N
Sbjct: 7 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 66
Query: 715 LTG 717
L
Sbjct: 67 LGD 69
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 5e-04
Identities = 15/93 (16%), Positives = 34/93 (36%), Gaps = 10/93 (10%)
Query: 223 NLRVFRAGQNAISGSIPAEI-SGCQSLQILGLAQNDIGG----SLPKEIGMLESLTEIVL 277
+++ +S + AE+ Q Q++ L + + + + +L E+ L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 278 WDNQLTGFIPSELG-----NCTKLQTLALYSNN 305
N+L + K+Q L+L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCC 95
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 17/82 (20%), Positives = 32/82 (39%), Gaps = 9/82 (10%)
Query: 362 FSKITGLRLLFLFQNQLTGV----IPNELSSLRNLTKLDLSINYLTGPIPVGF-----QH 412
+ LR+L+L ++ + L + +L +LDLS N L + Q
Sbjct: 365 GQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQP 424
Query: 413 LTQMRQLQLFENSLTGGIPPGL 434
+ QL L++ + + L
Sbjct: 425 GCLLEQLVLYDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 14/84 (16%), Positives = 30/84 (35%), Gaps = 9/84 (10%)
Query: 316 NLKFLTKLYLYRNELNGT----IPREIGNLSMVTEIDLSENSLNGEIPTEFSKI-----T 366
L L+L +++ + + + + E+DLS N L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 367 GLRLLFLFQNQLTGVIPNELSSLR 390
L L L+ + + + L +L
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.0 bits (91), Expect = 0.001
Identities = 13/91 (14%), Positives = 25/91 (27%), Gaps = 5/91 (5%)
Query: 536 LQRLHIANNYFTSE-LPKEVGNLSQLVTFNISSNMLTG----LIPPEIVNCMTLQRLDIS 590
+Q L I + + + L Q + LT I + L L++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 591 HNSFVGSLPNELGTLQQLEILKLSENKFSGN 621
N + + Q K+ +
Sbjct: 64 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.002
Identities = 15/91 (16%), Positives = 28/91 (30%), Gaps = 5/91 (5%)
Query: 271 SLTEIVLWDNQLTGFIPSEL-GNCTKLQTLALYSNNL----VGQIPKEVGNLKFLTKLYL 325
+ + + +L+ +EL + Q + L L I + L +L L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 326 YRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
NEL + + + SL
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.2 bits (89), Expect = 0.003
Identities = 12/74 (16%), Positives = 23/74 (31%), Gaps = 5/74 (6%)
Query: 296 LQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRNELNG----TIPREIGNLSMVTEIDLS 350
+Q+L + L E+ L+ + L L I + + E++L
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 351 ENSLNGEIPTEFSK 364
N L +
Sbjct: 64 SNELGDVGVHCVLQ 77
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 48.3 bits (113), Expect = 1e-06
Identities = 42/178 (23%), Positives = 61/178 (34%), Gaps = 13/178 (7%)
Query: 89 CSWIGVNCTS--------DFEPVVWSLDLNAMNFTGSL-SPSIGGLVHLTYLDLAYNELT 139
C V+CT D L LN G L HL L+L N+LT
Sbjct: 8 CEGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLT 67
Query: 140 GYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSS 199
G P S ++ L L N+ L L +LN+ +N IS +P +L+S
Sbjct: 68 GIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNS 127
Query: 200 LVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQND 257
L +N LR A P+++ +QI L ++
Sbjct: 128 LTSLNLASNPFNCNCHL-AWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSE 181
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 44.0 bits (102), Expect = 3e-05
Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 7/168 (4%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGGSLPKEI-GMLESLTEIVLWDNQLTGFIPSELGNCTK 295
IP +I L L N++G + G L L ++ L NQLTG P+ +
Sbjct: 22 EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 296 LQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355
+Q L L N + K L L L LY N+++ +P +L+ +T ++L+ N N
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLT 403
+ LR L P S +R++ DL +
Sbjct: 140 CNCHLAWFA-EWLRKKSLNGGAARCGAP---SKVRDVQIKDLPHSEFK 183
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 41.3 bits (95), Expect = 2e-04
Identities = 38/182 (20%), Positives = 65/182 (35%), Gaps = 8/182 (4%)
Query: 423 ENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQN-SNLIMLNLGYNKLFGNIPTD 481
L IP + L+ + + N L L +L+ L L N+L G P
Sbjct: 17 GRGLKE-IPRDIPLH--TTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNA 73
Query: 482 VLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHI 541
+ +L+L N + L L + L N+ S +P E+ L L++
Sbjct: 74 FEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNL 133
Query: 542 ANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNE 601
A+N F L +++ P ++ + +Q D+ H+ F S N
Sbjct: 134 ASNPFNCNCH-LAWFAEWLRKKSLNGGAARCGAPSKVRD---VQIKDLPHSEFKCSSENS 189
Query: 602 LG 603
G
Sbjct: 190 EG 191
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 39.8 bits (91), Expect = 7e-04
Identities = 34/184 (18%), Positives = 70/184 (38%), Gaps = 7/184 (3%)
Query: 292 NCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREI-GNLSMVTEIDLS 350
C T + + +IP+++ T+L L NEL + G L + +++L
Sbjct: 5 MCHCEGTTVDCTGRGLKEIPRDIPLH--TTELLLNDNELGRISSDGLFGRLPHLVKLELK 62
Query: 351 ENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGF 410
N L G P F + ++ L L +N++ + L L L+L N ++ +P F
Sbjct: 63 RNQLTGIEPNAFEGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSF 122
Query: 411 QHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLG 470
+HL + L ++ L + P + ++ + +L
Sbjct: 123 EHLNSLTSLN-LASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLP 178
Query: 471 YNKL 474
+++
Sbjct: 179 HSEF 182
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.8 bits (114), Expect = 1e-06
Identities = 32/228 (14%), Positives = 58/228 (25%), Gaps = 7/228 (3%)
Query: 345 TEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404
E+ + EIP++ L +L + S +L K+++S N +
Sbjct: 11 RVFLCQESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLE 67
Query: 405 PIPVGFQHLTQMRQLQLFE--NSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPP--HLCQ 460
I E N+L P L + S+ +
Sbjct: 68 VIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSL 127
Query: 461 NSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQN 520
L+ + N + V + L L N + + D N
Sbjct: 128 QKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNN 187
Query: 521 KFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSN 568
L I+ S + NL +L + +
Sbjct: 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 48.4 bits (113), Expect = 1e-06
Identities = 30/229 (13%), Positives = 63/229 (27%), Gaps = 10/229 (4%)
Query: 376 NQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLG 435
+++T IP++L RN +L + L F + ++++ +N + I +
Sbjct: 18 SKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVF 74
Query: 436 LYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLF----GNIPTDVLNCETLLQL 491
+ + L + ++ + LL +
Sbjct: 75 SNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDI 134
Query: 492 RLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELP 551
+ N T + + L++N Q + NN
Sbjct: 135 QDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEELPN 194
Query: 552 KEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPN 600
S V +IS + L + N L+ + LP
Sbjct: 195 DVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLPT 240
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.2 bits (97), Expect = 1e-04
Identities = 16/123 (13%), Positives = 25/123 (20%)
Query: 62 HYLLELKNSLHDEFNFLKSWKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPS 121
+ L + D I N L LN + +
Sbjct: 113 TGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCA 172
Query: 122 IGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNI 181
G N L S L ++ + L L L + +
Sbjct: 173 FNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232
Query: 182 CNN 184
N
Sbjct: 233 YNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.002
Identities = 27/245 (11%), Positives = 54/245 (22%), Gaps = 20/245 (8%)
Query: 89 CSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGN 148
CS C T + + + L +L
Sbjct: 8 CSNRVFLCQE-------------SKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSG 51
Query: 149 CSRLEHLYLNNNQFSGKIPAELGKLSSL----VSLNICNNMISGALPEGLGNLSSLVDFV 204
LE + ++ N I A++ N + +
Sbjct: 52 FGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLIS 111
Query: 205 AYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPK 264
+ + + L + N + + + IL L +N I
Sbjct: 112 NTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNC 171
Query: 265 EIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLY 324
+ + +N L + L + + + NLK L
Sbjct: 172 AFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARS 231
Query: 325 LYRNE 329
Y +
Sbjct: 232 TYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.0 bits (86), Expect = 0.004
Identities = 36/247 (14%), Positives = 72/247 (29%), Gaps = 12/247 (4%)
Query: 455 PPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYA 514
+C SN + +K+ IP+D+ ++LR V L +L
Sbjct: 2 HHRICHCSNRV-FLCQESKV-TEIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEK 57
Query: 515 IELDQNKFSGPIPPEIENCQKL----QRLHIANNYFTSELPKEVGNLSQLVTFNISSNML 570
IE+ QN I ++ + + N + + + Q + + +
Sbjct: 58 IEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKH 117
Query: 571 TGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLS 630
+ L + + N + +G + IL L++N
Sbjct: 118 LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQ 177
Query: 631 HLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNH 690
N S I L++S + L L L + +
Sbjct: 178 LDELNLSDNNNLEELPNDVFHGASGPVI-LDISRTRIHSLPSYGLENLKKLR--ARSTYN 234
Query: 691 LSGEIPS 697
L ++P+
Sbjct: 235 LK-KLPT 240
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 45.1 bits (106), Expect = 4e-06
Identities = 30/107 (28%), Positives = 40/107 (37%), Gaps = 6/107 (5%)
Query: 369 RLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQLFENSLTG 428
R+L L LT + L L +T LDLS N L P L + LQ +N
Sbjct: 1 RVLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 429 GIPPGLGLYSLLWVVDFSHNYLTG-RIPPHLCQNSNLIMLNLGYNKL 474
G+ L + +N L L L++LNL N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 102
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.7 bits (105), Expect = 5e-06
Identities = 24/119 (20%), Positives = 40/119 (33%), Gaps = 5/119 (4%)
Query: 610 ILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSG 669
+L L+ + + L L +T L + N +PP L L L++ +N
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVLQA--SDNALE 56
Query: 670 SIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSIPQFQNM 728
++ L E LL NN + L+ N N+L + M
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 44.3 bits (104), Expect = 7e-06
Identities = 26/109 (23%), Positives = 40/109 (36%), Gaps = 6/109 (5%)
Query: 297 QTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356
+ L L +L + + L +T L L N L P + L + + S+N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 357 EIPTEFSKITGLRLLFLFQNQLTGV-IPNELSSLRNLTKLDLSINYLTG 404
E + + L+ L L N+L L S L L+L N L
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 43.2 bits (101), Expect = 2e-05
Identities = 27/124 (21%), Positives = 43/124 (34%), Gaps = 32/124 (25%)
Query: 107 LDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRL-------------- 152
L L + T + L+ +T+LDL++N L P + L
Sbjct: 3 LHLAHKDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 153 --------EHLYLNNNQF-SGKIPAELGKLSSLVSLNICNNMISG------ALPEGLGNL 197
+ L L NN+ L LV LN+ N + L E L ++
Sbjct: 60 GVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSV 119
Query: 198 SSLV 201
SS++
Sbjct: 120 SSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.8 bits (100), Expect = 2e-05
Identities = 27/129 (20%), Positives = 52/129 (40%), Gaps = 14/129 (10%)
Query: 442 VVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGS 501
V+ +H LT + HL Q + L+L +N+L P L L ++ S
Sbjct: 2 VLHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP----ALAALRCLEVLQASDNAL 55
Query: 502 FPLE-LCKLENLYAIELDQNKF-SGPIPPEIENCQKLQRLHIANNYFTSE------LPKE 553
++ + L L + L N+ + +C +L L++ N E L +
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEM 115
Query: 554 VGNLSQLVT 562
+ ++S ++T
Sbjct: 116 LPSVSSILT 124
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 41.6 bits (97), Expect = 5e-05
Identities = 23/109 (21%), Positives = 39/109 (35%), Gaps = 6/109 (5%)
Query: 466 MLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGP 525
+L+L + L + + + L L N L P L L L L + +
Sbjct: 2 VLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLE--VLQASDNALE 56
Query: 526 IPPEIENCQKLQRLHIANNYFTS-ELPKEVGNLSQLVTFNISSNMLTGL 573
+ N +LQ L + NN + + + +LV N+ N L
Sbjct: 57 NVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 1e-04
Identities = 24/107 (22%), Positives = 41/107 (38%), Gaps = 6/107 (5%)
Query: 347 IDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPI 406
+ L+ L + ++ + L L N+L + P L++LR L L S N L
Sbjct: 3 LHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVD 59
Query: 407 PVGFQHLTQMRQLQLFENSLTGGIPPG-LGLYSLLWVVDFSHNYLTG 452
V ++++L L N L L L +++ N L
Sbjct: 60 GVANLP--RLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 40.5 bits (94), Expect = 2e-04
Identities = 26/110 (23%), Positives = 49/110 (44%), Gaps = 6/110 (5%)
Query: 249 QILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVG 308
++L LA D+ ++ + L +T + L N+L P+ L L+ L +++
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVL--QASDNAL 55
Query: 309 QIPKEVGNLKFLTKLYLYRNELNGT-IPREIGNLSMVTEIDLSENSLNGE 357
+ V NL L +L L N L + + + + + ++L NSL E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE 105
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 37.8 bits (87), Expect = 0.001
Identities = 23/125 (18%), Positives = 44/125 (35%), Gaps = 12/125 (9%)
Query: 491 LRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSEL 550
L L LT L +L + ++L N+ PP + + L+ L ++N +
Sbjct: 3 LHLAHKDLTV--LCHLEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVD 59
Query: 551 PKEVGNLSQLVTFNISSNMLTGLIPPE-IVNCMTLQRLDISHN------SFVGSLPNELG 603
Q + +N L + +V+C L L++ N L L
Sbjct: 60 GVANLPRLQ--ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLP 117
Query: 604 TLQQL 608
++ +
Sbjct: 118 SVSSI 122
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 36.2 bits (83), Expect = 0.004
Identities = 20/114 (17%), Positives = 39/114 (34%), Gaps = 7/114 (6%)
Query: 208 NNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIG 267
+LT + L + N + P ++ + L++L + N +
Sbjct: 8 KDLTVL--CHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDNALENVDGVANL 64
Query: 268 MLESLTEIVLWDNQLTGF-IPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFL 320
E++L +N+L L +C +L L L N+L L +
Sbjct: 65 PRL--QELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 46.8 bits (109), Expect = 9e-06
Identities = 49/340 (14%), Positives = 93/340 (27%), Gaps = 35/340 (10%)
Query: 334 IPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLT 393
+ + V EI LS N++ E + ++S ++L
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAAR--------------------WLSENIASKKDLE 62
Query: 394 KLDLSINY---LTGPIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYL 450
+ S + + IP + L Q +++ + S +
Sbjct: 63 IAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTP 122
Query: 451 TGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLE 510
+ H + + N L + N L E K
Sbjct: 123 LEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTF 182
Query: 511 NLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNML 570
+ + I PE L+ L +L I+
Sbjct: 183 QSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSW 242
Query: 571 TGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTL---- 626
L + +C+ R + L N L+ L+L N+ + TL
Sbjct: 243 PNLRELGLNDCLLSARGAAAVVDAFSKLEN-----IGLQTLRLQYNEIELDAVRTLKTVI 297
Query: 627 -GNLSHLTELQMGGNLFS--GEIPPELGDLSSLQIALNLS 663
+ L L++ GN FS ++ E+ ++ S + L
Sbjct: 298 DEKMPDLLFLELNGNRFSEEDDVVDEIREVFSTRGRGELD 337
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.5 bits (103), Expect = 5e-05
Identities = 32/308 (10%), Positives = 89/308 (28%), Gaps = 32/308 (10%)
Query: 127 HLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGK----IPAELGKLSSLVSLNIC 182
L + + + + ++ + L+ N + + + L
Sbjct: 9 SLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 183 NNM---ISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIP 239
+ + +PE L L + + + + + ++ +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 240 AEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLT----GFIPSELGNCTK 295
+G +A+ ++ K+ L I+ N+L +
Sbjct: 128 LHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRL 187
Query: 296 LQTLALYSNNLVGQIPKEVGNLKFLTKLYL---------YRNELNGTIPREIGNLSMVTE 346
L T+ + N + + + + L + + + + + + + E
Sbjct: 188 LHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247
Query: 347 IDLSENSLNGEIPTEFSKI------TGLRLLFLFQNQLTGVIPNELSS-----LRNLTKL 395
+ L++ L+ GL+ L L N++ L + + +L L
Sbjct: 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFL 307
Query: 396 DLSINYLT 403
+L+ N +
Sbjct: 308 ELNGNRFS 315
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 43.7 bits (101), Expect = 9e-05
Identities = 44/355 (12%), Positives = 84/355 (23%), Gaps = 50/355 (14%)
Query: 367 GLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGP----IPVGFQHLTQMRQLQLF 422
L+L + + L ++ ++ LS N + + + +
Sbjct: 9 SLKLDAITTEDEKS-VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFS 67
Query: 423 ENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLFGNIPTDV 482
+ LL L + + +
Sbjct: 68 DIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLY 127
Query: 483 LNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIA 542
L+ L ++ + + + +N L+ +
Sbjct: 128 LHN---------------------NGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICG 166
Query: 543 NNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNEL 602
N + KE Q + M R + + + L
Sbjct: 167 RNRLENGSMKEWAKTFQSHRLLHTVKM-----------VQNGIRPEGIEHLLLEGLAYCQ 215
Query: 603 GTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGD------LSSL 656
+ S + L + +L EL + L S + D L
Sbjct: 216 ELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGL 275
Query: 657 QIALNLSYNNLSGSIPPEL-----GKLDLLEFLLLNNNHLSGEIPSAFENLSSLL 706
Q L L YN + L K+ L FL LN N S E + + +
Sbjct: 276 QT-LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE-DDVVDEIREVF 328
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 42.2 bits (97), Expect = 2e-04
Identities = 19/114 (16%), Positives = 37/114 (32%), Gaps = 10/114 (8%)
Query: 81 WKSTDQTPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLS----PSIGGLVHLTYLDLAYN 136
+ S + + S L+ ++ G+ + S + L L L YN
Sbjct: 224 DNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYN 283
Query: 137 ELTGYIPREI-----GNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNM 185
E+ R + L L LN N+F + + ++ + S +
Sbjct: 284 EIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVVDEIREVFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.4 bits (95), Expect = 4e-04
Identities = 37/308 (12%), Positives = 81/308 (26%), Gaps = 32/308 (10%)
Query: 286 IPSELGNCTKLQTLALYSNNL----VGQIPKEVGNLKFLTKLYLYRN---ELNGTIPREI 338
+ + L ++ + L N + + + + + K L + IP +
Sbjct: 23 VFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEAL 82
Query: 339 GNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLS 398
L +++ + FL ++ + + L ++
Sbjct: 83 RLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIA 142
Query: 399 INYLTGPIPVGFQHLTQMRQLQLFENSLTGGI----PPGLGLYSLLWVVDFSHNYLTGRI 454
+ ++ +R + N L G + LL V N +
Sbjct: 143 RALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEG 202
Query: 455 PPHLCQNSNLIMLNL---------GYNKLFGNIPTDVLNCETLLQLRLVGNSLTG----- 500
HL L + + + + L +L L L+
Sbjct: 203 IEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAA 262
Query: 501 -SFPLELCKLENLYAIELDQNKFSGPIPPEI-----ENCQKLQRLHIANNYFTSELPKEV 554
+ L + L N+ + E L L + N F SE V
Sbjct: 263 VVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRF-SEEDDVV 321
Query: 555 GNLSQLVT 562
+ ++ +
Sbjct: 322 DEIREVFS 329
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 41.0 bits (94), Expect = 6e-04
Identities = 47/321 (14%), Positives = 91/321 (28%), Gaps = 33/321 (10%)
Query: 237 SIPAEISGCQSLQILGLAQNDIGG----SLPKEIGMLESLTEIVLWDNQLTGFIPSELGN 292
S+ A + S++ + L+ N IG L + I + L D
Sbjct: 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEA 81
Query: 293 CTKLQTLALYSNNLV---GQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDL 349
L L L + +L ++ + L +
Sbjct: 82 LRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKI 141
Query: 350 SENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVG 409
+ + + LR + +N+L E + +L ++ + I
Sbjct: 142 ARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPE 201
Query: 410 FQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNL 469
+ L + L L + + + + L NL L L
Sbjct: 202 GIEHLLLEGLAYCQE-----------LKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 250
Query: 470 GYNKLFGNIPTDVLNC------ETLLQLRLVGNSLTGSFPLELC-----KLENLYAIELD 518
L V++ L LRL N + L K+ +L +EL+
Sbjct: 251 NDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELN 310
Query: 519 QNKFSGPIPPEIENCQKLQRL 539
N+FS E + +++ +
Sbjct: 311 GNRFSE----EDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 40.6 bits (93), Expect = 8e-04
Identities = 27/324 (8%), Positives = 79/324 (24%), Gaps = 30/324 (9%)
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNG----TIPREIGNLSMVTEIDLSENS---LN 355
+ + + + ++ L N + + I + + + S+ +
Sbjct: 16 TTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVK 75
Query: 356 GEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQ 415
EIP + L + + + + LS + + + L
Sbjct: 76 DEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGP 135
Query: 416 MRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGYNKLF 475
++ + L + N L + L +
Sbjct: 136 QAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQ 195
Query: 476 GNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQK 535
I + + + S + +++
Sbjct: 196 NGIRPEGIEHLL-----------LEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 536 LQRLHIANNYFTSELPKEVGN------LSQLVTFNISSNMLTGLIPPEIV-----NCMTL 584
L+ L + + ++ V + L T + N + + L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 585 QRLDISHNSFVGSLPNELGTLQQL 608
L+++ N F + + ++++
Sbjct: 305 LFLELNGNRF-SEEDDVVDEIREV 327
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 39.1 bits (89), Expect = 0.002
Identities = 39/329 (11%), Positives = 94/329 (28%), Gaps = 38/329 (11%)
Query: 106 SLDLNAMNFTG--SLSPSIGGLVHLTYLDLAYNELTG----YIPREIGNCSRLEHLYLNN 159
SL L+A+ S+ + + + L+ N + ++ I + LE ++
Sbjct: 9 SLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSD 68
Query: 160 NQ---FSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQ 216
+IP L L + + + + + + L
Sbjct: 69 IFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYL 128
Query: 217 SIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIV 276
L + + ++ + L+ + +N + KE ++
Sbjct: 129 HNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLL 188
Query: 277 LWDNQLTGFIPSELGNCTKLQTL-------------ALYSNNLVGQIPKEVGNLKFLTKL 323
+ I E L+ L +++ + + + L +L
Sbjct: 189 HTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLREL 248
Query: 324 YLYRNELNGTIPREIGN------LSMVTEIDLSENSLNGEIPTE-----FSKITGLRLLF 372
L L+ + + + + L N + + K+ L L
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308
Query: 373 LFQNQLT--GVIPNELSSL---RNLTKLD 396
L N+ + + +E+ + R +LD
Sbjct: 309 LNGNRFSEEDDVVDEIREVFSTRGRGELD 337
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (103), Expect = 2e-05
Identities = 22/131 (16%), Positives = 45/131 (34%), Gaps = 5/131 (3%)
Query: 303 SNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEF 362
V Q+ + ++ L L ++ ++ ++ + +
Sbjct: 5 KPEQVEQLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLRIIE 61
Query: 363 SKITGLRLLFLFQNQLTGV--IPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQ 420
I L L L N+L + + + + NL L+LS N L + ++ +L
Sbjct: 62 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELW 121
Query: 421 LFENSLTGGIP 431
L NSL+
Sbjct: 122 LDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 3e-04
Identities = 24/150 (16%), Positives = 41/150 (27%), Gaps = 6/150 (4%)
Query: 597 SLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSL 656
L + L L + L ++ + + ++ L
Sbjct: 11 QLKLIMSKRYDGSQQALDLKGL--RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPEL 67
Query: 657 QIALNLSYNNLSG--SIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNN 714
LNLS N L + + K L+ L L+ N L E L N+
Sbjct: 68 LS-LNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNS 126
Query: 715 LTGPLPSIPQFQNMDISSFLGNEGLCGRPV 744
L+ + + F L G +
Sbjct: 127 LSDTFRDQSTYISAIRERFPKLLRLDGHEL 156
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.1 bits (95), Expect = 2e-04
Identities = 13/84 (15%), Positives = 28/84 (33%), Gaps = 5/84 (5%)
Query: 565 ISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPS 624
+++ ++ + N + + LD+ + N TL Q + + S+N+
Sbjct: 3 LTAELIEQA--AQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEI--RKLD 57
Query: 625 TLGNLSHLTELQMGGNLFSGEIPP 648
L L L + N
Sbjct: 58 GFPLLRRLKTLLVNNNRICRIGEG 81
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.7 bits (94), Expect = 2e-04
Identities = 18/91 (19%), Positives = 36/91 (39%), Gaps = 3/91 (3%)
Query: 361 EFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTGPIPVGFQHLTQMRQLQ 420
+++ R L L ++ VI N ++L +D S N + + GF L +++ L
Sbjct: 13 QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLL 69
Query: 421 LFENSLTGGIPPGLGLYSLLWVVDFSHNYLT 451
+ N + L + ++N L
Sbjct: 70 VNNNRICRIGEGLDQALPDLTELILTNNSLV 100
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.5 bits (93), Expect = 3e-04
Identities = 23/150 (15%), Positives = 49/150 (32%), Gaps = 4/150 (2%)
Query: 245 CQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSEL-GNCTKLQTLALYS 303
L ++ + E+LTE+ + + Q + +L+ L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 304 NNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN-GEIPTEF 362
+ L P L++L L N ++ + + E+ LS N L+
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 363 SKITGLRLLFLFQNQLTGVIPNELSSLRNL 392
+ L + + +L L+ + N
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQGPLAHMPNA 154
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (92), Expect = 3e-04
Identities = 25/155 (16%), Positives = 44/155 (28%), Gaps = 4/155 (2%)
Query: 505 ELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEV-GNLSQLVTF 563
+ C + ++ + + L L+I N L L +L
Sbjct: 3 DACCPHGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNL 61
Query: 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIP 623
I + L + P L RL++S N+ SL + L+ L LS N +
Sbjct: 62 TIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLHCSCA 120
Query: 624 ST-LGNLSHLTELQMGGNLFSGEIPPELGDLSSLQ 657
L + L + +
Sbjct: 121 LRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.5 bits (85), Expect = 0.003
Identities = 16/145 (11%), Positives = 36/145 (24%), Gaps = 2/145 (1%)
Query: 270 ESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEV-GNLKFLTKLYLYRN 328
+ + + L L L + + + + L L L + ++
Sbjct: 8 HGSSGLRCTRDGALD-SLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 329 ELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSS 388
L P ++ ++LS N+L ++ L+ L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 389 LRNLTKLDLSINYLTGPIPVGFQHL 413
+ L H+
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHM 151
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.9 bits (89), Expect = 0.001
Identities = 32/190 (16%), Positives = 60/190 (31%), Gaps = 21/190 (11%)
Query: 509 LENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSN 568
L L + + + + ++ L S V L+ L N S+N
Sbjct: 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIKS--IDGVEYLNNLTQINFSNN 72
Query: 569 MLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGN 628
LT + P + + + ++ + + + L N + + L
Sbjct: 73 QLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNR 132
Query: 629 LSHLTELQMGGNLFSGEI--------------PPELGDLSSLQIALNLSYNNLSGSIPPE 674
L + + SG L +L++L+ L++S N +S
Sbjct: 133 LELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLER-LDISSNKVSD--ISV 189
Query: 675 LGKLDLLEFL 684
L KL LE L
Sbjct: 190 LAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 34/200 (17%), Positives = 61/200 (30%), Gaps = 16/200 (8%)
Query: 124 GLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICN 183
L L +T + + + ++ L + I + L++L +N N
Sbjct: 16 ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIK-SIDG-VEYLNNLTQINFSN 71
Query: 184 NMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEIS 243
N ++ P L + + L + G + I
Sbjct: 72 NQLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDP 123
Query: 244 GCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYS 303
+ L + S + L SL ++ NQ+T P L N T L+ L + S
Sbjct: 124 LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISS 181
Query: 304 NNLVGQIPKEVGNLKFLTKL 323
N + + L L L
Sbjct: 182 NKVSD--ISVLAKLTNLESL 199
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.7 bits (86), Expect = 0.004
Identities = 29/188 (15%), Positives = 55/188 (29%), Gaps = 20/188 (10%)
Query: 462 SNLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNK 521
+ + LG + + + + + L+ + +E L NL I N+
Sbjct: 18 AEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGIKSIDGVE--YLNNLTQINFSNNQ 73
Query: 522 FSGPI-----PPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGL--- 573
+ ++ ++ + + +T LT L
Sbjct: 74 LTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRL 133
Query: 574 ------IPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLG 627
I ++ +S + L L LE L +S NK S S L
Sbjct: 134 ELSSNTISDISALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKVSD--ISVLA 191
Query: 628 NLSHLTEL 635
L++L L
Sbjct: 192 KLTNLESL 199
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 1078 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 99.97 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.94 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.93 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.91 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.91 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.9 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.87 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.83 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.8 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.8 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.69 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.63 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.61 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.58 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 99.1 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.88 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.78 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.63 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 98.16 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 98.14 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 98.11 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 98.01 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.64 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.68 Aligned_cols=263 Identities=28% Similarity=0.425 Sum_probs=211.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 05877617702672599999978995999999434678851489999999998059988255475179845913899960
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|...+.||+|+||+||+|..+ ..||||++..........+.+.+|+.++++++||||+++++++. +...++||||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey 84 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQW 84 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred CCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEEEEEC
T ss_conf 51899889830788589999999--98999999734699899999999999998479987864567971-5589999965
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC-CC
Q ss_conf 56899776730799999966899999999965645420689966963788782897899966990114530027988-88
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-SK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~ 938 (1078)
+++|+|.+++......+++..+..++.|+++|++|||++ +|+||||||+|||++.++.+||+|||+|+...... ..
T Consensus 85 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 85 CEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp CCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCCC
T ss_conf 899888999852357899999999999999998887509---99516147899798189978875002213335567763
Q ss_pred CCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 6444455557556101022---8778767651078999999929999999999988899999985119999863357788
Q 001434 939 SMSAVAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
......||+.|+|||++.+ ..|+.++||||||+++|||+||+.||............+.. ....+.. . ...
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~----~~~~p~~-~-~~~ 235 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR----GYLSPDL-S-KVR 235 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHH----TSCCCCG-G-GSC
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHC----CCCCCCC-H-HCC
T ss_conf 125665574317999995056899995315163599999999788998998969999999965----8889860-0-036
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 651468999999999997618999999999999999999400237
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1060 (1078)
. +....+.+++.+||+.||++|||+++++++|+.+....
T Consensus 236 ---~---~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~ 274 (276)
T d1uwha_ 236 ---S---NCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274 (276)
T ss_dssp ---T---TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred ---C---CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCC
T ss_conf ---5---55499999999975889768929999999999999709
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.60 Aligned_cols=253 Identities=22% Similarity=0.316 Sum_probs=209.6
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984591389996
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||+||+|.++ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ--PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC--SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCC--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 053887898128582999999989998999999843017--279999999999986799988058577988999899997
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 05689977673079999996689999999996564542068996696378878289789996699011453002798888
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|++||+|.+++... .+++.++..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 98 y~~gg~L~~~~~~~--~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~ 171 (293)
T d1yhwa1 98 YLAGGSLTDVVTET--CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QS 171 (293)
T ss_dssp CCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST-TC
T ss_pred ECCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC-CC
T ss_conf 03798089886415--999999999999999999999987---9722677688868878996864251564132136-66
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 64444555575561010228778767651078999999929999999999988899999985119999863357788651
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......||+.|+|||++.+..++.++||||+||++|+|++|+.||.... .................. +.
T Consensus 172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~----~~~~~~~~~~~~~~~~~~-~~------ 240 (293)
T d1yhwa1 172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN----PLRALYLIATNGTPELQN-PE------ 240 (293)
T ss_dssp CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHHCSCCCSS-GG------
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHCCCCCCCC-CC------
T ss_conf 4444444777368266447998801203137299999804889989979----999999998579998888-55------
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 4689999999999976189999999999999999994
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
.....+.+++.+||+.||++|||++|+++|-+-
T Consensus 241 ----~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~ 273 (293)
T d1yhwa1 241 ----KLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273 (293)
T ss_dssp ----GSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred ----CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf ----379999999999866996689099999649965
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=358.80 Aligned_cols=254 Identities=20% Similarity=0.235 Sum_probs=212.2
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984591389996
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP--LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 035998999317782999999989997999999887264--679999999999986799798919999998999999998
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCCC
Q ss_conf 0568997767307999999668999999999656454206899669637887828978--99966990114530027988
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD--DKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~--~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|++||+|.+++......+++.++..++.|++.||+|||++ ||+||||||+|||++ .++.+||+|||+|.... .
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~--~ 181 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLN--P 181 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECC--T
T ss_pred CCCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCCCCCCCCEEEEEECCCCEECC--C
T ss_conf 2899808888986389989999999999999999999977---9265131445531134678848995256303437--8
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 88644445555755610102287787676510789999999299999999999888999999851199998633577886
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
........|++.|+|||++.+..++.++||||+||++|||++|+.||.+ .................+......
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~----~~~~~~~~~i~~~~~~~~~~~~~~--- 254 (352)
T d1koba_ 182 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAG----EDDLETLQNVKRCDWEFDEDAFSS--- 254 (352)
T ss_dssp TSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCC----SSHHHHHHHHHHCCCCCCSSTTTT---
T ss_pred CCCEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCC----CCHHHHHHHHHHCCCCCCCCCCCC---
T ss_conf 8720100476453489997479989763338989999999968899899----799999999984788989300247---
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 51468999999999997618999999999999999999
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
....+.+++.+||+.||++|||++|+++|-|
T Consensus 255 -------~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~ 285 (352)
T d1koba_ 255 -------VSPEAKDFIKNLLQKEPRKRLTVHDALEHPW 285 (352)
T ss_dssp -------SCHHHHHHHHTTSCSSGGGSCCHHHHHTSTT
T ss_pred -------CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf -------9999999999975699668918999960973
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=358.06 Aligned_cols=255 Identities=22% Similarity=0.270 Sum_probs=212.1
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 405877617702672599999978-9959999994346788514899999999980599882554751798459138999
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..+|+..+.||+|+||.||+|.++ +|+.||+|++..... ...+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE--SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH--HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 6575898898407681999999889998999999845243--16999999999998679979992999999899999999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCC
Q ss_conf 605689977673079999996689999999996564542068996696378878289789--996699011453002798
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD--KFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~--~~~~kl~Dfg~a~~~~~~ 935 (1078)
||++||+|.+++......+++..+..++.|++.||+|||++ |++||||||+||+++. ++.+||+|||+++...
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-- 177 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 177 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCEEEEECHHHEEECCCCCCEEEEEECCHHEECC--
T ss_conf 85799889999976237899999999999999999999756---9760001546736416889869995452104425--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 88864444555575561010228778767651078999999929999999999988899999985119999863357788
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||.+. ...+....+.......+..
T Consensus 178 ~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~----~~~~~~~~i~~~~~~~~~~------ 247 (350)
T d1koaa2 178 PKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE----NDDETLRNVKSCDWNMDDS------ 247 (350)
T ss_dssp TTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCCCSCCG------
T ss_pred CCCCCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCC----CHHHHHHHHHHCCCCCCCC------
T ss_conf 654320006862421889975899872676554659999998598998997----9999999998478898942------
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 651468999999999997618999999999999999999
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
........+.+++.+||+.||++|||++|+++|-+
T Consensus 248 ----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~ 282 (350)
T d1koaa2 248 ----AFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPW 282 (350)
T ss_dssp ----GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTT
T ss_pred ----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf ----23589999999999975689667908999862913
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.20 Aligned_cols=268 Identities=23% Similarity=0.357 Sum_probs=208.2
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 405877617702672599999978-9959999994346788514899999999980599882554751798459138999
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..+|+..+.||+|+||+||+|.+. +++.||+|++..... ......+.+|+.++++++||||+++++++.+++..++||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 5688897897127780999999989996999999875409-789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 6056899776730799999966899999999965645420-689966963788782897899966990114530027988
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
||++||+|.+++.+.+ .+++..+..++.|++.|+.|||+ + +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~~-~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG-RIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred ECCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEEEECCCCCCCCC--
T ss_conf 7679986899874249-9999999999999999999999859---997144577994687899899954877625678--
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCC-----------
Q ss_conf 886444455557556101022877876765107899999992999999999998889999998511999-----------
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSL----------- 1005 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~----------- 1005 (1078)
......+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+....................
T Consensus 158 -~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 -SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp -HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred -CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCCCC
T ss_conf -8621113771411946875899894888998999999999888998998878999999887517754577421233322
Q ss_pred -CCCCCCCCCCCCHHHHH--------------HHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf -98633577886514689--------------99999999997618999999999999999999
Q 001434 1006 -TPGIFDTRLNVEDESIV--------------DHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1006 -~~~~~~~~~~~~~~~~~--------------~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
.....+........... .....+.+++.+||..||++|||++|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHH
T ss_conf 1111222354134778876650268766764448999999999986899467908999960986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.55 Aligned_cols=257 Identities=25% Similarity=0.384 Sum_probs=213.4
Q ss_pred HCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 05877617702672599999978995999999434678851489999999998059988255475179845913899960
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|+||.||+|.+++++.||||++..... ..+.+.+|++.+++++||||+++++++.+++..++||||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~ 81 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF 81 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEE
T ss_conf 99588889820888299999988999999999878867---689999999999966899756535243159933799983
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 56899776730799999966899999999965645420689966963788782897899966990114530027988886
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++|+|.+++......+++..+..++.|++.|++|+|++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCEE
T ss_conf 699918997520134788999999999999987765316---43104431532666688776865532100236887335
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHH
Q ss_conf 44445555755610102287787676510789999999299999999999888999999851199998633577886514
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
.....||+.|+|||++.+..++.++||||||+++|||+|+..|+.. .....+............ .+..
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~---~~~~~~~~~~i~~~~~~~----~p~~----- 226 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYE---NRSNSEVVEDISTGFRLY----KPRL----- 226 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTC---SCCHHHHHHHHHHTCCCC----CCTT-----
T ss_pred ECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCC---CCCHHHHHHHHHHCCCCC----CCCC-----
T ss_conf 0430017666785786079998403321059999999878988877---899999999998068889----9543-----
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 689999999999976189999999999999999994002
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
....+.+++.+||+.||++|||+++++++|+++.+
T Consensus 227 ----~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e 261 (263)
T d1sm2a_ 227 ----ASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE 261 (263)
T ss_dssp ----SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----67999999999765797689199999999999985
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=358.89 Aligned_cols=257 Identities=26% Similarity=0.409 Sum_probs=208.7
Q ss_pred CCCCCCEEECCCCEEEEEEEECC-C---CEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEE
Q ss_conf 58776177026725999999789-9---5999999434678851489999999998059988255475179845913899
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDS-G---KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 781 ~~~~~~~ig~G~~g~V~~~~~~~-~---~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
+|+..+.||+|+||+||+|.++. + ..||||++..... ....+.|.+|+.++++++|||||++++++.+++..++|
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT-EKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 42785698027882999999957997889999999784459-89999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 96056899776730799999966899999999965645420689966963788782897899966990114530027988
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++|+|.+++......+++.++..++.|+++||+|||++ +++||||||+|||++.++.+||+|||+++......
T Consensus 106 ~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEECCCCCCEEEECCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCCEECCCCC
T ss_conf 972279853002104567999999999999999988988527---98357615044898899919988844315756777
Q ss_pred CC----CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 88----6444455557556101022877876765107899999992-999999999998889999998511999986335
Q 001434 937 SK----SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 937 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.. ......|++.|+|||.+.++.++.++||||||+++|||+| |+.||.... ..+...........+. +
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~----~~~~~~~i~~~~~~~~---~ 255 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT----NQDVINAIEQDYRLPP---P 255 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC----HHHHHHHHHTTCCCCC---C
T ss_pred CCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCC----HHHHHHHHHCCCCCCC---C
T ss_conf 76536502566688300387888369978612144535789999867999999999----9999999973788999---7
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 77886514689999999999976189999999999999999994002
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
. +....+.+++.+||+.||++|||++++++.|+++..
T Consensus 256 ~----------~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~ 292 (299)
T d1jpaa_ 256 M----------DCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR 292 (299)
T ss_dssp T----------TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred C----------CCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 4----------226999999999758797689299999999999841
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.89 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=207.4
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984591389996
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||+||+|.++ +++.||+|++...... ...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 4608998972174809999999999979999998456641-279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC-C
Q ss_conf 056899776730799999966899999999965645420689966963788782897899966990114530027988-8
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ-S 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~ 937 (1078)
|++||+|.+++.... .+++.++..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|+...... .
T Consensus 84 y~~gg~L~~~l~~~~-~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 84 YCSGGELFDRIEPDI-GMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp CCTTEEGGGGSBTTT-BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred CCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCCC
T ss_conf 458980899975379-999999999999999999999975---9835754689978878998798323142240468865
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 86444455557556101022877-87676510789999999299999999999888999999851199998633577886
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......||+.|+|||++.+..+ +.++||||+||++|||++|+.||....+...... ..........
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~---~~~~~~~~~~--------- 227 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS---DWKEKKTYLN--------- 227 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH---HHHTTCTTST---------
T ss_pred CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHH---HHHCCCCCCC---------
T ss_conf 3111325574742872861899999710161737999999829978888985999999---9863888788---------
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 51468999999999997618999999999999999999
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
... .....+.+++.+||+.||++|||+++++++-|
T Consensus 228 ~~~---~~s~~~~~li~~~L~~dP~~R~t~~eil~hpw 262 (271)
T d1nvra_ 228 PWK---KIDSAPLALLHKILVENPSARITIPDIKKDRW 262 (271)
T ss_dssp TGG---GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTT
T ss_pred CCC---CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 644---69999999999976799668909999961984
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=357.92 Aligned_cols=255 Identities=24% Similarity=0.290 Sum_probs=210.2
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 405877617702672599999978-9959999994346788514899999999980599882554751798459138999
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
...|+..+.||+|+||+||+|.++ +++.||+|++....... ..+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH-HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 666699889940658399999999999899999981577312-8999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCCC
Q ss_conf 60568997767307999999668999999999656454206899669637887828978---999669901145300279
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLD---DKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~---~~~~~kl~Dfg~a~~~~~ 934 (1078)
||++||+|.+++...+ .+++..+..++.|++.|++|||++ +|+||||||+||++. +++.+||+|||+|+...
T Consensus 87 E~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~- 161 (307)
T d1a06a_ 87 QLVSGGELFDRIVEKG-FYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED- 161 (307)
T ss_dssp CCCCSCBHHHHHHTCS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC--------
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---EEEEEEECCCCEEECCCCCCCEEEEECCCEEEECC-
T ss_conf 5268984888653036-788789999999999998752413---05568704630011046888249983154358725-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 88886444455557556101022877876765107899999992999999999998889999998511999986335778
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.........||+.|+|||++.+..|+.++||||+||++|||++|+.||.. ........................
T Consensus 162 -~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~~~~~~~~i~~~~~~~~~~~~~~- 235 (307)
T d1a06a_ 162 -PGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYD----ENDAKLFEQILKAEYEFDSPYWDD- 235 (307)
T ss_dssp ------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHTTCCCCCTTTTTT-
T ss_pred -CCCEEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC----CCHHHHHHHHHCCCCCCCCCCCCC-
T ss_conf -89704400328422591887379998078734515999999859799999----899999999861687778766667-
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 8651468999999999997618999999999999999999
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
....+.+++.+||+.||++|||++|+++|-+
T Consensus 236 ---------~s~~~~~li~~~L~~dP~~R~s~~eil~hp~ 266 (307)
T d1a06a_ 236 ---------ISDSAKDFIRHLMEKDPEKRFTCEQALQHPW 266 (307)
T ss_dssp ---------SCHHHHHHHHHHSCSSGGGSCCHHHHHHSTT
T ss_pred ---------CCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf ---------8999999999976089757918999862984
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.40 Aligned_cols=251 Identities=27% Similarity=0.372 Sum_probs=210.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 05877617702672599999978-995999999434678-8514899999999980599882554751798459138999
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||+||+|+++ +++.||+|++.+... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 60568997767307999999668999999999656454206899669637887828978999669901145300279888
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+|.....
T Consensus 86 Ey~~~g~L~~~l~~~~-~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-KFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp ECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCCEECCCCCEEECCCCEEEECCC---
T ss_conf 5047985898875048-999999999999999999999988---946522023441466899871155563354488---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 86444455557556101022877876765107899999992999999999998889999998511999986335778865
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......||+.|+|||++.+..++.++||||+||++|||++|+.||.. ...........+..... +..+
T Consensus 159 ~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~----~~~~~~~~~i~~~~~~~----p~~~--- 227 (263)
T d2j4za1 159 SRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA----NTYQETYKRISRVEFTF----PDFV--- 227 (263)
T ss_dssp CCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCC----SSHHHHHHHHHTTCCCC----CTTS---
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC----CCHHHHHHHHHCCCCCC----CCCC---
T ss_conf 852355788763499997589989314404675999998329999888----99999999997189999----8668---
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 14689999999999976189999999999999999994
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
...+.+++.+||+.||++|||++|+++|-|-
T Consensus 228 -------s~~~~~li~~~L~~dp~~R~t~~eil~hp~~ 258 (263)
T d2j4za1 228 -------TEGARDLISRLLKHNPSQRPMLREVLEHPWI 258 (263)
T ss_dssp -------CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHH
T ss_pred -------CHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf -------9999999999764797689099999719070
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.67 Aligned_cols=256 Identities=23% Similarity=0.368 Sum_probs=209.4
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE--CCCEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984--5913899
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--QGSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--~~~~~lv 856 (1078)
.+|+..+.||+|+||.||+|+++ +|+.||+|++......+...+.+.+|++++++++||||+++++++.+ ++..|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EEECCCCCHHHHHCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC--CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 960568997767307---9999996689999999996564542068--99669637887828978999669901145300
Q 001434 857 YEYMERGSLGELLHG---SSCNLEWPTRFMIALGAAEGLAYLHHDC--KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~~i~~~L~~LH~~~--~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 931 (1078)
|||+++|+|.+++.. ....+++..++.++.|++.||+|+|+++ ..+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 27988886444455557556101022877876765107899999992999999999998889999998511999986335
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.... ........||+.|+|||++.+..|+.++||||+|+++|||++|+.||... ...+............ .+
T Consensus 164 ~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~----~~~~~~~~i~~~~~~~---~~ 235 (269)
T d2java1 164 LNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF----SQKELAGKIREGKFRR---IP 235 (269)
T ss_dssp C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS----SHHHHHHHHHHTCCCC---CC
T ss_pred CCCC-CCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCC----CHHHHHHHHHCCCCCC---CC
T ss_conf 2457-77556677882327999983999993898875278999980188998998----9999999997189988---97
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 778865146899999999999761899999999999999999
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1053 (1078)
..+ ...+.+++.+||+.||++|||++|+++|-
T Consensus 236 ~~~----------s~~l~~li~~~L~~dp~~Rps~~ell~hp 267 (269)
T d2java1 236 YRY----------SDELNEIITRMLNLKDYHRPSVEEILENP 267 (269)
T ss_dssp TTS----------CHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred CCC----------CHHHHHHHHHHCCCCHHHCCCHHHHHHCC
T ss_conf 435----------99999999997679955791899997298
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.81 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=206.2
Q ss_pred CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 5877617702672599999978-995999999434678851489999999998059988255475179845913899960
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 781 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.|+..+.||+|+||.||+|.++ +++.||+|++..... ...+.+.+|++++++++||||+++++++.+++..++||||
T Consensus 13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy 90 (288)
T d2jfla1 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSE--EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 90 (288)
T ss_dssp TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSS--GGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCH--HHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 75984799307781999999999993999999872899--9999999999999867999988498898009958999962
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 56899776730799999966899999999965645420689966963788782897899966990114530027988886
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++|+|.+++......+++.++..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|...... ...
T Consensus 91 ~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~-~~~ 166 (288)
T d2jfla1 91 CAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT-IQR 166 (288)
T ss_dssp CTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-HHH
T ss_pred CCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-CCC
T ss_conf 799818899986289999999999999999999999988---9887140700314878999899716123035778-641
Q ss_pred CCCCCCCCCCCCCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 44445555755610102-----2877876765107899999992999999999998889999998511999986335778
Q 001434 940 MSAVAGSYGYIAPEYAY-----TMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.....||+.|+|||++. +..|+.++||||+||++|||++|+.||....... .............. .+.
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~----~~~~i~~~~~~~~~-~~~-- 239 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR----VLLKIAKSEPPTLA-QPS-- 239 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG----HHHHHHHSCCCCCS-SGG--
T ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHH----HHHHHHCCCCCCCC-CCC--
T ss_conf 00102562647999983202578888806657878999999820889999989999----99999707998777-656--
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 8651468999999999997618999999999999999999
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
.....+.+++.+||+.||++|||++|+++|-+
T Consensus 240 --------~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~ 271 (288)
T d2jfla1 240 --------RWSSNFKDFLKKCLEKNVDARWTTSQLLQHPF 271 (288)
T ss_dssp --------GSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGG
T ss_pred --------CCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf --------69999999999976699668919999962923
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=361.66 Aligned_cols=259 Identities=24% Similarity=0.343 Sum_probs=212.0
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 405877617702672599999978-9959999994346788514899999999980599882554751798459138999
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
..+|+..+.||+|+||+||+|.++ +++.||||++..... ..+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC---HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 7993986598208880899999999996999999777610---3999999999998679998826775274578547876
Q ss_pred EECCCCCHHHHHCC-CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 60568997767307-99999966899999999965645420689966963788782897899966990114530027988
Q 001434 858 EYMERGSLGELLHG-SSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 858 e~~~~gsL~~~l~~-~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
||+++|+|.+++.. ....+++..+..++.|++.||+|||++ +|+||||||+|||++.++.+||+|||+|+......
T Consensus 93 E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 93 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp ECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred ECCCCCCHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 314676067775303554157999999999999978889878---93057604576899899928983244546537887
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 88644445555755610102287787676510789999999299999999999888999999851199998633577886
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
........|++.|+|||.+.++.|+.++||||+|+++|||++|..||.... ........... ....+ . +..
T Consensus 170 ~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~---~~~~~~~~i~~-~~~~~-~-~~~--- 240 (287)
T d1opja_ 170 YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEK-DYRME-R-PEG--- 240 (287)
T ss_dssp SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHT-TCCCC-C-CTT---
T ss_pred CEEECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHHC-CCCCC-C-CCC---
T ss_conf 221035566546669278727999810430217899999986799887742---59999999855-88888-8-743---
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 5146899999999999761899999999999999999940023
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1059 (1078)
....+.+++.+||+.||++|||++++++.|+.+...
T Consensus 241 -------~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~ 276 (287)
T d1opja_ 241 -------CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276 (287)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred -------CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf -------309999999997577976893999999999999875
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.51 Aligned_cols=255 Identities=25% Similarity=0.387 Sum_probs=206.8
Q ss_pred HCCCCCCEEECCCCEEEEEEEECC-C-----CEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECCC
Q ss_conf 058776177026725999999789-9-----5999999434678851489999999998059-98825547517984591
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS-G-----KIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~-~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 852 (1078)
.+|+..+.||+|+||+||+|++.. + ..||+|++...... .....+.+|+.++.++ +|||||++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS-SEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCH-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 993970198307881999999857885542049999996633587-8999999999999971589968687788862995
Q ss_pred EEEEEEECCCCCHHHHHCCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf 389996056899776730799----------------------9999668999999999656454206899669637887
Q 001434 853 NLLIYEYMERGSLGELLHGSS----------------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKS 910 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp 910 (1078)
.++||||+++|+|.++++... ..+++..+..++.|++.|++|||++ +|+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCH
T ss_conf 89999727999599999862577751022100001222001257789999999999999999999739---905052703
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 8289789996699011453002798888-6444455557556101022877876765107899999992-9999999999
Q 001434 911 NNILLDDKFEAHVGDFGLAKVIDMPQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDD 988 (1078)
Q Consensus 911 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~ 988 (1078)
+||+++.++.+||+|||+|+........ ......||+.|+|||++.++.++.++||||+||++|||++ |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 988899999985119999863357788651468999999999997618999999999999999999
Q 001434 989 GGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 989 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
...+...+....+ .+ .+.. ....+.+++.+||+.||++|||+++++++|.
T Consensus 273 ~~~~~~~~~~~~~----~~--~p~~----------~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~ 322 (325)
T d1rjba_ 273 DANFYKLIQNGFK----MD--QPFY----------ATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG 322 (325)
T ss_dssp SHHHHHHHHTTCC----CC--CCTT----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHHHHCCCC----CC--CCCC----------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHH
T ss_conf 9999999856998----99--8876----------7899999999975889668939999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.06 Aligned_cols=254 Identities=22% Similarity=0.353 Sum_probs=214.7
Q ss_pred HCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 05877617702672599999978995999999434678851489999999998059988255475179845913899960
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|+||+||+|++++++.||||++..... ..+.+.+|+..+++++||||+++++++.+++..++||||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~---~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey 80 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM---SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 80 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS---CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEEC
T ss_conf 99799689820788399999988998999999874757---789999999999966898601588998507816999970
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 56899776730799999966899999999965645420689966963788782897899966990114530027988886
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+++|++.+++......+++..+.+++.|+++|++|||++ +|+||||||+||+++.++.+||+|||+++.........
T Consensus 81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred CCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCEE
T ss_conf 489938886410246776899999999999999987546---84346654135887699847988614420235787225
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 444455557556101022877876765107899999992-9999999999988899999985119999863357788651
Q 001434 940 MSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
.....|++.|+|||.+.+..++.++||||||+++|||+| |+.||.... ..+............ .+.
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~----~~~~~~~i~~~~~~~----~p~----- 224 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT----NSETAEHIAQGLRLY----RPH----- 224 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC----HHHHHHHHHTTCCCC----CCT-----
T ss_pred ECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCC----HHHHHHHHHHCCCCC----CCC-----
T ss_conf 2465788775780786379988521033643246739755999988999----999999998079789----965-----
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 46899999999999761899999999999999999940
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1056 (1078)
.....+.+++.+||+.||++|||+++++++|.++
T Consensus 225 ----~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 225 ----LASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp ----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred ----CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf ----4659999999997668976893999999874188
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.13 Aligned_cols=254 Identities=26% Similarity=0.389 Sum_probs=207.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 05877617702672599999978995999999434678851489999999998059988255475179845913899960
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
.+|+..+.||+|+||.||+|.+++++.||||++..... ..+.+.+|+.++++++||||+++++++. ++..++||||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~---~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey 88 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM---SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEY 88 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEEC
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEC-CCCEEEEEEE
T ss_conf 99388679810798289999999999999999864768---8899999999998679998857873104-5976999995
Q ss_pred CCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 56899776730799-99996689999999996564542068996696378878289789996699011453002798888
Q 001434 860 MERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
+++|+|.+++.... ..+++..+..++.|+++|+.|||++ +|+||||||+||+++.++.+||+|||+|+........
T Consensus 89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf 7898288887514789887889999999999999999748---9546756422515620244042341014773588644
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 64444555575561010228778767651078999999929999999999988899999985119999863357788651
Q 001434 939 SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVED 1018 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1018 (1078)
......|++.|+|||++.++.++.++||||||+++|||+||..|+... .................. +..
T Consensus 166 ~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~---~~~~~~~~~i~~~~~~~~---p~~----- 234 (272)
T d1qpca_ 166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG---MTNPEVIQNLERGYRMVR---PDN----- 234 (272)
T ss_dssp CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHHHHHHTTCCCCC---CTT-----
T ss_pred CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHHCCCCCC---CCC-----
T ss_conf 203567744445828983799982456452579999999689888888---899999999970688889---655-----
Q ss_pred HHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 46899999999999761899999999999999999940
Q 001434 1019 ESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1019 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1056 (1078)
....+.+++.+||+.||++|||++++++.|++.
T Consensus 235 -----~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ 267 (272)
T d1qpca_ 235 -----CPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267 (272)
T ss_dssp -----CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred -----CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHH
T ss_conf -----719999999997588976893999999986113
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.98 Aligned_cols=256 Identities=23% Similarity=0.282 Sum_probs=211.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEE
Q ss_conf 05877617702672599999978-9959999994346788----514899999999980599882554751798459138
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG----NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||+||+|.++ +|+.||+|++.+.... ....+.+.+|+.++++++||||+++++++.+++..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEE
T ss_conf 67798279811789599999999999899999987566321340689999999999998679989993889999799899
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC----CEEEEECCCCC
Q ss_conf 99960568997767307999999668999999999656454206899669637887828978999----66990114530
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF----EAHVGDFGLAK 930 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~----~~kl~Dfg~a~ 930 (1078)
+||||++||+|.+++...+ .+++..+..++.|++.|++|||++ +|+||||||+||+++.++ .+|++|||++.
T Consensus 90 iv~E~~~gg~L~~~i~~~~-~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~ 165 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKE-SLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH 165 (293)
T ss_dssp EEEECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred EEEECCCCCCCCCHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEEECCCCCCCCEEECCHHHHH
T ss_conf 9998677864310010356-421557899999999998766625---422113330127982589866646964334421
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 02798888644445555755610102287787676510789999999299999999999888999999851199998633
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1078)
... .........|++.|+|||++.+..++.++||||+||++|||++|+.||.+ ....+............+
T Consensus 166 ~~~--~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~~~~~~~~i~~~~~~~~--- 236 (293)
T d1jksa_ 166 KID--FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLG----DTKQETLANVSAVNYEFE--- 236 (293)
T ss_dssp ECT--TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHTTCCCCC---
T ss_pred HCC--CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC----CCHHHHHHHHHHCCCCCC---
T ss_conf 057--77631224777743099998189999766522140999999708899889----999999999981688887---
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 577886514689999999999976189999999999999999994
Q 001434 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
..........+.+++.+||+.||++|||++++++|-+-
T Consensus 237 -------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 274 (293)
T d1jksa_ 237 -------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274 (293)
T ss_dssp -------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred -------CHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf -------01047889999999999863896689199999619041
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.56 Aligned_cols=248 Identities=25% Similarity=0.365 Sum_probs=201.2
Q ss_pred CCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE----CCCEEEEE
Q ss_conf 77617702672599999978-99599999943467885148999999999805998825547517984----59138999
Q 001434 783 HDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH----QGSNLLIY 857 (1078)
Q Consensus 783 ~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~----~~~~~lv~ 857 (1078)
+..+.||+|+||+||+|.++ +++.||+|++..........+.+.+|++++++++||||+++++++.+ +...++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCC--EEECCCCCCCEEEC-CCCCEEEEECCCCCCCCC
Q ss_conf 605689977673079999996689999999996564542068996--69637887828978-999669901145300279
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPR--IFHRDIKSNNILLD-DKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~--ivH~Dlkp~Nil~~-~~~~~kl~Dfg~a~~~~~ 934 (1078)
||+++|+|.+++.... .+++..+..++.|++.||+|||++ + |+||||||+|||++ +++.+||+|||+|+...
T Consensus 92 E~~~~g~L~~~l~~~~-~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~- 166 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK-VMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR- 166 (270)
T ss_dssp ECCCSCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCEEECCCCHHHCEEECCCCCEEEEECCCCEECC-
T ss_conf 5789894899975135-546999999999999999999978---99799687674351166799988980057654236-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 88886444455557556101022877876765107899999992999999999998889999998511999986335778
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
........||+.|+|||++.+ .++.++||||+||++|||++|+.||... .............. .+ ..++...
T Consensus 167 --~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~---~~~~~~~~~i~~~~-~~-~~~~~~~ 238 (270)
T d1t4ha_ 167 --ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC---QNAAQIYRRVTSGV-KP-ASFDKVA 238 (270)
T ss_dssp --TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC---SSHHHHHHHHTTTC-CC-GGGGGCC
T ss_pred --CCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCC---CCHHHHHHHHHCCC-CC-CCCCCCC
T ss_conf --876677553813008988478-9998671100799999998788999876---55999999997389-98-6567557
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf 865146899999999999761899999999999999999
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1053 (1078)
...+.+++.+||++||++|||++|+++|-
T Consensus 239 ----------~~~~~~li~~~l~~dp~~R~s~~ell~Hp 267 (270)
T d1t4ha_ 239 ----------IPEVKEIIEGCIRQNKDERYSIKDLLNHA 267 (270)
T ss_dssp ----------CHHHHHHHHHHSCSSGGGSCCHHHHHTSG
T ss_pred ----------CHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf ----------89999999997637975892999996775
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.69 Aligned_cols=253 Identities=21% Similarity=0.292 Sum_probs=210.1
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 05877617702672599999978-995999999434678-8514899999999980599882554751798459138999
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||+||+|.++ +++.||+|++.+... .....+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC-
Q ss_conf 6056899776730799999966899999999965645420689966963788782897899966990114530027988-
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ- 936 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~- 936 (1078)
||++||+|.+++...+ .+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+|+......
T Consensus 88 Ey~~gg~L~~~~~~~~-~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~ 163 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-SFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK 163 (288)
T ss_dssp CCCTTEEHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCCC
T ss_conf 7048987777653159-999999999999999999762165---088476774123668885388603210242256776
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 88644445555755610102287787676510789999999299999999999888999999851199998633577886
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.. ................. +..+
T Consensus 164 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~----~~~~~~~~~i~~~~~~~----p~~~-- 233 (288)
T d1uu3a_ 164 QARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA----GNEYLIFQKIIKLEYDF----PEKF-- 233 (288)
T ss_dssp ------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHTTCCCC----CTTC--
T ss_pred CCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCC----CCHHHHHHHHHCCCCCC----CCCC--
T ss_conf 4333555677552584400268989666230456999998038899899----59999999997189999----8547--
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 51468999999999997618999999999999999999
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
...+.+++.+||+.||++|||++|++.+-+
T Consensus 234 --------s~~~~~li~~~L~~dP~~R~t~~e~~~~~~ 263 (288)
T d1uu3a_ 234 --------FPKARDLVEKLLVLDATKRLGCEEMEGYGP 263 (288)
T ss_dssp --------CHHHHHHHHTTSCSSGGGSTTSGGGTCHHH
T ss_pred --------CHHHHHHHHHHCCCCHHHCCCHHHHCCCHH
T ss_conf --------999999999985579768919789737789
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.19 Aligned_cols=258 Identities=23% Similarity=0.325 Sum_probs=207.5
Q ss_pred HCCCCCCE-EECCCCEEEEEEEEC---CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEE
Q ss_conf 05877617-702672599999978---99599999943467885148999999999805998825547517984591389
Q 001434 780 YNFHDSFI-VGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~-ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
+++...+. ||+|+||+||+|.++ ++..||||++..... ....+.+.+|++++++++||||+++++++.+ +..++
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEE
T ss_conf 471887848730608099999996089768999999882039-7899999999999986799888068656036-80799
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99605689977673079999996689999999996564542068996696378878289789996699011453002798
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++|+|.+++......+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+||+|||+++.....
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 9980789968997521256999999999999999987899868---8105767646604546885420331342115543
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 88--86444455557556101022877876765107899999992-9999999999988899999985119999863357
Q 001434 936 QS--KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 936 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.. .......|++.|+|||++.++.++.++||||||+++|||+| |+.||..... .+......... ..+ .++
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~----~~~~~~i~~~~-~~~--~p~ 235 (285)
T d1u59a_ 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG----PEVMAFIEQGK-RME--CPP 235 (285)
T ss_dssp SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT----HHHHHHHHTTC-CCC--CCT
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH----HHHHHHHHCCC-CCC--CCC
T ss_conf 43211356211374335868872799995412322017899999389999999799----99999998189-999--997
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 78865146899999999999761899999999999999999940023
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1059 (1078)
.+ ...+.+++.+||+.+|++|||+.++.+.|+.....
T Consensus 236 ~~----------~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 236 EC----------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp TC----------CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CC----------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf 67----------89999999997577976890999999999999998
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.84 Aligned_cols=252 Identities=22% Similarity=0.250 Sum_probs=211.2
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 05877617702672599999978-995999999434678-8514899999999980599882554751798459138999
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||.||+|.++ +++.||+|++.+... .....+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 60568997767307999999668999999999656454206899669637887828978999669901145300279888
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||++||+|.+++...+ .+++..+..++.|++.||+|+|++ +|+||||||+||+++.++.+||+|||+|+.... ..
T Consensus 85 ey~~gg~L~~~~~~~~-~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~-~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-VFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS-DG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-TT
T ss_pred ECCCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEECCCCCEEEEECCCCCCCCC-CC
T ss_conf 0357986055553256-775999999999996521134315---962246477784765899888820565200356-78
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 86444455557556101022877876765107899999992999999999998889999998511999986335778865
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......+||+.|+|||++.+..|+.++||||+||++|||++|++||.+ .+............... +..+
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~----~~~~~~~~~i~~~~~~~----p~~~--- 228 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN----QDHERLFELILMEEIRF----PRTL--- 228 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCCCC----CTTS---
T ss_pred CCCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCC----CCHHHHHHHHHCCCCCC----CCCC---
T ss_conf 620551008899666650489888333102230678899878999999----69999999985289989----8668---
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHH
Q ss_conf 1468999999999997618999999999-----999999999
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPS-----MREVVSMLI 1054 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 1054 (1078)
...+.+++.+||++||++||+ +.++++|-+
T Consensus 229 -------s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~ 263 (337)
T d1o6la_ 229 -------SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263 (337)
T ss_dssp -------CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGG
T ss_pred -------CHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHCCCC
T ss_conf -------99999999866638934422565234999972915
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=350.59 Aligned_cols=250 Identities=25% Similarity=0.373 Sum_probs=204.2
Q ss_pred CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 5877617702672599999978-9959999994346788-5148999999999805998825547517984591389996
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 781 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.|+..+.||+|+||+||+|++. +++.||+|++...... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEE
T ss_conf 56762797018880999999989993999999844443588999999999999997789998238999998998899998
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 05689977673079999996689999999996564542068996696378878289789996699011453002798888
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+.+|++..++.... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|.....
T Consensus 96 ~~~~g~l~~~~~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---- 167 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKK-PLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 167 (309)
T ss_dssp CCSEEHHHHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred ECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCCCEEEECCCCCEEEEECCCCCCCCC----
T ss_conf 069994578997379-999999999999999999999868---976667884217987999789844365334677----
Q ss_pred CCCCCCCCCCCCCCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCC
Q ss_conf 6444455557556101022---8778767651078999999929999999999988899999985119999863357788
Q 001434 939 SMSAVAGSYGYIAPEYAYT---MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLN 1015 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1015 (1078)
.....||+.|+|||++.+ +.|+.++||||+||++|||++|+.||.... ............... ..+..+
T Consensus 168 -~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~----~~~~~~~i~~~~~~~--~~~~~~- 239 (309)
T d1u5ra_ 168 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN----AMSALYHIAQNESPA--LQSGHW- 239 (309)
T ss_dssp -BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC----HHHHHHHHHHSCCCC--CSCTTS-
T ss_pred -CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC----HHHHHHHHHHCCCCC--CCCCCC-
T ss_conf -873134766368899834678886721454558999999987889999979----999999998289998--887888-
Q ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 6514689999999999976189999999999999999994
Q 001434 1016 VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1016 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
...+.+++.+||+.||++|||++++++|-+-
T Consensus 240 ---------s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~ 270 (309)
T d1u5ra_ 240 ---------SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270 (309)
T ss_dssp ---------CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred ---------CHHHHHHHHHHCCCCHHHCCCHHHHHHCHHH
T ss_conf ---------9999999999773796579189999719975
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.25 Aligned_cols=249 Identities=23% Similarity=0.357 Sum_probs=203.6
Q ss_pred CEEECCCCEEEEEEEEC---CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEECCC
Q ss_conf 17702672599999978---995999999434678851489999999998059988255475179845913899960568
Q 001434 786 FIVGSGAYGTVYKAVMD---SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 786 ~~ig~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~ 862 (1078)
+.||+|+||.||+|.++ .++.||||++..........+.+.+|+.++++++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC--CC
Q ss_conf 9977673079999996689999999996564542068996696378878289789996699011453002798888--64
Q 001434 863 GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK--SM 940 (1078)
Q Consensus 863 gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~--~~ 940 (1078)
|+|.+++.... .+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+|++|||+++........ ..
T Consensus 92 g~L~~~l~~~~-~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~ 167 (277)
T d1xbba_ 92 GPLNKYLQQNR-HVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ 167 (277)
T ss_dssp EEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred CCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCCCC
T ss_conf 96899975225-789999999999999997668747---95567776113102356751234134533134323443224
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHH
Q ss_conf 44455557556101022877876765107899999992-99999999999888999999851199998633577886514
Q 001434 941 SAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDE 1019 (1078)
Q Consensus 941 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1019 (1078)
....||+.|+|||.+.+..++.++||||||+++|||++ |+.||.... ..+............ .+..+
T Consensus 168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~----~~~~~~~i~~~~~~~---~p~~~----- 235 (277)
T d1xbba_ 168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK----GSEVTAMLEKGERMG---CPAGC----- 235 (277)
T ss_dssp ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC----HHHHHHHHHTTCCCC---CCTTC-----
T ss_pred CCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCC----HHHHHHHHHCCCCCC---CCCCC-----
T ss_conf 456778420391665379998434430340313289658999999989----999999998289999---98656-----
Q ss_pred HHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 6899999999999761899999999999999999940
Q 001434 1020 SIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1020 ~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1056 (1078)
...+.+++.+||+.||++|||++++.+.|+..
T Consensus 236 -----~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~ 267 (277)
T d1xbba_ 236 -----PREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267 (277)
T ss_dssp -----CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred -----CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCH
T ss_conf -----79999999997588976890989999985288
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.25 Aligned_cols=254 Identities=20% Similarity=0.240 Sum_probs=211.1
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984591389996
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|...+.||+|+||+||+|.++ +++.||+|++.... .....+.+|++++++++||||+++++++++++..|+|||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC---CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEE
T ss_conf 10588789831778399999998999699999975786---659999999999985799798909899988998899995
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCC--CCEEEEECCCCCCCCCCC
Q ss_conf 056899776730799999966899999999965645420689966963788782897899--966990114530027988
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDK--FEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~--~~~kl~Dfg~a~~~~~~~ 936 (1078)
|++||+|.+++...+..+++.++..++.|++.|++|||++ ||+||||||+||+++.+ ..++++|||.++... .
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~--~ 156 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK--P 156 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--T
T ss_pred CCCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCC--C
T ss_conf 3899808899875389999999999999999999999876---9975135544434437885189976441110034--6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 88644445555755610102287787676510789999999299999999999888999999851199998633577886
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
........+++.|+|||...+..++.++||||+||++|+|++|+.||.. .................+
T Consensus 157 ~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~----~~~~~~~~~i~~~~~~~~--------- 223 (321)
T d1tkia_ 157 GDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA----ETNQQIIENIMNAEYTFD--------- 223 (321)
T ss_dssp TCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCC----SSHHHHHHHHHHTCCCCC---------
T ss_pred CCCCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCC----CCHHHHHHHHHHCCCCCC---------
T ss_conf 7753212233222340210487778401130279999999828999999----899999999983899988---------
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 514689999999999976189999999999999999994
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
.+.+......+.+++.+|+..||++|||++|+++|-|-
T Consensus 224 -~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~ 261 (321)
T d1tkia_ 224 -EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261 (321)
T ss_dssp -HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred -HHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf -02236789999999999866996689099999639965
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.37 Aligned_cols=258 Identities=24% Similarity=0.377 Sum_probs=208.7
Q ss_pred CCCCCCEEECCCCEEEEEEEECCC-----CEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEE
Q ss_conf 587761770267259999997899-----599999943467885148999999999805998825547517984591389
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMDSG-----KIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 781 ~~~~~~~ig~G~~g~V~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
.|+..++||+|+||.||+|.++.+ ..||||++..... ......+.+|+.++++++||||+++++++.+.+..++
T Consensus 8 ~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 968615981177909999999689987879999999884459-6899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99605689977673079999996689999999996564542068996696378878289789996699011453002798
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+.++++.+++......+++.++..++.|++.|++|||++ +|+||||||+|||++.++.+||+|||+++.....
T Consensus 87 v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred EEEECCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CCCCCCCCCCEEEECCCCEEEECCCCHHHCCCCC
T ss_conf 9972135740222102345420899999999999854121212---3425765644278889984998455103003578
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 88--8644445555755610102287787676510789999999299999999999888999999851199998633577
Q 001434 936 QS--KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 936 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
.. .......||+.|+|||.+.++.++.++||||||+++|||++|..|+.... ...+...........+
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~---~~~~~~~~i~~~~~~~------- 233 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKAINDGFRLP------- 233 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCCCC-------
T ss_pred CCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCC---CHHHHHHHHHCCCCCC-------
T ss_conf 765267426777734348888704999973556344898999996798865568---9999999986357899-------
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 886514689999999999976189999999999999999994002
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
.+. +....+.+++.+||+.+|++|||+.++++.|+++..
T Consensus 234 ~~~------~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 234 TPM------DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp CCT------TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred CCH------HHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 850------457999999999776797689399999999999866
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=344.86 Aligned_cols=253 Identities=23% Similarity=0.249 Sum_probs=202.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEE
Q ss_conf 05877617702672599999978-9959999994346788----514899999999980599882554751798459138
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG----NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||.||+|.++ +|+.||+|++.+.... ........+++..++.++||||+++++++.+++..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99960568997767307999999668999999999656454206899669637887828978999669901145300279
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||++||+|.+++.... .+++..+..++.|++.||+|||++ +++||||||+|||++.++.+||+|||+|+....
T Consensus 84 ivmE~~~gg~L~~~l~~~~-~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~ 159 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-VFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSK 159 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSS
T ss_pred EEEEECCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCEEECCCEEEECCCCCEEEEEECEEEECCC
T ss_conf 9999148983899987325-532789999999999999999977---962204442216785889679822010233378
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 88886444455557556101022-87787676510789999999299999999999888999999851199998633577
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTR 1013 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1013 (1078)
.......||+.|+|||++.+ ..|+.++||||+||++|||++|+.||..... .......+........ ++..
T Consensus 160 ---~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~-~~~~~~~~~~~~~~~~----~~~~ 231 (364)
T d1omwa3 160 ---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT-KDKHEIDRMTLTMAVE----LPDS 231 (364)
T ss_dssp ---SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCS-SCHHHHHHHSSSCCCC----CCSS
T ss_pred ---CCCCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHCCCCCCC----CCCC
T ss_conf ---8643311345542168760389998441046778999999859998888998-9999999860468887----8877
Q ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHHHHH
Q ss_conf 88651468999999999997618999999999-----999999999
Q 001434 1014 LNVEDESIVDHMILVLKVALMCTSISPFDRPS-----MREVVSMLI 1054 (1078)
Q Consensus 1014 ~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs-----~~eil~~L~ 1054 (1078)
+ ...+.+++.+||+.||++||| ++++++|-+
T Consensus 232 ~----------s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~ 267 (364)
T d1omwa3 232 F----------SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF 267 (364)
T ss_dssp S----------CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGG
T ss_pred C----------CHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHCCCC
T ss_conf 8----------99999999998566988808874357999974910
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=343.04 Aligned_cols=249 Identities=24% Similarity=0.318 Sum_probs=209.0
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 05877617702672599999978-995999999434678-8514899999999980599882554751798459138999
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||+||+|+++ +|+.||+|++.+... .....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 60568997767307999999668999999999656454206899669637887828978999669901145300279888
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||++||++..++.... ..++..+..++.|++.|++|+|++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 84 E~~~gg~l~~~~~~~~-~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~--- 156 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-RFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 156 (316)
T ss_dssp CCCCSCBHHHHHHHTS-SCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EECCCCCCCCCCCCCC-CCCCCHHHHHHHHHHHHHHHHCCC---CEECCCCCCHHEEECCCCCEEEECCCCCEEECC---
T ss_conf 5037863223432222-111007999999998765541247---677055681050386899889831752167124---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 86444455557556101022877876765107899999992999999999998889999998511999986335778865
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......||+.|+|||++.+..|+.++||||+||++|||++|+.||.. ................. ++.+
T Consensus 157 -~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~----~~~~~~~~~i~~~~~~~----p~~~--- 224 (316)
T d1fota_ 157 -VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYD----SNTMKTYEKILNAELRF----PPFF--- 224 (316)
T ss_dssp -CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCC----SSHHHHHHHHHHCCCCC----CTTS---
T ss_pred -CCCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC----CCHHHHHHHHHCCCCCC----CCCC---
T ss_conf -56434576343599998389998043046533368999759899999----69999999997089889----9778---
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHH
Q ss_conf 146899999999999761899999999-----9999999999
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 1054 (1078)
...+.+++.+|+..||.+|+ |++++++|-+
T Consensus 225 -------s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~ 259 (316)
T d1fota_ 225 -------NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 259 (316)
T ss_dssp -------CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -------CHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHCCCC
T ss_conf -------99999999999544997666431021999981935
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=343.70 Aligned_cols=249 Identities=19% Similarity=0.222 Sum_probs=209.1
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEE
Q ss_conf 05877617702672599999978-995999999434678-8514899999999980599882554751798459138999
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||.||+|.++ +|+.||+|++.+... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 60568997767307999999668999999999656454206899669637887828978999669901145300279888
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
||+.+|+|.+++...+ .+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||+|+....
T Consensus 121 e~~~~g~l~~~l~~~~-~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp ECCTTCBHHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred CCCCCCCHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHCCCCCCCCEEEEECEEEEECCC---
T ss_conf 2334662266675158-989999999999999989999859---986176799993607789788610103332256---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 86444455557556101022877876765107899999992999999999998889999998511999986335778865
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
......||+.|+|||++.+..++.++||||+||++|||++|+.||.+ ................. +..+
T Consensus 194 -~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~----~~~~~~~~~i~~~~~~~----p~~~--- 261 (350)
T d1rdqe_ 194 -RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA----DQPIQIYEKIVSGKVRF----PSHF--- 261 (350)
T ss_dssp -CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCCCC----CTTC---
T ss_pred -CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC----CCHHHHHHHHHCCCCCC----CCCC---
T ss_conf -66433676356788997179988533114500789999758899899----59999999986179889----7668---
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHH
Q ss_conf 146899999999999761899999999-----9999999999
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 1054 (1078)
...+.+++.+||+.||.+|+ |++++++|-+
T Consensus 262 -------s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~ 296 (350)
T d1rdqe_ 262 -------SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296 (350)
T ss_dssp -------CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGG
T ss_pred -------CHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHCCCC
T ss_conf -------99999999998340998606553454999971905
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=346.02 Aligned_cols=257 Identities=25% Similarity=0.375 Sum_probs=210.7
Q ss_pred HHCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 40587761770267259999997899599999943467885148999999999805998825547517984591389996
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
..+|+..+.||+|+||.||+|.+++++.||||++..... ..+.|.+|+..+++++||||+++++++. ++..++|||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~---~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~E 91 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM---SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 91 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS---CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCC---CHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEEE
T ss_conf 799798469930798099999999999999999880448---8899999999998666678868999982-397599999
Q ss_pred ECCCCCHHHHHCCC-CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 05689977673079-99999668999999999656454206899669637887828978999669901145300279888
Q 001434 859 YMERGSLGELLHGS-SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~-~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+++|+|..++... ...+++.++..++.|++.|++|||++ +++||||||+||+++.++.+||+|||+++.......
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~ 168 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred ECCCCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHHH---HEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCC
T ss_conf 44799435420000355305999999999999999987541---143353123079998999299844255542568873
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 86444455557556101022877876765107899999992999999999998889999998511999986335778865
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNVE 1017 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1017 (1078)
.......|++.|+|||.+.++.++.++||||+|+++|||++|..|+... ....+............ .+..+
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~---~~~~~~~~~i~~~~~~~---~~~~~--- 239 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG---MVNREVLDQVERGYRMP---CPPEC--- 239 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT---CCHHHHHHHHHTTCCCC---CCTTS---
T ss_pred EEECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCC---CCHHHHHHHHHHCCCCC---CCCCC---
T ss_conf 3524545566545808983799891774132358999998689999988---88999999998268999---98323---
Q ss_pred HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 14689999999999976189999999999999999994002
Q 001434 1018 DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1018 ~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
...+.+++.+||+.||++||+++++++.|++...
T Consensus 240 -------~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~ 273 (285)
T d1fmka3 240 -------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273 (285)
T ss_dssp -------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred -------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf -------7999999999756697589199999998766623
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=338.90 Aligned_cols=260 Identities=25% Similarity=0.354 Sum_probs=214.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCC-CHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCC----E
Q ss_conf 05877617702672599999978-9959999994346788-5148999999999805998825547517984591----3
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREG-NNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGS----N 853 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~----~ 853 (1078)
++|+..+.||+|+||.||+|.+. +++.||+|++...... ....+.+.+|+.++++++||||+++++++..++. .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCEE
T ss_conf 20698689960899299999999999899999985566469899999999999998569998873114354326887669
Q ss_pred EEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 89996056899776730799999966899999999965645420689966963788782897899966990114530027
Q 001434 854 LLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVID 933 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 933 (1078)
|+||||++|++|.+++...+ .+++.++..++.|++.|++|+|++ |++||||||+||+++.++..+++|||.+....
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~-~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred EEEEECCCCCEEHHHHCCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCEEEHHHHHHHHC
T ss_conf 99997788987101120358-999999999999999999999857---95276346755665754320100344432212
Q ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 988--886444455557556101022877876765107899999992999999999998889999998511999986335
Q 001434 934 MPQ--SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 934 ~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
... ........||+.|+|||++.+..+++++||||+|+++|||++|+.||.. .................+....
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~----~~~~~~~~~~~~~~~~~~~~~~ 238 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG----DSPVSVAYQHVREDPIPPSARH 238 (277)
T ss_dssp ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCC----SSHHHHHHHHHHCCCCCGGGTS
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCC----CCHHHHHHHHHHCCCCCCCHHC
T ss_conf 354433334642576243699998399999663202652899999769799899----6999999999846999971003
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHC
Q ss_conf 778865146899999999999761899999999-9999999999400
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRP-SMREVVSMLIESN 1057 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-s~~eil~~L~~~~ 1057 (1078)
..++ ..+.+++.+|+++||++|| |++++++.|.++.
T Consensus 239 ~~~s----------~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 239 EGLS----------ADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp SSCC----------HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred CCCC----------HHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf 4789----------999999999866797677739999999999975
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.05 Aligned_cols=254 Identities=20% Similarity=0.237 Sum_probs=202.6
Q ss_pred HCCCCC-CEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCC-CCCCCEEEEEEEEEE----CCC
Q ss_conf 058776-17702672599999978-99599999943467885148999999999805-998825547517984----591
Q 001434 780 YNFHDS-FIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGK-IRHRNIVKLYGFCYH----QGS 852 (1078)
Q Consensus 780 ~~~~~~-~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~-l~h~~iv~l~~~~~~----~~~ 852 (1078)
.+|... ++||+|+||.||+|.+. +++.||+|++... ..+.+|+.++.+ .+||||+++++++++ +..
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC-------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCE
T ss_conf 48798107965454869999998899989999998974-------77999999999866999978298999503468978
Q ss_pred EEEEEEECCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 389996056899776730799-99996689999999996564542068996696378878289789---99669901145
Q 001434 853 NLLIYEYMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGL 928 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~ 928 (1078)
.|+||||++||+|.+++...+ ..+++.++..++.|++.|++|||++ +|+||||||+||+++. .+.+||+|||+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 99999778998499999862787757999999999999999999976---986444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 30027988886444455557556101022877876765107899999992999999999998889999998511999986
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1078)
|+.... ........||+.|+|||++.+..|+.++||||+||++|+|++|+.||.+...............
T Consensus 161 a~~~~~--~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~-------- 230 (335)
T d2ozaa1 161 AKETTS--HNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR-------- 230 (335)
T ss_dssp CEECCC--CCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCC--------
T ss_pred EEECCC--CCCCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHH--------
T ss_conf 233368--8864322677563792777489888888887645167788658899889887788999999985--------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 33577886514689999999999976189999999999999999994
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
.................+.+++.+|++.||++|||+.++++|-|-
T Consensus 231 --~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~ 275 (335)
T d2ozaa1 231 --MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275 (335)
T ss_dssp --SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred --CCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf --388888985434699999999999756996579099999709876
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.02 Aligned_cols=279 Identities=25% Similarity=0.311 Sum_probs=206.3
Q ss_pred CCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCC---HHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 7617702672599999978-99599999943467885---1489999999998059988255475179845913899960
Q 001434 784 DSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN---NIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 784 ~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
..++||+|+||+||+|.++ +++.||+|++....... ...+.+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 56899776730799999966899999999965645420689966963788782897899966990114530027988886
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+.++++..+... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.++..... ...
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~-~~~ 156 (299)
T d1ua2a_ 82 METDLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRA 156 (299)
T ss_dssp CSEEHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-CCC
T ss_pred HCCHHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCC-CCC
T ss_conf 345077655412-66778999999999999999886316---3550357762588537784114657610005787-554
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC-------
Q ss_conf 4444555575561010228-77876765107899999992999999999998889999998511999986335-------
Q 001434 940 MSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD------- 1011 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------- 1011 (1078)
.....||+.|+|||++... .|+.++||||+||++|||++|++||....+.+....+.... .......+.
T Consensus 157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~---~~~~~~~~~~~~~~~~ 233 (299)
T d1ua2a_ 157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL---GTPTEEQWPDMCSLPD 233 (299)
T ss_dssp CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH---CCCCTTTSSSTTSSTT
T ss_pred CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHC---CCCCHHHCCCHHCCCH
T ss_conf 3302047333639997267788805643630428999985969999999999999999851---8997254521000213
Q ss_pred ----CCCCCC--HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf ----778865--146899999999999761899999999999999999940023798999999999987
Q 001434 1012 ----TRLNVE--DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNSSPTYDLPQI 1074 (1078)
Q Consensus 1012 ----~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~~~~~~~~~~ 1074 (1078)
...+.. ..........+.+++.+|+..||++|||++|+++|-+-- ..+.+.|...+|.|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~----~~p~p~~~~~~p~p 298 (299)
T d1ua2a_ 234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS----NRPGPTPGCQLPRP 298 (299)
T ss_dssp CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGT----SSSCCCCSSSSCCC
T ss_pred HHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHC----CCCCCCCCCCCCCC
T ss_conf 443034789886785656899999999997638945690899996799657----89999898889999
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=342.46 Aligned_cols=258 Identities=24% Similarity=0.373 Sum_probs=211.1
Q ss_pred HCCCCCCEEECCCCEEEEEEEECC----CCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEE
Q ss_conf 058776177026725999999789----9599999943467885148999999999805998825547517984591389
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l 855 (1078)
.+|+..+.||+|+||.||+|.+.. +..||+|++..... ....+.+.+|+.++++++||||+++++++. ++..++
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS-DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 996987799307882999999936996449999999365668-799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 99605689977673079999996689999999996564542068996696378878289789996699011453002798
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMP 935 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 935 (1078)
||||+++|++.+++......+++..+..++.|++.|++|+|++ +++||||||+||+++.++.+|++|||+|+.....
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~ 161 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS 161 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC----------
T ss_pred EEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHCCC---CEECCCCCHHHEEECCCCCEEECCCHHHEECCCC
T ss_conf 9984069807765422478999999999999998775230226---7441410265532067896787650342133677
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 8886444455557556101022877876765107899999992-999999999998889999998511999986335778
Q 001434 936 QSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRL 1014 (1078)
Q Consensus 936 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1014 (1078)
.........||+.|+|||.+.+..++.++||||+|+++|||++ |.+||....... ...........+ .++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~----~~~~i~~~~~~~---~~~~~ 234 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRIENGERLP---MPPNC 234 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----HHHHHHTTCCCC---CCTTC
T ss_pred CCEECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHH----HHHHHHCCCCCC---CCCCC
T ss_conf 62330540058310326675169988745244424789999826999988899999----999998189998---98777
Q ss_pred CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCC
Q ss_conf 865146899999999999761899999999999999999940023
Q 001434 1015 NVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNER 1059 (1078)
Q Consensus 1015 ~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~ 1059 (1078)
...+.+++.+||+.||++|||+.+++++|+.+.+.
T Consensus 235 ----------~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~ 269 (273)
T d1mp8a_ 235 ----------PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 269 (273)
T ss_dssp ----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHH
T ss_conf ----------99999999997687976892999999999999778
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.83 Aligned_cols=267 Identities=24% Similarity=0.340 Sum_probs=206.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984591389996
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||+||+|.+. +++.||+|++......+...+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 05689977673079999996689999999996564542068996696378878289789996699011453002798888
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
|+.++.+..........+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.|+..... ..
T Consensus 82 ~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~~ 157 (298)
T d1gz8a_ 82 FLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-VR 157 (298)
T ss_dssp CCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-SB
T ss_pred ECCCCHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCHHEEECCCCCCEECCCCCCEECCCC-CC
T ss_conf 2377445554420256888899999999999999986528---8992135711401134676210357861343688-64
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC------
Q ss_conf 644445555755610102287-7876765107899999992999999999998889999998511999986335------
Q 001434 939 SMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD------ 1011 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------ 1011 (1078)
......|++.|+|||...... ++.++||||+|+++|+|++|+.||................ .......+.
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~ 234 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL---GTPDEVVWPGVTSMP 234 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH---CCCCTTTSTTGGGST
T ss_pred CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHC---CCCCHHHCCCCCCCC
T ss_conf 10010365215411221366577742210333313427966879989889999999999832---898333144422242
Q ss_pred -------CCCCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf -------778865-146899999999999761899999999999999999
Q 001434 1012 -------TRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1012 -------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1053 (1078)
...... ..........+.+++.+|++.||++|||++|+++|-
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ 284 (298)
T d1gz8a_ 235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHP 284 (298)
T ss_dssp TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred CCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 12434543222204441667899999999997639955791899996787
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=335.73 Aligned_cols=255 Identities=24% Similarity=0.324 Sum_probs=208.0
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCC-------HHHHHHHHHHHHHCCCC-CCCEEEEEEEEEEC
Q ss_conf 05877617702672599999978-99599999943467885-------14899999999980599-88255475179845
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN-------NIESSFRAEILTLGKIR-HRNIVKLYGFCYHQ 850 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~ 850 (1078)
.+|+..+.||+|+||+||+|+++ +++.||+|++.+..... ...+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 91389996056899776730799999966899999999965645420689966963788782897899966990114530
Q 001434 851 GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 930 (1078)
+..|+||||+++|+|.+++...+ .+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~ 158 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSC 158 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred CCEEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCHHEE
T ss_conf 60599997689866899998659-999999999999999999999875---99432346254898689983871240316
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCC
Q ss_conf 027988886444455557556101022------87787676510789999999299999999999888999999851199
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYT------MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHS 1004 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~ 1004 (1078)
.... ........||+.|.|||.+.+ ..++.++||||+|+++|||++|+.||.+. ..............
T Consensus 159 ~~~~--~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~----~~~~~~~~i~~~~~ 232 (277)
T d1phka_ 159 QLDP--GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR----KQMLMLRMIMSGNY 232 (277)
T ss_dssp ECCT--TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS----SHHHHHHHHHHTCC
T ss_pred ECCC--CCCEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCC----CHHHHHHHHHHCCC
T ss_conf 7268--87213452467888988860534456788992331856560231032288898899----99999999981898
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 99863357788651468999999999997618999999999999999999
Q 001434 1005 LTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1005 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
..+.. ........+.+++.+||++||++|||++++++|-|
T Consensus 233 ~~~~~----------~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~ 272 (277)
T d1phka_ 233 QFGSP----------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF 272 (277)
T ss_dssp CCCTT----------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred CCCCC----------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 88985----------43468999999999976589668919999973978
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.43 Aligned_cols=259 Identities=25% Similarity=0.382 Sum_probs=208.0
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCC--EEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECCCEEE
Q ss_conf 05877617702672599999978-995--999999434678851489999999998059-98825547517984591389
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGK--IVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~~~l 855 (1078)
.+|+..+.||+|+||.||+|.++ ++. .||||++...... ...+.+.+|+.++.++ +||||+++++++.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEE
T ss_conf 996887798207882899999989996999999997823385-7999999999999862289988367888841873699
Q ss_pred EEEECCCCCHHHHHCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCC
Q ss_conf 99605689977673079---------------999996689999999996564542068996696378878289789996
Q 001434 856 IYEYMERGSLGELLHGS---------------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFE 920 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~---------------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~ 920 (1078)
||||+++|+|.++++.. ...+++..+..++.|++.|+.|+|++ +++||||||+|||++.++.
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~ 165 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV 165 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred EEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCC
T ss_conf 9980289869999864035555512310123457899999999999999998766308---9545550520489868876
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCHHHHHHHH
Q ss_conf 6990114530027988886444455557556101022877876765107899999992999-999999998889999998
Q 001434 921 AHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRT-PVQPLDDGGDLATWVRNY 999 (1078)
Q Consensus 921 ~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~-p~~~~~~~~~~~~~~~~~ 999 (1078)
+||+|||+++... .........|+..|+|||.+.++.++.++||||||+++|||++|.. ||.. ..........
T Consensus 166 ~kl~DfG~a~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~----~~~~~~~~~i 239 (309)
T d1fvra_ 166 AKIADFGLSRGQE--VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG----MTCAELYEKL 239 (309)
T ss_dssp EEECCTTCEESSC--EECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTT----CCHHHHHHHG
T ss_pred EEECCCCCCCCCC--CCCCCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCC----CCHHHHHHHH
T ss_conf 3874344322444--223455301377555538752699996221531388999998368999999----9999999999
Q ss_pred HHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 51199998633577886514689999999999976189999999999999999994002379
Q 001434 1000 IRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 1000 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1061 (1078)
....... . +.. ....+.+++.+||+.||++|||+.+++++|+++.+...
T Consensus 240 ~~~~~~~--~-~~~----------~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~~ 288 (309)
T d1fvra_ 240 PQGYRLE--K-PLN----------CDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK 288 (309)
T ss_dssp GGTCCCC--C-CTT----------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred HHCCCCC--C-CCC----------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHCCC
T ss_conf 8268888--8-766----------78999999999767896689499999999999986186
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.85 Aligned_cols=256 Identities=25% Similarity=0.421 Sum_probs=206.3
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCC----EEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEE
Q ss_conf 05877617702672599999978-995----9999994346788514899999999980599882554751798459138
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGK----IVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||+||+|.+. +|+ .||+|++...... ...+.+.+|+.++++++||||+++++++.++ ..+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSP-KANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCH-HHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEE
T ss_conf 99978319820899299999995899889899999996513497-9999999999999867998881589999619-836
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99960568997767307999999668999999999656454206899669637887828978999669901145300279
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+++|++.+|+|.+++......+++..+..++.|++.|++|||++ +|+||||||+||+++.++.+||+|||+|+....
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEEEECCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 99984268740101113345799999999999999999999876---950476212031167998758602552223354
Q ss_pred CCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 8888-6444455557556101022877876765107899999992-9999999999988899999985119999863357
Q 001434 935 PQSK-SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDT 1012 (1078)
Q Consensus 935 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1012 (1078)
.... ......||+.|+|||.+.++.++.++||||||+++|||+| |++||...... .....+.. ...... ++
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~-~~~~~i~~---~~~~~~---p~ 236 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISSILEK---GERLPQ---PP 236 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG-GHHHHHHH---TCCCCC---CT
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHC---CCCCCC---CC
T ss_conf 445322365105864467088746999835654407999999997799999999989-99999975---998999---85
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHC
Q ss_conf 788651468999999999997618999999999999999999400
Q 001434 1013 RLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESN 1057 (1078)
Q Consensus 1013 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~ 1057 (1078)
. ....+.+++.+||+.||++|||+.+++++++.+.
T Consensus 237 ~----------~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~ 271 (317)
T d1xkka_ 237 I----------CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA 271 (317)
T ss_dssp T----------BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C----------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 5----------6899999999847899346919999999999987
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=336.75 Aligned_cols=260 Identities=27% Similarity=0.426 Sum_probs=210.7
Q ss_pred HHHCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC
Q ss_conf 7405877617702672599999978------9959999994346788514899999999980599882554751798459
Q 001434 778 ATYNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG 851 (1078)
Q Consensus 778 ~~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~ 851 (1078)
.+.+|+..+.||+|+||+||+|.++ +++.||||++..... ....+.+.+|+.++++++||||+++++++.+.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS-ADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCC-HHHHHHHHHHHHHHHHCCCCCCCCCEEEECCCC
T ss_conf 9889388679820788399999988876577882999999882108-579999999999999668997655246660598
Q ss_pred CEEEEEEECCCCCHHHHHCCCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCC
Q ss_conf 1389996056899776730799-----------------------99996689999999996564542068996696378
Q 001434 852 SNLLIYEYMERGSLGELLHGSS-----------------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDI 908 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~-----------------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dl 908 (1078)
..++||||+++|+|.+++.... ..+++..+..++.|++.|++|+|++ +++||||
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDl 166 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDL 166 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCC---CEEEEEE
T ss_conf 0389998158992999998527554210000111001210346788989999999999999985541357---8685488
Q ss_pred CCCCEEECCCCCEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCC
Q ss_conf 8782897899966990114530027988-88644445555755610102287787676510789999999299-999999
Q 001434 909 KSNNILLDDKFEAHVGDFGLAKVIDMPQ-SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR-TPVQPL 986 (1078)
Q Consensus 909 kp~Nil~~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~-~p~~~~ 986 (1078)
||+||+++.++.+||+|||+|+...... ........|++.|+|||.+.+..++.++||||||+++|||++|. +||...
T Consensus 167 Kp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~ 246 (301)
T d1lufa_ 167 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246 (301)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred CCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCC
T ss_conf 40116898999289833144211367764111577776767679899726889805630252362999980689999998
Q ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 999888999999851199998633577886514689999999999976189999999999999999994002
Q 001434 987 DDGGDLATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 987 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
...+......... .++ . +..+ ...+.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 247 ----~~~e~~~~v~~~~-~~~-~-p~~~----------~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 247 ----AHEEVIYYVRDGN-ILA-C-PENC----------PLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp ----CHHHHHHHHHTTC-CCC-C-CTTC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred ----CHHHHHHHHHCCC-CCC-C-CCCC----------HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf ----9999999997399-788-8-7325----------2999999999748896579399999999998429
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.90 Aligned_cols=258 Identities=27% Similarity=0.392 Sum_probs=207.3
Q ss_pred CCEEECCCCEEEEEEEECC----CCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC-CCEEEEEEE
Q ss_conf 6177026725999999789----95999999434678851489999999998059988255475179845-913899960
Q 001434 785 SFIVGSGAYGTVYKAVMDS----GKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ-GSNLLIYEY 859 (1078)
Q Consensus 785 ~~~ig~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~lv~e~ 859 (1078)
.++||+|+||+||+|.+.. ...||||++.... .....+++.+|++++++++||||+++++++.+. ...++||||
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~ 110 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEEC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEE
T ss_conf 669813688099999997799879999999988436-9789999999999998678999867867898069943899987
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC--
Q ss_conf 568997767307999999668999999999656454206899669637887828978999669901145300279888--
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS-- 937 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-- 937 (1078)
+++|+|.+++.......++..++.++.|++.|+.|+|+. +|+||||||+|||+++++.+||+|||+++.......
T Consensus 111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EECCCHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCCC
T ss_conf 406741442101345404899999999988765200336---76257766875767799988991065232255665553
Q ss_pred -CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf -8644445555755610102287787676510789999999299999999999888999999851199998633577886
Q 001434 938 -KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
.......|++.|+|||...++.++.++||||||+++|||++|+.||.......+... ......... .+..
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~---~i~~g~~~~---~p~~--- 258 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV---YLLQGRRLL---QPEY--- 258 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH---HHHTTCCCC---CCTT---
T ss_pred CEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH---HHHCCCCCC---CCCC---
T ss_conf 1002565556455676887437999745746619999999978999988899999999---998089889---9644---
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCC
Q ss_conf 5146899999999999761899999999999999999940023798
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGR 1062 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~ 1062 (1078)
....+.+++.+||+.||++||++.|++++|+.+......
T Consensus 259 -------~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~ 297 (311)
T d1r0pa_ 259 -------CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG 297 (311)
T ss_dssp -------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred -------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHHHH
T ss_conf -------759999999997688976893999999999999975201
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=338.41 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=204.6
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCC-CCHHHHHHHHHHHHHC-CCCCCCEEEEEEEEEECCCEEEE
Q ss_conf 05877617702672599999978-995999999434678-8514899999999980-59988255475179845913899
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNRE-GNNIESSFRAEILTLG-KIRHRNIVKLYGFCYHQGSNLLI 856 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~l~~~~~~~~~~~lv 856 (1078)
.+|...+.||+|+||+||+|.++ +++.||+|++.+... .....+.+.+|...+. .++||||+++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 96056899776730799999966899999999965645420689966963788782897899966990114530027988
Q 001434 857 YEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQ 936 (1078)
Q Consensus 857 ~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 936 (1078)
|||+++|+|.+++.... .+++.++..++.|++.||+|||++ +++||||||+|||++..+.+|++|||.++.... .
T Consensus 82 mEy~~~g~L~~~i~~~~-~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~-~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENML-G 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS-SCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-T
T ss_pred EEECCCCCHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCEEECCCCCEECCCCCHHHHCCC-C
T ss_conf 75037980899864047-899999999999999999999868---934034765404444899630155530232356-6
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 88644445555755610102287787676510789999999299999999999888999999851199998633577886
Q 001434 937 SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 937 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
........||+.|+|||++.+..++.++||||+||++|||++|+.||.+ ..............+.. +..+
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~----~~~~~~~~~i~~~~~~~----p~~~-- 226 (320)
T d1xjda_ 157 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG----QDEEELFHSIRMDNPFY----PRWL-- 226 (320)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCC----SSHHHHHHHHHHCCCCC----CTTS--
T ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC----CCHHHHHHHHHCCCCCC----CCCC--
T ss_conf 5334545787776899998279988323201122789898738899999----89999999997189989----7567--
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHHHH
Q ss_conf 5146899999999999761899999999999-999999
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMR-EVVSML 1053 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~L 1053 (1078)
...+.+++.+||..||++||++. ++++|-
T Consensus 227 --------s~~~~dli~~~L~~dP~~R~s~~~~l~~hp 256 (320)
T d1xjda_ 227 --------EKEAKDLLVKLFVREPEKRLGVRGDIRQHP 256 (320)
T ss_dssp --------CHHHHHHHHHHSCSSGGGSBTTBSCGGGSG
T ss_pred --------CHHHHHHHHHHCCCCCCCCCCHHHHHHHCC
T ss_conf --------999999999965448987838899998090
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.86 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=208.1
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEECCC
Q ss_conf 05877617702672599999978------995999999434678851489999999998059-98825547517984591
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~~~ 852 (1078)
.+|+..+.||+|+||.||+|.+. +++.||||++..... ......+.+|+..++++ +||||+++++++.+.+.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 99698549820688299999980664477886999999874248-77999999999998762699988789989831997
Q ss_pred EEEEEEECCCCCHHHHHCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf 389996056899776730799-----------------999966899999999965645420689966963788782897
Q 001434 853 NLLIYEYMERGSLGELLHGSS-----------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL 915 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~-----------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~ 915 (1078)
.++||||+++|+|.++++... ..+++..+..++.|++.|++|||++ +++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCCCCC
T ss_conf 899997379987999998535665444445332223345889999999999999999988757---92666241021000
Q ss_pred CCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHH
Q ss_conf 8999669901145300279888-86444455557556101022877876765107899999992-999999999998889
Q 001434 916 DDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLA 993 (1078)
Q Consensus 916 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~ 993 (1078)
+..+.++++|||.++....... .......|++.|+|||.+.++.++.++||||||+++|||+| |.+||........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 99999851199998633577886514689999999999976189999999999999999994002
Q 001434 994 TWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
..+....+.. .+.. ....+.+++.+||+.||++|||++++++.|++...
T Consensus 259 ~~i~~~~~~~------~~~~----------~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~ 307 (311)
T d1t46a_ 259 KMIKEGFRML------SPEH----------APAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307 (311)
T ss_dssp HHHHHTCCCC------CCTT----------SCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCCC------CCCC----------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHC
T ss_conf 9986689889------8543----------65999999999757796579299999999987653
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.62 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=203.4
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEEC-
Q ss_conf 405877617702672599999978------995999999434678851489999999998059-988255475179845-
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ- 850 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~- 850 (1078)
..+|+..+.||+|+||.||+|.+. +++.||+|++...... ...+.+.+|...+.++ +|++|+.+++++..+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~ 90 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPG 90 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCC-HHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
T ss_conf 7997984498416783999999867775557839999998600171-789999999999886149984997411540479
Q ss_pred CCEEEEEEECCCCCHHHHHCCCC---------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf 91389996056899776730799---------------999966899999999965645420689966963788782897
Q 001434 851 GSNLLIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL 915 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~ 915 (1078)
...++||||+++|+|.+++.... ..+++.++..++.|++.|++|||++ +|+||||||+|||+
T Consensus 91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl 167 (299)
T d1ywna1 91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILL 167 (299)
T ss_dssp SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEE
T ss_pred CEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEE
T ss_conf 757999984589929999985366666532220233214689999999999999999988737---97178677310657
Q ss_pred CCCCCEEEEECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCCHH
Q ss_conf 8999669901145300279888-8644445555755610102287787676510789999999299-9999999998889
Q 001434 916 DDKFEAHVGDFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR-TPVQPLDDGGDLA 993 (1078)
Q Consensus 916 ~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~-~p~~~~~~~~~~~ 993 (1078)
+.++.+||+|||+|+....... .......||+.|+|||.+.++.++.++||||+|+++|||++|. +||..........
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~ 247 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247 (299)
T ss_dssp CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 79982898457520011356652224751667210203686468899663221367899999868899998999899999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 99999851199998633577886514689999999999976189999999999999999994002
Q 001434 994 TWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
..+.. ..... . +.. ....+.+++.+||+.||++|||+++++++|+++.+
T Consensus 248 ~~~~~----~~~~~-~-~~~----------~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 RRLKE----GTRMR-A-PDY----------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHH----TCCCC-C-CTT----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHC----CCCCC-C-CCC----------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99963----89888-8-865----------78999999999767796679199999999979986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=335.28 Aligned_cols=250 Identities=26% Similarity=0.387 Sum_probs=203.6
Q ss_pred HCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE-CCCEEEEEE
Q ss_conf 0587761770267259999997899599999943467885148999999999805998825547517984-591389996
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH-QGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~lv~e 858 (1078)
.+|+..+.||+|+||.||+|.++ |+.||||+++... ..+.+.+|++++++++||||+++++++.+ ++..++|||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~e 81 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE 81 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEEC
T ss_pred HHEEEEEEEECCCCEEEEEEEEC-CEEEEEEEECCHH----HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEE
T ss_conf 99488579820798089999999-9099999988577----799999999999867898985498788723892899996
Q ss_pred ECCCCCHHHHHCCCC-CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 056899776730799-9999668999999999656454206899669637887828978999669901145300279888
Q 001434 859 YMERGSLGELLHGSS-CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQS 937 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~-~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 937 (1078)
|+++|+|.+++.... ..+++..++.++.|++.|+.|+|+. +++||||||+||+++.++.+|++|||.++....
T Consensus 82 y~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~--- 155 (262)
T d1byga_ 82 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 155 (262)
T ss_dssp CCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCCHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCC---CEECCCCCHHHHEECCCCCEEECCCCCCEECCC---
T ss_conf 36999899998745788889999999999998523211337---655366656760146899776324560034478---
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCC
Q ss_conf 86444455557556101022877876765107899999992-99999999999888999999851199998633577886
Q 001434 938 KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFDTRLNV 1016 (1078)
Q Consensus 938 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1016 (1078)
......++..|+|||.+.++.+++++||||||+++|||+| |++||.... ..+ +......... ++ ++...
T Consensus 156 -~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~-~~~---~~~~i~~~~~-~~--~~~~~-- 225 (262)
T d1byga_ 156 -TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKD---VVPRVEKGYK-MD--APDGC-- 225 (262)
T ss_dssp -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC-GGG---HHHHHTTTCC-CC--CCTTC--
T ss_pred -CCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-HHH---HHHHHHCCCC-CC--CCCCC--
T ss_conf -77655666467781787279888588777579999999978999999999-999---9999980899-99--97657--
Q ss_pred CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 514689999999999976189999999999999999994002
Q 001434 1017 EDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 1017 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
...+.+++.+||+.||++|||+.+++++|++++.
T Consensus 226 --------~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 226 --------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp --------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred --------CHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf --------9999999999756697689399999999999986
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=332.50 Aligned_cols=265 Identities=25% Similarity=0.360 Sum_probs=206.2
Q ss_pred HCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEEE
Q ss_conf 05877617702672599999978995999999434678851489999999998059988255475179845913899960
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYEY 859 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~ 859 (1078)
++|+..+.||+|+||+||+|.+++++.||+|++......+...+.+.+|+.++++++||||+++++++.+++..+++||+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 56899776730799999966899999999965645420689966963788782897899966990114530027988886
Q 001434 860 MERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSKS 939 (1078)
Q Consensus 860 ~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~ 939 (1078)
+.++.+..+... ...+++..+..++.|++.||+|||+. +|+||||||+||+++.++.+|++|||.+.....+. ..
T Consensus 82 ~~~~~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~ 156 (286)
T d1ob3a_ 82 LDQDLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RK 156 (286)
T ss_dssp CSEEHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EHHHHHHHHHHH-CCCCCHHHHHHHHHHHHHHHHHHCCC---CEEECCCCCCEEEECCCCCEEECCCCCCEECCCCC-CC
T ss_conf 004567899860-47751445689999999999986057---48826787750568689978732366430114676-54
Q ss_pred CCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCCCCCCC-------
Q ss_conf 4444555575561010228-77876765107899999992999999999998889999998511-99998633-------
Q 001434 940 MSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD-HSLTPGIF------- 1010 (1078)
Q Consensus 940 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~------- 1010 (1078)
.....|++.|+|||.+.+. .++.++||||+|+++|||++|+.||..... .+........ .......+
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE----ADQLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred CCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCH----HHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 10102431101378871788888410021117589999779799898898----99999999863899711042123332
Q ss_pred ------CCCCCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH
Q ss_conf ------5778865-146899999999999761899999999999999999
Q 001434 1011 ------DTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML 1053 (1078)
Q Consensus 1011 ------~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L 1053 (1078)
....... ..........+.+++.+||+.||++|||++|+++|-
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp 282 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSG
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCC
T ss_conf 21433333567646665125899999999998668966890999985692
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=326.35 Aligned_cols=270 Identities=25% Similarity=0.317 Sum_probs=202.9
Q ss_pred HCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC----CEEE
Q ss_conf 058776177026725999999789959999994346788514899999999980599882554751798459----1389
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG----SNLL 855 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~~~l 855 (1078)
.+|...+.||+|+||.||+|++. |+.||||++.... ........|+..+.+++||||+++++++.+++ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEEC-CEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 68999889820788199999999-9899999987200---4679999999999627998683268899837986048999
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-----CCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 9960568997767307999999668999999999656454206-----89966963788782897899966990114530
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD-----CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~-----~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 930 (1078)
||||+++|+|.+++++. .+++..+..++.|++.|++|+|+. ..++|+||||||+||+++.++.+||+|||++.
T Consensus 79 v~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEECCCCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCCC
T ss_conf 99646698989998658--9998999999999999999988766520468986615317313578688776887638662
Q ss_pred CCCCCCC---CCCCCCCCCCCCCCCCCCCCC------CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCC----------CC
Q ss_conf 0279888---864444555575561010228------7787676510789999999299999999999----------88
Q 001434 931 VIDMPQS---KSMSAVAGSYGYIAPEYAYTM------KVTEKCDIYSYGVVLLELLTGRTPVQPLDDG----------GD 991 (1078)
Q Consensus 931 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslGvil~elltG~~p~~~~~~~----------~~ 991 (1078)
....... .......||+.|+|||++.+. .++.++||||||+++|||+||..||...... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~ 236 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred CCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCCCCC
T ss_conf 34677762001355250354767822105654546777675012201599999996289988766311241012255643
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCC
Q ss_conf 8999999851199998633577886514689999999999976189999999999999999994002379
Q 001434 992 LATWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREG 1061 (1078)
Q Consensus 992 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~ 1061 (1078)
.............. ++.++.... ..+....+.+++.+||+.||++|||+.|+++.|+++....+
T Consensus 237 ~~~~~~~~~~~~~~-----~p~~~~~~~-~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~ 300 (303)
T d1vjya_ 237 SVEEMRKVVCEQKL-----RPNIPNRWQ-SCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG 300 (303)
T ss_dssp CHHHHHHHHTTSCC-----CCCCCGGGG-GCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred HHHHHHHHHHCCCC-----CCCCCCCCC-CHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCC
T ss_conf 09999998750246-----888776557-76899999999999760698589599999999998888659
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=334.20 Aligned_cols=267 Identities=22% Similarity=0.323 Sum_probs=200.7
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC-C-CCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC---CCCCEEEEEEEEEE----
Q ss_conf 405877617702672599999978-9-95999999434678851489999999998059---98825547517984----
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-S-GKIVAVKKLASNREGNNIESSFRAEILTLGKI---RHRNIVKLYGFCYH---- 849 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l---~h~~iv~l~~~~~~---- 849 (1078)
..+|+..+.||+|+||+||+|++. + ++.||+|++............+.+|+..++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred -CCCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf -5913899960568997767307999999668999999999656454206899669637887828978999669901145
Q 001434 850 -QGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGL 928 (1078)
Q Consensus 850 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 928 (1078)
....+++|||++++.+..........+++..+..++.|++.||+|||++ +|+||||||+|||++..+.+|++|||.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~ 162 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGL 162 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCCCEEEECCCCCEEECCHHH
T ss_conf 67469999974058714444430378999899999999999999999758---898357986278985899754210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHC-CCCCC
Q ss_conf 30027988886444455557556101022877876765107899999992999999999998889999998511-99998
Q 001434 929 AKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRD-HSLTP 1007 (1078)
Q Consensus 929 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~-~~~~~ 1007 (1078)
+.... .........||+.|+|||++.+..|+.++||||+||++|||++|++||..... ......+... .....
T Consensus 163 ~~~~~--~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 163 ARIYS--FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD----VDQLGKILDVIGLPGE 236 (305)
T ss_dssp CCCCC--GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHHHCCCCG
T ss_pred HHHHC--CCCCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCH----HHHHHHHHHHHCCCCH
T ss_conf 01100--23457776548511483100179888111000328999999878799899898----9999999984079961
Q ss_pred CCCCC-----------CCCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 63357-----------78865-1468999999999997618999999999999999999
Q 001434 1008 GIFDT-----------RLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1008 ~~~~~-----------~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
..++. ..... ..........+.+++.+||+.||++|||++|+++|-+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpf 295 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 295 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 10532111103330223456454404458999999999987489667918999966963
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=333.70 Aligned_cols=257 Identities=25% Similarity=0.383 Sum_probs=208.3
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC--C--CCEEEEEEECCCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEE
Q ss_conf 05877617702672599999978--9--95999999434678-8514899999999980599882554751798459138
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD--S--GKIVAVKKLASNRE-GNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNL 854 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~--~--~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 854 (1078)
.+|+..+.||+|+||.||+|... + ...||||++.+... .....+.+.+|+.++++++||||+++++++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99960568997767307999999668999999999656454206899669637887828978999669901145300279
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 934 (1078)
+||||+++|++.+++......+++..+..++.|++.|+.|||++ +|+||||||+||+++.++.+|++|||+++....
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~ 163 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred EEEEEECCCCHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECHHHHCCCCCCCEEECCCHHHHHCCC
T ss_conf 14654238612544421268999999999999999999875217---875205668881565565433256115553035
Q ss_pred CCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 8888--6444455557556101022877876765107899999992-999999999998889999998511999986335
Q 001434 935 PQSK--SMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 935 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
.... ......|+..|+|||.+.+..++.++||||||+++|||+| |+.||... ...+......+.....+. .
T Consensus 164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~----~~~~~~~~i~~~~~~~~~--~ 237 (273)
T d1u46a_ 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL----NGSQILHKIDKEGERLPR--P 237 (273)
T ss_dssp -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC----CHHHHHHHHHTSCCCCCC--C
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC----CHHHHHHHHHHCCCCCCC--C
T ss_conf 8875265476325731079999837999942156614899999996899999996----999999999847999998--5
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 778865146899999999999761899999999999999999940
Q 001434 1012 TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIES 1056 (1078)
Q Consensus 1012 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~ 1056 (1078)
.. ....+.+++.+||+.||++|||++++.+.|.+.
T Consensus 238 ~~----------~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~ 272 (273)
T d1u46a_ 238 ED----------CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA 272 (273)
T ss_dssp TT----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred CC----------CCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHC
T ss_conf 44----------539999999997688966792999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=328.99 Aligned_cols=258 Identities=26% Similarity=0.373 Sum_probs=207.6
Q ss_pred HCCCCCCEEECCCCEEEEEEEECC--------CCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-CCCCEEEEEEEEEEC
Q ss_conf 058776177026725999999789--------95999999434678851489999999998059-988255475179845
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMDS--------GKIVAVKKLASNREGNNIESSFRAEILTLGKI-RHRNIVKLYGFCYHQ 850 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~ 850 (1078)
.+|...+.||+|+||.||+|+... +..||+|++...... .....+.+|...+.++ +||||+++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCH-HHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286-88999999999999813999697346522018
Q ss_pred CCEEEEEEECCCCCHHHHHCCCC---------------CCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf 91389996056899776730799---------------999966899999999965645420689966963788782897
Q 001434 851 GSNLLIYEYMERGSLGELLHGSS---------------CNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILL 915 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~ 915 (1078)
+..++||||+++|+|.+++.... ..+++.++..++.|++.|++|+|++ +++||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEEEECCCCEEE
T ss_conf 868999973699909999986067764322233457434679999999999999999876637---97863022102245
Q ss_pred CCCCCEEEEECCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCHH
Q ss_conf 899966990114530027988-886444455557556101022877876765107899999992-999999999998889
Q 001434 916 DDKFEAHVGDFGLAKVIDMPQ-SKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLT-GRTPVQPLDDGGDLA 993 (1078)
Q Consensus 916 ~~~~~~kl~Dfg~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ellt-G~~p~~~~~~~~~~~ 993 (1078)
+.++.+||+|||.++...... ........|++.|+|||.+.++.|+.++||||||+++|||++ |++||... ...
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~----~~~ 244 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV----PVE 244 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC----CHH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCC----CHH
T ss_conf 4789767622111011355555431466788846632667517988825554775888887401798989999----999
Q ss_pred HHHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCC
Q ss_conf 99999851199998633577886514689999999999976189999999999999999994002
Q 001434 994 TWVRNYIRDHSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNE 1058 (1078)
Q Consensus 994 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~ 1058 (1078)
..... +....... .+..+ ...+.+++.+||+.||++|||+.++++.|+++.+
T Consensus 245 ~~~~~-i~~~~~~~--~p~~~----------~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a 296 (299)
T d1fgka_ 245 ELFKL-LKEGHRMD--KPSNC----------TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296 (299)
T ss_dssp HHHHH-HHTTCCCC--CCSSC----------CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHH-HHCCCCCC--CCCCC----------HHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 99999-97288889--87435----------2999999999766797679399999999988860
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.00 Aligned_cols=260 Identities=24% Similarity=0.349 Sum_probs=208.7
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC------CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCE
Q ss_conf 05877617702672599999978------995999999434678851489999999998059988255475179845913
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD------SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSN 853 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~ 853 (1078)
.+|...+.||+|+||.||+|.+. +++.||||++..... ......+.+|+.++++++||||+++++++..++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~-~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC-HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 99188359820788189999987864477896899999870128-68999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHCCC---------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 8999605689977673079---------9999966899999999965645420689966963788782897899966990
Q 001434 854 LLIYEYMERGSLGELLHGS---------SCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVG 924 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~~~---------~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~ 924 (1078)
++||||+++|+|.+++... ...+++..+..++.|++.|+.|||++ +|+||||||+|||++.++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECEECCCCEEECCCCEEEEE
T ss_conf 677760489988999875033211344468879999999999999999987647---96543286775403599649994
Q ss_pred ECCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCCHHHHHHHHHHC
Q ss_conf 1145300279888-8644445555755610102287787676510789999999299-9999999998889999998511
Q 001434 925 DFGLAKVIDMPQS-KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGR-TPVQPLDDGGDLATWVRNYIRD 1002 (1078)
Q Consensus 925 Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~-~p~~~~~~~~~~~~~~~~~~~~ 1002 (1078)
|||+++....... .......|++.|+|||.+.++.++.++||||||+++|||+||. +||.. ....++.......
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~----~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG----LSNEQVLRFVMEG 251 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT----SCHHHHHHHHHTT
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC----CCHHHHHHHHHHC
T ss_conf 245420235776303134023163237888873699883334443789999999689999999----8999999999808
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCC
Q ss_conf 9999863357788651468999999999997618999999999999999999400237
Q 001434 1003 HSLTPGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNERE 1060 (1078)
Q Consensus 1003 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~ 1060 (1078)
.. .+ . +.. ....+.+++.+||+.+|++|||+.+++++|++..++.
T Consensus 252 ~~-~~-~-p~~----------~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~ 296 (308)
T d1p4oa_ 252 GL-LD-K-PDN----------CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG 296 (308)
T ss_dssp CC-CC-C-CTT----------CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred CC-CC-C-CCC----------CHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCCCC
T ss_conf 88-88-8-633----------5399999999975779658939999999978761778
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=322.16 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=204.1
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC------
Q ss_conf 405877617702672599999978-9959999994346788514899999999980599882554751798459------
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG------ 851 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~------ 851 (1078)
..+|+..+.||+|+||+||+|.++ +++.||+|++..........+.+.+|+.++++++||||+++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 13899960568997767307999999668999999999656454206899669637887828978999669901145300
Q 001434 852 SNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 852 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 931 (1078)
..++||||+ +.+|...+... .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+|++|||.|+.
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~ 170 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKHE--KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQ 170 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEEEECC-CCCHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCHHHCCCCCCCCCCCCCCEEC
T ss_conf 599998405-52189998740--226999999999999999998737---876456685111121001221134310220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 279888864444555575561010228-7787676510789999999299999999999888999999851199998633
Q 001434 932 IDMPQSKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 932 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1078)
... ......|++.|+|||.+.+. .++.++||||+||++|+|++|+.||............... ....+....
T Consensus 171 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~---~~~~~~~~~ 243 (346)
T d1cm8a_ 171 ADS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKV---TGTPPAEFV 243 (346)
T ss_dssp CCS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH---HCCCCHHHH
T ss_pred CCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHC---CCCCCHHHH
T ss_conf 687----6310245533358899817878996501030038999999786998889768999999850---378848888
Q ss_pred C---------------CCCCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH--HHHC
Q ss_conf 5---------------778865-146899999999999761899999999999999999--9400
Q 001434 1011 D---------------TRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML--IESN 1057 (1078)
Q Consensus 1011 ~---------------~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L--~~~~ 1057 (1078)
. ...... ..........+.+++.+||..||++|||+.++++|- +.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 244 QRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCC
T ss_conf 65300034433115786665566775568999999999997729955792999996396237587
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=319.80 Aligned_cols=267 Identities=25% Similarity=0.278 Sum_probs=194.4
Q ss_pred CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC------CCE
Q ss_conf 5877617702672599999978-995999999434678851489999999998059988255475179845------913
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------GSN 853 (1078)
Q Consensus 781 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------~~~ 853 (1078)
+|...++||+|+||+||+|++. +++.||+|++...... ..+|+.++++++|+||+++++++... ...
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH------HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEE
T ss_conf 767516982176839999999999979999998816068------99999999866898987387899744765773189
Q ss_pred EEEEEECCCCCHHHHHC--CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCC
Q ss_conf 89996056899776730--7999999668999999999656454206899669637887828978999-66990114530
Q 001434 854 LLIYEYMERGSLGELLH--GSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAK 930 (1078)
Q Consensus 854 ~lv~e~~~~gsL~~~l~--~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~ 930 (1078)
++||||++++.+..... .....+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEEECCCCCEEEECCCCHH
T ss_conf 99984168860788886310368999999999999999999999866---876457886037873589711673366054
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH--------HH
Q ss_conf 027988886444455557556101022-877876765107899999992999999999998889999998--------51
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNY--------IR 1001 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~--------~~ 1001 (1078)
.... ........|++.|+|||.+.+ ..++.++||||+||++|||++|+.||...........+.+.. ..
T Consensus 172 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~ 249 (350)
T d1q5ka_ 172 QLVR--GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249 (350)
T ss_dssp ECCT--TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred HCCC--CCCCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHHHHH
T ss_conf 4047--76532002555556827764046888210002465277855028799898799999999999748981776543
Q ss_pred CCCC-CCCCCCCCCCCC--HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHH--HHHCC
Q ss_conf 1999-986335778865--146899999999999761899999999999999999--94002
Q 001434 1002 DHSL-TPGIFDTRLNVE--DESIVDHMILVLKVALMCTSISPFDRPSMREVVSML--IESNE 1058 (1078)
Q Consensus 1002 ~~~~-~~~~~~~~~~~~--~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L--~~~~~ 1058 (1078)
.... ....+....... ..........+.+++.+||..||++|||+.|+++|- +++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHHCCCCC
T ss_conf 06210110355445674444315689999999999976589557929999966984524667
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=324.07 Aligned_cols=295 Identities=29% Similarity=0.478 Sum_probs=185.9
Q ss_pred CCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCC--CCCCEEEECCC-CCCEEEEECCCCCCCC--CCCCCCCCCCCCC
Q ss_conf 79721699999999734458878779668999998--54516931599-9968997079986566--6788645777438
Q 001434 55 EGLNSEGHYLLELKNSLHDEFNFLKSWKSTDQTPC--SWIGVNCTSDF-EPVVWSLDLNAMNFTG--SLSPSIGGLVHLT 129 (1078)
Q Consensus 55 ~~~~~~~~~ll~~k~~~~~~~~~l~sW~~~~~~~C--~W~gv~C~~~~-~~~v~~l~l~~~~l~g--~~~~~l~~l~~L~ 129 (1078)
.|.++|++||++||+++.++. .+++|... .||| .|.||+|+.+. ..||+.++|+++++.| .+|+.+++|++|+
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~-~l~sW~~~-~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~~l~~L~~L~ 79 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPT-TLSSWLPT-TDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLN 79 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCG-GGTTCCTT-SCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCGGGGGCTTCS
T ss_pred CCCHHHHHHHHHHHHHCCCCC-CCCCCCCC-CCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCCCCCCHHHHCCCCCC
T ss_conf 989899999999999779998-67788999-9998894889697489994798899898998888887984784675335
Q ss_pred EEECCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCHHHHHCCCC
Q ss_conf 685336-7433313977657677957784587423533321266788813011354345778851449864567740167
Q 001434 130 YLDLAY-NELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTN 208 (1078)
Q Consensus 130 ~L~L~~-n~l~~~~p~~~~~l~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~n 208 (1078)
+|+|++ |+++|.+|..|+++++|++|+|++|++.+..+..+..+..|+++++++|.+.+.+|..+.+++.++.+++++|
T Consensus 80 ~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n 159 (313)
T d1ogqa_ 80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN 159 (313)
T ss_dssp EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHCCCCCCCEEECCCC
T ss_conf 20202654333002431145420011020356434433222220111001111224555568512206740000002355
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC
Q ss_conf 43243565556766545898378643345697755666554155103466888887567544554665047856677875
Q 001434 209 NLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPS 288 (1078)
Q Consensus 209 ~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~ 288 (1078)
.+.+.+|..+..+.++ ++.++++.|++++..+..++.+.. ..+++.++...+.+|.
T Consensus 160 ~l~~~ip~~~~~l~~l-----------------------~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~ 215 (313)
T d1ogqa_ 160 RISGAIPDSYGSFSKL-----------------------FTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASV 215 (313)
T ss_dssp CCEEECCGGGGCCCTT-----------------------CCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGG
T ss_pred CCCCCCCCCCCCCCCC-----------------------CCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCC
T ss_conf 3356203121443112-----------------------323102246435332433222222-2333333433222222
Q ss_pred CCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCC
Q ss_conf 55675645434301333334434212232234301123788888547555676654578426987877521233320153
Q 001434 289 ELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGL 368 (1078)
Q Consensus 289 ~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 368 (1078)
.+..+++++.+++++|.+.+.++ .++.+++|+.|+|++|++++.+|..++++++|++|+|++|+++|.+|. ++.+++|
T Consensus 216 ~~~~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L 293 (313)
T d1ogqa_ 216 LFGSDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRF 293 (313)
T ss_dssp GCCTTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGS
T ss_pred CCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCC
T ss_conf 22222221112222222222222-222455444444765706660876884799999897958835166898-6667998
Q ss_pred CHHCCCCCC
Q ss_conf 301023552
Q 001434 369 RLLFLFQNQ 377 (1078)
Q Consensus 369 ~~L~L~~n~ 377 (1078)
+.+++.+|+
T Consensus 294 ~~l~l~~N~ 302 (313)
T d1ogqa_ 294 DVSAYANNK 302 (313)
T ss_dssp CGGGTCSSS
T ss_pred CHHHHCCCC
T ss_conf 978868895
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.98 Aligned_cols=269 Identities=22% Similarity=0.335 Sum_probs=203.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEE--------C
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984--------5
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYH--------Q 850 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~--------~ 850 (1078)
.+|+..+.||+|+||+||+|++. +++.||||++......+....++.+|+.++++++|+|++++++++.. +
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred CCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 91389996056899776730799999966899999999965645420689966963788782897899966990114530
Q 001434 851 GSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAK 930 (1078)
Q Consensus 851 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 930 (1078)
+..++||||+.++.+.... .....++...+..++.|++.|+.|||++ +|+||||||+||+++.++.+|++|||++.
T Consensus 90 ~~~~iv~e~~~~~~~~~~~-~~~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLS-NVLVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp -CEEEEEECCCEEHHHHHT-CTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CEEEEEEECCCCCCCCHHH-HCCCCCCCHHHHHHHHHHHHHHHHHCCC---CEEECCCCCHHEEECCCCCEEEEECCEEE
T ss_conf 6389998535787410122-2034433089999999999999885229---98856767222036689968763135002
Q ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 027988---8864444555575561010228-778767651078999999929999999999988899999985119999
Q 001434 931 VIDMPQ---SKSMSAVAGSYGYIAPEYAYTM-KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 931 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
...... ........||+.|+|||.+.+. .++.++||||+|+++|||++|+.||.+..+.......... .. ...
T Consensus 166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~-~~--~~~ 242 (318)
T d3blha1 166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL-CG--SIT 242 (318)
T ss_dssp ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HC--CCC
T ss_pred ECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHH-CC--CCC
T ss_conf 235544432113566024978742899707999891787006786466174487998998999999999984-18--998
Q ss_pred CCCCCC--------------CCCCC-HHHH--HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 863357--------------78865-1468--9999999999976189999999999999999994
Q 001434 1007 PGIFDT--------------RLNVE-DESI--VDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 1007 ~~~~~~--------------~~~~~-~~~~--~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
...... ..... .+.+ ......+.+++.+||..||++|||++|+++|-+-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff 308 (318)
T d3blha1 243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308 (318)
T ss_dssp TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred HHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHHH
T ss_conf 255344320344433201334455503340444599899999999873896589099999749501
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.46 Aligned_cols=267 Identities=23% Similarity=0.288 Sum_probs=208.4
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC------CC
Q ss_conf 05877617702672599999978-995999999434678851489999999998059988255475179845------91
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ------GS 852 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~------~~ 852 (1078)
.+|+..+.||+|+||+||+|.+. +|+.||||++...........++.+|+.++++++||||+++++++... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 38999605689977673079999996689999999996564542068996696378878289789996699011453002
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 932 (1078)
.|+||||+.++ +.+.+.. .+++..++.++.|++.|++|||++ ||+||||||+||+++.++.++++|||.++..
T Consensus 97 ~~iv~Ey~~~~-l~~~~~~---~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~ 169 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVIQM---ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_dssp EEEEEECCSEE-HHHHHTS---CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEECCCHH-HHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCEEEECHHHHHCC
T ss_conf 69998414467-7876503---899999999999999999886522---1124567763211365443132010232114
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH---------------
Q ss_conf 79888864444555575561010228778767651078999999929999999999988899999---------------
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVR--------------- 997 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~--------------- 997 (1078)
. .........||+.|+|||.+.+..+++++||||+||++|+|++|+.||.+............
T Consensus 170 ~--~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 170 G--TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp -------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred C--CCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_conf 6--66553322146555581331477778774333566257898659899888977889999997205898799987656
Q ss_pred ---HHHHCCCCCCC------CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf ---98511999986------33577886514689999999999976189999999999999999994
Q 001434 998 ---NYIRDHSLTPG------IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIE 1055 (1078)
Q Consensus 998 ---~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~ 1055 (1078)
........... ...................+.+++.+|+..||++||||+|+++|-|-
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~ 314 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred HHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCCC
T ss_conf 6777764175435666421264333543210133379999999999876994579089999669420
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.35 Aligned_cols=266 Identities=22% Similarity=0.286 Sum_probs=199.3
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECC----CEE
Q ss_conf 05877617702672599999978-9959999994346788514899999999980599882554751798459----138
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQG----SNL 854 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~----~~~ 854 (1078)
.+|+..+.||+|+||+||+|.+. +++.||||++..... ....+.+.+|+.++++++||+|+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH-QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC-HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCC-HHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 985997899406480999999999994999999803109-5899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 99960568997767307999999668999999999656454206899669637887828978999669901145300279
Q 001434 855 LIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 855 lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~ 934 (1078)
++++++.+|+|.+++... .+++..+..++.|++.||+|||++ ||+||||||+||+++.++.+||+|||++.....
T Consensus 87 ~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~ 161 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADP 161 (345)
T ss_dssp EEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred EEEEEECCCCHHHHHHCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCEEEECCCCCEEECCCCCEEECCC
T ss_conf 999962598656644058--999999999999999999999978---986777876437887999778754570565047
Q ss_pred CC--CCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC-
Q ss_conf 88--886444455557556101022-87787676510789999999299999999999888999999851199998633-
Q 001434 935 PQ--SKSMSAVAGSYGYIAPEYAYT-MKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF- 1010 (1078)
Q Consensus 935 ~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 1010 (1078)
.. ........|++.|+|||++.. ..++.++||||+|+++|+|++|+.||............. ...........
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~ 238 (345)
T d1pmea_ 162 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL---GILGSPSQEDLN 238 (345)
T ss_dssp GGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH---HHHCSCCHHHHH
T ss_pred CCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHH---HHCCCCCHHHHH
T ss_conf 77641010110265200038786047888741010046701337766979978888899999876---520699756642
Q ss_pred --------------CCCCCCC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf --------------5778865-1468999999999997618999999999999999999
Q 001434 1011 --------------DTRLNVE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1011 --------------~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
....... ..........+.+++.+|+..||++|||++++++|-+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf 297 (345)
T d1pmea_ 239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297 (345)
T ss_dssp TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred HHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 34332222024467755778777837899999999999976489567908999861986
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=324.17 Aligned_cols=244 Identities=23% Similarity=0.375 Sum_probs=197.0
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCC----HHHHHHHHHHHHHCCCC--CCCEEEEEEEEEECCC
Q ss_conf 05877617702672599999978-99599999943467885----14899999999980599--8825547517984591
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGN----NIESSFRAEILTLGKIR--HRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~~~~e~~~l~~l~--h~~iv~l~~~~~~~~~ 852 (1078)
.+|+..+.||+|+||+||+|.+. +++.||+|++.+..... ....++.+|+.++++++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEEECCC-CCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-CCCEEEEECCCCC
Q ss_conf 3899960568-9977673079999996689999999996564542068996696378878289789-9966990114530
Q 001434 853 NLLIYEYMER-GSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-KFEAHVGDFGLAK 930 (1078)
Q Consensus 853 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~-~~~~kl~Dfg~a~ 930 (1078)
.++||||+.+ +++.+++.... .+++.++..++.|++.||+|+|++ +|+||||||+||+++. .+.+|++|||.|+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEEECCCCCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEEECCCCEEEECCCCCCE
T ss_conf 8999983368622899986158-999999999999999999999877---975566761114774478848977546535
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCC
Q ss_conf 027988886444455557556101022877-8767651078999999929999999999988899999985119999863
Q 001434 931 VIDMPQSKSMSAVAGSYGYIAPEYAYTMKV-TEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGI 1009 (1078)
Q Consensus 931 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1009 (1078)
.... .......||+.|+|||++.+..+ +.++||||+||++|||++|+.||... ... .+....
T Consensus 160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~i----~~~~~~---- 222 (273)
T d1xwsa_ 160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEI----IRGQVF---- 222 (273)
T ss_dssp ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HHH----HHCCCC----
T ss_pred ECCC---CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCC------HHH----HHCCCC----
T ss_conf 3244---45566565877479999848997886533255403453675688998873------677----615447----
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 357788651468999999999997618999999999999999999
Q 001434 1010 FDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1010 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
++..++ ..+.+++.+||+.||++|||++|+++|-+
T Consensus 223 ~~~~~s----------~~~~~li~~~L~~dp~~R~s~~eil~hp~ 257 (273)
T d1xwsa_ 223 FRQRVS----------SECQHLIRWCLALRPSDRPTFEEIQNHPW 257 (273)
T ss_dssp CSSCCC----------HHHHHHHHHHTCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCC----------HHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 787799----------99999999976089758939999853986
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.39 Aligned_cols=267 Identities=22% Similarity=0.326 Sum_probs=208.9
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEECCCEEEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998825547517984591389996
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQGSNLLIYE 858 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e 858 (1078)
.+|+..+.||+|+||+||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 05689977673079999996689999999996564542068996696378878289789996699011453002798888
Q 001434 859 YMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPQSK 938 (1078)
Q Consensus 859 ~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~ 938 (1078)
++.++++..++...+ .+++..+..++.|++.||+|||++ +|+||||||+||+++.++.+|++|||.++...... .
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~ 156 (292)
T d1unla_ 82 FCDQDLKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-R 156 (292)
T ss_dssp CCSEEHHHHHHHTTT-CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-S
T ss_pred ECCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHHHHHHHCC---CEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC-C
T ss_conf 023322211212356-540367899999999998774339---98600146761211337826652046011046887-5
Q ss_pred CCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC-CCCCC-----
Q ss_conf 644445555755610102287-78767651078999999929999999999988899999985119999-86335-----
Q 001434 939 SMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT-PGIFD----- 1011 (1078)
Q Consensus 939 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~----- 1011 (1078)
......+++.|.|||.+.... ++.++||||+||++|||++|+.||... .+..+............ ...++
T Consensus 157 ~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG---NDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC---SSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCC---CCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 1001034431014667506988880444026541889985189999889---9999999999861189973551344322
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf ---------7788651468999999999997618999999999999999999
Q 001434 1012 ---------TRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1012 ---------~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
................+.+++.+|++.||++|||++|+++|-|
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~ 285 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGG
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 2113344454431043306568999999999986499668909999964953
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.00 Aligned_cols=257 Identities=26% Similarity=0.299 Sum_probs=213.0
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC----CCCEEEEEEECCCCC--CCHHHHHHHHHHHHHCCCCC-CCEEEEEEEEEECCC
Q ss_conf 05877617702672599999978----995999999434678--85148999999999805998-825547517984591
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD----SGKIVAVKKLASNRE--GNNIESSFRAEILTLGKIRH-RNIVKLYGFCYHQGS 852 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~----~~~~vaiK~~~~~~~--~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~ 852 (1078)
.+|+..+.||+|+||+||+|.+. +|+.||+|++.+... .....+.+.+|+.++++++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 38999605689977673079999996689999999996564542068996696378878289789996699011453002
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 932 (1078)
.++||||+.+|+|.+++.... ...+.....++.|++.|++|+|++ +++||||||+||+++.++.++|+|||.++.+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred EEEEEECCCCCHHHHHHHHCC-CCCHHHHHHHHHHHHHHHHHHHCC---CEEECCCCCCCEEECCCCCEEEEECCCHHHH
T ss_conf 001231234117999987304-543788888899999999885149---9896547732012469998887413202220
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
Q ss_conf 79888864444555575561010228--7787676510789999999299999999999888999999851199998633
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTM--KVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIF 1010 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1010 (1078)
............|++.|++||.+.+. .++.++||||+||++|||++|+.||.......................+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--- 256 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--- 256 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC---
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCCCCC---
T ss_conf 34444322122233333106876057768871325177779999997689998888777799999983356899886---
Q ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHHHHH
Q ss_conf 5778865146899999999999761899999999-----9999999999
Q 001434 1011 DTRLNVEDESIVDHMILVLKVALMCTSISPFDRP-----SMREVVSMLI 1054 (1078)
Q Consensus 1011 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP-----s~~eil~~L~ 1054 (1078)
. .....+.+++.+||++||++|| |++|+++|-+
T Consensus 257 -~----------~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpf 294 (322)
T d1vzoa_ 257 -Q----------EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 294 (322)
T ss_dssp -T----------TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGG
T ss_pred -C----------CCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHCCHH
T ss_conf -5----------4799999999997445898819997450999974972
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=316.93 Aligned_cols=267 Identities=19% Similarity=0.239 Sum_probs=204.3
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCC-EEEEEEEEEECCCEEEEE
Q ss_conf 05877617702672599999978-9959999994346788514899999999980599882-554751798459138999
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRN-IVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~-iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||.||+|.+. +++.||+|++..... ...+.+|++++++++|++ |+.+..++.+.+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC----CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEE
T ss_conf 889996898507880999999988998999999721005----8889999999997038996017999995198778999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCEEEEECCCCCCCCC
Q ss_conf 605689977673079999996689999999996564542068996696378878289789---99669901145300279
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD---KFEAHVGDFGLAKVIDM 934 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~---~~~~kl~Dfg~a~~~~~ 934 (1078)
||+ ++++.+.+......+++..+..++.|++.|++|+|++ +|+||||||+||+++. +..++++|||.|+....
T Consensus 83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred EEC-CCCHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHCCCCCCCCCCEEEEECCCCCEECCC
T ss_conf 873-8713332443068876899999999999999999979---944266787660643357776156504675134255
Q ss_pred CCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCC
Q ss_conf 888------86444455557556101022877876765107899999992999999999998889999998511999986
Q 001434 935 PQS------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPG 1008 (1078)
Q Consensus 935 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 1008 (1078)
... .......||+.|+|||.+.+..++.++||||+|+++|||++|+.||......................+..
T Consensus 159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred CCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCHH
T ss_conf 44554100013577678735329999918998983218861778999984987665530577999999852356789835
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCC
Q ss_conf 33577886514689999999999976189999999999999999994002379899
Q 001434 1009 IFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFN 1064 (1078)
Q Consensus 1009 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~ 1064 (1078)
.... .....+.+++.+||+.+|++||+++++.+.|++.....+...
T Consensus 239 ~~~~----------~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~ 284 (299)
T d1ckia_ 239 VLCK----------GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284 (299)
T ss_dssp HHTT----------TSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred HHCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHHCCCCC
T ss_conf 7534----------788999999999843995579199999999999999769997
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=314.74 Aligned_cols=268 Identities=19% Similarity=0.230 Sum_probs=210.1
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC-CCEEEEEEEEEECCCEEEEE
Q ss_conf 05877617702672599999978-99599999943467885148999999999805998-82554751798459138999
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH-RNIVKLYGFCYHQGSNLLIY 857 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-~~iv~l~~~~~~~~~~~lv~ 857 (1078)
.+|+..+.||+|+||+||+|++. +++.||+|++...... ..+.+|++.++.+.| ++++.+++++.++...++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 8069979984178829999999889979999997502582----999999999999648999877999960188117999
Q ss_pred EECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCCCC
Q ss_conf 605689977673079999996689999999996564542068996696378878289789-----996699011453002
Q 001434 858 EYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDD-----KFEAHVGDFGLAKVI 932 (1078)
Q Consensus 858 e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~-----~~~~kl~Dfg~a~~~ 932 (1078)
||+ +++|.+++......++..++..++.|++.|++|+|++ ||+||||||+||+++. .+.++++|||+|+..
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 81 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEC-CCCHHHHHHHHCCCHHHHHHHHHHHHHHHHHHHHHHC---CCEECCCCCCCEEECCCCCCCCCCEEECCCCEEEEC
T ss_conf 964-8887999975203110689999999999999999977---966266771315234754344795687236605771
Q ss_pred CCCCC------CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCC
Q ss_conf 79888------864444555575561010228778767651078999999929999999999988899999985119999
Q 001434 933 DMPQS------KSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLT 1006 (1078)
Q Consensus 933 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~ 1006 (1078)
..... .......||+.|+|||.+.+..+++++||||+|+++|||++|+.||..............-........
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~ 236 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred CCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCCC
T ss_conf 46766541110246762775102679896488888699989831999999869876788530219999999970567999
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCC
Q ss_conf 86335778865146899999999999761899999999999999999940023798999
Q 001434 1007 PGIFDTRLNVEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLIESNEREGRFNS 1065 (1078)
Q Consensus 1007 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~~~~~~~~~~~~ 1065 (1078)
.....+. ....+.+++..|+..+|++||+++.+.+.++++..+.+...+
T Consensus 237 ~~~l~~~----------~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~~ 285 (293)
T d1csna_ 237 LRELCAG----------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTED 285 (293)
T ss_dssp HHHHTTT----------SCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCSC
T ss_pred HHHHCCC----------CCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCC
T ss_conf 5896579----------989999999998439930085999999999999997599999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=312.77 Aligned_cols=261 Identities=20% Similarity=0.244 Sum_probs=197.5
Q ss_pred HCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEEC--CCEEE
Q ss_conf 05877617702672599999978-9959999994346788514899999999980599-88255475179845--91389
Q 001434 780 YNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQ--GSNLL 855 (1078)
Q Consensus 780 ~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~--~~~~l 855 (1078)
.+|+..+.||+|+||+||+|++. +++.||+|++.... .+.+.+|+.+++++. ||||+++++++... ...++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEE
T ss_conf 67189789831748199999988999799999988899-----9999999999985157998767999998168771268
Q ss_pred EEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 9960568997767307999999668999999999656454206899669637887828978999-669901145300279
Q 001434 856 IYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKF-EAHVGDFGLAKVIDM 934 (1078)
Q Consensus 856 v~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~ 934 (1078)
||||+.+++|.+... .+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .++++|||.|+....
T Consensus 110 v~e~~~~~~L~~~~~----~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEECCCSCBGGGTTT----SCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EEEECCCCCHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 886317985899746----899999999999999999887643---3443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHH---------H-CC
Q ss_conf 8888644445555755610102287-78767651078999999929999999999988899999985---------1-19
Q 001434 935 PQSKSMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYI---------R-DH 1003 (1078)
Q Consensus 935 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~---------~-~~ 1003 (1078)
........+|+.|+|||...+.. ++.++||||+|+++||+++|+.||....+..+....+.... . ..
T Consensus 183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~ 260 (328)
T d3bqca1 183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260 (328)
T ss_dssp --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred --CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHHHHCC
T ss_conf --874443224864247610268888884523233545558760488999887601899999999878841555554225
Q ss_pred CCCCCCCC----CCCC------CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 99986335----7788------651468999999999997618999999999999999999
Q 001434 1004 SLTPGIFD----TRLN------VEDESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1004 ~~~~~~~~----~~~~------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
......+. .... ............+.+++.+|+..||++|||++|+++|-+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 321 (328)
T d3bqca1 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321 (328)
T ss_dssp CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred CCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCCC
T ss_conf 4447430000033343311211552112448999999999986699568908999964935
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=314.97 Aligned_cols=263 Identities=23% Similarity=0.315 Sum_probs=203.4
Q ss_pred HHCCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCCCCEEEEEEEEEEC-----CC
Q ss_conf 405877617702672599999978-995999999434678851489999999998059988255475179845-----91
Q 001434 779 TYNFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIRHRNIVKLYGFCYHQ-----GS 852 (1078)
Q Consensus 779 ~~~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-----~~ 852 (1078)
..+|+..+.||+|+||+||+|.+. +++.||||++.+........+.+.+|+.++++++|||++++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 38999605689977673079999996689999999996564542068996696378878289789996699011453002
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVI 932 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~ 932 (1078)
.+++++++.||+|.+++... .+++.++..++.|++.||+|||++ ||+||||||+||+++.++.++++|||.+...
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~--~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~ 171 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ--KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHT 171 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC--CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred EEEEEEEECCCCHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCCCCCCCCCCCCCCCCCCCHHCCC
T ss_conf 49999962588623200224--530999999999999999999738---8765166776334554322001321000125
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
Q ss_conf 798888644445555755610102287-7876765107899999992999999999998889999998511999986335
Q 001434 933 DMPQSKSMSAVAGSYGYIAPEYAYTMK-VTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDLATWVRNYIRDHSLTPGIFD 1011 (1078)
Q Consensus 933 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 1011 (1078)
. .......|++.|+|||...+.. ++.++||||+|+++|+|++|+.||.+.+.......+... .........
T Consensus 172 ~----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~----~~~~~~~~~ 243 (348)
T d2gfsa1 172 D----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL----VGTPGAELL 243 (348)
T ss_dssp T----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH----HCCCCHHHH
T ss_pred C----CCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH----CCCCCHHHH
T ss_conf 7----54444345435558355337756785512432058999997688997889889999999973----079975773
Q ss_pred CC---------------CC-CC-HHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHH
Q ss_conf 77---------------88-65-1468999999999997618999999999999999999
Q 001434 1012 TR---------------LN-VE-DESIVDHMILVLKVALMCTSISPFDRPSMREVVSMLI 1054 (1078)
Q Consensus 1012 ~~---------------~~-~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~L~ 1054 (1078)
.. .. .. ..........+.+++.+|+..||++|||++|+++|-+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~ 303 (348)
T d2gfsa1 244 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAY 303 (348)
T ss_dssp TTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 200102445444303557875556626789999999999977588345938999855995
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=276.17 Aligned_cols=264 Identities=19% Similarity=0.189 Sum_probs=189.6
Q ss_pred CCCCCCEEECCCCEEEEEEEEC-CCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC-----------CCCEEEEEEEEE
Q ss_conf 5877617702672599999978-9959999994346788514899999999980599-----------882554751798
Q 001434 781 NFHDSFIVGSGAYGTVYKAVMD-SGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-----------HRNIVKLYGFCY 848 (1078)
Q Consensus 781 ~~~~~~~ig~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~iv~l~~~~~ 848 (1078)
+|+..+.||+|+||+||+|++. +|+.||||++.... ...+.+.+|+.+++.+. |+||+++++++.
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~ 90 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN 90 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred CEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC---CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEE
T ss_conf 5799899750778189999999999799999983431---3368999999999984014555554227676478998763
Q ss_pred EC--CCEEEEEEECCCCCHHH--HHCCCCCCCCHHHHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCCC----
Q ss_conf 45--91389996056899776--730799999966899999999965645420-6899669637887828978999----
Q 001434 849 HQ--GSNLLIYEYMERGSLGE--LLHGSSCNLEWPTRFMIALGAAEGLAYLHH-DCKPRIFHRDIKSNNILLDDKF---- 919 (1078)
Q Consensus 849 ~~--~~~~lv~e~~~~gsL~~--~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~-~~~~~ivH~Dlkp~Nil~~~~~---- 919 (1078)
.. ...+++++++..+.... ........+++..+..++.|++.|++|+|+ . ||+||||||+|||++.++
T Consensus 91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 91 HKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred ECCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHEEEECCCCCCC
T ss_conf 1256520234320003542000001223467868999999999999988876405---8646567705705630576564
Q ss_pred --CEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCH--HHH
Q ss_conf --6699011453002798888644445555755610102287787676510789999999299999999999888--999
Q 001434 920 --EAHVGDFGLAKVIDMPQSKSMSAVAGSYGYIAPEYAYTMKVTEKCDIYSYGVVLLELLTGRTPVQPLDDGGDL--ATW 995 (1078)
Q Consensus 920 --~~kl~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~p~~~~~~~~~~--~~~ 995 (1078)
.++++|||.+.... .......|++.|+|||......++.++||||+|+++++|++|+.||......... ...
T Consensus 168 ~~~~kl~dfg~s~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~ 243 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYD----EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH 243 (362)
T ss_dssp EEEEEECCCTTCEETT----BCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred CCEEEEEECCCCCCCC----CCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCHHHH
T ss_conf 4305675314421234----454223665210571321466777643201237899999878899898755432102689
Q ss_pred HHHHHH-C--------------------CCCCCCCCCCCCCC-------CHHHHHHHHHHHHHHHHHCCCCCCCCCCCHH
Q ss_conf 999851-1--------------------99998633577886-------5146899999999999761899999999999
Q 001434 996 VRNYIR-D--------------------HSLTPGIFDTRLNV-------EDESIVDHMILVLKVALMCTSISPFDRPSMR 1047 (1078)
Q Consensus 996 ~~~~~~-~--------------------~~~~~~~~~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ 1047 (1078)
...... . ......+....... ...........+.+++.+|+..||++|||++
T Consensus 244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~ 323 (362)
T d1q8ya_ 244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 323 (362)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred HHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH
T ss_conf 99999983799878862453220001320122024323577644421000156743589999999998779945790899
Q ss_pred HHHHHHH
Q ss_conf 9999999
Q 001434 1048 EVVSMLI 1054 (1078)
Q Consensus 1048 eil~~L~ 1054 (1078)
|+++|-+
T Consensus 324 e~L~Hp~ 330 (362)
T d1q8ya_ 324 GLVNHPW 330 (362)
T ss_dssp HHHTCGG
T ss_pred HHHCCCC
T ss_conf 9966934
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=1.4e-45 Score=263.91 Aligned_cols=259 Identities=29% Similarity=0.526 Sum_probs=192.1
Q ss_pred CCCEEEEECCCCCC--CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 46249963677668--6651000344333000233-43369995222332333043302453246887665775556189
Q 001434 487 TLLQLRLVGNSLTG--SFPLELCKLENLYAIELDQ-NKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTF 563 (1078)
Q Consensus 487 ~L~~L~L~~N~l~~--~~~~~l~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 563 (1078)
.+++|+|++|.+.+ .+|..++.+++|+.|+|++ |.+.|.+|..|.++++|++|++++|++.+..+..+..+..|+++
T Consensus 51 ~v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l 130 (313)
T d1ogqa_ 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTL 130 (313)
T ss_dssp CEEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEE
T ss_pred EEEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCC
T ss_conf 98899898998888887984784675335202026543330024311454200110203564344332222201110011
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 711664468688332244446477513763358887202573348-5533366545787788667765210773257648
Q 001434 564 NISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQL-EILKLSENKFSGNIPSTLGNLSHLTELQMGGNLF 642 (1078)
Q Consensus 564 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L-~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 642 (1078)
++++|.+...+|..+..++.++.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..++.+..+ .++++.|.+
T Consensus 131 ~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~ 209 (313)
T d1ogqa_ 131 DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNML 209 (313)
T ss_dssp ECCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEE
T ss_pred CCCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCC
T ss_conf 1122455556851220674000000235533562031214431123231022464353324332222222-333333433
Q ss_pred CCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCC
Q ss_conf 78897001680348999720122235988855584100101115899575787735653101451013345357999998
Q 001434 643 SGEIPPELGDLSSLQIALNLSYNNLSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGSNFSYNNLTGPLPSI 722 (1078)
Q Consensus 643 ~g~ip~~~~~l~~l~~~l~Ls~N~l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l~ls~N~l~g~~p~~ 722 (1078)
.|.+|..++.+..+. .+++++|.+++.+| .++.+.+|+.|+|++|+++|.+|..|.++++|+.+++++|+|+|.+|..
T Consensus 210 ~~~~~~~~~~~~~l~-~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~ 287 (313)
T d1ogqa_ 210 EGDASVLFGSDKNTQ-KIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287 (313)
T ss_dssp EECCGGGCCTTSCCS-EEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCS
T ss_pred CCCCCCCCCCCCCCC-CCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCC
T ss_conf 222222222222211-12222222222222-2224554444447657066608768847999998979588351668986
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 64676555533467676798888778
Q 001434 723 PQFQNMDISSFLGNEGLCGRPVGNCG 748 (1078)
Q Consensus 723 ~~~~~~~~~~~~~n~~lcg~p~~~c~ 748 (1078)
..+.++....+.+|..+||.|+++|.
T Consensus 288 ~~L~~L~~l~l~~N~~l~g~plp~c~ 313 (313)
T d1ogqa_ 288 GNLQRFDVSAYANNKCLCGSPLPACT 313 (313)
T ss_dssp TTGGGSCGGGTCSSSEEESTTSSCCC
T ss_pred CCCCCCCHHHHCCCCCCCCCCCCCCC
T ss_conf 66799897886889500198988989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=3.8e-40 Score=233.23 Aligned_cols=101 Identities=23% Similarity=0.366 Sum_probs=40.6
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 32333043302453246887665775556189711664468688332244446477513763358887202573348553
Q 001434 532 NCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEIL 611 (1078)
Q Consensus 532 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 611 (1078)
.++.++.+.+..|.+++ ...+..++++++|++++|++.+.. .+..+++|+.|++++|.+++ ++ .+..+++|++|
T Consensus 283 ~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L 356 (384)
T d2omza2 283 GLTALTNLELNENQLED--ISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWL 356 (384)
T ss_dssp TCTTCSEEECCSSCCSC--CGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEE
T ss_pred CCCCCCCCCCCCCCCCC--CCCCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCCCCCCC-CH-HHCCCCCCCEE
T ss_conf 56522223323233333--221000024676777788778984--53668988989898998999-74-67089999989
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEEECCCC
Q ss_conf 33665457877886677652107732576
Q 001434 612 KLSENKFSGNIPSTLGNLSHLTELQMGGN 640 (1078)
Q Consensus 612 ~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 640 (1078)
++++|++++..| ++++++|+.|+|++|
T Consensus 357 ~l~~N~l~~l~~--l~~l~~L~~L~L~~N 383 (384)
T d2omza2 357 SAGHNQISDLTP--LANLTRITQLGLNDQ 383 (384)
T ss_dssp ECCSSCCCBCGG--GTTCTTCSEEECCCE
T ss_pred ECCCCCCCCCHH--HCCCCCCCEEECCCC
T ss_conf 897995899800--003999999639789
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-35 Score=207.85 Aligned_cols=85 Identities=24% Similarity=0.337 Sum_probs=55.4
Q ss_pred CCCCCCCEEEECCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 99854516931599996899707998656667886457774386853367433313977657677957784587423533
Q 001434 87 TPCSWIGVNCTSDFEPVVWSLDLNAMNFTGSLSPSIGGLVHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI 166 (1078)
Q Consensus 87 ~~C~W~gv~C~~~~~~~v~~l~l~~~~l~g~~~~~l~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~~~~~~ 166 (1078)
|-|.|.+|.|+.. +++ .+|+.+. +.+++|+|++|.++...+..|..+++|++|++++|.+....
T Consensus 8 c~c~~~~~~C~~~-------------~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~ 71 (305)
T d1xkua_ 8 CQCHLRVVQCSDL-------------GLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKIS 71 (305)
T ss_dssp CEEETTEEECTTS-------------CCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBC
T ss_pred CEECCCEEEECCC-------------CCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCC
T ss_conf 8955999985599-------------988-5198889--99798978499189869657604656523112344344523
Q ss_pred CCCCCCCCCCCEECCCCCCCC
Q ss_conf 321266788813011354345
Q 001434 167 PAELGKLSSLVSLNICNNMIS 187 (1078)
Q Consensus 167 p~~l~~l~~L~~L~L~~n~~~ 187 (1078)
|..|..+++|++|++++|+++
T Consensus 72 ~~~f~~l~~L~~L~l~~n~l~ 92 (305)
T d1xkua_ 72 PGAFAPLVKLERLYLSKNQLK 92 (305)
T ss_dssp TTTTTTCTTCCEEECCSSCCS
T ss_pred HHHHHCCCCCCEECCCCCCCC
T ss_conf 566527985578315687567
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.3e-33 Score=197.34 Aligned_cols=83 Identities=23% Similarity=0.381 Sum_probs=26.8
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 30433024532468876657755561897116644686883322444464775137633588872025733485533366
Q 001434 536 LQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSE 615 (1078)
Q Consensus 536 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 615 (1078)
|+.|++++|.++...+..|.+++.+++|++++|.+.+..+..+.++++|+.|+|++|.|+ .+|.+|..+++|+.|+|++
T Consensus 173 L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~-~lp~~l~~l~~L~~L~Ls~ 251 (305)
T d1xkua_ 173 LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHN 251 (305)
T ss_dssp CSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCS
T ss_pred CCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC-CCCCCCCCCCCCCEEECCC
T ss_conf 678989788677888267641341330154455332223454334433224302554002-4631103346789898989
Q ss_pred CCCC
Q ss_conf 5457
Q 001434 616 NKFS 619 (1078)
Q Consensus 616 N~l~ 619 (1078)
|+|+
T Consensus 252 N~i~ 255 (305)
T d1xkua_ 252 NNIS 255 (305)
T ss_dssp SCCC
T ss_pred CCCC
T ss_conf 8657
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-35 Score=204.42 Aligned_cols=206 Identities=20% Similarity=0.270 Sum_probs=98.6
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCC-CCCCCCCCCCCCCCCHHHHH
Q ss_conf 74386853367433313977657677957784587423533321266788813011354-34577885144986456774
Q 001434 126 VHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNN-MISGALPEGLGNLSSLVDFV 204 (1078)
Q Consensus 126 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~L~~n-~~~~~~p~~l~~l~~L~~L~ 204 (1078)
+.+++|+|++|+|+...+..|..+++|++|++++|.+.+..+..+..++.++.++...+ .++.
T Consensus 32 ~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~~---------------- 95 (284)
T d1ozna_ 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRS---------------- 95 (284)
T ss_dssp TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCC----------------
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC----------------
T ss_conf 9988897748817987977864142130000134454332111212222222222221022354----------------
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 01674324356555676654589837864334569775566655415510346688888756754455466504785667
Q 001434 205 AYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTG 284 (1078)
Q Consensus 205 l~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~ 284 (1078)
..+..+.++++|+.|++++|.+....+..+...++|+.+++++|.+++..+..|..+++|+.|++++|++++
T Consensus 96 --------l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~ 167 (284)
T d1ozna_ 96 --------VDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISS 167 (284)
T ss_dssp --------CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCE
T ss_pred --------CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCC
T ss_conf --------462010101027787568854432013533200012110200143144580574043405022314176566
Q ss_pred CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 78755567564543430133333443421223223430112378888854755567665457842698787
Q 001434 285 FIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLN 355 (1078)
Q Consensus 285 ~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~ 355 (1078)
..+..|..+++|+++++++|++.+..|..|.++++|++|++++|.+.+..+..|..+++|++|++++|.+.
T Consensus 168 l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 168 VPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred CCHHHHCCCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 25666546563413142114346628167665320002333335221000002355465688981199887
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-34 Score=201.66 Aligned_cols=142 Identities=20% Similarity=0.237 Sum_probs=65.9
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 51000344333000233433699952223323330433024532468876657755561897116644686883322444
Q 001434 503 PLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCM 582 (1078)
Q Consensus 503 ~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~ 582 (1078)
+..+..+++|+.|++++|.+....+..+....+|+.+++++|.++++.+..|..+++|+.|++++|++..+.+..|.+++
T Consensus 98 ~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~ 177 (284)
T d1ozna_ 98 PATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLH 177 (284)
T ss_dssp TTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCT
T ss_pred CHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHCCCC
T ss_conf 20101010277875688544320135332000121102001431445805740434050223141765662566654656
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC
Q ss_conf 46477513763358887202573348553336654578778866776521077325764878
Q 001434 583 TLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSG 644 (1078)
Q Consensus 583 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g 644 (1078)
+|+.+++++|++++..|..|..+++|++|++++|++++..+..++.+++|++|++++|++..
T Consensus 178 ~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 178 SLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
T ss_conf 34131421143466281676653200023333352210000023554656889811998878
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.8e-31 Score=181.89 Aligned_cols=177 Identities=23% Similarity=0.248 Sum_probs=69.9
Q ss_pred CCCEEEEEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECC
Q ss_conf 66506422100245578687562346249963677668665100034433300023343369995222332333043302
Q 001434 463 NLIMLNLGYNKLFGNIPTDVLNCETLLQLRLVGNSLTGSFPLELCKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIA 542 (1078)
Q Consensus 463 ~L~~L~Ls~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 542 (1078)
++++|+|++|+|++..+..|.++++|++|++++|+|+.. + .+..+++|+.|++++|++. ..+..+..+++|+.|+++
T Consensus 32 ~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~~l-~-~~~~l~~L~~L~Ls~N~l~-~~~~~~~~l~~L~~L~l~ 108 (266)
T d1p9ag_ 32 DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL-Q-VDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108 (266)
T ss_dssp TCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCCEE-E-CCSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC-C-CCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCC
T ss_conf 889898849928985977863456552213566544443-1-1111223211111222221-111121222222222222
Q ss_pred CCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 45324688766577555618971166446868833224444647751376335888720257334855333665457877
Q 001434 543 NNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNI 622 (1078)
Q Consensus 543 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~ 622 (1078)
+|.+....+..+..+.++.+|++++|.+....+..+..++.++.+++++|++++..+..|..+++|+.|+|++|+|+ .+
T Consensus 109 ~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~l 187 (266)
T d1p9ag_ 109 FNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TI 187 (266)
T ss_dssp SSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CC
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCHHCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC-CC
T ss_conf 23110110011222211112212434210221233322111000000015652237200134212423430139785-56
Q ss_pred CCCCCCCCCCEEEECCCCCCC
Q ss_conf 886677652107732576487
Q 001434 623 PSTLGNLSHLTELQMGGNLFS 643 (1078)
Q Consensus 623 p~~~~~l~~L~~L~Ls~N~l~ 643 (1078)
|..+..+++|+.|+|++|++.
T Consensus 188 p~~~~~~~~L~~L~L~~Np~~ 208 (266)
T d1p9ag_ 188 PKGFFGSHLLPFAFLHGNPWL 208 (266)
T ss_dssp CTTTTTTCCCSEEECCSCCBC
T ss_pred CHHHCCCCCCCEEEECCCCCC
T ss_conf 866777888999983699987
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=5.5e-26 Score=155.58 Aligned_cols=51 Identities=29% Similarity=0.320 Sum_probs=19.4
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCC
Q ss_conf 38685336743331397765767795778458742353332126678881301135434
Q 001434 128 LTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMI 186 (1078)
Q Consensus 128 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~L~~n~~ 186 (1078)
+++|||+++.++ .+|+. +++|++|+|++|+++ .+|..+ .+|+.|++++|++
T Consensus 40 l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l 90 (353)
T d1jl5a_ 40 AHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNL 90 (353)
T ss_dssp CSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCC
T ss_pred CCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCC
T ss_conf 989993799988-78898---789888989999796-336203---3203326655143
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=6.7e-26 Score=155.12 Aligned_cols=14 Identities=36% Similarity=0.204 Sum_probs=4.8
Q ss_pred CCCCCEEECCCCCC
Q ss_conf 46567165447424
Q 001434 389 LRNLTKLDLSINYL 402 (1078)
Q Consensus 389 l~~L~~L~Ls~N~l 402 (1078)
++.++.+++++|..
T Consensus 161 l~~l~~L~l~~n~~ 174 (353)
T d1jl5a_ 161 LPFLTAIYADNNSL 174 (353)
T ss_dssp CTTCCEEECCSSCC
T ss_pred CCCCEECCCCCCCC
T ss_conf 12220011123344
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=5.5e-31 Score=183.02 Aligned_cols=61 Identities=18% Similarity=0.246 Sum_probs=31.3
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 4386853367433313-9776576779577845874235----33321266788813011354345
Q 001434 127 HLTYLDLAYNELTGYI-PREIGNCSRLEHLYLNNNQFSG----KIPAELGKLSSLVSLNICNNMIS 187 (1078)
Q Consensus 127 ~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~n~~~~----~~p~~l~~l~~L~~L~L~~n~~~ 187 (1078)
+|+.||++.+++++.. .+.+..+++++.|+|++|+++. .++..+..+++|++|||++|.++
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~ 68 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELG 68 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCH
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCC
T ss_conf 877798208958868999999767799999828999988999999999853999888979598597
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=3.4e-27 Score=162.25 Aligned_cols=166 Identities=17% Similarity=0.163 Sum_probs=120.9
Q ss_pred CCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCC----------------CHHHHHHHHHHHHHCCCCCCCEEEEEEEE
Q ss_conf 76177026725999999789959999994346788----------------51489999999998059988255475179
Q 001434 784 DSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREG----------------NNIESSFRAEILTLGKIRHRNIVKLYGFC 847 (1078)
Q Consensus 784 ~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----------------~~~~~~~~~e~~~l~~l~h~~iv~l~~~~ 847 (1078)
.++.||+|+||+||+|.+.+|+.||+|++...... ........+|...+.++.|.+++..+++.
T Consensus 4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~ 83 (191)
T d1zara2 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE 83 (191)
T ss_dssp EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred HCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEC
T ss_conf 27780248565999999799999999998604434666556563000888999999778999999981699914499862
Q ss_pred EECCCEEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECC
Q ss_conf 84591389996056899776730799999966899999999965645420689966963788782897899966990114
Q 001434 848 YHQGSNLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFG 927 (1078)
Q Consensus 848 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg 927 (1078)
..+++|||+++..+.+ ++......++.|++.+++|+|++ |++||||||+||+++++ .++++|||
T Consensus 84 ----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~liDFG 147 (191)
T d1zara2 84 ----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFP 147 (191)
T ss_dssp ----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEEECCCT
T ss_pred ----CCEEEEEEECCCCCCC--------HHHHHHHHHHHHHHHHHHHHHHC---CEEECCCCHHHEEEECC-CEEEEECC
T ss_conf ----8889999504565420--------01578999999999999998268---88983689036114289-89998778
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC-----CCCCCCCCCCCCCHHHHHHHH
Q ss_conf 53002798888644445555755610-----102287787676510789999
Q 001434 928 LAKVIDMPQSKSMSAVAGSYGYIAPE-----YAYTMKVTEKCDIYSYGVVLL 974 (1078)
Q Consensus 928 ~a~~~~~~~~~~~~~~~gt~~y~aPE-----~~~~~~~~~~~DiwslGvil~ 974 (1078)
.|.....+... .|.... ......|+.++|+||+.--+.
T Consensus 148 ~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 148 QSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp TCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCH---------HHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
T ss_conf 84308998709---------99987799999997578998446899999874
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.6e-31 Score=185.89 Aligned_cols=37 Identities=11% Similarity=0.111 Sum_probs=17.8
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEECCCCCCCC
Q ss_conf 7957784587423533-321266788813011354345
Q 001434 151 RLEHLYLNNNQFSGKI-PAELGKLSSLVSLNICNNMIS 187 (1078)
Q Consensus 151 ~L~~L~Ls~n~~~~~~-p~~l~~l~~L~~L~L~~n~~~ 187 (1078)
+|+.||++++++++.. ..-+..+++++.|+|++|.++
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~ 40 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLT 40 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCC
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCC
T ss_conf 87779820895886899999976779999982899998
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.91 E-value=3.1e-24 Score=146.00 Aligned_cols=175 Identities=20% Similarity=0.265 Sum_probs=125.5
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC-CCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 300023343369995222332333043302453246-8876657755561897116644686883322444464775137
Q 001434 513 YAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTS-ELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQRLDISH 591 (1078)
Q Consensus 513 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 591 (1078)
+.+++++++++ .+|..+. +.+++|+|++|.|++ ..+..|.++++|++|+|++|.+....+..+..++.|+.|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf 99997089967-0298989--78788984898775530200257876272130136322121212221122221010035
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCC
Q ss_conf 63358887202573348553336654578778866776521077325764878897001680348999720122235988
Q 001434 592 NSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNNLSGSI 671 (1078)
Q Consensus 592 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~~l~Ls~N~l~g~~ 671 (1078)
|+++...+..|.++++|+.|+|++|+|++..+..|..+++|++|+|++|++....+..+ -...+. .+.+..|.++...
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~~~~-~~~~l~-~~~l~~~~~~c~~ 165 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCHLAW-FAEWLR-KKSLNGGAARCGA 165 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGGGHH-HHHHHH-HHCCSGGGCBBCS
T ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCHHH-HHHHHH-HHCCCCCCEEECC
T ss_conf 53443497998079746552457745353597785687533420003644343530277-764235-4035689827689
Q ss_pred CCCCCCCCCCCHHHCCCCCCCCCC
Q ss_conf 855584100101115899575787
Q 001434 672 PPELGKLDLLEFLLLNNNHLSGEI 695 (1078)
Q Consensus 672 p~~~~~l~~L~~L~Ls~N~l~~~~ 695 (1078)
|..+. .++.++|+.|.+.-..
T Consensus 166 p~~l~---~~~l~~L~~n~l~C~~ 186 (192)
T d1w8aa_ 166 PSKVR---DVQIKDLPHSEFKCSS 186 (192)
T ss_dssp STTTT---TSBGGGSCTTTCCCCC
T ss_pred CHHHC---CCEEEECCHHHCCCCC
T ss_conf 84336---9886144875575899
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=2.2e-23 Score=141.37 Aligned_cols=57 Identities=16% Similarity=0.169 Sum_probs=30.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCCEECCC
Q ss_conf 74386853367433313977657677957784587423533-3212667888130113
Q 001434 126 VHLTYLDLAYNELTGYIPREIGNCSRLEHLYLNNNQFSGKI-PAELGKLSSLVSLNIC 182 (1078)
Q Consensus 126 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~n~~~~~~-p~~l~~l~~L~~L~L~ 182 (1078)
+++++|+|++|.++...+..|.++++|++|++++|.+...+ +..|..++.++++.+.
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~ 86 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIE 86 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCC
T ss_conf 9889998769918964966861464323211022112420100112222222221111
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=1.6e-23 Score=142.05 Aligned_cols=37 Identities=11% Similarity=0.082 Sum_probs=16.1
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEECCCCCCCC
Q ss_conf 7957784587423533321266788813011354345
Q 001434 151 RLEHLYLNNNQFSGKIPAELGKLSSLVSLNICNNMIS 187 (1078)
Q Consensus 151 ~L~~L~Ls~n~~~~~~p~~l~~l~~L~~L~L~~n~~~ 187 (1078)
++++|+|++|.++...+..|.++++|++|++++|.+.
T Consensus 30 ~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~ 66 (242)
T d1xwdc1 30 NAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVL 66 (242)
T ss_dssp CCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTC
T ss_pred CCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCC
T ss_conf 8899987699189649668614643232110221124
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.90 E-value=1.3e-23 Score=142.67 Aligned_cols=209 Identities=22% Similarity=0.360 Sum_probs=0.0
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 66554155103466888887567544554665047856677875556756454343013333344342122322343011
Q 001434 245 CQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLY 324 (1078)
Q Consensus 245 l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~ 324 (1078)
++++..++++.+++.+.. .++.+.+|++|++.+|.++.. ..+..+++|++|++++|.+.+..+ +.+++++++++
T Consensus 18 l~~~~~~~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~ 91 (227)
T d1h6ua2 18 LANAIKIAAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELE 91 (227)
T ss_dssp HHHHHHHHTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEE
T ss_pred HHHHHHHHHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCC
T ss_conf 999999984888767757--987848868997779999766--457448888376357853202543--11233432012
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCHHHHHHCCCCHHCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 23788888547555676654578426987877521233320153301023552567889864224656716544742458
Q 001434 325 LYRNELNGTIPREIGNLSMVTEIDLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSINYLTG 404 (1078)
Q Consensus 325 L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 404 (1078)
+++|.++.. ..+..+++|+.++++++...+..+ +...+.+..+.++.+.+... ..+..+++|+.|++++|.+.+
T Consensus 92 ~~~n~~~~i--~~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~--~~~~~~~~L~~L~l~~n~~~~ 165 (227)
T d1h6ua2 92 LSGNPLKNV--SAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSD 165 (227)
T ss_dssp CCSCCCSCC--GGGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCC--GGGGGCTTCCEEECCSSCCCC
T ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCH--HCCCCCHHHHHCHHHHHCHH--HHHCCCCCCCCCCCCCCCCCC
T ss_conf 111222222--222222222122122244331100--00023012220000000000--000102111002333333331
Q ss_pred CCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCCEEEEEE
Q ss_conf 9885542334455467304523468998542368510999038878899891111787665064221
Q 001434 405 PIPVGFQHLTQMRQLQLFENSLTGGIPPGLGLYSLLWVVDFSHNYLTGRIPPHLCQNSNLIMLNLGY 471 (1078)
Q Consensus 405 ~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~L~~L~ls~N~l~~~~p~~~~~~~~L~~L~Ls~ 471 (1078)
..+ +..+++|+.|++++|+++...+ +..+++|++|++++|++++..+ +..+++|+.|++++
T Consensus 166 ~~~--l~~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 166 LTP--LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred CHH--HCCCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf 001--0564633564458884177853--4479999989795996899802--03699989897129
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=4.7e-22 Score=134.02 Aligned_cols=187 Identities=22% Similarity=0.315 Sum_probs=0.0
Q ss_pred CCCHHHHHCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 86456774016743243565556766545898378643345697755666554155103466888887567544554665
Q 001434 197 LSSLVDFVAYTNNLTGPLPQSIGNLRNLRVFRAGQNAISGSIPAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIV 276 (1078)
Q Consensus 197 l~~L~~L~l~~n~l~~~~p~~l~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~ 276 (1078)
+.+.....+..+.+.+.++. ..+.+|+.|++++|.+..... +..+++|++|++++|++++..+ ++.+++|++|+
T Consensus 23 l~~~i~~~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~ 96 (210)
T d1h6ta2 23 FAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLF 96 (210)
T ss_dssp HHHHHHHHTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEE
T ss_pred HHHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCC
T ss_conf 99999998575765775188--795484589782798887444--7648998987698960258601--13586212014
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 04785667787555675645434301333334434212232234301123788888547555676654578426987877
Q 001434 277 LWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGTIPREIGNLSMVTEIDLSENSLNG 356 (1078)
Q Consensus 277 L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~~l~~l~~L~~L~Ls~N~l~~ 356 (1078)
+++|+++ .++ .+..+++|+.|++++|.+... ..+..++.++.+++++|.+. .+..+..+++|+.+++++|++++
T Consensus 97 l~~n~i~-~l~-~l~~l~~L~~L~l~~~~~~~~--~~l~~l~~l~~l~~~~n~l~--~~~~~~~l~~L~~l~l~~n~l~~ 170 (210)
T d1h6ta2 97 LDENKVK-DLS-SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISD 170 (210)
T ss_dssp CCSSCCC-CGG-GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCC
T ss_pred CCCCCCC-CCC-CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3333321-222-121222111223456532211--22011111222112223334--54310001332100134643025
Q ss_pred CCCHHHHHHCCCCHHCCCCCCCCCCCCCCCCCCCCCCEEECCC
Q ss_conf 5212333201533010235525678898642246567165447
Q 001434 357 EIPTEFSKITGLRLLFLFQNQLTGVIPNELSSLRNLTKLDLSI 399 (1078)
Q Consensus 357 ~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~Ls~ 399 (1078)
..+ +..+++|+.|++++|+++.+ ..+..+++|+.|+|++
T Consensus 171 i~~--l~~l~~L~~L~Ls~N~i~~l--~~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 171 IVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLELFS 209 (210)
T ss_dssp CGG--GTTCTTCCEEECCSSCCCBC--GGGTTCTTCSEEEEEE
T ss_pred CCC--CCCCCCCCEEECCCCCCCCC--HHHCCCCCCCEEECCC
T ss_conf 645--36789899998979989987--2116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87 E-value=1.4e-22 Score=136.94 Aligned_cols=185 Identities=28% Similarity=0.387 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCE
Q ss_conf 03443330002334336999522233233304330245324688766577555618971166446868833224444647
Q 001434 507 CKLENLYAIELDQNKFSGPIPPEIENCQKLQRLHIANNYFTSELPKEVGNLSQLVTFNISSNMLTGLIPPEIVNCMTLQR 586 (1078)
Q Consensus 507 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 586 (1078)
..+.+...+.++.+.+++.++. ..+.+++.|++++|.++.. ..+..+++|++|++++|++++..+ +..+++|+.
T Consensus 15 ~~l~~~i~~~l~~~~~~~~~~~--~~l~~l~~L~l~~~~i~~l--~~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~ 88 (199)
T d2omxa2 15 TALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVD 88 (199)
T ss_dssp HHHHHHHHHHTTCSSTTSEECH--HHHTTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCE
T ss_pred HHHHHHHHHHHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCC
T ss_conf 8999999999677877885598--7946878998999999775--202137886757545655667640--167752231
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCHHHHHHHHCCCCC
Q ss_conf 75137633588872025733485533366545787788667765210773257648788970016803489997201222
Q 001434 587 LDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSHLTELQMGGNLFSGEIPPELGDLSSLQIALNLSYNN 666 (1078)
Q Consensus 587 L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~g~ip~~~~~l~~l~~~l~Ls~N~ 666 (1078)
|++++|.+. .++. +.+++.|+.|++++|.+....+ +..+++|+.|++++|++. .++ .+..++.+. .|++++|+
T Consensus 89 L~l~~n~~~-~~~~-l~~l~~L~~L~l~~~~~~~~~~--~~~l~~L~~L~l~~n~l~-~~~-~l~~~~~L~-~L~l~~n~ 161 (199)
T d2omxa2 89 ILMNNNQIA-DITP-LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTIS-DIS-ALSGLTSLQ-QLNFSSNQ 161 (199)
T ss_dssp EECCSSCCC-CCGG-GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCC-CCG-GGTTCTTCS-EEECCSSC
T ss_pred CCCCCCCCC-CCCC-CCCCCCCCCCCCCCCCCCCCCC--CCHHHHHHHHHHHHHHHC-CCC-CCCCCCCCC-CCCCCCCC
T ss_conf 111222222-2211-1112232221112222223210--001223677643111100-234-333211111-12234555
Q ss_pred CCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHCCCCCC
Q ss_conf 359888555841001011158995757877356531014510
Q 001434 667 LSGSIPPELGKLDLLEFLLLNNNHLSGEIPSAFENLSSLLGS 708 (1078)
Q Consensus 667 l~g~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~l 708 (1078)
+++..+ ++.+++|+.|++++|+++ .++ .+.++++|+.|
T Consensus 162 l~~l~~--l~~l~~L~~L~ls~N~i~-~i~-~l~~L~~L~~L 199 (199)
T d2omxa2 162 VTDLKP--LANLTTLERLDISSNKVS-DIS-VLAKLTNLESL 199 (199)
T ss_dssp CCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGGGCTTCSEE
T ss_pred CCCCCC--CCCCCCCCEEECCCCCCC-CCC-CCCCCCCCCCC
T ss_conf 567701--167998999978799799-881-01278998949
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.83 E-value=2.4e-22 Score=135.60 Aligned_cols=15 Identities=20% Similarity=0.146 Sum_probs=5.3
Q ss_pred CCCCCCCEECCCCCC
Q ss_conf 667888130113543
Q 001434 171 GKLSSLVSLNICNNM 185 (1078)
Q Consensus 171 ~~l~~L~~L~L~~n~ 185 (1078)
..+++|++|+++++.
T Consensus 68 ~~c~~L~~L~L~~~~ 82 (284)
T d2astb2 68 SQCSKLQNLSLEGLR 82 (284)
T ss_dssp TTBCCCSEEECTTCB
T ss_pred HHCCCCCCCCCCCCC
T ss_conf 748776514523467
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.80 E-value=2.4e-21 Score=130.18 Aligned_cols=13 Identities=15% Similarity=0.393 Sum_probs=5.0
Q ss_pred CCCCEECCCCCCC
Q ss_conf 8881301135434
Q 001434 174 SSLVSLNICNNMI 186 (1078)
Q Consensus 174 ~~L~~L~L~~n~~ 186 (1078)
.+|++||++++.+
T Consensus 46 ~~L~~LdLs~~~i 58 (284)
T d2astb2 46 FRVQHMDLSNSVI 58 (284)
T ss_dssp BCCCEEECTTCEE
T ss_pred CCCCEEECCCCCC
T ss_conf 8788788989845
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.80 E-value=4.9e-22 Score=133.94 Aligned_cols=251 Identities=16% Similarity=0.148 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCC
Q ss_conf 139776576779577845874235----3332126678881301135434577885144986456774016743243565
Q 001434 141 YIPREIGNCSRLEHLYLNNNQFSG----KIPAELGKLSSLVSLNICNNMISGALPEGLGNLSSLVDFVAYTNNLTGPLPQ 216 (1078)
Q Consensus 141 ~~p~~~~~l~~L~~L~Ls~n~~~~----~~p~~l~~l~~L~~L~L~~n~~~~~~p~~l~~l~~L~~L~l~~n~l~~~~p~ 216 (1078)
.+...+.....|++|+|++|.+.. .+...+...++|+.|+++++...............+...
T Consensus 22 ~l~~~L~~~~~l~~L~Ls~n~i~~~~~~~l~~~l~~~~~L~~l~l~~~~~~~~~~~~~~~~~~l~~~------------- 88 (344)
T d2ca6a1 22 SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKDEIPEALRLLLQA------------- 88 (344)
T ss_dssp TTSHHHHHCSCCCEEECTTSEECHHHHHHHHHTTTTCTTCCEEECCSCCTTSCGGGSHHHHHHHHHH-------------
T ss_pred HHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCHHHHHHHHH-------------
T ss_conf 9999996389978897849837789999999999858998888887775433454210678799988-------------
Q ss_pred CCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEEECCCCCCCCCCCC-------------CCCCCCCEEEECC
Q ss_conf 556766545898378643345----69775566655415510346688888756-------------7544554665047
Q 001434 217 SIGNLRNLRVFRAGQNAISGS----IPAEISGCQSLQILGLAQNDIGGSLPKEI-------------GMLESLTEIVLWD 279 (1078)
Q Consensus 217 ~l~~l~~L~~L~l~~n~l~~~----~~~~~~~l~~L~~L~L~~n~l~~~~~~~l-------------~~l~~L~~L~L~~ 279 (1078)
+...++|+.|++++|.++.. +...+..+++|+.|++++|.++......+ ...+.|+.+.+++
T Consensus 89 -l~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~~~~~~~~~~L~~l~l~~ 167 (344)
T d2ca6a1 89 -LLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 167 (344)
T ss_dssp -HTTCTTCCEEECCSCCCCTTTHHHHHHHHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCS
T ss_pred -HHHCCCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCHHEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEECCC
T ss_conf -7547775633000013455433310111002343210000024666654311112122221100014676421110136
Q ss_pred CCCC----CCCCCCCCCCCCCCEEEECCCCCCCC-----CCCCCCCCCCCCEEECCCCCCCCC----CCCCCCCCCCCCE
Q ss_conf 8566----77875556756454343013333344-----342122322343011237888885----4755567665457
Q 001434 280 NQLT----GFIPSELGNCTKLQTLALYSNNLVGQ-----IPKEVGNLKFLTKLYLYRNELNGT----IPREIGNLSMVTE 346 (1078)
Q Consensus 280 n~l~----~~~p~~l~~l~~L~~L~L~~n~l~~~-----~p~~l~~l~~L~~L~L~~N~l~~~----~~~~l~~l~~L~~ 346 (1078)
|.++ ..+...+...+.|+.|++++|.+... +...+...+.|+.|+|++|.++.. +...+..+++|++
T Consensus 168 n~i~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~ 247 (344)
T d2ca6a1 168 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRE 247 (344)
T ss_dssp SCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCE
T ss_pred CCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCHHHHHCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 50135543322111123332133543332222222320024332110121122233332222222234443323221111
Q ss_pred EECCCCCCCCCCCHHHHHH------CCCCHHCCCCCCCCCCCCCCCC-----CCCCCCEEECCCCCCCCC
Q ss_conf 8426987877521233320------1533010235525678898642-----246567165447424589
Q 001434 347 IDLSENSLNGEIPTEFSKI------TGLRLLFLFQNQLTGVIPNELS-----SLRNLTKLDLSINYLTGP 405 (1078)
Q Consensus 347 L~Ls~N~l~~~~~~~~~~l------~~L~~L~L~~n~l~~~~~~~l~-----~l~~L~~L~Ls~N~l~~~ 405 (1078)
|++++|.+++.....+... +.|+.|++++|+++......+. +.+.|+.|++++|++...
T Consensus 248 L~Ls~n~i~~~g~~~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~ 317 (344)
T d2ca6a1 248 LGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE 317 (344)
T ss_dssp EECTTCCCCHHHHHHHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred HHHHCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHHHCCCCCCCEEECCCCCCCCC
T ss_conf 0300475671566788877631568888989898986980899999999970389999897879808986
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.69 E-value=3.4e-17 Score=107.39 Aligned_cols=131 Identities=19% Similarity=0.147 Sum_probs=0.0
Q ss_pred CCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCC
Q ss_conf 97755666554155103466888887567544554665047856677875556756454343013333344342122322
Q 001434 239 PAEISGCQSLQILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLK 318 (1078)
Q Consensus 239 ~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~ 318 (1078)
...+.++..+++|+|++|+++ .++..+..+++|+.|++++|+++.. ..+..+++|++|++++|+++...+..+..++
T Consensus 11 ~~~~~n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~ 87 (162)
T d1a9na_ 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALP 87 (162)
T ss_dssp SCEEECTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCT
T ss_pred HHHCCCCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 175168574848978899788-6576200414599898979978764--7744576130643102134577763223345
Q ss_pred CCCEEECCCCCCCCCCC-CCCCCCCCCCEEECCCCCCCCCC---CHHHHHHCCCCHHC
Q ss_conf 34301123788888547-55567665457842698787752---12333201533010
Q 001434 319 FLTKLYLYRNELNGTIP-REIGNLSMVTEIDLSENSLNGEI---PTEFSKITGLRLLF 372 (1078)
Q Consensus 319 ~L~~L~L~~N~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L~ 372 (1078)
+|++|++++|.+..... ..+..+++|++|++++|.++... +..+..+++|+.|+
T Consensus 88 ~L~~L~L~~N~i~~~~~l~~l~~l~~L~~L~l~~N~i~~~~~~r~~~i~~lp~L~~LD 145 (162)
T d1a9na_ 88 DLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKKHYRLYVIYKVPQVRVLD 145 (162)
T ss_dssp TCCEEECCSCCCCCGGGGGGGGGCTTCCEEECCSSGGGGSTTHHHHHHHHCTTCSEET
T ss_pred CCCCCEECCCCCCCCCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHCCCCCEEC
T ss_conf 3443420300016654211001365320664079963456106999998789958337
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.63 E-value=4e-18 Score=112.48 Aligned_cols=18 Identities=33% Similarity=0.552 Sum_probs=6.7
Q ss_pred CCCCCCCEEEECCCCCCC
Q ss_conf 677652107732576487
Q 001434 626 LGNLSHLTELQMGGNLFS 643 (1078)
Q Consensus 626 ~~~l~~L~~L~Ls~N~l~ 643 (1078)
++.+++|+.|++++|++.
T Consensus 136 l~~l~~L~~L~L~~N~l~ 153 (198)
T d1m9la_ 136 LAALDKLEDLLLAGNPLY 153 (198)
T ss_dssp HTTTTTCSEEEECSSHHH
T ss_pred CCCCCCCCEEECCCCCCC
T ss_conf 367776302342798434
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.61 E-value=1.5e-15 Score=98.39 Aligned_cols=118 Identities=25% Similarity=0.291 Sum_probs=0.0
Q ss_pred CEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCC
Q ss_conf 41551034668888875675445546650478566778755567564543430133333443421223223430112378
Q 001434 249 QILGLAQNDIGGSLPKEIGMLESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRN 328 (1078)
Q Consensus 249 ~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N 328 (1078)
++|+|++|+++ .++. ++.+++|++|++++|+++ .+|..++.+++|++|++++|.++ .++. +..+++|++|++++|
T Consensus 1 R~L~Ls~n~l~-~l~~-l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~-~l~~-~~~l~~L~~L~l~~N 75 (124)
T d1dcea3 1 RVLHLAHKDLT-VLCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 75 (124)
T ss_dssp SEEECTTSCCS-SCCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC-CCGG-GTTCSSCCEEECCSS
T ss_pred CEEECCCCCCC-CCCC-CCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC-CCCC-CCCCCCCCEEECCCC
T ss_conf 98986899898-8710-105898898979787168-65215655431354532432112-3574-123355576888898
Q ss_pred CCCCCCC-CCCCCCCCCCEEECCCCCCCCCC---CHHHHHHCCCCHH
Q ss_conf 8888547-55567665457842698787752---1233320153301
Q 001434 329 ELNGTIP-REIGNLSMVTEIDLSENSLNGEI---PTEFSKITGLRLL 371 (1078)
Q Consensus 329 ~l~~~~~-~~l~~l~~L~~L~Ls~N~l~~~~---~~~~~~l~~L~~L 371 (1078)
++..... ..+..+++|+.|++++|+++... ...+..+++|+.+
T Consensus 76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~~~~~~~l~~~lp~L~~L 122 (124)
T d1dcea3 76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPSVSSI 122 (124)
T ss_dssp CCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSCTTHHHHHCTTCSEE
T ss_pred CCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCHHHHHHHHCCCCCEE
T ss_conf 65888882565379999999897996886826799999989673138
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.58 E-value=2.3e-14 Score=91.92 Aligned_cols=89 Identities=21% Similarity=0.207 Sum_probs=34.2
Q ss_pred CCCCCCCCCEEEECCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 6577555618971166-446868833224444647751376335888720257334855333665457877886677652
Q 001434 553 EVGNLSQLVTFNISSN-MLTGLIPPEIVNCMTLQRLDISHNSFVGSLPNELGTLQQLEILKLSENKFSGNIPSTLGNLSH 631 (1078)
Q Consensus 553 ~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 631 (1078)
.+..+++|++|++++| .+..+.+..|.++++|+.|++++|+|+...+..|..+++|+.|+|++|+|+...+..+.. ..
T Consensus 26 ~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~-~~ 104 (156)
T d2ifga3 26 HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQG-LS 104 (156)
T ss_dssp TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCSTTTCS-CC
T ss_pred CCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCHHHHCC-CC
T ss_conf 02576565743168986644369212256666672162021247742011124554333322678785157456335-32
Q ss_pred CEEEECCCCCC
Q ss_conf 10773257648
Q 001434 632 LTELQMGGNLF 642 (1078)
Q Consensus 632 L~~L~Ls~N~l 642 (1078)
|+.|+|++|++
T Consensus 105 l~~L~L~~Np~ 115 (156)
T d2ifga3 105 LQELVLSGNPL 115 (156)
T ss_dssp CCEEECCSSCC
T ss_pred CCCCCCCCCCC
T ss_conf 12433579863
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=99.10 E-value=5.6e-10 Score=67.82 Aligned_cols=149 Identities=17% Similarity=0.091 Sum_probs=94.2
Q ss_pred HHHHHHHCCCCCCEEECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEECCC
Q ss_conf 699974058776177026725999999789959999994346788514899999999980599-8825547517984591
Q 001434 774 DVVEATYNFHDSFIVGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGS 852 (1078)
Q Consensus 774 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~ 852 (1078)
++.....+|+..+..+.++.+.||+.... +..+++|+........ ...+.+|...+..+. +-.+++++.+..+++.
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~ 84 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGW 84 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEEC-CCEEEEEECCCCCCCC--HHHHHHHHHHHHHHHCCCCCCCEEEEEECCCC
T ss_conf 99975135279976789987718999908-9869999848876532--55699999999987606998728999750896
Q ss_pred EEEEEEECCCCCHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---------------------------------
Q ss_conf 38999605689977673079999996689999999996564542068---------------------------------
Q 001434 853 NLLIYEYMERGSLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHDC--------------------------------- 899 (1078)
Q Consensus 853 ~~lv~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~~--------------------------------- 899 (1078)
.++||++++|.++.+..... .....++.++.+.+..+|+..
T Consensus 85 ~~lv~~~l~G~~~~~~~~~~------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 85 SNLLMSEADGVLCSEEYEDE------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEEEECCSSEEHHHHTTTC------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEEEECCCCCCCCCCCCC------CCHHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 49999860433435433440------269999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----------------------99669637887828978999669901145300
Q 001434 900 -----------------------KPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 900 -----------------------~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 931 (1078)
...++|+|+.|.||++++++.+-++||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.88 E-value=2.9e-10 Score=69.45 Aligned_cols=122 Identities=20% Similarity=0.114 Sum_probs=0.0
Q ss_pred CCCCEEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCCCCCEE
Q ss_conf 4554665047856677875556756454343013333344342122322343011237888885--47555676654578
Q 001434 270 ESLTEIVLWDNQLTGFIPSELGNCTKLQTLALYSNNLVGQIPKEVGNLKFLTKLYLYRNELNGT--IPREIGNLSMVTEI 347 (1078)
Q Consensus 270 ~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~N~l~~~--~~~~l~~l~~L~~L 347 (1078)
...+.|++++. .....+..+..+..+....+... .++.....++.|++|+|++|+|+.. ++..+..+++|+.|
T Consensus 22 ~~~~~Ldls~l----~~~~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 22 GSQQALDLKGL----RSDPDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSSCCBCCCCC----SSCTTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHHCEEECCCC----CCCCHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 33086534359----89821554664011225556766-60788974878788637776666773158898658856100
Q ss_pred ECCCCCCCCCCCHHHHHHCCCCHHCCCCCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 42698787752123332015330102355256788986-------42246567165
Q 001434 348 DLSENSLNGEIPTEFSKITGLRLLFLFQNQLTGVIPNE-------LSSLRNLTKLD 396 (1078)
Q Consensus 348 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~-------l~~l~~L~~L~ 396 (1078)
++++|.++...+..+.....|+.|++.+|.+....... +..+|+|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.78 E-value=5.4e-08 Score=56.95 Aligned_cols=131 Identities=16% Similarity=0.085 Sum_probs=82.3
Q ss_pred EEECCCC-EEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC--CCCCEEEEEEEEEECCCEEEEEEECCCC
Q ss_conf 7702672-599999978995999999434678851489999999998059--9882554751798459138999605689
Q 001434 787 IVGSGAY-GTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI--RHRNIVKLYGFCYHQGSNLLIYEYMERG 863 (1078)
Q Consensus 787 ~ig~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l--~h~~iv~l~~~~~~~~~~~lv~e~~~~g 863 (1078)
.+..|.. +.||+....++..+++|....... ..+.+|...++.+ ..-.+++++.+..+++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCH-----HHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECC
T ss_conf 76786547758999938987899995896677-----6899999999999865999886132224566159998744135
Q ss_pred CHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHCC---------------------------------------------
Q ss_conf 97767307999999668999999999656454206---------------------------------------------
Q 001434 864 SLGELLHGSSCNLEWPTRFMIALGAAEGLAYLHHD--------------------------------------------- 898 (1078)
Q Consensus 864 sL~~~l~~~~~~~~~~~~~~i~~~i~~~L~~LH~~--------------------------------------------- 898 (1078)
++.+.. .... ..+.++.+.+..||+.
T Consensus 92 ~~~~~~------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 92 DLLSSH------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp ETTTSC------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCCCC------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 543221------2689---9999999999987368854488755412468899999987541101134011213799999
Q ss_pred ----------CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf ----------899669637887828978999669901145300
Q 001434 899 ----------CKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 899 ----------~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 931 (1078)
....++|+|+.|.||+++++..+.++||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.63 E-value=2.9e-07 Score=52.96 Aligned_cols=79 Identities=11% Similarity=0.120 Sum_probs=49.9
Q ss_pred CCEEECCCCEEEEEEEECC-CCEEEEEEECCCC--CC---CHHHHHHHHHHHHHCCCC---CCCEEEEEEEEEECCCEEE
Q ss_conf 6177026725999999789-9599999943467--88---514899999999980599---8825547517984591389
Q 001434 785 SFIVGSGAYGTVYKAVMDS-GKIVAVKKLASNR--EG---NNIESSFRAEILTLGKIR---HRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 785 ~~~ig~G~~g~V~~~~~~~-~~~vaiK~~~~~~--~~---~~~~~~~~~e~~~l~~l~---h~~iv~l~~~~~~~~~~~l 855 (1078)
.+.||.|....||++...+ ++.+++|...... .+ .....+...|...++.+. ...+++++. .+++..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEE--ECCCCCEE
T ss_conf 9980798527689999579984899961771303467778887789999999999865057988552899--85988779
Q ss_pred EEEECCCCCH
Q ss_conf 9960568997
Q 001434 856 IYEYMERGSL 865 (1078)
Q Consensus 856 v~e~~~~gsL 865 (1078)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=98.16 E-value=1e-05 Score=44.48 Aligned_cols=74 Identities=19% Similarity=0.197 Sum_probs=47.0
Q ss_pred CCEEECCCCEEEEEEEECC--------CCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCC-CCCEEEEEEEEEECCCEEE
Q ss_conf 6177026725999999789--------959999994346788514899999999980599-8825547517984591389
Q 001434 785 SFIVGSGAYGTVYKAVMDS--------GKIVAVKKLASNREGNNIESSFRAEILTLGKIR-HRNIVKLYGFCYHQGSNLL 855 (1078)
Q Consensus 785 ~~~ig~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~l 855 (1078)
.+.++.|-...+|++...+ .+.|.+++.-.. .. .....+|..+++.+. +.-.+++++++. .++
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~----~g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFS----GGR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEET----TEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCCC-CH---HHHHHHHHHHHHHHHHCCCCCEEEEECC----CCE
T ss_conf 999178533434899968877544578981799965996-11---6589999999999975799980899818----956
Q ss_pred EEEECCCCCHH
Q ss_conf 99605689977
Q 001434 856 IYEYMERGSLG 866 (1078)
Q Consensus 856 v~e~~~~gsL~ 866 (1078)
|+||++|.++.
T Consensus 119 I~efi~g~~l~ 129 (395)
T d1nw1a_ 119 LEEYIPSRPLS 129 (395)
T ss_dssp EECCCCEEECC
T ss_pred EEEEECCCCCC
T ss_conf 99973455488
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=98.14 E-value=4.9e-07 Score=51.73 Aligned_cols=111 Identities=10% Similarity=0.033 Sum_probs=0.0
Q ss_pred CCCCCCCEEEECC-CCCCCC----CCCCCCCCCCCCEEEECCCCCC----CCCCCCCCCCCCCCEEECCCCCCC----CC
Q ss_conf 7544554665047-856677----8755567564543430133333----443421223223430112378888----85
Q 001434 267 GMLESLTEIVLWD-NQLTGF----IPSELGNCTKLQTLALYSNNLV----GQIPKEVGNLKFLTKLYLYRNELN----GT 333 (1078)
Q Consensus 267 ~~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~L~~n~l~----~~~p~~l~~l~~L~~L~L~~N~l~----~~ 333 (1078)
.+.++|++|+|++ +.++.. +...+...+.|+.|++++|.+. ..+...+...+.|++|+|++|.+. ..
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCEEECCCCCCCCC-------CCHHHHHHCCCCHHCCCCCC
Q ss_conf 475556766545784269878775-------21233320153301023552
Q 001434 334 IPREIGNLSMVTEIDLSENSLNGE-------IPTEFSKITGLRLLFLFQNQ 377 (1078)
Q Consensus 334 ~~~~l~~l~~L~~L~Ls~N~l~~~-------~~~~~~~l~~L~~L~L~~n~ 377 (1078)
+..++...+.|++|++++|.+... +...+...+.|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=98.11 E-value=2e-05 Score=42.85 Aligned_cols=157 Identities=11% Similarity=0.049 Sum_probs=81.0
Q ss_pred CCHHHHHHHHHCCCCCCE-----EECCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCC-----CCCC
Q ss_conf 886769997405877617-----702672599999978995999999434678851489999999998059-----9882
Q 001434 770 FSFQDVVEATYNFHDSFI-----VGSGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKI-----RHRN 839 (1078)
Q Consensus 770 ~~~~~~~~~~~~~~~~~~-----ig~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-----~h~~ 839 (1078)
.+.+++.....+|..+++ |..|...+.|.+...+| .|++|++....... .+..|...+..+ ..|.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~~~----~l~~~~~~l~~L~~~g~pvp~ 77 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVEKN----DLPFFLGLMQHLAAKGLSCPL 77 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC---CC----HHHHHHHHHHHHHHTTCCCCC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCC-CEEEEECCCCCCHH----HHHHHHHHHHHHHHCCCCCCC
T ss_conf 8999999999867999856852378885267389997897-28999807899988----999999998754302555455
Q ss_pred EEEEEE---EEEECCCEEEEEEECCCCCHHHH--------------HC----CCCC----CCC-----------------
Q ss_conf 554751---79845913899960568997767--------------30----7999----999-----------------
Q 001434 840 IVKLYG---FCYHQGSNLLIYEYMERGSLGEL--------------LH----GSSC----NLE----------------- 877 (1078)
Q Consensus 840 iv~l~~---~~~~~~~~~lv~e~~~~gsL~~~--------------l~----~~~~----~~~----------------- 877 (1078)
.+...+ +....+..+.++.+..|...... ++ .... ...
T Consensus 78 pi~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (316)
T d2ppqa1 78 PLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADE 157 (316)
T ss_dssp BCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGG
T ss_pred CCEECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHH
T ss_conf 64104897621341255024531146553332046788888998764544432024531011101200245677776531
Q ss_pred -HHHHHHHHHHHHHHHHHHH-CCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -6689999999996564542-06899669637887828978999669901145300
Q 001434 878 -WPTRFMIALGAAEGLAYLH-HDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 878 -~~~~~~i~~~i~~~L~~LH-~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 931 (1078)
.......+......+...+ ...+.|++|+|+.+.|++++++...-++||+.+..
T Consensus 158 ~~~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 158 VEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 14127999999987642048554545033378636564020454126742221236
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=98.01 E-value=0.00011 Score=38.90 Aligned_cols=137 Identities=15% Similarity=0.101 Sum_probs=75.6
Q ss_pred CCCCEEEEEEEECCCCEEEEEEECCCCCCCHHHHHHHHHHHHHCCCCC-----CCEEEEE--EEEEECCCEEEEEEECCC
Q ss_conf 267259999997899599999943467885148999999999805998-----8255475--179845913899960568
Q 001434 790 SGAYGTVYKAVMDSGKIVAVKKLASNREGNNIESSFRAEILTLGKIRH-----RNIVKLY--GFCYHQGSNLLIYEYMER 862 (1078)
Q Consensus 790 ~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~~iv~l~--~~~~~~~~~~lv~e~~~~ 862 (1078)
.+....||++..++|+.|++|....... ..+.+..|...+..+.. +..+..- ..+..++..+.++++++|
T Consensus 32 ~s~EN~vy~v~~~dg~~~VlK~~rp~~~---s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G 108 (325)
T d1zyla1 32 NSYENRVYQFQDEDRRRFVVKFYRPERW---TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG 108 (325)
T ss_dssp CCSSSEEEEECCTTCCCEEEEEECTTTS---CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred CCCCCEEEEEECCCCCEEEEEEECCCCC---CHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCC
T ss_conf 6612026999838999799998478778---8999999999999998559987875206898056653479999865277
Q ss_pred CCHH-----HHH---------C----CC----CCCCCH-------------------H---HHHHHHHHHHHHHHHH-HC
Q ss_conf 9977-----673---------0----79----999996-------------------6---8999999999656454-20
Q 001434 863 GSLG-----ELL---------H----GS----SCNLEW-------------------P---TRFMIALGAAEGLAYL-HH 897 (1078)
Q Consensus 863 gsL~-----~~l---------~----~~----~~~~~~-------------------~---~~~~i~~~i~~~L~~L-H~ 897 (1078)
..+. ... + .. +...+. . .....+..+...+... ..
T Consensus 109 ~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 188 (325)
T d1zyla1 109 RQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRE 188 (325)
T ss_dssp EECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCS
T ss_pred CCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCC
T ss_conf 68899999999998999999886303578655677897887665689998747699889899999999999999984545
Q ss_pred CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 6899669637887828978999669901145300
Q 001434 898 DCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKV 931 (1078)
Q Consensus 898 ~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 931 (1078)
....+++|+|+.+.||+++++ ..++||+-++.
T Consensus 189 ~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 189 DFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CCCCEEECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 687120247888042878389--35886520146
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.64 E-value=3.3e-06 Score=47.19 Aligned_cols=111 Identities=14% Similarity=0.129 Sum_probs=0.0
Q ss_pred CCCCCCCEEEECC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCCEEECCCCCCCCCCC--
Q ss_conf 6756454343013-333344----3421223223430112378888----8547555676654578426987877521--
Q 001434 291 GNCTKLQTLALYS-NNLVGQ----IPKEVGNLKFLTKLYLYRNELN----GTIPREIGNLSMVTEIDLSENSLNGEIP-- 359 (1078)
Q Consensus 291 ~~l~~L~~L~L~~-n~l~~~----~p~~l~~l~~L~~L~L~~N~l~----~~~~~~l~~l~~L~~L~Ls~N~l~~~~~-- 359 (1078)
.+.++|++|++++ +.++.. +...+...+.|++|++++|.+. ..+...+...+.++.+++++|.+.....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --HHHHHHCCCCH--HCCCCCCCCC----CCCCCCCCCCCCCEEECCCCC
Q ss_conf --23332015330--1023552567----889864224656716544742
Q 001434 360 --TEFSKITGLRL--LFLFQNQLTG----VIPNELSSLRNLTKLDLSINY 401 (1078)
Q Consensus 360 --~~~~~l~~L~~--L~L~~n~l~~----~~~~~l~~l~~L~~L~Ls~N~ 401 (1078)
..+...++|+. |+++.|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|